Citrus Sinensis ID: 012233
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 468 | 2.2.26 [Sep-21-2011] | |||||||
| Q96287 | 472 | Shaggy-related protein ki | yes | no | 0.993 | 0.985 | 0.805 | 0.0 | |
| O04160 | 468 | Shaggy-related protein ki | N/A | no | 0.972 | 0.972 | 0.778 | 0.0 | |
| Q8VZD5 | 410 | Shaggy-related protein ki | no | no | 0.861 | 0.982 | 0.779 | 0.0 | |
| Q40518 | 409 | Shaggy-related protein ki | N/A | no | 0.858 | 0.982 | 0.774 | 0.0 | |
| P43289 | 409 | Shaggy-related protein ki | no | no | 0.858 | 0.982 | 0.762 | 0.0 | |
| P51139 | 411 | Glycogen synthase kinase- | N/A | no | 0.854 | 0.973 | 0.766 | 0.0 | |
| P43288 | 405 | Shaggy-related protein ki | no | no | 0.850 | 0.982 | 0.772 | 0.0 | |
| P51137 | 411 | Glycogen synthase kinase- | N/A | no | 0.863 | 0.982 | 0.755 | 0.0 | |
| P51138 | 411 | Glycogen synthase kinase- | N/A | no | 0.850 | 0.968 | 0.762 | 0.0 | |
| O23145 | 431 | Shaggy-related protein ki | no | no | 0.920 | 1.0 | 0.677 | 0.0 |
| >sp|Q96287|KSG8_ARATH Shaggy-related protein kinase theta OS=Arabidopsis thaliana GN=ASK8 PE=2 SV=3 | Back alignment and function desciption |
|---|
Score = 790 bits (2041), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 377/468 (80%), Positives = 414/468 (88%), Gaps = 3/468 (0%)
Query: 1 MNVMRRLKSIASGRTSISSDPGGDSGIKRAKVDKELE-VNGEANLVERSASSLEQHMAST 59
MNVMRRLKSIASGRTSISSDPGGD +KRAK+D+E + + + V++++S E
Sbjct: 1 MNVMRRLKSIASGRTSISSDPGGDYALKRAKLDQENDNLCVDPMQVDQNSSCFEMKADVL 60
Query: 60 SLEPVASTSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDKDLEPSIVNGNGTEAG 119
S E VA TS V +E+ DQLP M EM+IRDE+N N +DKD+E ++VNG+GTE G
Sbjct: 61 SQESVAGTSNVPAV--SEKPVDDQLPDVMIEMKIRDERNANREDKDMETTVVNGSGTETG 118
Query: 120 QVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR 179
QVI TTVGGR+G+PKQTISYMA+RVVGTGSFGVVFQAKCLETG+ VAIKKVLQDKRYKNR
Sbjct: 119 QVITTTVGGRDGKPKQTISYMAQRVVGTGSFGVVFQAKCLETGEQVAIKKVLQDKRYKNR 178
Query: 180 ELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY 239
ELQIMRL +HPNVV L+H FFSTT+KDELYLNLVLEY+ ETVYR SKHYT+MNQH+PI++
Sbjct: 179 ELQIMRLQDHPNVVRLRHSFFSTTDKDELYLNLVLEYVPETVYRASKHYTKMNQHMPIIF 238
Query: 240 VQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISY 299
VQLYTYQICRALNYLH VVGVCHRDIKPQNLLVNP THQLKICDFGSAKMLVPGEPNISY
Sbjct: 239 VQLYTYQICRALNYLHRVVGVCHRDIKPQNLLVNPQTHQLKICDFGSAKMLVPGEPNISY 298
Query: 300 ICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTP 359
ICSRYYRAPELIFGATEYT AIDMWS GCV+AELLLGQPLFPGESG+DQLVEIIKILGTP
Sbjct: 299 ICSRYYRAPELIFGATEYTNAIDMWSGGCVMAELLLGQPLFPGESGIDQLVEIIKILGTP 358
Query: 360 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419
TREEI+CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEA+DLVSRLLQYSP+LRCTALEACA
Sbjct: 359 TREEIRCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACA 418
Query: 420 HPFFDDLRDPNTCLPNGRPLPTLFNFTAQELAGASNELRQRLIPEHAR 467
HPFFDDLRDPN LPNGR LP LFNFTAQELAGAS ELRQRLIP H +
Sbjct: 419 HPFFDDLRDPNVSLPNGRALPPLFNFTAQELAGASTELRQRLIPAHCQ 466
|
May mediate extracellular signals to regulate transcription in differentiating cells. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|O04160|KSGT_BRANA Shaggy-related protein kinase theta OS=Brassica napus PE=2 SV=2 | Back alignment and function description |
|---|
Score = 758 bits (1957), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 369/474 (77%), Positives = 403/474 (85%), Gaps = 19/474 (4%)
Query: 1 MNVMRRLKSIASGRTSISSDPGGDSGIKRAKVDKELEVNGEANLVERSASSLE----QHM 56
MNVMRRLKSIASGRTSISSDPG DS +KR K+D++ + NL R ++ M
Sbjct: 1 MNVMRRLKSIASGRTSISSDPGVDSSLKRPKLDQDND-----NLSSRGDDPMQVDQSTDM 55
Query: 57 ASTSLEPVASTSEAATVARTERSGFDQLPKEMNEMRIRDEK---NVNHDDKDLEPSIVNG 113
S + VA TS DQLP+ MN+MR+R+++ N +DKD+EP IVNG
Sbjct: 56 VVVSQDTVAGTSNVPPPP-------DQLPEVMNDMRLREDEPHANRGEEDKDMEPPIVNG 108
Query: 114 NGTEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD 173
GTE GQVI TTVGGR+G+PKQTISYMA+RVVGTGSFGVVFQAKCLETG+ VAIKKVLQD
Sbjct: 109 CGTETGQVITTTVGGRDGKPKQTISYMAQRVVGTGSFGVVFQAKCLETGEQVAIKKVLQD 168
Query: 174 KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQ 233
KRYKNRELQIMRL +HPNVV L+H FFSTT+KDELYLNLVLE++ ETVYR KHYT+MNQ
Sbjct: 169 KRYKNRELQIMRLQDHPNVVRLRHSFFSTTDKDELYLNLVLEFVPETVYRALKHYTKMNQ 228
Query: 234 HVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293
H+PI+ VQLYTYQICRALNYLH VVGVCHRDIKPQNLLVN HTHQLKICDFGSAKMLVPG
Sbjct: 229 HMPIILVQLYTYQICRALNYLHRVVGVCHRDIKPQNLLVNTHTHQLKICDFGSAKMLVPG 288
Query: 294 EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEII 353
EPNISYICSRYYRAPELIFGATEYT AIDMWS GCV+AELLLGQPLFPGESG+DQLVEII
Sbjct: 289 EPNISYICSRYYRAPELIFGATEYTNAIDMWSGGCVMAELLLGQPLFPGESGIDQLVEII 348
Query: 354 KILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCT 413
KILGTPTREEI+CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEA+DLVSRLLQYSP+LRCT
Sbjct: 349 KILGTPTREEIRCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT 408
Query: 414 ALEACAHPFFDDLRDPNTCLPNGRPLPTLFNFTAQELAGASNELRQRLIPEHAR 467
ALEACAHPFFDDLR PN LPNGR LP LFNFTAQELAGAS ELRQRLIP H +
Sbjct: 409 ALEACAHPFFDDLRAPNVSLPNGRALPPLFNFTAQELAGASTELRQRLIPAHCQ 462
|
May mediate extracellular signals to regulate transcription in differentiating cells. Brassica napus (taxid: 3708) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8VZD5|KSG5_ARATH Shaggy-related protein kinase epsilon OS=Arabidopsis thaliana GN=ASK5 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 682 bits (1760), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 322/413 (77%), Positives = 359/413 (86%), Gaps = 10/413 (2%)
Query: 56 MASTSLEPVASTSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDKDLEPSIVNGNG 115
MAS P +S AT ++LP+ +NEM+I+D DK++E ++V+GNG
Sbjct: 1 MASVGTLPASSM---ATKQSNASICAEKLPEGINEMKIKD-------DKEMEAAVVDGNG 50
Query: 116 TEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR 175
TE G +I TT+GG+NGQPKQTISYMAER+VG GSFG+VFQAKCLETG++VAIKKVLQDKR
Sbjct: 51 TETGHIIVTTIGGKNGQPKQTISYMAERIVGQGSFGIVFQAKCLETGETVAIKKVLQDKR 110
Query: 176 YKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHV 235
YKNRELQ MRLL+HPNVVSLKHCFFSTTEKDELYLNLVLEY+ ETVYRVSKHY+R NQ +
Sbjct: 111 YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVYRVSKHYSRANQRM 170
Query: 236 PILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEP 295
PI+YV+LYTYQICRAL Y+H VGVCHRDIKPQNLLVNPHTHQ+K+CDFGSAK+LV GEP
Sbjct: 171 PIIYVKLYTYQICRALAYIHGGVGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP 230
Query: 296 NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKI 355
NISYICSRYYRAPELIFGATEYTT ID+WS GCVLAELLLGQPLFPGESGVDQLVEIIK+
Sbjct: 231 NISYICSRYYRAPELIFGATEYTTTIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 290
Query: 356 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTAL 415
LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKR PPEA+DLVSRLLQYSP+LR TA+
Sbjct: 291 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRTPPEAVDLVSRLLQYSPNLRSTAM 350
Query: 416 EACAHPFFDDLRDPNTCLPNGRPLPTLFNFTAQELAGASNELRQRLIPEHARK 468
EA HPFFD+LRDPNT LPNGR LP LFNF QEL GAS EL +LIP+HARK
Sbjct: 351 EAIVHPFFDELRDPNTRLPNGRALPPLFNFKPQELKGASLELLSKLIPDHARK 403
|
May mediate extracellular signals to regulate transcription in differentiating cells. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q40518|MSK1_TOBAC Shaggy-related protein kinase NtK-1 OS=Nicotiana tabacum GN=NTK-1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 682 bits (1759), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 320/413 (77%), Positives = 360/413 (87%), Gaps = 11/413 (2%)
Query: 56 MASTSLEPVASTSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDKDLEPSIVNGNG 115
M S L PV+ E+++ G D+LP+EMN+MRIRD DK++E +IV+GNG
Sbjct: 1 MTSVGLAPVSGLRESSS----HSVGVDRLPEEMNDMRIRD-------DKEIEAAIVDGNG 49
Query: 116 TEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR 175
TE G +I TT+GGR+GQPKQTISYMAER+VG GSFGVVFQAKCLETG++VAIKKVLQDKR
Sbjct: 50 TETGHIIVTTIGGRHGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR 109
Query: 176 YKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHV 235
YKNRELQ MRLL+HPNVV LKHCFFSTTEKDE+YLNLVLEY+ ETV+RV KHY ++NQ +
Sbjct: 110 YKNRELQTMRLLDHPNVVCLKHCFFSTTEKDEVYLNLVLEYVPETVHRVIKHYNKLNQRM 169
Query: 236 PILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEP 295
P++ V+LYTYQI RAL+Y+HH +GVCHRDIKPQNLLVNPHTHQ+K+CDFGSAK+LV GEP
Sbjct: 170 PLILVKLYTYQIFRALSYIHHTIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP 229
Query: 296 NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKI 355
NISYICSRYYRAPELIFGATEYTTAID+WS GCVLAELLLGQPLFPGESGVDQLVEIIK+
Sbjct: 230 NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 289
Query: 356 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTAL 415
LGTPTREEIKCMNPNY EFKFPQIKAHPWHKIFHKRMPPEA+DLVSRLLQYSP+LRCTAL
Sbjct: 290 LGTPTREEIKCMNPNYNEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTAL 349
Query: 416 EACAHPFFDDLRDPNTCLPNGRPLPTLFNFTAQELAGASNELRQRLIPEHARK 468
EA H FFD+LRDPNT LPNGR LP LFNF A EL G S E +L+PEHARK
Sbjct: 350 EAVTHAFFDELRDPNTRLPNGRVLPPLFNFKAHELKGVSAENLLKLVPEHARK 402
|
May mediate extracellular signals to regulate transcription in differentiating cells. Nicotiana tabacum (taxid: 4097) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P43289|KSG3_ARATH Shaggy-related protein kinase gamma OS=Arabidopsis thaliana GN=ASK3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 671 bits (1730), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 315/413 (76%), Positives = 358/413 (86%), Gaps = 11/413 (2%)
Query: 56 MASTSLEPVASTSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDKDLEPSIVNGNG 115
MAS +EP A+ E+ + D+LP+EM +M+I+D DK++E +IVNGN
Sbjct: 1 MASVGIEPSAAVRESTG----NVTDADRLPEEMKDMKIQD-------DKEMEATIVNGNV 49
Query: 116 TEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR 175
TE G +I TT+GGRNGQPKQTISYMAERVVG GSFGVVFQAKCLETG++VAIKKVLQD+R
Sbjct: 50 TETGHIIVTTIGGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDRR 109
Query: 176 YKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHV 235
YKNRELQ MRLL+HPNVVSLKHCFFSTTEKDELYLNLVLEY+ ETV+RV KHY ++NQ +
Sbjct: 110 YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHYNKLNQRM 169
Query: 236 PILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEP 295
P++YV+LYTYQI R+L+Y+H +GVCHRDIKPQNLLVNPHTHQ+K+CDFGSAK+LV GEP
Sbjct: 170 PLVYVKLYTYQIFRSLSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP 229
Query: 296 NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKI 355
NISYICSRYYRAPELIFGATEYTTAID+WS GCVLAELLLGQPLFPGESGVDQLVEIIK+
Sbjct: 230 NISYICSRYYRAPELIFGATEYTTAIDVWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 289
Query: 356 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTAL 415
LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEA+DLVSRLLQYSP+LRC AL
Sbjct: 290 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCAAL 349
Query: 416 EACAHPFFDDLRDPNTCLPNGRPLPTLFNFTAQELAGASNELRQRLIPEHARK 468
++ HPFFD+LRDPN LPNGR LP LFNF EL G E+ +L+PEHARK
Sbjct: 350 DSLVHPFFDELRDPNARLPNGRFLPPLFNFKPHELKGVPVEMVAKLVPEHARK 402
|
May mediate extracellular signals to regulate transcription in differentiating cells. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P51139|MSK3_MEDSA Glycogen synthase kinase-3 homolog MsK-3 OS=Medicago sativa GN=MSK-3 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 671 bits (1730), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 319/416 (76%), Positives = 359/416 (86%), Gaps = 16/416 (3%)
Query: 56 MASTSLEPVAS--TSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDKDLEP-SIVN 112
MAS + P + A++V G ++LP+EMN+M+IRD DK++E +IV+
Sbjct: 1 MASGGVAPASGFIDKNASSV------GVEKLPEEMNDMKIRD-------DKEMEAATIVD 47
Query: 113 GNGTEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ 172
GNGTE G +I TT+GG+NGQPKQTISYMAERVVG GSFGVVFQAKCLETG++VAIKKVLQ
Sbjct: 48 GNGTETGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQ 107
Query: 173 DKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMN 232
DKRYKNRELQ MRLL+HPNVVSLKHCFFSTTEKDELYLNLVLEY+ ETV RV +HY +MN
Sbjct: 108 DKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVSRVIRHYNKMN 167
Query: 233 QHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292
Q +P++YV+LY+YQICRAL Y+H+ +GVCHRDIKPQNLLVNPHTHQLKICDFGSAK+LV
Sbjct: 168 QRMPMIYVKLYSYQICRALAYIHNSIGVCHRDIKPQNLLVNPHTHQLKICDFGSAKVLVK 227
Query: 293 GEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEI 352
GEPNISYICSRYYRAPELIFGATEYTTAID+WS GCVL ELLLGQPLFPGESGVDQLVEI
Sbjct: 228 GEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVLGELLLGQPLFPGESGVDQLVEI 287
Query: 353 IKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC 412
IK+LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEA+DLVSRLLQYSP+LR
Sbjct: 288 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRS 347
Query: 413 TALEACAHPFFDDLRDPNTCLPNGRPLPTLFNFTAQELAGASNELRQRLIPEHARK 468
TALEA HPF+DD+RDPNT LPNGR LP LFNF EL G E+ +L+P HARK
Sbjct: 348 TALEALVHPFYDDVRDPNTRLPNGRFLPPLFNFKVNELKGVPAEMLVKLVPPHARK 403
|
Medicago sativa (taxid: 3879) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P43288|KSG1_ARATH Shaggy-related protein kinase alpha OS=Arabidopsis thaliana GN=ASK1 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 670 bits (1728), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 313/405 (77%), Positives = 354/405 (87%), Gaps = 7/405 (1%)
Query: 64 VASTSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDKDLEPSIVNGNGTEAGQVIA 123
+AS A + +G D+LP+EMN+M+IRD DK++E ++V+GNGTE G +I
Sbjct: 1 MASVGIAPNPGARDSTGVDKLPEEMNDMKIRD-------DKEMEATVVDGNGTETGHIIV 53
Query: 124 TTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQI 183
TT+GGRNGQPKQTISYMAERVVG GSFGVVFQAKCLETG++VAIKKVLQD+RYKNRELQ
Sbjct: 54 TTIGGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDRRYKNRELQT 113
Query: 184 MRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLY 243
MRLL+HPNVVSLKHCFFSTTEKDELYLNLVLEY+ ETV+RV KHY ++NQ +P++YV+LY
Sbjct: 114 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHYNKLNQRMPLIYVKLY 173
Query: 244 TYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSR 303
TYQI RAL+Y+H +GVCHRDIKPQNLLVNPHTHQ+K+CDFGSAK+LV GEPNISYICSR
Sbjct: 174 TYQIFRALSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR 233
Query: 304 YYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREE 363
YYRAPELIFGATEYTTAID+WS GCVLAELLLGQPLFPGESGVDQLVEIIK+LGTPTREE
Sbjct: 234 YYRAPELIFGATEYTTAIDVWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 293
Query: 364 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEA+DLVSRLLQYSP+LR AL+ HPFF
Sbjct: 294 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRSAALDTLVHPFF 353
Query: 424 DDLRDPNTCLPNGRPLPTLFNFTAQELAGASNELRQRLIPEHARK 468
D+LRDPN LPNGR LP LFNF EL G E+ +L+PEHARK
Sbjct: 354 DELRDPNARLPNGRFLPPLFNFKPHELKGVPLEMVAKLVPEHARK 398
|
May mediate extracellular signals to regulate transcription in differentiating cells. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P51137|MSK1_MEDSA Glycogen synthase kinase-3 homolog MsK-1 OS=Medicago sativa GN=MSK-1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 661 bits (1706), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 312/413 (75%), Positives = 354/413 (85%), Gaps = 9/413 (2%)
Query: 56 MASTSLEPVASTSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDKDLEPSIVNGNG 115
MAS + P + E + E D LP+EM++M+IRD D+++E ++V+GNG
Sbjct: 1 MASVGVAPTSGFREV--LGDGEIGVDDILPEEMSDMKIRD-------DREMEATVVDGNG 51
Query: 116 TEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR 175
TE G +I TT+GGRNGQPKQTISYMAERVVG GSFGVVFQAKCLETG++VAIKKVLQDKR
Sbjct: 52 TETGHIIVTTIGGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDKR 111
Query: 176 YKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHV 235
YKNRELQ MRLL+HPNVVSLKHCFFSTTEKDELYLNLVLEY+ ETV+RV KHY+++NQ +
Sbjct: 112 YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHYSKLNQRM 171
Query: 236 PILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEP 295
P++YV+LYTYQI RAL+Y+H +GVCHRDIKPQNLLVNPHTHQ+K+CDFGSAK+LV GEP
Sbjct: 172 PMIYVKLYTYQIFRALSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP 231
Query: 296 NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKI 355
NISYICSRYYRAPELIFGATEYTTAID+WS+GCVLAELLLGQPLFPGE GVDQLVEIIK+
Sbjct: 232 NISYICSRYYRAPELIFGATEYTTAIDVWSVGCVLAELLLGQPLFPGERGVDQLVEIIKV 291
Query: 356 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTAL 415
LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMP EA+DLVSRLLQYSP+LRC AL
Sbjct: 292 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPAEAVDLVSRLLQYSPNLRCQAL 351
Query: 416 EACAHPFFDDLRDPNTCLPNGRPLPTLFNFTAQELAGASNELRQRLIPEHARK 468
+ HPFFD+LRDPN LP GR LP LFNF EL G E +L+PEHARK
Sbjct: 352 DCLTHPFFDELRDPNARLPTGRFLPPLFNFKPHELKGVPVETLMKLVPEHARK 404
|
Medicago sativa (taxid: 3879) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P51138|MSK2_MEDSA Glycogen synthase kinase-3 homolog MsK-2 OS=Medicago sativa GN=MSK-2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 659 bits (1701), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 309/405 (76%), Positives = 348/405 (85%), Gaps = 7/405 (1%)
Query: 64 VASTSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDKDLEPSIVNGNGTEAGQVIA 123
VA S V + D+LP E+ MRI+D DK++E +V+GN TEAG VI
Sbjct: 6 VAPASGIVDVNASSAIAVDKLPDEILGMRIKD-------DKEMEAHVVDGNSTEAGHVIV 58
Query: 124 TTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQI 183
TT+GG+NGQPKQTISYMAER VG GSFGVVFQAKCLETG++VAIKKVLQDKRYKNRELQ
Sbjct: 59 TTIGGKNGQPKQTISYMAERAVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQT 118
Query: 184 MRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLY 243
MRLL+HPNVV+LKHCFFSTTEKDELYLNLVLE++ ETV+RV +HY++MNQ +P++YV+LY
Sbjct: 119 MRLLDHPNVVTLKHCFFSTTEKDELYLNLVLEFVPETVHRVIRHYSKMNQRMPLIYVKLY 178
Query: 244 TYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSR 303
+YQICR+L Y+H+ VGV HRDIKPQNLLVNPHTHQLK+CDFGSAK+LV GEPNISYICSR
Sbjct: 179 SYQICRSLAYIHNCVGVSHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 238
Query: 304 YYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREE 363
YYRAPELIFGATEYT+AID+WS GCVL ELLLGQPLFPG SGVDQLVEIIK+LGTPTREE
Sbjct: 239 YYRAPELIFGATEYTSAIDIWSAGCVLGELLLGQPLFPGASGVDQLVEIIKVLGTPTREE 298
Query: 364 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
IKCMNPNYTEFKFPQIKAHPWHKIF KRMPPEA+DLVSRLLQYSP+LR TALEA HPFF
Sbjct: 299 IKCMNPNYTEFKFPQIKAHPWHKIFRKRMPPEAVDLVSRLLQYSPNLRSTALEALVHPFF 358
Query: 424 DDLRDPNTCLPNGRPLPTLFNFTAQELAGASNELRQRLIPEHARK 468
D+LRDPNT LPNGR LP LFNF A EL G E+ +L+P HARK
Sbjct: 359 DELRDPNTRLPNGRHLPPLFNFKANELKGVPAEMLVKLVPSHARK 403
|
Medicago sativa (taxid: 3879) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O23145|KSG2_ARATH Shaggy-related protein kinase beta OS=Arabidopsis thaliana GN=ASK2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 653 bits (1684), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 317/468 (67%), Positives = 365/468 (77%), Gaps = 37/468 (7%)
Query: 1 MNVMRRLKSIASGRTSISSDPGGDSGIKRAKVDKELEVNGEANLVERSASSLEQHMASTS 60
MNV+RRL SIASGR +SSD G++ R+K ++ +
Sbjct: 1 MNVVRRLTSIASGRNFVSSDNVGETETPRSKPNQN---------------------REET 39
Query: 61 LEPVASTSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDKDLEPSIVNGNGTEAGQ 120
++ E +V+ +E S D LPKE+ E D++ I+ GNGTE+G+
Sbjct: 40 ESTETTSYEKDSVSSSENS--DHLPKEIRE--------------DMDCGIIKGNGTESGR 83
Query: 121 VIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRE 180
+I T G N Q +TISY AE V+GTGSFGVVFQAKCLET + VAIKKVLQDKRYKNRE
Sbjct: 84 IITTKKKGLNDQKDKTISYRAEHVIGTGSFGVVFQAKCLETEEKVAIKKVLQDKRYKNRE 143
Query: 181 LQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYV 240
LQIMR+L+HPNVV LKH FFSTTEKDELYLNLVLEY+ ET+YR S+ YT+MNQH+P++Y+
Sbjct: 144 LQIMRMLDHPNVVELKHSFFSTTEKDELYLNLVLEYVPETIYRASRSYTKMNQHMPLIYI 203
Query: 241 QLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYI 300
QLYTYQICRA+NYLH VVGVCHRDIKPQNLLVN TH++KICDFGSAKML+PGEPNISYI
Sbjct: 204 QLYTYQICRAMNYLHQVVGVCHRDIKPQNLLVNNVTHEVKICDFGSAKMLIPGEPNISYI 263
Query: 301 CSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPT 360
CSRYYRAPELIFGATEYT+AIDMWS+GCV+AEL LG PLFPGE+ VDQLVEIIKILGTP
Sbjct: 264 CSRYYRAPELIFGATEYTSAIDMWSVGCVMAELFLGHPLFPGETSVDQLVEIIKILGTPA 323
Query: 361 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420
REEIK MNP Y +FKFPQIKA PWHKIF +++ PEA+DL SRLLQYSP+LRCTALEACAH
Sbjct: 324 REEIKNMNPRYNDFKFPQIKAQPWHKIFRRQVSPEAMDLASRLLQYSPNLRCTALEACAH 383
Query: 421 PFFDDLRDPNTCLPNGRPLPTLFNFTAQELAGASNELRQRLIPEHARK 468
PFFDDLRDP LPNGR LP LF+FTAQELAGAS ELR RLIPEHARK
Sbjct: 384 PFFDDLRDPRASLPNGRALPPLFDFTAQELAGASVELRHRLIPEHARK 431
|
May mediate extracellular signals to regulate transcription in differentiating cells. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 468 | ||||||
| 255541478 | 474 | Glycogen synthase kinase-3 beta, putativ | 1.0 | 0.987 | 0.847 | 0.0 | |
| 449454478 | 469 | PREDICTED: shaggy-related protein kinase | 0.995 | 0.993 | 0.850 | 0.0 | |
| 449522286 | 469 | PREDICTED: shaggy-related protein kinase | 0.995 | 0.993 | 0.850 | 0.0 | |
| 225453724 | 468 | PREDICTED: shaggy-related protein kinase | 0.995 | 0.995 | 0.831 | 0.0 | |
| 356520459 | 470 | PREDICTED: shaggy-related protein kinase | 0.997 | 0.993 | 0.801 | 0.0 | |
| 356504991 | 470 | PREDICTED: shaggy-related protein kinase | 0.997 | 0.993 | 0.795 | 0.0 | |
| 224130108 | 438 | predicted protein [Populus trichocarpa] | 0.927 | 0.990 | 0.862 | 0.0 | |
| 62857012 | 467 | Ser/Thr protein kinase [Lotus japonicus] | 0.991 | 0.993 | 0.791 | 0.0 | |
| 1617200 | 471 | NSK6 [Nicotiana tabacum] | 0.997 | 0.991 | 0.790 | 0.0 | |
| 297810099 | 472 | hypothetical protein ARALYDRAFT_490498 [ | 0.993 | 0.985 | 0.803 | 0.0 |
| >gi|255541478|ref|XP_002511803.1| Glycogen synthase kinase-3 beta, putative [Ricinus communis] gi|223548983|gb|EEF50472.1| Glycogen synthase kinase-3 beta, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 847 bits (2188), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 399/471 (84%), Positives = 434/471 (92%), Gaps = 3/471 (0%)
Query: 1 MNVMRRLKSIASGRTSISSDPGGDSGIKRAKVDKELE--VNGEANLVERSASSLEQHMAS 58
MN+MRRLKSIASGRTSISSDPGGDS KR KVD+E E ++GE ER+A+ LEQHMAS
Sbjct: 1 MNMMRRLKSIASGRTSISSDPGGDSLTKRVKVDQETEQKIDGEVYSDERNATGLEQHMAS 60
Query: 59 TSLEPVASTSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDKDLEPSIVNGNGTEA 118
TSLE ASTS +A+V +TE+SGFDQLPKEM+EMRI+D+K +HD+KD+E +IV+G GTE
Sbjct: 61 TSLENPASTSNSASVVKTEKSGFDQLPKEMHEMRIKDDKTTSHDEKDMEAAIVSGTGTET 120
Query: 119 GQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN 178
G +IATT+GGRNGQPKQTIS+MAERVVGTGSFGVV+QAKCLETG++VAIKKVLQD+RYKN
Sbjct: 121 GHIIATTLGGRNGQPKQTISFMAERVVGTGSFGVVYQAKCLETGEAVAIKKVLQDRRYKN 180
Query: 179 RELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMN-QHVPI 237
RELQIMRLL HPNVV LKHCF STTEKDELYLNLVLEYI ETVYRVS+HY +MN QH+PI
Sbjct: 181 RELQIMRLLGHPNVVELKHCFISTTEKDELYLNLVLEYIPETVYRVSRHYNKMNHQHMPI 240
Query: 238 LYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI 297
+YVQLY YQICR L+YLHHVVGVCHRDIKPQNLLVNP TH+LKICDFGSAKMLVPGEPNI
Sbjct: 241 IYVQLYAYQICRGLSYLHHVVGVCHRDIKPQNLLVNPQTHELKICDFGSAKMLVPGEPNI 300
Query: 298 SYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILG 357
SYICSRYYRAPELIFGAT YT AIDMWS GCVLAELLLGQPLFPGESGVDQLVEIIK+LG
Sbjct: 301 SYICSRYYRAPELIFGATTYTNAIDMWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 360
Query: 358 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEA 417
TPTREEIKCMNPNYTEFKFPQIKAHPWHK+FHKRMPPEA+DLVSRLLQYSP+LRCTALEA
Sbjct: 361 TPTREEIKCMNPNYTEFKFPQIKAHPWHKLFHKRMPPEAVDLVSRLLQYSPNLRCTALEA 420
Query: 418 CAHPFFDDLRDPNTCLPNGRPLPTLFNFTAQELAGASNELRQRLIPEHARK 468
CAHPFFDDLRDPN CLPNGR LP LFNFTAQELAGAS ELRQRLIPEHARK
Sbjct: 421 CAHPFFDDLRDPNACLPNGRALPPLFNFTAQELAGASAELRQRLIPEHARK 471
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449454478|ref|XP_004144981.1| PREDICTED: shaggy-related protein kinase theta-like [Cucumis sativus] gi|449473157|ref|XP_004153803.1| PREDICTED: shaggy-related protein kinase theta-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 834 bits (2155), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 399/469 (85%), Positives = 436/469 (92%), Gaps = 3/469 (0%)
Query: 1 MNVMRRLKSIASGRTSISSDPGGDSGIKRAKVDKELE--VNGEANLVERSASSLEQHMAS 58
MN+MRRLKSIASGRTSISSDPGGD GIKRAKVD+E E V G ++ V R+AS L +S
Sbjct: 1 MNMMRRLKSIASGRTSISSDPGGDFGIKRAKVDQETEQKVGGVSDDVGRAASGLGLDSSS 60
Query: 59 TSLEPVASTSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDKDLEPSIVNGNGTEA 118
+SL+ VASTS +++A E+SGFD LP+EM EMRI+DEK+ NHD+KDLEP++VNGNGTEA
Sbjct: 61 SSLDNVASTSNISSIAGAEKSGFDHLPREMREMRIKDEKS-NHDEKDLEPAVVNGNGTEA 119
Query: 119 GQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN 178
GQ+IATTVGGRNG+PKQTISYMAERVVGTGSFGVVFQAKCLET ++VAIKKVLQDKRYKN
Sbjct: 120 GQIIATTVGGRNGKPKQTISYMAERVVGTGSFGVVFQAKCLETNEAVAIKKVLQDKRYKN 179
Query: 179 RELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPIL 238
RELQIMR+L+H N+V LKHCFFSTT+KDELYLNLVLEYISETVY+VSKHY RMN+ +PI+
Sbjct: 180 RELQIMRMLDHSNIVQLKHCFFSTTDKDELYLNLVLEYISETVYKVSKHYIRMNRSMPII 239
Query: 239 YVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS 298
YVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML+PGEPNIS
Sbjct: 240 YVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLMPGEPNIS 299
Query: 299 YICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGT 358
YICSRYYRAPELIFGATEYT AIDMWS+GCV+AELLLGQPLFPGESGVDQLVEIIKILGT
Sbjct: 300 YICSRYYRAPELIFGATEYTNAIDMWSVGCVMAELLLGQPLFPGESGVDQLVEIIKILGT 359
Query: 359 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEAC 418
PTREEIKCMNPNYTEFKFPQIKAHPWHKIFH RMP EA+DLVSRLLQYSP+LRCTALEAC
Sbjct: 360 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHMRMPVEAIDLVSRLLQYSPNLRCTALEAC 419
Query: 419 AHPFFDDLRDPNTCLPNGRPLPTLFNFTAQELAGASNELRQRLIPEHAR 467
AHPFFDDLRDPN CLPNG+ LP LFNFTAQELAGAS ELRQRLIPEHA+
Sbjct: 420 AHPFFDDLRDPNACLPNGQALPPLFNFTAQELAGASTELRQRLIPEHAQ 468
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449522286|ref|XP_004168158.1| PREDICTED: shaggy-related protein kinase theta-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 833 bits (2153), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 399/469 (85%), Positives = 435/469 (92%), Gaps = 3/469 (0%)
Query: 1 MNVMRRLKSIASGRTSISSDPGGDSGIKRAKVDKELE--VNGEANLVERSASSLEQHMAS 58
MN+MRRLKSIASGRTSISSDPGGD GIKRAKVD+E E V G ++ V R+AS L +S
Sbjct: 1 MNMMRRLKSIASGRTSISSDPGGDFGIKRAKVDQETEQKVGGVSDDVGRAASGLGLDSSS 60
Query: 59 TSLEPVASTSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDKDLEPSIVNGNGTEA 118
+SL+ VASTS +++A E+SGFD LP+EM EMRI+DEK+ NHD+KDLEP++VNGNGTEA
Sbjct: 61 SSLDNVASTSNISSIAGAEKSGFDHLPREMREMRIKDEKS-NHDEKDLEPAVVNGNGTEA 119
Query: 119 GQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN 178
GQ+IATTVGGRNG+PKQTISYMAERVVGTGSFGVVFQAKCLET ++VAIKKVLQDKRYKN
Sbjct: 120 GQIIATTVGGRNGKPKQTISYMAERVVGTGSFGVVFQAKCLETNEAVAIKKVLQDKRYKN 179
Query: 179 RELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPIL 238
RELQIMR+L H N+V LKHCFFSTT+KDELYLNLVLEYISETVY+VSKHY RMN+ +PI+
Sbjct: 180 RELQIMRMLEHSNIVQLKHCFFSTTDKDELYLNLVLEYISETVYKVSKHYIRMNRSMPII 239
Query: 239 YVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS 298
YVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML+PGEPNIS
Sbjct: 240 YVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLMPGEPNIS 299
Query: 299 YICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGT 358
YICSRYYRAPELIFGATEYT AIDMWS+GCV+AELLLGQPLFPGESGVDQLVEIIKILGT
Sbjct: 300 YICSRYYRAPELIFGATEYTNAIDMWSVGCVMAELLLGQPLFPGESGVDQLVEIIKILGT 359
Query: 359 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEAC 418
PTREEIKCMNPNYTEFKFPQIKAHPWHKIFH RMP EA+DLVSRLLQYSP+LRCTALEAC
Sbjct: 360 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHMRMPVEAIDLVSRLLQYSPNLRCTALEAC 419
Query: 419 AHPFFDDLRDPNTCLPNGRPLPTLFNFTAQELAGASNELRQRLIPEHAR 467
AHPFFDDLRDPN CLPNG+ LP LFNFTAQELAGAS ELRQRLIPEHA+
Sbjct: 420 AHPFFDDLRDPNACLPNGQALPPLFNFTAQELAGASTELRQRLIPEHAQ 468
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225453724|ref|XP_002272112.1| PREDICTED: shaggy-related protein kinase theta isoform 1 [Vitis vinifera] gi|296089061|emb|CBI38764.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 832 bits (2148), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 391/470 (83%), Positives = 433/470 (92%), Gaps = 4/470 (0%)
Query: 1 MNVMRRLKSIASGRTSISSDPGGDSGIKRAKVDKELE--VNGEANLVERSASSLEQHMAS 58
MNVMRRLKSIASGR+S+S DPGGDS KRAKVD+E E V E + VE+S +SLEQHMAS
Sbjct: 1 MNVMRRLKSIASGRSSVS-DPGGDSSTKRAKVDQEAEQKVADETHSVEKS-TSLEQHMAS 58
Query: 59 TSLEPVASTSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDKDLEPSIVNGNGTEA 118
TS E ASTS +++ARTE+SG+DQLPKEM++M+IRDEK HDDKD EP++V+G+GTE
Sbjct: 59 TSQETAASTSNVSSIARTEQSGYDQLPKEMHDMKIRDEKVDPHDDKDAEPTVVSGSGTET 118
Query: 119 GQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN 178
GQ+IATT+GGRNGQPKQT+SYMAERVVGTGSFGVVFQAKCLETG++VAIKKVLQDKRYKN
Sbjct: 119 GQIIATTIGGRNGQPKQTVSYMAERVVGTGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN 178
Query: 179 RELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPIL 238
RELQIMR+L+HPNVV LKHCFFST+EKD +YLNLVLEY+SETVYRVS+H++RMNQH+PI+
Sbjct: 179 RELQIMRVLDHPNVVQLKHCFFSTSEKDVVYLNLVLEYVSETVYRVSRHHSRMNQHMPII 238
Query: 239 YVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS 298
YVQLY YQICRALNY+H V+GVCHRDIKPQNLLVNP THQLKICDFGSAK LVPGEPNIS
Sbjct: 239 YVQLYAYQICRALNYMHSVIGVCHRDIKPQNLLVNPQTHQLKICDFGSAKKLVPGEPNIS 298
Query: 299 YICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGT 358
YICSRYYRAPELIFGATEYTTAIDMWS GCV+AELLLGQPLFPGESGVDQLVEIIKILGT
Sbjct: 299 YICSRYYRAPELIFGATEYTTAIDMWSAGCVVAELLLGQPLFPGESGVDQLVEIIKILGT 358
Query: 359 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEAC 418
PTREEIKCMNPNY EFKFPQIKAHPWHK+FHKRMPPEA+DLVSRLLQYSP+LRCTALEAC
Sbjct: 359 PTREEIKCMNPNYNEFKFPQIKAHPWHKLFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC 418
Query: 419 AHPFFDDLRDPNTCLPNGRPLPTLFNFTAQELAGASNELRQRLIPEHARK 468
AH FFDDLR+ N CLPNGRPLP LFNFT QEL ++ ELRQRLIPEHARK
Sbjct: 419 AHHFFDDLRETNACLPNGRPLPPLFNFTPQELVHSTPELRQRLIPEHARK 468
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356520459|ref|XP_003528879.1| PREDICTED: shaggy-related protein kinase theta-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 812 bits (2097), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 376/469 (80%), Positives = 423/469 (90%), Gaps = 2/469 (0%)
Query: 1 MNVMRRLKSIASGRTSISSDPGGDSGIKRAKVDKELE--VNGEANLVERSASSLEQHMAS 58
MN+MRRLKSIASGRTSISSDPGGDS KRAK + E E + + N +E + EQ + +
Sbjct: 1 MNMMRRLKSIASGRTSISSDPGGDSNSKRAKFEPETEGKADEKTNTIETICTDQEQPIDT 60
Query: 59 TSLEPVASTSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDKDLEPSIVNGNGTEA 118
+ TS+ +TVARTE+SGFD+LPKE+NEM+IRDEK+ N+++KD+E ++V+GNGTE
Sbjct: 61 SKETSNVGTSDVSTVARTEKSGFDELPKELNEMKIRDEKSKNNNEKDIEATVVSGNGTET 120
Query: 119 GQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN 178
GQ+I T +GGR+GQPKQTISYMAERVVGTGSFGVVFQAKCLETG+SVAIKKVLQD+RYKN
Sbjct: 121 GQIITTAIGGRDGQPKQTISYMAERVVGTGSFGVVFQAKCLETGESVAIKKVLQDRRYKN 180
Query: 179 RELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPIL 238
RELQ+MR ++HPNVV LKH FFSTT+KDELYLNLVLEY+ ETVY+VSKHY RM+QH+PI+
Sbjct: 181 RELQVMRTVDHPNVVKLKHYFFSTTDKDELYLNLVLEYVPETVYKVSKHYVRMHQHMPII 240
Query: 239 YVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS 298
YVQLYTYQICRALNYLH V+GVCHRDIKPQNLLVNP THQLKICDFGSAK+LVPGEPNIS
Sbjct: 241 YVQLYTYQICRALNYLHQVIGVCHRDIKPQNLLVNPQTHQLKICDFGSAKVLVPGEPNIS 300
Query: 299 YICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGT 358
YICSRYYRAPELIFGATEYT AIDMWS+GCVLAELLLGQPLFPGESGVDQLVEIIK+LGT
Sbjct: 301 YICSRYYRAPELIFGATEYTIAIDMWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 360
Query: 359 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEAC 418
PTREEI+CMNPNY EFKFPQIKAHPWHK+FHKRMPPEA+DLVSRLLQYSP+LRCTAL AC
Sbjct: 361 PTREEIRCMNPNYNEFKFPQIKAHPWHKVFHKRMPPEAVDLVSRLLQYSPNLRCTALAAC 420
Query: 419 AHPFFDDLRDPNTCLPNGRPLPTLFNFTAQELAGASNELRQRLIPEHAR 467
AHPFF+DLRDPN CLPNGRPLP LFNFT+QELA A ELRQRLIPEHAR
Sbjct: 421 AHPFFNDLRDPNACLPNGRPLPPLFNFTSQELANAPEELRQRLIPEHAR 469
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356504991|ref|XP_003521276.1| PREDICTED: shaggy-related protein kinase theta [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 805 bits (2078), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 373/469 (79%), Positives = 420/469 (89%), Gaps = 2/469 (0%)
Query: 1 MNVMRRLKSIASGRTSISSDPGGDSGIKRAKVDKELEVNGE--ANLVERSASSLEQHMAS 58
MN+MRRLKSIASGRTSISSDPGGDS KRAK + E EV + N E + EQ + +
Sbjct: 1 MNMMRRLKSIASGRTSISSDPGGDSNSKRAKFEPETEVKADEKTNTTETICTDQEQLIDT 60
Query: 59 TSLEPVASTSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDKDLEPSIVNGNGTEA 118
+ TS+ +TVARTE+SGF++LPKE+NEM+IRDEK+ N+ +KD+E ++V+GNGTE
Sbjct: 61 SKETSNVGTSDVSTVARTEKSGFEELPKELNEMKIRDEKSKNNSEKDIEATVVSGNGTET 120
Query: 119 GQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN 178
GQ+I T +GGR+GQPKQTISYMAERVVGTGSFG+VFQAKCLETG+SVAIKKVLQD+RYKN
Sbjct: 121 GQIITTAIGGRDGQPKQTISYMAERVVGTGSFGIVFQAKCLETGESVAIKKVLQDRRYKN 180
Query: 179 RELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPIL 238
RELQ+MR +++ NVV LKH FFSTT+KDELYLNLVLEY+ ETVY+VSKHY RM+QH+PI+
Sbjct: 181 RELQVMRTVDNSNVVKLKHYFFSTTDKDELYLNLVLEYVPETVYKVSKHYVRMHQHMPII 240
Query: 239 YVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS 298
YVQLYTYQICRALNYLH V+GVCHRDIKPQNLLVN THQLKICDFGSAK+LVPGEPNIS
Sbjct: 241 YVQLYTYQICRALNYLHQVIGVCHRDIKPQNLLVNTQTHQLKICDFGSAKVLVPGEPNIS 300
Query: 299 YICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGT 358
YICSRYYRAPELIFGATEYTTAIDMWS+GCVLAELLLGQPLFPGESG+DQLVEIIKILGT
Sbjct: 301 YICSRYYRAPELIFGATEYTTAIDMWSVGCVLAELLLGQPLFPGESGIDQLVEIIKILGT 360
Query: 359 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEAC 418
PTREEI+CMNPNY EFKFPQIKAHPWHK+FHKRMPPEA+DLVSRLLQYSP+LRCTAL AC
Sbjct: 361 PTREEIRCMNPNYNEFKFPQIKAHPWHKVFHKRMPPEAVDLVSRLLQYSPNLRCTALAAC 420
Query: 419 AHPFFDDLRDPNTCLPNGRPLPTLFNFTAQELAGASNELRQRLIPEHAR 467
AHPFFDDLRDPN CLPNGRPLP LFNFT+QELA A ELRQRLIPE+AR
Sbjct: 421 AHPFFDDLRDPNACLPNGRPLPPLFNFTSQELANAPEELRQRLIPEYAR 469
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224130108|ref|XP_002320754.1| predicted protein [Populus trichocarpa] gi|222861527|gb|EEE99069.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 803 bits (2075), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 375/435 (86%), Positives = 405/435 (93%), Gaps = 1/435 (0%)
Query: 35 ELEVNGEANLVERSASSLEQHMASTSLEPVASTSEAATVARTERSGFDQLPKEMNEMRIR 94
E +++GE+ LVERS + EQHMASTS E AS S +V RTE+ G+DQLPKEM+EM+IR
Sbjct: 2 EQKIDGESYLVERSVTEQEQHMASTSQENAASASNVTSVTRTEKPGYDQLPKEMHEMKIR 61
Query: 95 DEKNVNHDDKDLEPSIVNGNGTEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVF 154
D+KN NHD+KD+E +IV+GNGTE GQ+IATTVGGRNGQPKQ ISYMAERVVGTGSFGVV+
Sbjct: 62 DDKNTNHDEKDMEAAIVSGNGTETGQIIATTVGGRNGQPKQIISYMAERVVGTGSFGVVY 121
Query: 155 QAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214
QAKCLETG++VAIKKVLQDKRYKNRELQIMRLL+HPNVV LKHCF+STTEKDELYLNLVL
Sbjct: 122 QAKCLETGEAVAIKKVLQDKRYKNRELQIMRLLDHPNVVQLKHCFYSTTEKDELYLNLVL 181
Query: 215 EYISETVYRVSKHYTRMNQ-HVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVN 273
EYISETV+RVS+H+ RMNQ H PILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVN
Sbjct: 182 EYISETVHRVSRHFNRMNQQHTPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVN 241
Query: 274 PHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAEL 333
PHTHQLKICDFGSAKMLVPGE NISYICSRYYRAPELIFGATEYTTAID+WS+GCVLAEL
Sbjct: 242 PHTHQLKICDFGSAKMLVPGETNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAEL 301
Query: 334 LLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMP 393
LLG PLFPGESGVDQLVEIIK+LGTPTREEIKCMNPNYTEFKFPQIK HPW+KIFHKRMP
Sbjct: 302 LLGHPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKTHPWYKIFHKRMP 361
Query: 394 PEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNTCLPNGRPLPTLFNFTAQELAGA 453
PEA+DLVSRLLQYSP+LRCTALEACAHPFFDDLRD N CLPNGR LP LFNFTAQELAGA
Sbjct: 362 PEAVDLVSRLLQYSPNLRCTALEACAHPFFDDLRDANACLPNGRALPPLFNFTAQELAGA 421
Query: 454 SNELRQRLIPEHARK 468
S ELRQRLIPEHARK
Sbjct: 422 SAELRQRLIPEHARK 436
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|62857012|dbj|BAD95891.1| Ser/Thr protein kinase [Lotus japonicus] | Back alignment and taxonomy information |
|---|
Score = 794 bits (2050), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 371/469 (79%), Positives = 421/469 (89%), Gaps = 5/469 (1%)
Query: 1 MNVMRRLKSIASGRTSISSDPGGDSGIKRAKVDKELE--VNGEANLVERSASSLEQHMAS 58
MN+MRRLKSIASGRTSISSDPGGDS KRAK+D+E E VN E + EQH+
Sbjct: 1 MNMMRRLKSIASGRTSISSDPGGDSNSKRAKLDQETEKKVNEETKTL--GGKDQEQHV-D 57
Query: 59 TSLEPVASTSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDKDLEPSIVNGNGTEA 118
S E TS+ +TVA+TE+SGFD+LPKE++EM+I+DEK+ N+++KD+E SIV+GNGTE
Sbjct: 58 ASKESTVGTSDVSTVAKTEKSGFDELPKELHEMKIKDEKSKNNNEKDIEASIVSGNGTET 117
Query: 119 GQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN 178
GQ+I T +GGR+GQPKQTISYMAERVVGTGSFGVVFQAKCLETG++VAIKKVLQDKRYKN
Sbjct: 118 GQIITTAIGGRDGQPKQTISYMAERVVGTGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN 177
Query: 179 RELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPIL 238
RELQ+MR ++HPN+V LKHCFFSTT+KDELYLNLVLE++ ETVY+VSK Y R++QH+PI+
Sbjct: 178 RELQVMRTVDHPNIVKLKHCFFSTTDKDELYLNLVLEFVPETVYKVSKQYIRVHQHMPII 237
Query: 239 YVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS 298
YVQLY YQICRALNYLH V+GVCHRDIKPQNLLVNP THQLKICDFGSAKMLVPGEPNIS
Sbjct: 238 YVQLYIYQICRALNYLHQVIGVCHRDIKPQNLLVNPQTHQLKICDFGSAKMLVPGEPNIS 297
Query: 299 YICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGT 358
YICSRYYRAPELIFGATEYTTAIDMWS+GCVLAELLLG PLFPGESGVDQLVEIIK+LGT
Sbjct: 298 YICSRYYRAPELIFGATEYTTAIDMWSVGCVLAELLLGHPLFPGESGVDQLVEIIKVLGT 357
Query: 359 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEAC 418
PTREEI+CMNP+Y EFKFPQIKAHPWHK+F+KRMPPEA+DLVSRLLQYSP+LRCTAL AC
Sbjct: 358 PTREEIRCMNPHYNEFKFPQIKAHPWHKVFYKRMPPEAVDLVSRLLQYSPNLRCTALAAC 417
Query: 419 AHPFFDDLRDPNTCLPNGRPLPTLFNFTAQELAGASNELRQRLIPEHAR 467
AHPFF+DLRDPN LPNG+PLP LFNFT +ELA A +ELR RLIPEHAR
Sbjct: 418 AHPFFNDLRDPNASLPNGQPLPPLFNFTPEELAHAPDELRLRLIPEHAR 466
|
Source: Lotus japonicus Species: Lotus japonicus Genus: Lotus Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|1617200|emb|CAA69899.1| NSK6 [Nicotiana tabacum] | Back alignment and taxonomy information |
|---|
Score = 791 bits (2044), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 373/472 (79%), Positives = 424/472 (89%), Gaps = 5/472 (1%)
Query: 1 MNVMRRLKSIASGRTSISSDPGGDSGIKRAKVDKELE--VNGEANLVERSASSLEQHMAS 58
MNVMRRLKSIASGR+S+S DPGGDS IKR KV++E++ V GE + ER + + + +
Sbjct: 1 MNVMRRLKSIASGRSSVS-DPGGDSSIKRVKVEQEVDQRVVGETQMEERCTTIVPKEDMA 59
Query: 59 TSLEPVASTSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDD--KDLEPSIVNGNGT 116
++ + + S + R E S FD+LPKEM+EM+I+DEK +H+D KD+EP++V+GNGT
Sbjct: 60 STSKGTTTGSTSTMDTRPENSEFDELPKEMHEMKIKDEKADSHEDNLKDMEPAVVSGNGT 119
Query: 117 EAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRY 176
E GQ+I TTV GRNGQ KQT+SYMAERVVGTGSFG VFQAKCLETG+SVAIKKVLQD+RY
Sbjct: 120 ETGQIIVTTVSGRNGQQKQTLSYMAERVVGTGSFGTVFQAKCLETGESVAIKKVLQDRRY 179
Query: 177 KNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVP 236
KNRELQIMR L+HPNVV L+HCF+STTEK+E+YLNLVLEY+SETVYRVS+HY+RMNQH+P
Sbjct: 180 KNRELQIMRTLDHPNVVKLRHCFYSTTEKNEVYLNLVLEYVSETVYRVSRHYSRMNQHMP 239
Query: 237 ILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPN 296
I+YVQLYTYQICRALNY+H V+GVCHRDIKPQNLLVNPHTHQLK+CDFGSAKMLVPGEPN
Sbjct: 240 IIYVQLYTYQICRALNYMHGVLGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKMLVPGEPN 299
Query: 297 ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKIL 356
ISYICSRYYRAPELIFGATEYTTAIDMWS GCV+AELLLGQPLFPGESGVDQLVEIIKIL
Sbjct: 300 ISYICSRYYRAPELIFGATEYTTAIDMWSAGCVMAELLLGQPLFPGESGVDQLVEIIKIL 359
Query: 357 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALE 416
GTPTREEI+CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEA+DLVSRLLQYSP+LRCTALE
Sbjct: 360 GTPTREEIRCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPTLRCTALE 419
Query: 417 ACAHPFFDDLRDPNTCLPNGRPLPTLFNFTAQELAGASNELRQRLIPEHARK 468
ACAHPFFD LR+PN CLPNGRPLP LFNFTAQEL+GA +LR+RLIPEH RK
Sbjct: 420 ACAHPFFDPLREPNACLPNGRPLPPLFNFTAQELSGAPADLRKRLIPEHMRK 471
|
Source: Nicotiana tabacum Species: Nicotiana tabacum Genus: Nicotiana Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297810099|ref|XP_002872933.1| hypothetical protein ARALYDRAFT_490498 [Arabidopsis lyrata subsp. lyrata] gi|297318770|gb|EFH49192.1| hypothetical protein ARALYDRAFT_490498 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 791 bits (2042), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 376/468 (80%), Positives = 416/468 (88%), Gaps = 3/468 (0%)
Query: 1 MNVMRRLKSIASGRTSISSDPGGDSGIKRAKVDKELE-VNGEANLVERSASSLEQHMAST 59
MNVMRRLKSIASGRTSISSDPGGD +KRAK+D+E + + + V++++S E
Sbjct: 1 MNVMRRLKSIASGRTSISSDPGGDYALKRAKLDQENDNLCADPMQVDQNSSCFEMKADIL 60
Query: 60 SLEPVASTSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDKDLEPSIVNGNGTEAG 119
S E VA TS A +E++ DQLP+ M +MRIRDE+N N ++KD+E ++VNG+GTE G
Sbjct: 61 SHESVAGTSNVP--AASEKTVDDQLPEVMIDMRIRDERNANREEKDMETTVVNGSGTETG 118
Query: 120 QVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR 179
QVI TTVGGR+G+PKQTISYMA+RVVGTGSFGVVFQAKCLETG+ VAIKKVLQDKRYKNR
Sbjct: 119 QVITTTVGGRDGKPKQTISYMAQRVVGTGSFGVVFQAKCLETGEQVAIKKVLQDKRYKNR 178
Query: 180 ELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY 239
ELQIMRL +HPNVV L+H FFSTT+KDELYLNLVLEY+ ETVYR SKHYT+MNQH+PI++
Sbjct: 179 ELQIMRLQDHPNVVRLRHSFFSTTDKDELYLNLVLEYVPETVYRASKHYTKMNQHMPIIF 238
Query: 240 VQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISY 299
VQLYTYQICRALNYLH VVGVCHRDIKPQNLLVNP THQLKICDFGSAKMLVPGEPNISY
Sbjct: 239 VQLYTYQICRALNYLHRVVGVCHRDIKPQNLLVNPQTHQLKICDFGSAKMLVPGEPNISY 298
Query: 300 ICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTP 359
ICSRYYRAPELIFGATEYT AIDMWS GCV+AELLLGQPLFPGESG+DQLVEIIKILGTP
Sbjct: 299 ICSRYYRAPELIFGATEYTNAIDMWSGGCVMAELLLGQPLFPGESGIDQLVEIIKILGTP 358
Query: 360 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419
TREEI+CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEA+DLVSRLLQYSP+LRCTALEACA
Sbjct: 359 TREEIRCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACA 418
Query: 420 HPFFDDLRDPNTCLPNGRPLPTLFNFTAQELAGASNELRQRLIPEHAR 467
HPFFDDLRDPN LPNGR LP LFNFTAQELAGAS ELRQRLIP H +
Sbjct: 419 HPFFDDLRDPNVSLPNGRALPPLFNFTAQELAGASTELRQRLIPAHCQ 466
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 468 | ||||||
| TAIR|locus:2126993 | 472 | SK32 "shaggy-like protein kina | 0.993 | 0.985 | 0.786 | 7.6e-199 | |
| TAIR|locus:2222642 | 410 | SK13 "shaggy-like kinase 13" [ | 0.861 | 0.982 | 0.779 | 7.5e-176 | |
| TAIR|locus:2832141 | 405 | SK 11 "AT5G26751" [Arabidopsis | 0.850 | 0.982 | 0.772 | 6.1e-174 | |
| TAIR|locus:2074464 | 409 | ATSK12 [Arabidopsis thaliana ( | 0.858 | 0.982 | 0.767 | 9.9e-174 | |
| TAIR|locus:2098896 | 438 | AT3G61160 [Arabidopsis thalian | 0.880 | 0.940 | 0.728 | 3.8e-170 | |
| TAIR|locus:2024341 | 421 | SK41 "shaggy-like protein kina | 0.880 | 0.978 | 0.714 | 3.8e-165 | |
| TAIR|locus:2202255 | 407 | GSK1 "GSK3/SHAGGY-like protein | 0.779 | 0.896 | 0.778 | 3.9e-163 | |
| TAIR|locus:2052861 | 412 | SKdZeta "SHAGGY-related protei | 0.782 | 0.888 | 0.779 | 5e-163 | |
| TAIR|locus:2124082 | 380 | BIN2 "BRASSINOSTEROID-INSENSIT | 0.782 | 0.963 | 0.757 | 9.6e-160 | |
| RGD|70982 | 420 | Gsk3b "glycogen synthase kinas | 0.747 | 0.833 | 0.664 | 1.2e-127 |
| TAIR|locus:2126993 SK32 "shaggy-like protein kinase 32" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1925 (682.7 bits), Expect = 7.6e-199, P = 7.6e-199
Identities = 368/468 (78%), Positives = 404/468 (86%)
Query: 1 MNVMRRLKSIASGRTXXXXXXXXXXXXKRAKVDKELE-VNGEANLVERSASSLEQHMAST 59
MNVMRRLKSIASGRT KRAK+D+E + + + V++++S E
Sbjct: 1 MNVMRRLKSIASGRTSISSDPGGDYALKRAKLDQENDNLCVDPMQVDQNSSCFEMKADVL 60
Query: 60 SLEPVASTSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDKDLEPSIVNGNGTEAG 119
S E VA TS V+ E+ DQLP M EM+IRDE+N N +DKD+E ++VNG+GTE G
Sbjct: 61 SQESVAGTSNVPAVS--EKPVDDQLPDVMIEMKIRDERNANREDKDMETTVVNGSGTETG 118
Query: 120 QVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR 179
QVI TTVGGR+G+PKQTISYMA+RVVGTGSFGVVFQAKCLETG+ VAIKKVLQDKRYKNR
Sbjct: 119 QVITTTVGGRDGKPKQTISYMAQRVVGTGSFGVVFQAKCLETGEQVAIKKVLQDKRYKNR 178
Query: 180 ELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY 239
ELQIMRL +HPNVV L+H FFSTT+KDELYLNLVLEY+ ETVYR SKHYT+MNQH+PI++
Sbjct: 179 ELQIMRLQDHPNVVRLRHSFFSTTDKDELYLNLVLEYVPETVYRASKHYTKMNQHMPIIF 238
Query: 240 VQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISY 299
VQLYTYQICRALNYLH VVGVCHRDIKPQNLLVNP THQLKICDFGSAKMLVPGEPNISY
Sbjct: 239 VQLYTYQICRALNYLHRVVGVCHRDIKPQNLLVNPQTHQLKICDFGSAKMLVPGEPNISY 298
Query: 300 ICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTP 359
ICSRYYRAPELIFGATEYT AIDMWS GCV+AELLLGQPLFPGESG+DQLVEIIKILGTP
Sbjct: 299 ICSRYYRAPELIFGATEYTNAIDMWSGGCVMAELLLGQPLFPGESGIDQLVEIIKILGTP 358
Query: 360 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419
TREEI+CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEA+DLVSRLLQYSP+LRCTALEACA
Sbjct: 359 TREEIRCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACA 418
Query: 420 HPFFDDLRDPNTCLPNGRPLPTLFNFTAQELAGASNELRQRLIPEHAR 467
HPFFDDLRDPN LPNGR LP LFNFTAQELAGAS ELRQRLIP H +
Sbjct: 419 HPFFDDLRDPNVSLPNGRALPPLFNFTAQELAGASTELRQRLIPAHCQ 466
|
|
| TAIR|locus:2222642 SK13 "shaggy-like kinase 13" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1708 (606.3 bits), Expect = 7.5e-176, P = 7.5e-176
Identities = 322/413 (77%), Positives = 359/413 (86%)
Query: 56 MASTSLEPVASTSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDKDLEPSIVNGNG 115
MAS P +S AT ++LP+ +NEM+I+D DK++E ++V+GNG
Sbjct: 1 MASVGTLPASSM---ATKQSNASICAEKLPEGINEMKIKD-------DKEMEAAVVDGNG 50
Query: 116 TEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR 175
TE G +I TT+GG+NGQPKQTISYMAER+VG GSFG+VFQAKCLETG++VAIKKVLQDKR
Sbjct: 51 TETGHIIVTTIGGKNGQPKQTISYMAERIVGQGSFGIVFQAKCLETGETVAIKKVLQDKR 110
Query: 176 YKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHV 235
YKNRELQ MRLL+HPNVVSLKHCFFSTTEKDELYLNLVLEY+ ETVYRVSKHY+R NQ +
Sbjct: 111 YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVYRVSKHYSRANQRM 170
Query: 236 PILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEP 295
PI+YV+LYTYQICRAL Y+H VGVCHRDIKPQNLLVNPHTHQ+K+CDFGSAK+LV GEP
Sbjct: 171 PIIYVKLYTYQICRALAYIHGGVGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP 230
Query: 296 NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKI 355
NISYICSRYYRAPELIFGATEYTT ID+WS GCVLAELLLGQPLFPGESGVDQLVEIIK+
Sbjct: 231 NISYICSRYYRAPELIFGATEYTTTIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 290
Query: 356 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTAL 415
LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKR PPEA+DLVSRLLQYSP+LR TA+
Sbjct: 291 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRTPPEAVDLVSRLLQYSPNLRSTAM 350
Query: 416 EACAHPFFDDLRDPNTCLPNGRPLPTLFNFTAQELAGASNELRQRLIPEHARK 468
EA HPFFD+LRDPNT LPNGR LP LFNF QEL GAS EL +LIP+HARK
Sbjct: 351 EAIVHPFFDELRDPNTRLPNGRALPPLFNFKPQELKGASLELLSKLIPDHARK 403
|
|
| TAIR|locus:2832141 SK 11 "AT5G26751" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1690 (600.0 bits), Expect = 6.1e-174, P = 6.1e-174
Identities = 313/405 (77%), Positives = 354/405 (87%)
Query: 64 VASTSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDKDLEPSIVNGNGTEAGQVIA 123
+AS A + +G D+LP+EMN+M+IRD DK++E ++V+GNGTE G +I
Sbjct: 1 MASVGIAPNPGARDSTGVDKLPEEMNDMKIRD-------DKEMEATVVDGNGTETGHIIV 53
Query: 124 TTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQI 183
TT+GGRNGQPKQTISYMAERVVG GSFGVVFQAKCLETG++VAIKKVLQD+RYKNRELQ
Sbjct: 54 TTIGGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDRRYKNRELQT 113
Query: 184 MRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLY 243
MRLL+HPNVVSLKHCFFSTTEKDELYLNLVLEY+ ETV+RV KHY ++NQ +P++YV+LY
Sbjct: 114 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHYNKLNQRMPLIYVKLY 173
Query: 244 TYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSR 303
TYQI RAL+Y+H +GVCHRDIKPQNLLVNPHTHQ+K+CDFGSAK+LV GEPNISYICSR
Sbjct: 174 TYQIFRALSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR 233
Query: 304 YYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREE 363
YYRAPELIFGATEYTTAID+WS GCVLAELLLGQPLFPGESGVDQLVEIIK+LGTPTREE
Sbjct: 234 YYRAPELIFGATEYTTAIDVWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 293
Query: 364 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEA+DLVSRLLQYSP+LR AL+ HPFF
Sbjct: 294 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRSAALDTLVHPFF 353
Query: 424 DDLRDPNTCLPNGRPLPTLFNFTAQELAGASNELRQRLIPEHARK 468
D+LRDPN LPNGR LP LFNF EL G E+ +L+PEHARK
Sbjct: 354 DELRDPNARLPNGRFLPPLFNFKPHELKGVPLEMVAKLVPEHARK 398
|
|
| TAIR|locus:2074464 ATSK12 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1688 (599.3 bits), Expect = 9.9e-174, P = 9.9e-174
Identities = 317/413 (76%), Positives = 360/413 (87%)
Query: 56 MASTSLEPVASTSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDKDLEPSIVNGNG 115
MAS +EP A+ E+ T T+ D+LP+EM +M+I+D DK++E +IVNGN
Sbjct: 1 MASVGIEPSAAVRES-TGNVTDA---DRLPEEMKDMKIQD-------DKEMEATIVNGNV 49
Query: 116 TEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR 175
TE G +I TT+GGRNGQPKQTISYMAERVVG GSFGVVFQAKCLETG++VAIKKVLQD+R
Sbjct: 50 TETGHIIVTTIGGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDRR 109
Query: 176 YKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHV 235
YKNRELQ MRLL+HPNVVSLKHCFFSTTEKDELYLNLVLEY+ ETV+RV KHY ++NQ +
Sbjct: 110 YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHYNKLNQRM 169
Query: 236 PILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEP 295
P++YV+LYTYQI R+L+Y+H +GVCHRDIKPQNLLVNPHTHQ+K+CDFGSAK+LV GEP
Sbjct: 170 PLVYVKLYTYQIFRSLSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP 229
Query: 296 NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKI 355
NISYICSRYYRAPELIFGATEYTTAID+WS GCVLAELLLGQPLFPGESGVDQLVEIIK+
Sbjct: 230 NISYICSRYYRAPELIFGATEYTTAIDVWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 289
Query: 356 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTAL 415
LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEA+DLVSRLLQYSP+LRC AL
Sbjct: 290 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCAAL 349
Query: 416 EACAHPFFDDLRDPNTCLPNGRPLPTLFNFTAQELAGASNELRQRLIPEHARK 468
++ HPFFD+LRDPN LPNGR LP LFNF EL G E+ +L+PEHARK
Sbjct: 350 DSLVHPFFDELRDPNARLPNGRFLPPLFNFKPHELKGVPVEMVAKLVPEHARK 402
|
|
| TAIR|locus:2098896 AT3G61160 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1614 (573.2 bits), Expect = 3.8e-170, Sum P(2) = 3.8e-170
Identities = 309/424 (72%), Positives = 351/424 (82%)
Query: 46 ERSASSLEQHMASTSLEPVASTS-EAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDK 104
E S Q+ T E +TS E +V+ +E S D LPKE+ E+ + D DK
Sbjct: 26 ETPRSKPNQNREET--ESTETTSYEKDSVSSSENS--DHLPKEIREVGLGD-------DK 74
Query: 105 DLEPSIVNGNGTEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDS 164
D++ I+ GNGTE+G++I T G N Q +TISY AE V+GTGSFGVVFQAKCLET +
Sbjct: 75 DMDCGIIKGNGTESGRIITTKKKGLNDQKDKTISYRAEHVIGTGSFGVVFQAKCLETEEK 134
Query: 165 VAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRV 224
VAIKKVLQDKRYKNRELQIMR+L+HPNVV LKH FFSTTEKDELYLNLVLEY+ ET+YR
Sbjct: 135 VAIKKVLQDKRYKNRELQIMRMLDHPNVVELKHSFFSTTEKDELYLNLVLEYVPETIYRA 194
Query: 225 SKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDF 284
S+ YT+MNQH+P++Y+QLYTYQICRA+NYLH VVGVCHRDIKPQNLLVN TH++KICDF
Sbjct: 195 SRSYTKMNQHMPLIYIQLYTYQICRAMNYLHQVVGVCHRDIKPQNLLVNNVTHEVKICDF 254
Query: 285 GSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGES 344
GSAKML+PGEPNISYICSRYYRAPELIFGATEYT+AIDMWS+GCV+AEL LG PLFPGE+
Sbjct: 255 GSAKMLIPGEPNISYICSRYYRAPELIFGATEYTSAIDMWSVGCVMAELFLGHPLFPGET 314
Query: 345 GVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLL 404
VDQLVEIIKILGTP REEIK MNP Y +FKFPQIKA PWHKIF +++ PEA+DL SRLL
Sbjct: 315 SVDQLVEIIKILGTPAREEIKNMNPRYNDFKFPQIKAQPWHKIFRRQVSPEAMDLASRLL 374
Query: 405 QYSPSLRCTALEACAHPFFDDLRDPNTCLPNGRPLPTLFNFTAQELAGASNELRQRLIPE 464
QYSP+LRCTALEACAHPFFDDLRDP LPNGR LP LF+FTAQELAGAS ELR RLIPE
Sbjct: 375 QYSPNLRCTALEACAHPFFDDLRDPRASLPNGRALPPLFDFTAQELAGASVELRHRLIPE 434
Query: 465 HARK 468
HARK
Sbjct: 435 HARK 438
|
|
| TAIR|locus:2024341 SK41 "shaggy-like protein kinase 41" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1607 (570.8 bits), Expect = 3.8e-165, P = 3.8e-165
Identities = 295/413 (71%), Positives = 349/413 (84%)
Query: 56 MASTSLEPVASTSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDKDLEPSIVNGNG 115
MAS+ L TS +A ++ S D L +++ E RIRD+ + D++D EP I++G G
Sbjct: 1 MASSGLGNGVGTSRSAKGLKSSSSSVDWLTRDLAETRIRDKVETD-DERDSEPDIIDGAG 59
Query: 116 TEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR 175
E G VI TT+ GRNGQ +QT+SY++E VVGTGSFG+VFQAKC ETG+ VAIKKVLQDKR
Sbjct: 60 AEPGHVIRTTLRGRNGQSRQTVSYISEHVVGTGSFGMVFQAKCRETGEVVAIKKVLQDKR 119
Query: 176 YKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHV 235
YKNRELQIM++L+HPN V+LKH FFS T+ +E+YLNLVLE++ ETV RV++ Y+R NQ +
Sbjct: 120 YKNRELQIMQMLDHPNAVALKHSFFSRTDNEEVYLNLVLEFVPETVNRVARSYSRTNQLM 179
Query: 236 PILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEP 295
P++YV+LYTYQICRAL Y+H+ G+CHRDIKPQNLLVNPHTHQLKICDFGSAK+LV GEP
Sbjct: 180 PLIYVKLYTYQICRALAYIHNSFGLCHRDIKPQNLLVNPHTHQLKICDFGSAKVLVKGEP 239
Query: 296 NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKI 355
N+SYICSRYYRAPELIFGA+EYTTAID+WS GCV+AELLLGQPLFPGESGVDQLVEIIK+
Sbjct: 240 NVSYICSRYYRAPELIFGASEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 299
Query: 356 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTAL 415
LGTPTREEIKCMNPNYTEFKFPQIK HPWHK+F KR+PPEA+DL+ R QYSP+LRCTAL
Sbjct: 300 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLLCRFFQYSPNLRCTAL 359
Query: 416 EACAHPFFDDLRDPNTCLPNGRPLPTLFNFTAQELAGASNELRQRLIPEHARK 468
EAC HP FD+LRDPNT LPNGRPLP LFNF QEL+G E+ RL+PEHARK
Sbjct: 360 EACIHPLFDELRDPNTRLPNGRPLPPLFNFKPQELSGIPPEIVNRLVPEHARK 412
|
|
| TAIR|locus:2202255 GSK1 "GSK3/SHAGGY-like protein kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1588 (564.1 bits), Expect = 3.9e-163, P = 3.9e-163
Identities = 285/366 (77%), Positives = 329/366 (89%)
Query: 103 DKDLEPSIVNGNGTEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETG 162
DK++ +++ GN G +I+TT+GG+NG+PKQTISYMAERVVGTGSFG+VFQAKCLETG
Sbjct: 34 DKEMSAAVIEGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETG 93
Query: 163 DSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVY 222
+SVAIKKVLQD+RYKNRELQ+MR ++HPNV+SLKHCFFSTT +DEL+LNLV+EY+ ET+Y
Sbjct: 94 ESVAIKKVLQDRRYKNRELQLMRPMDHPNVISLKHCFFSTTSRDELFLNLVMEYVPETLY 153
Query: 223 RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKIC 282
RV +HYT NQ +PI YV+LYTYQI R L Y+H V GVCHRD+KPQNLLV+P THQ+K+C
Sbjct: 154 RVLRHYTSSNQRMPIFYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLC 213
Query: 283 DFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPG 342
DFGSAK+LV GEPNISYICSRYYRAPELIFGATEYT +ID+WS GCVLAELLLGQPLFPG
Sbjct: 214 DFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTASIDIWSAGCVLAELLLGQPLFPG 273
Query: 343 ESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSR 402
E+ VDQLVEIIK+LGTPTREEI+CMNPNYT+F+FPQIKAHPWHK+FHKRMPPEA+DL SR
Sbjct: 274 ENSVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASR 333
Query: 403 LLQYSPSLRCTALEACAHPFFDDLRDPNTCLPNGRPLPTLFNFTAQELAGASNELRQRLI 462
LLQYSPSLRCTALEACAHPFF++LR+PN LPNGRPLP LFNF QEL GAS EL RLI
Sbjct: 334 LLQYSPSLRCTALEACAHPFFNELREPNARLPNGRPLPPLFNFK-QELGGASMELINRLI 392
Query: 463 PEHARK 468
PEH R+
Sbjct: 393 PEHVRR 398
|
|
| TAIR|locus:2052861 SKdZeta "SHAGGY-related protein kinase dZeta" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1587 (563.7 bits), Expect = 5.0e-163, P = 5.0e-163
Identities = 286/367 (77%), Positives = 330/367 (89%)
Query: 102 DDKDLEPSIVNGNGTEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLET 161
+DK++ +++ GN G +I+TT+GG+NG+PKQTISYMAERVVGTGSFG+VFQAKCLET
Sbjct: 35 NDKEMSAAVIEGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLET 94
Query: 162 GDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETV 221
G+SVAIKKVLQD+RYKNRELQ+MRL++HPNVVSLKHCFFSTT +DEL+LNLV+EY+ ET+
Sbjct: 95 GESVAIKKVLQDRRYKNRELQLMRLMDHPNVVSLKHCFFSTTTRDELFLNLVMEYVPETL 154
Query: 222 YRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKI 281
YRV KHYT NQ +PI YV+LYTYQI R L Y+H GVCHRD+KPQNLLV+P THQ K+
Sbjct: 155 YRVLKHYTSSNQRMPIFYVKLYTYQIFRGLAYIHTAPGVCHRDVKPQNLLVDPLTHQCKL 214
Query: 282 CDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFP 341
CDFGSAK+LV GE NISYICSRYYRAPELIFGATEYT++ID+WS GCVLAELLLGQPLFP
Sbjct: 215 CDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTSSIDIWSAGCVLAELLLGQPLFP 274
Query: 342 GESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVS 401
GE+ VDQLVEIIK+LGTPTREEI+CMNPNYT+F+FPQIKAHPWHK+FHKRMPPEA+DL S
Sbjct: 275 GENSVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLAS 334
Query: 402 RLLQYSPSLRCTALEACAHPFFDDLRDPNTCLPNGRPLPTLFNFTAQELAGASNELRQRL 461
RLLQYSPSLRCTALEACAHPFF++LR+PN LPNGRPLP LFNF QEL+GAS EL RL
Sbjct: 335 RLLQYSPSLRCTALEACAHPFFNELREPNARLPNGRPLPPLFNFK-QELSGASPELINRL 393
Query: 462 IPEHARK 468
IPEH R+
Sbjct: 394 IPEHVRR 400
|
|
| TAIR|locus:2124082 BIN2 "BRASSINOSTEROID-INSENSITIVE 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1556 (552.8 bits), Expect = 9.6e-160, P = 9.6e-160
Identities = 278/367 (75%), Positives = 330/367 (89%)
Query: 102 DDKDLEPSIVNGNGTEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLET 161
DDK++ ++V+G+ G +I+TT+GG+NG+PKQTISYMAERVVGTGSFG+VFQAKCLET
Sbjct: 3 DDKEMPAAVVDGHDQVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLET 62
Query: 162 GDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETV 221
G++VAIKKVLQD+RYKNRELQ+MR+++HPNVV LKHCFFSTT KDEL+LNLV+EY+ E++
Sbjct: 63 GETVAIKKVLQDRRYKNRELQLMRVMDHPNVVCLKHCFFSTTSKDELFLNLVMEYVPESL 122
Query: 222 YRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKI 281
YRV KHY+ NQ +P++YV+LY YQI R L Y+H+V GVCHRD+KPQNLLV+P THQ+KI
Sbjct: 123 YRVLKHYSSANQRMPLVYVKLYMYQIFRGLAYIHNVAGVCHRDLKPQNLLVDPLTHQVKI 182
Query: 282 CDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFP 341
CDFGSAK LV GE NISYICSR+YRAPELIFGATEYTT+ID+WS GCVLAELLLGQPLFP
Sbjct: 183 CDFGSAKQLVKGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 242
Query: 342 GESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVS 401
GE+ VDQLVEIIK+LGTPTREEI+CMNP+YT+F+FPQIKAHPWHKIFHKRMPPEA+D S
Sbjct: 243 GENAVDQLVEIIKVLGTPTREEIRCMNPHYTDFRFPQIKAHPWHKIFHKRMPPEAIDFAS 302
Query: 402 RLLQYSPSLRCTALEACAHPFFDDLRDPNTCLPNGRPLPTLFNFTAQELAGASNELRQRL 461
RLLQYSPSLRCTALEACAHPFFD+LR+PN LPNGRP P LFNF QE+AG+S EL +L
Sbjct: 303 RLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFK-QEVAGSSPELVNKL 361
Query: 462 IPEHARK 468
IP+H ++
Sbjct: 362 IPDHIKR 368
|
|
| RGD|70982 Gsk3b "glycogen synthase kinase 3 beta" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 1253 (446.1 bits), Expect = 1.2e-127, P = 1.2e-127
Identities = 236/355 (66%), Positives = 290/355 (81%)
Query: 114 NGTEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD 173
+G++ V+AT G+ Q +SY +V+G GSFGVV+QAK ++G+ VAIKKVLQD
Sbjct: 33 DGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD 90
Query: 174 KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEK-DELYLNLVLEYISETVYRVSKHYTRMN 232
KR+KNRELQIMR L+H N+V L++ F+S+ EK DE+YLNLVL+Y+ ETVYRV++HY+R
Sbjct: 91 KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK 150
Query: 233 QHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292
Q +P++YV+LY YQ+ R+L Y+H G+CHRDIKPQNLL++P T LK+CDFGSAK LV
Sbjct: 151 QTLPVIYVKLYMYQLFRSLAYIHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 209
Query: 293 GEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEI 352
GEPN+SYICSRYYRAPELIFGAT+YT++IDMWS GCVLAELLLGQP+FPG+SGVDQLVEI
Sbjct: 210 GEPNVSYICSRYYRAPELIFGATDYTSSIDMWSAGCVLAELLLGQPIFPGDSGVDQLVEI 269
Query: 353 IKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC 412
IK+LGTPTRE+I+ MNPNYTEFKFPQIKAHPW K+F R PPEA+ L SRLL+Y+P+ R
Sbjct: 270 IKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARL 329
Query: 413 TALEACAHPFFDDLRDPNTCLPNGRPLPTLFNFTAQELAGASNELRQRLIPEHAR 467
T LEACAH FFD+LRDPN LPNGR P LFNFT QEL+ ++ L LIP HAR
Sbjct: 330 TPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELS-SNPPLATILIPPHAR 383
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| P43289 | KSG3_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7627 | 0.8589 | 0.9828 | no | no |
| P43288 | KSG1_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7728 | 0.8504 | 0.9827 | no | no |
| Q96287 | KSG8_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.8055 | 0.9935 | 0.9851 | yes | no |
| Q10452 | GSK3_SCHPO | 2, ., 7, ., 1, 1, ., 1 | 0.6051 | 0.7286 | 0.8811 | yes | no |
| Q39019 | KSG10_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7142 | 0.8803 | 0.9786 | no | no |
| P38615 | RIM11_YEAST | 2, ., 7, ., 1, 1, ., 1 | 0.5773 | 0.6196 | 0.7837 | yes | no |
| Q9U2Q9 | GSK3_CAEEL | 2, ., 7, ., 1, 1, ., 2, 6 | 0.6404 | 0.6965 | 0.9005 | yes | no |
| Q9FVS6 | KSG4_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7074 | 0.8782 | 0.9785 | no | no |
| Q40518 | MSK1_TOBAC | 2, ., 7, ., 1, 1, ., 1 | 0.7748 | 0.8589 | 0.9828 | N/A | no |
| Q9WV60 | GSK3B_MOUSE | 2, ., 7, ., 1, 1, ., 1 | 0.6582 | 0.7521 | 0.8380 | yes | no |
| P51136 | GSK3_DICDI | 2, ., 7, ., 1, 1, ., 2, 6 | 0.6435 | 0.7008 | 0.7023 | yes | no |
| P51137 | MSK1_MEDSA | 2, ., 7, ., 1, 1, ., 1 | 0.7554 | 0.8632 | 0.9829 | N/A | no |
| P51138 | MSK2_MEDSA | 2, ., 7, ., 1, 1, ., 1 | 0.7629 | 0.8504 | 0.9683 | N/A | no |
| P51139 | MSK3_MEDSA | 2, ., 7, ., 1, 1, ., 1 | 0.7668 | 0.8547 | 0.9732 | N/A | no |
| O04160 | KSGT_BRANA | 2, ., 7, ., 1, 1, ., 1 | 0.7784 | 0.9722 | 0.9722 | N/A | no |
| P18266 | GSK3B_RAT | 2, ., 7, ., 1, 1, ., 1 | 0.6610 | 0.7521 | 0.8380 | yes | no |
| Q8VZD5 | KSG5_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7796 | 0.8611 | 0.9829 | no | no |
| P49841 | GSK3B_HUMAN | 2, ., 7, ., 1, 1, ., 1 | 0.6582 | 0.7521 | 0.8380 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.979 |
| 3rd Layer | 2.7.11 | 0.983 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 468 | |||
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-137 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-95 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 4e-87 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 7e-86 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-82 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-81 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 5e-81 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-78 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 8e-78 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-75 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-72 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-72 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-71 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 7e-71 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 9e-68 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-67 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 7e-65 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 4e-64 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-63 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 6e-63 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-61 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-61 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-61 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-59 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-59 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-58 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 4e-56 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 9e-56 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-55 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-55 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 7e-55 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-54 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 6e-54 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 7e-54 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-53 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-53 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-53 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-53 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-53 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 4e-53 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 6e-53 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-51 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-50 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-50 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-47 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-47 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-47 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 7e-47 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 7e-47 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-46 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 6e-46 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-45 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-45 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 5e-45 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-42 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-40 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-40 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-39 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-37 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-36 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-36 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-36 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 5e-36 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-35 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-35 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 9e-35 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-34 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 6e-34 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 9e-34 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 9e-34 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 7e-33 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-32 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-31 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 4e-31 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-30 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 9e-30 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-29 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-29 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-28 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 5e-28 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-27 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 6e-27 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 6e-27 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 7e-27 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-26 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 8e-26 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 6e-25 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-24 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-24 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-24 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-24 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 7e-24 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-23 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-23 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-23 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-23 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-23 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-22 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-22 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-22 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 5e-22 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 5e-22 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 6e-22 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 7e-22 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 8e-22 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-21 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-21 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 4e-21 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 7e-21 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 9e-21 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-20 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-20 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 4e-20 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 7e-20 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 9e-20 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-19 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-19 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-19 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-19 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-19 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 5e-19 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 6e-19 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 6e-19 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 8e-19 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-18 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-18 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-18 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-18 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-18 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-18 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-18 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-18 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 5e-18 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 8e-18 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 8e-18 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-17 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-17 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-17 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-17 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 4e-17 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 5e-17 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 5e-17 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 7e-17 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 7e-17 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 7e-17 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 8e-17 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-16 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-16 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-16 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-16 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-16 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-16 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-16 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-16 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-16 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-16 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-16 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-16 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-16 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-16 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 4e-16 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-16 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 5e-16 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 5e-16 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 6e-16 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 8e-16 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 9e-16 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-15 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-15 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-15 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-15 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-15 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-15 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-15 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 5e-15 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 6e-15 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 9e-15 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-14 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-14 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-14 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-14 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-14 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-14 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 8e-14 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 8e-14 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-13 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-13 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-13 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-13 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 5e-13 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 5e-13 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-12 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-12 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-12 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-12 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-12 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-12 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-12 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-12 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 4e-12 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 4e-12 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 5e-12 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 8e-12 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 1e-11 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-11 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-11 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-11 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 3e-11 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 4e-11 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 5e-11 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 6e-11 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 8e-11 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 9e-11 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-10 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-10 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-10 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-10 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-10 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 4e-10 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 6e-10 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 9e-10 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-09 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-09 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-09 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-09 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-09 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-09 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 3e-09 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-09 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 4e-09 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 5e-09 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 5e-09 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 6e-09 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 7e-09 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 8e-09 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-08 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-08 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-08 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-08 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-08 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-08 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-08 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 7e-08 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 8e-08 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 8e-08 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 8e-08 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-07 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-07 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-07 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 2e-07 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-07 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-07 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-07 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 5e-07 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 5e-07 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 6e-07 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 9e-07 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-06 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-06 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 4e-06 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 5e-06 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 5e-06 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 5e-06 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 6e-06 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 6e-06 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 7e-06 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 7e-06 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 8e-06 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-05 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-05 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-05 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-05 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-05 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-05 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 4e-05 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 6e-05 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 9e-05 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-04 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-04 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-04 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 2e-04 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-04 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-04 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 4e-04 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 6e-04 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 0.001 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 0.001 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 0.001 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 0.003 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 0.003 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 400 bits (1030), Expect = e-137
Identities = 179/357 (50%), Positives = 251/357 (70%), Gaps = 7/357 (1%)
Query: 112 NGNGTEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVL 171
N N E N P + SY ++G GSFGVV++A C++T + VAIKKVL
Sbjct: 43 NNNAGEDEDEEKMIDNDINRSPNK--SYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVL 100
Query: 172 QDKRYKNRELQIMRLLNHPNVVSLKHCFFSTT-EKDE--LYLNLVLEYISETVYRVSKHY 228
QD +YKNREL IM+ LNH N++ LK +++ +K+E ++LN+V+E+I +TV++ KHY
Sbjct: 101 QDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHY 160
Query: 229 TRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288
R N +P+ V+LY+YQ+CRAL Y+H +CHRD+KPQNLL++P+TH LK+CDFGSAK
Sbjct: 161 ARNNHALPLFLVKLYSYQLCRALAYIHSKF-ICHRDLKPQNLLIDPNTHTLKLCDFGSAK 219
Query: 289 MLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQ 348
L+ G+ ++SYICSR+YRAPEL+ GAT YTT ID+WS+GC++AE++LG P+F G+S VDQ
Sbjct: 220 NLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQ 279
Query: 349 LVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSP 408
LV II++LGTPT +++K MNPNY + KFP +K K+F K P +A++ +S+ L+Y P
Sbjct: 280 LVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEP 339
Query: 409 SLRCTALEACAHPFFDDLRDPNTCLPNG-RPLPTLFNFTAQELAGASNELRQRLIPE 464
R +EA A PFFDDLRDP LP LP LFNF E+ S+ R+++IP+
Sbjct: 340 LKRLNPIEALADPFFDDLRDPCIKLPKYIDKLPDLFNFCDAEIKEMSDACRRKIIPK 396
|
Length = 440 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 291 bits (747), Expect = 1e-95
Identities = 116/307 (37%), Positives = 175/307 (57%), Gaps = 24/307 (7%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV------LQDKRYKNRELQIMRLLNHPNV 192
Y + +G+G++GVV A TG VAIKK+ L D + RE++++R L H N+
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENI 61
Query: 193 VSLKHCF--FSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRA 250
+ L S + +++Y+ V E + +++V + Q + ++Q + YQI R
Sbjct: 62 IGLLDILRPPSPEDFNDVYI--VTELMETDLHKV----IKSPQPLTDDHIQYFLYQILRG 115
Query: 251 LNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS----YICSRYYR 306
L YLH V HRD+KP N+LVN LKICDFG A+ + P E Y+ +R+YR
Sbjct: 116 LKYLHSA-NVIHRDLKPSNILVN-SNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYR 173
Query: 307 APELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKC 366
APEL+ ++ YT AID+WS+GC+ AELL +PLFPG +DQL I+++LGTP+ E++K
Sbjct: 174 APELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF 233
Query: 367 M-NPNYTEF--KFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
+ + + P+ P K+F PEA+DL+ ++L + P R TA EA AHP+
Sbjct: 234 ITSEKARNYLKSLPKKPKKPLSKLF-PGASPEAIDLLEKMLVFDPKKRITADEALAHPYL 292
Query: 424 DDLRDPN 430
L DP
Sbjct: 293 AQLHDPE 299
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 267 bits (685), Expect = 4e-87
Identities = 115/295 (38%), Positives = 171/295 (57%), Gaps = 22/295 (7%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR---YKN---RELQIMRLLNHPNV 192
Y +G G++GVV++A+ TG+ VAIKK+ RE+++++ LNHPN+
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
+ L F K +LYL V E++ +Y++ K R +P ++ Y YQ+ + L
Sbjct: 61 IKLLDVFR---HKGDLYL--VFEFMDTDLYKLIKDRQR---GLPESLIKSYLYQLLQGLA 112
Query: 253 YLH-HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML-VPGEPNISYICSRYYRAPEL 310
+ H H G+ HRD+KP+NLL+N LK+ DFG A+ P P Y+ +R+YRAPEL
Sbjct: 113 FCHSH--GILHRDLKPENLLINTEG-VLKLADFGLARSFGSPVRPYTHYVVTRWYRAPEL 169
Query: 311 IFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPN 370
+ G Y+T +D+WS+GC+ AELL +PLFPG+S +DQL +I + LGTP E
Sbjct: 170 LLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSL 229
Query: 371 --YTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
+F FP+ P K+F P+ALDL+S++L Y P R TA +A AHP+F
Sbjct: 230 ARNYKFSFPKKAGMPLPKLF-PNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 264 bits (677), Expect = 7e-86
Identities = 108/295 (36%), Positives = 171/295 (57%), Gaps = 35/295 (11%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN--------RELQIMRLLNHPNVVSLK 196
+G G++GVV++A+ +TG+ VA+KK+ D + RE+ +++ L HPN+V L
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLD--NEEEGIPSTALREISLLKELKHPNIVKLL 64
Query: 197 HCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH 256
+ + +LYL V EY + K+ + + ++ YQ+ R L Y H
Sbjct: 65 DVIHT---ERKLYL--VFEYCD---MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHS 116
Query: 257 VVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISY---ICSRYYRAPELIFG 313
+ HRD+KPQN+L+N LK+ DFG A+ G P +Y + + +YRAPE++ G
Sbjct: 117 H-RILHRDLKPQNILIN-RDGVLKLADFGLARAF--GIPLRTYTHEVVTLWYRAPEILLG 172
Query: 314 ATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTE 373
+ Y+TA+D+WS+GC+ AE++ G+PLFPG+S +DQL +I +ILGTPT E P T+
Sbjct: 173 SKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESW----PGVTK 228
Query: 374 FK-----FPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
FP+ K+ R+ PE +DL+S++LQY+P+ R +A EA HP+F
Sbjct: 229 LPDYKPTFPKFPPKDLEKVL-PRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 255 bits (653), Expect = 1e-82
Identities = 105/291 (36%), Positives = 155/291 (53%), Gaps = 43/291 (14%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV-----LQDKRYKNRELQIMRLLNHPNVV 193
Y +G GSFG V+ A+ +TG VAIK + +D+ RE++I++ L HPN+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
L F ++D+LYL V+EY ++ + K R+++ + Y QI AL
Sbjct: 61 RLYDVF---EDEDKLYL--VMEYCEGGDLFDLLKKRGRLSEDE----ARFYLRQILSALE 111
Query: 253 YLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIF 312
YLH G+ HRD+KP+N+L++ H +K+ DFG A+ L PGE +++ + Y APE++
Sbjct: 112 YLHSK-GIVHRDLKPENILLDEDGH-VKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLL 169
Query: 313 GATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYT 372
G Y A+D+WS+G +L ELL G+P FPG+ DQL+E+ K +G P
Sbjct: 170 G-KGYGKAVDIWSLGVILYELLTGKPPFPGD---DQLLELFKKIGKPK------------ 213
Query: 373 EFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
P + PEA DL+ +LL P R TA EA HPFF
Sbjct: 214 ----------PPFPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 252 bits (646), Expect = 1e-81
Identities = 98/289 (33%), Positives = 141/289 (48%), Gaps = 39/289 (13%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSL 195
R +G+GSFG V++AK TG VA+K + + RE++I+R L+HPN+V L
Sbjct: 4 LRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRL 63
Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
F +KD LYL V+EY Y + + QI R L YLH
Sbjct: 64 IDAF---EDKDHLYL--VMEYCEGGDL---FDYLSRGGPLSEDEAKKIALQILRGLEYLH 115
Query: 256 HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML-VPGEPNISYICSRYYRAPELIFGA 314
G+ HRD+KP+N+L++ +KI DFG AK L +++ + +Y APE++ G
Sbjct: 116 SN-GIIHRDLKPENILLD-ENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGG 173
Query: 315 TEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEF 374
Y +D+WS+G +L ELL G+P F GE+ +DQL I +ILG P
Sbjct: 174 NGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPL-------------- 219
Query: 375 KFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
+ + EA DL+ + L PS R TA E HP+F
Sbjct: 220 --------EFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 252 bits (645), Expect = 5e-81
Identities = 110/292 (37%), Positives = 164/292 (56%), Gaps = 23/292 (7%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLK 196
+G G+ G+VF+AK ETG++VA+KKV + RE++ ++ HP VV L
Sbjct: 6 GRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLL 65
Query: 197 HCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH 256
F LV+EY+ + V + R +P V+ Y + + + Y+H
Sbjct: 66 DVF-----PHGSGFVLVMEYMPSDLSEVLRDEER---PLPEAQVKSYMRMLLKGVAYMHA 117
Query: 257 VVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISY--ICSRYYRAPELIFGA 314
G+ HRD+KP NLL++ LKI DFG A++ EP + + +R+YRAPEL++GA
Sbjct: 118 N-GIMHRDLKPANLLISADGV-LKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGA 175
Query: 315 TEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTRE---EIKCMNPNY 371
+Y +D+W++GC+ AELL G PLFPGE+ ++QL + + LGTP E + + P+Y
Sbjct: 176 RKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSL-PDY 234
Query: 372 TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
+ FP+ K P +IF PEALDL+ LL Y PS R +A EA HP+F
Sbjct: 235 NKITFPESKPIPLEEIFPD-ASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 246 bits (629), Expect = 1e-78
Identities = 111/291 (38%), Positives = 164/291 (56%), Gaps = 21/291 (7%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQ---DKRYKN---RELQIMRLLNHPNVVSLKH 197
VVG G++GVV + + TG+ VAIKK + D+ K RE++++R L H N+V+LK
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 198 CFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV 257
F K LYL V EY+ T+ + + +P V+ Y +Q+ +A+ Y H
Sbjct: 68 AFRR---KGRLYL--VFEYVERTLLELLE---ASPGGLPPDAVRSYIWQLLQAIAYCHSH 119
Query: 258 VGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV--PGEPNISYICSRYYRAPELIFGAT 315
+ HRDIKP+N+LV+ LK+CDFG A+ L P P Y+ +R+YRAPEL+ G T
Sbjct: 120 -NIIHRDIKPENILVSESG-VLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDT 177
Query: 316 EYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILG--TPTREEIKCMNPNYTE 373
Y +D+W+IGC++AELL G+PLFPG+S +DQL I K LG P+ +E+ NP +
Sbjct: 178 NYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAG 237
Query: 374 FKFPQIKA-HPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
FP+ + + ++ ALD + L+ P R T E HP+F
Sbjct: 238 VAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 244 bits (625), Expect = 8e-78
Identities = 116/314 (36%), Positives = 165/314 (52%), Gaps = 37/314 (11%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---------RELQIMRLLNH 189
Y + +G G++ VV++A+ ETG VAIKK+ +R + RE+++++ L H
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKH 61
Query: 190 PNVVSLKHCFFSTTEKDELYLNLVLEYIS---ETVYRVSKHYTRMNQHVPILYVQLYTYQ 246
PN++ L F K +NLV E++ E V + K + + Y
Sbjct: 62 PNIIGLLDVF---GHKS--NINLVFEFMETDLEKVIK-DKSIVLTPADI-----KSYMLM 110
Query: 247 ICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC---SR 303
R L YLH + HRD+KP NLL+ LK+ DFG A+ G PN +R
Sbjct: 111 TLRGLEYLHSN-WILHRDLKPNNLLIASDG-VLKLADFGLARSF--GSPNRKMTHQVVTR 166
Query: 304 YYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREE 363
+YRAPEL+FGA Y +DMWS+GC+ AELLL P PG+S +DQL +I + LGTPT E
Sbjct: 167 WYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEEN 226
Query: 364 IKCMN--PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHP 421
+ P+Y EFK P +IF +ALDL+ RLL +P+ R TA +A HP
Sbjct: 227 WPGVTSLPDYVEFKP--FPPTPLKQIF-PAASDDALDLLQRLLTLNPNKRITARQALEHP 283
Query: 422 FFDDLRDPNTCLPN 435
+F + DP P+
Sbjct: 284 YFSN--DPAPTPPS 295
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 238 bits (610), Expect = 1e-75
Identities = 108/293 (36%), Positives = 172/293 (58%), Gaps = 26/293 (8%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-------RELQ-IMRLLNHPNVVS 194
+ +G G+FG V+ A+ ETG+ VAIKK+ + ++ + RE++ + +L HPN+V
Sbjct: 5 KQLGDGTFGSVYLARNKETGELVAIKKMKK--KFYSWEECMNLREVKSLRKLNEHPNIVK 62
Query: 195 LKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
LK F E DELY V EY+ +Y++ K R + ++ YQI + L ++
Sbjct: 63 LKEVF---RENDELYF--VFEYMEGNLYQLMK--DRKGKPFSESVIRSIIYQILQGLAHI 115
Query: 255 HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGA 314
H G HRD+KP+NLLV+ +KI DFG A+ + P Y+ +R+YRAPE++ +
Sbjct: 116 HKH-GFFHRDLKPENLLVSGPE-VVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRS 173
Query: 315 TEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREE----IKCMNPN 370
T Y++ +D+W++GC++AEL +PLFPG S +DQL +I +LGTPT+++ K +
Sbjct: 174 TSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK- 232
Query: 371 YTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
F+FPQ H++ PEA+DL+ +L++ P R TA +A HP+F
Sbjct: 233 -LGFRFPQFAPTSLHQLI-PNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 232 bits (593), Expect = 1e-72
Identities = 107/309 (34%), Positives = 172/309 (55%), Gaps = 31/309 (10%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVL------QDKRYKNRELQIM---RLLNH 189
Y + +G G++G+V++A T + VA+KK+ D + RE IM L +H
Sbjct: 9 YEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFRE--IMFLQELGDH 66
Query: 190 PNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICR 249
PN+V L + + +KD +YL V EY+ ++ V + + H + YQ+ +
Sbjct: 67 PNIVKLLNVIKAENDKD-IYL--VFEYMETDLHAVIRANILEDVHK-----RYIMYQLLK 118
Query: 250 ALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS------YICSR 303
AL Y+H V HRD+KP N+L+N +K+ DFG A+ L E N Y+ +R
Sbjct: 119 ALKYIHSG-NVIHRDLKPSNILLNSDCR-VKLADFGLARSLSELEENPENPVLTDYVATR 176
Query: 304 YYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREE 363
+YRAPE++ G+T YT +DMWS+GC+L E+LLG+PLFPG S ++QL +II+++G P+ E+
Sbjct: 177 WYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED 236
Query: 364 IKCMNPNYTEF---KFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420
I+ + + P P ++ + +ALDL+ +LL ++P+ R TA EA H
Sbjct: 237 IESIKSPFAATMLDSLPSRPRKPLDELL-PKASDDALDLLKKLLVFNPNKRLTAEEALEH 295
Query: 421 PFFDDLRDP 429
P+ +P
Sbjct: 296 PYVAQFHNP 304
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 230 bits (588), Expect = 2e-72
Identities = 94/291 (32%), Positives = 153/291 (52%), Gaps = 22/291 (7%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-------RELQIMRLLNHPNVVSLKH 197
+G G++G V++A+ +TG+ VA+KK+ + K RE+++++ L HPN+V LK
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRME-NEKEGFPITAIREIKLLQKLRHPNIVRLKE 65
Query: 198 CFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV 257
T K + + +V EY+ + + ++ Y Q+ L YLH
Sbjct: 66 I---VTSKGKGSIYMVFEYMDHDLTGLLDSP---EVKFTESQIKCYMKQLLEGLQYLHSN 119
Query: 258 VGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI--SYICSRYYRAPELIFGAT 315
G+ HRDIK N+L+N LK+ DFG A+ + + + +YR PEL+ GAT
Sbjct: 120 -GILHRDIKGSNILINNDGV-LKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGAT 177
Query: 316 EYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTRE---EIKCMNPNYT 372
Y +DMWS+GC+LAEL LG+P+F G + ++QL +I ++ G+PT E + + P +
Sbjct: 178 RYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKL-PWFE 236
Query: 373 EFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
K + + F + P ALDL+ +LL P R +A +A H +F
Sbjct: 237 NLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 229 bits (586), Expect = 2e-71
Identities = 111/308 (36%), Positives = 173/308 (56%), Gaps = 28/308 (9%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV------LQDKRYKNRELQIMRLLNHPNV 192
Y +G G++G+V A TG VAIKK+ +R RE++I+R H N+
Sbjct: 7 YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQR-TLREIKILRRFKHENI 65
Query: 193 VSLKHCFFSTT--EKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRA 250
+ + + +++Y+ V E + +Y++ K N H+ Q + YQI R
Sbjct: 66 IGILDIIRPPSFESFNDVYI--VQELMETDLYKLIKTQHLSNDHI-----QYFLYQILRG 118
Query: 251 LNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS----YICSRYYR 306
L Y+H V HRD+KP NLL+N LKICDFG A++ P + Y+ +R+YR
Sbjct: 119 LKYIHSA-NVLHRDLKPSNLLLN-TNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYR 176
Query: 307 APELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKC 366
APE++ + YT AID+WS+GC+LAE+L +PLFPG+ + QL I+ +LGTP++E++ C
Sbjct: 177 APEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNC 236
Query: 367 M-NP---NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPF 422
+ + NY + P PW+K+F P+ALDL+ ++L ++P R T EA AHP+
Sbjct: 237 IISLRARNYIK-SLPFKPKVPWNKLF-PNADPKALDLLDKMLTFNPHKRITVEEALAHPY 294
Query: 423 FDDLRDPN 430
+ DP+
Sbjct: 295 LEQYHDPS 302
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 227 bits (581), Expect = 7e-71
Identities = 123/345 (35%), Positives = 186/345 (53%), Gaps = 34/345 (9%)
Query: 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKK------VLQDKRYKNRELQIMRLLNHPN 191
Y +G+G++GVV A +G VAIKK V + REL+I+R H N
Sbjct: 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDN 65
Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
+++++ D + +V++ + ++ H +Q + +++ + YQ+ R L
Sbjct: 66 IIAIRD-ILRPPGADFKDVYVVMDLMESDLH----HIIHSDQPLTEEHIRYFLYQLLRGL 120
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV--PGEPN---ISYICSRYYR 306
Y+H V HRD+KP NLLVN L+I DFG A+ L P E Y+ +R+YR
Sbjct: 121 KYIHSA-NVIHRDLKPSNLLVNEDCE-LRIGDFGMARGLSSSPTEHKYFMTEYVATRWYR 178
Query: 307 APELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKC 366
APEL+ EYTTAIDMWS+GC+ AE+L + LFPG++ V QL I+ +LG+P+ E +
Sbjct: 179 APELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNR 238
Query: 367 MNP----NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPF 422
+ Y + P+ + PW KIF K PEALDL+S++LQ+ P R T +A HPF
Sbjct: 239 IGSDRVRKYIQ-NLPRKQPVPWSKIFPKA-SPEALDLLSQMLQFDPEERITVEQALQHPF 296
Query: 423 FDDLRDPN---TCLPNGRPLPTLFNFTAQELAGASNELRQRLIPE 464
DP+ TC P P F+F A EL+ +L++ ++ E
Sbjct: 297 LAQYHDPDDEPTCPP-----PFDFDFEAIELSR--EQLKEAIVKE 334
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 217 bits (556), Expect = 9e-68
Identities = 104/297 (35%), Positives = 168/297 (56%), Gaps = 38/297 (12%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLKHC 198
+G G++GVV++A+ TG+ VA+KK+ + + RE+ +++ LNHPN+V L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY-----VQLYTYQICRALNY 253
S + LYL V E++ + K Y M+ P+ ++ Y YQ+ + + Y
Sbjct: 67 VHSENK---LYL--VFEFLDLDL----KKY--MD-SSPLTGLDPPLIKSYLYQLLQGIAY 114
Query: 254 LH-HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISY---ICSRYYRAPE 309
H H V HRD+KPQNLL++ LK+ DFG A+ G P +Y + + +YRAPE
Sbjct: 115 CHSH--RVLHRDLKPQNLLID-REGALKLADFGLARAF--GVPVRTYTHEVVTLWYRAPE 169
Query: 310 LIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTRE---EIKC 366
++ G+ +Y+T +D+WSIGC+ AE++ +PLFPG+S +DQL I + LGTP + +
Sbjct: 170 ILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTS 229
Query: 367 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
+ P+Y FP+ K+ + + LDL+S++L Y P+ R +A A HP+F
Sbjct: 230 L-PDYKP-TFPKWARQDLSKVV-PNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 219 bits (559), Expect = 2e-67
Identities = 104/305 (34%), Positives = 163/305 (53%), Gaps = 26/305 (8%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KR-YKNRELQIMRLLNHP 190
Y VG+G++G V A +TG VAIKK+ + KR Y REL++++ ++H
Sbjct: 17 YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTY--RELRLLKHMDHE 74
Query: 191 NVVSLKHCFFSTTEKDELY-LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICR 249
NV+ L F + ++ + LV + + + K + H+ L YQI R
Sbjct: 75 NVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFL-----VYQILR 129
Query: 250 ALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPE 309
L Y+H G+ HRD+KP N+ VN +LKI DFG A+ + Y+ +R+YRAPE
Sbjct: 130 GLKYIHSA-GIIHRDLKPSNIAVNEDC-ELKILDFGLARHT--DDEMTGYVATRWYRAPE 185
Query: 310 LIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369
++ Y +D+WS+GC++AELL G+ LFPG +DQL I+ ++GTP E ++ ++
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISS 245
Query: 370 ----NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDD 425
NY + PQ+ + ++F P A+DL+ ++L P R TA EA AHP+ +
Sbjct: 246 ESARNYIQ-SLPQMPKKDFKEVF-SGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAE 303
Query: 426 LRDPN 430
DP
Sbjct: 304 YHDPE 308
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 212 bits (541), Expect = 7e-65
Identities = 115/327 (35%), Positives = 182/327 (55%), Gaps = 29/327 (8%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV------LQDKRYKNRELQIMRLLNHPNV 192
Y+ + +G G++G+V AK ET + VAIKK+ D + RE++++R L+H NV
Sbjct: 7 YVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENV 66
Query: 193 VSLKHCFFSTTEK--DELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRA 250
+++K + +++Y+ V E + ++++ R +Q + + Q + YQ+ R
Sbjct: 67 IAIKDIMPPPHREAFNDVYI--VYELMDTDLHQI----IRSSQTLSDDHCQYFLYQLLRG 120
Query: 251 LNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM-LVPGEPNISYICSRYYRAPE 309
L Y+H V HRD+KP NLL+N + LKICDFG A+ G+ Y+ +R+YRAPE
Sbjct: 121 LKYIHSA-NVLHRDLKPSNLLLNANC-DLKICDFGLARTTSEKGDFMTEYVVTRWYRAPE 178
Query: 310 LIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM-N 368
L+ +EYTTAID+WS+GC+ AELL +PLFPG+ V QL I ++LG+P+ E++ + N
Sbjct: 179 LLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRN 238
Query: 369 PNYTEF--KFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426
+ P + ++F P A+DL+ ++L + PS R T EA AHP+ L
Sbjct: 239 EKARRYIRSLPYTPRQSFARLF-PHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297
Query: 427 RDPN---TCLPNGRPLPTLFNFTAQEL 450
DP+ C P F+F L
Sbjct: 298 HDPSDEPVC-----QTPFSFDFEEDAL 319
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 209 bits (533), Expect = 4e-64
Identities = 107/292 (36%), Positives = 165/292 (56%), Gaps = 30/292 (10%)
Query: 148 GSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLKHCFFS 201
G++GVV++A+ +TG+ VA+KK+ +K + RE+ I+ L HPN+V++K
Sbjct: 16 GTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVG 75
Query: 202 TTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVC 261
+ D++Y+ V+EY+ + + + M Q V+ Q+ + +LH +
Sbjct: 76 SNL-DKIYM--VMEYVEHDLKSLMET---MKQPFLQSEVKCLMLQLLSGVAHLHDN-WIL 128
Query: 262 HRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISY---ICSRYYRAPELIFGATEYT 318
HRD+K NLL+N + LKICDFG A+ G P Y + + +YRAPEL+ GA EY+
Sbjct: 129 HRDLKTSNLLLN-NRGILKICDFGLAREY--GSPLKPYTQLVVTLWYRAPELLLGAKEYS 185
Query: 319 TAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQ 378
TAIDMWS+GC+ AELL +PLFPG+S +DQL +I K+LGTPT + P ++E +
Sbjct: 186 TAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIW----PGFSELPGAK 241
Query: 379 IKAHPWH-------KIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
K + K + DL++RLL Y P+ R +A +A HP+F
Sbjct: 242 KKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 208 bits (530), Expect = 3e-63
Identities = 124/329 (37%), Positives = 182/329 (55%), Gaps = 27/329 (8%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV------LQDKRYKNRELQIMRLLNHPNV 192
Y + V+G GS+GVV A TG+ VAIKK+ + D RE++++RLL HP++
Sbjct: 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 61
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
V +KH + ++ + +V E + +++V K N + + Q + YQ+ RAL
Sbjct: 62 VEIKHIMLPPSRREFKDIYVVFELMESDLHQVIK----ANDDLTPEHHQFFLYQLLRALK 117
Query: 253 YLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPN----ISYICSRYYRAP 308
Y+H V HRD+KP+N+L N +LKICDFG A++ P Y+ +R+YRAP
Sbjct: 118 YIH-TANVFHRDLKPKNILANADC-KLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 175
Query: 309 ELIFGA--TEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEI-K 365
EL G+ ++YT AID+WSIGC+ AE+L G+PLFPG++ V QL I +LGTP+ E I +
Sbjct: 176 ELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR 234
Query: 366 CMNPNYTEFKFPQIKAHPWHKIFHKRMP---PEALDLVSRLLQYSPSLRCTALEACAHPF 422
N + K P F ++ P P AL L+ RLL + P R TA EA A P+
Sbjct: 235 VRNEKARRYLSSMRKKQP--VPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPY 292
Query: 423 FDDLRDPNTCLPNGRPLPTL-FNFTAQEL 450
F L P+ +P+ L F F + L
Sbjct: 293 FKGLAKVER-EPSAQPITKLEFEFERRRL 320
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 205 bits (524), Expect = 6e-63
Identities = 101/287 (35%), Positives = 152/287 (52%), Gaps = 21/287 (7%)
Query: 146 GTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-------RELQIMRLLN-HPNVVSLKH 197
G G+F V +A+ +TG AIK + K +K+ RE+Q +R L+ HPN++ L
Sbjct: 8 GEGTFSEVLKAQSRKTGKYYAIKCM--KKHFKSLEQVNNLREIQALRRLSPHPNILRLIE 65
Query: 198 CFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV 257
F L LV E + +Y + K R +P V+ Y YQ+ ++L+++H
Sbjct: 66 VLFDRKTGR---LALVFELMDMNLYELIKGRKR---PLPEKRVKSYMYQLLKSLDHMHRN 119
Query: 258 VGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEY 317
G+ HRDIKP+N+L+ LK+ DFGS + + P YI +R+YRAPE + Y
Sbjct: 120 -GIFHRDIKPENILIKDDI--LKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYY 176
Query: 318 TTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP-NYTEFKF 376
+D+W++GCV E+L PLFPG + +DQ+ +I +LGTP E +K + + F
Sbjct: 177 GPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNF 236
Query: 377 PQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
P K K+ E LDL+ +LL Y P R TA +A HP+F
Sbjct: 237 PSKKGTGLRKLLPN-ASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 202 bits (515), Expect = 1e-61
Identities = 114/290 (39%), Positives = 168/290 (57%), Gaps = 21/290 (7%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQ---DKRYKN---RELQIMRLLNHPNVVSLKH 197
+VG GS+G+V + K ETG VAIKK L+ DK K RE+++++ L H N+V+L
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 198 CFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV 257
F K LYL V E++ TV + Y + V+ Y +QI R + + H
Sbjct: 68 VF---RRKKRLYL--VFEFVDHTVLDDLEKYP---NGLDESRVRKYLFQILRGIEFCHSH 119
Query: 258 VGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV-PGEPNISYICSRYYRAPELIFGATE 316
+ HRDIKP+N+LV+ + +K+CDFG A+ L PGE Y+ +R+YRAPEL+ G T+
Sbjct: 120 -NIIHRDIKPENILVSQ-SGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTK 177
Query: 317 YTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGT--PTREEIKCMNPNYTEF 374
Y A+D+W++GC++ E+L G+PLFPG+S +DQL IIK LG P +EI NP +
Sbjct: 178 YGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM 237
Query: 375 KFPQIK-AHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
+ P++K P K F K + LDL + L+ P R ++ + H FF
Sbjct: 238 RLPEVKEIEPLEKRFPK-LSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 203 bits (518), Expect = 1e-61
Identities = 111/304 (36%), Positives = 172/304 (56%), Gaps = 25/304 (8%)
Query: 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNH 189
T Y+ + VG G+FG+V A+ TG +VAIKK+++ + REL++++ L H
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68
Query: 190 PNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICR 249
N++SL F S E ++Y V E + ++R+ Q ++Q + YQI R
Sbjct: 69 ENIISLSDIFISPLE--DIYF--VTELLGTDLHRLLTSRPLEKQ-----FIQYFLYQILR 119
Query: 250 ALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS-YICSRYYRAP 308
L Y+H GV HRD+KP N+L+N + LKICDFG A+ +P ++ Y+ +RYYRAP
Sbjct: 120 GLKYVHSA-GVVHRDLKPSNILINENC-DLKICDFGLAR---IQDPQMTGYVSTRYYRAP 174
Query: 309 ELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM- 367
E++ +Y +D+WS GC+ AE+L G+PLFPG+ V+Q I +LGTP + I +
Sbjct: 175 EIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTIC 234
Query: 368 NPNYTEF--KFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDD 425
+ N F P+ + P+ + F K P A+DL+ ++L + P R +A EA AHP+
Sbjct: 235 SENTLRFVQSLPKREPVPFSEKF-KNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAP 293
Query: 426 LRDP 429
DP
Sbjct: 294 YHDP 297
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 201 bits (513), Expect = 2e-61
Identities = 106/289 (36%), Positives = 160/289 (55%), Gaps = 21/289 (7%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHC 198
+G GS+GVVF+ + ETG VAIKK ++ K+ RE+++++ L HPN+V+L
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV 258
F + + L+LV EY TV + R VP ++ +Q +A+N+ H
Sbjct: 69 F-----RRKRKLHLVFEYCDHTVLNELEKNPR---GVPEHLIKKIIWQTLQAVNFCHKH- 119
Query: 259 GVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS-YICSRYYRAPELIFGATEY 317
HRD+KP+N+L+ Q+K+CDFG A++L + + Y+ +R+YRAPEL+ G T+Y
Sbjct: 120 NCIHRDVKPENILITKQ-GQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQY 178
Query: 318 TTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILG--TPTREEIKCMNPNYTEFK 375
+D+W+IGCV AELL GQPL+PG+S VDQL I K LG P ++I N +
Sbjct: 179 GPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLS 238
Query: 376 FPQIKA-HPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
P+ + P F + AL + LQ P+ R + E HP+F
Sbjct: 239 IPEPETREPLESKFPN-ISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 197 bits (502), Expect = 2e-59
Identities = 111/306 (36%), Positives = 163/306 (53%), Gaps = 26/306 (8%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLKHC 198
+G G++G+V++A+ +G+ VA+KKV D RE+ ++ L HPN+V LK
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEV 74
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV 258
D ++L V+EY + + + + M V+ Q+ R L YLH
Sbjct: 75 VVGK-HLDSIFL--VMEYCEQDLASLLDN---MPTPFSESQVKCLMLQLLRGLQYLHENF 128
Query: 259 GVCHRDIKPQNLLVNPHTHQLKICDFGSAKML-VPGEPNISYICSRYYRAPELIFGATEY 317
+ HRD+K NLL+ LKI DFG A+ +P +P + + +YRAPEL+ G T Y
Sbjct: 129 -IIHRDLKVSNLLLTDKGC-LKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTY 186
Query: 318 TTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN--PNYTEFK 375
TTAIDMW++GC+LAELL +PL PG+S ++QL II++LGTP + P +F
Sbjct: 187 TTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFT 246
Query: 376 FPQIKAHPWHKIFHKRMP--PEA-LDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNTC 432
P+ P++ + HK P EA L L++ LL Y P R TA EA +F + P C
Sbjct: 247 LPK---QPYNNLKHK-FPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKE--KPLPC 300
Query: 433 LPNGRP 438
P P
Sbjct: 301 EPEMMP 306
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 195 bits (498), Expect = 4e-59
Identities = 97/293 (33%), Positives = 158/293 (53%), Gaps = 19/293 (6%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLKHC 198
+G G++G V++A+ TG VA+KK + + RE+ ++++L+ +
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLD 68
Query: 199 FFSTTEKD-ELYLNLVLEYISETVYRVSKHYTRMNQH-VPILYVQLYTYQICRALNYLHH 256
EK+ + L LV EY+ + + R +P ++ + YQ+ + + + H
Sbjct: 69 VEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK 128
Query: 257 VVGVCHRDIKPQNLLVNPHTHQLKICDFG-SAKMLVPGEPNISYICSRYYRAPELIFGAT 315
GV HRD+KPQNLLV+ LKI D G +P + I + +YRAPE++ G+T
Sbjct: 129 H-GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGST 187
Query: 316 EYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFK 375
Y+T +D+WS+GC+ AE+ QPLFPG+S + QL+ I K+LGTPT + P ++ +
Sbjct: 188 HYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW----PGVSKLR 243
Query: 376 ----FPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFD 424
FPQ K + + PE LDL+ ++L+Y P+ R +A A HP+FD
Sbjct: 244 DWHEFPQWKPQDLSRAV-PDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 195 bits (498), Expect = 1e-58
Identities = 119/341 (34%), Positives = 169/341 (49%), Gaps = 38/341 (11%)
Query: 145 VGTGSFGVVFQAKCLETGDS--VAIKKV-------LQDKRYKNRELQIMRLL-NHPNVVS 194
+G G++G+V A+ ET + VAIKK+ + KR REL+++R H N+
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKR-ALRELKLLRHFRGHKNITC 66
Query: 195 LKHCFFSTTEK-DELYLNLVL-EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
L +ELYL L E + R + T + H Q + YQI L
Sbjct: 67 LYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLT--DAHF-----QSFIYQILCGLK 119
Query: 253 YLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG----EPNIS-YICSRYYRA 307
Y+H V HRD+KP NLLVN +LKICDFG A+ ++ Y+ +R+YRA
Sbjct: 120 YIHSA-NVLHRDLKPGNLLVNADC-ELKICDFGLARGFSENPGENAGFMTEYVATRWYRA 177
Query: 308 PELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTRE---EI 364
PE++ YT AID+WS+GC+LAELL +P+F G+ VDQL +I+++LGTP E I
Sbjct: 178 PEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRI 237
Query: 365 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFD 424
P I P+ IF P ALDL+ +LL + P+ R + EA HP+
Sbjct: 238 GSPKAQNYIRSLPNIPKKPFESIFPN-ANPLALDLLEKLLAFDPTKRISVEEALEHPYLA 296
Query: 425 DLRDPNTCLPNGRP-LPTLFNFTAQELAGASNELRQRLIPE 464
DP+ P F+F+ + ELR +I E
Sbjct: 297 IWHDPDD-----EPVCQKPFDFSFESEDSME-ELRDMIIEE 331
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 188 bits (480), Expect = 4e-56
Identities = 111/319 (34%), Positives = 161/319 (50%), Gaps = 50/319 (15%)
Query: 145 VGTGSFGVVFQAKCLE--TGDSVAIKKVLQDKRYKN-------RELQIMRLLNHPNVVSL 195
+G G++G V++AK G AIKK DK RE+ ++R L H NVVSL
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67
Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQH-VPILYVQLYTYQICRALNYL 254
F +K +YL + +Y ++++ K + + + +P V+ +QI ++YL
Sbjct: 68 VEVFLEHADK-SVYL--LFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYL 124
Query: 255 H--HVVGVCHRDIKPQNLLV---NPHTHQLKICDFGSA----KMLVP---GEPNISYICS 302
H V+ HRD+KP N+LV P +KI D G A L P +P + I
Sbjct: 125 HSNWVL---HRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTI-- 179
Query: 303 RYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESG---------VDQLVEII 353
+YRAPEL+ GA YT AID+W+IGC+ AELL +P+F G DQL I
Sbjct: 180 -WYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIF 238
Query: 354 KILGTPTREE---IKCMNPNY----TEFKFPQIKAHPWHKIFHKRMP--PEALDLVSRLL 404
++LGTPT ++ IK M P Y +FK ++ K K + DL+ +LL
Sbjct: 239 EVLGTPTEKDWPDIKKM-PEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLL 297
Query: 405 QYSPSLRCTALEACAHPFF 423
+Y P+ R TA EA HP+F
Sbjct: 298 EYDPTKRITAEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 186 bits (475), Expect = 9e-56
Identities = 103/299 (34%), Positives = 159/299 (53%), Gaps = 26/299 (8%)
Query: 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKV-LQDKR----YKNRELQIMRLLNHPNV 192
+Y +G GS+ V++ + TG VA+K++ L+ + RE +++ L H N+
Sbjct: 6 TYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANI 65
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY---VQLYTYQICR 249
V+L H T + L LV EY + K Y M+ L V+L+ +Q+ R
Sbjct: 66 VTL-HDIIHTKKT----LTLVFEY----LDTDLKQY--MDDCGGGLSMHNVRLFLFQLLR 114
Query: 250 ALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML-VPGEPNISYICSRYYRAP 308
L Y H V HRD+KPQNLL++ +LK+ DFG A+ VP + + + + +YR P
Sbjct: 115 GLAYCHQR-RVLHRDLKPQNLLIS-ERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPP 172
Query: 309 ELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGV-DQLVEIIKILGTPTREEIK-- 365
+++ G+TEY+T++DMW +GC+ E+ G+PLFPG + V DQL +I ++LGTPT E
Sbjct: 173 DVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGV 232
Query: 366 CMNPNYTEFKFPQIKAHPWHKIFHK-RMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
NP + + FP P + P +L + LQY P R +A EA HP+F
Sbjct: 233 SSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 186 bits (474), Expect = 1e-55
Identities = 103/293 (35%), Positives = 159/293 (54%), Gaps = 30/293 (10%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLKHC 198
+G G++G VF+AK ET + VA+K+V D + RE+ +++ L H N+V L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH-HV 257
S + L LV EY + + K++ N + V+ + +Q+ + L + H H
Sbjct: 68 LHSDKK-----LTLVFEYCDQDL---KKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH- 118
Query: 258 VGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISY---ICSRYYRAPELIFGA 314
V HRD+KPQNLL+N + +LK+ DFG A+ G P Y + + +YR P+++FGA
Sbjct: 119 -NVLHRDLKPQNLLINKNG-ELKLADFGLARAF--GIPVRCYSAEVVTLWYRPPDVLFGA 174
Query: 315 TEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN--PNY 371
Y+T+IDMWS GC+ AEL G+PLFPG DQL I ++LGTPT E ++ P+Y
Sbjct: 175 KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDY 234
Query: 372 TEF-KFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
+ +P + + ++ DL+ LL +P R +A EA HP+F
Sbjct: 235 KPYPMYPATTS--LVNVV-PKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 185 bits (471), Expect = 3e-55
Identities = 100/290 (34%), Positives = 165/290 (56%), Gaps = 24/290 (8%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----RELQIMRLLNHPNVVSLKHCF 199
+G G++ V++ + TG+ VA+K++ D RE+ +M+ L H N+V L H
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRL-HDV 66
Query: 200 FSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQH---VPILYVQLYTYQICRALNYLHH 256
T K L LV EY+ + + K Y + + V+ +TYQ+ + + + H
Sbjct: 67 IHTENK----LMLVFEYMDKDL----KKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE 118
Query: 257 VVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML-VPGEPNISYICSRYYRAPELIFGAT 315
V HRD+KPQNLL+N +LK+ DFG A+ +P + + + +YRAP+++ G+
Sbjct: 119 N-RVLHRDLKPQNLLINKRG-ELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSR 176
Query: 316 EYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN--PNYTE 373
Y+T+ID+WS+GC++AE++ G+PLFPG + DQL++I +I+GTPT ++ P Y +
Sbjct: 177 TYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY-K 235
Query: 374 FKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
FP+ ++F P +DL+ RLLQ +P LR +A +A HP+F
Sbjct: 236 PTFPRYPPQDLQQLF-PHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 184 bits (468), Expect = 7e-55
Identities = 103/299 (34%), Positives = 169/299 (56%), Gaps = 42/299 (14%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLKHC 198
+G G++GVV++A+ TG+ VA+KK+ D + RE+ +++ LNHPN+V L
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQ--HVPILYVQLYTYQICRALNYLH- 255
+ +++LYL V E++ + + K + + +P+ ++ Y +Q+ + L + H
Sbjct: 68 IHT---ENKLYL--VFEFLHQDL----KKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS 118
Query: 256 HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISY---ICSRYYRAPELIF 312
H V HRD+KPQNLL+N +K+ DFG A+ G P +Y + + +YRAPE++
Sbjct: 119 H--RVLHRDLKPQNLLINTEGA-IKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILL 173
Query: 313 GATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYT 372
G Y+TA+D+WS+GC+ AE++ + LFPG+S +DQL I + LGTP + P T
Sbjct: 174 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV----VWPGVT 229
Query: 373 EFK-----FPQIKAHPWHKIFHKRMPP---EALDLVSRLLQYSPSLRCTALEACAHPFF 423
FP+ + K+ +PP + DL+S++L Y P+ R +A A AHPFF
Sbjct: 230 SLPDYKPSFPKWARQDFSKV----VPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 183 bits (466), Expect = 2e-54
Identities = 100/297 (33%), Positives = 164/297 (55%), Gaps = 37/297 (12%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN----------RELQIMRLLNHPNVVS 194
+G G++GVV++ + +TG VA+KK+ R ++ RE+ +++ L HPN+V
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKI----RLESEEEGVPSTAIREISLLKELQHPNIVC 63
Query: 195 LKHCFFSTTEKDELYLNLVLEYISETVYRVSKHY---TRMNQHVPILYVQLYTYQICRAL 251
L+ ++ LYL + E++S + K Y Q++ V+ Y YQI + +
Sbjct: 64 LQDVLM---QESRLYL--IFEFLSMDL----KKYLDSLPKGQYMDAELVKSYLYQILQGI 114
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISY---ICSRYYRAP 308
+ H V HRD+KPQNLL++ + +K+ DFG A+ G P Y + + +YRAP
Sbjct: 115 LFCHSR-RVLHRDLKPQNLLID-NKGVIKLADFGLARAF--GIPVRVYTHEVVTLWYRAP 170
Query: 309 ELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368
E++ G+ Y+T +D+WSIG + AE+ +PLF G+S +DQL I +ILGTPT + +
Sbjct: 171 EVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVT 230
Query: 369 --PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
P+Y FP+ K K + + LDL+ ++L Y P+ R +A +A HP+F
Sbjct: 231 SLPDYKN-TFPKWKKGSLRSAV-KNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 182 bits (465), Expect = 6e-54
Identities = 101/322 (31%), Positives = 152/322 (47%), Gaps = 71/322 (22%)
Query: 146 GTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-------RELQIMRLLNHPNVVSLKHC 198
G G+FG V++A+ ++TG VA+KK+L K+ RE++I++ L HPNVV L
Sbjct: 17 GEGTFGEVYKARQIKTGRVVALKKILM-HNEKDGFPITALREIKILKKLKHPNVVPL--- 72
Query: 199 FFSTTEKDELYLNLVLEYISET------VYRVSK----------HYTRMNQHVPILYVQL 242
+++ +E ++ VY V+ + ++
Sbjct: 73 -----------IDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTES--QIKC 119
Query: 243 YTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK---------MLVPG 293
Y Q+ +NYLH + HRDIK N+L++ + LKI DFG A+ G
Sbjct: 120 YMLQLLEGINYLHEN-HILHRDIKAANILID-NQGILKIADFGLARPYDGPPPNPKGGGG 177
Query: 294 EPNISY---ICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLV 350
Y + +R+YR PEL+ G YTTA+D+W IGCV AE+ +P+ G+S +DQL
Sbjct: 178 GGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLH 237
Query: 351 EIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWH---------KIFHKRMPPEALDLVS 401
I K+ GTPT E P + P H + ++ PE LDL+S
Sbjct: 238 LIFKLCGTPTEETW----PGWR--SLP--GCEGVHSFTNYPRTLEERFGKLGPEGLDLLS 289
Query: 402 RLLQYSPSLRCTALEACAHPFF 423
+LL P R TA +A HP+F
Sbjct: 290 KLLSLDPYKRLTASDALEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 182 bits (463), Expect = 7e-54
Identities = 102/303 (33%), Positives = 169/303 (55%), Gaps = 27/303 (8%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNV 192
Y +G G++GVV++A+ T +++A+KK+ ++ + RE+ +++ + H N+
Sbjct: 4 YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI 63
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYR---VSKHYTRMNQHVPILYVQLYTYQICR 249
V L+ S E L LV EY+ + + S + + N + ++ Y YQI R
Sbjct: 64 VRLQDVVHS-----EKRLYLVFEYLDLDLKKHMDSSPDFAK-NPRL----IKTYLYQILR 113
Query: 250 ALNYLH-HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML-VPGEPNISYICSRYYRA 307
+ Y H H V HRD+KPQNLL++ T+ LK+ DFG A+ +P + + +YRA
Sbjct: 114 GIAYCHSH--RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRA 171
Query: 308 PELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367
PE++ G+ Y+T +D+WS+GC+ AE++ +PLFPG+S +D+L +I +ILGTP E +
Sbjct: 172 PEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGV 231
Query: 368 N--PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDD 425
P+Y FP+ + + P +DL+S++L+ PS R TA A H +F D
Sbjct: 232 TSLPDYKS-AFPKWPPKDLATVV-PTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKD 289
Query: 426 LRD 428
L D
Sbjct: 290 LGD 292
|
Length = 294 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 182 bits (464), Expect = 1e-53
Identities = 109/332 (32%), Positives = 158/332 (47%), Gaps = 55/332 (16%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-------------------RELQIMR 185
+G G++G V +A TG VAIKKV + N REL+IM
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKV-KIIEISNDVTKDRQLVGMCGIHFTTLRELKIMN 75
Query: 186 LLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTY 245
+ H N++ L + E D ++NLV++ ++ + +V R+ V+
Sbjct: 76 EIKHENIMGLVDVY---VEGD--FINLVMDIMASDLKKVVDRKIRLT----ESQVKCILL 126
Query: 246 QICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK-----MLVPGEPNISYI 300
QI LN LH + HRD+ P N+ +N KI DFG A+ +
Sbjct: 127 QILNGLNVLHKWYFM-HRDLSPANIFINSKG-ICKIADFGLARRYGYPPYSDTLSKDETM 184
Query: 301 CSR----------YYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLV 350
R +YRAPEL+ GA +Y A+DMWS+GC+ AELL G+PLFPGE+ +DQL
Sbjct: 185 QRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLG 244
Query: 351 EIIKILGTPTRE---EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYS 407
I ++LGTP + + K + P YTEF + K K +A+DL+ LL+ +
Sbjct: 245 RIFELLGTPNEDNWPQAKKL-PLYTEFTPRKPKD---LKTIFPNASDDAIDLLQSLLKLN 300
Query: 408 PSLRCTALEACAHPFFDDLRDPNTCLPNGRPL 439
P R +A EA H +F DP C P+ P
Sbjct: 301 PLERISAKEALKHEYFKS--DPLPCDPSQLPF 330
|
Length = 335 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 178 bits (453), Expect = 2e-53
Identities = 69/247 (27%), Positives = 116/247 (46%), Gaps = 40/247 (16%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----RELQIMRLLNHPNVVSLKHCF 199
+G G FG V+ A+ +TG VAIK + ++ RE++I++ LNHPN+V L F
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 200 FSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV 258
+DE +L LV+EY ++ + + QI L YLH
Sbjct: 61 -----EDENHLYLVMEYCEGGSLK---DLLKENEGKLSEDEILRILLQILEGLEYLHSN- 111
Query: 259 GVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC-SRYYRAPELIFGATEY 317
G+ HRD+KP+N+L++ ++K+ DFG +K+L + + I + Y APE++ G Y
Sbjct: 112 GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYY 171
Query: 318 TTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTE-FKF 376
+ D+WS+G +L EL +L ++I+ K + + +
Sbjct: 172 SEKSDIWSLGVILYEL-------------PELKDLIR----------KMLQKDPEKRPSA 208
Query: 377 PQIKAHP 383
+I H
Sbjct: 209 KEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 180 bits (458), Expect = 3e-53
Identities = 100/309 (32%), Positives = 157/309 (50%), Gaps = 58/309 (18%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN----------RELQIMRLL---NHPN 191
+G G++G V++A+ L TG VA+KKV R RE+ +++ L HPN
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKV----RVPLSEEGIPLSTLREIALLKQLESFEHPN 62
Query: 192 VVSLKH-CFFSTTEKDELYLNLVLEYISE--TVY--RVSKHYTRMNQHVPILYVQLYTYQ 246
+V L C T++ EL L LV E++ + Y + K +P ++ Q
Sbjct: 63 IVRLLDVCHGPRTDR-ELKLTLVFEHVDQDLATYLSKCPK------PGLPPETIKDLMRQ 115
Query: 247 ICRALNYLH-HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYY 305
+ R +++LH H + HRD+KPQN+LV Q+KI DFG A++ S + + +Y
Sbjct: 116 LLRGVDFLHSHRI--VHRDLKPQNILVT-SDGQVKIADFGLARIYSFEMALTSVVVTLWY 172
Query: 306 RAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIK 365
RAPE++ ++ Y T +DMWS+GC+ AEL +PLF G S DQL +I ++G P+ EE
Sbjct: 173 RAPEVLLQSS-YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEE-- 229
Query: 366 CMNPNYTEFKFPQIKAHPWHKIFHKR-----------MPPEALDLVSRLLQYSPSLRCTA 414
+P+ + P F + E LDL+ ++L ++P R +A
Sbjct: 230 ----------WPRNVSLPRSS-FPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISA 278
Query: 415 LEACAHPFF 423
EA HP+F
Sbjct: 279 FEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 182 bits (462), Expect = 3e-53
Identities = 103/298 (34%), Positives = 166/298 (55%), Gaps = 24/298 (8%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKV-------LQDKRYKNRELQIMRLLNHPNVVSLKH 197
VG+G++G V A TG VAIKK+ L KR REL++++ + H NV+ L
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKR-AYRELRLLKHMKHENVIGLLD 81
Query: 198 CFFSTTEKDELY-LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH 256
F D + LV+ ++ + ++ KH ++++ +Q YQ+ + L Y+H
Sbjct: 82 VFTPDLSLDRFHDFYLVMPFMGTDLGKLMKH-EKLSED----RIQFLVYQMLKGLKYIH- 135
Query: 257 VVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATE 316
G+ HRD+KP NL VN +LKI DFG A+ Y+ +R+YRAPE+I
Sbjct: 136 AAGIIHRDLKPGNLAVNEDC-ELKILDFGLARQ--TDSEMTGYVVTRWYRAPEVILNWMH 192
Query: 317 YTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP----NYT 372
YT +D+WS+GC++AE+L G+PLF G +DQL+EI+K+ GTP++E ++ + NY
Sbjct: 193 YTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYV 252
Query: 373 EFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPN 430
+ K P+ + + + P A++++ ++L R TA EA AHP+F++ DP
Sbjct: 253 K-KLPRFRKKDFRSLL-PNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPE 308
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 178 bits (455), Expect = 4e-53
Identities = 92/292 (31%), Positives = 141/292 (48%), Gaps = 48/292 (16%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKV-LQDKRYKN-----RELQIMRLLNHPNVVSLK 196
++G GSFG V+ A +TG+ +A+K V L + RE++I+ L HPN+V
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIV--- 62
Query: 197 HCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
+ S ++++ LN+ LEY+S ++ + K + ++ + V ++ YT QI L YLH
Sbjct: 63 RYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPV----IRKYTRQILEGLAYLH 118
Query: 256 -HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML---VPGEPNISYICSRYYRAPELI 311
+ G+ HRDIK N+LV+ +K+ DFG AK L GE S + Y+ APE+I
Sbjct: 119 SN--GIVHRDIKGANILVDS-DGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVI 175
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNY 371
G EY A D+WS+GC + E+ G+P + + I G P
Sbjct: 176 RG-EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEP------------ 222
Query: 372 TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
P+I H + EA D + + L+ P R TA E HPF
Sbjct: 223 -----PEIPEH---------LSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 181 bits (461), Expect = 4e-53
Identities = 102/303 (33%), Positives = 161/303 (53%), Gaps = 23/303 (7%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV---LQDKRYKNR---ELQIMRLLNHPNV 192
Y + + VG+G++G V A TG+ VAIKK+ Q + + R EL +++ + H NV
Sbjct: 17 YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENV 76
Query: 193 VSLKHCFFSTTEKDELY-LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
+ L F S DE LV+ Y+ + ++ M + VQ YQ+ L
Sbjct: 77 IGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKI------MGHPLSEDKVQYLVYQMLCGL 130
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELI 311
Y+H G+ HRD+KP NL VN +LKI DFG A+ Y+ +R+YRAPE+I
Sbjct: 131 KYIHSA-GIIHRDLKPGNLAVNEDC-ELKILDFGLARH--ADAEMTGYVVTRWYRAPEVI 186
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN--- 368
Y +D+WS+GC++AE+L G+ LF G+ +DQL +I+K+ G P E ++ +
Sbjct: 187 LNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKA 246
Query: 369 -PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427
+Y + P+ + +F + P+A+DL+ ++L+ R TA EA HP+FD R
Sbjct: 247 AKSYIK-SLPKYPRKDFSTLF-PKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304
Query: 428 DPN 430
D +
Sbjct: 305 DAD 307
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 181 bits (460), Expect = 6e-53
Identities = 99/318 (31%), Positives = 161/318 (50%), Gaps = 42/318 (13%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKK-VLQDKR---YKNRELQIMRLLNHPNVVS 194
YM R +G GS G+VF A + VA+KK VL D + + RE++I+R L+H N+V
Sbjct: 7 YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 66
Query: 195 LKHCFFST-----------TEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLY 243
+ + TE + +Y+ V EY+ + V + +H +L+
Sbjct: 67 VYEVLGPSGSDLTEDVGSLTELNSVYI--VQEYMETDLANVLEQGPLSEEHA-----RLF 119
Query: 244 TYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYI--- 300
YQ+ R L Y+H V HRD+KP N+ +N LKI DFG A+++ P + Y+
Sbjct: 120 MYQLLRGLKYIHSA-NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEG 178
Query: 301 -CSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQL---VEIIKIL 356
+++YR+P L+ YT AIDMW+ GC+ AE+L G+PLF G ++Q+ +E + ++
Sbjct: 179 LVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVV 238
Query: 357 GTPTREEIKCMNPNYTEFKFPQIKAHPW--HKIFHKRMP---PEALDLVSRLLQYSPSLR 411
R E+ + P++ ++ + +P PEALD + ++L ++P R
Sbjct: 239 REEDRNELLNVIPSF-------VRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDR 291
Query: 412 CTALEACAHPFFDDLRDP 429
TA EA HP+ P
Sbjct: 292 LTAEEALMHPYMSCYSCP 309
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 175 bits (445), Expect = 2e-51
Identities = 114/292 (39%), Positives = 166/292 (56%), Gaps = 24/292 (8%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKH 197
VVG G++GVV + + ET + VAIKK K REL+++R L N+V LK
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67
Query: 198 CFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV 257
F + +LYL V EY+ + + + + M VP V+ Y YQ+ +A+++ H
Sbjct: 68 AF---RRRGKLYL--VFEYVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHKN 119
Query: 258 VGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG-EPNIS-YICSRYYRAPELIFGAT 315
+ HRDIKP+NLL++ H LK+CDFG A+ L G N + Y+ +R+YR+PEL+ GA
Sbjct: 120 -DIVHRDIKPENLLIS-HNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAP 177
Query: 316 EYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM--NPNYTE 373
Y A+DMWS+GC+L EL GQPLFPGES +DQL I K+LG E++K NP +
Sbjct: 178 -YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHG 236
Query: 374 FKFPQIKAHP--WHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
+FP + HP + + + LDL+ LL+ +P+ R + HP F
Sbjct: 237 LRFPAV-NHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 175 bits (446), Expect = 1e-50
Identities = 105/306 (34%), Positives = 160/306 (52%), Gaps = 35/306 (11%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKK---VLQD----KRYKNRELQIMRLLNHPNVVS 194
+R +G G+FGVV+ G VA+KK V Q+ KR REL+++ H NV+S
Sbjct: 5 DRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVF-RELKMLCFFKHDNVLS 63
Query: 195 --------LKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQ 246
F +E+Y+ V E + ++++ Q + +V+++ YQ
Sbjct: 64 ALDILQPPHIDPF------EEIYV--VTELMQSDLHKI----IVSPQPLSSDHVKVFLYQ 111
Query: 247 ICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI--SYICSRY 304
I R L YLH G+ HRDIKP NLLVN + LKICDFG A++ P E + ++Y
Sbjct: 112 ILRGLKYLHSA-GILHRDIKPGNLLVNSNC-VLKICDFGLARVEEPDESKHMTQEVVTQY 169
Query: 305 YRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEI 364
YRAPE++ G+ YT+A+D+WS+GC+ AELL + LF +S + QL I +LGTP+ E +
Sbjct: 170 YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAM 229
Query: 365 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPP---EALDLVSRLLQYSPSLRCTALEACAHP 421
+ P + + EA+ L+ R+L + P R +A +A AHP
Sbjct: 230 RSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHP 289
Query: 422 FFDDLR 427
+ D+ R
Sbjct: 290 YLDEGR 295
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 176 bits (445), Expect = 2e-50
Identities = 92/321 (28%), Positives = 138/321 (42%), Gaps = 48/321 (14%)
Query: 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-------RELQIMRLLNHP 190
SY R +G GSFG V+ A+ + VA+K + + K+ RE+QI+ LNHP
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRKL---VALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 191 -NVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICR 249
N+V L F +DE L LV+EY+ + QI
Sbjct: 58 PNIVKLYDFF-----QDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILS 112
Query: 250 ALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI-------SYICS 302
AL YLH G+ HRDIKP+N+L++ +K+ DFG AK+L + + +
Sbjct: 113 ALEYLHSK-GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGT 171
Query: 303 RYYRAPELIFGATE--YTTAIDMWSIGCVLAELLLGQPLFPGESG---VDQLVEIIKILG 357
Y APE++ G + +++ D+WS+G L ELL G P F GE Q ++II L
Sbjct: 172 PGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELP 231
Query: 358 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEA 417
TP A P + + A DL+ +LL P R ++
Sbjct: 232 TP-------------------SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSD 272
Query: 418 CAHPFFDDLRDPNTCLPNGRP 438
+H L+ + L +
Sbjct: 273 LSHDLLAHLKLKESDLSDLLK 293
|
Length = 384 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 164 bits (417), Expect = 1e-47
Identities = 95/292 (32%), Positives = 140/292 (47%), Gaps = 55/292 (18%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKR--YKNRELQIMRLLNHPNVVSLKH 197
+G GSFG V + +TG A+K K+++ K + E I+ +NHP +V L +
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 198 CFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
F + E L LVLEY E +SK R ++ + Y +I AL YLH
Sbjct: 61 AF-----QTEEKLYLVLEYAPGGELFSHLSKE-GRFSEER----ARFYAAEIVLALEYLH 110
Query: 256 HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC-SRYYRAPELIFGA 314
+ G+ +RD+KP+N+L++ H +K+ DFG AK L + C + Y APE++ G
Sbjct: 111 SL-GIIYRDLKPENILLDADGH-IKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGK 168
Query: 315 TEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEF 374
Y A+D WS+G +L E+L G+P F E ++ E KIL
Sbjct: 169 -GYGKAVDWWSLGVLLYEMLTGKPPFYAED-RKEIYE--KIL--------------KDPL 210
Query: 375 KFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEAC---AHPFF 423
+FP + + PEA DL+S LLQ P+ R + A AHPFF
Sbjct: 211 RFP------------EFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 165 bits (419), Expect = 2e-47
Identities = 103/311 (33%), Positives = 170/311 (54%), Gaps = 29/311 (9%)
Query: 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----RELQIMRLLNHPNV 192
+Y+ +G G++ V++ + T + VA+K++ + RE+ +++ L H N+
Sbjct: 7 TYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 66
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHY-----TRMNQHVPILYVQLYTYQI 247
V+L TEK L LV EY+ + + K Y +N H V+L+ +Q+
Sbjct: 67 VTLHDIIH--TEKS---LTLVFEYLDKDL----KQYLDDCGNSINMH----NVKLFLFQL 113
Query: 248 CRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML-VPGEPNISYICSRYYR 306
R LNY H V HRD+KPQNLL+N +LK+ DFG A+ +P + + + + +YR
Sbjct: 114 LRGLNYCHRR-KVLHRDLKPQNLLINERG-ELKLADFGLARAKSIPTKTYSNEVVTLWYR 171
Query: 307 APELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKC 366
P+++ G+T+Y+T IDMW +GC+ E+ G+PLFPG + +QL I +ILGTPT E
Sbjct: 172 PPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPG 231
Query: 367 M--NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFD 424
+ N + + +P+ +A H R+ + +L+S+LLQ+ R +A EA HP+F
Sbjct: 232 ILSNEEFKSYNYPKYRADCLHN-HAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFH 290
Query: 425 DLRDPNTCLPN 435
L + LP+
Sbjct: 291 CLGERIHKLPD 301
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 166 bits (422), Expect = 3e-47
Identities = 108/327 (33%), Positives = 171/327 (52%), Gaps = 54/327 (16%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKK-------VLQDKR-YKNRELQIMRLLNHP 190
Y + +G+G+ G+V A TG +VAIKK V KR Y REL +M+L+NH
Sbjct: 18 YQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAY--RELVLMKLVNHK 75
Query: 191 NVVSLKHCFF---STTEKDELYLNLVLEYISETVYRVSKHYTRMN-QHVPILYVQLYTYQ 246
N++ L + F S E ++YL V+E + + +V +M+ H + Y+ YQ
Sbjct: 76 NIIGLLNVFTPQKSLEEFQDVYL--VMELMDANLCQV----IQMDLDHERMSYL---LYQ 126
Query: 247 ICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK------MLVPGEPNISYI 300
+ + +LH G+ HRD+KP N++V LKI DFG A+ M+ P Y+
Sbjct: 127 MLCGIKHLHSA-GIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMMTP------YV 178
Query: 301 CSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPT 360
+RYYRAPE+I G Y +D+WS+GC++ E++ G LFPG +DQ +II+ LGTP+
Sbjct: 179 VTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPS 237
Query: 361 REEIKCMNP---NYTEFKFPQIKAHPWHKIF------------HKRMPPEALDLVSRLLQ 405
E + + P NY E + P+ + + ++F +K +A DL+S++L
Sbjct: 238 DEFMSRLQPTVRNYVENR-PKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLV 296
Query: 406 YSPSLRCTALEACAHPFFDDLRDPNTC 432
P R + +A HP+ + DP+
Sbjct: 297 IDPEKRISVDDALQHPYINVWYDPSEV 323
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 165 bits (418), Expect = 7e-47
Identities = 101/304 (33%), Positives = 157/304 (51%), Gaps = 24/304 (7%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV------LQDKRYKNRELQIMRLLNHPNV 192
Y VG+G++G V A VA+KK+ L R REL++++ + H NV
Sbjct: 17 YQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENV 76
Query: 193 VSLKHCFFSTT---EKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICR 249
+ L F T +E+YL V + + + K ++HV Q YQ+ R
Sbjct: 77 IGLLDVFTPATSIENFNEVYL--VTNLMGADLNNIVKCQKLSDEHV-----QFLIYQLLR 129
Query: 250 ALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPE 309
L Y+H G+ HRD+KP N+ VN +L+I DFG A+ + Y+ +R+YRAPE
Sbjct: 130 GLKYIHSA-GIIHRDLKPSNVAVNEDC-ELRILDFGLARQ--ADDEMTGYVATRWYRAPE 185
Query: 310 LIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369
++ Y +D+WS+GC++AELL G+ LFPG +DQL I++++GTP+ E +K ++
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISS 245
Query: 370 NYTEFKF---PQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426
+ P + KIF + P A+DL+ ++L R +A EA AHP+F
Sbjct: 246 EHARKYIQSLPHMPQQDLKKIF-RGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQY 304
Query: 427 RDPN 430
DP
Sbjct: 305 HDPE 308
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 165 bits (418), Expect = 7e-47
Identities = 101/298 (33%), Positives = 156/298 (52%), Gaps = 24/298 (8%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKK-------VLQDKRYKNRELQIMRLLNHPNVVSLKH 197
VG+G++G V A +TG VA+KK ++ KR REL++++ + H NV+ L
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 83
Query: 198 CFFSTTEKDELY-LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH 256
F +E + LV + + + K + HV Q YQI R L Y+H
Sbjct: 84 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV-----QFLIYQILRGLKYIHS 138
Query: 257 VVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATE 316
+ HRD+KP NL VN +LKI DFG A+ + Y+ +R+YRAPE++
Sbjct: 139 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 194
Query: 317 YTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP----NYT 372
Y +D+WS+GC++AELL G+ LFPG +DQL I++++GTP E +K ++ NY
Sbjct: 195 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 254
Query: 373 EFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPN 430
+ Q+ + +F P A+DL+ ++L R TA +A AH +F DP+
Sbjct: 255 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 310
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 161 bits (411), Expect = 1e-46
Identities = 81/287 (28%), Positives = 129/287 (44%), Gaps = 46/287 (16%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKV-LQDKRYKN---RELQIMRLLNHPNVVSLKHC 198
+G G FG V++A+ TG VAIK + L+ K K E+QI++ HPN+V
Sbjct: 6 EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGS 65
Query: 199 FFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH-- 255
+ +KDEL+ +V+E+ S ++ + K + I YV ++ + L YLH
Sbjct: 66 YL---KKDELW--IVMEFCSGGSLKDLLKSTNQTLTESQIAYV---CKELLKGLEYLHSN 117
Query: 256 HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGAT 315
++ HRDIK N+L+ ++K+ DFG + L + + + + Y+ APE+I G
Sbjct: 118 GII---HRDIKAANILLT-SDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVING-K 172
Query: 316 EYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFK 375
Y D+WS+G EL G+P + E + + I G P +
Sbjct: 173 PYDYKADIWSLGITAIELAEGKPPY-SELPPMKALFKIATNGPPG-------------LR 218
Query: 376 FPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPF 422
P W F D + + LQ +P R TA + HPF
Sbjct: 219 NP----EKWSDEFK--------DFLKKCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 160 bits (407), Expect = 6e-46
Identities = 101/300 (33%), Positives = 163/300 (54%), Gaps = 31/300 (10%)
Query: 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----RELQIMRLLNHPNV 192
+Y+ +G G++ VF+ + T + VA+K++ + RE+ +++ L H N+
Sbjct: 6 TYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANI 65
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHY-----TRMNQHVPILYVQLYTYQI 247
V+L H T E L LV EY+ + K Y M+ H V+++ +Q+
Sbjct: 66 VTL-HDIIHT----ERCLTLVFEYLDSDL----KQYLDNCGNLMSMH----NVKIFMFQL 112
Query: 248 CRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM-LVPGEPNISYICSRYYR 306
R L+Y H + HRD+KPQNLL+N +LK+ DFG A+ VP + + + + +YR
Sbjct: 113 LRGLSYCHKR-KILHRDLKPQNLLINEKG-ELKLADFGLARAKSVPTKTYSNEVVTLWYR 170
Query: 307 APELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIK- 365
P+++ G+TEY+T IDMW +GC+L E+ G+P+FPG + ++L I ++LGTPT E
Sbjct: 171 PPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPG 230
Query: 366 -CMNPNYTEFKFPQIKAHPWHKIFH-KRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
N + + FPQ +A P I H R+ + +DL+S LL Y R +A A H +F
Sbjct: 231 ITSNEEFRSYLFPQYRAQPL--INHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 160 bits (405), Expect = 1e-45
Identities = 102/300 (34%), Positives = 161/300 (53%), Gaps = 28/300 (9%)
Query: 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPN 191
SY+ +G GS+ V++ G VA+K V+ K + RE +++ L H N
Sbjct: 6 SYLNLEKLGEGSYATVYKGISRINGQLVALK-VISMKTEEGVPFTAIREASLLKGLKHAN 64
Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY---VQLYTYQIC 248
+V L H T E L V EY+ + + M QH L+ V+L+ +Q+
Sbjct: 65 IVLL-HDIIHTKET----LTFVFEYMHTDLAQY------MIQHPGGLHPYNVRLFMFQLL 113
Query: 249 RALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML-VPGEPNISYICSRYYRA 307
R L Y+H + HRD+KPQNLL++ + +LK+ DFG A+ +P + S + + +YR
Sbjct: 114 RGLAYIHGQ-HILHRDLKPQNLLIS-YLGELKLADFGLARAKSIPSQTYSSEVVTLWYRP 171
Query: 308 PELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGV-DQLVEIIKILGTPTREEIKC 366
P+++ GAT+Y++A+D+W GC+ E+L GQP FPG S V +QL +I +LG PT +
Sbjct: 172 PDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPG 231
Query: 367 MN--PNYTEFKFPQIKAHPWHKIFHK-RMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
++ PNY F K ++ + PP+A DL S++L P R +A +A HP+F
Sbjct: 232 VSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 159 bits (403), Expect = 4e-45
Identities = 95/306 (31%), Positives = 147/306 (48%), Gaps = 45/306 (14%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLKH 197
+G G++G V++A+ +TG+ VA+KKV D + RE++I+R LNH N+V+LK
Sbjct: 14 QIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKE 73
Query: 198 CFFSTTE-----KDELYLNLVLEYISETVYRV--SKHYTRMNQHVPILYVQLYTYQICRA 250
+ KD+ LV EY+ + + S H+ QL
Sbjct: 74 IVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLL-----EG 128
Query: 251 LNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGE--PNISYICSRYYRAP 308
LNY H HRDIK N+L+N + Q+K+ DFG A++ E P + + + +YR P
Sbjct: 129 LNYCHKK-NFLHRDIKCSNILLN-NKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPP 186
Query: 309 ELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368
EL+ G Y AID+WS GC+L EL +P+F + QL I ++ G+P +
Sbjct: 187 ELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPC----PAVW 242
Query: 369 PNYTEFKFPQIKAHPWHKIFHKRM------------PPEALDLVSRLLQYSPSLRCTALE 416
P+ + + ++ + K+ P ALDL+ +L PS RCTA E
Sbjct: 243 PDVIKLPY-------FNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEE 295
Query: 417 ACAHPF 422
A P+
Sbjct: 296 ALNSPW 301
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 159 bits (402), Expect = 5e-45
Identities = 101/299 (33%), Positives = 167/299 (55%), Gaps = 23/299 (7%)
Query: 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----RELQIMRLLNHPNV 192
+Y+ +G G++ VF+ + T + VA+K++ + RE+ +++ L H N+
Sbjct: 7 TYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 66
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY-VQLYTYQICRAL 251
V+L H T + L LV EY+ + + K Y ++ ++ V+++ YQI R L
Sbjct: 67 VTL-HDIVHTDKS----LTLVFEYLDKDL----KQYMDDCGNIMSMHNVKIFLYQILRGL 117
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML-VPGEPNISYICSRYYRAPEL 310
Y H V HRD+KPQNLL+N +LK+ DFG A+ VP + + + + +YR P++
Sbjct: 118 AYCHRR-KVLHRDLKPQNLLINERG-ELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDV 175
Query: 311 IFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPN 370
+ G++EY+T IDMW +GC+ E+ G+PLFPG + D+L I ++LGTPT E ++ N
Sbjct: 176 LLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSN 235
Query: 371 --YTEFKFPQIKAHPWHKIFHK-RMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426
+ + FP+ K P I H R+ E ++L+++ LQY R +A EA H +F L
Sbjct: 236 DEFKNYNFPKYKPQPL--INHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL 292
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 151 bits (384), Expect = 1e-42
Identities = 85/306 (27%), Positives = 130/306 (42%), Gaps = 70/306 (22%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV------LQDKRYKNRELQIMRLLNHPNV 192
Y + +G GSFG V+ + G +K++ +++ E++I++ LNHPN+
Sbjct: 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNI 61
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVP---ILYVQLYTYQIC 248
+ F EK L +V+EY + + K + + P IL + Q+C
Sbjct: 62 IKYYESFE---EKG--KLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILD---WFVQLC 113
Query: 249 RALNYLH--HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML---------VPGEPNI 297
AL YLH ++ HRDIKPQN+ + +K+ DFG +K+L V G P
Sbjct: 114 LALKYLHSRKIL---HRDIKPQNIFLT-SNGLVKLGDFGISKVLSSTVDLAKTVVGTP-- 167
Query: 298 SYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILG 357
YY +PEL Y D+WS+GCVL EL + F GE+ + +L KIL
Sbjct: 168 ------YYLSPELCQNK-PYNYKSDIWSLGCVLYELCTLKHPFEGEN-LLELAL--KIL- 216
Query: 358 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEA 417
+ + + Y E +LVS LLQ P R + +
Sbjct: 217 ---KGQYPPIPSQY---------------------SSELRNLVSSLLQKDPEERPSIAQI 252
Query: 418 CAHPFF 423
PF
Sbjct: 253 LQSPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 147 bits (371), Expect = 1e-40
Identities = 101/305 (33%), Positives = 161/305 (52%), Gaps = 32/305 (10%)
Query: 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKV-LQDKR----YKNRELQIMRLLNHPNV 192
SY +G GS+ V++ K G VA+K + LQ++ RE +++ L H N+
Sbjct: 6 SYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANI 65
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY---VQLYTYQICR 249
V L H T E L LV EY+ + + M++H L+ V+L+ +Q+ R
Sbjct: 66 VLL-HDIIHTKET----LTLVFEYVHTDLCQY------MDKHPGGLHPENVKLFLFQLLR 114
Query: 250 ALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM-LVPGEPNISYICSRYYRAP 308
L+Y+H + HRD+KPQNLL++ T +LK+ DFG A+ VP + + + +YR P
Sbjct: 115 GLSYIHQRY-ILHRDLKPQNLLIS-DTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPP 172
Query: 309 ELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGV-DQLVEIIKILGTPTREEIKCM 367
+++ G+TEY+T +DMW +GC+ E++ G FPG + DQL I +LGTP + +
Sbjct: 173 DVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGV 232
Query: 368 N--PNYTEFKFPQIKA----HPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHP 421
+ P++ +F W+K+ + A DL S+LLQ P R +A A +H
Sbjct: 233 HSLPHFKPERFTLYSPKNLRQAWNKLSYVN---HAEDLASKLLQCFPKNRLSAQAALSHE 289
Query: 422 FFDDL 426
+F DL
Sbjct: 290 YFSDL 294
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 145 bits (369), Expect = 4e-40
Identities = 90/300 (30%), Positives = 141/300 (47%), Gaps = 30/300 (10%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLKH- 197
+G G+FG VF+A+ +T VA+KKVL + + RE++I++LL H NVV+L
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 79
Query: 198 CFFSTTE----KDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTY--QICRAL 251
C T K YL V E+ + + N++V ++ + L
Sbjct: 80 CRTKATPYNRYKGSFYL--VFEFCEHDLAGLLS-----NKNVKFTLSEIKKVMKMLLNGL 132
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV---PGEPN--ISYICSRYYR 306
Y+H + HRD+K N+L+ LK+ DFG A+ +PN + + + +YR
Sbjct: 133 YYIHRN-KILHRDMKAANILITKDG-ILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYR 190
Query: 307 APELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEI-K 365
PEL+ G +Y IDMW GC++AE+ P+ G + QL I ++ G+ T E
Sbjct: 191 PPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPG 250
Query: 366 CMN-PNYTEFKFPQ-IKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
+ + + PQ K ++ P ALDL+ +LL P+ R A A H FF
Sbjct: 251 VDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 2e-39
Identities = 90/323 (27%), Positives = 138/323 (42%), Gaps = 83/323 (25%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRE----------LQIMRLLN 188
+ +++G GSF V AK ET AI K+L DKR +E + RL
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAI-KIL-DKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 189 HPNVVSLKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQI 247
HP ++ L + F +DE L VLEY + + + Y +++ + Y +I
Sbjct: 61 HPGIIKLYYTF-----QDEENLYFVLEYAPNGELLQYIRKYGSLDEKC----TRFYAAEI 111
Query: 248 CRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML----VPGEPNISYICSR 303
AL YLH G+ HRD+KP+N+L++ H +KI DFG+AK+L P
Sbjct: 112 LLALEYLHS-KGIIHRDLKPENILLDKDMH-IKITDFGTAKVLDPNSSPESNKGDATNID 169
Query: 304 Y-----------------YRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGV 346
Y +PEL+ + D+W++GC++ ++L G+P F G +
Sbjct: 170 SQIEKNRRRFASFVGTAEYVSPELL-NEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN-- 226
Query: 347 DQLV--EIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLL 404
+ L +I+K+ E+ FP PP+A DL+ +LL
Sbjct: 227 EYLTFQKILKL-----------------EYSFPPN------------FPPDAKDLIEKLL 257
Query: 405 QYSPSLRCTALEAC----AHPFF 423
P R E AHPFF
Sbjct: 258 VLDPQDRLGVNEGYDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 1e-37
Identities = 85/292 (29%), Positives = 139/292 (47%), Gaps = 50/292 (17%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKV-LQDKRYKN-----RELQIMRLLNHPNVVSLKHC 198
+G G+FG V+ A L+TG+ +A+K++ +QD K E++++ LL HPN+V
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVK---Y 64
Query: 199 FFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV 257
+ ++++Y + +EY S T+ + +H +++HV +++YT Q+ L YLH
Sbjct: 65 YGVEVHREKVY--IFMEYCSGGTLEELLEHGRILDEHV----IRVYTLQLLEGLAYLHS- 117
Query: 258 VGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML-----VPGEPNISYICSRYYRAPELIF 312
G+ HRDIKP N+ ++ H +K+ DFG A L GE S + Y APE+I
Sbjct: 118 HGIVHRDIKPANIFLD-HNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVIT 176
Query: 313 GAT--EYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPN 370
G + A D+WS+GCV+ E+ G+ + Q++ + P
Sbjct: 177 GGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPP---------- 226
Query: 371 YTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPF 422
P ++ PE D + R L+ P R TA E HPF
Sbjct: 227 -----IPD----------SLQLSPEGKDFLDRCLESDPKKRPTASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 1e-36
Identities = 97/312 (31%), Positives = 160/312 (51%), Gaps = 31/312 (9%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV---LQDKRYKNR---ELQIMRLLNHPNV 192
Y + +G+G+ G+V A G +VA+KK+ Q++ + R EL +++ +NH N+
Sbjct: 23 YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNI 82
Query: 193 VSLKHCFFSTTEKDELY-LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
+SL + F +E + LV+E + + +V H ++ + L YQ+ +
Sbjct: 83 ISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVI-HMELDHERMSYLL-----YQMLCGI 136
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELI 311
+LH G+ HRD+KP N++V LKI DFG A+ Y+ +RYYRAPE+I
Sbjct: 137 KHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTACTNFMMTPYVVTRYYRAPEVI 194
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP-- 369
G Y +D+WS+GC++ EL+ G +F G +DQ ++I+ LGTP+ E + + P
Sbjct: 195 LG-MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTV 253
Query: 370 -NYTEFKFPQIKAHPWHKIFHKRMPP-----------EALDLVSRLLQYSPSLRCTALEA 417
NY E + PQ + ++F + P +A DL+S++L P R + EA
Sbjct: 254 RNYVENR-PQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEA 312
Query: 418 CAHPFFDDLRDP 429
HP+ DP
Sbjct: 313 LRHPYITVWYDP 324
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 1e-36
Identities = 89/290 (30%), Positives = 138/290 (47%), Gaps = 48/290 (16%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVL---QDKRYK------NRELQIMRLLNHPNVV 193
++G+GSFG V++ L+ GD A+K+V + + +E+ ++ L HPN+V
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
+ TE++E L + LE + ++ ++ K Y + V ++LYT QI L
Sbjct: 66 Q-----YLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPV----IRLYTRQILLGLE 116
Query: 253 YLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIF 312
YLH HRDIK N+LV+ +K+ DFG AK +V S+ S Y+ APE+I
Sbjct: 117 YLHDR-NTVHRDIKGANILVDT-NGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIA 174
Query: 313 GATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYT 372
Y A D+WS+GC + E+ G+P + S ++ + + KI + I
Sbjct: 175 QQGGYGLAADIWSLGCTVLEMATGKPPW---SQLEGVAAVFKIGRSKELPPI-------- 223
Query: 373 EFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPF 422
P H + EA D + + LQ PSLR TA E HPF
Sbjct: 224 ----------PDH------LSDEAKDFILKCLQRDPSLRPTAAELLEHPF 257
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 2e-36
Identities = 92/301 (30%), Positives = 136/301 (45%), Gaps = 63/301 (20%)
Query: 148 GSFGVVFQAKCLETGDSVAIKKV-LQDKRYKNR------ELQIMRLLNHPNVVSLKHCFF 200
G++G VF AK TGD AIK + D KN+ E I+ P VV L ++
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL---YY 60
Query: 201 STTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG 259
S K LYL V+EY+ + + ++ +++ V ++Y +I AL YLH G
Sbjct: 61 SFQGKKNLYL--VMEYLPGGDLASLLENVGSLDEDV----ARIYIAEIVLALEYLHSN-G 113
Query: 260 VCHRDIKPQNLLVNPHTHQLKICDFG---------SAKMLVPGEPNISYICSRYYRAPEL 310
+ HRD+KP N+L++ + H LK+ DFG + + + + + Y APE+
Sbjct: 114 IIHRDLKPDNILIDSNGH-LKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEV 172
Query: 311 IFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPN 370
I G ++ +D WS+GC+L E L+G P F GE T EEI
Sbjct: 173 ILGQG-HSKTVDWWSLGCILYEFLVGIPPFHGE----------------TPEEI------ 209
Query: 371 YTEFKFPQIKAH--PWHKIFHKRMPPEALDLVSRLLQYSPSLRCTAL---EACAHPFFDD 425
F I W + + EA+DL+S+LL P R A E HPFF
Sbjct: 210 -----FQNILNGKIEWPEDVE--VSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKG 262
Query: 426 L 426
+
Sbjct: 263 I 263
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 5e-36
Identities = 99/312 (31%), Positives = 162/312 (51%), Gaps = 31/312 (9%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV---LQDKRYKNR---ELQIMRLLNHPNV 192
Y + +G+G+ G+V A +VAIKK+ Q++ + R EL +M+ +NH N+
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 193 VSLKHCFFSTTEKDELY-LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
+SL + F +E + LV+E + + +V + H + Y+ YQ+ +
Sbjct: 79 ISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMEL---DHERMSYL---LYQMLCGI 132
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELI 311
+LH G+ HRD+KP N++V LKI DFG A+ Y+ +RYYRAPE+I
Sbjct: 133 KHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 190
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP-- 369
G Y +D+WS+GC++ E++ + LFPG +DQ ++I+ LGTP E +K + P
Sbjct: 191 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249
Query: 370 -NYTEFKFPQIKAHPWHKIFHKRMPP-----------EALDLVSRLLQYSPSLRCTALEA 417
NY E + P+ + K+F + P +A DL+S++L P+ R + EA
Sbjct: 250 RNYVENR-PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEA 308
Query: 418 CAHPFFDDLRDP 429
HP+ + DP
Sbjct: 309 LQHPYINVWYDP 320
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (333), Expect = 1e-35
Identities = 81/288 (28%), Positives = 139/288 (48%), Gaps = 48/288 (16%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKV-LQDKRYKN-----RELQIMRLLNHPNVVSLKH 197
++G G+FGVV++ LETGD VAIK++ L+ + + +E+ +++ L HPN+V
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66
Query: 198 CFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH 256
+ L ++LEY ++ ++ K + + + +YV YQ+ + L YLH
Sbjct: 67 SI-----ETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYV----YQVLQGLAYLHE 117
Query: 257 VVGVCHRDIKPQNLLVNPHTHQLKICDFGSA-KMLVPGEPNISYICSRYYRAPELIFGAT 315
GV HRDIK N+L +K+ DFG A K+ + + S + + Y+ APE+I +
Sbjct: 118 -QGVIHRDIKAANILTTKDGV-VKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEM-S 174
Query: 316 EYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFK 375
+TA D+WS+GC + ELL G P + ++ + + +I+
Sbjct: 175 GASTASDIWSLGCTVIELLTGNPPY---YDLNPMAALFRIVQDD---------------- 215
Query: 376 FPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
H + + PE D + + Q P+LR TA + HP+
Sbjct: 216 ---------HPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 2e-35
Identities = 97/312 (31%), Positives = 160/312 (51%), Gaps = 31/312 (9%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV---LQDKRYKNR---ELQIMRLLNHPNV 192
Y + +G+G+ G+V A +VAIKK+ Q++ + R EL +M+ +NH N+
Sbjct: 26 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 193 VSLKHCFFSTTEKDELY-LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
+ L + F +E + +V+E + + +V + H + Y+ YQ+ +
Sbjct: 86 IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMEL---DHERMSYL---LYQMLCGI 139
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELI 311
+LH G+ HRD+KP N++V LKI DFG A+ Y+ +RYYRAPE+I
Sbjct: 140 KHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP-- 369
G Y +D+WS+GC++ E++ G LFPG +DQ ++I+ LGTP E +K + P
Sbjct: 198 LGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 256
Query: 370 -NYTEFKFPQIKAHPWHKIFHKRMPP-----------EALDLVSRLLQYSPSLRCTALEA 417
Y E + P+ + + K+F + P +A DL+S++L S R + EA
Sbjct: 257 RTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315
Query: 418 CAHPFFDDLRDP 429
HP+ + DP
Sbjct: 316 LQHPYINVWYDP 327
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 130 bits (330), Expect = 9e-35
Identities = 84/299 (28%), Positives = 139/299 (46%), Gaps = 60/299 (20%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKRYK--NRELQIMRLLNHPNVVSL 195
+ +GTGSFG V + +G A+K K+++ K+ + E +I++ + HP +V+L
Sbjct: 7 KTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNL 66
Query: 196 KHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
F +D+ L LV+EY+ E + R + P + Y Q+ AL Y
Sbjct: 67 YGSF-----QDDSNLYLVMEYVPGGELF-----SHLRKSGRFPEPVARFYAAQVVLALEY 116
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC-SRYYRAPELIF 312
LH + + +RD+KP+NLL++ + +KI DFG AK + + +C + Y APE+I
Sbjct: 117 LHS-LDIVYRDLKPENLLLDSDGY-IKITDFGFAKRV---KGRTYTLCGTPEYLAPEIIL 171
Query: 313 GATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYT 372
Y A+D W++G ++ E+L G P F ++ Q+ E KIL
Sbjct: 172 S-KGYGKAVDWWALGILIYEMLAGYPPFFDDN-PIQIYE--KILE--------------G 213
Query: 373 EFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA-----HPFFDDL 426
+ +FP P+A DL+ LLQ + R L+ HP+F +
Sbjct: 214 KVRFP------------SFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGI 260
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 3e-34
Identities = 88/292 (30%), Positives = 136/292 (46%), Gaps = 54/292 (18%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKVL----QDKRYK-NRELQIMRLLNHPNVVSLKHC 198
V+G GS GVV++ + TG A+KK+ ++ R + REL+ +R P VV
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67
Query: 199 FFSTTEKDELYLNLVLEY-----ISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
F+ E +++VLEY +++ + +V K +P + QI + L+Y
Sbjct: 68 FYK-----EGEISIVLEYMDGGSLADLLKKVGK--------IPEPVLAYIARQILKGLDY 114
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG-EPNISYICSRYYRAPELIF 312
LH + HRDIKP NLL+N ++KI DFG +K+L + +++ + Y +PE I
Sbjct: 115 LHTKRHIIHRDIKPSNLLIN-SKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQ 173
Query: 313 GATEYTTAIDMWSIGCVLAELLLGQ-P-LFPGESGVDQLVEIIKILGTPTREEIKCMNPN 370
G + Y+ A D+WS+G L E LG+ P L PG+ +L++ I C P
Sbjct: 174 GES-YSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI------------CDGPP 220
Query: 371 YTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPF 422
+ PE D +S LQ P R +A E HPF
Sbjct: 221 P----SLP----------AEEFSPEFRDFISACLQKDPKKRPSAAELLQHPF 258
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 6e-34
Identities = 94/292 (32%), Positives = 153/292 (52%), Gaps = 23/292 (7%)
Query: 145 VGTGSFGVVFQAKCLETGDS-VAIKKVLQDKRYKN------RELQIMRLLN---HPNVVS 194
+G G++G VF+A+ L+ G VA+K+V + RE+ ++R L HPNVV
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 195 L-KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
L C S T++ E L LV E++ + + VP ++ +Q+ R L++
Sbjct: 69 LFDVCTVSRTDR-ETKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDF 125
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFG 313
LH V HRD+KPQN+LV + Q+K+ DFG A++ S + + +YRAPE++
Sbjct: 126 LHSH-RVVHRDLKPQNILVTS-SGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ 183
Query: 314 ATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTE 373
++ Y T +D+WS+GC+ AE+ +PLF G S VDQL +I+ ++G P E+ P
Sbjct: 184 SS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW----PRDVA 238
Query: 374 FKFPQIKAHPWHKI--FHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
+ I F + DL+ + L ++P+ R +A A +HP+F
Sbjct: 239 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 128 bits (322), Expect = 9e-34
Identities = 83/294 (28%), Positives = 142/294 (48%), Gaps = 28/294 (9%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN----------RELQIMRLL---NHPN 191
+G G++G V++A+ +G VA+K V R + RE+ +++ L +HPN
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSV----RVQTNEDGLPLSTVREVALLKRLEAFDHPN 63
Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRM--NQHVPILYVQLYTYQICR 249
+V L ++ E + LV E++ + + + Y +P ++ Q R
Sbjct: 64 IVRLMDVCATSRTDRETKVTLVFEHVDQDL----RTYLDKVPPPGLPAETIKDLMRQFLR 119
Query: 250 ALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPE 309
L++LH + HRD+KP+N+LV Q+K+ DFG A++ + + +YRAPE
Sbjct: 120 GLDFLH-ANCIVHRDLKPENILVTSGG-QVKLADFGLARIYSCQMALTPVVVTLWYRAPE 177
Query: 310 LIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369
++ +T Y T +DMWS+GC+ AE+ +PLF G S DQL +I ++G P ++ +
Sbjct: 178 VLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP-RDV 235
Query: 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
F P + L+ +L ++P R +A A HPFF
Sbjct: 236 TLPRGAFSPRGPRPVQS-VVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 9e-34
Identities = 81/288 (28%), Positives = 133/288 (46%), Gaps = 48/288 (16%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKV-LQDKRYKN--RELQIMRLLNHPNVVSLKHCFF 200
+G G+ G V++A TG VAIKK+ L+ + + E+ IM+ HPN+V +
Sbjct: 26 KIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSY- 84
Query: 201 STTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH--H 256
L +V+EY+ +++++ RMN+ I YV ++ + L YLH +
Sbjct: 85 ----LVGDELWVVMEYMDGGSLTDIITQNFVRMNEP-QIAYVCR---EVLQGLEYLHSQN 136
Query: 257 VVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPN-ISYICSRYYRAPELIFGAT 315
V+ HRDIK N+L++ +K+ DFG A L + S + + Y+ APE+I
Sbjct: 137 VI---HRDIKSDNILLS-KDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKR-K 191
Query: 316 EYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFK 375
+Y +D+WS+G + E+ G+P + E + L +I G P +K NP
Sbjct: 192 DYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALF-LITTKGIP---PLK--NPE----- 240
Query: 376 FPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
+ PE D +++ L P R +A E HPF
Sbjct: 241 ---------------KWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 124 bits (315), Expect = 7e-33
Identities = 68/236 (28%), Positives = 109/236 (46%), Gaps = 44/236 (18%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS----VAIKKVLQDKRYKN-----RELQIMRLLNHPNV 192
+ +G G+FG V++ GD VA+K + +D + RE +IMR L+HPN+
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL--YTYQICRA 250
V L TE++ L +V+EY+ Y R N+ + L + QI R
Sbjct: 64 VKLLGV---CTEEEPLM--IVMEYMP---GGDLLDYLRKNRPKELSLSDLLSFALQIARG 115
Query: 251 LNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR---- 306
+ YL HRD+ +N LV +KI DFG ++ L + YY+
Sbjct: 116 MEYLES-KNFIHRDLAARNCLVG-ENLVVKISDFGLSRDLYDDD---------YYKVKGG 164
Query: 307 -------APELIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVDQLVEIIK 354
APE + ++T+ D+WS G +L E+ LG+ +PG S +++E +K
Sbjct: 165 KLPIRWMAPESLK-EGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMS-NAEVLEYLK 218
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 2e-32
Identities = 101/316 (31%), Positives = 158/316 (50%), Gaps = 44/316 (13%)
Query: 145 VGTGSFGVVFQAKCLETGDS--VAIKKVLQD--KRYKNRELQIMRLLNHPNVVSLKHCFF 200
VG G++G V++AK + D A+K++ RE+ ++R L HPNV+SL+ F
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68
Query: 201 STTEKDELYLNLVLEYISETVYRVSKHY--TRMNQ---HVPILYVQLYTYQICRALNYLH 255
S ++ + L+ +Y ++ + K + ++ N+ +P V+ YQI ++YLH
Sbjct: 69 SHADRK---VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 125
Query: 256 HVVGVCHRDIKPQNLLV---NPHTHQLKICDFGSAKM----LVPGEPNISYICSRYYRAP 308
V HRD+KP N+LV P ++KI D G A++ L P + + +YRAP
Sbjct: 126 -ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184
Query: 309 ELIFGATEYTTAIDMWSIGCVLAELLLGQPLF---------PGESGVDQLVEIIKILGTP 359
EL+ GA YT AID+W+IGC+ AELL +P+F DQL I ++G P
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFP 244
Query: 360 TR---EEIKCMNPNYTEFK-FPQ--------IKAHPWHKIFHKRMPPEALDLVSRLLQYS 407
E+IK M + T K F + IK HK+ + +A L+ +LL
Sbjct: 245 ADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKV---KPDSKAFHLLQKLLTMD 301
Query: 408 PSLRCTALEACAHPFF 423
P R T+ +A P+F
Sbjct: 302 PIKRITSEQAMQDPYF 317
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 3e-31
Identities = 73/291 (25%), Positives = 124/291 (42%), Gaps = 47/291 (16%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVL--QDKRYKN---RELQIMRLLNHPNVVSLKH 197
+G G+ GVV + TG +A+K + ++ + REL I+ N P +V
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYG 66
Query: 198 CFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV 257
F++ + +++ +EY+ + K + +P + + + L YLH
Sbjct: 67 AFYNNGD-----ISICMEYMDGG--SLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEK 119
Query: 258 VGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEY 317
+ HRD+KP N+LVN Q+K+CDFG + LV +++ + Y APE I G +Y
Sbjct: 120 HKIIHRDVKPSNILVN-SRGQIKLCDFGVSGQLVNSLAK-TFVGTSSYMAPERIQG-NDY 176
Query: 318 TTAIDMWSIGCVLAELLLGQPLFPGESG-----VDQLVEIIKILGTPTREEIKCMNPNYT 372
+ D+WS+G L EL G+ +P E+ + L I+ P
Sbjct: 177 SVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN------------EPP--- 221
Query: 373 EFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
P++ + + P+ D V+ L P R + E HPF
Sbjct: 222 ----PRLPSGKF--------SPDFQDFVNLCLIKDPRERPSYKELLEHPFI 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 4e-31
Identities = 97/314 (30%), Positives = 159/314 (50%), Gaps = 40/314 (12%)
Query: 145 VGTGSFGVVFQAKCLETGDS--VAIKKVLQD--KRYKNRELQIMRLLNHPNVVSLKHCFF 200
VG G++G V++AK + D A+K++ RE+ ++R L HPNV++L+ F
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68
Query: 201 STTEKDELYLNLVLEYISETVYRVSKHY--TRMNQ---HVPILYVQLYTYQICRALNYLH 255
S +++ + L+ +Y ++ + K + ++ N+ +P V+ YQI ++YLH
Sbjct: 69 SHSDRK---VWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH 125
Query: 256 HVVGVCHRDIKPQNLLV---NPHTHQLKICDFGSAKM----LVPGEPNISYICSRYYRAP 308
V HRD+KP N+LV P ++KI D G A++ L P + + +YRAP
Sbjct: 126 -ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184
Query: 309 ELIFGATEYTTAIDMWSIGCVLAELLLGQPLF---------PGESGVDQLVEIIKILGTP 359
EL+ GA YT AID+W+IGC+ AELL +P+F DQL I ++G P
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFP 244
Query: 360 TR---EEIKCMNPNY----TEFKFPQIKAHPWHKIFHK-RMPPEA--LDLVSRLLQYSPS 409
E+I+ M P Y +F+ K K ++ P++ L+ +LL P+
Sbjct: 245 ADKDWEDIRKM-PEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPT 303
Query: 410 LRCTALEACAHPFF 423
R T+ +A P+F
Sbjct: 304 KRITSEQALQDPYF 317
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 118 bits (299), Expect = 1e-30
Identities = 71/236 (30%), Positives = 111/236 (47%), Gaps = 45/236 (19%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS----VAIKKVLQDKRYKN-----RELQIMRLLNHPNV 192
+ +G G+FG V++ K G VA+K + +D + RE +IMR L+HPNV
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL--YTYQICRA 250
V L TE++ LY +V+EY+ Y R N+ + L + QI R
Sbjct: 64 VKLLGV---CTEEEPLY--IVMEYME---GGDLLSYLRKNRPK-LSLSDLLSFALQIARG 114
Query: 251 LNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR---- 306
+ YL HRD+ +N LV +KI DFG ++ L + YYR
Sbjct: 115 MEYLES-KNFIHRDLAARNCLVG-ENLVVKISDFGLSRDLYDDD---------YYRKRGG 163
Query: 307 -------APELIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVDQLVEIIK 354
APE + ++T+ D+WS G +L E+ LG+ +PG S ++++E +K
Sbjct: 164 KLPIRWMAPESLK-EGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMS-NEEVLEYLK 217
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 9e-30
Identities = 87/294 (29%), Positives = 133/294 (45%), Gaps = 58/294 (19%)
Query: 148 GSFGVVFQAKCLETGDSVAIK-----KVLQDKRYKNRELQIMRLLNH---PNVVSLKHCF 199
G+FG V+ AK TGD AIK ++ + N + + ++ P V L +
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKL---Y 63
Query: 200 FSTTEKDELYLNLVLEYIS----ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
+S KD YL LV+EY++ ++ + +P + + Y ++ + LH
Sbjct: 64 YSFQSKD--YLYLVMEYLNGGDCASL-------IKTLGGLPEDWAKQYIAEVVLGVEDLH 114
Query: 256 HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGAT 315
G+ HRDIKP+NLL++ H LK+ DFG ++ G N ++ + Y APE I G
Sbjct: 115 QR-GIIHRDIKPENLLIDQTGH-LKLTDFGLSRN---GLENKKFVGTPDYLAPETILGVG 169
Query: 316 EYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFK 375
+ D WS+GCV+ E L G P F E+ D + + IL I N+ E
Sbjct: 170 D-DKMSDWWSLGCVIFEFLFGYPPFHAET-PDAVFD--NIL----SRRI-----NWPEEV 216
Query: 376 FPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTA---LEACAHPFFDDL 426
PEA+DL++RLL P+ R A E +HPFF +
Sbjct: 217 KEFCS-------------PEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSI 257
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 2e-29
Identities = 78/292 (26%), Positives = 131/292 (44%), Gaps = 50/292 (17%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKRYKN--RELQIMRLLNHPNVVSL 195
RV+G G+FG V + +T A+K K ++ +N E +I++ LNHP +V+L
Sbjct: 6 RVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNL 65
Query: 196 KHCFFSTTEKDELYLNLVLEYI--SETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
+ F +DE + LV++ + + Y +S+ + ++ V+ + +I AL Y
Sbjct: 66 WYSF-----QDEENMYLVVDLLLGGDLRYHLSQK-VKFSEEQ----VKFWICEIVLALEY 115
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFG 313
LH G+ HRDIKP N+L++ H + I DF A + P S + Y APE++
Sbjct: 116 LHSK-GIIHRDIKPDNILLDEQGH-VHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCR 173
Query: 314 ATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTE 373
Y+ A+D WS+G E L G+ + G S R++I+
Sbjct: 174 QG-YSVAVDWWSLGVTAYECLRGKRPYRGHS-------------RTIRDQIRAKQETADV 219
Query: 374 FKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLR--CTALEACAHPFF 423
+P EA+D +++LL+ P R + HP+F
Sbjct: 220 -LYP--ATW----------STEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 3e-29
Identities = 78/295 (26%), Positives = 126/295 (42%), Gaps = 50/295 (16%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKV-------LQDKRYKNRELQIMRLLNHPNVVSLKH 197
+G G FG V K + A+K V + + E +I+ NHP +V L +
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL-Y 59
Query: 198 CFFSTTEKDELYLNLVLEYI-SETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH 256
F KD+ Y+ +++EY ++ R + Y + A YLH+
Sbjct: 60 RTF----KDKKYIYMLMEYCLGGELW----TILRDRGLFDEYTARFYIACVVLAFEYLHN 111
Query: 257 VVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATE 316
G+ +RD+KP+NLL++ +K+ DFG AK L G+ ++ + Y APE+I
Sbjct: 112 R-GIIYRDLKPENLLLD-SNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKG- 168
Query: 317 YTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKF 376
Y ++D WS+G +L ELL G+P F GE D + +I N +F
Sbjct: 169 YDFSVDYWSLGILLYELLTGRPPF-GEDDEDPME---------IYNDILKGNGKL---EF 215
Query: 377 PQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA-----HPFFDDL 426
P + A DL+ +LL+ +P R L+ H +F+
Sbjct: 216 PNY------------IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGF 258
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 1e-28
Identities = 60/232 (25%), Positives = 100/232 (43%), Gaps = 51/232 (21%)
Query: 143 RVVGTGSFGVVFQAKCLETGDS----VAIKKVLQDKRYKN-----RELQIMRLLNHPNVV 193
+ +G G+FG V++ G+ VA+K + + + E IM+ L+HPN+V
Sbjct: 5 KKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIV 64
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVS-KHYTRMNQHVPILYVQL--YTYQICRA 250
L T+ + LY +V EY + + R + + L QI +
Sbjct: 65 RLLGVC---TQGEPLY--IVTEY----MPGGDLLDFLRKHGE-KLTLKDLLQMALQIAKG 114
Query: 251 LNYLH--HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR-- 306
+ YL + V HRD+ +N LV +KI DFG ++ + + YYR
Sbjct: 115 MEYLESKNFV---HRDLAARNCLVT-ENLVVKISDFGLSRDIYEDD---------YYRKR 161
Query: 307 ----------APELIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVD 347
APE + ++T+ D+WS G +L E+ LG+ +PG S +
Sbjct: 162 GGGKLPIKWMAPESLK-DGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE 212
|
Length = 258 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 111 bits (281), Expect = 5e-28
Identities = 59/225 (26%), Positives = 106/225 (47%), Gaps = 22/225 (9%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKV------LQDKRYKNRELQIMRLLNHPNVVSLKH 197
+G GSFG V + + G + K++ ++K+ E+ I+R L HPN+V
Sbjct: 7 TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYD 66
Query: 198 CFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH 256
+ + L +V+EY + ++ + + +++ ++ Q+ AL H+
Sbjct: 67 RIIDRSNQT---LYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHN 123
Query: 257 VVG----VCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI---SYICSRYYRAPE 309
V HRD+KP N+ ++ + +K+ DFG AK+L G + +Y+ + YY +PE
Sbjct: 124 RSDPGNTVLHRDLKPANIFLD-ANNNVKLGDFGLAKIL--GHDSSFAKTYVGTPYYMSPE 180
Query: 310 LIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIK 354
+ + Y D+WS+GC++ EL P F QL IK
Sbjct: 181 QLNHMS-YDEKSDIWSLGCLIYELCALSPPFTA-RNQLQLASKIK 223
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 1e-27
Identities = 75/288 (26%), Positives = 120/288 (41%), Gaps = 49/288 (17%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN--RELQIMRLLNHPNVVSLKHCFFS 201
+G GS+G V++A ETG VAIK V ++ + +E+ I++ + P +V +F
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFK 69
Query: 202 TTEKDELYLNLVLEY-----ISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH 256
T+ L +V+EY +S+ + +K T + YQ + L YLH
Sbjct: 70 NTD-----LWIVMEYCGAGSVSDIMKITNKTLTEEE-------IAAILYQTLKGLEYLHS 117
Query: 257 VVGVCHRDIKPQNLLVNPHTHQLKICDFG-SAKMLVPGEPNISYICSRYYRAPELIFGAT 315
HRDIK N+L+N Q K+ DFG S ++ + I + ++ APE+I
Sbjct: 118 -NKKIHRDIKAGNILLN-EEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQE-I 174
Query: 316 EYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFK 375
Y D+WS+G E+ G+P + + + I P T
Sbjct: 175 GYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPN-------------KPPPT-LS 220
Query: 376 FPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
P W F+ D V + L P R +A++ HPF
Sbjct: 221 DP----EKWSPEFN--------DFVKKCLVKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 6e-27
Identities = 64/227 (28%), Positives = 99/227 (43%), Gaps = 44/227 (19%)
Query: 143 RVVGTGSFGVVFQAKCLETGDS---VAIKKVLQDKRYKNR-----ELQIMRLLNHPNVVS 194
+ +G G+FG V++ K VA+K + +D + R E ++M+ L HPNVV
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 195 LKHCFFSTTEKDELYLNLVLEYISE----TVYRVSKHYTRMNQHVPILYVQL--YTYQIC 248
L TE++ LY LVLEY+ R S+ + + L + QI
Sbjct: 61 LLGV---CTEEEPLY--LVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIA 115
Query: 249 RALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR-- 306
+ + YL HRD+ +N LV +KI DFG ++ + + YYR
Sbjct: 116 KGMEYLAS-KKFVHRDLAARNCLVG-EDLVVKISDFGLSRDVYDDD---------YYRKK 164
Query: 307 ----------APELIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPG 342
APE + +T+ D+WS G +L E+ LG +PG
Sbjct: 165 TGGKLPIRWMAPESLKDGI-FTSKSDVWSFGVLLWEIFTLGATPYPG 210
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 6e-27
Identities = 83/297 (27%), Positives = 139/297 (46%), Gaps = 51/297 (17%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKV--------LQDKRYKN--RELQIMRLLNHPNV 192
+ +GTG+F +QA+ ++TG +A+K+V Q++ + +E+++M LNHP++
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
+ +T E + NL +E+++ +V + Y + V I Y T Q+ R L
Sbjct: 66 I---RMLGATCEDS--HFNLFVEWMAGGSVSHLLSKYGAFKEAVIINY----TEQLLRGL 116
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP-----GEPNISYICSRYYR 306
+YLH + HRD+K NLL++ +L+I DFG+A L GE + + +
Sbjct: 117 SYLHEN-QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFM 175
Query: 307 APELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKC 366
APE++ G +Y + D+WS+GCV+ E+ +P + E + L I KI T
Sbjct: 176 APEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTA----- 229
Query: 367 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
P I H + P D+ R L+ P R + E HP F
Sbjct: 230 ----------PSIPEH---------LSPGLRDVTLRCLELQPEDRPPSRELLKHPVF 267
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 7e-27
Identities = 82/298 (27%), Positives = 121/298 (40%), Gaps = 56/298 (18%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----RELQIMRLLNHPNVVSLKHC 198
V+G G+ VV+ A CL + VAIK++ +K + +E+Q M NHPNVV +
Sbjct: 8 VIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKY-YT 66
Query: 199 FFSTTEKDELYLNLVLEYISE-TVYRVSKH-YTRMNQHVPILYVQLYTYQICRALNYLHH 256
F DEL+ LV+ Y+S ++ + K Y R I+ L ++ + L YLH
Sbjct: 67 SF--VVGDELW--LVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVL--KEVLKGLEYLHS 120
Query: 257 VVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS-----YICSRYYRAPELI 311
G HRDIK N+L+ +KI DFG + L G ++ + + APE++
Sbjct: 121 -NGQIHRDIKAGNILLGEDG-SVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVM 178
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQP----LFPGESGVDQLVEIIKILGT--PTREEIK 365
Y D+WS G EL G P + ++ L P+ E
Sbjct: 179 EQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV-------LMLTLQNDPPSLETGA 231
Query: 366 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
F+ ++S LQ PS R TA E H FF
Sbjct: 232 DYKKYSKSFR----------------------KMISLCLQKDPSKRPTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 87/331 (26%), Positives = 140/331 (42%), Gaps = 86/331 (25%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQ-------IMRLLNHPNVVSLK 196
V+G G+FG V+ + +TG A+K + + K ++ I+ + P +V L
Sbjct: 8 VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKL- 66
Query: 197 HCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
+ F +DE +L LV+EY+ + + + + P + Y ++ AL+ +
Sbjct: 67 YYSF----QDEEHLYLVMEYMPGGDLMNLLIRKDV-----FPEETARFYIAELVLALDSV 117
Query: 255 HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK-----------------------MLV 291
H + G HRDIKP N+L++ H +K+ DFG K +LV
Sbjct: 118 HKL-GFIHRDIKPDNILIDADGH-IKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLV 175
Query: 292 PGEPNISYICSRY-------YRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGES 344
+ Y APE++ G T Y D WS+G +L E+L G P F ++
Sbjct: 176 RRRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPPFYSDT 234
Query: 345 GVDQLVEIIKILGTPTREEIKCMNPNYTE-FKFPQIKAHPWHKIFHKRMPPEALDLVSRL 403
L E T +I N+ E +FP + PEA+DL+ RL
Sbjct: 235 ----LQE--------TYNKII----NWKESLRFPP----------DPPVSPEAIDLICRL 268
Query: 404 LQYSPSLR-CTALEACAHPFF-----DDLRD 428
L P R + E +HPFF ++LR+
Sbjct: 269 LC-DPEDRLGSFEEIKSHPFFKGIDWENLRE 298
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 8e-26
Identities = 71/223 (31%), Positives = 109/223 (48%), Gaps = 35/223 (15%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV----LQDKRYKNR---ELQIMRLLNHPN 191
+ E+ +G G F VV++A CL G VA+KKV + D + + E+ +++ L+HPN
Sbjct: 4 FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPN 63
Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRA 250
V+ F E LN+VLE + R+ KH+ + + +P + Y Q+C A
Sbjct: 64 VIKYLASFIENNE-----LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSA 118
Query: 251 LNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG----------SAKMLVPGEPNISYI 300
L ++H + HRDIKP N+ + T +K+ D G +A LV G P
Sbjct: 119 LEHMHS-KRIMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLV-GTP----- 170
Query: 301 CSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGE 343
YY +PE I Y D+WS+GC+L E+ Q F G+
Sbjct: 171 ---YYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGD 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 6e-25
Identities = 71/243 (29%), Positives = 114/243 (46%), Gaps = 28/243 (11%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----RELQIMRLLNH---PNVVSL 195
++G G++G V++ K + TG VA+K + D + RE+ ++ L PN+
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPI--LYVQLYTYQICRALNY 253
+ L +++EY R T M PI Y+ + ++ AL Y
Sbjct: 68 YGSYLKGPR-----LWIIMEYAEGGSVR-----TLMKAG-PIAEKYISVIIREVLVALKY 116
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGE-PNISYICSRYYRAPELIF 312
+H V GV HRDIK N+LV +T +K+CDFG A +L +++ + Y+ APE+I
Sbjct: 117 IHKV-GVIHRDIKAANILVT-NTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVIT 174
Query: 313 GATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGT-PTREEIKCMNPNY 371
Y T D+WS+G + E+ G P + S VD ++ I + P R E +
Sbjct: 175 EGKYYDTKADIWSLGITIYEMATGNPPY---SDVDAFRAMMLIPKSKPPRLEDNGYSKLL 231
Query: 372 TEF 374
EF
Sbjct: 232 REF 234
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 1e-24
Identities = 87/308 (28%), Positives = 142/308 (46%), Gaps = 67/308 (21%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVL-------QDKRYKN------RELQIMR 185
++ ++G+GSFG V+ +G+ +A+K+V R ++ RE+ +++
Sbjct: 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLK 61
Query: 186 LLNHPNVVSLKHCFFSTTEKDELYLNLVLEYI-SETVYRVSKHYTRMNQHVPILYVQLYT 244
L H N+V D +LN+ LEY+ +V + +Y + + V+ +
Sbjct: 62 ELQHENIVQYLGS-----SLDADHLNIFLEYVPGGSVAALLNNYGAFEETL----VRNFV 112
Query: 245 YQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI------- 297
QI + LNYLH+ G+ HRDIK N+LV+ + +KI DFG +K L E N
Sbjct: 113 RQILKGLNYLHNR-GIIHRDIKGANILVD-NKGGIKISDFGISKKL---EANSLSTKTNG 167
Query: 298 ---SYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIK 354
S S ++ APE++ T YT D+WS+GC++ E+L G+ FP QL I K
Sbjct: 168 ARPSLQGSVFWMAPEVV-KQTSYTRKADIWSLGCLVVEMLTGKHPFP---DCTQLQAIFK 223
Query: 355 ILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTA 414
I E P+I ++ + EA+D + + + + R TA
Sbjct: 224 I----------------GENASPEIPSN---------ISSEAIDFLEKTFEIDHNKRPTA 258
Query: 415 LEACAHPF 422
E HPF
Sbjct: 259 AELLKHPF 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 88/297 (29%), Positives = 141/297 (47%), Gaps = 47/297 (15%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR------ELQIMRLLNHPNVVSLKHC 198
+G GS G+V A TG VA+KK+ D R + R E+ IMR HPN+V +
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKM--DLRKQQRRELLFNEVVIMRDYQHPNIVEM--- 81
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV 258
+ S DEL++ V+E++ +TRMN+ I V L + +AL++LH
Sbjct: 82 YSSYLVGDELWV--VMEFLEGGALTDIVTHTRMNEE-QIATVCL---AVLKALSFLH-AQ 134
Query: 259 GVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPN-ISYICSRYYRAPELIFGATEY 317
GV HRDIK ++L+ ++K+ DFG + P S + + Y+ APE+I Y
Sbjct: 135 GVIHRDIKSDSILLT-SDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVI-SRLPY 192
Query: 318 TTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFP 377
T +D+WS+G ++ E++ G+P + E + + + I+ P P
Sbjct: 193 GTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAM------------KRIRDNLP-------P 233
Query: 378 QIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNTCLP 434
++K HK+ P + R+L P+ R TA E HPF P++ +P
Sbjct: 234 KLKNL--HKV-----SPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGPPSSIVP 283
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 3e-24
Identities = 80/294 (27%), Positives = 136/294 (46%), Gaps = 58/294 (19%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKV-LQDK---RYKNRELQIMRLLNHPNVVSLKHCFF 200
+G+G++G V++A+ + TG+ VAIK + L+ +E+ +++ HPN+V+ +
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70
Query: 201 STTEKDELYLNLVLEY-----ISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
+D+L+ +V+EY + + +Y+V++ Q I YV T + L YLH
Sbjct: 71 R---RDKLW--IVMEYCGGGSLQD-IYQVTRGPLSELQ---IAYVCRETLK---GLAYLH 118
Query: 256 HVVGVCHRDIKPQNLLVNPHTHQLKICDFG-SAKMLVPGEPNISYICSRYYRAPELIFGA 314
G HRDIK N+L+ +K+ DFG SA++ S+I + Y+ APE+ A
Sbjct: 119 E-TGKIHRDIKGANILLTEDGD-VKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVA--A 174
Query: 315 TE----YTTAIDMWSIGCVLAELLLGQ-PLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369
E Y D+W++G EL Q P+F + ++ L ++
Sbjct: 175 VERKGGYDGKCDIWALGITAIELAELQPPMFD--------LHPMRALFLISKS------- 219
Query: 370 NYTEFKFPQIKA-HPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPF 422
F P++K W +FH D + + L P R TA + HPF
Sbjct: 220 ---NFPPPKLKDKEKWSPVFH--------DFIKKCLTKDPKKRPTATKLLQHPF 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 3e-24
Identities = 82/295 (27%), Positives = 128/295 (43%), Gaps = 48/295 (16%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR--------ELQIMRLLNHPNVVSLK 196
+G G FG V + TG A KK L KR K R E +I+ ++ +VSL
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKK-LDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLA 59
Query: 197 HCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH 256
+ F + KD+L L + L + Y + ++ Y QI L +LH
Sbjct: 60 YAFET---KDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIF---YAAQIICGLEHLHQ 113
Query: 257 VVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATE 316
+ +RD+KP+N+L++ H + ++I D G A L G+ + Y APE++ G
Sbjct: 114 R-RIVYRDLKPENVLLDDHGN-VRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGE-V 170
Query: 317 YTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKF 376
Y ++D +++GC L E++ G+ F Q E ++ +EE+K ++
Sbjct: 171 YDFSVDWFALGCTLYEMIAGRSPF------RQRKEKVE------KEELKRRTLE-MAVEY 217
Query: 377 PQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC-----TALEACAHPFFDDL 426
P + PEA DL LLQ P R +A E HP F DL
Sbjct: 218 PD------------KFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDL 260
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 7e-24
Identities = 87/300 (29%), Positives = 126/300 (42%), Gaps = 62/300 (20%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV-LQDKRYKNR-----ELQIMRLLNHPNV 192
Y+ RV+G G+FG + E V K+V L K R E+ I+ LL HPN+
Sbjct: 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNI 61
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
++ + F D+ L + +EY + T+Y + Q V Y +QI A+
Sbjct: 62 IAYYNHFM-----DDNTLLIEMEYANGGTLYDKIVR--QKGQLFEEEMVLWYLFQIVSAV 114
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML---------VPGEPNISYICS 302
+Y+H G+ HRDIK N+ + +K+ DFG +K+L V G P
Sbjct: 115 SYIHKA-GILHRDIKTLNIFLT-KAGLIKLGDFGISKILGSEYSMAETVVGTP------- 165
Query: 303 RYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTRE 362
YY +PEL G +Y D+W++GCVL ELL + F + L ++KI
Sbjct: 166 -YYMSPELCQGV-KYNFKSDIWALGCVLYELLTLKRTF---DATNPLNLVVKI------- 213
Query: 363 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPF 422
+ NYT E + LV LLQ P R TA E P
Sbjct: 214 ----VQGNYTPVVSVYSS--------------ELISLVHSLLQQDPEKRPTADEVLDQPL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 99.9 bits (249), Expect = 2e-23
Identities = 78/298 (26%), Positives = 125/298 (41%), Gaps = 49/298 (16%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-------RELQIMRLLNHPNVVSL 195
R +G GSFG V+ A+ + T + VAIKK+ + N +E++ ++ L HPN +
Sbjct: 21 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80
Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
K C+ E LV+EY + + + + + Q V I + + + L YLH
Sbjct: 81 KGCYLR-----EHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAI---CHGALQGLAYLH 132
Query: 256 HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGAT 315
HRDIK N+L+ +K+ DFGSA ++ P S++ + Y+ APE+I
Sbjct: 133 S-HERIHRDIKAGNILLTEPG-TVKLADFGSASLVSPAN---SFVGTPYWMAPEVILAMD 187
Query: 316 E--YTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTE 373
E Y +D+WS+G EL +P + + L I +
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI-------------------AQ 228
Query: 374 FKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNT 431
P + ++ W F + V LQ P R ++ E H F R P
Sbjct: 229 NDSPTLSSNDWSDYFR--------NFVDSCLQKIPQDRPSSEELLKHRFVLRERPPTV 278
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 2e-23
Identities = 85/304 (27%), Positives = 139/304 (45%), Gaps = 55/304 (18%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV--------LQDKRYK------NRELQIM 184
++ ++G G++G V+ A + TG+ +A+K+V D R K E++ +
Sbjct: 3 WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETL 62
Query: 185 RLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLY 243
+ L+H N+V E E YL++ LEY+ ++ + Y R + + V+ +
Sbjct: 63 KDLDHLNIVQYLGF-----ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQL----VRFF 113
Query: 244 TYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM---LVPGEPNISYI 300
T Q+ L YLH G+ HRD+K NLLV+ KI DFG +K + + N+S
Sbjct: 114 TEQVLEGLAYLHSK-GILHRDLKADNLLVD-ADGICKISDFGISKKSDDIYDNDQNMSMQ 171
Query: 301 CSRYYRAPELIFGATE-YTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTP 359
S ++ APE+I ++ Y+ +D+WS+GCV+ E+ G+ + E
Sbjct: 172 GSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDE---------------- 215
Query: 360 TREEIKCMNPNYTEFK-FPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEAC 418
E I M FK + A P + P ALD ++ +P R TA E
Sbjct: 216 --EAIAAM------FKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELL 267
Query: 419 AHPF 422
HPF
Sbjct: 268 QHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 2e-23
Identities = 78/297 (26%), Positives = 132/297 (44%), Gaps = 57/297 (19%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKV---LQDKRYKNR------ELQIMRLLNHPNVV 193
+++G G+FG V+ ++TG +A+K+V K E+Q+++ L H +V
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
C +D+ L++ +EY+ +V K Y + + V + YT QI +
Sbjct: 68 QYYGC-----LRDDETLSIFMEYMPGGSVKDQLKAYGALTETV----TRKYTRQILEGVE 118
Query: 253 YLH--HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML----VPGEPNISYICSRYYR 306
YLH +V HRDIK N+L + +K+ DFG++K L G S + Y+
Sbjct: 119 YLHSNMIV---HRDIKGANILRDS-AGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWM 174
Query: 307 APELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKC 366
+PE+I G Y D+WS+GC + E+L +P + + + + I KI PT
Sbjct: 175 SPEVISGEG-YGRKADVWSVGCTVVEMLTEKPPW---AEFEAMAAIFKIATQPTN----- 225
Query: 367 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
PQ+ +H + P+A + + R + R +A E H F
Sbjct: 226 ----------PQLPSH---------VSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 99.9 bits (249), Expect = 2e-23
Identities = 86/291 (29%), Positives = 127/291 (43%), Gaps = 61/291 (20%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK--RYKNRELQIMR----LLN---HPNVV 193
+V+G GSFG V AK G A+ KVLQ K K + IM LL HP +V
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAV-KVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLV 59
Query: 194 SLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
L H F T +K LY VL+Y++ E + H R + P + Y +I AL
Sbjct: 60 GL-HYSFQTADK--LY--FVLDYVNGGELFF----HLQR-ERSFPEPRARFYAAEIASAL 109
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC-SRYYRAPEL 310
YLH + + +RD+KP+N+L++ H + + DFG K + S C + Y APE+
Sbjct: 110 GYLHS-LNIIYRDLKPENILLDSQGH-VVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEV 167
Query: 311 IFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPN 370
+ Y +D W +G VL E+L G P F ++ + IL P R + PN
Sbjct: 168 LR-KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-TAEMYD--NILNKPLR-----LKPN 218
Query: 371 YT---------------------EFKFPQIKAHP------WHKIFHKRMPP 394
+ + F +IK H W + +K++ P
Sbjct: 219 ISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINWDDLVNKKITP 269
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 81/297 (27%), Positives = 130/297 (43%), Gaps = 57/297 (19%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIK----KVLQDKRYKNRELQ---IMRLLNHPNVVSLKH 197
VG G +G VF AK +TG+ VA+K +L L I+ +V L +
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 198 CFFSTTEKDELYLNLVLEYISETVYR--------VSKHYTRMNQHVPILYVQLYTYQICR 249
F +D+ YL L +EY+ +R +S+ + R Y ++
Sbjct: 69 AF-----QDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHAR-----------FYMAEMFE 112
Query: 250 ALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPE 309
A++ LH + G HRD+KP+N L++ H +K+ DFG +K +V S + S Y APE
Sbjct: 113 AVDALHEL-GYIHRDLKPENFLIDASGH-IKLTDFGLSKGIV--TYANSVVGSPDYMAPE 168
Query: 310 LIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369
++ G Y +D WS+GC+L E L G P F G + + + T R P
Sbjct: 169 VLRG-KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQR-------P 220
Query: 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426
Y + +F + EA DL+++L+ + + HPFF ++
Sbjct: 221 VYDDPRF--------------NLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEV 263
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 3e-22
Identities = 77/285 (27%), Positives = 118/285 (41%), Gaps = 48/285 (16%)
Query: 146 GTGSFGVVFQAKCLETGDSVAIKKV-LQDKRYKNR-----ELQIMRLLNHPNVVSLKHCF 199
G GS+G V++ K L A+K+V L K R E++I+ +NHPN++S K F
Sbjct: 9 GKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAF 68
Query: 200 FSTTEKDELYLNLVLEY--ISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV 257
D L +V+EY + +SK + +P + Q+ R L LH
Sbjct: 69 L-----DGNKLCIVMEYAPFGDLSKAISKRKKKRKL-IPEQEIWRIFIQLLRGLQALHEQ 122
Query: 258 VGVCHRDIKPQN-LLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATE 316
+ HRD+K N LLV +KI D G +K+L + I + +Y APE ++
Sbjct: 123 -KILHRDLKSANILLVAND--LVKIGDLGISKVLKKNMAK-TQIGTPHYMAPE-VWKGRP 177
Query: 317 YTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKF 376
Y+ D+WS+GC+L E+ P F S D K+ K+
Sbjct: 178 YSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRY---KVQRG----------------KY 218
Query: 377 PQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHP 421
P I + + + +LQ P LR + A P
Sbjct: 219 PPIPP---------IYSQDLQNFIRSMLQVKPKLRPNCDKILASP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 3e-22
Identities = 70/215 (32%), Positives = 109/215 (50%), Gaps = 17/215 (7%)
Query: 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKV----LQDKRYKN---RELQIMRLLNHP 190
++ E+ +G G F V++A CL G VA+KKV L D + + +E+ +++ LNHP
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 191 NVVSLKHCFFSTTEKDELYLNLVLEYI-SETVYRVSKHYTRMNQHVPILYVQLYTYQICR 249
NV+ F E LN+VLE + + R+ KH+ + + +P V Y Q+C
Sbjct: 63 NVIKYYASFIEDNE-----LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCS 117
Query: 250 ALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI-SYICSRYYRAP 308
AL ++H V HRDIKP N+ + T +K+ D G + S + + YY +P
Sbjct: 118 ALEHMHS-RRVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175
Query: 309 ELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGE 343
E I Y D+WS+GC+L E+ Q F G+
Sbjct: 176 ERIH-ENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 3e-22
Identities = 68/291 (23%), Positives = 114/291 (39%), Gaps = 47/291 (16%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV-----LQDKRYKNRELQIMRLLNHPNVV 193
+ +G GSFG V++A T VAIK + + +E+Q + P +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
F ++ L +++EY + + K ++ + ++ L
Sbjct: 63 KYYGSFLKGSK-----LWIIMEYCGGGSCLDLLKPGKLDETYIAFI-----LREVLLGLE 112
Query: 253 YLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG-SAKMLVPGEPNISYICSRYYRAPELI 311
YLH G HRDIK N+L++ +K+ DFG S ++ +++ + ++ APE+I
Sbjct: 113 YLHEE-GKIHRDIKAANILLSEEG-DVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVI 170
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNY 371
+ Y D+WS+G EL G+P + L I K NP
Sbjct: 171 KQ-SGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPK------------NNP-- 215
Query: 372 TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPF 422
P ++ + + K F D VS L P R +A E H F
Sbjct: 216 -----PSLEGNKFSKPFK--------DFVSLCLNKDPKERPSAKELLKHKF 253
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 5e-22
Identities = 63/213 (29%), Positives = 105/213 (49%), Gaps = 16/213 (7%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR------ELQIMRLLNHPNV 192
Y RVVG G+FG+V + V IK++ ++ K+ E Q+++LL+HPN+
Sbjct: 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNI 61
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYI-SETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
+ F L +V+EY T+ + R N + + + QI AL
Sbjct: 62 IEYYENFLEDKA-----LMIVMEYAPGGTLAEYIQK--RCNSLLDEDTILHFFVQILLAL 114
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELI 311
+++H + + HRD+K QN+L++ H +KI DFG +K+L + + + Y +PEL
Sbjct: 115 HHVHTKL-ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELC 173
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQPLFPGES 344
G Y D+W++GCVL EL + F +
Sbjct: 174 EG-KPYNQKSDIWALGCVLYELASLKRAFEAAN 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 5e-22
Identities = 83/297 (27%), Positives = 124/297 (41%), Gaps = 48/297 (16%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR--------ELQIMRLLNHPNVVS 194
RV+G G FG V + TG A KK L+ KR K R E QI+ +N VVS
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKK-LEKKRIKKRKGEAMALNEKQILEKVNSRFVVS 64
Query: 195 LKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
L + + KD L L L L + + + Y N Y +I L L
Sbjct: 65 LAYAY---ETKDALCLVLTLMNGGDLKFHI---YNMGNPGFDEERAVFYAAEITCGLEDL 118
Query: 255 HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGA 314
H + +RD+KP+N+L++ + H ++I D G A + GE + + Y APE++
Sbjct: 119 HRE-RIVYRDLKPENILLDDYGH-IRISDLGLAVEIPEGETIRGRVGTVGYMAPEVV-KN 175
Query: 315 TEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEF 374
YT + D W +GC++ E++ G+ F E +K REE++ E
Sbjct: 176 ERYTFSPDWWGLGCLIYEMIEGKSPFRQRK------EKVK------REEVERRVKEDQE- 222
Query: 375 KFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLR--C---TALEACAHPFFDDL 426
+ ++ A + +LL P R C A E AHPFF
Sbjct: 223 ------------EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTA 267
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 95.9 bits (239), Expect = 6e-22
Identities = 80/297 (26%), Positives = 128/297 (43%), Gaps = 58/297 (19%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKK-----VLQDKRYK--NRELQIMRLL-NHPNVVS 194
+V+G GSFG V A+ T + A+K +LQD + E +++ L HP +
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60
Query: 195 LKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
L H F T KD L+ V+EY++ + ++ + + R ++ Y +I L
Sbjct: 61 L-HSCFQT--KDRLFF--VMEYVNGGDLMFHIQR-SGRFDEPRARFYAA----EIVLGLQ 110
Query: 253 YLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC-SRYYRAPELI 311
+LH G+ +RD+K N+L++ H +KI DFG K + G S C + Y APE++
Sbjct: 111 FLHER-GIIYRDLKLDNVLLDSEGH-IKIADFGMCKEGILGGVTTSTFCGTPDYIAPEIL 168
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNY 371
Y A+D W++G +L E+L GQ F G+ D+L
Sbjct: 169 SY-QPYGPAVDWWALGVLLYEMLAGQSPFEGD-DEDEL---------------------- 204
Query: 372 TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA-----HPFF 423
F I + + + EA ++ L +P R L HPFF
Sbjct: 205 ----FQSILEDEVR--YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFF 255
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 7e-22
Identities = 87/304 (28%), Positives = 142/304 (46%), Gaps = 57/304 (18%)
Query: 143 RVVGTGSFGVVFQAKCL---ETGDSVAIK-----KVLQDKR---YKNRELQIMRLLNH-P 190
RV+GTG++G VF + + + G A+K ++Q + + E Q++ + P
Sbjct: 6 RVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCP 65
Query: 191 NVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQ--HVPILYVQLYTYQIC 248
+V+L H F T K L+L+L+Y+ + +T + Q H V++Y +I
Sbjct: 66 FLVTL-HYAFQTDTK----LHLILDYV-----NGGELFTHLYQREHFTESEVRVYIAEIV 115
Query: 249 RALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPN--ISYICSRYYR 306
AL++LH + G+ +RDIK +N+L++ H + + DFG +K + E S+ + Y
Sbjct: 116 LALDHLHQL-GIIYRDIKLENILLDSEGH-VVLTDFGLSKEFLAEEEERAYSFCGTIEYM 173
Query: 307 APELIFGATE-YTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIK 365
APE+I G + + A+D WS+G + ELL G F + + EI +R +K
Sbjct: 174 APEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEI-------SRRILK 226
Query: 366 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC---TALEACAHPF 422
P FP K M EA D + +LL+ P R A E HPF
Sbjct: 227 SKPP------FP------------KTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPF 268
Query: 423 FDDL 426
F +
Sbjct: 269 FQGI 272
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 8e-22
Identities = 67/218 (30%), Positives = 106/218 (48%), Gaps = 37/218 (16%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR-----ELQIMRLL-NHPNVVSLKH 197
V+G G++G V++A+ +TG VAIK + D E I+R NHPN+ +
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIK--IMDIIEDEEEEIKEEYNILRKYSNHPNIATFYG 70
Query: 198 CFF---STTEKDELYLNLVLEY-----ISETVYRVSKHYTRMNQHVPILYVQLYTYQICR 249
F D+L+ LV+E +++ V + K R+ + I Y+ + R
Sbjct: 71 AFIKKNPPGNDDQLW--LVMELCGGGSVTDLVKGLRKKGKRLKEEW-IAYI---LRETLR 124
Query: 250 ALNYLH--HVVGVCHRDIKPQNLLVNPHTHQLKICDFG-SAKMLVPGEPNISYICSRYYR 306
L YLH V+ HRDIK QN+L+ ++K+ DFG SA++ ++I + Y+
Sbjct: 125 GLAYLHENKVI---HRDIKGQNILLT-KNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWM 180
Query: 307 APELIFGATE------YTTAIDMWSIGCVLAELLLGQP 338
APE+I A + Y D+WS+G EL G+P
Sbjct: 181 APEVI--ACDEQPDASYDARSDVWSLGITAIELADGKP 216
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 1e-21
Identities = 87/299 (29%), Positives = 133/299 (44%), Gaps = 55/299 (18%)
Query: 142 ERVV-GTGSFGVVFQAKCLETGDSVAIKKV-LQDKRYK---NRELQIMRLLNHPNVVSLK 196
ERVV G G++G+V+ A+ L T +AIK++ +D RY + E+ + L H N+V
Sbjct: 12 ERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYL 71
Query: 197 HCFFSTTEKDELYLNLVLEYI---SETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
+E + + +E + S + SK + I++ YT QI L Y
Sbjct: 72 GSD---SENG--FFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIF---YTKQILEGLKY 123
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI-SYICSRYYRAPELI- 311
LH + HRDIK N+LVN ++ +KI DFG++K L P ++ + Y APE+I
Sbjct: 124 LHDN-QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVID 182
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNY 371
G Y D+WS+GC + E+ G+P F I+ P
Sbjct: 183 KGPRGYGAPADIWSLGCTIVEMATGKPPF-----------------------IELGEPQA 219
Query: 372 TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDD-LRDP 429
FK K HP +I PE+L ++ + LRC + D L+DP
Sbjct: 220 AMFKVGMFKIHP--EI------PESLSAEAK----NFILRCFEPDPDKRASAHDLLQDP 266
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 2e-21
Identities = 65/215 (30%), Positives = 107/215 (49%), Gaps = 17/215 (7%)
Query: 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKV----LQDKRYKN---RELQIMRLLNHP 190
++ E+ +G G F V++A CL VA+KKV + D + + +E+ +++ LNHP
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 191 NVVSLKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICR 249
NV+ F E LN+VLE + ++ K++ + + +P V Y Q+C
Sbjct: 63 NVIKYLDSFIEDNE-----LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCS 117
Query: 250 ALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI-SYICSRYYRAP 308
A+ ++H V HRDIKP N+ + T +K+ D G + S + + YY +P
Sbjct: 118 AVEHMHS-RRVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175
Query: 309 ELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGE 343
E I Y D+WS+GC+L E+ Q F G+
Sbjct: 176 ERIH-ENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 4e-21
Identities = 84/311 (27%), Positives = 140/311 (45%), Gaps = 65/311 (20%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKV-LQDKRYKNR------ELQIMRLLNHPNVVSL 195
+++ G++G V+ + ET A+KK+ Q+ +N+ E I+ +P VVS+
Sbjct: 7 KLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSM 66
Query: 196 KHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
C F T +L +V+EY+ + K+ + P+ ++Y + AL YL
Sbjct: 67 -FCSFETKR----HLCMVMEYVEGGDCATLLKNIGAL----PVDMARMYFAETVLALEYL 117
Query: 255 HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM-LVPGEPNI--------------SY 299
H+ G+ HRD+KP NLL+ H +K+ DFG +K+ L+ N+
Sbjct: 118 HNY-GIVHRDLKPDNLLITSMGH-IKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQ 175
Query: 300 IC-SRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGT 358
+C + Y APE+I Y +D W++G +L E L+G F G++ + ++I
Sbjct: 176 VCGTPEYIAPEVIL-RQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS---- 230
Query: 359 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC---TAL 415
++I P E +P +A DL+SRLL+ +P R A
Sbjct: 231 ---DDI--EWPEGDE-----------------ALPADAQDLISRLLRQNPLERLGTGGAF 268
Query: 416 EACAHPFFDDL 426
E H FF L
Sbjct: 269 EVKQHRFFLGL 279
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 7e-21
Identities = 77/298 (25%), Positives = 130/298 (43%), Gaps = 47/298 (15%)
Query: 146 GTGSFGVVFQAKCLETGDSVAIKKV---LQDKRYKNRELQIMRLLNHPNVVSLK--HCFF 200
G G++GVV + + + TG +A+K++ + + K RLL ++ S++ C +
Sbjct: 10 GRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQK-------RLLMDLDI-SMRSVDCPY 61
Query: 201 STTEKDELYLN----LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH 256
+ T L+ + +E + ++ + K +P + I +AL YLH
Sbjct: 62 TVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS 121
Query: 257 VVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATE 316
+ V HRD+KP N+L+N Q+K+CDFG + LV + Y APE I
Sbjct: 122 KLSVIHRDVKPSNVLIN-RNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELN 180
Query: 317 ---YTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTE 373
Y D+WS+G + EL G+ FP +S TP +++K
Sbjct: 181 QKGYDVKSDVWSLGITMIELATGR--FPYDS-----------WKTPF-QQLK-------- 218
Query: 374 FKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNT 431
Q+ P ++ ++ PE D V++ L+ + R E HPFF+ NT
Sbjct: 219 ----QVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLSKNT 272
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 9e-21
Identities = 84/285 (29%), Positives = 135/285 (47%), Gaps = 47/285 (16%)
Query: 143 RVVGTGSFGVVFQAKCLETGDS--VAIKKVLQDKRYKNR-------ELQIMRLLNHPNVV 193
+V+G GSFG VF + + D+ + KVL+ K R E I+ +NHP +V
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIV 61
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY--VQLYTYQICRAL 251
L H F T K L L+L+++ R +TR+++ V V+ Y ++ AL
Sbjct: 62 KL-HYAFQTEGK----LYLILDFL-----RGGDLFTRLSKEVMFTEEDVKFYLAELALAL 111
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRY-YRAPEL 310
++LH + G+ +RD+KP+N+L++ H +K+ DFG +K + E C Y APE+
Sbjct: 112 DHLHSL-GIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEV 169
Query: 311 IFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKI-LGTPT--------- 360
+ +T + D WS G ++ E+L G F G+ + + I+K LG P
Sbjct: 170 V-NRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSL 228
Query: 361 -REEIKCMNPNYTEFKFPQ----IKAHP------WHKIFHKRMPP 394
R K NP P IK HP W+K++ + + P
Sbjct: 229 LRALFK-RNPANRLGAGPDGVEEIKRHPFFSTIDWNKLYRREIKP 272
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 2e-20
Identities = 78/286 (27%), Positives = 124/286 (43%), Gaps = 36/286 (12%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----RELQIMRLLNHPNVVSLKHCF 199
+G G+ G V + K + TG +A K V + RELQIM P +VS F
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 200 FSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV 258
+ E + + +E++ ++ R+ K + + + + L YL++V
Sbjct: 73 LN-----ENNICMCMEFMDCGSLDRIYKKGGPIPVEI----LGKIAVAVVEGLTYLYNVH 123
Query: 259 GVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYT 318
+ HRDIKP N+LVN Q+K+CDFG + L+ + +++ + Y +PE I G +YT
Sbjct: 124 RIMHRDIKPSNILVNSRG-QIKLCDFGVSGELINSIAD-TFVGTSTYMSPERIQGG-KYT 180
Query: 319 TAIDMWSIGCVLAELLLGQ-PLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFP 377
D+WS+G + EL LG+ P D + + IL
Sbjct: 181 VKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDL-----------------LQ 223
Query: 378 QIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
QI P ++ P + D V L P+ R T + CA P F
Sbjct: 224 QIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPF 269
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 4e-20
Identities = 71/280 (25%), Positives = 123/280 (43%), Gaps = 73/280 (26%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKV-------LQDKRYKNRELQIMRLLNHPNVVSLKH 197
VGTG+FG V + + A+K + L+ +++ + E ++++ ++HP ++ L
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLF- 67
Query: 198 CFFSTTEKDELYLNLVLEYISE----TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
TE D+ +L +++EY+ + R S ++ Y +I AL Y
Sbjct: 68 ----WTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTG-------LFYASEIVCALEY 116
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP------GEPNISYICSRYYRA 307
LH + +RD+KP+N+L++ H +K+ DFG AK L G P Y A
Sbjct: 117 LHSK-EIVYRDLKPENILLDKEGH-IKLTDFGFAKKLRDRTWTLCGTPE--------YLA 166
Query: 308 PELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEII-KILGTPTREEIKC 366
PE+I + + A+D W++G ++ E+L+G P F D I KIL
Sbjct: 167 PEVI-QSKGHNKAVDWWALGILIYEMLVGYPPFFD----DNPFGIYEKILA--------- 212
Query: 367 MNPNYTEFKFPQIKAHPWHKI-FHKRMPPEALDLVSRLLQ 405
K+ F + + A DL+ +LL
Sbjct: 213 ------------------GKLEFPRHLDLYAKDLIKKLLV 234
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 4e-20
Identities = 86/295 (29%), Positives = 135/295 (45%), Gaps = 55/295 (18%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQ-------IMRLLNHPNVVSLKH 197
+G GSFG V Q + +T A+K + + E+ ++ +N P +V LK
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLK- 59
Query: 198 CFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
FS ++LYL VL +I+ E + + + R + + YT ++ AL LH
Sbjct: 60 --FSFQSPEKLYL--VLAFINGGELFHHLQRE-GRFDLS----RARFYTAELLCALENLH 110
Query: 256 HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC-SRYYRAPELIFGA 314
V +RD+KP+N+L++ + + +CDFG K+ + + + C + Y APEL+ G
Sbjct: 111 KF-NVIYRDLKPENILLD-YQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGH 168
Query: 315 TEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEF 374
YT A+D W++G +L E+L G P F E+ V+++ KIL P R
Sbjct: 169 G-YTKAVDWWTLGVLLYEMLTGLPPFYDEN-VNEMYR--KILQEPLR------------- 211
Query: 375 KFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC---TALEACAHPFFDDL 426
FP +A DL+ LL P+ R A E HPFF L
Sbjct: 212 -FPD------------GFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQL 253
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 7e-20
Identities = 92/310 (29%), Positives = 147/310 (47%), Gaps = 50/310 (16%)
Query: 131 GQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR------ELQIM 184
G P++ + + +G GS G+V A TG VA+KK+ D R + R E+ IM
Sbjct: 18 GDPREYLDSFIK--IGEGSTGIVCIATEKHTGKQVAVKKM--DLRKQQRRELLFNEVVIM 73
Query: 185 RLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYT 244
R +H NVV + + S DEL++ V+E++ +TRMN+ +
Sbjct: 74 RDYHHENVVDM---YNSYLVGDELWV--VMEFLEGGALTDIVTHTRMNEE----QIATVC 124
Query: 245 YQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPN-ISYICSR 303
+ RAL+YLH+ GV HRDIK ++L+ ++K+ DFG + P S + +
Sbjct: 125 LSVLRALSYLHNQ-GVIHRDIKSDSILLTSDG-RIKLSDFGFCAQVSKEVPKRKSLVGTP 182
Query: 304 YYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREE 363
Y+ APE+I Y T +D+WS+G ++ E++ G+P + E + + I R+
Sbjct: 183 YWMAPEVI-SRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRI--------RDN 233
Query: 364 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
+ P++K HK+ + LDL +L PS R TA E HPF
Sbjct: 234 LP-----------PRVKDS--HKV--SSVLRGFLDL---MLVREPSQRATAQELLQHPFL 275
Query: 424 DDLRDPNTCL 433
L P +C+
Sbjct: 276 -KLAGPPSCI 284
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 9e-20
Identities = 88/311 (28%), Positives = 139/311 (44%), Gaps = 49/311 (15%)
Query: 131 GQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR------ELQIM 184
G P+ + + +G GS G+V A +G VA+KK+ D R + R E+ IM
Sbjct: 16 GDPRTYLDNFIK--IGEGSTGIVCIATVKSSGKLVAVKKM--DLRKQQRRELLFNEVVIM 71
Query: 185 RLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYT 244
R H NVV + + + DEL++ V+E++ +TRMN+ +
Sbjct: 72 RDYQHENVVEMYNSYLV---GDELWV--VMEFLEGGALTDIVTHTRMNEE----QIAAVC 122
Query: 245 YQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPN-ISYICSR 303
+ +AL+ LH GV HRDIK ++L+ H ++K+ DFG + P S + +
Sbjct: 123 LAVLKALSVLH-AQGVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKSLVGTP 180
Query: 304 YYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREE 363
Y+ APELI Y +D+WS+G ++ E++ G+P + E P +
Sbjct: 181 YWMAPELI-SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE---------------PPLKA 224
Query: 364 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
+K + N P K HK + P + RLL P+ R TA E HPF
Sbjct: 225 MKMIRDNLP----------PKLKNLHK-VSPSLKGFLDRLLVRDPAQRATAAELLKHPFL 273
Query: 424 DDLRDPNTCLP 434
P+ +P
Sbjct: 274 AKAGPPSCIVP 284
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 1e-19
Identities = 87/300 (29%), Positives = 132/300 (44%), Gaps = 61/300 (20%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAI--KKVLQ---------DKRYKNRELQIMRLLNHPN 191
+V+G G +G VFQ + + D+ I KVL+ D + E I+ + HP
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61
Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICR 249
+V L F T K LYL +LEY+S E + + M Y +I
Sbjct: 62 IVDL-IYAFQTGGK--LYL--ILEYLSGGELFMHLEREGIFMED-----TACFYLSEISL 111
Query: 250 ALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRY-YRAP 308
AL +LH G+ +RD+KP+N+L++ H +K+ DFG K + C Y AP
Sbjct: 112 ALEHLHQQ-GIIYRDLKPENILLDAQGH-VKLTDFGLCKESIHEGTVTHTFCGTIEYMAP 169
Query: 309 ELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368
E I + + A+D WS+G ++ ++L G P F E+ + +I+K K
Sbjct: 170 E-ILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILK---------GKLNL 219
Query: 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC-----TALEACAHPFF 423
P Y + PEA DL+ +LL+ +PS R A E +HPFF
Sbjct: 220 PPY--------------------LTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFF 259
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 1e-19
Identities = 80/299 (26%), Positives = 131/299 (43%), Gaps = 35/299 (11%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKV-LQDK-RYKN---RELQIMRLLNHPNVVSLKHC 198
+G G+ GVV + +G +A K + L+ K +N REL+++ N P +V
Sbjct: 8 ELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGA 67
Query: 199 FFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV 257
F+S E +++ +E++ ++ +V K R +P + + + R L YL
Sbjct: 68 FYSDGE-----ISICMEHMDGGSLDQVLKKAGR----IPENILGKISIAVLRGLTYLREK 118
Query: 258 VGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEY 317
+ HRD+KP N+LVN ++K+CDFG + L+ N S++ +R Y +PE + G T Y
Sbjct: 119 HKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-THY 175
Query: 318 TTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFP 377
T D+WS+G L E+ +G+ P E+ + G P E + P
Sbjct: 176 TVQSDIWSLGLSLVEMAIGRYPIPPPDA----KELEAMFGRPVSEGEAKESHRPVSGHPP 231
Query: 378 Q-------------IKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
I P K+ E D V + L+ +P R E HPF
Sbjct: 232 DSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFI 290
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 2e-19
Identities = 89/307 (28%), Positives = 139/307 (45%), Gaps = 62/307 (20%)
Query: 143 RVVGTGSFGVVF--------------QAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLN 188
+V+GTG++G VF K L+ V K ++ R + L+ +R
Sbjct: 6 KVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVR--Q 63
Query: 189 HPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQ--HVPILYVQLYTYQ 246
P +V+L H F T K L+L+L+Y+S + +T + Q + V+ Y+ +
Sbjct: 64 SPFLVTL-HYAFQTEAK----LHLILDYVSG-----GEMFTHLYQRDNFSEDEVRFYSGE 113
Query: 247 ICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISY-ICSRY- 304
I AL +LH + G+ +RDIK +N+L++ H + + DFG +K + E +Y C
Sbjct: 114 IILALEHLHKL-GIVYRDIKLENILLDSEGH-VVLTDFGLSKEFLSEEKERTYSFCGTIE 171
Query: 305 YRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEI 364
Y APE+I G + A+D WS+G ++ ELL G F E + E+ +R +
Sbjct: 172 YMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEV-------SRRIL 224
Query: 365 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA----- 419
KC P F + PEA DL+ +LL+ P R A A
Sbjct: 225 KCDPP------------------FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266
Query: 420 HPFFDDL 426
HPFF L
Sbjct: 267 HPFFKGL 273
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 2e-19
Identities = 86/291 (29%), Positives = 134/291 (46%), Gaps = 54/291 (18%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKRYK--NRELQIMRLLNHPNVVSLKH 197
+GTGSFG V AK TG+ AIK ++L+ K+ + +E I+ L+HP +V++
Sbjct: 26 LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMC 85
Query: 198 CFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV 257
F +++ +Y +LE++ + H R P + Y ++ A YLH
Sbjct: 86 SF---QDENRVYF--LLEFVVGG--ELFTHL-RKAGRFPNDVAKFYHAELVLAFEYLHSK 137
Query: 258 VGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEY 317
+ +RD+KP+NLL++ H +K+ DFG AK VP + + + Y APE+I + +
Sbjct: 138 -DIIYRDLKPENLLLDNKGH-VKVTDFGFAKK-VP-DRTFTLCGTPEYLAPEVI-QSKGH 192
Query: 318 TTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFP 377
A+D W++G +L E + G P F + TP R K + KFP
Sbjct: 193 GKAVDWWTMGVLLYEFIAGYPPFFDD--------------TPFRIYEKILA---GRLKFP 235
Query: 378 QIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA-----HPFF 423
W F R A DLV LLQ + R L+ HP+F
Sbjct: 236 N-----W---FDGR----ARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYF 274
|
Length = 329 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 4e-19
Identities = 83/301 (27%), Positives = 133/301 (44%), Gaps = 52/301 (17%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-------RELQIMRLLNHPNVVSL 195
R +G GSFG V+ A+ + T + VAIKK+ + N +E++ ++ + HPN +
Sbjct: 31 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEY 90
Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
K C+ E LV+EY + + + + + Q V I + T+ + L YLH
Sbjct: 91 KGCYLR-----EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAI---THGALQGLAYLH 142
Query: 256 HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGAT 315
+ HRDIK N+L+ Q+K+ DFGSA + P S++ + Y+ APE+I
Sbjct: 143 S-HNMIHRDIKAGNILLT-EPGQVKLADFGSASIASPAN---SFVGTPYWMAPEVILAMD 197
Query: 316 E--YTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTE 373
E Y +D+WS+G EL +P + + L I +
Sbjct: 198 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI-------------------AQ 238
Query: 374 FKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRD-PNTC 432
+ P ++++ W F + V LQ P R T+ E H F LR+ P T
Sbjct: 239 NESPTLQSNEWSDYFR--------NFVDSCLQKIPQDRPTSEELLKHMFV--LRERPETV 288
Query: 433 L 433
L
Sbjct: 289 L 289
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 5e-19
Identities = 86/299 (28%), Positives = 132/299 (44%), Gaps = 66/299 (22%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKK-----VLQDKRYKNR--ELQIMRL-LNHPNVVS 194
+V+G GSFG V A+ T + AIK VL+D + E +++ L HP +
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60
Query: 195 LKHCFFSTTEKDELYLNLVLEYIS--------ETVYRVSKHYTRMNQHVPILYVQLYTYQ 246
L C F T E +L V+EY++ ++ R + R Y +
Sbjct: 61 L-FCTFQTKE----HLFFVMEYLNGGDLMFHIQSSGRFDEARAR-----------FYAAE 104
Query: 247 ICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC-SRYY 305
I L +LH G+ +RD+K N+L++ H +KI DFG K + GE S C + Y
Sbjct: 105 IICGLQFLHKK-GIIYRDLKLDNVLLDKDGH-IKIADFGMCKENMNGEGKASTFCGTPDY 162
Query: 306 RAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIK 365
APE++ G +Y ++D WS G +L E+L+GQ F GE D+L + I +
Sbjct: 163 IAPEILKG-QKYNESVDWWSFGVLLYEMLIGQSPFHGE-DEDELFDSI-------LNDR- 212
Query: 366 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC-TALEACAHPFF 423
P F + + EA D +S+L + P+ R + HPFF
Sbjct: 213 -----------------PH---FPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFF 251
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 6e-19
Identities = 80/301 (26%), Positives = 132/301 (43%), Gaps = 63/301 (20%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKK----VLQDKR---YKNRELQIMRLLNHPNVVSLK 196
+VG G FG V + TGD A+K VL + + E I+ + N P + L+
Sbjct: 8 LVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQ 67
Query: 197 HCFFSTTEKDELYLNLVLEYI--SETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
+ F +KD LYL V+EY + + ++++ + ++ + Q Y ++ A++ +
Sbjct: 68 YAF---QDKDNLYL--VMEYQPGGDLLSLLNRYEDQFDEDM----AQFYLAELVLAIHSV 118
Query: 255 HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA------KMLVPGEPNISYICSRYYRAP 308
H + G HRDIKP+N+L++ H +K+ DFGSA KM+ P + + Y AP
Sbjct: 119 HQM-GYVHRDIKPENVLIDRTGH-IKLADFGSAARLTANKMVNSKLP----VGTPDYIAP 172
Query: 309 ELI-----FGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREE 363
E++ G Y D WS+G + E++ G+ F + I+
Sbjct: 173 EVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA---KTYNNIM------- 222
Query: 364 IKCMNPNYTEF-KFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPF 422
N+ F KFP+ ++ + LDL+ LL R C HPF
Sbjct: 223 ------NFQRFLKFPE----------DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPF 265
Query: 423 F 423
F
Sbjct: 266 F 266
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 6e-19
Identities = 74/303 (24%), Positives = 130/303 (42%), Gaps = 56/303 (18%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKV---LQDKRYKN--RELQIMRLLNHPNVVSLKHCF 199
+G G++G V++ TG ++A+K++ L + ++ EL I+ P +V F
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68
Query: 200 FSTTEKDELYLNLVLEYIS----ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
F E + + +EY+ + +Y + + V ++ TY + + L +L
Sbjct: 69 FI-----EGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDV----LRRITYAVVKGLKFLK 119
Query: 256 HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELI---- 311
+ HRD+KP N+LVN + Q+K+CDFG + LV + C Y APE I
Sbjct: 120 EEHNIIHRDVKPTNVLVNGNG-QVKLCDFGVSGNLVASLAKTNIGCQSYM-APERIKSGG 177
Query: 312 -FGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVD---QLVEIIKILGTPTREEIKCM 367
YT D+WS+G + E+ LG+ +P E+ + QL I+ G P +
Sbjct: 178 PNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVD--GDPPT-----L 230
Query: 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427
Y+ +A D V++ L P+ R T + HP+ +
Sbjct: 231 PSGYS---------------------DDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK 269
Query: 428 DPN 430
+ +
Sbjct: 270 NAD 272
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 8e-19
Identities = 69/210 (32%), Positives = 105/210 (50%), Gaps = 26/210 (12%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQ---------IMRLLNHPNVV 193
+V+G GSFG V AK G A+K VLQ K NR+ Q +++ + HP +V
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVK-VLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLV 59
Query: 194 SLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
L H F TTEK L VL++++ E + + + + P + Y +I AL
Sbjct: 60 GL-HYSFQTTEK----LYFVLDFVNGGELFFHLQRERS-----FPEPRARFYAAEIASAL 109
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC-SRYYRAPEL 310
YLH + + +RD+KP+N+L++ H + + DFG K + + C + Y APE+
Sbjct: 110 GYLHSI-NIVYRDLKPENILLDSQGH-VVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEV 167
Query: 311 IFGATEYTTAIDMWSIGCVLAELLLGQPLF 340
I Y +D W +G VL E+L G P F
Sbjct: 168 I-RKQPYDNTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 1e-18
Identities = 76/283 (26%), Positives = 122/283 (43%), Gaps = 50/283 (17%)
Query: 146 GTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFF 200
G G+ G V + + TG A+K + D ++ REL+I + P +V F
Sbjct: 10 GEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAF- 68
Query: 201 STTEKDELYLNLVLEYIS----ETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
++ + + +EY +++Y +V K R+ + V + + + + L+YLH
Sbjct: 69 --LDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKV-LGKI---AESVLKGLSYLH 122
Query: 256 HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS----YICSRYYRAPELI 311
+ HRDIKP N+L+ Q+K+CDFG V GE S + + +Y APE I
Sbjct: 123 SR-KIIHRDIKPSNILLTRKG-QVKLCDFG-----VSGELVNSLAGTFTGTSFYMAPERI 175
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQPLFPGES----GVDQLVEIIKILGTPT------- 360
G Y+ D+WS+G L E+ + FP E G +L+ I + P
Sbjct: 176 QGKP-YSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGN 234
Query: 361 ----REEIK-----CMNPNYTEFKFP-QIKAHPWHKIFHKRMP 393
EE K C+ + T P + HPW K K+
Sbjct: 235 GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKKKV 277
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 1e-18
Identities = 77/294 (26%), Positives = 121/294 (41%), Gaps = 49/294 (16%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-------RELQIMRLLNHPNVVSLKH 197
+G GSFG V+ A T + VA+KK+ + N +E++ ++ L HPN + K
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 198 CFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV 257
C+ E LV+EY + + + + + Q V I + T+ + L YLH
Sbjct: 89 CYLK-----EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAI---THGALQGLAYLHSH 140
Query: 258 VGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATE- 316
+ HRDIK N+L+ Q+K+ DFGSA P S++ + Y+ APE+I E
Sbjct: 141 NMI-HRDIKAGNILLT-EPGQVKLADFGSASKSSPAN---SFVGTPYWMAPEVILAMDEG 195
Query: 317 -YTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFK 375
Y +D+WS+G EL +P + + L I +
Sbjct: 196 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI-------------------AQND 236
Query: 376 FPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDP 429
P ++++ W F V LQ P R + E H F R
Sbjct: 237 SPTLQSNEWTDSFRG--------FVDYCLQKIPQERPASAELLRHDFVRRDRPA 282
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 1e-18
Identities = 60/203 (29%), Positives = 103/203 (50%), Gaps = 19/203 (9%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----RELQIMRLLNHPNVV 193
Y RVVG GSFG + + + A+K++ K +E ++ + HPN+V
Sbjct: 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIV 61
Query: 194 SLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
+ K F + + +L +V+EY + + ++ ++ IL Q + Q+C +
Sbjct: 62 AFKESF-----EADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTIL--QWFV-QMCLGV 113
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV-PGEPNISYICSRYYRAPEL 310
++H V HRDIK +N+ + ++K+ DFGSA++L PG +Y+ + YY PE
Sbjct: 114 QHIHEK-RVLHRDIKSKNIFLT-QNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPE- 170
Query: 311 IFGATEYTTAIDMWSIGCVLAEL 333
I+ Y D+WS+GC+L EL
Sbjct: 171 IWENMPYNNKSDIWSLGCILYEL 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 2e-18
Identities = 86/299 (28%), Positives = 135/299 (45%), Gaps = 51/299 (17%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR------ELQIMRLLNHPNVVSLKHC 198
+G GS G+V A+ +G VA+K + D R + R E+ IMR H NVV +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVK--MMDLRKQQRRELLFNEVVIMRDYQHQNVVEM--- 83
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTY--QICRALNYLHH 256
+ S +EL++ ++E++ TR+N+ Q+ T + +AL YLH
Sbjct: 84 YKSYLVGEELWV--LMEFLQGGALTDIVSQTRLNEE------QIATVCESVLQALCYLH- 134
Query: 257 VVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPN-ISYICSRYYRAPELIFGAT 315
GV HRDIK ++L+ ++K+ DFG + P S + + Y+ APE+I T
Sbjct: 135 SQGVIHRDIKSDSILLTLDG-RVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVI-SRT 192
Query: 316 EYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFK 375
Y T +D+WS+G ++ E++ G+P + +S V + + R+
Sbjct: 193 PYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL--------RDS------------ 232
Query: 376 FPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNTCLP 434
P K HKI P D + R+L P R TA E HPF P +P
Sbjct: 233 -PPPKLKNAHKI-----SPVLRDFLERMLTREPQERATAQELLDHPFLLQTGLPECLVP 285
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 2e-18
Identities = 61/205 (29%), Positives = 102/205 (49%), Gaps = 22/205 (10%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-------RELQIMRLLNHPNVVSL 195
R +G GSFG V+ A+ + + VAIKK+ + N +E++ ++ L HPN +
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
+ C+ E LV+EY + + + + + Q V I V T+ + L YLH
Sbjct: 81 RGCYLR-----EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAV---THGALQGLAYLH 132
Query: 256 HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGAT 315
+ HRD+K N+L++ +K+ DFGSA ++ P ++ + Y+ APE+I
Sbjct: 133 S-HNMIHRDVKAGNILLS-EPGLVKLGDFGSASIMAPAN---XFVGTPYWMAPEVILAMD 187
Query: 316 E--YTTAIDMWSIGCVLAELLLGQP 338
E Y +D+WS+G EL +P
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKP 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 2e-18
Identities = 63/209 (30%), Positives = 97/209 (46%), Gaps = 29/209 (13%)
Query: 143 RVVGTGSFGVVFQAKCLE-----TGDSVAIKK-----VLQDKRYKNRELQIMRLLNHPNV 192
+ +G G FG V + TG+ VA+K Q + RE++I+R L+H N+
Sbjct: 10 KQLGEGHFGKVELC-RYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENI 68
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
V K + L L++EY+ R R ++ L L++ QIC+ ++
Sbjct: 69 VKYKGVCEKPGGRS---LRLIMEYLPSGSLRDYLQRHRDQINLKRLL--LFSSQICKGMD 123
Query: 253 YLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG-------EPNISYICSRYY 305
YL HRD+ +N+LV +KI DFG AK+L EP S I +Y
Sbjct: 124 YLGS-QRYIHRDLAARNILVE-SEDLVKISDFGLAKVLPEDKDYYYVKEPGESPI--FWY 179
Query: 306 RAPELIFGATEYTTAIDMWSIGCVLAELL 334
APE + + +++A D+WS G L EL
Sbjct: 180 -APECLRTSK-FSSASDVWSFGVTLYELF 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 2e-18
Identities = 85/308 (27%), Positives = 143/308 (46%), Gaps = 63/308 (20%)
Query: 143 RVVGTGSFGVVFQAKCL---ETGDSVAIK-----------KVLQDKRYKNRELQIMRLLN 188
+V+GTG++G VF + + ++G A+K K + R + + L+ +R
Sbjct: 6 KVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR--Q 63
Query: 189 HPNVVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQ 246
P +V+L + F + T+ L+L+L+YI+ E +S+ R + VQ+Y+ +
Sbjct: 64 SPFLVTLHYAFQTDTK-----LHLILDYINGGELFTHLSQR-ERFKEQ----EVQIYSGE 113
Query: 247 ICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISY-ICSRY- 304
I AL +LH + G+ +RDIK +N+L++ + H + + DFG +K E +Y C
Sbjct: 114 IVLALEHLHKL-GIIYRDIKLENILLDSNGH-VVLTDFGLSKEFHEDEVERAYSFCGTIE 171
Query: 305 YRAPELIFGA-TEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREE 363
Y AP+++ G + A+D WS+G ++ ELL G F + + EI +R
Sbjct: 172 YMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEI-------SRRI 224
Query: 364 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC-----TALEAC 418
+K P +PQ M A D++ RLL P R A E
Sbjct: 225 LKSEPP------YPQ------------EMSALAKDIIQRLLMKDPKKRLGCGPSDADEIK 266
Query: 419 AHPFFDDL 426
HPFF +
Sbjct: 267 KHPFFQKI 274
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 4e-18
Identities = 85/297 (28%), Positives = 126/297 (42%), Gaps = 48/297 (16%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR--------ELQIMRLLNHPNVVS 194
RV+G G FG V + TG A KK L+ KR K R E QI+ +N VVS
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKK-LEKKRIKKRKGESMALNEKQILEKVNSRFVVS 64
Query: 195 LKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
L + + KD L L L L + + + Y Y +IC L L
Sbjct: 65 LAYAY---ETKDALCLVLTLMNGGDLKFHI---YHMGEAGFEEGRAVFYAAEICCGLEDL 118
Query: 255 HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGA 314
H + +RD+KP+N+L++ H H ++I D G A + G+ + + Y APE++
Sbjct: 119 HQE-RIVYRDLKPENILLDDHGH-IRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVV-KN 175
Query: 315 TEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEF 374
YT + D W++GC+L E++ GQ F Q + IK REE++ + E
Sbjct: 176 ERYTFSPDWWALGCLLYEMIAGQSPF------QQRKKKIK------REEVERLVKEVQE- 222
Query: 375 KFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC-----TALEACAHPFFDDL 426
+ ++ P+A L LL P R A E HP F +
Sbjct: 223 ------------EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQI 267
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 5e-18
Identities = 70/208 (33%), Positives = 104/208 (50%), Gaps = 34/208 (16%)
Query: 145 VGTGSFGVVFQAKCL------ETGDSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVS 194
+G G+FG V C TG+ VA+KK+ R RE++I++ L H N+V
Sbjct: 12 LGKGNFGSV--ELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK 69
Query: 195 LKHCFFSTTEKDELYLNLVLEYISETVYR--VSKHYTRMNQHVPILYVQLYTYQICRALN 252
K +S ++ L LV+EY+ R + KH R++ H +L LY QIC+ +
Sbjct: 70 YKGVCYSAGRRN---LRLVMEYLPYGSLRDYLQKHRERLD-HRKLL---LYASQICKGME 122
Query: 253 YLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML-------VPGEPNISYICSRYY 305
YL V HRD+ +N+LV +KI DFG K+L EP S I ++
Sbjct: 123 YLGSKRYV-HRDLATRNILVESENR-VKIGDFGLTKVLPQDKEYYKVREPGESPI---FW 177
Query: 306 RAPELIFGATEYTTAIDMWSIGCVLAEL 333
APE + ++++ A D+WS G VL EL
Sbjct: 178 YAPESL-TESKFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 8e-18
Identities = 77/297 (25%), Positives = 131/297 (44%), Gaps = 59/297 (19%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNREL-------QIMRLLNHPNVVSL 195
+++G G+FG V + TG A+K + ++ E+ ++++ HP + +L
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60
Query: 196 KHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
K+ F D L V+EY + E + +S+ + Y +I AL Y
Sbjct: 61 KYSF---QTHD--RLCFVMEYANGGELFFHLSRERVFSEDRA-----RFYGAEIVSALGY 110
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC-SRYYRAPELIF 312
LH V +RD+K +NL+++ H +KI DFG K + + C + Y APE +
Sbjct: 111 LHSC-DVVYRDLKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPE-VL 167
Query: 313 GATEYTTAIDMWSIGCVLAELLLGQ-PLFPGESGVDQLVEIIKILGTPTREEIKCMNPNY 371
+Y A+D W +G V+ E++ G+ P + + ++L E+I + EEI
Sbjct: 168 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--EKLFELILM------EEI------- 212
Query: 372 TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC-----TALEACAHPFF 423
+FP + + PEA L++ LL+ P R A E H FF
Sbjct: 213 ---RFP------------RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFF 254
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 8e-18
Identities = 66/213 (30%), Positives = 109/213 (51%), Gaps = 26/213 (12%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIM----RLLN----HPNVVS 194
+++G GSFG VF A+ T AIK + +D + +++ R+L+ HP +
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 195 LKHCFFSTTEKDELYLNLVLEYIS--ETVYRV-SKHYTRMNQHVPILYVQLYTYQICRAL 251
L +C F T E L V+EY++ + ++ + S H + + Y +I L
Sbjct: 61 L-YCTFQTKE----NLFFVMEYLNGGDLMFHIQSCHKFDLPR------ATFYAAEIICGL 109
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC-SRYYRAPEL 310
+LH G+ +RD+K N+L++ H +KI DFG K + G+ C + Y APE+
Sbjct: 110 QFLHSK-GIVYRDLKLDNILLDTDGH-IKIADFGMCKENMLGDAKTCTFCGTPDYIAPEI 167
Query: 311 IFGATEYTTAIDMWSIGCVLAELLLGQPLFPGE 343
+ G +Y T++D WS G +L E+L+GQ F G
Sbjct: 168 LLG-QKYNTSVDWWSFGVLLYEMLIGQSPFHGH 199
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 2e-17
Identities = 65/218 (29%), Positives = 105/218 (48%), Gaps = 27/218 (12%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-------RELQIMRLLNHPNVVSL 195
+V+G G+FG V + + A+K + + + K E IM N +V L
Sbjct: 49 KVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQL 108
Query: 196 KHCFFSTTEKDELYLNLVLEYI--SETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
H F +D+ YL +V+EY+ + V +S N +P + + YT ++ AL+
Sbjct: 109 -HYAF----QDDKYLYMVMEYMPGGDLVNLMS------NYDIPEKWARFYTAEVVLALDA 157
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA-KMLVPGEPNISY-ICSRYYRAPELI 311
+H + G HRD+KP N+L++ H LK+ DFG+ KM G + + Y +PE++
Sbjct: 158 IHSM-GFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVL 215
Query: 312 F---GATEYTTAIDMWSIGCVLAELLLGQPLFPGESGV 346
G Y D WS+G L E+L+G F +S V
Sbjct: 216 KSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV 253
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 2e-17
Identities = 77/299 (25%), Positives = 129/299 (43%), Gaps = 58/299 (19%)
Query: 146 GTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----RELQIMRLLNHPNVVSLKHCFF 200
G G+FG V++A+ ETG A K++Q + + E+ I+ HPN+V L +F
Sbjct: 14 GDGAFGKVYKAQHKETG-LFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 201 STTEKDELYLNLVLEY-----ISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
+++L++ ++E+ + + + + T ++ Q+ ALN+LH
Sbjct: 73 Y---ENKLWI--LIEFCDGGALDSIMLELERGLTEP-------QIRYVCRQMLEALNFLH 120
Query: 256 HVVGVCHRDIKPQNLLVNPHTHQLKICDFG-SAKMLVPGEPNISYICSRYYRAPELI--- 311
V HRD+K N+L+ +K+ DFG SAK + ++I + Y+ APE++
Sbjct: 121 SHK-VIHRDLKAGNILLTLDG-DVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACE 178
Query: 312 -FGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPN 370
F Y D+WS+G L EL +P P ++ + ++KIL +
Sbjct: 179 TFKDNPYDYKADIWSLGITLIELAQMEP--P-HHELNPMRVLLKILKSEP---------- 225
Query: 371 YTEFKFPQIKA-HPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRD 428
P + W F+ D + L P R TA E HPF D D
Sbjct: 226 ------PTLDQPSKWSSSFN--------DFLKSCLVKDPDDRPTAAELLKHPFVSDQSD 270
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 2e-17
Identities = 76/291 (26%), Positives = 132/291 (45%), Gaps = 49/291 (16%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKV------LQDKRYKNRELQIMRLLNHPNVVSLK 196
+ +G GSFG ++ AK + IK++ +++K +E+ ++ + HPN+V+
Sbjct: 6 KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTF- 64
Query: 197 HCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
F S E L++ V+EY + + R+++ + IL + QI L ++
Sbjct: 65 --FASFQENGRLFI--VMEYCDGGDLMKRINRQRGVLFSEDQIL---SWFVQISLGLKHI 117
Query: 255 HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC--SRYYRAPELIF 312
H + HRDIK QN+ ++ + K+ DFG A+ L ++Y C + YY +PE I
Sbjct: 118 HDR-KILHRDIKSQNIFLSKNGMVAKLGDFGIARQL-NDSMELAYTCVGTPYYLSPE-IC 174
Query: 313 GATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYT 372
Y D+WS+GCVL EL + F G + + QLV +KI + ++PN++
Sbjct: 175 QNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN-LHQLV--LKI----CQGYFAPISPNFS 227
Query: 373 EFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
+ L+S+L + SP R + PF
Sbjct: 228 R---------------------DLRSLISQLFKVSPRDRPSITSILKRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 3e-17
Identities = 77/266 (28%), Positives = 123/266 (46%), Gaps = 39/266 (14%)
Query: 143 RVVGTGSFGVVFQAKCLETGD--SVAIKKVLQDKRYKNR-------ELQIMRLLNHPNVV 193
R +GTGSFG V A + D VAIK+ + K K + E +I+ +NHP V
Sbjct: 36 RTLGTGSFGRVILAT-YKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCV 94
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
+L F KDE YL LVLE++ + + R N+ P Y QI Y
Sbjct: 95 NLYGSF-----KDESYLYLVLEFVIGGEFFT---FLRRNKRFPNDVGCFYAAQIVLIFEY 146
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC-SRYYRAPELIF 312
L + + +RD+KP+NLL++ +K+ DFG AK++ + +C + Y APE++
Sbjct: 147 LQSL-NIVYRDLKPENLLLDKDGF-IKMTDFGFAKVV---DTRTYTLCGTPEYIAPEILL 201
Query: 313 GATEYTTAIDMWSIGCVLAELLLG-------QPLFPGESGVDQLVEIIKILGTPTREEIK 365
+ A D W++G + E+L+G +PL + ++ ++ K L + +K
Sbjct: 202 NVG-HGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHLMK 260
Query: 366 C-----MNPNYTEFK--FPQIKAHPW 384
+ Y K +K HPW
Sbjct: 261 KLLSHDLTKRYGNLKKGAQNVKEHPW 286
|
Length = 340 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 4e-17
Identities = 82/294 (27%), Positives = 142/294 (48%), Gaps = 56/294 (19%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIM----RLL----NHPNVVS 194
+V+G GSFG V A+ G+ A+K + +D + +++ R+L +P +
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 195 LKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILY-VQLYTYQICRAL 251
L +C F T K+ L+ V+E+++ + ++ + R + LY Y +I L
Sbjct: 61 L-YCTFQT--KEHLFF--VMEFLNGGDLMFHIQDK-GRFD-----LYRATFYAAEIVCGL 109
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC-SRYYRAPEL 310
+LH G+ +RD+K N++++ H +KI DFG K V G+ S C + Y APE+
Sbjct: 110 QFLHSK-GIIYRDLKLDNVMLDRDGH-IKIADFGMCKENVFGDNRASTFCGTPDYIAPEI 167
Query: 311 IFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPN 370
+ G +YT ++D WS G +L E+L+GQ F G+ D+L E I++ TP
Sbjct: 168 LQG-LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE-DELFESIRV-DTP----------- 213
Query: 371 YTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTAL-EACAHPFF 423
+P+ W + E+ D++ +L + P+ R + HPFF
Sbjct: 214 ----HYPR-----W-------ITKESKDILEKLFERDPTRRLGVVGNIRGHPFF 251
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 5e-17
Identities = 66/231 (28%), Positives = 108/231 (46%), Gaps = 26/231 (11%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKV--LQDKRYKNRELQ----IMRLLNHPNVVSLKHC 198
+G G+FG V + +G +A+K++ D++ + R L +MR + P +V
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71
Query: 199 FFSTTEKD-----ELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
F E D EL +++ L+ + VY V + +P + +ALNY
Sbjct: 72 LF--REGDCWICMEL-MDISLDKFYKYVYEV------LKSVIPEEILGKIAVATVKALNY 122
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELI-- 311
L + + HRD+KP N+L++ + + +K+CDFG + LV R Y APE I
Sbjct: 123 LKEELKIIHRDVKPSNILLDRNGN-IKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDP 181
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQPLFPG-ESGVDQLVEIIKILGTPTR 361
Y D+WS+G L E+ G+ +P S DQL +++K G P
Sbjct: 182 SARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVK--GDPPI 230
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 5e-17
Identities = 58/215 (26%), Positives = 101/215 (46%), Gaps = 28/215 (13%)
Query: 145 VGTGSFGVVFQAKCLETGDS-VAIKKVL-------QDKRYKNR-------ELQIMR-LLN 188
+G+G+FG V++ + G + +A+K++ +DKR +++ E+ I++ L
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 189 HPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRM---NQHVPILYVQLYTY 245
HPN+V F E D LY+ V++ I +H+ + Q +
Sbjct: 68 HPNIVRYYKTF---LENDRLYI--VMDLIEGAPLG--EHFNSLKEKKQRFTEERIWNIFV 120
Query: 246 QICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYY 305
Q+ AL YLH + HRD+ P N+++ ++ I DFG AK P S + + Y
Sbjct: 121 QMVLALRYLHKEKRIVHRDLTPNNIMLG-EDDKVTITDFGLAKQKQPESKLTSVVGTILY 179
Query: 306 RAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLF 340
PE++ Y D+W+ GC+L ++ QP F
Sbjct: 180 SCPEIVKN-EPYGEKADVWAFGCILYQMCTLQPPF 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 7e-17
Identities = 83/324 (25%), Positives = 137/324 (42%), Gaps = 79/324 (24%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIK---KVLQDKRYKNR----ELQIMRLLNHPNVVSL 195
+++G G G VF + TG A+K K KR K + E +I+ L+HP + +L
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66
Query: 196 KHCFFSTTEKDELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
F + T YL LV++Y ++R+ + + + + + Y ++ AL YL
Sbjct: 67 YASFQTET-----YLCLVMDYCPGGELFRLLQ--RQPGKCLSEEVARFYAAEVLLALEYL 119
Query: 255 HHVVGVCHRDIKPQNLLVNPHTHQLKICDF-------------------GSAKMLV---- 291
H ++G+ +RD+KP+N+L++ H + + DF GS + V
Sbjct: 120 H-LLGIVYRDLKPENILLHESGH-IMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIP 177
Query: 292 -------PGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGES 344
P + S++ + Y APE+I G + +A+D W++G +L E+L G F G +
Sbjct: 178 SETFSEEPSFRSNSFVGTEEYIAPEVISGDG-HGSAVDWWTLGILLYEMLYGTTPFKGSN 236
Query: 345 GVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLL 404
+ I+K E FP + A DL+ +LL
Sbjct: 237 RDETFSNILK-----------------KEVTFPG----------SPPVSSSARDLIRKLL 269
Query: 405 QYSPSLRC----TALEACAHPFFD 424
PS R A E HPFF
Sbjct: 270 VKDPSKRLGSKRGAAEIKQHPFFR 293
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 7e-17
Identities = 71/229 (31%), Positives = 113/229 (49%), Gaps = 27/229 (11%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ-------DKRYKNRELQIMRLLNHPN 191
Y +V+G G+FG V + + A+K + + D + E IM N P
Sbjct: 45 YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 104
Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYI--SETVYRVSKHYTRMNQHVPILYVQLYTYQICR 249
VV L C F +D+ YL +V+EY+ + V +S N VP + + YT ++
Sbjct: 105 VVQL-FCAF----QDDKYLYMVMEYMPGGDLVNLMS------NYDVPEKWAKFYTAEVVL 153
Query: 250 ALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA-KMLVPGEPNI-SYICSRYYRA 307
AL+ +H + G+ HRD+KP N+L++ H H LK+ DFG+ KM G + + + Y +
Sbjct: 154 ALDAIHSM-GLIHRDVKPDNMLLDKHGH-LKLADFGTCMKMDETGMVRCDTAVGTPDYIS 211
Query: 308 PELIF---GATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEII 353
PE++ G Y D WS+G L E+L+G F +S V +I+
Sbjct: 212 PEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIM 260
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 7e-17
Identities = 80/298 (26%), Positives = 134/298 (44%), Gaps = 45/298 (15%)
Query: 131 GQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKV-LQDKRYKN---RELQIMRL 186
G PK+ Y +G G+ G V+ A + TG VAIK++ LQ + K E+ +MR
Sbjct: 15 GDPKK--KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRE 72
Query: 187 LNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQ 246
HPN+V+ + DEL+ +V+EY++ T M++ + +
Sbjct: 73 NKHPNIVNYLDSYLVG---DELW--VVMEYLAGGSLTDVVTETCMDEGQ----IAAVCRE 123
Query: 247 ICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS-YICSRYY 305
+AL +L H V HRDIK N+L+ +K+ DFG + P + S + + Y+
Sbjct: 124 CLQALEFL-HSNQVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYW 181
Query: 306 RAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIK 365
APE++ Y +D+WS+G + E++ G+P + E+ + L +I GTP
Sbjct: 182 MAPEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATNGTP------ 233
Query: 366 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
E + P+ ++ D ++R L+ R +A E HPF
Sbjct: 234 -------ELQNPE------------KLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 8e-17
Identities = 81/301 (26%), Positives = 136/301 (45%), Gaps = 59/301 (19%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKK-----VLQDKRYK--NRELQIMRLL-NHPNVVS 194
RV+G GSFG V A+ E+G A+K +LQD + E +I+ L NHP +
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 195 LKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
L +C F T ++ L V+E+++ + ++ + K R ++ + Y +I AL
Sbjct: 61 L-YCCFQTPDR----LFFVMEFVNGGDLMFHIQKS-RRFDEA----RARFYAAEITSALM 110
Query: 253 YLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC-SRYYRAPELI 311
+LH G+ +RD+K N+L++ H K+ DFG K + S C + Y APE I
Sbjct: 111 FLHD-KGIIYRDLKLDNVLLD-HEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPE-I 167
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNY 371
Y ++D W++G +L E+L G F E+ D L E I +E+
Sbjct: 168 LQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE-DDLFEAI------LNDEV------- 213
Query: 372 TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLR--CTALEA----CAHPFFDD 425
++ + +A+D++ + +P++R L HPFF +
Sbjct: 214 ---------------VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKE 258
Query: 426 L 426
L
Sbjct: 259 L 259
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 1e-16
Identities = 70/220 (31%), Positives = 111/220 (50%), Gaps = 23/220 (10%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKRYKNR--ELQIMRLLNHPNVVSLK 196
V+G GSFG V A+ T + AIK V+QD + E +++ L + P ++
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQL 66
Query: 197 HCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
H F T D LY V+EY++ + +Y H ++ + V Y +I L +L
Sbjct: 67 HSCFQTV--DRLYF--VMEYVNGGDLMY----HIQQVGKFKEPQAV-FYAAEISVGLFFL 117
Query: 255 HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK-MLVPGEPNISYICSRYYRAPELIFG 313
H G+ +RD+K N++++ H +KI DFG K +V G ++ + Y APE+I
Sbjct: 118 HRR-GIIYRDLKLDNVMLDSEGH-IKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEII-A 174
Query: 314 ATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEII 353
Y ++D W+ G +L E+L GQP F GE D+L + I
Sbjct: 175 YQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE-DELFQSI 213
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 1e-16
Identities = 80/286 (27%), Positives = 126/286 (44%), Gaps = 51/286 (17%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQ---------IMRLLNHPNVV 193
+V+G GSFG V AK G A+K VLQ K ++ Q +++ L HP +V
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVK-VLQKKTILKKKEQNHIMAERNVLLKNLKHPFLV 59
Query: 194 SLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
L H F T EK L VL+Y++ E + + + + + Y ++ A+
Sbjct: 60 GL-HYSFQTAEK----LYFVLDYVNGGELFFHLQRERCFLEPRA-----RFYAAEVASAI 109
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC-SRYYRAPEL 310
YLH + + +RD+KP+N+L++ H + + DFG K V E S C + Y APE
Sbjct: 110 GYLHSL-NIIYRDLKPENILLDSQGHVV-LTDFGLCKEGVEPEETTSTFCGTPEYLAPE- 166
Query: 311 IFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEII----------------K 354
+ Y +D W +G VL E+L G P F V Q+ + I
Sbjct: 167 VLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-VSQMYDNILHKPLQLPGGKTVAACD 225
Query: 355 ILGTPTREEIKCMNPNYTEFKFPQIKAH------PWHKIFHKRMPP 394
+L ++ + +F +IK H W ++HKR+ P
Sbjct: 226 LLVGLLHKDQRRRLGAKADFL--EIKNHVFFSPINWDDLYHKRITP 269
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 1e-16
Identities = 63/208 (30%), Positives = 97/208 (46%), Gaps = 18/208 (8%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR--------ELQIMRLLNHPNVVS 194
RV+G G FG V + TG A K+ L+ KR K R E QI+ +N VV+
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKR-LEKKRIKKRKGESMALNEKQILEKVNSQFVVN 64
Query: 195 LKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
L + + KD L L L + + + + Y N Y +I L L
Sbjct: 65 LAYAY---ETKDALCLVLTIMNGGDLKFHI---YNMGNPGFEEERALFYAAEILCGLEDL 118
Query: 255 HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGA 314
H +RD+KP+N+L++ + H ++I D G A + GE + + Y APE++
Sbjct: 119 HRE-NTVYRDLKPENILLDDYGH-IRISDLGLAVKIPEGESIRGRVGTVGYMAPEVL-NN 175
Query: 315 TEYTTAIDMWSIGCVLAELLLGQPLFPG 342
YT + D W +GC++ E++ GQ F G
Sbjct: 176 QRYTLSPDYWGLGCLIYEMIEGQSPFRG 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 79.8 bits (196), Expect = 1e-16
Identities = 81/298 (27%), Positives = 135/298 (45%), Gaps = 45/298 (15%)
Query: 131 GQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR----ELQIMRL 186
G PK+ Y +G G+ G VF A + TG VAIK++ K+ K E+ +M+
Sbjct: 15 GDPKK--KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKE 72
Query: 187 LNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQ 246
L +PN+V+ F DEL++ V+EY++ T M++ + +
Sbjct: 73 LKNPNIVNFLDSFLV---GDELFV--VMEYLAGGSLTDVVTETCMDE----AQIAAVCRE 123
Query: 247 ICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS-YICSRYY 305
+AL +LH V HRDIK N+L+ +K+ DFG + P + S + + Y+
Sbjct: 124 CLQALEFLH-ANQVIHRDIKSDNVLLGMDG-SVKLTDFGFCAQITPEQSKRSTMVGTPYW 181
Query: 306 RAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIK 365
APE++ Y +D+WS+G + E++ G+P + E+ + L +I GTP +
Sbjct: 182 MAPEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATNGTP-----E 234
Query: 366 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
NP +++ P D ++R L+ R +A E HPF
Sbjct: 235 LQNP--------------------EKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 1e-16
Identities = 64/236 (27%), Positives = 115/236 (48%), Gaps = 27/236 (11%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR---------ELQIMRLLNHPNVV 193
+++G G+FG V+ +TG +A+K+V D E+Q+++ L H +V
Sbjct: 8 KLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIV 67
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
C E+ L++ +E++ ++ K Y + ++V + YT QI ++
Sbjct: 68 QYYGCLRDPMERT---LSIFMEHMPGGSIKDQLKSYGALTENV----TRKYTRQILEGVS 120
Query: 253 YLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML----VPGEPNISYICSRYYRAP 308
YLH + + HRDIK N+L + +K+ DFG++K L + G S + Y+ +P
Sbjct: 121 YLHSNM-IVHRDIKGANILRDS-VGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSP 178
Query: 309 ELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEI 364
E+I G Y D+WS+GC + E+L +P + + + + I KI PT +
Sbjct: 179 EVISGEG-YGRKADIWSVGCTVVEMLTEKPPW---AEFEAMAAIFKIATQPTNPVL 230
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 2e-16
Identities = 64/236 (27%), Positives = 117/236 (49%), Gaps = 27/236 (11%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR---------ELQIMRLLNHPNVV 193
+++G G+FG V+ +TG +A+K+V D + E+Q+++ L H +V
Sbjct: 8 KLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIV 67
Query: 194 SLKHCFFSTTEKDELYLNLVLEYI-SETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
C EK L++ +EY+ ++ K Y + ++V + YT QI + ++
Sbjct: 68 QYYGCLRDPEEKK---LSIFVEYMPGGSIKDQLKAYGALTENV----TRRYTRQILQGVS 120
Query: 253 YLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML----VPGEPNISYICSRYYRAP 308
YLH + + HRDIK N+L + +K+ DFG++K + + G S + Y+ +P
Sbjct: 121 YLHSNM-IVHRDIKGANILRDS-AGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSP 178
Query: 309 ELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEI 364
E+I G Y D+WS+ C + E+L +P + + + + I KI PT+ +
Sbjct: 179 EVISGEG-YGRKADVWSVACTVVEMLTEKPPW---AEYEAMAAIFKIATQPTKPML 230
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 2e-16
Identities = 61/229 (26%), Positives = 109/229 (47%), Gaps = 32/229 (13%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQD--------KRYK--NRELQIMRLLNHPNVV 193
V+G G++G V+ G +A+K+V D K Y+ E+ +++ L H N+V
Sbjct: 7 VLGKGAYGTVY-CGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
+ T D+ +++ +E++ +S R ++ + YT QI + Y
Sbjct: 66 Q-----YLGTCLDDNTISIFMEFVPGG--SISSILNRFGPLPEPVFCK-YTKQILDGVAY 117
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYI-------CSRYYR 306
LH+ V HRDIK N+++ P +K+ DFG A+ L + ++ + Y+
Sbjct: 118 LHNNC-VVHRDIKGNNVMLMP-NGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWM 175
Query: 307 APELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKI 355
APE+I + Y D+WSIGC + E+ G+P + +D+L + I
Sbjct: 176 APEVI-NESGYGRKSDIWSIGCTVFEMATGKPPL---ASMDRLAAMFYI 220
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-16
Identities = 62/231 (26%), Positives = 120/231 (51%), Gaps = 34/231 (14%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRE----LQIMRLL-----NHPNVV 193
RV+G GS+ V + L+ + + KV++ + + E +Q + + NHP +V
Sbjct: 1 RVIGRGSYAKVLLVR-LKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLV 59
Query: 194 SLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
L CF + E L V+EY++ + ++ + + + +P + + Y+ +I AL
Sbjct: 60 GLHSCF-----QTESRLFFVIEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEISLAL 109
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM-LVPGEPNISYICSRYYRAPEL 310
NYLH G+ +RD+K N+L++ H +K+ D+G K L PG+ ++ + Y APE+
Sbjct: 110 NYLHER-GIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEI 167
Query: 311 IFGATEYTTAIDMWSIGCVLAELLLGQPLF--------PGESGVDQLVEII 353
+ G +Y ++D W++G ++ E++ G+ F P ++ D L ++I
Sbjct: 168 LRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI 217
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-16
Identities = 64/236 (27%), Positives = 121/236 (51%), Gaps = 32/236 (13%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNH--------PNVVS 194
RV+G GS+ V + + A+K V ++ + + ++ ++ H P +V
Sbjct: 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60
Query: 195 LKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
L CF +T+ L LV+EY++ + ++ + + + +P + + Y +IC ALN
Sbjct: 61 LHSCFQTTSR-----LFLVIEYVNGGDLMFHMQRQ-----RKLPEEHARFYAAEICIALN 110
Query: 253 YLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM-LVPGEPNISYICSRYYRAPELI 311
+LH G+ +RD+K N+L++ H +K+ D+G K L PG+ ++ + Y APE++
Sbjct: 111 FLHER-GIIYRDLKLDNVLLDADGH-IKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEIL 168
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQPLF------PGESGVDQLVEIIKILGTPTR 361
G EY ++D W++G ++ E++ G+ F P + D L ++ IL P R
Sbjct: 169 RGE-EYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQV--ILEKPIR 221
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 2e-16
Identities = 60/218 (27%), Positives = 103/218 (47%), Gaps = 18/218 (8%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKV-LQ--DKRYKN---RELQIMRLLNHPNVVSLKHC 198
+G GSFGVVF+ A+K++ L ++R + E +++ L+ ++
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYES 67
Query: 199 FFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV 257
F D+ LN+V+EY ++++ K + +P V + QI L +LH
Sbjct: 68 FL-----DKGKLNIVMEYAENGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHSK 120
Query: 258 VGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC-SRYYRAPELIFGATE 316
+ HRDIK NL ++ + +KI D G AK+L + I + YY +PEL
Sbjct: 121 -KILHRDIKSLNLFLDAYD-NVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELC-EDKP 177
Query: 317 YTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIK 354
Y D+W++G VL E G+ F + +++II+
Sbjct: 178 YNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIR 215
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 3e-16
Identities = 56/183 (30%), Positives = 97/183 (53%), Gaps = 19/183 (10%)
Query: 179 RELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPI 237
RELQ++ N P +V F+S E +++ +E++ ++ +V K R+ + +
Sbjct: 52 RELQVLHECNSPYIVGFYGAFYSDGE-----ISICMEHMDGGSLDQVLKEAKRIPEEI-- 104
Query: 238 LYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI 297
+ + + R L YL + HRD+KP N+LVN ++K+CDFG + L+ N
Sbjct: 105 --LGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN- 160
Query: 298 SYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQ-PLFPGESGVDQLVEIIKIL 356
S++ +R Y +PE + G T Y+ D+WS+G L EL +G+ P+ P ++ E+ I
Sbjct: 161 SFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVELAIGRYPIPPPDAK-----ELEAIF 214
Query: 357 GTP 359
G P
Sbjct: 215 GRP 217
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 3e-16
Identities = 70/274 (25%), Positives = 131/274 (47%), Gaps = 39/274 (14%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQ-DKRYKN----RELQIMRLLNH--PNVVSLKH 197
+G+G+ G V++ + +TG +A+K++ + + +N +L ++ L +H P +V
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVV-LKSHDCPYIVKCYG 81
Query: 198 CFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV 257
F + ++ + + +E +S + ++ K R+ +P + T I +AL+YL
Sbjct: 82 YFITDSD-----VFICMELMSTCLDKLLK---RIQGPIPEDILGKMTVAIVKALHYLKEK 133
Query: 258 VGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI-SYICSRYYRAPELIFGAT- 315
GV HRD+KP N+L++ + +K+CDFG + LV + S C+ Y APE I
Sbjct: 134 HGVIHRDVKPSNILLD-ASGNVKLCDFGISGRLVDSKAKTRSAGCAAYM-APERIDPPDP 191
Query: 316 --EYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGT-----PTREE----- 363
+Y D+WS+G L EL GQ FP ++ + + KIL P E
Sbjct: 192 NPKYDIRADVWSLGISLVELATGQ--FPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPDF 249
Query: 364 ----IKCMNPNYTEF-KFPQIKAHPWHKIFHKRM 392
C+ ++ + K+ ++ HP+ + +
Sbjct: 250 CSFVDLCLTKDHRKRPKYRELLQHPFIRRYETAE 283
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 3e-16
Identities = 68/242 (28%), Positives = 117/242 (48%), Gaps = 27/242 (11%)
Query: 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR---------ELQIMRLL 187
I++ +++G G+FG V+ ++TG +A K+V D E+Q+++ L
Sbjct: 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL 61
Query: 188 NHPNVVSLKHCFFSTTEKDELYLNLVLEYI-SETVYRVSKHYTRMNQHVPILYVQLYTYQ 246
H +V C EK L + +EY+ +V K Y + + V + YT Q
Sbjct: 62 QHERIVQYYGCLRDRAEKT---LTIFMEYMPGGSVKDQLKAYGALTESV----TRKYTRQ 114
Query: 247 ICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML----VPGEPNISYICS 302
I ++YLH + + HRDIK N+L + +K+ DFG++K L + G S +
Sbjct: 115 ILEGMSYLHSNM-IVHRDIKGANILRDS-AGNVKLGDFGASKRLQTICMSGTGIRSVTGT 172
Query: 303 RYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTRE 362
Y+ +PE+I G Y D+WS+GC + E+L +P + + + + I KI PT
Sbjct: 173 PYWMSPEVISGEG-YGRKADVWSLGCTVVEMLTEKPPW---AEYEAMAAIFKIATQPTNP 228
Query: 363 EI 364
++
Sbjct: 229 QL 230
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 3e-16
Identities = 78/300 (26%), Positives = 128/300 (42%), Gaps = 59/300 (19%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQ-------IMRLLN---HPNVV 193
V+G G FG V A+ +TG+ AIK + + E++ I N HP +V
Sbjct: 6 VLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLV 65
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
+L CF +D + V+EY + + H ++ Y + L Y
Sbjct: 66 NLFACF---QTEDHVCF--VMEYAAGGDLMMHIHTDVFSEP----RAVFYAACVVLGLQY 116
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM-LVPGEPNISYICSRYYRAPELIF 312
LH + +RD+K NLL++ +KI DFG K + G+ ++ + + APE++
Sbjct: 117 LHEN-KIVYRDLKLDNLLLDTEGF-VKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLT 174
Query: 313 GATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYT 372
T YT A+D W +G ++ E+L+G+ FPG+ EE+
Sbjct: 175 E-TSYTRAVDWWGLGVLIYEMLVGESPFPGD----------------DEEEV-------- 209
Query: 373 EFKFPQIKA-HPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA-----HPFFDDL 426
F I + F + EA+ ++ RLL+ +P R + E A PFF D+
Sbjct: 210 ---FDSIVNDEVRYPRF---LSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDI 263
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 4e-16
Identities = 64/230 (27%), Positives = 117/230 (50%), Gaps = 32/230 (13%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVA---IKKVL----QDKRYKNRELQIMRLL-NHPNVVS 194
RV+G GS+ V + +T A IKK L +D + E + NHP +V
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60
Query: 195 LKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
L CF + + L V+E++S + ++ H R + +P + + Y+ +I ALN
Sbjct: 61 LHSCFQTESR-----LFFVIEFVSGGDLMF----HMQR-QRKLPEEHARFYSAEISLALN 110
Query: 253 YLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM-LVPGEPNISYICSRYYRAPELI 311
+LH G+ +RD+K N+L++ H +K+ D+G K + PG+ ++ + Y APE++
Sbjct: 111 FLHER-GIIYRDLKLDNVLLDAEGH-IKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEIL 168
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQPLF--------PGESGVDQLVEII 353
G +Y ++D W++G ++ E++ G+ F P ++ D L ++I
Sbjct: 169 RG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVI 217
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 4e-16
Identities = 64/234 (27%), Positives = 96/234 (41%), Gaps = 47/234 (20%)
Query: 145 VGTGSFGVVFQAKCLETGDS---VAIK-----KVLQDKRYKNRELQIMRLLNHPNVVSLK 196
+G G+FG V + L VA+K + K+ RE +M L+HP +V L
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRL- 61
Query: 197 HCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH 256
+ + L LV+E Y + + +P+ ++ +Q+ + YL
Sbjct: 62 ---IGVCKGEPLM--LVMELAPLGPLL---KYLKKRREIPVSDLKELAHQVAMGMAYLES 113
Query: 257 VVGVCHRDIKPQN-LLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR--------- 306
V HRD+ +N LLVN HQ KI DFG ++ L G S YYR
Sbjct: 114 KHFV-HRDLAARNVLLVN--RHQAKISDFGMSRALGAG--------SDYYRATTAGRWPL 162
Query: 307 ---APELIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVDQLVEIIKIL 356
APE I +++ D+WS G L E G + G E+I +L
Sbjct: 163 KWYAPECINYGK-FSSKSDVWSYGVTLWEAFSYGAKPYGEMKG----AEVIAML 211
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 5e-16
Identities = 69/210 (32%), Positives = 99/210 (47%), Gaps = 26/210 (12%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRY--KNRELQIMRLLN-------HPNVV 193
+V+G GSFG V A+ A+K VLQ K K E IM N HP +V
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVK-VLQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 59
Query: 194 SLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
L H F T +K L VL+YI+ E Y + + + + Y +I AL
Sbjct: 60 GL-HFSFQTADK----LYFVLDYINGGELFYHLQRERCFLEPRA-----RFYAAEIASAL 109
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC-SRYYRAPEL 310
YLH + + +RD+KP+N+L++ H + + DFG K + S C + Y APE+
Sbjct: 110 GYLHSL-NIVYRDLKPENILLDSQGH-IVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEV 167
Query: 311 IFGATEYTTAIDMWSIGCVLAELLLGQPLF 340
+ Y +D W +G VL E+L G P F
Sbjct: 168 LH-KQPYDRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 5e-16
Identities = 64/229 (27%), Positives = 118/229 (51%), Gaps = 23/229 (10%)
Query: 145 VGTGSFGVVFQAKCLETGDSVA-------IKKVLQDKRYKNRELQIMRLLNHPNVVSLKH 197
+G G+ GVVF+ +G +A IK ++++ RELQ++ N P +V
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQII--RELQVLHECNSPYIVGFYG 70
Query: 198 CFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH 256
F+S E +++ +E++ ++ +V K R+ + + + + + + L YL
Sbjct: 71 AFYSDGE-----ISICMEHMDGGSLDQVLKKAGRIPEQI----LGKVSIAVIKGLTYLRE 121
Query: 257 VVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATE 316
+ HRD+KP N+LVN ++K+CDFG + L+ N S++ +R Y +PE + G T
Sbjct: 122 KHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-TH 178
Query: 317 YTTAIDMWSIGCVLAELLLGQ-PLFPGESGVDQLVEIIKILGTPTREEI 364
Y+ D+WS+G L E+ +G+ P+ P ++ +L+ + G P E
Sbjct: 179 YSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESET 227
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 6e-16
Identities = 74/286 (25%), Positives = 128/286 (44%), Gaps = 52/286 (18%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQ-------IMRLLNHPNVVSLK 196
V+G GSFG V A+ T + AIK + +D ++ +++ ++ L P ++
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQL 66
Query: 197 HCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
H F T D LY V+EY++ + +Y + + + + + Y +I L +L
Sbjct: 67 HSCFQTM--DRLYF--VMEYVNGGDLMYHIQQ-VGKFKEPHAVFYAA----EIAIGLFFL 117
Query: 255 HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM-LVPGEPNISYICSRYYRAPELIFG 313
H G+ +RD+K N++++ H +KI DFG K + G+ ++ + Y APE+I
Sbjct: 118 HSK-GIIYRDLKLDNVMLDAEGH-IKIADFGMCKENIFGGKTTRTFCGTPDYIAPEII-A 174
Query: 314 ATEYTTAIDMWSIGCVLAELLLGQPLFPGE-------SGVDQLVEIIKILGTPTREEIKC 366
Y ++D W+ G +L E+L GQP F GE S ++ V K L ++E +
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSL---SKEAVSI 231
Query: 367 MNPNYTEFKFP------------QIKAHP------WHKIFHKRMPP 394
T K P I+ H W K+ + + P
Sbjct: 232 CKGLLT--KHPAKRLGCGPTGERDIREHAFFRRIDWEKLERREIQP 275
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 8e-16
Identities = 70/293 (23%), Positives = 125/293 (42%), Gaps = 41/293 (13%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHC 198
++G G+ G V++A L T +A+K + D ++ EL+I+ + P ++
Sbjct: 8 ILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGA 67
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV 258
FF E +++ E++ V Y ++ +HV + + + L YL +
Sbjct: 68 FFV-----ENRISICTEFMDGGSLDV---YRKIPEHV----LGRIAVAVVKGLTYLWSL- 114
Query: 259 GVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYT 318
+ HRD+KP N+LVN Q+K+CDFG + LV +Y+ + Y APE I G +Y
Sbjct: 115 KILHRDVKPSNMLVNTRG-QVKLCDFGVSTQLVNSIAK-TYVGTNAYMAPERISG-EQYG 171
Query: 319 TAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQ 378
D+WS+G EL LG+ +P + +++L E+ P
Sbjct: 172 IHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDP------------PV 219
Query: 379 IKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNT 431
+ + + F + +++ ++ P R HPF D N
Sbjct: 220 LPVGQFSEKF--------VHFITQCMRKQPKERPAPENLMDHPFIVQYNDGNA 264
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 9e-16
Identities = 81/289 (28%), Positives = 130/289 (44%), Gaps = 49/289 (16%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVL----QDKRYKNRELQIMRLLNHPNVVSLKHCFF 200
+G+G++G V++A+ + TG+ AIK + +D +E+ +M+ H N+V+ F
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAY---FG 73
Query: 201 STTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGV 260
S +D+L++ +E+ + H T I YV T Q L YLH G
Sbjct: 74 SYLRRDKLWIC--MEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQ---GLYYLHS-KGK 127
Query: 261 CHRDIKPQNLLVNPHTHQLKICDFG-SAKMLVPGEPNISYICSRYYRAPELIFGATE--- 316
HRDIK N+L+ + H +K+ DFG SA++ S+I + Y+ APE+ A E
Sbjct: 128 MHRDIKGANILLTDNGH-VKLADFGVSAQITATIAKRKSFIGTPYWMAPEV--AAVERKG 184
Query: 317 -YTTAIDMWSIGCVLAELL-LGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEF 374
Y D+W++G EL L P+F + ++ L T+ + F
Sbjct: 185 GYNQLCDIWAVGITAIELAELQPPMFD--------LHPMRALFLMTK----------SNF 226
Query: 375 KFPQIKAH-PWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPF 422
+ P++K W FH V L +P R TA + HPF
Sbjct: 227 QPPKLKDKMKWSNSFHH--------FVKMALTKNPKKRPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 1e-15
Identities = 70/229 (30%), Positives = 111/229 (48%), Gaps = 27/229 (11%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ-------DKRYKNRELQIMRLLNHPN 191
Y +V+G G+FG V + T A+K + + D + E IM N P
Sbjct: 45 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 104
Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYI--SETVYRVSKHYTRMNQHVPILYVQLYTYQICR 249
VV L + F +D+ YL +V+EY+ + V +S N VP + + YT ++
Sbjct: 105 VVQLFYAF-----QDDRYLYMVMEYMPGGDLVNLMS------NYDVPEKWARFYTAEVVL 153
Query: 250 ALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA-KMLVPGEPNI-SYICSRYYRA 307
AL+ +H + G HRD+KP N+L++ H LK+ DFG+ KM G + + + Y +
Sbjct: 154 ALDAIHSM-GFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMNKEGMVRCDTAVGTPDYIS 211
Query: 308 PELIF---GATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEII 353
PE++ G Y D WS+G L E+L+G F +S V +I+
Sbjct: 212 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 260
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 1e-15
Identities = 60/207 (28%), Positives = 99/207 (47%), Gaps = 24/207 (11%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV----LQDKRYKN--RELQIMRLLNHPNV 192
Y+ + +G GSFG K E G IK++ + K + +E+ ++ + HPN+
Sbjct: 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNI 61
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY----VQLYTYQIC 248
V + F E LY+ V++Y Y ++N +L+ + + QIC
Sbjct: 62 VQYQESF---EENGNLYI--VMDYCEG-----GDLYKKINAQRGVLFPEDQILDWFVQIC 111
Query: 249 RALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG-EPNISYICSRYYRA 307
AL ++H + HRDIK QN+ + +K+ DFG A++L E + I + YY +
Sbjct: 112 LALKHVHDR-KILHRDIKSQNIFLTKDG-TIKLGDFGIARVLNSTVELARTCIGTPYYLS 169
Query: 308 PELIFGATEYTTAIDMWSIGCVLAELL 334
PE I Y D+W++GCVL E+
Sbjct: 170 PE-ICENRPYNNKSDIWALGCVLYEMC 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 1e-15
Identities = 88/324 (27%), Positives = 137/324 (42%), Gaps = 60/324 (18%)
Query: 116 TEAGQVIATTVGGRNGQPKQTISYMA-ERV--VGTGSFGVVFQAKCLETGDSVAIKKVLQ 172
+ +++ P S ERV +G+G+ G V++ TG A+K +
Sbjct: 50 PSSSSSSSSSSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYG 109
Query: 173 D-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKH 227
+ +R RE++I+R +NHPNVV F E + ++LE++ S
Sbjct: 110 NHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGE-----IQVLLEFMD----GGSLE 160
Query: 228 YTRMNQHVPILYVQLYTYQICRALNYLH--HVVGVCHRDIKPQNLLVNPHTHQLKICDFG 285
T + ++ QI + YLH H+V HRDIKP NLL+N +KI DFG
Sbjct: 161 GTHIADE---QFLADVARQILSGIAYLHRRHIV---HRDIKPSNLLINS-AKNVKIADFG 213
Query: 286 SAKMLVPG-EPNISYICSRYYRAPELI-----FGATEYTTAIDMWSIGCVLAELLLGQ-P 338
+++L +P S + + Y +PE I GA + A D+WS+G + E LG+ P
Sbjct: 214 VSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYD-GYAGDIWSLGVSILEFYLGRFP 272
Query: 339 LFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALD 398
G G D + I CM+ P+ A E
Sbjct: 273 FGVGRQG-DWASLMCAI----------CMSQP------PEAPAT---------ASREFRH 306
Query: 399 LVSRLLQYSPSLRCTALEACAHPF 422
+S LQ P+ R +A++ HPF
Sbjct: 307 FISCCLQREPAKRWSAMQLLQHPF 330
|
Length = 353 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-15
Identities = 67/222 (30%), Positives = 115/222 (51%), Gaps = 25/222 (11%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKRYKNR--ELQIMRL-LNHPNVVS 194
+V+G GSFG V A+ T + AIK +LQD E +I+ L HP + +
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 195 LKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
L HC F T ++ L V+EY++ + ++++ + + ++ + Y ++ AL
Sbjct: 61 L-HCCFQTKDR----LFFVMEYVNGGDLMFQIQRS-RKFDEP----RSRFYAAEVTLALM 110
Query: 253 YLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM-LVPGEPNISYICSRYYRAPELI 311
+LH GV +RD+K N+L++ H K+ DFG K ++ G ++ + Y APE I
Sbjct: 111 FLHRH-GVIYRDLKLDNILLDAEGH-CKLADFGMCKEGILNGVTTTTFCGTPDYIAPE-I 167
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEII 353
EY ++D W++G ++ E++ GQP F ++ D L E I
Sbjct: 168 LQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE-DDLFESI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 2e-15
Identities = 83/345 (24%), Positives = 127/345 (36%), Gaps = 116/345 (33%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQ-DKRYKNR------ELQIMRLLNHPNVVSL 195
+V+G G+FG V + +TG A+KK+ + + K + E I+ ++P VV L
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKL 66
Query: 196 KHCFFSTTEKDELYLNLVLEYI---------------SETVYRVSKHYTRMNQHVPILYV 240
+ F +DE YL L++EY+ +E
Sbjct: 67 YYSF-----QDENYLYLIMEYLPGGDMMTLLMKKDTFTEEE------------------T 103
Query: 241 QLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG------------SAK 288
+ Y + A++ +H + G HRDIKP NLL++ H +K+ DFG +
Sbjct: 104 RFYIAETILAIDSIHKL-GYIHRDIKPDNLLLDAKGH-IKLSDFGLCTGLKKSHRTEFYR 161
Query: 289 MLVPGEPNISYICSR--------------------Y-------YRAPELIFGATEYTTAI 321
+L P+ Y Y APE +F T Y
Sbjct: 162 ILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPE-VFLQTGYNKEC 220
Query: 322 DMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKA 381
D WS+G ++ E+L+G P F + P K +N T +FP
Sbjct: 221 DWWSLGVIMYEMLVGYPPFCSD--------------NPQETYRKIINWKET-LQFPD--- 262
Query: 382 HPWHKIFHKRMPPEALDLVSRLLQYSPSLRC---TALEACAHPFF 423
+ PEA DL+ RL R E +HPFF
Sbjct: 263 -------EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFF 299
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 4e-15
Identities = 66/285 (23%), Positives = 119/285 (41%), Gaps = 46/285 (16%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRE-----------LQIMRLLNHPNV 192
++G G FG V+ + +TG A+K L KR K ++ L ++ + P +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
V + + F + D+L L L + Y +S+H + + Y +I L
Sbjct: 60 VCMSYAFHT---PDKLSFILDLMNGGDLHYHLSQHGVFSEAEM-----RFYAAEIILGLE 111
Query: 253 YLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIF 312
++H V +RD+KP N+L++ H H ++I D G A +P+ S + + Y APE++
Sbjct: 112 HMH-NRFVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQ 168
Query: 313 GATEYTTAIDMWSIGCVLAELLLGQ----------------------PLFPGESGVDQLV 350
Y ++ D +S+GC+L +LL G P +
Sbjct: 169 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRS 228
Query: 351 EIIKILGTPTREEIKCMNPNYTEFK-FPQIKAHPWHKIFHKRMPP 394
+ +L + C+ E K P ++ W +F ++ PP
Sbjct: 229 LLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMVFLQKYPP 273
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 4e-15
Identities = 80/298 (26%), Positives = 135/298 (45%), Gaps = 45/298 (15%)
Query: 131 GQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKV-LQDKRYKN---RELQIMRL 186
G PK+ Y +G G+ G V+ A + TG VAIK++ LQ + K E+ +MR
Sbjct: 15 GDPKK--KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRE 72
Query: 187 LNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQ 246
+PN+V+ + DEL++ V+EY++ T M++ + +
Sbjct: 73 NKNPNIVNYLDSYLV---GDELWV--VMEYLAGGSLTDVVTETCMDEG----QIAAVCRE 123
Query: 247 ICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS-YICSRYY 305
+AL++LH V HRDIK N+L+ +K+ DFG + P + S + + Y+
Sbjct: 124 CLQALDFLHSN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYW 181
Query: 306 RAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIK 365
APE++ Y +D+WS+G + E++ G+P + E+ + L +I GTP +
Sbjct: 182 MAPEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATNGTP-----E 234
Query: 366 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
NP +R+ D ++R L+ R +A E HPF
Sbjct: 235 LQNP--------------------ERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 5e-15
Identities = 64/242 (26%), Positives = 111/242 (45%), Gaps = 31/242 (12%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR--------ELQIMRLLNHPNVVSLK 196
+G G FG V + TG A KK L KR K + E +I+ +N P +V+L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKK-LDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLA 59
Query: 197 HCFFSTTEKDELYLNLVLEYISET-----VYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
+ F S T +L LV+ ++ +Y V + M + V Y+ QI +
Sbjct: 60 YAFESKT-----HLCLVMSLMNGGDLKYHIYNVGERGLEMER------VIHYSAQITCGI 108
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELI 311
+LH + + +RD+KP+N+L++ ++ D G A L G+ + Y APE I
Sbjct: 109 LHLHSM-DIVYRDMKPENVLLDDQG-NCRLSDLGLAVELKDGKTITQRAGTNGYMAPE-I 165
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNY 371
Y+ +D +++GC + E++ G+ F + V ++ +E+K + N+
Sbjct: 166 LKEEPYSYPVDWFAMGCSIYEMVAGRTPF---KDHKEKVAKEELKRRTLEDEVKFEHQNF 222
Query: 372 TE 373
TE
Sbjct: 223 TE 224
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 6e-15
Identities = 66/216 (30%), Positives = 102/216 (47%), Gaps = 45/216 (20%)
Query: 143 RVVGTGSFGVV----FQAKCLETGDSVAIKKVLQDKRYKNR-----ELQIMRLLNHPNVV 193
RV+G G FG V + TG+ VA+K + ++ +N E+ I++ L H N+V
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYR--VSKHYTRMNQHVPILYVQLYTYQICRAL 251
K C +E+ L L++EY+ R + KH + Q + L+ QIC +
Sbjct: 70 KYKGC---CSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQ------LLLFAQQICEGM 120
Query: 252 NYLH--HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPE 309
YLH H + HRD+ +N+L++ + +KI DFG AK + G YYR E
Sbjct: 121 AYLHSQHYI---HRDLAARNVLLD-NDRLVKIGDFGLAKAVPEGH--------EYYRVRE 168
Query: 310 -----LIFGATE------YTTAIDMWSIGCVLAELL 334
+ + A E ++ A D+WS G L ELL
Sbjct: 169 DGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 9e-15
Identities = 75/299 (25%), Positives = 124/299 (41%), Gaps = 57/299 (19%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRE----------LQIMRLLNHPNVVS 194
+G G+FG V+Q + +T A+K + + + +E L L P +V
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 195 LKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
LK FS +LYL V +Y+S E + + K + Y ++ AL
Sbjct: 61 LK---FSFQTDSDLYL--VTDYMSGGELFWHLQK-----EGRFSEDRAKFYIAELVLALE 110
Query: 253 YLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC-SRYYRAPELI 311
+LH + +RD+KP+N+L++ H + +CDFG +K + + C + Y APE++
Sbjct: 111 HLHKY-DIVYRDLKPENILLDATGH-IALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVL 168
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNY 371
YT +D WS+G ++ E+ G F E Q+ I +
Sbjct: 169 LDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED-TQQMYRNIA----------------F 211
Query: 372 TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC----TALEACAHPFFDDL 426
+ +FP+ + E V LL +P R A+E HPFF D+
Sbjct: 212 GKVRFPK-----------NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADI 259
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 82/299 (27%), Positives = 132/299 (44%), Gaps = 62/299 (20%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----------KRYKNRELQIMRLLNHPNV 192
+++G G+FG V K TG A+K + ++ +NR LQ R HP +
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR---HPFL 57
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRA 250
+LK+ F T ++ L V+EY + E + +S+ + Y +I A
Sbjct: 58 TALKYSF-QTHDR----LCFVMEYANGGELFFHLSRERVFSEDRA-----RFYGAEIVSA 107
Query: 251 LNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC-SRYYRAPE 309
L+YLH V +RD+K +NL+++ H +KI DFG K + + C + Y APE
Sbjct: 108 LDYLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKTFCGTPEYLAPE 166
Query: 310 LIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369
+ +Y A+D W +G V+ E++ G+ F + ++L E+I + EEI+
Sbjct: 167 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEIR---- 214
Query: 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC-----TALEACAHPFF 423
F + + PEA L+S LL+ P R A E H FF
Sbjct: 215 ------------------FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFF 255
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 1e-14
Identities = 79/304 (25%), Positives = 132/304 (43%), Gaps = 48/304 (15%)
Query: 129 RNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR-----ELQI 183
R+ P + + E +G G+FG V++AK ETG ++A KV++ K + E++I
Sbjct: 6 RDLDPNEVWEIIGE--LGDGAFGKVYKAKNKETG-ALAAAKVIETKSEEELEDYMVEIEI 62
Query: 184 MRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLY 243
+ NHP +V L F+ + L +++E+ V +++ + +Q+
Sbjct: 63 LATCNHPYIVKLLGAFYWDGK-----LWIMIEFCPGGA--VDAIMLELDRGLTEPQIQVI 115
Query: 244 TYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG-SAKMLVPGEPNISYICS 302
Q+ AL YLH + + HRD+K N+L+ +K+ DFG SAK + + S+I +
Sbjct: 116 CRQMLEALQYLHS-MKIIHRDLKAGNVLLT-LDGDIKLADFGVSAKNVKTLQRRDSFIGT 173
Query: 303 RYYRAPELIFGAT----EYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGT 358
Y+ APE++ T Y D+WS+G L E+ +P
Sbjct: 174 PYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEP-------------------- 213
Query: 359 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEAC 418
P E +NP K K+ P + E D + L P R +A +
Sbjct: 214 PHHE----LNPMRVLLKIA--KSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLL 267
Query: 419 AHPF 422
HPF
Sbjct: 268 EHPF 271
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 1e-14
Identities = 63/206 (30%), Positives = 97/206 (47%), Gaps = 18/206 (8%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR--------ELQIMRLLNHPNVVS 194
RV+G G FG V + TG A KK L+ KR K R E +I+ +N VVS
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKK-LEKKRIKKRKGEAMALNEKRILEKVNSRFVVS 64
Query: 195 LKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
L + + KD L L L + + + + Y N Y ++C L L
Sbjct: 65 LAYAY---ETKDALCLVLTIMNGGDLKFHI---YNMGNPGFDEQRAIFYAAELCCGLEDL 118
Query: 255 HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGA 314
+ +RD+KP+N+L++ H ++I D G A + GE + + Y APE+I
Sbjct: 119 QRE-RIVYRDLKPENILLDDRGH-IRISDLGLAVQIPEGETVRGRVGTVGYMAPEVI-NN 175
Query: 315 TEYTTAIDMWSIGCVLAELLLGQPLF 340
+YT + D W +GC++ E++ GQ F
Sbjct: 176 EKYTFSPDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 1e-14
Identities = 83/307 (27%), Positives = 133/307 (43%), Gaps = 64/307 (20%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMR-----LLNHPN--VVSL 195
+V+G G+FG V K TG A+K + + + K E R L+N + +L
Sbjct: 7 KVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNL 66
Query: 196 KHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
+ F +DE L LV++Y + + +SK +P + Y ++ A++
Sbjct: 67 HYAF-----QDENNLYLVMDYYVGGDLLTLLSK----FEDRLPEDMARFYLAEMVLAIDS 117
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP----------GEPNISYICSR 303
+H + G HRDIKP N+L++ + H +++ DFGS L+ G P+ YI
Sbjct: 118 VHQL-GYVHRDIKPDNVLLDKNGH-IRLADFGSCLRLLADGTVQSNVAVGTPD--YISPE 173
Query: 304 YYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREE 363
+A E G Y D WS+G + E+L G+ F ES V+ +I+
Sbjct: 174 ILQAME--DGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM---------- 221
Query: 364 IKCMNPNYTE-FKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC---TALEACA 419
N+ E F+FP + EA DL+ RL+ SP R +
Sbjct: 222 ------NHKEHFQFPPDVTD---------VSEEAKDLIRRLI-CSPETRLGRNGLQDFKD 265
Query: 420 HPFFDDL 426
HPFF+ +
Sbjct: 266 HPFFEGI 272
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 73.0 bits (180), Expect = 2e-14
Identities = 70/293 (23%), Positives = 123/293 (41%), Gaps = 71/293 (24%)
Query: 148 GSFGVVFQAKCLETGDS-VAIKKVLQDKRYKNREL---QIMRLLNHPNVVSLKHCFFSTT 203
G FG V K + ++K+++ K + E Q+M+ ++PN + L + TT
Sbjct: 27 GKFGKVSVLK--HKPTQKLFVQKIIKAKNFNAIEPMVHQLMK--DNPNFIKLYYSV--TT 80
Query: 204 EKDELYLNLVLEYIS-----ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH--H 256
K + L+++YI + + + + V+ Q+ ALN LH +
Sbjct: 81 LKGHV---LIMDYIKDGDLFDLL--------KKEGKLSEAEVKKIIRQLVEALNDLHKHN 129
Query: 257 VVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRY-----YRAPELI 311
++ H DIK +N+L + ++ +CD+G K++ G P S Y Y +PE I
Sbjct: 130 II---HNDIKLENVLYDRAKDRIYLCDYGLCKII--GTP------SCYDGTLDYFSPEKI 178
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNY 371
G Y + D W++G + ELL G+ P + D E + +++ +
Sbjct: 179 KGHN-YDVSFDWWAVGVLTYELLTGK--HPFKEDED---EEL---------DLESLLKRQ 223
Query: 372 TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA-HPFF 423
+ K P F K + A D V +L+Y+ + R T HPF
Sbjct: 224 -QKKLP----------FIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFL 265
|
Length = 267 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 3e-14
Identities = 61/206 (29%), Positives = 103/206 (50%), Gaps = 21/206 (10%)
Query: 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKV------LQDKRYKNRELQIMRLLNHPN 191
+Y RVVG GS+G V + G IKK+ ++++ +E Q++ L HPN
Sbjct: 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPN 60
Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRA 250
+V+ + + E ++ L +V+ + +Y K + + +P V + QI A
Sbjct: 61 IVAYRESW----EGEDGLLYIVMGFCEGGDLYHKLKE--QKGKLLPENQVVEWFVQIAMA 114
Query: 251 LNYLH--HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS-YICSRYYRA 307
L YLH H++ HRD+K QN+ + T+ +K+ D G A++L S I + YY +
Sbjct: 115 LQYLHEKHIL---HRDLKTQNVFLT-RTNIIKVGDLGIARVLENQCDMASTLIGTPYYMS 170
Query: 308 PELIFGATEYTTAIDMWSIGCVLAEL 333
PEL F Y D+W++GC + E+
Sbjct: 171 PEL-FSNKPYNYKSDVWALGCCVYEM 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 8e-14
Identities = 58/208 (27%), Positives = 103/208 (49%), Gaps = 23/208 (11%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRE-----------LQIMRLLNHPNV 192
++G G FG V+ + +TG A+K L KR K ++ L ++ + P +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
V + + F + D+L L L + Y +S+H + + + Y +I L
Sbjct: 60 VCMTYAFHT---PDKLCFILDLMNGGDLHYHLSQHGVFSEKEM-----RFYATEIILGLE 111
Query: 253 YLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIF 312
++H+ V +RD+KP N+L++ H H ++I D G A +P+ S + + Y APE++
Sbjct: 112 HMHNRF-VVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQ 168
Query: 313 GATEYTTAIDMWSIGCVLAELLLGQPLF 340
T Y ++ D +S+GC+L +LL G F
Sbjct: 169 KGTAYDSSADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 8e-14
Identities = 68/249 (27%), Positives = 122/249 (48%), Gaps = 20/249 (8%)
Query: 131 GQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKV-LQDKRYKN---RELQIMRL 186
G PK+ Y +G G+ G V+ A + TG VAI+++ LQ + K E+ +MR
Sbjct: 16 GDPKK--KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73
Query: 187 LNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQ 246
+PN+V+ + DEL++ V+EY++ T M++ + +
Sbjct: 74 NKNPNIVNYLDSYLV---GDELWV--VMEYLAGGSLTDVVTETCMDEG----QIAAVCRE 124
Query: 247 ICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS-YICSRYY 305
+AL +LH V HRDIK N+L+ +K+ DFG + P + S + + Y+
Sbjct: 125 CLQALEFLHSN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYW 182
Query: 306 RAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIK 365
APE++ Y +D+WS+G + E++ G+P + E+ + L +I GTP + +
Sbjct: 183 MAPEVV-TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPELQNPE 240
Query: 366 CMNPNYTEF 374
++ + +F
Sbjct: 241 KLSAIFRDF 249
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 77/299 (25%), Positives = 133/299 (44%), Gaps = 57/299 (19%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNREL-------QIMRLLNHPNVVSL 195
+++G G+FG V + TG A+K + ++ E+ ++++ HP + +L
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 196 KHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
K+ F T ++ L V+EY + E + +S+ + + Y +I AL Y
Sbjct: 61 KYAF-QTHDR----LCFVMEYANGGELFFHLSRERVFTEERA-----RFYGAEIVSALEY 110
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC-SRYYRAPELIF 312
LH V +RDIK +NL+++ H +KI DFG K + + C + Y APE +
Sbjct: 111 LHSR-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPE-VL 167
Query: 313 GATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYT 372
+Y A+D W +G V+ E++ G+ F + ++L E+I + EEI+
Sbjct: 168 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR------- 213
Query: 373 EFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC-----TALEACAHPFFDDL 426
F + + PEA L++ LL+ P R A E H FF +
Sbjct: 214 ---------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 257
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 93/373 (24%), Positives = 150/373 (40%), Gaps = 52/373 (13%)
Query: 84 LPKEMNEMRIRDEKNVNHDDKDLEPSIVN----GNGTEAGQVIATTVGGRNGQPKQTISY 139
P EMN I + + ++DK ++ I + + ++A +A R G K S
Sbjct: 38 FPSEMNP-GIESDDDCLYEDKHMDIDIFDIFADEDESDADASLALCAEARAGIEKAGFSI 96
Query: 140 MAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCF 199
+ G+ G F +T + V IK + E I+R +NHP+++ LK F
Sbjct: 97 L--ETFTPGAEGFAFACIDNKTCEHVVIKA--GQRGGTATEAHILRAINHPSIIQLKGTF 152
Query: 200 FSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG 259
T K + L+L +Y Y +++ I + + RA+ YLH
Sbjct: 153 --TYNK---FTCLILPRYKTDLY----CYLAAKRNIAICDILAIERSVLRAIQYLHEN-R 202
Query: 260 VCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYY--------RAPELI 311
+ HRDIK +N+ +N H + + DFG+A V N +YY APEL+
Sbjct: 203 IIHRDIKAENIFIN-HPGDVCLGDFGAACFPVDINAN------KYYGWAGTIATNAPELL 255
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVD-------QLVEIIKILGTPTREEI 364
Y A+D+WS G VL E+ + G+D Q+ II+ GT E
Sbjct: 256 -ARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFP 314
Query: 365 KCMNPNYTEFKFPQIK-------AHP-WHKIFHKRMPPEALDLVSRLLQYSPSLRCTALE 416
N E K + P W ++ +P + L+ ++L + R +A
Sbjct: 315 IDAQANLDEIYIGLAKKSSRKPGSRPLWTNLY--ELPIDLEYLICKMLAFDAHHRPSAEA 372
Query: 417 ACAHPFFDDLRDP 429
F D+ DP
Sbjct: 373 LLDFAAFQDIPDP 385
|
Length = 391 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 2e-13
Identities = 73/295 (24%), Positives = 127/295 (43%), Gaps = 30/295 (10%)
Query: 148 GSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207
GS G VF A D V +K + K E +++ +NHP+V+ +K S
Sbjct: 77 GSEGRVFVATKPGQPDPVVLK--IGQKGTTLIEAMLLQNVNHPSVIRMKDTLVSGA---- 130
Query: 208 LYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKP 267
+VL + S +Y + T+ ++ +PI + QI L YLH + HRD+K
Sbjct: 131 -ITCMVLPHYSSDLY---TYLTKRSRPLPIDQALIIEKQILEGLRYLHAQ-RIIHRDVKT 185
Query: 268 QNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIG 327
+N+ +N Q+ I D G+A+ V + + APE + +Y + D+WS G
Sbjct: 186 ENIFIN-DVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPE-VLARDKYNSKADIWSAG 243
Query: 328 CVLAELLL----------GQPLFPGESGVDQLVEIIKILGT-----PTREEIKCMNPNYT 372
VL E+L P +S L++II L P + + +
Sbjct: 244 IVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSR-LVRGFI 302
Query: 373 EFKFPQIKAHPWHKIFHK-RMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426
E+ + + + + F + +P + LV ++L + ++R +A E +P F L
Sbjct: 303 EYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQL 357
|
Length = 357 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 2e-13
Identities = 64/229 (27%), Positives = 103/229 (44%), Gaps = 36/229 (15%)
Query: 143 RVVGTGSFGVVFQAKCLETGDS----VAIKKVLQDKRYKN-----RELQIMRLLNHPNVV 193
+V+G+G+FG V++ + G+ VAIK + ++ K E +M ++HP+VV
Sbjct: 13 KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVV 72
Query: 194 SLKH-CFFSTTEKDELYLNL--VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRA 250
L C S + + L +L+Y V H + Y+ + QI +
Sbjct: 73 RLLGICLSSQVQLITQLMPLGCLLDY-------VRNHKDNIGS----QYLLNWCVQIAKG 121
Query: 251 LNYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRY---Y 305
++YL +V HRD+ +N+LV H +KI DFG AK+L E + +
Sbjct: 122 MSYLEEKRLV---HRDLAARNVLVKTPQH-VKITDFGLAKLLDVDEKEYHAEGGKVPIKW 177
Query: 306 RAPELIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVD--QLVE 351
A E I YT D+WS G + EL+ G + G V+ L+E
Sbjct: 178 MALESIL-HRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE 225
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 5e-13
Identities = 66/252 (26%), Positives = 116/252 (46%), Gaps = 45/252 (17%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ---DKRYKNR---ELQIMRLLNHPNV 192
Y + +G G FG VF K T + K + +R K++ E+ +MR L H N+
Sbjct: 15 YEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNI 74
Query: 193 VSLKHCFFSTTEKDELYLNLVLEY-----ISETVYRVSKHYTRMNQHVPILYVQLYTYQI 247
V F + + L +++E+ +S + + K + ++ +H + T Q+
Sbjct: 75 VRYIDRFLNKANQK---LYILMEFCDAGDLSRNIQKCYKMFGKIEEHA----IVDITRQL 127
Query: 248 CRALNYLHHVVG------VCHRDIKPQNLLVNPHTHQL----------------KICDFG 285
AL Y H++ V HRD+KPQN+ ++ + KI DFG
Sbjct: 128 LHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFG 187
Query: 286 SAKMLVPGEPNISYIC--SRYYRAPELIFGATE-YTTAIDMWSIGCVLAELLLGQPLFPG 342
+K + G ++++ C + YY +PEL+ T+ Y DMW++GC++ EL G+ F
Sbjct: 188 LSKNI--GIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245
Query: 343 ESGVDQLVEIIK 354
+ QL+ +K
Sbjct: 246 ANNFSQLISELK 257
|
Length = 1021 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 5e-13
Identities = 67/220 (30%), Positives = 107/220 (48%), Gaps = 23/220 (10%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKRYKNR--ELQIMRLLNHPNVVSLK 196
V+G GSFG V A+ T + AIK V+QD + E +++ L P ++
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQL 66
Query: 197 HCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
H F T D LY V+EY++ + +Y++ + H Y +I L +L
Sbjct: 67 HSCFQTM--DRLYF--VMEYVNGGDLMYQIQQVGRFKEPHA-----VFYAAEIAIGLFFL 117
Query: 255 HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM-LVPGEPNISYICSRYYRAPELIFG 313
H G+ +RD+K N++++ H +KI DFG K + G ++ + Y APE+I
Sbjct: 118 HSK-GIIYRDLKLDNVMLDSEGH-IKIADFGMCKENMWDGVTTKTFCGTPDYIAPEII-A 174
Query: 314 ATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEII 353
Y ++D W+ G +L E+L GQ F GE D+L + I
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-DELFQSI 213
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-12
Identities = 61/217 (28%), Positives = 100/217 (46%), Gaps = 28/217 (12%)
Query: 143 RVVGTGSFGVVFQAKCLETGDS-----VAIKKVLQDKRYKNR-----ELQIMRLL-NHPN 191
+ +G G+FG V +A S VA+K + R EL+IM L NH N
Sbjct: 41 KTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHEN 100
Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL--YTYQICR 249
+V+L + T + + + EY Y ++ R + + L ++YQ+ +
Sbjct: 101 IVNL---LGACTIGGPILV--ITEY---CCYGDLLNFLRRKRESFLTLEDLLSFSYQVAK 152
Query: 250 ALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRY---YR 306
+ +L + HRD+ +N+L+ H +KICDFG A+ ++ + +R +
Sbjct: 153 GMAFLASKNCI-HRDLAARNVLLT-HGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWM 210
Query: 307 APELIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPG 342
APE IF YT D+WS G +L E+ LG +PG
Sbjct: 211 APESIFNCV-YTFESDVWSYGILLWEIFSLGSNPYPG 246
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 1e-12
Identities = 86/340 (25%), Positives = 140/340 (41%), Gaps = 97/340 (28%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMR----LL---NHPNVVSL 195
+V+G G+FG V + +TG A+K +L+ + +K +L ++ +L + P VVSL
Sbjct: 7 KVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSL 66
Query: 196 KHCFFSTTEKDELYLNLVLEYI-SETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
+ F +D YL L++E++ + + Y ++ V + Y + A+ +
Sbjct: 67 YYSF-----QDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDV----TRFYMAECVLAIEAV 117
Query: 255 HHVVGVCHRDIKPQNLLVNPHTHQLKICDFG------------SAKMLVPGEPNISYICS 302
H + G HRDIKP N+L++ H +K+ DFG + L+ G+ N + I +
Sbjct: 118 HKL-GFIHRDIKPDNILIDRGGH-IKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDN 175
Query: 303 RY------------------------------------YRAPELIFGATEYTTAIDMWSI 326
R Y APE IF Y D WS+
Sbjct: 176 RNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPE-IFLQQGYGQECDWWSL 234
Query: 327 GCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTE-FKFPQIKAHPWH 385
G ++ E L+G P F E+ + +II N+ E FP H
Sbjct: 235 GAIMFECLIGWPPFCSENSHETYRKII----------------NWRETLYFPD-DIH--- 274
Query: 386 KIFHKRMPPEALDLVSRLLQYSPSL--RCTALEACAHPFF 423
+ EA DL+ RL+ + + R A E +HPFF
Sbjct: 275 ------LSVEAEDLIRRLITNAENRLGRGGAHEIKSHPFF 308
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 1e-12
Identities = 66/243 (27%), Positives = 102/243 (41%), Gaps = 68/243 (27%)
Query: 133 PKQTISYMAERVVGTGSFGVVFQAKCL-----ETGDSVAIK--------KVLQDKRYKNR 179
P + ++ E +G G+FG V++ + + SVAIK KV Q+ R +
Sbjct: 3 PLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFR---Q 57
Query: 180 ELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYIS-----ETVYRVSKH------- 227
E ++M L HPN+V C K++ L EY++ E + R S H
Sbjct: 58 EAELMSDLQHPNIV----CLLGVCTKEQPTCML-FEYLAHGDLHEFLVRNSPHSDVGAES 112
Query: 228 YTRMNQHV--PILYVQLYTYQICRALNYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICD 283
+ ++ + QI + YL HH V HRD+ +N LV +KI D
Sbjct: 113 GDETVKSSLDCSDFLHI-AIQIAAGMEYLSSHHFV---HRDLAARNCLVGEG-LTVKISD 167
Query: 284 FGSAKMLVPGEPNISYICSRYYR------------APELI-FGATEYTTAIDMWSIGCVL 330
FG ++ + + YYR PE I +G ++TT D+WS G VL
Sbjct: 168 FGLSRDIYSAD---------YYRVQSKSLLPVRWMPPEAILYG--KFTTESDIWSFGVVL 216
Query: 331 AEL 333
E+
Sbjct: 217 WEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 2e-12
Identities = 59/221 (26%), Positives = 108/221 (48%), Gaps = 24/221 (10%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNREL-------QIMRLLNHPNVVSL 195
+++G G+FG V + +G A+K + ++ E+ ++++ HP + SL
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 196 KHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
K+ F KD L V+EY++ E + +S+ + Y +I AL+Y
Sbjct: 61 KYSF---QTKDRLCF--VMEYVNGGELFFHLSRERVFSEDRT-----RFYGAEIVSALDY 110
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC-SRYYRAPELIF 312
LH + +RD+K +NL+++ H +KI DFG K + + C + Y APE +
Sbjct: 111 LHSG-KIVYRDLKLENLMLDKDGH-IKITDFGLCKEGITDAATMKTFCGTPEYLAPE-VL 167
Query: 313 GATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEII 353
+Y A+D W +G V+ E++ G+ F + ++L E+I
Sbjct: 168 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELI 207
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 2e-12
Identities = 62/203 (30%), Positives = 100/203 (49%), Gaps = 21/203 (10%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVL----QDKRYKNRELQIMRLLNHPNVVSLKHCFF 200
VG+G++G V++A+ L TG+ A+K + D +E+ +++ H N+V+ F
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAY---FG 73
Query: 201 STTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGV 260
S +++L+ + +EY + H T + I YV T Q L YL H G
Sbjct: 74 SYLSREKLW--ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQ---GLAYL-HSKGK 127
Query: 261 CHRDIKPQNLLVNPHTHQLKICDFG-SAKMLVPGEPNISYICSRYYRAPELIFGATE--- 316
HRDIK N+L+ + +K+ DFG +AK+ S+I + Y+ APE+ A E
Sbjct: 128 MHRDIKGANILLTDNG-DVKLADFGVAAKITATIAKRKSFIGTPYWMAPEV--AAVEKNG 184
Query: 317 -YTTAIDMWSIGCVLAELLLGQP 338
Y D+W++G EL QP
Sbjct: 185 GYNQLCDIWAVGITAIELAELQP 207
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 2e-12
Identities = 62/215 (28%), Positives = 103/215 (47%), Gaps = 33/215 (15%)
Query: 143 RVVGTGSFGVVFQAKCLETGD---SVAIKKVLQDKRYKNREL-----QIMRLLNHPNVVS 194
R +G G FG V+Q + + +VA+K RE IMR +HP++V
Sbjct: 12 RCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVK 71
Query: 195 LKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQH-VPILYVQLYTYQICRALNY 253
L ++ +++ + L + E + Y ++N++ + + + LY+YQ+ AL Y
Sbjct: 72 L----IGVITENPVWIVMELAPLGEL-----RSYLQVNKYSLDLASLILYSYQLSTALAY 122
Query: 254 LHHVVGVCHRDIKPQNLLV-NPHTHQLKICDFGSAKMLVPGEPNISYICSR-----YYRA 307
L V HRDI +N+LV +P +K+ DFG ++ L E Y S+ + A
Sbjct: 123 LESKRFV-HRDIAARNVLVSSPDC--VKLGDFGLSRYL---EDESYYKASKGKLPIKWMA 176
Query: 308 PELIFGATEYTTAIDMWSIG-CVLAELLLG-QPLF 340
PE I +T+A D+W G C+ L+LG +P
Sbjct: 177 PESI-NFRRFTSASDVWMFGVCMWEILMLGVKPFQ 210
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 2e-12
Identities = 77/292 (26%), Positives = 122/292 (41%), Gaps = 54/292 (18%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR-----ELQIMRLLNHPNVVSLKHCF 199
+G G+FG V++A+ ETG +A KV+ K + E+ I+ +HPN+V L F
Sbjct: 13 LGDGAFGKVYKAQNKETG-VLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 200 FSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG 259
+ E L +++E+ + V + + + +++ Q ALNYLH
Sbjct: 72 YY-----ENNLWILIEFCAGGA--VDAVMLELERPLTEPQIRVVCKQTLEALNYLHE-NK 123
Query: 260 VCHRDIKPQNLLVNPHTHQLKICDFG-SAKMLVPGEPNISYICSRYYRAPELIFGATE-- 316
+ HRD+K N+L +K+ DFG SAK + S+I + Y+ APE++ T
Sbjct: 124 IIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 182
Query: 317 --YTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEF 374
Y D+WS+G L E+ +P P E +NP
Sbjct: 183 RPYDYKADVWSLGITLIEMAQIEP--------------------PHHE----LNPMRVLL 218
Query: 375 KF----PQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPF 422
K P A P R E D + + L+ + R T + HPF
Sbjct: 219 KIAKSEPPTLAQP------SRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPF 264
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 2e-12
Identities = 65/247 (26%), Positives = 115/247 (46%), Gaps = 55/247 (22%)
Query: 145 VGTGSFGVVFQAKCLETGD-----SVAIKKVLQDKRYKN-----RELQIMRLL-NHPNVV 193
+G G+FG V +A+ + + +VA+K + D K+ E+++M+++ H N++
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYR--------VSKHYTRMNQHVPILYVQLY-- 243
+L T++ LY+ V+EY + R ++ + + P +
Sbjct: 80 NLLGV---CTQEGPLYV--VVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDL 134
Query: 244 ---TYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYI 300
YQ+ R + +L + HRD+ +N+LV H +KI DFG A+ +I +I
Sbjct: 135 VSFAYQVARGMEFLASKKCI-HRDLAARNVLVT-EDHVMKIADFGLAR-------DIHHI 185
Query: 301 CSRYYR------------APELIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVD 347
YYR APE +F YT D+WS G +L E+ LG +PG V+
Sbjct: 186 --DYYRKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPGIP-VE 241
Query: 348 QLVEIIK 354
+L +++K
Sbjct: 242 ELFKLLK 248
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 4e-12
Identities = 67/319 (21%), Positives = 117/319 (36%), Gaps = 38/319 (11%)
Query: 143 RVVGTGSFG--VVFQAKCLETGDSVAIKKVLQDKRYKNR------ELQIMRLLNHPNVVS 194
++G +V AK T VA+KK+ D K E+ R L HPN++
Sbjct: 4 TLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILP 63
Query: 195 LKHCFFSTTEKDELYLNLVL-EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
F ELY+ L Y S + H+ + +P L + + AL+Y
Sbjct: 64 YVTSF---IVDSELYVVSPLMAYGSCEDL-LKTHF---PEGLPELAIAFILKDVLNALDY 116
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA--------KMLVPGEPNISYICSRYY 305
+H G HR +K ++L++ + + + + V + S + + +
Sbjct: 117 IHS-KGFIHRSVKASHILLSGDGK-VVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPW 174
Query: 306 RAPELIFGATE-YTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTR--- 361
+PE++ + Y D++S+G EL G F L+E K+ GT
Sbjct: 175 LSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLE--KVRGTVPCLLD 232
Query: 362 -----EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALE 416
M+ + + + P + + + V LQ P R +A +
Sbjct: 233 KSTYPLYEDSMSQSRSSNEHPNNRDSV-DHPYTRTFSEHFHQFVELCLQRDPESRPSASQ 291
Query: 417 ACAHPFFDDLRDPNTCLPN 435
H FF + NT L +
Sbjct: 292 LLNHSFFKQCKRRNTSLLD 310
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 4e-12
Identities = 60/208 (28%), Positives = 98/208 (47%), Gaps = 27/208 (12%)
Query: 143 RVVGTGSFGVV----FQAKCLETGDSVAIKKVLQDKRYKN-----RELQIMRLLNHPNVV 193
R +G G FG V + + TG+ VA+K + + + +E++I+R L H N+V
Sbjct: 10 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 69
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
K TE + L++E++ + ++ R + + Y QIC+ ++Y
Sbjct: 70 KYKGI---CTEDGGNGIKLIMEFLPSG--SLKEYLPRNKNKINLKQQLKYAVQICKGMDY 124
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSR-------YYR 306
L V HRD+ +N+LV HQ+KI DFG K + E + Y + ++
Sbjct: 125 LGSRQYV-HRDLAARNVLVE-SEHQVKIGDFGLTKAI---ETDKEYYTVKDDLDSPVFWY 179
Query: 307 APELIFGATEYTTAIDMWSIGCVLAELL 334
APE + + Y A D+WS G L ELL
Sbjct: 180 APECLIQSKFY-IASDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 5e-12
Identities = 67/223 (30%), Positives = 110/223 (49%), Gaps = 20/223 (8%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFST 202
+V+G G+FG V K T A+K + + + K E R NV+ C + T
Sbjct: 7 KVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFR--EERNVLVNGDCQWIT 64
Query: 203 TE----KDELYLNLVLEYI--SETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH 256
T +DE YL LV++Y + + +SK R+ + + Y+ I +++ LH+
Sbjct: 65 TLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAI-HSIHQLHY 123
Query: 257 VVGVCHRDIKPQNLLVNPHTHQLKICDFGSA-KMLVPGEPNISY-ICSRYYRAPELIF-- 312
V HRDIKP N+L++ + H +++ DFGS KM G S + + Y +PE++
Sbjct: 124 V----HRDIKPDNVLLDMNGH-IRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAM 178
Query: 313 --GATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEII 353
G +Y D WS+G + E+L G+ F ES V+ +I+
Sbjct: 179 EDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 8e-12
Identities = 64/246 (26%), Positives = 98/246 (39%), Gaps = 60/246 (24%)
Query: 133 PKQTISYMAERVVGTGSFGVVFQAKC--LETGDS---VAIKKVLQD------KRYKNREL 181
+ TI R +G G+FG VF +C LE + VA+ K L++ ++ RE
Sbjct: 3 QRDTIVLK--RELGEGAFGKVFLGECYHLEPENDKELVAV-KTLKETASNDARKDFEREA 59
Query: 182 QIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEY-----ISETVYRVSKHYTRM----N 232
+++ H N+V TE D +V EY +++ + + +
Sbjct: 60 ELLTNFQHENIVKFYGV---CTEGDPPI--MVFEYMEHGDLNKFLRSHGPDAAFLKSPDS 114
Query: 233 QHVPILYVQLY--TYQICRALNYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288
+ QL QI + YL H V HRD+ +N LV + +KI DFG ++
Sbjct: 115 PMGELTLSQLLQIAVQIASGMVYLASQHFV---HRDLATRNCLVG-YDLVVKIGDFGMSR 170
Query: 289 MLVPGEPNISYICSRYYR------------APELIFGATEYTTAIDMWSIGCVLAELLL- 335
+ Y YYR PE I +TT D+WS G VL E+
Sbjct: 171 DV--------YTTD-YYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVVLWEIFTY 220
Query: 336 -GQPLF 340
QP +
Sbjct: 221 GKQPWY 226
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 1e-11
Identities = 57/207 (27%), Positives = 93/207 (44%), Gaps = 33/207 (15%)
Query: 245 YQICRALNYLHHVVGVCHRDIKPQNLL-------VNPHTHQ--------LKICDFGSAKM 289
+Q AL+Y H + + H D+KP+N+L V+P T++ ++ICD G
Sbjct: 238 FQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGC-- 295
Query: 290 LVPGEPNISYICSRYYRAPELIFG-ATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQ 348
+ + +R+YR+PE++ G Y+T DMWS+GC++ EL G+ L+ ++
Sbjct: 296 CDERHSRTAIVSTRHYRSPEVVLGLGWMYST--DMWSMGCIIYELYTGKLLYDTHDNLEH 353
Query: 349 LVEIIKILGT-PTREEIKCMNPN----YTEFKFPQIKAHPWH--KIFHKRMPPEAL---- 397
L + K LG P+ +C Y + P H +I R E +
Sbjct: 354 LHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDL 413
Query: 398 --DLVSRLLQYSPSLRCTALEACAHPF 422
DL+ LL Y R A + HP+
Sbjct: 414 LCDLIYGLLHYDRQKRLNARQMTTHPY 440
|
Length = 467 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 72/296 (24%), Positives = 122/296 (41%), Gaps = 63/296 (21%)
Query: 142 ERVVGTGSFGVVFQ--AKCLETGDS---VAIKKVLQDKRYKNR-----ELQIMRLLNHPN 191
R +G GSFG+V++ AK + G+ VAIK V ++ + R E +M+ N +
Sbjct: 11 IRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHH 70
Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRM----NQHV----PILYVQLY 243
VV L +T + L +V+E +++ K Y R ++ P +
Sbjct: 71 VVRLLG--VVSTGQPTL---VVMELMAKGDL---KSYLRSRRPEAENNPGLGPPTLQKFI 122
Query: 244 TY--QICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC 301
+I + YL HRD+ +N +V +KI DFG + +I
Sbjct: 123 QMAAEIADGMAYLAAK-KFVHRDLAARNCMVA-EDLTVKIGDFGMTR-------DIYE-- 171
Query: 302 SRYYR------------APELIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVDQ 348
+ YYR APE + +TT D+WS G VL E+ L + + G S ++
Sbjct: 172 TDYYRKGGKGLLPVRWMAPESLKDGV-FTTKSDVWSFGVVLWEMATLAEQPYQGLSN-EE 229
Query: 349 LVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLL 404
+++ + G E C + + W ++ +M P L++VS L
Sbjct: 230 VLKFVIDGGHLDLPE-NCPDKLLELMR------MCWQ--YNPKMRPTFLEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 3e-11
Identities = 58/219 (26%), Positives = 92/219 (42%), Gaps = 48/219 (21%)
Query: 144 VVGTGSFGVVFQAK----CLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVV 193
+G G FG VF AK E G+++ + K LQ + +N REL + R L+H NVV
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 194 SLKHCFFSTTEKDELYLNLVLEYIS----ETVYRVSKHYTRMNQHVPILYVQLYT--YQI 247
L E + Y ++LEY + R +K + P+ Q QI
Sbjct: 72 RL---LGLCREAEPHY--MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQI 126
Query: 248 CRALNYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYY 305
+++L V HRD+ +N LV + Q + K+ + Y S YY
Sbjct: 127 ALGMDHLSNARFV---HRDLAARNCLV---SSQRE------VKVSLLSLSKDVY-NSEYY 173
Query: 306 R-----------APELIFGATEYTTAIDMWSIGCVLAEL 333
+ APE + +++T D+WS G ++ E+
Sbjct: 174 KLRNALIPLRWLAPEAVQ-EDDFSTKSDVWSFGVLMWEV 211
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 3e-11
Identities = 63/230 (27%), Positives = 98/230 (42%), Gaps = 41/230 (17%)
Query: 145 VGTGSFGVVFQAKCLETGD---SVAIKKVLQDKRYKN-----RELQIMRLLNHPNVVSL- 195
+G GSFGVV + + +G VA+K + DK +E IM L+H N++ L
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 196 ----KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
H TE L +L+ R+ K H I + Y QI +
Sbjct: 63 GVVLTHPLMMVTELAPL--GSLLD-------RLRKDALG---HFLISTLCDYAVQIANGM 110
Query: 252 NYLH--HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR--- 306
YL + HRD+ +N+L+ ++KI DFG + L E + Y+ + +
Sbjct: 111 RYLESKRFI---HRDLAARNILL-ASDDKVKIGDFGLMRALPQNEDH--YVMEEHLKVPF 164
Query: 307 ---APELIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVDQLVEI 352
APE + T ++ A D+W G L E+ G+ + G SG L +I
Sbjct: 165 AWCAPESLRTRT-FSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI 213
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-11
Identities = 88/341 (25%), Positives = 138/341 (40%), Gaps = 93/341 (27%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR--------ELQIMRLLNHPNVVS 194
+ +G G+FG V A ++T A+K L+ K NR E I+ ++ VV
Sbjct: 7 KTLGIGAFGEVCLACKVDTHALYAMK-TLRKKDVLNRNQVAHVKAERDILAEADNEWVVK 65
Query: 195 LKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
L ++S +KD LY V++YI + RM + P + + Y ++ A+ +
Sbjct: 66 L---YYSFQDKDNLYF--VMDYIPGG--DMMSLLIRM-EVFPEVLARFYIAELTLAIESV 117
Query: 255 HHVVGVCHRDIKPQNLLVNPH----------------THQLKICDFGSAKMLVPGEPNI- 297
H + G HRDIKP N+L++ TH K GS EP+
Sbjct: 118 HKM-GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDL 176
Query: 298 ------------------------------SYICSRYYRAPELIFGATEYTTAIDMWSIG 327
S + + Y APE++ YT D WS+G
Sbjct: 177 WDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLL-RKGYTQLCDWWSVG 235
Query: 328 CVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKI 387
+L E+L+GQP F + TPT ++K +N T PQ+K
Sbjct: 236 VILFEMLVGQPPF--------------LAPTPTETQLKVINWENTLHIPPQVK------- 274
Query: 388 FHKRMPPEALDLVSRLLQYSPSL--RCTALEACAHPFFDDL 426
+ PEA+DL+++L + R A + AHPFF ++
Sbjct: 275 ----LSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEV 311
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 4e-11
Identities = 82/348 (23%), Positives = 125/348 (35%), Gaps = 117/348 (33%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR--------ELQIMRLLNHPNVVS 194
+ +G G+FG V + ++T A+K L+ R E I+ ++ VV
Sbjct: 7 KTIGIGAFGEVCLVRKVDTNALYAMKT-LRKADVLMRNQAAHVKAERDILAEADNEWVVK 65
Query: 195 LKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
L ++S +KD LY V++YI + R+ + Y ++ A+ +
Sbjct: 66 L---YYSFQDKDNLYF--VMDYIPGG--DMMSLLIRLGI-FEEDLARFYIAELTCAIESV 117
Query: 255 HHVVGVCHRDIKPQNLLVNPH----------------THQLK------------------ 280
H + G HRDIKP N+L++ TH K
Sbjct: 118 HKM-GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEE 176
Query: 281 ICDFGSAKM------------------LVPGEPNISYICSRYYRAPELIFGATEYTTAID 322
+ ++ LV G PN Y APE++ T YT D
Sbjct: 177 WSEIDRCRLKPLERRRKRQHQRCLAHSLV-GTPN--------YIAPEVLL-RTGYTQLCD 226
Query: 323 MWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAH 382
WS+G +L E+L+GQP F + TP ++K +N
Sbjct: 227 WWSVGVILYEMLVGQPPFLAD--------------TPAETQLKVIN-------------- 258
Query: 383 PWHKIFH----KRMPPEALDLVSRLLQYSPSLRC---TALEACAHPFF 423
W H ++ EA DL+ RL R A E AHPFF
Sbjct: 259 -WETTLHIPSQAKLSREASDLILRLCC-GAEDRLGKNGADEIKAHPFF 304
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 5e-11
Identities = 67/227 (29%), Positives = 113/227 (49%), Gaps = 28/227 (12%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-KRYKNRELQIMR-----LLNHPN--VVS 194
+V+G G+FG V K L+ D V K+L + K E R L+N N + +
Sbjct: 7 KVIGRGAFGEVAVVK-LKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITT 65
Query: 195 LKHCFFSTTEKDELYLNLVLEYI--SETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
L + F +DE L LV++Y + + +SK R+ + + Y+ I +++
Sbjct: 66 LHYAF-----QDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAI-DSVH 119
Query: 253 YLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA-KMLVPGEPNISY-ICSRYYRAPEL 310
LH+V HRDIKP N+L++ + H +++ DFGS K++ G S + + Y +PE+
Sbjct: 120 QLHYV----HRDIKPDNILMDMNGH-IRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEI 174
Query: 311 IF----GATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEII 353
+ G +Y D WS+G + E+L G+ F ES V+ +I+
Sbjct: 175 LQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 6e-11
Identities = 67/296 (22%), Positives = 129/296 (43%), Gaps = 50/296 (16%)
Query: 139 YMAERVVGTGSFGVVF--QAKCLETGDSVAIKKVL-------QDKRYKNRELQIMRLLNH 189
Y+ ++ +G GSFG V+ + K + + + K + + N+E Q++ L+H
Sbjct: 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDH 61
Query: 190 PNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVS-KHYTRMNQHVPILYVQLYTYQIC 248
P +V F E+D + + EY + + + V + Q+
Sbjct: 62 PAIVKFHASFL---ERDAFCI--ITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLL 116
Query: 249 RALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI--SYICSRYYR 306
++Y+H + HRD+K +N+ + + LKI DFG +++L+ G ++ ++ + YY
Sbjct: 117 LGVHYMH-QRRILHRDLKAKNIFLK--NNLLKIGDFGVSRLLM-GSCDLATTFTGTPYYM 172
Query: 307 APELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKC 366
+PE + Y + D+WS+GC+L E+ F G+ + L +++I+ PT
Sbjct: 173 SPEAL-KHQGYDSKSDIWSLGCILYEMCCLAHAFEGQ---NFLSVVLRIVEGPT------ 222
Query: 367 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPF 422
P+ E + ++ +L PSLR +A E +PF
Sbjct: 223 --PSLPE-----------------TYSRQLNSIMQSMLNKDPSLRPSAAEILRNPF 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 8e-11
Identities = 60/228 (26%), Positives = 107/228 (46%), Gaps = 42/228 (18%)
Query: 133 PKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNH 189
P++++ ER +G G FG V+ T VA+K + +E QIM+ L H
Sbjct: 4 PRESLKL--ERKLGAGQFGEVWMGTWNGTTK-VAVKTLKPGTMSPEAFLQEAQIMKKLRH 60
Query: 190 PNVVSLKHCFFSTTEKDELYLNLVLEYIS-----ETVYRVSKHYTRMNQHVPILYVQLYT 244
+V L + +E++ +Y +V EY+S + + R+ Q V +
Sbjct: 61 DKLVQL---YAVCSEEEPIY--IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDM------A 109
Query: 245 YQICRALNYL---HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI--SY 299
QI + YL +++ HRD+ +N+LV + KI DFG A+++ E + +
Sbjct: 110 AQIAEGMAYLESRNYI----HRDLAARNILVGEN-LVCKIADFGLARLI---EDDEYTAR 161
Query: 300 ICSRY---YRAPELI-FGATEYTTAIDMWSIGCVLAELL-LGQPLFPG 342
+++ + APE +G +T D+WS G +L E++ G+ +PG
Sbjct: 162 EGAKFPIKWTAPEAANYG--RFTIKSDVWSFGILLTEIVTYGRVPYPG 207
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 9e-11
Identities = 62/228 (27%), Positives = 107/228 (46%), Gaps = 30/228 (13%)
Query: 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNHPNVV 193
+++M E +G+G FGVV K VAIK + + + E ++M L+HP +V
Sbjct: 6 LTFMKE--LGSGQFGVVHLGK-WRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLV 62
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQ-ICRALN 252
L + T++ LY+ V E++ +Y R Q + L Q +C +
Sbjct: 63 QL---YGVCTQQKPLYI--VTEFMENGCLL---NYLRQRQGKLSKDMLLSMCQDVCEGME 114
Query: 253 YLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSR------YYR 306
YL HRD+ +N LV+ T +K+ DFG + ++ E Y S +
Sbjct: 115 YLERN-SFIHRDLAARNCLVS-STGVVKVSDFGMTRYVLDDE----YTSSSGAKFPVKWS 168
Query: 307 APELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEII 353
PE +F ++Y++ D+WS G ++ E+ G+ F +S ++VE+I
Sbjct: 169 PPE-VFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY-EVVEMI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 1e-10
Identities = 58/204 (28%), Positives = 95/204 (46%), Gaps = 27/204 (13%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR--------ELQIMRLLNHPNVVSLK 196
+G G FG V + TG A KK L KR K R E +I+ ++ +VSL
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKK-LNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLA 59
Query: 197 HCFFSTTEKDELYLNLVLEY-----ISETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
+ F + T+ L LV+ + +Y V + + Y T QI L
Sbjct: 60 YAFQTKTD-----LCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFY----TAQIISGL 110
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI-SYICSRYYRAPEL 310
+LH + +RD+KP+N+L++ + ++I D G A L G+ Y + + APEL
Sbjct: 111 EHLHQR-RIIYRDLKPENVLLDNDGN-VRISDLGLAVELKDGQSKTKGYAGTPGFMAPEL 168
Query: 311 IFGATEYTTAIDMWSIGCVLAELL 334
+ G EY ++D +++G L E++
Sbjct: 169 LQG-EEYDFSVDYFALGVTLYEMI 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 2e-10
Identities = 64/244 (26%), Positives = 106/244 (43%), Gaps = 58/244 (23%)
Query: 143 RVVGTGSFGVVFQAKCLE-----TGDS-VAIKK-----VLQDKRYKNRELQIMRLLNHPN 191
+G+G+FG V++ + +G VA+K Q+K+ +E +M NHPN
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 192 VVS-LKHCFFSTTEKDELYLNL-------VLEYISETVYRVSKHYTRMNQHVPILYVQLY 243
+V L C + Y+ + +L Y+ + RV + + +L + L
Sbjct: 61 IVKLLGVCL----LNEPQYIIMELMEGGDLLSYLRDA--RVERFGPPLLTLKELLDICLD 114
Query: 244 TYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQ----LKICDFGSAKMLVPGEPNISY 299
+ C L +H + HRD+ +N LV+ + +KI DFG A+ +
Sbjct: 115 VAKGCVYLEQMHFI----HRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYK------- 163
Query: 300 ICSRYYR------------APE-LIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESG 345
S YYR APE L+ G +TT D+WS G ++ E+L LGQ +P +
Sbjct: 164 --SDYYRKEGEGLLPVRWMAPESLLDGK--FTTQSDVWSFGVLMWEILTLGQQPYPALNN 219
Query: 346 VDQL 349
+ L
Sbjct: 220 QEVL 223
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-10
Identities = 69/296 (23%), Positives = 115/296 (38%), Gaps = 70/296 (23%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKV-LQDKRYK----NRELQIMRLLNHPNVVSLKHCF 199
+G GSFG VF+ T VAIK + L++ + +E+ ++ + P V +
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 200 FSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTY--QICRALNYLHHV 257
T+ L +++EY+ + + P Q+ T +I + L+YLH
Sbjct: 72 LKGTK-----LWIIMEYLG------GGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSE 120
Query: 258 VGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGE-PNISYICSRYYRAPELIFGATE 316
+ HRDIK N+L++ +K+ DFG A L + +++ + ++ APE+I +
Sbjct: 121 KKI-HRDIKAANVLLSEQG-DVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-QQSA 177
Query: 317 YTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKF 376
Y + D+WS+G EL G+P
Sbjct: 178 YDSKADIWSLGITAIELAKGEP-------------------------------------- 199
Query: 377 PQIKAHPWHKIFH-KRMPPEAL---------DLVSRLLQYSPSLRCTALEACAHPF 422
P HP +F + P L + + L PS R TA E H F
Sbjct: 200 PNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKF 255
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 3e-10
Identities = 70/217 (32%), Positives = 104/217 (47%), Gaps = 21/217 (9%)
Query: 139 YMAERVVGTGSFGVVFQA-KCLETGDSVAIKKV-LQDKR---YKNRELQIMRLLNHPNVV 193
Y+ +VG F A + + + V K V L D+R Y EL + +H +V
Sbjct: 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIV 128
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYT-RMNQHVPI--LYVQLYTYQICRA 250
KH F + D+ L L++EY S ++K R+ +H+P V L YQI A
Sbjct: 129 --KH--FDDFKSDDKLL-LIMEYGSGG--DLNKQIKQRLKEHLPFQEYEVGLLFYQIVLA 181
Query: 251 LNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML---VPGEPNISYICSRYYRA 307
L+ +H + HRD+K N+ + P T +K+ DFG +K V + S+ + YY A
Sbjct: 182 LDEVHSRK-MMHRDLKSANIFLMP-TGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLA 239
Query: 308 PELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGES 344
PEL + Y+ DMWS+G +L ELL F G S
Sbjct: 240 PEL-WERKRYSKKADMWSLGVILYELLTLHRPFKGPS 275
|
Length = 478 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 3e-10
Identities = 58/216 (26%), Positives = 106/216 (49%), Gaps = 33/216 (15%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIK--KVLQDKRYK-NRELQIMRLLN-HPNVVSLKHC 198
VVG G++G V++ + ++TG AIK V +D+ + E+ +++ + H N+ +
Sbjct: 22 EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGA 81
Query: 199 FFSTT---EKDELYLNLVLEY-----ISETVYRVSKHYTRMNQHVPILYVQLYTYQICRA 250
F + D+L+ LV+E+ +++ V + + + ++ +I R
Sbjct: 82 FIKKSPPGHDDQLW--LVMEFCGAGSVTDLVKNTKGNALKED------WIAYICREILRG 133
Query: 251 LNYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML--VPGEPNISYICSRYYR 306
L +L H V+ HRDIK QN+L+ + ++K+ DFG + L G N ++I + Y+
Sbjct: 134 LAHLHAHKVI---HRDIKGQNVLLTENA-EVKLVDFGVSAQLDRTVGRRN-TFIGTPYWM 188
Query: 307 APELIF----GATEYTTAIDMWSIGCVLAELLLGQP 338
APE+I Y D+WS+G E+ G P
Sbjct: 189 APEVIACDENPDATYDYRSDIWSLGITAIEMAEGAP 224
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 3e-10
Identities = 55/202 (27%), Positives = 99/202 (49%), Gaps = 22/202 (10%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKV-LQDKRYK----NRELQIMRLLNHPNVVSLKHCF 199
+G GSFG VF+ T VAIK + L++ + +E+ ++ + P V +
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 200 FSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTY--QICRALNYLHHV 257
T+ L +++EY+ + + P+ Q+ T +I + L+YLH
Sbjct: 72 LKDTK-----LWIIMEYLG------GGSALDLLEPGPLDETQIATILREILKGLDYLHSE 120
Query: 258 VGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS-YICSRYYRAPELIFGATE 316
+ HRDIK N+L++ H ++K+ DFG A L + + ++ + ++ APE+I +
Sbjct: 121 KKI-HRDIKAANVLLSEHG-EVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-KQSA 177
Query: 317 YTTAIDMWSIGCVLAELLLGQP 338
Y + D+WS+G EL G+P
Sbjct: 178 YDSKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 4e-10
Identities = 63/221 (28%), Positives = 105/221 (47%), Gaps = 20/221 (9%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV------LQDKRYKNRELQIMRLLNHPNV 192
Y RV+G+G+ G V AK + G+ A+K V DK E+ + + ++
Sbjct: 34 YWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSI 93
Query: 193 VSLKHCFFSTTEKDE---LYLNLVLEYISETVYRVS-KHYTRMNQHVPILYVQLYTYQIC 248
V F ++ L + LVL+Y + R K + N+ L Q+
Sbjct: 94 VKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVL 153
Query: 249 RALNYLH--HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML---VPGEPNISYICSR 303
A++++H H++ HRDIK N+L+ + +K+ DFG +KM V + ++ +
Sbjct: 154 LAVHHVHSKHMI---HRDIKSANILLCSNG-LVKLGDFGFSKMYAATVSDDVGRTFCGTP 209
Query: 304 YYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGES 344
YY APE I+ Y+ DM+S+G +L ELL + F GE+
Sbjct: 210 YYVAPE-IWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN 249
|
Length = 496 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 6e-10
Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 35/211 (16%)
Query: 142 ERVVGTGSFGVVFQAKCLETGD---SVAIKKV---LQDKRYKN--RELQIMRLLNHPNVV 193
E+V+G G FG V + + G VAIK + DK+ + E IM +HPN++
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 194 SLKHCFFSTTEKDELYLNLVLEYIS----ETVYRVSKHYTRMNQHVPILYVQLYTYQICR 249
L+ + + ++ EY+ + R + + Q V +L I
Sbjct: 69 RLEGVVTKSRP-----VMIITEYMENGSLDKFLRENDGKFTVGQLVGMLR------GIAS 117
Query: 250 ALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISY------ICSR 303
+ YL + V HRD+ +N+LVN + K+ DFG ++ L + +Y I R
Sbjct: 118 GMKYLSEMNYV-HRDLAARNILVNSNL-VCKVSDFGLSRRL--EDSEATYTTKGGKIPIR 173
Query: 304 YYRAPELIFGATEYTTAIDMWSIGCVLAELL 334
+ APE I ++T+A D+WS G V+ E++
Sbjct: 174 W-TAPEAI-AYRKFTSASDVWSFGIVMWEVM 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 9e-10
Identities = 53/201 (26%), Positives = 95/201 (47%), Gaps = 30/201 (14%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNHPNVVSLKHCFFS 201
+G+G FGVV K D VAIK + + ++ E ++M L+HPN+V L +
Sbjct: 12 LGSGQFGVVHLGKWRGKID-VAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQL---YGV 67
Query: 202 TTEKDELYLNLVLEYISE----TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV 257
T++ +++ V EY++ R K +L + +C A+ YL
Sbjct: 68 CTKQRPIFI--VTEYMANGCLLNYLRERKGKLGTEW---LLDMCS---DVCEAMEYLESN 119
Query: 258 VGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR-----APELIF 312
G HRD+ +N LV + +K+ DFG A+ ++ + Y S+ + AP +F
Sbjct: 120 -GFIHRDLAARNCLVG-EDNVVKVSDFGLARYVLDDQ----YTSSQGTKFPVKWAPPEVF 173
Query: 313 GATEYTTAIDMWSIGCVLAEL 333
+ +++ D+WS G ++ E+
Sbjct: 174 DYSRFSSKSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 1e-09
Identities = 60/220 (27%), Positives = 96/220 (43%), Gaps = 38/220 (17%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKK-----VLQDKRYKNRELQIMRLLNHPNVVSLKH 197
+G G+FG V++ L+ VA+K KR +E +I++ +HPN+V L
Sbjct: 1 EKIGKGNFGDVYKGV-LKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKL-- 57
Query: 198 CFFSTTEKDELYLNLVLEYISE----TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
+K +Y+ V+E + T R K+ + + + + + + Y
Sbjct: 58 -IGVCVQKQPIYI--VMELVPGGSLLTFLRKKKNRLTVKKLLQM------SLDAAAGMEY 108
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR------- 306
L + HRD+ +N LV + LKI DFG ++ E Y S +
Sbjct: 109 LESKNCI-HRDLAARNCLVG-ENNVLKISDFGMSRE----EEGGIYTVSDGLKQIPIKWT 162
Query: 307 APE-LIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGES 344
APE L +G YT+ D+WS G +L E LG +PG S
Sbjct: 163 APEALNYG--RYTSESDVWSYGILLWETFSLGDTPYPGMS 200
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 2e-09
Identities = 58/238 (24%), Positives = 104/238 (43%), Gaps = 49/238 (20%)
Query: 143 RVVGTGSFGVVFQAKCLETG-----DSVAIKKVLQDK-----RYKNRELQIMRLLNHPNV 192
+ +G G FG V +A +VA+K + ++ R E +++ +NHP+V
Sbjct: 6 KTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHV 65
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL---------- 242
+ L + + ++ L L ++EY Y + + R ++ V Y+
Sbjct: 66 IKL---YGACSQDGPLLL--IVEYAK---YGSLRSFLRESRKVGPSYLGSDGNRNSSYLD 117
Query: 243 --------------YTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288
+ +QI R + YL + V HRD+ +N+LV ++KI DFG ++
Sbjct: 118 NPDERALTMGDLISFAWQISRGMQYLAEMKLV-HRDLAARNVLV-AEGRKMKISDFGLSR 175
Query: 289 MLVPGEPNISYICSRY---YRAPELIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPG 342
+ + + R + A E +F YTT D+WS G +L E++ LG +PG
Sbjct: 176 DVYEEDSYVKRSKGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPG 232
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 56/205 (27%), Positives = 96/205 (46%), Gaps = 14/205 (6%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQ----IMRLL-NHPNVVSLKHCF 199
+G G++G V++ + G S+A K+L + E++ I++ L NHPNVV F
Sbjct: 30 IGKGTYGKVYKVTNKKDG-SLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMF 88
Query: 200 FSTTEKDELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV 258
+ + L LVLE + +V + K Q + + Y L +LH+
Sbjct: 89 YKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN-N 147
Query: 259 GVCHRDIKPQNLLVNPHTHQLKICDFG-SAKMLVPGEPNISYICSRYYRAPELIFGATEY 317
+ HRD+K N+L+ +K+ DFG SA++ + + + ++ APE+I +Y
Sbjct: 148 RIIHRDVKGNNILLTTEG-GVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQY 206
Query: 318 TTA----IDMWSIGCVLAELLLGQP 338
+ D+WS+G EL G P
Sbjct: 207 DYSYDARCDVWSLGITAIELGDGDP 231
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 2e-09
Identities = 54/203 (26%), Positives = 83/203 (40%), Gaps = 38/203 (18%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR---ELQIMRLLNHPNVVSLKHCFFS 201
+G G FG V G VA+K + D E +M L HPN+V L
Sbjct: 14 IGKGEFGDVMLG--DYRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVL- 70
Query: 202 TTEKDELYLNLVLEYISETVY------RVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
+ + LY+ V EY+++ R T Q + +C + YL
Sbjct: 71 --QGNPLYI--VTEYMAKGSLVDYLRSRGRAVITLAQQL-------GFALDVCEGMEYLE 119
Query: 256 HVVGVCHRDIKPQNLLVNPHTHQL--KICDFGSAKMLVPGEPNISYICSRY---YRAPEL 310
V HRD+ +N+LV + L K+ DFG AK E + + + APE
Sbjct: 120 EKNFV-HRDLAARNVLV---SEDLVAKVSDFGLAK-----EASQGQDSGKLPVKWTAPEA 170
Query: 311 IFGATEYTTAIDMWSIGCVLAEL 333
+ +++T D+WS G +L E+
Sbjct: 171 L-REKKFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 2e-09
Identities = 58/208 (27%), Positives = 102/208 (49%), Gaps = 19/208 (9%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIK--KVLQDKRYK-NRELQIMRLLN-HPNVVSLKHCF 199
+VG G++G V++ + ++TG AIK V D+ + +E+ +++ + H N+ + F
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 72
Query: 200 FSTTE---KDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH 256
D+L+ LV+E+ T+ N + ++ +I R L++LH
Sbjct: 73 IKKNPPGMDDQLW--LVMEFCGAGSVTDLIKNTKGNT-LKEEWIAYICREILRGLSHLHQ 129
Query: 257 VVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML--VPGEPNISYICSRYYRAPELIF-- 312
V HRDIK QN+L+ + ++K+ DFG + L G N ++I + Y+ APE+I
Sbjct: 130 -HKVIHRDIKGQNVLLTENA-EVKLVDFGVSAQLDRTVGRRN-TFIGTPYWMAPEVIACD 186
Query: 313 --GATEYTTAIDMWSIGCVLAELLLGQP 338
Y D+WS+G E+ G P
Sbjct: 187 ENPDATYDFKSDLWSLGITAIEMAEGAP 214
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 59/209 (28%), Positives = 98/209 (46%), Gaps = 33/209 (15%)
Query: 143 RVVGTGSFGVVFQAKCLETGDS----VAIKKVLQDKRYK-NREL----QIMRLLNHPNVV 193
+V+G+G+FG V++ + G+ VAIK++ + K N+E+ +M +++P+V
Sbjct: 13 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 72
Query: 194 SLKH-CFFSTTE--KDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRA 250
L C ST + + +L+Y+ E + Y +N + QI +
Sbjct: 73 RLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL-LN----------WCVQIAKG 121
Query: 251 LNYLH--HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRY---Y 305
+NYL +V HRD+ +N+LV H +KI DFG AK+L E + +
Sbjct: 122 MNYLEERRLV---HRDLAARNVLVKTPQH-VKITDFGLAKLLGADEKEYHAEGGKVPIKW 177
Query: 306 RAPELIFGATEYTTAIDMWSIGCVLAELL 334
A E I YT D+WS G + EL+
Sbjct: 178 MALESILHRI-YTHQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 3e-09
Identities = 51/196 (26%), Positives = 83/196 (42%), Gaps = 45/196 (22%)
Query: 234 HVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293
++P V+ + ++ AL+ LH VC RD+ P N+L++ H +++ F +
Sbjct: 81 NIPEECVKRWAAEMVVALDALHREGIVC-RDLNPNNILLDDRGH-IQLTYFSRWSEVEDS 138
Query: 294 EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGE-SGVDQLVEI 352
+ Y APE + G +E T A D WS+G +L ELL G+ L SG++
Sbjct: 139 CDGEA--VENMYCAPE-VGGISEETEACDWWSLGAILFELLTGKTLVECHPSGINT---- 191
Query: 353 IKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC 412
+T P+ + EA L+ +LLQ++P+ R
Sbjct: 192 ------------------HTTLNIPEW------------VSEEARSLLQQLLQFNPTERL 221
Query: 413 TALEAC-----AHPFF 423
A A +HPFF
Sbjct: 222 GAGVAGVEDIKSHPFF 237
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 3e-09
Identities = 57/216 (26%), Positives = 100/216 (46%), Gaps = 34/216 (15%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR----ELQIMRLLNHPNVVSLKH 197
ER +G+G FG V++ VAIK + D K + E+Q ++ L H +++SL
Sbjct: 11 ERKLGSGYFGEVWEGLWKNR-VRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL-- 67
Query: 198 CFFSTTEKDELYLNLVLEYISETVYRVS-KHYTRM--NQHVPILYVQLYTYQICRALNYL 254
F + + +Y+ I+E + + S + R Q +P+ + Q+ + YL
Sbjct: 68 -FAVCSVGEPVYI------ITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYL 120
Query: 255 --HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML-----VPGEPNISYICSRYYRA 307
+ + HRD+ +N+LV K+ DFG A+++ + + I Y + A
Sbjct: 121 EEQNSI---HRDLAARNILVGEDL-VCKVADFGLARLIKEDVYLSSDKKIPY----KWTA 172
Query: 308 PELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPG 342
PE ++T D+WS G +L E+ GQ +PG
Sbjct: 173 PEAA-SHGTFSTKSDVWSFGILLYEMFTYGQVPYPG 207
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 4e-09
Identities = 60/244 (24%), Positives = 106/244 (43%), Gaps = 52/244 (21%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMR----LLNHPNVVSLKHC 198
+V+G G+FG V + +TG A+K + + + ++ +R +L + + +
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKM 66
Query: 199 FFSTTEKDELYLNLVLEYI--SETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH 256
F+S +K LYL ++E++ + + + K T + Q Y + A++ +H
Sbjct: 67 FYSFQDKLNLYL--IMEFLPGGDMMTLLMKKDTLTEEET-----QFYIAETVLAIDSIHQ 119
Query: 257 VVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML---------------VPGEPNISYIC 301
+ G HRDIKP NLL++ H +K+ DFG L +P + +
Sbjct: 120 L-GFIHRDIKPDNLLLDSKGH-VKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMN 177
Query: 302 SRY---------------------YRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLF 340
S+ Y APE +F T Y D WS+G ++ E+L+G P F
Sbjct: 178 SKRKAETWKRNRRQLAFSTVGTPDYIAPE-VFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236
Query: 341 PGES 344
E+
Sbjct: 237 CSET 240
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 5e-09
Identities = 72/281 (25%), Positives = 122/281 (43%), Gaps = 41/281 (14%)
Query: 143 RVVGTGSFGVVFQAKCLETGDS---VAIKKV-----LQDKRYKNRELQIMRLLNHPNVVS 194
RV+G G FG V+ +++ A+K + L++ +E IM+ +HPNV+S
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 195 LKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL-YTYQICRALNY 253
L E +VL Y+ R ++ R H P + + + Q+ + + Y
Sbjct: 61 L----LGICLPSEGSPLVVLPYMKHGDLR---NFIRSETHNPTVKDLIGFGLQVAKGMEY 113
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPEL--I 311
L V HRD+ +N +++ + +K+ DFG A+ + E Y + +L
Sbjct: 114 LASKKFV-HRDLAARNCMLD-ESFTVKVADFGLARDIYDKE----YYSVHNHTGAKLPVK 167
Query: 312 FGATE------YTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEI 364
+ A E +TT D+WS G +L EL+ G P +P D V +++ G +
Sbjct: 168 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQ--GRRLLQPE 225
Query: 365 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQ 405
C +P Y ++ WH R P +LVSR+ Q
Sbjct: 226 YCPDPLY------EVMLSCWHPKPEMR--PTFSELVSRIEQ 258
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 5e-09
Identities = 60/210 (28%), Positives = 88/210 (41%), Gaps = 42/210 (20%)
Query: 160 ETGDSVAIKKVLQD--------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211
TG VAIK + D R++ RE + L HPN+V+L + E L
Sbjct: 1 MTGHEVAIKLLRTDAPEEEHQRARFR-RETALCARLYHPNIVAL----LDSGEAPPGLLF 55
Query: 212 LVLEYIS-ETVYRVSKHYTRMNQHV--PILYVQLYTYQICRALNYLHHVVGVCHRDIKPQ 268
V EY+ T+ V +L Q+ AL H+ G+ HRD+KPQ
Sbjct: 56 AVFEYVPGRTLREVLA-----ADGALPAGETGRLML-QVLDALACAHNQ-GIVHRDLKPQ 108
Query: 269 NLLVN-----PHTHQLKICDFGSAKMLVPGEPNI---------SYICSRYYRAPELIFGA 314
N++V+ PH K+ DFG +L PG + + + Y APE + G
Sbjct: 109 NIMVSQTGVRPHA---KVLDFGIGTLL-PGVRDADVATLTRTTEVLGTPTYCAPEQLRGE 164
Query: 315 TEYTTAIDMWSIGCVLAELLLGQPLFPGES 344
T D+++ G + E L GQ + G S
Sbjct: 165 PV-TPNSDLYAWGLIFLECLTGQRVVQGAS 193
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 6e-09
Identities = 70/303 (23%), Positives = 127/303 (41%), Gaps = 54/303 (17%)
Query: 148 GSFGVVFQAKCLETGDSV---AIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTE 204
GS G VF C + GD I K + + RE+ I++ ++H +++L H +
Sbjct: 103 GSEGEVFV--CTKHGDEQRKKVIVKAVTGGKTPGREIDILKTISHRAIINLIHAY----- 155
Query: 205 KDELYLNLVLEYISETVYRVSKH--YTRMNQHVPILYVQLYTYQ--ICRALNYLHHVVGV 260
+ + V V K +T +++ P+ Q T Q + AL YLH G+
Sbjct: 156 ---RWKSTVC-----MVMPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGR-GI 206
Query: 261 CHRDIKPQNLLVNPHTHQLKICDFGSAKMLV--PGEPN-ISYICSRYYRAPELIFGATEY 317
HRD+K +N+ ++ + + + DFG+A L P P + + +PEL+ Y
Sbjct: 207 IHRDVKTENIFLDEPENAV-LGDFGAACKLDAHPDTPQCYGWSGTLETNSPELL-ALDPY 264
Query: 318 TTAIDMWSIGCVLAELLLGQ-PLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEF-- 374
D+WS G VL E+ + LF + +K + R I+CM + EF
Sbjct: 265 CAKTDIWSAGLVLFEMSVKNVTLFGKQ---------VKSSSSQLRSIIRCMQVHPLEFPQ 315
Query: 375 -----------KFPQIKAHPWH--KIFHKRMPPEALD-LVSRLLQYSPSLRCTALEACAH 420
++ + P+ + K ++ L++++L + R +A + +
Sbjct: 316 NGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375
Query: 421 PFF 423
P F
Sbjct: 376 PLF 378
|
Length = 392 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 7e-09
Identities = 60/244 (24%), Positives = 105/244 (43%), Gaps = 52/244 (21%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMR----LLNHPNVVSLKHC 198
+V+G G+FG V + +TG A+K + + + ++ +R +L + +
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKM 66
Query: 199 FFSTTEKDELYLNLVLEYI--SETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH 256
F+S +K LYL ++E++ + + + K T + Q Y + A++ +H
Sbjct: 67 FYSFQDKRNLYL--IMEFLPGGDMMTLLMKKDTLSEEAT-----QFYIAETVLAIDAIHQ 119
Query: 257 VVGVCHRDIKPQNLLVNPHTHQLKICDFGSA------------KMLVPGEPN-------- 296
+ G HRDIKP NLL++ H +K+ DFG + L P+
Sbjct: 120 L-GFIHRDIKPDNLLLDAKGH-VKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMN 177
Query: 297 ----------------ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLF 340
S + + Y APE +F T Y D WS+G ++ E+L+G P F
Sbjct: 178 SKRKAETWKKNRRQLAYSTVGTPDYIAPE-VFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236
Query: 341 PGES 344
E+
Sbjct: 237 CSET 240
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 8e-09
Identities = 55/217 (25%), Positives = 101/217 (46%), Gaps = 14/217 (6%)
Query: 133 PKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQ----IMRLL- 187
P + ++ +G G++G VF+ + G A+K +L + E++ I++ L
Sbjct: 14 PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVK-ILDPIHDIDEEIEAEYNILKALS 72
Query: 188 NHPNVVSLKHCFFSTTEKDELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQ 246
+HPNVV ++ K+ L LVLE + +V + K + + + + + ++
Sbjct: 73 DHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHE 132
Query: 247 ICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG-SAKMLVPGEPNISYICSRYY 305
L +L HV HRD+K N+L+ +K+ DFG SA++ + + + ++
Sbjct: 133 ALMGLQHL-HVNKTIHRDVKGNNILLTTEG-GVKLVDFGVSAQLTSTRLRRNTSVGTPFW 190
Query: 306 RAPELIFGA----TEYTTAIDMWSIGCVLAELLLGQP 338
APE+I + Y D+WS+G EL G P
Sbjct: 191 MAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDP 227
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 74/282 (26%), Positives = 123/282 (43%), Gaps = 56/282 (19%)
Query: 145 VGTGSFGVVFQAKCL-------ETGDSVAIKKVLQDKRYKN-----RELQIMRLL-NHPN 191
+G G FG V A+ L + +VA+K + D K+ E+++M+++ H N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYISETVYR------------VSKHYTRMNQHVPILY 239
+++L + T+ LY+ ++EY S+ R S R+ + +
Sbjct: 83 IINL---LGACTQDGPLYV--IVEYASKGNLREYLRARRPPGMEYSYDIARVPDE-QMTF 136
Query: 240 VQLY--TYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI 297
L TYQ+ R + YL + HRD+ +N+LV + +KI DFG A+ + NI
Sbjct: 137 KDLVSCTYQVARGMEYLASQKCI-HRDLAARNVLVT-ENNVMKIADFGLARDV----NNI 190
Query: 298 SYICSRY-------YRAPELIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVDQL 349
Y + APE +F YT D+WS G ++ E+ LG +PG V++L
Sbjct: 191 DYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIP-VEEL 248
Query: 350 VEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKR 391
+++K G + C N Y + WH I R
Sbjct: 249 FKLLK-EGHRMDKPANCTNELYMMMR------DCWHAIPSHR 283
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 1e-08
Identities = 55/206 (26%), Positives = 96/206 (46%), Gaps = 24/206 (11%)
Query: 142 ERVVGTGSFGVVFQAKCLETGD---SVAIKKV---LQDKRYKN--RELQIMRLLNHPNVV 193
E+V+G G FG V + G VAIK + +K+ ++ E IM +HPN++
Sbjct: 9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
L+ T K + +V EY+ + + + ++ + I + Y
Sbjct: 69 HLEGVV--TKSKPVM---IVTEYMENG--SLDAFLRKHDGQFTVIQLVGMLRGIASGMKY 121
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSR-----YYRAP 308
L + G HRD+ +N+LVN + K+ DFG +++L +P +Y + AP
Sbjct: 122 LSDM-GYVHRDLAARNILVNSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTAP 178
Query: 309 ELIFGATEYTTAIDMWSIGCVLAELL 334
E I ++T+A D+WS G V+ E++
Sbjct: 179 EAI-AYRKFTSASDVWSYGIVMWEVM 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 2e-08
Identities = 57/209 (27%), Positives = 92/209 (44%), Gaps = 28/209 (13%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS---VAIKKVLQDKRYKNR-----ELQIMRLLNHPNVV 193
E V+G G FG V + + G VAIK + K R E IM +HPN++
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMN--QHVPILYVQLYTYQICRAL 251
L+ + + ++ E++ + R N Q I V + I +
Sbjct: 69 HLEGVVTKSRP-----VMIITEFMENGAL---DSFLRQNDGQFTVIQLVGMLR-GIAAGM 119
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSR------YY 305
YL + V HRD+ +N+LVN + K+ DFG ++ L + +Y S +
Sbjct: 120 KYLSEMNYV-HRDLAARNILVNSNL-VCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRW 177
Query: 306 RAPELIFGATEYTTAIDMWSIGCVLAELL 334
APE I ++T+A D+WS G V+ E++
Sbjct: 178 TAPEAI-AYRKFTSASDVWSYGIVMWEVM 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 2e-08
Identities = 54/211 (25%), Positives = 104/211 (49%), Gaps = 29/211 (13%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNHPNVVSL------ 195
+G G +G V++ + +VA+K + +D +E +M+ + HPN+V L
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 73
Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
+ F+ TE Y NL L+Y+ E + +N ++ + + T QI A+ YL
Sbjct: 74 EPPFYIITEF-MTYGNL-LDYLREC------NRQEVN---AVVLLYMAT-QISSAMEYLE 121
Query: 256 HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRY---YRAPELIF 312
HRD+ +N LV + H +K+ DFG +++ + G+ ++ +++ + APE +
Sbjct: 122 K-KNFIHRDLAARNCLVGEN-HLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESL- 177
Query: 313 GATEYTTAIDMWSIGCVLAEL-LLGQPLFPG 342
+++ D+W+ G +L E+ G +PG
Sbjct: 178 AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 208
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 47/165 (28%), Positives = 78/165 (47%), Gaps = 16/165 (9%)
Query: 243 YTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICS 302
Y++Q+ + + +L + HRD+ +N+L++ + +KICDFG A+ + + +
Sbjct: 184 YSFQVAKGMEFLASRKCI-HRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYVRKGDA 241
Query: 303 RY---YRAPELIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVDQLVEIIKILGT 358
R + APE IF YT D+WS G +L E+ LG +PG V+I +
Sbjct: 242 RLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VKIDEEFCR 293
Query: 359 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRL 403
+E + P+YT + Q WH +R P +LV L
Sbjct: 294 RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQR--PTFSELVEHL 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 3e-08
Identities = 55/227 (24%), Positives = 101/227 (44%), Gaps = 38/227 (16%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNHPNVVSLKHCF 199
R +G G FG V++ T VA+K + E QIM+ L HP ++ L +
Sbjct: 12 RKLGAGQFGEVWEGLWNNT-TPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQL---Y 67
Query: 200 FSTTEKDELYL-------NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
T ++ +Y+ +LEY+ R K + Q + + Q+ +
Sbjct: 68 AVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALK----LPQLIDM------AAQVASGMA 117
Query: 253 YL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRY---YRA 307
YL + + HRD+ +N+LV + + K+ DFG A+++ + +++ + A
Sbjct: 118 YLEAQNYI---HRDLAARNVLVGEN-NICKVADFGLARVIKEDIYE-AREGAKFPIKWTA 172
Query: 308 PELIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESG--VDQLVE 351
PE ++ D+WS G +L E++ G+ +PG + V Q V+
Sbjct: 173 PEAAL-YNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVD 218
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 3e-08
Identities = 70/242 (28%), Positives = 96/242 (39%), Gaps = 60/242 (24%)
Query: 133 PKQTISYMAERVVGTGSFGVVFQAKCL-----ETGDSVAIKKV-----LQDKRYKNRELQ 182
P+ I Y R +G G+FG VFQA+ E VA+K + + RE
Sbjct: 3 PRNNIEY--VRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 60
Query: 183 IMRLLNHPNVVSL--------KHC--FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMN 232
+M +HPN+V L C F D LN L + S H T
Sbjct: 61 LMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGD---LNEFLRHRSPRAQCSLSHSTSSA 117
Query: 233 QHVPILYVQLY-TYQICRALN------YL--HHVVGVCHRDIKPQNLLVNPHTHQLKICD 283
+ + + L T Q+C A YL V HRD+ +N LV + +KI D
Sbjct: 118 RKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFV---HRDLATRNCLVGENM-VVKIAD 173
Query: 284 FGSAKMLVPGEPNISYICSRYYRA------------PELIFGATEYTTAIDMWSIGCVLA 331
FG ++ NI + YY+A PE IF YTT D+W+ G VL
Sbjct: 174 FGLSR-------NI--YSADYYKASENDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLW 223
Query: 332 EL 333
E+
Sbjct: 224 EI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 7e-08
Identities = 61/256 (23%), Positives = 96/256 (37%), Gaps = 68/256 (26%)
Query: 246 QICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRY- 304
QI AL+ LH G+ HRD+KPQN++ + + KI D G+A L G I+YI +
Sbjct: 263 QILFALDGLHST-GIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVG---INYIPKEFL 318
Query: 305 ----YRAPELIFGATEYTTA---------------------IDMWSIGCVLAELLLGQPL 339
Y APE +T+ +A D++S G L+ Q
Sbjct: 319 LDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG-----LIFLQMA 373
Query: 340 FPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPP----- 394
FP L++ ++K + + W K+ R P
Sbjct: 374 FPNLRSDSNLIQF--------NRQLKRNDYDLVA----------WRKLVEPRASPDLRRG 415
Query: 395 -EALD--------LVSRLLQYSPSLRCTALEACAHPFFDDLRDPNTCLPNGRPLPTLFNF 445
E LD L+ ++++ R +A A AHP+FD + L LF
Sbjct: 416 FEVLDLDGGAGWELLKSMMRFKGRQRISAKAALAHPYFDREGLLGLSVMQNLRLQ-LFRA 474
Query: 446 TAQELAGASNELRQRL 461
T Q+ A+ + +
Sbjct: 475 TQQDYGEAAAWVVFLM 490
|
Length = 566 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 8e-08
Identities = 44/168 (26%), Positives = 78/168 (46%), Gaps = 15/168 (8%)
Query: 243 YTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICS 302
Y++Q+ R + +L + HRD+ +N+L++ + +KICDFG A+ + + +
Sbjct: 179 YSFQVARGMEFLASRKCI-HRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYVRKGSA 236
Query: 303 RY---YRAPELIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVDQLVEIIKILGT 358
R + APE IF YTT D+WS G +L E+ LG +PG V+I +
Sbjct: 237 RLPLKWMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPG-------VQINEEFCQ 288
Query: 359 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMP-PEALDLVSRLLQ 405
++ + P + +I W +R ++++ LLQ
Sbjct: 289 RLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 8e-08
Identities = 51/202 (25%), Positives = 96/202 (47%), Gaps = 22/202 (10%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKV-LQDKRYK----NRELQIMRLLNHPNVVSLKHCF 199
+G GSFG V++ T + VAIK + L++ + +E+ ++ + P + +
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71
Query: 200 FSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPI--LYVQLYTYQICRALNYLHHV 257
T+ L +++EY+ + + P+ Y+ +I + L+YLH
Sbjct: 72 LKGTK-----LWIIMEYLG------GGSALDLLKPGPLEETYIATILREILKGLDYLHSE 120
Query: 258 VGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGE-PNISYICSRYYRAPELIFGATE 316
+ HRDIK N+L++ +K+ DFG A L + +++ + ++ APE+I +
Sbjct: 121 RKI-HRDIKAANVLLSEQG-DVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-KQSA 177
Query: 317 YTTAIDMWSIGCVLAELLLGQP 338
Y D+WS+G EL G+P
Sbjct: 178 YDFKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 8e-08
Identities = 37/104 (35%), Positives = 55/104 (52%), Gaps = 7/104 (6%)
Query: 243 YTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS---Y 299
+TYQ+ R + +L V HRD+ +N+L+ +KICDFG A+ ++ +S
Sbjct: 242 FTYQVARGMEFLASKNCV-HRDLAARNVLLA-QGKIVKICDFGLARDIMHDSNYVSKGST 299
Query: 300 ICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPG 342
+ APE IF YTT D+WS G +L E+ LG +PG
Sbjct: 300 FLPVKWMAPESIFDNL-YTTLSDVWSYGILLWEIFSLGGTPYPG 342
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 1e-07
Identities = 58/208 (27%), Positives = 94/208 (45%), Gaps = 28/208 (13%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS---VAIKKVLQDKRYKNR-----ELQIMRLLNHPNVV 193
++V+G G FG VF+ G VAIK + K R E IM +H N++
Sbjct: 10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNII 69
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMN--QHVPILYVQLYTYQICRAL 251
L+ T K + ++ EY+ Y R + + V + I +
Sbjct: 70 RLEGVV--TKFKPAM---IITEYMENGAL---DKYLRDHDGEFSSYQLVGMLR-GIAAGM 120
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSR-----YYR 306
YL + V HRD+ +N+LVN + K+ DFG +++L +P +Y S +
Sbjct: 121 KYLSDMNYV-HRDLAARNILVN-SNLECKVSDFGLSRVL-EDDPEGTYTTSGGKIPIRWT 177
Query: 307 APELIFGATEYTTAIDMWSIGCVLAELL 334
APE I ++T+A D+WS G V+ E++
Sbjct: 178 APEAI-AYRKFTSASDVWSFGIVMWEVM 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 1e-07
Identities = 51/199 (25%), Positives = 95/199 (47%), Gaps = 26/199 (13%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNHPNVVSLKHCFFS 201
+GTG FGVV K D VAIK + + ++ E ++M L+H +V L +
Sbjct: 12 LGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQL---YGV 67
Query: 202 TTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL--YTYQICRALNYL--HHV 257
T++ +Y +V EY+S +Y R + QL +C + YL
Sbjct: 68 CTKQRPIY--IVTEYMSNGCLL---NYLREHGKRFQP-SQLLEMCKDVCEGMAYLESKQF 121
Query: 258 VGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRY---YRAPELIFGA 314
+ HRD+ +N LV+ +K+ DFG ++ ++ E S + S++ + PE +
Sbjct: 122 I---HRDLAARNCLVDDQG-CVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPE-VLLY 175
Query: 315 TEYTTAIDMWSIGCVLAEL 333
+++++ D+W+ G ++ E+
Sbjct: 176 SKFSSKSDVWAFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 1e-07
Identities = 66/249 (26%), Positives = 110/249 (44%), Gaps = 57/249 (22%)
Query: 145 VGTGSFGVVFQAKCLETGDS-------VAIKKVLQDKRYKN-----RELQIMRLL-NHPN 191
+G G FG V A+ + VA+K + D K+ E+++M+++ H N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYISETVYR--------VSKHYTRMNQHVPILYVQLY 243
+++L + T+ LY+ ++EY S+ R Y VP +
Sbjct: 86 IINL---LGACTQDGPLYV--IVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFK 140
Query: 244 -----TYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS 298
YQ+ R + YL + HRD+ +N+LV + +KI DFG A+ +I
Sbjct: 141 DLVSCAYQVARGMEYLASKKCI-HRDLAARNVLVT-EDNVMKIADFGLAR-------DIH 191
Query: 299 YICSRYYR------------APELIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESG 345
+I YY+ APE +F YT D+WS G +L E+ LG +PG
Sbjct: 192 HI--DYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVP- 247
Query: 346 VDQLVEIIK 354
V++L +++K
Sbjct: 248 VEELFKLLK 256
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 77/349 (22%), Positives = 135/349 (38%), Gaps = 89/349 (25%)
Query: 144 VVGTG--SFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSL 195
V+G G V A+ TG+ V ++++ + + EL + +L NHPN+V
Sbjct: 5 VIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPY 64
Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYR--VSKHYTRMNQHVPILYVQLYTYQICRALNY 253
+ F + E L +V +++ + + H+ + I Y+ + +AL+Y
Sbjct: 65 RATFIADNE-----LWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQ---GVLKALDY 116
Query: 254 LHHVVGVCHRDIKPQNLLVN-----------------PHTHQLKIC-DFG--SAKMLVPG 293
+HH +G HR +K ++L++ H +L++ DF S K+L
Sbjct: 117 IHH-MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVL--- 172
Query: 294 EPNISYICSRYYRAPELIFGATE-YTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEI 352
P +S PE++ + Y D++S+G EL G F L+E
Sbjct: 173 -PWLS---------PEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLE- 221
Query: 353 IKILGT------------------PTR--------EEIKCMNPNYTEFKFPQIKAHPWHK 386
K+ GT P+R E P + + +HP+++
Sbjct: 222 -KLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSN---GESSSHPYNR 277
Query: 387 IFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL-RDPNTCLP 434
F P V + LQ +P R +A H FF + R + LP
Sbjct: 278 TF----SPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKRRASEALP 322
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 3e-07
Identities = 60/240 (25%), Positives = 104/240 (43%), Gaps = 43/240 (17%)
Query: 145 VGTGSFGVVFQA--KCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLK 196
+G+G+FG V + K ++ +VA+K + D K RE +M+ L++P +V +
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM- 61
Query: 197 HCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH 256
E + L + L + + + N+HV + +Q+ + YL
Sbjct: 62 ---IGICEAESWMLVMELAELGPL-----NKFLQKNKHVTEKNITELVHQVSMGMKYLEE 113
Query: 257 VVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR---------- 306
V HRD+ +N+L+ H KI DFG +K L E YY+
Sbjct: 114 TNFV-HRDLAARNVLLVTQ-HYAKISDFGLSKALGADE--------NYYKAKTHGKWPVK 163
Query: 307 --APELIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESG--VDQLVEIIKILGTPTR 361
APE + ++++ D+WS G ++ E GQ + G G V Q++E + + P R
Sbjct: 164 WYAPECM-NYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQR 222
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 4e-07
Identities = 57/207 (27%), Positives = 95/207 (45%), Gaps = 29/207 (14%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIK---KVLQDKRY--KNREL----QIMRLLNHPNVV 193
+V+G+G+FG V++ + G++V I KVL++ N+E+ +M + P V
Sbjct: 13 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVC 72
Query: 194 SLKH-CFFSTTE--KDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRA 250
L C ST + + +L+Y+ E R+ +N + QI +
Sbjct: 73 RLLGICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDL-LN----------WCVQIAKG 121
Query: 251 LNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRY---YRA 307
++YL V V HRD+ +N+LV H +KI DFG A++L E + + A
Sbjct: 122 MSYLEEVRLV-HRDLAARNVLVKSPNH-VKITDFGLARLLDIDETEYHADGGKVPIKWMA 179
Query: 308 PELIFGATEYTTAIDMWSIGCVLAELL 334
E I +T D+WS G + EL+
Sbjct: 180 LESIL-HRRFTHQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 4e-07
Identities = 60/232 (25%), Positives = 105/232 (45%), Gaps = 54/232 (23%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNR---ELQIMRLLNHPNVVSL 195
R++G G G V+ A VA+KK+ +D K R E +I L HP +V +
Sbjct: 8 RLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPV 67
Query: 196 KHCFFSTTEKDELYLNL------VLEYISETVYR---VSKHY---TRMNQHVPILYVQLY 243
+ ++ D +Y + L+ + ++V++ +SK T + + I +
Sbjct: 68 ---YSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFH---- 120
Query: 244 TYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM----------LVPG 293
+IC + Y+H GV HRD+KP N+L+ + I D+G+A +
Sbjct: 121 --KICATIEYVHSK-GVLHRDLKPDNILLGLFGEVV-ILDWGAAIFKKLEEEDLLDIDVD 176
Query: 294 EPNISY---------ICSRYYRAPELIFG--ATEYTTAIDMWSIGCVLAELL 334
E NI Y + + Y APE + G A+E T D++++G +L ++L
Sbjct: 177 ERNICYSSMTIPGKIVGTPDYMAPERLLGVPASEST---DIYALGVILYQML 225
|
Length = 932 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 5e-07
Identities = 52/199 (26%), Positives = 97/199 (48%), Gaps = 26/199 (13%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKV----LQDKRYKNRELQIMRLLNHPNVVSLKHCFF 200
+G+G FG+V+ LE VAIK + + ++ + E Q+M L+HP +V L +
Sbjct: 12 IGSGQFGLVWLGYWLEK-RKVAIKTIREGAMSEEDFI-EEAQVMMKLSHPKLVQL---YG 66
Query: 201 STTEKDELYLNLVLEYISE---TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV 257
TE+ + L V E++ + Y ++ + +L + L +C + YL
Sbjct: 67 VCTERSPICL--VFEFMEHGCLSDYLRAQRGKFSQE--TLLGMCL---DVCEGMAYLESS 119
Query: 258 VGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRY---YRAPELIFGA 314
V HRD+ +N LV +K+ DFG + V + S +++ + +PE +F
Sbjct: 120 -NVIHRDLAARNCLVG-ENQVVKVSDFGMTR-FVLDDQYTSSTGTKFPVKWSSPE-VFSF 175
Query: 315 TEYTTAIDMWSIGCVLAEL 333
++Y++ D+WS G ++ E+
Sbjct: 176 SKYSSKSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 5e-07
Identities = 52/223 (23%), Positives = 90/223 (40%), Gaps = 47/223 (21%)
Query: 144 VVGTGSFGVVFQAKCLETGDS----VAIKKVLQDKRYKNRELQIMRLL---------NHP 190
++ G+FG +F ++ V +K V E+Q+ LL +H
Sbjct: 13 LLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHAS----EIQVTLLLQESCLLYGLSHQ 68
Query: 191 NVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYT------ 244
N++ + H E + + K + + + Q +
Sbjct: 69 NILPILHVCIEDGEPPFVLYPY-------MNWGNLKLFLQQCRLGEANNPQALSTQQLVH 121
Query: 245 --YQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC- 301
QI ++YLH GV H+DI +N +++ Q+KI D ++ L P + Y C
Sbjct: 122 MAIQIACGMSYLHKR-GVIHKDIAARNCVID-EELQVKITDNALSRDLFPMD----YHCL 175
Query: 302 ----SRYYR--APELIFGATEYTTAIDMWSIGCVLAELL-LGQ 337
+R + A E + EY++A D+WS G +L EL+ LGQ
Sbjct: 176 GDNENRPVKWMALESLVN-KEYSSASDVWSFGVLLWELMTLGQ 217
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 6e-07
Identities = 49/168 (29%), Positives = 76/168 (45%), Gaps = 22/168 (13%)
Query: 243 YTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICS 302
Y++Q+ R + +L + HRD+ +N+L++ + +KICDFG A+ + + Y+
Sbjct: 178 YSFQVARGMEFLASRKCI-HRDLAARNILLS-ENNVVKICDFGLARDIYK---DPDYVRK 232
Query: 303 RYYR------APELIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVDQLVEIIKI 355
R APE IF YTT D+WS G +L E+ LG +PG V+I +
Sbjct: 233 GDARLPLKWMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPG-------VQIDEE 284
Query: 356 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRL 403
+E + P Y + I WH R P +LV L
Sbjct: 285 FCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDR--PTFSELVEIL 330
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 9e-07
Identities = 49/190 (25%), Positives = 78/190 (41%), Gaps = 42/190 (22%)
Query: 166 AIKKVLQDKRYKNRELQIMRLLNHPNVVSL-------KHCFFSTTEKDELY-LNLVL-EY 216
A +D +E++I+ L+ PN+ L E E LN L ++
Sbjct: 58 ASDNAREDFL---KEVKILSRLSDPNIARLLGVCTVDPPLCM-IMEYMENGDLNQFLQKH 113
Query: 217 ISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHT 276
++ET ++ +LY+ QI + YL + V HRD+ +N LV
Sbjct: 114 VAETSG--LACNSKSLSFSTLLYMAT---QIASGMRYLESLNFV-HRDLATRNCLVGK-N 166
Query: 277 HQLKICDFGSAKMLVPGEPNISYICSRYY----RAP--------ELIFGATEYTTAIDMW 324
+ +KI DFG ++ L Y YY RAP E + ++TT D+W
Sbjct: 167 YTIKIADFGMSRNL--------YSSD-YYRVQGRAPLPIRWMAWESVLL-GKFTTKSDVW 216
Query: 325 SIGCVLAELL 334
+ G L E+L
Sbjct: 217 AFGVTLWEIL 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 1e-06
Identities = 53/201 (26%), Positives = 93/201 (46%), Gaps = 17/201 (8%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN--RELQIMRLLNHPNVVSLKHCFFS 201
++G G FG V Q + TG VA+K + D + E +M L+H N+V L
Sbjct: 13 IIGEGEFGAVLQGE--YTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILH 70
Query: 202 TTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVC 261
L +V+E +S+ V+ TR V ++ + ++ + + YL +
Sbjct: 71 NG------LYIVMELMSKGNL-VNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK-KLV 122
Query: 262 HRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAI 321
HRD+ +N+LV+ K+ DFG A++ G N + APE + ++++
Sbjct: 123 HRDLAARNILVS-EDGVAKVSDFGLARVGSMGVDNSKLPVK--WTAPEAL-KHKKFSSKS 178
Query: 322 DMWSIGCVLAELL-LGQPLFP 341
D+WS G +L E+ G+ +P
Sbjct: 179 DVWSYGVLLWEVFSYGRAPYP 199
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 33/107 (30%), Positives = 54/107 (50%), Gaps = 13/107 (12%)
Query: 243 YTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICS 302
++ Q+ + +++L HRD+ +N+L+ KICDFG A+ + + +Y+
Sbjct: 217 FSSQVAQGMDFLA-SKNCIHRDVAARNVLLT-DGRVAKICDFGLARDI---MNDSNYVVK 271
Query: 303 RYYR------APELIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPG 342
R APE IF YT D+WS G +L E+ LG+ +PG
Sbjct: 272 GNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGKSPYPG 317
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 2e-06
Identities = 48/162 (29%), Positives = 81/162 (50%), Gaps = 21/162 (12%)
Query: 148 GSFGVVFQAKCLETGDSVAIKKVLQ-DKRYKNRELQI------MRLLNHPNVVSLKHCFF 200
G+FG V+ + A+K V + D KN Q+ + L P +V L ++
Sbjct: 15 GAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHL---YY 71
Query: 201 STTEKDELYLNLVLEY-ISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH-HVV 258
S + +YL V+EY I V + Y ++ + + Y+ ++ AL+YLH H
Sbjct: 72 SLQSANNVYL--VMEYLIGGDVKSLLHIYGYFDEEMAVKYIS----EVALALDYLHRH-- 123
Query: 259 GVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYI 300
G+ HRD+KP N+L++ H +K+ DFG +K+ + E N+ I
Sbjct: 124 GIIHRDLKPDNMLISNEGH-IKLTDFGLSKVTLNRELNMMDI 164
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 2e-06
Identities = 55/213 (25%), Positives = 98/213 (46%), Gaps = 31/213 (14%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIK---KVLQDKRYKNRELQ------IMRLLNHPNVV 193
+V+G+G+FG V++ + G++V I K+L + ++ IM ++HP++V
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72
Query: 194 SLKHCFFSTTEKDELYL---NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRA 250
L S T + L +L+Y+ E H + + + + QI +
Sbjct: 73 RLLGVCLSPTIQLVTQLMPHGCLLDYVHE-------HKDNIGSQLLLNWC----VQIAKG 121
Query: 251 LNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRY---YRA 307
+ YL + HRD+ +N+LV H +KI DFG A++L E + + + A
Sbjct: 122 MMYLEE-RRLVHRDLAARNVLVKSPNH-VKITDFGLARLLEGDEKEYNADGGKMPIKWMA 179
Query: 308 PELIFGATEYTTAIDMWSIGCVLAELLL--GQP 338
E I ++T D+WS G + EL+ G+P
Sbjct: 180 LECIH-YRKFTHQSDVWSYGVTIWELMTFGGKP 211
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 3e-06
Identities = 35/107 (32%), Positives = 55/107 (51%), Gaps = 13/107 (12%)
Query: 243 YTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICS 302
++YQ+ + +++L HRD+ +N+L+ H KICDFG A+ + + +Y+
Sbjct: 219 FSYQVAKGMSFLASK-NCIHRDLAARNILLT-HGRITKICDFGLARDI---RNDSNYVVK 273
Query: 303 RYYR------APELIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPG 342
R APE IF YT D+WS G +L E+ LG +PG
Sbjct: 274 GNARLPVKWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSSPYPG 319
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 4e-06
Identities = 81/319 (25%), Positives = 130/319 (40%), Gaps = 77/319 (24%)
Query: 145 VGTGSFGVVFQAKCL-------ETGDSVAIKKVLQDKRYKN-----RELQIMRLL-NHPN 191
+G G FG V A+ + +VA+K + D K+ E+++M+++ H N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYV---------QL 242
+++L + T+ LY+ ++EY S+ R Y R + + Y QL
Sbjct: 80 IINL---LGACTQDGPLYV--LVEYASKGNLR---EYLRARRPPGMDYSFDTCKLPEEQL 131
Query: 243 Y-------TYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEP 295
YQ+ R + YL + HRD+ +N+LV + +KI DFG A+ +
Sbjct: 132 TFKDLVSCAYQVARGMEYLASQKCI-HRDLAARNVLVT-EDNVMKIADFGLARDV----H 185
Query: 296 NISYICSRY-------YRAPELIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVD 347
NI Y + APE +F YT D+WS G +L E+ LG +PG V+
Sbjct: 186 NIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPGIP-VE 243
Query: 348 QLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKR---------------- 391
+L +++K E + P + I WH + +R
Sbjct: 244 ELFKLLK-------EGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTV 296
Query: 392 -MPPEALDLVSRLLQYSPS 409
E LDL QYSP
Sbjct: 297 TSTDEYLDLSVPFEQYSPG 315
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 5e-06
Identities = 60/206 (29%), Positives = 96/206 (46%), Gaps = 32/206 (15%)
Query: 145 VGTGSFGVVFQA--KCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLK 196
+G+G+FG V + K + VAIK VL+++ K+ RE +IM L++P +V +
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIK-VLKNENEKSVRDEMMREAEIMHQLDNPYIVRM- 60
Query: 197 HCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH 256
E + L L V+E S ++K + + + V +Q+ + YL
Sbjct: 61 ---IGVCEAEALML--VMEMASGG--PLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEG 113
Query: 257 VVGVCHRDIKPQN-LLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRY-------YRAP 308
V HRD+ +N LLVN H KI DFG +K L + SY +R + AP
Sbjct: 114 KNFV-HRDLAARNVLLVN--QHYAKISDFGLSKALGADD---SYYKARSAGKWPLKWYAP 167
Query: 309 ELIFGATEYTTAIDMWSIGCVLAELL 334
E I ++++ D+WS G + E
Sbjct: 168 ECI-NFRKFSSRSDVWSYGITMWEAF 192
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 5e-06
Identities = 67/294 (22%), Positives = 108/294 (36%), Gaps = 63/294 (21%)
Query: 143 RVVGTGSFGVVFQAKCL-ETGDS----VAIKKVLQDKRYKNR-----ELQIMRLLNHPNV 192
R +G G+FG V++ GD+ VA+K + + ++ E IM NH N+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVP-------ILYVQLYTY 245
V + E+ + ++LE ++ + R P +L+
Sbjct: 72 V---RLIGVSFERLPRF--ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVA 126
Query: 246 QICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQ--LKICDFGSAKMLVPGEPNISYICSR 303
+ C+ L H + HRDI +N L+ KI DFG A+ + +
Sbjct: 127 KGCKYLEENHFI----HRDIAARNCLLTCKGPGRVAKIADFGMARDIYR---------AS 173
Query: 304 YYR-----------APELIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESG--VDQL 349
YYR P F +T+ D+WS G +L E+ LG +PG + V +
Sbjct: 174 YYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEF 233
Query: 350 VEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRL 403
V L P C P Y +I W R P ++ R+
Sbjct: 234 VTGGGRLDPPK----GCPGPVY------RIMTDCWQHTPEDR--PNFATILERI 275
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 5e-06
Identities = 77/316 (24%), Positives = 135/316 (42%), Gaps = 72/316 (22%)
Query: 145 VGTGSFGVVFQAKCL-------ETGDSVAIKKVLQDKRYKN-----RELQIMRLLN-HPN 191
+G G FG V +A+ + +VA+K + + K+ E+++M+L+ H N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYISETVYR------------VSKHYTRMNQHVPILY 239
+++L T++ LY+ ++EY ++ R + T++ + + +
Sbjct: 80 IINL---LGVCTQEGPLYV--IVEYAAKGNLREFLRARRPPGPDYTFDITKVPEE-QLSF 133
Query: 240 VQLYT--YQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI 297
L + YQ+ R + YL + HRD+ +N+LV + +KI DFG A+ G +I
Sbjct: 134 KDLVSCAYQVARGMEYLESRRCI-HRDLAARNVLVT-EDNVMKIADFGLAR----GVHDI 187
Query: 298 SYICSRY-------YRAPELIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVDQL 349
Y + APE +F YT D+WS G ++ E+ LG +PG +
Sbjct: 188 DYYKKTSNGRLPVKWMAPEALFDRV-YTHQSDVWSFGILMWEIFTLGGSPYPGIP----V 242
Query: 350 VEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKR----------------MP 393
E+ K+L RE + P+ + + WH + +R +
Sbjct: 243 EELFKLL----REGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVS 298
Query: 394 PEALDLVSRLLQYSPS 409
E LDL QYSPS
Sbjct: 299 EEYLDLSMPFEQYSPS 314
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 6e-06
Identities = 39/138 (28%), Positives = 57/138 (41%), Gaps = 46/138 (33%)
Query: 293 GEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEI 352
G PN Y APE++ T YT D WS+G +L E+L+GQP F ++ ++ +++
Sbjct: 210 GTPN--------YIAPEVLL-RTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKV 260
Query: 353 IKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFH----KRMPPEALDLVSRLLQYSP 408
I W H ++ PEA DL+ +L + P
Sbjct: 261 IN-----------------------------WQTSLHIPPQAKLSPEASDLIIKLCR-GP 290
Query: 409 SLRC---TALEACAHPFF 423
R A E AHPFF
Sbjct: 291 EDRLGKNGADEIKAHPFF 308
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 6e-06
Identities = 58/240 (24%), Positives = 114/240 (47%), Gaps = 46/240 (19%)
Query: 133 PKQTISYMAERVVGTGSFGVVFQA----------KCLETGDSVAIKKVLQDKRYKNRELQ 182
P+++I + + +G G FG V+ K L+ G +++++ L+ E
Sbjct: 4 PRESIKLV--KKLGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLE-------EAN 53
Query: 183 IMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL 242
+M+ L H +V L + T+++ +Y+ + EY+++ + + ++ +L +L
Sbjct: 54 LMKTLQHDKLVRL---YAVVTKEEPIYI--ITEYMAKGSLL---DFLKSDEGGKVLLPKL 105
Query: 243 --YTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYI 300
++ QI + Y+ HRD++ N+LV+ + KI DFG A+++ E Y
Sbjct: 106 IDFSAQIAEGMAYIERK-NYIHRDLRAANVLVS-ESLMCKIADFGLARVIEDNE----YT 159
Query: 301 CSR------YYRAPELI-FGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVDQLVEI 352
+ APE I FG+ +T D+WS G +L E++ G+ +PG S D + +
Sbjct: 160 AREGAKFPIKWTAPEAINFGS--FTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSAL 217
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 7e-06
Identities = 54/197 (27%), Positives = 87/197 (44%), Gaps = 45/197 (22%)
Query: 165 VAIKKVLQD--KRYKN---RELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISE 219
VA+K + D K +N +E++IM L +PN++ L S L ++ EY+
Sbjct: 47 VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDP-----LCMITEYMEN 101
Query: 220 -------TVYRVSKHYTRMNQHVPILYVQLYTY---QICRALNYLHHVVGVCHRDIKPQN 269
+ + +T N ++P + + Y QI + YL + V HRD+ +N
Sbjct: 102 GDLNQFLSQREIESTFTHAN-NIPSVSIANLLYMAVQIASGMKYLASLNFV-HRDLATRN 159
Query: 270 LLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR------------APELIFGATEY 317
LV H + +KI DFG ++ L G+ YYR A E I ++
Sbjct: 160 CLVGNH-YTIKIADFGMSRNLYSGD---------YYRIQGRAVLPIRWMAWESIL-LGKF 208
Query: 318 TTAIDMWSIGCVLAELL 334
TTA D+W+ G L E+
Sbjct: 209 TTASDVWAFGVTLWEMF 225
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 7e-06
Identities = 49/205 (23%), Positives = 90/205 (43%), Gaps = 25/205 (12%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIK---KVLQDKRYKNRELQI------MRLLNHPNVV 193
+++G+G FG V + + GDS+ I K +QD+ + +I M L+H +V
Sbjct: 13 KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIV 72
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
L L L L + + V +H ++ P + + QI + + Y
Sbjct: 73 RL----LGICPGASLQLVTQLSPLGSLLDHVRQHRDSLD---PQRLLN-WCVQIAKGMYY 124
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISY----ICSRYYRAPE 309
L + HR++ +N+L+ + ++I DFG A +L P + Y ++
Sbjct: 125 LEEH-RMVHRNLAARNILLKSDS-IVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALES 182
Query: 310 LIFGATEYTTAIDMWSIGCVLAELL 334
++FG YT D+WS G + E++
Sbjct: 183 ILFG--RYTHQSDVWSYGVTVWEMM 205
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 8e-06
Identities = 53/169 (31%), Positives = 82/169 (48%), Gaps = 40/169 (23%)
Query: 180 ELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV--LEYISETVYRVSKHYTRMNQHV-P 236
E +++R L+HP V++L L + +V L + YR S YT + + P
Sbjct: 210 EARLLRRLSHPAVLAL------------LDVRVVGGLTCLVLPKYR-SDLYTYLGARLRP 256
Query: 237 ILYVQL--YTYQICRALNYLHHVVGVCHRDIKPQNLLVN-PHTHQLKIC--DFGSAKMLV 291
+ Q+ Q+ A++Y+H G+ HRDIK +N+LVN P IC DFG+A
Sbjct: 257 LGLAQVTAVARQLLSAIDYIHGE-GIIHRDIKTENVLVNGPE----DICLGDFGAA-CFA 310
Query: 292 PGEPNISYICSRYY--------RAPELIFGATEYTTAIDMWSIGCVLAE 332
G S+ +Y APE++ G YT ++D+WS G V+ E
Sbjct: 311 RG----SWSTPFHYGIAGTVDTNAPEVLAG-DPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 1e-05
Identities = 58/220 (26%), Positives = 97/220 (44%), Gaps = 27/220 (12%)
Query: 143 RVVGTGSFGVVFQAKCLETGDS---VAIK--KVLQDKRYKN----RELQIMRLLNHPNVV 193
+ +G G FG V + + L DS VA+K K+ R + E M+ +HPNV+
Sbjct: 5 KTLGEGEFGSVMEGQ-LNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVM 63
Query: 194 SLKHCFFSTTEKDELYLNLV-LEYISETVYRVSKHYTRMN---QHVPILYVQLYTYQICR 249
L T E + +V L ++ Y+R+ Q++P + + I
Sbjct: 64 RLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIAS 123
Query: 250 ALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPE 309
+ YL HRD+ +N ++N + + + + DFG +K + G+ Y R + P
Sbjct: 124 GMEYL-SSKSFIHRDLAARNCMLNENMN-VCVADFGLSKKIYNGD---YYRQGRIAKMP- 177
Query: 310 LIFGATE------YTTAIDMWSIGCVLAELLL-GQPLFPG 342
+ + A E YTT D+WS G + E+ GQ +PG
Sbjct: 178 VKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPG 217
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 1e-05
Identities = 58/221 (26%), Positives = 97/221 (43%), Gaps = 29/221 (13%)
Query: 133 PKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNH 189
P++T+ + +G G FG V+ VAIK + Q E +M+ L H
Sbjct: 4 PRETLKL--VKKLGAGQFGEVWMG-YYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQH 60
Query: 190 PNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICR 249
P +V L ++ ++ +Y+ + EY+ E V T + I + QI
Sbjct: 61 PRLVRL----YAVVTQEPIYI--ITEYM-ENGSLVDFLKTPEGIKLTINKLIDMAAQIAE 113
Query: 250 ALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSR------ 303
+ ++ HRD++ N+LV+ T KI DFG A+++ E Y
Sbjct: 114 GMAFIE-RKNYIHRDLRAANILVS-ETLCCKIADFGLARLIEDNE----YTAREGAKFPI 167
Query: 304 YYRAPELI-FGATEYTTAIDMWSIGCVLAELL-LGQPLFPG 342
+ APE I +G +T D+WS G +L E++ G+ +PG
Sbjct: 168 KWTAPEAINYGT--FTIKSDVWSFGILLTEIVTYGRIPYPG 206
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 1e-05
Identities = 61/216 (28%), Positives = 96/216 (44%), Gaps = 37/216 (17%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQD--KRYKNRELQIMRLL---NHPNVVSLKHC 198
++G G+FG VF+ L+ VA+K +D + K + L R+L +HPN+V L
Sbjct: 2 LLGKGNFGEVFKGT-LKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKL--- 57
Query: 199 FFSTTEKDELYLNLVLEYISE----TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
T++ +Y +V+E + + R K + Q V + + YL
Sbjct: 58 IGVCTQRQPIY--IVMELVPGGDFLSFLRKKKDELKTKQLVK------FALDAAAGMAYL 109
Query: 255 HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRY------YRAP 308
HRD+ +N LV + LKI DFG ++ E + Y S + AP
Sbjct: 110 -ESKNCIHRDLAARNCLVG-ENNVLKISDFGMSRQ----EDDGIYSSSGLKQIPIKWTAP 163
Query: 309 E-LIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPG 342
E L +G Y++ D+WS G +L E LG +PG
Sbjct: 164 EALNYG--RYSSESDVWSYGILLWETFSLGVCPYPG 197
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 52/183 (28%), Positives = 80/183 (43%), Gaps = 17/183 (9%)
Query: 229 TRMNQHVPILYVQL--YTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286
T +N+ + Y+ L ++YQ+ + +L V HRD+ +N+L+ +KICDFG
Sbjct: 228 TLINESPALSYMDLVGFSYQVANGMEFLASKNCV-HRDLAARNVLIC-EGKLVKICDFGL 285
Query: 287 AKMLVPGEPNIS---YICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPG 342
A+ ++ IS + APE IF YTT D+WS G +L E+ LG +P
Sbjct: 286 ARDIMRDSNYISKGSTFLPLKWMAPESIFNNL-YTTLSDVWSFGILLWEIFTLGGTPYPE 344
Query: 343 ESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAL-DLVS 401
+Q IK + P + + +I W + F R L LV
Sbjct: 345 LPMNEQFYNAIK-------RGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVG 397
Query: 402 RLL 404
LL
Sbjct: 398 DLL 400
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 2e-05
Identities = 54/213 (25%), Positives = 99/213 (46%), Gaps = 27/213 (12%)
Query: 142 ERVVGTGSFGVVFQAKCLETG--DSVAIKKVLQ-----DKRYKNRELQIM-RLLNHPNVV 193
+ V+G G+FG V +A+ + G AIK++ + D R EL+++ +L +HPN++
Sbjct: 12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71
Query: 194 SLKHCFFSTTEKDELYLNL-------VLEYISET-VYRVSKHYTRMNQHVPILYVQ---L 242
+ + + LYL + +L+++ ++ V + N L Q
Sbjct: 72 ---NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 128
Query: 243 YTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG-SAKMLVPGEPNISYIC 301
+ + R ++YL + HRD+ +N+LV + KI DFG S V + + +
Sbjct: 129 FAADVARGMDYLSQKQFI-HRDLAARNILVG-ENYVAKIADFGLSRGQEVYVKKTMGRLP 186
Query: 302 SRYYRAPELIFGATEYTTAIDMWSIGCVLAELL 334
R+ L + YTT D+WS G +L E++
Sbjct: 187 VRWMAIESLNYSV--YTTNSDVWSYGVLLWEIV 217
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 2e-05
Identities = 67/288 (23%), Positives = 114/288 (39%), Gaps = 50/288 (17%)
Query: 143 RVVGTGSFGVVFQAKCLETGDS---VAIKKVLQDKRYKN------RELQIMRLLNHPNVV 193
R++G G FG V +A+ S VA+K + D + RE M+ +HPNV+
Sbjct: 5 RMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVI 64
Query: 194 SLKHCFFSTTEKDELYLNLV-LEYISETVYRVSKHYTRMNQH---VPILYVQLYTYQICR 249
L + K L + +V L ++ +R+ + +P+ + + I
Sbjct: 65 KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124
Query: 250 ALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKIC--DFGSAKMLVPGEPNISYICSRYYR- 306
+ YL HRD+ +N ++N + +C DFG +K + G+ YYR
Sbjct: 125 GMEYLSS-KNFIHRDLAARNCMLN---ENMTVCVADFGLSKKIYSGD---------YYRQ 171
Query: 307 --APELIFG--ATE------YTTAIDMWSIGCVLAELL-LGQPLFPGESGVDQLVEIIKI 355
A +L A E YTT D+W+ G + E++ GQ + G + +IK
Sbjct: 172 GCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIK- 230
Query: 356 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRL 403
G ++ C+ Y ++ W R P L +L
Sbjct: 231 -GNRLKQPPDCLEDVY------ELMCQCWSPEPKCR--PSFQHLRDQL 269
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 3e-05
Identities = 65/246 (26%), Positives = 108/246 (43%), Gaps = 38/246 (15%)
Query: 136 TISYMAERVVGTGSFGVVFQAKCL-----ETGDSVAIKKVLQDK-----RYKNRELQIMR 185
T+ +M E +G FG V++ E +VAIK L+DK R + + +MR
Sbjct: 6 TVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIK-TLKDKAEGPLREEFKHEAMMR 62
Query: 186 L-LNHPNVVSL---------KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHV 235
L HPN+V L FS +L+ LV+ V T +
Sbjct: 63 SRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLE 122
Query: 236 PILYVQLYTYQICRALNYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293
P +V + T QI + +L HHV H+D+ +N+LV + +KI D G + +
Sbjct: 123 PADFVHIVT-QIAAGMEFLSSHHV---VHKDLATRNVLVFDKLN-VKISDLGLFREVYAA 177
Query: 294 E----PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVDQ 348
+ S + R+ +++G +++ D+WS G VL E+ G + G S D
Sbjct: 178 DYYKLMGNSLLPIRWMSPEAIMYG--KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD- 234
Query: 349 LVEIIK 354
++E+I+
Sbjct: 235 VIEMIR 240
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 3e-05
Identities = 50/228 (21%), Positives = 96/228 (42%), Gaps = 42/228 (18%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIK---KVLQDKRYKNRELQ-------IMRLLNHPNV 192
+++G G FG V + + L D +K K ++ + E++ M+ +HPNV
Sbjct: 5 KILGEGEFGSVMEGQ-LSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNV 63
Query: 193 VSLKHCFFSTTEKDELYLNLV-LEYISETVYRVSKHYTRMN---QHVPILYVQLYTYQIC 248
+ L F + ++ +V L ++ Y+R+ + +P+ + + I
Sbjct: 64 MKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIA 123
Query: 249 RALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKIC--DFGSAKMLVPGEPNISYICSRYYR 306
+ YL + HRD+ +N ++ + +C DFG +K + G+ YYR
Sbjct: 124 LGMEYLSN-RNFIHRDLAARNCMLR---EDMTVCVADFGLSKKIYSGD---------YYR 170
Query: 307 APELI-----FGATE------YTTAIDMWSIGCVLAELL-LGQPLFPG 342
+ + A E YT+ D+W+ G + E+ GQ +PG
Sbjct: 171 QGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPG 218
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 4e-05
Identities = 44/150 (29%), Positives = 75/150 (50%), Gaps = 17/150 (11%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQ-DKRYKNR------ELQIMRLLNHPNVVSL 195
+ +G G+FG V A+ ++T A+K + + D +N+ E I+ ++ VV L
Sbjct: 7 KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRL 66
Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
++S +KD LY V++YI + RM P + Y ++ A+ +H
Sbjct: 67 ---YYSFQDKDNLYF--VMDYIPGG--DMMSLLIRMGI-FPEDLARFYIAELTCAVESVH 118
Query: 256 HVVGVCHRDIKPQNLLVNPHTHQLKICDFG 285
+ G HRDIKP N+L++ H +K+ DFG
Sbjct: 119 KM-GFIHRDIKPDNILIDRDGH-IKLTDFG 146
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 6e-05
Identities = 39/121 (32%), Positives = 57/121 (47%), Gaps = 29/121 (23%)
Query: 246 QICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYY 305
QI + YL + V HRD+ +N LV + +KI DFG ++ L G+ YY
Sbjct: 146 QIASGMKYLSSLNFV-HRDLATRNCLVGENLT-IKIADFGMSRNLYAGD---------YY 194
Query: 306 R------------APELIFGATEYTTAIDMWSIGCVLAELLL---GQPLFPGESGVDQLV 350
R A E I ++TTA D+W+ G L E+L+ QP GE +Q++
Sbjct: 195 RIQGRAVLPIRWMAWECIL-MGKFTTASDVWAFGVTLWEILMLCKEQPY--GELTDEQVI 251
Query: 351 E 351
E
Sbjct: 252 E 252
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 9e-05
Identities = 60/226 (26%), Positives = 101/226 (44%), Gaps = 39/226 (17%)
Query: 133 PKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNH 189
P++++ E +G G FG V+ T VAIK + +E Q+M+ L H
Sbjct: 4 PRESLRL--EVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRH 60
Query: 190 PNVVSLKHCFFSTTEKDELYLNLVLEYIS-----ETVYRVSKHYTRMNQHVPILYVQLYT 244
+V L ++ ++ +Y+ V EY+S + + Y R+ Q V
Sbjct: 61 EKLVQL----YAVVSEEPIYI--VTEYMSKGSLLDFLKGEMGKYLRLPQLVD------MA 108
Query: 245 YQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSR- 303
QI + Y+ + V HRD++ N+LV + K+ DFG A+++ E Y +
Sbjct: 109 AQIASGMAYVERMNYV-HRDLRAANILVGENL-VCKVADFGLARLIEDNE----YTARQG 162
Query: 304 -----YYRAPEL-IFGATEYTTAIDMWSIGCVLAELLL-GQPLFPG 342
+ APE ++G +T D+WS G +L EL G+ +PG
Sbjct: 163 AKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTKGRVPYPG 206
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 1e-04
Identities = 57/225 (25%), Positives = 89/225 (39%), Gaps = 54/225 (24%)
Query: 145 VGTGSFGVVFQAKC---LETGDSV-----AIKKVLQDKRYK-NRELQIMRLLNHPNVVSL 195
+G G+FG VF A+C L D + A+K+ + R RE +++ +L H ++V
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR- 71
Query: 196 KHCFFSTTEKDELYLNLVLEYISE-------TVYRVSKHYTRMNQHVPILYVQL-----Y 243
F+ + L +V EY+ + + V + L
Sbjct: 72 ---FYGVCTEGRP-LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127
Query: 244 TYQICRALNYLH--HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC 301
QI + YL H V HRD+ +N LV +KI DFG ++ + +
Sbjct: 128 ASQIASGMVYLASLHFV---HRDLATRNCLVGQGL-VVKIGDFGMSRDIYSTD------- 176
Query: 302 SRYYRA------------PELIFGATEYTTAIDMWSIGCVLAELL 334
YYR PE I ++TT D+WS G VL E+
Sbjct: 177 --YYRVGGRTMLPIRWMPPESIL-YRKFTTESDIWSFGVVLWEIF 218
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 53/201 (26%), Positives = 89/201 (44%), Gaps = 28/201 (13%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKV-------LQDKRYKNRELQIMRLLNHPNVVSLKH 197
+G G+FG VF + VA+K L+ K + E +I++ +HPN+V L
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQ--EARILKQYSHPNIVRL-- 58
Query: 198 CFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV 257
T+K +Y +V+E + + T + P L V+ + A + ++
Sbjct: 59 -IGVCTQKQPIY--IVMELVQGGDFL-----TFLRTEGPRLKVKELIQMVENAAAGMEYL 110
Query: 258 VGVC--HRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRY---YRAPE-LI 311
HRD+ +N LV + LKI DFG ++ G + + + APE L
Sbjct: 111 ESKHCIHRDLAARNCLVT-EKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALN 169
Query: 312 FGATEYTTAIDMWSIGCVLAE 332
+G Y++ D+WS G +L E
Sbjct: 170 YG--RYSSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 2e-04
Identities = 60/234 (25%), Positives = 107/234 (45%), Gaps = 47/234 (20%)
Query: 142 ERVVGTGSFGVVFQA----------KCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPN 191
E+ +G G FG V+ A K ++ G S++++ L E +M+ L H
Sbjct: 11 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLA-------EANVMKTLQHDK 62
Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRA 250
+V L + K+ +Y+ + E++++ ++ K Q +P L ++ QI
Sbjct: 63 LVKLH----AVVTKEPIYI--ITEFMAKGSLLDFLKSDEGSKQPLPKLID--FSAQIAEG 114
Query: 251 LNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSR------Y 304
+ ++ HRD++ N+LV+ KI DFG A+++ E Y
Sbjct: 115 MAFIEQR-NYIHRDLRAANILVSASL-VCKIADFGLARVIEDNE----YTAREGAKFPIK 168
Query: 305 YRAPELI-FGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVDQLVEIIKIL 356
+ APE I FG+ +T D+WS G +L E++ G+ +PG S E+I+ L
Sbjct: 169 WTAPEAINFGS--FTIKSDVWSFGILLMEIVTYGRIPYPGMSN----PEVIRAL 216
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 28/69 (40%), Positives = 37/69 (53%), Gaps = 5/69 (7%)
Query: 246 QICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG---EPNISYICS 302
Q+ L LH + G+ HRDIKP+NLLV Q+KI DFG+A + G P +
Sbjct: 317 QVLTGLRKLHRI-GIVHRDIKPENLLVTVDG-QVKIIDFGAAVDMCTGINFNPLYGMLDP 374
Query: 303 RYYRAPELI 311
RY EL+
Sbjct: 375 RYSPPEELV 383
|
Length = 507 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 3e-04
Identities = 57/217 (26%), Positives = 96/217 (44%), Gaps = 29/217 (13%)
Query: 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNHPNVVS 194
S + +G G FG V+ VA+K + E QIM+ L H +V
Sbjct: 7 SLQLIKKLGNGQFGEVWMGTWNGN-TKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQ 65
Query: 195 LKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
L ++ ++ +Y+ V EY+S+ ++ K +P L V + Q+ + Y
Sbjct: 66 L----YAVVSEEPIYI--VTEYMSKGSLLDFLKDGEGRALKLPNL-VDMAA-QVAAGMAY 117
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSR------YYRA 307
+ + HRD++ N+LV KI DFG A+++ E Y + + A
Sbjct: 118 IERM-NYIHRDLRSANILVG-DGLVCKIADFGLARLIEDNE----YTARQGAKFPIKWTA 171
Query: 308 PEL-IFGATEYTTAIDMWSIGCVLAELLL-GQPLFPG 342
PE ++G +T D+WS G +L EL+ G+ +PG
Sbjct: 172 PEAALYG--RFTIKSDVWSFGILLTELVTKGRVPYPG 206
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 4e-04
Identities = 61/237 (25%), Positives = 95/237 (40%), Gaps = 57/237 (24%)
Query: 142 ERVVGTGSFGVVFQAKCLE---TGDS--VAIKKV----LQDKRYKNRELQIMRLLNHPNV 192
+R +G G+FG VF A+C T D VA+K + L ++ RE +++ L H ++
Sbjct: 10 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 69
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYIS-------------ETVYRVSKHYTRMNQHVPILY 239
V F D L +V EY+ + + V + + +
Sbjct: 70 VK-----FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 124
Query: 240 VQLYTYQICRALNYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI 297
+ QI + YL H V HRD+ +N LV + +KI DFG ++
Sbjct: 125 MLHIASQIASGMVYLASQHFV---HRDLATRNCLVGANL-LVKIGDFGMSR--------- 171
Query: 298 SYICSRYYRA------------PELIFGATEYTTAIDMWSIGCVLAELLL--GQPLF 340
+ YYR PE I ++TT D+WS G +L E+ QP F
Sbjct: 172 DVYSTDYYRVGGHTMLPIRWMPPESIM-YRKFTTESDVWSFGVILWEIFTYGKQPWF 227
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 4e-04
Identities = 54/217 (24%), Positives = 98/217 (45%), Gaps = 35/217 (16%)
Query: 142 ERVVGTGSFGVVFQAKCLETGD--SVAIKKVLQ-----DKRYKNRELQIM-RLLNHPNVV 193
E V+G G+FG V +A + G + AIK + + D R EL+++ +L +HPN++
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 194 SLKHCFFSTTEKDELYLNL-------VLEYISET-VYRVSKHYTRMNQHVPILYVQLYTY 245
+L + + LY+ + +L+++ ++ V + + + L Q
Sbjct: 67 NL---LGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQ 123
Query: 246 QICRALNYLHHVVG--VCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSR 303
+ ++ HRD+ +N+LV + KI DFG ++ GE Y+
Sbjct: 124 FASDVATGMQYLSEKQFIHRDLAARNVLVGENLAS-KIADFGLSR----GEE--VYVKKT 176
Query: 304 YYRAPELIFGATE------YTTAIDMWSIGCVLAELL 334
R P + + A E YTT D+WS G +L E++
Sbjct: 177 MGRLP-VRWMAIESLNYSVYTTKSDVWSFGVLLWEIV 212
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 6e-04
Identities = 53/200 (26%), Positives = 90/200 (45%), Gaps = 26/200 (13%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN--RELQIMRLLNHPNVVSLKHCF 199
+ +G G FG V G+ VA+K + D + E +M L H N+V L
Sbjct: 11 LQTIGKGEFGDVMLGD--YRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 68
Query: 200 FSTTEKDELYLNLVLEYISETV---YRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH 256
EK LY+ V EY+++ Y S+ + + + + + +C A+ YL
Sbjct: 69 --VEEKGGLYI--VTEYMAKGSLVDYLRSRGRSVLGGDCLLKF----SLDVCEAMEYLEA 120
Query: 257 VVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRY---YRAPELIFG 313
V HRD+ +N+LV+ + K+ DFG K E + + + + APE +
Sbjct: 121 NNFV-HRDLAARNVLVS-EDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEAL-R 172
Query: 314 ATEYTTAIDMWSIGCVLAEL 333
+++T D+WS G +L E+
Sbjct: 173 EKKFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 56/214 (26%), Positives = 95/214 (44%), Gaps = 37/214 (17%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNHPNVVSLKHCFFS 201
+G G FG V+ T VAIK + +E QIM+ L H +V L ++
Sbjct: 14 LGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPL----YA 68
Query: 202 TTEKDELYLNLVLEYIS-----ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH 256
++ +Y+ V E++ + + Y ++ Q V + QI + Y+
Sbjct: 69 VVSEEPIYI--VTEFMGKGSLLDFLKEGDGKYLKLPQLVDM------AAQIADGMAYIER 120
Query: 257 VVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSR------YYRAPEL 310
+ HRD++ N+LV + KI DFG A+++ E Y + + APE
Sbjct: 121 M-NYIHRDLRAANILVGDNL-VCKIADFGLARLIEDNE----YTARQGAKFPIKWTAPEA 174
Query: 311 -IFGATEYTTAIDMWSIGCVLAELLL-GQPLFPG 342
++G +T D+WS G +L EL+ G+ +PG
Sbjct: 175 ALYG--RFTIKSDVWSFGILLTELVTKGRVPYPG 206
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.001
Identities = 80/331 (24%), Positives = 135/331 (40%), Gaps = 85/331 (25%)
Query: 133 PKQTISYMAERVVGTGSFGVVFQ--AKCLETGDS---VAIKKVLQDKRYKNR-----ELQ 182
++ I+ + E +G GSFG+V++ A+ + G++ VA+K V + + R E
Sbjct: 4 SREKITLLRE--LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 61
Query: 183 IMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYIS----ETVYRVSKHYTRMNQHVPIL 238
+M+ +VV L K + L +V+E ++ ++ R + N P
Sbjct: 62 VMKGFTCHHVVRL----LGVVSKGQPTL-VVMELMAHGDLKSYLRSLRPEAENNPGRPPP 116
Query: 239 YVQ---LYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEP 295
+Q +I + YL+ V HRD+ +N +V H +KI DFG + + +
Sbjct: 117 TLQEMIQMAAEIADGMAYLNAKKFV-HRDLAARNCMV-AHDFTVKIGDFGMTRDIYETD- 173
Query: 296 NISYICSRYYR------------APELIFGATEYTTAIDMWSIGCVLAEL--LLGQPLFP 341
YYR APE + +TT+ DMWS G VL E+ L QP +
Sbjct: 174 --------YYRKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQP-YQ 223
Query: 342 GESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVS 401
G S +Q+++ + M+ Y + P P DL+
Sbjct: 224 GLSN-EQVLKFV-------------MDGGYLD--------QP------DNCPERVTDLMR 255
Query: 402 RLLQYSPSLRCTALEACA------HPFFDDL 426
Q++P +R T LE HP F ++
Sbjct: 256 MCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV 286
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 53/233 (22%), Positives = 98/233 (42%), Gaps = 46/233 (19%)
Query: 133 PKQTISYMAERVVGTGSFGVVFQAKC----LETGDSVAIKKVLQDKRYKN--------RE 180
P + +M E +G +FG +++ ++ VAIK + K N +E
Sbjct: 3 PLSAVRFMEE--LGECAFGKIYKGHLYLPGMDHAQLVAIKTL---KDINNPQQWGEFQQE 57
Query: 181 LQIMRLLNHPNVVSLKHC---------FFSTTEKDELYLNLVLEYISETVYRVSKHYTRM 231
+M L+HPN+V L F + +L+ L++ V S +
Sbjct: 58 ASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTV 117
Query: 232 NQ---HVPILYVQLYTYQICRALNYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286
H L++ + QI + YL H V H+D+ +N+L+ H +KI D G
Sbjct: 118 KSSLDHGDFLHIAI---QIAAGMEYLSSHFFV---HKDLAARNILIGEQLH-VKISDLGL 170
Query: 287 AKMLVPG-----EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELL 334
++ + +P S + R+ +++G ++++ D+WS G VL E+
Sbjct: 171 SREIYSADYYRVQPK-SLLPIRWMPPEAIMYG--KFSSDSDIWSFGVVLWEIF 220
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 39.3 bits (91), Expect = 0.003
Identities = 58/230 (25%), Positives = 91/230 (39%), Gaps = 60/230 (26%)
Query: 142 ERVVGTGSFGVVFQAKCL----ETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNV 192
+R +G G+FG VF A+C E + K L+D ++ +RE +++ L H ++
Sbjct: 10 KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHI 69
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISE--------------TVYRVSKHYTRMNQHVPIL 238
V + E D L + V EY+ + + Q +
Sbjct: 70 VKF---YGVCVEGDPLIM--VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLH 124
Query: 239 YVQLYTYQICRALNYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPN 296
Q QI + YL H V HRD+ +N LV + +KI DFG ++
Sbjct: 125 IAQ----QIAAGMVYLASQHFV---HRDLATRNCLVGENL-LVKIGDFGMSR-------- 168
Query: 297 ISYICSRYYRA------------PELIFGATEYTTAIDMWSIGCVLAELL 334
+ YYR PE I ++TT D+WS+G VL E+
Sbjct: 169 -DVYSTDYYRVGGHTMLPIRWMPPESIM-YRKFTTESDVWSLGVVLWEIF 216
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.003
Identities = 64/235 (27%), Positives = 97/235 (41%), Gaps = 38/235 (16%)
Query: 145 VGTGSFGVVFQAKCLETGDSVA--IKKVLQDKRYKNRELQIM------RLLNHPNVVS-L 195
+G G FG V + G S A + K L+ + +L + R LNHPNV+ L
Sbjct: 3 IGNGWFGKVLLGE-AHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61
Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQ-----ICRA 250
C S YL LVLE+ K+Y R N+ + Q Q +
Sbjct: 62 GQCIESIP-----YL-LVLEFCP---LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASG 112
Query: 251 LNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRY---YRA 307
L +LH + H D+ +N + +KI D+G A P + I+ C + A
Sbjct: 113 LLWLHQADFI-HSDLALRNCQLTADL-SVKIGDYGLALEQYPEDYYITKDCHAVPLRWLA 170
Query: 308 PEL--IFGA----TEYTTAIDMWSIGCVLAEL--LLGQPLFPGESGVDQLVEIIK 354
PEL I G + T ++WS+G + EL QP +P S L ++++
Sbjct: 171 PELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQP-YPDLSDEQVLKQVVR 224
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 468 | |||
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.95 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.93 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.93 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.92 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.91 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.9 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.89 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.88 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.87 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.86 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.86 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.85 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.84 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.81 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.8 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.8 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.79 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.74 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.73 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.72 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.71 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.7 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.68 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.66 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.61 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.6 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.6 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.56 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.48 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.39 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.38 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.38 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.38 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.34 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.3 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.26 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.2 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.14 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.14 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.09 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.01 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.94 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.92 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.82 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.74 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.58 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.55 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.53 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.49 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.47 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.41 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.26 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.22 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.19 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.14 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.02 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.92 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.91 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.63 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.55 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.54 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.53 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.52 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.52 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.5 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.42 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.35 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.33 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.33 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.22 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.14 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.1 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.96 | |
| PLN02236 | 344 | choline kinase | 96.78 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.76 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.73 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.72 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.68 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.53 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.44 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.2 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.09 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.94 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.22 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.06 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 94.45 | |
| KOG2269 | 531 | consensus Serine/threonine protein kinase [Signal | 93.01 | |
| PTZ00296 | 442 | choline kinase; Provisional | 92.93 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 92.12 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 92.09 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 92.04 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 91.96 |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-73 Score=533.41 Aligned_cols=347 Identities=73% Similarity=1.186 Sum_probs=331.3
Q ss_pred ceeeeccCCCCCCCCcccceEEeceecccCceEEEEEEEcCCCCEEEEEEeecccchHHHHHHHHHHcCCCCccccccee
Q 012233 120 QVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCF 199 (468)
Q Consensus 120 ~~~~~~~~~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~ 199 (468)
....+...+....+.....|...+++|.|+||.||+|....+++.||||++..+.++..+|+.+|+.+.|||||+|..+|
T Consensus 7 ~~~~~~~~~~~~~~~~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~knrEl~im~~l~HpNIV~L~~~f 86 (364)
T KOG0658|consen 7 HVIQTVAEGRNDGKKVEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYKNRELQIMRKLDHPNIVRLLYFF 86 (364)
T ss_pred eEEEEEeecCCCCcceEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcCcHHHHHHHhcCCcCeeeEEEEE
Confidence 34455556666677788899999999999999999999999999999999999999999999999999999999999999
Q ss_pred eecCCCCceEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcE
Q 012233 200 FSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQL 279 (468)
Q Consensus 200 ~~~~~~~~~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~v 279 (468)
....+.+..|+.+||||++.++++.++++...+..++...++.|++||++||.|||+ .||+||||||.|+|||.+.+.+
T Consensus 87 ~~~~~~d~~~lnlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~-~~IcHRDIKPqNlLvD~~tg~L 165 (364)
T KOG0658|consen 87 SSSTESDEVYLNLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS-HGICHRDIKPQNLLVDPDTGVL 165 (364)
T ss_pred EecCCCchhHHHHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh-cCcccCCCChheEEEcCCCCeE
Confidence 888877678999999999999999999999999999999999999999999999998 9999999999999999997799
Q ss_pred EEeeecCccccCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Q 012233 280 KICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTP 359 (468)
Q Consensus 280 kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~ 359 (468)
||||||.|+.+..+++..++.+|..|+|||.+.|...|+.+.||||.||++.||+.|++.|+|.+..+++..|++.+|.|
T Consensus 166 KicDFGSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~P 245 (364)
T KOG0658|consen 166 KICDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTP 245 (364)
T ss_pred EeccCCcceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCCCCCCCCCCCC
Q 012233 360 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNTCLPNGRPL 439 (468)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~~~~~~~~~ 439 (468)
+.+.+.+|++++.++++|.++..+|.+.+...+++++.+|+.++|+++|.+|.++.|+|.||||.++++++..+++++++
T Consensus 246 t~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~~~~l~~g~~l 325 (364)
T KOG0658|consen 246 TREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDPNTKLPNGRPL 325 (364)
T ss_pred CHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCcCccCcCCCcC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CcccccCHHHHhcCCHHHHHhcccccccC
Q 012233 440 PTLFNFTAQELAGASNELRQRLIPEHARK 468 (468)
Q Consensus 440 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 468 (468)
|++|+|++. ..+...|.+..++|+|.|+
T Consensus 326 p~lf~f~~~-e~~~~~~~~~~l~p~~~~~ 353 (364)
T KOG0658|consen 326 PPLFNFKRA-ELGISPELVNVLIPEHLRE 353 (364)
T ss_pred CCccCchHH-HhccchHHHHhhccHhhhh
Confidence 999999977 7889999999999999874
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-57 Score=462.99 Aligned_cols=329 Identities=52% Similarity=0.992 Sum_probs=294.7
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeecccchHHHHHHHHHHcCCCCcccccceeeecC---CCCceEEEEE
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTT---EKDELYLNLV 213 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~---~~~~~~~~lv 213 (468)
.+|.+.+.||+|+||.||+|.+..+++.||||++........+|+.+|+.++||||++++++|+... .....++++|
T Consensus 66 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lv 145 (440)
T PTZ00036 66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVV 145 (440)
T ss_pred CeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEE
Confidence 4699999999999999999999999999999999877777778999999999999999999875432 1234578899
Q ss_pred eecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCCC
Q 012233 214 LEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293 (468)
Q Consensus 214 ~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~~ 293 (468)
|||+++++...+..+......+++..++.++.||+.||.|||+ +||+||||||+||||+.++..+||+|||+++.+...
T Consensus 146 mE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~-~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~ 224 (440)
T PTZ00036 146 MEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS-KFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAG 224 (440)
T ss_pred EecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCcCHHHEEEcCCCCceeeeccccchhccCC
Confidence 9999999888777666667789999999999999999999998 899999999999999977657999999999877655
Q ss_pred CCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCcc
Q 012233 294 EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTE 373 (468)
Q Consensus 294 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 373 (468)
......+||+.|+|||++.+...++.++|||||||++|||++|.+||.+.+..+.+.++++.++.|..+.+..+.+.+..
T Consensus 225 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~ 304 (440)
T PTZ00036 225 QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYAD 304 (440)
T ss_pred CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhc
Confidence 55566788999999999877666999999999999999999999999999999999999999999999999989999999
Q ss_pred CCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCCCCCCCC-CCCCCcccccCHHHHhc
Q 012233 374 FKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNTCLPN-GRPLPTLFNFTAQELAG 452 (468)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 452 (468)
+.++.+....+...++...++++++||.+||++||.+|||+.|+|.||||++++++...++. ...+|.+++|++.++.+
T Consensus 305 ~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (440)
T PTZ00036 305 IKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRDPCIKLPKYIDKLPDLFNFCDAEIKE 384 (440)
T ss_pred ccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhcccccCCCCCCCCCCCcCCCHHHHhh
Confidence 99998888888888888899999999999999999999999999999999999887666555 46789999999999999
Q ss_pred CCHHHHHhcccccc
Q 012233 453 ASNELRQRLIPEHA 466 (468)
Q Consensus 453 ~~~~~~~~~~~~~~ 466 (468)
+.++.+++++|.+.
T Consensus 385 ~~~~~~~~~~~~~~ 398 (440)
T PTZ00036 385 MSDACRRKIIPKCT 398 (440)
T ss_pred CCHHHHHHHhhHHH
Confidence 99999999998653
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-57 Score=415.76 Aligned_cols=282 Identities=36% Similarity=0.651 Sum_probs=250.4
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeecccc------hHHHHHHHHHHcCCCCcccccceeeecCCCCceEE
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR------YKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~~------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~ 210 (468)
+.|...-.+|+|+||.||+|+++.+|+.||||++...+. ...||+++|++|.|+|+|.|+.+| .....+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVF-----rrkrkl 76 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVF-----RRKRKL 76 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHH-----Hhccee
Confidence 358888899999999999999999999999999965543 345899999999999999999999 777789
Q ss_pred EEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcccc
Q 012233 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (468)
Q Consensus 211 ~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~ 290 (468)
++|+|||..++++.+.. ....++...++.|++|++.|+.|+|+ +++||||||||||||+.++ .+||||||+|+.+
T Consensus 77 hLVFE~~dhTvL~eLe~---~p~G~~~~~vk~~l~Q~l~ai~~cHk-~n~IHRDIKPENILit~~g-vvKLCDFGFAR~L 151 (396)
T KOG0593|consen 77 HLVFEYCDHTVLHELER---YPNGVPSELVKKYLYQLLKAIHFCHK-NNCIHRDIKPENILITQNG-VVKLCDFGFARTL 151 (396)
T ss_pred EEEeeecchHHHHHHHh---ccCCCCHHHHHHHHHHHHHHhhhhhh-cCeecccCChhheEEecCC-cEEeccchhhHhh
Confidence 99999999998886554 46789999999999999999999998 9999999999999999998 8999999999988
Q ss_pred C-CCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH--hhc
Q 012233 291 V-PGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEI--KCM 367 (468)
Q Consensus 291 ~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~--~~~ 367 (468)
. ++...+.++.|.+|+|||.+.|...|+..+||||+||++.||++|.+.|++.+..+++..|...+|.-.+... -..
T Consensus 152 ~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~ 231 (396)
T KOG0593|consen 152 SAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSS 231 (396)
T ss_pred cCCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhcc
Confidence 7 6777778899999999999999888999999999999999999999999999999999999999997666544 456
Q ss_pred CCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCC
Q 012233 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRD 428 (468)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~ 428 (468)
++.|..+.+|......-.+.-.+.++.-+.||+++||+.||.+|++-+|+|.||||.++.+
T Consensus 232 N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~~e 292 (396)
T KOG0593|consen 232 NPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGFIE 292 (396)
T ss_pred CCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHHHH
Confidence 6888899999866544333344567889999999999999999999999999999977543
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-58 Score=436.23 Aligned_cols=260 Identities=34% Similarity=0.494 Sum_probs=216.2
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-----------chHHHHHHHHHHcCCCCcccccceeeecCCC
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEK 205 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-----------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 205 (468)
+.|.+.+.||+|+||.|-+|..+.+|+.||||++.+.. ....+|++||++|+|||||+++++| .
T Consensus 172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f-----~ 246 (475)
T KOG0615|consen 172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFF-----E 246 (475)
T ss_pred ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeee-----e
Confidence 46899999999999999999999999999999985532 1235899999999999999999999 4
Q ss_pred CceEEEEEeecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCC--CcEEEe
Q 012233 206 DELYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHT--HQLKIC 282 (468)
Q Consensus 206 ~~~~~~lv~e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~--~~vkL~ 282 (468)
...+.||||||+.|| +.+.+- .++.+.+..-+.+++|++.||.|||+ +||+||||||+|||+..+. ..+||+
T Consensus 247 ~~ds~YmVlE~v~GGeLfd~vv----~nk~l~ed~~K~~f~Qll~avkYLH~-~GI~HRDiKPeNILl~~~~e~~llKIt 321 (475)
T KOG0615|consen 247 VPDSSYMVLEYVEGGELFDKVV----ANKYLREDLGKLLFKQLLTAVKYLHS-QGIIHRDIKPENILLSNDAEDCLLKIT 321 (475)
T ss_pred cCCceEEEEEEecCccHHHHHH----hccccccchhHHHHHHHHHHHHHHHH-cCcccccCCcceEEeccCCcceEEEec
Confidence 555689999999976 333332 25667777889999999999999998 8999999999999997662 259999
Q ss_pred eecCccccCCCCCCccccccCCccccccccCCC--CCCcchhHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhCCC
Q 012233 283 DFGSAKMLVPGEPNISYICSRYYRAPELIFGAT--EYTTAIDMWSIGCVLAELLLGQPLFPGESGVD-QLVEIIKILGTP 359 (468)
Q Consensus 283 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~-~~~~i~~~~~~~ 359 (468)
|||+|+....+....+.||||.|.|||++.+.. .+..++|+||+||+||-+|+|.+||....... ...+|.+.
T Consensus 322 DFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G---- 397 (475)
T KOG0615|consen 322 DFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKG---- 397 (475)
T ss_pred ccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcC----
Confidence 999999988888888999999999999996442 25568999999999999999999998876555 33444331
Q ss_pred CHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCCCC
Q 012233 360 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNT 431 (468)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~ 431 (468)
...+....|..+++++.+||.+||..||+.|||++|+|+||||+..+....
T Consensus 398 ---------------------~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~~~s~ 448 (475)
T KOG0615|consen 398 ---------------------RYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAPCLSK 448 (475)
T ss_pred ---------------------cccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcccccch
Confidence 111222356779999999999999999999999999999999998876653
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-57 Score=438.72 Aligned_cols=283 Identities=37% Similarity=0.655 Sum_probs=253.6
Q ss_pred ccceEEeceecccCceEEEEEEEcCCCCEEEEEEeecccc-----hHHHHHHHHHHcC-CCCcccccceeeecCCCCceE
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR-----YKNRELQIMRLLN-HPNVVSLKHCFFSTTEKDELY 209 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~~-----~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~~~~ 209 (468)
.++|.+.+.||.|.||.||+|+.+.+|+.||||.+++.-. ...||++-|++|+ |||||+|.+++.... ..
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~----~~ 84 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDND----RI 84 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccC----ce
Confidence 4579999999999999999999999999999998865432 2347999999999 999999999984322 17
Q ss_pred EEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccc
Q 012233 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (468)
Q Consensus 210 ~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~ 289 (468)
+|+|||||...++++++.. ++.|++..++.|++||+.||+|+|+ +|+.||||||||||+.... .|||+|||+|+.
T Consensus 85 L~fVfE~Md~NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk-~GfFHRDlKPENiLi~~~~-~iKiaDFGLARe 159 (538)
T KOG0661|consen 85 LYFVFEFMDCNLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHK-HGFFHRDLKPENILISGND-VIKIADFGLARE 159 (538)
T ss_pred EeeeHHhhhhhHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHh-cCcccccCChhheEecccc-eeEecccccccc
Confidence 9999999999999988764 6889999999999999999999998 9999999999999999665 799999999999
Q ss_pred cCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc--
Q 012233 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM-- 367 (468)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~-- 367 (468)
+....+.+.++.|.+|+|||++.....|+.++|||++|||++|+.+-++.|+|.+..|++.+|++++|+|....|...
T Consensus 160 v~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~ 239 (538)
T KOG0661|consen 160 VRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYN 239 (538)
T ss_pred cccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHH
Confidence 988888889999999999999998888999999999999999999999999999999999999999999998877542
Q ss_pred CCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCC
Q 012233 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRD 428 (468)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~ 428 (468)
-.+-..+.||..+..++...++. ++.++.+||.+||.+||.+||||.|+|+||||+.-..
T Consensus 240 La~~mnf~~P~~~~~~l~~L~p~-~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~ 299 (538)
T KOG0661|consen 240 LASAMNFRFPQVKPSPLKDLLPN-ASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRA 299 (538)
T ss_pred HHHHhccCCCcCCCCChHHhCcc-cCHHHHHHHHHHhcCCCccCccHHHHhcCcccccccc
Confidence 13335678888888888887777 9999999999999999999999999999999997443
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-55 Score=435.54 Aligned_cols=263 Identities=32% Similarity=0.531 Sum_probs=227.6
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc-------cchHHHHHHHHHHcCCCCcccccceeeecCCCCceE
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~-------~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 209 (468)
..|...++||+|||++||.+++..+|+.||+|++.+. .....+|++|.+.|+|||||+++++| +|..+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~F-----EDs~n 92 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFF-----EDSNN 92 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEe-----ecCCc
Confidence 4699999999999999999999999999999999652 23345799999999999999999999 88889
Q ss_pred EEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccc
Q 012233 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (468)
Q Consensus 210 ~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~ 289 (468)
+|||+|+|..+.+..+. +..+.+++.+++.+++||+.||.|||+ ++|||||||..|+||+.+. +|||+|||+|..
T Consensus 93 VYivLELC~~~sL~el~---Krrk~ltEpEary~l~QIv~GlkYLH~-~~IiHRDLKLGNlfL~~~~-~VKIgDFGLAt~ 167 (592)
T KOG0575|consen 93 VYIVLELCHRGSLMELL---KRRKPLTEPEARYFLRQIVEGLKYLHS-LGIIHRDLKLGNLFLNENM-NVKIGDFGLATQ 167 (592)
T ss_pred eEEEEEecCCccHHHHH---HhcCCCCcHHHHHHHHHHHHHHHHHHh-cCceecccchhheeecCcC-cEEecccceeee
Confidence 99999999966544322 235779999999999999999999998 8999999999999999998 799999999998
Q ss_pred cCC-CCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 012233 290 LVP-GEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368 (468)
Q Consensus 290 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 368 (468)
+.. ++...+.||||.|.|||++... ..+..+||||+||+||.||+|++||...+-.+.+.+|..
T Consensus 168 le~~~Erk~TlCGTPNYIAPEVl~k~-gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~-------------- 232 (592)
T KOG0575|consen 168 LEYDGERKKTLCGTPNYIAPEVLNKS-GHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKL-------------- 232 (592)
T ss_pred ecCcccccceecCCCcccChhHhccC-CCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHh--------------
Confidence 864 4788899999999999999754 589999999999999999999999999888888888876
Q ss_pred CCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCC----CCCCCCCCCCCCCC
Q 012233 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDD----LRDPNTCLPNGRPL 439 (468)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~----~~~~~~~~~~~~~~ 439 (468)
.++.+ |..++.++++||.+||+.||.+|||++++|.|+||+. -+.+..|+...+..
T Consensus 233 ---~~Y~~------------P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g~~p~~lp~~~l~~~p~~ 292 (592)
T KOG0575|consen 233 ---NEYSM------------PSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSGFTPARLPSSCLTMVPRF 292 (592)
T ss_pred ---cCccc------------ccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCCCcCCCCCccccccCCcC
Confidence 34443 4569999999999999999999999999999999954 23344444444433
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-55 Score=394.59 Aligned_cols=278 Identities=39% Similarity=0.722 Sum_probs=241.9
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc------chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 211 (468)
+|...+.||+|.||.||+|++..+|+.||||+++..+ ...-||++.|+.++|+||+.|+++| .....+.
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F-----~~~~~l~ 77 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVF-----PHKSNLS 77 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhc-----cCCCceE
Confidence 5888999999999999999999999999999996542 2345899999999999999999999 4444588
Q ss_pred EEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccC
Q 012233 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (468)
Q Consensus 212 lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~ 291 (468)
||+||++.++...++.. ...++...++.|+.++++||+|||. +.|+||||||.|+|+++++ .+||+|||+|+.+.
T Consensus 78 lVfEfm~tdLe~vIkd~---~i~l~pa~iK~y~~m~LkGl~y~H~-~~IlHRDlKPnNLLis~~g-~lKiADFGLAr~f~ 152 (318)
T KOG0659|consen 78 LVFEFMPTDLEVVIKDK---NIILSPADIKSYMLMTLKGLAYCHS-KWILHRDLKPNNLLISSDG-QLKIADFGLARFFG 152 (318)
T ss_pred EEEEeccccHHHHhccc---ccccCHHHHHHHHHHHHHHHHHHHh-hhhhcccCCccceEEcCCC-cEEeecccchhccC
Confidence 99999999888876653 4668889999999999999999998 9999999999999999999 89999999999885
Q ss_pred CCC-CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC--
Q 012233 292 PGE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN-- 368 (468)
Q Consensus 292 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-- 368 (468)
+.. .....+.|.+|+|||.++|...|+..+||||.|||+.||+.|.+-|++.+..+++..|++.+|+|.++.|..+.
T Consensus 153 ~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~l 232 (318)
T KOG0659|consen 153 SPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSL 232 (318)
T ss_pred CCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccc
Confidence 443 33344789999999999999999999999999999999999999999999999999999999999999998765
Q ss_pred CCCccCC-CCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCC
Q 012233 369 PNYTEFK-FPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDP 429 (468)
Q Consensus 369 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~ 429 (468)
|.|.+++ +|. .+... +...++.++.||+.+||.+||.+|+++.|+|.|+||+..+.+
T Consensus 233 pdY~~~~~~P~---~~~~~-lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~p 290 (318)
T KOG0659|consen 233 PDYVKIQQFPK---PPLNN-LFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLP 290 (318)
T ss_pred ccHHHHhcCCC---Ccccc-ccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCC
Confidence 6666655 332 22222 345678899999999999999999999999999999985443
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-55 Score=422.51 Aligned_cols=285 Identities=37% Similarity=0.615 Sum_probs=241.5
Q ss_pred CCCCcccceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc------chHHHHHHHHHHcCCCCcccccceeeecCC
Q 012233 131 GQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTE 204 (468)
Q Consensus 131 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 204 (468)
..+...+.|+.++.||+|.||.||+|++..+|+.||+|++..+. ...-+|+.||++|.||||++|.+.....
T Consensus 111 w~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~-- 188 (560)
T KOG0600|consen 111 WGPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSK-- 188 (560)
T ss_pred ccccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEec--
Confidence 34556678999999999999999999999999999999986543 2335899999999999999999988654
Q ss_pred CCceEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeee
Q 012233 205 KDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDF 284 (468)
Q Consensus 205 ~~~~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DF 284 (468)
....+|||+|||..+|..++.. ..-.|++.+++.|+.||+.||+|||. +||+|||||.+|||||.++ .+||+||
T Consensus 189 -~~~siYlVFeYMdhDL~GLl~~---p~vkft~~qIKc~mkQLl~Gl~~cH~-~gvlHRDIK~SNiLidn~G-~LKiaDF 262 (560)
T KOG0600|consen 189 -LSGSIYLVFEYMDHDLSGLLSS---PGVKFTEPQIKCYMKQLLEGLEYCHS-RGVLHRDIKGSNILIDNNG-VLKIADF 262 (560)
T ss_pred -CCceEEEEEecccchhhhhhcC---CCcccChHHHHHHHHHHHHHHHHHhh-cCeeeccccccceEEcCCC-CEEeccc
Confidence 3345999999999987775542 34579999999999999999999997 9999999999999999998 8999999
Q ss_pred cCccccCCCC--CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 012233 285 GSAKMLVPGE--PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTRE 362 (468)
Q Consensus 285 G~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~ 362 (468)
|+|+++.... ..+..+.|.+|+|||++.|...|+.++|+||.||||.||++|++.|++.+..+++.+|++.+|.|.+.
T Consensus 263 GLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~ 342 (560)
T KOG0600|consen 263 GLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTED 342 (560)
T ss_pred cceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChh
Confidence 9999775544 45677889999999999999999999999999999999999999999999999999999999999998
Q ss_pred HHhhcC-CCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCC
Q 012233 363 EIKCMN-PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFD 424 (468)
Q Consensus 363 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~ 424 (468)
.|.... |.+..++-...-.....+. ...++..+.+|+..||.+||.+|.||.++|.|+||.
T Consensus 343 ~W~~~kLP~~~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~ 404 (560)
T KOG0600|consen 343 YWPVSKLPHATIFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFT 404 (560)
T ss_pred ccccccCCcccccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhcCcccc
Confidence 876211 2223322222112222232 467899999999999999999999999999999994
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-55 Score=402.82 Aligned_cols=286 Identities=34% Similarity=0.587 Sum_probs=250.7
Q ss_pred ccceEEeceecccCceEEEEEEEcCCCCEEEEEEeecccc------hHHHHHHHHHHcCCCCcccccceeeecCCCCceE
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR------YKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~~------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 209 (468)
...|+....|++|+||.||+|+++.+++.||+|+++.+.. ...+|+.+|.+++|||||.+..+..... .+ -
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~-~d--~ 151 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSN-MD--K 151 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccc-cc--e
Confidence 3469999999999999999999999999999999865432 2258999999999999999988875543 33 3
Q ss_pred EEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccc
Q 012233 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (468)
Q Consensus 210 ~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~ 289 (468)
+|||||||..++..++.. +.+.|...+++.++.|+++||+|||. +.|+||||||+|+|++..| .+||+|||+|+.
T Consensus 152 iy~VMe~~EhDLksl~d~---m~q~F~~~evK~L~~QlL~glk~lH~-~wilHRDLK~SNLLm~~~G-~lKiaDFGLAR~ 226 (419)
T KOG0663|consen 152 IYIVMEYVEHDLKSLMET---MKQPFLPGEVKTLMLQLLRGLKHLHD-NWILHRDLKTSNLLLSHKG-ILKIADFGLARE 226 (419)
T ss_pred eeeeHHHHHhhHHHHHHh---ccCCCchHHHHHHHHHHHHHHHHHhh-ceeEecccchhheeeccCC-cEEecccchhhh
Confidence 889999999988876654 35789999999999999999999998 8999999999999999888 799999999998
Q ss_pred cCCC-CCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 012233 290 LVPG-EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368 (468)
Q Consensus 290 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 368 (468)
+... .+.+..+.|.+|+|||++.+...|+.++|+||+|||+.||+++.+.|++.+..+++.+|++.+|+|++..|....
T Consensus 227 ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~ 306 (419)
T KOG0663|consen 227 YGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYS 306 (419)
T ss_pred hcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcc
Confidence 8544 345567889999999999999999999999999999999999999999999999999999999999999887644
Q ss_pred --CCCccCCCCcccCCCcccccccC-CCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCC
Q 012233 369 --PNYTEFKFPQIKAHPWHKIFHKR-MPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDP 429 (468)
Q Consensus 369 --~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~ 429 (468)
+....+.|+..+...+...|... +++...+|+..+|.+||.+|+||.|+|.|+||.+.+.+
T Consensus 307 ~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p 370 (419)
T KOG0663|consen 307 ELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLP 370 (419)
T ss_pred ccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCC
Confidence 44445777777777777777665 78999999999999999999999999999999995543
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-54 Score=406.33 Aligned_cols=312 Identities=39% Similarity=0.670 Sum_probs=259.5
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc------cchHHHHHHHHHHcCCCCcccccceeeecCCCCceEEE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~------~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 211 (468)
.|...+.||.|+||.|+.|.++.+|+.||||++... .....+|+++|+.++|+||+.+.+.+.......-.-+|
T Consensus 23 ~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvY 102 (359)
T KOG0660|consen 23 YYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVY 102 (359)
T ss_pred eecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeE
Confidence 366678999999999999999999999999988522 23335799999999999999999998663433444589
Q ss_pred EEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccC
Q 012233 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (468)
Q Consensus 212 lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~ 291 (468)
+|+|+|+.++..+++. ++.+....++.+++||++||+|+|+ .+|+||||||.|+|++.+. .+||||||+|+...
T Consensus 103 iV~elMetDL~~iik~----~~~L~d~H~q~f~YQiLrgLKyiHS-AnViHRDLKPsNll~n~~c-~lKI~DFGLAR~~~ 176 (359)
T KOG0660|consen 103 LVFELMETDLHQIIKS----QQDLTDDHAQYFLYQILRGLKYIHS-ANVIHRDLKPSNLLLNADC-DLKICDFGLARYLD 176 (359)
T ss_pred EehhHHhhHHHHHHHc----CccccHHHHHHHHHHHHHhcchhhc-ccccccccchhheeeccCC-CEEeccccceeecc
Confidence 9999998887776654 4558899999999999999999998 8999999999999999887 79999999999875
Q ss_pred C---CCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 012233 292 P---GEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368 (468)
Q Consensus 292 ~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 368 (468)
. ....+.++.|.+|+|||++.....|+.++||||+|||+.||++|++.|+|.+..+++..|...+|+|..+.+.+..
T Consensus 177 ~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~ 256 (359)
T KOG0660|consen 177 KFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIR 256 (359)
T ss_pred ccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhc
Confidence 3 3445677889999999999888889999999999999999999999999999999999999999999988877654
Q ss_pred CCC---ccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCCCCCCCCCCCCCccccc
Q 012233 369 PNY---TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNTCLPNGRPLPTLFNF 445 (468)
Q Consensus 369 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~ 445 (468)
... --...|..+..+|...|+ .+++.+.||+.+||..||.+|+|++|+|.||||..+.+++.- |..++.+.. |
T Consensus 257 s~~ar~yi~slp~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dE-P~~~~~~~~--~ 332 (359)
T KOG0660|consen 257 SEKARPYIKSLPQIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDE-PVCQPIFDS--F 332 (359)
T ss_pred cHHHHHHHHhCCCCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccC-CCCCCCCcc--c
Confidence 111 123456677778877776 899999999999999999999999999999999999887765 333333333 2
Q ss_pred CHHHHhcCCHHHHHhccc
Q 012233 446 TAQELAGASNELRQRLIP 463 (468)
Q Consensus 446 ~~~~~~~~~~~~~~~~~~ 463 (468)
. .. ...|.++.+|+
T Consensus 333 ~---~~-~~~~~~r~~i~ 346 (359)
T KOG0660|consen 333 E---HE-LTEEELRELIY 346 (359)
T ss_pred c---cc-ccHHHHHHHHH
Confidence 2 22 55566665554
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-54 Score=406.14 Aligned_cols=259 Identities=31% Similarity=0.515 Sum_probs=215.7
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc-----cchHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~-----~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~l 212 (468)
+.+....||+|..|+||+++++.+++.+|+|++... .+...+|+++++.++||+||++|++|+.... .++|
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~----~isI 155 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE----EISI 155 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc----eEEe
Confidence 466778899999999999999999999999999432 2344689999999999999999999976442 4889
Q ss_pred EeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCC
Q 012233 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (468)
Q Consensus 213 v~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~ 292 (468)
+||||++|.|+.+... .+.+++..+..++.+|++||.|||+.++||||||||+||||+..+ +|||||||.++.+..
T Consensus 156 ~mEYMDgGSLd~~~k~---~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskG-eVKicDFGVS~~lvn 231 (364)
T KOG0581|consen 156 CMEYMDGGSLDDILKR---VGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKG-EVKICDFGVSGILVN 231 (364)
T ss_pred ehhhcCCCCHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCC-CEEeccccccHHhhh
Confidence 9999998877654432 367999999999999999999999558999999999999999998 899999999998866
Q ss_pred CCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC--CcHHHHHHHHHHhCCCCHHHHhhcCCC
Q 012233 293 GEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGE--SGVDQLVEIIKILGTPTREEIKCMNPN 370 (468)
Q Consensus 293 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~--~~~~~~~~i~~~~~~~~~~~~~~~~~~ 370 (468)
. ...+++||..|||||.+.+.. |+.++||||||+.++|+.+|+.||... .....+..+..++..|++
T Consensus 232 S-~a~tfvGT~~YMsPERi~g~~-Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP--------- 300 (364)
T KOG0581|consen 232 S-IANTFVGTSAYMSPERISGES-YSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPP--------- 300 (364)
T ss_pred h-hcccccccccccChhhhcCCc-CCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCC---------
Confidence 6 567899999999999998765 999999999999999999999999874 222223322232222221
Q ss_pred CccCCCCcccCCCcccccccC-CCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCCCC
Q 012233 371 YTEFKFPQIKAHPWHKIFHKR-MPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNT 431 (468)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~ 431 (468)
. ++.. +|+++++||..||++||.+|+++.|+++|||+++...++.
T Consensus 301 -------~---------lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~~~v 346 (364)
T KOG0581|consen 301 -------R---------LPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFEDPNV 346 (364)
T ss_pred -------C---------CCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcccccc
Confidence 1 2333 7999999999999999999999999999999998766544
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-54 Score=402.92 Aligned_cols=255 Identities=33% Similarity=0.524 Sum_probs=219.5
Q ss_pred CcccceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-------chHHHHHHHHHHcCCCCcccccceeeecCCCC
Q 012233 134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD 206 (468)
Q Consensus 134 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 206 (468)
....+|++.++||+|+||+||+++.+.+++.||+|++.+.. .....|..||..++||+||+++..| ++
T Consensus 22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysF-----Qt 96 (357)
T KOG0598|consen 22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSF-----QT 96 (357)
T ss_pred CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEec-----cc
Confidence 34457999999999999999999999999999999986543 3445799999999999999999888 66
Q ss_pred ceEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecC
Q 012233 207 ELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (468)
Q Consensus 207 ~~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~ 286 (468)
...+|+|+||+.||-|.. +. ...+.|++..++.|+..|+.||.|||+ +|||||||||+|||||.+|| ++|+|||+
T Consensus 97 ~~kLylVld~~~GGeLf~--hL-~~eg~F~E~~arfYlaEi~lAL~~LH~-~gIiyRDlKPENILLd~~GH-i~LtDFgL 171 (357)
T KOG0598|consen 97 EEKLYLVLDYLNGGELFY--HL-QREGRFSEDRARFYLAEIVLALGYLHS-KGIIYRDLKPENILLDEQGH-IKLTDFGL 171 (357)
T ss_pred CCeEEEEEeccCCccHHH--HH-HhcCCcchhHHHHHHHHHHHHHHHHHh-CCeeeccCCHHHeeecCCCc-EEEecccc
Confidence 777999999999874432 22 225779999999999999999999998 99999999999999999995 99999999
Q ss_pred cccc-CCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 012233 287 AKML-VPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIK 365 (468)
Q Consensus 287 a~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 365 (468)
++.. ..+....++|||+.|||||++.+.+ |+.++|+||||+++|||++|.+||.+.+....+.+|.+.-
T Consensus 172 ~k~~~~~~~~t~tfcGT~eYmAPEil~~~g-y~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k--------- 241 (357)
T KOG0598|consen 172 CKEDLKDGDATRTFCGTPEYMAPEILLGKG-YDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK--------- 241 (357)
T ss_pred chhcccCCCccccccCCccccChHHHhcCC-CCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc---------
Confidence 9855 3445666789999999999998765 9999999999999999999999999999888888887621
Q ss_pred hcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCC----CHHHHhCCCCCCCCC
Q 012233 366 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC----TALEACAHPFFDDLR 427 (468)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~----s~~ell~hp~f~~~~ 427 (468)
. ...+.-++.++++||+++|..||++|. .+.++.+||||+++.
T Consensus 242 --------~-----------~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~in 288 (357)
T KOG0598|consen 242 --------L-----------PLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGIN 288 (357)
T ss_pred --------C-----------CCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCC
Confidence 0 012234899999999999999999996 688999999999864
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-53 Score=416.41 Aligned_cols=256 Identities=34% Similarity=0.600 Sum_probs=225.0
Q ss_pred CcccceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc-------cchHHHHHHHHHHc-CCCCcccccceeeecCCC
Q 012233 134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLL-NHPNVVSLKHCFFSTTEK 205 (468)
Q Consensus 134 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~-------~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~ 205 (468)
+...+|..++.||.|+|++|++|+++.+++.||||++.+. ..+..+|..+|.+| .||.|++|+..| +
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TF-----Q 144 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTF-----Q 144 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEe-----e
Confidence 3445799999999999999999999999999999988443 34566899999999 799999999988 7
Q ss_pred CceEEEEEeeccc-chHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeee
Q 012233 206 DELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDF 284 (468)
Q Consensus 206 ~~~~~~lv~e~~~-~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DF 284 (468)
|...+|+|+||++ |+++.++.++ +.|++..++.|+.||+.||+|||+ +|||||||||||||||.++ .+||+||
T Consensus 145 D~~sLYFvLe~A~nGdll~~i~K~----Gsfde~caR~YAAeIldAleylH~-~GIIHRDlKPENILLd~dm-hikITDF 218 (604)
T KOG0592|consen 145 DEESLYFVLEYAPNGDLLDLIKKY----GSFDETCARFYAAEILDALEYLHS-NGIIHRDLKPENILLDKDG-HIKITDF 218 (604)
T ss_pred cccceEEEEEecCCCcHHHHHHHh----CcchHHHHHHHHHHHHHHHHHHHh-cCceeccCChhheeEcCCC-cEEEeec
Confidence 7778999999998 5677766654 668999999999999999999998 9999999999999999999 5999999
Q ss_pred cCccccCCCCCC--------------ccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Q 012233 285 GSAKMLVPGEPN--------------ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLV 350 (468)
Q Consensus 285 G~a~~~~~~~~~--------------~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~ 350 (468)
|.|+.+.+.... .+++||..|++||++.... .++.+|+|+||||||+|+.|.+||.+.+..-.+.
T Consensus 219 GsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~-~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFq 297 (604)
T KOG0592|consen 219 GSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSP-AGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQ 297 (604)
T ss_pred cccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCC-CCcccchHHHHHHHHHHhcCCCCCccccHHHHHH
Confidence 999887543211 4589999999999997654 8999999999999999999999999999888888
Q ss_pred HHHHHhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCCC
Q 012233 351 EIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPN 430 (468)
Q Consensus 351 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~ 430 (468)
+|+.+ ++. |++..++.+.|||+++|..||.+|+|+.||.+||||.+|.-.+
T Consensus 298 kI~~l-----------------~y~------------fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~n 348 (604)
T KOG0592|consen 298 KIQAL-----------------DYE------------FPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWEN 348 (604)
T ss_pred HHHHh-----------------ccc------------CCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhh
Confidence 88873 333 4467899999999999999999999999999999999987766
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-53 Score=387.67 Aligned_cols=252 Identities=30% Similarity=0.507 Sum_probs=222.0
Q ss_pred CcccceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-------chHHHHHHHHHHcCCCCcccccceeeecCCCC
Q 012233 134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD 206 (468)
Q Consensus 134 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 206 (468)
....+|...+.||.|+||+|.+++.+.+|..+|+|++.+.. ....+|..+|+.+.||+++++++.| .+
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~-----~d 115 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTF-----KD 115 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEee-----cc
Confidence 44557999999999999999999999999999999986543 2335799999999999999999988 77
Q ss_pred ceEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecC
Q 012233 207 ELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (468)
Q Consensus 207 ~~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~ 286 (468)
..++||||||++||-+- .+.+..++|++..++.|+.||+.||+|||+ ++|++|||||||||+|.+| .+||+|||+
T Consensus 116 ~~~lymvmeyv~GGElF---S~Lrk~~rF~e~~arFYAAeivlAleylH~-~~iiYRDLKPENiLlD~~G-~iKitDFGF 190 (355)
T KOG0616|consen 116 NSNLYMVMEYVPGGELF---SYLRKSGRFSEPHARFYAAEIVLALEYLHS-LDIIYRDLKPENLLLDQNG-HIKITDFGF 190 (355)
T ss_pred CCeEEEEEeccCCccHH---HHHHhcCCCCchhHHHHHHHHHHHHHHHHh-cCeeeccCChHHeeeccCC-cEEEEeccc
Confidence 88899999999987443 233446789999999999999999999998 8999999999999999999 599999999
Q ss_pred ccccCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 012233 287 AKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKC 366 (468)
Q Consensus 287 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 366 (468)
|+.+... ..+.||||.|+|||++...+ |+.++|+|||||++|||+.|.+||...+....+.+|++
T Consensus 191 AK~v~~r--T~TlCGTPeYLAPEii~sk~-ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~------------ 255 (355)
T KOG0616|consen 191 AKRVSGR--TWTLCGTPEYLAPEIIQSKG-YNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILE------------ 255 (355)
T ss_pred eEEecCc--EEEecCCccccChHHhhcCC-CCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHh------------
Confidence 9987543 67899999999999997655 99999999999999999999999999999999999988
Q ss_pred cCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCC-----CHHHHhCCCCCCCCC
Q 012233 367 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC-----TALEACAHPFFDDLR 427 (468)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~-----s~~ell~hp~f~~~~ 427 (468)
..+.|| ..+++++++||+++|+.|-.+|. ...++.+||||+++.
T Consensus 256 -----~~v~fP------------~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~ 304 (355)
T KOG0616|consen 256 -----GKVKFP------------SYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVD 304 (355)
T ss_pred -----CcccCC------------cccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCccccccc
Confidence 344444 45899999999999999999994 577899999999853
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-52 Score=407.42 Aligned_cols=272 Identities=30% Similarity=0.488 Sum_probs=226.4
Q ss_pred cccceEEeceecccCceEEEEEEEcCCCCEEEEEEeecccch-------HHHHHHHHHHcCCCCcccccceeeecCCCCc
Q 012233 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRY-------KNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (468)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~~~-------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 207 (468)
..++|.++.+||+|+||.||+|+-+.||..||+|++.+.... ...|..||....+|+||+||-.| ++.
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsF-----QD~ 213 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSF-----QDK 213 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEe-----cCC
Confidence 456899999999999999999999999999999999776543 34588899999999999999988 888
Q ss_pred eEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCc
Q 012233 208 LYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (468)
Q Consensus 208 ~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a 287 (468)
.++||||||++||-..-+ ......+++..++.|+.+++.|++.||+ .|||||||||+|+|||..|| +||+|||++
T Consensus 214 ~~LYLiMEylPGGD~mTL---L~~~~~L~e~~arfYiaE~vlAI~~iH~-~gyIHRDIKPdNlLiD~~GH-iKLSDFGLs 288 (550)
T KOG0605|consen 214 EYLYLIMEYLPGGDMMTL---LMRKDTLTEDWARFYIAETVLAIESIHQ-LGYIHRDIKPDNLLIDAKGH-IKLSDFGLS 288 (550)
T ss_pred CeeEEEEEecCCccHHHH---HHhcCcCchHHHHHHHHHHHHHHHHHHH-cCcccccCChhheeecCCCC-Eeecccccc
Confidence 899999999997644322 2235779999999999999999999998 89999999999999999996 999999998
Q ss_pred cccCC-----------------------CCC-------------------------CccccccCCccccccccCCCCCCc
Q 012233 288 KMLVP-----------------------GEP-------------------------NISYICSRYYRAPELIFGATEYTT 319 (468)
Q Consensus 288 ~~~~~-----------------------~~~-------------------------~~~~~gt~~y~aPE~~~~~~~~~~ 319 (468)
+-+.. +.. ....+|||.|||||++.+.. |+.
T Consensus 289 ~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kg-Y~~ 367 (550)
T KOG0605|consen 289 TGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKG-YGK 367 (550)
T ss_pred chhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCC-CCc
Confidence 43211 000 02468999999999998876 999
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHH
Q 012233 320 AIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDL 399 (468)
Q Consensus 320 ~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 399 (468)
.+|+||||||+||||.|.+||.+.++.+.+.+|+... ..+.||. ...++++++||
T Consensus 368 ~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr---------------~~l~fP~----------~~~~s~eA~DL 422 (550)
T KOG0605|consen 368 ECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWR---------------ETLKFPE----------EVDLSDEAKDL 422 (550)
T ss_pred cccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh---------------hhccCCC----------cCcccHHHHHH
Confidence 9999999999999999999999999999999988731 1233332 13477999999
Q ss_pred HHHhcccCCCCCCC---HHHHhCCCCCCCCCCCCCCCCCCCCCCccc
Q 012233 400 VSRLLQYSPSLRCT---ALEACAHPFFDDLRDPNTCLPNGRPLPTLF 443 (468)
Q Consensus 400 i~~~L~~dP~~R~s---~~ell~hp~f~~~~~~~~~~~~~~~~~~~~ 443 (468)
|.+||. ||.+|+. ++||..||||+.|.=....-...+=+|.+.
T Consensus 423 I~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W~~l~~~~apfvP~v~ 468 (550)
T KOG0605|consen 423 ITRLLC-DPENRLGSKGAEEIKKHPFFKGVDWDHLREMPAPFVPQVN 468 (550)
T ss_pred HHHHhc-CHHHhcCcccHHHHhcCCccccCCcchhhcCCCCCCCCCC
Confidence 999999 9999984 899999999999876666555544466653
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-51 Score=385.90 Aligned_cols=293 Identities=34% Similarity=0.686 Sum_probs=245.5
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeecccc------hHHHHHHHHHHcCCCC-cccccceeeecCC-CCce
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR------YKNRELQIMRLLNHPN-VVSLKHCFFSTTE-KDEL 208 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~~------~~~~E~~il~~l~hpn-Iv~l~~~~~~~~~-~~~~ 208 (468)
..|...+.||+|+||+||+|+.+.+|+.||+|++..+.. ...+|+.+|+.|+|+| ||+|++++..... ....
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 358888889999999999999999999999999865433 2368999999999999 9999999865442 2233
Q ss_pred EEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcc
Q 012233 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (468)
Q Consensus 209 ~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~ 288 (468)
.+++||||+.-++...+.......+.++...++.+++||+.||+|||+ +||+||||||+||||++++ .+||+|||+|+
T Consensus 91 ~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~-~~IlHRDLKPQNlLi~~~G-~lKlaDFGlAr 168 (323)
T KOG0594|consen 91 KLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS-HGILHRDLKPQNLLISSSG-VLKLADFGLAR 168 (323)
T ss_pred eEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh-CCeecccCCcceEEECCCC-cEeeeccchHH
Confidence 688999999988887766655433578888999999999999999998 9999999999999999988 89999999998
Q ss_pred ccC-CCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 012233 289 MLV-PGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367 (468)
Q Consensus 289 ~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 367 (468)
... +.......++|.+|+|||++.+...|+..+||||+|||++||+++++.|++.+..+++..|++.+|+|....|...
T Consensus 169 a~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v 248 (323)
T KOG0594|consen 169 AFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGV 248 (323)
T ss_pred HhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCc
Confidence 775 4445667889999999999999988999999999999999999999999999999999999999999999888754
Q ss_pred C--CCCccCCCCccc-CCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCCCCCC
Q 012233 368 N--PNYTEFKFPQIK-AHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNTCL 433 (468)
Q Consensus 368 ~--~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~~~ 433 (468)
. +.|.. .|+... ...+.... +..+++..+++.+||+++|.+|.|+..+|.||||.++.......
T Consensus 249 ~~~~~~k~-~f~~~~~~~~l~~~~-~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~~~~~ 315 (323)
T KOG0594|consen 249 SSLPDYKA-PFPKWPGPKDLSSIL-PKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEKSSQL 315 (323)
T ss_pred cccccccc-cCcCCCCccchHHhc-cccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccchhhh
Confidence 3 33332 333333 22333322 34457999999999999999999999999999999987765543
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-51 Score=408.39 Aligned_cols=280 Identities=37% Similarity=0.624 Sum_probs=231.5
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeecccchHH---HHHHHHHHcC-C-----CCcccccceeeecCCCCce
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLN-H-----PNVVSLKHCFFSTTEKDEL 208 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~~~~~---~E~~il~~l~-h-----pnIv~l~~~~~~~~~~~~~ 208 (468)
+|.+.++||+|+||+|.+|.+..+++.||||+++....+.. .|+.||..|+ | -|||+++++| ....
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F-----~fr~ 261 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYF-----YFRN 261 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecc-----cccc
Confidence 68999999999999999999999999999999988877665 5889999987 3 4899999999 4455
Q ss_pred EEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeec-CCCCcEEEeeecCc
Q 012233 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVN-PHTHQLKICDFGSA 287 (468)
Q Consensus 209 ~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~-~~~~~vkL~DFG~a 287 (468)
++|||+|.++..|+++++... ..++++..++.++.||+.||.+||+ .||||+|||||||||. .....|||+|||.|
T Consensus 262 HlciVfELL~~NLYellK~n~--f~Glsl~~ir~~~~Qil~~L~~L~~-l~IIHcDLKPENILL~~~~r~~vKVIDFGSS 338 (586)
T KOG0667|consen 262 HLCIVFELLSTNLYELLKNNK--FRGLSLPLVRKFAQQILTALLFLHE-LGIIHCDLKPENILLKDPKRSRIKVIDFGSS 338 (586)
T ss_pred ceeeeehhhhhhHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCChhheeeccCCcCceeEEecccc
Confidence 699999999999999887643 4569999999999999999999998 8999999999999984 33447999999999
Q ss_pred cccCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 012233 288 KMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367 (468)
Q Consensus 288 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 367 (468)
+.... ...+++.+..|+|||++.|.+ |+.+.||||||||++||++|.+.|++.+..+++..|++.+|.|+...+...
T Consensus 339 c~~~q--~vytYiQSRfYRAPEVILGlp-Y~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~ 415 (586)
T KOG0667|consen 339 CFESQ--RVYTYIQSRFYRAPEVILGLP-YDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTA 415 (586)
T ss_pred cccCC--cceeeeeccccccchhhccCC-CCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 87543 334889999999999999876 999999999999999999999999999999999999999999998776543
Q ss_pred CCCCccCCC----Cc-----------------------------c-cCCCcccccccCCCHHHHHHHHHhcccCCCCCCC
Q 012233 368 NPNYTEFKF----PQ-----------------------------I-KAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCT 413 (468)
Q Consensus 368 ~~~~~~~~~----~~-----------------------------~-~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s 413 (468)
.....-+.- +. . ....|...+...-...+.|||++||.+||.+|+|
T Consensus 416 ~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~t 495 (586)
T KOG0667|consen 416 KKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERIT 495 (586)
T ss_pred cccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCC
Confidence 322111111 00 0 1111222222233356899999999999999999
Q ss_pred HHHHhCCCCCCCCCC
Q 012233 414 ALEACAHPFFDDLRD 428 (468)
Q Consensus 414 ~~ell~hp~f~~~~~ 428 (468)
+.++|+||||.....
T Consensus 496 p~qal~Hpfl~~~~~ 510 (586)
T KOG0667|consen 496 PAQALNHPFLTGTSL 510 (586)
T ss_pred HHHHhcCcccccccc
Confidence 999999999996443
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-51 Score=389.47 Aligned_cols=256 Identities=33% Similarity=0.544 Sum_probs=218.3
Q ss_pred ccceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc------chHHHHHHHHHHcCCCCcccccceeeecCCCCceE
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 209 (468)
..+|.+.+.||.|+||+||+|+.+.++..||||.+.+.. ..+..|+.||+.++|||||+|++++ ....+
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~-----~~~~~ 83 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCI-----EDDDF 83 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEE-----ecCCe
Confidence 446999999999999999999999999999999986552 3345799999999999999999999 55557
Q ss_pred EEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCC-C----CcEEEeee
Q 012233 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPH-T----HQLKICDF 284 (468)
Q Consensus 210 ~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~-~----~~vkL~DF 284 (468)
+|||||||.||.|.. +.+..+.+++..++.++.||+.||++||+ ++||||||||+||||+.. + -.+||+||
T Consensus 84 i~lVMEyC~gGDLs~---yi~~~~~l~e~t~r~Fm~QLA~alq~L~~-~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADF 159 (429)
T KOG0595|consen 84 IYLVMEYCNGGDLSD---YIRRRGRLPEATARHFMQQLASALQFLHE-NNIIHRDLKPQNILLSTTARNDTSPVLKIADF 159 (429)
T ss_pred EEEEEEeCCCCCHHH---HHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCCcceEEeccCCCCCCCceEEeccc
Confidence 999999999775542 33345689999999999999999999998 999999999999999764 2 25899999
Q ss_pred cCccccCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 012233 285 GSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEI 364 (468)
Q Consensus 285 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 364 (468)
|+|+.+.++....+.||+|.|||||++.. ..|+.|+|+||+|+|+|+|++|++||...+..+.+..+.+.-.
T Consensus 160 GfAR~L~~~~~a~tlcGSplYMAPEV~~~-~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~------- 231 (429)
T KOG0595|consen 160 GFARFLQPGSMAETLCGSPLYMAPEVIMS-QQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNE------- 231 (429)
T ss_pred chhhhCCchhHHHHhhCCccccCHHHHHh-ccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcccc-------
Confidence 99999998888889999999999999964 4599999999999999999999999999988887775443211
Q ss_pred hhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q 012233 365 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (468)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~ 427 (468)
....++..++..+.+|+..+|+.+|..|.+..+-+.|+++..-.
T Consensus 232 -------------------~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 232 -------------------IVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred -------------------ccCchhhhccCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 11123445777888999999999999999999999999997633
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-51 Score=386.08 Aligned_cols=276 Identities=27% Similarity=0.424 Sum_probs=232.5
Q ss_pred cccceEEeceecccCceEEEEEEEcCCCCEEEEEEeecccch-------HHHHHHHHHHcCCCCcccccceeeecCCCCc
Q 012233 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRY-------KNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (468)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~~~-------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 207 (468)
....|++.+.||.|..|+||+|....++..+|+|++.+.... ...|.+||+.++||.++.||..| +..
T Consensus 75 ~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~f-----et~ 149 (459)
T KOG0610|consen 75 GLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASF-----ETD 149 (459)
T ss_pred CHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhee-----ecc
Confidence 344699999999999999999999999999999999654322 23599999999999999999999 777
Q ss_pred eEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCc
Q 012233 208 LYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (468)
Q Consensus 208 ~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a 287 (468)
.+.|+|||||+||.+..+++ ....+.|++..++.|+..++.||+|||. .|||+||||||||||..+|| |.|+||.++
T Consensus 150 ~~~cl~meyCpGGdL~~Lrq-kQp~~~fse~~aRFYaAEvl~ALEYLHm-lGivYRDLKPENILvredGH-IMLsDFDLS 226 (459)
T KOG0610|consen 150 KYSCLVMEYCPGGDLHSLRQ-KQPGKRFSESAARFYAAEVLLALEYLHM-LGIVYRDLKPENILVREDGH-IMLSDFDLS 226 (459)
T ss_pred ceeEEEEecCCCccHHHHHh-hCCCCccchhhHHHHHHHHHHHHHHHHh-hceeeccCCcceeEEecCCc-EEeeecccc
Confidence 78999999999887766654 4457789999999999999999999996 89999999999999999996 999999987
Q ss_pred cccCC-----------------------------------C----------------------CCCccccccCCcccccc
Q 012233 288 KMLVP-----------------------------------G----------------------EPNISYICSRYYRAPEL 310 (468)
Q Consensus 288 ~~~~~-----------------------------------~----------------------~~~~~~~gt~~y~aPE~ 310 (468)
..... . .....++||-.|+|||+
T Consensus 227 ~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEv 306 (459)
T KOG0610|consen 227 LRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEV 306 (459)
T ss_pred ccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccccccccee
Confidence 32200 0 01135788999999999
Q ss_pred ccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccCCCCcccCCCccccccc
Q 012233 311 IFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHK 390 (468)
Q Consensus 311 ~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (468)
+.|.. .+.++|+|+|||++||||.|.+||.+.+..+.+.+|+. .+..||.. +
T Consensus 307 I~G~G-HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~-----------------~~l~Fp~~----------~ 358 (459)
T KOG0610|consen 307 IRGEG-HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVG-----------------QPLKFPEE----------P 358 (459)
T ss_pred eecCC-CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhc-----------------CCCcCCCC----------C
Confidence 98876 89999999999999999999999999999999999887 45566653 2
Q ss_pred CCCHHHHHHHHHhcccCCCCCCC----HHHHhCCCCCCCCCCCCCCCCCCCCCCcccccC
Q 012233 391 RMPPEALDLVSRLLQYSPSLRCT----ALEACAHPFFDDLRDPNTCLPNGRPLPTLFNFT 446 (468)
Q Consensus 391 ~~~~~l~~li~~~L~~dP~~R~s----~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~~ 446 (468)
.++..++|||+++|.+||.+|+. |.||.+||||+.|.=.-..-...+-+|......
T Consensus 359 ~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWaLir~~~PP~iP~~~d~~ 418 (459)
T KOG0610|consen 359 EVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWALIRCARPPEIPKPVDGG 418 (459)
T ss_pred cchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCChhheeccCCCcCCCccccC
Confidence 47889999999999999999998 999999999999866544444444466666554
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-51 Score=408.45 Aligned_cols=260 Identities=32% Similarity=0.492 Sum_probs=229.6
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc-------cchHHHHHHHHHHcCCCCcccccceeeecCCCCceEE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~-------~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~ 210 (468)
-|++++.||.|+.|.|.+|++..||+.+|||++.+. ....++|+-||+.+.||||++||+++ ++..++
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVw-----e~~~~l 87 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVW-----ENKQHL 87 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeee-----ccCceE
Confidence 499999999999999999999999999999999776 45567899999999999999999999 666779
Q ss_pred EEEeecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccc
Q 012233 211 NLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (468)
Q Consensus 211 ~lv~e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~ 289 (468)
|+|.||++|| ++++ ...++.+++.++++++.||+.|+.|+|. .+|+||||||+|+|||.+. +|||+|||+|..
T Consensus 88 ylvlEyv~gGELFdy----lv~kG~l~e~eaa~ff~QIi~gv~yCH~-~~icHRDLKpENlLLd~~~-nIKIADFGMAsL 161 (786)
T KOG0588|consen 88 YLVLEYVPGGELFDY----LVRKGPLPEREAAHFFRQILDGVSYCHA-FNICHRDLKPENLLLDVKN-NIKIADFGMASL 161 (786)
T ss_pred EEEEEecCCchhHHH----HHhhCCCCCHHHHHHHHHHHHHHHHHhh-hcceeccCCchhhhhhccc-CEeeeccceeec
Confidence 9999999966 3333 3336889999999999999999999997 8999999999999999888 599999999998
Q ss_pred cCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 012233 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (468)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 369 (468)
-.++.-..+.||+|.|.|||++.|.+..+.++||||+|||||.||+|+.||.+.+....+.++.+
T Consensus 162 e~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~--------------- 226 (786)
T KOG0588|consen 162 EVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQR--------------- 226 (786)
T ss_pred ccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHc---------------
Confidence 88888888999999999999999999889999999999999999999999998877777777765
Q ss_pred CCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCCCCCCCCCC
Q 012233 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNTCLPNGR 437 (468)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~~~~~~~ 437 (468)
..|. ++..++.++++||.+||..||++|+|.+|++.|||+............+.
T Consensus 227 --G~f~------------MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~~~~~~~~ 280 (786)
T KOG0588|consen 227 --GVFE------------MPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLPSSKSLRP 280 (786)
T ss_pred --Cccc------------CCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCCChhhhcCC
Confidence 2333 33569999999999999999999999999999999998776555543333
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-50 Score=400.24 Aligned_cols=250 Identities=34% Similarity=0.517 Sum_probs=216.3
Q ss_pred ccceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc---------cchHHHHHHHHHHcC-CCCcccccceeeecCCC
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---------KRYKNRELQIMRLLN-HPNVVSLKHCFFSTTEK 205 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~---------~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~ 205 (468)
...|.+++.||+|+||+|+.|.+..+|..||+|++.+. .....+|+.+++.+. ||||++++.++..
T Consensus 16 ~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t---- 91 (370)
T KOG0583|consen 16 IGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFAT---- 91 (370)
T ss_pred cCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEec----
Confidence 44699999999999999999999999999999976443 223457999999999 9999999999944
Q ss_pred CceEEEEEeecccc-hHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCC-CCcEEEee
Q 012233 206 DELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPH-THQLKICD 283 (468)
Q Consensus 206 ~~~~~~lv~e~~~~-~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~-~~~vkL~D 283 (468)
...+|+|||||.| .+++.+.. ...+.+..++.++.||+.|++|||+ +||+||||||+|||++.+ + ++||+|
T Consensus 92 -~~~~~ivmEy~~gGdL~~~i~~----~g~l~E~~ar~~F~Qlisav~y~H~-~gi~HRDLK~ENilld~~~~-~~Kl~D 164 (370)
T KOG0583|consen 92 -PTKIYIVMEYCSGGDLFDYIVN----KGRLKEDEARKYFRQLISAVAYCHS-RGIVHRDLKPENILLDGNEG-NLKLSD 164 (370)
T ss_pred -CCeEEEEEEecCCccHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHh-CCEeeCCCCHHHEEecCCCC-CEEEec
Confidence 3349999999997 55554433 5778889999999999999999998 999999999999999988 6 899999
Q ss_pred ecCcccc-CCCCCCccccccCCccccccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 012233 284 FGSAKML-VPGEPNISYICSRYYRAPELIFGAT-EYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTR 361 (468)
Q Consensus 284 FG~a~~~-~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~ 361 (468)
||++... ..+....+.+||+.|+|||++.+.. .-+.++||||+||+||.|++|+.||...+....+.+|.+
T Consensus 165 FG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~------- 237 (370)
T KOG0583|consen 165 FGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRK------- 237 (370)
T ss_pred cccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhc-------
Confidence 9999887 4666778899999999999998766 446899999999999999999999999877777777655
Q ss_pred HHHhhcCCCCccCCCCcccCCCcccccccCC-CHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q 012233 362 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRM-PPEALDLVSRLLQYSPSLRCTALEACAHPFFDD 425 (468)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~ 425 (468)
..+.+| ..+ ++++++||.+||..||.+|+|+.+++.||||+.
T Consensus 238 ----------~~~~~p------------~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 238 ----------GEFKIP------------SYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred ----------CCccCC------------CCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 334433 346 999999999999999999999999999999997
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-51 Score=407.72 Aligned_cols=254 Identities=30% Similarity=0.517 Sum_probs=221.8
Q ss_pred CCcccceEEeceecccCceEEEEEEEcCCCCEEEEEEeecccc-------hHHHHHHHHHHcC-CCCcccccceeeecCC
Q 012233 133 PKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR-------YKNRELQIMRLLN-HPNVVSLKHCFFSTTE 204 (468)
Q Consensus 133 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~~-------~~~~E~~il~~l~-hpnIv~l~~~~~~~~~ 204 (468)
+....+|++.++||+|+||+|+++..+.+++.||||+++++.. ....|..|+.... ||.++.|+.+|
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~f----- 438 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCF----- 438 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccc-----
Confidence 4455689999999999999999999999999999999877542 3346888888776 99999999999
Q ss_pred CCceEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeee
Q 012233 205 KDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDF 284 (468)
Q Consensus 205 ~~~~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DF 284 (468)
+...++|+||||+.||.+. + ......|++..++.|+..|+.||.|||+ +||||||||.+|||||.+|+ +||+||
T Consensus 439 QT~~~l~fvmey~~Ggdm~---~-~~~~~~F~e~rarfyaAev~l~L~fLH~-~~IIYRDlKLdNiLLD~eGh-~kiADF 512 (694)
T KOG0694|consen 439 QTKEHLFFVMEYVAGGDLM---H-HIHTDVFSEPRARFYAAEVVLGLQFLHE-NGIIYRDLKLDNLLLDTEGH-VKIADF 512 (694)
T ss_pred ccCCeEEEEEEecCCCcEE---E-EEecccccHHHHHHHHHHHHHHHHHHHh-cCceeeecchhheEEcccCc-EEeccc
Confidence 6667799999999988522 2 2235779999999999999999999998 99999999999999999995 999999
Q ss_pred cCccccC-CCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 012233 285 GSAKMLV-PGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREE 363 (468)
Q Consensus 285 G~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~ 363 (468)
|+++... .+....++||||.|||||++.+.. |+.++|+|||||+|||||.|+.||++++..+....|+.
T Consensus 513 GlcKe~m~~g~~TsTfCGTpey~aPEil~e~~-Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~--------- 582 (694)
T KOG0694|consen 513 GLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQS-YTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVN--------- 582 (694)
T ss_pred ccccccCCCCCccccccCChhhcChhhhccCc-ccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc---------
Confidence 9998765 555677899999999999998765 99999999999999999999999999998888888876
Q ss_pred HhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCC-----HHHHhCCCCCCCCC
Q 012233 364 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCT-----ALEACAHPFFDDLR 427 (468)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s-----~~ell~hp~f~~~~ 427 (468)
.+.. ++..++.++.++++++|.+||++|.. +++|..||||+.|.
T Consensus 583 --------d~~~------------yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~ 631 (694)
T KOG0694|consen 583 --------DEVR------------YPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSID 631 (694)
T ss_pred --------CCCC------------CCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCC
Confidence 2333 34569999999999999999999985 58899999999976
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-51 Score=366.41 Aligned_cols=255 Identities=30% Similarity=0.441 Sum_probs=218.4
Q ss_pred cccceEEeceecccCceEEEEEEEcCCCCEEEEEEeec------ccchHHHHHHHHHHcCCCCcccccceeeecCCCCce
Q 012233 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ------DKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (468)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~------~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 208 (468)
..+.|.+.++||+|.|+.||++....+|+.+|+|++.. +...+++|+.|-+.|+|||||+|.+.+ ....
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti-----~~~~ 83 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEES 83 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhh-----cccc
Confidence 34569999999999999999999999999999997732 334567899999999999999999988 6777
Q ss_pred EEEEEeecccchHH-HHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCC--CCcEEEeeec
Q 012233 209 YLNLVLEYISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPH--THQLKICDFG 285 (468)
Q Consensus 209 ~~~lv~e~~~~~ll-~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~--~~~vkL~DFG 285 (468)
+.|||+|++.|+-+ ..+-.. ..+++..+-.++.||+.||.|+|. +||||||+||+|+|+-+. +.-+||+|||
T Consensus 84 ~~ylvFe~m~G~dl~~eIV~R----~~ySEa~aSH~~rQiLeal~yCH~-n~IvHRDvkP~nllLASK~~~A~vKL~~FG 158 (355)
T KOG0033|consen 84 FHYLVFDLVTGGELFEDIVAR----EFYSEADASHCIQQILEALAYCHS-NGIVHRDLKPENLLLASKAKGAAVKLADFG 158 (355)
T ss_pred eeEEEEecccchHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHh-cCceeccCChhheeeeeccCCCceeecccc
Confidence 89999999997633 222211 335777788999999999999997 999999999999999433 3369999999
Q ss_pred CccccCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 012233 286 SAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIK 365 (468)
Q Consensus 286 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 365 (468)
+|..+..+....+++|||.|||||++...+ |+..+|||+.|||||-||.|++||.+.+..+.+..|++.
T Consensus 159 vAi~l~~g~~~~G~~GtP~fmaPEvvrkdp-y~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g---------- 227 (355)
T KOG0033|consen 159 LAIEVNDGEAWHGFAGTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAG---------- 227 (355)
T ss_pred eEEEeCCccccccccCCCcccCHHHhhcCC-CCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhcc----------
Confidence 999988777777889999999999997655 999999999999999999999999999999999988873
Q ss_pred hcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q 012233 366 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDD 425 (468)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~ 425 (468)
.+.++. ..|+.+++++++||++||..||.+|+|+.|+|+|||+.+
T Consensus 228 -------~yd~~~--------~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~ 272 (355)
T KOG0033|consen 228 -------AYDYPS--------PEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICN 272 (355)
T ss_pred -------ccCCCC--------cccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcc
Confidence 333332 245779999999999999999999999999999999976
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-52 Score=373.63 Aligned_cols=254 Identities=30% Similarity=0.521 Sum_probs=211.7
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc------cchHHHHHHHHHHcCCCCcccccceeeecCCCCceEE
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~------~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~ 210 (468)
..|+++++||.|+||.||++.+..+|..||.|.+.-+ +...-.|+.+|++|+|||||+++++-+. ++..-+
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~---~~~evl 95 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFI---EDNEVL 95 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhh---ccchhh
Confidence 3699999999999999999999999999999988532 2334469999999999999999984332 233348
Q ss_pred EEEeeccc-chHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHh--cC-CccccCCCCCCeeecCCCCcEEEeeecC
Q 012233 211 NLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH--VV-GVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (468)
Q Consensus 211 ~lv~e~~~-~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~--~~-givHrDlkp~NILl~~~~~~vkL~DFG~ 286 (468)
+||||||. |++-..++++....+.+++..+|+++.|+|.||..+|+ .+ -|+||||||.||+|+.+| .+||+|||+
T Consensus 96 nivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~g-vvKLGDfGL 174 (375)
T KOG0591|consen 96 NIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANG-VVKLGDFGL 174 (375)
T ss_pred HHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCC-ceeeccchh
Confidence 89999998 67778899999999999999999999999999999996 22 288999999999999998 899999999
Q ss_pred ccccCCCCC-CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 012233 287 AKMLVPGEP-NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIK 365 (468)
Q Consensus 287 a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 365 (468)
++.+..... ..+.+|||+||+||.+.+.+ |+.++||||+||++|||+.-++||.+.+-.+...+|.++ ..|+
T Consensus 175 ~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~-Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qg-d~~~----- 247 (375)
T KOG0591|consen 175 GRFLSSKTTFAHSLVGTPYYMSPERIHESG-YNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQG-DYPP----- 247 (375)
T ss_pred HhHhcchhHHHHhhcCCCcccCHHHHhcCC-CCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcC-CCCC-----
Confidence 998855442 34689999999999998765 999999999999999999999999999666666666553 1111
Q ss_pred hcCCCCccCCCCcccCCCcccccc-cCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCC
Q 012233 366 CMNPNYTEFKFPQIKAHPWHKIFH-KRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRD 428 (468)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~ 428 (468)
+| ..+|.++..||..|+..||..||+. +|++.++..
T Consensus 248 ----------------------~p~~~YS~~l~~li~~ci~vd~~~RP~t-----~~~v~di~~ 284 (375)
T KOG0591|consen 248 ----------------------LPDEHYSTDLRELINMCIAVDPEQRPDT-----VPYVQDIQS 284 (375)
T ss_pred ----------------------CcHHHhhhHHHHHHHHHccCCcccCCCc-----chHHHHHHH
Confidence 11 4478999999999999999999986 555555443
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-50 Score=385.02 Aligned_cols=259 Identities=30% Similarity=0.455 Sum_probs=218.7
Q ss_pred CCCcccceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc------------------chHHHHHHHHHHcCCCCcc
Q 012233 132 QPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------------------RYKNRELQIMRLLNHPNVV 193 (468)
Q Consensus 132 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~------------------~~~~~E~~il~~l~hpnIv 193 (468)
..++.++|.+++.||+|.||.|-+|++..+++.||||++.+.+ ....+|+.||++|.|||||
T Consensus 92 ~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV 171 (576)
T KOG0585|consen 92 DRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVV 171 (576)
T ss_pred cceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCee
Confidence 3456678999999999999999999999999999999985432 1335799999999999999
Q ss_pred cccceeeecCCCCceEEEEEeecccchHHHHHhhhhhcCCC-CCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeee
Q 012233 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQH-VPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLV 272 (468)
Q Consensus 194 ~l~~~~~~~~~~~~~~~~lv~e~~~~~ll~~~~~~~~~~~~-~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl 272 (468)
+|+.+..... ...+|||+|||..|-+. +...... +.+.+++.|+++++.||+|||. +|||||||||.|+||
T Consensus 172 ~LiEvLDDP~---s~~~YlVley~s~G~v~----w~p~d~~els~~~Ar~ylrDvv~GLEYLH~-QgiiHRDIKPsNLLl 243 (576)
T KOG0585|consen 172 KLIEVLDDPE---SDKLYLVLEYCSKGEVK----WCPPDKPELSEQQARKYLRDVVLGLEYLHY-QGIIHRDIKPSNLLL 243 (576)
T ss_pred EEEEeecCcc---cCceEEEEEeccCCccc----cCCCCcccccHHHHHHHHHHHHHHHHHHHh-cCeeccccchhheEE
Confidence 9999884433 34699999999977443 2333444 8999999999999999999997 999999999999999
Q ss_pred cCCCCcEEEeeecCccccCCCC------CCccccccCCccccccccCC---CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 012233 273 NPHTHQLKICDFGSAKMLVPGE------PNISYICSRYYRAPELIFGA---TEYTTAIDMWSIGCVLAELLLGQPLFPGE 343 (468)
Q Consensus 273 ~~~~~~vkL~DFG~a~~~~~~~------~~~~~~gt~~y~aPE~~~~~---~~~~~~~DvwSlG~il~ell~G~~pf~~~ 343 (468)
+.++ .|||+|||.+.....+. .....+|||.|+|||.+.+. ...+.+.||||+||+||.|+.|+.||-+.
T Consensus 244 ~~~g-~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~ 322 (576)
T KOG0585|consen 244 SSDG-TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDD 322 (576)
T ss_pred cCCC-cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccc
Confidence 9998 79999999997663221 22347899999999999763 33577999999999999999999999999
Q ss_pred CcHHHHHHHHHHhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 012233 344 SGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (468)
Q Consensus 344 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f 423 (468)
...+.+.+|++ ..+.||.. +.+.++++|||++||.+||.+|+++.++..|||.
T Consensus 323 ~~~~l~~KIvn-----------------~pL~fP~~----------pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwv 375 (576)
T KOG0585|consen 323 FELELFDKIVN-----------------DPLEFPEN----------PEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWV 375 (576)
T ss_pred hHHHHHHHHhc-----------------CcccCCCc----------ccccHHHHHHHHHHhhcChhheeehhhheeccee
Confidence 99999999887 45556542 2478899999999999999999999999999999
Q ss_pred CCC
Q 012233 424 DDL 426 (468)
Q Consensus 424 ~~~ 426 (468)
..-
T Consensus 376 t~~ 378 (576)
T KOG0585|consen 376 TRD 378 (576)
T ss_pred ccC
Confidence 763
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-48 Score=379.11 Aligned_cols=277 Identities=32% Similarity=0.630 Sum_probs=229.2
Q ss_pred ccceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-----chHHHHHHHHHHcCCCCcccccceeeecCCCCceEE
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~ 210 (468)
..+|.+.+.||.|+||.||+|.+..++..||+|++.... ....+|+.+++.++||||+++++++ ....+.
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~ 78 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII-----HTERCL 78 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEE-----cCCCeE
Confidence 346999999999999999999999999999999885321 2345799999999999999999988 445568
Q ss_pred EEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcccc
Q 012233 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (468)
Q Consensus 211 ~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~ 290 (468)
++||||+.+++...+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++..
T Consensus 79 ~lv~e~~~~~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~dlkp~Nil~~~~~-~~kl~DfG~~~~~ 153 (288)
T cd07871 79 TLVFEYLDSDLKQYLDN---CGNLMSMHNVKIFMFQLLRGLSYCHK-RKILHRDLKPQNLLINEKG-ELKLADFGLARAK 153 (288)
T ss_pred EEEEeCCCcCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEECCCC-CEEECcCcceeec
Confidence 99999999877765432 23457888999999999999999998 8999999999999999888 7999999998764
Q ss_pred CCCC-CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC-
Q 012233 291 VPGE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN- 368 (468)
Q Consensus 291 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~- 368 (468)
.... ......+++.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+...++.|..+.+....
T Consensus 154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07871 154 SVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITS 233 (288)
T ss_pred cCCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhcccc
Confidence 3222 23345789999999998766668999999999999999999999999999889999999999998888776533
Q ss_pred -CCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 012233 369 -PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (468)
Q Consensus 369 -~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f 423 (468)
..+....++.....++.. ....+++++++||.+||++||.+|||++|+|+||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 234 NEEFRSYLFPQYRAQPLIN-HAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred chhhhccccCccCCCchHH-hCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 233334444433333332 234678999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-49 Score=378.87 Aligned_cols=257 Identities=32% Similarity=0.507 Sum_probs=207.8
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc----cchHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEEE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV 213 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~----~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv 213 (468)
+|...+.||+|+||.||++.+..+|..+|||.+... ...+.+|+.+|++++|||||++++....... ..++|.
T Consensus 18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~---~~~~i~ 94 (313)
T KOG0198|consen 18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSREN---DEYNIF 94 (313)
T ss_pred hhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccC---eeeEee
Confidence 588889999999999999999999999999988665 3446889999999999999999986432221 468899
Q ss_pred eecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecC-CCCcEEEeeecCccccCC
Q 012233 214 LEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNP-HTHQLKICDFGSAKMLVP 292 (468)
Q Consensus 214 ~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~-~~~~vkL~DFG~a~~~~~ 292 (468)
|||+++|.+..+.. +....+++..++.++.||+.||+|||+ +|||||||||+||||+. ++ .+||+|||+++....
T Consensus 95 mEy~~~GsL~~~~~--~~g~~l~E~~v~~ytr~iL~GL~ylHs-~g~vH~DiK~~NiLl~~~~~-~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 95 MEYAPGGSLSDLIK--RYGGKLPEPLVRRYTRQILEGLAYLHS-KGIVHCDIKPANILLDPSNG-DVKLADFGLAKKLES 170 (313)
T ss_pred eeccCCCcHHHHHH--HcCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeccCcccceEEEeCCCC-eEEeccCcccccccc
Confidence 99999875553322 222269999999999999999999997 99999999999999998 56 799999999987653
Q ss_pred ----CCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC-CcHHHHHHHHHHhCCCCHHHHhhc
Q 012233 293 ----GEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGE-SGVDQLVEIIKILGTPTREEIKCM 367 (468)
Q Consensus 293 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~ 367 (468)
........||+.|||||++........++|||||||++.||+||.+||... ...+.+..+.. ..
T Consensus 171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~---~~-------- 239 (313)
T KOG0198|consen 171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGR---ED-------- 239 (313)
T ss_pred ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhc---cC--------
Confidence 223446789999999999975322345999999999999999999999873 33333333322 10
Q ss_pred CCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCC
Q 012233 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRD 428 (468)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~ 428 (468)
..| .++..+++++++||.+||.+||.+||||+++|.|||.+.-..
T Consensus 240 -------~~P---------~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 240 -------SLP---------EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred -------CCC---------CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 111 255679999999999999999999999999999999987544
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-49 Score=350.78 Aligned_cols=252 Identities=31% Similarity=0.456 Sum_probs=220.3
Q ss_pred cccceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc-------cchHHHHHHHHHHcCCCCcccccceeeecCCCCc
Q 012233 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (468)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~-------~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 207 (468)
..++|.+++.||+|-||.||+|+.+.++..||+|++.+. ...+.+|++|...|+||||+++|++| .+.
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~f-----hd~ 94 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYF-----HDS 94 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhhe-----ecc
Confidence 345799999999999999999999999999999998654 34556899999999999999999999 677
Q ss_pred eEEEEEeecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecC
Q 012233 208 LYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (468)
Q Consensus 208 ~~~~lv~e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~ 286 (468)
..+||++||.+.+ ++..+.. .....+.+..++.|+.|++.||.|+|. ++||||||||+|+|++..+ .+||+|||.
T Consensus 95 ~riyLilEya~~gel~k~L~~--~~~~~f~e~~~a~Yi~q~A~Al~y~h~-k~VIhRdiKpenlLlg~~~-~lkiAdfGw 170 (281)
T KOG0580|consen 95 KRIYLILEYAPRGELYKDLQE--GRMKRFDEQRAATYIKQLANALLYCHL-KRVIHRDIKPENLLLGSAG-ELKIADFGW 170 (281)
T ss_pred ceeEEEEEecCCchHHHHHHh--cccccccccchhHHHHHHHHHHHHhcc-CCcccCCCCHHHhccCCCC-CeeccCCCc
Confidence 7799999999855 4443331 235668899999999999999999997 9999999999999999988 799999999
Q ss_pred ccccCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 012233 287 AKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKC 366 (468)
Q Consensus 287 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 366 (468)
+...+ .....+.|||..|.+||.+.+.. ++..+|+|++|++.||++.|.+||...+..+.+.+|.+
T Consensus 171 sV~~p-~~kR~tlcgt~dyl~pEmv~~~~-hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k------------ 236 (281)
T KOG0580|consen 171 SVHAP-SNKRKTLCGTLDYLPPEMVEGRG-HDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRK------------ 236 (281)
T ss_pred eeecC-CCCceeeecccccCCHhhcCCCC-ccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHH------------
Confidence 96544 56677899999999999997665 89999999999999999999999999998888888877
Q ss_pred cCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q 012233 367 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426 (468)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 426 (468)
.++.+ +..++.++.|||.+||.++|.+|++..|++.|||+...
T Consensus 237 -----~~~~~------------p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a~ 279 (281)
T KOG0580|consen 237 -----VDLKF------------PSTISGGAADLISRLLVKNPIERLALTEVMDHPWIVAN 279 (281)
T ss_pred -----ccccC------------CcccChhHHHHHHHHhccCccccccHHHHhhhHHHHhc
Confidence 23333 35699999999999999999999999999999998753
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-49 Score=386.96 Aligned_cols=248 Identities=32% Similarity=0.535 Sum_probs=215.4
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeecccc------hHHHHHHHHHHcCCCCcccccceeeecCCCCceEE
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR------YKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~~------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~ 210 (468)
.+|.+.+.||+|+||.||+|+.+.+.+.||||.+.+..+ ...+|++|++.|+|||||.++++| +....+
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esf-----Et~~~~ 76 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESF-----ETSAHL 76 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhh-----cccceE
Confidence 369999999999999999999999999999999865432 246899999999999999999999 555669
Q ss_pred EEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcccc
Q 012233 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (468)
Q Consensus 211 ~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~ 290 (468)
|+|+|||.|++..++.. +..+++..++.+++|++.||.|||+ .+|+|||+||.|||++..+ .+|+||||+|+..
T Consensus 77 ~vVte~a~g~L~~il~~----d~~lpEe~v~~~a~~LVsaL~yLhs-~rilhrd~kPqniLl~~~~-~~KlcdFg~Ar~m 150 (808)
T KOG0597|consen 77 WVVTEYAVGDLFTILEQ----DGKLPEEQVRAIAYDLVSALYYLHS-NRILHRDMKPQNILLEKGG-TLKLCDFGLARAM 150 (808)
T ss_pred EEEehhhhhhHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHh-cCcccccCCcceeeecCCC-ceeechhhhhhhc
Confidence 99999999988776554 6889999999999999999999998 8999999999999999888 7999999999987
Q ss_pred CCCC-CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 012233 291 VPGE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (468)
Q Consensus 291 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 369 (468)
..+. ......|||.|||||++.+.+ |+..+|+||+|||+|||.+|++||...+-.+.+..|..
T Consensus 151 ~~~t~vltsikGtPlYmAPElv~e~p-yd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~--------------- 214 (808)
T KOG0597|consen 151 STNTSVLTSIKGTPLYMAPELVEEQP-YDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILK--------------- 214 (808)
T ss_pred ccCceeeeeccCcccccCHHHHcCCC-ccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhc---------------
Confidence 5543 334567999999999998655 99999999999999999999999987766555555544
Q ss_pred CCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q 012233 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDD 425 (468)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~ 425 (468)
.+.. ++..++..+.+|++.+|.+||.+|+|-.+++.|||.+.
T Consensus 215 --d~v~------------~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~ 256 (808)
T KOG0597|consen 215 --DPVK------------PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKG 256 (808)
T ss_pred --CCCC------------CcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhh
Confidence 1222 22468999999999999999999999999999999986
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=375.30 Aligned_cols=281 Identities=31% Similarity=0.552 Sum_probs=219.2
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-----chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEE
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 211 (468)
++|.+.+.||+|+||.||+|.+..+++.||||++.... ....+|+.+++.++||||+++++++ .+..+.|
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~~ 79 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII-----HTKETLT 79 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEE-----ecCCeEE
Confidence 46999999999999999999999999999999985432 2345799999999999999999988 4445689
Q ss_pred EEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccC
Q 012233 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (468)
Q Consensus 212 lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~ 291 (468)
+||||+.++++..+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++....
T Consensus 80 lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~ 154 (303)
T cd07869 80 LVFEYVHTDLCQYMDK---HPGGLHPENVKLFLFQLLRGLSYIHQ-RYILHRDLKPQNLLISDTG-ELKLADFGLARAKS 154 (303)
T ss_pred EEEECCCcCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECCCC-CEEECCCCcceecc
Confidence 9999999988775543 23568889999999999999999998 8999999999999999887 79999999987543
Q ss_pred CC-CCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHHHhCCCCHHHHhhcC-
Q 012233 292 PG-EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESG-VDQLVEIIKILGTPTREEIKCMN- 368 (468)
Q Consensus 292 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~- 368 (468)
.. .......+++.|+|||++.+...++.++|||||||++|+|++|..||.+... .+.+..+...++.+....+....
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (303)
T cd07869 155 VPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHS 234 (303)
T ss_pred CCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhh
Confidence 22 2233467899999999987666689999999999999999999999987644 45566676766766655443221
Q ss_pred -CCCccCCCCcccCCCcccccc-cCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q 012233 369 -PNYTEFKFPQIKAHPWHKIFH-KRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (468)
Q Consensus 369 -~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~ 427 (468)
+.+....+.......+...+. ...++++.+||.+||++||.+|||+.|+|+||||+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~ 295 (303)
T cd07869 235 LPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP 295 (303)
T ss_pred ccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence 111111111111111111111 13567899999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=380.94 Aligned_cols=297 Identities=39% Similarity=0.669 Sum_probs=231.3
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc------cchHHHHHHHHHHcCCCCcccccceeeecCCCCceEEE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~------~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 211 (468)
+|.+.+.||+|+||.||+|.+..+|..||||++... .....+|+.+++.++||||+++++++..........+|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 499999999999999999999999999999988532 12345799999999999999999988655444445689
Q ss_pred EEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccC
Q 012233 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (468)
Q Consensus 212 lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~ 291 (468)
+|||||++++...+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++...
T Consensus 81 lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIll~~~~-~~kL~Dfg~~~~~~ 154 (338)
T cd07859 81 VVFELMESDLHQVIKA----NDDLTPEHHQFFLYQLLRALKYIHT-ANVFHRDLKPKNILANADC-KLKICDFGLARVAF 154 (338)
T ss_pred EEEecCCCCHHHHHHh----cccCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECCCC-cEEEccCccccccc
Confidence 9999999887765542 4568999999999999999999998 8999999999999999888 79999999997543
Q ss_pred CCCC----CccccccCCccccccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 012233 292 PGEP----NISYICSRYYRAPELIFGA-TEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKC 366 (468)
Q Consensus 292 ~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 366 (468)
.... .....||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+....+..+...++.+....+..
T Consensus 155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (338)
T cd07859 155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR 234 (338)
T ss_pred cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 2211 1345789999999998542 4589999999999999999999999999888888888888888777665433
Q ss_pred cCCCCccC---CCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCCCCCCCCCCCCCcc
Q 012233 367 MNPNYTEF---KFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNTCLPNGRPLPTL 442 (468)
Q Consensus 367 ~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~~~~~~~~~~~~ 442 (468)
....-... ........++... .+.+++++.+||.+||+.||.+|||+.++++||||+.+...... +..++++.+
T Consensus 235 i~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~~~~~-~~~~~~~~~ 311 (338)
T cd07859 235 VRNEKARRYLSSMRKKQPVPFSQK-FPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVERE-PSAQPITKL 311 (338)
T ss_pred hhhhhHHHHHHhhcccCCCchHHh-cCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCccccc-cccCccccc
Confidence 22110000 0000000111111 23478899999999999999999999999999999998775544 455565554
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-48 Score=385.14 Aligned_cols=250 Identities=28% Similarity=0.469 Sum_probs=216.3
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc----cchHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEEE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV 213 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~----~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv 213 (468)
.|.....||+|+.|.||.|+...+++.||||++... +....+|+.+|+..+|+|||.+++.|+..++ +++|
T Consensus 274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~de-----LWVV 348 (550)
T KOG0578|consen 274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDE-----LWVV 348 (550)
T ss_pred hhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccce-----eEEE
Confidence 588889999999999999999999999999998543 3455689999999999999999999976543 8999
Q ss_pred eecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCCC
Q 012233 214 LEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293 (468)
Q Consensus 214 ~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~~ 293 (468)
|||+.|+.|..+.. ...+++.++..++++++.||+|||. +||+|||||.+|||++.++ .+||+|||++..+...
T Consensus 349 MEym~ggsLTDvVt----~~~~~E~qIA~Icre~l~aL~fLH~-~gIiHrDIKSDnILL~~~g-~vKltDFGFcaqi~~~ 422 (550)
T KOG0578|consen 349 MEYMEGGSLTDVVT----KTRMTEGQIAAICREILQGLKFLHA-RGIIHRDIKSDNILLTMDG-SVKLTDFGFCAQISEE 422 (550)
T ss_pred EeecCCCchhhhhh----cccccHHHHHHHHHHHHHHHHHHHh-cceeeeccccceeEeccCC-cEEEeeeeeeeccccc
Confidence 99999877665443 3448899999999999999999997 9999999999999999998 7999999999888665
Q ss_pred C-CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCc
Q 012233 294 E-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYT 372 (468)
Q Consensus 294 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 372 (468)
. ...+.+|||+|||||++... .|++++||||||++++||+-|.+||-.+++...+..|.... .|
T Consensus 423 ~~KR~TmVGTPYWMAPEVvtrk-~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng-~P------------- 487 (550)
T KOG0578|consen 423 QSKRSTMVGTPYWMAPEVVTRK-PYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG-TP------------- 487 (550)
T ss_pred cCccccccCCCCccchhhhhhc-ccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcC-CC-------------
Confidence 5 56688999999999999655 49999999999999999999999999988877777765531 11
Q ss_pred cCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q 012233 373 EFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDD 425 (468)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~ 425 (468)
+++ .+..+|+.++||+.+||+.|+.+|++|.|||.||||+.
T Consensus 488 ~lk------------~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~ 528 (550)
T KOG0578|consen 488 KLK------------NPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKM 528 (550)
T ss_pred CcC------------CccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhh
Confidence 111 34569999999999999999999999999999999943
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-47 Score=378.58 Aligned_cols=257 Identities=34% Similarity=0.564 Sum_probs=220.2
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeecccc-------hHHHHHHHHHHcC-CCCcccccceeeecCCCCce
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR-------YKNRELQIMRLLN-HPNVVSLKHCFFSTTEKDEL 208 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~~-------~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~~~ 208 (468)
..|.+.+.||.|.||.||+|..+.+|+.+|+|.+.+... ...+|+.||+.+. |||||.+++.| ++..
T Consensus 35 ~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~-----e~~~ 109 (382)
T KOG0032|consen 35 EKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAF-----EDPD 109 (382)
T ss_pred ccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEE-----EcCC
Confidence 469999999999999999999999999999999965533 5678999999999 99999999999 5555
Q ss_pred EEEEEeecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCC---CcEEEeee
Q 012233 209 YLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHT---HQLKICDF 284 (468)
Q Consensus 209 ~~~lv~e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~---~~vkL~DF 284 (468)
.+++|||+|.|+ +++.+... .+++..+..++.||+.++.|||+ .||+||||||+|+|+.... ..+|++||
T Consensus 110 ~~~lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~-~gvvHrDlKpEN~L~~~~~~~~~~ik~~DF 183 (382)
T KOG0032|consen 110 SVYLVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHS-LGVVHRDLKPENLLLASKDEGSGRIKLIDF 183 (382)
T ss_pred eEEEEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCHHHeeeccccCCCCcEEEeeC
Confidence 799999999965 44433332 39999999999999999999998 8999999999999996442 26999999
Q ss_pred cCccccCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 012233 285 GSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEI 364 (468)
Q Consensus 285 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 364 (468)
|++.....+......+||+.|+|||++... .|+..+||||+||++|.|++|.+||.+.+......+|...
T Consensus 184 Gla~~~~~~~~~~~~~Gtp~y~APEvl~~~-~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~--------- 253 (382)
T KOG0032|consen 184 GLAKFIKPGERLHTIVGTPEYVAPEVLGGR-PYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRG--------- 253 (382)
T ss_pred CCceEccCCceEeeecCCccccCchhhcCC-CCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcC---------
Confidence 999998876677889999999999999654 4999999999999999999999999999988877766552
Q ss_pred hhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCCC
Q 012233 365 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPN 430 (468)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~ 430 (468)
++.|+ ...|..++..+++||.+||..||.+|+|+.++|+|||++......
T Consensus 254 --------~~~f~--------~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~~~~ 303 (382)
T KOG0032|consen 254 --------DFDFT--------SEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIGEAT 303 (382)
T ss_pred --------CCCCC--------CCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCcccc
Confidence 22221 224466899999999999999999999999999999998864443
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-47 Score=367.03 Aligned_cols=275 Identities=39% Similarity=0.718 Sum_probs=222.2
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc------chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 211 (468)
+|.+.+.||+|+||.||+|++..+++.||+|++.... ....+|+.+++.++||||+++++++ .....+|
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~ 76 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAF-----RRRGKLY 76 (287)
T ss_pred CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhE-----ecCCEEE
Confidence 5999999999999999999999999999999886432 2345799999999999999999988 4445689
Q ss_pred EEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccC
Q 012233 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (468)
Q Consensus 212 lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~ 291 (468)
+||||+.++++..+.. ....+++..++.++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||++....
T Consensus 77 lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dlkp~Nill~~~~-~~kl~Dfg~~~~~~ 151 (287)
T cd07848 77 LVFEYVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHK-NDIVHRDIKPENLLISHND-VLKLCDFGFARNLS 151 (287)
T ss_pred EEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcCCC-cEEEeeccCccccc
Confidence 9999999987775432 24568999999999999999999998 8999999999999999887 79999999998764
Q ss_pred CCC--CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc--
Q 012233 292 PGE--PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM-- 367 (468)
Q Consensus 292 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~-- 367 (468)
... ......|++.|+|||++.+.. ++.++|||||||++|||++|++||.+.+..+....+....+..+...+...
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (287)
T cd07848 152 EGSNANYTEYVATRWYRSPELLLGAP-YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYS 230 (287)
T ss_pred ccccccccccccccccCCcHHHcCCC-CCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhc
Confidence 322 223457899999999997654 899999999999999999999999998888888777777766665544322
Q ss_pred CCCCccCCCCccc-CCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 012233 368 NPNYTEFKFPQIK-AHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (468)
Q Consensus 368 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f 423 (468)
.+.+....++... ...+...+...++.++.+||++||++||.+|||++++|+||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 231 NPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred cchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 1222222222211 1122233445688999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-47 Score=364.14 Aligned_cols=284 Identities=25% Similarity=0.415 Sum_probs=225.6
Q ss_pred CCCCcccceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc-----cchHHHHHHHHHHcCCCCcccccceeeecCCC
Q 012233 131 GQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEK 205 (468)
Q Consensus 131 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~-----~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 205 (468)
..+.....|.+..+||.|..++||+|++..+++.||||++.-+ ...+.+|+..|+.++||||++++.+|..
T Consensus 20 ~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv---- 95 (516)
T KOG0582|consen 20 EFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVV---- 95 (516)
T ss_pred cCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEe----
Confidence 3455556799999999999999999999999999999998533 2456689999999999999999998844
Q ss_pred CceEEEEEeeccc-chHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeee
Q 012233 206 DELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDF 284 (468)
Q Consensus 206 ~~~~~~lv~e~~~-~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DF 284 (468)
...+|+||.||. |+++++++.+. ...+.+..+..+.+++++||.|||. +|.||||||+.||||+.+| .|||+||
T Consensus 96 -~~~LWvVmpfMa~GS~ldIik~~~--~~Gl~E~~Ia~iLre~LkaL~YLH~-~G~IHRdvKAgnILi~~dG-~VkLadF 170 (516)
T KOG0582|consen 96 -DSELWVVMPFMAGGSLLDIIKTYY--PDGLEEASIATILREVLKALDYLHQ-NGHIHRDVKAGNILIDSDG-TVKLADF 170 (516)
T ss_pred -cceeEEeehhhcCCcHHHHHHHHc--cccccHHHHHHHHHHHHHHHHHHHh-cCceecccccccEEEcCCC-cEEEcCc
Confidence 345999999998 56677776654 4559999999999999999999998 9999999999999999999 8999999
Q ss_pred cCccccCCCCC-----CccccccCCccccccc-cCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Q 012233 285 GSAKMLVPGEP-----NISYICSRYYRAPELI-FGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGT 358 (468)
Q Consensus 285 G~a~~~~~~~~-----~~~~~gt~~y~aPE~~-~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~ 358 (468)
|.+..+..... ..+++||++|||||++ ....+|+.|+||||||++..||.+|+.||....+...+..-++ +.
T Consensus 171 gvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLq--n~ 248 (516)
T KOG0582|consen 171 GVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQ--ND 248 (516)
T ss_pred eeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhc--CC
Confidence 99866643321 1567899999999995 4445699999999999999999999999998877776554333 22
Q ss_pred CCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCC-CCCCCCCCC
Q 012233 359 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRD-PNTCLPNGR 437 (468)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~-~~~~~~~~~ 437 (468)
|+... .......-.+..+..++++|..||++||.+||||+++|.|+||+.... ........+
T Consensus 249 pp~~~-----------------t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~~~~~~~~l~ 311 (516)
T KOG0582|consen 249 PPTLL-----------------TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSKEYLVKKLLQ 311 (516)
T ss_pred CCCcc-----------------cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccchhhcchhhhc
Confidence 22110 000111112346778999999999999999999999999999998755 333444445
Q ss_pred CCCcc
Q 012233 438 PLPTL 442 (468)
Q Consensus 438 ~~~~~ 442 (468)
.+|.+
T Consensus 312 ~l~~l 316 (516)
T KOG0582|consen 312 SLPPL 316 (516)
T ss_pred cCCcH
Confidence 55555
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-49 Score=355.36 Aligned_cols=259 Identities=29% Similarity=0.468 Sum_probs=218.6
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc------------cchHHHHHHHHHHcC-CCCcccccceeeecCC
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------------KRYKNRELQIMRLLN-HPNVVSLKHCFFSTTE 204 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~------------~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~ 204 (468)
.|...++||.|..+.|.+|..+.+|..+|+|++... .....+|+.||+++. ||+|+++.++|
T Consensus 18 ~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y----- 92 (411)
T KOG0599|consen 18 KYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY----- 92 (411)
T ss_pred hcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec-----
Confidence 488889999999999999999999999999988321 112236999999984 99999999999
Q ss_pred CCceEEEEEeecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEee
Q 012233 205 KDELYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICD 283 (468)
Q Consensus 205 ~~~~~~~lv~e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~D 283 (468)
+...++|+|+|.|+.| +.+.+. ..-.+++...+.+++|++.|+.|||. ++||||||||+|||++.+. ++||+|
T Consensus 93 es~sF~FlVFdl~prGELFDyLt----s~VtlSEK~tR~iMrqlfegVeylHa-~~IVHRDLKpENILlddn~-~i~isD 166 (411)
T KOG0599|consen 93 ESDAFVFLVFDLMPRGELFDYLT----SKVTLSEKETRRIMRQLFEGVEYLHA-RNIVHRDLKPENILLDDNM-NIKISD 166 (411)
T ss_pred cCcchhhhhhhhcccchHHHHhh----hheeecHHHHHHHHHHHHHHHHHHHH-hhhhhcccChhheeecccc-ceEEec
Confidence 7777899999999954 444332 24568899999999999999999996 9999999999999999887 899999
Q ss_pred ecCccccCCCCCCccccccCCcccccccc-----CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Q 012233 284 FGSAKMLVPGEPNISYICSRYYRAPELIF-----GATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGT 358 (468)
Q Consensus 284 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~ 358 (468)
||+++.+.+++.....||||.|+|||.+. +.++|+..+|+|++|||||.||.|.+||......-.+..|++.
T Consensus 167 FGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeG--- 243 (411)
T KOG0599|consen 167 FGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEG--- 243 (411)
T ss_pred cceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhc---
Confidence 99999999999999999999999999984 4466999999999999999999999999877666666666652
Q ss_pred CCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCCCCC
Q 012233 359 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNTC 432 (468)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~~ 432 (468)
.+.|. ..-|.+++.+.+|||.+||+.||.+|+|++|+|.||||..+.....+
T Consensus 244 --------------kyqF~--------speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~~~r 295 (411)
T KOG0599|consen 244 --------------KYQFR--------SPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQQAR 295 (411)
T ss_pred --------------ccccC--------CcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHhccc
Confidence 22221 11345689999999999999999999999999999999876554443
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-47 Score=370.08 Aligned_cols=283 Identities=33% Similarity=0.628 Sum_probs=230.2
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-----chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEE
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 211 (468)
..|.+.+.||+|+||.||+|.+..+++.||+|.+.... ....+|+.+++.++||||+++++++. .....+
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~ 80 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVH-----TDKSLT 80 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEe-----eCCeEE
Confidence 46999999999999999999999999999999885332 23457999999999999999999883 344689
Q ss_pred EEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccC
Q 012233 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (468)
Q Consensus 212 lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~ 291 (468)
+||||+.+++...+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++....
T Consensus 81 lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~lH~-~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~ 155 (309)
T cd07872 81 LVFEYLDKDLKQYMDD---CGNIMSMHNVKIFLYQILRGLAYCHR-RKVLHRDLKPQNLLINERG-ELKLADFGLARAKS 155 (309)
T ss_pred EEEeCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECCCC-CEEECccccceecC
Confidence 9999999887765433 23457888999999999999999998 8999999999999999887 79999999987543
Q ss_pred CCC-CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC-
Q 012233 292 PGE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP- 369 (468)
Q Consensus 292 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~- 369 (468)
... ......+++.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+...++.+....+.....
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
T cd07872 156 VPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSN 235 (309)
T ss_pred CCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcch
Confidence 222 223456789999999987666689999999999999999999999999998899999999998888776654332
Q ss_pred -CCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCCC
Q 012233 370 -NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPN 430 (468)
Q Consensus 370 -~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~ 430 (468)
.+..+.++......+.. ....+++++++||.+||+.||.+|||+.|++.||||+.+....
T Consensus 236 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~~ 296 (309)
T cd07872 236 DEFKNYNFPKYKPQPLIN-HAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGTRI 296 (309)
T ss_pred hhhhhhhcCccCCCchhh-hccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhccccc
Confidence 22233333332222222 2245889999999999999999999999999999999875443
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-46 Score=384.92 Aligned_cols=282 Identities=23% Similarity=0.372 Sum_probs=212.9
Q ss_pred ccceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc---chHHHHHHHHHHcCCC------CcccccceeeecCCCC
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLLNHP------NVVSLKHCFFSTTEKD 206 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~---~~~~~E~~il~~l~hp------nIv~l~~~~~~~~~~~ 206 (468)
..+|.+.+.||+|+||+||+|.+..+++.||||++.... .....|+.+++.++|. +|++++++|.. .
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~----~ 203 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN----E 203 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc----C
Confidence 457999999999999999999999999999999986432 2345688888888654 47778777642 2
Q ss_pred ceEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCC---------
Q 012233 207 ELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTH--------- 277 (468)
Q Consensus 207 ~~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~--------- 277 (468)
..++|||||++++.++..+.. ...+++..++.++.||+.||.|||+..|||||||||+||||+.++.
T Consensus 204 ~~~~~iv~~~~g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~ 279 (467)
T PTZ00284 204 TGHMCIVMPKYGPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRA 279 (467)
T ss_pred CceEEEEEeccCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccc
Confidence 336889999998888875543 3568999999999999999999995249999999999999986542
Q ss_pred ------cEEEeeecCccccCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Q 012233 278 ------QLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVE 351 (468)
Q Consensus 278 ------~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~ 351 (468)
.+||+|||.+... .......+||+.|+|||++.+.. |+.++|||||||++|||++|++||.+.+..+.+..
T Consensus 280 ~~~~~~~vkl~DfG~~~~~--~~~~~~~~gt~~Y~APE~~~~~~-~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~ 356 (467)
T PTZ00284 280 LPPDPCRVRICDLGGCCDE--RHSRTAIVSTRHYRSPEVVLGLG-WMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHL 356 (467)
T ss_pred cCCCCceEEECCCCccccC--ccccccccCCccccCcHHhhcCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 4999999987543 22344678999999999997654 99999999999999999999999999888888888
Q ss_pred HHHHhCCCCHHHHhhcCCC-----CccCC--CCcccCCCcccc-----c-ccCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 012233 352 IIKILGTPTREEIKCMNPN-----YTEFK--FPQIKAHPWHKI-----F-HKRMPPEALDLVSRLLQYSPSLRCTALEAC 418 (468)
Q Consensus 352 i~~~~~~~~~~~~~~~~~~-----~~~~~--~~~~~~~~~~~~-----~-~~~~~~~l~~li~~~L~~dP~~R~s~~ell 418 (468)
+.+.++.++.......... +.... .+......+... + ....++.+.|||.+||++||.+|||+.|+|
T Consensus 357 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L 436 (467)
T PTZ00284 357 MEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMT 436 (467)
T ss_pred HHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHh
Confidence 8888887665433211100 00000 000000000000 0 001246788999999999999999999999
Q ss_pred CCCCCCCCCC
Q 012233 419 AHPFFDDLRD 428 (468)
Q Consensus 419 ~hp~f~~~~~ 428 (468)
+||||.....
T Consensus 437 ~Hp~~~~~~~ 446 (467)
T PTZ00284 437 THPYVLKYYP 446 (467)
T ss_pred cCccccccCC
Confidence 9999987533
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=365.66 Aligned_cols=279 Identities=33% Similarity=0.574 Sum_probs=220.1
Q ss_pred ceEEeceecccCceEEEEEEEcC-CCCEEEEEEeeccc------chHHHHHHHHHHc---CCCCcccccceeeecCCCCc
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLE-TGDSVAIKKVLQDK------RYKNRELQIMRLL---NHPNVVSLKHCFFSTTEKDE 207 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~-~g~~vaiK~~~~~~------~~~~~E~~il~~l---~hpnIv~l~~~~~~~~~~~~ 207 (468)
+|.+.+.||+|+||.||+|.+.. +|..||+|.+.... ....+|+.+++.+ .||||+++++++........
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 59999999999999999999854 46889999875321 2334677777766 69999999998854433344
Q ss_pred eEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCc
Q 012233 208 LYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (468)
Q Consensus 208 ~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a 287 (468)
..+++||||+.+++...+... ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++
T Consensus 82 ~~~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~-~~iiH~dlkp~Nil~~~~~-~~kl~Dfg~~ 157 (290)
T cd07862 82 TKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHS-HRVVHRDLKPQNILVTSSG-QIKLADFGLA 157 (290)
T ss_pred CcEEEEEccCCCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHHHEEEcCCC-CEEEccccce
Confidence 568899999998877765432 23458899999999999999999998 8999999999999999888 7999999999
Q ss_pred cccCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 012233 288 KMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367 (468)
Q Consensus 288 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 367 (468)
.............||+.|+|||++.+. .++.++|||||||++|||++|.+||.+.+..+.+.+++...+.+....+...
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (290)
T cd07862 158 RIYSFQMALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 236 (290)
T ss_pred EeccCCcccccccccccccChHHHhCC-CCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhh
Confidence 876544444566789999999999655 4899999999999999999999999999999999999988877765544321
Q ss_pred CCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 012233 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (468)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f 423 (468)
.. .....+......+. ..+.+.+++.+++||.+||+.||.+|||+.++|+||||
T Consensus 237 ~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 237 VA-LPRQAFHSKSAQPI-EKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hc-ccchhccCCCCCCH-HHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 10 11111111111111 12335688999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-46 Score=375.19 Aligned_cols=296 Identities=31% Similarity=0.541 Sum_probs=232.9
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc------chHHHHHHHHHHcCCCCcccccceeeecCC-CCceE
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTE-KDELY 209 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~-~~~~~ 209 (468)
.+|.+.+.||+|+||.||+|.+..+++.||||++.... ....+|+.+++.++||||+++++++..... .....
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~ 103 (364)
T cd07875 24 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 103 (364)
T ss_pred cceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCe
Confidence 46999999999999999999999999999999885421 234579999999999999999998743321 22345
Q ss_pred EEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccc
Q 012233 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (468)
Q Consensus 210 ~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~ 289 (468)
+|+||||+.+++...+. ..++...++.++.|++.||.|||+ +||+||||||+|||++.++ .+||+|||+++.
T Consensus 104 ~~lv~e~~~~~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~-~~kL~DfG~a~~ 175 (364)
T cd07875 104 VYIVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDC-TLKILDFGLART 175 (364)
T ss_pred EEEEEeCCCCCHHHHHH------hcCCHHHHHHHHHHHHHHHHHHhh-CCeecCCCCHHHEEECCCC-cEEEEeCCCccc
Confidence 78999999998776542 347788899999999999999998 8999999999999999888 799999999986
Q ss_pred cCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 012233 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (468)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 369 (468)
...........+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+.+++..++.|..+.+....+
T Consensus 176 ~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (364)
T cd07875 176 AGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP 254 (364)
T ss_pred cCCCCcccCCcccCCcCCHHHHhCC-CCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhH
Confidence 6544444566889999999999765 489999999999999999999999999999999999988888877655443321
Q ss_pred ----------CCccCCCCccc---CCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCCCCCCCCC
Q 012233 370 ----------NYTEFKFPQIK---AHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNTCLPNG 436 (468)
Q Consensus 370 ----------~~~~~~~~~~~---~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~~~~~~ 436 (468)
.+..+.+.... ..++........+..+++||.+||+.||.+|||+.++|+||||..+.++..+....
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~~~~~~ 334 (364)
T cd07875 255 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPP 334 (364)
T ss_pred HHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccccCcccCCCCC
Confidence 11111111100 01112222334567899999999999999999999999999999887776665444
Q ss_pred CCCCc
Q 012233 437 RPLPT 441 (468)
Q Consensus 437 ~~~~~ 441 (468)
+.+|.
T Consensus 335 ~~~~~ 339 (364)
T cd07875 335 PKIPD 339 (364)
T ss_pred CCCCC
Confidence 44443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=376.24 Aligned_cols=286 Identities=31% Similarity=0.553 Sum_probs=224.2
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc------cchHHHHHHHHHHcCCCCcccccceeeecCC-CCceE
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTE-KDELY 209 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~------~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~-~~~~~ 209 (468)
.+|.+.+.||+|+||.||+|.+..+|..||+|++... .....+|+.+++.++||||++++++|..... .....
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 100 (359)
T cd07876 21 KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQD 100 (359)
T ss_pred hceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccce
Confidence 4699999999999999999999999999999998542 2234579999999999999999998854332 12235
Q ss_pred EEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccc
Q 012233 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (468)
Q Consensus 210 ~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~ 289 (468)
+|+||||+.+++...+. ..++...+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++.
T Consensus 101 ~~lv~e~~~~~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~-~~ivHrDlkp~NIl~~~~~-~~kl~Dfg~a~~ 172 (359)
T cd07876 101 VYLVMELMDANLCQVIH------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDC-TLKILDFGLART 172 (359)
T ss_pred eEEEEeCCCcCHHHHHh------ccCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEECCCC-CEEEecCCCccc
Confidence 78999999988776442 347888899999999999999998 8999999999999999888 799999999976
Q ss_pred cCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc--
Q 012233 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM-- 367 (468)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~-- 367 (468)
...........||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+++.++.|....+...
T Consensus 173 ~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (359)
T cd07876 173 ACTNFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQP 251 (359)
T ss_pred cccCccCCCCcccCCCCCchhccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHH
Confidence 5444444556889999999999765 4899999999999999999999999998888888888888887775433221
Q ss_pred --------CCCCccCCCCcc-cCC--CcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCCCC
Q 012233 368 --------NPNYTEFKFPQI-KAH--PWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNT 431 (468)
Q Consensus 368 --------~~~~~~~~~~~~-~~~--~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~ 431 (468)
.+.+....+... ..+ +.........++++++||.+||+.||.+|||+.|+|+||||..+..+..
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~~ 326 (359)
T cd07876 252 TVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDPAE 326 (359)
T ss_pred HHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcCccc
Confidence 111111111100 000 0001122345788999999999999999999999999999997666543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-47 Score=369.50 Aligned_cols=257 Identities=28% Similarity=0.440 Sum_probs=226.7
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeecccc------hHHHHHHHHHHcCCCCcccccceeeecCCCCceEEE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR------YKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~~------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 211 (468)
-|.+++.||+|.|+.|-+|++.-+|+.||||++.+.+. .+.+|+..|+.++|||||+||.+..+. ..+|
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQ-----TKly 93 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQ-----TKLY 93 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhccc-----ceEE
Confidence 49999999999999999999999999999999976543 345799999999999999999988443 3499
Q ss_pred EEeecccc-hHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcccc
Q 012233 212 LVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (468)
Q Consensus 212 lv~e~~~~-~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~ 290 (468)
||+|+-.+ ++++++ .+....+.+..+++|+.||+.|+.|+|+ ..+|||||||+||.+-..-+-|||+|||++..+
T Consensus 94 LiLELGD~GDl~DyI---mKHe~Gl~E~La~kYF~QI~~AI~YCHq-LHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf 169 (864)
T KOG4717|consen 94 LILELGDGGDLFDYI---MKHEEGLNEDLAKKYFAQIVHAISYCHQ-LHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKF 169 (864)
T ss_pred EEEEecCCchHHHHH---HhhhccccHHHHHHHHHHHHHHHHHHhh-hhhhcccCCcceeEEeeecCceEeeeccccccC
Confidence 99999986 555543 3446789999999999999999999998 899999999999876555447999999999999
Q ss_pred CCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCC
Q 012233 291 VPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPN 370 (468)
Q Consensus 291 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 370 (468)
.++....+.||+..|.|||++.|.....+++||||||||||.|++|++||...+..+.+..|+.+.
T Consensus 170 ~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCK-------------- 235 (864)
T KOG4717|consen 170 QPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCK-------------- 235 (864)
T ss_pred CCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhccc--------------
Confidence 999999999999999999999998877789999999999999999999999999999999998843
Q ss_pred CccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCCCCC
Q 012233 371 YTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNTC 432 (468)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~~ 432 (468)
+. ++..++.++++||.+||..||.+|.+.+++..|+|++.+..+...
T Consensus 236 ---Yt------------vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~sT 282 (864)
T KOG4717|consen 236 ---YT------------VPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRGLST 282 (864)
T ss_pred ---cc------------CchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCCCccc
Confidence 22 345689999999999999999999999999999999998765544
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=366.09 Aligned_cols=248 Identities=25% Similarity=0.396 Sum_probs=207.8
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc-------cchHHHHHHHHHHcCCCCcccccceeeecCCCCceEE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~-------~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~ 210 (468)
+|.+.+.||+|+||.||+|.+..+|+.||+|++... .....+|+.+++.++||||+++++++ .+..++
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~ 76 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTE-----HDQRFL 76 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhh-----ccCCeE
Confidence 599999999999999999999999999999998542 22345799999999999999999887 555679
Q ss_pred EEEeecccchHH-HHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccc
Q 012233 211 NLVLEYISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (468)
Q Consensus 211 ~lv~e~~~~~ll-~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~ 289 (468)
|+||||+.++.+ +.+. ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++..
T Consensus 77 ~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~NIli~~~~-~~kl~Dfg~~~~ 150 (291)
T cd05612 77 YMLMEYVPGGELFSYLR----NSGRFSNSTGLFYASEIVCALEYLHS-KEIVYRDLKPENILLDKEG-HIKLTDFGFAKK 150 (291)
T ss_pred EEEEeCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHeEECCCC-CEEEEecCcchh
Confidence 999999987644 3332 24568899999999999999999998 8999999999999999887 799999999976
Q ss_pred cCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 012233 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (468)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 369 (468)
... .....+|++.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..+...
T Consensus 151 ~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~-------------- 213 (291)
T cd05612 151 LRD--RTWTLCGTPEYLAPEVIQSKG-HNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAG-------------- 213 (291)
T ss_pred ccC--CcccccCChhhcCHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--------------
Confidence 533 233567899999999986654 899999999999999999999999987766666555431
Q ss_pred CCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCC-----HHHHhCCCCCCCCCC
Q 012233 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCT-----ALEACAHPFFDDLRD 428 (468)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s-----~~ell~hp~f~~~~~ 428 (468)
... ++..+++.+++||++||+.||.+|++ +.+++.||||+.+..
T Consensus 214 ---~~~------------~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~ 262 (291)
T cd05612 214 ---KLE------------FPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDW 262 (291)
T ss_pred ---CcC------------CCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCCH
Confidence 111 23457889999999999999999995 999999999987654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-46 Score=359.80 Aligned_cols=279 Identities=29% Similarity=0.531 Sum_probs=221.3
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc------chHHHHHHHHHHc---CCCCcccccceeeecCCCCce
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLL---NHPNVVSLKHCFFSTTEKDEL 208 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~------~~~~~E~~il~~l---~hpnIv~l~~~~~~~~~~~~~ 208 (468)
+|.+.+.||+|+||.||+|.++.+|+.||+|.+.... ....+|+.+++.+ +||||+++++++.........
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4899999999999999999999999999999885421 2334677777766 699999999988654444456
Q ss_pred EEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcc
Q 012233 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (468)
Q Consensus 209 ~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~ 288 (468)
.+++||||+.+++...+... ....+++..++.++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||++.
T Consensus 81 ~~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dikp~Nili~~~~-~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVDQDLRTYLDKV--PPPGLPAETIKDLMRQFLRGLDFLHA-NCIVHRDLKPENILVTSGG-QVKLADFGLAR 156 (288)
T ss_pred eEEEEEcccccCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECCCC-CEEECccCccc
Confidence 68899999998777655432 23458999999999999999999998 8999999999999999888 79999999998
Q ss_pred ccCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 012233 289 MLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368 (468)
Q Consensus 289 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 368 (468)
............+|..|+|||++.+.. ++.++|||||||++|+|++|++||.+....+.+.+++...+.+....+....
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07863 157 IYSCQMALTPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV 235 (288)
T ss_pred cccCcccCCCccccccccCchHhhCCC-CCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccc
Confidence 765444444567899999999997654 8999999999999999999999999988888888888887776655443211
Q ss_pred CCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 012233 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (468)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f 423 (468)
......+......++ ..+.+.+++.+.+||.+||++||.+|||+.+++.||||
T Consensus 236 -~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 236 -TLPRGAFSPRGPRPV-QSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred -cccccccCCCCCCch-HHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 000111111111111 12334678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-46 Score=372.01 Aligned_cols=285 Identities=33% Similarity=0.564 Sum_probs=226.5
Q ss_pred ccceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc------chHHHHHHHHHHcCCCCcccccceeeecCC-CCce
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTE-KDEL 208 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~-~~~~ 208 (468)
..+|.+.+.||+|+||.||+|.+..+++.||||.+.... ....+|+.+++.++||||++++++|..... ....
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 95 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ 95 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence 346999999999999999999999999999999885431 233469999999999999999998754332 2233
Q ss_pred EEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcc
Q 012233 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (468)
Q Consensus 209 ~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~ 288 (468)
.+|+||||+.+++...+. ..++...++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++
T Consensus 96 ~~~lv~e~~~~~l~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDikp~Nill~~~~-~~kl~Dfg~~~ 167 (355)
T cd07874 96 DVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDC-TLKILDFGLAR 167 (355)
T ss_pred eeEEEhhhhcccHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCChHHEEECCCC-CEEEeeCcccc
Confidence 578999999988776442 347888899999999999999998 8999999999999999888 79999999998
Q ss_pred ccCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 012233 289 MLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368 (468)
Q Consensus 289 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 368 (468)
............||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..++..++.+..+.+....
T Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (355)
T cd07874 168 TAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_pred cCCCccccCCccccCCccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhc
Confidence 66544444567889999999999765 48999999999999999999999999998888888888888877765443322
Q ss_pred ----------CCCccCCCCcccC---CCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCC
Q 012233 369 ----------PNYTEFKFPQIKA---HPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDP 429 (468)
Q Consensus 369 ----------~~~~~~~~~~~~~---~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~ 429 (468)
+.+....++..-. .+.........+.++++||.+||+.||.+|||+.|+|+||||...-++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~~~ 320 (355)
T cd07874 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWYDP 320 (355)
T ss_pred HHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcccCh
Confidence 2222222221100 111122334457789999999999999999999999999999876554
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-46 Score=363.22 Aligned_cols=256 Identities=25% Similarity=0.389 Sum_probs=207.3
Q ss_pred eEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-------chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEE
Q 012233 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (468)
Q Consensus 139 y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 211 (468)
|.+.+.||+|+||.||+|.+..+|+.||+|.+.... ....+|+.+++.++|+||+++++++ .+..+++
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~-----~~~~~~~ 76 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAY-----ETKDALC 76 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEE-----ccCCeEE
Confidence 888999999999999999999999999999885432 2345799999999999999999888 4445689
Q ss_pred EEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccC
Q 012233 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (468)
Q Consensus 212 lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~ 291 (468)
+||||+.++.+..... ......+++..+..++.|++.||.|||+ .||+||||||+|||++.++ .++|+|||++....
T Consensus 77 lv~e~~~~g~L~~~~~-~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~iiH~dikp~Nill~~~~-~~kl~Dfg~~~~~~ 153 (285)
T cd05631 77 LVLTIMNGGDLKFHIY-NMGNPGFDEQRAIFYAAELCCGLEDLQR-ERIVYRDLKPENILLDDRG-HIRISDLGLAVQIP 153 (285)
T ss_pred EEEEecCCCcHHHHHH-hhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCEEeCCCCHHHEEECCCC-CEEEeeCCCcEEcC
Confidence 9999999775543222 1123468899999999999999999998 8999999999999999887 79999999998765
Q ss_pred CCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCC
Q 012233 292 PGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNY 371 (468)
Q Consensus 292 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 371 (468)
.........||+.|+|||++.+. .++.++|||||||++|+|++|+.||...........+...+...
T Consensus 154 ~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~------------ 220 (285)
T cd05631 154 EGETVRGRVGTVGYMAPEVINNE-KYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKED------------ 220 (285)
T ss_pred CCCeecCCCCCCCccCHhhhcCC-CCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcc------------
Confidence 44444566889999999999755 48999999999999999999999998765433333322211110
Q ss_pred ccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCC-----HHHHhCCCCCCCCCC
Q 012233 372 TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCT-----ALEACAHPFFDDLRD 428 (468)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s-----~~ell~hp~f~~~~~ 428 (468)
...++..+++++.+||.+||+.||.+|++ ++++++||||+++..
T Consensus 221 -------------~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~ 269 (285)
T cd05631 221 -------------QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINF 269 (285)
T ss_pred -------------cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCH
Confidence 01133458899999999999999999997 899999999998653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-46 Score=370.88 Aligned_cols=249 Identities=29% Similarity=0.436 Sum_probs=207.8
Q ss_pred cccceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-------chHHHHHHHHHHcCCCCcccccceeeecCCCCc
Q 012233 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (468)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 207 (468)
...+|.+.+.||+|+||.||+|.+..+|+.||||++.... ....+|+.+++.++||||+++++++ .+.
T Consensus 16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~ 90 (329)
T PTZ00263 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSF-----QDE 90 (329)
T ss_pred CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEE-----EcC
Confidence 3457999999999999999999999999999999986432 2345799999999999999999988 445
Q ss_pred eEEEEEeecccchHHH-HHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecC
Q 012233 208 LYLNLVLEYISETVYR-VSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (468)
Q Consensus 208 ~~~~lv~e~~~~~ll~-~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~ 286 (468)
.++|+||||+.++.+. .+. ....+++..++.++.||+.||.|||+ +||+||||||+||||+.++ .+||+|||+
T Consensus 91 ~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~dlkp~NIll~~~~-~~kl~Dfg~ 164 (329)
T PTZ00263 91 NRVYFLLEFVVGGELFTHLR----KAGRFPNDVAKFYHAELVLAFEYLHS-KDIIYRDLKPENLLLDNKG-HVKVTDFGF 164 (329)
T ss_pred CEEEEEEcCCCCChHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHEEECCCC-CEEEeeccC
Confidence 5689999999876443 322 24568899999999999999999998 8999999999999999888 799999999
Q ss_pred ccccCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 012233 287 AKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKC 366 (468)
Q Consensus 287 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 366 (468)
+...... .....||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+.+..+...
T Consensus 165 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~----------- 230 (329)
T PTZ00263 165 AKKVPDR--TFTLCGTPEYLAPEVIQSKG-HGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAG----------- 230 (329)
T ss_pred ceEcCCC--cceecCChhhcCHHHHcCCC-CCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcC-----------
Confidence 9865332 33568999999999997654 899999999999999999999999887766555544331
Q ss_pred cCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCC-----HHHHhCCCCCCCC
Q 012233 367 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCT-----ALEACAHPFFDDL 426 (468)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s-----~~ell~hp~f~~~ 426 (468)
... ++..++..+++||.+||+.||.+|++ +.+++.||||+++
T Consensus 231 ------~~~------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~ 277 (329)
T PTZ00263 231 ------RLK------------FPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGA 277 (329)
T ss_pred ------CcC------------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCC
Confidence 111 22347889999999999999999997 7999999999875
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-47 Score=320.84 Aligned_cols=279 Identities=35% Similarity=0.623 Sum_probs=234.3
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc------chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 211 (468)
.|.-.+.||+|.||+||+|++..+++.||+|.+.-+. ....+|+.+|+.+.|.|||++++.. ..+..+-
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvl-----hsdkklt 77 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL-----HSDKKLT 77 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhh-----ccCceeE
Confidence 4677789999999999999999999999999886443 2346899999999999999999988 4445588
Q ss_pred EEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccC
Q 012233 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (468)
Q Consensus 212 lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~ 291 (468)
+|+|||..++.. .+...++.++...++.++.|+++||.|+|+ +++.||||||.|+||+.++ ++||+|||+++.+.
T Consensus 78 lvfe~cdqdlkk---yfdslng~~d~~~~rsfmlqllrgl~fchs-hnvlhrdlkpqnllin~ng-elkladfglarafg 152 (292)
T KOG0662|consen 78 LVFEFCDQDLKK---YFDSLNGDLDPEIVRSFMLQLLRGLGFCHS-HNVLHRDLKPQNLLINRNG-ELKLADFGLARAFG 152 (292)
T ss_pred EeHHHhhHHHHH---HHHhcCCcCCHHHHHHHHHHHHhhhhhhhh-hhhhhccCCcceEEeccCC-cEEecccchhhhcC
Confidence 999999987655 455668889999999999999999999997 9999999999999999999 89999999998763
Q ss_pred CCC-CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 012233 292 PGE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (468)
Q Consensus 292 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 369 (468)
-.. -....+.|.+|.+|.++.|..-|+...|+||.|||+.|+.. |++.|++.+-.+++..|+..+|.|.++.|..+..
T Consensus 153 ipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~ 232 (292)
T KOG0662|consen 153 IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTK 232 (292)
T ss_pred CceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCcccc
Confidence 222 12345679999999999999889999999999999999984 9999999999999999999999999998877653
Q ss_pred CCccCCCCcccC-CCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q 012233 370 NYTEFKFPQIKA-HPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (468)
Q Consensus 370 ~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~ 427 (468)
--.-..+|..+. ..|.. +-+.+...-+||++++|..+|.+|++++++++||||.+..
T Consensus 233 lpdyk~yp~ypattswsq-ivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~s 290 (292)
T KOG0662|consen 233 LPDYKPYPIYPATTSWSQ-IVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDFS 290 (292)
T ss_pred CCCCcccCCccccchHHH-HhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccccC
Confidence 332233333222 22333 3345677789999999999999999999999999998753
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=378.93 Aligned_cols=281 Identities=24% Similarity=0.332 Sum_probs=214.4
Q ss_pred ccceEEeceecccCceEEEEEEEcCCCCEEEEEEeecccchHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEEEee
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLE 215 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv~e 215 (468)
..+|.+.+.||+|+||.||+|.+..+++.||||.... ....+|+.+++.|+||||++++++|. ...+.++|||
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~~~~lv~e 163 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--GGTATEAHILRAINHPSIIQLKGTFT-----YNKFTCLILP 163 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--hhhHHHHHHHHhCCCCCCCCEeEEEE-----ECCeeEEEEe
Confidence 3469999999999999999999999999999997543 34568999999999999999999883 3446889999
Q ss_pred cccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCCC--
Q 012233 216 YISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG-- 293 (468)
Q Consensus 216 ~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~~-- 293 (468)
++.++++..+.. ...+++..++.++.||+.||.|||+ +||+||||||+||||+.++ .+||+|||+++.....
T Consensus 164 ~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~ylH~-~~IvHrDiKP~NIll~~~~-~vkL~DFG~a~~~~~~~~ 237 (391)
T PHA03212 164 RYKTDLYCYLAA----KRNIAICDILAIERSVLRAIQYLHE-NRIIHRDIKAENIFINHPG-DVCLGDFGAACFPVDINA 237 (391)
T ss_pred cCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCChHhEEEcCCC-CEEEEeCCcccccccccc
Confidence 999887765432 3568899999999999999999998 8999999999999999888 7999999999653221
Q ss_pred CCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-------cHHHHHHHHHHhCCCCHHHHhh
Q 012233 294 EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGES-------GVDQLVEIIKILGTPTREEIKC 366 (468)
Q Consensus 294 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~-------~~~~~~~i~~~~~~~~~~~~~~ 366 (468)
......+||+.|+|||++.+. .++.++|||||||++|||++|..||.... ...++..++...+.++......
T Consensus 238 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~ 316 (391)
T PHA03212 238 NKYYGWAGTIATNAPELLARD-PYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID 316 (391)
T ss_pred cccccccCccCCCChhhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence 223356899999999999765 48999999999999999999998875432 3455666777666544221000
Q ss_pred cCCCCc-------cCCCCcc-cCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCCCCC
Q 012233 367 MNPNYT-------EFKFPQI-KAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNTC 432 (468)
Q Consensus 367 ~~~~~~-------~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~~ 432 (468)
...... ....... ....|... ..++.++.+||.+||++||.+|||+.|+|+||||+++..+...
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~~~~ 388 (391)
T PHA03212 317 AQANLDEIYIGLAKKSSRKPGSRPLWTNL--YELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPDPYPN 388 (391)
T ss_pred hhHHHHHHHHHHHhccCCCCCCCCCHHHH--hhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCCCCCC
Confidence 000000 0000000 00011111 2357789999999999999999999999999999998766443
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=361.10 Aligned_cols=288 Identities=33% Similarity=0.608 Sum_probs=231.8
Q ss_pred ccceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-----chHHHHHHHHHHcCCCCcccccceeeecCCCCceEE
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~ 210 (468)
..+|.+.+.||.|+||.||+|.+..+++.||+|.+.... ....+|+.+++.++||||+++++++ ....++
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~-----~~~~~~ 79 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII-----HTEKSL 79 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEE-----ecCCeE
Confidence 346999999999999999999999999999999885332 2345799999999999999999998 444568
Q ss_pred EEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcccc
Q 012233 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (468)
Q Consensus 211 ~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~ 290 (468)
++||||+.+++...+.. ....+++..++.++.||+.||.|||+ .||+|+||||+|||++.++ .++|+|||++...
T Consensus 80 ~lv~e~~~~~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~lH~-~~i~H~dlkp~Nil~~~~~-~~kl~dfg~~~~~ 154 (301)
T cd07873 80 TLVFEYLDKDLKQYLDD---CGNSINMHNVKLFLFQLLRGLNYCHR-RKVLHRDLKPQNLLINERG-ELKLADFGLARAK 154 (301)
T ss_pred EEEEeccccCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCCHHHEEECCCC-cEEECcCcchhcc
Confidence 99999999877765433 24568889999999999999999998 8999999999999999887 7999999998754
Q ss_pred CCCC-CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC-
Q 012233 291 VPGE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN- 368 (468)
Q Consensus 291 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~- 368 (468)
.... ......+++.|+|||++.+...++.++|||||||++|+|++|++||...+..+.+..+...++.+....+..+.
T Consensus 155 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (301)
T cd07873 155 SIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS 234 (301)
T ss_pred CCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhc
Confidence 3222 22345678999999998766668899999999999999999999999988888888888888877766554321
Q ss_pred -CCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCCCCCCC
Q 012233 369 -PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNTCLP 434 (468)
Q Consensus 369 -~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~~~~ 434 (468)
..+....++....... ......+++++++||.+||+.||.+|||+.|+++||||+.+.+..+.+|
T Consensus 235 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~~~~~~~ 300 (301)
T cd07873 235 NEEFKSYNYPKYRADCL-HNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGERIHKLP 300 (301)
T ss_pred cccccccccCccccccH-HhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccchhhcCC
Confidence 1122222332211111 1233568899999999999999999999999999999999887776655
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-46 Score=375.84 Aligned_cols=284 Identities=35% Similarity=0.582 Sum_probs=224.7
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc------cchHHHHHHHHHHcCCCCcccccceeeecCCCCceEEE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~------~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 211 (468)
+|.+.+.||+|+||.||+|.+..+|+.||||++... .....+|+.+++.++||||+++++++..........+|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 378889999999999999999999999999988542 12345799999999999999999988544322223688
Q ss_pred EEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccC
Q 012233 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (468)
Q Consensus 212 lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~ 291 (468)
+||||+.+++...+.. ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||++....
T Consensus 81 lv~e~~~~~l~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivH~dlkp~Nili~~~~-~~kL~Dfg~a~~~~ 154 (372)
T cd07853 81 VVTELMQSDLHKIIVS----PQPLSSDHVKVFLYQILRGLKYLHS-AGILHRDIKPGNLLVNSNC-VLKICDFGLARVEE 154 (372)
T ss_pred EEeeccccCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChHHEEECCCC-CEEeccccceeecc
Confidence 9999999887765432 4568999999999999999999998 8999999999999999888 79999999997653
Q ss_pred CCC--CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 012233 292 PGE--PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (468)
Q Consensus 292 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 369 (468)
... ......+++.|+|||++.+...++.++|||||||++|||++|++||.+.+..+++..+...++.+....+.....
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 234 (372)
T cd07853 155 PDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE 234 (372)
T ss_pred cCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhH
Confidence 322 223456789999999998766689999999999999999999999999999999999999999888765433211
Q ss_pred CCccCCC--Cc-ccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q 012233 370 NYTEFKF--PQ-IKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (468)
Q Consensus 370 ~~~~~~~--~~-~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~ 427 (468)
....... +. .+.......+....++++.+||.+||+.||.+|||+.|+|.||||+..+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 295 (372)
T cd07853 235 GARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR 295 (372)
T ss_pred HHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence 0000000 00 0000001113345789999999999999999999999999999999854
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-46 Score=369.43 Aligned_cols=285 Identities=34% Similarity=0.607 Sum_probs=225.4
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc------chHHHHHHHHHHcCCCCcccccceeeecCC-CCceE
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTE-KDELY 209 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~-~~~~~ 209 (468)
.+|.+.+.||.|+||.||+|.+..+++.||||++.... ....+|+.+++.++||||++++++|..... .....
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07878 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNE 94 (343)
T ss_pred hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCc
Confidence 36999999999999999999999999999999885432 223479999999999999999998743321 22234
Q ss_pred EEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccc
Q 012233 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (468)
Q Consensus 210 ~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~ 289 (468)
.|++|+++++.+..... ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++.
T Consensus 95 ~~~~~~~~~~~l~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrdikp~Nil~~~~~-~~kl~Dfg~~~~ 167 (343)
T cd07878 95 VYLVTNLMGADLNNIVK-----CQKLSDEHVQFLIYQLLRGLKYIHS-AGIIHRDLKPSNVAVNEDC-ELRILDFGLARQ 167 (343)
T ss_pred EEEEeecCCCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecccCChhhEEECCCC-CEEEcCCcccee
Confidence 78999999877665443 3568999999999999999999998 8999999999999999888 799999999986
Q ss_pred cCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 012233 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (468)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 369 (468)
... ......||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+....+.+..........
T Consensus 168 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (343)
T cd07878 168 ADD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISS 245 (343)
T ss_pred cCC--CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcch
Confidence 533 234567899999999997756689999999999999999999999999888888888888777776654433221
Q ss_pred CCccC---CCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCCCC
Q 012233 370 NYTEF---KFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNT 431 (468)
Q Consensus 370 ~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~ 431 (468)
..... .++......+.. +...+++.+.+||.+||+.||.+|||+.|+|.||||.....+..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~~~~ 309 (343)
T cd07878 246 EHARKYIQSLPHMPQQDLKK-IFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDPED 309 (343)
T ss_pred hhHHHHhhccccccchhHHH-hccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCCCcc
Confidence 11110 011111111111 22346788999999999999999999999999999998776553
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-46 Score=369.04 Aligned_cols=245 Identities=28% Similarity=0.454 Sum_probs=201.4
Q ss_pred ceecccCceEEEEEEEcCCCCEEEEEEeeccc-------chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEEEee
Q 012233 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLE 215 (468)
Q Consensus 143 ~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv~e 215 (468)
++||+|+||.||+|.+..+|+.||||++.... ....+|+.+++.++||||++++++| ....++|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~-----~~~~~~~lv~e 75 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSF-----QTHDRLCFVME 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEE-----EcCCEEEEEEe
Confidence 46999999999999999999999999986432 2234689999999999999999888 44557899999
Q ss_pred cccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCC-CC
Q 012233 216 YISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP-GE 294 (468)
Q Consensus 216 ~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~-~~ 294 (468)
|+.++.+.... .....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++.... ..
T Consensus 76 ~~~~~~L~~~l---~~~~~~~~~~~~~~~~qi~~~L~~lH~-~~ivHrDlkp~NIll~~~~-~~kl~DfG~a~~~~~~~~ 150 (323)
T cd05571 76 YANGGELFFHL---SRERVFSEDRARFYGAEIVSALGYLHS-CDVVYRDLKLENLMLDKDG-HIKITDFGLCKEGISDGA 150 (323)
T ss_pred CCCCCcHHHHH---HHcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeCCCCHHHEEECCCC-CEEEeeCCCCcccccCCC
Confidence 99976553222 224568999999999999999999998 8999999999999999888 799999999875422 22
Q ss_pred CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccC
Q 012233 295 PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEF 374 (468)
Q Consensus 295 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 374 (468)
.....+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+.......+.. ...
T Consensus 151 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~-----------------~~~ 212 (323)
T cd05571 151 TMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM-----------------EEI 212 (323)
T ss_pred cccceecCccccChhhhcCC-CCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHc-----------------CCC
Confidence 33456799999999999765 489999999999999999999999987765544443322 111
Q ss_pred CCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCC-----CHHHHhCCCCCCCCC
Q 012233 375 KFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC-----TALEACAHPFFDDLR 427 (468)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~-----s~~ell~hp~f~~~~ 427 (468)
. ++..+++++.+||.+||+.||.+|| ++.++++||||+.+.
T Consensus 213 ~------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~ 258 (323)
T cd05571 213 R------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASIN 258 (323)
T ss_pred C------------CCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence 1 3345889999999999999999999 899999999998853
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-46 Score=365.73 Aligned_cols=247 Identities=31% Similarity=0.451 Sum_probs=202.7
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCE-EEEEEeeccc------chHHHHHHHHHHcCCCCcccccceeeecCCCCceEE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDS-VAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~-vaiK~~~~~~------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~ 210 (468)
...+.+.||.|+||+||+|.+ .|.. ||+|++.... ..+.+|+.+|.+++|||||++++++..... .+
T Consensus 42 ~l~~~~~iG~G~~g~V~~~~~--~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~----~~ 115 (362)
T KOG0192|consen 42 ELPIEEVLGSGSFGTVYKGKW--RGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG----SL 115 (362)
T ss_pred HhhhhhhcccCCceeEEEEEe--CCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC----ce
Confidence 345566799999999999999 5667 9999986532 356789999999999999999999843321 48
Q ss_pred EEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCC-ccccCCCCCCeeecCCCCcEEEeeecCccc
Q 012233 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG-VCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (468)
Q Consensus 211 ~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~g-ivHrDlkp~NILl~~~~~~vkL~DFG~a~~ 289 (468)
+|||||+++|.|..+.+.. ....+++..+..++.||++||.|||+ ++ ||||||||+||||+.+...+||+|||+++.
T Consensus 116 ~iVtEy~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~-~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~ 193 (362)
T KOG0192|consen 116 CIVTEYMPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHS-EGPIIHRDLKSDNILVDLKGKTLKIADFGLSRE 193 (362)
T ss_pred EEEEEeCCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhc-CCCeeecccChhhEEEcCCCCEEEECCCcccee
Confidence 8999999988776555432 46789999999999999999999998 89 999999999999998854699999999987
Q ss_pred cCCC-CCCccccccCCccccccccC-CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 012233 290 LVPG-EPNISYICSRYYRAPELIFG-ATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367 (468)
Q Consensus 290 ~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 367 (468)
.... .......||+.|||||++.+ ...|+.++||||||+++|||+||..||.+....+....+......|.
T Consensus 194 ~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~------- 266 (362)
T KOG0192|consen 194 KVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPP------- 266 (362)
T ss_pred eccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCC-------
Confidence 6544 33444789999999999975 34599999999999999999999999999888555555544222221
Q ss_pred CCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
++...++.+.+||.+||..||.+||+..+++.
T Consensus 267 --------------------~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 267 --------------------IPKECPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred --------------------CCccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 33457899999999999999999999988764
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-46 Score=373.39 Aligned_cols=254 Identities=30% Similarity=0.476 Sum_probs=206.0
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-------chHHHHHHHHHHcCCCCcccccceeeecCCCCceEE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~ 210 (468)
+|.+.+.||+|+||.||+|.+..+|+.||||++.... ....+|+.+++.++||||++++++| .+..++
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~~ 76 (364)
T cd05599 2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSF-----QDENYL 76 (364)
T ss_pred CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-----EcCCeE
Confidence 5999999999999999999999999999999986432 2345799999999999999999988 455579
Q ss_pred EEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcccc
Q 012233 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (468)
Q Consensus 211 ~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~ 290 (468)
||||||+.++.+.... .....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++..+
T Consensus 77 ~lv~E~~~~g~L~~~l---~~~~~l~~~~~~~~~~qi~~aL~~lH~-~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~~~~~ 151 (364)
T cd05599 77 YLIMEYLPGGDMMTLL---MKKDTFTEEETRFYIAETILAIDSIHK-LGYIHRDIKPDNLLLDAKG-HIKLSDFGLCTGL 151 (364)
T ss_pred EEEECCCCCcHHHHHH---HHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCCHHHeEECCCC-CEEEeecccceec
Confidence 9999999876544322 224568999999999999999999998 8999999999999999888 7999999998754
Q ss_pred CCCC---------------------------------------CCccccccCCccccccccCCCCCCcchhHHHHHHHHH
Q 012233 291 VPGE---------------------------------------PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLA 331 (468)
Q Consensus 291 ~~~~---------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ 331 (468)
.... .....+||+.|+|||++.+. .++.++|||||||++|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ 230 (364)
T cd05599 152 KKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQT-GYNKECDWWSLGVIMY 230 (364)
T ss_pred cccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCC-CCCCeeeeecchhHHH
Confidence 2211 01134689999999998654 4899999999999999
Q ss_pred HHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCC
Q 012233 332 ELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLR 411 (468)
Q Consensus 332 ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 411 (468)
||++|..||.+.+..+.+..+.... ..+.++. ...+++++++||.+||. +|.+|
T Consensus 231 el~~G~~Pf~~~~~~~~~~~i~~~~---------------~~~~~~~----------~~~~s~~~~~li~~ll~-~p~~R 284 (364)
T cd05599 231 EMLVGYPPFCSDNPQETYRKIINWK---------------ETLQFPD----------EVPLSPEAKDLIKRLCC-EAERR 284 (364)
T ss_pred HhhcCCCCCCCCCHHHHHHHHHcCC---------------CccCCCC----------CCCCCHHHHHHHHHHcc-CHhhc
Confidence 9999999999887766655554310 0111111 11368999999999997 99999
Q ss_pred CC---HHHHhCCCCCCCCCC
Q 012233 412 CT---ALEACAHPFFDDLRD 428 (468)
Q Consensus 412 ~s---~~ell~hp~f~~~~~ 428 (468)
++ +.+++.||||+.+..
T Consensus 285 ~~~~~~~~ll~h~~~~~~~~ 304 (364)
T cd05599 285 LGNNGVNEIKSHPFFKGVDW 304 (364)
T ss_pred CCCCCHHHHhcCCCcCCCCH
Confidence 98 999999999998754
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-45 Score=359.75 Aligned_cols=277 Identities=31% Similarity=0.529 Sum_probs=208.8
Q ss_pred eceecccCceEEEEEEEc--CCCCEEEEEEeeccc--chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEEEeecc
Q 012233 142 ERVVGTGSFGVVFQAKCL--ETGDSVAIKKVLQDK--RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYI 217 (468)
Q Consensus 142 ~~~lG~G~fg~Vy~~~~~--~~g~~vaiK~~~~~~--~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv~e~~ 217 (468)
++.||+|+||.||+|.++ .++..||+|.+.... ....+|+.+|+.++||||++++++|... ....+|+||||+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---~~~~~~lv~e~~ 82 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSH---ADRKVWLLFDYA 82 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEecC---CCcEEEEEEecc
Confidence 457999999999999975 467899999886542 3456799999999999999999988543 234688999999
Q ss_pred cchHHHHHhhhhh-----cCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeec----CCCCcEEEeeecCcc
Q 012233 218 SETVYRVSKHYTR-----MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVN----PHTHQLKICDFGSAK 288 (468)
Q Consensus 218 ~~~ll~~~~~~~~-----~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~----~~~~~vkL~DFG~a~ 288 (468)
++++...+..... ....+++..++.++.||+.||.|||+ .||+||||||+|||++ .++ .+||+|||+++
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~ivHrDlkp~Nil~~~~~~~~~-~~kl~DfG~a~ 160 (317)
T cd07868 83 EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA-NWVLHRDLKPANILVMGEGPERG-RVKIADMGFAR 160 (317)
T ss_pred CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh-CCEEcCCCCHHHEEEecCCCCcC-cEEEeecCcee
Confidence 9988776543211 12358899999999999999999998 8999999999999994 334 79999999997
Q ss_pred ccCCCC----CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCc---------HHHHHHHHHH
Q 012233 289 MLVPGE----PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESG---------VDQLVEIIKI 355 (468)
Q Consensus 289 ~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~---------~~~~~~i~~~ 355 (468)
...... ......||+.|+|||++.+...++.++|||||||++|+|++|++||..... .+++..++..
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 240 (317)
T cd07868 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNV 240 (317)
T ss_pred ccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHh
Confidence 654322 223467899999999998766689999999999999999999999975432 3567778888
Q ss_pred hCCCCHHHHhhcCCCC---------ccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 012233 356 LGTPTREEIKCMNPNY---------TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (468)
Q Consensus 356 ~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f 423 (468)
++.|....+....... ....+.......+........+.++.+||.+||++||.+|||++|+|+||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 241 MGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred cCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 8877766554322100 0000000000000011112346789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=369.96 Aligned_cols=254 Identities=26% Similarity=0.395 Sum_probs=203.8
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-------chHHHHHHHHHHcCCCCcccccceeeecCCCCceEE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~ 210 (468)
+|.+.+.||+|+||+||+|.+..+++.||||++.+.. ....+|+.+++.++|+||+++++++ .+..++
T Consensus 2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~-----~~~~~~ 76 (363)
T cd05628 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSF-----QDKLNL 76 (363)
T ss_pred CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEE-----ecCCeE
Confidence 5999999999999999999999999999999986532 2345699999999999999999988 455578
Q ss_pred EEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcccc
Q 012233 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (468)
Q Consensus 211 ~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~ 290 (468)
||||||++++.+.... .....+++..++.++.||+.||.|||+ +||+||||||+||||+.++ .+||+|||+++..
T Consensus 77 ~lv~E~~~gg~L~~~l---~~~~~l~~~~~~~~~~qi~~aL~~lH~-~givHrDlKp~NILi~~~~-~vkL~DFGla~~~ 151 (363)
T cd05628 77 YLIMEFLPGGDMMTLL---MKKDTLTEEETQFYIAETVLAIDSIHQ-LGFIHRDIKPDNLLLDSKG-HVKLSDFGLCTGL 151 (363)
T ss_pred EEEEcCCCCCcHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEecCCCHHHeEECCCC-CEEEeeccCcccc
Confidence 9999999876443222 124568999999999999999999998 8999999999999999888 7999999998754
Q ss_pred CCCC------------------------------------CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHH
Q 012233 291 VPGE------------------------------------PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELL 334 (468)
Q Consensus 291 ~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell 334 (468)
.... .....+||+.|+|||++.+. .++.++|||||||++|||+
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~~~DvwSlGvil~ell 230 (363)
T cd05628 152 KKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYEML 230 (363)
T ss_pred cccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCC-CCCCchhhhhhHHHHHHHH
Confidence 3211 01245799999999999765 4899999999999999999
Q ss_pred hCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCC---CC
Q 012233 335 LGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPS---LR 411 (468)
Q Consensus 335 ~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~---~R 411 (468)
+|+.||.+.+..+.+.++..... ...+|. ...+++++++||.+|+. +|. .|
T Consensus 231 ~G~~Pf~~~~~~~~~~~i~~~~~---------------~~~~p~----------~~~~s~~~~~li~~l~~-~~~~r~~r 284 (363)
T cd05628 231 IGYPPFCSETPQETYKKVMNWKE---------------TLIFPP----------EVPISEKAKDLILRFCC-EWEHRIGA 284 (363)
T ss_pred hCCCCCCCCCHHHHHHHHHcCcC---------------cccCCC----------cCCCCHHHHHHHHHHcC-ChhhcCCC
Confidence 99999998877776666554110 111111 01368899999999775 444 46
Q ss_pred CCHHHHhCCCCCCCCCC
Q 012233 412 CTALEACAHPFFDDLRD 428 (468)
Q Consensus 412 ~s~~ell~hp~f~~~~~ 428 (468)
|+++|+++||||+++.-
T Consensus 285 ~~~~ei~~hp~f~~~~~ 301 (363)
T cd05628 285 PGVEEIKTNPFFEGVDW 301 (363)
T ss_pred CCHHHHhCCCCCCCCCH
Confidence 89999999999998643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=366.76 Aligned_cols=252 Identities=30% Similarity=0.446 Sum_probs=206.9
Q ss_pred CcccceEEeceecccCceEEEEEEEcCCC-CEEEEEEeeccc-------chHHHHHHHHHHcCCCCcccccceeeecCCC
Q 012233 134 KQTISYMAERVVGTGSFGVVFQAKCLETG-DSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEK 205 (468)
Q Consensus 134 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g-~~vaiK~~~~~~-------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 205 (468)
....+|.+.+.||+|+||.||+|.+..++ ..||+|.+.... ....+|+.+++.++||||+++++++ .
T Consensus 27 ~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~ 101 (340)
T PTZ00426 27 MKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSF-----K 101 (340)
T ss_pred CChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEE-----E
Confidence 34457999999999999999999976655 689999885431 2345799999999999999999998 4
Q ss_pred CceEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeec
Q 012233 206 DELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG 285 (468)
Q Consensus 206 ~~~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG 285 (468)
+..++|+||||+.++.+.... .....+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||
T Consensus 102 ~~~~~~lv~Ey~~~g~L~~~i---~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDLkp~NILl~~~~-~ikL~DFG 176 (340)
T PTZ00426 102 DESYLYLVLEFVIGGEFFTFL---RRNKRFPNDVGCFYAAQIVLIFEYLQS-LNIVYRDLKPENLLLDKDG-FIKMTDFG 176 (340)
T ss_pred eCCEEEEEEeCCCCCcHHHHH---HHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEccCCCHHHEEECCCC-CEEEecCC
Confidence 445689999999876443221 224568999999999999999999998 8999999999999999888 79999999
Q ss_pred CccccCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 012233 286 SAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIK 365 (468)
Q Consensus 286 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 365 (468)
++..... ......||+.|+|||++.+.. ++.++|||||||++|||++|..||.+.+....+..+...
T Consensus 177 ~a~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~---------- 243 (340)
T PTZ00426 177 FAKVVDT--RTYTLCGTPEYIAPEILLNVG-HGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEG---------- 243 (340)
T ss_pred CCeecCC--CcceecCChhhcCHHHHhCCC-CCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcC----------
Confidence 9976532 234568999999999997654 899999999999999999999999887766555554431
Q ss_pred hcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCC-----CHHHHhCCCCCCCCC
Q 012233 366 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC-----TALEACAHPFFDDLR 427 (468)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~-----s~~ell~hp~f~~~~ 427 (468)
... ++..+++.+.++|++||+.||.+|+ ++++++.||||+++.
T Consensus 244 -------~~~------------~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~ 291 (340)
T PTZ00426 244 -------IIY------------FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNID 291 (340)
T ss_pred -------CCC------------CCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence 111 2345788999999999999999996 899999999999864
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=354.55 Aligned_cols=247 Identities=27% Similarity=0.453 Sum_probs=217.6
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-------chHHHHHHHHHHcCCCCcccccceeeecCCCCceE
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 209 (468)
.+|.+.+.||+|.||+|-+|.....|+.||||.|.++. ....+|++||..|+||||+.+|.+| ++...
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVF-----ENkdK 127 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVF-----ENKDK 127 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhh-----cCCce
Confidence 46999999999999999999999999999999886553 2346899999999999999999999 55556
Q ss_pred EEEEeecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcc
Q 012233 210 LNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (468)
Q Consensus 210 ~~lv~e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~ 288 (468)
+.|||||..+| |++.+ ...+.+++.+++.+++||+.|+.|+|. ++++|||||.+|||+|.++ ++||+|||++.
T Consensus 128 IvivMEYaS~GeLYDYi----Ser~~LsErEaRhfFRQIvSAVhYCHk-nrVvHRDLKLENILLD~N~-NiKIADFGLSN 201 (668)
T KOG0611|consen 128 IVIVMEYASGGELYDYI----SERGSLSEREARHFFRQIVSAVHYCHK-NRVVHRDLKLENILLDQNN-NIKIADFGLSN 201 (668)
T ss_pred EEEEEEecCCccHHHHH----HHhccccHHHHHHHHHHHHHHHHHHhh-ccceecccchhheeecCCC-Ceeeeccchhh
Confidence 89999999865 44433 335779999999999999999999998 9999999999999999988 79999999999
Q ss_pred ccCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 012233 289 MLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368 (468)
Q Consensus 289 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 368 (468)
.+.......++||+|-|.+||++.|.+.-++.+|.|||||+||.|+.|..||.+.+....+.+|...
T Consensus 202 ly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~G------------- 268 (668)
T KOG0611|consen 202 LYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRG------------- 268 (668)
T ss_pred hhccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcc-------------
Confidence 8888888889999999999999999887789999999999999999999999998877777776552
Q ss_pred CCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCC
Q 012233 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFD 424 (468)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~ 424 (468)
.+ +.+.-+.++.-||+.||-.||.+|.|++++..|-|..
T Consensus 269 ----aY-------------rEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 269 ----AY-------------REPETPSDASGLIRWMLMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred ----cc-------------cCCCCCchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence 11 1234577899999999999999999999999998875
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=365.30 Aligned_cols=257 Identities=29% Similarity=0.460 Sum_probs=209.3
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-------chHHHHHHHHHHcCCCCcccccceeeecCCCCceEE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~ 210 (468)
+|.+.+.||+|+||.||+|.+..+++.||||++.... ....+|+.+++.++||||+++++++ .+..++
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~-----~~~~~~ 76 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAF-----QDDEYL 76 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEE-----EcCCEE
Confidence 5999999999999999999999999999999986432 2345699999999999999999888 445578
Q ss_pred EEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcccc
Q 012233 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (468)
Q Consensus 211 ~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~ 290 (468)
||||||+.++.+.... .....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++...
T Consensus 77 ~lv~e~~~g~~L~~~l---~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~~~-~~kL~Dfg~a~~~ 151 (333)
T cd05600 77 YLAMEYVPGGDFRTLL---NNLGVLSEDHARFYMAEMFEAVDALHE-LGYIHRDLKPENFLIDASG-HIKLTDFGLSKGI 151 (333)
T ss_pred EEEEeCCCCCCHHHHH---HHcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEECCCC-CEEEEeCcCCccc
Confidence 9999999876544322 224568899999999999999999998 8999999999999999888 7999999999765
Q ss_pred CCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCC
Q 012233 291 VPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPN 370 (468)
Q Consensus 291 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 370 (468)
.. ......||+.|+|||++.+. .++.++|||||||++|||++|..||...+..+.+..+......
T Consensus 152 ~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~------------ 216 (333)
T cd05600 152 VT--YANSVVGSPDYMAPEVLRGK-GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKET------------ 216 (333)
T ss_pred cc--ccCCcccCccccChhHhcCC-CCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcccc------------
Confidence 33 33456899999999999766 5899999999999999999999999987776665554431100
Q ss_pred CccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCC
Q 012233 371 YTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRD 428 (468)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~ 428 (468)
...+... .....+++++.+||.+||..+|.+|+++.+++.||||+++..
T Consensus 217 ---~~~~~~~------~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~~ 265 (333)
T cd05600 217 ---LQRPVYD------DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVDW 265 (333)
T ss_pred ---ccCCCCC------ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCCCH
Confidence 0001000 001247899999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=371.19 Aligned_cols=253 Identities=28% Similarity=0.462 Sum_probs=202.8
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-------chHHHHHHHHHHcCCCCcccccceeeecCCCCceEE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~ 210 (468)
+|.+.+.||+|+||.||+|.+..+|+.||||++.+.. ....+|+.+++.++||||++++++| .+..++
T Consensus 2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~-----~~~~~~ 76 (377)
T cd05629 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSF-----QDAQYL 76 (377)
T ss_pred CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEE-----EcCCee
Confidence 5999999999999999999999999999999885432 2345699999999999999999988 455579
Q ss_pred EEEeecccchHH-HHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccc
Q 012233 211 NLVLEYISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (468)
Q Consensus 211 ~lv~e~~~~~ll-~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~ 289 (468)
||||||++++.+ ..+. ....+++..++.++.|++.||.|||+ +||+||||||+|||++.++ .+||+|||+++.
T Consensus 77 ~lv~E~~~gg~L~~~l~----~~~~~~~~~~~~~~~ql~~aL~~LH~-~givHrDlkp~NIll~~~~-~~kl~DfGla~~ 150 (377)
T cd05629 77 YLIMEFLPGGDLMTMLI----KYDTFSEDVTRFYMAECVLAIEAVHK-LGFIHRDIKPDNILIDRGG-HIKLSDFGLSTG 150 (377)
T ss_pred EEEEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEECCCC-CEEEeecccccc
Confidence 999999986544 3332 24568899999999999999999998 8999999999999999888 799999999863
Q ss_pred cCCCC------------------------------------------------CCccccccCCccccccccCCCCCCcch
Q 012233 290 LVPGE------------------------------------------------PNISYICSRYYRAPELIFGATEYTTAI 321 (468)
Q Consensus 290 ~~~~~------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~ 321 (468)
..... .....+||+.|+|||++.+. .++.++
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~ 229 (377)
T cd05629 151 FHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQ-GYGQEC 229 (377)
T ss_pred cccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccC-CCCCce
Confidence 31100 00124689999999999765 489999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHH
Q 012233 322 DMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVS 401 (468)
Q Consensus 322 DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 401 (468)
|||||||++|||++|.+||.+.+..+.+..+.... ....+|. ...++.++++||.
T Consensus 230 DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~---------------~~~~~p~----------~~~~s~~~~dli~ 284 (377)
T cd05629 230 DWWSLGAIMFECLIGWPPFCSENSHETYRKIINWR---------------ETLYFPD----------DIHLSVEAEDLIR 284 (377)
T ss_pred eeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccC---------------CccCCCC----------CCCCCHHHHHHHH
Confidence 99999999999999999998877666655554310 0111111 1247889999999
Q ss_pred HhcccCCCCC---CCHHHHhCCCCCCCCCC
Q 012233 402 RLLQYSPSLR---CTALEACAHPFFDDLRD 428 (468)
Q Consensus 402 ~~L~~dP~~R---~s~~ell~hp~f~~~~~ 428 (468)
+||. +|.+| +++.+++.||||+++..
T Consensus 285 ~lL~-~~~~r~~r~~~~~~l~hp~~~~~~~ 313 (377)
T cd05629 285 RLIT-NAENRLGRGGAHEIKSHPFFRGVDW 313 (377)
T ss_pred HHhc-CHhhcCCCCCHHHHhcCCCcCCCCH
Confidence 9998 67665 59999999999997643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=367.29 Aligned_cols=257 Identities=31% Similarity=0.501 Sum_probs=210.5
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc-------cchHHHHHHHHHHcCCCCcccccceeeecCCCCceEE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~-------~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~ 210 (468)
+|.+.+.||+|+||.||+|.+..+|+.||||++... .....+|+.++..++||||+++++++ .+..++
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~ 76 (350)
T cd05573 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSF-----QDEEHL 76 (350)
T ss_pred CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhe-----ecCCeE
Confidence 599999999999999999999999999999998643 22345799999999999999999988 455579
Q ss_pred EEEeecccchHH-HHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccc
Q 012233 211 NLVLEYISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (468)
Q Consensus 211 ~lv~e~~~~~ll-~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~ 289 (468)
|+||||+.++.+ ..+.. ...+++..++.++.||+.||.|||+ +||+||||||+||||+.++ .+||+|||++..
T Consensus 77 ~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~-~giiH~Dlkp~NIll~~~~-~~kL~Dfg~~~~ 150 (350)
T cd05573 77 YLVMEYMPGGDLMNLLIR----KDVFPEETARFYIAELVLALDSVHK-LGFIHRDIKPDNILIDADG-HIKLADFGLCKK 150 (350)
T ss_pred EEEEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEECCCC-CEEeecCCCCcc
Confidence 999999986544 33322 3578999999999999999999998 9999999999999999888 799999999976
Q ss_pred cCCCC------------------------------CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCC
Q 012233 290 LVPGE------------------------------PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPL 339 (468)
Q Consensus 290 ~~~~~------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~p 339 (468)
..... ......||+.|+|||++.+. .++.++|||||||++|||++|+.|
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~P 229 (350)
T cd05573 151 MNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT-PYGLECDWWSLGVILYEMLYGFPP 229 (350)
T ss_pred CcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCC-CCCCceeeEecchhhhhhccCCCC
Confidence 54332 22345789999999999765 589999999999999999999999
Q ss_pred CCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCC-HHHHh
Q 012233 340 FPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCT-ALEAC 418 (468)
Q Consensus 340 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s-~~ell 418 (468)
|...+..+....+.... ....+|. ...+++++.+||.+||. ||.+|++ +.+++
T Consensus 230 f~~~~~~~~~~~i~~~~---------------~~~~~p~----------~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll 283 (350)
T cd05573 230 FYSDTLQETYNKIINWK---------------ESLRFPP----------DPPVSPEAIDLICRLLC-DPEDRLGSFEEIK 283 (350)
T ss_pred CCCCCHHHHHHHHhccC---------------CcccCCC----------CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHh
Confidence 99887666555554311 0111111 12268999999999998 9999999 99999
Q ss_pred CCCCCCCCCCCCCC
Q 012233 419 AHPFFDDLRDPNTC 432 (468)
Q Consensus 419 ~hp~f~~~~~~~~~ 432 (468)
.||||+++......
T Consensus 284 ~hp~~~~~~~~~~~ 297 (350)
T cd05573 284 SHPFFKGIDWENLR 297 (350)
T ss_pred cCCCcCCCCHHHHh
Confidence 99999987665444
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=350.48 Aligned_cols=276 Identities=34% Similarity=0.539 Sum_probs=217.9
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc------chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 211 (468)
+|.+.+.||+|+||.||+|.+..+|+.||+|.+.... ....+|+.+++.++||||+++++++ .+..+++
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~-----~~~~~~~ 75 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVL-----HSDKKLT 75 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHh-----ccCCceE
Confidence 4889999999999999999999999999999885421 2345799999999999999999998 4555689
Q ss_pred EEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccC
Q 012233 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (468)
Q Consensus 212 lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~ 291 (468)
+|+||++++++..+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++....
T Consensus 76 lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~-~~i~H~dl~~~nil~~~~~-~~~l~dfg~~~~~~ 150 (284)
T cd07839 76 LVFEYCDQDLKKYFDS---CNGDIDPEIVKSFMFQLLKGLAFCHS-HNVLHRDLKPQNLLINKNG-ELKLADFGLARAFG 150 (284)
T ss_pred EEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHEEEcCCC-cEEECccchhhccC
Confidence 9999999887765432 24568999999999999999999998 8999999999999999887 79999999987653
Q ss_pred CCC-CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCC-CCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 012233 292 PGE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLF-PGESGVDQLVEIIKILGTPTREEIKCMNP 369 (468)
Q Consensus 292 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 369 (468)
... ......+++.|+|||++.+...++.++|||||||++|+|++|..|| .+.+..+.+..+...++.+....+.....
T Consensus 151 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07839 151 IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSK 230 (284)
T ss_pred CCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhh
Confidence 322 2234567899999999877666899999999999999999988774 55666677777777777766554433221
Q ss_pred CCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 012233 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (468)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f 423 (468)
......++............+.+++++.+||.+||+.||.+|||+.+++.||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred cccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 111111222111111122335688999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-45 Score=365.60 Aligned_cols=257 Identities=27% Similarity=0.434 Sum_probs=209.0
Q ss_pred CcccceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc-------cchHHHHHHHHHHcCCCCcccccceeeecCCCC
Q 012233 134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD 206 (468)
Q Consensus 134 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~-------~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 206 (468)
....+|.+.+.||+|+||.||+|.+..+++.||+|++.+. .....+|+.+++.++||||+++++++ .+
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~-----~~ 114 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAF-----QD 114 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-----ec
Confidence 3445799999999999999999999999999999998542 12345799999999999999999888 45
Q ss_pred ceEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecC
Q 012233 207 ELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (468)
Q Consensus 207 ~~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~ 286 (468)
..++|+||||++++.+..+.. ...+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~l~----~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDLkp~NILl~~~~-~~kL~DfG~ 188 (370)
T cd05596 115 DKYLYMVMEYMPGGDLVNLMS----NYDIPEKWARFYTAEVVLALDAIHS-MGFIHRDVKPDNMLLDKSG-HLKLADFGT 188 (370)
T ss_pred CCEEEEEEcCCCCCcHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHEEEcCCC-CEEEEeccc
Confidence 557999999998765543322 2357888899999999999999998 8999999999999999888 799999999
Q ss_pred ccccCCCC--CCccccccCCccccccccCCC---CCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 012233 287 AKMLVPGE--PNISYICSRYYRAPELIFGAT---EYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTR 361 (468)
Q Consensus 287 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~---~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~ 361 (468)
+....... .....+||+.|+|||++.+.. .++.++|||||||++|||++|..||.+.+....+.++....
T Consensus 189 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~----- 263 (370)
T cd05596 189 CMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHK----- 263 (370)
T ss_pred eeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCC-----
Confidence 97654322 223567999999999986532 37889999999999999999999999887766666554311
Q ss_pred HHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCC--CCCHHHHhCCCCCCCC
Q 012233 362 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSL--RCTALEACAHPFFDDL 426 (468)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~--R~s~~ell~hp~f~~~ 426 (468)
....+|. ...++.++++||++||+.+|.+ |++++++++||||+..
T Consensus 264 ----------~~~~~~~----------~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~ 310 (370)
T cd05596 264 ----------NSLTFPD----------DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKND 310 (370)
T ss_pred ----------CcCCCCC----------cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCC
Confidence 0111111 1247899999999999999988 9999999999999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-45 Score=360.25 Aligned_cols=245 Identities=28% Similarity=0.450 Sum_probs=201.3
Q ss_pred ceecccCceEEEEEEEcCCCCEEEEEEeeccc-------chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEEEee
Q 012233 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLE 215 (468)
Q Consensus 143 ~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv~e 215 (468)
+.||+|+||.||++.+..+|..||+|++.... ....+|+.+++.++||||++++++| ....++|||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~-----~~~~~~~lv~E 75 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHDRLCFVME 75 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCEEEEEEe
Confidence 46999999999999999999999999986432 1234689999999999999999988 44456899999
Q ss_pred cccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCC-CC
Q 012233 216 YISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP-GE 294 (468)
Q Consensus 216 ~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~-~~ 294 (468)
|+.++.+.... .....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++..... ..
T Consensus 76 ~~~~~~L~~~l---~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~-~~kL~Dfg~~~~~~~~~~ 150 (323)
T cd05595 76 YANGGELFFHL---SRERVFTEERARFYGAEIVSALEYLHS-RDVVYRDIKLENLMLDKDG-HIKITDFGLCKEGISDGA 150 (323)
T ss_pred CCCCCcHHHHH---HHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHEEEcCCC-CEEecccHHhccccCCCC
Confidence 99977554222 224568999999999999999999998 8999999999999999888 799999999875422 22
Q ss_pred CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccC
Q 012233 295 PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEF 374 (468)
Q Consensus 295 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 374 (468)
......||+.|+|||++.+. .++.++|||||||++|||++|+.||...+.......+.. ...
T Consensus 151 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~-----------------~~~ 212 (323)
T cd05595 151 TMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM-----------------EEI 212 (323)
T ss_pred ccccccCCcCcCCcccccCC-CCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhc-----------------CCC
Confidence 23356789999999999655 489999999999999999999999987766555444432 111
Q ss_pred CCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCC-----CHHHHhCCCCCCCCC
Q 012233 375 KFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC-----TALEACAHPFFDDLR 427 (468)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~-----s~~ell~hp~f~~~~ 427 (468)
. ++..+++++.+||.+||+.||.+|+ ++.++++||||..+.
T Consensus 213 ~------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~ 258 (323)
T cd05595 213 R------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 258 (323)
T ss_pred C------------CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCC
Confidence 1 2345789999999999999999998 899999999999854
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-45 Score=358.43 Aligned_cols=245 Identities=29% Similarity=0.502 Sum_probs=199.9
Q ss_pred ceecccCceEEEEEEEcCCCCEEEEEEeeccc-------chHHHHHHHHHHc-CCCCcccccceeeecCCCCceEEEEEe
Q 012233 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDELYLNLVL 214 (468)
Q Consensus 143 ~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-------~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~lv~ 214 (468)
+.||+|+||.||+|+++.+++.||||++.+.. .....|..++..+ +||||+++++++ .+...+|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~-----~~~~~~~iv~ 75 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCF-----QTPDRLFFVM 75 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEE-----EcCCEEEEEE
Confidence 46999999999999999999999999986432 2233577777766 699999999988 4445689999
Q ss_pred ecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccC-CC
Q 012233 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV-PG 293 (468)
Q Consensus 215 e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~-~~ 293 (468)
||+.++.+.... .....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++... ..
T Consensus 76 Ey~~~g~L~~~i---~~~~~l~~~~~~~~~~ql~~~L~~lH~-~~ivH~dlkp~NIli~~~~-~~kL~DfG~~~~~~~~~ 150 (320)
T cd05590 76 EFVNGGDLMFHI---QKSRRFDEARARFYAAEITSALMFLHD-KGIIYRDLKLDNVLLDHEG-HCKLADFGMCKEGIFNG 150 (320)
T ss_pred cCCCCchHHHHH---HHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCCHHHeEECCCC-cEEEeeCCCCeecCcCC
Confidence 999976554222 224568999999999999999999998 8999999999999999888 79999999987542 22
Q ss_pred CCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCcc
Q 012233 294 EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTE 373 (468)
Q Consensus 294 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 373 (468)
.......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+... .
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~-----------------~ 212 (320)
T cd05590 151 KTTSTFCGTPDYIAPEILQEM-LYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND-----------------E 212 (320)
T ss_pred CcccccccCccccCHHHHcCC-CCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcC-----------------C
Confidence 233456789999999999654 4899999999999999999999999987766655554331 1
Q ss_pred CCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCH------HHHhCCCCCCCCC
Q 012233 374 FKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTA------LEACAHPFFDDLR 427 (468)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~------~ell~hp~f~~~~ 427 (468)
.. ++..++.++.+||.+||+.||.+|+++ ++++.||||+.+.
T Consensus 213 ~~------------~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~ 260 (320)
T cd05590 213 VV------------YPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELD 260 (320)
T ss_pred CC------------CCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCC
Confidence 11 223478999999999999999999998 8999999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-45 Score=361.21 Aligned_cols=244 Identities=27% Similarity=0.435 Sum_probs=199.9
Q ss_pred ceecccCceEEEEEEEcCCCCEEEEEEeeccc-------chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEEEee
Q 012233 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLE 215 (468)
Q Consensus 143 ~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv~e 215 (468)
+.||+|+||.||++.+..+|+.||+|++.+.. ....+|+.+++.++||||+++++++ .+...+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~~lv~E 75 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSF-----QTKDRLCFVME 75 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-----EcCCEEEEEEe
Confidence 36999999999999999999999999986432 2334689999999999999999888 44456899999
Q ss_pred cccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCCC-C
Q 012233 216 YISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG-E 294 (468)
Q Consensus 216 ~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~~-~ 294 (468)
|++++.+.... .....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++..... .
T Consensus 76 y~~~g~L~~~l---~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDikp~NIll~~~~-~~kL~DfG~~~~~~~~~~ 150 (328)
T cd05593 76 YVNGGELFFHL---SRERVFSEDRTRFYGAEIVSALDYLHS-GKIVYRDLKLENLMLDKDG-HIKITDFGLCKEGITDAA 150 (328)
T ss_pred CCCCCCHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEecccCHHHeEECCCC-cEEEecCcCCccCCCccc
Confidence 99876553222 224568999999999999999999998 8999999999999999888 7999999998754222 2
Q ss_pred CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccC
Q 012233 295 PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEF 374 (468)
Q Consensus 295 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 374 (468)
.....+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+.. ...
T Consensus 151 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~-----------------~~~ 212 (328)
T cd05593 151 TMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM-----------------EDI 212 (328)
T ss_pred ccccccCCcCccChhhhcCC-CCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhcc-----------------CCc
Confidence 23346799999999999655 489999999999999999999999987765544433321 111
Q ss_pred CCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCC-----CHHHHhCCCCCCCC
Q 012233 375 KFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC-----TALEACAHPFFDDL 426 (468)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~-----s~~ell~hp~f~~~ 426 (468)
. ++..+++++.+||.+||+.||.+|+ ++.++++||||..+
T Consensus 213 ~------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~ 257 (328)
T cd05593 213 K------------FPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGV 257 (328)
T ss_pred c------------CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 1 3345889999999999999999997 89999999999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-45 Score=358.56 Aligned_cols=243 Identities=31% Similarity=0.513 Sum_probs=199.2
Q ss_pred ecccCceEEEEEEEcCCCCEEEEEEeeccc-------chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEEEeecc
Q 012233 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYI 217 (468)
Q Consensus 145 lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv~e~~ 217 (468)
||+|+||.||+|.+..+++.||+|++.... ....+|+.+++.++||||++++++| .+...+|+||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv~e~~ 75 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSF-----QSPEKLYLVLAFI 75 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEE-----ecCCeEEEEEcCC
Confidence 799999999999999999999999986431 2234699999999999999999888 4445689999999
Q ss_pred cchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCCC-CCC
Q 012233 218 SETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG-EPN 296 (468)
Q Consensus 218 ~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~~-~~~ 296 (468)
.++.+.... .....+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++..... ...
T Consensus 76 ~~g~L~~~l---~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~HrDlkp~Nili~~~~-~~kl~Dfg~~~~~~~~~~~~ 150 (312)
T cd05585 76 NGGELFHHL---QREGRFDLSRARFYTAELLCALENLHK-FNVIYRDLKPENILLDYQG-HIALCDFGLCKLNMKDDDKT 150 (312)
T ss_pred CCCcHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeCCCCHHHeEECCCC-cEEEEECcccccCccCCCcc
Confidence 976543222 224568999999999999999999998 8999999999999999888 7999999998754322 223
Q ss_pred ccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccCCC
Q 012233 297 ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKF 376 (468)
Q Consensus 297 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 376 (468)
...+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+.. ....
T Consensus 151 ~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~-----------------~~~~- 211 (312)
T cd05585 151 NTFCGTPEYLAPELLLGH-GYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQ-----------------EPLR- 211 (312)
T ss_pred ccccCCcccCCHHHHcCC-CCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHc-----------------CCCC-
Confidence 356799999999999765 489999999999999999999999988766555544432 1111
Q ss_pred CcccCCCcccccccCCCHHHHHHHHHhcccCCCCCC---CHHHHhCCCCCCCCC
Q 012233 377 PQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC---TALEACAHPFFDDLR 427 (468)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~---s~~ell~hp~f~~~~ 427 (468)
++..+++++.+||.+||+.||.+|+ ++.+++.||||.+..
T Consensus 212 -----------~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~~ 254 (312)
T cd05585 212 -----------FPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLS 254 (312)
T ss_pred -----------CCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCCC
Confidence 3345789999999999999999997 589999999999863
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=356.77 Aligned_cols=314 Identities=35% Similarity=0.640 Sum_probs=241.4
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc-----cchHHHHHHHHHHcCCCCcccccceeeecCCCCceEEE
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~-----~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 211 (468)
.+|.+.+.||+|+||.||+|.+..+|+.||||++... .....+|+.+++.++||||+++++++..........+|
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 84 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVY 84 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEE
Confidence 4699999999999999999999999999999988532 12234699999999999999999987554444445689
Q ss_pred EEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccC
Q 012233 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (468)
Q Consensus 212 lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~ 291 (468)
+|+||+.+.+...+. ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||++....
T Consensus 85 lv~e~~~~~l~~~~~-----~~~l~~~~~~~i~~ql~~aL~~LH~-~~ivH~dlkp~Nill~~~~-~~kl~dfg~~~~~~ 157 (336)
T cd07849 85 IVQELMETDLYKLIK-----TQHLSNDHIQYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLNTNC-DLKICDFGLARIAD 157 (336)
T ss_pred EEehhcccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEECCCC-CEEECcccceeecc
Confidence 999999987766443 3568999999999999999999998 8999999999999999888 79999999987653
Q ss_pred CCCC----CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 012233 292 PGEP----NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367 (468)
Q Consensus 292 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 367 (468)
.... .....|++.|+|||.+.+...++.++|||||||++|+|++|+.||.+.+.......+...++.+..+.+...
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (336)
T cd07849 158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCI 237 (336)
T ss_pred ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence 3221 123567899999998766556899999999999999999999999988877778888888887776554432
Q ss_pred CCCCccCC---CCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCCCCCCCCCCCCCcccc
Q 012233 368 NPNYTEFK---FPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNTCLPNGRPLPTLFN 444 (468)
Q Consensus 368 ~~~~~~~~---~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~ 444 (468)
........ .+.....++.. ..+.+++++.+||.+||+.||.+|||+.+++.||||+.+.++........++ -
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~~~~~~~~~~~----~ 312 (336)
T cd07849 238 ISLRARNYIKSLPFKPKVPWNK-LFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPSDEPVAEEPF----P 312 (336)
T ss_pred hchhhhhHHhhcCcCCcccHHH-HhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCCCCcccCCCCC----C
Confidence 21110000 01111111111 2234688999999999999999999999999999999988764432222222 3
Q ss_pred cCHHHHhcCCHHHHHhcc
Q 012233 445 FTAQELAGASNELRQRLI 462 (468)
Q Consensus 445 ~~~~~~~~~~~~~~~~~~ 462 (468)
|+-..+..++-|..+++|
T Consensus 313 ~~~~~~~~~~~~~~~~~~ 330 (336)
T cd07849 313 FDFELFDDLPKEKLKELI 330 (336)
T ss_pred hhhccccccCHHHHHHHH
Confidence 444466788888888877
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-45 Score=368.56 Aligned_cols=255 Identities=27% Similarity=0.436 Sum_probs=201.7
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-------chHHHHHHHHHHcCCCCcccccceeeecCCCCceEE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~ 210 (468)
.|.+.+.||+|+||+||+|.+..+++.||||++.+.. ....+|+.+++.++||||+++++++ .+..++
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~-----~~~~~~ 76 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSF-----QDKDNL 76 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEE-----ecCCEE
Confidence 4899999999999999999999999999999986432 2345799999999999999999988 444569
Q ss_pred EEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcccc
Q 012233 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (468)
Q Consensus 211 ~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~ 290 (468)
|+||||++++.+.... .....+++..++.++.||+.||.|||+ .||+||||||+||||+.++ .+||+|||++...
T Consensus 77 ~lv~E~~~gg~L~~~l---~~~~~~~e~~~~~~~~qi~~aL~~LH~-~givHrDlKp~Nili~~~~-~~kL~DFGl~~~~ 151 (381)
T cd05626 77 YFVMDYIPGGDMMSLL---IRMEVFPEVLARFYIAELTLAIESVHK-MGFIHRDIKPDNILIDLDG-HIKLTDFGLCTGF 151 (381)
T ss_pred EEEEecCCCCcHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCcHHHEEECCCC-CEEEeeCcCCccc
Confidence 9999999876443221 124568899999999999999999998 8999999999999999887 7999999997532
Q ss_pred CCCC------------------------------------------------CCccccccCCccccccccCCCCCCcchh
Q 012233 291 VPGE------------------------------------------------PNISYICSRYYRAPELIFGATEYTTAID 322 (468)
Q Consensus 291 ~~~~------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~D 322 (468)
.... .....+||+.|+|||++.+.. ++.++|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~~D 230 (381)
T cd05626 152 RWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKG-YTQLCD 230 (381)
T ss_pred ccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCC-CCCccc
Confidence 1000 012357999999999997654 899999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHH
Q 012233 323 MWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSR 402 (468)
Q Consensus 323 vwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 402 (468)
||||||++|||++|..||...+..+....++.... ...++. ...+++++++||.+
T Consensus 231 iwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~---------------~~~~~~----------~~~~s~~~~dli~~ 285 (381)
T cd05626 231 WWSVGVILFEMLVGQPPFLAPTPTETQLKVINWEN---------------TLHIPP----------QVKLSPEAVDLITK 285 (381)
T ss_pred eeehhhHHHHHHhCCCCCcCCCHHHHHHHHHcccc---------------ccCCCC----------CCCCCHHHHHHHHH
Confidence 99999999999999999988776655555443100 111111 12478999999999
Q ss_pred hcc--cCCCCCCCHHHHhCCCCCCCCCC
Q 012233 403 LLQ--YSPSLRCTALEACAHPFFDDLRD 428 (468)
Q Consensus 403 ~L~--~dP~~R~s~~ell~hp~f~~~~~ 428 (468)
||. .+|..|+++.+++.||||+++..
T Consensus 286 ll~~~~~~~~R~~~~~~l~hp~f~~~~~ 313 (381)
T cd05626 286 LCCSAEERLGRNGADDIKAHPFFSEVDF 313 (381)
T ss_pred HccCcccccCCCCHHHHhcCcccCCCCh
Confidence 654 45556999999999999998643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-46 Score=342.10 Aligned_cols=254 Identities=30% Similarity=0.456 Sum_probs=217.0
Q ss_pred cccceEEeceecccCceEEEEEEEcCCCCEEEEEEeecccchHH-------HHHHHHHHcCCCCcccccceeeecCCCCc
Q 012233 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-------RELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (468)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~~~~~-------~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 207 (468)
..++|...++||+|.||+|.+|+.+.+|+.||||+++++....+ .|-.+|+..+||.+..|.-.| +..
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsF-----Qt~ 240 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSF-----QTQ 240 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhh-----ccC
Confidence 45689999999999999999999999999999998876543332 477899999999999887777 444
Q ss_pred eEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCc
Q 012233 208 LYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (468)
Q Consensus 208 ~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a 287 (468)
..+|+||||..||-+-. +..+ .+.|++..++.|...|+.||.|||+ ++||+||||.+|+|+|.+|| +||+|||++
T Consensus 241 drlCFVMeyanGGeLf~--HLsr-er~FsE~RtRFYGaEIvsAL~YLHs-~~ivYRDlKLENLlLDkDGH-IKitDFGLC 315 (516)
T KOG0690|consen 241 DRLCFVMEYANGGELFF--HLSR-ERVFSEDRTRFYGAEIVSALGYLHS-RNIVYRDLKLENLLLDKDGH-IKITDFGLC 315 (516)
T ss_pred ceEEEEEEEccCceEee--ehhh-hhcccchhhhhhhHHHHHHhhhhhh-CCeeeeechhhhheeccCCc-eEeeecccc
Confidence 56999999999874432 2222 5679999999999999999999998 99999999999999999995 999999999
Q ss_pred ccc-CCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 012233 288 KML-VPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKC 366 (468)
Q Consensus 288 ~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 366 (468)
+.- ..+....++||||.|+|||++... .|+.++|+|.+||++|||++|+.||.+.+....+..|..
T Consensus 316 KE~I~~g~t~kTFCGTPEYLAPEVleDn-DYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~------------ 382 (516)
T KOG0690|consen 316 KEEIKYGDTTKTFCGTPEYLAPEVLEDN-DYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILM------------ 382 (516)
T ss_pred hhcccccceeccccCChhhcCchhhccc-cccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHh------------
Confidence 764 334566789999999999999655 499999999999999999999999999888777776655
Q ss_pred cCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCC-----CHHHHhCCCCCCCCCC
Q 012233 367 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC-----TALEACAHPFFDDLRD 428 (468)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~-----s~~ell~hp~f~~~~~ 428 (468)
.+++| +..++++++.|+..+|.+||.+|. .+.|+.+|+||..+.=
T Consensus 383 -----ed~kF------------Pr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W 432 (516)
T KOG0690|consen 383 -----EDLKF------------PRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDW 432 (516)
T ss_pred -----hhccC------------CccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCH
Confidence 34444 457999999999999999999998 5889999999998754
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=348.61 Aligned_cols=276 Identities=34% Similarity=0.633 Sum_probs=217.8
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc------cchHHHHHHHHHHcCCCCcccccceeeecCCCCceEEE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~------~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 211 (468)
+|.+.+.||+|+||.||+|.+..++..||||.+... .....+|+.+++.++||||+++++++. +..++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 75 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLM-----QESRLY 75 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEe-----eCCeEE
Confidence 488999999999999999999999999999987532 123567999999999999999999983 445689
Q ss_pred EEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccC
Q 012233 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (468)
Q Consensus 212 lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~ 291 (468)
+||||+.+++...+.... ....+++..++.++.||+.||.|||+ +||+|+||||+|||++.++ .++|+|||++....
T Consensus 76 ~v~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~ 152 (285)
T cd07861 76 LIFEFLSMDLKKYLDSLP-KGQYMDAELVKSYLYQILQGILFCHS-RRVLHRDLKPQNLLIDNKG-VIKLADFGLARAFG 152 (285)
T ss_pred EEEecCCCCHHHHHhcCC-CCCcCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCHHHEEEcCCC-cEEECcccceeecC
Confidence 999999987766554322 24568999999999999999999998 8999999999999999888 79999999987553
Q ss_pred CCC-CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC--
Q 012233 292 PGE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN-- 368 (468)
Q Consensus 292 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-- 368 (468)
... ......+++.|+|||++.+...++.++|||||||++|+|++|++||.+....+....+....+.+....+....
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (285)
T cd07861 153 IPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSL 232 (285)
T ss_pred CCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhh
Confidence 221 22334678899999998766667899999999999999999999999988888888877777766554432211
Q ss_pred CCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 012233 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (468)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f 423 (468)
+.+. ..++...... .......+++++++||.+||+.||.+|||+.+++.||||
T Consensus 233 ~~~~-~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 233 PDYK-NTFPKWKKGS-LRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred HHHH-hhccccCcch-hHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 0000 0011111111 111234589999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-45 Score=369.53 Aligned_cols=253 Identities=28% Similarity=0.453 Sum_probs=203.4
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-------chHHHHHHHHHHcCCCCcccccceeeecCCCCceEE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~ 210 (468)
.|.+.+.||+|+||.||+|++..+++.||+|++.+.. ....+|+.+++.++||||++++++| .+..++
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~-----~~~~~~ 76 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSF-----QDKDNL 76 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEE-----EeCCEE
Confidence 4899999999999999999999999999999986532 2345799999999999999999998 444569
Q ss_pred EEEeecccchHH-HHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccc
Q 012233 211 NLVLEYISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (468)
Q Consensus 211 ~lv~e~~~~~ll-~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~ 289 (468)
|+|||||+++.+ ..+. ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++..
T Consensus 77 ~lv~E~~~gg~L~~~l~----~~~~~~e~~~~~~~~qi~~al~~lH~-~~ivHrDlKp~NILl~~~g-~~kL~DFGla~~ 150 (382)
T cd05625 77 YFVMDYIPGGDMMSLLI----RMGIFPEDLARFYIAELTCAVESVHK-MGFIHRDIKPDNILIDRDG-HIKLTDFGLCTG 150 (382)
T ss_pred EEEEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECCCC-CEEEeECCCCcc
Confidence 999999987644 3332 23568899999999999999999998 8999999999999999888 799999999753
Q ss_pred cCCC------------------------------------------------CCCccccccCCccccccccCCCCCCcch
Q 012233 290 LVPG------------------------------------------------EPNISYICSRYYRAPELIFGATEYTTAI 321 (468)
Q Consensus 290 ~~~~------------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 321 (468)
.... ......+||+.|+|||++.+. .++.++
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~ 229 (382)
T cd05625 151 FRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT-GYTQLC 229 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCC-CCCCee
Confidence 2100 001235789999999999765 489999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHH
Q 012233 322 DMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVS 401 (468)
Q Consensus 322 DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 401 (468)
|||||||++|||++|++||.+.+..+...++..... ...+| ....+++++.+||.
T Consensus 230 DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~---------------~~~~p----------~~~~~s~~~~~li~ 284 (382)
T cd05625 230 DWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQT---------------SLHIP----------PQAKLSPEASDLII 284 (382)
T ss_pred eEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCC---------------CcCCC----------CcccCCHHHHHHHH
Confidence 999999999999999999998877666555543110 01111 11347899999999
Q ss_pred HhcccCCCCCCC---HHHHhCCCCCCCCCC
Q 012233 402 RLLQYSPSLRCT---ALEACAHPFFDDLRD 428 (468)
Q Consensus 402 ~~L~~dP~~R~s---~~ell~hp~f~~~~~ 428 (468)
+|+ .||.+|++ +.++++||||+.+..
T Consensus 285 ~l~-~~p~~R~~~~~~~ei~~hp~f~~~~~ 313 (382)
T cd05625 285 KLC-RGPEDRLGKNGADEIKAHPFFKTIDF 313 (382)
T ss_pred HHc-cCHhHcCCCCCHHHHhcCCCcCCcCh
Confidence 987 59999997 999999999998643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=357.83 Aligned_cols=248 Identities=29% Similarity=0.497 Sum_probs=202.8
Q ss_pred eEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-------chHHHHHHHH---HHcCCCCcccccceeeecCCCCce
Q 012233 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIM---RLLNHPNVVSLKHCFFSTTEKDEL 208 (468)
Q Consensus 139 y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-------~~~~~E~~il---~~l~hpnIv~l~~~~~~~~~~~~~ 208 (468)
|.+.+.||+|+||.||+|.+..+|+.||||++.+.. ....+|+.++ +.++||||+++++++ ....
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~-----~~~~ 75 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACF-----QTED 75 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEE-----EcCC
Confidence 678899999999999999999999999999986432 1233455554 466799999999988 4445
Q ss_pred EEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcc
Q 012233 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (468)
Q Consensus 209 ~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~ 288 (468)
.+|+||||+.++.+..... ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||+++
T Consensus 76 ~~~lv~E~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~-~~ivHrdlkp~Nill~~~~-~~kL~Dfg~~~ 149 (324)
T cd05589 76 HVCFVMEYAAGGDLMMHIH----TDVFSEPRAVFYAACVVLGLQYLHE-NKIVYRDLKLDNLLLDTEG-FVKIADFGLCK 149 (324)
T ss_pred EEEEEEcCCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEecCCCHHHeEECCCC-cEEeCcccCCc
Confidence 6899999999875543322 3568999999999999999999998 8999999999999999888 79999999987
Q ss_pred ccCC-CCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 012233 289 MLVP-GEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367 (468)
Q Consensus 289 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 367 (468)
.... .......+|++.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+...
T Consensus 150 ~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~------------ 216 (324)
T cd05589 150 EGMGFGDRTSTFCGTPEFLAPEVLTET-SYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVND------------ 216 (324)
T ss_pred cCCCCCCcccccccCccccCHhHhcCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC------------
Confidence 5432 2233456799999999999765 4899999999999999999999999987766655554431
Q ss_pred CCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCC-----CHHHHhCCCCCCCCC
Q 012233 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC-----TALEACAHPFFDDLR 427 (468)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~-----s~~ell~hp~f~~~~ 427 (468)
... ++..+++++.+||.+||+.||.+|| ++.+++.||||+++.
T Consensus 217 -----~~~------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~ 264 (324)
T cd05589 217 -----EVR------------YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDIN 264 (324)
T ss_pred -----CCC------------CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCC
Confidence 111 2345789999999999999999999 799999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-44 Score=357.36 Aligned_cols=254 Identities=28% Similarity=0.375 Sum_probs=200.0
Q ss_pred CcccceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-----chHHHHHHHHHHcCCCCcccccceeeecCCCCce
Q 012233 134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (468)
Q Consensus 134 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 208 (468)
....+|...+.||+|+||.||+|.+..+|+.||||++.... ..+.+|+++++.++|+||+++++++ ....
T Consensus 71 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~ 145 (353)
T PLN00034 71 KSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMF-----DHNG 145 (353)
T ss_pred CCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEe-----ccCC
Confidence 33456899999999999999999999999999999985432 2345799999999999999999988 4455
Q ss_pred EEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcc
Q 012233 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (468)
Q Consensus 209 ~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~ 288 (468)
.+++||||+.++.+.. .....+..+..++.||+.||.|||+ +||+||||||+||||+.++ .+||+|||+++
T Consensus 146 ~~~lv~e~~~~~~L~~-------~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~-~~kL~DfG~~~ 216 (353)
T PLN00034 146 EIQVLLEFMDGGSLEG-------THIADEQFLADVARQILSGIAYLHR-RHIVHRDIKPSNLLINSAK-NVKIADFGVSR 216 (353)
T ss_pred eEEEEEecCCCCcccc-------cccCCHHHHHHHHHHHHHHHHHHHH-CCEeecCCCHHHEEEcCCC-CEEEcccccce
Confidence 6899999999875531 2234567788899999999999998 8999999999999999887 79999999997
Q ss_pred ccCCCC-CCccccccCCccccccccCC----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 012233 289 MLVPGE-PNISYICSRYYRAPELIFGA----TEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREE 363 (468)
Q Consensus 289 ~~~~~~-~~~~~~gt~~y~aPE~~~~~----~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~ 363 (468)
.+.... ......||..|+|||++... ...+.++|||||||++|||++|+.||......+....+.......
T Consensus 217 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~---- 292 (353)
T PLN00034 217 ILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQ---- 292 (353)
T ss_pred ecccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccC----
Confidence 654322 23456789999999987432 224568999999999999999999997443222211111110000
Q ss_pred HhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q 012233 364 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426 (468)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 426 (468)
....+..++.++++||.+||+.||.+|||+.|+++||||..-
T Consensus 293 ---------------------~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~ 334 (353)
T PLN00034 293 ---------------------PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRA 334 (353)
T ss_pred ---------------------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence 001224578899999999999999999999999999999984
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-45 Score=360.96 Aligned_cols=258 Identities=28% Similarity=0.460 Sum_probs=208.7
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-------chHHHHHHHHHHcCCCCcccccceeeecCCCCceEE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~ 210 (468)
+|.+.+.||+|+||.||+|.+..+|+.||||++.... ....+|+.+++.++|+||+++++++ .+..++
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~-----~~~~~~ 76 (330)
T cd05601 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAF-----QDKDNL 76 (330)
T ss_pred CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCeE
Confidence 5999999999999999999999999999999986532 2345789999999999999999888 444568
Q ss_pred EEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcccc
Q 012233 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (468)
Q Consensus 211 ~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~ 290 (468)
|+||||++++.+.... ......+++..++.++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||++...
T Consensus 77 ~lv~e~~~~~~L~~~l--~~~~~~l~~~~~~~~~~qi~~aL~~lH~-~~i~H~Dlkp~NIll~~~~-~~kL~Dfg~a~~~ 152 (330)
T cd05601 77 YLVMEYQPGGDLLSLL--NRYEDQFDEDMAQFYLAELVLAIHSVHQ-MGYVHRDIKPENVLIDRTG-HIKLADFGSAARL 152 (330)
T ss_pred EEEECCCCCCCHHHHH--HHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEcccCchHheEECCCC-CEEeccCCCCeEC
Confidence 9999999865443222 1223568999999999999999999998 8999999999999999888 7999999999766
Q ss_pred CCCCC--CccccccCCccccccccC-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 012233 291 VPGEP--NISYICSRYYRAPELIFG-----ATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREE 363 (468)
Q Consensus 291 ~~~~~--~~~~~gt~~y~aPE~~~~-----~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~ 363 (468)
..... .....||+.|+|||++.. ...++.++|||||||++|+|++|..||...+....+.++....
T Consensus 153 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~------- 225 (330)
T cd05601 153 TANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQ------- 225 (330)
T ss_pred CCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCC-------
Confidence 43332 223478999999999863 3347889999999999999999999998877766666554310
Q ss_pred HhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCCC
Q 012233 364 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPN 430 (468)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~ 430 (468)
....+|. ...+++++.+||.+||. ||.+|||+.+++.||||+.+....
T Consensus 226 --------~~~~~~~----------~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~~~~ 273 (330)
T cd05601 226 --------RFLKFPE----------DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKIDWNN 273 (330)
T ss_pred --------CccCCCC----------CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCCHHH
Confidence 0111111 12478999999999998 999999999999999999875443
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-46 Score=338.75 Aligned_cols=260 Identities=29% Similarity=0.460 Sum_probs=209.7
Q ss_pred ccceEEe-ceecccCceEEEEEEEcCCCCEEEEEEeecccchHHHHHHHHHH-cCCCCcccccceeeecCCCCceEEEEE
Q 012233 136 TISYMAE-RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRL-LNHPNVVSLKHCFFSTTEKDELYLNLV 213 (468)
Q Consensus 136 ~~~y~~~-~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~~~~~~E~~il~~-l~hpnIv~l~~~~~~~~~~~~~~~~lv 213 (468)
+++|.+. ++||-|-.|+|..|..+.+|+.+|+|++....+ .++|+++--. -.|||||.++++|.... .+..++.||
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~K-ARrEVeLHw~~s~h~~iV~IidVyeNs~-~~rkcLLiV 137 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSPK-ARREVELHWMASGHPHIVSIIDVYENSY-QGRKCLLIV 137 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCHH-HHhHhhhhhhhcCCCceEEeehhhhhhc-cCceeeEee
Confidence 3457665 689999999999999999999999998765444 3568877444 46999999999985544 556788899
Q ss_pred eecccchHH-HHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCC--CcEEEeeecCcccc
Q 012233 214 LEYISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHT--HQLKICDFGSAKML 290 (468)
Q Consensus 214 ~e~~~~~ll-~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~--~~vkL~DFG~a~~~ 290 (468)
||++.||-| ..+ ..+..+.|++.++..|+.||+.|+.|||+ .+|.||||||+|+|..... ..+||+|||+|+..
T Consensus 138 mE~meGGeLfsri--q~~g~~afTErea~eI~~qI~~Av~~lH~-~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t 214 (400)
T KOG0604|consen 138 MECMEGGELFSRI--QDRGDQAFTEREASEIMKQIGLAVRYLHS-MNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKET 214 (400)
T ss_pred eecccchHHHHHH--HHcccccchHHHHHHHHHHHHHHHHHHHh-cchhhccCChhheeeecCCCCcceEeccccccccc
Confidence 999997643 322 34456779999999999999999999998 8999999999999996443 26999999999977
Q ss_pred CCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHH----HHHHHHHhCCCCHHHHhh
Q 012233 291 VPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQ----LVEIIKILGTPTREEIKC 366 (468)
Q Consensus 291 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~----~~~i~~~~~~~~~~~~~~ 366 (468)
.......+.|.||+|.|||++ |...|+..+|+||+||++|-||+|.+||....+... -.+|..
T Consensus 215 ~~~~~L~TPc~TPyYvaPevl-g~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~------------ 281 (400)
T KOG0604|consen 215 QEPGDLMTPCFTPYYVAPEVL-GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRT------------ 281 (400)
T ss_pred CCCccccCCcccccccCHHHh-CchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhc------------
Confidence 655667788999999999998 566699999999999999999999999987654321 122222
Q ss_pred cCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q 012233 367 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426 (468)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 426 (468)
..+.||. . -|..+|++++|+|+++|..+|.+|+|+.++++|||+..-
T Consensus 282 -----gqy~FP~---p-----EWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~ 328 (400)
T KOG0604|consen 282 -----GQYEFPE---P-----EWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQY 328 (400)
T ss_pred -----cCccCCC---h-----hHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccc
Confidence 2333432 1 234589999999999999999999999999999999863
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-45 Score=364.73 Aligned_cols=257 Identities=28% Similarity=0.459 Sum_probs=206.9
Q ss_pred cccceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc-------cchHHHHHHHHHHcCCCCcccccceeeecCCCCc
Q 012233 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (468)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~-------~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 207 (468)
...+|.+.+.||+|+||.||++.+..+++.||+|++.+. .....+|+.+++.++||||+++++++ .+.
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~-----~~~ 115 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAF-----QDD 115 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcC
Confidence 345699999999999999999999999999999998542 22345799999999999999999988 455
Q ss_pred eEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCc
Q 012233 208 LYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (468)
Q Consensus 208 ~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a 287 (468)
.++|+||||++++.+..... ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~----~~~~~~~~~~~~~~qil~aL~~LH~-~~IvHrDLKp~NILl~~~~-~~kL~DFG~a 189 (370)
T cd05621 116 KYLYMVMEYMPGGDLVNLMS----NYDVPEKWAKFYTAEVVLALDAIHS-MGLIHRDVKPDNMLLDKHG-HLKLADFGTC 189 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHEEECCCC-CEEEEecccc
Confidence 57999999998764443222 2357889999999999999999998 8999999999999999888 7999999999
Q ss_pred cccCCCC--CCccccccCCccccccccCCC---CCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 012233 288 KMLVPGE--PNISYICSRYYRAPELIFGAT---EYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTRE 362 (468)
Q Consensus 288 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~---~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~ 362 (468)
....... .....+||+.|+|||++.+.. .++.++|||||||++|+|++|+.||.+.+....+.++.....
T Consensus 190 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~----- 264 (370)
T cd05621 190 MKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKN----- 264 (370)
T ss_pred eecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc-----
Confidence 8654322 223567999999999986532 378899999999999999999999998877666666554211
Q ss_pred HHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCC--CCCHHHHhCCCCCCCCC
Q 012233 363 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSL--RCTALEACAHPFFDDLR 427 (468)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~--R~s~~ell~hp~f~~~~ 427 (468)
...+|. ...++..+++||.+||..++.+ |+++.++++||||+...
T Consensus 265 ----------~~~~p~----------~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~ 311 (370)
T cd05621 265 ----------SLNFPE----------DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQ 311 (370)
T ss_pred ----------ccCCCC----------cccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCCC
Confidence 111111 1246899999999999866544 89999999999998743
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=338.40 Aligned_cols=298 Identities=37% Similarity=0.612 Sum_probs=233.5
Q ss_pred cceEEeceecccCceEEEEEEEcCCCC----EEEEEEeeccc------chHHHHHHHHHHcCCCCcccccceeeecCCCC
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGD----SVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD 206 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~----~vaiK~~~~~~------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 206 (468)
..|++...||+|.||.||+|..+.++. .+|||++...+ ...-+|+.+++.++||||+.|..+|...
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~---- 99 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH---- 99 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc----
Confidence 469999999999999999997655443 68999886552 2234899999999999999999999653
Q ss_pred ceEEEEEeecccchHHHHHhhhhh-cCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCC----CCcEEE
Q 012233 207 ELYLNLVLEYISETVYRVSKHYTR-MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPH----THQLKI 281 (468)
Q Consensus 207 ~~~~~lv~e~~~~~ll~~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~----~~~vkL 281 (468)
+..+++++||.+.+++.++.+... ....++...++.++.||+.|+.|||+ +=|+||||||.||||..+ | .|||
T Consensus 100 d~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~-NWvlHRDLKPaNIlvmgdgperG-~VKI 177 (438)
T KOG0666|consen 100 DKKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS-NWVLHRDLKPANILVMGDGPERG-RVKI 177 (438)
T ss_pred CceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh-hheeeccCCcceEEEeccCCccC-eeEe
Confidence 346999999999999998875433 33568889999999999999999997 789999999999999776 5 7999
Q ss_pred eeecCccccCCCC----CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC---------cHHH
Q 012233 282 CDFGSAKMLVPGE----PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGES---------GVDQ 348 (468)
Q Consensus 282 ~DFG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~---------~~~~ 348 (468)
+|||+++.+...- .....+.|.+|+|||++.|...|+++.|||++|||+.||++-.+.|.+.. ..++
T Consensus 178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQ 257 (438)
T KOG0666|consen 178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQ 257 (438)
T ss_pred ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHH
Confidence 9999998874332 22345679999999999999999999999999999999999999997632 3478
Q ss_pred HHHHHHHhCCCCHHHHhhcC--CCCcc--CCCC--cccCCCccccc--ccCCCHHHHHHHHHhcccCCCCCCCHHHHhCC
Q 012233 349 LVEIIKILGTPTREEIKCMN--PNYTE--FKFP--QIKAHPWHKIF--HKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (468)
Q Consensus 349 ~~~i~~~~~~~~~~~~~~~~--~~~~~--~~~~--~~~~~~~~~~~--~~~~~~~l~~li~~~L~~dP~~R~s~~ell~h 420 (468)
+..|++.+|.|+...|..+. |.+.. -.|+ ......+...+ ++.-++.+.+|+.+||.+||-+|+|++++|+|
T Consensus 258 l~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh 337 (438)
T KOG0666|consen 258 LDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH 337 (438)
T ss_pred HHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence 99999999999988776533 22210 0111 11111112222 23345569999999999999999999999999
Q ss_pred CCCCCCCCCCCCCCCCCCCCcccccC
Q 012233 421 PFFDDLRDPNTCLPNGRPLPTLFNFT 446 (468)
Q Consensus 421 p~f~~~~~~~~~~~~~~~~~~~~~~~ 446 (468)
+||..-..+ .+|+...+||+
T Consensus 338 ~yF~~d~lp------p~pt~~~vnf~ 357 (438)
T KOG0666|consen 338 PYFTEDPLP------PLPTSDNVNFE 357 (438)
T ss_pred cccccCCCC------CCcccceeecc
Confidence 999875444 34555666666
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=356.45 Aligned_cols=313 Identities=35% Similarity=0.631 Sum_probs=241.2
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc------cchHHHHHHHHHHcCCCCcccccceeeecCCCCceEEE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~------~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 211 (468)
+|.+.+.||.|+||.||+|.+..++..||||.+... .....+|+.+++.++|+||+++++++..........+|
T Consensus 6 ~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 85 (337)
T cd07858 6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVY 85 (337)
T ss_pred ceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEE
Confidence 599999999999999999999999999999987542 12344699999999999999999987544333334589
Q ss_pred EEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccC
Q 012233 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (468)
Q Consensus 212 lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~ 291 (468)
+||||+.++++..+.. ...+++..+..++.||+.||.|||+ +|++|+||||+|||++.++ .+||+|||++....
T Consensus 86 lv~e~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~-~~i~H~dlkp~Nil~~~~~-~~kL~Dfg~~~~~~ 159 (337)
T cd07858 86 IVYELMDTDLHQIIRS----SQTLSDDHCQYFLYQLLRGLKYIHS-ANVLHRDLKPSNLLLNANC-DLKICDFGLARTTS 159 (337)
T ss_pred EEEeCCCCCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEcCCC-CEEECcCccccccC
Confidence 9999999877665432 4568999999999999999999998 8999999999999999887 79999999997654
Q ss_pred CC-CCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCC
Q 012233 292 PG-EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPN 370 (468)
Q Consensus 292 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 370 (468)
.. .......++..|+|||.+.+...++.++|+|||||++|+|++|++||.+.+....+..+....+.+..+.+......
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd07858 160 EKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNE 239 (337)
T ss_pred CCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCch
Confidence 33 22334567899999999865445899999999999999999999999998888888888888777766554321110
Q ss_pred CccC---CCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCCCCCCCCCCCCCcccccCH
Q 012233 371 YTEF---KFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNTCLPNGRPLPTLFNFTA 447 (468)
Q Consensus 371 ~~~~---~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~~~ 447 (468)
.... ..+......+ ....+.+++++.+||++||+.||.+|||+.+++.||||+.+.+++.- +. .+.|-.++|++
T Consensus 240 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~~-~~-~~~~~~~~~~~ 316 (337)
T cd07858 240 KARRYIRSLPYTPRQSF-ARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSDE-PV-CQTPFSFDFEE 316 (337)
T ss_pred hhhHHHHhcCcccccCH-HHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcccC-cc-CCCccchhhhh
Confidence 0000 0000000011 11235689999999999999999999999999999999999887753 33 34566677774
Q ss_pred HHHhcCCHHHHHhcc
Q 012233 448 QELAGASNELRQRLI 462 (468)
Q Consensus 448 ~~~~~~~~~~~~~~~ 462 (468)
.+ .+.+..+++|
T Consensus 317 ~~---~~~~~~~~~~ 328 (337)
T cd07858 317 DA---LTEEDIKELI 328 (337)
T ss_pred hh---cCHHHHHHHH
Confidence 44 5555666555
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=348.20 Aligned_cols=285 Identities=35% Similarity=0.562 Sum_probs=225.1
Q ss_pred ccceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc------chHHHHHHHHHHcCCCCcccccceeeecCCCCceE
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 209 (468)
..+|.+.+.||.|+||.||+|.+..+|+.||+|.+.... ....+|+.+++.++|+||+++++++... ....
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~~~ 82 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGK---HLDS 82 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecC---CCCe
Confidence 346999999999999999999999999999999885322 1234799999999999999999987432 2235
Q ss_pred EEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccc
Q 012233 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (468)
Q Consensus 210 ~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~ 289 (468)
+++||||+.+++..++... ...+++..++.++.||+.||.|||+ .|++||||||+|||++.++ .+||+|||++..
T Consensus 83 ~~lv~e~~~~~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nil~~~~~-~~kL~dfg~~~~ 157 (309)
T cd07845 83 IFLVMEYCEQDLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHE-NFIIHRDLKVSNLLLTDKG-CLKIADFGLART 157 (309)
T ss_pred EEEEEecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECCCC-CEEECccceeee
Confidence 7899999998776655432 3568999999999999999999998 8999999999999999887 799999999976
Q ss_pred cCCCC-CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 012233 290 LVPGE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368 (468)
Q Consensus 290 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 368 (468)
..... ......+++.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+...++.+....+....
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07845 158 YGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFS 237 (309)
T ss_pred cCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhh
Confidence 64332 22233457889999998766668999999999999999999999999999999999998888877665443221
Q ss_pred --CCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCC
Q 012233 369 --PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDP 429 (468)
Q Consensus 369 --~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~ 429 (468)
+....+.++......+.. ....+++++.+||.+||+.||.+|||+.+++.||||++...+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~ 299 (309)
T cd07845 238 DLPLVGKFTLPKQPYNNLKH-KFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLP 299 (309)
T ss_pred cccccccccccCCCCCchHH-hccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCC
Confidence 111122222111111111 113368899999999999999999999999999999875554
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-45 Score=366.82 Aligned_cols=253 Identities=28% Similarity=0.428 Sum_probs=202.7
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc-------cchHHHHHHHHHHcCCCCcccccceeeecCCCCceEE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~-------~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~ 210 (468)
+|.+.+.||+|+||.||+|++..+++.||||++.+. .....+|+.+|+.++||||+++++.| .+..++
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~~ 76 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSF-----QDKDNL 76 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-----EcCCEE
Confidence 599999999999999999999999999999998542 22345799999999999999999988 445579
Q ss_pred EEEeecccchHH-HHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccc
Q 012233 211 NLVLEYISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (468)
Q Consensus 211 ~lv~e~~~~~ll-~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~ 289 (468)
|+|||||+++.+ +.+. ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++..
T Consensus 77 ~lv~E~~~~g~L~~~i~----~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivHrDlkp~Nill~~~~-~ikL~DFG~a~~ 150 (376)
T cd05598 77 YFVMDYIPGGDMMSLLI----RLGIFEEDLARFYIAELTCAIESVHK-MGFIHRDIKPDNILIDRDG-HIKLTDFGLCTG 150 (376)
T ss_pred EEEEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCCHHHEEECCCC-CEEEEeCCCCcc
Confidence 999999987644 3332 24568889999999999999999998 8999999999999999888 799999999753
Q ss_pred cCCC--------------------------------------------CCCccccccCCccccccccCCCCCCcchhHHH
Q 012233 290 LVPG--------------------------------------------EPNISYICSRYYRAPELIFGATEYTTAIDMWS 325 (468)
Q Consensus 290 ~~~~--------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwS 325 (468)
+... ......+||+.|+|||++.+.. ++.++||||
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwS 229 (376)
T cd05598 151 FRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTG-YTQLCDWWS 229 (376)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCC-CCcceeeee
Confidence 2100 0011357999999999997654 899999999
Q ss_pred HHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcc
Q 012233 326 IGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQ 405 (468)
Q Consensus 326 lG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 405 (468)
|||++|||++|+.||.+.+..+....+.... ....++ ....+++++.+||.+|+
T Consensus 230 lGvilyell~G~~Pf~~~~~~~~~~~i~~~~---------------~~~~~~----------~~~~~s~~~~~li~~l~- 283 (376)
T cd05598 230 VGVILYEMLVGQPPFLADTPAETQLKVINWE---------------TTLHIP----------SQAKLSREASDLILRLC- 283 (376)
T ss_pred ccceeeehhhCCCCCCCCCHHHHHHHHhccC---------------ccccCC----------CCCCCCHHHHHHHHHHh-
Confidence 9999999999999999877665554443210 001111 11347899999999987
Q ss_pred cCCCCCC---CHHHHhCCCCCCCCCC
Q 012233 406 YSPSLRC---TALEACAHPFFDDLRD 428 (468)
Q Consensus 406 ~dP~~R~---s~~ell~hp~f~~~~~ 428 (468)
.+|.+|+ ++.++++||||+.+..
T Consensus 284 ~~p~~R~~~~t~~ell~h~~~~~~~~ 309 (376)
T cd05598 284 CGAEDRLGKNGADEIKAHPFFKGIDF 309 (376)
T ss_pred cCHhhcCCCCCHHHHhCCCCcCCCCH
Confidence 5999999 9999999999998643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=348.45 Aligned_cols=255 Identities=27% Similarity=0.392 Sum_probs=206.7
Q ss_pred eEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-------chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEE
Q 012233 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (468)
Q Consensus 139 y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 211 (468)
|++.+.||+|+||.||++.+..+++.||||++.... ....+|+.+++.++||||+++++++ ....++|
T Consensus 2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~ 76 (285)
T cd05605 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY-----ETKDALC 76 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeee-----cCCCeEE
Confidence 889999999999999999999999999999885431 2335699999999999999999888 4445689
Q ss_pred EEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccC
Q 012233 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (468)
Q Consensus 212 lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~ 291 (468)
+||||+.++.+..... ......+++..+..++.|++.||.|||+ .||+||||||+||+++.++ .++|+|||++....
T Consensus 77 lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~~~-~~~l~Dfg~~~~~~ 153 (285)
T cd05605 77 LVLTLMNGGDLKFHIY-NMGNPGFDEERAVFYAAEITCGLEDLHR-ERIVYRDLKPENILLDDYG-HIRISDLGLAVEIP 153 (285)
T ss_pred EEEeccCCCcHHHHHH-hcCcCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCHHHEEECCCC-CEEEeeCCCceecC
Confidence 9999998765543222 1223568999999999999999999998 8999999999999999887 79999999998765
Q ss_pred CCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCC
Q 012233 292 PGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNY 371 (468)
Q Consensus 292 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 371 (468)
.........|++.|+|||++.+. .++.++|||||||++|+|++|+.||.+.........+...+....
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~----------- 221 (285)
T cd05605 154 EGETIRGRVGTVGYMAPEVVKNE-RYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQ----------- 221 (285)
T ss_pred CCCccccccCCCCccCcHHhcCC-CCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcc-----------
Confidence 44444456889999999999754 489999999999999999999999987665443333322111000
Q ss_pred ccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCC-----CHHHHhCCCCCCCCC
Q 012233 372 TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC-----TALEACAHPFFDDLR 427 (468)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~-----s~~ell~hp~f~~~~ 427 (468)
..++..+++.+.+||.+||+.||.+|| ++.+++.||||....
T Consensus 222 --------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~ 268 (285)
T cd05605 222 --------------EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTAN 268 (285)
T ss_pred --------------cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCC
Confidence 012345789999999999999999999 999999999998743
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=355.51 Aligned_cols=250 Identities=28% Similarity=0.448 Sum_probs=202.6
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-------chHHHHHHHHHHcCCC-CcccccceeeecCCCCceE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHP-NVVSLKHCFFSTTEKDELY 209 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-------~~~~~E~~il~~l~hp-nIv~l~~~~~~~~~~~~~~ 209 (468)
+|.+.+.||+|+||.||+|.+..+++.||||++.+.. .....|..++..+.|+ +|++++++| .+...
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~ 75 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QTMDR 75 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEE-----EcCCE
Confidence 4899999999999999999999999999999986432 2234688888888765 577888777 34446
Q ss_pred EEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccc
Q 012233 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (468)
Q Consensus 210 ~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~ 289 (468)
+|+||||+.++.+.... .....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++..
T Consensus 76 ~~lv~E~~~~g~L~~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dlkp~Nill~~~~-~~kL~Dfg~~~~ 150 (324)
T cd05587 76 LYFVMEYVNGGDLMYHI---QQVGKFKEPHAVFYAAEIAIGLFFLHS-KGIIYRDLKLDNVMLDAEG-HIKIADFGMCKE 150 (324)
T ss_pred EEEEEcCCCCCcHHHHH---HHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEEcCCC-CEEEeecCccee
Confidence 89999999876543221 224568899999999999999999998 8999999999999999888 799999999864
Q ss_pred cC-CCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 012233 290 LV-PGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368 (468)
Q Consensus 290 ~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 368 (468)
.. ........+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..+...
T Consensus 151 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~------------- 216 (324)
T cd05587 151 NIFGGKTTRTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEH------------- 216 (324)
T ss_pred cCCCCCceeeecCCccccChhhhcCCC-CCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcC-------------
Confidence 32 222334567999999999997654 899999999999999999999999887766655554331
Q ss_pred CCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCH-----HHHhCCCCCCCCC
Q 012233 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTA-----LEACAHPFFDDLR 427 (468)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~-----~ell~hp~f~~~~ 427 (468)
... ++..+++++.+||.+||..||.+|++. .+++.||||+.+.
T Consensus 217 ----~~~------------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~ 264 (324)
T cd05587 217 ----NVS------------YPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRID 264 (324)
T ss_pred ----CCC------------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCC
Confidence 111 334578999999999999999999976 8999999999863
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-45 Score=359.29 Aligned_cols=246 Identities=28% Similarity=0.444 Sum_probs=200.4
Q ss_pred ceecccCceEEEEEEEcCCCCEEEEEEeeccc-------chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEEEee
Q 012233 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLE 215 (468)
Q Consensus 143 ~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv~e 215 (468)
+.||+|+||.||++.+..+|..||+|++.... ....+|+.+++.++||||++++++| ....++|||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~-----~~~~~~~lv~E 75 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF-----QTHDRLCFVME 75 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEE-----EcCCEEEEEEe
Confidence 46999999999999999999999999986432 2234688899999999999999888 44456899999
Q ss_pred cccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCC-CC
Q 012233 216 YISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP-GE 294 (468)
Q Consensus 216 ~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~-~~ 294 (468)
|+.++.+.... .....+++..++.++.||+.||.|||+..||+||||||+|||++.++ .+||+|||+++.... ..
T Consensus 76 ~~~~~~L~~~l---~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~-~~kL~Dfg~~~~~~~~~~ 151 (325)
T cd05594 76 YANGGELFFHL---SRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG-HIKITDFGLCKEGIKDGA 151 (325)
T ss_pred CCCCCcHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCC-CEEEecCCCCeecCCCCc
Confidence 99987554222 22456899999999999999999999536999999999999999888 799999999875432 22
Q ss_pred CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccC
Q 012233 295 PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEF 374 (468)
Q Consensus 295 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 374 (468)
......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.......+.. ...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~-----------------~~~ 213 (325)
T cd05594 152 TMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM-----------------EEI 213 (325)
T ss_pred ccccccCCcccCCHHHHccC-CCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhc-----------------CCC
Confidence 33356799999999999665 489999999999999999999999987765544443322 111
Q ss_pred CCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCC-----CHHHHhCCCCCCCCC
Q 012233 375 KFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC-----TALEACAHPFFDDLR 427 (468)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~-----s~~ell~hp~f~~~~ 427 (468)
. ++..+++++.+||.+||+.||.+|+ ++.+++.||||..+.
T Consensus 214 ~------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~ 259 (325)
T cd05594 214 R------------FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIV 259 (325)
T ss_pred C------------CCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCC
Confidence 1 2345789999999999999999997 899999999999753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=358.36 Aligned_cols=255 Identities=30% Similarity=0.470 Sum_probs=200.4
Q ss_pred ceEEeceecccCceEEEEEEEc---CCCCEEEEEEeeccc--------chHHHHHHHHHHcC-CCCcccccceeeecCCC
Q 012233 138 SYMAERVVGTGSFGVVFQAKCL---ETGDSVAIKKVLQDK--------RYKNRELQIMRLLN-HPNVVSLKHCFFSTTEK 205 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~---~~g~~vaiK~~~~~~--------~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~ 205 (468)
+|.+.+.||+|+||.||++++. .+++.||+|++.+.. ....+|+.+++.++ ||||+++++++ .
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-----~ 75 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAF-----Q 75 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEE-----e
Confidence 4899999999999999999864 478999999985421 22346899999994 99999999887 4
Q ss_pred CceEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeec
Q 012233 206 DELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG 285 (468)
Q Consensus 206 ~~~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG 285 (468)
....+++||||+.++.+.... .....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||
T Consensus 76 ~~~~~~lv~e~~~~g~L~~~l---~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivHrDlkp~Nili~~~~-~~kl~DfG 150 (332)
T cd05614 76 TEAKLHLILDYVSGGEMFTHL---YQRDNFSEDEVRFYSGEIILALEHLHK-LGIVYRDIKLENILLDSEG-HVVLTDFG 150 (332)
T ss_pred cCCEEEEEEeCCCCCcHHHHH---HHcCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCHHHeEECCCC-CEEEeeCc
Confidence 555689999999876443221 224568999999999999999999998 8999999999999999888 79999999
Q ss_pred CccccCCCC--CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 012233 286 SAKMLVPGE--PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREE 363 (468)
Q Consensus 286 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~ 363 (468)
+++...... .....+||+.|+|||++.+...++.++|||||||++|||++|..||...........+......
T Consensus 151 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~----- 225 (332)
T cd05614 151 LSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILK----- 225 (332)
T ss_pred CCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhc-----
Confidence 997653322 2334679999999999976655889999999999999999999999754322111111111000
Q ss_pred HhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCC-----CHHHHhCCCCCCCCC
Q 012233 364 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC-----TALEACAHPFFDDLR 427 (468)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~-----s~~ell~hp~f~~~~ 427 (468)
....++..+++.+.+||.+||+.||.+|+ +++++++||||+++.
T Consensus 226 --------------------~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~ 274 (332)
T cd05614 226 --------------------CDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLD 274 (332)
T ss_pred --------------------CCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence 00113345789999999999999999999 888999999999864
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=354.65 Aligned_cols=311 Identities=31% Similarity=0.541 Sum_probs=237.3
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc------chHHHHHHHHHHcCCCCcccccceeeecCC-CCceE
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTE-KDELY 209 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~-~~~~~ 209 (468)
.+|.+.+.||+|+||.||+|.+..+|+.||||.+.+.. ....+|+.+++.++||||++++++|..... .+..+
T Consensus 16 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 95 (353)
T cd07850 16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQD 95 (353)
T ss_pred cceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCc
Confidence 46999999999999999999999999999999885421 233469999999999999999998754322 12235
Q ss_pred EEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccc
Q 012233 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (468)
Q Consensus 210 ~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~ 289 (468)
.|+||||+.+++...+.. .++...+..++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||++..
T Consensus 96 ~~lv~e~~~~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~-~gi~H~dlkp~Nil~~~~~-~~kL~Dfg~~~~ 167 (353)
T cd07850 96 VYLVMELMDANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDC-TLKILDFGLART 167 (353)
T ss_pred EEEEEeccCCCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEECCCC-CEEEccCcccee
Confidence 789999999887765432 27888899999999999999998 8999999999999999888 799999999987
Q ss_pred cCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 012233 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (468)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 369 (468)
...........+++.|+|||.+.+.. ++.++|||||||++|+|++|+.||...+..+.+.++...++.|+...+.....
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (353)
T cd07850 168 AGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQP 246 (353)
T ss_pred CCCCCCCCCCcccccccCHHHHhCCC-CCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence 65444444567889999999997654 89999999999999999999999999888888888888888887654443221
Q ss_pred CC----------ccCCCCcccC-CCc---ccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCCCCCCCC
Q 012233 370 NY----------TEFKFPQIKA-HPW---HKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNTCLPN 435 (468)
Q Consensus 370 ~~----------~~~~~~~~~~-~~~---~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~~~~~ 435 (468)
.. ....+..+.. ..+ ....+...++.+.+||.+||+.||.+|||+.|+|.||||+.+-++..+..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~~~~~~~- 325 (353)
T cd07850 247 TVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYDPSEVEA- 325 (353)
T ss_pred hhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccCCccCCC-
Confidence 11 1111111000 000 00012345678999999999999999999999999999997766555433
Q ss_pred CCCCCcccccCHHHHhcCCHHHHHh
Q 012233 436 GRPLPTLFNFTAQELAGASNELRQR 460 (468)
Q Consensus 436 ~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (468)
|.|.+++.. ++-.+..-+-|+.
T Consensus 326 --~~~~~~~~~-~~~~~~~~~~~~~ 347 (353)
T cd07850 326 --PPPAPYDHS-IDEREHTVEEWKE 347 (353)
T ss_pred --CCCCccccc-cccccccHHHHHH
Confidence 346666655 3344555555554
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-44 Score=350.34 Aligned_cols=277 Identities=31% Similarity=0.555 Sum_probs=206.1
Q ss_pred eceecccCceEEEEEEEcC--CCCEEEEEEeeccc--chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEEEeecc
Q 012233 142 ERVVGTGSFGVVFQAKCLE--TGDSVAIKKVLQDK--RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYI 217 (468)
Q Consensus 142 ~~~lG~G~fg~Vy~~~~~~--~g~~vaiK~~~~~~--~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv~e~~ 217 (468)
+..||+|+||.||+|.+.. ++..||+|.+.... ....+|+.+++.++||||+++++++... ....+++||||+
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---~~~~~~lv~e~~ 82 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSH---SDRKVWLLFDYA 82 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEecc---CCCeEEEEEeee
Confidence 3579999999999999754 56889999886543 2456799999999999999999988543 234688999999
Q ss_pred cchHHHHHhhhhh-----cCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeec----CCCCcEEEeeecCcc
Q 012233 218 SETVYRVSKHYTR-----MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVN----PHTHQLKICDFGSAK 288 (468)
Q Consensus 218 ~~~ll~~~~~~~~-----~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~----~~~~~vkL~DFG~a~ 288 (468)
+++++..+..... ....+++..++.++.||+.||.|||+ .||+||||||+|||+. .++ .+||+|||+++
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~-~~kl~DfG~a~ 160 (317)
T cd07867 83 EHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA-NWVLHRDLKPANILVMGEGPERG-RVKIADMGFAR 160 (317)
T ss_pred CCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh-CCEEcCCCCHHHEEEccCCCCCC-cEEEeecccee
Confidence 9988776543211 12357888899999999999999998 8999999999999993 334 79999999998
Q ss_pred ccCCCC----CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC---------cHHHHHHHHHH
Q 012233 289 MLVPGE----PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGES---------GVDQLVEIIKI 355 (468)
Q Consensus 289 ~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~---------~~~~~~~i~~~ 355 (468)
...... ......+|+.|+|||++.+...++.++|||||||++|||++|.+||.... ...++..++..
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 240 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSV 240 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHh
Confidence 654322 12345779999999999776668999999999999999999999997543 23456667777
Q ss_pred hCCCCHHHHhhcC--CCCccCC----CCcccCCC---cccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 012233 356 LGTPTREEIKCMN--PNYTEFK----FPQIKAHP---WHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (468)
Q Consensus 356 ~~~~~~~~~~~~~--~~~~~~~----~~~~~~~~---~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f 423 (468)
++.+....+.... +.+.... ........ .........+..+++||.+||+.||.+|||+.|+|+||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 241 MGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred cCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 7766655443321 1110000 00000000 0111122346779999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-44 Score=358.09 Aligned_cols=277 Identities=25% Similarity=0.376 Sum_probs=205.8
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeecccchHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEEEeec
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEY 216 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv~e~ 216 (468)
..|.+.+.||+|+||.||+|.+..++..||+|+.... ....|+.+++.++||||+++++++. ...+.++||||
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~e~ 138 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--TTLIEAMLLQNVNHPSVIRMKDTLV-----SGAITCMVLPH 138 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--ccHHHHHHHHhCCCCCCcChhheEE-----eCCeeEEEEEc
Confidence 3699999999999999999999999999999975433 3346999999999999999999984 33458899999
Q ss_pred ccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCCCCCC
Q 012233 217 ISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPN 296 (468)
Q Consensus 217 ~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~~~~~ 296 (468)
+.++++..+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++.........
T Consensus 139 ~~~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~Nill~~~~-~~kl~DfG~a~~~~~~~~~ 213 (357)
T PHA03209 139 YSSDLYTYLTK---RSRPLPIDQALIIEKQILEGLRYLHA-QRIIHRDVKTENIFINDVD-QVCIGDLGAAQFPVVAPAF 213 (357)
T ss_pred cCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECCCC-CEEEecCccccccccCccc
Confidence 99887775543 34568999999999999999999998 8999999999999999888 7999999999754444444
Q ss_pred ccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCC-CCCCCCCc---------HHHHHHHHHHhCCCCHHHHhh
Q 012233 297 ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQ-PLFPGESG---------VDQLVEIIKILGTPTREEIKC 366 (468)
Q Consensus 297 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~-~pf~~~~~---------~~~~~~i~~~~~~~~~~~~~~ 366 (468)
....||+.|+|||++.+.. ++.++|||||||++|||+++. ++|..... ...+..++..++..+......
T Consensus 214 ~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 292 (357)
T PHA03209 214 LGLAGTVETNAPEVLARDK-YNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRD 292 (357)
T ss_pred ccccccccccCCeecCCCC-CCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCC
Confidence 5677999999999997654 899999999999999999854 44443221 223444444444322111000
Q ss_pred cCCCCc--cCCCCcccCCCc---ccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q 012233 367 MNPNYT--EFKFPQIKAHPW---HKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426 (468)
Q Consensus 367 ~~~~~~--~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 426 (468)
...... -+.+......++ ...-...++.++.+||.+||++||.+|||+.|+|+||||+++
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~~ 357 (357)
T PHA03209 293 PGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQL 357 (357)
T ss_pred CccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhccC
Confidence 000000 000000000000 001123567889999999999999999999999999999874
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-44 Score=360.51 Aligned_cols=278 Identities=21% Similarity=0.321 Sum_probs=211.6
Q ss_pred cceEEeceecccCceEEEEEEEc--CCCCEEEEEEeecccchHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEEEe
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCL--ETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~--~~g~~vaiK~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv~ 214 (468)
.+|.+.+.||.|+||.||+|... .++..||+|.+... ....+|+.+|+.++||||++++++| .....+|+||
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~~~lv~ 165 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-KTPGREIDILKTISHRAIINLIHAY-----RWKSTVCMVM 165 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-ccHHHHHHHHHhcCCCCccceeeeE-----eeCCEEEEEe
Confidence 46999999999999999999764 35678999987654 3456899999999999999999988 4445689999
Q ss_pred ecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCCCC
Q 012233 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGE 294 (468)
Q Consensus 215 e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~~~ 294 (468)
|++.++++..+. ....+++..++.++.||+.||.|||+ +||+||||||+||||+.++ .++|+|||++.......
T Consensus 166 e~~~~~l~~~l~----~~~~l~~~~~~~i~~ql~~aL~~LH~-~givHrDlkp~Nill~~~~-~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 166 PKYKCDLFTYVD----RSGPLPLEQAITIQRRLLEALAYLHG-RGIIHRDVKTENIFLDEPE-NAVLGDFGAACKLDAHP 239 (392)
T ss_pred hhcCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEEcCCC-CEEEccCccccccCccc
Confidence 999988877552 24678999999999999999999998 8999999999999999888 79999999997654332
Q ss_pred C---CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC---cHHHHHHHHHHhCCCCHHHHhhc-
Q 012233 295 P---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGES---GVDQLVEIIKILGTPTREEIKCM- 367 (468)
Q Consensus 295 ~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~- 367 (468)
. .....||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+.. ....+..+++.++..+.......
T Consensus 240 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~ 318 (392)
T PHA03207 240 DTPQCYGWSGTLETNSPELLALDP-YCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS 318 (392)
T ss_pred ccccccccccccCccCHhHhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence 1 23467899999999996554 8999999999999999999999997653 34566667766554332110000
Q ss_pred ---CCCCccCCCCcccCCCccccc-ccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q 012233 368 ---NPNYTEFKFPQIKAHPWHKIF-HKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (468)
Q Consensus 368 ---~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~ 427 (468)
...+..+....-....+...+ ...++.++.+||++||..||.+|||+.++|.||||+..+
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~ 382 (392)
T PHA03207 319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEP 382 (392)
T ss_pred hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccc
Confidence 000001111100000111111 124677899999999999999999999999999997743
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=359.42 Aligned_cols=253 Identities=28% Similarity=0.449 Sum_probs=221.5
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc------cchHHHHHHHHHHcCCCCcccccceeeecCCCCceEE
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~------~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~ 210 (468)
++|..++.+|+|+||.+++++.+.++..|++|.+.-. +....+|+.+++++.|||||.+++.|. .+..++
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~----~~~~~l 79 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFE----EDGQLL 79 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchh----cCCceE
Confidence 4699999999999999999999999999999988433 234567999999999999999999994 334459
Q ss_pred EEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcccc
Q 012233 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (468)
Q Consensus 211 ~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~ 290 (468)
||||+||.|+.+.......+ ...|++..+..|+.|++.|+.|||+ ..|+|||||+.|||++.++ .|||+|||+|+.+
T Consensus 80 ~Ivm~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~-~~iLHRDlK~~Nifltk~~-~VkLgDfGlaK~l 156 (426)
T KOG0589|consen 80 CIVMEYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHE-NRVLHRDLKCANIFLTKDK-KVKLGDFGLAKIL 156 (426)
T ss_pred EEEEeecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHh-hhhhcccchhhhhhccccC-ceeecchhhhhhc
Confidence 99999999876654333222 5779999999999999999999997 8999999999999999998 6899999999998
Q ss_pred CCCC-CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 012233 291 VPGE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (468)
Q Consensus 291 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 369 (468)
.+.. ...+.+||+.||.||++.+.+ |+.++|||||||++|||++-+++|.+.+....+.+|++....|
T Consensus 157 ~~~~~~a~tvvGTp~YmcPEil~d~p-Yn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~P---------- 225 (426)
T KOG0589|consen 157 NPEDSLASTVVGTPYYMCPEILSDIP-YNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSP---------- 225 (426)
T ss_pred CCchhhhheecCCCcccCHHHhCCCC-CCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCC----------
Confidence 7776 667889999999999997765 9999999999999999999999999999999999998865444
Q ss_pred CCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q 012233 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDD 425 (468)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~ 425 (468)
++..++.+++.||+.||..+|..||++.++|.+|.+..
T Consensus 226 ------------------lp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~ 263 (426)
T KOG0589|consen 226 ------------------LPSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLR 263 (426)
T ss_pred ------------------CCccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhh
Confidence 33457899999999999999999999999999998874
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=355.06 Aligned_cols=244 Identities=27% Similarity=0.484 Sum_probs=199.8
Q ss_pred ceecccCceEEEEEEEcCCCCEEEEEEeeccc-------chHHHHHHHHHHc-CCCCcccccceeeecCCCCceEEEEEe
Q 012233 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDELYLNLVL 214 (468)
Q Consensus 143 ~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-------~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~lv~ 214 (468)
++||+|+||.||+|.+..+++.||||++.+.. .....|..+++.+ +||||++++++| .+...+|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~-----~~~~~~~lv~ 75 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCF-----QTKDRLFFVM 75 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCeEEEEE
Confidence 36999999999999999999999999986532 1233577888766 799999999998 4445689999
Q ss_pred ecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCC-C
Q 012233 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP-G 293 (468)
Q Consensus 215 e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~-~ 293 (468)
||+.++.+.... .....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++..... .
T Consensus 76 E~~~~~~L~~~l---~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDikp~Nill~~~~-~~kL~Dfg~~~~~~~~~ 150 (321)
T cd05591 76 EYVNGGDLMFQI---QRSRKFDEPRSRFYAAEVTLALMFLHR-HGVIYRDLKLDNILLDAEG-HCKLADFGMCKEGILNG 150 (321)
T ss_pred eCCCCCcHHHHH---HHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEECCCC-CEEEeecccceecccCC
Confidence 999976553221 224568899999999999999999998 8999999999999999888 799999999875432 2
Q ss_pred CCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCcc
Q 012233 294 EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTE 373 (468)
Q Consensus 294 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 373 (468)
.......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+..+.+..+... .
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~-----------------~ 212 (321)
T cd05591 151 VTTTTFCGTPDYIAPEILQEL-EYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHD-----------------D 212 (321)
T ss_pred ccccccccCccccCHHHHcCC-CCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcC-----------------C
Confidence 233456789999999998654 4899999999999999999999999988776666655431 1
Q ss_pred CCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCC-------CHHHHhCCCCCCCC
Q 012233 374 FKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC-------TALEACAHPFFDDL 426 (468)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~-------s~~ell~hp~f~~~ 426 (468)
.. ++..++.++.+||.+||+.||.+|+ ++.+++.||||..+
T Consensus 213 ~~------------~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~ 260 (321)
T cd05591 213 VL------------YPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEI 260 (321)
T ss_pred CC------------CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCC
Confidence 11 2234789999999999999999999 99999999999875
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-46 Score=356.79 Aligned_cols=250 Identities=26% Similarity=0.402 Sum_probs=207.6
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-----chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~l 212 (468)
.|...++||+|.||.||+|.+..+++.||||++.-+. ....+|+.+|..++++||.++|+.|+... .+++
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~-----~Lwi 88 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGT-----KLWI 88 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecc-----cHHH
Confidence 4888899999999999999999999999999985432 34458999999999999999999996554 4899
Q ss_pred EeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCC
Q 012233 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (468)
Q Consensus 213 v~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~ 292 (468)
+||||.||....+. +....+.+..+..++++++.||.|||. .+.+|||||+.||||..++ .+||+|||.+..+..
T Consensus 89 iMey~~gGsv~~lL---~~~~~~~E~~i~~ilre~l~~l~ylH~-~~kiHrDIKaanil~s~~g-~vkl~DfgVa~ql~~ 163 (467)
T KOG0201|consen 89 IMEYCGGGSVLDLL---KSGNILDEFEIAVILREVLKGLDYLHS-EKKIHRDIKAANILLSESG-DVKLADFGVAGQLTN 163 (467)
T ss_pred HHHHhcCcchhhhh---ccCCCCccceeeeehHHHHHHhhhhhh-cceecccccccceeEeccC-cEEEEecceeeeeec
Confidence 99999976443222 223444777888899999999999997 8999999999999999987 799999999987755
Q ss_pred CC-CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCC
Q 012233 293 GE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNY 371 (468)
Q Consensus 293 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 371 (468)
.. ...+++|||.|||||++.+. .|+.++||||||++.+||.+|.+||....++..+..|-+. .|
T Consensus 164 ~~~rr~tfvGTPfwMAPEVI~~~-~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~--~P------------ 228 (467)
T KOG0201|consen 164 TVKRRKTFVGTPFWMAPEVIKQS-GYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKS--AP------------ 228 (467)
T ss_pred hhhccccccccccccchhhhccc-cccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCC--CC------------
Confidence 43 33789999999999999854 5999999999999999999999999887664433333220 00
Q ss_pred ccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q 012233 372 TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426 (468)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 426 (468)
..+....++.+++||..||++||+.||+|.++|.|+|++.-
T Consensus 229 --------------P~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a 269 (467)
T KOG0201|consen 229 --------------PRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKRA 269 (467)
T ss_pred --------------CccccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHhc
Confidence 11223578899999999999999999999999999999883
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-44 Score=353.29 Aligned_cols=277 Identities=25% Similarity=0.403 Sum_probs=205.4
Q ss_pred ccceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-----chHHHHHHHHHHcCCCCcccccceeeecCCCCceEE
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~ 210 (468)
.++|.+.+.||+|+||.||++.+..+|..||+|.+.... ..+.+|+++|+.++||||+++++++.. ...+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~ 78 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DGEI 78 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-----CCEE
Confidence 356999999999999999999999999999999886432 235679999999999999999998843 3458
Q ss_pred EEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcccc
Q 012233 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (468)
Q Consensus 211 ~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~ 290 (468)
++||||+.++.+.... .....+++..+..++.|++.||.|||+..+|+||||||+|||++.++ .+||+|||++...
T Consensus 79 ~lv~e~~~~~~L~~~l---~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~ 154 (331)
T cd06649 79 SICMEHMDGGSLDQVL---KEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRG-EIKLCDFGVSGQL 154 (331)
T ss_pred EEEeecCCCCcHHHHH---HHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCC-cEEEccCcccccc
Confidence 8999999976554322 22356889999999999999999999734699999999999999888 7999999998765
Q ss_pred CCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh----
Q 012233 291 VPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKC---- 366 (468)
Q Consensus 291 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~---- 366 (468)
... ......|++.|+|||++.+. .++.++|||||||++|||++|+.||...+..+. ..++ +.+.......
T Consensus 155 ~~~-~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~-~~~~---~~~~~~~~~~~~~~ 228 (331)
T cd06649 155 IDS-MANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVELAIGRYPIPPPDAKEL-EAIF---GRPVVDGEEGEPHS 228 (331)
T ss_pred ccc-ccccCCCCcCcCCHhHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHh---cccccccccCCccc
Confidence 332 23456789999999999765 489999999999999999999999987654432 2222 1111000000
Q ss_pred cCCCCcc-------CCCCc------------ccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q 012233 367 MNPNYTE-------FKFPQ------------IKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (468)
Q Consensus 367 ~~~~~~~-------~~~~~------------~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~ 427 (468)
..+.... ..... +............+++++++||.+||++||++|||+.+++.||||+...
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 308 (331)
T cd06649 229 ISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSE 308 (331)
T ss_pred cCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcc
Confidence 0000000 00000 0000000001124788999999999999999999999999999998743
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=355.72 Aligned_cols=247 Identities=26% Similarity=0.492 Sum_probs=196.6
Q ss_pred ceecccCceEEEEEEEcCCCCEEEEEEeeccc-------chHHHHHHHHHHc-CCCCcccccceeeecCCCCceEEEEEe
Q 012233 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDELYLNLVL 214 (468)
Q Consensus 143 ~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-------~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~lv~ 214 (468)
++||+|+||.||+|.+..+++.||+|++.+.. ....+|..+++.+ +||||++++++| .+...+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~-----~~~~~~~lv~ 75 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCF-----QTESRLFFVI 75 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEE-----EcCCEEEEEE
Confidence 46999999999999999999999999986532 2244688888888 699999999988 4455689999
Q ss_pred ecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcccc-CCC
Q 012233 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML-VPG 293 (468)
Q Consensus 215 e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~-~~~ 293 (468)
||++++.+... ......+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++.. ...
T Consensus 76 e~~~~g~L~~~---~~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nili~~~~-~~kL~Dfg~~~~~~~~~ 150 (329)
T cd05588 76 EFVSGGDLMFH---MQRQRKLPEEHARFYSAEISLALNFLHE-RGIIYRDLKLDNVLLDAEG-HIKLTDYGMCKEGIRPG 150 (329)
T ss_pred eCCCCCCHHHH---HHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEECCCC-CEEECcCccccccccCC
Confidence 99987654322 1224679999999999999999999998 8999999999999999887 7999999998753 223
Q ss_pred CCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC--------cHHHHHHHHHHhCCCCHHHHh
Q 012233 294 EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGES--------GVDQLVEIIKILGTPTREEIK 365 (468)
Q Consensus 294 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~--------~~~~~~~i~~~~~~~~~~~~~ 365 (468)
......+||+.|+|||++.+. .++.++|+|||||++|+|++|+.||.... ..+.+.+.+..
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~---------- 219 (329)
T cd05588 151 DTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILE---------- 219 (329)
T ss_pred CccccccCCccccCHHHHcCC-CCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHc----------
Confidence 334457899999999999765 48999999999999999999999996321 11112221110
Q ss_pred hcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCC------HHHHhCCCCCCCCCC
Q 012233 366 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCT------ALEACAHPFFDDLRD 428 (468)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s------~~ell~hp~f~~~~~ 428 (468)
.... ++..++.++.+||.+||+.||.+|++ +.+++.||||..+..
T Consensus 220 ------~~~~------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~ 270 (329)
T cd05588 220 ------KQIR------------IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDW 270 (329)
T ss_pred ------CCCC------------CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence 0111 33457899999999999999999997 789999999987643
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-44 Score=345.72 Aligned_cols=251 Identities=26% Similarity=0.377 Sum_probs=199.5
Q ss_pred ecccCceEEEEEEEcCCCCEEEEEEeeccc-------chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEEEeecc
Q 012233 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYI 217 (468)
Q Consensus 145 lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv~e~~ 217 (468)
||+|+||+||++.+..+|+.||+|++.... .....|+.+++.++|+||++++++| .....+|+||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAF-----QTKTDLCLVMTIM 75 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEE-----cCCCeEEEEEeCC
Confidence 699999999999999999999999985432 2234689999999999999998887 4445689999999
Q ss_pred cchHHHHHh-hhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCCCCC-
Q 012233 218 SETVYRVSK-HYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEP- 295 (468)
Q Consensus 218 ~~~ll~~~~-~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~~~~- 295 (468)
+++.+.... ........+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .++|+|||++........
T Consensus 76 ~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nili~~~~-~~~l~dfg~~~~~~~~~~~ 153 (280)
T cd05608 76 NGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ-RRIIYRDLKPENVLLDNDG-NVRISDLGLAVELKDGQSK 153 (280)
T ss_pred CCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCC-CEEEeeCccceecCCCCcc
Confidence 976554332 222334568999999999999999999998 8999999999999999887 799999999976543322
Q ss_pred CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccCC
Q 012233 296 NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFK 375 (468)
Q Consensus 296 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 375 (468)
.....||+.|+|||++.+. .++.++|||||||++|+|++|+.||...........+...... ...
T Consensus 154 ~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~-------------~~~- 218 (280)
T cd05608 154 TKGYAGTPGFMAPELLQGE-EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILN-------------DSV- 218 (280)
T ss_pred ccccCCCcCccCHHHhcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcc-------------cCC-
Confidence 2345789999999999765 4899999999999999999999999865433222222211100 000
Q ss_pred CCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCC-----CHHHHhCCCCCCCCCC
Q 012233 376 FPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC-----TALEACAHPFFDDLRD 428 (468)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~-----s~~ell~hp~f~~~~~ 428 (468)
.++..+++++.+||.+||+.||.+|+ +++++++||||+++..
T Consensus 219 -----------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~ 265 (280)
T cd05608 219 -----------TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNW 265 (280)
T ss_pred -----------CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCH
Confidence 13345889999999999999999999 8899999999998643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=360.78 Aligned_cols=253 Identities=26% Similarity=0.425 Sum_probs=203.5
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-------chHHHHHHHHHHcCCCCcccccceeeecCCCCceEE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~ 210 (468)
+|.+.+.||+|+||.||+|.+..+++.||||++.... ....+|+.++..++||||+++++.| .+..++
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~-----~~~~~~ 76 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSF-----QDKRNL 76 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCCEE
Confidence 5899999999999999999999999999999985421 2345689999999999999999988 455578
Q ss_pred EEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcccc
Q 012233 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (468)
Q Consensus 211 ~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~ 290 (468)
|+||||++++.+.... .....+++..++.++.||+.||.|||+ +||+||||||+||||+.++ .+||+|||++...
T Consensus 77 ~lv~E~~~gg~L~~~l---~~~~~l~~~~~~~~~~qi~~~L~~lH~-~givHrDLkp~NIli~~~~-~vkL~DfG~~~~~ 151 (360)
T cd05627 77 YLIMEFLPGGDMMTLL---MKKDTLSEEATQFYIAETVLAIDAIHQ-LGFIHRDIKPDNLLLDAKG-HVKLSDFGLCTGL 151 (360)
T ss_pred EEEEeCCCCccHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEccCCCHHHEEECCCC-CEEEeeccCCccc
Confidence 9999999876443222 224568999999999999999999998 8999999999999999888 7999999998654
Q ss_pred CCCC------------------------------------CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHH
Q 012233 291 VPGE------------------------------------PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELL 334 (468)
Q Consensus 291 ~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell 334 (468)
.... .....+||+.|+|||++.+.. ++.++|||||||++|||+
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~-~~~~~DiwSlGvilyel~ 230 (360)
T cd05627 152 KKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTG-YNKLCDWWSLGVIMYEML 230 (360)
T ss_pred ccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCC-CCCcceeccccceeeecc
Confidence 2110 012457999999999997654 899999999999999999
Q ss_pred hCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCC--
Q 012233 335 LGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC-- 412 (468)
Q Consensus 335 ~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~-- 412 (468)
+|++||.+.+..+.+.++.... ....+|. ...+++++++||.+|+. ||.+|+
T Consensus 231 tG~~Pf~~~~~~~~~~~i~~~~---------------~~~~~p~----------~~~~s~~~~~li~~l~~-~p~~R~~~ 284 (360)
T cd05627 231 IGYPPFCSETPQETYRKVMNWK---------------ETLVFPP----------EVPISEKAKDLILRFCT-DSENRIGS 284 (360)
T ss_pred cCCCCCCCCCHHHHHHHHHcCC---------------CceecCC----------CCCCCHHHHHHHHHhcc-ChhhcCCC
Confidence 9999999887766655554310 0111111 01368899999999874 999998
Q ss_pred -CHHHHhCCCCCCCCC
Q 012233 413 -TALEACAHPFFDDLR 427 (468)
Q Consensus 413 -s~~ell~hp~f~~~~ 427 (468)
++.+++.||||+++.
T Consensus 285 ~~~~ei~~hp~f~~~~ 300 (360)
T cd05627 285 NGVEEIKSHPFFEGVD 300 (360)
T ss_pred CCHHHHhcCCCCCCCC
Confidence 489999999999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=362.62 Aligned_cols=274 Identities=24% Similarity=0.329 Sum_probs=206.2
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeecccchHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEEEeec
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEY 216 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv~e~ 216 (468)
..|.+.+.||+|+||.||+|.+..+++.||||.... ....+|+.+|++|+|+|||++++++.. ....++|||+
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--~~~~~E~~iL~~L~HpnIv~l~~~~~~-----~~~~~lv~e~ 241 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--ASSVHEARLLRRLSHPAVLALLDVRVV-----GGLTCLVLPK 241 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--cCHHHHHHHHHHCCCCCCCcEEEEEEE-----CCEEEEEEEc
Confidence 469999999999999999999999999999996432 334679999999999999999998743 3357899999
Q ss_pred ccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCCCC--
Q 012233 217 ISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGE-- 294 (468)
Q Consensus 217 ~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~~~-- 294 (468)
+.++++..+.. ....+++..++.++.||+.||.|||+ +||+||||||+||||+.++ .+||+|||+++......
T Consensus 242 ~~~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~-~gIvHrDLKP~NILl~~~~-~vkL~DFGla~~~~~~~~~ 316 (461)
T PHA03211 242 YRSDLYTYLGA---RLRPLGLAQVTAVARQLLSAIDYIHG-EGIIHRDIKTENVLVNGPE-DICLGDFGAACFARGSWST 316 (461)
T ss_pred cCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCEEECcCCHHHEEECCCC-CEEEcccCCceeccccccc
Confidence 99887775543 23468999999999999999999998 8999999999999999887 79999999997653322
Q ss_pred -CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-------cHHHHHHHHHHhCCCCHHH---
Q 012233 295 -PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGES-------GVDQLVEIIKILGTPTREE--- 363 (468)
Q Consensus 295 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~-------~~~~~~~i~~~~~~~~~~~--- 363 (468)
......||+.|+|||++.+.. ++.++|||||||++|||++|..|+.... ...++.++++.........
T Consensus 317 ~~~~~~~GT~~Y~APE~~~~~~-~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~ 395 (461)
T PHA03211 317 PFHYGIAGTVDTNAPEVLAGDP-YTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQH 395 (461)
T ss_pred ccccccCCCcCCcCHHHHcCCC-CCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCC
Confidence 122457899999999997654 8999999999999999999876553321 1344555555433221100
Q ss_pred -----HhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q 012233 364 -----IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDD 425 (468)
Q Consensus 364 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~ 425 (468)
.............+......|... ..++.++.+||.+||++||.+|||+.|+|+||||+.
T Consensus 396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 396 AGSRLVSQYRHRAARNRRPAYTRPAWTRY--YKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred cchHHHHHHHhhhhcccCCccCCcchhhh--ccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 000000000011111112223222 146778999999999999999999999999999975
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=343.97 Aligned_cols=285 Identities=34% Similarity=0.594 Sum_probs=222.0
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc------chHHHHHHHHHHcC-CCCcccccceeeecCCCCceEE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLN-HPNVVSLKHCFFSTTEKDELYL 210 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~------~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~~~~~ 210 (468)
+|.+.+.||+|+||.||+|.+..+|+.||||.+.... ....+|+.+++.+. ||||+++++++...........
T Consensus 2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~ 81 (295)
T cd07837 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSL 81 (295)
T ss_pred CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceE
Confidence 5999999999999999999999999999999875432 23457999999995 6999999998865444344568
Q ss_pred EEEeecccchHHHHHhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccc
Q 012233 211 NLVLEYISETVYRVSKHYTRM-NQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (468)
Q Consensus 211 ~lv~e~~~~~ll~~~~~~~~~-~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~ 289 (468)
|+||||+.+++...+...... ...+++..++.++.||+.||.|||+ +||+||||||+|||++.+...+||+|||++..
T Consensus 82 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~-~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~ 160 (295)
T cd07837 82 YLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK-HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRA 160 (295)
T ss_pred EEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCChHHEEEecCCCeEEEeeccccee
Confidence 899999999877766543332 3568999999999999999999998 89999999999999998334899999999876
Q ss_pred cCCC-CCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 012233 290 LVPG-EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368 (468)
Q Consensus 290 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 368 (468)
.... .......+++.|+|||++.+...++.++|+|||||++|+|++|..||.+.+..+.+.+++..++.+....+....
T Consensus 161 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (295)
T cd07837 161 FSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVS 240 (295)
T ss_pred cCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchh
Confidence 5322 222234668899999998765668999999999999999999999999998888888888877776654432211
Q ss_pred CCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCC
Q 012233 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFD 424 (468)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~ 424 (468)
.......++...... .....+.+++++.+||.+||..||.+||++.+++.||||+
T Consensus 241 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 241 KLRDWHEFPQWKPQD-LSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred hccchhhcCcccchh-HHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 111111111111100 1112245789999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-44 Score=352.18 Aligned_cols=245 Identities=27% Similarity=0.462 Sum_probs=196.8
Q ss_pred ceecccCceEEEEEEEcCCCCEEEEEEeeccc-------chHHHHHHHHHHc-CCCCcccccceeeecCCCCceEEEEEe
Q 012233 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDELYLNLVL 214 (468)
Q Consensus 143 ~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-------~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~lv~ 214 (468)
+.||+|+||.||+|.++.+|+.||+|++.... .....|..++..+ +||||+++++++ .+..++|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~~~lv~ 75 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTF-----QTKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEE-----EeCCEEEEEE
Confidence 46999999999999999999999999986532 2234577777654 899999999988 4455799999
Q ss_pred ecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCC-C
Q 012233 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP-G 293 (468)
Q Consensus 215 e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~-~ 293 (468)
||+.++.+.... .....+++..+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++.... .
T Consensus 76 E~~~~g~L~~~i---~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivHrDlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~ 150 (316)
T cd05620 76 EFLNGGDLMFHI---QDKGRFDLYRATFYAAEIVCGLQFLHS-KGIIYRDLKLDNVMLDRDG-HIKIADFGMCKENVFGD 150 (316)
T ss_pred CCCCCCcHHHHH---HHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEECCCC-CEEeCccCCCeecccCC
Confidence 999876443221 224568899999999999999999998 8999999999999999888 799999999865322 2
Q ss_pred CCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCcc
Q 012233 294 EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTE 373 (468)
Q Consensus 294 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 373 (468)
......+||+.|+|||++.+.. ++.++|||||||++|||++|..||.+.+..+....+... .
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~-----------------~ 212 (316)
T cd05620 151 NRASTFCGTPDYIAPEILQGLK-YTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVD-----------------T 212 (316)
T ss_pred CceeccCCCcCccCHHHHcCCC-CCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-----------------C
Confidence 2334567899999999997654 899999999999999999999999877655444433220 0
Q ss_pred CCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCH-HHHhCCCCCCCCC
Q 012233 374 FKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTA-LEACAHPFFDDLR 427 (468)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~-~ell~hp~f~~~~ 427 (468)
.. ++..++.++++||.+||+.||.+|+++ +++++||||+.+.
T Consensus 213 ~~------------~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~~ 255 (316)
T cd05620 213 PH------------YPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTIN 255 (316)
T ss_pred CC------------CCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCCC
Confidence 01 223478999999999999999999998 5899999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-44 Score=353.37 Aligned_cols=250 Identities=27% Similarity=0.420 Sum_probs=202.9
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeecccc-------hHHHHHHHHHHc-CCCCcccccceeeecCCCCceE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR-------YKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDELY 209 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~~-------~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~~~~ 209 (468)
+|.+.+.||+|+||.||+|.+..+++.||||++.+... ....|..++..+ .|++|+++++++ .+...
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~ 75 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCF-----QTMDR 75 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEE-----ecCCE
Confidence 48899999999999999999999999999999865321 223466777766 588999998888 44456
Q ss_pred EEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccc
Q 012233 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (468)
Q Consensus 210 ~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~ 289 (468)
+|+||||++++.+... ......+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++.
T Consensus 76 ~~lv~E~~~~g~L~~~---~~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~Nill~~~~-~~kL~DfG~~~~ 150 (323)
T cd05616 76 LYFVMEYVNGGDLMYQ---IQQVGRFKEPHAVFYAAEIAIGLFFLHS-KGIIYRDLKLDNVMLDSEG-HIKIADFGMCKE 150 (323)
T ss_pred EEEEEcCCCCCCHHHH---HHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCEEecCCCHHHeEECCCC-cEEEccCCCcee
Confidence 8999999987644322 1224568899999999999999999998 8999999999999999888 799999999875
Q ss_pred cCC-CCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 012233 290 LVP-GEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368 (468)
Q Consensus 290 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 368 (468)
... .......+||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+.+..+.+..+...
T Consensus 151 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~------------- 216 (323)
T cd05616 151 NMWDGVTTKTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH------------- 216 (323)
T ss_pred cCCCCCccccCCCChhhcCHHHhcCCC-CCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhC-------------
Confidence 432 22334567899999999997654 899999999999999999999999987766665555431
Q ss_pred CCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCC-----HHHHhCCCCCCCCC
Q 012233 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCT-----ALEACAHPFFDDLR 427 (468)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s-----~~ell~hp~f~~~~ 427 (468)
... ++..++.++.+||.+||+.||.+|++ ..++++||||+.+.
T Consensus 217 ----~~~------------~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~ 264 (323)
T cd05616 217 ----NVA------------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID 264 (323)
T ss_pred ----CCC------------CCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCC
Confidence 111 33458899999999999999999997 48999999999764
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-45 Score=383.23 Aligned_cols=270 Identities=29% Similarity=0.456 Sum_probs=228.3
Q ss_pred ccceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc-------cchHHHHHHHHHHcCCCCcccccceeeecCCCCce
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~-------~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 208 (468)
..+|.++++||+|+||.|.+++.+.+++.||+|++.+. ...+.+|..||--.+.+-|+.|+-.| +|..
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAF-----QD~~ 148 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAF-----QDER 148 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHh-----cCcc
Confidence 45799999999999999999999999999999988653 34567899999999999999999888 8999
Q ss_pred EEEEEeecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCc
Q 012233 209 YLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (468)
Q Consensus 209 ~~~lv~e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a 287 (468)
|+|+||||++|| ++.++..+ . .+|+..+++|+..|+.||.-||+ .|+|||||||+|||||..|| |||+|||.+
T Consensus 149 ~LYlVMdY~pGGDlltLlSk~---~-~~pE~~ArFY~aEiVlAldslH~-mgyVHRDiKPDNvLld~~GH-ikLADFGsC 222 (1317)
T KOG0612|consen 149 YLYLVMDYMPGGDLLTLLSKF---D-RLPEDWARFYTAEIVLALDSLHS-MGYVHRDIKPDNVLLDKSGH-IKLADFGSC 222 (1317)
T ss_pred ceEEEEecccCchHHHHHhhc---C-CChHHHHHHHHHHHHHHHHHHHh-ccceeccCCcceeEecccCc-EeeccchhH
Confidence 999999999865 55544433 3 79999999999999999999998 89999999999999999996 999999999
Q ss_pred cccCCCC--CCccccccCCccccccccC----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 012233 288 KMLVPGE--PNISYICSRYYRAPELIFG----ATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTR 361 (468)
Q Consensus 288 ~~~~~~~--~~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~ 361 (468)
-.+..+. .....+|||.|++||++.. ...|+..+|+||+||++|||++|.+||+..+-.+.+.+|+...
T Consensus 223 lkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk----- 297 (1317)
T KOG0612|consen 223 LKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHK----- 297 (1317)
T ss_pred HhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchh-----
Confidence 7775333 3446799999999999942 2458999999999999999999999999999999999998741
Q ss_pred HHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCC---HHHHhCCCCCCCCCCCCCCCCCCCC
Q 012233 362 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCT---ALEACAHPFFDDLRDPNTCLPNGRP 438 (468)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s---~~ell~hp~f~~~~~~~~~~~~~~~ 438 (468)
..+.||.. ..+|+++++||++++. +|..|.. ++++.+||||.++.=.+-.-...|=
T Consensus 298 ----------~~l~FP~~----------~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~ 356 (1317)
T KOG0612|consen 298 ----------ESLSFPDE----------TDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPV 356 (1317)
T ss_pred ----------hhcCCCcc----------cccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhhhcCCCC
Confidence 34455521 3489999999999886 4778887 9999999999997766666555555
Q ss_pred CCcc
Q 012233 439 LPTL 442 (468)
Q Consensus 439 ~~~~ 442 (468)
+|.+
T Consensus 357 vPev 360 (1317)
T KOG0612|consen 357 VPEV 360 (1317)
T ss_pred CCcC
Confidence 6666
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-44 Score=352.52 Aligned_cols=244 Identities=31% Similarity=0.516 Sum_probs=198.7
Q ss_pred ceecccCceEEEEEEEc---CCCCEEEEEEeeccc--------chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEE
Q 012233 143 RVVGTGSFGVVFQAKCL---ETGDSVAIKKVLQDK--------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (468)
Q Consensus 143 ~~lG~G~fg~Vy~~~~~---~~g~~vaiK~~~~~~--------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 211 (468)
+.||+|+||.||++++. .+++.||+|++.... ....+|+.+|+.++||||++++++| .....+|
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~-----~~~~~~~ 76 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAF-----QTGGKLY 76 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEE-----ecCCeEE
Confidence 57999999999999864 478899999986431 2234699999999999999999988 3444689
Q ss_pred EEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccC
Q 012233 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (468)
Q Consensus 212 lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~ 291 (468)
+||||+.++.+.... .....+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++...
T Consensus 77 lv~e~~~~~~L~~~~---~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~ 151 (323)
T cd05584 77 LILEYLSGGELFMHL---EREGIFMEDTACFYLSEISLALEHLHQ-QGIIYRDLKPENILLDAQG-HVKLTDFGLCKESI 151 (323)
T ss_pred EEEeCCCCchHHHHH---HHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECCCC-CEEEeeCcCCeecc
Confidence 999999976553222 224567888899999999999999998 8999999999999999888 79999999987543
Q ss_pred C-CCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCC
Q 012233 292 P-GEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPN 370 (468)
Q Consensus 292 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 370 (468)
. ........||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+....+..+...
T Consensus 152 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~--------------- 215 (323)
T cd05584 152 HEGTVTHTFCGTIEYMAPEILMRSG-HGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKG--------------- 215 (323)
T ss_pred cCCCcccccCCCccccChhhccCCC-CCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcC---------------
Confidence 2 22233467899999999997654 889999999999999999999999887766555554331
Q ss_pred CccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCC-----CHHHHhCCCCCCCC
Q 012233 371 YTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC-----TALEACAHPFFDDL 426 (468)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~-----s~~ell~hp~f~~~ 426 (468)
... ++..+++++.+||.+||+.||.+|+ ++.+++.||||...
T Consensus 216 --~~~------------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~ 262 (323)
T cd05584 216 --KLN------------LPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHV 262 (323)
T ss_pred --CCC------------CCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCC
Confidence 111 2345789999999999999999999 89999999999875
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-44 Score=357.63 Aligned_cols=257 Identities=28% Similarity=0.443 Sum_probs=206.4
Q ss_pred cccceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc-------cchHHHHHHHHHHcCCCCcccccceeeecCCCCc
Q 012233 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (468)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~-------~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 207 (468)
...+|.+.+.||+|+||.||+|.+..+++.||+|++.+. .....+|+.+++.++||||+++++++ .+.
T Consensus 41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~-----~~~ 115 (371)
T cd05622 41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF-----QDD 115 (371)
T ss_pred chhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EcC
Confidence 345799999999999999999999999999999998542 12345789999999999999999988 445
Q ss_pred eEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCc
Q 012233 208 LYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (468)
Q Consensus 208 ~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a 287 (468)
.++|+||||++++.+..+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++
T Consensus 116 ~~~~lv~Ey~~gg~L~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDLkp~NIll~~~~-~ikL~DfG~a 189 (371)
T cd05622 116 RYLYMVMEYMPGGDLVNLMS----NYDVPEKWARFYTAEVVLALDAIHS-MGFIHRDVKPDNMLLDKSG-HLKLADFGTC 189 (371)
T ss_pred CEEEEEEcCCCCCcHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHH-CCEEeCCCCHHHEEECCCC-CEEEEeCCce
Confidence 57999999998765543322 2458888999999999999999998 8999999999999999888 7999999999
Q ss_pred cccCCCC--CCccccccCCccccccccCCC---CCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 012233 288 KMLVPGE--PNISYICSRYYRAPELIFGAT---EYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTRE 362 (468)
Q Consensus 288 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~---~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~ 362 (468)
....... .....+||+.|+|||++.+.. .++.++|||||||++|||++|..||.+.+....+.++....
T Consensus 190 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~------ 263 (371)
T cd05622 190 MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHK------ 263 (371)
T ss_pred eEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCC------
Confidence 8664322 223567999999999986432 37889999999999999999999999877666665554311
Q ss_pred HHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCC--CCCHHHHhCCCCCCCCC
Q 012233 363 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSL--RCTALEACAHPFFDDLR 427 (468)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~--R~s~~ell~hp~f~~~~ 427 (468)
....+|. ...++..+++||.+||..++.+ |+++.++++||||++..
T Consensus 264 ---------~~~~~~~----------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~ 311 (371)
T cd05622 264 ---------NSLTFPD----------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ 311 (371)
T ss_pred ---------CcccCCC----------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCC
Confidence 0111221 1358899999999999854443 78999999999998853
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-44 Score=350.74 Aligned_cols=245 Identities=29% Similarity=0.484 Sum_probs=196.7
Q ss_pred ceecccCceEEEEEEEcCCCCEEEEEEeeccc-------chHHHHHHHHHH-cCCCCcccccceeeecCCCCceEEEEEe
Q 012233 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRL-LNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (468)
Q Consensus 143 ~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-------~~~~~E~~il~~-l~hpnIv~l~~~~~~~~~~~~~~~~lv~ 214 (468)
+.||+|+||.||+|.+..+++.||||++.... .....|..++.. ++||||+++++++ ....++|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~-----~~~~~~~lv~ 75 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTF-----QTKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCEEEEEE
Confidence 36999999999999999999999999986532 112345566654 4799999999888 4445689999
Q ss_pred ecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCCC-
Q 012233 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG- 293 (468)
Q Consensus 215 e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~~- 293 (468)
||+.++.+.... .....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++.....
T Consensus 76 e~~~gg~L~~~~---~~~~~~~~~~~~~~~~qi~~al~~LH~-~~ivH~dlkp~Nill~~~~-~~kL~Dfg~a~~~~~~~ 150 (316)
T cd05592 76 EYLNGGDLMFHI---QSSGRFDEARARFYAAEIICGLQFLHK-KGIIYRDLKLDNVLLDKDG-HIKIADFGMCKENMNGE 150 (316)
T ss_pred cCCCCCcHHHHH---HHcCCCCHHHHHHHHHHHHHHHHHHHH-CCEEeCCCCHHHeEECCCC-CEEEccCcCCeECCCCC
Confidence 999876554222 224568999999999999999999998 8999999999999999888 7999999999764322
Q ss_pred CCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCcc
Q 012233 294 EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTE 373 (468)
Q Consensus 294 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 373 (468)
......+||+.|+|||++.+.. ++.++|||||||++|||++|..||.+.+..+.+..+... .
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~-----------------~ 212 (316)
T cd05592 151 GKASTFCGTPDYIAPEILKGQK-YNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILND-----------------R 212 (316)
T ss_pred CccccccCCccccCHHHHcCCC-CCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC-----------------C
Confidence 2334567899999999997654 899999999999999999999999987765555444320 0
Q ss_pred CCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCH-HHHhCCCCCCCCC
Q 012233 374 FKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTA-LEACAHPFFDDLR 427 (468)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~-~ell~hp~f~~~~ 427 (468)
..++..++.++.+||.+||+.||.+|+++ .++++||||+.+.
T Consensus 213 ------------~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~~ 255 (316)
T cd05592 213 ------------PHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGID 255 (316)
T ss_pred ------------CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCCC
Confidence 01234578899999999999999999986 4888999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-44 Score=351.34 Aligned_cols=245 Identities=28% Similarity=0.496 Sum_probs=199.8
Q ss_pred ceecccCceEEEEEEEcCCCCEEEEEEeeccc-------chHHHHHHHHHHc-CCCCcccccceeeecCCCCceEEEEEe
Q 012233 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDELYLNLVL 214 (468)
Q Consensus 143 ~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-------~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~lv~ 214 (468)
+.||+|+||.||+|.+..+++.||||++.+.. ....+|..+++.+ +||||+++++++ .+..++|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~-----~~~~~~~lv~ 75 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCF-----QTKDRLFFVM 75 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCEEEEEE
Confidence 46999999999999999999999999986532 2234688888877 699999999988 4445689999
Q ss_pred ecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccC-CC
Q 012233 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV-PG 293 (468)
Q Consensus 215 e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~-~~ 293 (468)
||+.++.+.... .....+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++... ..
T Consensus 76 e~~~~~~L~~~~---~~~~~l~~~~~~~~~~qi~~~l~~LH~-~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~ 150 (318)
T cd05570 76 EYVNGGDLMFHI---QRSGRFDEPRARFYAAEIVLGLQFLHE-RGIIYRDLKLDNVLLDSEG-HIKIADFGMCKEGILGG 150 (318)
T ss_pred cCCCCCCHHHHH---HHcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEccCCCHHHeEECCCC-cEEecccCCCeecCcCC
Confidence 999876554222 224568999999999999999999998 8999999999999999888 79999999986532 22
Q ss_pred CCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCcc
Q 012233 294 EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTE 373 (468)
Q Consensus 294 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 373 (468)
......+|++.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+.......+... .
T Consensus 151 ~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~-----------------~ 212 (318)
T cd05570 151 VTTSTFCGTPDYIAPEILSYQP-YGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILED-----------------E 212 (318)
T ss_pred CcccceecCccccCHHHhcCCC-CCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC-----------------C
Confidence 2334467899999999997654 899999999999999999999999877755544443320 1
Q ss_pred CCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCH-----HHHhCCCCCCCCC
Q 012233 374 FKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTA-----LEACAHPFFDDLR 427 (468)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~-----~ell~hp~f~~~~ 427 (468)
.. ++..+++++.+||.+||+.||.+||++ .+++.||||+.+.
T Consensus 213 ~~------------~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~ 259 (318)
T cd05570 213 VR------------YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREID 259 (318)
T ss_pred CC------------CCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCCC
Confidence 11 234578999999999999999999999 9999999998864
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=351.05 Aligned_cols=258 Identities=26% Similarity=0.428 Sum_probs=204.4
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc-------cchHHHHHHHHHHcCCCCcccccceeeecCCCCceEE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~-------~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~ 210 (468)
+|.+.+.||+|+||.||++++..+++.||+|++.+. ...+.+|+.+++.++|+||++++++| .+..++
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~ 76 (331)
T cd05597 2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAF-----QDENNL 76 (331)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEE-----ecCCeE
Confidence 599999999999999999999999999999998642 12345789999999999999999988 445579
Q ss_pred EEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcccc
Q 012233 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (468)
Q Consensus 211 ~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~ 290 (468)
|+||||+.++.+.... ......+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++...
T Consensus 77 ~lv~e~~~g~~L~~~l--~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~ 152 (331)
T cd05597 77 YLVMDYYVGGDLLTLL--SKFEDRLPEDMARFYLAEMVLAIDSVHQ-LGYVHRDIKPDNVLLDKNG-HIRLADFGSCLRL 152 (331)
T ss_pred EEEEecCCCCcHHHHH--HHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEECCCCHHHEEECCCC-CEEEEECCceeec
Confidence 9999999865443222 1224568999999999999999999998 8999999999999999888 7999999998765
Q ss_pred CCCCC--CccccccCCccccccccC----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 012233 291 VPGEP--NISYICSRYYRAPELIFG----ATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEI 364 (468)
Q Consensus 291 ~~~~~--~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 364 (468)
..... .....||+.|+|||++.+ ...++.++|||||||++|+|++|+.||.+.+..+.+..+....
T Consensus 153 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~-------- 224 (331)
T cd05597 153 LADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK-------- 224 (331)
T ss_pred CCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCC--------
Confidence 43322 123468999999999863 2347889999999999999999999998877666655554311
Q ss_pred hhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCC--CCCHHHHhCCCCCCCCCC
Q 012233 365 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSL--RCTALEACAHPFFDDLRD 428 (468)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~--R~s~~ell~hp~f~~~~~ 428 (468)
..+.++. ....+++++++||++||..++.+ |+++.++++||||.++..
T Consensus 225 -------~~~~~~~---------~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~ 274 (331)
T cd05597 225 -------EHFQFPP---------DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDW 274 (331)
T ss_pred -------CcccCCC---------ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCH
Confidence 0011111 11347899999999999764444 889999999999988643
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=341.56 Aligned_cols=283 Identities=37% Similarity=0.637 Sum_probs=223.2
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeecccc---------hHHHHHHHHHHcCCCCcccccceeeecCCCCce
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR---------YKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~~---------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 208 (468)
+|.+.+.||.|+||.||+|.+..+|+.||||.+..... ....|+.+++.++|+||+++++++ .+..
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~ 75 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVF-----GHKS 75 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhhee-----ecCC
Confidence 38889999999999999999999999999999864422 234689999999999999999998 3445
Q ss_pred EEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcc
Q 012233 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (468)
Q Consensus 209 ~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~ 288 (468)
++++||||+.+++...+... ...+++..++.++.||+.||.|||+ +||+|+||||+|||++.++ .++|+|||++.
T Consensus 76 ~~~lv~e~~~~~L~~~i~~~---~~~~~~~~~~~~~~qi~~al~~lH~-~~i~H~dl~p~nill~~~~-~~~l~dfg~~~ 150 (298)
T cd07841 76 NINLVFEFMETDLEKVIKDK---SIVLTPADIKSYMLMTLRGLEYLHS-NWILHRDLKPNNLLIASDG-VLKLADFGLAR 150 (298)
T ss_pred EEEEEEcccCCCHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCChhhEEEcCCC-CEEEccceeee
Confidence 68999999966665544321 1368999999999999999999998 8999999999999999887 79999999997
Q ss_pred ccCCCC-CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 012233 289 MLVPGE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367 (468)
Q Consensus 289 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 367 (468)
...... ......+++.|+|||.+.+...++.++|+|||||++|+|++|.+||.+.+..+.+.++...++.+....+...
T Consensus 151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (298)
T cd07841 151 SFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGV 230 (298)
T ss_pred eccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhc
Confidence 764432 2233456888999999866556889999999999999999999999988888888888887777665554322
Q ss_pred CCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCCCC
Q 012233 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNT 431 (468)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~ 431 (468)
...............+. .......+.++.+||.+||..||.+|||+.+++.||||++...+..
T Consensus 231 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~~ 293 (298)
T cd07841 231 TSLPDYVEFKPFPPTPL-KQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPTP 293 (298)
T ss_pred ccccccccccccCCcch-hhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCCC
Confidence 11111111111111111 1233456889999999999999999999999999999999877764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=338.85 Aligned_cols=276 Identities=36% Similarity=0.648 Sum_probs=216.2
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc------chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 211 (468)
+|++.+.||+|+||.||+|.+..+|+.||+|.+.... ....+|+.+++.++|+||+++++++ .....++
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~ 76 (286)
T cd07847 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVF-----RRKRKLH 76 (286)
T ss_pred ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEE-----eeCCEEE
Confidence 5999999999999999999999999999999875332 2345799999999999999999988 4445688
Q ss_pred EEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccC
Q 012233 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (468)
Q Consensus 212 lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~ 291 (468)
+||||++++++..... ....+++..++.++.||+.||.|||+ .||+|+||||+||+++.++ .++|+|||++....
T Consensus 77 ~v~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~ql~~~l~~LH~-~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~ 151 (286)
T cd07847 77 LVFEYCDHTVLNELEK---NPRGVPEHLIKKIIWQTLQAVNFCHK-HNCIHRDVKPENILITKQG-QIKLCDFGFARILT 151 (286)
T ss_pred EEEeccCccHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCChhhEEEcCCC-cEEECccccceecC
Confidence 9999999987764432 24568999999999999999999998 8999999999999999888 79999999998764
Q ss_pred CCC-CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC--
Q 012233 292 PGE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN-- 368 (468)
Q Consensus 292 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-- 368 (468)
... ......++..|+|||.+.+...++.++|+|||||++|+|++|..||.+.+..+....+....+...........
T Consensus 152 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07847 152 GPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTN 231 (286)
T ss_pred CCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccc
Confidence 433 22345678899999998765668899999999999999999999999888877777776655543332111110
Q ss_pred CCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 012233 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (468)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f 423 (468)
..+.....+......-.......++..+.+||.+||+.||.+||++.|++.||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 232 QFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred cccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 1111112222111111111234578999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=339.23 Aligned_cols=276 Identities=39% Similarity=0.716 Sum_probs=224.1
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc------chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 211 (468)
+|.+.+.||.|+||.||+|.+..+|..||+|++.... ....+|+.+++.++||||+++++++ .+..+.+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~ 75 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVF-----PHGSGFV 75 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCeeE
Confidence 4899999999999999999999999999999886432 2455799999999999999999988 4455689
Q ss_pred EEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccC
Q 012233 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (468)
Q Consensus 212 lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~ 291 (468)
+||||+++++...+... ...+++..++.++.||+.||.|||+ .||+|+||||+||+++.++ .++|+|||++....
T Consensus 76 ~v~e~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~ni~~~~~~-~~~l~dfg~~~~~~ 150 (286)
T cd07832 76 LVMEYMPSDLSEVLRDE---ERPLPEAQVKSYMRMLLKGVAYMHA-NGIMHRDLKPANLLISADG-VLKIADFGLARLFS 150 (286)
T ss_pred EEecccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCcCHHHEEEcCCC-cEEEeeeeeccccc
Confidence 99999966666544322 3568999999999999999999998 8999999999999999887 79999999987664
Q ss_pred CCC--CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC-
Q 012233 292 PGE--PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN- 368 (468)
Q Consensus 292 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~- 368 (468)
... ......++..|+|||.+.+...++.++|||||||++|+|++|.+||.+......+..+...++.+....+....
T Consensus 151 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07832 151 EEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTS 230 (286)
T ss_pred CCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccC
Confidence 332 13345789999999998766667899999999999999999999999888888888888888887765554322
Q ss_pred -CCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCC
Q 012233 369 -PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFD 424 (468)
Q Consensus 369 -~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~ 424 (468)
+.+....++......+.. ..+..+.++.+||.+||+.||.+|||+++++.||||.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 231 LPDYNKITFPESKPIPLEE-IFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred cchhhcccCCCCCcchHHH-hCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 222333333333333322 2345679999999999999999999999999999994
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=349.38 Aligned_cols=245 Identities=28% Similarity=0.476 Sum_probs=196.6
Q ss_pred ceecccCceEEEEEEEcCCCCEEEEEEeeccc-------chHHHHHHHHHH-cCCCCcccccceeeecCCCCceEEEEEe
Q 012233 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRL-LNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (468)
Q Consensus 143 ~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-------~~~~~E~~il~~-l~hpnIv~l~~~~~~~~~~~~~~~~lv~ 214 (468)
+.||+|+||.||+|.+..+++.||||++.... .....|..+++. ++||||+++++++. +..++|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~-----~~~~~~lv~ 75 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQ-----TKENLFFVM 75 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEE-----eCCEEEEEE
Confidence 46999999999999999999999999986532 123356777765 48999999999883 444689999
Q ss_pred ecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCC-C
Q 012233 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP-G 293 (468)
Q Consensus 215 e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~-~ 293 (468)
||+.++.+.... .....+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++..... .
T Consensus 76 ey~~~g~L~~~l---~~~~~~~~~~~~~~~~qi~~al~~LH~-~~ivHrdikp~Nil~~~~~-~~kl~Dfg~~~~~~~~~ 150 (316)
T cd05619 76 EYLNGGDLMFHI---QSCHKFDLPRATFYAAEIICGLQFLHS-KGIVYRDLKLDNILLDTDG-HIKIADFGMCKENMLGD 150 (316)
T ss_pred eCCCCCcHHHHH---HHcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeCCCCHHHEEECCCC-CEEEccCCcceECCCCC
Confidence 999876443222 223568889999999999999999998 8999999999999999888 799999999875422 2
Q ss_pred CCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCcc
Q 012233 294 EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTE 373 (468)
Q Consensus 294 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 373 (468)
.......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+.+..+... .
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~-----------------~ 212 (316)
T cd05619 151 AKTCTFCGTPDYIAPEILLGQK-YNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD-----------------N 212 (316)
T ss_pred CceeeecCCccccCHHHHcCCC-CCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-----------------C
Confidence 2334567899999999997654 899999999999999999999999887655544433220 0
Q ss_pred CCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHH-HHhCCCCCCCCC
Q 012233 374 FKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTAL-EACAHPFFDDLR 427 (468)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~-ell~hp~f~~~~ 427 (468)
.. ++..++.++++||.+||+.||.+|+++. ++++||||+.+.
T Consensus 213 ~~------------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~~ 255 (316)
T cd05619 213 PC------------YPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREID 255 (316)
T ss_pred CC------------CCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCCC
Confidence 01 2234788999999999999999999996 899999999875
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-44 Score=352.82 Aligned_cols=245 Identities=28% Similarity=0.468 Sum_probs=196.8
Q ss_pred ceecccCceEEEEEEEcCCCCEEEEEEeecccc-------hHHHHH-HHHHHcCCCCcccccceeeecCCCCceEEEEEe
Q 012233 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR-------YKNREL-QIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (468)
Q Consensus 143 ~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~~-------~~~~E~-~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv~ 214 (468)
+.||+|+||+||+|.+..+|+.||||++..... ...+|. .+++.++||||+++++++ .+...+|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~-----~~~~~~~lv~ 75 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSF-----QTADKLYFVL 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEE-----EeCCEEEEEE
Confidence 469999999999999999999999999864321 112233 356789999999999888 3444689999
Q ss_pred ecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCC-C
Q 012233 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP-G 293 (468)
Q Consensus 215 e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~-~ 293 (468)
||+.++.+.... .....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++..... .
T Consensus 76 e~~~~g~L~~~l---~~~~~~~~~~~~~~~~qi~~~l~~lH~-~givH~dikp~NIll~~~~-~~kl~Dfg~~~~~~~~~ 150 (323)
T cd05575 76 DYVNGGELFFHL---QRERSFPEPRARFYAAEIASALGYLHS-LNIIYRDLKPENILLDSQG-HVVLTDFGLCKEGIEHS 150 (323)
T ss_pred cCCCCCCHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCCHHHeEECCCC-cEEEeccCCCcccccCC
Confidence 999976543222 224568899999999999999999998 8999999999999999888 799999999875422 2
Q ss_pred CCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCcc
Q 012233 294 EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTE 373 (468)
Q Consensus 294 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 373 (468)
......+||+.|+|||++.+.. ++.++|||||||++|+|++|..||...+..+.+..+... .
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~-----------------~ 212 (323)
T cd05575 151 KTTSTFCGTPEYLAPEVLRKQP-YDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNK-----------------P 212 (323)
T ss_pred CccccccCChhhcChhhhcCCC-CCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcC-----------------C
Confidence 2334567899999999997654 899999999999999999999999887765555544331 0
Q ss_pred CCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCH----HHHhCCCCCCCCC
Q 012233 374 FKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTA----LEACAHPFFDDLR 427 (468)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~----~ell~hp~f~~~~ 427 (468)
.. ++..+++.+.+||.+||+.||.+||++ .+++.||||..+.
T Consensus 213 ~~------------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~ 258 (323)
T cd05575 213 LR------------LKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSIN 258 (323)
T ss_pred CC------------CCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCC
Confidence 00 234578999999999999999999987 6999999998754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=351.39 Aligned_cols=246 Identities=27% Similarity=0.506 Sum_probs=194.8
Q ss_pred ceecccCceEEEEEEEcCCCCEEEEEEeeccc-------chHHHHHHHHHHc-CCCCcccccceeeecCCCCceEEEEEe
Q 012233 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDELYLNLVL 214 (468)
Q Consensus 143 ~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-------~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~lv~ 214 (468)
+.||+|+||.||+|.+..+++.||+|++.+.. ....+|+.++..+ +||||+++++++ .....+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~-----~~~~~~~lv~ 75 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-----QTESRLFFVI 75 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEE-----EeCCEEEEEE
Confidence 46999999999999999999999999986532 1234677777766 799999999988 3445689999
Q ss_pred ecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccC-CC
Q 012233 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV-PG 293 (468)
Q Consensus 215 e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~-~~ 293 (468)
||+.++.+... ......+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++... ..
T Consensus 76 E~~~~~~L~~~---~~~~~~l~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dikp~Nili~~~~-~~kL~DfG~~~~~~~~~ 150 (329)
T cd05618 76 EYVNGGDLMFH---MQRQRKLPEEHARFYSAEISLALNYLHE-RGIIYRDLKLDNVLLDSEG-HIKLTDYGMCKEGLRPG 150 (329)
T ss_pred eCCCCCCHHHH---HHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHHHEEECCCC-CEEEeeCCccccccCCC
Confidence 99997655422 2224578999999999999999999998 8999999999999999888 79999999987532 22
Q ss_pred CCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC--------cHHHHHHHHHHhCCCCHHHHh
Q 012233 294 EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGES--------GVDQLVEIIKILGTPTREEIK 365 (468)
Q Consensus 294 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~--------~~~~~~~i~~~~~~~~~~~~~ 365 (468)
.......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.... ..+.+.+.+..
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~---------- 219 (329)
T cd05618 151 DTTSTFCGTPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE---------- 219 (329)
T ss_pred CccccccCCccccCHHHHcCCC-CCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhc----------
Confidence 2334568999999999997654 8999999999999999999999995311 11112111110
Q ss_pred hcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCC------HHHHhCCCCCCCCC
Q 012233 366 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCT------ALEACAHPFFDDLR 427 (468)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s------~~ell~hp~f~~~~ 427 (468)
... .++..++..+.+||.+||+.||.+|++ +.++++||||+.+.
T Consensus 220 ------~~~------------~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~ 269 (329)
T cd05618 220 ------KQI------------RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD 269 (329)
T ss_pred ------CCC------------CCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCC
Confidence 011 134557899999999999999999998 57999999998763
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-45 Score=347.57 Aligned_cols=263 Identities=29% Similarity=0.414 Sum_probs=217.1
Q ss_pred CCCcccceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc-------cchHHHHHHHHHHcCCCCcccccceeeecCC
Q 012233 132 QPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTE 204 (468)
Q Consensus 132 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~-------~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 204 (468)
+|.....|..-++||+|+||.||-|+.+.+|+.||+|++.+. +....+|..||.+++.+.||.+--.|
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAf----- 254 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAF----- 254 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeee-----
Confidence 444556788999999999999999999999999999977332 23345799999999999999997777
Q ss_pred CCceEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeee
Q 012233 205 KDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDF 284 (468)
Q Consensus 205 ~~~~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DF 284 (468)
+....+|+||..|+||-+.... +.-.+..|++..++.|+.+|+.||.+||+ .+||+|||||+|||+|.+| .|+|+|+
T Consensus 255 eTkd~LClVLtlMNGGDLkfHi-yn~g~~gF~e~ra~FYAAEi~cGLehlH~-~~iVYRDLKPeNILLDd~G-hvRISDL 331 (591)
T KOG0986|consen 255 ETKDALCLVLTLMNGGDLKFHI-YNHGNPGFDEQRARFYAAEIICGLEHLHR-RRIVYRDLKPENILLDDHG-HVRISDL 331 (591)
T ss_pred cCCCceEEEEEeecCCceeEEe-eccCCCCCchHHHHHHHHHHHhhHHHHHh-cceeeccCChhheeeccCC-CeEeecc
Confidence 3344599999999988665433 23334689999999999999999999998 8999999999999999999 4999999
Q ss_pred cCccccCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 012233 285 GSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEI 364 (468)
Q Consensus 285 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 364 (468)
|+|..+..+.+....+||..|||||++.+.. |+...|+|||||+||||+.|+.||........-.++-+..-..
T Consensus 332 GLAvei~~g~~~~~rvGT~GYMAPEvl~ne~-Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~----- 405 (591)
T KOG0986|consen 332 GLAVEIPEGKPIRGRVGTVGYMAPEVLQNEV-YDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLED----- 405 (591)
T ss_pred ceEEecCCCCccccccCcccccCHHHHcCCc-ccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcc-----
Confidence 9999999888888889999999999997665 9999999999999999999999998654333222222211111
Q ss_pred hhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCC-----CHHHHhCCCCCCCCCC
Q 012233 365 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC-----TALEACAHPFFDDLRD 428 (468)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~-----s~~ell~hp~f~~~~~ 428 (468)
+ ..++...|+++++|++.+|++||.+|. ++.++.+||||+++.-
T Consensus 406 --------~------------~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw 454 (591)
T KOG0986|consen 406 --------P------------EEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNW 454 (591)
T ss_pred --------h------------hhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCH
Confidence 1 114466899999999999999999998 6889999999999643
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=342.21 Aligned_cols=279 Identities=37% Similarity=0.624 Sum_probs=224.5
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc------chHHHHHHHHHHcCCCCcccccceeeecCCCCceEE
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~ 210 (468)
.+|.+.+.||.|+||.||+|.+..+++.+|+|.+.... ....+|+.+++.++||||+++++++.... ..+.
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~---~~~~ 81 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSN---LDKI 81 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecC---CCcE
Confidence 35999999999999999999999999999999885332 12346999999999999999999875431 2468
Q ss_pred EEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcccc
Q 012233 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (468)
Q Consensus 211 ~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~ 290 (468)
|+||||+.+++..++... ...+++..++.++.||+.||.|||+ .||+|+||||+|||++.++ .++|+|||++...
T Consensus 82 ~lv~e~~~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~-~~i~H~dl~p~nili~~~~-~~~l~d~g~~~~~ 156 (293)
T cd07843 82 YMVMEYVEHDLKSLMETM---KQPFLQSEVKCLMLQLLSGVAHLHD-NWILHRDLKTSNLLLNNRG-ILKICDFGLAREY 156 (293)
T ss_pred EEEehhcCcCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCCHHHEEECCCC-cEEEeecCceeec
Confidence 999999998776654432 2368999999999999999999998 8999999999999999887 7999999998766
Q ss_pred CCC-CCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC-
Q 012233 291 VPG-EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN- 368 (468)
Q Consensus 291 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~- 368 (468)
... .......+++.|+|||.+.+...++.++|+|||||++|+|++|.+||...+..+.+.+++...+.|....+....
T Consensus 157 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (293)
T cd07843 157 GSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE 236 (293)
T ss_pred cCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence 443 223345678899999998766557899999999999999999999999999888889898888888776665432
Q ss_pred -CCCccCCCCcccCCCcccccccC-CCHHHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 012233 369 -PNYTEFKFPQIKAHPWHKIFHKR-MPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (468)
Q Consensus 369 -~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f 423 (468)
+......+.......+...++.. +++.+.+||++||+.||++|||+.|++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred cchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 11111222222222333444444 68999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-43 Score=338.58 Aligned_cols=275 Identities=35% Similarity=0.651 Sum_probs=217.2
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc------chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 211 (468)
+|.+.+.||.|+||.||+|.+..+|..||||.+.... ....+|++++++++||||+++++++ .+....+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 75 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENKLY 75 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhc-----ccCCcEE
Confidence 3889999999999999999999999999999885432 2356799999999999999999988 4445689
Q ss_pred EEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccC
Q 012233 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (468)
Q Consensus 212 lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~ 291 (468)
+||||+.+++...+... ....+++..++.++.|++.||+|||+ .|++|+||+|+||+++.++ .+||+|||++....
T Consensus 76 ~v~e~~~~~l~~~~~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~-~~i~H~~l~p~nill~~~~-~~~l~dfg~~~~~~ 151 (284)
T cd07860 76 LVFEFLHQDLKKFMDAS--PLSGIPLPLIKSYLFQLLQGLAFCHS-HRVLHRDLKPQNLLINTEG-AIKLADFGLARAFG 151 (284)
T ss_pred EEeeccccCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECCCC-CEEEeeccchhhcc
Confidence 99999987766554332 23568899999999999999999998 8999999999999999888 79999999987653
Q ss_pred CCC-CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC--
Q 012233 292 PGE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN-- 368 (468)
Q Consensus 292 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-- 368 (468)
... ......+++.|+|||++.+...++.++|||||||++|+|++|..||...+..+.+.++++..+.+....+....
T Consensus 152 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07860 152 VPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSL 231 (284)
T ss_pred cCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHH
Confidence 322 22334568899999998766557889999999999999999999999988888888888887777654332110
Q ss_pred CCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 012233 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (468)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f 423 (468)
+.+. ..++........ ...+.+++++++||.+||+.||.+|||+.+++.||||
T Consensus 232 ~~~~-~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 232 PDYK-PSFPKWARQDFS-KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred HHHH-hhcccccccCHH-HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 0000 011111111111 1234578899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-43 Score=340.39 Aligned_cols=283 Identities=34% Similarity=0.596 Sum_probs=221.4
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc------chHHHHHHHHHHcCCCCcccccceeeecCCCCceEE
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~ 210 (468)
.+|.+.+.||.|+||.||+|.+..+|+.||+|.+.... ....+|+++++.++||||+++++++ .+..+.
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 76 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVV-----HSEKRL 76 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEE-----ecCCeE
Confidence 35999999999999999999999999999999875321 2345799999999999999999988 444568
Q ss_pred EEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcccc
Q 012233 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (468)
Q Consensus 211 ~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~ 290 (468)
|+||||++++++..+... ....+++..++.++.||+.||+|||+ +||+|+||+|+||+++..+..+||+|||++...
T Consensus 77 ~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~-~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~ 153 (294)
T PLN00009 77 YLVFEYLDLDLKKHMDSS--PDFAKNPRLIKTYLYQILRGIAYCHS-HRVLHRDLKPQNLLIDRRTNALKLADFGLARAF 153 (294)
T ss_pred EEEEecccccHHHHHHhC--CCCCcCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCCcceEEEECCCCEEEEccccccccc
Confidence 999999998777654332 22335788888999999999999998 899999999999999865557999999999755
Q ss_pred CCCC-CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 012233 291 VPGE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (468)
Q Consensus 291 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 369 (468)
.... ......+++.|+|||.+.+...++.++|||||||++|+|++|++||...+..+.+.+++...+.+....+.....
T Consensus 154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (294)
T PLN00009 154 GIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTS 233 (294)
T ss_pred CCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccc
Confidence 3322 223346788999999987655688999999999999999999999999888888888888877776655432111
Q ss_pred CCc-cCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCC
Q 012233 370 NYT-EFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRD 428 (468)
Q Consensus 370 ~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~ 428 (468)
... ...++.... .......+.+++++.++|.+||+.||.+||++.+++.||||++++.
T Consensus 234 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~~ 292 (294)
T PLN00009 234 LPDYKSAFPKWPP-KDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLGD 292 (294)
T ss_pred chhhhhhcccCCC-CCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHhc
Confidence 000 000110000 0111123457899999999999999999999999999999998764
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=347.52 Aligned_cols=249 Identities=27% Similarity=0.437 Sum_probs=201.4
Q ss_pred eEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-------chHHHHHHHHHHcC-CCCcccccceeeecCCCCceEE
Q 012233 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLN-HPNVVSLKHCFFSTTEKDELYL 210 (468)
Q Consensus 139 y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-------~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~~~~~ 210 (468)
|...+.||+|+||.||+|.++.+|+.||||++.+.. .....|..+++.+. |++|+++++++ .+...+
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~~ 76 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCF-----QTVDRL 76 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEE-----ecCCEE
Confidence 788899999999999999999999999999986432 12345788888886 56777888877 444468
Q ss_pred EEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcccc
Q 012233 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (468)
Q Consensus 211 ~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~ 290 (468)
|+||||++++.+... ......+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++..
T Consensus 77 ~lv~Ey~~~g~L~~~---i~~~~~l~~~~~~~i~~qi~~al~~lH~-~~ivHrDikp~Nill~~~~-~ikL~Dfg~~~~~ 151 (323)
T cd05615 77 YFVMEYVNGGDLMYH---IQQVGKFKEPQAVFYAAEISVGLFFLHR-RGIIYRDLKLDNVMLDSEG-HIKIADFGMCKEH 151 (323)
T ss_pred EEEEcCCCCCcHHHH---HHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEECCCC-CEEEecccccccc
Confidence 999999987644322 2224568999999999999999999998 8999999999999999888 7999999998754
Q ss_pred CCC-CCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 012233 291 VPG-EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (468)
Q Consensus 291 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 369 (468)
... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+....+..+...
T Consensus 152 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~-------------- 216 (323)
T cd05615 152 MVDGVTTRTFCGTPDYIAPEIIAYQ-PYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEH-------------- 216 (323)
T ss_pred CCCCccccCccCCccccCHHHHcCC-CCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--------------
Confidence 322 223356789999999999755 4899999999999999999999999887766555555431
Q ss_pred CCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCC-----HHHHhCCCCCCCCC
Q 012233 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCT-----ALEACAHPFFDDLR 427 (468)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s-----~~ell~hp~f~~~~ 427 (468)
... ++..++.++.+||.+||+.||.+|++ ..+++.||||+.+.
T Consensus 217 ---~~~------------~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~ 264 (323)
T cd05615 217 ---NVS------------YPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRID 264 (323)
T ss_pred ---CCC------------CCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCC
Confidence 111 23457889999999999999999997 57899999999864
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-43 Score=336.89 Aligned_cols=275 Identities=36% Similarity=0.644 Sum_probs=217.2
Q ss_pred eEEeceecccCceEEEEEEEcCCCCEEEEEEeecccc-----hHHHHHHHHHHcC-CCCcccccceeeecCCCCceEEEE
Q 012233 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR-----YKNRELQIMRLLN-HPNVVSLKHCFFSTTEKDELYLNL 212 (468)
Q Consensus 139 y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~~-----~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~~~~~~l 212 (468)
|.+.+.||+|+||.||+|.+..++..||+|.+..... ...+|+.+++++. |+||+++++++... ...++++
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~---~~~~~~l 77 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDR---KTGRLAL 77 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecC---CCCcEEE
Confidence 6788899999999999999999999999998864321 2235888888885 99999999988543 1145889
Q ss_pred EeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCC
Q 012233 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (468)
Q Consensus 213 v~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~ 292 (468)
||||+.+++++.+... ...+++..++.++.||+.||.|||+ .||+||||||+||+++. + .+||+|||++.....
T Consensus 78 v~e~~~~~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~-~~i~H~dl~p~ni~l~~-~-~~kl~dfg~~~~~~~ 151 (282)
T cd07831 78 VFELMDMNLYELIKGR---KRPLPEKRVKSYMYQLLKSLDHMHR-NGIFHRDIKPENILIKD-D-ILKLADFGSCRGIYS 151 (282)
T ss_pred EEecCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecccCHHHEEEcC-C-CeEEEeccccccccc
Confidence 9999998887755432 3568999999999999999999998 89999999999999998 5 799999999987654
Q ss_pred CCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCC-C
Q 012233 293 GEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPN-Y 371 (468)
Q Consensus 293 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~-~ 371 (468)
........++..|+|||++.....++.++|||||||++|||++|.+||.+.+..+.+..+...++.+........... .
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07831 152 KPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRH 231 (282)
T ss_pred CCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccc
Confidence 444445678899999998765555789999999999999999999999998888888888887777766443222111 1
Q ss_pred ccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 012233 372 TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (468)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f 423 (468)
..+.++....... ..+...++.++.+||.+||++||.+||++.+++.||||
T Consensus 232 ~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 232 MNYNFPSKKGTGL-RKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred ccccCcccccccH-HHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 1222222111111 11234578999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-44 Score=352.39 Aligned_cols=245 Identities=29% Similarity=0.471 Sum_probs=199.9
Q ss_pred ceecccCceEEEEEEE---cCCCCEEEEEEeeccc------chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEEE
Q 012233 143 RVVGTGSFGVVFQAKC---LETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV 213 (468)
Q Consensus 143 ~~lG~G~fg~Vy~~~~---~~~g~~vaiK~~~~~~------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv 213 (468)
+.||+|+||.||++++ ..+|+.||+|++.... ....+|+++++.++||||+++++++ .+...+|+|
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~~lv 76 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAF-----QTEGKLYLI 76 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEE-----EcCCEEEEE
Confidence 5799999999999986 3578999999986432 2234699999999999999999988 444568999
Q ss_pred eecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCCC
Q 012233 214 LEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293 (468)
Q Consensus 214 ~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~~ 293 (468)
|||+.++.+... ......+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++......
T Consensus 77 ~e~~~~~~L~~~---l~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~-~~kL~Dfg~~~~~~~~ 151 (318)
T cd05582 77 LDFLRGGDLFTR---LSKEVMFTEEDVKFYLAELALALDHLHS-LGIIYRDLKPENILLDEEG-HIKLTDFGLSKESIDH 151 (318)
T ss_pred EcCCCCCcHHHH---HHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHeEECCCC-cEEEeeccCCcccCCC
Confidence 999986544322 1224568999999999999999999998 8999999999999999888 7999999998765433
Q ss_pred -CCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCc
Q 012233 294 -EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYT 372 (468)
Q Consensus 294 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 372 (468)
.......|++.|+|||++.+. .++.++|||||||++|+|++|+.||...+..+.+..+...
T Consensus 152 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~----------------- 213 (318)
T cd05582 152 EKKAYSFCGTVEYMAPEVVNRR-GHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKA----------------- 213 (318)
T ss_pred CCceecccCChhhcCHHHHcCC-CCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcC-----------------
Confidence 233456789999999999654 4889999999999999999999999887766655554331
Q ss_pred cCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCC-----HHHHhCCCCCCCCC
Q 012233 373 EFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCT-----ALEACAHPFFDDLR 427 (468)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s-----~~ell~hp~f~~~~ 427 (468)
... ++..+++++.+||.+||+.||.+||+ +.+++.||||+.+.
T Consensus 214 ~~~------------~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~ 261 (318)
T cd05582 214 KLG------------MPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTID 261 (318)
T ss_pred CCC------------CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCC
Confidence 111 23457899999999999999999999 77899999998763
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=340.78 Aligned_cols=282 Identities=30% Similarity=0.553 Sum_probs=221.0
Q ss_pred ccceEEeceecccCceEEEEEEEcCCCCEEEEEEeecccchHH---HHHHHHHHcCC--C----CcccccceeeecCCCC
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNH--P----NVVSLKHCFFSTTEKD 206 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~~~~~---~E~~il~~l~h--p----nIv~l~~~~~~~~~~~ 206 (468)
..+|.+...+|+|.||.|..|.+..++..||||+++...++.+ -|+++|+++.+ | -+|++.++| .-
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF-----dy 162 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWF-----DY 162 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh-----hc
Confidence 3469999999999999999999999999999999876655443 49999999943 2 278888888 44
Q ss_pred ceEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCC-----------
Q 012233 207 ELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPH----------- 275 (468)
Q Consensus 207 ~~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~----------- 275 (468)
..++|||+|.++-++++.+... ....+++..++.+++|++.+++|||+ .+++|.||||||||+.+.
T Consensus 163 rghiCivfellG~S~~dFlk~N--~y~~fpi~~ir~m~~QL~~sv~fLh~-~kl~HTDLKPENILfvss~~~~~~~~k~~ 239 (415)
T KOG0671|consen 163 RGHICIVFELLGLSTFDFLKEN--NYIPFPIDHIRHMGYQLLESVAFLHD-LKLTHTDLKPENILFVSSEYFKTYNPKKK 239 (415)
T ss_pred cCceEEEEeccChhHHHHhccC--CccccchHHHHHHHHHHHHHHHHHHh-cceeecCCChheEEEeccceEEEeccCCc
Confidence 5569999999998888866542 24568999999999999999999998 899999999999997311
Q ss_pred --------CCcEEEeeecCccccCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHH
Q 012233 276 --------THQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVD 347 (468)
Q Consensus 276 --------~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~ 347 (468)
...|+|+|||.|+... ......+.|..|+|||++.+-+ ++..+||||+||||+||.+|...|+..++.+
T Consensus 240 ~~~~r~~ks~~I~vIDFGsAtf~~--e~hs~iVsTRHYRAPEViLgLG-wS~pCDvWSiGCIL~ElytG~~LFqtHen~E 316 (415)
T KOG0671|consen 240 VCFIRPLKSTAIKVIDFGSATFDH--EHHSTIVSTRHYRAPEVILGLG-WSQPCDVWSIGCILVELYTGETLFQTHENLE 316 (415)
T ss_pred cceeccCCCcceEEEecCCcceec--cCcceeeeccccCCchheeccC-cCCccCceeeeeEEEEeeccceecccCCcHH
Confidence 1158999999998653 3446788999999999999765 9999999999999999999999999999999
Q ss_pred HHHHHHHHhCCCCHHHHhhc-CCCCc---cCCCCcc-----------cCCCcccccc--cCCCHHHHHHHHHhcccCCCC
Q 012233 348 QLVEIIKILGTPTREEIKCM-NPNYT---EFKFPQI-----------KAHPWHKIFH--KRMPPEALDLVSRLLQYSPSL 410 (468)
Q Consensus 348 ~~~~i~~~~~~~~~~~~~~~-~~~~~---~~~~~~~-----------~~~~~~~~~~--~~~~~~l~~li~~~L~~dP~~ 410 (468)
.+..+..++|..+...+... ...|. .+.++.. .+.+...... ...-.++.|||++||.+||.+
T Consensus 317 HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~ 396 (415)
T KOG0671|consen 317 HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPAR 396 (415)
T ss_pred HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccc
Confidence 99999999997776665543 11110 1111110 0111111110 111235899999999999999
Q ss_pred CCCHHHHhCCCCCCCCCC
Q 012233 411 RCTALEACAHPFFDDLRD 428 (468)
Q Consensus 411 R~s~~ell~hp~f~~~~~ 428 (468)
|+|+.|+|.||||+.+..
T Consensus 397 RiTl~EAL~HpFF~~~~~ 414 (415)
T KOG0671|consen 397 RITLREALSHPFFARLTP 414 (415)
T ss_pred cccHHHHhcCHHhhcCCC
Confidence 999999999999987653
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=340.35 Aligned_cols=255 Identities=27% Similarity=0.421 Sum_probs=202.7
Q ss_pred eEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-------chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEE
Q 012233 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (468)
Q Consensus 139 y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 211 (468)
|++.+.||+|+||.||+|.+..+++.||+|.+.... ....+|+.+++.++|+||+++++.+ .+..++|
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~~ 76 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAY-----ETKDALC 76 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEE-----ecCCEEE
Confidence 778899999999999999999999999999885431 2234699999999999999998887 3444689
Q ss_pred EEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccC
Q 012233 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (468)
Q Consensus 212 lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~ 291 (468)
+||||+.++.+...... .....+++..+..++.|++.||.|||+ .||+||||||+||+++.++ .++|+|||++....
T Consensus 77 lv~e~~~g~~L~~~l~~-~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~iiH~dikp~Nil~~~~~-~~~l~Dfg~~~~~~ 153 (285)
T cd05630 77 LVLTLMNGGDLKFHIYH-MGEAGFEEGRAVFYAAEICCGLEDLHQ-ERIVYRDLKPENILLDDHG-HIRISDLGLAVHVP 153 (285)
T ss_pred EEEEecCCCcHHHHHHH-hcccCCCHHHHHHHHHHHHHHHHHHHh-CCEEeCCCCHHHEEECCCC-CEEEeeccceeecC
Confidence 99999987655433221 223468899999999999999999998 8999999999999999887 79999999997655
Q ss_pred CCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCC
Q 012233 292 PGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNY 371 (468)
Q Consensus 292 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 371 (468)
.........|+..|+|||++.+.. ++.++|+|||||++|+|++|+.||...................
T Consensus 154 ~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~------------ 220 (285)
T cd05630 154 EGQTIKGRVGTVGYMAPEVVKNER-YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV------------ 220 (285)
T ss_pred CCccccCCCCCccccChHHHcCCC-CCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhh------------
Confidence 444444567899999999997654 8999999999999999999999998654321111111100000
Q ss_pred ccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCC-----HHHHhCCCCCCCCC
Q 012233 372 TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCT-----ALEACAHPFFDDLR 427 (468)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s-----~~ell~hp~f~~~~ 427 (468)
...++..+++++.+||.+||+.||.+|+| +.|+++||||+.+.
T Consensus 221 -------------~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~ 268 (285)
T cd05630 221 -------------QEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQIN 268 (285)
T ss_pred -------------hhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhccC
Confidence 00123457889999999999999999999 99999999998753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=350.80 Aligned_cols=245 Identities=28% Similarity=0.484 Sum_probs=196.7
Q ss_pred ceecccCceEEEEEEEcCCCCEEEEEEeeccc-------chHHHHH-HHHHHcCCCCcccccceeeecCCCCceEEEEEe
Q 012233 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNREL-QIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (468)
Q Consensus 143 ~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-------~~~~~E~-~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv~ 214 (468)
+.||+|+||+||+|.+..+|+.||+|++.+.. .....|. .+++.++||||+++++++ .....+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~-----~~~~~~~lv~ 75 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSF-----QTTEKLYFVL 75 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEE-----ecCCEEEEEE
Confidence 46999999999999999999999999986432 1122333 357789999999999888 4444689999
Q ss_pred ecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCC-C
Q 012233 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP-G 293 (468)
Q Consensus 215 e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~-~ 293 (468)
||+.++.+... ......+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++.... .
T Consensus 76 e~~~~~~L~~~---l~~~~~~~~~~~~~~~~qi~~al~~lH~-~givH~Dlkp~NIll~~~~-~~kL~DfG~~~~~~~~~ 150 (325)
T cd05604 76 DFVNGGELFFH---LQRERSFPEPRARFYAAEIASALGYLHS-INIVYRDLKPENILLDSQG-HVVLTDFGLCKEGIAQS 150 (325)
T ss_pred cCCCCCCHHHH---HHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHeEECCCC-CEEEeecCCcccCCCCC
Confidence 99997655322 2234678999999999999999999998 8999999999999999888 799999999875422 2
Q ss_pred CCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCcc
Q 012233 294 EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTE 373 (468)
Q Consensus 294 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 373 (468)
......+||+.|+|||++.+.. ++.++|||||||++|+|++|..||...+..+.+..+... .
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~-----------------~ 212 (325)
T cd05604 151 DTTTTFCGTPEYLAPEVIRKQP-YDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHK-----------------P 212 (325)
T ss_pred CCcccccCChhhCCHHHHcCCC-CCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcC-----------------C
Confidence 2334567999999999997654 899999999999999999999999887766555544331 0
Q ss_pred CCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCH----HHHhCCCCCCCCC
Q 012233 374 FKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTA----LEACAHPFFDDLR 427 (468)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~----~ell~hp~f~~~~ 427 (468)
. .+.+.++..+.++|.+||+.||.+||++ .+++.||||+.+.
T Consensus 213 ~------------~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~ 258 (325)
T cd05604 213 L------------VLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLS 258 (325)
T ss_pred c------------cCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCC
Confidence 0 0223578899999999999999999976 5899999999753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=348.37 Aligned_cols=256 Identities=25% Similarity=0.416 Sum_probs=204.3
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-------chHHHHHHHHHHcCCCCcccccceeeecCCCCceEE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~ 210 (468)
+|.+.+.||+|+||.||++.+..+++.||+|++.+.. ....+|+.++..++|+||+++++++ .+...+
T Consensus 2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~ 76 (332)
T cd05623 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAF-----QDENNL 76 (332)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEE-----ecCCEE
Confidence 5999999999999999999999999999999985421 2245688899999999999999888 445568
Q ss_pred EEEeecccchHH-HHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccc
Q 012233 211 NLVLEYISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (468)
Q Consensus 211 ~lv~e~~~~~ll-~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~ 289 (468)
|+||||+.++.+ ..+. .....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++..
T Consensus 77 ~lv~ey~~~g~L~~~l~---~~~~~l~~~~~~~~~~qi~~al~~lH~-~~iiHrDlkp~Nili~~~~-~~kL~DfG~a~~ 151 (332)
T cd05623 77 YLVMDYYVGGDLLTLLS---KFEDRLPEDMARFYLAEMVIAIDSVHQ-LHYVHRDIKPDNILMDMNG-HIRLADFGSCLK 151 (332)
T ss_pred EEEEeccCCCcHHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHEEECCCC-CEEEeecchhee
Confidence 999999986544 3332 224568899999999999999999998 8999999999999999887 799999999876
Q ss_pred cCCCCC--CccccccCCccccccccC----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 012233 290 LVPGEP--NISYICSRYYRAPELIFG----ATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREE 363 (468)
Q Consensus 290 ~~~~~~--~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~ 363 (468)
...... ....+||+.|+|||++.+ ...++.++|||||||++|||++|+.||...+..+.+..+....
T Consensus 152 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~------- 224 (332)
T cd05623 152 LMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK------- 224 (332)
T ss_pred cccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC-------
Confidence 533222 223578999999999852 3347899999999999999999999999887766666554310
Q ss_pred HhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCC--CCCHHHHhCCCCCCCCC
Q 012233 364 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSL--RCTALEACAHPFFDDLR 427 (468)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~--R~s~~ell~hp~f~~~~ 427 (468)
..+.+|. ....+++++++||.+||..++.+ |+++.++++||||..+.
T Consensus 225 --------~~~~~p~---------~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~ 273 (332)
T cd05623 225 --------ERFQFPA---------QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGID 273 (332)
T ss_pred --------ccccCCC---------ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCC
Confidence 1111111 12357899999999999765544 78999999999999864
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-43 Score=346.30 Aligned_cols=302 Identities=36% Similarity=0.650 Sum_probs=234.1
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc------chHHHHHHHHHHcCCCCcccccceeeecCCCCceEE
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~ 210 (468)
.+|.+.+.||.|+||.||+|.+..+|+.||+|++.... ....+|+.+|+.++||||++++++|.... .....+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~ 83 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG-ADFKDV 83 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC-CCCceE
Confidence 36999999999999999999999999999999885432 22346999999999999999999875433 344568
Q ss_pred EEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcccc
Q 012233 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (468)
Q Consensus 211 ~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~ 290 (468)
|+||||+.+++...+. ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++...
T Consensus 84 ~lv~e~~~~~l~~~~~----~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~Nil~~~~~-~~kl~dfg~~~~~ 157 (334)
T cd07855 84 YVVMDLMESDLHHIIH----SDQPLTEEHIRYFLYQLLRGLKYIHS-ANVIHRDLKPSNLLVNEDC-ELRIGDFGMARGL 157 (334)
T ss_pred EEEEehhhhhHHHHhc----cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcCCC-cEEecccccceee
Confidence 8999999887665433 24558999999999999999999998 8999999999999999888 7999999998765
Q ss_pred CCCCC-----CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 012233 291 VPGEP-----NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIK 365 (468)
Q Consensus 291 ~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 365 (468)
..... .....++..|+|||.+.+...++.++|||||||++|+|++|+.||.+.+....+..+....+.|+...+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~ 237 (334)
T cd07855 158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLN 237 (334)
T ss_pred cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhh
Confidence 32221 1235788999999998665568999999999999999999999999988888888888888888765543
Q ss_pred hcCCCCcc---CCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCCCCCCCCCCCCCcc
Q 012233 366 CMNPNYTE---FKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNTCLPNGRPLPTL 442 (468)
Q Consensus 366 ~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~~~~~~~~~~~~ 442 (468)
........ ..++.....+|.. +.+.+++++.++|++||+.||.+||++.+++.||||+....+..-.. ..-|-.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~~~~~--~~~~~~ 314 (334)
T cd07855 238 RIGSDRVRKYIQNLPRKQPVPWSK-IFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPDDEPT--CPPPFD 314 (334)
T ss_pred hhchhhHHHHHhhcccCCCCCHHH-HcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCccccc--CCCCCC
Confidence 22111100 0122222222322 23457899999999999999999999999999999998877666322 222333
Q ss_pred cccCHH
Q 012233 443 FNFTAQ 448 (468)
Q Consensus 443 ~~~~~~ 448 (468)
++|+.+
T Consensus 315 ~~~~~~ 320 (334)
T cd07855 315 FDFEAI 320 (334)
T ss_pred CChhhh
Confidence 555544
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-44 Score=352.34 Aligned_cols=245 Identities=27% Similarity=0.466 Sum_probs=195.7
Q ss_pred ecccCceEEEEEEEcCCCCEEEEEEeecccc-------hHHHHHHHHHHc---CCCCcccccceeeecCCCCceEEEEEe
Q 012233 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKR-------YKNRELQIMRLL---NHPNVVSLKHCFFSTTEKDELYLNLVL 214 (468)
Q Consensus 145 lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~~-------~~~~E~~il~~l---~hpnIv~l~~~~~~~~~~~~~~~~lv~ 214 (468)
||+|+||+||+|++..+|+.||||++.+... ....|..++..+ .||||++++++| .....+|+||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~-----~~~~~~~lv~ 75 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSF-----QTDSDLYLVT 75 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEE-----ecCCeEEEEE
Confidence 7999999999999999999999999854321 112355666555 699999999988 4445689999
Q ss_pred ecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCC-C
Q 012233 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP-G 293 (468)
Q Consensus 215 e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~-~ 293 (468)
||+.++.+... ......+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++..... .
T Consensus 76 e~~~~g~L~~~---l~~~~~~~~~~~~~~~~qil~al~~LH~-~~ivHrDlkp~Nili~~~~-~~kl~Dfg~a~~~~~~~ 150 (330)
T cd05586 76 DYMSGGELFWH---LQKEGRFSEDRAKFYIAELVLALEHLHK-YDIVYRDLKPENILLDATG-HIALCDFGLSKANLTDN 150 (330)
T ss_pred cCCCCChHHHH---HHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCCHHHeEECCCC-CEEEecCCcCcCCCCCC
Confidence 99987644322 1224668999999999999999999998 8999999999999999888 799999999875432 2
Q ss_pred CCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCcc
Q 012233 294 EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTE 373 (468)
Q Consensus 294 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 373 (468)
......+||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+.. ..
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~-----------------~~ 213 (330)
T cd05586 151 KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAF-----------------GK 213 (330)
T ss_pred CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHc-----------------CC
Confidence 2334567999999999997665689999999999999999999999988765554444322 11
Q ss_pred CCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCC----CHHHHhCCCCCCCCC
Q 012233 374 FKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC----TALEACAHPFFDDLR 427 (468)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~----s~~ell~hp~f~~~~ 427 (468)
..++ ...+++++.+||.+||..||.+|| ++.++++||||+++.
T Consensus 214 ~~~~-----------~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~ 260 (330)
T cd05586 214 VRFP-----------KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADID 260 (330)
T ss_pred CCCC-----------CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCC
Confidence 1111 123688999999999999999998 799999999998754
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=337.18 Aligned_cols=276 Identities=34% Similarity=0.641 Sum_probs=216.4
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-----chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEE
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 211 (468)
.+|.+.+.||.|+||.||+|.++.+++.||||.+.... ....+|+.+++.++|+||+++++++ .+..+.+
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 79 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDII-----HTKKTLT 79 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEE-----ecCCeEE
Confidence 46999999999999999999999899999999885432 2345799999999999999999988 4445789
Q ss_pred EEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccC
Q 012233 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (468)
Q Consensus 212 lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~ 291 (468)
+||||+.+++...+.. ....+++..++.++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||++....
T Consensus 80 lv~e~~~~~L~~~~~~---~~~~~~~~~~~~~~~ql~~al~~lH~-~~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~~~ 154 (291)
T cd07844 80 LVFEYLDTDLKQYMDD---CGGGLSMHNVRLFLFQLLRGLAYCHQ-RRVLHRDLKPQNLLISERG-ELKLADFGLARAKS 154 (291)
T ss_pred EEEecCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecccCCHHHEEEcCCC-CEEECccccccccC
Confidence 9999999877665432 23468899999999999999999998 8999999999999999888 79999999986542
Q ss_pred CC-CCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-cHHHHHHHHHHhCCCCHHHHhhcCC
Q 012233 292 PG-EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGES-GVDQLVEIIKILGTPTREEIKCMNP 369 (468)
Q Consensus 292 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~ 369 (468)
.. .......++..|+|||++.+...++.++|||||||++|+|++|+.||.... ..+.+..+.+..+.+....+.....
T Consensus 155 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (291)
T cd07844 155 VPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSS 234 (291)
T ss_pred CCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhh
Confidence 21 122234568899999998765668999999999999999999999998766 5566666777777777665543322
Q ss_pred C--CccCCCCcccCCCcccccccCCC--HHHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 012233 370 N--YTEFKFPQIKAHPWHKIFHKRMP--PEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (468)
Q Consensus 370 ~--~~~~~~~~~~~~~~~~~~~~~~~--~~l~~li~~~L~~dP~~R~s~~ell~hp~f 423 (468)
. +....++.......... ...++ .++.++|.+||+.||.+|||+.+++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 235 NPEFKPYSFPFYPPRPLINH-APRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred ccccccccccccCChhHHHh-CcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 1 22222222111111111 12344 889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-43 Score=341.98 Aligned_cols=281 Identities=37% Similarity=0.634 Sum_probs=215.0
Q ss_pred ceEEeceecccCceEEEEEEEcC--CCCEEEEEEeeccc-------chHHHHHHHHHHcCCCCcccccceeeecCCCCce
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLE--TGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~--~g~~vaiK~~~~~~-------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 208 (468)
+|.+.+.||+|+||.||+|.+.. ++..||||.+.... ....+|+.+++.++||||+++++++... ...
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~ 77 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEH---ADK 77 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCC---CCc
Confidence 38899999999999999999988 89999999986632 2345799999999999999999988432 225
Q ss_pred EEEEEeecccchHHHHHhhhhhcC-CCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecC----CCCcEEEee
Q 012233 209 YLNLVLEYISETVYRVSKHYTRMN-QHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNP----HTHQLKICD 283 (468)
Q Consensus 209 ~~~lv~e~~~~~ll~~~~~~~~~~-~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~----~~~~vkL~D 283 (468)
.+++||||++++++..+....... ..+++..++.++.||+.||.|||+ .||+||||||+|||++. ++ .+||+|
T Consensus 78 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~h~dlkp~Nil~~~~~~~~~-~~kl~D 155 (316)
T cd07842 78 SVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS-NWVLHRDLKPANILVMGEGPERG-VVKIGD 155 (316)
T ss_pred eEEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh-CCEeeCCCCHHHEEEcCCCCccc-eEEECC
Confidence 689999999988887665443333 368899999999999999999998 89999999999999998 66 799999
Q ss_pred ecCccccCCCCC----CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcH---------HHHH
Q 012233 284 FGSAKMLVPGEP----NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGV---------DQLV 350 (468)
Q Consensus 284 FG~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~---------~~~~ 350 (468)
||++........ .....++..|+|||++.+...++.++|||||||++|+|++|++||.+.... ..+.
T Consensus 156 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (316)
T cd07842 156 LGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLE 235 (316)
T ss_pred CccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHH
Confidence 999876533221 224567889999999877666899999999999999999999999865432 3456
Q ss_pred HHHHHhCCCCHHHHhhcC--CCCcc----CCCCcccCCCcccccc--cCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCC
Q 012233 351 EIIKILGTPTREEIKCMN--PNYTE----FKFPQIKAHPWHKIFH--KRMPPEALDLVSRLLQYSPSLRCTALEACAHPF 422 (468)
Q Consensus 351 ~i~~~~~~~~~~~~~~~~--~~~~~----~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~ 422 (468)
.++..++.+....+.... +.+.. ..............+. ...+.++.++|.+||+.||.+|||+.|++.|||
T Consensus 236 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~ 315 (316)
T cd07842 236 RIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPY 315 (316)
T ss_pred HHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCC
Confidence 666666666554443211 11111 0000000001111111 257889999999999999999999999999999
Q ss_pred C
Q 012233 423 F 423 (468)
Q Consensus 423 f 423 (468)
|
T Consensus 316 f 316 (316)
T cd07842 316 F 316 (316)
T ss_pred C
Confidence 8
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=347.66 Aligned_cols=246 Identities=26% Similarity=0.493 Sum_probs=196.4
Q ss_pred ceecccCceEEEEEEEcCCCCEEEEEEeeccc-------chHHHHHHHHHHc-CCCCcccccceeeecCCCCceEEEEEe
Q 012233 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDELYLNLVL 214 (468)
Q Consensus 143 ~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-------~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~lv~ 214 (468)
+.||+|+||.||+|.+..+++.||+|++.+.. ....+|+.++..+ .||||+++++++ .+...+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~ 75 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCF-----QTTSRLFLVI 75 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEE-----EeCCEEEEEE
Confidence 46999999999999999999999999986532 2234688888887 599999999988 4445689999
Q ss_pred ecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccC-CC
Q 012233 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV-PG 293 (468)
Q Consensus 215 e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~-~~ 293 (468)
||+.++.+.... .....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++... ..
T Consensus 76 e~~~~~~L~~~~---~~~~~l~~~~~~~~~~qi~~al~~lH~-~~ivHrDlkp~Nili~~~~-~~kl~Dfg~~~~~~~~~ 150 (327)
T cd05617 76 EYVNGGDLMFHM---QRQRKLPEEHARFYAAEICIALNFLHE-RGIIYRDLKLDNVLLDADG-HIKLTDYGMCKEGLGPG 150 (327)
T ss_pred eCCCCCcHHHHH---HHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHEEEeCCC-CEEEeccccceeccCCC
Confidence 999876553221 224568999999999999999999998 8999999999999999888 79999999987532 23
Q ss_pred CCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC------cHHHHHHHHHHhCCCCHHHHhhc
Q 012233 294 EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGES------GVDQLVEIIKILGTPTREEIKCM 367 (468)
Q Consensus 294 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~------~~~~~~~i~~~~~~~~~~~~~~~ 367 (468)
......+||+.|+|||++.+. .++.++|||||||++|+|++|..||.... ..+.+.+++..
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~------------ 217 (327)
T cd05617 151 DTTSTFCGTPNYIAPEILRGE-EYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE------------ 217 (327)
T ss_pred CceecccCCcccCCHHHHCCC-CCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh------------
Confidence 334457899999999999765 48999999999999999999999996422 22222222211
Q ss_pred CCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCC------HHHHhCCCCCCCCC
Q 012233 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCT------ALEACAHPFFDDLR 427 (468)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s------~~ell~hp~f~~~~ 427 (468)
.... ++..++..+.++|.+||+.||.+|++ +.++++||||+.+.
T Consensus 218 ----~~~~------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~ 267 (327)
T cd05617 218 ----KPIR------------IPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSID 267 (327)
T ss_pred ----CCCC------------CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCC
Confidence 0111 33457899999999999999999998 57999999999875
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=363.64 Aligned_cols=261 Identities=25% Similarity=0.346 Sum_probs=210.8
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc------chHHHHHHHHHHcCCCCcccccceeeecCC---CCc
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTE---KDE 207 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~---~~~ 207 (468)
.+|.+.+.||+|+||+||+|.+..+|+.||||++.... ....+|+.++..++|+||++++..+..... ...
T Consensus 32 ~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~ 111 (496)
T PTZ00283 32 KKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENV 111 (496)
T ss_pred CCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccc
Confidence 36999999999999999999999999999999985432 234568999999999999999887644332 122
Q ss_pred eEEEEEeecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecC
Q 012233 208 LYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (468)
Q Consensus 208 ~~~~lv~e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~ 286 (468)
.++++||||+.++ +.+.+.........+++..++.++.|++.||.|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus 112 ~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~-~~IiHrDLKP~NILl~~~~-~vkL~DFGl 189 (496)
T PTZ00283 112 LMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS-KHMIHRDIKSANILLCSNG-LVKLGDFGF 189 (496)
T ss_pred eEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEeCCC-CEEEEeccc
Confidence 3578999999865 445444444445678999999999999999999998 8999999999999999888 799999999
Q ss_pred ccccCCC---CCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 012233 287 AKMLVPG---EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREE 363 (468)
Q Consensus 287 a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~ 363 (468)
++..... ......+||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+.+..+.+..+.....
T Consensus 190 s~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~------ 262 (496)
T PTZ00283 190 SKMYAATVSDDVGRTFCGTPYYVAPEIWRRKP-YSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRY------ 262 (496)
T ss_pred CeeccccccccccccccCCcceeCHHHhCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCC------
Confidence 9765332 1233567999999999997654 89999999999999999999999988766555544433100
Q ss_pred HhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCC
Q 012233 364 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRD 428 (468)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~ 428 (468)
..++..+++++.+||.+||+.||.+||++.++++|||++....
T Consensus 263 ----------------------~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~~~ 305 (496)
T PTZ00283 263 ----------------------DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLFIS 305 (496)
T ss_pred ----------------------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHhhh
Confidence 0133457899999999999999999999999999999886533
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=348.42 Aligned_cols=244 Identities=27% Similarity=0.435 Sum_probs=196.3
Q ss_pred ceecccCceEEEEEEEcCCCCEEEEEEeecccc-------hHHHH-HHHHHHcCCCCcccccceeeecCCCCceEEEEEe
Q 012233 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR-------YKNRE-LQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (468)
Q Consensus 143 ~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~~-------~~~~E-~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv~ 214 (468)
+.||+|+||.||+|.+..+++.||+|++.+... ...+| ..+++.++||||+++++++ .....+|+||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~-----~~~~~~~lv~ 75 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF-----QTADKLYFVL 75 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEE-----EcCCeEEEEE
Confidence 369999999999999999999999999864321 11223 3456788999999999888 4445689999
Q ss_pred ecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCC-C
Q 012233 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP-G 293 (468)
Q Consensus 215 e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~-~ 293 (468)
||+.++.+.... .....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++.... .
T Consensus 76 e~~~~~~L~~~~---~~~~~~~~~~~~~~~~qi~~~L~~lH~-~giiHrDlkp~Nili~~~~-~~kl~DfG~a~~~~~~~ 150 (325)
T cd05602 76 DYINGGELFYHL---QRERCFLEPRARFYAAEIASALGYLHS-LNIVYRDLKPENILLDSQG-HIVLTDFGLCKENIEHN 150 (325)
T ss_pred eCCCCCcHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEECCCC-CEEEccCCCCcccccCC
Confidence 999976554222 224568888899999999999999998 8999999999999999888 799999999875422 2
Q ss_pred CCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCcc
Q 012233 294 EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTE 373 (468)
Q Consensus 294 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 373 (468)
......+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+.+..+... .
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~-----------------~ 212 (325)
T cd05602 151 GTTSTFCGTPEYLAPEVLHKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK-----------------P 212 (325)
T ss_pred CCcccccCCccccCHHHHcCC-CCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhC-----------------C
Confidence 233456799999999999765 4899999999999999999999999987766655554431 0
Q ss_pred CCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHH----HHhCCCCCCCC
Q 012233 374 FKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTAL----EACAHPFFDDL 426 (468)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~----ell~hp~f~~~ 426 (468)
. .+.+.+++.+.+||.+||+.||.+|+++. ++++|+||..+
T Consensus 213 ~------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~ 257 (325)
T cd05602 213 L------------QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPI 257 (325)
T ss_pred c------------CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCC
Confidence 0 02345789999999999999999999876 89999999765
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=338.63 Aligned_cols=251 Identities=24% Similarity=0.369 Sum_probs=197.1
Q ss_pred ecccCceEEEEEEEcCCCCEEEEEEeeccc-------chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEEEeecc
Q 012233 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYI 217 (468)
Q Consensus 145 lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv~e~~ 217 (468)
||+|+||.||++.++.+|+.||+|.+.... .....|+++++.++||||+++++++ .+..++|+||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~-----~~~~~~~lv~e~~ 75 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAF-----ESKTHLCLVMSLM 75 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEE-----ecCCeEEEEEecC
Confidence 799999999999999999999999885321 2234589999999999999998888 4455689999999
Q ss_pred cchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCCCCCCc
Q 012233 218 SETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI 297 (468)
Q Consensus 218 ~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~~~~~~ 297 (468)
.++.+..... ......+++..+..++.||+.||.|||+ .||+||||||+|||++.++ .++|+|||++..........
T Consensus 76 ~g~~L~~~~~-~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dikp~Nili~~~~-~~~l~Dfg~~~~~~~~~~~~ 152 (277)
T cd05607 76 NGGDLKYHIY-NVGERGLEMERVIHYSAQITCGILHLHS-MDIVYRDMKPENVLLDDQG-NCRLSDLGLAVELKDGKTIT 152 (277)
T ss_pred CCCCHHHHHH-hccccCCCHHHHHHHHHHHHHHHHHHHH-CCEEEccCChHhEEEcCCC-CEEEeeceeeeecCCCceee
Confidence 8765543222 1223457888899999999999999998 8999999999999999887 79999999997765444444
Q ss_pred cccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccCCCC
Q 012233 298 SYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFP 377 (468)
Q Consensus 298 ~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (468)
...|++.|+|||++.+.. ++.++|||||||++|+|++|+.||...........+...... ....+
T Consensus 153 ~~~~~~~y~aPE~~~~~~-~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~-------------~~~~~- 217 (277)
T cd05607 153 QRAGTNGYMAPEILKEEP-YSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLE-------------DEVKF- 217 (277)
T ss_pred ccCCCCCccCHHHHccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhc-------------ccccc-
Confidence 567899999999997665 899999999999999999999999765432222222111000 00000
Q ss_pred cccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCH----HHHhCCCCCCCCCC
Q 012233 378 QIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTA----LEACAHPFFDDLRD 428 (468)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~----~ell~hp~f~~~~~ 428 (468)
....+++++++||.+||+.||.+||++ ++++.||||+.+..
T Consensus 218 ----------~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~~ 262 (277)
T cd05607 218 ----------EHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINF 262 (277)
T ss_pred ----------ccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCCH
Confidence 113478899999999999999999999 67889999998644
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-43 Score=374.00 Aligned_cols=265 Identities=28% Similarity=0.415 Sum_probs=210.6
Q ss_pred CcccceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc------cchHHHHHHHHHHcCCCCcccccceeeecCCCCc
Q 012233 134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (468)
Q Consensus 134 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~------~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 207 (468)
....+|.+.+.||.|+||+||+|.+..++..||+|++... ...+..|+.+|+.|+|||||+++++|... ..
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de---~~ 86 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNK---AN 86 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEec---CC
Confidence 3445799999999999999999999999999999988532 22345799999999999999999988543 23
Q ss_pred eEEEEEeecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhc------CCccccCCCCCCeeecCCC----
Q 012233 208 LYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV------VGVCHRDIKPQNLLVNPHT---- 276 (468)
Q Consensus 208 ~~~~lv~e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~------~givHrDlkp~NILl~~~~---- 276 (468)
..+||||||+.++ |...+.........+++..++.|+.||+.||.|||+. .+||||||||+||||+.+.
T Consensus 87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg 166 (1021)
T PTZ00266 87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG 166 (1021)
T ss_pred CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence 4688999999864 5555544444456799999999999999999999972 2499999999999996421
Q ss_pred ------------CcEEEeeecCccccCCCCCCccccccCCccccccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 012233 277 ------------HQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGA-TEYTTAIDMWSIGCVLAELLLGQPLFPGE 343 (468)
Q Consensus 277 ------------~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwSlG~il~ell~G~~pf~~~ 343 (468)
..+||+|||++..+.........+||+.|+|||++.+. ..++.++||||||||||+|++|..||...
T Consensus 167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 167 KITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred cccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 14899999999876444444456899999999998643 34789999999999999999999999877
Q ss_pred CcHHHHHHHHHHhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 012233 344 SGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (468)
Q Consensus 344 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f 423 (468)
.....+...+... + .++ ....+.++.+||.+||+.+|.+||++.|+|.||||
T Consensus 247 ~~~~qli~~lk~~--p---------------~lp-----------i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~i 298 (1021)
T PTZ00266 247 NNFSQLISELKRG--P---------------DLP-----------IKGKSKELNILIKNLLNLSAKERPSALQCLGYQII 298 (1021)
T ss_pred CcHHHHHHHHhcC--C---------------CCC-----------cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHH
Confidence 6665554443311 0 000 12367899999999999999999999999999999
Q ss_pred CCCCCC
Q 012233 424 DDLRDP 429 (468)
Q Consensus 424 ~~~~~~ 429 (468)
+.+..+
T Consensus 299 k~i~~p 304 (1021)
T PTZ00266 299 KNVGPP 304 (1021)
T ss_pred hhcCCC
Confidence 977554
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-44 Score=349.78 Aligned_cols=243 Identities=26% Similarity=0.359 Sum_probs=201.5
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc---cchHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEEEe
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~---~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv~ 214 (468)
.+.+++.||+|.||.||.|.+.. ...||+|.++.. ...+.+|+++|++|+|+|||++++++.. ..-+||||
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~-----~~piyIVt 280 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTK-----QEPIYIVT 280 (468)
T ss_pred HHHHHHHhcCCccceEEEEEEcC-CCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEec-----CCceEEEE
Confidence 46677899999999999999943 247999988653 3445689999999999999999999843 22489999
Q ss_pred ecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCCC
Q 012233 215 EYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293 (468)
Q Consensus 215 e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~~ 293 (468)
||+..| |++.++. .....+.......|+.|||.|++||++ +++|||||-..||||+.+. .+||+|||+|+...++
T Consensus 281 E~m~~GsLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes-~~~IHRDLAARNiLV~~~~-~vKIsDFGLAr~~~d~ 356 (468)
T KOG0197|consen 281 EYMPKGSLLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLES-KNYIHRDLAARNILVDEDL-VVKISDFGLARLIGDD 356 (468)
T ss_pred EecccCcHHHHhhh--cCCCccchHHHHHHHHHHHHHHHHHHh-CCccchhhhhhheeeccCc-eEEEcccccccccCCC
Confidence 999954 6665544 346778889999999999999999998 8999999999999999887 8999999999955444
Q ss_pred CCCcc--ccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCC
Q 012233 294 EPNIS--YICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPN 370 (468)
Q Consensus 294 ~~~~~--~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 370 (468)
..... .-....|.|||.+... .++.++|||||||+||||+| |+.||.+.++.+.+..+.+....|.
T Consensus 357 ~Y~~~~~~kfPIkWtAPEa~~~~-~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~---------- 425 (468)
T KOG0197|consen 357 EYTASEGGKFPIKWTAPEALNYG-KFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPR---------- 425 (468)
T ss_pred ceeecCCCCCCceecCHHHHhhC-CcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCC----------
Confidence 33222 2336789999999654 59999999999999999997 9999999999999888877554442
Q ss_pred CccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 371 YTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
|..+|+++.+++..||..+|++|||++.+..
T Consensus 426 ------------------P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~ 456 (468)
T KOG0197|consen 426 ------------------PEGCPDEVYELMKSCWHEDPEDRPTFETLRE 456 (468)
T ss_pred ------------------CCCCCHHHHHHHHHHhhCCcccCCCHHHHHH
Confidence 3568999999999999999999999997653
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=347.44 Aligned_cols=257 Identities=25% Similarity=0.405 Sum_probs=204.2
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-------chHHHHHHHHHHcCCCCcccccceeeecCCCCceEE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~ 210 (468)
+|.+.+.||+|+||.||++++..+++.||+|++.+.. ....+|..++..+.|+||+++++++ .+..++
T Consensus 2 ~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~-----~~~~~~ 76 (331)
T cd05624 2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAF-----QDENYL 76 (331)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCCEE
Confidence 5999999999999999999999999999999986421 2245688999999999999999988 455579
Q ss_pred EEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcccc
Q 012233 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (468)
Q Consensus 211 ~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~ 290 (468)
|+||||+.++.+..... .....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++...
T Consensus 77 ~lv~Ey~~gg~L~~~l~--~~~~~l~~~~~~~~~~qi~~~L~~lH~-~~iiHrDlkp~Nill~~~~-~~kl~DfG~a~~~ 152 (331)
T cd05624 77 YLVMDYYVGGDLLTLLS--KFEDRLPEDMARFYIAEMVLAIHSIHQ-LHYVHRDIKPDNVLLDMNG-HIRLADFGSCLKM 152 (331)
T ss_pred EEEEeCCCCCcHHHHHH--HhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCchHHEEEcCCC-CEEEEeccceeec
Confidence 99999998765443222 224568899999999999999999998 9999999999999999888 7999999999766
Q ss_pred CCCCC--CccccccCCccccccccCC----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 012233 291 VPGEP--NISYICSRYYRAPELIFGA----TEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEI 364 (468)
Q Consensus 291 ~~~~~--~~~~~gt~~y~aPE~~~~~----~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 364 (468)
..... .....||+.|+|||++.+. ..++.++|||||||++|+|++|+.||...+..+.+..+....
T Consensus 153 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~-------- 224 (331)
T cd05624 153 NQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHE-------- 224 (331)
T ss_pred cCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCC--------
Confidence 43322 1235789999999998642 347889999999999999999999998877666555544310
Q ss_pred hhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCC--CCCHHHHhCCCCCCCCC
Q 012233 365 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSL--RCTALEACAHPFFDDLR 427 (468)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~--R~s~~ell~hp~f~~~~ 427 (468)
..+.+|. ....+++++++||.+||..++.+ |++++++++||||+.+.
T Consensus 225 -------~~~~~p~---------~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~ 273 (331)
T cd05624 225 -------ERFQFPS---------HITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGID 273 (331)
T ss_pred -------CcccCCC---------ccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCC
Confidence 0111111 11347899999999999976654 57999999999999864
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=335.27 Aligned_cols=276 Identities=34% Similarity=0.634 Sum_probs=221.4
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-----chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~l 212 (468)
+|.+.+.||.|++|.||+|.+..+|..||||++.... ....+|+.+++.++|+||+++++++. +....++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~l 75 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIH-----TENKLML 75 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEe-----eCCcEEE
Confidence 4899999999999999999999999999999885432 23457999999999999999999984 3345889
Q ss_pred EeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCC
Q 012233 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (468)
Q Consensus 213 v~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~ 292 (468)
||||+++++...+.... ....+++..+..++.||+.||.|||+ .||+|+||||+||+++.++ .++|+|||++.....
T Consensus 76 v~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~h~dl~p~ni~~~~~~-~~~l~d~g~~~~~~~ 152 (284)
T cd07836 76 VFEYMDKDLKKYMDTHG-VRGALDPNTVKSFTYQLLKGIAFCHE-NRVLHRDLKPQNLLINKRG-ELKLADFGLARAFGI 152 (284)
T ss_pred EEecCCccHHHHHHhcC-CCCCcCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHHHEEECCCC-cEEEeecchhhhhcC
Confidence 99999988777654322 13468999999999999999999998 8999999999999999887 799999999875532
Q ss_pred CC-CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCC
Q 012233 293 GE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNY 371 (468)
Q Consensus 293 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 371 (468)
.. ......++..|++||++.+...++.++|+|||||++|+|++|..||.+.+..+.+..+.+....|....+.... ..
T Consensus 153 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 231 (284)
T cd07836 153 PVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGIS-QL 231 (284)
T ss_pred CccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHh-cC
Confidence 21 22345678899999998766667899999999999999999999999999888888888888777776554333 11
Q ss_pred cc--CCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 012233 372 TE--FKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (468)
Q Consensus 372 ~~--~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f 423 (468)
.. ..++....... ..+.+.++.+++++|.+||+.||.+||++.+++.||||
T Consensus 232 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 232 PEYKPTFPRYPPQDL-QQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred chhcccccCCChHHH-HHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 11 11221111111 12234568899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=347.52 Aligned_cols=246 Identities=28% Similarity=0.437 Sum_probs=195.7
Q ss_pred ceecccCceEEEEEEEcCCCCEEEEEEeecccc-------hHHHH-HHHHHHcCCCCcccccceeeecCCCCceEEEEEe
Q 012233 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR-------YKNRE-LQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (468)
Q Consensus 143 ~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~~-------~~~~E-~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv~ 214 (468)
++||+|+||.||+|++..+|+.||+|++.+... ...+| ..+++.++||||+++++++ .+...+|+||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~-----~~~~~~~lv~ 75 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSF-----QTAEKLYFVL 75 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEE-----EcCCEEEEEE
Confidence 369999999999999999999999999864321 11223 3467889999999999887 4445689999
Q ss_pred ecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccC-CC
Q 012233 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV-PG 293 (468)
Q Consensus 215 e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~-~~ 293 (468)
||++++.+.... .....+++..++.++.||+.||.|||+ +||+||||||+||||+.++ .+||+|||+++... ..
T Consensus 76 e~~~~~~L~~~l---~~~~~~~~~~~~~~~~qi~~~L~~lH~-~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~~~~~~~~~ 150 (321)
T cd05603 76 DYVNGGELFFHL---QRERCFLEPRARFYAAEVASAIGYLHS-LNIIYRDLKPENILLDSQG-HVVLTDFGLCKEGVEPE 150 (321)
T ss_pred cCCCCCCHHHHH---HHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCCHHHeEECCCC-CEEEccCCCCccCCCCC
Confidence 999976553221 224568889999999999999999998 8999999999999999888 79999999987532 22
Q ss_pred CCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCcc
Q 012233 294 EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTE 373 (468)
Q Consensus 294 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 373 (468)
......+||+.|+|||++.+. .++.++|||||||++|||++|..||.+.+....+..+... .
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~-----------------~ 212 (321)
T cd05603 151 ETTSTFCGTPEYLAPEVLRKE-PYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK-----------------P 212 (321)
T ss_pred CccccccCCcccCCHHHhcCC-CCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcC-----------------C
Confidence 233456789999999999654 4899999999999999999999999887655544443320 1
Q ss_pred CCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCH----HHHhCCCCCCCCCC
Q 012233 374 FKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTA----LEACAHPFFDDLRD 428 (468)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~----~ell~hp~f~~~~~ 428 (468)
.. ++...+.++.++|.+||+.||.+|+++ .++++||||..+..
T Consensus 213 ~~------------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~~ 259 (321)
T cd05603 213 LQ------------LPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINW 259 (321)
T ss_pred CC------------CCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCCCH
Confidence 11 234568899999999999999999975 59999999987543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=363.98 Aligned_cols=253 Identities=27% Similarity=0.342 Sum_probs=206.3
Q ss_pred ceEEeceecccCceEEEEEEEcCC-CCEEEEEEeeccc----chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLET-GDSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~-g~~vaiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~l 212 (468)
.|.+.+.||+|+||.||+|....+ +..||+|.+.... ....+|+.+|+.++|||||+++++|. ....+||
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~-----~~~~~~l 142 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFK-----SDDKLLL 142 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEE-----ECCEEEE
Confidence 499999999999999999998777 7889999764322 23457999999999999999999883 3446899
Q ss_pred EeecccchHH-HHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccC
Q 012233 213 VLEYISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (468)
Q Consensus 213 v~e~~~~~ll-~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~ 291 (468)
||||+.++.+ ..+.........+++..+..++.||+.||.|||+ +||+||||||+||||+.++ .+||+|||+++...
T Consensus 143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivHrDlkp~NIll~~~~-~~kL~DFgla~~~~ 220 (478)
T PTZ00267 143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS-RKMMHRDLKSANIFLMPTG-IIKLGDFGFSKQYS 220 (478)
T ss_pred EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh-CCEEECCcCHHhEEECCCC-cEEEEeCcCceecC
Confidence 9999986544 3333333344568899999999999999999998 8999999999999999888 79999999998764
Q ss_pred CCC---CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 012233 292 PGE---PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368 (468)
Q Consensus 292 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 368 (468)
... .....+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+......
T Consensus 221 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~---------- 289 (478)
T PTZ00267 221 DSVSLDVASSFCGTPYYLAPELWERK-RYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYD---------- 289 (478)
T ss_pred CccccccccccCCCccccCHhHhCCC-CCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC----------
Confidence 332 23356799999999998654 4899999999999999999999999887766555554431000
Q ss_pred CCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q 012233 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426 (468)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 426 (468)
.++..++.++.+||.+||+.||.+||++.+++.|||++.+
T Consensus 290 ------------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~~ 329 (478)
T PTZ00267 290 ------------------PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYV 329 (478)
T ss_pred ------------------CCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHHH
Confidence 0223478899999999999999999999999999998754
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=336.84 Aligned_cols=256 Identities=27% Similarity=0.391 Sum_probs=207.0
Q ss_pred eEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-------chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEE
Q 012233 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (468)
Q Consensus 139 y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 211 (468)
|+..+.||+|+||+||+|.+..+++.||+|.+.... ....+|+.+++.++|+||+++++++ .....+|
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~~ 76 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAY-----ETKDALC 76 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEE-----ecCCEEE
Confidence 778899999999999999999999999999885431 2245699999999999999998887 3444689
Q ss_pred EEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccC
Q 012233 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (468)
Q Consensus 212 lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~ 291 (468)
+||||+.++.+...... .....+++..+..++.|++.||.|||+ .||+||||||+||+++.++ .++|+|||++....
T Consensus 77 lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~~ql~~~l~~lH~-~~iiH~dikp~Nili~~~~-~~kl~Dfg~~~~~~ 153 (285)
T cd05632 77 LVLTIMNGGDLKFHIYN-MGNPGFEEERALFYAAEILCGLEDLHR-ENTVYRDLKPENILLDDYG-HIRISDLGLAVKIP 153 (285)
T ss_pred EEEEeccCccHHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCHHHEEECCCC-CEEEecCCcceecC
Confidence 99999997755433221 223468999999999999999999998 8999999999999999887 79999999997654
Q ss_pred CCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCC
Q 012233 292 PGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNY 371 (468)
Q Consensus 292 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 371 (468)
.........|+..|+|||++.+. .++.++|+|||||++|+|++|..||.+.........+........
T Consensus 154 ~~~~~~~~~g~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~----------- 221 (285)
T cd05632 154 EGESIRGRVGTVGYMAPEVLNNQ-RYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETE----------- 221 (285)
T ss_pred CCCcccCCCCCcCccChHHhcCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccc-----------
Confidence 44444456789999999999765 489999999999999999999999987665444333332111100
Q ss_pred ccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCC-----HHHHhCCCCCCCCCC
Q 012233 372 TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCT-----ALEACAHPFFDDLRD 428 (468)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s-----~~ell~hp~f~~~~~ 428 (468)
..+...+++++.+||.+||+.||.+||+ +.+++.||||..+..
T Consensus 222 --------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~ 269 (285)
T cd05632 222 --------------EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNF 269 (285)
T ss_pred --------------cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCH
Confidence 0123457889999999999999999999 889999999998743
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=332.55 Aligned_cols=290 Identities=26% Similarity=0.436 Sum_probs=234.1
Q ss_pred CcccceEEeceecccCceEEEEEEEcCCCCEEEEEEeecccchHH---HHHHHHHHcC-----C---CCcccccceeeec
Q 012233 134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLN-----H---PNVVSLKHCFFST 202 (468)
Q Consensus 134 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~~~~~---~E~~il~~l~-----h---pnIv~l~~~~~~~ 202 (468)
....+|.+.++||.|.|++||+|.+..+.+.||+|+.+....+.+ .|+++|++++ | .+||+|++.|--.
T Consensus 75 F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs 154 (590)
T KOG1290|consen 75 FNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS 154 (590)
T ss_pred ccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec
Confidence 344579999999999999999999999999999999987766654 5999999885 2 4699999998554
Q ss_pred CCCCceEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeec---------
Q 012233 203 TEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVN--------- 273 (468)
Q Consensus 203 ~~~~~~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~--------- 273 (468)
. ....++|||+|+++..||.++.... .+.+++..++.|++||+.||.|||+.+||||.||||+|||+.
T Consensus 155 G-pNG~HVCMVfEvLGdnLLklI~~s~--YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~~ 231 (590)
T KOG1290|consen 155 G-PNGQHVCMVFEVLGDNLLKLIKYSN--YRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAKD 231 (590)
T ss_pred C-CCCcEEEEEehhhhhHHHHHHHHhC--CCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccchhhh
Confidence 4 5667899999999999999887654 577999999999999999999999889999999999999973
Q ss_pred --------------------------------------------------------------------------------
Q 012233 274 -------------------------------------------------------------------------------- 273 (468)
Q Consensus 274 -------------------------------------------------------------------------------- 273 (468)
T Consensus 232 ~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~ 311 (590)
T KOG1290|consen 232 AREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRING 311 (590)
T ss_pred hhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCc
Confidence
Q ss_pred -------------------------CC---------------------------------------------------CC
Q 012233 274 -------------------------PH---------------------------------------------------TH 277 (468)
Q Consensus 274 -------------------------~~---------------------------------------------------~~ 277 (468)
.. ..
T Consensus 312 ~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di 391 (590)
T KOG1290|consen 312 NESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDI 391 (590)
T ss_pred cccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccce
Confidence 00 00
Q ss_pred cEEEeeecCccccCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC------CcHHHHHH
Q 012233 278 QLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGE------SGVDQLVE 351 (468)
Q Consensus 278 ~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~------~~~~~~~~ 351 (468)
+|||+|||.|.+. ....+..+.|..|+|||++.|.. |++.+||||++|++|||+||...|... ..++.++.
T Consensus 392 ~vKIaDlGNACW~--~khFT~DIQTRQYRapEVllGsg-Y~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~ 468 (590)
T KOG1290|consen 392 RVKIADLGNACWV--HKHFTEDIQTRQYRAPEVLLGSG-YSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIAL 468 (590)
T ss_pred eEEEeeccchhhh--hhhhchhhhhhhccCcceeecCC-CCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHH
Confidence 3688888888765 23344567899999999999876 999999999999999999999999653 36688999
Q ss_pred HHHHhCCCCHHHHhhc-------CCCCccCCCCcccCCCccccc------ccCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 012233 352 IIKILGTPTREEIKCM-------NPNYTEFKFPQIKAHPWHKIF------HKRMPPEALDLVSRLLQYSPSLRCTALEAC 418 (468)
Q Consensus 352 i~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~------~~~~~~~l~~li~~~L~~dP~~R~s~~ell 418 (468)
|++.+|..++.....- +..-.--.+..++.+++.+++ +..-..++.+|+.-||+++|++|+||.++|
T Consensus 469 i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl 548 (590)
T KOG1290|consen 469 IMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCL 548 (590)
T ss_pred HHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHh
Confidence 9999998887654421 111122233455666655443 233345788999999999999999999999
Q ss_pred CCCCCCCCCCC
Q 012233 419 AHPFFDDLRDP 429 (468)
Q Consensus 419 ~hp~f~~~~~~ 429 (468)
+|||+..+..+
T Consensus 549 ~hPwLn~~~~~ 559 (590)
T KOG1290|consen 549 KHPWLNPVAGP 559 (590)
T ss_pred cCccccCCCCC
Confidence 99999988775
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=317.68 Aligned_cols=259 Identities=25% Similarity=0.412 Sum_probs=207.6
Q ss_pred CCCcccceEEeceecccCceEEEEEEEcCCCCEEEEEEeecccchHH-----HHHHHHHHc-CCCCcccccceeeecCCC
Q 012233 132 QPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----RELQIMRLL-NHPNVVSLKHCFFSTTEK 205 (468)
Q Consensus 132 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~~~~~-----~E~~il~~l-~hpnIv~l~~~~~~~~~~ 205 (468)
........+.+..||.|+.|.||+++.+.+|...|||.+.......+ ..+.++.+. .+|+||+++++|....+
T Consensus 87 ~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~d- 165 (391)
T KOG0983|consen 87 YQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTD- 165 (391)
T ss_pred cccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCch-
Confidence 33444556777889999999999999999999999999966533221 233333333 48999999999977655
Q ss_pred CceEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeec
Q 012233 206 DELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG 285 (468)
Q Consensus 206 ~~~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG 285 (468)
++|.||.|..-.-.+++ +....+|+..+-++...++.||.||.+.+||||||+||+|||+|..| ++||||||
T Consensus 166 ----V~IcMelMs~C~ekLlk---rik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~G-niKlCDFG 237 (391)
T KOG0983|consen 166 ----VFICMELMSTCAEKLLK---RIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERG-NIKLCDFG 237 (391)
T ss_pred ----HHHHHHHHHHHHHHHHH---HhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCC-CEEeeccc
Confidence 77899998754333332 34577999999999999999999999878999999999999999988 89999999
Q ss_pred CccccCCCCCCccccccCCccccccccC--CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHHHhCCCCHH
Q 012233 286 SAKMLVPGEPNISYICSRYYRAPELIFG--ATEYTTAIDMWSIGCVLAELLLGQPLFPGESG-VDQLVEIIKILGTPTRE 362 (468)
Q Consensus 286 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~-~~~~~~i~~~~~~~~~~ 362 (468)
++-.+.+...+....|.+.|||||.+.- ...|+.++||||||+.++||.||+.||.+.+. .+.+.++.+. .|+
T Consensus 238 IsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~--ePP-- 313 (391)
T KOG0983|consen 238 ISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNE--EPP-- 313 (391)
T ss_pred ccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhc--CCC--
Confidence 9999888888888899999999999853 34589999999999999999999999998654 4555555541 111
Q ss_pred HHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q 012233 363 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDD 425 (468)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~ 425 (468)
.++ .....|+++.+|+..||.+|+.+||.-.++|+|||+..
T Consensus 314 ---------------~L~-------~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ 354 (391)
T KOG0983|consen 314 ---------------LLP-------GHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKR 354 (391)
T ss_pred ---------------CCC-------cccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceee
Confidence 100 12337899999999999999999999999999997654
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=355.31 Aligned_cols=255 Identities=24% Similarity=0.377 Sum_probs=212.4
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc----chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEEE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV 213 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv 213 (468)
.|.|+-.||.|+||+||+|..+.++-..|.|+|.... ....-|++||..+.||+||+|++.||..+ .++|+
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~en-----kLwil 107 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFEN-----KLWIL 107 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccC-----ceEEE
Confidence 4888899999999999999999888888889884332 22335999999999999999999996544 38999
Q ss_pred eecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCC-
Q 012233 214 LEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP- 292 (468)
Q Consensus 214 ~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~- 292 (468)
.|||+||-.+.+.. .....+.+.+++.+++|+|.||.|||+ ++|||||||..|||++.+| .|+|+|||.+.....
T Consensus 108 iEFC~GGAVDaiml--EL~r~LtE~QIqvvc~q~ldALn~LHs-~~iIHRDLKAGNiL~TldG-dirLADFGVSAKn~~t 183 (1187)
T KOG0579|consen 108 IEFCGGGAVDAIML--ELGRVLTEDQIQVVCYQVLDALNWLHS-QNIIHRDLKAGNILLTLDG-DIRLADFGVSAKNKST 183 (1187)
T ss_pred EeecCCchHhHHHH--HhccccchHHHHHHHHHHHHHHHHHhh-cchhhhhccccceEEEecC-cEeeecccccccchhH
Confidence 99999987765433 346789999999999999999999998 8999999999999999999 799999999865432
Q ss_pred CCCCccccccCCccccccccC----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 012233 293 GEPNISYICSRYYRAPELIFG----ATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368 (468)
Q Consensus 293 ~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 368 (468)
.....+++|||+|||||++.. ...|++++||||||++|.||.-+.+|-...+++..+.+|.+. .|+.
T Consensus 184 ~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKS--ePPT------- 254 (1187)
T KOG0579|consen 184 RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS--EPPT------- 254 (1187)
T ss_pred HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhc--CCCc-------
Confidence 224457999999999999843 234999999999999999999999999988888888877652 1110
Q ss_pred CCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q 012233 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (468)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~ 427 (468)
..-+...+..+.||+++||.+||..||++.++|.||||+.++
T Consensus 255 -----------------LlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~ 296 (1187)
T KOG0579|consen 255 -----------------LLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAP 296 (1187)
T ss_pred -----------------ccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCC
Confidence 012234577899999999999999999999999999998754
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-43 Score=345.64 Aligned_cols=279 Identities=25% Similarity=0.394 Sum_probs=203.0
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-----chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEE
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 211 (468)
++|.+.+.||.|+||.||+|.+..++..+|+|.+.... ..+.+|+++++.++||||++++++|.. ..++|
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~ 79 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DGEIS 79 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEE-----CCEEE
Confidence 46999999999999999999999999999999875432 235579999999999999999999843 34689
Q ss_pred EEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccC
Q 012233 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (468)
Q Consensus 212 lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~ 291 (468)
+||||+.++.+.... .....+++..+..++.|++.||.|||+..+|+|+||||+|||++.++ .+||+|||++....
T Consensus 80 lv~e~~~~~~L~~~l---~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~-~~kL~Dfg~~~~~~ 155 (333)
T cd06650 80 ICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLI 155 (333)
T ss_pred EEEecCCCCcHHHHH---HHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCC-CEEEeeCCcchhhh
Confidence 999999875444222 22456888999999999999999999634799999999999999887 79999999987553
Q ss_pred CCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHH--hCCCCHHHHhh-cC
Q 012233 292 PGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKI--LGTPTREEIKC-MN 368 (468)
Q Consensus 292 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~-~~ 368 (468)
.. ......|+..|+|||++.+. .++.++|||||||++|+|++|+.||......+.. .++.. .+.+....... ..
T Consensus 156 ~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 232 (333)
T cd06650 156 DS-MANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELE-LMFGCPVEGDPAESETSPRPR 232 (333)
T ss_pred hh-ccccCCCCccccCHHHhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHH-HHhcCcccCCccccccCcccC
Confidence 22 22345789999999999764 4899999999999999999999999876543322 11110 00000000000 00
Q ss_pred ------CCCccCCCCc---------ccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q 012233 369 ------PNYTEFKFPQ---------IKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (468)
Q Consensus 369 ------~~~~~~~~~~---------~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~ 427 (468)
..+.....+. +....-.......++.++++||.+||++||.+|||+.|++.||||+...
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 306 (333)
T cd06650 233 PPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE 306 (333)
T ss_pred CccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence 0000000000 0000000000123678899999999999999999999999999998754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=334.62 Aligned_cols=276 Identities=36% Similarity=0.654 Sum_probs=217.1
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc------chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 211 (468)
+|.+.+.||+|+||.||+|.+..+++.||+|.+.... ....+|+++++.++||||+++++++ .+..+.|
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 76 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVF-----RRKKRLY 76 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhc-----ccCCeEE
Confidence 5999999999999999999999899999999875422 2345799999999999999999998 4555789
Q ss_pred EEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccC
Q 012233 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (468)
Q Consensus 212 lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~ 291 (468)
+||||+.++.+..... ....+++..+..++.||+.||.|||+ .||+|+||+|+||+++.++ .++|+|||++....
T Consensus 77 lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~h~~l~p~ni~~~~~~-~~~l~dfg~~~~~~ 151 (286)
T cd07846 77 LVFEFVDHTVLDDLEK---YPNGLDESRVRKYLFQILRGIEFCHS-HNIIHRDIKPENILVSQSG-VVKLCDFGFARTLA 151 (286)
T ss_pred EEEecCCccHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEECCCC-cEEEEeeeeeeecc
Confidence 9999999887764332 23458899999999999999999998 8999999999999999888 79999999987654
Q ss_pred CCC-CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc--C
Q 012233 292 PGE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM--N 368 (468)
Q Consensus 292 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~--~ 368 (468)
... ......++..|+|||++.+...++.++|||||||++|+|++|.+||...+..+....+....+.......... .
T Consensus 152 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07846 152 APGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKN 231 (286)
T ss_pred CCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccc
Confidence 332 2234567899999999876666789999999999999999999999988877777777766655433221111 1
Q ss_pred CCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 012233 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (468)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f 423 (468)
+......++......-.....+.++..+.+||.+||+.||.+||++.+++.||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred hHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 1111122222211111112245688999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=341.57 Aligned_cols=288 Identities=39% Similarity=0.685 Sum_probs=229.5
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc------chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 211 (468)
+|.+.+.||.|+||.||+|.+..+|+.||||++.... ....+|+.+++.++|+||+++++++..........+|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4899999999999999999998899999999885432 3455799999999999999999988554422334689
Q ss_pred EEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccC
Q 012233 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (468)
Q Consensus 212 lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~ 291 (468)
+||||+++++...+.. ...+++..++.++.||+.||+|||+ .||+|+||||+|||++.++ .++|+|||++....
T Consensus 81 lv~e~~~~~l~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~-~gi~H~dlkp~nili~~~~-~~~L~dfg~~~~~~ 154 (330)
T cd07834 81 IVTELMETDLHKVIKS----PQPLTDDHIQYFLYQILRGLKYLHS-ANVIHRDLKPSNILVNSNC-DLKICDFGLARGVD 154 (330)
T ss_pred EEecchhhhHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCC-CEEEcccCceEeec
Confidence 9999999876654432 3478999999999999999999998 8999999999999999887 79999999998765
Q ss_pred CCC----CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 012233 292 PGE----PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367 (468)
Q Consensus 292 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 367 (468)
... ......+++.|+|||.+.+...++.++|+|||||++|+|++|++||.+.+..+.+..+....+.+....+...
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 234 (330)
T cd07834 155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFI 234 (330)
T ss_pred ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhc
Confidence 443 2334567899999999977646899999999999999999999999999988888889888888876654421
Q ss_pred CCCC-ccC--CCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCCCCC
Q 012233 368 NPNY-TEF--KFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNTC 432 (468)
Q Consensus 368 ~~~~-~~~--~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~~ 432 (468)
.... ..+ ..+......+.. +...++.++.+||.+||++||.+||++.+++.||||+.+.++...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~~ 301 (330)
T cd07834 235 TSEKARNYLKSLPKKPKKPLSK-LFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDE 301 (330)
T ss_pred cccchhhHHhhcccCCcchhHH-hcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccccC
Confidence 1111 000 001111111222 234578999999999999999999999999999999998775444
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-42 Score=332.58 Aligned_cols=276 Identities=33% Similarity=0.588 Sum_probs=211.5
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-----chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEE
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 211 (468)
.+|.+.+.||+|+||.||+|.+..+|..||+|.+.... ....+|+.+++.++|+||+++++++ .+..+.|
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~-----~~~~~~~ 79 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII-----HTKETLT 79 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEE-----ecCCeEE
Confidence 46999999999999999999999999999999885432 2345799999999999999999988 3444688
Q ss_pred EEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccC
Q 012233 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (468)
Q Consensus 212 lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~ 291 (468)
+||||+.++++..+.. ....+++..++.++.||+.||.|||+ .||+|+||||+|||++.++ .++|+|||+++...
T Consensus 80 lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dlkp~Nil~~~~~-~~~l~Dfg~~~~~~ 154 (291)
T cd07870 80 FVFEYMHTDLAQYMIQ---HPGGLHPYNVRLFMFQLLRGLAYIHG-QHILHRDLKPQNLLISYLG-ELKLADFGLARAKS 154 (291)
T ss_pred EEEecccCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCChHHEEEcCCC-cEEEeccccccccC
Confidence 9999999887765432 23457788889999999999999998 8999999999999999887 79999999987542
Q ss_pred CC-CCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHHHhCCCCHHHHhhcC-
Q 012233 292 PG-EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESG-VDQLVEIIKILGTPTREEIKCMN- 368 (468)
Q Consensus 292 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~- 368 (468)
.. .......+++.|+|||.+.+...++.++|||||||++|+|++|..||..... .+.+.++....+.|.........
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (291)
T cd07870 155 IPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSK 234 (291)
T ss_pred CCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhh
Confidence 22 1223456789999999987655688999999999999999999999987553 35556666666666554332211
Q ss_pred -CCCccCCCCcccCCCccccccc--CCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 012233 369 -PNYTEFKFPQIKAHPWHKIFHK--RMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (468)
Q Consensus 369 -~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f 423 (468)
+.+....++....... ...+. ..+.++.++|.+||..||.+|||+.|++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 235 LPNYKPEWFLPCKPQQL-RVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred cccccchhccccCCcch-hhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 1222211111111110 01111 236789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-43 Score=332.74 Aligned_cols=252 Identities=35% Similarity=0.562 Sum_probs=202.9
Q ss_pred eEEeceecccCceEEEEEEEcCCCCEEEEEEeecccchH------HHHHHHHHHcCCCCcccccceeeecCCCCceEEEE
Q 012233 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYK------NRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (468)
Q Consensus 139 y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~~~~------~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~l 212 (468)
|++.+.||+|+||+||++.+..+++.||+|++....... .+|+.+++.++||||+++++++.. ...+++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~~ 75 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD-----DNYLYI 75 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE-----SSEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc-----cccccc
Confidence 889999999999999999999999999999996653222 248999999999999999999844 446889
Q ss_pred Eeecccc-hHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcccc-
Q 012233 213 VLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML- 290 (468)
Q Consensus 213 v~e~~~~-~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~- 290 (468)
||||+.+ .+...+. ....+++..+..++.||+.||.+||+ .||+|+||||+|||++.++ .++|+|||.+...
T Consensus 76 v~~~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~Lh~-~~i~H~dikp~NIl~~~~~-~~~l~Dfg~~~~~~ 149 (260)
T PF00069_consen 76 VMEYCPGGSLQDYLQ----KNKPLSEEEILKIAYQILEALAYLHS-KGIVHRDIKPENILLDENG-EVKLIDFGSSVKLS 149 (260)
T ss_dssp EEEEETTEBHHHHHH----HHSSBBHHHHHHHHHHHHHHHHHHHH-TTEEESSBSGGGEEESTTS-EEEESSGTTTEEST
T ss_pred ccccccccccccccc----cccccccccccccccccccccccccc-ccccccccccccccccccc-cccccccccccccc
Confidence 9999998 5555444 34678999999999999999999998 8999999999999999877 7999999999763
Q ss_pred CCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCC
Q 012233 291 VPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPN 370 (468)
Q Consensus 291 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 370 (468)
..........++..|+|||++.....++.++|+||||+++|+|++|..||......+....+.+...........
T Consensus 150 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----- 224 (260)
T PF00069_consen 150 ENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQ----- 224 (260)
T ss_dssp STTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTT-----
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccccccc-----
Confidence 223344457789999999998634558999999999999999999999999874444444433322211111000
Q ss_pred CccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 012233 371 YTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (468)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f 423 (468)
.....+..+.++|.+||+.||.+||++.++++||||
T Consensus 225 -----------------~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 225 -----------------QSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp -----------------SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred -----------------ccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 001123789999999999999999999999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=339.60 Aligned_cols=314 Identities=35% Similarity=0.591 Sum_probs=240.5
Q ss_pred ceEEeceecccCceEEEEEEEcCC--CCEEEEEEeecc------cchHHHHHHHHHHc-CCCCcccccceeeecCCCCce
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLET--GDSVAIKKVLQD------KRYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDEL 208 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~--g~~vaiK~~~~~------~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~~~ 208 (468)
+|.+.+.||+|+||.||++.+..+ +..||+|.+... .....+|+.+++.+ .||||+++++.+.... ....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFP-GNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecc-ccCC
Confidence 488999999999999999999887 899999987542 12345699999999 5999999988754332 2234
Q ss_pred EEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcc
Q 012233 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (468)
Q Consensus 209 ~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~ 288 (468)
.+|+++||+++++...+. ....+++..++.++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||++.
T Consensus 80 ~~~~~~e~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~-~givH~dlkp~Nili~~~~-~~kl~Dfg~a~ 153 (332)
T cd07857 80 ELYLYEELMEADLHQIIR----SGQPLTDAHFQSFIYQILCGLKYIHS-ANVLHRDLKPGNLLVNADC-ELKICDFGLAR 153 (332)
T ss_pred cEEEEEecccCCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHeEEcCCC-CEEeCcCCCce
Confidence 578999999987766543 24668999999999999999999998 8999999999999999887 79999999997
Q ss_pred ccCCCC-----CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 012233 289 MLVPGE-----PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREE 363 (468)
Q Consensus 289 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~ 363 (468)
...... ......|++.|+|||.+.+...++.++|+|||||++|+|++|.+||...+....+..++..++.+....
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 233 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET 233 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 654322 122357899999999886655689999999999999999999999999888888899999888887665
Q ss_pred HhhcCCCCcc---CCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCCCCCCCCCCCCC
Q 012233 364 IKCMNPNYTE---FKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNTCLPNGRPLP 440 (468)
Q Consensus 364 ~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~~~~~~~~~~ 440 (468)
+..+...... ..+.......+. ...+.++..+.+||.+||+.||.+|||+.+++.||||+.++++....- -..|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~~~~~~--~~~~ 310 (332)
T cd07857 234 LSRIGSPKAQNYIRSLPNIPKKPFE-SIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDPDDEPV--CQKP 310 (332)
T ss_pred HHhhhhhhHHHHHHhccccCCcchH-hhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCcccccc--cccc
Confidence 4432211000 000011111111 123446889999999999999999999999999999999887655433 2556
Q ss_pred cccccCHHHHhcCCHHHHHhcccc
Q 012233 441 TLFNFTAQELAGASNELRQRLIPE 464 (468)
Q Consensus 441 ~~~~~~~~~~~~~~~~~~~~~~~~ 464 (468)
.-++|+.++ .-+|++.+|+.+
T Consensus 311 ~~~~~~~~~---~~~~~~~~~~~~ 331 (332)
T cd07857 311 FDFSFESED---SMEELRDMIIEE 331 (332)
T ss_pred ccCCccccc---cHHHHHHHHhhc
Confidence 667777433 346778887754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=329.49 Aligned_cols=248 Identities=26% Similarity=0.449 Sum_probs=201.7
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc---------chHHHHHHHHHHcCCCCcccccceeeecCCCCce
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~---------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 208 (468)
+|.+.+.||+|+||.||.|.+..++..||+|.+.... ....+|+.+++.++||||+++++++ .+..
T Consensus 3 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~ 77 (263)
T cd06625 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCL-----RDDE 77 (263)
T ss_pred cccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEE-----ccCC
Confidence 5899999999999999999999999999999875321 2345799999999999999999988 4444
Q ss_pred EEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcc
Q 012233 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (468)
Q Consensus 209 ~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~ 288 (468)
.+++||||++++.+.... .....++...+..++.|++.||.|||+ .||+|+||||+||+++.++ .++|+|||+++
T Consensus 78 ~~~~v~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dl~p~nilv~~~~-~~~l~dfg~~~ 152 (263)
T cd06625 78 TLSIFMEYMPGGSVKDQL---KAYGALTETVTRKYTRQILEGVEYLHS-NMIVHRDIKGANILRDSAG-NVKLGDFGASK 152 (263)
T ss_pred eEEEEEEECCCCcHHHHH---HHhCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCC-CEEEeecccce
Confidence 799999999876443221 123568888999999999999999998 8999999999999999887 79999999987
Q ss_pred ccCCCCCC----ccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 012233 289 MLVPGEPN----ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEI 364 (468)
Q Consensus 289 ~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 364 (468)
........ ....++..|+|||++.+.. ++.++|||||||++|+|++|+.||...+.......+....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-------- 223 (263)
T cd06625 153 RLQTICSSGTGMKSVTGTPYWMSPEVISGEG-YGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQP-------- 223 (263)
T ss_pred eccccccccccccCCCcCccccCcceeccCC-CCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccC--------
Confidence 65332211 2356788999999997654 8999999999999999999999998766555444332210
Q ss_pred hhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 012233 365 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (468)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f 423 (468)
....++..++.++.+||.+||..+|.+|||+.+++.||||
T Consensus 224 -------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 224 -------------------TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred -------------------CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 0011344578999999999999999999999999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=337.07 Aligned_cols=267 Identities=28% Similarity=0.463 Sum_probs=213.4
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-------chHHHHHHHHHHcCCCCcccccceeeecCCCCceEE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~ 210 (468)
+|.+.+.||+|+||.||+|.+..+++.||||.+.... ....+|+++++.++|+||+++++.+ .+..+.
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~ 76 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASF-----QTETYL 76 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeee-----ecCCEE
Confidence 5999999999999999999999999999999886532 2345699999999999999999988 445578
Q ss_pred EEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcccc
Q 012233 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (468)
Q Consensus 211 ~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~ 290 (468)
|+||||+.++.+..... ......+++..++.++.||+.||.|||+ .|++|+||||+|||++.++ .++|+|||++...
T Consensus 77 ~lv~e~~~~~~L~~~~~-~~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nili~~~~-~~~l~dfg~~~~~ 153 (316)
T cd05574 77 CLVMDYCPGGELFRLLQ-RQPGKCLSEEVARFYAAEVLLALEYLHL-LGIVYRDLKPENILLHESG-HIMLSDFDLSKQS 153 (316)
T ss_pred EEEEEecCCCCHHHHHH-hCCCCccCHHHHHHHHHHHHHHHHHHHH-CCeeccCCChHHeEEcCCC-CEEEeecchhhcc
Confidence 99999998754443322 1223568999999999999999999998 8999999999999999887 7999999998654
Q ss_pred CCCCC------------------------------CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 012233 291 VPGEP------------------------------NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLF 340 (468)
Q Consensus 291 ~~~~~------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf 340 (468)
..... .....|+..|+|||++.+.. ++.++|||||||++|+|++|..||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Di~slG~ll~~l~~g~~pf 232 (316)
T cd05574 154 DVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDG-HGSAVDWWTLGILLYEMLYGTTPF 232 (316)
T ss_pred cccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCC-CCchHHHHHHHHHHHHHhhCCCCC
Confidence 22111 11346788999999997654 899999999999999999999999
Q ss_pred CCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCC----HHH
Q 012233 341 PGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCT----ALE 416 (468)
Q Consensus 341 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s----~~e 416 (468)
.+.+....+.++... ...++. ...+++++.++|.+||..||.+||+ +++
T Consensus 233 ~~~~~~~~~~~~~~~-----------------~~~~~~----------~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ 285 (316)
T cd05574 233 KGSNRDETFSNILKK-----------------EVTFPG----------SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAE 285 (316)
T ss_pred CCCchHHHHHHHhcC-----------------CccCCC----------ccccCHHHHHHHHHHccCCHhHCCCchhhHHH
Confidence 887766665554421 111111 1126899999999999999999999 999
Q ss_pred HhCCCCCCCCCCCCCCCCCCCCCC
Q 012233 417 ACAHPFFDDLRDPNTCLPNGRPLP 440 (468)
Q Consensus 417 ll~hp~f~~~~~~~~~~~~~~~~~ 440 (468)
+|+||||+.++.+...+...+..|
T Consensus 286 ll~~~~~~~~~~~~~~~~~~~~~~ 309 (316)
T cd05574 286 IKQHPFFRGVNWALIRHTTPPIIP 309 (316)
T ss_pred HHcCchhhcCChhhcccCCCCCCC
Confidence 999999999887777764333333
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=339.92 Aligned_cols=258 Identities=25% Similarity=0.419 Sum_probs=199.5
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc------cchHHHHHHHHHHcC-CCCcccccceeeecCCCCceEE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLN-HPNVVSLKHCFFSTTEKDELYL 210 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~------~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~~~~~ 210 (468)
.|.+.+.||+||-+.||++... +...||+|++... ...+.+|+.+|.+|+ |.+||+||++- ..+.++
T Consensus 362 ~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYE-----v~d~~l 435 (677)
T KOG0596|consen 362 EYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYE-----VTDGYL 435 (677)
T ss_pred hhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeee-----ccCceE
Confidence 5999999999999999999964 3456777765322 223457999999996 99999999986 446689
Q ss_pred EEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcccc
Q 012233 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (468)
Q Consensus 211 ~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~ 290 (468)
||||||...+|-.++.... ...+...++.|..|++.|++++|. +||||.||||.|+|+-. | .+||+|||+|..+
T Consensus 436 YmvmE~Gd~DL~kiL~k~~---~~~~~~~lk~ywkqML~aV~~IH~-~gIVHSDLKPANFLlVk-G-~LKLIDFGIA~aI 509 (677)
T KOG0596|consen 436 YMVMECGDIDLNKILKKKK---SIDPDWFLKFYWKQMLLAVKTIHQ-HGIVHSDLKPANFLLVK-G-RLKLIDFGIANAI 509 (677)
T ss_pred EEEeecccccHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHHH-hceeecCCCcccEEEEe-e-eEEeeeechhccc
Confidence 9999999988877766543 334445889999999999999998 89999999999999984 4 6999999999988
Q ss_pred CCCCC---CccccccCCccccccccCCC----------CCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Q 012233 291 VPGEP---NISYICSRYYRAPELIFGAT----------EYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILG 357 (468)
Q Consensus 291 ~~~~~---~~~~~gt~~y~aPE~~~~~~----------~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~ 357 (468)
..+.. ....+||+.||+||.+.... +.+.++||||||||||+|+.|++||....+ .+.++ ..+.
T Consensus 510 ~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n--~~aKl-~aI~ 586 (677)
T KOG0596|consen 510 QPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN--QIAKL-HAIT 586 (677)
T ss_pred CccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH--HHHHH-Hhhc
Confidence 66543 34689999999999985321 256799999999999999999999964321 12221 1121
Q ss_pred CCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCCCCC
Q 012233 358 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNTC 432 (468)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~~ 432 (468)
.| -.++.||.+.. ..++.++++.||..||.+|||+.++|+|||++-..-+...
T Consensus 587 ~P-----------~~~Iefp~~~~-----------~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~~i~~~~ 639 (677)
T KOG0596|consen 587 DP-----------NHEIEFPDIPE-----------NDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQPIPVEQ 639 (677)
T ss_pred CC-----------CccccccCCCC-----------chHHHHHHHHHHhcCcccCCCcHHHhcCcccccccccchH
Confidence 22 13455655322 2249999999999999999999999999999876555443
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-42 Score=334.52 Aligned_cols=281 Identities=35% Similarity=0.606 Sum_probs=220.0
Q ss_pred ccceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc------chHHHHHHHHHHcCCCCcccccceeeecCC---CC
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTE---KD 206 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~---~~ 206 (468)
.++|.+.+.||.|+||.||+|.+..+++.||||++.... ....+|+++++.++||||+++++++..... ..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 457999999999999999999999999999999884321 234579999999999999999998754432 23
Q ss_pred ceEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecC
Q 012233 207 ELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (468)
Q Consensus 207 ~~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~ 286 (468)
..++++||||+.+++...+.. ....+++..++.++.||+.||.|||+ .||+|+||||+|||++.++ .++|+|||+
T Consensus 87 ~~~~~lv~~~~~~~l~~~~~~---~~~~~~~~~~~~i~~~l~~al~~lH~-~~i~H~dl~p~nil~~~~~-~~~l~dfg~ 161 (311)
T cd07866 87 RGSVYMVTPYMDHDLSGLLEN---PSVKLTESQIKCYMLQLLEGINYLHE-NHILHRDIKAANILIDNQG-ILKIADFGL 161 (311)
T ss_pred CceEEEEEecCCcCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECCCC-CEEECcCcc
Confidence 446889999999877664432 24568999999999999999999998 8999999999999999888 799999999
Q ss_pred ccccCCCCC------------CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH
Q 012233 287 AKMLVPGEP------------NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIK 354 (468)
Q Consensus 287 a~~~~~~~~------------~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~ 354 (468)
+........ .....+++.|+|||.+.+...++.++|||||||++|+|++|++||.+.+.......+..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~ 241 (311)
T cd07866 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK 241 (311)
T ss_pred chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 976533221 12235688899999987665689999999999999999999999999988888888888
Q ss_pred HhCCCCHHHHhhcC--CCCcc-CCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 012233 355 ILGTPTREEIKCMN--PNYTE-FKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (468)
Q Consensus 355 ~~~~~~~~~~~~~~--~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f 423 (468)
..+.+....+..+. +.... ...... ...... ....+++++.+||.+||+.||.+|||+.+++.||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 242 LCGTPTEETWPGWRSLPGCEGVHSFTNY-PRTLEE-RFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred HhCCCChhhchhhhhcccccccccCCCC-CccHHH-HcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 87777665543322 11111 000100 011111 123456889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=340.55 Aligned_cols=286 Identities=31% Similarity=0.536 Sum_probs=214.9
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc----chHHHHHHHHHHcCCCCcccccceeeecCCC-------
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEK------- 205 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~------- 205 (468)
.+|.+.+.||.|+||.||+|.+..+|+.||+|++.... ....+|+.+++.++||||+++++++......
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 36999999999999999999999999999999885432 2345799999999999999999877443211
Q ss_pred --CceEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEee
Q 012233 206 --DELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICD 283 (468)
Q Consensus 206 --~~~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~D 283 (468)
.....|+||||+++++...+. ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++..+||+|
T Consensus 85 ~~~~~~~~lv~e~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~-~givH~dikp~Nili~~~~~~~kl~d 158 (342)
T cd07854 85 LTELNSVYIVQEYMETDLANVLE-----QGPLSEEHARLFMYQLLRGLKYIHS-ANVLHRDLKPANVFINTEDLVLKIGD 158 (342)
T ss_pred ccccceEEEEeecccccHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEEcCCCceEEECC
Confidence 123578999999986655432 3468899999999999999999998 89999999999999986655799999
Q ss_pred ecCccccCCCCC----CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Q 012233 284 FGSAKMLVPGEP----NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTP 359 (468)
Q Consensus 284 FG~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~ 359 (468)
||.+........ .....++..|+|||.+.+...++.++|||||||++|+|++|+.||...+..+....+......+
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 238 (342)
T cd07854 159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVV 238 (342)
T ss_pred cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 999876532211 1234578899999987665568899999999999999999999999888777777666554333
Q ss_pred CHHHHhhcCCCCccCCC--CcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCC
Q 012233 360 TREEIKCMNPNYTEFKF--PQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDP 429 (468)
Q Consensus 360 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~ 429 (468)
................. ......+.. .+.+.++.++.+||.+||+.||.+|||+.+++.||||+.+..+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~~ 309 (342)
T cd07854 239 REEDRNELLNVIPSFVRNDGGEPRRPLR-DLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSCP 309 (342)
T ss_pred ChHHhhhhhhhhhhhhhhcccccCCCHH-HHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccccCC
Confidence 32222111000000000 000011111 1234578999999999999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-43 Score=321.49 Aligned_cols=292 Identities=26% Similarity=0.415 Sum_probs=217.4
Q ss_pred ceEEe-ceecccCceEEEEEEEcCCCCEEEEEEeeccc----chHHHHHHHHHHcC-CCCcccccceeeecCCCCceEEE
Q 012233 138 SYMAE-RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK----RYKNRELQIMRLLN-HPNVVSLKHCFFSTTEKDELYLN 211 (468)
Q Consensus 138 ~y~~~-~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~----~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~~~~~~ 211 (468)
-|.+. ++||+|+|+.|--|....+|..||||++.+.. ....+|++++..++ |+||++|+++| +++..+|
T Consensus 78 ~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefF-----Edd~~FY 152 (463)
T KOG0607|consen 78 MYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFF-----EDDTRFY 152 (463)
T ss_pred HHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHh-----cccceEE
Confidence 35543 68999999999999999999999999996653 34458999999986 99999999999 7777799
Q ss_pred EEeecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCC--cEEEeeecCcc
Q 012233 212 LVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTH--QLKICDFGSAK 288 (468)
Q Consensus 212 lv~e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~--~vkL~DFG~a~ 288 (468)
||||-+.|| +|..+. ....|.+.++.+++.+|+.||.|||. +||.||||||+|||-..-.+ -||||||.+..
T Consensus 153 LVfEKm~GGplLshI~----~~~~F~E~EAs~vvkdia~aLdFlH~-kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgS 227 (463)
T KOG0607|consen 153 LVFEKMRGGPLLSHIQ----KRKHFNEREASRVVKDIASALDFLHT-KGIAHRDLKPENILCESPNKVSPVKICDFDLGS 227 (463)
T ss_pred EEEecccCchHHHHHH----HhhhccHHHHHHHHHHHHHHHHHHhh-cCcccccCCccceeecCCCCcCceeeecccccc
Confidence 999999876 333222 25679999999999999999999998 99999999999999753321 48999999875
Q ss_pred ccCCC--------CCCccccccCCcccccccc----CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHH---------
Q 012233 289 MLVPG--------EPNISYICSRYYRAPELIF----GATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVD--------- 347 (468)
Q Consensus 289 ~~~~~--------~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~--------- 347 (468)
-+.-. ....+.+|+..|||||++. ....|+.++|+||||||||.||.|.+||.+.-+.+
T Consensus 228 g~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~C 307 (463)
T KOG0607|consen 228 GIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVC 307 (463)
T ss_pred ccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCcc
Confidence 43211 2234678889999999973 23459999999999999999999999998743321
Q ss_pred ------HHHHHHHHhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCC
Q 012233 348 ------QLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHP 421 (468)
Q Consensus 348 ------~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp 421 (468)
.+..|.+ ..+.||. .-|..+|.+++|||..+|..|+..|.++.++++||
T Consensus 308 r~CQ~~LFesIQE-----------------GkYeFPd--------kdWahIS~eakdlisnLlvrda~~rlsa~~vlnhP 362 (463)
T KOG0607|consen 308 RVCQNKLFESIQE-----------------GKYEFPD--------KDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHP 362 (463)
T ss_pred HHHHHHHHHHHhc-----------------cCCcCCh--------hhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCc
Confidence 1122222 2334443 13456999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCCCCCCCCcccccCHHHHhcCCHHHHHhccccc
Q 012233 422 FFDDLRDPNTCLPNGRPLPTLFNFTAQELAGASNELRQRLIPEH 465 (468)
Q Consensus 422 ~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (468)
|++.+..+ +.++..+-+....+.-+-.+-.+..=-++|.++.|
T Consensus 363 w~~~~~~e-kalptp~v~~r~~s~~~lslfa~~aia~~R~~~~h 405 (463)
T KOG0607|consen 363 WVQRCAPE-KALPTPQVLQRNSSTMDLSLFAAEAIALNRQLSQH 405 (463)
T ss_pred cccccchh-ccCCCCcccccCccchhhHHHHHHHHHHhhccchh
Confidence 99988766 22233333333333332222222222356666655
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-42 Score=329.89 Aligned_cols=274 Identities=35% Similarity=0.646 Sum_probs=216.3
Q ss_pred eEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc------chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEE
Q 012233 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (468)
Q Consensus 139 y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~l 212 (468)
|.+.+.||.|++|.||+|.+..+|..||+|++.... ....+|+.+++.++||||+++++++ .+..+.|+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~-----~~~~~~~i 75 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVV-----HSENKLYL 75 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhhee-----ccCCeEEE
Confidence 567789999999999999999999999999885432 2345799999999999999999988 44457899
Q ss_pred EeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCC
Q 012233 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (468)
Q Consensus 213 v~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~ 292 (468)
||||+++.+...+.... ...+++..+..++.|++.||.|||+ ++++|+||+|+||+++.++ .++|+|||++.....
T Consensus 76 v~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~-~~~~H~dl~p~nil~~~~~-~~~l~df~~~~~~~~ 151 (283)
T cd07835 76 VFEFLDLDLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCHS-HRVLHRDLKPQNLLIDREG-ALKLADFGLARAFGV 151 (283)
T ss_pred EEeccCcCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHH-CCeeCCCCCHHHEEEcCCC-cEEEeecccccccCC
Confidence 99999877666544322 2468899999999999999999998 8999999999999999877 799999999875432
Q ss_pred CC-CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC--C
Q 012233 293 GE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN--P 369 (468)
Q Consensus 293 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~--~ 369 (468)
.. ......+++.|+|||++.+...++.++|+|||||++|+|++|.+||...+..+.+.++++..+.|....+.... +
T Consensus 152 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07835 152 PVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLP 231 (283)
T ss_pred CccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhch
Confidence 21 22234568899999988765557899999999999999999999999988888888888887777665442211 1
Q ss_pred CCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 012233 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (468)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f 423 (468)
.+. ..++....... ....+.++.++.++|.+||+.||.+|||+.+++.||||
T Consensus 232 ~~~-~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 232 DYK-PTFPKWARQDL-SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred hhh-hhcccccccch-hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 110 01111111111 11235678999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=330.10 Aligned_cols=276 Identities=38% Similarity=0.686 Sum_probs=221.2
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc------cchHHHHHHHHHHcCCCCcccccceeeecCCCCceEEE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~------~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 211 (468)
+|++.+.||+|+||.||+|.+..+++.||+|.+... .....+|+++++.++|+||+++++++.. ....+
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~ 76 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR-----KGRLY 76 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE-----CCEEE
Confidence 599999999999999999999999999999987532 1345679999999999999999999843 44588
Q ss_pred EEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccC
Q 012233 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (468)
Q Consensus 212 lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~ 291 (468)
+||||++++++..... ....+++..++.++.||+.||.|||+ .||+|+||+|+||+++.++ .+||+|||++....
T Consensus 77 iv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dl~~~ni~~~~~~-~~kl~d~g~~~~~~ 151 (288)
T cd07833 77 LVFEYVERTLLELLEA---SPGGLPPDAVRSYIWQLLQAIAYCHS-HNIIHRDIKPENILVSESG-VLKLCDFGFARALR 151 (288)
T ss_pred EEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECCCC-CEEEEeeecccccC
Confidence 9999999987765432 24558899999999999999999998 8999999999999999887 79999999987765
Q ss_pred CCC--CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc--
Q 012233 292 PGE--PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM-- 367 (468)
Q Consensus 292 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~-- 367 (468)
... ......++..|+|||++.+...++.++|+||||+++|+|++|++||.+....+.+..+...++.........+
T Consensus 152 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07833 152 ARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSS 231 (288)
T ss_pred CCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhccc
Confidence 433 3334677899999999977646899999999999999999999999988888888777776665554333222
Q ss_pred CCCCccCCCCcccC-CCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 012233 368 NPNYTEFKFPQIKA-HPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (468)
Q Consensus 368 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f 423 (468)
.+.+....++.... ..+...++..++.++.+||++||..||++||++.+++.||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 232 NPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred CccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 12222222222111 112223445568999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=332.98 Aligned_cols=282 Identities=29% Similarity=0.492 Sum_probs=213.8
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc------chHHHHHHHHHHcCCCCcccccceeeecCC---CCc
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTE---KDE 207 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~---~~~ 207 (468)
.+|.+.+.||+|+||.||+|.+..+++.||||.+.... ....+|+.+++.++||||+++++++..... ...
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 46999999999999999999999999999999885332 123469999999999999999998754332 123
Q ss_pred eEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCc
Q 012233 208 LYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (468)
Q Consensus 208 ~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a 287 (468)
...++||||+.+++...+.. ....+++..++.++.||+.||.|||+ +||+|+||||+|||++.++ .+||+|||++
T Consensus 92 ~~~~lv~e~~~~~l~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~-~~i~H~dl~p~nil~~~~~-~~kl~dfg~~ 166 (310)
T cd07865 92 GSFYLVFEFCEHDLAGLLSN---KNVKFTLSEIKKVMKMLLNGLYYIHR-NKILHRDMKAANILITKDG-ILKLADFGLA 166 (310)
T ss_pred ceEEEEEcCCCcCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHEEECCCC-cEEECcCCCc
Confidence 45789999999877665432 23468999999999999999999998 8999999999999999887 7999999999
Q ss_pred cccCCCCC-----CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 012233 288 KMLVPGEP-----NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTRE 362 (468)
Q Consensus 288 ~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~ 362 (468)
........ .....++..|+|||.+.+...++.++|+||||+++|+|++|+.||.+.+.......+....+..+..
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (310)
T cd07865 167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE 246 (310)
T ss_pred ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 76533221 1234568889999998766557899999999999999999999999887777666666665554443
Q ss_pred HHhhcC--CCCccCCCCcccCCCccccc-ccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 012233 363 EIKCMN--PNYTEFKFPQIKAHPWHKIF-HKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (468)
Q Consensus 363 ~~~~~~--~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f 423 (468)
.+.... ..+....++..........+ +...+..+.+||.+||..||.+|||++++++||||
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 247 VWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred hcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 322211 01111112211111111111 11246788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=332.92 Aligned_cols=260 Identities=25% Similarity=0.400 Sum_probs=205.6
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-----chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~l 212 (468)
+|++.+.||+|+||.||+|.+..+|..||+|.+.... ....+|+.+++.++|+||+++++++ ....++++
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~l 76 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF-----FIEGAVYM 76 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhhe-----ecCCeEEE
Confidence 5889999999999999999999899999999885431 2345799999999999999999988 34456899
Q ss_pred EeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCC
Q 012233 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (468)
Q Consensus 213 v~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~ 292 (468)
||||++++.+..+.........+++..+..++.||+.||.|||+..||+|+||||+|||++.++ .++|+|||++.....
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~ 155 (286)
T cd06622 77 CMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNG-QVKLCDFGVSGNLVA 155 (286)
T ss_pred EEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCC-CEEEeecCCcccccC
Confidence 9999998655433322222347899999999999999999999635999999999999999877 799999999876532
Q ss_pred CCCCccccccCCccccccccCCC-----CCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 012233 293 GEPNISYICSRYYRAPELIFGAT-----EYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367 (468)
Q Consensus 293 ~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 367 (468)
. ......+++.|+|||.+.+.. .++.++|+|||||++|+|++|..||...........+......+.
T Consensus 156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~------- 227 (286)
T cd06622 156 S-LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDP------- 227 (286)
T ss_pred C-ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCC-------
Confidence 2 223456788999999985432 257899999999999999999999976554333332222111110
Q ss_pred CCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCC
Q 012233 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDP 429 (468)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~ 429 (468)
..++..+++++.+||.+||+.+|.+||++.++++||||...+..
T Consensus 228 ------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~~ 271 (286)
T cd06622 228 ------------------PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNA 271 (286)
T ss_pred ------------------CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccCC
Confidence 01234578999999999999999999999999999999987765
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=330.66 Aligned_cols=258 Identities=26% Similarity=0.395 Sum_probs=203.9
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeecccc-----hHHHHHH-HHHHcCCCCcccccceeeecCCCCceEEE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR-----YKNRELQ-IMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~~-----~~~~E~~-il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 211 (468)
+|.+.+.||+|+||.||++.+..+|+.||||.+..... ....|+. .++.++||||+++++++. ....+|
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~-----~~~~~~ 76 (283)
T cd06617 2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALF-----REGDVW 76 (283)
T ss_pred CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEe-----cCCcEE
Confidence 58999999999999999999999999999998864321 1223444 467778999999999884 334589
Q ss_pred EEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcC-CccccCCCCCCeeecCCCCcEEEeeecCcccc
Q 012233 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV-GVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (468)
Q Consensus 212 lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~-givHrDlkp~NILl~~~~~~vkL~DFG~a~~~ 290 (468)
+||||+++++..++.........+++..++.++.||+.||.|||+ + +++||||||+|||++.++ .+||+|||++...
T Consensus 77 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~~i~h~dlkp~nil~~~~~-~~kl~dfg~~~~~ 154 (283)
T cd06617 77 ICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS-KLSVIHRDVKPSNVLINRNG-QVKLCDFGISGYL 154 (283)
T ss_pred EEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCeecCCCCHHHEEECCCC-CEEEeeccccccc
Confidence 999999988777665544445678999999999999999999997 6 999999999999999888 7999999999766
Q ss_pred CCCCCCccccccCCccccccccCC---CCCCcchhHHHHHHHHHHHHhCCCCCCCC-CcHHHHHHHHHHhCCCCHHHHhh
Q 012233 291 VPGEPNISYICSRYYRAPELIFGA---TEYTTAIDMWSIGCVLAELLLGQPLFPGE-SGVDQLVEIIKILGTPTREEIKC 366 (468)
Q Consensus 291 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~DvwSlG~il~ell~G~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~ 366 (468)
..........++..|+|||.+.+. ..++.++|+|||||++|+|++|+.||... ...+.+..+....
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---------- 224 (283)
T cd06617 155 VDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEP---------- 224 (283)
T ss_pred ccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcC----------
Confidence 443333345688999999988542 33688999999999999999999999653 2333333332210
Q ss_pred cCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCC
Q 012233 367 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDP 429 (468)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~ 429 (468)
...+ ....++.++.+||.+||..+|.+||++.+++.||||+.....
T Consensus 225 ------~~~~-----------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~ 270 (283)
T cd06617 225 ------SPQL-----------PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLSK 270 (283)
T ss_pred ------CCCC-----------CccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcccc
Confidence 0000 112368899999999999999999999999999999986543
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=340.34 Aligned_cols=285 Identities=34% Similarity=0.668 Sum_probs=223.0
Q ss_pred ccceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc------cchHHHHHHHHHHc-CCCCcccccceeeecCCCCce
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDEL 208 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~------~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~~~ 208 (468)
..+|.+.+.||+|+||.||+|.+..+|+.+|+|++... .....+|+.+++.+ +||||+++++++.. .+..
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~---~~~~ 82 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKA---ENDK 82 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeecc---CCCc
Confidence 34699999999999999999999889999999987432 12344699999999 99999999998743 2334
Q ss_pred EEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcc
Q 012233 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (468)
Q Consensus 209 ~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~ 288 (468)
..|+||||+.+++...+.. ..+++..++.++.||+.||.|||+ .||+|+||||+|||++.++ .+||+|||++.
T Consensus 83 ~~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~-~~i~H~dl~p~nill~~~~-~~kl~d~g~~~ 155 (337)
T cd07852 83 DIYLVFEYMETDLHAVIRA-----NILEDVHKRYIMYQLLKALKYIHS-GNVIHRDLKPSNILLNSDC-RVKLADFGLAR 155 (337)
T ss_pred eEEEEecccccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcCCC-cEEEeeccchh
Confidence 5789999999876654432 267888888999999999999998 8999999999999999988 79999999997
Q ss_pred ccCCCC------CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 012233 289 MLVPGE------PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTRE 362 (468)
Q Consensus 289 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~ 362 (468)
...... ......|+..|+|||.+.+...++.++|+|||||++|+|++|+.||.+....+....+....+.+...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07852 156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAE 235 (337)
T ss_pred ccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 654322 12235678999999998766668899999999999999999999999988888888888887777655
Q ss_pred HHhhcCCCCccCCCCcc---cCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCCCC
Q 012233 363 EIKCMNPNYTEFKFPQI---KAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNT 431 (468)
Q Consensus 363 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~ 431 (468)
.+..+...+....+..+ ..... ....+.++.++.+||.+||+.||.+|||+.++++||||+.+..+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~~~ 306 (337)
T cd07852 236 DIESIKSPFAATMLDSLPSRPRKPL-DELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNPSD 306 (337)
T ss_pred HHHHHHhhhHHHhhhhcccccccch-hhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccCCC
Confidence 44332221111111100 01111 1122347899999999999999999999999999999999865433
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=329.09 Aligned_cols=274 Identities=39% Similarity=0.739 Sum_probs=221.5
Q ss_pred eEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc------chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEE
Q 012233 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (468)
Q Consensus 139 y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~l 212 (468)
|.+.+.||.|++|.||+|.+..+|+.+++|.+.... ....+|+.+++.++|+||+++++++ .+...+++
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~~ 75 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVF-----RHKGDLYL 75 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhh-----ccCCCEEE
Confidence 567788999999999999998899999999885432 2345799999999999999999988 34456889
Q ss_pred EeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCC
Q 012233 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (468)
Q Consensus 213 v~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~ 292 (468)
||||+++++...+... ...+++..+..++.||+.||.|||+ .||+|+||||+||+++.++ .++|+|||.+.....
T Consensus 76 v~e~~~~~l~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dl~p~nili~~~~-~~~l~df~~~~~~~~ 150 (283)
T cd05118 76 VFEFMDTDLYKLIKDR---QRGLPESLIKSYLYQLLQGLAFCHS-HGILHRDLKPENLLINTEG-VLKLADFGLARSFGS 150 (283)
T ss_pred EEeccCCCHHHHHHhh---cccCCHHHHHHHHHHHHHHHHHHHH-CCeeecCcCHHHEEECCCC-cEEEeeeeeeEecCC
Confidence 9999998777654432 3568899999999999999999998 8999999999999999887 799999999976644
Q ss_pred CC-CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC--
Q 012233 293 GE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP-- 369 (468)
Q Consensus 293 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-- 369 (468)
.. ......++..|+|||.+.+...++.++|+|||||++|+|++|+.||...+..+.+..+...++.+....+.....
T Consensus 151 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd05118 151 PVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLA 230 (283)
T ss_pred CcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhh
Confidence 33 223356788999999987664689999999999999999999999999998888888888887776655544332
Q ss_pred CCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 012233 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (468)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f 423 (468)
.+..+.++....... ....+.++.++.+||.+||+.||.+||++.+++.||||
T Consensus 231 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 231 RNYKFSFPKKAGMPL-PKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hhhhhhhccccccCH-HHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 222223322211111 22335678999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=335.20 Aligned_cols=283 Identities=34% Similarity=0.619 Sum_probs=219.9
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc------chHHHHHHHHHHcCCCCcccccceeeecCC-CCceE
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTE-KDELY 209 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~-~~~~~ 209 (468)
.+|.+.+.||+|+||.||+|.+..+|+.||||++.... ....+|+.+++.++||||+++++++..... .....
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 94 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD 94 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence 36999999999999999999999999999999885421 224579999999999999999998854322 12234
Q ss_pred EEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccc
Q 012233 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (468)
Q Consensus 210 ~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~ 289 (468)
.|+||||+...+.... ...+++..+..++.|++.||.|||+ .||+||||||+|||++.++ .+||+|||+++.
T Consensus 95 ~~lv~e~~~~~l~~~~------~~~~~~~~~~~~~~qi~~aL~~LH~-~~i~H~dlkp~NIll~~~~-~~kL~dfg~~~~ 166 (342)
T cd07879 95 FYLVMPYMQTDLQKIM------GHPLSEDKVQYLVYQMLCGLKYIHS-AGIIHRDLKPGNLAVNEDC-ELKILDFGLARH 166 (342)
T ss_pred EEEEecccccCHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCC-CEEEeeCCCCcC
Confidence 6899999986544321 2458889999999999999999998 8999999999999999887 799999999875
Q ss_pred cCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 012233 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (468)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 369 (468)
... ......+++.|+|||.+.+...++.++|||||||++|||++|+.||.+.+....+..++...+.+..........
T Consensus 167 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (342)
T cd07879 167 ADA--EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLED 244 (342)
T ss_pred CCC--CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcc
Confidence 422 233457788999999987655588999999999999999999999998887888888888777666544332211
Q ss_pred CCcc---CCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCCC
Q 012233 370 NYTE---FKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPN 430 (468)
Q Consensus 370 ~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~ 430 (468)
.... ...+......+.. ..+.+++++.+||.+||+.||.+||++.+++.||||+.+++..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~ 307 (342)
T cd07879 245 KAAKSYIKSLPKYPRKDFST-LFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDAD 307 (342)
T ss_pred cchHHHHhhcCCcccchHHH-HhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccccc
Confidence 1000 0011111111111 1235788999999999999999999999999999999987644
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=337.46 Aligned_cols=310 Identities=33% Similarity=0.603 Sum_probs=232.9
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc------chHHHHHHHHHHcCCCCcccccceeeecCC-CCceE
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTE-KDELY 209 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~-~~~~~ 209 (468)
++|.+.+.||+|+||.||+|.+..+++.||+|++.... ....+|+.+++.+.||||+++++++..... .....
T Consensus 15 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07851 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQD 94 (343)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccccc
Confidence 36999999999999999999999999999999875421 223469999999999999999987744332 22234
Q ss_pred EEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccc
Q 012233 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (468)
Q Consensus 210 ~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~ 289 (468)
+++|+||+++++.+++.. ..+++..++.++.||+.||.|||+ .||+|+||||+||+++.++ .++|+|||++..
T Consensus 95 ~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~-~gi~H~dlkp~Nill~~~~-~~kL~dfg~~~~ 167 (343)
T cd07851 95 VYLVTHLMGADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHS-AGIIHRDLKPSNIAVNEDC-ELKILDFGLARH 167 (343)
T ss_pred EEEEEecCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECCCC-CEEEcccccccc
Confidence 889999998877665442 468999999999999999999998 8999999999999999887 799999999976
Q ss_pred cCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 012233 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (468)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 369 (468)
... ......++..|+|||.+.+...++.++|||||||++|+|++|+.||.+....+.+..+....+.+....+..+..
T Consensus 168 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 245 (343)
T cd07851 168 TDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISS 245 (343)
T ss_pred ccc--cccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccc
Confidence 533 234457788999999986655688999999999999999999999999888888888888877776554433221
Q ss_pred CCcc-C--CCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCCCCCCCCCCCCCcccccC
Q 012233 370 NYTE-F--KFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNTCLPNGRPLPTLFNFT 446 (468)
Q Consensus 370 ~~~~-~--~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~~ 446 (468)
.... + ..+......+.. ....+++++.+||.+||+.||.+|||+.+++.||||++...+... +++++++ .
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~-~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~~~-----~~~~~~~-~ 318 (343)
T cd07851 246 ESARNYIQSLPQMPKKDFKE-VFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPEDE-----PVAPPYD-Q 318 (343)
T ss_pred hhHHHHHHhccccCCCCHHH-HhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCccc-----ccccccC-c
Confidence 1100 0 000000011111 223468999999999999999999999999999999987665432 2233332 1
Q ss_pred HHHHhcCCHHHHHhcc
Q 012233 447 AQELAGASNELRQRLI 462 (468)
Q Consensus 447 ~~~~~~~~~~~~~~~~ 462 (468)
+=+-.+.+.++|+-++
T Consensus 319 ~~~~~~~~~~~~~~~~ 334 (343)
T cd07851 319 SFESRDLTVDEWKELV 334 (343)
T ss_pred chhhhhcCHHHHHHHh
Confidence 1223345566666554
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=329.86 Aligned_cols=247 Identities=30% Similarity=0.519 Sum_probs=205.2
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-------chHHHHHHHHHHcCCCCcccccceeeecCCCCceEE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~ 210 (468)
+|.+.+.||+|+||.||++.+..+++.||+|++.... ....+|+++++.++||||+++++++ .+...+
T Consensus 2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 76 (290)
T cd05580 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSF-----QDDSNL 76 (290)
T ss_pred ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEE-----EcCCeE
Confidence 5999999999999999999999999999999885432 2345799999999999999999988 444568
Q ss_pred EEEeecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccc
Q 012233 211 NLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (468)
Q Consensus 211 ~lv~e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~ 289 (468)
|+||||++++ +.+.+.. ...+++..+..++.||+.||.|||+ .||+|+||+|.||||+.++ .+||+|||++..
T Consensus 77 ~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~l~~lH~-~~i~H~dl~p~nili~~~~-~~kl~dfg~~~~ 150 (290)
T cd05580 77 YLVMEYVPGGELFSHLRK----SGRFPEPVARFYAAQVVLALEYLHS-LDIVYRDLKPENLLLDSDG-YIKITDFGFAKR 150 (290)
T ss_pred EEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHEEECCCC-CEEEeeCCCccc
Confidence 9999999654 4443322 3668999999999999999999998 8999999999999999888 799999999987
Q ss_pred cCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 012233 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (468)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 369 (468)
.... .....+++.|+|||.+.+. .++.++|+||||+++|+|++|..||...+..+....+...
T Consensus 151 ~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-------------- 213 (290)
T cd05580 151 VKGR--TYTLCGTPEYLAPEIILSK-GYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEG-------------- 213 (290)
T ss_pred cCCC--CCCCCCCccccChhhhcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--------------
Confidence 6443 3455789999999998655 4789999999999999999999999877754444443320
Q ss_pred CCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCC-----CHHHHhCCCCCCCCC
Q 012233 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC-----TALEACAHPFFDDLR 427 (468)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~-----s~~ell~hp~f~~~~ 427 (468)
... ++..++..++++|.+||..||.+|+ ++.++++||||+.+.
T Consensus 214 ---~~~------------~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 261 (290)
T cd05580 214 ---KVR------------FPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGID 261 (290)
T ss_pred ---Ccc------------CCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCC
Confidence 111 2344688999999999999999999 999999999999876
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-44 Score=318.04 Aligned_cols=283 Identities=30% Similarity=0.516 Sum_probs=229.8
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc-c-----chHHHHHHHHHHcCCCCcccccceeee---cCCCCce
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-K-----RYKNRELQIMRLLNHPNVVSLKHCFFS---TTEKDEL 208 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~-~-----~~~~~E~~il~~l~hpnIv~l~~~~~~---~~~~~~~ 208 (468)
.|.-...||+|.||.||+|+.+.+|+.||+|++.-+ + ....+|+.+|..|.|+|++.++..+-+ ....+..
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence 377778899999999999999999999999876331 1 123479999999999999998887633 2334455
Q ss_pred EEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcc
Q 012233 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (468)
Q Consensus 209 ~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~ 288 (468)
.+|+||++|..++..++.. ....++...++.++.+++.||.|+|+ ..|+|||+|++|+||+.++ .+||+|||+++
T Consensus 98 t~ylVf~~cehDLaGlLsn---~~vr~sls~Ikk~Mk~Lm~GL~~iHr-~kilHRDmKaaNvLIt~dg-ilklADFGlar 172 (376)
T KOG0669|consen 98 TFYLVFDFCEHDLAGLLSN---RKVRFSLSEIKKVMKGLMNGLYYIHR-NKILHRDMKAANVLITKDG-ILKLADFGLAR 172 (376)
T ss_pred eeeeeHHHhhhhHHHHhcC---ccccccHHHHHHHHHHHHHHHHHHHH-hhHHhhcccHhhEEEcCCc-eEEeecccccc
Confidence 6899999999887776543 34678999999999999999999998 8999999999999999998 89999999997
Q ss_pred ccCCCCC-----CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 012233 289 MLVPGEP-----NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREE 363 (468)
Q Consensus 289 ~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~ 363 (468)
.+..... ....+.|.+|++||.+.|...|+++.|||..|||+.||.+|.+.|.+.+...++..|-..+|..+.+.
T Consensus 173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkev 252 (376)
T KOG0669|consen 173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEV 252 (376)
T ss_pred ceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCccc
Confidence 6643221 23346699999999999999999999999999999999999999999999999999999999999888
Q ss_pred HhhcC--CCCccCCCCcccCCCccccc----ccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q 012233 364 IKCMN--PNYTEFKFPQIKAHPWHKIF----HKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDD 425 (468)
Q Consensus 364 ~~~~~--~~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~ 425 (468)
|..+. +.|..+..+.++.......- +---.+++.||+.+||.+||.+|++++++|+|.||..
T Consensus 253 WP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~k 320 (376)
T KOG0669|consen 253 WPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWK 320 (376)
T ss_pred CCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhc
Confidence 87654 44444443333332222110 0012468999999999999999999999999999976
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=343.48 Aligned_cols=241 Identities=24% Similarity=0.400 Sum_probs=202.0
Q ss_pred eEEeceecccCceEEEEEEEcCCCCEEEEEEeecccchHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEEEeeccc
Q 012233 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYIS 218 (468)
Q Consensus 139 y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv~e~~~ 218 (468)
..-++-||+|+.|.||+|+. .++.||||++.. ..+.+++-|++|+||||+.+.++| ....++|||||||.
T Consensus 126 IsELeWlGSGaQGAVF~Grl--~netVAVKKV~e---lkETdIKHLRkLkH~NII~FkGVC-----tqsPcyCIiMEfCa 195 (904)
T KOG4721|consen 126 ISELEWLGSGAQGAVFLGRL--HNETVAVKKVRE---LKETDIKHLRKLKHPNIITFKGVC-----TQSPCYCIIMEFCA 195 (904)
T ss_pred hhhhhhhccCcccceeeeec--cCceehhHHHhh---hhhhhHHHHHhccCcceeeEeeee-----cCCceeEEeeeccc
Confidence 33456799999999999997 679999997743 334588899999999999999999 66678999999999
Q ss_pred ch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCCCCCCc
Q 012233 219 ET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI 297 (468)
Q Consensus 219 ~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~~~~~~ 297 (468)
.| |+.+++. .+.+....+..|..+|+.|+.|||. +.|||||||.-||||..+. .|||+|||.++.........
T Consensus 196 ~GqL~~VLka----~~~itp~llv~Wsk~IA~GM~YLH~-hKIIHRDLKSPNiLIs~~d-~VKIsDFGTS~e~~~~STkM 269 (904)
T KOG4721|consen 196 QGQLYEVLKA----GRPITPSLLVDWSKGIAGGMNYLHL-HKIIHRDLKSPNILISYDD-VVKISDFGTSKELSDKSTKM 269 (904)
T ss_pred cccHHHHHhc----cCccCHHHHHHHHHHhhhhhHHHHH-hhHhhhccCCCceEeeccc-eEEeccccchHhhhhhhhhh
Confidence 55 5554443 5778888899999999999999997 9999999999999999887 79999999999887777778
Q ss_pred cccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccCCCC
Q 012233 298 SYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFP 377 (468)
Q Consensus 298 ~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (468)
.++||..|||||++...+ .++++|||||||+|||||||..||.+-+....+ ..
T Consensus 270 SFaGTVaWMAPEvIrneP-csEKVDIwSfGVVLWEmLT~EiPYkdVdssAII----wG---------------------- 322 (904)
T KOG4721|consen 270 SFAGTVAWMAPEVIRNEP-CSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAII----WG---------------------- 322 (904)
T ss_pred hhhhhHhhhCHHHhhcCC-cccccceehhHHHHHHHHhcCCCccccchheeE----Ee----------------------
Confidence 899999999999997665 899999999999999999999999775433221 11
Q ss_pred cccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 012233 378 QIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (468)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f 423 (468)
...+.++...+..+++-++=||+.||+-.|..||++.++|.|-=+
T Consensus 323 -VGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 323 -VGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred -ccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence 122233334667789999999999999999999999999998543
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=335.96 Aligned_cols=278 Identities=37% Similarity=0.580 Sum_probs=218.7
Q ss_pred ceE-EeceecccCceEEEEEEEcCCCCEEEEEEeecccc------------------hHHHHHHHHHHcCCCCcccccce
Q 012233 138 SYM-AERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR------------------YKNRELQIMRLLNHPNVVSLKHC 198 (468)
Q Consensus 138 ~y~-~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~~------------------~~~~E~~il~~l~hpnIv~l~~~ 198 (468)
+|. +.+.||.|+||.||+|.+..+++.||||++..... ...+|+.+++.++|+||++++++
T Consensus 9 ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 88 (335)
T PTZ00024 9 RYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDV 88 (335)
T ss_pred chhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEE
Confidence 465 56789999999999999999999999998854321 24579999999999999999998
Q ss_pred eeecCCCCceEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCc
Q 012233 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQ 278 (468)
Q Consensus 199 ~~~~~~~~~~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~ 278 (468)
+. ...+.++||||+.+++...+.. ...+++..+..++.||+.||.|||+ .||+|+||||+|||++.++ .
T Consensus 89 ~~-----~~~~~~lv~e~~~~~l~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~-~~i~H~dl~~~nill~~~~-~ 157 (335)
T PTZ00024 89 YV-----EGDFINLVMDIMASDLKKVVDR----KIRLTESQVKCILLQILNGLNVLHK-WYFMHRDLSPANIFINSKG-I 157 (335)
T ss_pred Ee-----cCCcEEEEEeccccCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecccccHHHeEECCCC-C
Confidence 83 4446899999999887765543 4558899999999999999999998 8999999999999999888 7
Q ss_pred EEEeeecCccccCCC---------------CCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 012233 279 LKICDFGSAKMLVPG---------------EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGE 343 (468)
Q Consensus 279 vkL~DFG~a~~~~~~---------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~ 343 (468)
++|+|||++...... .......+++.|+|||.+.+...++.++|+|||||++|+|++|.+||.+.
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~ 237 (335)
T PTZ00024 158 CKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGE 237 (335)
T ss_pred EEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999999998765411 11123356888999999976656799999999999999999999999999
Q ss_pred CcHHHHHHHHHHhCCCCHHHHhhcC--CCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCC
Q 012233 344 SGVDQLVEIIKILGTPTREEIKCMN--PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHP 421 (468)
Q Consensus 344 ~~~~~~~~i~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp 421 (468)
+..+.+..+...++.+....+.... +.+..+... ..... .......+.++.+||.+||+.||.+||+++++|.||
T Consensus 238 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~ 314 (335)
T PTZ00024 238 NEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPR--KPKDL-KTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHE 314 (335)
T ss_pred CHHHHHHHHHHHhCCCchhhCcchhhcccccccCcC--CcccH-HHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCc
Confidence 9888888888888877665443221 111111100 00000 112245688999999999999999999999999999
Q ss_pred CCCCCCCC
Q 012233 422 FFDDLRDP 429 (468)
Q Consensus 422 ~f~~~~~~ 429 (468)
||+.....
T Consensus 315 ~~~~~~~~ 322 (335)
T PTZ00024 315 YFKSDPLP 322 (335)
T ss_pred ccCCCCCC
Confidence 99875443
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=339.79 Aligned_cols=250 Identities=25% Similarity=0.363 Sum_probs=191.2
Q ss_pred ccceEEeceecccCceEEEEEEEc-----CCCCEEEEEEeeccc-----chHHHHHHHHHHc-CCCCcccccceeeecCC
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCL-----ETGDSVAIKKVLQDK-----RYKNRELQIMRLL-NHPNVVSLKHCFFSTTE 204 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~-----~~g~~vaiK~~~~~~-----~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~ 204 (468)
.++|++.+.||+|+||.||+|.+. .++..||+|++.... ....+|+.+++.+ +||||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~-- 83 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP-- 83 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC--
Confidence 357999999999999999999752 345789999886432 2345799999999 899999999977432
Q ss_pred CCceEEEEEeecccchHHH-HHhhhhh-----------------------------------------------------
Q 012233 205 KDELYLNLVLEYISETVYR-VSKHYTR----------------------------------------------------- 230 (468)
Q Consensus 205 ~~~~~~~lv~e~~~~~ll~-~~~~~~~----------------------------------------------------- 230 (468)
...+++||||++++.+. .+.....
T Consensus 84 --~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (338)
T cd05102 84 --NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ 161 (338)
T ss_pred --CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence 23478999999976543 3321100
Q ss_pred -----cCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCCCCC---Ccccccc
Q 012233 231 -----MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEP---NISYICS 302 (468)
Q Consensus 231 -----~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt 302 (468)
....+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++....... .....++
T Consensus 162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDiKp~Nil~~~~~-~~kl~DfG~a~~~~~~~~~~~~~~~~~~ 239 (338)
T cd05102 162 ETDDLWKSPLTMEDLICYSFQVARGMEFLAS-RKCIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGSARLP 239 (338)
T ss_pred hccccccCCCCHHHHHHHHHHHHHHHHHHHH-CCEECCCCccceEEEcCCC-cEEEeecccccccccCcchhcccCCCCC
Confidence 02347788889999999999999998 8999999999999999887 799999999976533221 1233456
Q ss_pred CCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccCCCCcccC
Q 012233 303 RYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKA 381 (468)
Q Consensus 303 ~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (468)
+.|+|||++.+.. ++.++|||||||++|||++ |..||.+....+.+...+.... ..
T Consensus 240 ~~y~aPE~~~~~~-~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~---------------~~------- 296 (338)
T cd05102 240 LKWMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGT---------------RM------- 296 (338)
T ss_pred ccccCcHHhhcCC-CCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCC---------------CC-------
Confidence 7899999997654 8999999999999999997 9999987654444333322100 00
Q ss_pred CCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 382 HPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 382 ~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
..+..+++++.+||.+||+.||.+|||+.+++.
T Consensus 297 -----~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 297 -----RAPENATPEIYRIMLACWQGDPKERPTFSALVE 329 (338)
T ss_pred -----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 022457889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=343.29 Aligned_cols=266 Identities=28% Similarity=0.401 Sum_probs=222.1
Q ss_pred CcccceEEeceecccCceEEEEEEEcCCCCEEEEEEeecccc------hHHHHHHHHHHcCCCCcccccceeeecCCCCc
Q 012233 134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR------YKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (468)
Q Consensus 134 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~~------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 207 (468)
.....|.+.+.||+|.|++|.+|++..++..||||.+.+... ...+|+++|+.|+|||||+++.+. ...
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~-----~t~ 127 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVI-----ETE 127 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeee-----eec
Confidence 445569999999999999999999999999999999866532 245799999999999999999998 444
Q ss_pred eEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCc
Q 012233 208 LYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (468)
Q Consensus 208 ~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a 287 (468)
..+|+||||+.++.+. .+...+....+..++.++.|+++|++|||. ++|||||||++||||+.+. ++||+|||++
T Consensus 128 ~~lylV~eya~~ge~~---~yl~~~gr~~e~~ar~~F~q~vsaveYcH~-k~ivHrdLk~eNilL~~~m-nikIaDfgfS 202 (596)
T KOG0586|consen 128 ATLYLVMEYASGGELF---DYLVKHGRMKEKEARAKFRQIVSAVEYCHS-KNIVHRDLKAENILLDENM-NIKIADFGFS 202 (596)
T ss_pred ceeEEEEEeccCchhH---HHHHhcccchhhhhhhhhHHHHHHHHHHhh-cceeccccchhhccccccc-ceeeeccccc
Confidence 4599999999976433 233335556668899999999999999998 9999999999999999998 7999999999
Q ss_pred cccCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 012233 288 KMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367 (468)
Q Consensus 288 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 367 (468)
..+..+....++||++.|.|||++.+....++.+|+||+|++||.|+.|..||.+.+-.+.-...+.
T Consensus 203 ~~~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~------------- 269 (596)
T KOG0586|consen 203 TFFDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLR------------- 269 (596)
T ss_pred eeecccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchhee-------------
Confidence 9999888889999999999999999988888999999999999999999999998763332221111
Q ss_pred CCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCCCCCCCCCCC
Q 012233 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNTCLPNGRP 438 (468)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~~~~~~~~ 438 (468)
..+. ++--++-++.++|+++|.++|.+|++.+++..|.|.........+.+...+
T Consensus 270 ----gk~r------------Ip~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~~~l~p~~e~ 324 (596)
T KOG0586|consen 270 ----GKYR------------IPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLEARLLAPLIER 324 (596)
T ss_pred ----eeec------------ccceeechhHHHHHHhhccCccccCCHHHhhhhcccchhhhhhhhhccccc
Confidence 1111 223378899999999999999999999999999999887666555555554
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-42 Score=337.81 Aligned_cols=277 Identities=21% Similarity=0.358 Sum_probs=198.3
Q ss_pred Eeceeccc--CceEEEEEEEcCCCCEEEEEEeeccc------chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEE
Q 012233 141 AERVVGTG--SFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (468)
Q Consensus 141 ~~~~lG~G--~fg~Vy~~~~~~~g~~vaiK~~~~~~------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~l 212 (468)
+.++||+| +|++||++.+..+|+.||+|.+.... ....+|+.+++.++||||++++++|. .....|+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~-----~~~~~~l 76 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFI-----ADNELWV 76 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEE-----ECCEEEE
Confidence 45789999 78999999999999999999986432 34557999999999999999999884 3345899
Q ss_pred EeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCC
Q 012233 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (468)
Q Consensus 213 v~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~ 292 (468)
||||+.++.+..+... .....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .++++||+.......
T Consensus 77 v~e~~~~~~l~~~~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~iiH~dlkp~Nil~~~~~-~~~l~~~~~~~~~~~ 153 (327)
T cd08227 77 VTSFMAYGSAKDLICT-HFMDGMSELAIAYILQGVLKALDYIHH-MGYVHRSVKASHILISVDG-KVYLSGLRSNLSMIN 153 (327)
T ss_pred EEeccCCCcHHHHHHh-hccCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCChhhEEEecCC-cEEEcccchhhcccc
Confidence 9999997655433221 113458899999999999999999998 8999999999999999887 799999987543321
Q ss_pred CCC--------CccccccCCccccccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC----
Q 012233 293 GEP--------NISYICSRYYRAPELIFGA-TEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTP---- 359 (468)
Q Consensus 293 ~~~--------~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~---- 359 (468)
... .....++..|+|||++.+. ..++.++|||||||++|||++|..||............... ..+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~ 232 (327)
T cd08227 154 HGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNG-TVPCLLD 232 (327)
T ss_pred ccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcC-Ccccccc
Confidence 111 1123467789999998653 34889999999999999999999999876544433332211 000
Q ss_pred ----CHHHHhhcCCC-------CccCCC----CcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCC
Q 012233 360 ----TREEIKCMNPN-------YTEFKF----PQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFD 424 (468)
Q Consensus 360 ----~~~~~~~~~~~-------~~~~~~----~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~ 424 (468)
+.+.. .+.+. +..... ...........+...+++++.+||.+||+.||.+|||+.++++||||+
T Consensus 233 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~ 311 (327)
T cd08227 233 TTTIPAEEL-TMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFK 311 (327)
T ss_pred ccchhhhhc-ccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhh
Confidence 00000 00000 000000 000000001112345688999999999999999999999999999998
Q ss_pred CCC
Q 012233 425 DLR 427 (468)
Q Consensus 425 ~~~ 427 (468)
.+.
T Consensus 312 ~~~ 314 (327)
T cd08227 312 QIK 314 (327)
T ss_pred hcc
Confidence 764
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=343.50 Aligned_cols=252 Identities=27% Similarity=0.427 Sum_probs=220.4
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc-------cchHHHHHHHHHHcCCCCcccccceeeecCCCCceEE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~-------~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~ 210 (468)
+..++..||-|+||.|-++........+|+|++++. ......|.+||..++.|.||+||..| .+..|+
T Consensus 421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTf-----rd~kyv 495 (732)
T KOG0614|consen 421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTF-----RDSKYV 495 (732)
T ss_pred hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHh-----ccchhh
Confidence 466777899999999999988655556899987543 23344699999999999999999999 899999
Q ss_pred EEEeecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccc
Q 012233 211 NLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (468)
Q Consensus 211 ~lv~e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~ 289 (468)
|+.||-|-|| +...+ +..+.|....+++|+..++.|++|||+ +|||+|||||+|++++.+| .+||.|||+|+.
T Consensus 496 YmLmEaClGGElWTiL----rdRg~Fdd~tarF~~acv~EAfeYLH~-k~iIYRDLKPENllLd~~G-y~KLVDFGFAKk 569 (732)
T KOG0614|consen 496 YMLMEACLGGELWTIL----RDRGSFDDYTARFYVACVLEAFEYLHR-KGIIYRDLKPENLLLDNRG-YLKLVDFGFAKK 569 (732)
T ss_pred hhhHHhhcCchhhhhh----hhcCCcccchhhhhHHHHHHHHHHHHh-cCceeccCChhheeeccCC-ceEEeehhhHHH
Confidence 9999999765 44433 335778889999999999999999998 9999999999999999998 799999999999
Q ss_pred cCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 012233 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (468)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 369 (468)
+..+....++||||.|.|||++.+.. .+.++|.||||+++|||++|.+||.+.+++..+..|.+.+..
T Consensus 570 i~~g~KTwTFcGTpEYVAPEIILnKG-HD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~----------- 637 (732)
T KOG0614|consen 570 IGSGRKTWTFCGTPEYVAPEIILNKG-HDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDK----------- 637 (732)
T ss_pred hccCCceeeecCCcccccchhhhccC-cchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhh-----------
Confidence 99999999999999999999998765 799999999999999999999999999999999999886532
Q ss_pred CCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCC-----HHHHhCCCCCCCCCC
Q 012233 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCT-----ALEACAHPFFDDLRD 428 (468)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s-----~~ell~hp~f~~~~~ 428 (468)
+. |+..++..+.+||++++..+|.+|.. +.++..|.||..+.-
T Consensus 638 ----i~------------~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdw 685 (732)
T KOG0614|consen 638 ----IE------------FPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDW 685 (732)
T ss_pred ----hh------------cccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCCh
Confidence 22 45678999999999999999999985 889999999997544
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=331.35 Aligned_cols=254 Identities=26% Similarity=0.446 Sum_probs=201.2
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-----chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~l 212 (468)
+|++.+.||+|+||.||+|.+..+++.||+|.+.... ..+.+|+.++++++||||+++++++.. ....++
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~l 76 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFV-----ENRISI 76 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEE-----CCEEEE
Confidence 4788899999999999999999999999999885432 234579999999999999999998843 345789
Q ss_pred EeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCC
Q 012233 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (468)
Q Consensus 213 v~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~ 292 (468)
||||++++.+... ..+++..+..++.|++.||.|||+ .||+|+||||+|||++.++ .++|+|||++.....
T Consensus 77 v~e~~~~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nill~~~~-~~~l~dfg~~~~~~~ 147 (279)
T cd06619 77 CTEFMDGGSLDVY-------RKIPEHVLGRIAVAVVKGLTYLWS-LKILHRDVKPSNMLVNTRG-QVKLCDFGVSTQLVN 147 (279)
T ss_pred EEecCCCCChHHh-------hcCCHHHHHHHHHHHHHHHHHHHH-CCEeeCCCCHHHEEECCCC-CEEEeeCCcceeccc
Confidence 9999998866532 346788899999999999999998 8999999999999999988 799999999976533
Q ss_pred CCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHH---HHHHHHHhCCCCHHHHhhcCC
Q 012233 293 GEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQ---LVEIIKILGTPTREEIKCMNP 369 (468)
Q Consensus 293 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~ 369 (468)
. ......++..|+|||++.+.. ++.++|+|||||++|+|++|..||......+. ..........+.
T Consensus 148 ~-~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--------- 216 (279)
T cd06619 148 S-IAKTYVGTNAYMAPERISGEQ-YGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED--------- 216 (279)
T ss_pred c-cccCCCCChhhcCceeecCCC-CCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC---------
Confidence 2 233467899999999997654 89999999999999999999999965322111 011111110000
Q ss_pred CCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCCC
Q 012233 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPN 430 (468)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~ 430 (468)
.+. ......++++.+||.+||+.||.+||++.+++.||||......+
T Consensus 217 ------~~~--------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~~~~ 263 (279)
T cd06619 217 ------PPV--------LPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYNDGN 263 (279)
T ss_pred ------CCC--------CCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccccCcc
Confidence 000 01133678999999999999999999999999999998875544
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=334.44 Aligned_cols=311 Identities=33% Similarity=0.584 Sum_probs=232.2
Q ss_pred ccceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc------chHHHHHHHHHHcCCCCcccccceeeecCCC-Cce
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEK-DEL 208 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~-~~~ 208 (468)
.++|.+.+.||+|+||.||+|.+..+|..||||++.... ....+|+.+|+.++||||+++++++...... ...
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFH 93 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccc
Confidence 346999999999999999999999999999999885421 2245799999999999999999988443221 123
Q ss_pred EEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcc
Q 012233 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (468)
Q Consensus 209 ~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~ 288 (468)
.+++||||+++.+..... ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++ .++|+|||++.
T Consensus 94 ~~~lv~e~~~~~l~~~~~-----~~~l~~~~~~~i~~qi~~al~~LH~-~gi~H~dlkp~Nill~~~~-~~kl~dfg~~~ 166 (343)
T cd07880 94 DFYLVMPFMGTDLGKLMK-----HEKLSEDRIQFLVYQMLKGLKYIHA-AGIIHRDLKPGNLAVNEDC-ELKILDFGLAR 166 (343)
T ss_pred eEEEEEecCCCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCC-CEEEeeccccc
Confidence 468999999776655432 3468999999999999999999998 8999999999999999887 79999999997
Q ss_pred ccCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 012233 289 MLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368 (468)
Q Consensus 289 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 368 (468)
.... ......+++.|+|||.+.+...++.++|+|||||++|+|++|.+||.+.+....+.+++.....++........
T Consensus 167 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd07880 167 QTDS--EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQ 244 (343)
T ss_pred cccc--CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhc
Confidence 6532 22345678999999998764558899999999999999999999999888888888877766655543322211
Q ss_pred CCCcc---CCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCCCCCCCCCCCCCccccc
Q 012233 369 PNYTE---FKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNTCLPNGRPLPTLFNF 445 (468)
Q Consensus 369 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~ 445 (468)
..... ...+..... ....+.+.+++++.++|.+||+.||.+|||+.+++.||||+.+.+.... +...+.+.
T Consensus 245 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~~~~-~~~~~~~~---- 318 (343)
T cd07880 245 SEDAKNYVKKLPRFRKK-DFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPEDE-TEAPPYDD---- 318 (343)
T ss_pred chhHHHHHHhccccCcc-hHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCcccc-cCCCCccc----
Confidence 11000 000111000 0112345688999999999999999999999999999999998765433 22222222
Q ss_pred CHHHHhcCCHHHHHhcc
Q 012233 446 TAQELAGASNELRQRLI 462 (468)
Q Consensus 446 ~~~~~~~~~~~~~~~~~ 462 (468)
+-+..+..=|.|+|+.
T Consensus 319 -~~~~~~~~~~~~~~~~ 334 (343)
T cd07880 319 -SFDEVDQSLEEWKRLT 334 (343)
T ss_pred -cHHhhccchHHHHHHH
Confidence 2344555666677764
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=326.19 Aligned_cols=275 Identities=38% Similarity=0.683 Sum_probs=220.1
Q ss_pred eEEeceecccCceEEEEEEEcCCCCEEEEEEeecccc-----hHHHHHHHHHHcC-CCCcccccceeeecCCCCceEEEE
Q 012233 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR-----YKNRELQIMRLLN-HPNVVSLKHCFFSTTEKDELYLNL 212 (468)
Q Consensus 139 y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~~-----~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~~~~~~l 212 (468)
|.+.+.||+|+||.||+|.+..+++.|+||.+..... ...+|+..++.+. |+||+++++++. +....++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~-----~~~~~~l 75 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFR-----ENDELYF 75 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhh-----cCCcEEE
Confidence 6788899999999999999988999999998754321 2346889999999 999999999983 3456889
Q ss_pred EeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCC
Q 012233 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (468)
Q Consensus 213 v~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~ 292 (468)
||||+.+.++..+.... ...+++..+..++.|++.+|.|||+ +|++|+||+|+||+++.++ .++|+|||.+.....
T Consensus 76 v~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~-~~i~H~dl~~~ni~i~~~~-~~~l~d~~~~~~~~~ 151 (283)
T cd07830 76 VFEYMEGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHK-HGFFHRDLKPENLLVSGPE-VVKIADFGLAREIRS 151 (283)
T ss_pred EEecCCCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChhhEEEcCCC-CEEEeecccceeccC
Confidence 99999877776544321 3468999999999999999999998 8999999999999999887 799999999987655
Q ss_pred CCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCc
Q 012233 293 GEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYT 372 (468)
Q Consensus 293 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 372 (468)
........++..|+|||++.+...++.++|+||||+++|+|++|++||...+..+.+.++...++.+....+........
T Consensus 152 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07830 152 RPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLAS 231 (283)
T ss_pred CCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhc
Confidence 44445567889999999986666689999999999999999999999999999999999988888877654432211111
Q ss_pred --cCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 012233 373 --EFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (468)
Q Consensus 373 --~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f 423 (468)
...++....... ..+.+..+.++.+||.+||+.||.+|||+.|++.||||
T Consensus 232 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 232 KLGFRFPQFAPTSL-HQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred cccccccccccccH-HHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 112221111111 11223347899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=355.80 Aligned_cols=255 Identities=25% Similarity=0.432 Sum_probs=203.0
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc----chHHHHHHHHHHcC-CCCcccccc-eeeecCCCC-ceEE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK----RYKNRELQIMRLLN-HPNVVSLKH-CFFSTTEKD-ELYL 210 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~----~~~~~E~~il~~l~-hpnIv~l~~-~~~~~~~~~-~~~~ 210 (468)
+++++++|.+|||+.||+|.+...|..||+|++.... ....+|+.+|++|. |+|||.+++ ......... ...+
T Consensus 38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Ev 117 (738)
T KOG1989|consen 38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEV 117 (738)
T ss_pred EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEE
Confidence 5899999999999999999998888999999875432 34468999999997 999999999 444443333 4567
Q ss_pred EEEeeccc-chHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCC--ccccCCCCCCeeecCCCCcEEEeeecCc
Q 012233 211 NLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG--VCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (468)
Q Consensus 211 ~lv~e~~~-~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~g--ivHrDlkp~NILl~~~~~~vkL~DFG~a 287 (468)
+|.||||. |++.+++..+. ...|.+.++.+|++|+|+|+.+||. .. |||||||-|||||+.++ ..||||||.+
T Consensus 118 llLmEyC~gg~Lvd~mn~Rl--q~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g-~~KLCDFGSa 193 (738)
T KOG1989|consen 118 LLLMEYCKGGSLVDFMNTRL--QTRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADG-NYKLCDFGSA 193 (738)
T ss_pred EeehhhccCCcHHHHHHHHH--hccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCC-CEEeCccccc
Confidence 89999999 68888776544 4459999999999999999999997 66 99999999999999998 7999999998
Q ss_pred cccCCCCC----------CccccccCCcccccccc--CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHH
Q 012233 288 KMLVPGEP----------NISYICSRYYRAPELIF--GATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKI 355 (468)
Q Consensus 288 ~~~~~~~~----------~~~~~gt~~y~aPE~~~--~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~ 355 (468)
+-...... .....-|+.|+|||++. .....++|+|||+|||+||-|+...+||....... |+.
T Consensus 194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la----Iln- 268 (738)
T KOG1989|consen 194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA----ILN- 268 (738)
T ss_pred ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee----EEe-
Confidence 65422221 11234589999999983 33448999999999999999999999997653222 111
Q ss_pred hCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC--------CCCCCCCC
Q 012233 356 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA--------HPFFDDLR 427 (468)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~--------hp~f~~~~ 427 (468)
..+.||.. +.++..+++||..||+.||.+||++.|++. ++|+.++.
T Consensus 269 ----------------g~Y~~P~~----------p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~~~~~ 322 (738)
T KOG1989|consen 269 ----------------GNYSFPPF----------PNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPIPDIY 322 (738)
T ss_pred ----------------ccccCCCC----------ccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCccccc
Confidence 23444431 458899999999999999999999998774 56666655
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=342.31 Aligned_cols=250 Identities=30% Similarity=0.558 Sum_probs=212.2
Q ss_pred eEE--eceecccCceEEEEEEEcCCCCEEEEEEeec------ccchHHHHHHHHHHcCCCCcccccceeeecCCCCceEE
Q 012233 139 YMA--ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ------DKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (468)
Q Consensus 139 y~~--~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~------~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~ 210 (468)
|++ .++||+|.||+||-|+.+.+|+.||||+|.+ .+...++|+.||+.+.||.||.+.-.| +....+
T Consensus 564 YQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~-----ET~erv 638 (888)
T KOG4236|consen 564 YQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMF-----ETPERV 638 (888)
T ss_pred HHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEee-----cCCceE
Confidence 544 3789999999999999999999999999843 345667899999999999999997666 334458
Q ss_pred EEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCC--CcEEEeeecCcc
Q 012233 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHT--HQLKICDFGSAK 288 (468)
Q Consensus 211 ~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~--~~vkL~DFG~a~ 288 (468)
|+|||-+.|+.++.+.... ...+++...+.++.||+.||.|||. ++|+|+||||+|||+.... -++||||||+|+
T Consensus 639 FVVMEKl~GDMLEMILSsE--kgRL~er~TkFlvtQIL~ALr~LH~-knIvHCDLKPENVLLas~~~FPQvKlCDFGfAR 715 (888)
T KOG4236|consen 639 FVVMEKLHGDMLEMILSSE--KGRLPERITKFLVTQILVALRYLHF-KNIVHCDLKPENVLLASASPFPQVKLCDFGFAR 715 (888)
T ss_pred EEEehhhcchHHHHHHHhh--cccchHHHHHHHHHHHHHHHHHhhh-cceeeccCCchheeeccCCCCCceeecccccee
Confidence 9999999999998877654 5779999999999999999999997 9999999999999996542 379999999999
Q ss_pred ccCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-cHHHHHHHHHHhCCCCHHHHhhc
Q 012233 289 MLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGES-GVDQLVEIIKILGTPTREEIKCM 367 (468)
Q Consensus 289 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~ 367 (468)
.+.......+.+|||.|+|||++... .|+...|+||.|||+|--|.|..||.... ..+++++
T Consensus 716 iIgEksFRrsVVGTPAYLaPEVLrnk-GyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQN---------------- 778 (888)
T KOG4236|consen 716 IIGEKSFRRSVVGTPAYLAPEVLRNK-GYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQN---------------- 778 (888)
T ss_pred ecchhhhhhhhcCCccccCHHHHhhc-cccccccceeeeEEEEEEecccccCCCccchhHHhhc----------------
Confidence 99877777889999999999999755 59999999999999999999999996432 2233332
Q ss_pred CCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q 012233 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDD 425 (468)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~ 425 (468)
..|.+| ..|| +.+++++.|||..+|+..-++|.|.+..|.|||+++
T Consensus 779 ----AaFMyP---p~PW-----~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~ 824 (888)
T KOG4236|consen 779 ----AAFMYP---PNPW-----SEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQD 824 (888)
T ss_pred ----cccccC---CCch-----hhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhc
Confidence 233333 3444 458999999999999999999999999999999987
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=327.56 Aligned_cols=277 Identities=33% Similarity=0.602 Sum_probs=216.7
Q ss_pred eEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc------chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEE
Q 012233 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (468)
Q Consensus 139 y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~l 212 (468)
|.+.+.||.|+||.||+|.+..+|+.+|+|.+.... ....+|+.+++.++|+|++++++++.... ....++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~l 77 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG---KGSIYM 77 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCC---CCcEEE
Confidence 678899999999999999999999999999986542 23457999999999999999999884321 246889
Q ss_pred EeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCC
Q 012233 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (468)
Q Consensus 213 v~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~ 292 (468)
||||+++++...+.. ....+++..++.++.||+.||+|||+ .|++|+||||+|||++.++ .++|+|||++.....
T Consensus 78 v~e~~~~~l~~~~~~---~~~~~~~~~~~~i~~~i~~al~~LH~-~~~~h~dl~p~nil~~~~~-~~~l~d~g~~~~~~~ 152 (287)
T cd07840 78 VFEYMDHDLTGLLDS---PEVKFTESQIKCYMKQLLEGLQYLHS-NGILHRDIKGSNILINNDG-VLKLADFGLARPYTK 152 (287)
T ss_pred EeccccccHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCcHHHeEEcCCC-CEEEccccceeeccC
Confidence 999999876665432 22568999999999999999999998 8999999999999999888 799999999976644
Q ss_pred CC--CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCC
Q 012233 293 GE--PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPN 370 (468)
Q Consensus 293 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 370 (468)
.. ......++..|+|||.+.+...++.++|||||||++|+|++|+.||...+..+.+..+....+.+....+......
T Consensus 153 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07840 153 RNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKL 232 (287)
T ss_pred CCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccc
Confidence 32 1233466888999998876656899999999999999999999999998888888888887777665544322111
Q ss_pred --CccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 012233 371 --YTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (468)
Q Consensus 371 --~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f 423 (468)
+................+...+++++.++|.+||+.||.+||++.+++.||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 233 PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred hhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 00000000000001112222348999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=326.94 Aligned_cols=261 Identities=24% Similarity=0.345 Sum_probs=206.4
Q ss_pred ccceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc---chHHHHHHHHHHc-CCCCcccccceeeecCCCCceEEE
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDELYLN 211 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~---~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~ 211 (468)
.++|.+.+.||+|+||.||+|.+..+++.+|+|.+.... ....+|+.+++.+ +||||+++++++...........+
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~ 100 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLW 100 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeE
Confidence 456999999999999999999999999999999885432 3345789999998 799999999998655433445688
Q ss_pred EEeecccchHHH-HHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcccc
Q 012233 212 LVLEYISETVYR-VSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (468)
Q Consensus 212 lv~e~~~~~ll~-~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~ 290 (468)
+||||+.++.+. ++.........+++..++.++.|++.||.|||+ .||+|+||||+||+++.++ .+||+|||++...
T Consensus 101 lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dlkp~nili~~~~-~~kl~dfg~~~~~ 178 (291)
T cd06639 101 LVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN-NRIIHRDVKGNNILLTTEG-GVKLVDFGVSAQL 178 (291)
T ss_pred EEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEEcCCC-CEEEeecccchhc
Confidence 999999875554 333333345668999999999999999999998 8999999999999999887 7999999998765
Q ss_pred CCCC-CCccccccCCccccccccCCC----CCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 012233 291 VPGE-PNISYICSRYYRAPELIFGAT----EYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIK 365 (468)
Q Consensus 291 ~~~~-~~~~~~gt~~y~aPE~~~~~~----~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 365 (468)
.... ......|+..|+|||++.... .++.++|||||||++|+|++|+.||........+..+.+. +.
T Consensus 179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~---~~----- 250 (291)
T cd06639 179 TSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRN---PP----- 250 (291)
T ss_pred ccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcC---CC-----
Confidence 4322 223456789999999985432 2678999999999999999999999876655544443221 00
Q ss_pred hcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCC
Q 012233 366 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFD 424 (468)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~ 424 (468)
... ..+..++..+.+||.+||+.||.+||++.++++||||+
T Consensus 251 ------~~~------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 251 ------PTL------------LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred ------CCC------------CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 000 01234677899999999999999999999999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=340.39 Aligned_cols=249 Identities=19% Similarity=0.271 Sum_probs=198.4
Q ss_pred CcccceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc------cchHHHHHHHHHHcCCCCcccccceeeecCCCCc
Q 012233 134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (468)
Q Consensus 134 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~------~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 207 (468)
.......+...||+|.||+||+|+| ...||||++..+ ...+++|+.++++-+|.||+-+.|++ ...
T Consensus 389 Ip~~ev~l~~rIGsGsFGtV~Rg~w---hGdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~-----~~p 460 (678)
T KOG0193|consen 389 IPPEEVLLGERIGSGSFGTVYRGRW---HGDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGAC-----MNP 460 (678)
T ss_pred cCHHHhhccceeccccccceeeccc---ccceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhh-----cCC
Confidence 3334567889999999999999998 346999998543 34567899999999999999999998 444
Q ss_pred eEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCc
Q 012233 208 LYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (468)
Q Consensus 208 ~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a 287 (468)
.+ .||+-+|.|..|....+.. ..+|.+...+.|+.||+.|+.|||. ++|||||||..|||+.+++ +|||+|||++
T Consensus 461 ~~-AIiTqwCeGsSLY~hlHv~--etkfdm~~~idIAqQiaqGM~YLHA-K~IIHrDLKSnNIFl~~~~-kVkIgDFGLa 535 (678)
T KOG0193|consen 461 PL-AIITQWCEGSSLYTHLHVQ--ETKFDMNTTIDIAQQIAQGMDYLHA-KNIIHRDLKSNNIFLHEDL-KVKIGDFGLA 535 (678)
T ss_pred ce-eeeehhccCchhhhhccch--hhhhhHHHHHHHHHHHHHhhhhhhh-hhhhhhhccccceEEccCC-cEEEecccce
Confidence 44 7999999998766555544 3678999999999999999999996 9999999999999999887 8999999998
Q ss_pred cccC---CCCCCccccccCCccccccccCC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 012233 288 KMLV---PGEPNISYICSRYYRAPELIFGA--TEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTRE 362 (468)
Q Consensus 288 ~~~~---~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~ 362 (468)
.... .+.......|...|||||++... ..|++.+|||||||++|||++|..||......+.+..+-+.+..|...
T Consensus 536 tvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s 615 (678)
T KOG0193|consen 536 TVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLS 615 (678)
T ss_pred eeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccch
Confidence 6442 12223345678899999999633 248999999999999999999999999555544455544433233221
Q ss_pred HHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 363 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
. ...+.+.++++|+..||.+++++||.+.+||.
T Consensus 616 ~------------------------~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 616 K------------------------IRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred h------------------------hhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 1 22457789999999999999999999999876
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=346.37 Aligned_cols=258 Identities=27% Similarity=0.436 Sum_probs=207.9
Q ss_pred eecccCceEEEEEEEcCCCCEEEEEEeeccc----chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEEEeecccc
Q 012233 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISE 219 (468)
Q Consensus 144 ~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv~e~~~~ 219 (468)
+||+|.||+||.|++..+...+|||.+.... .-+.+|+.+-+.|+|.|||++++++ ..+.++-|.||-++|
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~-----senGf~kIFMEqVPG 656 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSV-----SENGFFKIFMEQVPG 656 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhcc-----CCCCeEEEEeecCCC
Confidence 6999999999999999999999999885433 3356899999999999999999997 444578899999998
Q ss_pred hHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCCCCCC-cc
Q 012233 220 TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPN-IS 298 (468)
Q Consensus 220 ~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~~~~~-~~ 298 (468)
|.+..+.......-+-.+.....|..||+.||.|||+ +.|||||||-+||||+...+.+||+|||.++.+..-.+. -+
T Consensus 657 GSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHe-n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TET 735 (1226)
T KOG4279|consen 657 GSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHE-NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTET 735 (1226)
T ss_pred CcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhh-cceeeccccCCcEEEeeccceEEecccccchhhccCCccccc
Confidence 8776555433322223678889999999999999998 899999999999999987778999999999988655443 46
Q ss_pred ccccCCccccccccC-CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccCCCC
Q 012233 299 YICSRYYRAPELIFG-ATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFP 377 (468)
Q Consensus 299 ~~gt~~y~aPE~~~~-~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (468)
+.||..|||||++.. ..+|+.++|||||||++.||.||++||......+ ..+++..
T Consensus 736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq--AAMFkVG--------------------- 792 (1226)
T KOG4279|consen 736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ--AAMFKVG--------------------- 792 (1226)
T ss_pred cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh--Hhhhhhc---------------------
Confidence 889999999999953 3469999999999999999999999997543222 1122211
Q ss_pred cccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC-CCCCCCC
Q 012233 378 QIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL-RDPNTCL 433 (468)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~-~~~~~~~ 433 (468)
....+..++..++.+++.||.+|+..||.+||+|.++|..||++.- +++.+.+
T Consensus 793 ---myKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~~kk~r~~l 846 (1226)
T KOG4279|consen 793 ---MYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHNNKKPRPKL 846 (1226)
T ss_pred ---ceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccCCCCCCCCC
Confidence 1112233567788999999999999999999999999999999975 3343333
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=325.28 Aligned_cols=257 Identities=24% Similarity=0.364 Sum_probs=201.2
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc---cchHHHHHHHHHHc-CCCCcccccceeeecCCC-CceEEE
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLL-NHPNVVSLKHCFFSTTEK-DELYLN 211 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~---~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~-~~~~~~ 211 (468)
+.|.+.+.||+|+||.||+|.+..+++.||+|.+... .....+|+.+++.+ +|+||++++++|...... ....+|
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~ 85 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLW 85 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEE
Confidence 3589999999999999999999999999999988543 23456788999988 699999999988654321 234688
Q ss_pred EEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccC
Q 012233 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (468)
Q Consensus 212 lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~ 291 (468)
+||||++++.+...... .....+++..+..++.|++.||+|||+ +||+|+||||+||+++.++ .++|+|||++....
T Consensus 86 iv~e~~~~~~L~~~l~~-~~~~~l~~~~~~~~~~qi~~~l~~LH~-~~ivh~dl~~~nili~~~~-~~~l~Dfg~~~~~~ 162 (272)
T cd06637 86 LVMEFCGAGSVTDLIKN-TKGNTLKEEWIAYICREILRGLSHLHQ-HKVIHRDIKGQNVLLTENA-EVKLVDFGVSAQLD 162 (272)
T ss_pred EEEEcCCCCcHHHHHHh-ccCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCCHHHEEECCCC-CEEEccCCCceecc
Confidence 99999997554433221 123568899999999999999999998 8999999999999999888 79999999987653
Q ss_pred CC-CCCccccccCCccccccccCC----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 012233 292 PG-EPNISYICSRYYRAPELIFGA----TEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKC 366 (468)
Q Consensus 292 ~~-~~~~~~~gt~~y~aPE~~~~~----~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 366 (468)
.. .......|++.|+|||++.+. ..++.++|||||||++|||++|..||...........+... +
T Consensus 163 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~---~------- 232 (272)
T cd06637 163 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN---P------- 232 (272)
T ss_pred cccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcC---C-------
Confidence 32 223346789999999998532 24788999999999999999999999765543333222110 0
Q ss_pred cCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 012233 367 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (468)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f 423 (468)
........++.++.+||.+||..||.+|||+.+++.||||
T Consensus 233 -----------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 233 -----------------APRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred -----------------CCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 0001123467899999999999999999999999999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=328.03 Aligned_cols=282 Identities=33% Similarity=0.542 Sum_probs=218.6
Q ss_pred ccceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc------chHHHHHHHHHHcCCCCcccccceeeecCC-----
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTE----- 204 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~----- 204 (468)
..+|.+.+.||+|+||.||+|.+..+|+.||+|.+.... ....+|+.+++.++||||+++++++....+
T Consensus 6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~ 85 (302)
T cd07864 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFK 85 (302)
T ss_pred hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcc
Confidence 346999999999999999999999999999999885432 234579999999999999999998754331
Q ss_pred CCceEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeee
Q 012233 205 KDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDF 284 (468)
Q Consensus 205 ~~~~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DF 284 (468)
.+..++++||||++++++..+.. ....+++..++.++.||+.||.|||+ .||+|+||||+||+++.++ .+||+||
T Consensus 86 ~~~~~~~lv~e~~~~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~i~H~dl~p~nili~~~~-~~kl~df 160 (302)
T cd07864 86 KDKGAFYLVFEYMDHDLMGLLES---GLVHFSEDHIKSFMKQLLEGLNYCHK-KNFLHRDIKCSNILLNNKG-QIKLADF 160 (302)
T ss_pred ccCCcEEEEEcccCccHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECCCC-cEEeCcc
Confidence 12236899999999877665432 23468999999999999999999998 8999999999999999887 7999999
Q ss_pred cCccccCCCC--CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 012233 285 GSAKMLVPGE--PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTRE 362 (468)
Q Consensus 285 G~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~ 362 (468)
|++....... ......++..|+|||.+.+...++.++|||||||++|+|++|++||...+..+.+..+....+.+...
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (302)
T cd07864 161 GLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPA 240 (302)
T ss_pred cccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence 9997654332 12233567889999998665557899999999999999999999999888888888888877776654
Q ss_pred HHhhcC--CCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 012233 363 EIKCMN--PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (468)
Q Consensus 363 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f 423 (468)
.+.... +.+............+ ......++..+.+||.+||+.||.+||++.+++.||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 241 VWPDVIKLPYFNTMKPKKQYRRRL-REEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred hcccccccccccccccccccccch-hhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 433211 1111111000000111 11223578999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=324.28 Aligned_cols=274 Identities=38% Similarity=0.679 Sum_probs=223.9
Q ss_pred eEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc------chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEE
Q 012233 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (468)
Q Consensus 139 y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~l 212 (468)
|.+.+.||+|+||.||+|.+..+++.||+|.+.... .....|+.+++.++|+||+++++++. +..+.++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~~ 75 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIH-----TERKLYL 75 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhh-----cCCceEE
Confidence 567788999999999999999999999999886532 23356999999999999999999883 4456899
Q ss_pred EeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCC
Q 012233 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (468)
Q Consensus 213 v~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~ 292 (468)
||||+++++...+... ...+++..+..++.|++.||.|||+ .||+|+||+|+||+++.++ .++|+|||.+.....
T Consensus 76 v~e~~~~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~~l~~~ni~~~~~~-~~~l~d~g~~~~~~~ 150 (282)
T cd07829 76 VFEYCDMDLKKYLDKR---PGPLSPNLIKSIMYQLLRGLAYCHS-HRILHRDLKPQNILINRDG-VLKLADFGLARAFGI 150 (282)
T ss_pred EecCcCcCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChheEEEcCCC-CEEEecCCcccccCC
Confidence 9999998776655432 2468999999999999999999998 8999999999999999887 799999999876543
Q ss_pred CC-CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCC
Q 012233 293 GE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNY 371 (468)
Q Consensus 293 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 371 (468)
.. ......++..|+|||.+.+...++.++|||||||++|||++|.+||.+.+..+.+.++...++.+....+..+....
T Consensus 151 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07829 151 PLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLP 230 (282)
T ss_pred CccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccc
Confidence 32 22344567889999998766568999999999999999999999999999889999999988888887765543321
Q ss_pred -ccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 012233 372 -TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (468)
Q Consensus 372 -~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f 423 (468)
....++..........+ +.++..+.++|.+||+.||.+||++.+++.||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 231 DYKPTFPKFPPKDLEKVL-PRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred cccccccccCccchHHhc-ccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 23334443333333333 3458899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=330.21 Aligned_cols=279 Identities=24% Similarity=0.365 Sum_probs=202.7
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-----chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~l 212 (468)
+|++.+.||+|+||.||++.+..++..+|+|.+.... ....+|+++++.++||||++++++|. +..++|+
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~l 76 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFY-----SDGEISI 76 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----eCCEEEE
Confidence 5999999999999999999999999999999875431 23457999999999999999999984 4446899
Q ss_pred EeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCC
Q 012233 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (468)
Q Consensus 213 v~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~ 292 (468)
||||++++.+..... ....+++..+..++.||+.||.|||+..+|+|+||||+|||++.++ .+||+|||++.....
T Consensus 77 v~ey~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~ 152 (308)
T cd06615 77 CMEHMDGGSLDQVLK---KAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLID 152 (308)
T ss_pred EeeccCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCC-cEEEccCCCcccccc
Confidence 999998765543222 2356889999999999999999999635999999999999999887 799999999875533
Q ss_pred CCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCc
Q 012233 293 GEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYT 372 (468)
Q Consensus 293 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 372 (468)
. ......+++.|+|||++.+. .++.++|+|||||++|+|++|+.||...+... ...++...................
T Consensus 153 ~-~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 229 (308)
T cd06615 153 S-MANSFVGTRSYMSPERLQGT-HYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE-LEAMFGRPVSEGEAKESHRPVSGH 229 (308)
T ss_pred c-ccccCCCCcCccChhHhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCcchhh-HHHhhcCccccccccCCcccccCC
Confidence 2 23356789999999998654 48899999999999999999999997665332 222221110000000000000000
Q ss_pred cCCCCc----------ccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCC
Q 012233 373 EFKFPQ----------IKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRD 428 (468)
Q Consensus 373 ~~~~~~----------~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~ 428 (468)
....+. +........-...++.++++||.+||..||++|||+.+++.||||.....
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 295 (308)
T cd06615 230 PPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAEL 295 (308)
T ss_pred CCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhccc
Confidence 000000 00000000001236788999999999999999999999999999987533
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=317.69 Aligned_cols=249 Identities=27% Similarity=0.431 Sum_probs=200.6
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc------chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 211 (468)
.|++.+.||.|+||.||++.+..+++.||+|.+.... ....+|+.+++.++|+|++++++.+. ....++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----~~~~~~~ 76 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWE----GEDGLLY 76 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeec----CCCCEEE
Confidence 3899999999999999999999999999999885432 23457899999999999999988762 2234688
Q ss_pred EEeecccchHH-HHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcccc
Q 012233 212 LVLEYISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (468)
Q Consensus 212 lv~e~~~~~ll-~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~ 290 (468)
+||||++++.+ +.+.. .....+++..++.++.|++.||.|||+ .||+|+||||+||+++.++ .++|+|||++...
T Consensus 77 lv~e~~~~~~l~~~l~~--~~~~~l~~~~~~~~~~~l~~~l~~lH~-~~i~H~di~p~nil~~~~~-~~~l~df~~~~~~ 152 (257)
T cd08223 77 IVMGFCEGGDLYHKLKE--QKGKLLPENQVVEWFVQIAMALQYLHE-KHILHRDLKTQNVFLTRTN-IIKVGDLGIARVL 152 (257)
T ss_pred EEecccCCCcHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCchhEEEecCC-cEEEecccceEEe
Confidence 99999986544 33332 123458999999999999999999998 8999999999999999887 7999999999766
Q ss_pred CCCC-CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 012233 291 VPGE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (468)
Q Consensus 291 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 369 (468)
.... ......+++.|+|||++.+. .++.++|+|||||++|+|++|+.||...+.......+....
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~------------- 218 (257)
T cd08223 153 ENQCDMASTLIGTPYYMSPELFSNK-PYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGK------------- 218 (257)
T ss_pred cccCCccccccCCcCccChhHhcCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC-------------
Confidence 3322 22345688999999998655 48899999999999999999999998766544444333210
Q ss_pred CCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 012233 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (468)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f 423 (468)
.+ .++..+++.+.+||.+||+.||.+||++.+++.||||
T Consensus 219 ------~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 219 ------LP---------PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred ------CC---------CCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 00 0223478899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=321.36 Aligned_cols=256 Identities=29% Similarity=0.400 Sum_probs=205.0
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-----chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~l 212 (468)
+|.+.+.||.|+||+||+|.+..++..+|+|++.... ....+|+.+++.++|+||+++++.+ ......++
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~i 76 (267)
T cd06610 2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF-----VVGDELWL 76 (267)
T ss_pred cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEE-----eeCCEEEE
Confidence 5999999999999999999998899999999885432 3456799999999999999999887 33446889
Q ss_pred EeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCC
Q 012233 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (468)
Q Consensus 213 v~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~ 292 (468)
|||++.++.+............+++..++.++.||+.||.|||+ .||+|+||||+||+++.++ .++|+|||++.....
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~-~~i~h~~l~p~ni~~~~~~-~~~l~df~~~~~~~~ 154 (267)
T cd06610 77 VMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS-NGQIHRDIKAGNILLGEDG-SVKIADFGVSASLAD 154 (267)
T ss_pred EEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHhEEEcCCC-CEEEcccchHHHhcc
Confidence 99999876554333222223568899999999999999999998 8999999999999999887 799999999876644
Q ss_pred CCC-----CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 012233 293 GEP-----NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367 (468)
Q Consensus 293 ~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 367 (468)
... .....|+..|+|||++.....++.++|+|||||++|+|++|+.||...+....+.++... .+
T Consensus 155 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~---~~------- 224 (267)
T cd06610 155 GGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN---DP------- 224 (267)
T ss_pred CccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcC---CC-------
Confidence 322 234568899999999876645899999999999999999999999877665555444331 00
Q ss_pred CCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 012233 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (468)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f 423 (468)
+ .++. ......+++.+.+||.+||..||.+||++.+++.||||
T Consensus 225 -~-----~~~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 225 -P-----SLET-------GADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred -C-----CcCC-------ccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 0 0000 00123578899999999999999999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=324.14 Aligned_cols=261 Identities=23% Similarity=0.332 Sum_probs=205.3
Q ss_pred cccceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc---chHHHHHHHHHHc-CCCCcccccceeeecCCCCceEE
Q 012233 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDELYL 210 (468)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~---~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~~~~~ 210 (468)
..++|.+.+.||+|+||.||+|.+..+++.+|+|++.... ....+|+.+++.+ +||||+++++++......+..+.
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~ 95 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQL 95 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeE
Confidence 4457999999999999999999999999999999875422 3455799999999 69999999998865544455678
Q ss_pred EEEeecccchHHH-HHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccc
Q 012233 211 NLVLEYISETVYR-VSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (468)
Q Consensus 211 ~lv~e~~~~~ll~-~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~ 289 (468)
++||||++++.+. .+.........+++..++.++.|++.||.|||+ .+|+||||||+||+++.++ .++|+|||++..
T Consensus 96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~nili~~~~-~~kl~dfg~~~~ 173 (286)
T cd06638 96 WLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV-NKTIHRDVKGNNILLTTEG-GVKLVDFGVSAQ 173 (286)
T ss_pred EEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh-CCccccCCCHHhEEECCCC-CEEEccCCceee
Confidence 9999999876554 333333344668889999999999999999998 8999999999999999888 699999999876
Q ss_pred cCCCC-CCccccccCCccccccccCC----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 012233 290 LVPGE-PNISYICSRYYRAPELIFGA----TEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEI 364 (468)
Q Consensus 290 ~~~~~-~~~~~~gt~~y~aPE~~~~~----~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 364 (468)
..... ......|++.|+|||++... ..++.++|||||||++|+|++|..||........+..+... .+
T Consensus 174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~--~~----- 246 (286)
T cd06638 174 LTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRN--PP----- 246 (286)
T ss_pred cccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcccc--CC-----
Confidence 54322 22345689999999987432 33788999999999999999999999876544433222110 00
Q ss_pred hhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 012233 365 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (468)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f 423 (468)
.. ...+..++.++.+||.+||+.||.+|||+.++++|+||
T Consensus 247 -------~~------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 247 -------PT------------LHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred -------Cc------------ccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 00 00122357789999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=326.88 Aligned_cols=252 Identities=28% Similarity=0.460 Sum_probs=205.7
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc----chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEEE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV 213 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv 213 (468)
+|.+.+.||.|+||.||+|.+..+|+.||||.+.... ....+|+.+++.++||||+++++++. ....+|+|
T Consensus 20 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv 94 (296)
T cd06655 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL-----VGDELFVV 94 (296)
T ss_pred eEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEe-----cCceEEEE
Confidence 5999999999999999999999999999999885432 23456999999999999999999883 44468999
Q ss_pred eecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCCC
Q 012233 214 LEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293 (468)
Q Consensus 214 ~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~~ 293 (468)
+||+.++.+..... ...+++..+..++.|++.||+|||+ .|++|+||||+||+++.++ .++|+|||++......
T Consensus 95 ~e~~~~~~L~~~~~----~~~l~~~~~~~i~~~l~~al~~LH~-~~i~H~dL~p~Nili~~~~-~~kl~dfg~~~~~~~~ 168 (296)
T cd06655 95 MEYLAGGSLTDVVT----ETCMDEAQIAAVCRECLQALEFLHA-NQVIHRDIKSDNVLLGMDG-SVKLTDFGFCAQITPE 168 (296)
T ss_pred EEecCCCcHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCC-CEEEccCccchhcccc
Confidence 99999876654332 3458899999999999999999998 8999999999999999887 7999999998765433
Q ss_pred CC-CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCc
Q 012233 294 EP-NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYT 372 (468)
Q Consensus 294 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 372 (468)
.. .....++..|+|||.+.+. .++.++|+|||||++|+|++|..||...+.......+... ..+
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~-~~~------------- 233 (296)
T cd06655 169 QSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTP------------- 233 (296)
T ss_pred cccCCCcCCCccccCcchhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCc-------------
Confidence 22 2345688999999998654 4889999999999999999999999887765554433221 000
Q ss_pred cCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q 012233 373 EFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (468)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~ 427 (468)
.. ..+..+++.+.+||.+||..||.+||++.+++.||||+...
T Consensus 234 ~~------------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~ 276 (296)
T cd06655 234 EL------------QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAK 276 (296)
T ss_pred cc------------CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhcc
Confidence 00 02235788999999999999999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=333.44 Aligned_cols=286 Identities=34% Similarity=0.566 Sum_probs=221.4
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc------chHHHHHHHHHHcCCCCcccccceeeecCC-CCceE
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTE-KDELY 209 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~-~~~~~ 209 (468)
++|.+.+.||+|+||.||+|.+..+|+.||+|++.... ....+|+.+++.++||||+++++++..... .....
T Consensus 17 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (345)
T cd07877 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 96 (345)
T ss_pred CceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccccc
Confidence 46999999999999999999999999999999885432 234469999999999999999998754322 12234
Q ss_pred EEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccc
Q 012233 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (468)
Q Consensus 210 ~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~ 289 (468)
.|++++++++.+..... ...+++..++.++.||+.||.|||+ .||+||||||+||+++.++ .+||+|||++..
T Consensus 97 ~~lv~~~~~~~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIll~~~~-~~kl~dfg~~~~ 169 (345)
T cd07877 97 VYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDC-ELKILDFGLARH 169 (345)
T ss_pred EEEEehhcccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCChHHEEEcCCC-CEEEeccccccc
Confidence 78999998776655432 2458899999999999999999998 8999999999999999888 799999999875
Q ss_pred cCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 012233 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (468)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 369 (468)
.. .......++..|+|||.+.+...++.++|||||||++|+|++|+.||...+....+..+....+.+..........
T Consensus 170 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (345)
T cd07877 170 TD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 247 (345)
T ss_pred cc--ccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhccc
Confidence 43 2333467889999999987655688999999999999999999999998887777788877777666555433221
Q ss_pred CCccCC---CCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCCCCC
Q 012233 370 NYTEFK---FPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNTC 432 (468)
Q Consensus 370 ~~~~~~---~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~~ 432 (468)
...... .+......+. ......++++++||.+||+.||.+|+++.+++.||||++...+..-
T Consensus 248 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~~~~ 312 (345)
T cd07877 248 ESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 312 (345)
T ss_pred HhHHHHHHHhcccCCcchh-hhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCCCcc
Confidence 111000 0000011111 1122468899999999999999999999999999999987665533
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=326.29 Aligned_cols=257 Identities=26% Similarity=0.387 Sum_probs=204.1
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc----chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEE
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~l 212 (468)
+.|++.+.||.|+||.||+|.+..++..|++|.+.... ....+|+.+++.++||||+++++++. .....|+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l 86 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY-----WDGKLWI 86 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEE-----eCCeEEE
Confidence 35999999999999999999999999999999985433 23446899999999999999999884 3346899
Q ss_pred EeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCC
Q 012233 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (468)
Q Consensus 213 v~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~ 292 (468)
||||++++.+..... .....+++..+..++.||+.||.|||+ .||+||||||+||+++.++ .++|+|||++.....
T Consensus 87 v~e~~~~~~l~~~~~--~~~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~dlkp~Nili~~~~-~~kl~dfg~~~~~~~ 162 (292)
T cd06644 87 MIEFCPGGAVDAIML--ELDRGLTEPQIQVICRQMLEALQYLHS-MKIIHRDLKAGNVLLTLDG-DIKLADFGVSAKNVK 162 (292)
T ss_pred EEecCCCCcHHHHHH--hhcCCCCHHHHHHHHHHHHHHHHHHhc-CCeeecCCCcceEEEcCCC-CEEEccCccceeccc
Confidence 999999876653322 223568899999999999999999998 8999999999999999877 799999999865432
Q ss_pred CC-CCccccccCCccccccccC----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 012233 293 GE-PNISYICSRYYRAPELIFG----ATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367 (468)
Q Consensus 293 ~~-~~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 367 (468)
.. ......+++.|+|||++.+ ...++.++|+|||||++|+|++|..||...+....+.++... ..
T Consensus 163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~---~~------- 232 (292)
T cd06644 163 TLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS---EP------- 232 (292)
T ss_pred cccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcC---CC-------
Confidence 21 2234567899999999852 233688999999999999999999999876654444333221 00
Q ss_pred CCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCC
Q 012233 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRD 428 (468)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~ 428 (468)
... ..+..++.++.+||.+||..||++||++.++++||||..+..
T Consensus 233 ----~~~------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 277 (292)
T cd06644 233 ----PTL------------SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTS 277 (292)
T ss_pred ----ccC------------CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence 000 012346789999999999999999999999999999987644
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=322.72 Aligned_cols=253 Identities=28% Similarity=0.480 Sum_probs=201.4
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc----------chHHHHHHHHHHcCCCCcccccceeeecCCCCc
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK----------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~----------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 207 (468)
+|...+.||+|+||.||++.+..+++.||+|++.... ..+.+|+.+++.++|+||+++++++ .+.
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~ 75 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGAT-----CED 75 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhcee-----ccC
Confidence 3888899999999999999999999999999885422 2345799999999999999999998 444
Q ss_pred eEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCc
Q 012233 208 LYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (468)
Q Consensus 208 ~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a 287 (468)
...++||||+.++.+..... ....+++..+..++.||+.||.|||+ +|++|+||||+||+++.++..++|+|||.+
T Consensus 76 ~~~~~v~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~ql~~al~~LH~-~~i~H~~i~~~nil~~~~~~~~~l~dfg~~ 151 (268)
T cd06630 76 SHFNLFVEWMAGGSVSHLLS---KYGAFKEAVIINYTEQLLRGLSYLHE-NQIIHRDVKGANLLIDSTGQRLRIADFGAA 151 (268)
T ss_pred CeEEEEEeccCCCcHHHHHH---HhCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCCCEEEEcccccc
Confidence 56889999999765543322 23568889999999999999999998 899999999999999877657999999998
Q ss_pred cccCCCCC-----CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 012233 288 KMLVPGEP-----NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTRE 362 (468)
Q Consensus 288 ~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~ 362 (468)
........ .....++..|+|||.+.+. .++.++|+|||||++|+|++|..||...........+......
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~---- 226 (268)
T cd06630 152 ARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGE-QYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASA---- 226 (268)
T ss_pred cccccccccCCccccccccccceeCHhHhccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhcc----
Confidence 76643211 1234678899999998654 4889999999999999999999999765443333322221000
Q ss_pred HHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCC
Q 012233 363 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFD 424 (468)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~ 424 (468)
.. ...++..+++++.++|.+||..||.+||++.++++||||+
T Consensus 227 --------~~------------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 227 --------TT------------APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred --------CC------------CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 00 0113345788999999999999999999999999999995
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=329.41 Aligned_cols=261 Identities=23% Similarity=0.363 Sum_probs=202.7
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-----chHHHHHHHHHHcC-CCCcccccceeeecCCCCceEEE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLN-HPNVVSLKHCFFSTTEKDELYLN 211 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-----~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~~~~~~ 211 (468)
+|...+.||+|+||.||++.+..+++.||+|.+.... ....+|+.++.++. |+||+++++++.. ....+
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~-----~~~~~ 79 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFR-----EGDCW 79 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEec-----CCcEE
Confidence 4677789999999999999999999999999885432 23456888888886 9999999998843 33478
Q ss_pred EEeecccchHHHHHhhh-hhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcccc
Q 012233 212 LVLEYISETVYRVSKHY-TRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (468)
Q Consensus 212 lv~e~~~~~ll~~~~~~-~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~ 290 (468)
++|||+...+..+.... ......+++..+..++.|++.||+|||+..||+||||||+|||++.++ .++|+|||++...
T Consensus 80 ~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~-~~kl~dfg~~~~~ 158 (288)
T cd06616 80 ICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNG-NIKLCDFGISGQL 158 (288)
T ss_pred EEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCC-cEEEeecchhHHh
Confidence 99999987655443322 223467899999999999999999999635999999999999999887 7999999999766
Q ss_pred CCCCCCccccccCCccccccccCC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 012233 291 VPGEPNISYICSRYYRAPELIFGA--TEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368 (468)
Q Consensus 291 ~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 368 (468)
..........|++.|+|||++.+. ..++.++|||||||++|+|++|+.||..... ....+.+.....
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~--------- 227 (288)
T cd06616 159 VDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS--VFDQLTQVVKGD--------- 227 (288)
T ss_pred ccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch--HHHHHhhhcCCC---------
Confidence 544444455788999999999765 3589999999999999999999999976541 112221111000
Q ss_pred CCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q 012233 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (468)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~ 427 (468)
.+.+. ...+..++.++.+||.+||+.||.+|||+.+++.||||+...
T Consensus 228 -------~~~~~-----~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~ 274 (288)
T cd06616 228 -------PPILS-----NSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYE 274 (288)
T ss_pred -------CCcCC-----CcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchh
Confidence 00000 011234789999999999999999999999999999998754
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=327.88 Aligned_cols=251 Identities=26% Similarity=0.412 Sum_probs=202.5
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc----chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEEE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV 213 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv 213 (468)
+|.+.+.||+|+||.||+|.+..++..||+|.+.... ....+|+.+++.+.|+||+++++.|.. ..+.|+|
T Consensus 21 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~-----~~~~~lv 95 (296)
T cd06654 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-----GDELWVV 95 (296)
T ss_pred ceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEe-----CCEEEEe
Confidence 5999999999999999999999999999999885432 334579999999999999999998843 3468999
Q ss_pred eecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCCC
Q 012233 214 LEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293 (468)
Q Consensus 214 ~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~~ 293 (468)
|||+.++.+..... ...+++..+..++.|++.||.|||+ .||+|+||||+|||++.++ .++|+|||++......
T Consensus 96 ~e~~~~~~L~~~~~----~~~~~~~~~~~i~~ql~~aL~~LH~-~gi~H~dLkp~Nill~~~~-~~kl~dfg~~~~~~~~ 169 (296)
T cd06654 96 MEYLAGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPE 169 (296)
T ss_pred ecccCCCCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEcCCC-CEEECccccchhcccc
Confidence 99998765543322 2457888999999999999999998 8999999999999999887 7999999998765433
Q ss_pred C-CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCc
Q 012233 294 E-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYT 372 (468)
Q Consensus 294 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 372 (468)
. ......+++.|+|||.+.+. .++.++|||||||++|+|++|+.||...........+... ..+
T Consensus 170 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~-~~~------------- 234 (296)
T cd06654 170 QSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-GTP------------- 234 (296)
T ss_pred ccccCcccCCccccCHHHHcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcC-CCC-------------
Confidence 2 22345788999999998654 4789999999999999999999999877654433322210 000
Q ss_pred cCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q 012233 373 EFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426 (468)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 426 (468)
. ...+..++..+.+||.+||..||.+||++.+++.||||...
T Consensus 235 ~------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 235 E------------LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred C------------CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence 0 00123578899999999999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=324.27 Aligned_cols=252 Identities=25% Similarity=0.382 Sum_probs=205.0
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-----chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~l 212 (468)
+|.+.+.||.|+||.||+|.+..+++.||+|.+.... ..+.+|+.+++.++|+||+++++++. +..++|+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~~ 76 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFL-----KGSKLWI 76 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEE-----ECCeEEE
Confidence 5889999999999999999999999999999885432 23457999999999999999999884 3356899
Q ss_pred EeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCC
Q 012233 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (468)
Q Consensus 213 v~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~ 292 (468)
|+||+.++.+..... ...+++..++.++.|++.||.|||+ .||+|+||+|+||+++.++ .++|+|||+++....
T Consensus 77 v~e~~~~~~L~~~~~----~~~~~~~~~~~~~~ql~~~l~~lh~-~~i~h~dl~p~ni~i~~~~-~~~l~d~g~~~~~~~ 150 (274)
T cd06609 77 IMEYCGGGSCLDLLK----PGKLDETYIAFILREVLLGLEYLHE-EGKIHRDIKAANILLSEEG-DVKLADFGVSGQLTS 150 (274)
T ss_pred EEEeeCCCcHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEECCCC-CEEEcccccceeecc
Confidence 999998765443222 1278999999999999999999998 8999999999999999888 799999999987654
Q ss_pred C-CCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCC
Q 012233 293 G-EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNY 371 (468)
Q Consensus 293 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 371 (468)
. .......+++.|+|||.+.+.. ++.++|||||||++|+|++|..||...+.......+....
T Consensus 151 ~~~~~~~~~~~~~y~~PE~~~~~~-~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~--------------- 214 (274)
T cd06609 151 TMSKRNTFVGTPFWMAPEVIKQSG-YDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNN--------------- 214 (274)
T ss_pred cccccccccCCccccChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcC---------------
Confidence 3 2334567888999999997655 8999999999999999999999997765444333322210
Q ss_pred ccCCCCcccCCCcccccccC-CCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCC
Q 012233 372 TEFKFPQIKAHPWHKIFHKR-MPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDP 429 (468)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~ 429 (468)
.+ .+... +++++.++|.+||..||++|||+.+++.||||++....
T Consensus 215 ----~~---------~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~~~ 260 (274)
T cd06609 215 ----PP---------SLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAKKT 260 (274)
T ss_pred ----CC---------CCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCCCcc
Confidence 00 01122 68889999999999999999999999999999886554
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=318.14 Aligned_cols=249 Identities=29% Similarity=0.440 Sum_probs=203.9
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc------cchHHHHHHHHHHcCCCCcccccceeeecCCCCceEEE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~------~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 211 (468)
+|++.+.||+|+||.||+|.+..+++.+|+|.+... .....+|+.+++.++||||+++++.+ ......+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~ 75 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENF-----LEDKALM 75 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeE-----ecCCEEE
Confidence 489999999999999999999999999999988543 22345799999999999999999987 3444689
Q ss_pred EEeecccchHH-HHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcccc
Q 012233 212 LVLEYISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (468)
Q Consensus 212 lv~e~~~~~ll-~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~ 290 (468)
+||||++++.+ +.+.. .....+++..+..++.|++.||.|||+ +||+|+||||+||+++.++..++|+|||.+...
T Consensus 76 lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~ 152 (256)
T cd08220 76 IVMEYAPGGTLAEYIQK--RCNSLLDEDTILHFFVQILLALHHVHT-KLILHRDLKTQNILLDKHKMVVKIGDFGISKIL 152 (256)
T ss_pred EEEecCCCCCHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCCCEEEEccCCCceec
Confidence 99999987544 33322 123457889999999999999999998 899999999999999876657899999999877
Q ss_pred CCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCC
Q 012233 291 VPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPN 370 (468)
Q Consensus 291 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 370 (468)
..........++..|+|||.+.+. .++.++||||||+++|+|++|..||...+.......+......
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~------------ 219 (256)
T cd08220 153 SSKSKAYTVVGTPCYISPELCEGK-PYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFA------------ 219 (256)
T ss_pred CCCccccccccCCcccCchhccCC-CCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCC------------
Confidence 555444456789999999998654 4889999999999999999999999887665554444331000
Q ss_pred CccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 012233 371 YTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (468)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f 423 (468)
.++..++.++.++|.+||+.||.+|||+.|++.||||
T Consensus 220 ----------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 220 ----------------PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred ----------------CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence 0223478899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=317.67 Aligned_cols=249 Identities=25% Similarity=0.369 Sum_probs=201.5
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc------cchHHHHHHHHHHcCCCCcccccceeeecCCCCceEEE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~------~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 211 (468)
+|.+.+.||+|+||.||+|.+..+++.|++|.+... .....+|+.+++.++||||+++++++ ......|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 75 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESF-----LDKGKLN 75 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeee-----ccCCEEE
Confidence 388899999999999999999999999999987532 23345689999999999999999988 4445689
Q ss_pred EEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccC
Q 012233 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (468)
Q Consensus 212 lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~ 291 (468)
+||||+.++.+...... .....++...++.++.|++.||.|||+ .||+|+||||+||+++.++ .++|+|||++....
T Consensus 76 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~i~~~l~~al~~lH~-~~i~h~dl~~~nili~~~~-~~~l~df~~~~~~~ 152 (256)
T cd08529 76 IVMEYAENGDLHKLLKM-QRGRPLPEDQVWRFFIQILLGLAHLHS-KKILHRDIKSLNLFLDAYD-NVKIGDLGVAKLLS 152 (256)
T ss_pred EEEEeCCCCcHHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCcceEEEeCCC-CEEEcccccceecc
Confidence 99999986544432221 124568889999999999999999998 8999999999999999887 79999999987664
Q ss_pred CCCC-CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCC
Q 012233 292 PGEP-NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPN 370 (468)
Q Consensus 292 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 370 (468)
.... .....+++.|+|||++.+.. ++.++|+|||||++|+|++|+.||...+..+....+....
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-------------- 217 (256)
T cd08529 153 DNTNFANTIVGTPYYLSPELCEDKP-YNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGV-------------- 217 (256)
T ss_pred CccchhhccccCccccCHHHhcCCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--------------
Confidence 3322 23456889999999997654 8899999999999999999999998777554444433210
Q ss_pred CccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 012233 371 YTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (468)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f 423 (468)
++ .+...++.++.++|.+||+.+|++||++.+++.|||+
T Consensus 218 -----~~---------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 218 -----FP---------PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred -----CC---------CCccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 00 0222478899999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=322.70 Aligned_cols=246 Identities=30% Similarity=0.496 Sum_probs=198.4
Q ss_pred eEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-------------chHHHHHHHHHHcCCCCcccccceeeecCCC
Q 012233 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEK 205 (468)
Q Consensus 139 y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-------------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 205 (468)
|.+...||.|+||.||+|.+..++..||+|.+.... ....+|+.+++.++||||+++++++.
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~----- 76 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSL----- 76 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEE-----
Confidence 778899999999999999998899999999875321 23457899999999999999999873
Q ss_pred CceEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeec
Q 012233 206 DELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG 285 (468)
Q Consensus 206 ~~~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG 285 (468)
...+.++||||++++.+.... .....+++..+..++.|++.||.|||+ .|++||||+|+||+++.++ .++|+|||
T Consensus 77 ~~~~~~lv~e~~~~~~L~~~l---~~~~~l~~~~~~~~~~~l~~~l~~lH~-~~ivH~di~p~nil~~~~~-~~~l~dfg 151 (267)
T cd06628 77 DADHLNIFLEYVPGGSVAALL---NNYGAFEETLVRNFVRQILKGLNYLHN-RGIIHRDIKGANILVDNKG-GIKISDFG 151 (267)
T ss_pred eCCccEEEEEecCCCCHHHHH---HhccCccHHHHHHHHHHHHHHHHHHHh-cCcccccCCHHHEEEcCCC-CEEecccC
Confidence 344688999999875443222 223568888999999999999999998 8999999999999999887 79999999
Q ss_pred CccccCCCC-------CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Q 012233 286 SAKMLVPGE-------PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGT 358 (468)
Q Consensus 286 ~a~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~ 358 (468)
.++...... ......|+..|+|||.+.+. .++.++|+|||||++|+|++|+.||...+....+..+...
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--- 227 (267)
T cd06628 152 ISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQT-SYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGEN--- 227 (267)
T ss_pred CCcccccccccCCccccccccCCCcCccChhHhccC-CCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhcc---
Confidence 987664211 11234578899999998654 4889999999999999999999999876655444333220
Q ss_pred CCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 012233 359 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (468)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f 423 (468)
.. ..++..++.++.++|.+||+.||.+||++.+++.||||
T Consensus 228 ----------------~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 228 ----------------AS---------PEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred ----------------CC---------CcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 00 01234578899999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=350.66 Aligned_cols=283 Identities=19% Similarity=0.249 Sum_probs=198.4
Q ss_pred ccceEEeceecccCceEEEEEEEcCCCC-EEEEE------------------Eeecc---cchHHHHHHHHHHcCCCCcc
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLETGD-SVAIK------------------KVLQD---KRYKNRELQIMRLLNHPNVV 193 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~-~vaiK------------------~~~~~---~~~~~~E~~il~~l~hpnIv 193 (468)
..+|++.+.||+|+||+||+|..+.... .+++| .+... ...+.+|+.+|+.++|||||
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 3579999999999999999987643322 12222 11111 12345799999999999999
Q ss_pred cccceeeecCCCCceEEEEEeecccchHHHHHhhhh-hcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeee
Q 012233 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYT-RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLV 272 (468)
Q Consensus 194 ~l~~~~~~~~~~~~~~~~lv~e~~~~~ll~~~~~~~-~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl 272 (468)
++++++. +....|+|++++.++++..+.... ..........++.++.||+.||.|||+ +|||||||||+||||
T Consensus 227 ~l~~~~~-----~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~-~gIiHrDLKP~NILl 300 (501)
T PHA03210 227 KIEEILR-----SEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD-KKLIHRDIKLENIFL 300 (501)
T ss_pred cEeEEEE-----ECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEE
Confidence 9999883 344588999999988776543221 112334466788899999999999998 899999999999999
Q ss_pred cCCCCcEEEeeecCccccCCCC--CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCC-CCC--CCcHH
Q 012233 273 NPHTHQLKICDFGSAKMLVPGE--PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPL-FPG--ESGVD 347 (468)
Q Consensus 273 ~~~~~~vkL~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~p-f~~--~~~~~ 347 (468)
+.++ .+||+|||+++.+.... .....+||+.|+|||++.+.. ++.++|||||||++|||++|..+ |.. .....
T Consensus 301 ~~~~-~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~ 378 (501)
T PHA03210 301 NCDG-KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDG-YCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGK 378 (501)
T ss_pred CCCC-CEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCC-CCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHH
Confidence 9888 79999999998764432 223467999999999997654 89999999999999999998754 432 23445
Q ss_pred HHHHHHHHhCCCCHHHHhhc----CCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 012233 348 QLVEIIKILGTPTREEIKCM----NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (468)
Q Consensus 348 ~~~~i~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f 423 (468)
++.+++..+.....+ +... ........+.......-.......++.++.++|.+||++||.+|||+.|+|.||||
T Consensus 379 ~~~~~~~~~~~~~~~-~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f 457 (501)
T PHA03210 379 QLLKIIDSLSVCDEE-FPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLF 457 (501)
T ss_pred HHHHHHHhcccChhh-cCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhh
Confidence 666666655432211 0000 00000000000000000001122467889999999999999999999999999999
Q ss_pred CCCC
Q 012233 424 DDLR 427 (468)
Q Consensus 424 ~~~~ 427 (468)
....
T Consensus 458 ~~~~ 461 (501)
T PHA03210 458 SAEE 461 (501)
T ss_pred hcCC
Confidence 8754
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=328.43 Aligned_cols=305 Identities=36% Similarity=0.677 Sum_probs=229.9
Q ss_pred ccceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc------cchHHHHHHHHHHcCCCCcccccceeeecCCCCceE
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~------~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 209 (468)
.++|.+.+.||.|+||.||+|.+..+++.||||++.+. .....+|+.+++.++||||++++++|.... ..
T Consensus 9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~----~~ 84 (328)
T cd07856 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPL----ED 84 (328)
T ss_pred ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCC----Cc
Confidence 34699999999999999999999999999999987432 234457999999999999999999874322 24
Q ss_pred EEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccc
Q 012233 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (468)
Q Consensus 210 ~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~ 289 (468)
.|+||||+++++...+. ...++...+..++.||+.||.|||+ .||+|+||+|.|||++.++ .++|+|||.+..
T Consensus 85 ~~lv~e~~~~~L~~~~~-----~~~~~~~~~~~~~~ql~~aL~~LH~-~~iiH~dl~p~Nili~~~~-~~~l~dfg~~~~ 157 (328)
T cd07856 85 IYFVTELLGTDLHRLLT-----SRPLEKQFIQYFLYQILRGLKYVHS-AGVVHRDLKPSNILINENC-DLKICDFGLARI 157 (328)
T ss_pred EEEEeehhccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEeECCCC-CEEeCccccccc
Confidence 78999999877655433 3457888888999999999999998 8999999999999999887 799999999875
Q ss_pred cCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 012233 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (468)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 369 (468)
... ......++..|+|||.+.+...++.++|+|||||++|+|++|++||...........+.+.++.++.+.......
T Consensus 158 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (328)
T cd07856 158 QDP--QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICS 235 (328)
T ss_pred cCC--CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccc
Confidence 422 223456788999999986645689999999999999999999999998888777777778888777654432211
Q ss_pred CC-ccC--CCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCCCCCCCCCCCCCcccccC
Q 012233 370 NY-TEF--KFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNTCLPNGRPLPTLFNFT 446 (468)
Q Consensus 370 ~~-~~~--~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~~ 446 (468)
.- ..+ ..+.....+... ..+.+++.+.++|++||+.+|.+|||+.+++.||||+....+... +..-. .=.++|+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~~~-~~~~~-~~~~~~~ 312 (328)
T cd07856 236 ENTLRFVQSLPKREPVPFSE-KFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPTDE-PVAEE-KFDWSFN 312 (328)
T ss_pred hhhHHHHhhccccCCCcHHH-HcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCccc-cCchh-hcCCchh
Confidence 10 000 000000111111 224578899999999999999999999999999999987766444 22111 1124555
Q ss_pred HHHHhcCCHHHHH
Q 012233 447 AQELAGASNELRQ 459 (468)
Q Consensus 447 ~~~~~~~~~~~~~ 459 (468)
+ ++.+.++|+
T Consensus 313 ~---~~~~~~~~~ 322 (328)
T cd07856 313 D---ADLPVDTWK 322 (328)
T ss_pred c---ccCCHHHHH
Confidence 4 345555554
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=322.10 Aligned_cols=249 Identities=27% Similarity=0.441 Sum_probs=196.8
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc---------cchHHHHHHHHHHcCCCCcccccceeeecCCCCce
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~---------~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 208 (468)
+|...+.||+|+||.||+|.+..++..||+|++... .....+|+.+++.++||||+++++++... ...
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~ 79 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDR---AEK 79 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcC---CCC
Confidence 599999999999999999999999999999987532 12345799999999999999999877432 234
Q ss_pred EEEEEeecccchHHH-HHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCc
Q 012233 209 YLNLVLEYISETVYR-VSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (468)
Q Consensus 209 ~~~lv~e~~~~~ll~-~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a 287 (468)
.++++|||++++.+. .+. ....+++...+.++.|++.||.|||+ .||+|+||||+||+++.++ .++|+|||++
T Consensus 80 ~~~l~~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~LH~-~~i~H~~l~p~nil~~~~~-~~~l~dfg~~ 153 (266)
T cd06651 80 TLTIFMEYMPGGSVKDQLK----AYGALTESVTRKYTRQILEGMSYLHS-NMIVHRDIKGANILRDSAG-NVKLGDFGAS 153 (266)
T ss_pred EEEEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEECCCC-CEEEccCCCc
Confidence 678999999875443 332 23457888899999999999999998 8999999999999999887 7999999998
Q ss_pred cccCCC----CCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 012233 288 KMLVPG----EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREE 363 (468)
Q Consensus 288 ~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~ 363 (468)
...... .......++..|+|||.+.+. .++.++|+|||||++|+|++|+.||........+..+.. .+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~---~~---- 225 (266)
T cd06651 154 KRLQTICMSGTGIRSVTGTPYWMSPEVISGE-GYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIAT---QP---- 225 (266)
T ss_pred cccccccccCCccccCCccccccCHHHhCCC-CCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhc---CC----
Confidence 755321 111234578899999999764 489999999999999999999999987654443333221 00
Q ss_pred HhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCC
Q 012233 364 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFD 424 (468)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~ 424 (468)
....++..+++.+++|| +||..+|.+||++.|++.||||+
T Consensus 226 --------------------~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 226 --------------------TNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred --------------------CCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 00112345788899999 67778999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-41 Score=319.60 Aligned_cols=248 Identities=27% Similarity=0.418 Sum_probs=198.1
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc----------chHHHHHHHHHHcCCCCcccccceeeecCCCCc
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK----------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~----------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 207 (468)
+|++.+.||.|+||.||+|.+ .+|..+|+|.+.... ....+|+.+++.++|+||+++++++ .+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~ 74 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTC-----LDD 74 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEe-----ecC
Confidence 388899999999999999986 578899999875331 2345799999999999999999988 444
Q ss_pred eEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCc
Q 012233 208 LYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (468)
Q Consensus 208 ~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a 287 (468)
.+.++||||+.++.+.... .....+++..++.++.|++.||+|||+ .||+|+||+|+||+++.++ .++|+|||++
T Consensus 75 ~~~~lv~e~~~~~~L~~~l---~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nil~~~~~-~~~l~dfg~~ 149 (265)
T cd06631 75 NTISIFMEFVPGGSISSIL---NRFGPLPEPVFCKYTKQILDGVAYLHN-NCVVHRDIKGNNVMLMPNG-IIKLIDFGCA 149 (265)
T ss_pred CeEEEEEecCCCCcHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCcCHHhEEECCCC-eEEeccchhh
Confidence 5789999999886554332 223568889999999999999999998 8999999999999999887 7999999998
Q ss_pred cccCCC-------CCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Q 012233 288 KMLVPG-------EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPT 360 (468)
Q Consensus 288 ~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~ 360 (468)
...... .......++..|+|||++.+. .++.++|+|||||++|+|++|..||...+.......+.....
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~--- 225 (265)
T cd06631 150 RRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINES-GYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRG--- 225 (265)
T ss_pred HhhhhccccccccccccccCCCccccChhhhcCC-CCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccC---
Confidence 754211 112235678999999998654 488999999999999999999999987654443333222100
Q ss_pred HHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 012233 361 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (468)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f 423 (468)
.. ..++..++.++.+||.+||+.+|.+||++.+++.||||
T Consensus 226 --------------~~---------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 226 --------------LM---------PRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred --------------CC---------CCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 00 11234578999999999999999999999999999998
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=320.83 Aligned_cols=278 Identities=35% Similarity=0.608 Sum_probs=215.1
Q ss_pred eEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc------chHHHHHHHHHHc---CCCCcccccceeeecCCCCceE
Q 012233 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLL---NHPNVVSLKHCFFSTTEKDELY 209 (468)
Q Consensus 139 y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~------~~~~~E~~il~~l---~hpnIv~l~~~~~~~~~~~~~~ 209 (468)
|.+.+.||+|+||.||+|.+..++..||+|.+.... ....+|+.+++.+ .|+||+++++++..........
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 678899999999999999998889999999885321 1234577777666 5999999999986654434445
Q ss_pred EEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccc
Q 012233 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (468)
Q Consensus 210 ~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~ 289 (468)
++++|||+.+.+...+.... ...+++..++.++.||+.||.|||+ .||+|+||+|+||+++.++ .++|+|||++..
T Consensus 81 ~~l~~e~~~~~l~~~l~~~~--~~~l~~~~~~~~~~~i~~al~~LH~-~~i~h~~l~~~nili~~~~-~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVDQDLATYLSKCP--KPGLPPETIKDLMRQLLRGVDFLHS-HRIVHRDLKPQNILVTSDG-QVKIADFGLARI 156 (287)
T ss_pred eEEEehhcccCHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCChhhEEEccCC-CEEEeccCccee
Confidence 88999999987766544322 2358999999999999999999998 8999999999999999987 799999999977
Q ss_pred cCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 012233 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (468)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 369 (468)
...........++..|+|||++.+.. ++.++|+|||||++|+|++|++||...+..+.+.++......+....+....
T Consensus 157 ~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 234 (287)
T cd07838 157 YSFEMALTSVVVTLWYRAPEVLLQSS-YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNV- 234 (287)
T ss_pred ccCCcccccccccccccChHHhccCC-CCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCc-
Confidence 65444444556788999999997654 8999999999999999999999999988888888887766554433221100
Q ss_pred CCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 012233 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (468)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f 423 (468)
......++......+ ....+.+++.+.+||.+||+.||.+||++.+++.||||
T Consensus 235 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 235 SLPRSSFPSYTPRSF-KSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred ccchhhcccccccch-hhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 000111111111111 12234567889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=327.98 Aligned_cols=256 Identities=26% Similarity=0.408 Sum_probs=204.5
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc----chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEE
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~l 212 (468)
.+|.+.+.||+|+||.||+|.+..+++.||+|.+.... ....+|+.+++.++|+||+++++++ ....+.|+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~l 93 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY-----LVGDELWV 93 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEE-----ecCCEEEE
Confidence 36999999999999999999999999999999885432 2345789999999999999999988 34446899
Q ss_pred EeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCC
Q 012233 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (468)
Q Consensus 213 v~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~ 292 (468)
||||++++.+..... ...+++..+..++.|++.||.|||+ .||+||||||+|||++.++ .++|+|||++.....
T Consensus 94 v~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~l~~~L~~LH~-~~i~H~dL~p~Nili~~~~-~~~l~Dfg~~~~~~~ 167 (297)
T cd06656 94 VMEYLAGGSLTDVVT----ETCMDEGQIAAVCRECLQALDFLHS-NQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITP 167 (297)
T ss_pred eecccCCCCHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCC-CEEECcCccceEccC
Confidence 999998765543322 2457888999999999999999998 8999999999999999887 799999999876543
Q ss_pred CCC-CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCC
Q 012233 293 GEP-NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNY 371 (468)
Q Consensus 293 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 371 (468)
... .....+++.|+|||.+.+. .++.++|+|||||++|+|++|..||...+.......+.. .+.+
T Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~-~~~~------------ 233 (297)
T cd06656 168 EQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTP------------ 233 (297)
T ss_pred CccCcCcccCCccccCHHHHcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeecc-CCCC------------
Confidence 322 2345788999999998654 488999999999999999999999977654332221111 0000
Q ss_pred ccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCCC
Q 012233 372 TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPN 430 (468)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~ 430 (468)
....+..++..+.+||.+||..||.+||++.+++.||||+..+...
T Consensus 234 -------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~ 279 (297)
T cd06656 234 -------------ELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKPLS 279 (297)
T ss_pred -------------CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhccccccc
Confidence 0012245788899999999999999999999999999998765543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=324.58 Aligned_cols=253 Identities=26% Similarity=0.373 Sum_probs=203.6
Q ss_pred eEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc----chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEEEe
Q 012233 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (468)
Q Consensus 139 y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv~ 214 (468)
|++.+.||+|+||.||+|.+..++..+++|.+.... ....+|+++++.++||||+++++++. .....++||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~-----~~~~~~~v~ 81 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY-----YENNLWILI 81 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEe-----eCCEEEEEE
Confidence 788899999999999999999999999999885432 23456899999999999999999884 334688999
Q ss_pred ecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCCCC
Q 012233 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGE 294 (468)
Q Consensus 215 e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~~~ 294 (468)
||++++.+..... .....+++..+..++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||++.......
T Consensus 82 e~~~~~~l~~~~~--~~~~~l~~~~~~~~~~qi~~~L~~LH~-~~i~H~dlkp~nili~~~~-~~kl~dfg~~~~~~~~~ 157 (282)
T cd06643 82 EFCAGGAVDAVML--ELERPLTEPQIRVVCKQTLEALNYLHE-NKIIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRTI 157 (282)
T ss_pred EecCCCcHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCcccEEEccCC-CEEEccccccccccccc
Confidence 9999876654322 224568999999999999999999998 8999999999999999887 79999999986553221
Q ss_pred -CCccccccCCccccccccC----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 012233 295 -PNISYICSRYYRAPELIFG----ATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (468)
Q Consensus 295 -~~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 369 (468)
......+++.|+|||++.. ...++.++|+|||||++|+|++|.+||...+..+...++......
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~----------- 226 (282)
T cd06643 158 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPP----------- 226 (282)
T ss_pred cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCC-----------
Confidence 2234578999999999842 234778999999999999999999999887766655554331100
Q ss_pred CCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q 012233 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426 (468)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 426 (468)
.. ..+..++.++.+||.+||+.||.+||++.++++||||+..
T Consensus 227 ---~~------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 268 (282)
T cd06643 227 ---TL------------AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN 268 (282)
T ss_pred ---CC------------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence 00 0223478899999999999999999999999999999863
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=320.32 Aligned_cols=262 Identities=27% Similarity=0.399 Sum_probs=206.7
Q ss_pred CcccceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc---chHHHHHHHHHHc-CCCCcccccceeeecCC-CCce
Q 012233 134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLL-NHPNVVSLKHCFFSTTE-KDEL 208 (468)
Q Consensus 134 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~---~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~-~~~~ 208 (468)
...++|.+.+.||+|+||.||+|.+..+++.+++|++.... ..+.+|+.+++.+ .|+||+++++++..... ....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 34567999999999999999999999899999999886543 3456799999998 69999999999865443 3355
Q ss_pred EEEEEeecccchHHH-HHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCc
Q 012233 209 YLNLVLEYISETVYR-VSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (468)
Q Consensus 209 ~~~lv~e~~~~~ll~-~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a 287 (468)
++++||||+.++.+. ++.........+++..++.++.|++.||.|||+ .||+|+||+|+||+++.++ .++|+|||++
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~-~~i~H~~l~p~ni~~~~~~-~~~l~d~~~~ 160 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE-NKVIHRDIKGQNILLTKNA-EVKLVDFGVS 160 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc-CCcccCCCCHHHEEEccCC-eEEECCCccc
Confidence 688999999975443 333323335678999999999999999999998 8999999999999999887 7999999998
Q ss_pred cccCCCC-CCccccccCCccccccccCC----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 012233 288 KMLVPGE-PNISYICSRYYRAPELIFGA----TEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTRE 362 (468)
Q Consensus 288 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~----~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~ 362 (468)
....... ......++..|+|||++... ..++.++|||||||++|+|++|..||........+.++... +.
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---~~-- 235 (275)
T cd06608 161 AQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRN---PP-- 235 (275)
T ss_pred eecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhcc---CC--
Confidence 7653322 22345688999999987532 34678999999999999999999999876555544443321 00
Q ss_pred HHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 012233 363 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (468)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f 423 (468)
..+. ....++.++.+||.+||..||.+|||+.+++.|||+
T Consensus 236 ---------~~~~------------~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 236 ---------PTLK------------SPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred ---------CCCC------------chhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 0000 112367889999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=317.09 Aligned_cols=249 Identities=33% Similarity=0.510 Sum_probs=201.2
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc---------chHHHHHHHHHHcCCCCcccccceeeecCCCCce
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~---------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 208 (468)
+|+..+.||+|+||.||+|.+..++..|++|.+.... ..+.+|+.+++.++|+||+++++++ .+..
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~ 75 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTE-----REED 75 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeE-----ecCC
Confidence 3778899999999999999998899999999875432 2345799999999999999999987 4445
Q ss_pred EEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcc
Q 012233 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (468)
Q Consensus 209 ~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~ 288 (468)
.+++||||++++.+.... .....+++..+..++.||+.||.|||+ .||+|+||+|+||+++.++ .+||+|||++.
T Consensus 76 ~~~lv~e~~~~~~L~~~~---~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~~~ni~~~~~~-~~kl~d~~~~~ 150 (258)
T cd06632 76 NLYIFLELVPGGSLAKLL---KKYGSFPEPVIRLYTRQILLGLEYLHD-RNTVHRDIKGANILVDTNG-VVKLADFGMAK 150 (258)
T ss_pred eEEEEEEecCCCcHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCC-CEEEccCccce
Confidence 688999999875443222 223458889999999999999999998 8999999999999999887 79999999987
Q ss_pred ccCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 012233 289 MLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368 (468)
Q Consensus 289 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 368 (468)
............++..|+|||.+.....++.++|+|||||++|+|++|+.||......+....+.....
T Consensus 151 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~----------- 219 (258)
T cd06632 151 QVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKE----------- 219 (258)
T ss_pred eccccccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhccc-----------
Confidence 664444344567899999999986543488999999999999999999999977664444333222100
Q ss_pred CCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 012233 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (468)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f 423 (468)
. ..++..+++++.+||.+||+.+|.+||++.+++.||||
T Consensus 220 -------~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 220 -------L---------PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred -------C---------CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 0 01334578999999999999999999999999999997
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=324.52 Aligned_cols=253 Identities=28% Similarity=0.451 Sum_probs=211.3
Q ss_pred cccceEEeceecccCceEEEEEEEcCCCCEEEEEEeecccch-------HHHHHHHHHHcC-CCCcccccceeeecCCCC
Q 012233 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRY-------KNRELQIMRLLN-HPNVVSLKHCFFSTTEKD 206 (468)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~~~-------~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~ 206 (468)
...+|..+.+||+|+||+|.+|..+.+.+.||||+++++... ...|.++|.... -|.+++|+.||. .
T Consensus 347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQ-----T 421 (683)
T KOG0696|consen 347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQ-----T 421 (683)
T ss_pred eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhh-----h
Confidence 344699999999999999999999999999999988765322 235777877665 578999999883 3
Q ss_pred ceEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecC
Q 012233 207 ELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (468)
Q Consensus 207 ~~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~ 286 (468)
-..+|.||||+.|+-|-... ..-+.|.+..+..|+..|+-||-|||+ +|||+||||.+|||++.++| +||+|||+
T Consensus 422 mDRLyFVMEyvnGGDLMyhi---QQ~GkFKEp~AvFYAaEiaigLFFLh~-kgIiYRDLKLDNvmLd~eGH-iKi~DFGm 496 (683)
T KOG0696|consen 422 MDRLYFVMEYVNGGDLMYHI---QQVGKFKEPVAVFYAAEIAIGLFFLHS-KGIIYRDLKLDNVMLDSEGH-IKIADFGM 496 (683)
T ss_pred hhheeeEEEEecCchhhhHH---HHhcccCCchhhhhhHHHHHHhhhhhc-CCeeeeeccccceEeccCCc-eEeeeccc
Confidence 34589999999987443222 223567788899999999999999998 99999999999999999995 99999999
Q ss_pred ccccC-CCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 012233 287 AKMLV-PGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIK 365 (468)
Q Consensus 287 a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 365 (468)
++.-. .+....++||||.|+|||++.-.+ |+.++|+||+||+||||+.|++||.+++..+..+.|.+.
T Consensus 497 cKEni~~~~TTkTFCGTPdYiAPEIi~YqP-YgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~eh---------- 565 (683)
T KOG0696|consen 497 CKENIFDGVTTKTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEH---------- 565 (683)
T ss_pred ccccccCCcceeeecCCCcccccceEEecc-cccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHc----------
Confidence 97643 334556899999999999997555 999999999999999999999999999998888888762
Q ss_pred hcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCC-----HHHHhCCCCCCCCC
Q 012233 366 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCT-----ALEACAHPFFDDLR 427 (468)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s-----~~ell~hp~f~~~~ 427 (468)
... +++.+|.++.++++.+|.+.|.+|.. -.++..||||+.|.
T Consensus 566 -------nvs------------yPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iD 613 (683)
T KOG0696|consen 566 -------NVS------------YPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRID 613 (683)
T ss_pred -------cCc------------CcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhcc
Confidence 222 55789999999999999999999984 45899999999763
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=337.17 Aligned_cols=245 Identities=31% Similarity=0.460 Sum_probs=203.5
Q ss_pred cccceEEeceecccCceEEEEEEEcCCCCEEEEEEeecccchHHHHHHHHHHc-CCCCcccccceeeecCCCCceEEEEE
Q 012233 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDELYLNLV 213 (468)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~lv 213 (468)
....|.+...+|.|+|+.|..+.+..+++.+++|++.+......+|+.++... +||||+++.+.+ .+..++|+|
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~~~~e~~~~~~~~~h~niv~~~~v~-----~~~~~~~~v 394 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADDNQDEIPISLLVRDHPNIVKSHDVY-----EDGKEIYLV 394 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccccccccccchhhhhcCCCcceeeccee-----cCCceeeee
Confidence 46679999999999999999999999999999999988877777788776555 699999999999 777789999
Q ss_pred eecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeee-cCCCCcEEEeeecCccccCC
Q 012233 214 LEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLV-NPHTHQLKICDFGSAKMLVP 292 (468)
Q Consensus 214 ~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl-~~~~~~vkL~DFG~a~~~~~ 292 (468)
||++.|+.+-.. .+....+. ..+..|++||+.|+.|||. +|||||||||+|||+ +..+ .++|+|||.++....
T Consensus 395 ~e~l~g~ell~r---i~~~~~~~-~e~~~w~~~lv~Av~~LH~-~gvvhRDLkp~NIL~~~~~g-~lrltyFG~a~~~~~ 468 (612)
T KOG0603|consen 395 MELLDGGELLRR---IRSKPEFC-SEASQWAAELVSAVDYLHE-QGVVHRDLKPGNILLDGSAG-HLRLTYFGFWSELER 468 (612)
T ss_pred ehhccccHHHHH---HHhcchhH-HHHHHHHHHHHHHHHHHHh-cCeeecCCChhheeecCCCC-cEEEEEechhhhCch
Confidence 999998754321 22233333 6778899999999999998 999999999999999 4666 799999999987654
Q ss_pred CCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCc
Q 012233 293 GEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYT 372 (468)
Q Consensus 293 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 372 (468)
. ..+.+.|..|.|||++. ...|++++||||||++||+||+|+.||........+. ..++.+.
T Consensus 469 ~--~~tp~~t~~y~APEvl~-~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~---~~i~~~~------------ 530 (612)
T KOG0603|consen 469 S--CDTPALTLQYVAPEVLA-IQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIH---TRIQMPK------------ 530 (612)
T ss_pred h--hcccchhhcccChhhhc-cCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHH---HhhcCCc------------
Confidence 4 44557789999999997 4559999999999999999999999998776552222 2222221
Q ss_pred cCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 012233 373 EFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (468)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f 423 (468)
+...+|+++++||+.||+.||.+|+++.+++.||||
T Consensus 531 ---------------~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 531 ---------------FSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred ---------------cccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 224589999999999999999999999999999999
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=342.21 Aligned_cols=250 Identities=26% Similarity=0.422 Sum_probs=205.8
Q ss_pred EEeceecccCceEEEEEEEcCCCCEEEEEEee------ccc--chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEE
Q 012233 140 MAERVVGTGSFGVVFQAKCLETGDSVAIKKVL------QDK--RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (468)
Q Consensus 140 ~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~------~~~--~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 211 (468)
+...+||+|+|-+||+|.|..+|..||.-.++ ... ..+..|+.+|+.|+||||+++|+.+.+.. ..++.
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~---n~~in 119 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTD---NKTIN 119 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCC---Cceee
Confidence 45568999999999999999999999865432 112 34557999999999999999999986644 35688
Q ss_pred EEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhc-CCccccCCCCCCeeecCCCCcEEEeeecCcccc
Q 012233 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV-VGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (468)
Q Consensus 212 lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~-~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~ 290 (468)
+|+|.+..|.|. .|.+..+.+.+..++.|++||++||.|||+. ..|||||||.+||||+.+.+.|||+|+|+|+..
T Consensus 120 ~iTEL~TSGtLr---~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~ 196 (632)
T KOG0584|consen 120 FITELFTSGTLR---EYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLL 196 (632)
T ss_pred eeeecccCCcHH---HHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHh
Confidence 999999977665 4455567889999999999999999999962 369999999999999988779999999999876
Q ss_pred CCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCC
Q 012233 291 VPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPN 370 (468)
Q Consensus 291 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 370 (468)
..... ...+|||.|||||++. ..|+..+||||||++++||+|+..||.-..+..++.+-+...-.|.
T Consensus 197 r~s~a-ksvIGTPEFMAPEmYE--E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~---------- 263 (632)
T KOG0584|consen 197 RKSHA-KSVIGTPEFMAPEMYE--ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPA---------- 263 (632)
T ss_pred hcccc-ceeccCccccChHHHh--hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHH----------
Confidence 54433 3479999999999984 4699999999999999999999999999888877766443222211
Q ss_pred CccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q 012233 371 YTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDD 425 (468)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~ 425 (468)
. |.+--.+++++||.+||.. .++|+|+.|+|.||||..
T Consensus 264 ------------s----l~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~ 301 (632)
T KOG0584|consen 264 ------------A----LSKVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDE 301 (632)
T ss_pred ------------H----hhccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhcc
Confidence 1 2222467899999999999 999999999999999987
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-41 Score=323.23 Aligned_cols=257 Identities=25% Similarity=0.380 Sum_probs=200.3
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc---chHHHHHHHHHHc-CCCCcccccceeeecCC-CCceEEE
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLL-NHPNVVSLKHCFFSTTE-KDELYLN 211 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~---~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~-~~~~~~~ 211 (468)
..|++.+.||.|+||.||+|.+..+++.+|+|++.... .....|+.+++.+ +|+||+++++++..... ....++|
T Consensus 16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~ 95 (282)
T cd06636 16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLW 95 (282)
T ss_pred hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEE
Confidence 35999999999999999999999999999999885442 2345688888888 69999999998854321 2345788
Q ss_pred EEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccC
Q 012233 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (468)
Q Consensus 212 lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~ 291 (468)
++|||++++.+..+.... ....+++..++.++.||+.||.|||+ .||+|+||||+||+++.++ .++|+|||++....
T Consensus 96 iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~-~~ivH~dl~~~nili~~~~-~~~l~dfg~~~~~~ 172 (282)
T cd06636 96 LVMEFCGAGSVTDLVKNT-KGNALKEDWIAYICREILRGLAHLHA-HKVIHRDIKGQNVLLTENA-EVKLVDFGVSAQLD 172 (282)
T ss_pred EEEEeCCCCcHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCC-CEEEeeCcchhhhh
Confidence 999999875443332221 23457888899999999999999998 8999999999999999888 79999999987553
Q ss_pred CC-CCCccccccCCccccccccC----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 012233 292 PG-EPNISYICSRYYRAPELIFG----ATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKC 366 (468)
Q Consensus 292 ~~-~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 366 (468)
.. .......|++.|+|||.+.. ...++.++|+|||||++|+|++|..||........+..+... ..
T Consensus 173 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~---~~------ 243 (282)
T cd06636 173 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN---PP------ 243 (282)
T ss_pred ccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhC---CC------
Confidence 21 22334678999999999852 234788999999999999999999999766544333322110 00
Q ss_pred cCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 012233 367 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (468)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f 423 (468)
+ ......++.++.+||.+||+.||.+||++.|++.||||
T Consensus 244 ----------~--------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 244 ----------P--------KLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred ----------C--------CCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 0 00123478899999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=321.37 Aligned_cols=251 Identities=26% Similarity=0.387 Sum_probs=197.8
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc----cchHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEEE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV 213 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~----~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv 213 (468)
+|.+.+.||+|+||.||+|.+..+++.||+|++... .....+|+.+++.++||||+++++.+. ....+++|
T Consensus 10 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~-----~~~~~~iv 84 (267)
T cd06646 10 DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL-----SREKLWIC 84 (267)
T ss_pred hcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEE-----eCCEEEEE
Confidence 599999999999999999999999999999988543 223557999999999999999999884 33468899
Q ss_pred eecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCCC
Q 012233 214 LEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293 (468)
Q Consensus 214 ~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~~ 293 (468)
|||++++.+..... ....+++..+..++.|++.||.|||+ .||+||||||+||+++.++ .++|+|||++......
T Consensus 85 ~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nill~~~~-~~~l~dfg~~~~~~~~ 159 (267)
T cd06646 85 MEYCGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLAYLHS-KGKMHRDIKGANILLTDNG-DVKLADFGVAAKITAT 159 (267)
T ss_pred EeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEECCCC-CEEECcCccceeeccc
Confidence 99999765543222 23568899999999999999999998 8999999999999999887 7999999999765432
Q ss_pred C-CCccccccCCccccccccC--CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCC
Q 012233 294 E-PNISYICSRYYRAPELIFG--ATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPN 370 (468)
Q Consensus 294 ~-~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 370 (468)
. ......+++.|+|||.+.+ ...++.++|+|||||++|||++|..||......+....+..
T Consensus 160 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~---------------- 223 (267)
T cd06646 160 IAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSK---------------- 223 (267)
T ss_pred ccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeec----------------
Confidence 2 2334578899999998742 33477899999999999999999999965543332221111
Q ss_pred CccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCC
Q 012233 371 YTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPF 422 (468)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~ 422 (468)
..+..+... ....++..+.+||++||..||.+|||++++++|+|
T Consensus 224 -~~~~~~~~~-------~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 224 -SNFQPPKLK-------DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred -CCCCCCCCc-------cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 000101000 11246889999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=323.94 Aligned_cols=256 Identities=27% Similarity=0.383 Sum_probs=204.8
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc----chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEE
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~l 212 (468)
++|.+.+.||.|+||.||++.+..++..||+|.+.... ....+|+.+++.++||||+++++.+. ....+|+
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l 79 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF-----YENKLWI 79 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEe-----cCCeEEE
Confidence 45999999999999999999998899999999885432 23446999999999999999999884 3446899
Q ss_pred EeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCC
Q 012233 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (468)
Q Consensus 213 v~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~ 292 (468)
||||++++.+..... .....+++..++.++.|++.||.|||+ .||+|+||||+||+++.++ .++|+|||++.....
T Consensus 80 v~e~~~~~~L~~~~~--~~~~~l~~~~~~~~~~ql~~~l~~lh~-~~i~h~dl~p~nili~~~~-~~~l~d~g~~~~~~~ 155 (280)
T cd06611 80 LIEFCDGGALDSIML--ELERGLTEPQIRYVCRQMLEALNFLHS-HKVIHRDLKAGNILLTLDG-DVKLADFGVSAKNKS 155 (280)
T ss_pred EeeccCCCcHHHHHH--HhcCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChhhEEECCCC-CEEEccCccchhhcc
Confidence 999999865543322 223568999999999999999999998 8999999999999999888 799999999865533
Q ss_pred CC-CCccccccCCccccccccC----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 012233 293 GE-PNISYICSRYYRAPELIFG----ATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367 (468)
Q Consensus 293 ~~-~~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 367 (468)
.. ......+++.|+|||++.. ...++.++|+|||||++|+|++|+.||...+....+.++.... +
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~-------- 225 (280)
T cd06611 156 TLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSE--P-------- 225 (280)
T ss_pred cccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCC--C--------
Confidence 22 2234568999999999742 2336789999999999999999999998776555444432210 0
Q ss_pred CCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q 012233 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (468)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~ 427 (468)
+ .+ ..+..++.++.+||.+||+.||.+||++.++++||||....
T Consensus 226 -~---~~------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 269 (280)
T cd06611 226 -P---TL------------DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQS 269 (280)
T ss_pred -C---Cc------------CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhcccc
Confidence 0 00 01234788999999999999999999999999999998763
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=322.31 Aligned_cols=253 Identities=28% Similarity=0.401 Sum_probs=208.5
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc--cchHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEEEee
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD--KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLE 215 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~--~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv~e 215 (468)
.|.++..||+|+||.||+|.++.+|..+|||++.-+ ....-+|+.||+++..|++|++|+.|+-..+ ++||||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sD-----LWIVME 108 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSD-----LWIVME 108 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCc-----eEeehh
Confidence 388889999999999999999999999999998654 3445579999999999999999999976665 999999
Q ss_pred cccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCCC-C
Q 012233 216 YISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG-E 294 (468)
Q Consensus 216 ~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~~-~ 294 (468)
||+.|....+... .++.+.+.++..++...+.||.|||. ..-||||||..|||++.+| ..||+|||.|..+.+. .
T Consensus 109 YCGAGSiSDI~R~--R~K~L~E~EIs~iL~~TLKGL~YLH~-~~KIHRDIKAGNILLNT~G-~AKLADFGVAGQLTDTMA 184 (502)
T KOG0574|consen 109 YCGAGSISDIMRA--RRKPLSEQEISAVLRDTLKGLQYLHD-LKKIHRDIKAGNILLNTDG-IAKLADFGVAGQLTDTMA 184 (502)
T ss_pred hcCCCcHHHHHHH--hcCCccHHHHHHHHHHHHhHHHHHHH-HHHHHhhcccccEEEcccc-hhhhhhccccchhhhhHH
Confidence 9996644443332 25779999999999999999999998 6889999999999999999 5999999999766432 3
Q ss_pred CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccC
Q 012233 295 PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEF 374 (468)
Q Consensus 295 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 374 (468)
...+.+|||.|||||++..- .|+.++||||||+...||.-|++||.+..+...+..|- ..|++
T Consensus 185 KRNTVIGTPFWMAPEVI~EI-GY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIP---T~PPP------------- 247 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIEEI-GYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIP---TKPPP------------- 247 (502)
T ss_pred hhCccccCcccccHHHHHHh-ccchhhhHhhhcchhhhhhcCCCCcccccccceeEecc---CCCCC-------------
Confidence 45678999999999999654 49999999999999999999999998766554333221 11110
Q ss_pred CCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q 012233 375 KFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426 (468)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 426 (468)
.|. -++..+.++.|||++||.++|++|.||.++++|||+++-
T Consensus 248 TF~----------KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA 289 (502)
T KOG0574|consen 248 TFK----------KPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNA 289 (502)
T ss_pred CCC----------ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCC
Confidence 111 123457889999999999999999999999999999873
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=319.29 Aligned_cols=247 Identities=30% Similarity=0.467 Sum_probs=203.8
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-------chHHHHHHHHHHcCCCCcccccceeeecCCCCceEE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~ 210 (468)
+|++.+.||.|+||.||+|.+..+++.||+|++.+.. ....+|+++++.++||||+++++++ .+....
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 75 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSF-----QDEENM 75 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhh-----cCCCeE
Confidence 4899999999999999999999999999999886432 3445799999999999999999988 555579
Q ss_pred EEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcccc
Q 012233 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (468)
Q Consensus 211 ~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~ 290 (468)
|+|+||+.++.+..... ....+++..+..++.||+.||.|||+ +||+|+||+|+||+++.++ .++|+|||.+...
T Consensus 76 ~lv~e~~~~~~L~~~l~---~~~~l~~~~~~~~~~~i~~~l~~lh~-~~i~h~dl~~~nil~~~~~-~~~l~d~~~~~~~ 150 (258)
T cd05578 76 YLVVDLLLGGDLRYHLS---QKVKFSEEQVKFWICEIVLALEYLHS-KGIIHRDIKPDNILLDEQG-HVHITDFNIATKV 150 (258)
T ss_pred EEEEeCCCCCCHHHHHH---hcCCcCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHeEEcCCC-CEEEeeccccccc
Confidence 99999998875543222 13568899999999999999999998 8999999999999999888 7999999998776
Q ss_pred CCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCc--HHHHHHHHHHhCCCCHHHHhhcC
Q 012233 291 VPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESG--VDQLVEIIKILGTPTREEIKCMN 368 (468)
Q Consensus 291 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~ 368 (468)
..........|+..|+|||.+.+.. ++.++|+|||||++|+|++|..||...+. .+.+.+....
T Consensus 151 ~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~------------- 216 (258)
T cd05578 151 TPDTLTTSTSGTPGYMAPEVLCRQG-YSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET------------- 216 (258)
T ss_pred CCCccccccCCChhhcCHHHHcccC-CCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc-------------
Confidence 5544444567889999999986554 89999999999999999999999987764 2222221110
Q ss_pred CCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCH--HHHhCCCCC
Q 012233 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTA--LEACAHPFF 423 (468)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~--~ell~hp~f 423 (468)
....++..++.++.++|.+||+.||.+||++ .|+++||||
T Consensus 217 ---------------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 217 ---------------ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred ---------------ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 0011334578999999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=338.51 Aligned_cols=249 Identities=29% Similarity=0.448 Sum_probs=210.5
Q ss_pred eEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-------chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEE
Q 012233 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (468)
Q Consensus 139 y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 211 (468)
|.-.+.||.|+||.||.|++..+.+.||||++.-.. ..+.+|+..|+++.|||++.+.+||. .+...|
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyL-----re~TaW 102 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYL-----REHTAW 102 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceee-----ccchHH
Confidence 777789999999999999999999999999984332 23347999999999999999999994 444588
Q ss_pred EEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccC
Q 012233 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (468)
Q Consensus 212 lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~ 291 (468)
||||||-|+--+++.-. .+++-+..+..|+.+.+.||+|||+ ++.||||||..|||++..+ .|||+|||.|....
T Consensus 103 LVMEYClGSAsDlleVh---kKplqEvEIAAi~~gaL~gLaYLHS-~~~IHRDiKAGNILLse~g-~VKLaDFGSAsi~~ 177 (948)
T KOG0577|consen 103 LVMEYCLGSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHS-HNRIHRDIKAGNILLSEPG-LVKLADFGSASIMA 177 (948)
T ss_pred HHHHHHhccHHHHHHHH---hccchHHHHHHHHHHHHHHHHHHHH-hhHHhhhccccceEecCCC-eeeeccccchhhcC
Confidence 99999998766655432 4668888899999999999999998 8999999999999999888 79999999997653
Q ss_pred CCCCCccccccCCcccccccc--CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 012233 292 PGEPNISYICSRYYRAPELIF--GATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (468)
Q Consensus 292 ~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 369 (468)
+..+++|||+|||||++. ..+.|+-++||||||++..||.-.++|+.+.+.+..+..|.+.-
T Consensus 178 ---PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNe------------- 241 (948)
T KOG0577|consen 178 ---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE------------- 241 (948)
T ss_pred ---chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcC-------------
Confidence 456899999999999984 44569999999999999999999999999998888888876621
Q ss_pred CCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q 012233 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (468)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~ 427 (468)
-|.+.. ...+..+..||..||++-|.+|||.+++|.|+|...-+
T Consensus 242 ------sPtLqs--------~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~R 285 (948)
T KOG0577|consen 242 ------SPTLQS--------NEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRER 285 (948)
T ss_pred ------CCCCCC--------chhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccCC
Confidence 111122 23477899999999999999999999999999986543
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=327.38 Aligned_cols=257 Identities=28% Similarity=0.403 Sum_probs=206.3
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc----chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEEE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV 213 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv 213 (468)
.|.....||+|+||.||++.+..++..||||.+.... ....+|+.+++.++|+||+++++.+. ...+.|+|
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~-----~~~~~~lv 97 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL-----VGDELWVV 97 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHhee-----cCCeEEEE
Confidence 3555677999999999999999899999999875432 23457999999999999999999883 34468999
Q ss_pred eecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCCC
Q 012233 214 LEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293 (468)
Q Consensus 214 ~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~~ 293 (468)
|||++++.+..... ...+++..+..++.||+.||.|||+ +||+||||||+||+++.++ .++|+|||++......
T Consensus 98 ~e~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~-~~ivH~dlkp~Nill~~~~-~~kL~dfg~~~~~~~~ 171 (292)
T cd06658 98 MEFLEGGALTDIVT----HTRMNEEQIATVCLSVLRALSYLHN-QGVIHRDIKSDSILLTSDG-RIKLSDFGFCAQVSKE 171 (292)
T ss_pred EeCCCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecCCCHHHEEEcCCC-CEEEccCcchhhcccc
Confidence 99999876654332 2457889999999999999999998 8999999999999999887 7999999998755332
Q ss_pred C-CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCc
Q 012233 294 E-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYT 372 (468)
Q Consensus 294 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 372 (468)
. ......++..|+|||.+.+. .++.++|+|||||++|||++|..||...+....+..+......
T Consensus 172 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~-------------- 236 (292)
T cd06658 172 VPKRKSLVGTPYWMAPEVISRL-PYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPP-------------- 236 (292)
T ss_pred cccCceeecCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC--------------
Confidence 2 22345789999999998654 4899999999999999999999999877665544433221100
Q ss_pred cCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCCCCC
Q 012233 373 EFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNTC 432 (468)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~~ 432 (468)
.++ ....++..+.+||.+||..||.+|||+.++++||||+....+++.
T Consensus 237 --~~~----------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~~~~ 284 (292)
T cd06658 237 --RVK----------DSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGPPSCI 284 (292)
T ss_pred --ccc----------cccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCCcccc
Confidence 000 112368889999999999999999999999999999998888753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=322.41 Aligned_cols=241 Identities=18% Similarity=0.227 Sum_probs=192.6
Q ss_pred ceecccCceEEEEEEEcCCCCEEEEEEeeccc-------chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEEEee
Q 012233 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLE 215 (468)
Q Consensus 143 ~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv~e 215 (468)
..||+|++|.||+|.+ +|+.||||.+.... ..+.+|+.+|++++||||+++++++.... .+..++++|||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~-~~~~~~~lv~E 102 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIV-DDLPRLSLILE 102 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecc-cCCCceEEEEE
Confidence 4699999999999998 78999999885432 23458999999999999999999885422 22346889999
Q ss_pred cccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCCCCC
Q 012233 216 YISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEP 295 (468)
Q Consensus 216 ~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~~~~ 295 (468)
|+.++.+.... .....+++.....++.|++.||.|||+..+++||||||+|||++.++ .+||+|||+++.... .
T Consensus 103 y~~~g~L~~~l---~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~-~~kl~dfg~~~~~~~--~ 176 (283)
T PHA02988 103 YCTRGYLREVL---DKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENY-KLKIICHGLEKILSS--P 176 (283)
T ss_pred eCCCCcHHHHH---hhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCC-cEEEcccchHhhhcc--c
Confidence 99987554332 22456888889999999999999999735999999999999999888 799999999976532 2
Q ss_pred CccccccCCccccccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccC
Q 012233 296 NISYICSRYYRAPELIFGA-TEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEF 374 (468)
Q Consensus 296 ~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 374 (468)
.....++..|+|||++.+. ..++.++|||||||++|||++|..||.+.+..+.+..+...... .
T Consensus 177 ~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~---------------~ 241 (283)
T PHA02988 177 PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNS---------------L 241 (283)
T ss_pred cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCC---------------C
Confidence 2345788999999998652 35899999999999999999999999987766555544431111 0
Q ss_pred CCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 375 KFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
. ++..+++++++||.+||+.||.+|||+.+++.
T Consensus 242 ~------------~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 242 K------------LPLDCPLEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred C------------CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 1 22347889999999999999999999999975
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-41 Score=319.91 Aligned_cols=252 Identities=24% Similarity=0.376 Sum_probs=198.3
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc----chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEE
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~l 212 (468)
.+|.+.+.||+|+||.||+|.+..+++.||+|.+.... ....+|+.+++.++||||+++++.+. ....+|+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~-----~~~~~~l 83 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL-----RRDKLWI 83 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEE-----eCCEEEE
Confidence 36999999999999999999999999999999885432 23457999999999999999999883 3446899
Q ss_pred EeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCC
Q 012233 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (468)
Q Consensus 213 v~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~ 292 (468)
||||++++.+.... .....+++..++.++.|++.||.|||+ .||+|+||||+||+++.++ .++|+|||++.....
T Consensus 84 v~e~~~~~~L~~~~---~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~nili~~~~-~~~l~dfg~~~~~~~ 158 (267)
T cd06645 84 CMEFCGGGSLQDIY---HVTGPLSESQIAYVSRETLQGLYYLHS-KGKMHRDIKGANILLTDNG-HVKLADFGVSAQITA 158 (267)
T ss_pred EEeccCCCcHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECCCC-CEEECcceeeeEccC
Confidence 99999976554322 224568999999999999999999998 8999999999999999887 799999999875532
Q ss_pred CC-CCccccccCCcccccccc--CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 012233 293 GE-PNISYICSRYYRAPELIF--GATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (468)
Q Consensus 293 ~~-~~~~~~gt~~y~aPE~~~--~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 369 (468)
.. ......|+..|+|||++. ....++.++|+|||||++|+|++|..||........+..+...
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~-------------- 224 (267)
T cd06645 159 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKS-------------- 224 (267)
T ss_pred cccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhcc--------------
Confidence 22 223457899999999874 2234788999999999999999999999765544333322111
Q ss_pred CCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCC
Q 012233 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPF 422 (468)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~ 422 (468)
.+..+... ....++..+.+||.+||..||.+||++.++++|||
T Consensus 225 ---~~~~~~~~-------~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 225 ---NFQPPKLK-------DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred ---CCCCCccc-------ccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 00000000 01136788999999999999999999999999999
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=316.24 Aligned_cols=251 Identities=28% Similarity=0.418 Sum_probs=202.5
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc--chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEEEe
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK--RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~--~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv~ 214 (468)
++|.+.+.||+|+||.||+|.+..++..|++|.+.... ..+.+|+.+++.++|+||+++++++. ...++|+++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~~l~~ 77 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYF-----KNTDLWIVM 77 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCCCcEeeeeeeee-----cCCcEEEEE
Confidence 35999999999999999999998889999999886543 44568999999999999999999884 345689999
Q ss_pred ecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCCCC
Q 012233 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGE 294 (468)
Q Consensus 215 e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~~~ 294 (468)
||++++.+.... ......+++..++.++.|++.||.|||+ .||+|+||+|+||+++.++ .++|+|||++.......
T Consensus 78 e~~~~~~L~~~l--~~~~~~l~~~~~~~~~~~l~~~l~~lh~-~~i~H~dl~~~ni~~~~~~-~~~l~dfg~~~~~~~~~ 153 (256)
T cd06612 78 EYCGAGSVSDIM--KITNKTLTEEEIAAILYQTLKGLEYLHS-NKKIHRDIKAGNILLNEEG-QAKLADFGVSGQLTDTM 153 (256)
T ss_pred ecCCCCcHHHHH--HhCccCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCcceEEECCCC-cEEEcccccchhcccCc
Confidence 999976554332 1224568899999999999999999998 8999999999999999888 79999999988664433
Q ss_pred -CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCcc
Q 012233 295 -PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTE 373 (468)
Q Consensus 295 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 373 (468)
......++..|+|||++.+. .++.++|||||||++|+|++|+.||...........+... . ...
T Consensus 154 ~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~---~-----------~~~ 218 (256)
T cd06612 154 AKRNTVIGTPFWMAPEVIQEI-GYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNK---P-----------PPT 218 (256)
T ss_pred cccccccCCccccCHHHHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccC---C-----------CCC
Confidence 22334578899999998665 4899999999999999999999999876544332221110 0 000
Q ss_pred CCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 012233 374 FKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (468)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f 423 (468)
+ ..+..++.++.++|.+||+.||.+|||+.++|.||||
T Consensus 219 ~------------~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 219 L------------SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred C------------CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 0 0123467899999999999999999999999999998
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=315.45 Aligned_cols=252 Identities=25% Similarity=0.424 Sum_probs=203.5
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc------chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 211 (468)
+|.+.+.||.|+||.||++.+..+|..||+|.+.... ....+|+.+++.++||||+++++++.. .....++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~~~~~ 77 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIID---RSNQTLY 77 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeec---CCCCEEE
Confidence 4889999999999999999999999999999885422 233468999999999999999987753 2334578
Q ss_pred EEeecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhH-----hcCCccccCCCCCCeeecCCCCcEEEeeec
Q 012233 212 LVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH-----HVVGVCHRDIKPQNLLVNPHTHQLKICDFG 285 (468)
Q Consensus 212 lv~e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH-----~~~givHrDlkp~NILl~~~~~~vkL~DFG 285 (468)
++|||++++ +...+.........+++..++.++.||+.||.||| + .+|+|+||||+||+++.++ .+||+|||
T Consensus 78 ~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~-~~i~h~dl~p~nili~~~~-~~kl~d~g 155 (265)
T cd08217 78 IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPG-NTVLHRDLKPANIFLDANN-NVKLGDFG 155 (265)
T ss_pred EEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCcccc-CcceecCCCHHHEEEecCC-CEEEeccc
Confidence 999999865 44444444444567899999999999999999999 7 7999999999999999887 79999999
Q ss_pred CccccCCCCC-CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 012233 286 SAKMLVPGEP-NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEI 364 (468)
Q Consensus 286 ~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 364 (468)
++........ .....+++.|+|||.+.+.. ++.++|+||||+++|+|++|+.||...+.......+...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--------- 225 (265)
T cd08217 156 LAKILGHDSSFAKTYVGTPYYMSPEQLNHMS-YDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEG--------- 225 (265)
T ss_pred ccccccCCcccccccccCCCccChhhhcCCC-CCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcC---------
Confidence 9987654432 33457899999999986544 889999999999999999999999877643332222110
Q ss_pred hhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 012233 365 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (468)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f 423 (468)
.++ .++..++.++.+++.+||+.+|.+||++.+++.|||+
T Consensus 226 ----------~~~---------~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 226 ----------KFR---------RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred ----------CCC---------CCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 001 1334578899999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=323.15 Aligned_cols=255 Identities=29% Similarity=0.477 Sum_probs=202.1
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-------chHHHHHHHHHHcCCCCcccccceeeecCCCCceEE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~ 210 (468)
+|.+.+.||+|+||.||++.+..+++.||+|.+.... ....+|+.+++.++||||+++++.+ ....++
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~ 76 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSF-----ETKRHL 76 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEE-----ecCCEE
Confidence 5999999999999999999999999999999885432 2334789999999999999999888 344568
Q ss_pred EEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcccc
Q 012233 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (468)
Q Consensus 211 ~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~ 290 (468)
++||||+.++.+.... .....+++..+..++.|++.||.|||+ .||+||||||+|||++.++ .++|+|||+++..
T Consensus 77 ~lv~e~~~g~~L~~~l---~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~NIll~~~~-~~~l~dfg~~~~~ 151 (305)
T cd05609 77 CMVMEYVEGGDCATLL---KNIGALPVDMARMYFAETVLALEYLHN-YGIVHRDLKPDNLLITSMG-HIKLTDFGLSKIG 151 (305)
T ss_pred EEEEecCCCCcHHHHH---HHcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCchHHEEECCCC-CEEEeeCCCcccc
Confidence 9999999976554322 223568899999999999999999998 8999999999999999887 7999999998632
Q ss_pred CCCC----------------CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH
Q 012233 291 VPGE----------------PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIK 354 (468)
Q Consensus 291 ~~~~----------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~ 354 (468)
.... ......++..|+|||.+.+. .++.++|+|||||++|||++|..||.+.+..+....+..
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~ 230 (305)
T cd05609 152 LMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQ-GYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS 230 (305)
T ss_pred CcCccccccccccccchhhccccCCccCccccCchhccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 1000 01124578889999998654 489999999999999999999999987766554444433
Q ss_pred HhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCC---HHHHhCCCCCCCCCCC
Q 012233 355 ILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCT---ALEACAHPFFDDLRDP 429 (468)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s---~~ell~hp~f~~~~~~ 429 (468)
.. ..++. ....++.++.++|.+||+.||.+||+ +.++++||||...+-.
T Consensus 231 ~~-----------------~~~~~---------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~~ 282 (305)
T cd05609 231 DD-----------------IEWPE---------GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWN 282 (305)
T ss_pred cc-----------------cCCCC---------ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCHH
Confidence 10 01110 11247889999999999999999997 7999999999775443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=316.83 Aligned_cols=245 Identities=30% Similarity=0.484 Sum_probs=197.7
Q ss_pred ecccCceEEEEEEEcCCCCEEEEEEeeccc-------chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEEEeecc
Q 012233 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYI 217 (468)
Q Consensus 145 lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv~e~~ 217 (468)
||.|+||.||+|.+..+++.||+|++.... ..+.+|+.+++.++||||+++++.+ .+...+|+||||+
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTF-----KDKKYIYMLMEYC 75 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeE-----EcCCccEEEEecC
Confidence 699999999999998889999999985432 2345799999999999999999987 3444689999999
Q ss_pred cchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCCCCCCc
Q 012233 218 SETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI 297 (468)
Q Consensus 218 ~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~~~~~~ 297 (468)
.++.+.... .....++...+..++.||+.||.|||+ .|++|+||||+||+++.++ .++|+|||++..........
T Consensus 76 ~~~~L~~~l---~~~~~l~~~~~~~~~~~i~~~l~~lH~-~~~~h~dl~~~nilv~~~~-~~~l~df~~~~~~~~~~~~~ 150 (262)
T cd05572 76 LGGELWTIL---RDRGLFDEYTARFYIACVVLAFEYLHN-RGIIYRDLKPENLLLDSNG-YVKLVDFGFAKKLKSGQKTW 150 (262)
T ss_pred CCCcHHHHH---hhcCCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCHHHEEEcCCC-CEEEeeCCcccccCcccccc
Confidence 865443222 113458889999999999999999998 8999999999999999888 79999999998765543344
Q ss_pred cccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC--cHHHHHHHHHHhCCCCHHHHhhcCCCCccCC
Q 012233 298 SYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGES--GVDQLVEIIKILGTPTREEIKCMNPNYTEFK 375 (468)
Q Consensus 298 ~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 375 (468)
...+++.|++||.+.+. .++.++|+|||||++|+|++|..||.... ..+.+.++.... ....
T Consensus 151 ~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------------~~~~ 214 (262)
T cd05572 151 TFCGTPEYVAPEIILNK-GYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGN---------------GKLE 214 (262)
T ss_pred cccCCcCccChhHhcCC-CCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccC---------------CCCC
Confidence 56789999999998654 48999999999999999999999998765 333333332100 1111
Q ss_pred CCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCC-----HHHHhCCCCCCCCC
Q 012233 376 FPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCT-----ALEACAHPFFDDLR 427 (468)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s-----~~ell~hp~f~~~~ 427 (468)
++...++++.++|.+||+.||.+|++ +.|+++||||+++.
T Consensus 215 ------------~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 259 (262)
T cd05572 215 ------------FPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFD 259 (262)
T ss_pred ------------CCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCCC
Confidence 23345889999999999999999999 99999999999864
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=301.98 Aligned_cols=285 Identities=31% Similarity=0.613 Sum_probs=232.2
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc-cchHHHHHHHHHHcC-CCCcccccceeeecCCCCceEEEEEe
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-KRYKNRELQIMRLLN-HPNVVSLKHCFFSTTEKDELYLNLVL 214 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~-~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~~~~~~lv~ 214 (468)
++|++.+.+|+|-|+.||.|.+..+.+.++||+++.. .....+|+.||+.|. ||||++|++..-... .....||+
T Consensus 38 ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~---SktpaLiF 114 (338)
T KOG0668|consen 38 DDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPE---SKTPSLIF 114 (338)
T ss_pred chHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcCcc---ccCchhHh
Confidence 4699999999999999999999999999999988643 345678999999997 999999999874433 23456899
Q ss_pred ecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCCCC
Q 012233 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGE 294 (468)
Q Consensus 215 e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~~~ 294 (468)
||+...-... .-..++...++.++.|++.||.|+|+ .||+|||+||.|++||.....++|+|+|+|.+..++.
T Consensus 115 E~v~n~Dfk~------ly~tl~d~dIryY~~elLkALdyCHS-~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~ 187 (338)
T KOG0668|consen 115 EYVNNTDFKQ------LYPTLTDYDIRYYIYELLKALDYCHS-MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 187 (338)
T ss_pred hhhccccHHH------HhhhhchhhHHHHHHHHHHHHhHHHh-cCcccccCCcceeeechhhceeeeeecchHhhcCCCc
Confidence 9998753321 12446667799999999999999998 8999999999999999887789999999999998888
Q ss_pred CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCC-CCCCcHHHHHHHHHHhCCCCHHHHh-----hcC
Q 012233 295 PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLF-PGESGVDQLVEIIKILGTPTREEIK-----CMN 368 (468)
Q Consensus 295 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~-----~~~ 368 (468)
.-.-.+.+.+|--||.+.....|+...|+|||||++..|+..+-|| .+.++.+++.+|.+.+|+....... ..+
T Consensus 188 eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ld 267 (338)
T KOG0668|consen 188 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLD 267 (338)
T ss_pred eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCC
Confidence 7777888999999999988888999999999999999999987775 6789999999999999875432221 123
Q ss_pred CCCccCCCCcccCCCccccccc----CCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCCCCC
Q 012233 369 PNYTEFKFPQIKAHPWHKIFHK----RMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNTC 432 (468)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~~ 432 (468)
|.|..+- ......+|....+. -+++++.||+.++|.+|-.+|+||.|++.||||..++....+
T Consensus 268 p~~~~i~-~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~~~~~~ 334 (338)
T KOG0668|consen 268 PQFEDIL-GRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVREAESS 334 (338)
T ss_pred hhHhhHh-hccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHHHHhhc
Confidence 3333321 12233456555432 356999999999999999999999999999999987765444
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=302.21 Aligned_cols=256 Identities=28% Similarity=0.386 Sum_probs=202.8
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeec----ccchHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEEE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ----DKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV 213 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~----~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv 213 (468)
+|++.+.||+|||+.||+++...++..||+|++.- +.....+|++..++++||||++++++............||+
T Consensus 22 Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll 101 (302)
T KOG2345|consen 22 RYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLL 101 (302)
T ss_pred eEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEE
Confidence 69999999999999999999999999999998843 33445679999999999999999998866655567789999
Q ss_pred eecccc-hHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCC--ccccCCCCCCeeecCCCCcEEEeeecCcccc
Q 012233 214 LEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG--VCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (468)
Q Consensus 214 ~e~~~~-~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~g--ivHrDlkp~NILl~~~~~~vkL~DFG~a~~~ 290 (468)
++|... ++++.+......+..+++.++..|+.+|++||++||. .. ++||||||.|||+...+ .++|.|||.++..
T Consensus 102 ~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~-~~~~yAH~DiKP~NILls~~~-~~vl~D~GS~~~a 179 (302)
T KOG2345|consen 102 LPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHE-KEPPYAHRDIKPANILLSDSG-LPVLMDLGSATQA 179 (302)
T ss_pred eehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhc-cCCcccccCCCcceeEecCCC-ceEEEeccCcccc
Confidence 999984 5778777777777789999999999999999999997 77 99999999999999877 7999999998754
Q ss_pred CCCCC----------CccccccCCccccccccCC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Q 012233 291 VPGEP----------NISYICSRYYRAPELIFGA--TEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGT 358 (468)
Q Consensus 291 ~~~~~----------~~~~~gt~~y~aPE~~~~~--~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~ 358 (468)
.-... .....+|..|+|||.+.-. ...++++|||||||+||+|+.|.-||... .+..+.
T Consensus 180 ~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~---------~~~GgS 250 (302)
T KOG2345|consen 180 PIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERI---------YQQGGS 250 (302)
T ss_pred ceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHH---------hhcCCe
Confidence 21111 1134579999999998432 23788999999999999999999999431 111111
Q ss_pred CCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCC
Q 012233 359 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (468)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~h 420 (468)
-... -.-..+.+|. ...+|+.+.+||+.||+.||.+||++.+++.+
T Consensus 251 laLA------v~n~q~s~P~----------~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 251 LALA------VQNAQISIPN----------SSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred EEEe------eeccccccCC----------CCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 0000 0001233332 13478999999999999999999999999863
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=320.26 Aligned_cols=245 Identities=25% Similarity=0.378 Sum_probs=189.9
Q ss_pred eecccCceEEEEEEEcCCCCEEEEEEeeccc-------chHHHHHHHHHH---cCCCCcccccceeeecCCCCceEEEEE
Q 012233 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRL---LNHPNVVSLKHCFFSTTEKDELYLNLV 213 (468)
Q Consensus 144 ~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-------~~~~~E~~il~~---l~hpnIv~l~~~~~~~~~~~~~~~~lv 213 (468)
+||+|+||.||++.+..+++.||+|.+.+.. ....+|..+++. ..||||+.+++++. .....++|
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~-----~~~~~~lv 75 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFH-----TPDKLCFI 75 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEe-----cCCeEEEE
Confidence 4899999999999999999999999885432 112234433333 47999999988883 33458899
Q ss_pred eecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCCC
Q 012233 214 LEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293 (468)
Q Consensus 214 ~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~~ 293 (468)
|||+.++.+... ......+++..+..++.|++.||.|||+ .||+||||||+|||++.++ .++|+|||++......
T Consensus 76 ~e~~~~~~L~~~---i~~~~~l~~~~~~~i~~qi~~al~~lH~-~~ivH~dikp~Nil~~~~~-~~~l~dfg~~~~~~~~ 150 (279)
T cd05633 76 LDLMNGGDLHYH---LSQHGVFSEKEMRFYATEIILGLEHMHN-RFVVYRDLKPANILLDEHG-HVRISDLGLACDFSKK 150 (279)
T ss_pred EecCCCCCHHHH---HHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCcCCCCCCHHHEEECCCC-CEEEccCCcceecccc
Confidence 999997755432 2234568999999999999999999998 8999999999999999887 7999999998654322
Q ss_pred CCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHH--HHHHHHHHhCCCCHHHHhhcCCCC
Q 012233 294 EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVD--QLVEIIKILGTPTREEIKCMNPNY 371 (468)
Q Consensus 294 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~--~~~~i~~~~~~~~~~~~~~~~~~~ 371 (468)
......|++.|+|||.+.+...++.++|+|||||++|+|++|..||....... .+......
T Consensus 151 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~---------------- 213 (279)
T cd05633 151 -KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT---------------- 213 (279)
T ss_pred -CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhc----------------
Confidence 22345789999999998654558899999999999999999999997643221 11111100
Q ss_pred ccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCC-----CHHHHhCCCCCCCCC
Q 012233 372 TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC-----TALEACAHPFFDDLR 427 (468)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~-----s~~ell~hp~f~~~~ 427 (468)
+...++..+++++.++|.+||..||.+|+ ++.++++||||+++.
T Consensus 214 ------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~ 262 (279)
T cd05633 214 ------------VNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGID 262 (279)
T ss_pred ------------CCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCC
Confidence 00113345789999999999999999999 699999999999865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=320.04 Aligned_cols=250 Identities=28% Similarity=0.395 Sum_probs=196.9
Q ss_pred ecccCceEEEEEEEcCCCCEEEEEEeecc-------cchHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEEEeecc
Q 012233 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYI 217 (468)
Q Consensus 145 lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~-------~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv~e~~ 217 (468)
||+|+||+||+|.+..+|+.||+|.+... .....+|+++++.++||||+++++.+ ......|+||||+
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAF-----ETKDDLCLVMTLM 75 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEE-----ecCCeEEEEEecC
Confidence 68999999999999999999999988542 12234699999999999999999888 4445689999999
Q ss_pred cchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCCCCCCc
Q 012233 218 SETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI 297 (468)
Q Consensus 218 ~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~~~~~~ 297 (468)
+++.+...... .....+++..+..++.|++.||.|||+ .||+|+||+|+||+++.++ .++|+|||.+..........
T Consensus 76 ~~~~L~~~l~~-~~~~~~~~~~~~~~~~ql~~~l~~lH~-~~i~H~di~p~Nil~~~~~-~~~l~dfg~~~~~~~~~~~~ 152 (277)
T cd05577 76 NGGDLKYHIYN-VGEPGFPEARAIFYAAQIICGLEHLHQ-RRIVYRDLKPENVLLDDHG-NVRISDLGLAVELKGGKKIK 152 (277)
T ss_pred CCCcHHHHHHH-cCcCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEECCCC-CEEEccCcchhhhccCCccc
Confidence 97655422211 112468999999999999999999998 8999999999999999888 79999999987664444444
Q ss_pred cccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccCCCC
Q 012233 298 SYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFP 377 (468)
Q Consensus 298 ~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (468)
...++..|+|||++.+.. ++.++|+|||||++|+|++|+.||...........+...... ..
T Consensus 153 ~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-------------~~---- 214 (277)
T cd05577 153 GRAGTPGYMAPEVLQGEV-YDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE-------------MA---- 214 (277)
T ss_pred cccCCCCcCCHHHhcCCC-CCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcccc-------------cc----
Confidence 566788999999987655 899999999999999999999999775532211111110000 00
Q ss_pred cccCCCcccccccCCCHHHHHHHHHhcccCCCCCC-----CHHHHhCCCCCCCCCC
Q 012233 378 QIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC-----TALEACAHPFFDDLRD 428 (468)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~-----s~~ell~hp~f~~~~~ 428 (468)
..++..+++++.++|.+||+.||.+|| ++.+++.||||.++..
T Consensus 215 --------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~ 262 (277)
T cd05577 215 --------VEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNW 262 (277)
T ss_pred --------ccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCCh
Confidence 013345789999999999999999999 8999999999987653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=316.11 Aligned_cols=250 Identities=26% Similarity=0.439 Sum_probs=197.2
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc---------chHHHHHHHHHHcCCCCcccccceeeecCCCCce
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~---------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 208 (468)
+|.+.+.||+|+||.||.|.+..+|..||||.+.... ....+|+.+++.+.||||+++++++... ...
T Consensus 3 ~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~~ 79 (265)
T cd06652 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDP---MER 79 (265)
T ss_pred cceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccC---CCc
Confidence 5999999999999999999999999999999874321 2345699999999999999999977332 234
Q ss_pred EEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcc
Q 012233 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (468)
Q Consensus 209 ~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~ 288 (468)
++++||||++++.+.... .....+++..+..++.|++.||.|||+ .||+|+||||+|||++.++ .++|+|||++.
T Consensus 80 ~~~~v~e~~~~~~L~~~l---~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dl~p~nil~~~~~-~~~l~Dfg~~~ 154 (265)
T cd06652 80 TLSIFMEHMPGGSIKDQL---KSYGALTENVTRKYTRQILEGVSYLHS-NMIVHRDIKGANILRDSVG-NVKLGDFGASK 154 (265)
T ss_pred eEEEEEEecCCCcHHHHH---HHcCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEecCCC-CEEECcCcccc
Confidence 688999999876544221 123457888899999999999999998 8999999999999999887 79999999987
Q ss_pred ccCCC----CCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 012233 289 MLVPG----EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEI 364 (468)
Q Consensus 289 ~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 364 (468)
..... .......++..|+|||++.+. .++.++|+|||||++|+|++|+.||........+.++.. .+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~---~~~---- 226 (265)
T cd06652 155 RLQTICLSGTGMKSVTGTPYWMSPEVISGE-GYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT---QPT---- 226 (265)
T ss_pred ccccccccccccccCCCCccccChhhhcCC-CCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhc---CCC----
Confidence 54321 112234688899999998764 489999999999999999999999987654444333221 110
Q ss_pred hhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCC
Q 012233 365 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFD 424 (468)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~ 424 (468)
...++..++..+.++|.+||. +|.+||++++++.|||+.
T Consensus 227 --------------------~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 227 --------------------NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred --------------------CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 011234567889999999995 999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=324.45 Aligned_cols=261 Identities=26% Similarity=0.411 Sum_probs=208.2
Q ss_pred eEEeceecccCceEEEEEEEcCCCCEEEEEEeecc----cchHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEEEe
Q 012233 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (468)
Q Consensus 139 y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~----~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv~ 214 (468)
|.....||.|+||.||+|.+..++..||+|.+... .....+|+.+++.++||||+++++++. .....|+||
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~-----~~~~~~iv~ 97 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL-----VGEELWVLM 97 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhhee-----eCCeEEEEE
Confidence 44556799999999999999889999999988432 223457899999999999999999883 344689999
Q ss_pred ecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCCCC
Q 012233 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGE 294 (468)
Q Consensus 215 e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~~~ 294 (468)
||++++.+..... ...+++..++.++.|++.||.|||+ .||+|+||||+|||++.++ .+||+|||++.......
T Consensus 98 e~~~~~~L~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~-~~ivH~dl~p~Nill~~~~-~~kL~dfg~~~~~~~~~ 171 (297)
T cd06659 98 EFLQGGALTDIVS----QTRLNEEQIATVCESVLQALCYLHS-QGVIHRDIKSDSILLTLDG-RVKLSDFGFCAQISKDV 171 (297)
T ss_pred ecCCCCCHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHeEEccCC-cEEEeechhHhhccccc
Confidence 9999765543321 2458899999999999999999998 8999999999999999888 79999999987553322
Q ss_pred -CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCcc
Q 012233 295 -PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTE 373 (468)
Q Consensus 295 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 373 (468)
......++..|+|||++.+.. ++.++|||||||++|||++|..||...+..+.+..+... +. ..
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~---~~-----------~~ 236 (297)
T cd06659 172 PKRKSLVGTPYWMAPEVISRTP-YGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS---PP-----------PK 236 (297)
T ss_pred ccccceecCccccCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc---CC-----------CC
Confidence 223467899999999996554 899999999999999999999999876655544332210 00 00
Q ss_pred CCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCCCCCCCCCC
Q 012233 374 FKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNTCLPNGR 437 (468)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~~~~~~~ 437 (468)
. .....++.++.++|.+||+.+|.+||++.++++||||.+...+.+.++..+
T Consensus 237 ~------------~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~~~~~~~~~~~ 288 (297)
T cd06659 237 L------------KNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTGLPECLVPLIQ 288 (297)
T ss_pred c------------cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCCCcccccchHH
Confidence 0 012346889999999999999999999999999999999887776655544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=314.95 Aligned_cols=253 Identities=27% Similarity=0.398 Sum_probs=202.9
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc----cchHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEE
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~----~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~l 212 (468)
++|.+.+.||.|+||.||+|.+..+++.+++|++... .....+|+.+++.++||||+++++++ .+...+|+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~l 77 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSY-----LRRDKLWI 77 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEE-----EeCCEEEE
Confidence 3699999999999999999999889999999988643 23456799999999999999999988 34446899
Q ss_pred EeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCC
Q 012233 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (468)
Q Consensus 213 v~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~ 292 (468)
+|||++++.+..... .....+++..++.++.|++.||.|||+ +||+|+||||+||+++.++ .++|+|||++.....
T Consensus 78 ~~e~~~~~~l~~~~~--~~~~~l~~~~~~~~~~ql~~~l~~lh~-~~i~h~dl~p~ni~i~~~~-~~~l~d~g~~~~~~~ 153 (262)
T cd06613 78 VMEYCGGGSLQDIYQ--VTRGPLSELQIAYVCRETLKGLAYLHE-TGKIHRDIKGANILLTEDG-DVKLADFGVSAQLTA 153 (262)
T ss_pred EEeCCCCCcHHHHHH--hhccCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCChhhEEECCCC-CEEECccccchhhhh
Confidence 999999876654322 223568899999999999999999998 8999999999999999887 799999999876543
Q ss_pred CC-CCccccccCCccccccccCC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 012233 293 GE-PNISYICSRYYRAPELIFGA--TEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (468)
Q Consensus 293 ~~-~~~~~~gt~~y~aPE~~~~~--~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 369 (468)
.. ......++..|+|||.+.+. ..++.++|+|||||++|+|++|..||...+.......+......+
T Consensus 154 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~---------- 223 (262)
T cd06613 154 TIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPP---------- 223 (262)
T ss_pred hhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC----------
Confidence 22 23345788899999998654 247889999999999999999999998876555544432210000
Q ss_pred CCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCC
Q 012233 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPF 422 (468)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~ 422 (468)
+. ......++.++.+||.+||..||..|||+.+++.|||
T Consensus 224 -------~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 224 -------PK-------LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred -------cc-------ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 00 0012235788999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=314.31 Aligned_cols=248 Identities=26% Similarity=0.462 Sum_probs=201.9
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc------cchHHHHHHHHHHcCCCCcccccceeeecCCCCceEEE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~------~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 211 (468)
+|.+.+.||+|+||.||++.+..+|+.||+|.+... .....+|+.+++.++||||+++++++ .+..+.+
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~ 75 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESF-----EENGNLY 75 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeee-----cCCCeEE
Confidence 489999999999999999999999999999988532 12456799999999999999999988 4555789
Q ss_pred EEeecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcccc
Q 012233 212 LVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (468)
Q Consensus 212 lv~e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~ 290 (468)
+||||+.++ +...+.. .....+++..+..++.|++.||.|||+ +|++|+||+|+|||++.++ .++|+|||++...
T Consensus 76 lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~~l~~~nil~~~~~-~~~l~d~~~~~~~ 151 (256)
T cd08218 76 IVMDYCEGGDLYKKINA--QRGVLFPEDQILDWFVQICLALKHVHD-RKILHRDIKSQNIFLTKDG-TIKLGDFGIARVL 151 (256)
T ss_pred EEEecCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEcCCC-CEEEeeccceeec
Confidence 999999865 4333321 123457888999999999999999998 8999999999999999887 7999999999765
Q ss_pred CCCCC-CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 012233 291 VPGEP-NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (468)
Q Consensus 291 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 369 (468)
..... .....|++.|+|||++.+.. ++.++|+|||||++|+|++|..||......+.+..+....
T Consensus 152 ~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~------------- 217 (256)
T cd08218 152 NSTVELARTCIGTPYYLSPEICENRP-YNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGS------------- 217 (256)
T ss_pred CcchhhhhhccCCccccCHHHhCCCC-CCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCC-------------
Confidence 43221 22346788999999986654 8899999999999999999999998776666555543310
Q ss_pred CCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 012233 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (468)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f 423 (468)
++ ..+..++.++.++|.+||+.+|.+||++.+++.||||
T Consensus 218 ------~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 218 ------YP---------PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred ------CC---------CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 00 0224578899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=311.75 Aligned_cols=248 Identities=31% Similarity=0.490 Sum_probs=202.6
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc------chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 211 (468)
+|+..+.||.|+||.||.+++..++..+++|.+.... ....+|+.++++++|+||+++++++. +...++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~~ 75 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFM-----DDNTLL 75 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEe-----cCCeEE
Confidence 4899999999999999999999999999999875321 23457999999999999999999984 445689
Q ss_pred EEeecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcccc
Q 012233 212 LVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (468)
Q Consensus 212 lv~e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~ 290 (468)
++|||+.++ +.+.+... ....+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++ .+||+|||++...
T Consensus 76 ~~~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~dl~p~ni~~~~~~-~~kl~d~~~~~~~ 151 (256)
T cd08221 76 IEMEYANGGTLYDKIVRQ--KGQLFEEEMVLWYLFQIVSAVSYIHK-AGILHRDIKTLNIFLTKAG-LIKLGDFGISKIL 151 (256)
T ss_pred EEEEecCCCcHHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCChHhEEEeCCC-CEEECcCcceEEc
Confidence 999999865 44433321 13568899999999999999999998 8999999999999999888 7999999998765
Q ss_pred CCCC-CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 012233 291 VPGE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (468)
Q Consensus 291 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 369 (468)
.... ......+++.|+|||.+.+.. ++.++|+|||||++|+|++|..||......+....+... ..
T Consensus 152 ~~~~~~~~~~~~~~~y~ape~~~~~~-~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~--~~---------- 218 (256)
T cd08221 152 GSEYSMAETVVGTPYYMSPELCQGVK-YNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQG--NY---------- 218 (256)
T ss_pred ccccccccccCCCccccCHhhcCCCC-CCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC--CC----------
Confidence 4333 233456899999999987654 889999999999999999999999887666655554331 00
Q ss_pred CCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 012233 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (468)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f 423 (468)
.. ....++.++.++|.+||..||.+||++.+++.|||+
T Consensus 219 --~~--------------~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 219 --TP--------------VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred --CC--------------CccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 00 113478899999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=322.88 Aligned_cols=254 Identities=21% Similarity=0.279 Sum_probs=190.8
Q ss_pred cceEEeceecccCceEEEEEEEcC----------------CCCEEEEEEeeccc-----chHHHHHHHHHHcCCCCcccc
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLE----------------TGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSL 195 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~----------------~g~~vaiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l 195 (468)
.+|.+.+.||+|+||.||+|.+.. ++..||+|.+.... ..+.+|+.+++.++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 469999999999999999998632 34479999886432 235579999999999999999
Q ss_pred cceeeecCCCCceEEEEEeecccchHH-HHHhhhh---------------hcCCCCCHHHHHHHHHHHHHHHHHhHhcCC
Q 012233 196 KHCFFSTTEKDELYLNLVLEYISETVY-RVSKHYT---------------RMNQHVPILYVQLYTYQICRALNYLHHVVG 259 (468)
Q Consensus 196 ~~~~~~~~~~~~~~~~lv~e~~~~~ll-~~~~~~~---------------~~~~~~~~~~~~~~~~qi~~aL~yLH~~~g 259 (468)
++++.. ....++||||+.++.+ +.+.... .....+++..+..++.||+.||.|||+ .|
T Consensus 85 ~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~-~~ 158 (304)
T cd05096 85 LGVCVD-----EDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS-LN 158 (304)
T ss_pred EEEEec-----CCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH-CC
Confidence 998843 3458899999986544 3332211 111346778889999999999999998 89
Q ss_pred ccccCCCCCCeeecCCCCcEEEeeecCccccCCCCC---CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-
Q 012233 260 VCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL- 335 (468)
Q Consensus 260 ivHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~- 335 (468)
|+||||||+|||++.++ .+||+|||+++....... .....++..|+|||++.+.. ++.++|||||||++|||++
T Consensus 159 ivH~dlkp~Nill~~~~-~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~~~ 236 (304)
T cd05096 159 FVHRDLATRNCLVGENL-TIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGK-FTTASDVWAFGVTLWEILML 236 (304)
T ss_pred ccccCcchhheEEcCCc-cEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCC-CCchhhhHHHHHHHHHHHHc
Confidence 99999999999999887 799999999976533321 12234578899999986554 8999999999999999986
Q ss_pred -CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCH
Q 012233 336 -GQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTA 414 (468)
Q Consensus 336 -G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~ 414 (468)
|..||...+..+.+..+......... . .+ ...+..++..+.+||.+||+.||.+|||+
T Consensus 237 ~~~~p~~~~~~~~~~~~~~~~~~~~~~-----------~-~~---------~~~~~~~~~~~~~li~~cl~~~p~~RPs~ 295 (304)
T cd05096 237 CKEQPYGELTDEQVIENAGEFFRDQGR-----------Q-VY---------LFRPPPCPQGLYELMLQCWSRDCRERPSF 295 (304)
T ss_pred cCCCCCCcCCHHHHHHHHHHHhhhccc-----------c-cc---------ccCCCCCCHHHHHHHHHHccCCchhCcCH
Confidence 66788876665555444332111000 0 00 01223578899999999999999999999
Q ss_pred HHHhC
Q 012233 415 LEACA 419 (468)
Q Consensus 415 ~ell~ 419 (468)
.++..
T Consensus 296 ~~i~~ 300 (304)
T cd05096 296 SDIHA 300 (304)
T ss_pred HHHHH
Confidence 99943
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=315.65 Aligned_cols=253 Identities=29% Similarity=0.490 Sum_probs=198.8
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc--------------chHHHHHHHHHHcCCCCcccccceeeecC
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK--------------RYKNRELQIMRLLNHPNVVSLKHCFFSTT 203 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~--------------~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 203 (468)
+|.+.+.||.|+||.||+|.+..+|+.||+|.+.... ....+|+.+++.++||||+++++++
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~---- 77 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFE---- 77 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEe----
Confidence 5899999999999999999998899999999874311 1245689999999999999999987
Q ss_pred CCCceEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEee
Q 012233 204 EKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICD 283 (468)
Q Consensus 204 ~~~~~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~D 283 (468)
......++||||+.++.+.... .....++...+..++.||+.||.|||+ .|++|+||+|+||+++.++ .++|+|
T Consensus 78 -~~~~~~~lv~e~~~~~~L~~~l---~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~~~nil~~~~~-~~~l~d 151 (272)
T cd06629 78 -TTEEYLSIFLEYVPGGSIGSCL---RTYGRFEEQLVRFFTEQVLEGLAYLHS-KGILHRDLKADNLLVDADG-ICKISD 151 (272)
T ss_pred -ccCCceEEEEecCCCCcHHHHH---hhccCCCHHHHHHHHHHHHHHHHHHhh-CCeeecCCChhhEEEcCCC-eEEEee
Confidence 3444688999999876443222 123568888999999999999999998 8999999999999999887 799999
Q ss_pred ecCccccCCCC---CCccccccCCccccccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Q 012233 284 FGSAKMLVPGE---PNISYICSRYYRAPELIFGAT-EYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTP 359 (468)
Q Consensus 284 FG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~-~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~ 359 (468)
||++....... ......++..|+|||.+.... .++.++|+||||+++|+|++|..||........+.++....
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--- 228 (272)
T cd06629 152 FGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKR--- 228 (272)
T ss_pred ccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccc---
Confidence 99987543221 122356788999999986543 47899999999999999999999997655444333322110
Q ss_pred CHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 012233 360 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (468)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f 423 (468)
....++ ......++.++.+||.+||..||.+||++.+++.||||
T Consensus 229 ------------~~~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 229 ------------SAPPIP--------PDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred ------------cCCcCC--------ccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 000111 11234578999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=312.15 Aligned_cols=250 Identities=26% Similarity=0.411 Sum_probs=200.6
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc------cchHHHHHHHHHHcCCCCcccccceeeecCCCCceEEE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~------~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 211 (468)
+|.+.+.||.|+||.||++.+..+|..||+|.+... .....+|+.+++.++|+||+++++.+ ......+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~-----~~~~~~~ 75 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASF-----QENGRLF 75 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhhee-----ccCCeEE
Confidence 488999999999999999999999999999988532 23455799999999999999999988 4445689
Q ss_pred EEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccC
Q 012233 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (468)
Q Consensus 212 lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~ 291 (468)
+|+||+.++.+...... .....+++..+..++.|++.||.|||+ .+|+|+||||+||+++.++..+||+|||.+....
T Consensus 76 lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~ 153 (257)
T cd08225 76 IVMEYCDGGDLMKRINR-QRGVLFSEDQILSWFVQISLGLKHIHD-RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN 153 (257)
T ss_pred EEEecCCCCcHHHHHHh-ccCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCHHHEEEcCCCCeEEecccccchhcc
Confidence 99999986544322211 122357889999999999999999998 8999999999999999886567999999987664
Q ss_pred CCCC-CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCC
Q 012233 292 PGEP-NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPN 370 (468)
Q Consensus 292 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 370 (468)
.... .....|++.|+|||++.+.. ++.++|+|||||++|+|++|..||...+..+....+....
T Consensus 154 ~~~~~~~~~~~~~~~~ape~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-------------- 218 (257)
T cd08225 154 DSMELAYTCVGTPYYLSPEICQNRP-YNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGY-------------- 218 (257)
T ss_pred CCcccccccCCCccccCHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccc--------------
Confidence 3322 22346788999999986554 8899999999999999999999998766555444332210
Q ss_pred CccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 012233 371 YTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (468)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f 423 (468)
++ .....++.++.++|.+||..+|++|||+.+++.||||
T Consensus 219 -----~~---------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 219 -----FA---------PISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred -----CC---------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 00 0223478899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=332.11 Aligned_cols=251 Identities=22% Similarity=0.296 Sum_probs=191.9
Q ss_pred CcccceEEeceecccCceEEEEEEEcCC-----CCEEEEEEeeccc-----chHHHHHHHHHHc-CCCCcccccceeeec
Q 012233 134 KQTISYMAERVVGTGSFGVVFQAKCLET-----GDSVAIKKVLQDK-----RYKNRELQIMRLL-NHPNVVSLKHCFFST 202 (468)
Q Consensus 134 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~-----g~~vaiK~~~~~~-----~~~~~E~~il~~l-~hpnIv~l~~~~~~~ 202 (468)
....+|.+.+.||+|+||.||+|.+... +..||+|.+.... ....+|+.+++.+ +|+||+++++++
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~--- 111 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGAC--- 111 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEe---
Confidence 3345799999999999999999986543 3579999986432 2345799999999 899999999988
Q ss_pred CCCCceEEEEEeecccchHHH-HHhhhh----------------------------------------------------
Q 012233 203 TEKDELYLNLVLEYISETVYR-VSKHYT---------------------------------------------------- 229 (468)
Q Consensus 203 ~~~~~~~~~lv~e~~~~~ll~-~~~~~~---------------------------------------------------- 229 (468)
.....+++|||||.++.+. .+....
T Consensus 112 --~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (374)
T cd05106 112 --THGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSS 189 (374)
T ss_pred --cCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccc
Confidence 4444589999999865443 332110
Q ss_pred --------------hcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCCCCC
Q 012233 230 --------------RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEP 295 (468)
Q Consensus 230 --------------~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~~~~ 295 (468)
.....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++.......
T Consensus 190 ~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~giiHrDLkp~Nil~~~~~-~~kL~DfGla~~~~~~~~ 267 (374)
T cd05106 190 SSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS-KNCIHRDVAARNVLLTDGR-VAKICDFGLARDIMNDSN 267 (374)
T ss_pred cccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH-CCEEeccCchheEEEeCCC-eEEEeeceeeeeccCCcc
Confidence 011347788899999999999999998 8999999999999999877 799999999976543321
Q ss_pred C---ccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCC
Q 012233 296 N---ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNY 371 (468)
Q Consensus 296 ~---~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 371 (468)
. ....++..|+|||++.+. .++.++|||||||++|+|++ |..||........+..+......+
T Consensus 268 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~------------ 334 (374)
T cd05106 268 YVVKGNARLPVKWMAPESIFDC-VYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQM------------ 334 (374)
T ss_pred eeeccCCCCccceeCHHHhcCC-CCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCc------------
Confidence 1 122345679999998654 48999999999999999997 999998765544444433311000
Q ss_pred ccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 372 TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
..+..++++++++|.+||+.||.+|||+.++++
T Consensus 335 ---------------~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 335 ---------------SRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred ---------------cCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 012336889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-40 Score=313.57 Aligned_cols=248 Identities=27% Similarity=0.447 Sum_probs=191.4
Q ss_pred eceecccCceEEEEEEEcCCCCEEEEEEeeccc----chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEEEeecc
Q 012233 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYI 217 (468)
Q Consensus 142 ~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv~e~~ 217 (468)
...||+|+||.||+|.+..++..||+|.+.... ....+|+.+++.++|+||+++++++ ....+.++|+||+
T Consensus 13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv~e~~ 87 (268)
T cd06624 13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD-----SENGFFKIFMEQV 87 (268)
T ss_pred eEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeee-----ccCCEEEEEEecC
Confidence 357999999999999999899999999875432 3456799999999999999999988 4445689999999
Q ss_pred cchHHHHHhhhhhcCCCC--CHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCCCCC
Q 012233 218 SETVYRVSKHYTRMNQHV--PILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEP 295 (468)
Q Consensus 218 ~~~ll~~~~~~~~~~~~~--~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~~~~ 295 (468)
.++.+....... ...+ +...+..++.||+.||.|||+ .||+||||||+||+++.+...++|+|||.+........
T Consensus 88 ~~~~L~~~l~~~--~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~ 164 (268)
T cd06624 88 PGGSLSALLRSK--WGPLKDNEQTIIFYTKQILEGLKYLHD-NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP 164 (268)
T ss_pred CCCCHHHHHHHh--cccCCCcHHHHHHHHHHHHHHHHHHHH-CCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC
Confidence 876554322211 1234 777888899999999999998 89999999999999987444799999999876533222
Q ss_pred -CccccccCCccccccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCcc
Q 012233 296 -NISYICSRYYRAPELIFGA-TEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTE 373 (468)
Q Consensus 296 -~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 373 (468)
.....+++.|+|||.+.+. ..++.++|+||||+++|+|++|+.||................
T Consensus 165 ~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~----------------- 227 (268)
T cd06624 165 CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMF----------------- 227 (268)
T ss_pred ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhh-----------------
Confidence 2234678999999998543 237889999999999999999999997543221111000000
Q ss_pred CCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 012233 374 FKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (468)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f 423 (468)
.....++..+++++++||.+||+.+|.+|||+.+++.||||
T Consensus 228 ---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 228 ---------KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred ---------ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 00011344578899999999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=316.64 Aligned_cols=245 Identities=24% Similarity=0.384 Sum_probs=191.9
Q ss_pred eecccCceEEEEEEEcCCCCEEEEEEeecccc-------hHHHHH---HHHHHcCCCCcccccceeeecCCCCceEEEEE
Q 012233 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR-------YKNREL---QIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV 213 (468)
Q Consensus 144 ~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~~-------~~~~E~---~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv 213 (468)
+||+|+||.||+|.+..+++.||+|.+.+... ....|. .+++...||||+++++++ .+...+|+|
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~-----~~~~~~~~v 75 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-----HTPDKLSFI 75 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeee-----ecCCEEEEE
Confidence 48999999999999999999999998854321 122233 344455799999999888 444568999
Q ss_pred eecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCCC
Q 012233 214 LEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293 (468)
Q Consensus 214 ~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~~ 293 (468)
|||+.++.+.... .....+++..++.++.|++.||.|||+ .+|+||||||+||+++.++ .++|+|||++......
T Consensus 76 ~e~~~g~~L~~~l---~~~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~di~p~nili~~~~-~~kl~dfg~~~~~~~~ 150 (278)
T cd05606 76 LDLMNGGDLHYHL---SQHGVFSEAEMRFYAAEIILGLEHMHN-RFVVYRDLKPANILLDEHG-HVRISDLGLACDFSKK 150 (278)
T ss_pred EecCCCCcHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHH-CCEEcCCCCHHHEEECCCC-CEEEccCcCccccCcc
Confidence 9999987654322 224568999999999999999999998 8999999999999999887 7999999998755332
Q ss_pred CCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHH--HHHHHHHhCCCCHHHHhhcCCCC
Q 012233 294 EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQ--LVEIIKILGTPTREEIKCMNPNY 371 (468)
Q Consensus 294 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~--~~~i~~~~~~~~~~~~~~~~~~~ 371 (468)
......|+..|+|||++.+...++.++|+||+||++|+|++|+.||........ .......
T Consensus 151 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---------------- 213 (278)
T cd05606 151 -KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT---------------- 213 (278)
T ss_pred -CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhc----------------
Confidence 223457899999999997555589999999999999999999999987532211 1111100
Q ss_pred ccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCC-----CHHHHhCCCCCCCCC
Q 012233 372 TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC-----TALEACAHPFFDDLR 427 (468)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~-----s~~ell~hp~f~~~~ 427 (468)
.. ..++..++.++.++|.+||..||.+|+ ++.+++.||||+++.
T Consensus 214 ~~------------~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~ 262 (278)
T cd05606 214 MA------------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLD 262 (278)
T ss_pred cC------------CCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCC
Confidence 00 012344789999999999999999999 999999999999865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=314.86 Aligned_cols=266 Identities=24% Similarity=0.392 Sum_probs=201.4
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-----chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~l 212 (468)
+|...+.||.|++|.||+|.+..+++.||+|.+.... ....+|+++++.++||||++++++|... ....+|+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~~~~~~l 78 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDE---SSSSIGI 78 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcc---CCCeEEE
Confidence 5899999999999999999999999999999886432 2345799999999999999999988542 2335789
Q ss_pred EeecccchHH-HHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccC
Q 012233 213 VLEYISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (468)
Q Consensus 213 v~e~~~~~ll-~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~ 291 (468)
||||++++.+ +++.........+++..+..++.||+.||.|||+ .|++|+||+|+||+++.++ .++|+|||++....
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~-~~i~H~dl~~~nil~~~~~-~~~l~dfg~~~~~~ 156 (287)
T cd06621 79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS-RKIIHRDIKPSNILLTRKG-QVKLCDFGVSGELV 156 (287)
T ss_pred EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEecCC-eEEEeecccccccc
Confidence 9999986544 3333333345668889999999999999999998 8999999999999999887 79999999986543
Q ss_pred CCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCCCCHHHHhhcCCC
Q 012233 292 PGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGV-DQLVEIIKILGTPTREEIKCMNPN 370 (468)
Q Consensus 292 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~ 370 (468)
... .....++..|+|||.+.+. .++.++|||||||++|+|++|..||...... ....+....+......
T Consensus 157 ~~~-~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-------- 226 (287)
T cd06621 157 NSL-AGTFTGTSFYMAPERIQGK-PYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNP-------- 226 (287)
T ss_pred ccc-cccccCCccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCch--------
Confidence 222 2245678899999998654 4899999999999999999999999865220 0001111111110000
Q ss_pred CccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCC
Q 012233 371 YTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRD 428 (468)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~ 428 (468)
.++. .+ ......++.+.+||.+||..||.+|||+.|++.||||+....
T Consensus 227 ----~~~~---~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~ 274 (287)
T cd06621 227 ----ELKD---EP---GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMK 274 (287)
T ss_pred ----hhcc---CC---CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccccc
Confidence 0000 00 000124678999999999999999999999999999976544
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=314.67 Aligned_cols=254 Identities=28% Similarity=0.495 Sum_probs=199.0
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-----chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~l 212 (468)
+|.+.+.||.|+||.||+|.+..+++.||+|.+.... ....+|+++++.+.||||+++++.+. .....++
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~l 76 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFY-----NNGDISI 76 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeee-----cCCEEEE
Confidence 4888899999999999999999999999999885542 23457999999999999999999883 3456899
Q ss_pred EeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCC
Q 012233 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (468)
Q Consensus 213 v~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~ 292 (468)
|+||++++.+..... .....+++..+..++.|++.||+|||+..|++|+||||+||+++.++ .++|+|||.+.....
T Consensus 77 v~e~~~~~~L~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~-~~~l~d~g~~~~~~~ 153 (265)
T cd06605 77 CMEYMDGGSLDKILK--EVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRG-QIKLCDFGVSGQLVN 153 (265)
T ss_pred EEEecCCCcHHHHHH--HccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCC-CEEEeecccchhhHH
Confidence 999999654433222 11267889999999999999999999637999999999999999887 799999999876533
Q ss_pred CCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHHH-hCCCCHHHHhhcCCC
Q 012233 293 GEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESG-VDQLVEIIKI-LGTPTREEIKCMNPN 370 (468)
Q Consensus 293 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~-~~~~~~i~~~-~~~~~~~~~~~~~~~ 370 (468)
.... ...++..|+|||.+.+. .++.++|+|||||++|+|++|..||..... .+.....++. ...+
T Consensus 154 ~~~~-~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----------- 220 (265)
T cd06605 154 SLAK-TFVGTSSYMAPERIQGN-DYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEP----------- 220 (265)
T ss_pred HHhh-cccCChhccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCC-----------
Confidence 2222 26788999999998765 589999999999999999999999976421 1111111111 1000
Q ss_pred CccCCCCcccCCCccccccc-CCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q 012233 371 YTEFKFPQIKAHPWHKIFHK-RMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426 (468)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~-~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 426 (468)
.+. ++. .++.++.+||.+||..||.+|||+.+++.||||+..
T Consensus 221 -----~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 221 -----PPR---------LPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred -----CCC---------CChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence 000 111 268899999999999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=320.56 Aligned_cols=250 Identities=24% Similarity=0.356 Sum_probs=200.6
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-----chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~l 212 (468)
.|...+.||+|+||.||+|.+..++..||+|.+.... ....+|+.+++.++||||+++++++ .+....|+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l 79 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY-----LKGTKLWI 79 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhccc-----ccCCceEE
Confidence 3778889999999999999998899999999875332 2346799999999999999999988 44456899
Q ss_pred EeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCC
Q 012233 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (468)
Q Consensus 213 v~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~ 292 (468)
||||++++.+..... ...+++..++.++.||+.||.|||+ +||+|+||+|+||+++.++ .++|+|||++.....
T Consensus 80 v~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~-~~ivH~dl~p~ni~i~~~~-~~~l~dfg~~~~~~~ 153 (277)
T cd06642 80 IMEYLGGGSALDLLK----PGPLEETYIATILREILKGLDYLHS-ERKIHRDIKAANVLLSEQG-DVKLADFGVAGQLTD 153 (277)
T ss_pred EEEccCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhc-CCeeccCCChheEEEeCCC-CEEEccccccccccC
Confidence 999999765543221 3568889999999999999999998 8999999999999999887 799999999876543
Q ss_pred CC-CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCC
Q 012233 293 GE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNY 371 (468)
Q Consensus 293 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 371 (468)
.. ......++..|+|||.+.+. .++.++|+|||||++|||++|+.||...........+...
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~---------------- 216 (277)
T cd06642 154 TQIKRNTFVGTPFWMAPEVIKQS-AYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKN---------------- 216 (277)
T ss_pred cchhhhcccCcccccCHHHhCcC-CCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcC----------------
Confidence 32 12234678899999998655 4889999999999999999999999765443322221110
Q ss_pred ccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q 012233 372 TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (468)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~ 427 (468)
.. ..+...++.++.++|.+||+.+|.+||++.+++.||||..+.
T Consensus 217 ---~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 260 (277)
T cd06642 217 ---SP---------PTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRYT 260 (277)
T ss_pred ---CC---------CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHHh
Confidence 00 012234678899999999999999999999999999997654
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=316.50 Aligned_cols=252 Identities=24% Similarity=0.353 Sum_probs=202.6
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-----chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~l 212 (468)
.|...+.||.|+||.||.|.+..++..||+|.+.... ....+|+.+++.+.||||+++++++ .+..+.|+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l 79 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY-----LKGTKLWI 79 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EECCEEEE
Confidence 3888899999999999999999899999999886432 2345799999999999999999998 34456899
Q ss_pred EeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCC
Q 012233 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (468)
Q Consensus 213 v~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~ 292 (468)
||||++++.+..... ...++...+..++.|++.||.|||+ .+++|+||+|+||+++.++ .++|+|||++.....
T Consensus 80 v~e~~~~~~L~~~i~----~~~l~~~~~~~~~~~l~~~l~~lh~-~~ivH~dl~p~Nil~~~~~-~~~l~dfg~~~~~~~ 153 (277)
T cd06640 80 IMEYLGGGSALDLLR----AGPFDEFQIATMLKEILKGLDYLHS-EKKIHRDIKAANVLLSEQG-DVKLADFGVAGQLTD 153 (277)
T ss_pred EEecCCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCccCcCCChhhEEEcCCC-CEEEcccccceeccC
Confidence 999998765543221 2458888899999999999999998 8999999999999999887 799999999976543
Q ss_pred CC-CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCC
Q 012233 293 GE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNY 371 (468)
Q Consensus 293 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 371 (468)
.. ......++..|+|||.+.+.. ++.++|+|||||++|+|++|..||...........+...
T Consensus 154 ~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~---------------- 216 (277)
T cd06640 154 TQIKRNTFVGTPFWMAPEVIQQSA-YDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKN---------------- 216 (277)
T ss_pred CccccccccCcccccCHhHhccCC-CccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcC----------------
Confidence 32 222346788999999987554 899999999999999999999999876544333222110
Q ss_pred ccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCC
Q 012233 372 TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDP 429 (468)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~ 429 (468)
. ...+...++..+.++|.+||+.+|.+||++.+++.||||......
T Consensus 217 ---~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~ 262 (277)
T cd06640 217 ---N---------PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNAKK 262 (277)
T ss_pred ---C---------CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhcchh
Confidence 0 011233467889999999999999999999999999999875543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=362.37 Aligned_cols=259 Identities=27% Similarity=0.437 Sum_probs=212.5
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeec------ccchHHHHHHHHHHcCCCCcccccceeeecCCCCceEE
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ------DKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~------~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~ 210 (468)
.+|+-...||.|.||.||-|.+..+|+..|+|-+.- ......+|..++..|.|||+|++|++=.... -+
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRe-----kv 1309 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHRE-----KV 1309 (1509)
T ss_pred eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHH-----HH
Confidence 367788899999999999999999999999997632 2234468999999999999999998764332 37
Q ss_pred EEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcccc
Q 012233 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (468)
Q Consensus 211 ~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~ 290 (468)
+|.||||.+|.+..+... .+..++...+.|..|++.|++|||+ +|||||||||+||||+.+| .+|++|||.|..+
T Consensus 1310 ~IFMEyC~~GsLa~ll~~---gri~dE~vt~vyt~qll~gla~LH~-~gIVHRDIK~aNI~Ld~~g-~iK~~DFGsa~ki 1384 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLEH---GRIEDEMVTRVYTKQLLEGLAYLHE-HGIVHRDIKPANILLDFNG-LIKYGDFGSAVKI 1384 (1509)
T ss_pred HHHHHHhccCcHHHHHHh---cchhhhhHHHHHHHHHHHHHHHHHh-cCceecCCCccceeeecCC-cEEeecccceeEe
Confidence 899999998777644332 4556777888999999999999998 8999999999999999888 8999999999887
Q ss_pred CCCC-----CCccccccCCccccccccCCC--CCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 012233 291 VPGE-----PNISYICSRYYRAPELIFGAT--EYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREE 363 (468)
Q Consensus 291 ~~~~-----~~~~~~gt~~y~aPE~~~~~~--~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~ 363 (468)
.+.. ......||+.|||||++.+.. +...+.|||||||++.||+||+.||...++.-++.-.+.....|.
T Consensus 1385 ~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq--- 1461 (1509)
T KOG4645|consen 1385 KNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQ--- 1461 (1509)
T ss_pred cCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCC---
Confidence 5543 123578999999999997654 356799999999999999999999987665544433333333332
Q ss_pred HhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCCCCC
Q 012233 364 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNTC 432 (468)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~~ 432 (468)
++..++.+.+|||.+||+.||.+|.++.|+|.|-|=+..+++.+.
T Consensus 1462 ------------------------~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~~d~~s~ 1506 (1509)
T KOG4645|consen 1462 ------------------------IPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSCTDEDSS 1506 (1509)
T ss_pred ------------------------CchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhccccccccchh
Confidence 556799999999999999999999999999999998887765543
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=319.71 Aligned_cols=249 Identities=28% Similarity=0.434 Sum_probs=201.6
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-------chHHHHHHHHHHcCCCCcccccceeeecCCCCceEE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~ 210 (468)
.|.+.+.||+|+||.||+|.+..+|+.||+|++.... ....+|+.+++.++||||+++++++. +....
T Consensus 16 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~-----~~~~~ 90 (307)
T cd06607 16 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYL-----REHTA 90 (307)
T ss_pred hhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEE-----eCCeE
Confidence 4999999999999999999999899999999885321 23457999999999999999999984 33458
Q ss_pred EEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcccc
Q 012233 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (468)
Q Consensus 211 ~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~ 290 (468)
|+||||+.+++...+.. ....+++..+..++.||+.||.|||+ .||+|+||+|+||+++.++ .++|+|||++...
T Consensus 91 ~lv~e~~~g~l~~~~~~---~~~~l~~~~~~~~~~ql~~~L~~LH~-~~i~H~dl~p~nIl~~~~~-~~kL~dfg~~~~~ 165 (307)
T cd06607 91 WLVMEYCLGSASDILEV---HKKPLQEVEIAAICHGALQGLAYLHS-HERIHRDIKAGNILLTEPG-TVKLADFGSASLV 165 (307)
T ss_pred EEEHHhhCCCHHHHHHH---cccCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCcccEEECCCC-CEEEeecCcceec
Confidence 89999999887765432 23468899999999999999999998 8999999999999999888 7999999998754
Q ss_pred CCCCCCccccccCCccccccccC--CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 012233 291 VPGEPNISYICSRYYRAPELIFG--ATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368 (468)
Q Consensus 291 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 368 (468)
... ....+++.|+|||++.+ ...++.++||||||+++|+|++|..||.+.+.......+... .+
T Consensus 166 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~--~~--------- 231 (307)
T cd06607 166 SPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--DS--------- 231 (307)
T ss_pred CCC---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcC--CC---------
Confidence 322 34577889999998842 344788999999999999999999999876655443333210 00
Q ss_pred CCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q 012233 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426 (468)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 426 (468)
+.+ .....+..+.++|.+||+.||.+||++.+++.||||..-
T Consensus 232 --------~~~--------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 273 (307)
T cd06607 232 --------PTL--------SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRE 273 (307)
T ss_pred --------CCC--------CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccc
Confidence 000 012357789999999999999999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=316.24 Aligned_cols=257 Identities=28% Similarity=0.415 Sum_probs=200.7
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-----chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEE
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 211 (468)
.+|++.+.||+|+||+||++.+..+|..||+|++.... ..+.+|+++++.++||||+++++++ .+...++
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 79 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF-----LNENNIC 79 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeE-----ecCCEEE
Confidence 46999999999999999999999999999999875432 2345799999999999999999998 3445689
Q ss_pred EEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccC
Q 012233 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (468)
Q Consensus 212 lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~ 291 (468)
+||||++++.+.... .....+++..++.++.|++.||.|||+..||+|+||||+||+++.++ .++|+|||++....
T Consensus 80 lv~e~~~~~~L~~~~---~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~-~~~l~d~gl~~~~~ 155 (284)
T cd06620 80 MCMEFMDCGSLDRIY---KKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRG-QIKLCDFGVSGELI 155 (284)
T ss_pred EEEecCCCCCHHHHH---HhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCC-cEEEccCCcccchh
Confidence 999999987654332 22356889999999999999999999646999999999999999887 79999999986543
Q ss_pred CCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHH----H---HHHHHHHhCCCCHHHH
Q 012233 292 PGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVD----Q---LVEIIKILGTPTREEI 364 (468)
Q Consensus 292 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~----~---~~~i~~~~~~~~~~~~ 364 (468)
.. ......|+..|+|||++.+. .++.++|+|||||++|+|++|..||......+ . +.........
T Consensus 156 ~~-~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------ 227 (284)
T cd06620 156 NS-IADTFVGTSTYMSPERIQGG-KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQ------ 227 (284)
T ss_pred hh-ccCccccCcccCCHHHHccC-CCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhh------
Confidence 22 22345789999999998654 58999999999999999999999998654321 1 1111111000
Q ss_pred hhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q 012233 365 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (468)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~ 427 (468)
. ....+ ....++.++.+||.+||+.||.+|||+.|+++||||..-.
T Consensus 228 -~-----~~~~~-----------~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~ 273 (284)
T cd06620 228 -E-----PPPRL-----------PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQAL 273 (284)
T ss_pred -c-----cCCCC-----------CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 0 00000 0112678899999999999999999999999999997643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=314.02 Aligned_cols=245 Identities=21% Similarity=0.248 Sum_probs=192.6
Q ss_pred cceEEeceecccCceEEEEEEEc---CCCCEEEEEEeeccc-----chHHHHHHHHHHcCCCCcccccceeeecCCCCce
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCL---ETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~---~~g~~vaiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 208 (468)
.+|.+.+.||+|+||.||+|.+. ..+..||+|.+.... ..+.+|+.+++.++||||+++++++. ...
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~ 79 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVIT-----RGN 79 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEe-----cCC
Confidence 35999999999999999999875 346789999886542 23457999999999999999999884 334
Q ss_pred EEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcc
Q 012233 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (468)
Q Consensus 209 ~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~ 288 (468)
..++||||++++.+..... .....+++..++.++.||+.||+|||+ +|++||||||+|||++.++ .++|+|||.+.
T Consensus 80 ~~~lv~e~~~~~~L~~~l~--~~~~~l~~~~~~~~~~~i~~al~~lH~-~~iiH~dikp~nili~~~~-~~~l~dfg~~~ 155 (266)
T cd05064 80 TMMIVTEYMSNGALDSFLR--KHEGQLVAGQLMGMLPGLASGMKYLSE-MGYVHKGLAAHKVLVNSDL-VCKISGFRRLQ 155 (266)
T ss_pred CcEEEEEeCCCCcHHHHHH--hCCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeeccccHhhEEEcCCC-cEEECCCcccc
Confidence 5889999999876654332 223468899999999999999999998 8999999999999999887 79999999876
Q ss_pred ccCCCCCC--ccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 012233 289 MLVPGEPN--ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIK 365 (468)
Q Consensus 289 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 365 (468)
........ ....++..|+|||++.+. .++.++|||||||++||+++ |..||.+.+..+.+..+....
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~--------- 225 (266)
T cd05064 156 EDKSEAIYTTMSGKSPVLWAAPEAIQYH-HFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGF--------- 225 (266)
T ss_pred cccccchhcccCCCCceeecCHHHHhhC-CccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCC---------
Confidence 54222111 123346789999998654 48999999999999999775 999998877665444432210
Q ss_pred hcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 366 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
..+ .+..++..+.+++.+||+.+|.+||++.+++.
T Consensus 226 ---------~~~----------~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 226 ---------RLP----------APRNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred ---------CCC----------CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 001 22457889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=324.41 Aligned_cols=279 Identities=34% Similarity=0.571 Sum_probs=226.9
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeecccchH---HHHHHHHHHcC------CCCcccccceeeecCCCCce
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYK---NRELQIMRLLN------HPNVVSLKHCFFSTTEKDEL 208 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~~~~---~~E~~il~~l~------hpnIv~l~~~~~~~~~~~~~ 208 (468)
.|.+.-..|+|-|++|..|.+..-|..||||+|...+.+. .+|++||++|+ .-|+++|+..| ....
T Consensus 433 RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F-----~hkn 507 (752)
T KOG0670|consen 433 RYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHF-----KHKN 507 (752)
T ss_pred eeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHh-----hhcc
Confidence 6888888999999999999999999999999998766543 47999999996 34899999999 6666
Q ss_pred EEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcc
Q 012233 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (468)
Q Consensus 209 ~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~ 288 (468)
++|||+|-+.-.|.++++.+.+ +-.+.+..++.|+.|+..||..|.. +||+|.||||+||||+.....+||||||.|.
T Consensus 508 HLClVFE~LslNLRevLKKyG~-nvGL~ikaVRsYaqQLflALklLK~-c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~ 585 (752)
T KOG0670|consen 508 HLCLVFEPLSLNLREVLKKYGR-NVGLHIKAVRSYAQQLFLALKLLKK-CGVLHADIKPDNILVNESKNILKLCDFGSAS 585 (752)
T ss_pred eeEEEehhhhchHHHHHHHhCc-ccceeehHHHHHHHHHHHHHHHHHh-cCeeecccCccceEeccCcceeeeccCcccc
Confidence 7999999999999999888776 4568889999999999999999998 8999999999999999888789999999998
Q ss_pred ccCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh--
Q 012233 289 MLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKC-- 366 (468)
Q Consensus 289 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~-- 366 (468)
..... ....+..+..|.|||++.|.+ |+...|+||+||+||||.||+..|++.++.+.+...+.+.|..+...++.
T Consensus 586 ~~~en-eitPYLVSRFYRaPEIiLG~~-yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgq 663 (752)
T KOG0670|consen 586 FASEN-EITPYLVSRFYRAPEIILGLP-YDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQ 663 (752)
T ss_pred ccccc-cccHHHHHHhccCcceeecCc-ccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcc
Confidence 76443 334566788999999999876 99999999999999999999999999999999888888888877766653
Q ss_pred -cCCCCc-cCCCCcccCCCc---------cc---------cc--ccCCC-------HHHHHHHHHhcccCCCCCCCHHHH
Q 012233 367 -MNPNYT-EFKFPQIKAHPW---------HK---------IF--HKRMP-------PEALDLVSRLLQYSPSLRCTALEA 417 (468)
Q Consensus 367 -~~~~~~-~~~~~~~~~~~~---------~~---------~~--~~~~~-------~~l~~li~~~L~~dP~~R~s~~el 417 (468)
.++.|. .+.|-.+..... .. .+ -..++ ..+++|+.+||.+||++|+|..|+
T Consensus 664 F~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqA 743 (752)
T KOG0670|consen 664 FKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQA 743 (752)
T ss_pred hhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHH
Confidence 112221 111111111110 00 00 01122 258899999999999999999999
Q ss_pred hCCCCCCC
Q 012233 418 CAHPFFDD 425 (468)
Q Consensus 418 l~hp~f~~ 425 (468)
|.||||+.
T Consensus 744 L~HpFi~~ 751 (752)
T KOG0670|consen 744 LKHPFITE 751 (752)
T ss_pred hcCCcccC
Confidence 99999974
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=308.22 Aligned_cols=251 Identities=29% Similarity=0.486 Sum_probs=198.3
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeecccc------hHHHHHHHHHHcCCCCcccccceeeecCCCCceEEE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR------YKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~~------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 211 (468)
+|.+.+.||+|+||.||+|.+..++..||+|.+..... ...+|+.+++.++|+||+++++.+ .+...++
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~-----~~~~~~~ 75 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVE-----VHREKVY 75 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeE-----ecCCEEE
Confidence 48899999999999999999988999999999864432 345799999999999999999987 3445688
Q ss_pred EEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccC
Q 012233 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (468)
Q Consensus 212 lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~ 291 (468)
+|+||+.++.+..... ....+++..++.++.|++.||.|||+ .||+|+||+|+||+++.++ .+||+|||++....
T Consensus 76 lv~e~~~~~~L~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lh~-~~i~H~dl~~~nil~~~~~-~~kl~d~g~~~~~~ 150 (264)
T cd06626 76 IFMEYCSGGTLEELLE---HGRILDEHVIRVYTLQLLEGLAYLHS-HGIVHRDIKPANIFLDHNG-VIKLGDFGCAVKLK 150 (264)
T ss_pred EEEecCCCCcHHHHHh---hcCCCChHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCC-CEEEcccccccccC
Confidence 9999998765543322 23457888899999999999999998 8999999999999999877 79999999987764
Q ss_pred CCCCC-----ccccccCCccccccccCCC--CCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 012233 292 PGEPN-----ISYICSRYYRAPELIFGAT--EYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEI 364 (468)
Q Consensus 292 ~~~~~-----~~~~gt~~y~aPE~~~~~~--~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 364 (468)
..... ....+++.|+|||++.+.. .++.++|||||||++|+|++|+.||............+.. +.
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~------ 223 (264)
T cd06626 151 NNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-GH------ 223 (264)
T ss_pred CCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc-CC------
Confidence 33221 1346788999999986543 3788999999999999999999999765433322222111 00
Q ss_pred hhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 012233 365 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (468)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f 423 (468)
...+|. ...+++.+.+||.+||+.||.+||++.+++.|||+
T Consensus 224 --------~~~~~~----------~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 224 --------KPPIPD----------SLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred --------CCCCCc----------ccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 001111 12358899999999999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=311.11 Aligned_cols=246 Identities=33% Similarity=0.523 Sum_probs=192.3
Q ss_pred ceecccCceEEEEEEEcCCCCEEEEEEeecccc-------hHHHHHHH-HHHcCCCCcccccceeeecCCCCceEEEEEe
Q 012233 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR-------YKNRELQI-MRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (468)
Q Consensus 143 ~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~~-------~~~~E~~i-l~~l~hpnIv~l~~~~~~~~~~~~~~~~lv~ 214 (468)
+.||.|+||.||+|.+..+|+.||+|.+.+... ....|..+ ...+.|+||+++++++ .....+|+||
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~ 76 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF-----QSKDYLYLVM 76 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeE-----EcCCeEEEEE
Confidence 468999999999999999999999998854321 11234333 3455899999999988 3444689999
Q ss_pred ecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCCCC
Q 012233 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGE 294 (468)
Q Consensus 215 e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~~~ 294 (468)
||++++.+..+.. ....+++..+..++.||+.||.|||+ .||+|+||+|+|||++.++ .++|+|||++.....
T Consensus 77 e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~lH~-~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~-- 149 (260)
T cd05611 77 EYLNGGDCASLIK---TLGGLPEDWAKQYIAEVVLGVEDLHQ-RGIIHRDIKPENLLIDQTG-HLKLTDFGLSRNGLE-- 149 (260)
T ss_pred eccCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECCCC-cEEEeecccceeccc--
Confidence 9998765543322 23568899999999999999999998 8999999999999999887 799999999875432
Q ss_pred CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccC
Q 012233 295 PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEF 374 (468)
Q Consensus 295 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 374 (468)
.....++..|+|||.+.+.. ++.++||||||+++|+|++|..||...+.......+... ..
T Consensus 150 -~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-----------------~~ 210 (260)
T cd05611 150 -NKKFVGTPDYLAPETILGVG-DDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSR-----------------RI 210 (260)
T ss_pred -cccCCCCcCccChhhhcCCC-CcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhc-----------------cc
Confidence 23456888999999987655 899999999999999999999999877665544433221 00
Q ss_pred CCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCC---HHHHhCCCCCCCCC
Q 012233 375 KFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCT---ALEACAHPFFDDLR 427 (468)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s---~~ell~hp~f~~~~ 427 (468)
.++ ......+++++.++|.+||+.||++||+ ++|++.||||+++.
T Consensus 211 ~~~--------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~ 258 (260)
T cd05611 211 NWP--------EEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSIN 258 (260)
T ss_pred CCC--------CcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCC
Confidence 000 1122347899999999999999999995 57999999998753
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=316.81 Aligned_cols=260 Identities=25% Similarity=0.372 Sum_probs=200.6
Q ss_pred CcccceEEeceecccCceEEEEEEEcCCCCEEEEEEeecccc-----hHHHHHHHHHHc-CCCCcccccceeeecCCCCc
Q 012233 134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR-----YKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDE 207 (468)
Q Consensus 134 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~~-----~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~~ 207 (468)
...++|.+.+.||+|+||.||+|.+..+++.||||.+..... ...+|+.++..+ .||||+++++++ .+.
T Consensus 12 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~ 86 (296)
T cd06618 12 ADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYF-----ITD 86 (296)
T ss_pred CCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheee-----ecC
Confidence 344579999999999999999999988899999999864321 223466555555 499999999998 444
Q ss_pred eEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCc
Q 012233 208 LYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (468)
Q Consensus 208 ~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a 287 (468)
..+|+||||+++.+..+.... ...+++..+..++.||+.||.|||+..||+||||+|+||+++.++ .+||+|||++
T Consensus 87 ~~~~~v~e~~~~~l~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~-~~kL~dfg~~ 162 (296)
T cd06618 87 SDVFICMELMSTCLDKLLKRI---QGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASG-NVKLCDFGIS 162 (296)
T ss_pred CeEEEEeeccCcCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCC-CEEECccccc
Confidence 568999999987666554332 346888999999999999999999635999999999999999887 7999999998
Q ss_pred cccCCCCCCccccccCCccccccccCC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCCCCHHH
Q 012233 288 KMLVPGEPNISYICSRYYRAPELIFGA---TEYTTAIDMWSIGCVLAELLLGQPLFPGESGV-DQLVEIIKILGTPTREE 363 (468)
Q Consensus 288 ~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~-~~~~~i~~~~~~~~~~~ 363 (468)
..+..........++..|+|||.+.+. ..++.++|+|||||++|+|++|+.||...... +.+..+... .
T Consensus 163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~---~---- 235 (296)
T cd06618 163 GRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQE---E---- 235 (296)
T ss_pred hhccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcC---C----
Confidence 766444433445678899999998644 23788999999999999999999999764322 222222210 0
Q ss_pred HhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCC
Q 012233 364 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRD 428 (468)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~ 428 (468)
...++ ....++.++.+||.+||..||.+||++.+++.||||+..+.
T Consensus 236 ---------~~~~~----------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 281 (296)
T cd06618 236 ---------PPSLP----------PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYET 281 (296)
T ss_pred ---------CCCCC----------CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccch
Confidence 00000 01136789999999999999999999999999999986543
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=311.94 Aligned_cols=247 Identities=26% Similarity=0.368 Sum_probs=190.2
Q ss_pred ceEEecee--cccCceEEEEEEEcCCCCEEEEEEeecccchHHHHHHHHHHc-CCCCcccccceeeecCCCCceEEEEEe
Q 012233 138 SYMAERVV--GTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDELYLNLVL 214 (468)
Q Consensus 138 ~y~~~~~l--G~G~fg~Vy~~~~~~~g~~vaiK~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~lv~ 214 (468)
.|.+.+.+ |+|+||.||++..+.++..+|+|.+...... ..|+.+...+ +||||++++++|. .....|+||
T Consensus 15 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~-~~e~~~~~~~~~h~~iv~~~~~~~-----~~~~~~iv~ 88 (267)
T PHA03390 15 NCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN-AIEPMVHQLMKDNPNFIKLYYSVT-----TLKGHVLIM 88 (267)
T ss_pred hhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcc-hhhHHHHHHhhcCCCEEEEEEEEe-----cCCeeEEEE
Confidence 35565555 9999999999999999999999988653221 1234343333 6999999999884 344689999
Q ss_pred ecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCCC
Q 012233 215 EYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293 (468)
Q Consensus 215 e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~~ 293 (468)
||++++ +...+. ....+++..++.++.||+.||.|||+ .||+||||||+||+++.++..++|+|||++.....
T Consensus 89 e~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~- 162 (267)
T PHA03390 89 DYIKDGDLFDLLK----KEGKLSEAEVKKIIRQLVEALNDLHK-HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT- 162 (267)
T ss_pred EcCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEEeCCCCeEEEecCccceecCC-
Confidence 999865 444332 23478999999999999999999998 89999999999999998875799999999876532
Q ss_pred CCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHHhCCCCHHHHhhcCCCCc
Q 012233 294 EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQ-LVEIIKILGTPTREEIKCMNPNYT 372 (468)
Q Consensus 294 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~ 372 (468)
.....++..|+|||++.+.. ++.++|||||||++|+|++|..||........ ...+......
T Consensus 163 --~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-------------- 225 (267)
T PHA03390 163 --PSCYDGTLDYFSPEKIKGHN-YDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQK-------------- 225 (267)
T ss_pred --CccCCCCCcccChhhhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcc--------------
Confidence 22456889999999996554 89999999999999999999999986543321 1111111000
Q ss_pred cCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCC-HHHHhCCCCCCC
Q 012233 373 EFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCT-ALEACAHPFFDD 425 (468)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s-~~ell~hp~f~~ 425 (468)
. ....+.+++.+.+||.+||+.||.+|++ ++++|+||||+.
T Consensus 226 ~------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 226 K------------LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred c------------CCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence 0 0122358899999999999999999996 599999999974
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-41 Score=329.82 Aligned_cols=271 Identities=28% Similarity=0.457 Sum_probs=211.8
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-------chHHHHHHHHHHcCCCCcccccceeeecCCCCceEE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~ 210 (468)
-|..++.||-|+||+|.++....+...||+|.+.+.. ...+.|..||...+.+-||+||-.| .|...+
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySF-----QDkdnL 704 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSF-----QDKDNL 704 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEe-----ccCCce
Confidence 3888899999999999999988899999999885543 2334689999999999999998888 677779
Q ss_pred EEEeecccchHH-HHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccc
Q 012233 211 NLVLEYISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (468)
Q Consensus 211 ~lv~e~~~~~ll-~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~ 289 (468)
|+||||++||-. .++.. .+-|++..+++|+..+..|+++.|+ .|+|||||||+|||||.+|| |||+|||+++-
T Consensus 705 YFVMdYIPGGDmMSLLIr----mgIFeE~LARFYIAEltcAiesVHk-mGFIHRDiKPDNILIDrdGH-IKLTDFGLCTG 778 (1034)
T KOG0608|consen 705 YFVMDYIPGGDMMSLLIR----MGIFEEDLARFYIAELTCAIESVHK-MGFIHRDIKPDNILIDRDGH-IKLTDFGLCTG 778 (1034)
T ss_pred EEEEeccCCccHHHHHHH----hccCHHHHHHHHHHHHHHHHHHHHh-ccceecccCccceEEccCCc-eeeeecccccc
Confidence 999999997633 33222 4668999999999999999999998 89999999999999999995 99999999853
Q ss_pred cCC---------CCCC----------------------------------ccccccCCccccccccCCCCCCcchhHHHH
Q 012233 290 LVP---------GEPN----------------------------------ISYICSRYYRAPELIFGATEYTTAIDMWSI 326 (468)
Q Consensus 290 ~~~---------~~~~----------------------------------~~~~gt~~y~aPE~~~~~~~~~~~~DvwSl 326 (468)
+.. +... -..+||+.|+|||++... .|+..+|+||.
T Consensus 779 fRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~-g~~q~cdwws~ 857 (1034)
T KOG0608|consen 779 FRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLART-GYTQLCDWWSV 857 (1034)
T ss_pred ceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhccc-CccccchhhHh
Confidence 311 0000 146799999999999754 59999999999
Q ss_pred HHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhccc
Q 012233 327 GCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQY 406 (468)
Q Consensus 327 G~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 406 (468)
|||||||+.|++||...+..+...+++... ++ +.|+ +-..+++++.+||.+++.
T Consensus 858 gvil~em~~g~~pf~~~tp~~tq~kv~nw~-------------~~--l~~~----------~~~~ls~e~~~li~kLc~- 911 (1034)
T KOG0608|consen 858 GVILYEMLVGQPPFLADTPGETQYKVINWR-------------NF--LHIP----------YQGNLSKEALDLIQKLCC- 911 (1034)
T ss_pred hHHHHHHhhCCCCccCCCCCcceeeeeehh-------------hc--cccc----------cccccCHHHHHHHHHHhc-
Confidence 999999999999999887766655544310 01 1111 224689999999987653
Q ss_pred CCCCCC---CHHHHhCCCCCCCCCCCCCCCCCCCCCCcc------cccC
Q 012233 407 SPSLRC---TALEACAHPFFDDLRDPNTCLPNGRPLPTL------FNFT 446 (468)
Q Consensus 407 dP~~R~---s~~ell~hp~f~~~~~~~~~~~~~~~~~~~------~~~~ 446 (468)
+++.|+ .++|+..||||+.|...+...-..+=+|.+ .||+
T Consensus 912 sad~RLGkng~d~vKaHpfFkgIDfsslRkq~ApYIP~ItHptDTSNFd 960 (1034)
T KOG0608|consen 912 SADSRLGKNGADQVKAHPFFKGIDFSSLRKQRAPYIPRITHPTDTSNFD 960 (1034)
T ss_pred ChhhhhcccchhhhhcCccccccchHhhhhccCCcCccccCCCccccCC
Confidence 467776 578899999999988776553333335554 5666
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=325.93 Aligned_cols=278 Identities=20% Similarity=0.304 Sum_probs=196.9
Q ss_pred ceeccc--CceEEEEEEEcCCCCEEEEEEeeccc------chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEEEe
Q 012233 143 RVVGTG--SFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (468)
Q Consensus 143 ~~lG~G--~fg~Vy~~~~~~~g~~vaiK~~~~~~------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv~ 214 (468)
..||.| +||+||+|.+..+|+.||+|++.... ..+.+|+.+++.++||||++++++| ....++++||
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~-----~~~~~~~~v~ 78 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVF-----TTGSWLWVIS 78 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeE-----ecCCceEEEE
Confidence 456776 99999999999999999999885432 2345788999999999999999998 3444689999
Q ss_pred ecccchHH-HHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCCC
Q 012233 215 EYISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293 (468)
Q Consensus 215 e~~~~~ll-~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~~ 293 (468)
||+.++.+ .++... ....+++..+..++.||+.||+|||+ .||+||||||+|||++.++ .++++||+.+......
T Consensus 79 e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~qi~~aL~~lH~-~~ivHrDlkp~Nill~~~~-~~~~~~~~~~~~~~~~ 154 (328)
T cd08226 79 PFMAYGSANSLLKTY--FPEGMSEALIGNILFGALRGLNYLHQ-NGYIHRNIKASHILISGDG-LVSLSGLSHLYSLVRN 154 (328)
T ss_pred ecccCCCHHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEeCCC-cEEEechHHHhhhhcc
Confidence 99986544 333322 13458899999999999999999998 8999999999999999887 7999999865332211
Q ss_pred CCC--------ccccccCCccccccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH--
Q 012233 294 EPN--------ISYICSRYYRAPELIFGA-TEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTRE-- 362 (468)
Q Consensus 294 ~~~--------~~~~gt~~y~aPE~~~~~-~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~-- 362 (468)
... ....++..|+|||++.+. ..++.++|||||||++|+|++|..||........+..+.......+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (328)
T cd08226 155 GQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDIT 234 (328)
T ss_pred CccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCcccc
Confidence 110 112345679999998654 347899999999999999999999998876555444433211100000
Q ss_pred -------HHhhcCCCCc----cCCCC-----cccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q 012233 363 -------EIKCMNPNYT----EFKFP-----QIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426 (468)
Q Consensus 363 -------~~~~~~~~~~----~~~~~-----~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 426 (468)
........+. +.... ......+.......+++.+.+||.+||+.||.+|||+.++|+||||+.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~ 314 (328)
T cd08226 235 TFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQV 314 (328)
T ss_pred ccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHH
Confidence 0000000000 00000 0000111111233467889999999999999999999999999999987
Q ss_pred CCC
Q 012233 427 RDP 429 (468)
Q Consensus 427 ~~~ 429 (468)
.+.
T Consensus 315 ~~~ 317 (328)
T cd08226 315 KEQ 317 (328)
T ss_pred HHh
Confidence 764
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=309.43 Aligned_cols=245 Identities=26% Similarity=0.460 Sum_probs=197.6
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-----chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~l 212 (468)
+|.+.+.||.|+||.||++.+..++..||+|.+.... ....+|+.+++.++|+||+++++.+ .+..++|+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l 75 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF-----EADGHLYI 75 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEE-----EECCEEEE
Confidence 4889999999999999999999999999999875322 2345689999999999999999988 44456899
Q ss_pred Eeecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccC
Q 012233 213 VLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (468)
Q Consensus 213 v~e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~ 291 (468)
||||++++ +...+.. .....+++..+..++.||+.||.|||+ +||+|+||||+|||++.++ .++|+|||.+....
T Consensus 76 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~~~i~~al~~lH~-~~i~H~dl~p~nili~~~~-~~~l~dfg~~~~~~ 151 (255)
T cd08219 76 VMEYCDGGDLMQKIKL--QRGKLFPEDTILQWFVQMCLGVQHIHE-KRVLHRDIKSKNIFLTQNG-KVKLGDFGSARLLT 151 (255)
T ss_pred EEeeCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCcceEEECCCC-cEEEcccCcceeec
Confidence 99999865 4443322 123457889999999999999999998 8999999999999999887 79999999987654
Q ss_pred CCC-CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCC
Q 012233 292 PGE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPN 370 (468)
Q Consensus 292 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 370 (468)
... ......+++.|+|||++.+.. ++.++|+||||+++|+|++|..||...+.......+....
T Consensus 152 ~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~-------------- 216 (255)
T cd08219 152 SPGAYACTYVGTPYYVPPEIWENMP-YNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGS-------------- 216 (255)
T ss_pred ccccccccccCCccccCHHHHccCC-cCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCC--------------
Confidence 322 233467889999999986544 8999999999999999999999998776555444433210
Q ss_pred CccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCC
Q 012233 371 YTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (468)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~h 420 (468)
+ ..++..++..+.+||.+||+.||.+||++.+++.-
T Consensus 217 -----~---------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 217 -----Y---------KPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred -----C---------CCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 0 00223478889999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=327.96 Aligned_cols=249 Identities=23% Similarity=0.327 Sum_probs=191.0
Q ss_pred ccceEEeceecccCceEEEEEEE-----cCCCCEEEEEEeeccc-----chHHHHHHHHHHc-CCCCcccccceeeecCC
Q 012233 136 TISYMAERVVGTGSFGVVFQAKC-----LETGDSVAIKKVLQDK-----RYKNRELQIMRLL-NHPNVVSLKHCFFSTTE 204 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~-----~~~g~~vaiK~~~~~~-----~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~ 204 (468)
..+|.+.+.||+|+||.||+|.+ ..++..||||++.... ....+|+.+++.+ +||||+++++++
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~----- 108 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGAC----- 108 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeee-----
Confidence 34799999999999999999974 3456789999885432 2345799999999 899999999988
Q ss_pred CCceEEEEEeecccch-HHHHHhhhh------------------------------------------------------
Q 012233 205 KDELYLNLVLEYISET-VYRVSKHYT------------------------------------------------------ 229 (468)
Q Consensus 205 ~~~~~~~lv~e~~~~~-ll~~~~~~~------------------------------------------------------ 229 (468)
.+....++|||||+++ ++..+....
T Consensus 109 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 188 (375)
T cd05104 109 TVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS 188 (375)
T ss_pred ccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence 4444588999999865 433332211
Q ss_pred -----------------hcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCC
Q 012233 230 -----------------RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (468)
Q Consensus 230 -----------------~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~ 292 (468)
.....+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++....
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~Nill~~~~-~~kl~DfG~a~~~~~ 266 (375)
T cd05104 189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS-KNCIHRDLAARNILLTHGR-ITKICDFGLARDIRN 266 (375)
T ss_pred cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCchhhEEEECCC-cEEEecCccceeccC
Confidence 001246788889999999999999998 8999999999999999877 799999999976543
Q ss_pred CCCC---ccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 012233 293 GEPN---ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368 (468)
Q Consensus 293 ~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 368 (468)
.... ....++..|+|||++.+.. ++.++|||||||++|||++ |..||........+.+++.....
T Consensus 267 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~---------- 335 (375)
T cd05104 267 DSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYR---------- 335 (375)
T ss_pred cccccccCCCCCCcceeChhHhcCCC-CCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCcc----------
Confidence 2211 1233456799999997654 8999999999999999997 89999876555444443331100
Q ss_pred CCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
...+...+.++.+||.+||+.||.+||++.++++
T Consensus 336 -----------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 369 (375)
T cd05104 336 -----------------MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQ 369 (375)
T ss_pred -----------------CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 0012336789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=317.60 Aligned_cols=255 Identities=26% Similarity=0.418 Sum_probs=202.7
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc----chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEE
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~l 212 (468)
.+|.+.+.||+|+||.||++.+..++..||+|.+.... ....+|+.+++.++||||+++++.+. +....|+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~-----~~~~~~l 93 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL-----VGDELWV 93 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheee-----eCCcEEE
Confidence 46999999999999999999998899999999874322 23456899999999999999999884 3445889
Q ss_pred EeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCC
Q 012233 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (468)
Q Consensus 213 v~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~ 292 (468)
|+||+.++.+..... ...+++..+..++.|++.||.|||+ +|++|+||||+||+++.++ .++|+|||++.....
T Consensus 94 v~e~~~~~~L~~~~~----~~~l~~~~~~~i~~~l~~al~~LH~-~gi~H~dL~p~Nili~~~~-~~kL~dfg~~~~~~~ 167 (293)
T cd06647 94 VMEYLAGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITP 167 (293)
T ss_pred EEecCCCCcHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHh-CCEeeccCCHHHEEEcCCC-CEEEccCcceecccc
Confidence 999998765543221 2457888899999999999999998 8999999999999999887 799999998865543
Q ss_pred CC-CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCC
Q 012233 293 GE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNY 371 (468)
Q Consensus 293 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 371 (468)
.. ......+++.|+|||.+.+. .++.++|+|||||++|+|++|+.||...+..+.+..+.. .+.+
T Consensus 168 ~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~-~~~~------------ 233 (293)
T cd06647 168 EQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTP------------ 233 (293)
T ss_pred cccccccccCChhhcCchhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhc-CCCC------------
Confidence 32 22334688899999998654 488999999999999999999999987655443222111 0000
Q ss_pred ccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCC
Q 012233 372 TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDP 429 (468)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~ 429 (468)
.+ ..+..++..++++|.+||..+|.+||++.+++.||||+..+.-
T Consensus 234 ---~~----------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~~~ 278 (293)
T cd06647 234 ---EL----------QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKPL 278 (293)
T ss_pred ---CC----------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCccc
Confidence 00 0123467889999999999999999999999999999876543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=314.03 Aligned_cols=253 Identities=27% Similarity=0.464 Sum_probs=201.5
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc-----cchHHHHHHHHHHcC---CCCcccccceeeecCCCCceE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLN---HPNVVSLKHCFFSTTEKDELY 209 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~-----~~~~~~E~~il~~l~---hpnIv~l~~~~~~~~~~~~~~ 209 (468)
.|.+.+.||.|+||.||+|.+..+++.||+|.+... .....+|+.+++.+. ||||+++++++. +..+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~-----~~~~ 76 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYL-----KGPR 76 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeee-----eCCE
Confidence 388889999999999999999999999999987543 123457899999997 999999999883 3446
Q ss_pred EEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccc
Q 012233 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (468)
Q Consensus 210 ~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~ 289 (468)
.|+||||+.++.+..... ...+++..+..++.|++.||.|||+ .||+|+||+|+||+++.++ .++|+|||++..
T Consensus 77 ~~lv~e~~~~~~L~~~~~----~~~l~~~~~~~i~~~i~~~l~~lh~-~~i~H~dl~p~ni~i~~~~-~~~l~dfg~~~~ 150 (277)
T cd06917 77 LWIIMEYAEGGSVRTLMK----AGPIAEKYISVIIREVLVALKYIHK-VGVIHRDIKAANILVTNTG-NVKLCDFGVAAL 150 (277)
T ss_pred EEEEEecCCCCcHHHHHH----ccCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCcCHHHEEEcCCC-CEEEccCCceee
Confidence 889999998765543322 2368899999999999999999998 8999999999999999877 799999999977
Q ss_pred cCCCC-CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 012233 290 LVPGE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368 (468)
Q Consensus 290 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 368 (468)
..... ......|+..|+|||.+.+...++.++|+|||||++|+|++|..||...........+..
T Consensus 151 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~-------------- 216 (277)
T cd06917 151 LNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPK-------------- 216 (277)
T ss_pred cCCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhcccc--------------
Confidence 64432 233457889999999987655578999999999999999999999977654332221110
Q ss_pred CCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCC
Q 012233 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRD 428 (468)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~ 428 (468)
...+.+ ....++.++.++|.+||+.||.+||++.+++.||||++...
T Consensus 217 -----~~~~~~--------~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~~ 263 (277)
T cd06917 217 -----SKPPRL--------EDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHSK 263 (277)
T ss_pred -----CCCCCC--------CcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhcccc
Confidence 000000 01126789999999999999999999999999999987553
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=313.91 Aligned_cols=251 Identities=25% Similarity=0.367 Sum_probs=201.6
Q ss_pred eEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-----chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEEE
Q 012233 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV 213 (468)
Q Consensus 139 y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv 213 (468)
|.+.+.||.|+||.||+|.+..++..||||.+.... ..+.+|+.+++.++||||+++++++ .+..+.|+|
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv 80 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY-----LKDTKLWII 80 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEE-----EeCCeEEEE
Confidence 788889999999999999998899999999875332 2345799999999999999999988 344468899
Q ss_pred eecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCCC
Q 012233 214 LEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293 (468)
Q Consensus 214 ~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~~ 293 (468)
|||++++.+..... ...+++..+..++.|++.||.|||+ .|++|+||||+||+++.++ .++|+|||++......
T Consensus 81 ~e~~~~~~l~~~i~----~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~dl~p~Ni~i~~~~-~~~l~dfg~~~~~~~~ 154 (277)
T cd06641 81 MEYLGGGSALDLLE----PGPLDETQIATILREILKGLDYLHS-EKKIHRDIKAANVLLSEHG-EVKLADFGVAGQLTDT 154 (277)
T ss_pred EEeCCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHcc-CCeecCCCCHHhEEECCCC-CEEEeecccceecccc
Confidence 99999765543221 3457899999999999999999998 8999999999999999887 7999999998765432
Q ss_pred C-CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCc
Q 012233 294 E-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYT 372 (468)
Q Consensus 294 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 372 (468)
. ......++..|+|||.+.+. .++.++|+|||||++|+|++|..||...........+... .
T Consensus 155 ~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~--------------- 217 (277)
T cd06641 155 QIKRNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKN-N--------------- 217 (277)
T ss_pred hhhhccccCCccccChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcC-C---------------
Confidence 2 12234678899999998654 4788999999999999999999999765544333322110 0
Q ss_pred cCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCC
Q 012233 373 EFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDP 429 (468)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~ 429 (468)
. ..+...++.++.++|.+||+.+|.+||++.+++.||||......
T Consensus 218 ---~---------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~~~~ 262 (277)
T cd06641 218 ---P---------PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRFAKK 262 (277)
T ss_pred ---C---------CCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhhhhc
Confidence 0 01234578899999999999999999999999999999885443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=306.57 Aligned_cols=250 Identities=30% Similarity=0.492 Sum_probs=203.1
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc------chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 211 (468)
+|.+.+.||.|+||.||++.+..++..|++|++.... ....+|+++++.++|+|++++++.+.. ....+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~-----~~~~~ 75 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEE-----KGKLC 75 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEec-----CCEEE
Confidence 4889999999999999999998899999999986432 234579999999999999999998843 35688
Q ss_pred EEeecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcccc
Q 012233 212 LVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (468)
Q Consensus 212 lv~e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~ 290 (468)
+|+||++++ +...+.........+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++ .++|+|||.+...
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~H~dl~~~nil~~~~~-~~~l~d~~~~~~~ 153 (258)
T cd08215 76 IVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS-RKILHRDIKPQNIFLTSNG-LVKLGDFGISKVL 153 (258)
T ss_pred EEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh-CCEecccCChHHeEEcCCC-cEEECCccceeec
Confidence 999999875 444443332234678999999999999999999998 8999999999999999877 7999999999765
Q ss_pred CCCC-CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 012233 291 VPGE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (468)
Q Consensus 291 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 369 (468)
.... ......|++.|+|||.+.+.. ++.++|+||+|+++|+|++|..||...+..+....+....
T Consensus 154 ~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~------------- 219 (258)
T cd08215 154 SSTVDLAKTVVGTPYYLSPELCQNKP-YNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQ------------- 219 (258)
T ss_pred ccCcceecceeeeecccChhHhccCC-CCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCC-------------
Confidence 4332 223457889999999986554 8899999999999999999999998776444433332210
Q ss_pred CCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 012233 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (468)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f 423 (468)
.+ .++..++.++.++|.+||..+|.+|||+.++|.||||
T Consensus 220 ------~~---------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 220 ------YP---------PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred ------CC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 00 0223578899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=308.41 Aligned_cols=252 Identities=33% Similarity=0.472 Sum_probs=202.9
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-----chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~l 212 (468)
+|++.+.||.|++|.||+|.+..+++.|++|++.... ....+|+.+++.++|+||+++++++ .....+++
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~l 76 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF-----YKEGEISI 76 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEE-----ccCCeEEE
Confidence 5899999999999999999999999999999886542 3456799999999999999999988 34456899
Q ss_pred EeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCC
Q 012233 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (468)
Q Consensus 213 v~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~ 292 (468)
||||+.++.+..... ....+++..+..++.|++.||.|||+..|++|+||+|+||+++.++ .++|+|||.+.....
T Consensus 77 v~e~~~~~~L~~~l~---~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~-~~~l~df~~~~~~~~ 152 (264)
T cd06623 77 VLEYMDGGSLADLLK---KVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKG-EVKIADFGISKVLEN 152 (264)
T ss_pred EEEecCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCC-CEEEccCccceeccc
Confidence 999999654432221 1366899999999999999999999527999999999999999888 799999999987644
Q ss_pred CCCC-ccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC--cHHH-HHHHHHHhCCCCHHHHhhcC
Q 012233 293 GEPN-ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGES--GVDQ-LVEIIKILGTPTREEIKCMN 368 (468)
Q Consensus 293 ~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~--~~~~-~~~i~~~~~~~~~~~~~~~~ 368 (468)
.... ....++..|+|||.+.+. .++.++|+||||+++|+|++|..||.... .... ...+.. ..
T Consensus 153 ~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~---~~--------- 219 (264)
T cd06623 153 TLDQCNTFVGTVTYMSPERIQGE-SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICD---GP--------- 219 (264)
T ss_pred CCCcccceeecccccCHhhhCCC-CCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhc---CC---------
Confidence 3332 245678999999998655 58999999999999999999999997764 2222 222211 00
Q ss_pred CCCccCCCCcccCCCcccccccC-CCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q 012233 369 PNYTEFKFPQIKAHPWHKIFHKR-MPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (468)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~ 427 (468)
.+ .+... ++..+.++|.+||..+|.+||++.++++||||+...
T Consensus 220 -------~~---------~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~~ 263 (264)
T cd06623 220 -------PP---------SLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKAD 263 (264)
T ss_pred -------CC---------CCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhcc
Confidence 00 01223 788999999999999999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-42 Score=307.26 Aligned_cols=285 Identities=34% Similarity=0.537 Sum_probs=225.3
Q ss_pred EEeceecccCceEEEEEEEcCCCCEEEEEEeecc------cchHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEEE
Q 012233 140 MAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV 213 (468)
Q Consensus 140 ~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~------~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv 213 (468)
+-.+.||.|+||.||.+.+..+|+.||+|++..- .....+|+++|.-.+|.|++..++..-...-.--..+|+|
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 3446799999999999999999999999988542 2334579999999999999998887622211000126678
Q ss_pred eecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCCC
Q 012233 214 LEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293 (468)
Q Consensus 214 ~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~~ 293 (468)
+|.+..++..++- ..+.++...++.+.+||++||+|||+ .||.||||||.|+||+++- .+||||||+++....+
T Consensus 136 TELmQSDLHKIIV----SPQ~Ls~DHvKVFlYQILRGLKYLHs-A~ILHRDIKPGNLLVNSNC-vLKICDFGLARvee~d 209 (449)
T KOG0664|consen 136 TELMQSDLHKIIV----SPQALTPDHVKVFVYQILRGLKYLHT-ANILHRDIKPGNLLVNSNC-ILKICDFGLARTWDQR 209 (449)
T ss_pred HHHHHhhhhheec----cCCCCCcchhhhhHHHHHhhhHHHhh-cchhhccCCCccEEeccCc-eEEecccccccccchh
Confidence 8888877665443 36778889999999999999999998 8999999999999999887 7999999999876443
Q ss_pred C--CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCC
Q 012233 294 E--PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNY 371 (468)
Q Consensus 294 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 371 (468)
. .....+.|-+|+|||+++|...|+.++||||.|||+.||+..+..|...++.+++..|...+|+|..+.++.....-
T Consensus 210 ~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGA 289 (449)
T KOG0664|consen 210 DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGA 289 (449)
T ss_pred hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhh
Confidence 3 23345679999999999999999999999999999999999999999999999999999999999999887543322
Q ss_pred ccCCCCcccCCCcccccc-----cCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCCC
Q 012233 372 TEFKFPQIKAHPWHKIFH-----KRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPN 430 (468)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~ 430 (468)
..-.+......+....+. ..-..+..+++..+|..||.+|++.++++.|+++.+.+...
T Consensus 290 k~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R~r~ 353 (449)
T KOG0664|consen 290 KNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGRLRF 353 (449)
T ss_pred HHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccceee
Confidence 221111111111111111 13345788999999999999999999999999999877644
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=307.06 Aligned_cols=302 Identities=31% Similarity=0.527 Sum_probs=234.7
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc------cchHHHHHHHHHHcCCCCcccccceeeecCC-CCceEE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTE-KDELYL 210 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~------~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~-~~~~~~ 210 (468)
+|.-.+.+|.|.- .|..|.+.-.++.||+|++... .+...+|..++..+.|+||++++.+|..... .....+
T Consensus 18 Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~ 96 (369)
T KOG0665|consen 18 RYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEV 96 (369)
T ss_pred eeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhH
Confidence 5888899999998 8888999999999999987443 2334579999999999999999998843322 112237
Q ss_pred EEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcccc
Q 012233 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (468)
Q Consensus 211 ~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~ 290 (468)
|+|||++...+...+.. .++-..+..+.+|++.|+.|||+ .||+||||||+||+|..+. .+||.|||+|+..
T Consensus 97 y~v~e~m~~nl~~vi~~------elDH~tis~i~yq~~~~ik~lhs-~~IihRdLkPsnivv~~~~-~lKi~dfg~ar~e 168 (369)
T KOG0665|consen 97 YLVMELMDANLCQVILM------ELDHETISYILYQMLCGIKHLHS-AGIIHRDLKPSNIVVNSDC-TLKILDFGLARTE 168 (369)
T ss_pred HHHHHhhhhHHHHHHHH------hcchHHHHHHHHHHHHHHHHHHh-cceeecccCcccceecchh-heeeccchhhccc
Confidence 89999999888776541 23445688899999999999998 8999999999999999887 8999999999876
Q ss_pred CCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC--
Q 012233 291 VPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN-- 368 (468)
Q Consensus 291 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-- 368 (468)
...-....++.|..|.|||++.+.. |...+||||+||++.||++|...|++.+..++..++++.+|.|.+..+..+.
T Consensus 169 ~~~~~mtpyVvtRyyrapevil~~~-~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~ 247 (369)
T KOG0665|consen 169 DTDFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPT 247 (369)
T ss_pred CcccccCchhheeeccCchheeccC-CcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHH
Confidence 5554566788999999999998877 9999999999999999999999999999999999999999999887665433
Q ss_pred --------CCCccCCCCc-ccCCCccccc--ccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCCCCCCCCCC
Q 012233 369 --------PNYTEFKFPQ-IKAHPWHKIF--HKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNTCLPNGR 437 (468)
Q Consensus 369 --------~~~~~~~~~~-~~~~~~~~~~--~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~~~~~~~ 437 (468)
+.+..+.|.. ++...|.... .+.-+..+++|+.+||..||++|.+++++|.||||+-+-+++......+
T Consensus 248 ~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw~~~~ev~ap~p 327 (369)
T KOG0665|consen 248 VRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVWYDPDEVEAPPP 327 (369)
T ss_pred HHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeeecccccccCCCC
Confidence 3333333332 1222222111 1223456899999999999999999999999999995544544433333
Q ss_pred CCCcccccCHHHH
Q 012233 438 PLPTLFNFTAQEL 450 (468)
Q Consensus 438 ~~~~~~~~~~~~~ 450 (468)
+ +-...|+.++.
T Consensus 328 e-~~d~~~d~~~~ 339 (369)
T KOG0665|consen 328 E-IYDKQLDEREH 339 (369)
T ss_pred c-hhhhhcccccC
Confidence 3 33355553333
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=307.88 Aligned_cols=248 Identities=26% Similarity=0.437 Sum_probs=198.2
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc---------cchHHHHHHHHHHcCCCCcccccceeeecCCCCce
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~---------~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 208 (468)
+|.+.+.||+|+||.||+|.+..++..||+|.+... ...+.+|+.+++.++|+||+++++++... ...
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~---~~~ 79 (264)
T cd06653 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDP---EEK 79 (264)
T ss_pred ceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcC---CCC
Confidence 599999999999999999999999999999987422 12345799999999999999999987432 233
Q ss_pred EEEEEeecccchHHH-HHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCc
Q 012233 209 YLNLVLEYISETVYR-VSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (468)
Q Consensus 209 ~~~lv~e~~~~~ll~-~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a 287 (468)
.+++||||++++.+. .+. ....+++..++.++.||+.||.|||+ .||+|+||||+||+++.++ .++|+|||++
T Consensus 80 ~~~~v~e~~~~~~L~~~~~----~~~~l~~~~~~~~~~~i~~al~~LH~-~~i~H~dl~p~ni~i~~~~-~~~l~dfg~~ 153 (264)
T cd06653 80 KLSIFVEYMPGGSIKDQLK----AYGALTENVTRRYTRQILQGVSYLHS-NMIVHRDIKGANILRDSAG-NVKLGDFGAS 153 (264)
T ss_pred EEEEEEEeCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEcCCC-CEEECccccc
Confidence 578999999876443 322 23457888999999999999999998 8999999999999999887 7999999999
Q ss_pred cccCCC----CCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 012233 288 KMLVPG----EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREE 363 (468)
Q Consensus 288 ~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~ 363 (468)
+..... .......++..|+|||.+.+.. ++.++|+|||||++|+|++|+.||........+.++.. .+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~---- 225 (264)
T cd06653 154 KRIQTICMSGTGIKSVTGTPYWMSPEVISGEG-YGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIAT---QP---- 225 (264)
T ss_pred cccccccccCccccccCCcccccCHhhhcCCC-CCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHc---CC----
Confidence 765321 1122456889999999997644 88999999999999999999999987655544433321 11
Q ss_pred HhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 012233 364 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (468)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f 423 (468)
....++..+++.+.++|.+||. +|..||++.+++.|||.
T Consensus 226 --------------------~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 226 --------------------TKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred --------------------CCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 1112445688999999999999 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=314.07 Aligned_cols=248 Identities=23% Similarity=0.302 Sum_probs=194.9
Q ss_pred cceEEeceecccCceEEEEEEEcCCC-----CEEEEEEeeccc-----chHHHHHHHHHHcCCCCcccccceeeecCCCC
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETG-----DSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD 206 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g-----~~vaiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 206 (468)
.+|++.+.||+|+||.||+|.+...+ ..||+|.+.... ..+.+|+.+++.++||||+++++++ .+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~-----~~ 79 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVC-----TK 79 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEE-----cC
Confidence 46899999999999999999976555 679999885432 2345799999999999999999987 33
Q ss_pred ceEEEEEeecccchHH-HHHhhhhh------------cCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeec
Q 012233 207 ELYLNLVLEYISETVY-RVSKHYTR------------MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVN 273 (468)
Q Consensus 207 ~~~~~lv~e~~~~~ll-~~~~~~~~------------~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~ 273 (468)
....|++|||+.++.+ +.+..... ....+++..+..++.||+.||.|||+ +||+|+||||+|||++
T Consensus 80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~-~~i~H~dlkp~Nil~~ 158 (283)
T cd05048 80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS-HHFVHRDLAARNCLVG 158 (283)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccccccceEEEc
Confidence 4458899999986544 33332111 11457888899999999999999998 8999999999999999
Q ss_pred CCCCcEEEeeecCccccCCCC---CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHH
Q 012233 274 PHTHQLKICDFGSAKMLVPGE---PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQL 349 (468)
Q Consensus 274 ~~~~~vkL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~ 349 (468)
.++ .++|+|||++....... ......+++.|+|||.+.+.. ++.++|||||||++|||++ |..||.+.+..+..
T Consensus 159 ~~~-~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~ 236 (283)
T cd05048 159 EGL-TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGK-FTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVI 236 (283)
T ss_pred CCC-cEEECCCcceeeccccccccccCCCcccccccCHHHhccCc-CchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 887 79999999987653322 122345678899999986544 8999999999999999998 99999887765544
Q ss_pred HHHHHHhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCC
Q 012233 350 VEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (468)
Q Consensus 350 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~h 420 (468)
..+..... + ..+..+++++.+|+.+||+.||.+||++.+++++
T Consensus 237 ~~i~~~~~-------------------~---------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 237 EMIRSRQL-------------------L---------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HHHHcCCc-------------------C---------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 44332100 0 0224578999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=312.74 Aligned_cols=257 Identities=23% Similarity=0.315 Sum_probs=195.8
Q ss_pred cccceEEeceecccCceEEEEEEEcC-----CCCEEEEEEeecccc-----hHHHHHHHHHHcCCCCcccccceeeecCC
Q 012233 135 QTISYMAERVVGTGSFGVVFQAKCLE-----TGDSVAIKKVLQDKR-----YKNRELQIMRLLNHPNVVSLKHCFFSTTE 204 (468)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~-----~g~~vaiK~~~~~~~-----~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 204 (468)
..++|.+.+.||+|+||.||+|.++. .+..||+|.+..... ...+|+.+++.++||||+++++++
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~----- 78 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVV----- 78 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE-----
Confidence 34579999999999999999997642 345799998754322 234688999999999999999987
Q ss_pred CCceEEEEEeecccchHH-HHHhhhhhc------CCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCC
Q 012233 205 KDELYLNLVLEYISETVY-RVSKHYTRM------NQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTH 277 (468)
Q Consensus 205 ~~~~~~~lv~e~~~~~ll-~~~~~~~~~------~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~ 277 (468)
.+....|+||||+.++.+ +.+...... ........+..++.||+.||.|||+ +||+||||||+|||++.++
T Consensus 79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dikp~nili~~~~- 156 (288)
T cd05061 79 SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA-KKFVHRDLAARNCMVAHDF- 156 (288)
T ss_pred cCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcCCCCChheEEEcCCC-
Confidence 333458899999986544 443322111 1234567788899999999999998 8999999999999999887
Q ss_pred cEEEeeecCccccCCCCC---CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHH
Q 012233 278 QLKICDFGSAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEII 353 (468)
Q Consensus 278 ~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~ 353 (468)
.++|+|||+++....... .....++..|+|||.+.+.. ++.++|+|||||++|||++ |..||.+....+....+.
T Consensus 157 ~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~ 235 (288)
T cd05061 157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM 235 (288)
T ss_pred cEEECcCCccccccccccccccCCCcccccccCHHHhccCC-CChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 799999999876533221 11234467899999986544 8999999999999999998 789998766555443332
Q ss_pred HHhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC------CCCCCCCC
Q 012233 354 KILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA------HPFFDDLR 427 (468)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~------hp~f~~~~ 427 (468)
.. +. . .++...++.+.++|.+||+.||.+|||+.++++ ||||.++.
T Consensus 236 ~~-~~---------------~------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~ 287 (288)
T cd05061 236 DG-GY---------------L------------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVS 287 (288)
T ss_pred cC-CC---------------C------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCC
Confidence 20 00 0 022346789999999999999999999999986 99998763
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=312.19 Aligned_cols=254 Identities=28% Similarity=0.432 Sum_probs=202.1
Q ss_pred eEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc----chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEEEe
Q 012233 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (468)
Q Consensus 139 y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv~ 214 (468)
|.-.+.||+|++|.||++.+..+++.+++|++.... ....+|+.+++.++||||+++++++. ...+.++|+
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~-----~~~~~~~v~ 95 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL-----VGDELWVVM 95 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEE-----cCCeEEEEE
Confidence 444568999999999999998899999999875332 23457899999999999999999874 334588999
Q ss_pred ecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCCCC
Q 012233 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGE 294 (468)
Q Consensus 215 e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~~~ 294 (468)
||+.++.+..... ...+++..+..++.||+.||+|||+ +||+||||+|+||+++.++ .++|+|||.+.......
T Consensus 96 e~~~~~~L~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~-~~i~H~dl~p~Nil~~~~~-~~~l~d~g~~~~~~~~~ 169 (285)
T cd06648 96 EFLEGGALTDIVT----HTRMNEEQIATVCLAVLKALSFLHA-QGVIHRDIKSDSILLTSDG-RVKLSDFGFCAQVSKEV 169 (285)
T ss_pred eccCCCCHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCChhhEEEcCCC-cEEEcccccchhhccCC
Confidence 9998765543222 1457888999999999999999998 8999999999999999887 79999999886553322
Q ss_pred -CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCcc
Q 012233 295 -PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTE 373 (468)
Q Consensus 295 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 373 (468)
......|++.|+|||.+.+.. ++.++|+|||||++|+|++|..||...+....+..+... ..+
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~-~~~-------------- 233 (285)
T cd06648 170 PRRKSLVGTPYWMAPEVISRLP-YGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN-LPP-------------- 233 (285)
T ss_pred cccccccCCccccCHHHhcCCC-CCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhc-CCC--------------
Confidence 223356899999999987654 899999999999999999999999876655544433321 000
Q ss_pred CCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCCC
Q 012233 374 FKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPN 430 (468)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~ 430 (468)
.+ .....++..+.+||.+||+.||.+||++.+++.||||+..+++.
T Consensus 234 ----~~-------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~ 279 (285)
T cd06648 234 ----KL-------KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGPPS 279 (285)
T ss_pred ----CC-------cccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCCCcc
Confidence 00 01123678999999999999999999999999999999977643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=315.90 Aligned_cols=259 Identities=28% Similarity=0.420 Sum_probs=205.9
Q ss_pred eEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc----chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEEEe
Q 012233 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (468)
Q Consensus 139 y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv~ 214 (468)
|.....||+|+||.||++....+|+.||||++.... ....+|+.+++.++|+||+++++++. ...+.++||
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~ 96 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL-----VGDELWVVM 96 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEE-----eCCEEEEEE
Confidence 444567999999999999999999999999874322 23456999999999999999999884 344689999
Q ss_pred ecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCCCC
Q 012233 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGE 294 (468)
Q Consensus 215 e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~~~ 294 (468)
||++++.+..... ...+++..++.++.|++.||+|||+ .||+|+||+|+||+++.++ .++|+|||++.......
T Consensus 97 e~~~~~~L~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~-~givH~dl~p~Nilv~~~~-~~~l~dfg~~~~~~~~~ 170 (292)
T cd06657 97 EFLEGGALTDIVT----HTRMNEEQIAAVCLAVLKALSVLHA-QGVIHRDIKSDSILLTHDG-RVKLSDFGFCAQVSKEV 170 (292)
T ss_pred ecCCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECCCC-CEEEcccccceeccccc
Confidence 9999876654322 3457889999999999999999998 8999999999999999887 79999999986554322
Q ss_pred -CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCcc
Q 012233 295 -PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTE 373 (468)
Q Consensus 295 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 373 (468)
......+++.|+|||.+.+. .++.++|+|||||++|+|++|..||.+....+.+..+..... +
T Consensus 171 ~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~-----------~---- 234 (292)
T cd06657 171 PRRKSLVGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-----------P---- 234 (292)
T ss_pred ccccccccCccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCC-----------c----
Confidence 22345678999999988644 478999999999999999999999987665544443322110 0
Q ss_pred CCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCCCCCCCC
Q 012233 374 FKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNTCLPN 435 (468)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~~~~~ 435 (468)
.+. ....+++.+.++|.+||+.||.+||++.+++.||||.....+++.+++
T Consensus 235 -~~~----------~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~~~~~~~~~ 285 (292)
T cd06657 235 -KLK----------NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPSCIVPL 285 (292)
T ss_pred -ccC----------CcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccCCCcccccH
Confidence 000 113468899999999999999999999999999999998877764443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=315.00 Aligned_cols=248 Identities=28% Similarity=0.432 Sum_probs=201.5
Q ss_pred eEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-------chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEE
Q 012233 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (468)
Q Consensus 139 y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 211 (468)
|...+.||+|+||.||+|.+..+|..|++|++.... ....+|+.+++.++|||++++++++. +....|
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~ 97 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYL-----KEHTAW 97 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEE-----eCCEEE
Confidence 677788999999999999999999999999885321 22456899999999999999999884 444688
Q ss_pred EEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccC
Q 012233 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (468)
Q Consensus 212 lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~ 291 (468)
+||||+.++++..+.. ....+++..+..++.||+.||.|||+ .||+|+||||+||+++.++ .+||+|||++....
T Consensus 98 lv~e~~~~~l~~~l~~---~~~~l~~~~~~~~~~qi~~al~~LH~-~gi~H~dl~p~nili~~~~-~~kL~dfg~~~~~~ 172 (313)
T cd06633 98 LVMEYCLGSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHS-HNMIHRDIKAGNILLTEPG-QVKLADFGSASKSS 172 (313)
T ss_pred EEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCChhhEEECCCC-CEEEeecCCCcccC
Confidence 9999999887765432 23568889999999999999999998 8999999999999999887 79999999986432
Q ss_pred CCCCCccccccCCccccccccC--CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 012233 292 PGEPNISYICSRYYRAPELIFG--ATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (468)
Q Consensus 292 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 369 (468)
......|+..|+|||++.. ...++.++|||||||++|+|++|..||...+.......+.... .
T Consensus 173 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~-~----------- 237 (313)
T cd06633 173 ---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND-S----------- 237 (313)
T ss_pred ---CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC-C-----------
Confidence 2335678899999999842 2347889999999999999999999998876655555443210 0
Q ss_pred CCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q 012233 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426 (468)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 426 (468)
+. .....++..+++||.+||+.+|.+||++.+++.||||+..
T Consensus 238 -------~~--------~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~ 279 (313)
T cd06633 238 -------PT--------LQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRD 279 (313)
T ss_pred -------CC--------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence 00 0113367789999999999999999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=308.12 Aligned_cols=245 Identities=22% Similarity=0.324 Sum_probs=194.4
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeecccc---hHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEEEe
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR---YKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~~---~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv~ 214 (468)
.|.+.+.||+|+||.||+|.+..++..||+|.+..+.. ...+|+.+++.++|+||+++++++ .....+++||
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~lv~ 81 (263)
T cd05052 7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC-----TREPPFYIIT 81 (263)
T ss_pred HeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEE-----cCCCCcEEEE
Confidence 58999999999999999999999999999998865432 345799999999999999999987 3344588999
Q ss_pred ecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCCCC
Q 012233 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGE 294 (468)
Q Consensus 215 e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~~~ 294 (468)
||++++.+...... .....+++..+..++.|++.||+|||+ +||+||||||+|||++.++ .+||+|||++.......
T Consensus 82 e~~~~~~L~~~~~~-~~~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~dlkp~nil~~~~~-~~kl~df~~~~~~~~~~ 158 (263)
T cd05052 82 EFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLVGENH-LVKVADFGLSRLMTGDT 158 (263)
T ss_pred EeCCCCcHHHHHHh-CCCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeecccCcceEEEcCCC-cEEeCCCccccccccce
Confidence 99986644422211 123458888999999999999999998 8999999999999999887 79999999987654332
Q ss_pred CC--ccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCC
Q 012233 295 PN--ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNY 371 (468)
Q Consensus 295 ~~--~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 371 (468)
.. ....++..|+|||.+.+.. ++.++|||||||++|||++ |..||.+.+..+....+...
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~---------------- 221 (263)
T cd05052 159 YTAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKG---------------- 221 (263)
T ss_pred eeccCCCCCccccCCHHHhccCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC----------------
Confidence 11 1223456799999986554 8999999999999999998 99999876654443333211
Q ss_pred ccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 372 TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
+. ..++..++.++.++|.+||+.||++||++.++++
T Consensus 222 --~~----------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 222 --YR----------MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred --CC----------CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 00 0123457899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=308.37 Aligned_cols=243 Identities=33% Similarity=0.557 Sum_probs=195.6
Q ss_pred ecccCceEEEEEEEcCCCCEEEEEEeecccc-------hHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEEEeecc
Q 012233 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKR-------YKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYI 217 (468)
Q Consensus 145 lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~~-------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv~e~~ 217 (468)
||.|+||.||++.+..+|+.+++|.+..... ...+|+.+++.++||||+++++.+ ......|+||||+
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSF-----QGKKNLYLVMEYL 75 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHhe-----ecCcEEEEEEecC
Confidence 6899999999999998999999998854422 345688999999999999999887 4455689999999
Q ss_pred cchHHH-HHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCCCC--
Q 012233 218 SETVYR-VSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGE-- 294 (468)
Q Consensus 218 ~~~ll~-~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~~~-- 294 (468)
.++.+. .+.. ...+++..+..++.||+.||.|||+ .|++|+||+|+||+++.++ .++|+|||++.......
T Consensus 76 ~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~lH~-~~i~H~di~~~nil~~~~~-~~~l~dfg~~~~~~~~~~~ 149 (265)
T cd05579 76 PGGDLASLLEN----VGSLDEDVARIYIAEIVLALEYLHS-NGIIHRDLKPDNILIDSNG-HLKLTDFGLSKVGLVRRQI 149 (265)
T ss_pred CCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-cCeecCCCCHHHeEEcCCC-CEEEEecccchhcccCccc
Confidence 875443 3322 2368999999999999999999998 8999999999999999888 79999999987543321
Q ss_pred -------CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 012233 295 -------PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367 (468)
Q Consensus 295 -------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 367 (468)
......++..|+|||.+.+.. ++.++|+||||+++|+|++|..||......+....+...
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~------------ 216 (265)
T cd05579 150 NLNDDEKEDKRIVGTPDYIAPEVILGQG-HSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNG------------ 216 (265)
T ss_pred ccccccccccCcccCccccCHHHhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC------------
Confidence 122346788999999986655 889999999999999999999999877655544443220
Q ss_pred CCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCH---HHHhCCCCCCCC
Q 012233 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTA---LEACAHPFFDDL 426 (468)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~---~ell~hp~f~~~ 426 (468)
...++. ...++..+.+||.+||+.+|.+|||+ .++|+||||+++
T Consensus 217 -----~~~~~~----------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~ 263 (265)
T cd05579 217 -----KIEWPE----------DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGI 263 (265)
T ss_pred -----CcCCCc----------cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCC
Confidence 111111 01148899999999999999999999 999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=317.24 Aligned_cols=281 Identities=19% Similarity=0.260 Sum_probs=195.0
Q ss_pred eEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc------chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEE
Q 012233 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (468)
Q Consensus 139 y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~l 212 (468)
|.+++.+|.|+ .||.++...+++.||+|++.... ....+|+.+++.++|+||++++++| ......++
T Consensus 4 ~~i~~~~~~~~--~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~-----~~~~~~~~ 76 (314)
T cd08216 4 TLIGKCFEDLM--IVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF-----IVDSELYV 76 (314)
T ss_pred hhhhHhhcCCc--eEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhhee-----ecCCeEEE
Confidence 34444455554 45555556699999999985431 2455799999999999999999988 34445899
Q ss_pred EeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCC
Q 012233 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (468)
Q Consensus 213 v~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~ 292 (468)
+|||++++.+..+.... ....+++..+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||.+.....
T Consensus 77 ~~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~~~~l~~~L~~LH~-~~ivH~dlk~~Nili~~~~-~~kl~d~~~~~~~~~ 153 (314)
T cd08216 77 VSPLMAYGSCEDLLKTH-FPEGLPELAIAFILKDVLNALDYIHS-KGFIHRSVKASHILLSGDG-KVVLSGLRYSVSMIK 153 (314)
T ss_pred EEeccCCCCHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCcceEEEecCC-ceEEecCccceeecc
Confidence 99999976554332211 23458889999999999999999998 8999999999999999887 799999998865532
Q ss_pred CCC--------CccccccCCccccccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH-
Q 012233 293 GEP--------NISYICSRYYRAPELIFGA-TEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTRE- 362 (468)
Q Consensus 293 ~~~--------~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~- 362 (468)
... .....++..|+|||++.+. ..++.++|+|||||++|||++|..||........+.+...........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 233 (314)
T cd08216 154 HGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDK 233 (314)
T ss_pred ccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCcccccc
Confidence 211 1234567789999998653 348899999999999999999999998765544333322211000000
Q ss_pred -HHhhcCCCCcc----CCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCCC
Q 012233 363 -EIKCMNPNYTE----FKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPN 430 (468)
Q Consensus 363 -~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~ 430 (468)
........... ...+ .............++.++.+||.+||..||++|||+.++|.||||+.++...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~~~~ 305 (314)
T cd08216 234 STYPLYEDSMSQSRSSNEHP-NNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCKRRN 305 (314)
T ss_pred CchhhhcCCcCccccccccc-chhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhcccc
Confidence 00000000000 0000 0011111222334567899999999999999999999999999999887443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=303.44 Aligned_cols=251 Identities=33% Similarity=0.479 Sum_probs=201.2
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc------chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 211 (468)
+|.+.+.||+|++|.||+|.+..++..|++|++.... ....+|+.++++++|+||+++++++.... ...++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~ 77 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEE---KNTLN 77 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCC---CCeEE
Confidence 3888899999999999999999899999999885543 24567999999999999999998884321 15688
Q ss_pred EEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccC
Q 012233 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (468)
Q Consensus 212 lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~ 291 (468)
+|+||+.++.+..... ....+++..++.++.|++.||.|||+ .|++|+||+|+||+++.++ .++|+|||.+....
T Consensus 78 lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~-~~~~h~dl~p~ni~i~~~~-~~~l~d~~~~~~~~ 152 (260)
T cd06606 78 IFLEYVSGGSLSSLLK---KFGKLPEPVIRKYTRQILEGLAYLHS-NGIVHRDIKGANILVDSDG-VVKLADFGCAKRLG 152 (260)
T ss_pred EEEEecCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEEcCCC-CEEEcccccEEecc
Confidence 9999997654443222 12378999999999999999999998 8999999999999999877 79999999998775
Q ss_pred CCCC---CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 012233 292 PGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368 (468)
Q Consensus 292 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 368 (468)
.... .....++..|+|||.+.+.. ++.++||||||+++|+|++|..||........ .+.....
T Consensus 153 ~~~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~~----------- 218 (260)
T cd06606 153 DIETGEGTGSVRGTPYWMAPEVIRGEE-YGRAADIWSLGCTVIEMATGKPPWSELGNPMA--ALYKIGS----------- 218 (260)
T ss_pred cccccccccCCCCCccccCHhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCchHH--HHHhccc-----------
Confidence 5443 34567889999999986554 89999999999999999999999987652211 1111000
Q ss_pred CCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 012233 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (468)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f 423 (468)
......++..++..+.+||.+||+.||.+||++.+++.||||
T Consensus 219 -------------~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 219 -------------SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred -------------cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 000111334568999999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=313.87 Aligned_cols=247 Identities=22% Similarity=0.285 Sum_probs=190.0
Q ss_pred ceEEeceecccCceEEEEEEEcCCCC--EEEEEEeeccc-----chHHHHHHHHHHc-CCCCcccccceeeecCCCCceE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGD--SVAIKKVLQDK-----RYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDELY 209 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~--~vaiK~~~~~~-----~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~~~~ 209 (468)
+|.+.+.||+|+||.||+|.+..++. .+++|.+.... ..+.+|+.++.++ +||||+++++++ .....
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~-----~~~~~ 77 (297)
T cd05089 3 DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGAC-----ENRGY 77 (297)
T ss_pred cceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEE-----ccCCc
Confidence 59999999999999999999877765 46888775321 2345799999999 799999999987 34445
Q ss_pred EEEEeecccch-HHHHHhhhh------------hcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCC
Q 012233 210 LNLVLEYISET-VYRVSKHYT------------RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHT 276 (468)
Q Consensus 210 ~~lv~e~~~~~-ll~~~~~~~------------~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~ 276 (468)
+++||||++++ +.+.+.... .....+++..++.++.||+.||+|||+ +||+||||||+|||++.++
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~-~~ivH~dlkp~Nill~~~~ 156 (297)
T cd05089 78 LYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE-KQFIHRDLAARNVLVGENL 156 (297)
T ss_pred ceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCcCCcceEEECCCC
Confidence 88999999865 444432211 012357889999999999999999998 8999999999999999887
Q ss_pred CcEEEeeecCccccCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHH
Q 012233 277 HQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKI 355 (468)
Q Consensus 277 ~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~ 355 (468)
.+||+|||++..............+..|+|||++.+.. ++.++|||||||++|||++ |..||......+....+...
T Consensus 157 -~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~ 234 (297)
T cd05089 157 -ASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSV-YTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 234 (297)
T ss_pred -eEEECCcCCCccccceeccCCCCcCccccCchhhccCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Confidence 79999999986432211222223356799999986544 8999999999999999997 99999887665544443221
Q ss_pred hCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCC
Q 012233 356 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (468)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~h 420 (468)
.. ...+..++.++.+||.+||+.||.+||+++++++.
T Consensus 235 ~~----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 235 YR----------------------------MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred CC----------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00 00223578899999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=344.93 Aligned_cols=141 Identities=25% Similarity=0.400 Sum_probs=120.9
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-------chHHHHHHHHHHcCCCCcccccceeeecCCCCceE
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 209 (468)
.+|.+.+.||+|+||.||+|.+..+++.||||++.... ..+.+|+.+++.++||||+++++++ ....+
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~~~ 78 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL-----QSANN 78 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEE-----EECCE
Confidence 46999999999999999999999999999999986532 3456799999999999999999877 34446
Q ss_pred EEEEeecccchHH-HHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcc
Q 012233 210 LNLVLEYISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (468)
Q Consensus 210 ~~lv~e~~~~~ll-~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~ 288 (468)
+||||||+.++.+ .++.. ...+++..++.++.||+.||.|||. +|||||||||+||||+.++ .+||+|||+++
T Consensus 79 ~~lVmEy~~g~~L~~li~~----~~~l~~~~~~~i~~qil~aL~yLH~-~gIiHrDLKP~NILl~~~g-~vkL~DFGls~ 152 (669)
T cd05610 79 VYLVMEYLIGGDVKSLLHI----YGYFDEEMAVKYISEVALALDYLHR-HGIIHRDLKPDNMLISNEG-HIKLTDFGLSK 152 (669)
T ss_pred EEEEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCEEeCCccHHHEEEcCCC-CEEEEeCCCCc
Confidence 8999999976544 43322 3457888999999999999999998 8999999999999999888 79999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=320.22 Aligned_cols=250 Identities=25% Similarity=0.349 Sum_probs=191.5
Q ss_pred cceEEeceecccCceEEEEEEEcC-----CCCEEEEEEeeccc-----chHHHHHHHHHHc-CCCCcccccceeeecCCC
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLE-----TGDSVAIKKVLQDK-----RYKNRELQIMRLL-NHPNVVSLKHCFFSTTEK 205 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~-----~g~~vaiK~~~~~~-----~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~ 205 (468)
++|++.+.||.|+||.||+|.+.. +++.||+|++.... ....+|+.+++++ +|+||+++++++...
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~--- 83 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP--- 83 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC---
Confidence 469999999999999999997543 45789999885432 2234699999999 799999999987533
Q ss_pred CceEEEEEeecccchHHHHHhhhhh-------------------------------------------------------
Q 012233 206 DELYLNLVLEYISETVYRVSKHYTR------------------------------------------------------- 230 (468)
Q Consensus 206 ~~~~~~lv~e~~~~~ll~~~~~~~~------------------------------------------------------- 230 (468)
...++++|||+.++.+........
T Consensus 84 -~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (337)
T cd05054 84 -GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEG 162 (337)
T ss_pred -CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhh
Confidence 235789999999765543221110
Q ss_pred ---cCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCCCCC---CccccccCC
Q 012233 231 ---MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEP---NISYICSRY 304 (468)
Q Consensus 231 ---~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~ 304 (468)
....+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .++|+|||++..+..... .....++..
T Consensus 163 ~~~~~~~l~~~~~~~~~~qi~~aL~~lH~-~~ivHrDikp~Nill~~~~-~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd05054 163 DELYKEPLTLEDLISYSFQVARGMEFLAS-RKCIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGDARLPLK 240 (337)
T ss_pred hHHhhcCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCcceEEEeCCC-cEEEeccccchhcccCcchhhccCCCCCcc
Confidence 12367888999999999999999998 8999999999999999887 799999999986533221 122345678
Q ss_pred ccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccCCCCcccCCC
Q 012233 305 YRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHP 383 (468)
Q Consensus 305 y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (468)
|+|||++.+.. ++.++|||||||++|||++ |..||.+....+.+...+..... .
T Consensus 241 y~aPE~~~~~~-~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~---------------~--------- 295 (337)
T cd05054 241 WMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTR---------------M--------- 295 (337)
T ss_pred ccCcHHhcCCC-CCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCC---------------C---------
Confidence 99999997654 8999999999999999997 99999875544443333221000 0
Q ss_pred cccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCC
Q 012233 384 WHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (468)
Q Consensus 384 ~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~h 420 (468)
..+...++++.+++.+||+.+|.+||++.++++|
T Consensus 296 ---~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 296 ---RAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329 (337)
T ss_pred ---CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0123467899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=311.47 Aligned_cols=257 Identities=28% Similarity=0.463 Sum_probs=200.0
Q ss_pred ceEEeceecccCceEEEEEEEc---CCCCEEEEEEeeccc--------chHHHHHHHHHHc-CCCCcccccceeeecCCC
Q 012233 138 SYMAERVVGTGSFGVVFQAKCL---ETGDSVAIKKVLQDK--------RYKNRELQIMRLL-NHPNVVSLKHCFFSTTEK 205 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~---~~g~~vaiK~~~~~~--------~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~ 205 (468)
+|++.+.||.|+||.||+|.+. .+|..||+|++.... ....+|+.+++.+ +|+||++++++| .
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-----~ 75 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF-----Q 75 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEe-----e
Confidence 3889999999999999999874 478999999885421 2345699999999 599999999888 4
Q ss_pred CceEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeec
Q 012233 206 DELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG 285 (468)
Q Consensus 206 ~~~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG 285 (468)
....+|+||||+.++.+... ......+++..+..++.||+.||.|||+ .|++||||||+|||++.++ .+||+|||
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~---l~~~~~l~~~~~~~~~~qi~~al~~lH~-~~i~H~dl~p~nil~~~~~-~~kl~dfg 150 (290)
T cd05613 76 TDTKLHLILDYINGGELFTH---LSQRERFKEQEVQIYSGEIVLALEHLHK-LGIIYRDIKLENILLDSNG-HVVLTDFG 150 (290)
T ss_pred cCCeEEEEEecCCCCcHHHH---HHHcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHeEECCCC-CEEEeeCc
Confidence 45568899999997644322 1224568889999999999999999998 8999999999999999887 79999999
Q ss_pred CccccCCCC--CCccccccCCccccccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 012233 286 SAKMLVPGE--PNISYICSRYYRAPELIFGA-TEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTRE 362 (468)
Q Consensus 286 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~ 362 (468)
++....... ......|+..|+|||.+.+. ..++.++|||||||++|+|++|..||...........+.......
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~--- 227 (290)
T cd05613 151 LSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKS--- 227 (290)
T ss_pred cceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhcc---
Confidence 987654322 22345688999999998643 236789999999999999999999997543322222222211000
Q ss_pred HHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCC-----CHHHHhCCCCCCCCCCC
Q 012233 363 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC-----TALEACAHPFFDDLRDP 429 (468)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~-----s~~ell~hp~f~~~~~~ 429 (468)
. ..++..+++.+.+|+.+||+.||.+|+ ++.+++.||||+.+..+
T Consensus 228 ----------~------------~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~ 277 (290)
T cd05613 228 ----------E------------PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWD 277 (290)
T ss_pred ----------C------------CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCHH
Confidence 0 012345788999999999999999997 89999999999987643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=305.00 Aligned_cols=243 Identities=21% Similarity=0.296 Sum_probs=191.8
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc---chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEEEe
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~---~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv~ 214 (468)
.|.+.+.||+|+||.||++.+. .+..+|+|.+.... ....+|+.+++.++||||+++++++ .....+++||
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~iv~ 78 (256)
T cd05114 5 ELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVC-----TQQKPLYIVT 78 (256)
T ss_pred HcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEE-----ccCCCEEEEE
Confidence 5889999999999999999875 45689999875432 3456799999999999999999987 3444589999
Q ss_pred ecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCCCC
Q 012233 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGE 294 (468)
Q Consensus 215 e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~~~ 294 (468)
||++++.+..... .....+++..+..++.|++.||.|||+ +||+|+||||+||+++.++ .+||+|||.++......
T Consensus 79 e~~~~~~L~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~ni~i~~~~-~~kl~d~g~~~~~~~~~ 154 (256)
T cd05114 79 EFMENGCLLNYLR--QRQGKLSKDMLLSMCQDVCEGMEYLER-NSFIHRDLAARNCLVSSTG-VVKVSDFGMTRYVLDDE 154 (256)
T ss_pred EcCCCCcHHHHHH--hCccCCCHHHHHHHHHHHHHHHHHHHH-CCccccccCcceEEEcCCC-eEEECCCCCccccCCCc
Confidence 9998664432221 122458889999999999999999998 8999999999999999887 79999999987653322
Q ss_pred CC--ccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCC
Q 012233 295 PN--ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNY 371 (468)
Q Consensus 295 ~~--~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 371 (468)
.. ....++..|+|||++.+. .++.++|+|||||++|+|++ |+.||...+..+.+..+.+...
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~-------------- 219 (256)
T cd05114 155 YTSSSGAKFPVKWSPPEVFNFS-KYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFR-------------- 219 (256)
T ss_pred eeccCCCCCchhhCChhhcccC-ccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCC--------------
Confidence 21 123445689999998654 48999999999999999999 9999988776665555433100
Q ss_pred ccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 372 TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
.. .+...+..+.+||.+||+.||.+||++.++++
T Consensus 220 --~~------------~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 220 --LY------------RPKLASMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred --CC------------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 00 12235778999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=306.83 Aligned_cols=249 Identities=28% Similarity=0.452 Sum_probs=195.7
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-------chHHHHHHHHHHcCCCCcccccceeeecCCCCceE
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 209 (468)
.+|.+.+.||+|+||.||+|.+..+++.||||.+.... ....+|+.+++.++||||+++++++.. ...
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 76 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIE-----DNE 76 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEE-----CCe
Confidence 35999999999999999999999999999999774311 234569999999999999999998843 345
Q ss_pred EEEEeecccchHH-HHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcc
Q 012233 210 LNLVLEYISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (468)
Q Consensus 210 ~~lv~e~~~~~ll-~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~ 288 (468)
.++||||++++.+ .++.........+++..+..++.||+.||.|||+ +||+|+||||+|||++.++ .++|+|||++.
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dl~~~nil~~~~~-~~~l~d~g~~~ 154 (267)
T cd08228 77 LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS-RRVMHRDIKPANVFITATG-VVKLGDLGLGR 154 (267)
T ss_pred EEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh-CCeeCCCCCHHHEEEcCCC-CEEECccccce
Confidence 8899999997544 4444433344568889999999999999999998 8999999999999999887 79999999987
Q ss_pred ccCCCCC-CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHHHhCCCCHHHHhh
Q 012233 289 MLVPGEP-NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESG-VDQLVEIIKILGTPTREEIKC 366 (468)
Q Consensus 289 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~ 366 (468)
....... .....+++.|+|||.+.+.. ++.++|+|||||++|+|++|+.||..... ...+...+.....++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~------ 227 (267)
T cd08228 155 FFSSKTTAAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPP------ 227 (267)
T ss_pred eccchhHHHhcCCCCccccChhhhccCC-CCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCC------
Confidence 6543221 22356788999999987654 88999999999999999999999965432 222222222111110
Q ss_pred cCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 367 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
.....++..+.+||.+||..+|++||++.++++
T Consensus 228 --------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~ 260 (267)
T cd08228 228 --------------------LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQ 260 (267)
T ss_pred --------------------CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHH
Confidence 011246788999999999999999999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=309.61 Aligned_cols=245 Identities=34% Similarity=0.613 Sum_probs=200.6
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc-------cchHHHHHHHHHHcC-CCCcccccceeeecCCCCceE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLN-HPNVVSLKHCFFSTTEKDELY 209 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~-------~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~~~~ 209 (468)
+|.+.+.||+|+||.||+|.+..+|+.||+|++... .....+|+.+++.+. ||||+++++++ .+...
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~~ 76 (280)
T cd05581 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTF-----QDEEN 76 (280)
T ss_pred CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHh-----cCCce
Confidence 599999999999999999999999999999988542 123457889999998 99999999988 44556
Q ss_pred EEEEeecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcc
Q 012233 210 LNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (468)
Q Consensus 210 ~~lv~e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~ 288 (468)
.++||||+.++ +.+.+.. ...+++..++.++.|++.||.|||+ .|++|+||||+||+++.++ .++|+|||++.
T Consensus 77 ~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~Lh~-~~~~H~dl~~~ni~i~~~~-~~~l~df~~~~ 150 (280)
T cd05581 77 LYFVLEYAPNGELLQYIRK----YGSLDEKCTRFYAAEILLALEYLHS-KGIIHRDLKPENILLDKDM-HIKITDFGTAK 150 (280)
T ss_pred EEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHeEECCCC-CEEecCCcccc
Confidence 89999999654 4443332 3468999999999999999999998 8999999999999999888 79999999987
Q ss_pred ccCCCC---------------------CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHH
Q 012233 289 MLVPGE---------------------PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVD 347 (468)
Q Consensus 289 ~~~~~~---------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~ 347 (468)
...... ......++..|+|||++.+. .++.++|+|||||++|++++|+.||...+...
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~ 229 (280)
T cd05581 151 VLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEK-PAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL 229 (280)
T ss_pred ccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCC-CCChhhhHHHHHHHHHHHHhCCCCCCCccHHH
Confidence 653322 11234578899999998654 48899999999999999999999998876544
Q ss_pred HHHHHHHHhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCH----HHHhCCCCC
Q 012233 348 QLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTA----LEACAHPFF 423 (468)
Q Consensus 348 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~----~ell~hp~f 423 (468)
.+..+... ... ++..+++.+.+||.+||+.||.+||++ .++++||||
T Consensus 230 ~~~~~~~~-----------------~~~------------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 230 TFQKILKL-----------------EYS------------FPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred HHHHHHhc-----------------CCC------------CCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 44443321 111 234568899999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=309.11 Aligned_cols=249 Identities=22% Similarity=0.285 Sum_probs=190.9
Q ss_pred ccceEEeceecccCceEEEEEEEc-----CCCCEEEEEEeeccc-----chHHHHHHHHHHcCCCCcccccceeeecCCC
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCL-----ETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEK 205 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~-----~~g~~vaiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 205 (468)
..+|.+.+.||+|+||.||+|.+. .++..||+|.+.... ..+.+|+.+++.++||||+++++++ .
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~-----~ 79 (277)
T cd05062 5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV-----S 79 (277)
T ss_pred HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE-----c
Confidence 346999999999999999999864 245679999875432 1245789999999999999999987 3
Q ss_pred CceEEEEEeecccchHHH-HHhhhhh------cCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCc
Q 012233 206 DELYLNLVLEYISETVYR-VSKHYTR------MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQ 278 (468)
Q Consensus 206 ~~~~~~lv~e~~~~~ll~-~~~~~~~------~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~ 278 (468)
.....++||||++++.+. .+..... ....+++..+..++.|++.||.|||+ .|++|+||||+|||++.++ .
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~vH~dlkp~Nil~~~~~-~ 157 (277)
T cd05062 80 QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA-NKFVHRDLAARNCMVAEDF-T 157 (277)
T ss_pred CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCcchheEEEcCCC-C
Confidence 444588999999875444 3322111 12235677888999999999999998 8999999999999999887 7
Q ss_pred EEEeeecCccccCCCCC---CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHH
Q 012233 279 LKICDFGSAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIK 354 (468)
Q Consensus 279 vkL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~ 354 (468)
++|+|||+++....... .....+++.|+|||.+.+.. ++.++|||||||++|||++ |..||.+.+..+.+..+..
T Consensus 158 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~ 236 (277)
T cd05062 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVME 236 (277)
T ss_pred EEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCC-cCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 99999999875533221 11234577899999986544 8999999999999999998 7899987765544443322
Q ss_pred HhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCC
Q 012233 355 ILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (468)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~h 420 (468)
.. ++ .++..+++.+.++|.+||+.||.+|||+.+++.+
T Consensus 237 ~~-------------------~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 237 GG-------------------LL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred CC-------------------cC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 10 00 0223478899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=308.14 Aligned_cols=250 Identities=20% Similarity=0.294 Sum_probs=192.8
Q ss_pred eEEeceecccCceEEEEEEEcCC---CCEEEEEEeeccc------chHHHHHHHHHHcCCCCcccccceeeecCC-CCce
Q 012233 139 YMAERVVGTGSFGVVFQAKCLET---GDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTE-KDEL 208 (468)
Q Consensus 139 y~~~~~lG~G~fg~Vy~~~~~~~---g~~vaiK~~~~~~------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~-~~~~ 208 (468)
|.+.+.||+|+||.||.|....+ +..||+|.+..+. ....+|+.+++.++||||+++++++..... .+..
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 56788999999999999987653 4789999886432 234568999999999999999998755443 3344
Q ss_pred EEEEEeecccchHHHHHhhhh---hcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeec
Q 012233 209 YLNLVLEYISETVYRVSKHYT---RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG 285 (468)
Q Consensus 209 ~~~lv~e~~~~~ll~~~~~~~---~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG 285 (468)
+.++||||+.++.+....... .....+++..+..++.|++.||.|||+ .||+||||||+||+++.++ .+||+|||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~-~~i~H~dlkp~Nil~~~~~-~~kl~dfg 158 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN-RNFIHRDLAARNCMLREDM-TVCVADFG 158 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh-CCeeccccchheEEECCCC-eEEECCcc
Confidence 578999999875544332221 123468899999999999999999998 8999999999999999887 79999999
Q ss_pred CccccCCCCC---CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCH
Q 012233 286 SAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTR 361 (468)
Q Consensus 286 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~ 361 (468)
+++....... .....++..|+|||.+.+. .++.++|||||||++|||++ |..||.+....+.+..+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~----- 232 (273)
T cd05035 159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADR-VYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGN----- 232 (273)
T ss_pred ceeeccccccccccccccCCccccCHhhcccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-----
Confidence 9986643321 1122346789999998654 48999999999999999999 999998776655443332210
Q ss_pred HHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 362 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
... .+..++.++.++|.+||+.||.+|||+.+++.
T Consensus 233 -----------~~~------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~ 267 (273)
T cd05035 233 -----------RLK------------QPEDCLDELYDLMYSCWRADPKDRPTFTKLRE 267 (273)
T ss_pred -----------CCC------------CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 000 22357889999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=315.67 Aligned_cols=250 Identities=22% Similarity=0.310 Sum_probs=190.7
Q ss_pred cccceEEeceecccCceEEEEEEEcCCCCE--EEEEEeeccc-----chHHHHHHHHHHc-CCCCcccccceeeecCCCC
Q 012233 135 QTISYMAERVVGTGSFGVVFQAKCLETGDS--VAIKKVLQDK-----RYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKD 206 (468)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~--vaiK~~~~~~-----~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~ 206 (468)
...+|.+.+.||+|+||.||+|.+..++.. +|+|.+.... ..+.+|+.++.++ +|+||+++++++ ..
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~-----~~ 79 (303)
T cd05088 5 EWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC-----EH 79 (303)
T ss_pred chhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEE-----CC
Confidence 345799999999999999999998877765 5777664321 2345699999999 899999999988 44
Q ss_pred ceEEEEEeecccch-HHHHHhhhh------------hcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeec
Q 012233 207 ELYLNLVLEYISET-VYRVSKHYT------------RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVN 273 (468)
Q Consensus 207 ~~~~~lv~e~~~~~-ll~~~~~~~------------~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~ 273 (468)
..+.|+||||++++ +...+.... .....+++..++.++.||+.||+|||+ +||+||||||+|||++
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~-~gi~H~dlkp~Nili~ 158 (303)
T cd05088 80 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARNILVG 158 (303)
T ss_pred CCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh-CCccccccchheEEec
Confidence 45689999999865 444333221 112357889999999999999999998 8999999999999999
Q ss_pred CCCCcEEEeeecCccccCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHH
Q 012233 274 PHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEI 352 (468)
Q Consensus 274 ~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i 352 (468)
.++ .+||+|||++.............++..|+|||.+.+.. ++.++|||||||++|||++ |..||.+.+..+....+
T Consensus 159 ~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~ 236 (303)
T cd05088 159 ENY-VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 236 (303)
T ss_pred CCC-cEEeCccccCcccchhhhcccCCCcccccCHHHHhccC-CcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHH
Confidence 887 79999999986432211222233466799999886544 8899999999999999998 99999876654433322
Q ss_pred HHHhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCC
Q 012233 353 IKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (468)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~h 420 (468)
... ... ..+..+++++.+||.+||+.+|.+||++.+++.+
T Consensus 237 ~~~------------------~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 237 PQG------------------YRL----------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred hcC------------------CcC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 110 000 0123467899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=300.61 Aligned_cols=249 Identities=29% Similarity=0.471 Sum_probs=201.3
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc----chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEEE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV 213 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv 213 (468)
.|.+.+.||+|++|.||++.+..+++.+++|++.... ....+|+.+++.++|+||+++++++.. ....+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~l~ 75 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLK-----KDELWIV 75 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEec-----CCeEEEE
Confidence 3888899999999999999998899999999886543 345679999999999999999998833 3458899
Q ss_pred eecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCCC
Q 012233 214 LEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293 (468)
Q Consensus 214 ~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~~ 293 (468)
+||++++.+..... .....+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++ .++|+|||.+......
T Consensus 76 ~e~~~~~~L~~~~~--~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~i~h~dl~p~ni~i~~~~-~~~l~d~~~~~~~~~~ 151 (253)
T cd05122 76 MEFCSGGSLKDLLK--STNQTLTESQIAYVCKELLKGLEYLHS-NGIIHRDIKAANILLTSDG-EVKLIDFGLSAQLSDT 151 (253)
T ss_pred EecCCCCcHHHHHh--hcCCCCCHHHHHHHHHHHHHHHHHhhc-CCEecCCCCHHHEEEccCC-eEEEeecccccccccc
Confidence 99999655443222 122568999999999999999999998 8999999999999999887 7999999999876554
Q ss_pred CCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCcc
Q 012233 294 EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTE 373 (468)
Q Consensus 294 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 373 (468)
.......++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||...+....+..+... ..+ .
T Consensus 152 ~~~~~~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~-------------~ 216 (253)
T cd05122 152 KARNTMVGTPYWMAPEVINGKP-YDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATN-GPP-------------G 216 (253)
T ss_pred ccccceecCCcccCHHHHcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhc-CCC-------------C
Confidence 3344567889999999987654 889999999999999999999999877544444333220 000 0
Q ss_pred CCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCC
Q 012233 374 FKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPF 422 (468)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~ 422 (468)
++ ....++..+.++|.+||+.||.+|||+.+++.|||
T Consensus 217 --~~----------~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 217 --LR----------NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred --cC----------cccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 00 01124788999999999999999999999999999
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=304.69 Aligned_cols=239 Identities=22% Similarity=0.301 Sum_probs=185.6
Q ss_pred ceecccCceEEEEEEEcCCCCEEEEEEeeccc-----chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEEEeecc
Q 012233 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYI 217 (468)
Q Consensus 143 ~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv~e~~ 217 (468)
+.||+|+||.||+|.+..+++.||+|.+.... ..+.+|+++++.++||||+++++++ ......++||||+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC-----TQKQPIYIVMELV 75 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEE-----cCCCCeEEEEeec
Confidence 36999999999999999999999999875432 2356799999999999999999988 3444588999999
Q ss_pred cchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCCCCCCc
Q 012233 218 SETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI 297 (468)
Q Consensus 218 ~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~~~~~~ 297 (468)
.++.+.... ......+++..++.++.|++.||.|||+ +||+|+||||+|||++.++ .+||+|||++..........
T Consensus 76 ~~~~L~~~~--~~~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~~~~~~~~~ 151 (252)
T cd05084 76 QGGDFLTFL--RTEGPRLKVKELIQMVENAAAGMEYLES-KHCIHRDLAARNCLVTEKN-VLKISDFGMSREEEDGVYAS 151 (252)
T ss_pred cCCcHHHHH--HhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccchheEEEcCCC-cEEECccccCcccccccccc
Confidence 876444222 1223458899999999999999999998 8999999999999999887 79999999987543221111
Q ss_pred ---cccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCcc
Q 012233 298 ---SYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTE 373 (468)
Q Consensus 298 ---~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 373 (468)
...++..|+|||.+.+.. ++.++|||||||++|+|++ |..||...........+.... .
T Consensus 152 ~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~----------------~ 214 (252)
T cd05084 152 TGGMKQIPVKWTAPEALNYGR-YSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGV----------------R 214 (252)
T ss_pred cCCCCCCceeecCchhhcCCC-CChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCC----------------C
Confidence 112245699999986554 8999999999999999997 999997665544333222100 0
Q ss_pred CCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 374 FKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
. .++..++..+.+||.+||+.||.+|||+.+++.
T Consensus 215 ~------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 215 L------------PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred C------------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0 122346889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=309.97 Aligned_cols=249 Identities=20% Similarity=0.299 Sum_probs=192.0
Q ss_pred ccceEEeceecccCceEEEEEEEc----CCCCEEEEEEeeccc-----chHHHHHHHHHHcCCCCcccccceeeecCCCC
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCL----ETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD 206 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~----~~g~~vaiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 206 (468)
...|++.+.||+|+||.||+|.+. .++..||+|.+.... ..+.+|+.+++.++||||+++++++. .
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~ 78 (283)
T cd05090 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVT-----Q 78 (283)
T ss_pred hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEe-----c
Confidence 346899999999999999999853 456789999886422 23457999999999999999999873 3
Q ss_pred ceEEEEEeecccchHHHHHhhhh--------------hcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeee
Q 012233 207 ELYLNLVLEYISETVYRVSKHYT--------------RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLV 272 (468)
Q Consensus 207 ~~~~~lv~e~~~~~ll~~~~~~~--------------~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl 272 (468)
....|+||||+.++.+....... .....+++..+..++.|++.||.|||+ +||+||||||+|||+
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~-~~i~H~dlkp~nili 157 (283)
T cd05090 79 EQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS-HFFVHKDLAARNILI 157 (283)
T ss_pred CCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh-cCeehhccccceEEE
Confidence 34588999999865443222111 112347788889999999999999998 899999999999999
Q ss_pred cCCCCcEEEeeecCccccCCCC---CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHH
Q 012233 273 NPHTHQLKICDFGSAKMLVPGE---PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQ 348 (468)
Q Consensus 273 ~~~~~~vkL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~ 348 (468)
+.++ .+||+|||+++...... ......++..|+|||.+.+.. ++.++|||||||++|||++ |..||.+.+..+.
T Consensus 158 ~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~ 235 (283)
T cd05090 158 GEQL-HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGK-FSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEV 235 (283)
T ss_pred cCCC-cEEeccccccccccCCcceecccCCCccceecChHHhccCC-CCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 9887 79999999997653322 122344567899999986544 8999999999999999998 9999987665433
Q ss_pred HHHHHHHhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCC
Q 012233 349 LVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (468)
Q Consensus 349 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~h 420 (468)
...+... .. . ..+..+++.+.++|.+||+.||.+||++.+++++
T Consensus 236 ~~~~~~~-~~-----------------~----------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 236 IEMVRKR-QL-----------------L----------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HHHHHcC-Cc-----------------C----------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 3332210 00 0 0234578899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=314.01 Aligned_cols=247 Identities=28% Similarity=0.434 Sum_probs=201.6
Q ss_pred eEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-------chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEE
Q 012233 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (468)
Q Consensus 139 y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 211 (468)
|...+.||+|+||.||++.+..++..||+|.+.... ....+|+.+++.++|||++++++++. +....+
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~ 101 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYL-----REHTAW 101 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEe-----eCCeEE
Confidence 888899999999999999999999999999885331 13456899999999999999999884 334588
Q ss_pred EEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccC
Q 012233 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (468)
Q Consensus 212 lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~ 291 (468)
+||||+.+++++.+.. ....+++..+..++.||+.||.|||+ .||+|+||+|+||+++.++ .++|+|||++....
T Consensus 102 lv~e~~~g~l~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~-~~i~H~dL~p~Nil~~~~~-~~kl~dfg~~~~~~ 176 (317)
T cd06635 102 LVMEYCLGSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHS-HNMIHRDIKAGNILLTEPG-QVKLADFGSASIAS 176 (317)
T ss_pred EEEeCCCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCcccEEECCCC-CEEEecCCCccccC
Confidence 9999999887765432 24558899999999999999999998 8999999999999999887 79999999986543
Q ss_pred CCCCCccccccCCccccccccC--CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 012233 292 PGEPNISYICSRYYRAPELIFG--ATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (468)
Q Consensus 292 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 369 (468)
. .....+++.|+|||.+.. ...++.++|||||||++|+|++|..||........+..+......+
T Consensus 177 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~---------- 243 (317)
T cd06635 177 P---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPT---------- 243 (317)
T ss_pred C---cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCC----------
Confidence 2 234578899999999742 2347889999999999999999999998776555555544321100
Q ss_pred CCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q 012233 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDD 425 (468)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~ 425 (468)
.....+++.+++||.+||+.+|.+||++.+++.|+|+..
T Consensus 244 -----------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 244 -----------------LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred -----------------CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 011236788999999999999999999999999999965
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=309.88 Aligned_cols=247 Identities=22% Similarity=0.310 Sum_probs=194.1
Q ss_pred cceEEeceecccCceEEEEEEEcC-----CCCEEEEEEeeccc-----chHHHHHHHHHHcCCCCcccccceeeecCCCC
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLE-----TGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD 206 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~-----~g~~vaiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 206 (468)
.+|.+.+.||+|+||.||+|.+.. ++..||+|.+.... ..+.+|+++++.++|+||+++++++..
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----- 79 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTE----- 79 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEec-----
Confidence 458999999999999999998743 46789999886432 345579999999999999999998843
Q ss_pred ceEEEEEeecccchHHHH-Hhhh----------hhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCC
Q 012233 207 ELYLNLVLEYISETVYRV-SKHY----------TRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPH 275 (468)
Q Consensus 207 ~~~~~lv~e~~~~~ll~~-~~~~----------~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~ 275 (468)
....++||||+.++.+.. +... ......+++..+..++.||+.||.|||+ +||+||||||+|||++.+
T Consensus 80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~-~~i~h~dlkp~nili~~~ 158 (280)
T cd05049 80 GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS-QHFVHRDLATRNCLVGYD 158 (280)
T ss_pred CCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh-CCeeccccccceEEEcCC
Confidence 345899999998765443 2221 1123457888899999999999999998 899999999999999988
Q ss_pred CCcEEEeeecCccccCCCC---CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHH
Q 012233 276 THQLKICDFGSAKMLVPGE---PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVE 351 (468)
Q Consensus 276 ~~~vkL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~ 351 (468)
+ .+||+|||++....... ......+++.|+|||++.+.. ++.++|||||||++|||++ |..||...+..+....
T Consensus 159 ~-~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~ 236 (280)
T cd05049 159 L-VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIEC 236 (280)
T ss_pred C-eEEECCcccceecccCcceecCCCCcccceecChhhhccCC-cchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence 7 79999999987543222 122334578899999997654 8999999999999999998 9999987766554444
Q ss_pred HHHHhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 352 IIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 352 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
+.... . ...+..++..+.+||.+||+.||.+||++.|++.
T Consensus 237 ~~~~~-------------------~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 237 ITQGR-------------------L---------LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred HHcCC-------------------c---------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 33210 0 0022347889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=316.02 Aligned_cols=244 Identities=23% Similarity=0.361 Sum_probs=189.9
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCE----EEEEEeeccc-----chHHHHHHHHHHcCCCCcccccceeeecCCCCc
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDS----VAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~----vaiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 207 (468)
.+|++.+.||+|+||.||+|.+..+|.. ||+|.+.... ..+.+|+.+++.++||||+++++++...
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~----- 81 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS----- 81 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-----
Confidence 3599999999999999999998766664 8999875332 2345689999999999999999987432
Q ss_pred eEEEEEeecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecC
Q 012233 208 LYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (468)
Q Consensus 208 ~~~~lv~e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~ 286 (468)
..++|+||+.++ +++.+. .....++...+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus 82 -~~~~v~e~~~~g~l~~~l~---~~~~~~~~~~~~~~~~qi~~~L~~LH~-~~iiH~dlkp~Nill~~~~-~~kl~DfG~ 155 (316)
T cd05108 82 -TVQLITQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIAKGMNYLEE-RRLVHRDLAARNVLVKTPQ-HVKITDFGL 155 (316)
T ss_pred -CceeeeecCCCCCHHHHHH---hccccCCHHHHHHHHHHHHHHHHHHHh-cCeeccccchhheEecCCC-cEEEccccc
Confidence 256899999865 444332 223457888899999999999999998 8999999999999999887 799999999
Q ss_pred ccccCCCCCCc---cccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 012233 287 AKMLVPGEPNI---SYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTRE 362 (468)
Q Consensus 287 a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~ 362 (468)
++......... ...++..|+|||.+.+. .++.++|||||||++|||++ |..||.+....+ +..++...
T Consensus 156 a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~-~~~~~~~~------ 227 (316)
T cd05108 156 AKLLGADEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKG------ 227 (316)
T ss_pred cccccCCCcceeccCCccceeecChHHhccC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH-HHHHHhCC------
Confidence 98765433222 22346689999998654 48999999999999999997 999998765443 33333210
Q ss_pred HHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCC
Q 012233 363 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (468)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~h 420 (468)
..++ .+..++.++.++|.+||..||.+||++.+++.+
T Consensus 228 -----------~~~~----------~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 228 -----------ERLP----------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred -----------CCCC----------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0111 123467889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=307.35 Aligned_cols=251 Identities=20% Similarity=0.262 Sum_probs=189.9
Q ss_pred eEEeceecccCceEEEEEEEcCCCC--EEEEEEeecc------cchHHHHHHHHHHcCCCCcccccceeeecCC-CCceE
Q 012233 139 YMAERVVGTGSFGVVFQAKCLETGD--SVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTE-KDELY 209 (468)
Q Consensus 139 y~~~~~lG~G~fg~Vy~~~~~~~g~--~vaiK~~~~~------~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~-~~~~~ 209 (468)
|.+++.||+|+||.||+|.+..++. .||+|.+... ...+.+|+.+++.++|+||+++++.++.... .....
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3467889999999999999877765 5899987532 2234568999999999999999987644322 12234
Q ss_pred EEEEeecccchHHH-HHhhh--hhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecC
Q 012233 210 LNLVLEYISETVYR-VSKHY--TRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (468)
Q Consensus 210 ~~lv~e~~~~~ll~-~~~~~--~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~ 286 (468)
.++||||+.++.+. .+... ......+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~ 158 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS-KSFIHRDLAARNCMLNENM-NVCVADFGL 158 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH-CCeeccccchhheEEcCCC-CEEECCCCc
Confidence 67999999865443 22211 1123457899999999999999999998 8999999999999999887 799999999
Q ss_pred ccccCCCCC---CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 012233 287 AKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTRE 362 (468)
Q Consensus 287 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~ 362 (468)
++....... .....+++.|+|||.+.+. .++.++|||||||++|||++ |+.||.+....+....+... .
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~----- 231 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADR-VYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQG-N----- 231 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCC-CcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-C-----
Confidence 986643321 1223456789999998654 48999999999999999999 89999876654433332220 0
Q ss_pred HHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCC
Q 012233 363 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (468)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~h 420 (468)
.. .++..++..+.++|.+||+.||.+|||+.+++.+
T Consensus 232 ------------~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 232 ------------RL----------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred ------------CC----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 00 0223477889999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=300.98 Aligned_cols=247 Identities=34% Similarity=0.548 Sum_probs=202.2
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeecccc------hHHHHHHHHHHcCCCCcccccceeeecCCCCceEEE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR------YKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~~------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 211 (468)
+|.+.+.||+|++|.||++.+..+++.|++|.+..... ...+|+++++.++|+|++++++++. +....+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~ 75 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIE-----TSDSLY 75 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEE-----eCCEEE
Confidence 48889999999999999999998999999998855432 3457999999999999999999873 345688
Q ss_pred EEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccC
Q 012233 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (468)
Q Consensus 212 lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~ 291 (468)
+||||+.++.+.... .....+++..++.++.|++.||.|||+ .||+|+||||+||+++.++ .++|+|||.+....
T Consensus 76 ~v~e~~~~~~L~~~~---~~~~~l~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~ni~i~~~~-~~~l~d~~~~~~~~ 150 (254)
T cd06627 76 IILEYAENGSLRQII---KKFGPFPESLVAVYVYQVLQGLAYLHE-QGVIHRDIKAANILTTKDG-VVKLADFGVATKLN 150 (254)
T ss_pred EEEecCCCCcHHHHH---HhccCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCHHHEEECCCC-CEEEeccccceecC
Confidence 999999876444222 123568999999999999999999998 8999999999999999877 79999999998764
Q ss_pred CCCC-CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCC
Q 012233 292 PGEP-NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPN 370 (468)
Q Consensus 292 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 370 (468)
.... .....++..|+|||.+.+.. ++.++|+||||+++|+|++|..||...+......++...
T Consensus 151 ~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--------------- 214 (254)
T cd06627 151 DVSKDDASVVGTPYWMAPEVIEMSG-ASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQD--------------- 214 (254)
T ss_pred CCcccccccccchhhcCHhhhcCCC-CCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcc---------------
Confidence 4332 23456788999999986654 889999999999999999999999876654444333210
Q ss_pred CccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 012233 371 YTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (468)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f 423 (468)
. ...++..++..+.++|.+||..+|++|||+.+++.||||
T Consensus 215 ----~---------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 215 ----D---------HPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred ----C---------CCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence 0 011334578999999999999999999999999999998
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=333.78 Aligned_cols=286 Identities=22% Similarity=0.272 Sum_probs=185.4
Q ss_pred CcccceEEeceecccCceEEEEEEEcCC----CCEEEEEEeecccchHHHHHHHH---HHcCCCCcccccceeeecCC-C
Q 012233 134 KQTISYMAERVVGTGSFGVVFQAKCLET----GDSVAIKKVLQDKRYKNRELQIM---RLLNHPNVVSLKHCFFSTTE-K 205 (468)
Q Consensus 134 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~----g~~vaiK~~~~~~~~~~~E~~il---~~l~hpnIv~l~~~~~~~~~-~ 205 (468)
...++|.+.+.||+|+||.||+|.+..+ +..||+|++..... .|..+. +...+.+++.++..|..... .
T Consensus 129 ~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~---~e~~~~e~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 129 FKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA---VEIWMNERVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred CccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch---hHHHHHHHHHhhchhhHHHHHHhhhcccccc
Confidence 3456899999999999999999999888 99999998754322 222222 22233444444433322111 3
Q ss_pred CceEEEEEeecccchHHHHHhhhhhc-----------------CCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCC
Q 012233 206 DELYLNLVLEYISETVYRVSKHYTRM-----------------NQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQ 268 (468)
Q Consensus 206 ~~~~~~lv~e~~~~~ll~~~~~~~~~-----------------~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~ 268 (468)
....++|||||++++.+..+...... ........+..++.||+.||.|||+ +||+||||||+
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~-~gIiHRDLKP~ 284 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS-TGIVHRDVKPQ 284 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH-CCEEeCcCCHH
Confidence 34458899999987644332211100 0011223466799999999999998 89999999999
Q ss_pred CeeecCCCCcEEEeeecCccccCCCC--CCccccccCCccccccccCCC---------------------CCCcchhHHH
Q 012233 269 NLLVNPHTHQLKICDFGSAKMLVPGE--PNISYICSRYYRAPELIFGAT---------------------EYTTAIDMWS 325 (468)
Q Consensus 269 NILl~~~~~~vkL~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~---------------------~~~~~~DvwS 325 (468)
|||++.+...+||+|||+++.+.... .....++++.|+|||.+.... .++.++||||
T Consensus 285 NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwS 364 (566)
T PLN03225 285 NIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 364 (566)
T ss_pred HEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHH
Confidence 99998654479999999997653322 234568899999999763221 2345679999
Q ss_pred HHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcc
Q 012233 326 IGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQ 405 (468)
Q Consensus 326 lG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 405 (468)
|||+||||+++..++ .+....+..++...+...........+.. .+.+.. .. .........+.+||.+||+
T Consensus 365 lGviL~el~~~~~~~--~~~~~~~~~~l~~~~~~~~~~~~~~~~~~----~~~~~~--~~-~~~d~~~~~~~dLi~~mL~ 435 (566)
T PLN03225 365 AGLIFLQMAFPNLRS--DSNLIQFNRQLKRNDYDLVAWRKLVEPRA----SPDLRR--GF-EVLDLDGGAGWELLKSMMR 435 (566)
T ss_pred HHHHHHHHHhCcCCC--chHHHHHHHHHHhcCCcHHHHHHhhcccc----chhhhh--hh-hhccccchHHHHHHHHHcc
Confidence 999999999876554 34444455554443333222111111110 000000 00 0112234567799999999
Q ss_pred cCCCCCCCHHHHhCCCCCCCCCCCCCC
Q 012233 406 YSPSLRCTALEACAHPFFDDLRDPNTC 432 (468)
Q Consensus 406 ~dP~~R~s~~ell~hp~f~~~~~~~~~ 432 (468)
+||.+|||+.++|+||||+........
T Consensus 436 ~dP~kR~ta~e~L~Hpff~~~~~~~~~ 462 (566)
T PLN03225 436 FKGRQRISAKAALAHPYFDREGLLGLS 462 (566)
T ss_pred CCcccCCCHHHHhCCcCcCCCCccccc
Confidence 999999999999999999886554333
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=305.17 Aligned_cols=249 Identities=24% Similarity=0.447 Sum_probs=196.3
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc---------cchHHHHHHHHHHcCCCCcccccceeeecCCCCce
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~---------~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 208 (468)
+|.+.+.||+|+||.||++.+...+..+++|++... .....+|+.+++.++||||+++++++. +..
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~ 75 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFL-----ERD 75 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHh-----cCC
Confidence 489999999999999999999877777777765321 112346889999999999999999883 334
Q ss_pred EEEEEeecccchHHH-HHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCc
Q 012233 209 YLNLVLEYISETVYR-VSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (468)
Q Consensus 209 ~~~lv~e~~~~~ll~-~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a 287 (468)
..++||||+.++.+. .+.........+++..++.++.|++.||.|||+ .|++|+||||+||+++.+ .++|+|||++
T Consensus 76 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~h~~l~~~nili~~~--~~~l~d~g~~ 152 (260)
T cd08222 76 AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ-RRILHRDLKAKNIFLKNN--LLKIGDFGVS 152 (260)
T ss_pred ceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH-cCccccCCChhheEeecC--CEeecccCce
Confidence 588999999875444 333333445678999999999999999999998 899999999999999853 5999999998
Q ss_pred cccCCCC-CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 012233 288 KMLVPGE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKC 366 (468)
Q Consensus 288 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 366 (468)
....... ......+++.|+|||.+.+. .++.++|+||||+++|+|++|..||...........+... +
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~---~------- 221 (260)
T cd08222 153 RLLMGSCDLATTFTGTPYYMSPEALKHQ-GYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEG---P------- 221 (260)
T ss_pred eecCCCcccccCCCCCcCccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcC---C-------
Confidence 7654332 23345678899999998654 4788999999999999999999999766544444333220 0
Q ss_pred cCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 012233 367 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (468)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f 423 (468)
.+ .++..++.++.++|.+||..||.+||++.+++.||||
T Consensus 222 ---------~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 222 ---------TP---------SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred ---------CC---------CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 00 0224578899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=301.11 Aligned_cols=249 Identities=28% Similarity=0.431 Sum_probs=201.7
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc------chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 211 (468)
+|.+.+.||.|+||.||++.+..+++.+|+|.+.... ....+|+.+++.++|+||+++++++. +....+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~ 75 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFL-----DGNKLC 75 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhc-----cCCEEE
Confidence 4889999999999999999999999999999885421 23346889999999999999999884 335689
Q ss_pred EEeecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcccc
Q 012233 212 LVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (468)
Q Consensus 212 lv~e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~ 290 (468)
+||||+++. +...+.........+++..++.++.|++.||.|||+ .|++|+||+|.||+++.++ .+||+|||++...
T Consensus 76 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~-~~i~h~~l~~~ni~~~~~~-~~kl~d~g~~~~~ 153 (256)
T cd08530 76 IVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE-QKILHRDLKSANILLVAND-LVKIGDLGISKVL 153 (256)
T ss_pred EEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCcceEEEecCC-cEEEeeccchhhh
Confidence 999999765 444443333334668889999999999999999998 8999999999999999877 7999999999776
Q ss_pred CCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCC
Q 012233 291 VPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPN 370 (468)
Q Consensus 291 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 370 (468)
... ......+++.|+|||.+.+. .++.++|+||||+++|+|++|+.||...+..+....+...
T Consensus 154 ~~~-~~~~~~~~~~~~~Pe~~~~~-~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~--------------- 216 (256)
T cd08530 154 KKN-MAKTQIGTPHYMAPEVWKGR-PYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRG--------------- 216 (256)
T ss_pred ccC-CcccccCCccccCHHHHCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC---------------
Confidence 544 33345688999999999664 4889999999999999999999999877654433332210
Q ss_pred CccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 012233 371 YTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (468)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f 423 (468)
.++. ....++.+++++|.+||+.+|.+||++.++++||++
T Consensus 217 ----~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 217 ----KYPP---------IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred ----CCCC---------CchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 1111 223467889999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=311.24 Aligned_cols=247 Identities=21% Similarity=0.255 Sum_probs=192.9
Q ss_pred cceEEeceecccCceEEEEEEEcCC-----CCEEEEEEeeccc-----chHHHHHHHHHHcCCCCcccccceeeecCCCC
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLET-----GDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD 206 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~-----g~~vaiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 206 (468)
..|++.+.||.|+||.||+|.+..+ +..||||++.... ..+.+|+.++..++||||+++++++ ..
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~-----~~ 79 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVV-----TK 79 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEE-----cC
Confidence 3588999999999999999987543 5789999986443 2345789999999999999999988 34
Q ss_pred ceEEEEEeecccchHHHHHhhh-------------hhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeec
Q 012233 207 ELYLNLVLEYISETVYRVSKHY-------------TRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVN 273 (468)
Q Consensus 207 ~~~~~lv~e~~~~~ll~~~~~~-------------~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~ 273 (468)
....++++||+.++.+...... ......+++..+..++.|++.||.|||+ +||+||||||+|||++
T Consensus 80 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~-~gi~H~dlkp~Nil~~ 158 (283)
T cd05091 80 EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS-HHVVHKDLATRNVLVF 158 (283)
T ss_pred CCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH-cCccccccchhheEec
Confidence 4458899999986544332211 1112357888899999999999999998 8999999999999999
Q ss_pred CCCCcEEEeeecCccccCCCCC---CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHH
Q 012233 274 PHTHQLKICDFGSAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQL 349 (468)
Q Consensus 274 ~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~ 349 (468)
.++ .+||+|||+++....... .....+++.|+|||.+.+.. ++.++|||||||++|||++ |..||.+....+.+
T Consensus 159 ~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~ 236 (283)
T cd05091 159 DKL-NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGK-FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVI 236 (283)
T ss_pred CCC-ceEecccccccccccchheeeccCccCCccccCHHHHhcCC-CCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 887 799999999876533221 12334577899999986554 8999999999999999998 89999887665555
Q ss_pred HHHHHHhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 350 VEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 350 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
..+...... .++..++..+.+|+.+||+.+|.+||++.+++.
T Consensus 237 ~~i~~~~~~----------------------------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~ 278 (283)
T cd05091 237 EMIRNRQVL----------------------------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHS 278 (283)
T ss_pred HHHHcCCcC----------------------------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 444331000 123457889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=321.93 Aligned_cols=249 Identities=25% Similarity=0.363 Sum_probs=190.9
Q ss_pred ccceEEeceecccCceEEEEEEEcCC-----CCEEEEEEeeccc-----chHHHHHHHHHHcC-CCCcccccceeeecCC
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLET-----GDSVAIKKVLQDK-----RYKNRELQIMRLLN-HPNVVSLKHCFFSTTE 204 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~-----g~~vaiK~~~~~~-----~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~ 204 (468)
...|++++.||+|+||.||+|.+... +..||||++.... ..+.+|+++|+.+. ||||+++++++
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~----- 110 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGAC----- 110 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE-----
Confidence 44699999999999999999987432 3469999885432 23457999999996 99999999998
Q ss_pred CCceEEEEEeecccchHHH-HHhhhh------------------------------------------------------
Q 012233 205 KDELYLNLVLEYISETVYR-VSKHYT------------------------------------------------------ 229 (468)
Q Consensus 205 ~~~~~~~lv~e~~~~~ll~-~~~~~~------------------------------------------------------ 229 (468)
.+...+|||||||.++.+. .+....
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (400)
T cd05105 111 TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP 190 (400)
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence 4445689999999865443 222110
Q ss_pred --------------------------------------hcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCee
Q 012233 230 --------------------------------------RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLL 271 (468)
Q Consensus 230 --------------------------------------~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NIL 271 (468)
.....+++..+..++.||+.||.|||+ .||+||||||+|||
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivH~dikp~Nil 269 (400)
T cd05105 191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS-KNCVHRDLAARNVL 269 (400)
T ss_pred hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChHhEE
Confidence 012347788889999999999999998 89999999999999
Q ss_pred ecCCCCcEEEeeecCccccCCCCC---CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHH
Q 012233 272 VNPHTHQLKICDFGSAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVD 347 (468)
Q Consensus 272 l~~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~ 347 (468)
++.++ .+||+|||+++....... .....+++.|+|||++.+.. ++.++|||||||++|||++ |..||.......
T Consensus 270 l~~~~-~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~ 347 (400)
T cd05105 270 LAQGK-IVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNL-YTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS 347 (400)
T ss_pred EeCCC-EEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCcccchhH
Confidence 99887 799999999976533221 22345678899999987654 8999999999999999997 999998765444
Q ss_pred HHHHHHHHhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 348 QLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 348 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
.+...+... ... ..+..++.++.++|.+||+.||.+||++.++.+
T Consensus 348 ~~~~~~~~~-----------------~~~----------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 348 TFYNKIKSG-----------------YRM----------AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HHHHHHhcC-----------------CCC----------CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 433332210 000 022357889999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=341.58 Aligned_cols=249 Identities=23% Similarity=0.351 Sum_probs=190.9
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-------chHHHHHHHHHHcCCCCcccccceeeecCCCCceE
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 209 (468)
++|.+.+.||+|+||.||+|.+..+|+.||||++.... ....+|+.+++.++||||+++++++ .+...
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~-----~d~~~ 76 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSIC-----SDGDP 76 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEE-----eeCCE
Confidence 36999999999999999999999999999999986431 2345799999999999999999988 34446
Q ss_pred EEEEeecccchHHH-HHhhhh-------hcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEE
Q 012233 210 LNLVLEYISETVYR-VSKHYT-------RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKI 281 (468)
Q Consensus 210 ~~lv~e~~~~~ll~-~~~~~~-------~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL 281 (468)
.|+||||++|+.+. .+.... ......++..+..++.||+.||.|||+ +||+||||||+|||++.++ .++|
T Consensus 77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs-~GIIHRDLKPeNILLd~dg-~vKL 154 (932)
T PRK13184 77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS-KGVLHRDLKPDNILLGLFG-EVVI 154 (932)
T ss_pred EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH-CCccccCCchheEEEcCCC-CEEE
Confidence 89999999876544 332211 112345567788899999999999998 8999999999999999888 7999
Q ss_pred eeecCccccCCCC-------------------CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 012233 282 CDFGSAKMLVPGE-------------------PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPG 342 (468)
Q Consensus 282 ~DFG~a~~~~~~~-------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~ 342 (468)
+|||+++...... .....+||+.|+|||++.+.. ++.++|||||||++|||++|..||..
T Consensus 155 iDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~-~S~kSDIWSLGVILyELLTG~~PF~~ 233 (932)
T PRK13184 155 LDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVP-ASESTDIYALGVILYQMLTLSFPYRR 233 (932)
T ss_pred EecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCC-CCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence 9999997652110 011246899999999997654 89999999999999999999999987
Q ss_pred CCcHHHHHHHHHHhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 343 ESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 343 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
......... .....|. .. . -...+++.+.+++.+||+.||.+|++..+.+.
T Consensus 234 ~~~~ki~~~--~~i~~P~--------------~~-----~-----p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl 284 (932)
T PRK13184 234 KKGRKISYR--DVILSPI--------------EV-----A-----PYREIPPFLSQIAMKALAVDPAERYSSVQELK 284 (932)
T ss_pred cchhhhhhh--hhccChh--------------hc-----c-----ccccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 544332211 1000000 00 0 01347889999999999999999987666554
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=303.93 Aligned_cols=245 Identities=19% Similarity=0.262 Sum_probs=192.0
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc---chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEEE
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV 213 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~---~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv 213 (468)
.+|.+.+.||+|+||.||.|.+.. +..+|+|.+.... ....+|+.+++.++||||+++++++ .....+++|
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~lv 77 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVC-----TKQRPIYIV 77 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEE-----ccCCCcEEE
Confidence 359999999999999999998753 4569999886432 2356799999999999999999987 333457899
Q ss_pred eecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCCC
Q 012233 214 LEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293 (468)
Q Consensus 214 ~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~~ 293 (468)
|||+.++.+..... .....+++..++.++.||+.||.|||+ .||+|+||||+|||++.++ .+||+|||.++.....
T Consensus 78 ~e~~~~~~l~~~i~--~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~nili~~~~-~~kl~d~g~~~~~~~~ 153 (256)
T cd05113 78 TEYMSNGCLLNYLR--EHGKRFQPSQLLEMCKDVCEGMAYLES-KQFIHRDLAARNCLVDDQG-CVKVSDFGLSRYVLDD 153 (256)
T ss_pred EEcCCCCcHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccccCcceEEEcCCC-CEEECCCccceecCCC
Confidence 99998764432221 123368899999999999999999998 8999999999999999887 7999999998765433
Q ss_pred CC--CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCC
Q 012233 294 EP--NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPN 370 (468)
Q Consensus 294 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 370 (468)
.. .....++..|+|||.+.+.. ++.++|||||||++|+|++ |..||......+....+.+....
T Consensus 154 ~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~------------ 220 (256)
T cd05113 154 EYTSSVGSKFPVRWSPPEVLLYSK-FSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRL------------ 220 (256)
T ss_pred ceeecCCCccChhhCCHHHHhcCc-ccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCC------------
Confidence 21 11234567899999996544 8999999999999999998 99999876655544444331100
Q ss_pred CccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCC
Q 012233 371 YTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (468)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~h 420 (468)
. .+...+..+.+++.+||+.||.+||++.+++.+
T Consensus 221 ----~------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 221 ----Y------------RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred ----C------------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 0 112357899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=307.72 Aligned_cols=250 Identities=22% Similarity=0.278 Sum_probs=192.5
Q ss_pred ccceEEeceecccCceEEEEEEEcC-----CCCEEEEEEeeccc-----chHHHHHHHHHHcCCCCcccccceeeecCCC
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLE-----TGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEK 205 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~-----~g~~vaiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 205 (468)
..+|.+.+.||+|+||.||+|.+.. ++..||+|.+.... ..+.+|+.+++.++|+||+++++++..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---- 80 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFE---- 80 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc----
Confidence 3469999999999999999999977 67889999875332 234568999999999999999998743
Q ss_pred CceEEEEEeecccchHH-HHHhhhhh---cCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCC--CcE
Q 012233 206 DELYLNLVLEYISETVY-RVSKHYTR---MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHT--HQL 279 (468)
Q Consensus 206 ~~~~~~lv~e~~~~~ll-~~~~~~~~---~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~--~~v 279 (468)
....++||||+.++.+ .++..... ....+++..+..++.||+.||.|||+ +|++|+||||+|||++.++ ..+
T Consensus 81 -~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivH~dlkp~nil~~~~~~~~~~ 158 (277)
T cd05036 81 -RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE-NHFIHRDIAARNCLLTCKGPGRVA 158 (277)
T ss_pred -CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccchheEEEeccCCCcce
Confidence 3347899999976544 43332211 12358889999999999999999998 8999999999999998653 259
Q ss_pred EEeeecCccccCCCCC---CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHH
Q 012233 280 KICDFGSAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKI 355 (468)
Q Consensus 280 kL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~ 355 (468)
||+|||+++....... ......+..|+|||++.+.. ++.++|||||||++|||++ |+.||.+.+..+....+...
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~ 237 (277)
T cd05036 159 KIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGI-FTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGG 237 (277)
T ss_pred EeccCccccccCCccceecCCCCCccHhhCCHHHHhcCC-cCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence 9999999976532211 11223356799999997554 8999999999999999996 99999887665543332210
Q ss_pred hCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCC
Q 012233 356 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (468)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~h 420 (468)
. .. .++..++..+.++|.+||+.||.+||++.++++|
T Consensus 238 -~---------------~~------------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 238 -G---------------RL------------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred -C---------------cC------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 0 00 0234578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=311.82 Aligned_cols=253 Identities=27% Similarity=0.430 Sum_probs=202.6
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-------chHHHHHHHHHHcCCCCcccccceeeecCCCCceEE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~ 210 (468)
.|...+.||+|+||.||+|++..++..||+|.+.... ....+|+.+++.++|+|++++++++.. ....
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~ 90 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----EHTA 90 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEc-----CCee
Confidence 3778889999999999999999999999999875321 123469999999999999999998843 3458
Q ss_pred EEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcccc
Q 012233 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (468)
Q Consensus 211 ~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~ 290 (468)
++||||+.+++...+.. ....+++..+..++.|++.||.|||+ .|++||||||+|||++.++ .++|+|||++...
T Consensus 91 ~lv~e~~~~~l~~~~~~---~~~~l~~~~~~~~~~~l~~~l~~LH~-~~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~~ 165 (308)
T cd06634 91 WLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHS-HNMIHRDVKAGNILLSEPG-LVKLGDFGSASIM 165 (308)
T ss_pred EEEEEccCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHhEEECCCC-cEEECCcccceee
Confidence 89999999877665432 23458889999999999999999998 8999999999999999887 7999999998765
Q ss_pred CCCCCCccccccCCccccccccC--CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 012233 291 VPGEPNISYICSRYYRAPELIFG--ATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368 (468)
Q Consensus 291 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 368 (468)
.. .....+++.|+|||.+.+ ...++.++|||||||++|+|++|..||...+..+....+.... .
T Consensus 166 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~---------- 231 (308)
T cd06634 166 AP---ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE-S---------- 231 (308)
T ss_pred cC---cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcC-C----------
Confidence 33 234568899999999752 2347889999999999999999999997765554444333210 0
Q ss_pred CCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCCC
Q 012233 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPN 430 (468)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~ 430 (468)
+. .....++..+.+||.+||..+|.+||++.+++.||||.....+.
T Consensus 232 --------~~--------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~~~~ 277 (308)
T cd06634 232 --------PA--------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPT 277 (308)
T ss_pred --------CC--------cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccccCChh
Confidence 00 01124678899999999999999999999999999998854433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=308.51 Aligned_cols=255 Identities=28% Similarity=0.408 Sum_probs=204.3
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc---chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEEE
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV 213 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~---~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv 213 (468)
..|.....||+|+||.||+|.+..++..|++|++.... ....+|+++++.++|+||+++++++.. ..+.|+|
T Consensus 19 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~lv 93 (286)
T cd06614 19 ELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLV-----GDELWVV 93 (286)
T ss_pred ccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEE-----CCEEEEE
Confidence 35889999999999999999998889999999986543 345679999999999999999998844 3468999
Q ss_pred eecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCCC
Q 012233 214 LEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293 (468)
Q Consensus 214 ~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~~ 293 (468)
+||+.++.+....... ...++...+..++.|++.||.|||+ .||+|+||+|+||+++.++ .++|+|||++......
T Consensus 94 ~e~~~~~~L~~~l~~~--~~~l~~~~~~~i~~~i~~~L~~lH~-~gi~H~dl~p~ni~i~~~~-~~~l~d~~~~~~~~~~ 169 (286)
T cd06614 94 MEYMDGGSLTDIITQN--FVRMNEPQIAYVCREVLQGLEYLHS-QNVIHRDIKSDNILLSKDG-SVKLADFGFAAQLTKE 169 (286)
T ss_pred EeccCCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCChhhEEEcCCC-CEEECccchhhhhccc
Confidence 9999965444322211 1368999999999999999999998 9999999999999999887 7999999998655332
Q ss_pred C-CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCc
Q 012233 294 E-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYT 372 (468)
Q Consensus 294 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 372 (468)
. ......++..|+|||.+.+.. ++.++|+|||||++|+|++|..||...+.......+.... .+
T Consensus 170 ~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~-~~------------- 234 (286)
T cd06614 170 KSKRNSVVGTPYWMAPEVIKRKD-YGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKG-IP------------- 234 (286)
T ss_pred hhhhccccCCcccCCHhHhcCCC-CCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-CC-------------
Confidence 2 223345788999999986554 8999999999999999999999998776655444433210 00
Q ss_pred cCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q 012233 373 EFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (468)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~ 427 (468)
. + .....++.++++||.+||+.+|.+||++.+++.||||+...
T Consensus 235 ~--~----------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 277 (286)
T cd06614 235 P--L----------KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKAC 277 (286)
T ss_pred C--C----------cchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhccC
Confidence 0 0 01123678999999999999999999999999999999843
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=303.05 Aligned_cols=245 Identities=24% Similarity=0.330 Sum_probs=193.0
Q ss_pred ccceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc---chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEE
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~---~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~l 212 (468)
..+|++.+.||+|+||.||+|.+. ++..||+|.+.... ....+|+.+++.++|+||+++++++ .+....++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l 78 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVV-----TKEEPIYI 78 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEE-----cCCCCcEE
Confidence 456999999999999999999864 56789999875432 3445799999999999999999887 44445889
Q ss_pred EeecccchHH-HHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccC
Q 012233 213 VLEYISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (468)
Q Consensus 213 v~e~~~~~ll-~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~ 291 (468)
||||+.++.+ ..+.. .....+++..+..++.|++.||.|||+ .|++||||||+||+++.++ .++|+|||++....
T Consensus 79 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~~l~~~l~~LH~-~~i~H~dl~p~nili~~~~-~~~l~dfg~~~~~~ 154 (261)
T cd05072 79 ITEYMAKGSLLDFLKS--DEGGKVLLPKLIDFSAQIAEGMAYIER-KNYIHRDLRAANVLVSESL-MCKIADFGLARVIE 154 (261)
T ss_pred EEecCCCCcHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccchhhEEecCCC-cEEECCCccceecC
Confidence 9999986544 43322 124567888899999999999999998 8999999999999999887 79999999997654
Q ss_pred CCCC--CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 012233 292 PGEP--NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368 (468)
Q Consensus 292 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 368 (468)
.... .....++..|+|||.+.+. .++.++|||||||++|+|++ |..||......+....+....
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~------------ 221 (261)
T cd05072 155 DNEYTAREGAKFPIKWTAPEAINFG-SFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGY------------ 221 (261)
T ss_pred CCceeccCCCccceecCCHHHhccC-CCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCC------------
Confidence 3221 1223456789999998654 48899999999999999998 999998776655444433210
Q ss_pred CCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
.++ ....++.++.++|.+||..||++||++++++.
T Consensus 222 ------~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 222 ------RMP----------RMENCPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred ------CCC----------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 001 11347889999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=307.52 Aligned_cols=252 Identities=24% Similarity=0.331 Sum_probs=194.7
Q ss_pred cceEEeceecccCceEEEEEEEc-----CCCCEEEEEEeeccc----chHHHHHHHHHHcCCCCcccccceeeecCCCCc
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCL-----ETGDSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~-----~~g~~vaiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 207 (468)
.+|.+.+.||+|+||.||++.+. .++..+|+|.+.... ..+.+|+.+++.++||||+++++++. ..
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~ 79 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCV-----EG 79 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe-----cC
Confidence 46999999999999999999863 345679999885432 23567999999999999999999883 34
Q ss_pred eEEEEEeecccchHH-HHHhhhh---------hcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCC
Q 012233 208 LYLNLVLEYISETVY-RVSKHYT---------RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTH 277 (468)
Q Consensus 208 ~~~~lv~e~~~~~ll-~~~~~~~---------~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~ 277 (468)
.+.++||||+.++.+ +.+.... .....+++..+..++.||+.||+|||+ +||+||||||+|||++.++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~-~~i~H~dlkp~Nili~~~~- 157 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS-QHFVHRDLATRNCLVGENL- 157 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccCcceEEEccCC-
Confidence 468899999986544 3333211 112348999999999999999999998 8999999999999999888
Q ss_pred cEEEeeecCccccCCCCC---CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHH
Q 012233 278 QLKICDFGSAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEII 353 (468)
Q Consensus 278 ~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~ 353 (468)
.++|+|||++........ .....++..|+|||++.+. .++.++|+|||||++|+|++ |..||......+.+..+.
T Consensus 158 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~ 236 (288)
T cd05093 158 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT 236 (288)
T ss_pred cEEeccCCccccccCCceeecCCCCCccccccCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 799999999976533221 1223456789999998654 48999999999999999998 999998776655544443
Q ss_pred HHhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q 012233 354 KILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426 (468)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 426 (468)
... .+ ..+..++.++.+||.+||+.||.+|||+.+++. +|+++
T Consensus 237 ~~~-------------------~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~--~l~~~ 279 (288)
T cd05093 237 QGR-------------------VL---------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS--LLQNL 279 (288)
T ss_pred cCC-------------------cC---------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH--HHHHH
Confidence 210 00 012346789999999999999999999999865 34443
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=317.36 Aligned_cols=262 Identities=27% Similarity=0.352 Sum_probs=191.8
Q ss_pred ccceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc----cchHHHHHHHHHHcCCCCcccccceeeecCCCCceEEE
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~----~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 211 (468)
+++|....+||+|+||.||+|... +|..||||++... ...+.+|+.++.+++|||+|+|+|||..... ..+
T Consensus 74 T~~Fs~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~----~~~ 148 (361)
T KOG1187|consen 74 TNNFSESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGE----HRL 148 (361)
T ss_pred HhCCchhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCc----eEE
Confidence 356888889999999999999964 4589999988543 3457889999999999999999999954332 477
Q ss_pred EEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcC--CccccCCCCCCeeecCCCCcEEEeeecCccc
Q 012233 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV--GVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (468)
Q Consensus 212 lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~--givHrDlkp~NILl~~~~~~vkL~DFG~a~~ 289 (468)
||+||++.|.|....+..... .++|....+|+.++++||+|||+.. .|||||||++|||||.+. +.||+|||+|+.
T Consensus 149 LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~-~aKlsDFGLa~~ 226 (361)
T KOG1187|consen 149 LVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDF-NAKLSDFGLAKL 226 (361)
T ss_pred EEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCC-CEEccCccCccc
Confidence 999999977665544433222 7899999999999999999999744 399999999999999888 899999999976
Q ss_pred cCC-CCCCccc-cccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC--cHHHHHHHHH-HhCCCCHHHH
Q 012233 290 LVP-GEPNISY-ICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGES--GVDQLVEIIK-ILGTPTREEI 364 (468)
Q Consensus 290 ~~~-~~~~~~~-~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~--~~~~~~~i~~-~~~~~~~~~~ 364 (468)
... ....... .||..|+|||.+.. ...+.++|||||||+|.||++|+.+..... ....+..+.. .+...
T Consensus 227 ~~~~~~~~~~~~~gt~gY~~PEy~~~-g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~----- 300 (361)
T KOG1187|consen 227 GPEGDTSVSTTVMGTFGYLAPEYAST-GKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEG----- 300 (361)
T ss_pred CCccccceeeecCCCCccCChhhhcc-CCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCc-----
Confidence 554 3333333 89999999999965 458999999999999999999998887532 1111222221 11110
Q ss_pred hhcCCCCccCCCCcccCCCccccccc-CCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 365 KCMNPNYTEFKFPQIKAHPWHKIFHK-RMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
...++-=|.+.. ..+.. ..-..+..+..+|++.+|..||++.|++.
T Consensus 301 -----~~~eiiD~~l~~----~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 301 -----KLREIVDPRLKE----GEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred -----chhheeCCCccC----CCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 001111111110 00100 01123667889999999999999999754
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=305.41 Aligned_cols=248 Identities=24% Similarity=0.314 Sum_probs=193.0
Q ss_pred ccceEEeceecccCceEEEEEEEcCC-----CCEEEEEEeecccc-----hHHHHHHHHHHcCCCCcccccceeeecCCC
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLET-----GDSVAIKKVLQDKR-----YKNRELQIMRLLNHPNVVSLKHCFFSTTEK 205 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~-----g~~vaiK~~~~~~~-----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 205 (468)
.++|.+.+.||+|+||.||+|.+... +..||+|.+..... ...+|+.+++.++||||+++++++ .
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~ 79 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVV-----S 79 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEE-----c
Confidence 35799999999999999999998643 37899998754432 345789999999999999999988 3
Q ss_pred CceEEEEEeecccchHH-HHHhhhhh------cCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCc
Q 012233 206 DELYLNLVLEYISETVY-RVSKHYTR------MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQ 278 (468)
Q Consensus 206 ~~~~~~lv~e~~~~~ll-~~~~~~~~------~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~ 278 (468)
...+.++||||++++.+ ..+..... ....+++..+..++.||+.||.|||+ .||+||||||+|||++.++ .
T Consensus 80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~di~p~nill~~~~-~ 157 (277)
T cd05032 80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA-KKFVHRDLAARNCMVAEDL-T 157 (277)
T ss_pred CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccChheEEEcCCC-C
Confidence 44568899999986544 44332221 12346788899999999999999998 8999999999999999888 7
Q ss_pred EEEeeecCccccCCCC---CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHH
Q 012233 279 LKICDFGSAKMLVPGE---PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIK 354 (468)
Q Consensus 279 vkL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~ 354 (468)
+||+|||+++...... ......++..|+|||.+.+.. ++.++|||||||++|||++ |..||...+..+....+..
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~ 236 (277)
T cd05032 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGV-FTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVID 236 (277)
T ss_pred EEECCcccchhhccCcccccCCCCCccccccCHHHHhcCC-CCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhc
Confidence 9999999987654322 122345678899999986544 8999999999999999998 9999987665544333321
Q ss_pred HhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 355 ILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
... .. ++...+.++.+||.+||+.+|.+|||+.+++.
T Consensus 237 -~~~---------------~~------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 237 -GGH---------------LD------------LPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred -CCC---------------CC------------CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 000 00 22346889999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=303.84 Aligned_cols=249 Identities=30% Similarity=0.496 Sum_probs=194.6
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc-------cchHHHHHHHHHHcCCCCcccccceeeecCCCCceE
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~-------~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 209 (468)
.+|.+.+.||+|+||.||+|.+..++..+|||.+... .....+|+.+++.++|+||++++++|. ....
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~ 76 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI-----EDNE 76 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeE-----eCCe
Confidence 3589999999999999999999999999999987532 123456999999999999999999884 3345
Q ss_pred EEEEeecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcc
Q 012233 210 LNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (468)
Q Consensus 210 ~~lv~e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~ 288 (468)
.+++|||+.++ +.+++.........+++..++.++.||+.||.|||+ +||+|+||||+||+++.++ .++|+|||++.
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dl~p~nili~~~~-~~~l~dfg~~~ 154 (267)
T cd08229 77 LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS-RRVMHRDIKPANVFITATG-VVKLGDLGLGR 154 (267)
T ss_pred EEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcCCC-CEEECcchhhh
Confidence 88999999865 444444333445668999999999999999999998 8999999999999999887 79999999987
Q ss_pred ccCCCCC-CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCCCCHHHHhh
Q 012233 289 MLVPGEP-NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGV-DQLVEIIKILGTPTREEIKC 366 (468)
Q Consensus 289 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~ 366 (468)
....... .....++..|+|||.+.+.. ++.++|+||||+++|+|++|..||.+.... ....+.+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~ape~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~------------ 221 (267)
T cd08229 155 FFSSKTTAAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE------------ 221 (267)
T ss_pred ccccCCcccccccCCcCccCHHHhcCCC-ccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhh------------
Confidence 6543322 22457889999999986544 889999999999999999999999764322 11111111
Q ss_pred cCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 367 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
...++. ..+..+++++.+||.+||..||.+|||+.+++.
T Consensus 222 ------~~~~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 222 ------QCDYPP--------LPSDHYSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred ------cCCCCC--------CCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 001110 011347889999999999999999999997754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=300.43 Aligned_cols=242 Identities=27% Similarity=0.390 Sum_probs=194.1
Q ss_pred ceecccCceEEEEEEEcCC---CCEEEEEEeeccc-----chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEEEe
Q 012233 143 RVVGTGSFGVVFQAKCLET---GDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (468)
Q Consensus 143 ~~lG~G~fg~Vy~~~~~~~---g~~vaiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv~ 214 (468)
+.||+|+||.||+|.+... +..|++|.+.... ....+|+.+++.++|+||+++++++. ....+++||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~lv~ 75 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCT-----EEEPLYLVL 75 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeec-----CCCceEEEE
Confidence 4699999999999999765 8899999886543 34457999999999999999999884 345689999
Q ss_pred ecccch-HHHHHhhhhhc-----CCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcc
Q 012233 215 EYISET-VYRVSKHYTRM-----NQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (468)
Q Consensus 215 e~~~~~-ll~~~~~~~~~-----~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~ 288 (468)
||+.++ +.+.+...... ...+++..++.++.|++.||+|||+ +||+|+||||+||+++.++ .++|+|||.+.
T Consensus 76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~di~p~nili~~~~-~~~l~dfg~~~ 153 (262)
T cd00192 76 EYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS-KKFVHRDLAARNCLVGEDL-VVKISDFGLSR 153 (262)
T ss_pred EeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc-CCcccCccCcceEEECCCC-cEEEccccccc
Confidence 999654 44443332111 3678999999999999999999998 9999999999999999887 79999999998
Q ss_pred ccCCCC---CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 012233 289 MLVPGE---PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEI 364 (468)
Q Consensus 289 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 364 (468)
...... ......++..|+|||.+.+. .++.++|||||||++|+|++ |..||......+....+...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~--------- 223 (262)
T cd00192 154 DVYDDDYYRKKTGGKLPIRWMAPESLKDG-IFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKG--------- 223 (262)
T ss_pred ccccccccccccCCCcCccccCHHHhccC-CcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC---------
Confidence 765432 23345678899999998665 58999999999999999998 69999887655544443320
Q ss_pred hhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCC
Q 012233 365 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (468)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~h 420 (468)
+....+..++.++.++|.+||..||.+|||+.+++++
T Consensus 224 -------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 224 -------------------YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred -------------------CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 0011234578999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=341.59 Aligned_cols=258 Identities=29% Similarity=0.430 Sum_probs=197.0
Q ss_pred ccceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-----chHHHHHHHHHHcCCCCcccccceeeecCC------
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTE------ 204 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~------ 204 (468)
..+|+..++||+||||.||+++++-+|..||||+|.... ....+|+.+|.+|+|||||+++..+.....
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence 346888999999999999999999999999999985542 223579999999999999998765422100
Q ss_pred -------------------------------------------------------------------C------------
Q 012233 205 -------------------------------------------------------------------K------------ 205 (468)
Q Consensus 205 -------------------------------------------------------------------~------------ 205 (468)
+
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence 0
Q ss_pred -----------------------------CceEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHh
Q 012233 206 -----------------------------DELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH 256 (468)
Q Consensus 206 -----------------------------~~~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~ 256 (468)
...++||=||||...+++.+........ ....+|++++||+.||+|+|+
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYIH~ 715 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYIHD 715 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHHHh
Confidence 0157899999999988876655332221 467799999999999999998
Q ss_pred cCCccccCCCCCCeeecCCCCcEEEeeecCccccC-------------------CCCCCccccccCCccccccccCCC--
Q 012233 257 VVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV-------------------PGEPNISYICSRYYRAPELIFGAT-- 315 (468)
Q Consensus 257 ~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~~~-- 315 (468)
.|||||||||.|||++.+. .|||+|||+|+... +....++.+||.-|+|||++.+..
T Consensus 716 -~giIHRDLKP~NIFLd~~~-~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~ 793 (1351)
T KOG1035|consen 716 -QGIIHRDLKPRNIFLDSRN-SVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSN 793 (1351)
T ss_pred -CceeeccCCcceeEEcCCC-CeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccc
Confidence 8999999999999999887 79999999997621 111345678999999999997766
Q ss_pred CCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHH
Q 012233 316 EYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPE 395 (468)
Q Consensus 316 ~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 395 (468)
.|+.|+|+||||+|+|||+. ||.. .++....+ ..+..+ .+|.. ..|+..--+.
T Consensus 794 ~Yn~KiDmYSLGIVlFEM~y---PF~T--sMERa~iL-~~LR~g---------------~iP~~------~~f~~~~~~~ 846 (1351)
T KOG1035|consen 794 KYNSKIDMYSLGIVLFEMLY---PFGT--SMERASIL-TNLRKG---------------SIPEP------ADFFDPEHPE 846 (1351)
T ss_pred cccchhhhHHHHHHHHHHhc---cCCc--hHHHHHHH-HhcccC---------------CCCCC------cccccccchH
Confidence 69999999999999999996 5643 33333322 222211 11111 1122223355
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhCCCCCC
Q 012233 396 ALDLVSRLLQYSPSLRCTALEACAHPFFD 424 (468)
Q Consensus 396 l~~li~~~L~~dP~~R~s~~ell~hp~f~ 424 (468)
-..+|++||+.||++||||.|+|++.||-
T Consensus 847 e~slI~~Ll~hdP~kRPtA~eLL~s~llp 875 (1351)
T KOG1035|consen 847 EASLIRWLLSHDPSKRPTATELLNSELLP 875 (1351)
T ss_pred HHHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence 67899999999999999999999999995
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=300.01 Aligned_cols=244 Identities=23% Similarity=0.312 Sum_probs=191.8
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc---chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEEE
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV 213 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~---~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv 213 (468)
.+|++.+.||+|+||.||+|.+. ++..||+|.+.... ....+|+.+++.++||||+++++++ ......++|
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~lv 79 (261)
T cd05068 6 TSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVC-----TLEEPIYIV 79 (261)
T ss_pred hheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEE-----ecCCCeeee
Confidence 46999999999999999999974 45789999886533 3456799999999999999999987 333458899
Q ss_pred eecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCC
Q 012233 214 LEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (468)
Q Consensus 214 ~e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~ 292 (468)
|||+.++ +.+.+... ....+++..+..++.|++.||.|||+ .||+|+||||+||+++.++ .++|+|||++.....
T Consensus 80 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~Nil~~~~~-~~~l~dfg~~~~~~~ 155 (261)
T cd05068 80 TELMKYGSLLEYLQGG--AGRALKLPQLIDMAAQVASGMAYLEA-QNYIHRDLAARNVLVGENN-ICKVADFGLARVIKE 155 (261)
T ss_pred eecccCCcHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCCcceEEEcCCC-CEEECCcceEEEccC
Confidence 9999654 44433321 13468899999999999999999998 8999999999999999888 799999999987643
Q ss_pred CCCC--ccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 012233 293 GEPN--ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (468)
Q Consensus 293 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 369 (468)
.... .....+..|+|||.+.+. .++.++|+|||||++|+|++ |+.||.+......+..+....
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~------------- 221 (261)
T cd05068 156 DIYEAREGAKFPIKWTAPEAALYN-RFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGY------------- 221 (261)
T ss_pred CcccccCCCcCceeccCccccccC-CCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-------------
Confidence 2211 112224579999998654 48999999999999999999 999998876555444433210
Q ss_pred CCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
..+ .+..++..+.+++.+||+.||.+||++.+++.
T Consensus 222 -----~~~----------~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 222 -----RMP----------CPPGCPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred -----CCC----------CCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 000 12346889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=298.02 Aligned_cols=238 Identities=36% Similarity=0.588 Sum_probs=194.5
Q ss_pred ecccCceEEEEEEEcCCCCEEEEEEeeccc-------chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEEEeecc
Q 012233 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYI 217 (468)
Q Consensus 145 lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv~e~~ 217 (468)
||.|+||.||++.+..+++.||+|.+.... ....+|+.+++.++|+||+++++.+ .+....|+||||+
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~~v~e~~ 75 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAF-----QTEEKLYLVLEYA 75 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHe-----ecCCeeEEEEecC
Confidence 699999999999998889999999885432 2456799999999999999999988 4555789999999
Q ss_pred cch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCCC-CC
Q 012233 218 SET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG-EP 295 (468)
Q Consensus 218 ~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~~-~~ 295 (468)
.++ +.+.+.. ...+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++ .++|+|||.+...... ..
T Consensus 76 ~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lh~-~~~~H~~l~p~ni~~~~~~-~~~l~d~~~~~~~~~~~~~ 149 (250)
T cd05123 76 PGGELFSHLSK----EGRFSEERARFYAAEIVLALEYLHS-LGIIYRDLKPENILLDADG-HIKLTDFGLAKELSSEGSR 149 (250)
T ss_pred CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCcceEEEcCCC-cEEEeecCcceecccCCCc
Confidence 654 4443322 3468899999999999999999998 8999999999999999887 7999999998765433 22
Q ss_pred CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccCC
Q 012233 296 NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFK 375 (468)
Q Consensus 296 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 375 (468)
.....++..|+|||.+.+.. ++.++|+||||+++|+|++|..||...+.......+.. ....
T Consensus 150 ~~~~~~~~~~~~Pe~~~~~~-~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~-----------------~~~~ 211 (250)
T cd05123 150 TNTFCGTPEYLAPEVLLGKG-YGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK-----------------DPLR 211 (250)
T ss_pred ccCCcCCccccChHHhCCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc-----------------CCCC
Confidence 34556788999999986554 78899999999999999999999977665333333322 1111
Q ss_pred CCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCH---HHHhCCCCC
Q 012233 376 FPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTA---LEACAHPFF 423 (468)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~---~ell~hp~f 423 (468)
++..++..+.++|++||..||.+||++ .++++||||
T Consensus 212 ------------~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 212 ------------FPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred ------------CCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 234468899999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=303.85 Aligned_cols=244 Identities=22% Similarity=0.316 Sum_probs=195.3
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc----chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEE
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~l 212 (468)
.+|.+.+.||.|+||.||+|.+.. +..+|+|.+.... ....+|+.+++.++|+||+++++++ .+..+.++
T Consensus 6 ~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~l 79 (261)
T cd05148 6 EEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVC-----SVGEPVYI 79 (261)
T ss_pred HHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeE-----ecCCCeEE
Confidence 469999999999999999999877 8999999886543 2456799999999999999999987 34445889
Q ss_pred Eeecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccC
Q 012233 213 VLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (468)
Q Consensus 213 v~e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~ 291 (468)
||||++++ +.+.+... ....+++..+..++.||+.||.|||+ +||+|+||||+||||+.++ .+||+|||.+....
T Consensus 80 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~-~~i~h~dl~~~nilv~~~~-~~kl~d~g~~~~~~ 155 (261)
T cd05148 80 ITELMEKGSLLAFLRSP--EGQVLPVASLIDMACQVAEGMAYLEE-QNSIHRDLAARNILVGEDL-VCKVADFGLARLIK 155 (261)
T ss_pred EEeecccCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccCcceEEEcCCc-eEEEccccchhhcC
Confidence 99999875 44433321 23567889999999999999999998 8999999999999999888 79999999997653
Q ss_pred CCCC-CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 012233 292 PGEP-NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (468)
Q Consensus 292 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 369 (468)
.... .....++..|+|||.+.+. .++.++|||||||++|+|++ |+.||...+..+.+..+......
T Consensus 156 ~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~----------- 223 (261)
T cd05148 156 EDVYLSSDKKIPYKWTAPEAASHG-TFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRM----------- 223 (261)
T ss_pred CccccccCCCCceEecCHHHHccC-CCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcC-----------
Confidence 3221 1123456789999998654 48899999999999999998 89999887765555544331100
Q ss_pred CCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
..+..+++.+.++|.+||+.||.+|||+.++++
T Consensus 224 -----------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 224 -----------------PCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred -----------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 022357889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=301.97 Aligned_cols=242 Identities=21% Similarity=0.313 Sum_probs=190.6
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc---chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEEEe
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~---~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv~ 214 (468)
+|.+.+.||+|+||.||+|.+. ++..+|+|.+.... ....+|+.+++.++||||+++++++ ....+.|+||
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~lv~ 78 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVC-----TKQRPIFIVT 78 (256)
T ss_pred HcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEE-----cCCCceEEEE
Confidence 5889999999999999999875 46789999886432 2345799999999999999999887 3444688999
Q ss_pred ecccchH-HHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCCC
Q 012233 215 EYISETV-YRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293 (468)
Q Consensus 215 e~~~~~l-l~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~~ 293 (468)
||++++. .+.+.. ....+++..+..++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||+++.....
T Consensus 79 e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dl~p~ni~i~~~~-~~kl~dfg~~~~~~~~ 153 (256)
T cd05059 79 EYMANGCLLNYLRE---RKGKLGTEWLLDMCSDVCEAMEYLES-NGFIHRDLAARNCLVGEDN-VVKVSDFGLARYVLDD 153 (256)
T ss_pred ecCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH-CCcccccccHhhEEECCCC-cEEECCcccceecccc
Confidence 9998654 433321 23468899999999999999999998 8999999999999999888 7999999998765432
Q ss_pred CCC--ccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCC
Q 012233 294 EPN--ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPN 370 (468)
Q Consensus 294 ~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 370 (468)
... ....++..|+|||.+.+. .++.++|+|||||++|+|++ |..||...+..+....+.....
T Consensus 154 ~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~------------- 219 (256)
T cd05059 154 QYTSSQGTKFPVKWAPPEVFDYS-RFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYR------------- 219 (256)
T ss_pred cccccCCCCCCccccCHHHhccC-CCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCc-------------
Confidence 211 112234579999998754 48999999999999999998 8999987665554443322100
Q ss_pred CccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 371 YTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
. ..+..++.++.+++.+||..+|.+|||+.+++.
T Consensus 220 ---~------------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~ 253 (256)
T cd05059 220 ---L------------YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLS 253 (256)
T ss_pred ---C------------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 0 022347889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=302.19 Aligned_cols=246 Identities=23% Similarity=0.297 Sum_probs=192.4
Q ss_pred cceEEeceecccCceEEEEEEEcCC---CCEEEEEEeeccc-----chHHHHHHHHHHcCCCCcccccceeeecCCCCce
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLET---GDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~---g~~vaiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 208 (468)
.+|.+.+.||+|+||.||+|.+..+ ...||+|.+.... ..+.+|+.+++.++||||+++++++ ....
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~ 78 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVV-----TKSR 78 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEE-----ecCC
Confidence 4699999999999999999998654 4579999875432 2344699999999999999999987 3344
Q ss_pred EEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcc
Q 012233 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (468)
Q Consensus 209 ~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~ 288 (468)
..++||||+.++.+..... .....+++..+..++.|++.||.|||+ +||+|+||||+|||++.++ .++|+|||++.
T Consensus 79 ~~~iv~e~~~~~~L~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~Lh~-~~i~H~di~p~nili~~~~-~~~l~dfg~~~ 154 (266)
T cd05033 79 PVMIITEYMENGSLDKFLR--ENDGKFTVGQLVGMLRGIASGMKYLSE-MNYVHRDLAARNILVNSNL-VCKVSDFGLSR 154 (266)
T ss_pred ceEEEEEcCCCCCHHHHHH--hccCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCcceEEEcCCC-CEEECccchhh
Confidence 5889999998765543222 223468899999999999999999998 8999999999999999887 79999999998
Q ss_pred ccCCCCCC---ccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 012233 289 MLVPGEPN---ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEI 364 (468)
Q Consensus 289 ~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 364 (468)
........ ....++..|+|||.+.+. .++.++|||||||++|+|++ |..||......+....+....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~-------- 225 (266)
T cd05033 155 RLEDSEATYTTKGGKIPIRWTAPEAIAYR-KFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGY-------- 225 (266)
T ss_pred cccccccceeccCCCCCccccChhhhccC-CCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCC--------
Confidence 76422111 122346789999998654 48999999999999999997 999997766555444332210
Q ss_pred hhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCC
Q 012233 365 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (468)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~h 420 (468)
..+ .+..+++.+.+|+.+||+.+|.+||++.+++++
T Consensus 226 ----------~~~----------~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 226 ----------RLP----------PPMDCPSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred ----------CCC----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 000 123478899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=295.28 Aligned_cols=255 Identities=26% Similarity=0.485 Sum_probs=210.3
Q ss_pred CCcccceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-------chHHHHHHHHHHc-CCCCcccccceeeecCC
Q 012233 133 PKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLL-NHPNVVSLKHCFFSTTE 204 (468)
Q Consensus 133 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-------~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~ 204 (468)
.....+|.+.++||+|+|++|.+++.+.+.+.||+|++++.. .-...|..+..+. +||.+|-|+.||
T Consensus 246 ~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscf----- 320 (593)
T KOG0695|consen 246 GLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCF----- 320 (593)
T ss_pred ccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhh-----
Confidence 344557999999999999999999999999999999886532 1223566776665 699999999999
Q ss_pred CCceEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeee
Q 012233 205 KDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDF 284 (468)
Q Consensus 205 ~~~~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DF 284 (468)
+.+..+|+|.||++|+-+-. + ....+++|+..++.|...|+.||.|||+ +|||+||||.+|+|+|..++ +||+|+
T Consensus 321 qtesrlffvieyv~ggdlmf--h-mqrqrklpeeharfys~ei~lal~flh~-rgiiyrdlkldnvlldaegh-ikltdy 395 (593)
T KOG0695|consen 321 QTESRLFFVIEYVNGGDLMF--H-MQRQRKLPEEHARFYSAEICLALNFLHE-RGIIYRDLKLDNVLLDAEGH-IKLTDY 395 (593)
T ss_pred cccceEEEEEEEecCcceee--e-hhhhhcCcHHHhhhhhHHHHHHHHHHhh-cCeeeeeccccceEEccCCc-eeeccc
Confidence 66667999999999884432 2 2235779999999999999999999998 99999999999999999995 999999
Q ss_pred cCcccc-CCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCC-------CCcHHHHHHHHHHh
Q 012233 285 GSAKML-VPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPG-------ESGVDQLVEIIKIL 356 (468)
Q Consensus 285 G~a~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~-------~~~~~~~~~i~~~~ 356 (468)
|+++.- .++....++||||.|.|||++.+.. |+..+|+|+|||+++||+.|+.||.- .+.++.+.+++-.
T Consensus 396 gmcke~l~~gd~tstfcgtpnyiapeilrgee-ygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvile- 473 (593)
T KOG0695|consen 396 GMCKEGLGPGDTTSTFCGTPNYIAPEILRGEE-YGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILE- 473 (593)
T ss_pred chhhcCCCCCcccccccCCCcccchhhhcccc-cCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhh-
Confidence 999764 4566677899999999999998765 99999999999999999999999952 3445556655431
Q ss_pred CCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCC------CHHHHhCCCCCCCC
Q 012233 357 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC------TALEACAHPFFDDL 426 (468)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~------s~~ell~hp~f~~~ 426 (468)
.++. ++..++-.+..+++..|.+||.+|. ...++..|+||+.+
T Consensus 474 ---------------kqir------------iprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~i 522 (593)
T KOG0695|consen 474 ---------------KQIR------------IPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSI 522 (593)
T ss_pred ---------------hccc------------ccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhC
Confidence 1112 3345777889999999999999997 47899999999965
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=306.47 Aligned_cols=249 Identities=23% Similarity=0.346 Sum_probs=192.4
Q ss_pred ccceEEeceecccCceEEEEEEEcCCC-----CEEEEEEeeccc-----chHHHHHHHHHHc-CCCCcccccceeeecCC
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLETG-----DSVAIKKVLQDK-----RYKNRELQIMRLL-NHPNVVSLKHCFFSTTE 204 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g-----~~vaiK~~~~~~-----~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~ 204 (468)
..+|.+.+.||+|+||.||++.+...+ ..+|+|.+.... ....+|+.+++.+ +|+||+++++++
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~----- 85 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVC----- 85 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE-----
Confidence 346999999999999999999976433 679999886432 2245799999999 799999999987
Q ss_pred CCceEEEEEeecccchHHH-HHhhhh------------hcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCee
Q 012233 205 KDELYLNLVLEYISETVYR-VSKHYT------------RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLL 271 (468)
Q Consensus 205 ~~~~~~~lv~e~~~~~ll~-~~~~~~------------~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NIL 271 (468)
.....+++||||+.++.+. .+.... .....+++..+..++.||+.||.|||+ .||+||||||+|||
T Consensus 86 ~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~ivH~dlkp~Nil 164 (293)
T cd05053 86 TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS-KKCIHRDLAARNVL 164 (293)
T ss_pred cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH-CCccccccceeeEE
Confidence 3344589999999865443 332211 234568889999999999999999998 89999999999999
Q ss_pred ecCCCCcEEEeeecCccccCCCCC---CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHH
Q 012233 272 VNPHTHQLKICDFGSAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVD 347 (468)
Q Consensus 272 l~~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~ 347 (468)
++.++ .+||+|||+++....... .....++..|+|||++.+. .++.++|||||||++|||++ |..||.+....+
T Consensus 165 ~~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 242 (293)
T cd05053 165 VTEDH-VMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 242 (293)
T ss_pred EcCCC-eEEeCccccccccccccceeccCCCCCCccccCHHHhccC-CcCcccceeehhhHHHHHhcCCCCCCCCCCHHH
Confidence 99887 799999999986543221 1122345679999998654 48999999999999999997 999998766554
Q ss_pred HHHHHHHHhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCC
Q 012233 348 QLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (468)
Q Consensus 348 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~h 420 (468)
....+.... .. ..+...+.++.+||.+||..||.+|||+.+++++
T Consensus 243 ~~~~~~~~~----------------~~------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 243 LFKLLKEGY----------------RM------------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHHHHHcCC----------------cC------------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 443322100 00 0223468899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=304.94 Aligned_cols=256 Identities=30% Similarity=0.477 Sum_probs=196.1
Q ss_pred ceEEeceecccCceEEEEEEEc---CCCCEEEEEEeeccc--------chHHHHHHHHHHc-CCCCcccccceeeecCCC
Q 012233 138 SYMAERVVGTGSFGVVFQAKCL---ETGDSVAIKKVLQDK--------RYKNRELQIMRLL-NHPNVVSLKHCFFSTTEK 205 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~---~~g~~vaiK~~~~~~--------~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~ 205 (468)
+|.+.+.||+|+||.||++.+. .++..||||.+.+.. ....+|+.+++.+ +||||+++++++ .
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-----~ 75 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAF-----Q 75 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheee-----e
Confidence 3889999999999999999864 467889999886421 2245699999999 599999999887 4
Q ss_pred CceEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeec
Q 012233 206 DELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG 285 (468)
Q Consensus 206 ~~~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG 285 (468)
....+|+||||+.++.+.... .....+++..++.++.|++.||.|||+ .|++|+||||.||+++.++ .++|+|||
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~~---~~~~~~~~~~~~~~~~ql~~~l~~lH~-~~~~H~dl~p~nil~~~~~-~~~l~dfg 150 (288)
T cd05583 76 TDTKLHLILDYVNGGELFTHL---YQREHFTESEVRVYIAEIVLALDHLHQ-LGIIYRDIKLENILLDSEG-HVVLTDFG 150 (288)
T ss_pred cCCEEEEEEecCCCCcHHHHH---hhcCCcCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEECCCC-CEEEEECc
Confidence 444688999999876443221 123568889999999999999999998 8999999999999999887 79999999
Q ss_pred CccccCCCCC--CccccccCCccccccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 012233 286 SAKMLVPGEP--NISYICSRYYRAPELIFGAT-EYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTRE 362 (468)
Q Consensus 286 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~-~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~ 362 (468)
++........ .....|+..|+|||.+.+.. ..+.++|+||||+++|+|++|..||...........+.+....
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~---- 226 (288)
T cd05583 151 LSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILK---- 226 (288)
T ss_pred cccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHc----
Confidence 9876543322 22346789999999986532 3678999999999999999999999654322222222111000
Q ss_pred HHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCC---HHHHhCCCCCCCCCC
Q 012233 363 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCT---ALEACAHPFFDDLRD 428 (468)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s---~~ell~hp~f~~~~~ 428 (468)
.. ...+..++..+.++|.+||+.||++||| +.++|+||||+.+..
T Consensus 227 ---------~~------------~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~ 274 (288)
T cd05583 227 ---------SK------------PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDW 274 (288)
T ss_pred ---------cC------------CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCH
Confidence 00 0122347889999999999999999998 567899999998753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=298.36 Aligned_cols=248 Identities=30% Similarity=0.502 Sum_probs=194.9
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc-------cchHHHHHHHHHHcCCCCcccccceeeecCCCCceE
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~-------~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 209 (468)
++|.+.+.||+|+||.||+|.+..+|+.||+|.+... .....+|+++++.++|+||+++++++. ....
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~-----~~~~ 76 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFI-----ENNE 76 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeee-----cCCe
Confidence 4699999999999999999999989999999987421 234457999999999999999999984 3446
Q ss_pred EEEEeecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcc
Q 012233 210 LNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (468)
Q Consensus 210 ~~lv~e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~ 288 (468)
.++||||++++ +...+.........++...+..++.||+.||.|||+ .||+|+||||+||+++.++ .++|+|||++.
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~dl~p~nil~~~~~-~~~l~d~~~~~ 154 (267)
T cd08224 77 LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS-KRIMHRDIKPANVFITATG-VVKLGDLGLGR 154 (267)
T ss_pred EEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh-CCEecCCcChhhEEECCCC-cEEEeccceee
Confidence 88999999864 444444333345568899999999999999999998 8999999999999999888 79999999987
Q ss_pred ccCCCC-CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHHHHHhCCCCHHHHh
Q 012233 289 MLVPGE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGV--DQLVEIIKILGTPTREEIK 365 (468)
Q Consensus 289 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~ 365 (468)
...... ......+++.|+|||.+.+. .++.++|+|||||++|+|++|..||...... +....+...
T Consensus 155 ~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---------- 223 (267)
T cd08224 155 FFSSKTTAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKC---------- 223 (267)
T ss_pred eccCCCcccceecCCccccCHHHhccC-CCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcC----------
Confidence 653322 22345688999999998654 4899999999999999999999999654311 111111110
Q ss_pred hcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 366 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
.++. .....++.++.++|.+||..+|.+|||+.+++.
T Consensus 224 ---------~~~~--------~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 224 ---------DYPP--------LPADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred ---------CCCC--------CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 0000 011246789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=305.75 Aligned_cols=250 Identities=24% Similarity=0.337 Sum_probs=192.7
Q ss_pred CcccceEEeceecccCceEEEEEEE-----cCCCCEEEEEEeeccc-----chHHHHHHHHHHc-CCCCcccccceeeec
Q 012233 134 KQTISYMAERVVGTGSFGVVFQAKC-----LETGDSVAIKKVLQDK-----RYKNRELQIMRLL-NHPNVVSLKHCFFST 202 (468)
Q Consensus 134 ~~~~~y~~~~~lG~G~fg~Vy~~~~-----~~~g~~vaiK~~~~~~-----~~~~~E~~il~~l-~hpnIv~l~~~~~~~ 202 (468)
...++|.+.+.||+|+||.||+|.+ ..++..||+|.+.... ....+|+.+++++ +||||+++++++.
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~-- 109 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACT-- 109 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEe--
Confidence 3345799999999999999999985 2345689999876432 2345799999999 7999999999883
Q ss_pred CCCCceEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEe
Q 012233 203 TEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKIC 282 (468)
Q Consensus 203 ~~~~~~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~ 282 (468)
....+++||||+.++.+...... .....+++..+..++.||+.||.|||+ +||+|+||||+|||++.++ .++|+
T Consensus 110 ---~~~~~~lv~e~~~~~~L~~~i~~-~~~~~l~~~~~~~i~~~i~~~l~~lH~-~~ivH~dlkp~Nil~~~~~-~~~l~ 183 (302)
T cd05055 110 ---IGGPILVITEYCCYGDLLNFLRR-KRESFLTLEDLLSFSYQVAKGMAFLAS-KNCIHRDLAARNVLLTHGK-IVKIC 183 (302)
T ss_pred ---cCCceEEEEEcCCCCcHHHHHHh-CCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeehhhhccceEEEcCCC-eEEEC
Confidence 33458999999986544322221 112348999999999999999999998 8999999999999999777 79999
Q ss_pred eecCccccCCCCC---CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCC
Q 012233 283 DFGSAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGT 358 (468)
Q Consensus 283 DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~ 358 (468)
|||+++....... .....++..|+|||.+.+.. ++.++|||||||++|+|++ |..||......+.+.+.+...
T Consensus 184 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~-- 260 (302)
T cd05055 184 DFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEG-- 260 (302)
T ss_pred CCcccccccCCCceeecCCCCcccccCCHhhhccCC-CCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcC--
Confidence 9999976543221 11234567899999986654 8999999999999999998 999998766555444433310
Q ss_pred CCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 359 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
+. ...+..+++++.+||.+||+.+|.+|||+.+++.
T Consensus 261 ---------------~~----------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 261 ---------------YR----------MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred ---------------Cc----------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 00 0012346889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=303.93 Aligned_cols=257 Identities=26% Similarity=0.337 Sum_probs=188.6
Q ss_pred eEEeceecccCceEEEEEEE----cCCCCEEEEEEeeccc-----chHHHHHHHHHHcCCCCcccccceeeecCCCCceE
Q 012233 139 YMAERVVGTGSFGVVFQAKC----LETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (468)
Q Consensus 139 y~~~~~lG~G~fg~Vy~~~~----~~~g~~vaiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 209 (468)
|.+.+.||+|+||+||++.. ..++..||+|.+.... ..+.+|+++++.++||||+++++++.. .....
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~ 82 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSE---QGGKG 82 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CCCce
Confidence 48899999999999988653 3568899999886432 234579999999999999999987643 22346
Q ss_pred EEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccc
Q 012233 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (468)
Q Consensus 210 ~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~ 289 (468)
+++||||+.++.+..... ...+++..++.++.|++.||.|||+ +||+||||||+|||++.++ .++|+|||+++.
T Consensus 83 ~~lv~e~~~~~~l~~~~~----~~~l~~~~~~~i~~~l~~~l~~lH~-~~i~H~dlkp~Nili~~~~-~~~l~dfg~~~~ 156 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLP----KHKLNLAQLLLFAQQICEGMAYLHS-QHYIHRDLAARNVLLDNDR-LVKIGDFGLAKA 156 (283)
T ss_pred EEEEecCCCCCCHHHHHH----HcCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccChheEEEcCCC-cEEEeecccccc
Confidence 889999999765543322 2458999999999999999999998 8999999999999999887 799999999976
Q ss_pred cCCCCC----CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh-CCCCHHHH
Q 012233 290 LVPGEP----NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKIL-GTPTREEI 364 (468)
Q Consensus 290 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~-~~~~~~~~ 364 (468)
...... .....++..|+|||.+.+. .++.++|||||||++|+|++|..||...... +....... +.......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~ 233 (283)
T cd05080 157 VPEGHEYYRVREDGDSPVFWYAVECLKEN-KFSYASDVWSFGVTLYELLTHCDSKQSPPKK--FEEMIGPKQGQMTVVRL 233 (283)
T ss_pred cCCcchhhccCCCCCCCceeeCHhHhccc-CCCcccccHHHHHHHHHHHhCCCCCCCCcch--hhhhhcccccccchhhh
Confidence 643322 1123456779999998654 4899999999999999999999998654321 11111100 00000000
Q ss_pred hhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 365 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
. ...........+..++.++.+++.+||+.||++|||+.+++.
T Consensus 234 ~------------~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 234 I------------ELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred h------------hhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0 000000011123457889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=298.82 Aligned_cols=243 Identities=26% Similarity=0.349 Sum_probs=189.7
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc---chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEEE
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV 213 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~---~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv 213 (468)
.+|.+.+.||+|+||.||+|.+..+ ..||+|++.... ....+|+.+++.++||||+++++.+. . .+.++|
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-----~-~~~~lv 78 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-----E-EPIYIV 78 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEEC-----C-CCcEEE
Confidence 3599999999999999999998655 469999886532 23567999999999999999988652 1 236799
Q ss_pred eecccchH-HHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCC
Q 012233 214 LEYISETV-YRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (468)
Q Consensus 214 ~e~~~~~l-l~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~ 292 (468)
|||++++. .+.+... ....+++..+..++.|++.||.|||+ .||+|+||||+||+++.++ .++|+|||.+.....
T Consensus 79 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~-~~i~H~dl~p~Nill~~~~-~~~L~dfg~~~~~~~ 154 (262)
T cd05071 79 TEYMSKGSLLDFLKGE--MGKYLRLPQLVDMAAQIASGMAYVER-MNYVHRDLRAANILVGENL-VCKVADFGLARLIED 154 (262)
T ss_pred EEcCCCCcHHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHH-CCccccccCcccEEEcCCC-cEEeccCCceeeccc
Confidence 99998654 4433221 23457888999999999999999998 8999999999999999887 799999999976543
Q ss_pred CCCC--ccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 012233 293 GEPN--ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (468)
Q Consensus 293 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 369 (468)
.... ....++..|+|||++.+. .++.++|||||||++|+|++ |..||.+....+.+..+....
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~------------- 220 (262)
T cd05071 155 NEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY------------- 220 (262)
T ss_pred cccccccCCcccceecCHhHhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCC-------------
Confidence 3221 123456789999988654 48999999999999999999 899998776555444332210
Q ss_pred CCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
..+ ....++..+.+||.+||+.||.+||++.+++.
T Consensus 221 -----~~~----------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 221 -----RMP----------CPPECPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred -----CCC----------CccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 000 12347889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=304.57 Aligned_cols=247 Identities=23% Similarity=0.324 Sum_probs=192.2
Q ss_pred cceEEeceecccCceEEEEEEEc-----CCCCEEEEEEeeccc----chHHHHHHHHHHcCCCCcccccceeeecCCCCc
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCL-----ETGDSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~-----~~g~~vaiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 207 (468)
.+|.+.+.||+|+||.||+|.+. .++..+++|.+.... ..+.+|+.+++.++|+||+++++++ ...
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~ 79 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVC-----GDG 79 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEE-----ccC
Confidence 35999999999999999999864 245668999875442 3456799999999999999999988 344
Q ss_pred eEEEEEeecccchHHH-HHhhhh------------hcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecC
Q 012233 208 LYLNLVLEYISETVYR-VSKHYT------------RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNP 274 (468)
Q Consensus 208 ~~~~lv~e~~~~~ll~-~~~~~~------------~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~ 274 (468)
.+.++||||++++.+. .+.... .....+++..++.++.||+.||.|||+ +||+||||||+|||++.
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~-~~i~H~dlkp~Nil~~~ 158 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS-QHFVHRDLATRNCLVGA 158 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccCcceEEEcc
Confidence 4588999999865443 332211 112457889999999999999999998 89999999999999998
Q ss_pred CCCcEEEeeecCccccCCCC---CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHH
Q 012233 275 HTHQLKICDFGSAKMLVPGE---PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLV 350 (468)
Q Consensus 275 ~~~~vkL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~ 350 (468)
++ .++|+|||++....... ......++..|+|||.+.+. .++.++|||||||++|||++ |..||...+..+.+.
T Consensus 159 ~~-~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~ 236 (291)
T cd05094 159 NL-LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIE 236 (291)
T ss_pred CC-cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 87 79999999997653322 12234567889999998664 48999999999999999998 999998766554433
Q ss_pred HHHHHhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 351 EIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 351 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
.+... ..+ ..+...+..+.+||.+||+.||.+||++.++++
T Consensus 237 ~~~~~-------------------~~~---------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 237 CITQG-------------------RVL---------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred HHhCC-------------------CCC---------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 32210 000 012346789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=298.90 Aligned_cols=236 Identities=25% Similarity=0.319 Sum_probs=183.5
Q ss_pred eecccCceEEEEEEE--cCCCCEEEEEEeeccc------chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEEEee
Q 012233 144 VVGTGSFGVVFQAKC--LETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLE 215 (468)
Q Consensus 144 ~lG~G~fg~Vy~~~~--~~~g~~vaiK~~~~~~------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv~e 215 (468)
.||+|+||.||+|.+ ..++..+|+|++.... ..+.+|+.+++.+.||||+++++++ .+. ..++|||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~-~~~lv~e 75 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGIC-----EAE-SWMLVME 75 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEE-----cCC-CcEEEEe
Confidence 589999999999965 4567899999875432 2345789999999999999998876 222 3579999
Q ss_pred cccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCCCCC
Q 012233 216 YISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEP 295 (468)
Q Consensus 216 ~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~~~~ 295 (468)
|++++.+.... .....+++..+..++.|++.||.|||+ +||+||||||.|||++.++ .+||+|||++........
T Consensus 76 ~~~~~~L~~~l---~~~~~~~~~~~~~i~~qi~~al~~lH~-~~i~H~dlkp~nill~~~~-~~kl~Dfg~~~~~~~~~~ 150 (257)
T cd05116 76 LAELGPLNKFL---QKNKHVTEKNITELVHQVSMGMKYLEE-TNFVHRDLAARNVLLVTQH-YAKISDFGLSKALGADEN 150 (257)
T ss_pred cCCCCcHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccchhhEEEcCCC-eEEECCCccccccCCCCC
Confidence 99976443222 223568899999999999999999998 8999999999999999887 799999999976643322
Q ss_pred ----CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCC
Q 012233 296 ----NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPN 370 (468)
Q Consensus 296 ----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 370 (468)
.....++..|+|||.+... .++.++|+|||||++|||++ |..||...+..+....+.+..
T Consensus 151 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~-------------- 215 (257)
T cd05116 151 YYKAKTHGKWPVKWYAPECMNYY-KFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGE-------------- 215 (257)
T ss_pred eeeecCCCCCCccccCHhHhccC-CcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCC--------------
Confidence 1122345789999998544 48899999999999999997 999998776554444332210
Q ss_pred CccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 371 YTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
. ..++..+++++.+||.+||+.||.+||++.+|..
T Consensus 216 --~------------~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 216 --R------------MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred --C------------CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence 0 0123457899999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=305.26 Aligned_cols=246 Identities=23% Similarity=0.364 Sum_probs=188.4
Q ss_pred ceEEeceecccCceEEEEEEEcC-----CCCEEEEEEeeccc-----chHHHHHHHHHHcCCCCcccccceeeecCCCCc
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLE-----TGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~-----~g~~vaiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 207 (468)
+|++.+.||+|+||.||+|.+.. ....+|+|.+.... ....+|+.+++.++||||+++++.+ ...
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~ 75 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGAC-----SQD 75 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEE-----ecC
Confidence 37888999999999999998743 23568888875432 2345799999999999999999987 333
Q ss_pred eEEEEEeecccchHHHHH-hhhh--------------------hcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCC
Q 012233 208 LYLNLVLEYISETVYRVS-KHYT--------------------RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIK 266 (468)
Q Consensus 208 ~~~~lv~e~~~~~ll~~~-~~~~--------------------~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlk 266 (468)
...++||||+.++.+... .... .....+++..+..++.|++.||.|||+ .||+|||||
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~ivH~dik 154 (290)
T cd05045 76 GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE-MKLVHRDLA 154 (290)
T ss_pred CCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH-CCeehhhhh
Confidence 457899999996655432 2110 112457888899999999999999998 899999999
Q ss_pred CCCeeecCCCCcEEEeeecCccccCCCCC---CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 012233 267 PQNLLVNPHTHQLKICDFGSAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPG 342 (468)
Q Consensus 267 p~NILl~~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~ 342 (468)
|+|||++.++ .+||+|||+++....... .....++..|+|||.+.+. .++.++|||||||++|+|++ |..||.+
T Consensus 155 p~nill~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~ 232 (290)
T cd05045 155 ARNVLVAEGR-KMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDH-IYTTQSDVWSFGVLLWEIVTLGGNPYPG 232 (290)
T ss_pred hheEEEcCCC-cEEeccccccccccCccchhcccCCCCCccccCHHHHccC-CcchHhHHHHHHHHHHHHHhcCCCCCCC
Confidence 9999999877 799999999976533221 1223456789999998654 48999999999999999998 9999987
Q ss_pred CCcHHHHHHHHHHhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 343 ESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 343 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
....+....+... +.. ..+..++.++.+||.+||+.||.+||++.+++.
T Consensus 233 ~~~~~~~~~~~~~------------------~~~----------~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 233 IAPERLFNLLKTG------------------YRM----------ERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred CCHHHHHHHHhCC------------------CCC----------CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 6544433222110 000 122457889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=307.23 Aligned_cols=248 Identities=23% Similarity=0.346 Sum_probs=189.3
Q ss_pred ccceEEeceecccCceEEEEEEEcC-------CCCEEEEEEeeccc-----chHHHHHHHHHHc-CCCCcccccceeeec
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLE-------TGDSVAIKKVLQDK-----RYKNRELQIMRLL-NHPNVVSLKHCFFST 202 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~-------~g~~vaiK~~~~~~-----~~~~~E~~il~~l-~hpnIv~l~~~~~~~ 202 (468)
.++|.+.+.||+|+||.||+|.+.. ++..+|+|.+.... ....+|+.+++.+ +||||+++++++
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~--- 93 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC--- 93 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE---
Confidence 3579999999999999999998643 23579999886432 1344689999999 799999999988
Q ss_pred CCCCceEEEEEeecccch-HHHHHhhhhh------------cCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCC
Q 012233 203 TEKDELYLNLVLEYISET-VYRVSKHYTR------------MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQN 269 (468)
Q Consensus 203 ~~~~~~~~~lv~e~~~~~-ll~~~~~~~~------------~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~N 269 (468)
......|+||||++++ +...+..... ....+++..+..++.||+.||+|||+ +|++||||||+|
T Consensus 94 --~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~-~gi~H~dlkp~N 170 (307)
T cd05098 94 --TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS-KKCIHRDLAARN 170 (307)
T ss_pred --ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH-CCcccccccHHh
Confidence 3344588999999865 4444432211 12357888999999999999999998 899999999999
Q ss_pred eeecCCCCcEEEeeecCccccCCCCC---CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCc
Q 012233 270 LLVNPHTHQLKICDFGSAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESG 345 (468)
Q Consensus 270 ILl~~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~ 345 (468)
||++.++ .+||+|||++........ .....+++.|+|||.+.+.. ++.++|||||||++|+|++ |..||.+...
T Consensus 171 ill~~~~-~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~el~~~g~~p~~~~~~ 248 (307)
T cd05098 171 VLVTEDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 248 (307)
T ss_pred eEEcCCC-cEEECCCcccccccccchhhccccCCCccceeChHHhccCC-CCcHHHHHHHHHHHHHHHcCCCCCCCcCCH
Confidence 9999887 799999999876532211 11223456899999987654 8999999999999999998 8899976554
Q ss_pred HHHHHHHHHHhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 346 VDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 346 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
.+ +...+.... ...++..++.++++||.+||..+|.+||++.+++.
T Consensus 249 ~~-~~~~~~~~~---------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 294 (307)
T cd05098 249 EE-LFKLLKEGH---------------------------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 294 (307)
T ss_pred HH-HHHHHHcCC---------------------------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 33 332222100 00123457889999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=310.57 Aligned_cols=260 Identities=27% Similarity=0.426 Sum_probs=208.1
Q ss_pred CCcccceEEeceecccCceEEEEEEEcCCCCEEEEEEeecccc-----------hHHHHHHHHHHcCCCCcccccceeee
Q 012233 133 PKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR-----------YKNRELQIMRLLNHPNVVSLKHCFFS 201 (468)
Q Consensus 133 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~~-----------~~~~E~~il~~l~hpnIv~l~~~~~~ 201 (468)
+...++|.++++||+|||+.||+|.+....+.||||+-...+. ..-+|..|-+.|+||.||++|++|..
T Consensus 459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl 538 (775)
T KOG1151|consen 459 PTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL 538 (775)
T ss_pred cchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee
Confidence 3444579999999999999999999999999999997532211 12269999999999999999999854
Q ss_pred cCCCCceEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhc-CCccccCCCCCCeeecCCC--Cc
Q 012233 202 TTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV-VGVCHRDIKPQNLLVNPHT--HQ 278 (468)
Q Consensus 202 ~~~~~~~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~-~givHrDlkp~NILl~~~~--~~ 278 (468)
.++ .+|-|+|||+|.-|++ +.+.++.+++.+++.|+.||+.||.||.+. ..|||-||||.|||+.... +.
T Consensus 539 Dtd----sFCTVLEYceGNDLDF---YLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGe 611 (775)
T KOG1151|consen 539 DTD----SFCTVLEYCEGNDLDF---YLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGE 611 (775)
T ss_pred ccc----cceeeeeecCCCchhH---HHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccce
Confidence 433 4789999999986664 455577899999999999999999999862 3699999999999985432 26
Q ss_pred EEEeeecCccccCCCCCC--------ccccccCCccccccccC---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHH
Q 012233 279 LKICDFGSAKMLVPGEPN--------ISYICSRYYRAPELIFG---ATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVD 347 (468)
Q Consensus 279 vkL~DFG~a~~~~~~~~~--------~~~~gt~~y~aPE~~~~---~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~ 347 (468)
+||+|||+++.+..+... ....||.+|++||.+.- .+..+.++||||+|||+|+.+.|+.||.......
T Consensus 612 IKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ 691 (775)
T KOG1151|consen 612 IKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ 691 (775)
T ss_pred eEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH
Confidence 999999999988654322 24678999999999843 3457889999999999999999999997654333
Q ss_pred HHHH---HHHHhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCC
Q 012233 348 QLVE---IIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFD 424 (468)
Q Consensus 348 ~~~~---i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~ 424 (468)
.+.+ |++ ..++.||.. +.++.++++||++||++--+.|+...++..||||.
T Consensus 692 dILqeNTIlk----------------AtEVqFP~K----------PvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyll 745 (775)
T KOG1151|consen 692 DILQENTILK----------------ATEVQFPPK----------PVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLL 745 (775)
T ss_pred HHHhhhchhc----------------ceeccCCCC----------CccCHHHHHHHHHHHHhhhhhhhhHHHHccCcccc
Confidence 2221 222 145566642 34899999999999999999999999999999997
Q ss_pred C
Q 012233 425 D 425 (468)
Q Consensus 425 ~ 425 (468)
.
T Consensus 746 P 746 (775)
T KOG1151|consen 746 P 746 (775)
T ss_pred c
Confidence 5
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=305.26 Aligned_cols=254 Identities=19% Similarity=0.231 Sum_probs=192.4
Q ss_pred cceEEeceecccCceEEEEEEEcCCC----------------CEEEEEEeeccc-----chHHHHHHHHHHcCCCCcccc
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETG----------------DSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSL 195 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g----------------~~vaiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l 195 (468)
.+|++.+.||+|+||.||+|.+...+ ..||+|.+.... ....+|+.+++.++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 84 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL 84 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 36999999999999999999876543 457999886542 234579999999999999999
Q ss_pred cceeeecCCCCceEEEEEeecccchHH-HHHhhhh-------hcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCC
Q 012233 196 KHCFFSTTEKDELYLNLVLEYISETVY-RVSKHYT-------RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKP 267 (468)
Q Consensus 196 ~~~~~~~~~~~~~~~~lv~e~~~~~ll-~~~~~~~-------~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp 267 (468)
++++. .....++||||+.++.+ ..+.... .....+++..++.++.|++.||.|||+ +||+|+||||
T Consensus 85 ~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~-~~i~H~dlkp 158 (296)
T cd05051 85 LGVCT-----VDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES-LNFVHRDLAT 158 (296)
T ss_pred EEEEe-----cCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH-cCccccccch
Confidence 99883 33468899999986544 3332221 112368899999999999999999998 8999999999
Q ss_pred CCeeecCCCCcEEEeeecCccccCCCC---CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh--CCCCCCC
Q 012233 268 QNLLVNPHTHQLKICDFGSAKMLVPGE---PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL--GQPLFPG 342 (468)
Q Consensus 268 ~NILl~~~~~~vkL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~--G~~pf~~ 342 (468)
+|||++.++ .++|+|||++....... ......+++.|+|||.+.+. .++.++|||||||++|||++ |..||..
T Consensus 159 ~Nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~~~~~~~p~~~ 236 (296)
T cd05051 159 RNCLVGKNY-TIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLG-KFTTKSDVWAFGVTLWEILTLCREQPYEH 236 (296)
T ss_pred hceeecCCC-ceEEccccceeecccCcceeecCcCCCCceecCHHHhhcC-CCCccchhhhhHHHHHHHHhcCCCCCCCC
Confidence 999999887 79999999987653322 12234557789999998654 48999999999999999998 7788877
Q ss_pred CCcHHHHHHHHHHhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 343 ESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 343 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
.+..+.+..+........ .... ...+..++.++.+||.+||+.||.+|||+.+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~-----------~~~~----------~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 237 LTDQQVIENAGHFFRDDG-----------RQIY----------LPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred cChHHHHHHHHhcccccc-----------cccc----------CCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 665555444433111000 0000 0122346789999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=301.80 Aligned_cols=243 Identities=21% Similarity=0.319 Sum_probs=188.5
Q ss_pred cceEEeceecccCceEEEEEEEcCCCC----EEEEEEeeccc-----chHHHHHHHHHHcCCCCcccccceeeecCCCCc
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGD----SVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~----~vaiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 207 (468)
.+|++.+.||+|+||+||+|.+..+|. .||+|.+.... ....+|+.+++.+.||||+++++++.. .
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~ 81 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-----S 81 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-----C
Confidence 469999999999999999999877776 48999875432 234568899999999999999988742 1
Q ss_pred eEEEEEeecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecC
Q 012233 208 LYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (468)
Q Consensus 208 ~~~~lv~e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~ 286 (468)
..+++|||++++ +++.+. .....+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus 82 -~~~l~~~~~~~g~l~~~l~---~~~~~~~~~~~~~~~~qi~~~L~~lH~-~~iiH~dlkp~Nil~~~~~-~~kL~dfG~ 155 (279)
T cd05109 82 -TVQLVTQLMPYGCLLDYVR---ENKDRIGSQDLLNWCVQIAKGMSYLEE-VRLVHRDLAARNVLVKSPN-HVKITDFGL 155 (279)
T ss_pred -CcEEEEEcCCCCCHHHHHh---hccCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccccceEEEcCCC-cEEECCCCc
Confidence 256899999865 443332 223568999999999999999999998 8999999999999998877 799999999
Q ss_pred ccccCCCCCCc---cccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 012233 287 AKMLVPGEPNI---SYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTRE 362 (468)
Q Consensus 287 a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~ 362 (468)
++......... ...+++.|+|||.+.+. .++.++|||||||++|||++ |..||........ ...+.....+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~-~~~~~~~~~~--- 230 (279)
T cd05109 156 ARLLDIDETEYHADGGKVPIKWMALESILHR-RFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREI-PDLLEKGERL--- 230 (279)
T ss_pred eeecccccceeecCCCccchhhCCHHHhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHHCCCcC---
Confidence 98764332211 22346789999998655 48999999999999999998 9999976554333 2222211000
Q ss_pred HHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 363 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
+ .+..++.++.++|.+||..||..||++.+++.
T Consensus 231 --------------~----------~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 231 --------------P----------QPPICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred --------------C----------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0 12346889999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=312.22 Aligned_cols=250 Identities=25% Similarity=0.351 Sum_probs=189.1
Q ss_pred cceEEeceecccCceEEEEEEE-----cCCCCEEEEEEeeccc-----chHHHHHHHHHHc-CCCCcccccceeeecCCC
Q 012233 137 ISYMAERVVGTGSFGVVFQAKC-----LETGDSVAIKKVLQDK-----RYKNRELQIMRLL-NHPNVVSLKHCFFSTTEK 205 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~-----~~~g~~vaiK~~~~~~-----~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~ 205 (468)
++|++.+.||+|+||.||+|.+ ..+++.||||++.... ....+|+.++..+ +||||+++++++...
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~--- 83 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP--- 83 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC---
Confidence 4699999999999999999985 3467889999986432 2345799999999 689999999977432
Q ss_pred CceEEEEEeecccchHHHHHhhhhh-------------------------------------------------------
Q 012233 206 DELYLNLVLEYISETVYRVSKHYTR------------------------------------------------------- 230 (468)
Q Consensus 206 ~~~~~~lv~e~~~~~ll~~~~~~~~------------------------------------------------------- 230 (468)
...+++|||||.++.+........
T Consensus 84 -~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (343)
T cd05103 84 -GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVE 162 (343)
T ss_pred -CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccch
Confidence 235789999999765543221110
Q ss_pred ---------cCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCCCCC---Ccc
Q 012233 231 ---------MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEP---NIS 298 (468)
Q Consensus 231 ---------~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~~~~---~~~ 298 (468)
....+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++........ ...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~H~dikp~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~ 240 (343)
T cd05103 163 EEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLAS-RKCIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGD 240 (343)
T ss_pred hhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCccCeEEEcCCC-cEEEEecccccccccCcchhhcCC
Confidence 01246778888999999999999998 8999999999999999887 799999999876532221 112
Q ss_pred ccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccCCCC
Q 012233 299 YICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFP 377 (468)
Q Consensus 299 ~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (468)
..++..|+|||.+.+. .++.++|||||||++|+|++ |..||........+...+.... ...
T Consensus 241 ~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~---------------~~~-- 302 (343)
T cd05103 241 ARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT---------------RMR-- 302 (343)
T ss_pred CCCCcceECcHHhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccC---------------CCC--
Confidence 3346779999998654 48999999999999999996 9999987654433333222100 000
Q ss_pred cccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCC
Q 012233 378 QIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (468)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~h 420 (468)
.+..+++++.+++.+||+.||.+|||+.++++|
T Consensus 303 ----------~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 303 ----------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred ----------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 112367889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=296.77 Aligned_cols=242 Identities=23% Similarity=0.329 Sum_probs=190.4
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeecccc--hHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEEEe
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR--YKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~~--~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv~ 214 (468)
.+|.+.+.||+|+||.||++.. .|..||+|.+..+.. .+.+|+.+++.++|+||++++++++.. ....++||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----~~~~~lv~ 79 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KGGLYIVT 79 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEcC----CCceEEEE
Confidence 4699999999999999999987 588899998865432 355799999999999999999876432 23478999
Q ss_pred ecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCCC
Q 012233 215 EYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293 (468)
Q Consensus 215 e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~~ 293 (468)
||++++ +.+.+.. .....+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++......
T Consensus 80 e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~nil~~~~~-~~kl~dfg~~~~~~~~ 155 (256)
T cd05082 80 EYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLEA-NNFVHRDLAARNVLVSEDN-VAKVSDFGLTKEASST 155 (256)
T ss_pred ECCCCCcHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeccccchheEEEcCCC-cEEecCCccceecccc
Confidence 999865 4443322 122347888999999999999999997 8999999999999999887 7999999998754322
Q ss_pred CCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCc
Q 012233 294 EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYT 372 (468)
Q Consensus 294 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 372 (468)
. ....++..|+|||++.+. .++.++|||||||++|+|++ |+.||......+....+....
T Consensus 156 ~--~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~---------------- 216 (256)
T cd05082 156 Q--DTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY---------------- 216 (256)
T ss_pred C--CCCccceeecCHHHHccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC----------------
Confidence 2 233456789999998654 48999999999999999997 999998765444333332100
Q ss_pred cCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 373 EFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
.......+++.+.++|.+||+.||.+|||+.++++
T Consensus 217 ------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 217 ------------KMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred ------------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 00122457899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=298.93 Aligned_cols=228 Identities=26% Similarity=0.336 Sum_probs=180.8
Q ss_pred cCceEEEEEEEcCCCCEEEEEEeecccchHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEEEeecccchHH-HHHh
Q 012233 148 GSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVY-RVSK 226 (468)
Q Consensus 148 G~fg~Vy~~~~~~~g~~vaiK~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv~e~~~~~ll-~~~~ 226 (468)
|.||.||++.+..+++.||+|.+..... ..+|...+....||||+++++++ .+....|+||||++++.+ +.+.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~-~~~~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~ 77 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE-YSRERLTIIPHCVPNMVCLHKYI-----VSEDSVFLVLQHAEGGKLWSHIS 77 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh-hhhHHHHHHhcCCCceeehhhhe-----ecCCeEEEEEecCCCCCHHHHHH
Confidence 8999999999999999999999876543 33455556667799999999988 444568999999997544 4332
Q ss_pred hhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCCCCCCccccccCCcc
Q 012233 227 HYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR 306 (468)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~ 306 (468)
. ...+++..+..++.|++.||.|||+ +||+||||||+||+++.++ .++|+|||.+...... .....++..|+
T Consensus 78 ~----~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~dlkp~Nil~~~~~-~~~l~df~~~~~~~~~--~~~~~~~~~y~ 149 (237)
T cd05576 78 K----FLNIPEECVKRWAAEMVVALDALHR-EGIVCRDLNPNNILLDDRG-HIQLTYFSRWSEVEDS--CDGEAVENMYC 149 (237)
T ss_pred H----hcCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEEcCCC-CEEEecccchhccccc--cccCCcCcccc
Confidence 2 3458899999999999999999998 8999999999999999888 7999999987655332 23445677899
Q ss_pred ccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccCCCCcccCCCccc
Q 012233 307 APELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHK 386 (468)
Q Consensus 307 aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (468)
|||.+.+. .++.++|+||+||++|||++|..||...... + . ....+
T Consensus 150 aPE~~~~~-~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~-~---------------~~~~~------------ 195 (237)
T cd05576 150 APEVGGIS-EETEACDWWSLGAILFELLTGKTLVECHPSG-----I-N---------------THTTL------------ 195 (237)
T ss_pred CCcccCCC-CCCchhhHHHHHHHHHHHHHCcchhhcCchh-----c-c---------------ccccc------------
Confidence 99988544 4889999999999999999999887532110 0 0 00001
Q ss_pred ccccCCCHHHHHHHHHhcccCCCCCCCH-----HHHhCCCCC
Q 012233 387 IFHKRMPPEALDLVSRLLQYSPSLRCTA-----LEACAHPFF 423 (468)
Q Consensus 387 ~~~~~~~~~l~~li~~~L~~dP~~R~s~-----~ell~hp~f 423 (468)
.++..+++.+++||.+||+.||.+|+++ +++++||||
T Consensus 196 ~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 196 NIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred CCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 1234578999999999999999999986 999999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=315.34 Aligned_cols=250 Identities=23% Similarity=0.323 Sum_probs=192.5
Q ss_pred cccceEEeceecccCceEEEEEEEc-----CCCCEEEEEEeeccc-----chHHHHHHHHHHcC-CCCcccccceeeecC
Q 012233 135 QTISYMAERVVGTGSFGVVFQAKCL-----ETGDSVAIKKVLQDK-----RYKNRELQIMRLLN-HPNVVSLKHCFFSTT 203 (468)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~-----~~g~~vaiK~~~~~~-----~~~~~E~~il~~l~-hpnIv~l~~~~~~~~ 203 (468)
...+|.+.+.||+|+||.||+|.+. .++..||+|++.... ..+.+|+.+|..+. ||||+++++++.
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~--- 111 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT--- 111 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc---
Confidence 3446899999999999999999864 345689999986542 13457999999997 999999999883
Q ss_pred CCCceEEEEEeecccchHH-HHHhhhh-----------------------------------------------------
Q 012233 204 EKDELYLNLVLEYISETVY-RVSKHYT----------------------------------------------------- 229 (468)
Q Consensus 204 ~~~~~~~~lv~e~~~~~ll-~~~~~~~----------------------------------------------------- 229 (468)
....+++||||+.++.+ +.+....
T Consensus 112 --~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (401)
T cd05107 112 --KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY 189 (401)
T ss_pred --cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence 33458999999996544 3332110
Q ss_pred -----------------------------------------hcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCC
Q 012233 230 -----------------------------------------RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQ 268 (468)
Q Consensus 230 -----------------------------------------~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~ 268 (468)
.....+++..++.++.||+.||.|||+ .||+||||||+
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrdlkp~ 268 (401)
T cd05107 190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS-KNCVHRDLAAR 268 (401)
T ss_pred cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc-CCcCcccCCcc
Confidence 011236677788999999999999997 89999999999
Q ss_pred CeeecCCCCcEEEeeecCccccCCCC---CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 012233 269 NLLVNPHTHQLKICDFGSAKMLVPGE---PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGES 344 (468)
Q Consensus 269 NILl~~~~~~vkL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~ 344 (468)
|||++.++ .+||+|||+++...... ......+++.|+|||.+.+.. ++.++|||||||++|||++ |..||....
T Consensus 269 NiLl~~~~-~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslGvil~e~l~~g~~P~~~~~ 346 (401)
T cd05107 269 NVLICEGK-LVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNL-YTTLSDVWSFGILLWEIFTLGGTPYPELP 346 (401)
T ss_pred eEEEeCCC-EEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCC-CCcHhHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 99999877 79999999997653222 122345678899999996544 8999999999999999998 899998766
Q ss_pred cHHHHHHHHHHhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 345 GVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 345 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
..+.....+..... ...+..++.++.+||.+||..+|.+||++.+++.
T Consensus 347 ~~~~~~~~~~~~~~---------------------------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~ 394 (401)
T cd05107 347 MNEQFYNAIKRGYR---------------------------MAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVH 394 (401)
T ss_pred chHHHHHHHHcCCC---------------------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 55554443331100 0123457899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=302.84 Aligned_cols=251 Identities=17% Similarity=0.208 Sum_probs=184.4
Q ss_pred ceEEeceecccCceEEEEEEEcCC---CCEEEEEEeecccchHH---------------HHHHHHHHcCCCCccccccee
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLET---GDSVAIKKVLQDKRYKN---------------RELQIMRLLNHPNVVSLKHCF 199 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~---g~~vaiK~~~~~~~~~~---------------~E~~il~~l~hpnIv~l~~~~ 199 (468)
+|.+.+.||+|+||.||+|.+..+ +..+|+|+......... .+...+..+.|+||+++++++
T Consensus 13 ~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~ 92 (294)
T PHA02882 13 EWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCG 92 (294)
T ss_pred ceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEee
Confidence 599999999999999999998777 66777776432221111 122334556899999999876
Q ss_pred eecCCCCceEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcE
Q 012233 200 FSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQL 279 (468)
Q Consensus 200 ~~~~~~~~~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~v 279 (468)
.... ....+.+++++++...+...... ....++..++.++.|++.||.|||+ +||+||||||+|||++.++ .+
T Consensus 93 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~iiHrDiKp~Nill~~~~-~~ 165 (294)
T PHA02882 93 SFKR-CRMYYRFILLEKLVENTKEIFKR----IKCKNKKLIKNIMKDMLTTLEYIHE-HGISHGDIKPENIMVDGNN-RG 165 (294)
T ss_pred eEec-CCceEEEEEEehhccCHHHHHHh----hccCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCC-cE
Confidence 4433 22345678999887766554432 2335677889999999999999998 8999999999999999887 79
Q ss_pred EEeeecCccccCCCC--------CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Q 012233 280 KICDFGSAKMLVPGE--------PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVE 351 (468)
Q Consensus 280 kL~DFG~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~ 351 (468)
+|+|||+|+...... ......||+.|+|||++.+.. ++.++|||||||++|||++|..||.+.........
T Consensus 166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~-~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~ 244 (294)
T PHA02882 166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGAC-VTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIH 244 (294)
T ss_pred EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCC-CCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHH
Confidence 999999997653221 122356899999999987654 89999999999999999999999987743333222
Q ss_pred HHHH--hCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 352 IIKI--LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 352 i~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
.... ...... ... ..+.+++++.+++..||..+|.+||+..++++
T Consensus 245 ~~~~~~~~~~~~----------~~~-------------~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 245 AAKCDFIKRLHE----------GKI-------------KIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HhHHHHHHHhhh----------hhh-------------ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 1110 000000 000 11346889999999999999999999999864
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=299.93 Aligned_cols=245 Identities=24% Similarity=0.340 Sum_probs=191.3
Q ss_pred cceEEeceecccCceEEEEEEEcCCCC---EEEEEEeeccc-----chHHHHHHHHHHcCCCCcccccceeeecCCCCce
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGD---SVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~---~vaiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 208 (468)
.+|++.+.||+|+||.||+|.+..++. .+|+|.+.... ..+.+|+.+++.++||||+++++++ ....
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~ 78 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVV-----TKSK 78 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEE-----ecCC
Confidence 369999999999999999999865544 69999875432 2445799999999999999999987 3344
Q ss_pred EEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcc
Q 012233 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (468)
Q Consensus 209 ~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~ 288 (468)
+.|+||||++++.+..... .....+++..+..++.|++.||.|||+ +||+||||||+|||++.++ .++|+|||++.
T Consensus 79 ~~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~h~dlkp~nili~~~~-~~~l~dfg~~~ 154 (267)
T cd05066 79 PVMIVTEYMENGSLDAFLR--KHDGQFTVIQLVGMLRGIASGMKYLSD-MGYVHRDLAARNILVNSNL-VCKVSDFGLSR 154 (267)
T ss_pred ccEEEEEcCCCCCHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeehhhchhcEEECCCC-eEEeCCCCccc
Confidence 6889999998764443222 223468899999999999999999998 8999999999999999887 79999999997
Q ss_pred ccCCCCCC----ccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 012233 289 MLVPGEPN----ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREE 363 (468)
Q Consensus 289 ~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~ 363 (468)
........ ....++..|+|||.+.+. .++.++|+|||||++|++++ |..||......+....+.+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~------- 226 (267)
T cd05066 155 VLEDDPEAAYTTRGGKIPIRWTAPEAIAYR-KFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGY------- 226 (267)
T ss_pred ccccccceeeecCCCccceeecCHhHhccC-ccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCC-------
Confidence 65433211 112235679999999654 48999999999999999886 999998776555444433210
Q ss_pred HhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 364 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
..+ .+..+++.+.+++.+||+.+|.+||++.+++.
T Consensus 227 -----------~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 227 -----------RLP----------APMDCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred -----------cCC----------CCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 001 11346889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=304.87 Aligned_cols=254 Identities=22% Similarity=0.256 Sum_probs=190.5
Q ss_pred cceEEeceecccCceEEEEEEEcCCC--------------CEEEEEEeeccc-----chHHHHHHHHHHcCCCCcccccc
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETG--------------DSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKH 197 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g--------------~~vaiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l~~ 197 (468)
.+|++.+.||+|+||.||+|.+..++ ..||+|.+.... ..+.+|+++++.++|+||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 46999999999999999999875432 358999886432 23457999999999999999999
Q ss_pred eeeecCCCCceEEEEEeecccchHHHHHhhhhh---------cCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCC
Q 012233 198 CFFSTTEKDELYLNLVLEYISETVYRVSKHYTR---------MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQ 268 (468)
Q Consensus 198 ~~~~~~~~~~~~~~lv~e~~~~~ll~~~~~~~~---------~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~ 268 (468)
++ ......++||||+.++.+........ ....+++..+..++.|++.||.|||+ +|++|+||||+
T Consensus 85 ~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~-~~i~H~dlkp~ 158 (295)
T cd05097 85 VC-----VSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS-LNFVHRDLATR 158 (295)
T ss_pred EE-----cCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh-cCeeccccChh
Confidence 88 34445889999998754443222111 11236788889999999999999998 89999999999
Q ss_pred CeeecCCCCcEEEeeecCccccCCCCC---CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh--CCCCCCCC
Q 012233 269 NLLVNPHTHQLKICDFGSAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL--GQPLFPGE 343 (468)
Q Consensus 269 NILl~~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~--G~~pf~~~ 343 (468)
|||++.++ .+||+|||++........ .....++..|+|||++.+.. ++.++|+|||||++|+|++ |..||...
T Consensus 159 Nill~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlG~~l~el~~~~~~~p~~~~ 236 (295)
T cd05097 159 NCLVGNHY-TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGK-FTTASDVWAFGVTLWEMFTLCKEQPYSLL 236 (295)
T ss_pred hEEEcCCC-cEEecccccccccccCcceeccCcCcCceeecChhhhccCC-cCchhhHHHHHHHHHHHHHcCCCCCCccc
Confidence 99999887 799999999876533221 11234467899999986554 8999999999999999988 67888877
Q ss_pred CcHHHHHHHHHHhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 344 SGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 344 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
+..+.+..+........ ...+ ...++.+++.+.+||.+||+.||.+||++.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~------------~~~~---------~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 237 SDEQVIENTGEFFRNQG------------RQIY---------LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred ChHHHHHHHHHhhhhcc------------cccc---------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 66555544433110000 0000 0012346889999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=304.96 Aligned_cols=249 Identities=23% Similarity=0.329 Sum_probs=191.5
Q ss_pred cccceEEeceecccCceEEEEEEEc-------CCCCEEEEEEeeccc-----chHHHHHHHHHHc-CCCCcccccceeee
Q 012233 135 QTISYMAERVVGTGSFGVVFQAKCL-------ETGDSVAIKKVLQDK-----RYKNRELQIMRLL-NHPNVVSLKHCFFS 201 (468)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~-------~~g~~vaiK~~~~~~-----~~~~~E~~il~~l-~hpnIv~l~~~~~~ 201 (468)
...+|.+.+.||+|+||.||+|.+. ..+..||+|.+.... ....+|+.+++.+ +||||+++++++
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~-- 90 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC-- 90 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEE--
Confidence 3457999999999999999999753 234579999875432 2345799999999 899999999988
Q ss_pred cCCCCceEEEEEeecccchHH-HHHhhhhh------------cCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCC
Q 012233 202 TTEKDELYLNLVLEYISETVY-RVSKHYTR------------MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQ 268 (468)
Q Consensus 202 ~~~~~~~~~~lv~e~~~~~ll-~~~~~~~~------------~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~ 268 (468)
.....+++||||+.++.+ ..+..... ....+++..+..++.||+.||.|||+ +||+||||||+
T Consensus 91 ---~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~-~givH~dlkp~ 166 (304)
T cd05101 91 ---TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS-QKCIHRDLAAR 166 (304)
T ss_pred ---ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH-CCeeecccccc
Confidence 334468899999987544 33332111 12357888899999999999999998 89999999999
Q ss_pred CeeecCCCCcEEEeeecCccccCCCCC---CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 012233 269 NLLVNPHTHQLKICDFGSAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGES 344 (468)
Q Consensus 269 NILl~~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~ 344 (468)
|||++.++ .+||+|||+++....... .....+++.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+
T Consensus 167 Nili~~~~-~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 244 (304)
T cd05101 167 NVLVTENN-VMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 244 (304)
T ss_pred eEEEcCCC-cEEECCCccceecccccccccccCCCCCceeeCchhhccC-CCCchhhHHHHHHHHHHHHcCCCCCcccCC
Confidence 99999887 799999999976643221 1223456789999998664 48999999999999999998 889998766
Q ss_pred cHHHHHHHHHHhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 345 GVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 345 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
..+....+.... . ...+..++.++++||.+||+.+|.+|||+.++++
T Consensus 245 ~~~~~~~~~~~~------------------~----------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~ 291 (304)
T cd05101 245 VEELFKLLKEGH------------------R----------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVE 291 (304)
T ss_pred HHHHHHHHHcCC------------------c----------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 554433332100 0 0012357889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=296.87 Aligned_cols=243 Identities=23% Similarity=0.324 Sum_probs=190.6
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc---cchHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEEE
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV 213 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~---~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv 213 (468)
++|++.+.||+|+||.||+|.+. .+..+|+|.+... .....+|+.++++++|+||+++++++. . ...++|
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-----~-~~~~lv 78 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-----E-EPIYIV 78 (260)
T ss_pred HHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-----C-CCcEEE
Confidence 46999999999999999999865 5677999988643 234568999999999999999988762 1 136799
Q ss_pred eecccchHH-HHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCC
Q 012233 214 LEYISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (468)
Q Consensus 214 ~e~~~~~ll-~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~ 292 (468)
|||+.++.+ +.+.. .....+++..++.++.|++.||.|||+ .||+|+||||+||+++.++ .++|+|||++.....
T Consensus 79 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~di~p~Nili~~~~-~~~l~dfg~~~~~~~ 154 (260)
T cd05070 79 TEYMSKGSLLDFLKD--GEGRALKLPNLVDMAAQVAAGMAYIER-MNYIHRDLRSANILVGDGL-VCKIADFGLARLIED 154 (260)
T ss_pred EEecCCCcHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCccceEEEeCCc-eEEeCCceeeeeccC
Confidence 999986544 33322 123458899999999999999999998 8999999999999999887 799999999976543
Q ss_pred CCCC--ccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 012233 293 GEPN--ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (468)
Q Consensus 293 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 369 (468)
.... ....++..|+|||.+.+. .++.++|+|||||++|+|++ |.+||.+.+..+....+....
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~------------- 220 (260)
T cd05070 155 NEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGY------------- 220 (260)
T ss_pred cccccccCCCCCccccChHHHhcC-CCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-------------
Confidence 2211 123345679999998654 48999999999999999999 999998876655544432210
Q ss_pred CCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
.. ..+...+..+.+||.+||..||.+|||+.+++.
T Consensus 221 -----~~----------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 221 -----RM----------PCPQDCPISLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred -----CC----------CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 00 022357889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=301.47 Aligned_cols=246 Identities=23% Similarity=0.338 Sum_probs=190.4
Q ss_pred ceEEeceecccCceEEEEEEEc-----CCCCEEEEEEeeccc----chHHHHHHHHHHcCCCCcccccceeeecCCCCce
Q 012233 138 SYMAERVVGTGSFGVVFQAKCL-----ETGDSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~-----~~g~~vaiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 208 (468)
+|++.+.||+|+||.||++... .++..+|+|.+.... ..+.+|+++++.++|+||+++++++ .+..
T Consensus 6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~ 80 (280)
T cd05092 6 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVC-----TEGR 80 (280)
T ss_pred hceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEE-----ecCC
Confidence 5888999999999999999753 356789999875432 3456799999999999999999887 3344
Q ss_pred EEEEEeecccchHHH-HHhhhhh-----------cCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCC
Q 012233 209 YLNLVLEYISETVYR-VSKHYTR-----------MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHT 276 (468)
Q Consensus 209 ~~~lv~e~~~~~ll~-~~~~~~~-----------~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~ 276 (468)
..++||||+.++.+. .+..... ....+++..+..++.||+.||.|||+ .||+||||||+|||++.++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~-~~i~H~dlkp~nil~~~~~ 159 (280)
T cd05092 81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS-LHFVHRDLATRNCLVGQGL 159 (280)
T ss_pred ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH-CCeecccccHhhEEEcCCC
Confidence 588999999865443 3322110 11347888999999999999999998 8999999999999999877
Q ss_pred CcEEEeeecCccccCCCCC---CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHH
Q 012233 277 HQLKICDFGSAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEI 352 (468)
Q Consensus 277 ~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i 352 (468)
.+||+|||++........ .....+++.|+|||.+.+.. ++.++|||||||++|||++ |.+||......+.+..+
T Consensus 160 -~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 237 (280)
T cd05092 160 -VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK-FTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI 237 (280)
T ss_pred -CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCC-cCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHH
Confidence 799999999875533221 12234567899999986654 8999999999999999998 99999876665554443
Q ss_pred HHHhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 353 IKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
.... .. ..+..+++.+.+||.+||+.||.+||++.+++.
T Consensus 238 ~~~~----------------~~------------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 238 TQGR----------------EL------------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred HcCc----------------cC------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 3210 00 012347889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=308.52 Aligned_cols=249 Identities=23% Similarity=0.327 Sum_probs=190.7
Q ss_pred ccceEEeceecccCceEEEEEEEcCC-------CCEEEEEEeeccc-----chHHHHHHHHHHc-CCCCcccccceeeec
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLET-------GDSVAIKKVLQDK-----RYKNRELQIMRLL-NHPNVVSLKHCFFST 202 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~-------g~~vaiK~~~~~~-----~~~~~E~~il~~l-~hpnIv~l~~~~~~~ 202 (468)
..+|.+.+.||+|+||.||+|.+... +..||+|.+.... ....+|+.+++++ +||||+++++++
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~--- 87 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC--- 87 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE---
Confidence 34699999999999999999986432 2368999876432 2345799999999 799999999988
Q ss_pred CCCCceEEEEEeecccchHHH-HHhhhh------------hcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCC
Q 012233 203 TEKDELYLNLVLEYISETVYR-VSKHYT------------RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQN 269 (468)
Q Consensus 203 ~~~~~~~~~lv~e~~~~~ll~-~~~~~~------------~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~N 269 (468)
.....+++||||++++.+. .+.... .....+++..+..++.||+.||.|||+ +||+||||||+|
T Consensus 88 --~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~-~givH~dlkp~N 164 (334)
T cd05100 88 --TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS-QKCIHRDLAARN 164 (334)
T ss_pred --ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH-CCeeccccccce
Confidence 3344588999999875443 333211 112347788889999999999999998 899999999999
Q ss_pred eeecCCCCcEEEeeecCccccCCCCC---CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCc
Q 012233 270 LLVNPHTHQLKICDFGSAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESG 345 (468)
Q Consensus 270 ILl~~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~ 345 (468)
||++.++ .+||+|||+++....... .....++..|+|||++.+. .++.++|||||||++|||++ |..||.+.+.
T Consensus 165 ill~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 242 (334)
T cd05100 165 VLVTEDN-VMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV 242 (334)
T ss_pred EEEcCCC-cEEECCcccceecccccccccccCCCcCceEcCHHHhccC-CcCchhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence 9999887 799999999976543221 1122335679999999654 48999999999999999998 8999987765
Q ss_pred HHHHHHHHHHhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCC
Q 012233 346 VDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (468)
Q Consensus 346 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~h 420 (468)
.+....+.... . ...+..++.++.+||.+||+.+|.+||++.+++.+
T Consensus 243 ~~~~~~~~~~~------------------~----------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 243 EELFKLLKEGH------------------R----------MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HHHHHHHHcCC------------------C----------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 55443332200 0 00223468899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=298.37 Aligned_cols=244 Identities=23% Similarity=0.344 Sum_probs=191.2
Q ss_pred ceEEeceecccCceEEEEEEEcCCCC---EEEEEEeeccc-----chHHHHHHHHHHcCCCCcccccceeeecCCCCceE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGD---SVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~---~vaiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 209 (468)
.|++.+.||+|+||.||+|.+..++. .||||.+.... ..+..|+.+++.++||||+++++++ .+...
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~-----~~~~~ 79 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVV-----TKSRP 79 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEE-----CCCCc
Confidence 58999999999999999999877665 59999875431 2345799999999999999999987 44445
Q ss_pred EEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccc
Q 012233 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (468)
Q Consensus 210 ~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~ 289 (468)
.++||||++++.+..... .....+++..++.++.|++.||.|||+ +|++|+||||+|||++.++ .+||+|||++..
T Consensus 80 ~~lv~e~~~~~~L~~~l~--~~~~~~~~~~~~~i~~~l~~al~~lH~-~g~~H~dl~p~nili~~~~-~~kl~dfg~~~~ 155 (269)
T cd05065 80 VMIITEFMENGALDSFLR--QNDGQFTVIQLVGMLRGIAAGMKYLSE-MNYVHRDLAARNILVNSNL-VCKVSDFGLSRF 155 (269)
T ss_pred eEEEEecCCCCcHHHHHh--hCCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccChheEEEcCCC-cEEECCCccccc
Confidence 889999999765543322 223568899999999999999999998 8999999999999999887 799999999876
Q ss_pred cCCCCCCcc---cc---ccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 012233 290 LVPGEPNIS---YI---CSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTRE 362 (468)
Q Consensus 290 ~~~~~~~~~---~~---gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~ 362 (468)
......... .. .+..|+|||.+.+. .++.++|||||||++|||++ |..||...+..+....+...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~------- 227 (269)
T cd05065 156 LEDDTSDPTYTSSLGGKIPIRWTAPEAIAYR-KFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQD------- 227 (269)
T ss_pred cccCccccccccccCCCcceeecCHhHhccC-cccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcC-------
Confidence 543222111 11 24579999998654 48999999999999999886 99999876655544443221
Q ss_pred HHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 363 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
...+ .+..++..+.+++.+||+.+|.+||++.+++.
T Consensus 228 -----------~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 228 -----------YRLP----------PPMDCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred -----------CcCC----------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0111 12346889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=295.33 Aligned_cols=241 Identities=25% Similarity=0.370 Sum_probs=191.1
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeecccc---hHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEEE
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR---YKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV 213 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~~---~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv 213 (468)
.+|++.+.||.|+||.||+|.. .|+.||+|.+..... ...+|+.+++.++|+||+++++++. +....++|
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~~v 78 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVL-----QGNPLYIV 78 (256)
T ss_pred hhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEc-----CCCCeEEE
Confidence 3589999999999999999987 589999999866544 4457999999999999999999884 34458899
Q ss_pred eecccchHH-HHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCC
Q 012233 214 LEYISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (468)
Q Consensus 214 ~e~~~~~ll-~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~ 292 (468)
|||++++.+ +.+.. .....+++..+..++.|++.||.|||+ +||+|+||||+|||++.++ .++|+|||.+.....
T Consensus 79 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lh~-~~i~H~di~p~Nili~~~~-~~~l~d~g~~~~~~~ 154 (256)
T cd05039 79 TEYMAKGSLVDYLRS--RGRAVITLAQQLGFALDVCEGMEYLEE-KNFVHRDLAARNVLVSEDL-VAKVSDFGLAKEASQ 154 (256)
T ss_pred EEecCCCcHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccchhcccceEEEeCCC-CEEEccccccccccc
Confidence 999996544 33322 112368999999999999999999998 8999999999999999887 799999999976632
Q ss_pred CCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCC
Q 012233 293 GEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNY 371 (468)
Q Consensus 293 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 371 (468)
.. .....+..|+|||.+.+. .++.++|+|||||++|+|++ |..||......+....+...
T Consensus 155 ~~--~~~~~~~~~~ape~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~---------------- 215 (256)
T cd05039 155 GQ--DSGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKG---------------- 215 (256)
T ss_pred cc--ccCCCcccccCchhhcCC-cCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC----------------
Confidence 22 233446679999998654 48899999999999999997 99999876544433322110
Q ss_pred ccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 372 TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
+. ...+..+++++.++|.+||..+|.+||++.+++.
T Consensus 216 --~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 216 --YR----------MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred --CC----------CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 00 0122347899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=304.93 Aligned_cols=249 Identities=22% Similarity=0.322 Sum_probs=190.7
Q ss_pred cccceEEeceecccCceEEEEEEEcC-------CCCEEEEEEeeccc-----chHHHHHHHHHHc-CCCCcccccceeee
Q 012233 135 QTISYMAERVVGTGSFGVVFQAKCLE-------TGDSVAIKKVLQDK-----RYKNRELQIMRLL-NHPNVVSLKHCFFS 201 (468)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~-------~g~~vaiK~~~~~~-----~~~~~E~~il~~l-~hpnIv~l~~~~~~ 201 (468)
...+|.+.+.||+|+||.||+|.+.. ....+|+|.+.... ....+|+.+++.+ +||||+++++++
T Consensus 10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~-- 87 (314)
T cd05099 10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVC-- 87 (314)
T ss_pred cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEE--
Confidence 34579999999999999999998632 34579999876432 1245799999999 699999999988
Q ss_pred cCCCCceEEEEEeecccchHH-HHHhhhhh------------cCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCC
Q 012233 202 TTEKDELYLNLVLEYISETVY-RVSKHYTR------------MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQ 268 (468)
Q Consensus 202 ~~~~~~~~~~lv~e~~~~~ll-~~~~~~~~------------~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~ 268 (468)
.+..++++||||+.++.+ ..+..... ....+++..+..++.||+.||.|||+ +||+||||||+
T Consensus 88 ---~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~-~gi~H~dlkp~ 163 (314)
T cd05099 88 ---TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES-RRCIHRDLAAR 163 (314)
T ss_pred ---ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH-CCeeeccccce
Confidence 344468999999986544 33332211 12457888899999999999999998 89999999999
Q ss_pred CeeecCCCCcEEEeeecCccccCCCCC---CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 012233 269 NLLVNPHTHQLKICDFGSAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGES 344 (468)
Q Consensus 269 NILl~~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~ 344 (468)
|||++.++ .+||+|||+++....... .....++..|+|||++.+. .++.++|||||||++|+|++ |..||.+..
T Consensus 164 Nill~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~~g~~p~~~~~ 241 (314)
T cd05099 164 NVLVTEDN-VMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDR-VYTHQSDVWSFGILMWEIFTLGGSPYPGIP 241 (314)
T ss_pred eEEEcCCC-cEEEccccccccccccccccccccCCCCccccCHHHHccC-CcCccchhhHHHHHHHHHHhCCCCCCCCCC
Confidence 99999887 799999999976533211 1122334679999998654 48999999999999999998 899998766
Q ss_pred cHHHHHHHHHHhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 345 GVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 345 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
..+.+..+... ... .++..++.++++||.+||..||.+|||+.+++.
T Consensus 242 ~~~~~~~~~~~----------------~~~------------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 242 VEELFKLLREG----------------HRM------------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred HHHHHHHHHcC----------------CCC------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 54444433220 000 022357889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=297.33 Aligned_cols=237 Identities=24% Similarity=0.270 Sum_probs=184.1
Q ss_pred eecccCceEEEEEEEc--CCCCEEEEEEeeccc-----chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEEEeec
Q 012233 144 VVGTGSFGVVFQAKCL--ETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEY 216 (468)
Q Consensus 144 ~lG~G~fg~Vy~~~~~--~~g~~vaiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv~e~ 216 (468)
.||+|+||.||+|.+. ..+..||+|++.... ..+.+|+.++++++||||+++++++ .. ...++||||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~-----~~-~~~~lv~e~ 75 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVC-----EA-EALMLVMEM 75 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEE-----cC-CCeEEEEEe
Confidence 3899999999999875 445679999885432 2345799999999999999999876 22 247899999
Q ss_pred ccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCCCCC-
Q 012233 217 ISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEP- 295 (468)
Q Consensus 217 ~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~~~~- 295 (468)
++++.+..... .....+++..+..++.||+.||.|||+ +|++||||||+|||++.++ .+||+|||++........
T Consensus 76 ~~~~~L~~~l~--~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~nil~~~~~-~~kl~dfg~~~~~~~~~~~ 151 (257)
T cd05115 76 ASGGPLNKFLS--GKKDEITVSNVVELMHQVSMGMKYLEG-KNFVHRDLAARNVLLVNQH-YAKISDFGLSKALGADDSY 151 (257)
T ss_pred CCCCCHHHHHH--hCCCCCCHHHHHHHHHHHHHHHHHHHh-cCeeecccchheEEEcCCC-cEEeccCCccccccCCccc
Confidence 98765543221 224568999999999999999999998 8999999999999999887 799999999975533221
Q ss_pred ---CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCC
Q 012233 296 ---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNY 371 (468)
Q Consensus 296 ---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 371 (468)
.....++..|+|||.+.+.. ++.++|||||||++|+|++ |..||......+....+....
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~--------------- 215 (257)
T cd05115 152 YKARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGK--------------- 215 (257)
T ss_pred eeccCCCCCCcccCCHHHHccCC-CCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCC---------------
Confidence 11122357899999986544 8999999999999999996 999998876655444332210
Q ss_pred ccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 372 TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
. ..++...++++.++|.+||..||.+||++.++++
T Consensus 216 -~------------~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 216 -R------------LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred -C------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0 0123457899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=296.44 Aligned_cols=244 Identities=23% Similarity=0.319 Sum_probs=192.1
Q ss_pred ccceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc---chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEE
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~---~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~l 212 (468)
..+|++.+.||+|+||.||+|... +++.||+|.+.... ....+|+.+++.++|+||+++++++. + ...++
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~-~~~~~ 77 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-----Q-EPIYI 77 (260)
T ss_pred hHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-----c-CCcEE
Confidence 346999999999999999999864 57889999886543 34567999999999999999988651 1 23789
Q ss_pred Eeecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccC
Q 012233 213 VLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (468)
Q Consensus 213 v~e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~ 291 (468)
||||+.++ +.+.+.. .....+++..+..++.|++.||+|||+ .|++|+||||+||+++.++ .++|+|||++....
T Consensus 78 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~~i~~al~~LH~-~~i~H~dl~p~ni~i~~~~-~~~l~dfg~~~~~~ 153 (260)
T cd05067 78 ITEYMENGSLVDFLKT--PEGIKLTINKLIDMAAQIAEGMAFIER-KNYIHRDLRAANILVSETL-CCKIADFGLARLIE 153 (260)
T ss_pred EEEcCCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHhc-CCeecccccHHhEEEcCCC-CEEEccCcceeecC
Confidence 99999865 4443322 123568889999999999999999998 8999999999999999887 79999999997654
Q ss_pred CCCC--CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 012233 292 PGEP--NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368 (468)
Q Consensus 292 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 368 (468)
.... .....++..|+|||++.+. .++.++|||||||++|+|++ |++||.+.+..+....+......
T Consensus 154 ~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~---------- 222 (260)
T cd05067 154 DNEYTAREGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRM---------- 222 (260)
T ss_pred CCCcccccCCcccccccCHHHhccC-CcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC----------
Confidence 2221 1233456789999998654 48899999999999999998 99999887665544443221100
Q ss_pred CCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
+ .+..++.++.++|.+||..+|.+||++++++.
T Consensus 223 --------~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 223 --------P----------RPDNCPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred --------C----------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 0 12346789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=295.17 Aligned_cols=245 Identities=26% Similarity=0.328 Sum_probs=193.9
Q ss_pred ccceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc---chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEE
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~---~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~l 212 (468)
.++|.+.+.||.|+||.||+|.+. .+..||||.+.... ....+|+.+++.++|+||+++++++ ......++
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~~ 78 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVC-----SEEEPIYI 78 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeee-----ecCCceEE
Confidence 456999999999999999999975 55789999886542 3456799999999999999999887 33345889
Q ss_pred EeecccchHH-HHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccC
Q 012233 213 VLEYISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (468)
Q Consensus 213 v~e~~~~~ll-~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~ 291 (468)
||||+.++.+ +.+.. .....+++..+..++.||+.||.|||+ +||+|+||||+||+++.++ .++|+|||++....
T Consensus 79 v~e~~~~~~L~~~i~~--~~~~~~~~~~~~~~~~~i~~al~~lh~-~~i~h~di~p~nili~~~~-~~~l~d~g~~~~~~ 154 (261)
T cd05034 79 VTEYMSKGSLLDFLKS--GEGKKLRLPQLVDMAAQIAEGMAYLES-RNYIHRDLAARNILVGENL-VCKIADFGLARLIE 154 (261)
T ss_pred EEeccCCCCHHHHHhc--cccCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCcchheEEEcCCC-CEEECccccceecc
Confidence 9999986544 33322 123468899999999999999999998 8999999999999999887 79999999987654
Q ss_pred CCCC--CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 012233 292 PGEP--NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368 (468)
Q Consensus 292 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 368 (468)
.... .....++..|+|||.+.+.. ++.++|+|||||++|+|++ |+.||.+.+....+..+......
T Consensus 155 ~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~---------- 223 (261)
T cd05034 155 DDEYTAREGAKFPIKWTAPEAANYGR-FTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRM---------- 223 (261)
T ss_pred chhhhhhhccCCCccccCHHHhccCC-cCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC----------
Confidence 3211 11223456899999987544 8999999999999999998 99999887766555554331100
Q ss_pred CCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
..+...+.++.+++.+||+.||.+||++.+++.
T Consensus 224 ------------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 224 ------------------PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred ------------------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 012346789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=297.69 Aligned_cols=245 Identities=22% Similarity=0.317 Sum_probs=191.8
Q ss_pred cceEEeceecccCceEEEEEEEcCCCC---EEEEEEeeccc-----chHHHHHHHHHHcCCCCcccccceeeecCCCCce
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGD---SVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~---~vaiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 208 (468)
.+|...+.||+|+||.||+|.+..++. .+|+|.+.... ....+|+.+++.++|+||+++.+++ .+..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~ 79 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVV-----TKFK 79 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEE-----ccCC
Confidence 358889999999999999999876655 69999875432 2345689999999999999999988 3344
Q ss_pred EEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcc
Q 012233 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (468)
Q Consensus 209 ~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~ 288 (468)
..++||||++++.+..... .....+++..+..++.|++.||.|||+ .||+|+||||+|||++.++ .+||+|||++.
T Consensus 80 ~~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~dlkp~Nili~~~~-~~kl~dfg~~~ 155 (268)
T cd05063 80 PAMIITEYMENGALDKYLR--DHDGEFSSYQLVGMLRGIAAGMKYLSD-MNYVHRDLAARNILVNSNL-ECKVSDFGLSR 155 (268)
T ss_pred CcEEEEEcCCCCCHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccchhhEEEcCCC-cEEECCCccce
Confidence 5889999999876543322 223568899999999999999999998 8999999999999999887 79999999987
Q ss_pred ccCCCCCCc----cccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 012233 289 MLVPGEPNI----SYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREE 363 (468)
Q Consensus 289 ~~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~ 363 (468)
......... ....+..|+|||++.+. .++.++|||||||++|||++ |..||...+..+....+....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~------- 227 (268)
T cd05063 156 VLEDDPEGTYTTSGGKIPIRWTAPEAIAYR-KFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGF------- 227 (268)
T ss_pred ecccccccceeccCCCcCceecCHHHhhcC-CcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCC-------
Confidence 654322111 11234579999998654 48999999999999999997 999998776655444443211
Q ss_pred HhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 364 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
..+ ....++.++.+|+.+||+.+|.+||++.++++
T Consensus 228 -----------~~~----------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 228 -----------RLP----------APMDCPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred -----------CCC----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 000 11246789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=295.39 Aligned_cols=243 Identities=24% Similarity=0.322 Sum_probs=190.3
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc---chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEEE
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV 213 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~---~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv 213 (468)
.+|.+.+.||+|+||.||+|.+..+ ..+|+|.+.... ....+|+.+++.++|+||+++++++. . ...++|
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~-~~~~~v 78 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-----E-EPIYIV 78 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-----C-CCcEEE
Confidence 4699999999999999999987554 469999875433 23457999999999999999988762 1 236799
Q ss_pred eecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCC
Q 012233 214 LEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (468)
Q Consensus 214 ~e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~ 292 (468)
|||+.++ +.+.+... ....+++..+..++.|++.||.|||+ .||+|+||||+|||++.++ .++|+|||++.....
T Consensus 79 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~dl~~~Nill~~~~-~~~l~dfg~~~~~~~ 154 (260)
T cd05069 79 TEFMGKGSLLDFLKEG--DGKYLKLPQLVDMAAQIADGMAYIER-MNYIHRDLRAANILVGDNL-VCKIADFGLARLIED 154 (260)
T ss_pred EEcCCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeecccCcceEEEcCCC-eEEECCCccceEccC
Confidence 9999864 55544321 23457888999999999999999998 8999999999999999887 799999999976533
Q ss_pred CCC--CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 012233 293 GEP--NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (468)
Q Consensus 293 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 369 (468)
... .....++..|+|||.+.+.. ++.++|+|||||++|+|++ |..||.+....+....+....
T Consensus 155 ~~~~~~~~~~~~~~y~~Pe~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~------------- 220 (260)
T cd05069 155 NEYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGY------------- 220 (260)
T ss_pred CcccccCCCccchhhCCHHHhccCC-cChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-------------
Confidence 221 12234567899999886544 8999999999999999999 999998876655444332210
Q ss_pred CCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
.. .++..++..+.++|.+||..||.+||++++++.
T Consensus 221 -----~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 221 -----RM----------PCPQGCPESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred -----CC----------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 00 022357889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=301.91 Aligned_cols=247 Identities=24% Similarity=0.294 Sum_probs=190.7
Q ss_pred cceEEeceecccCceEEEEEEEcC-----CCCEEEEEEeeccc-----chHHHHHHHHHHcCCCCcccccceeeecCCCC
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLE-----TGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD 206 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~-----~g~~vaiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 206 (468)
.+|.+.+.||+|+||.||+|.+.. ++..||+|.+.... ..+.+|+.+++.++||||+++++++ .+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~-----~~ 79 (288)
T cd05050 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVC-----AV 79 (288)
T ss_pred HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEE-----cC
Confidence 469999999999999999998743 67889999886432 3355799999999999999999987 33
Q ss_pred ceEEEEEeecccch-HHHHHhhhh------------------hcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCC
Q 012233 207 ELYLNLVLEYISET-VYRVSKHYT------------------RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKP 267 (468)
Q Consensus 207 ~~~~~lv~e~~~~~-ll~~~~~~~------------------~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp 267 (468)
....++||||++++ +.+.+.... .....+++..+..++.||+.||.|||+ .|++||||||
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~-~~i~H~dl~p 158 (288)
T cd05050 80 GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE-RKFVHRDLAT 158 (288)
T ss_pred CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh-CCeecccccH
Confidence 44578999999965 444333211 112346788889999999999999998 8999999999
Q ss_pred CCeeecCCCCcEEEeeecCccccCCCCC---CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 012233 268 QNLLVNPHTHQLKICDFGSAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGE 343 (468)
Q Consensus 268 ~NILl~~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~ 343 (468)
+|||++.++ .++|+|||++........ ......+..|+|||.+.+. .++.++|||||||++|+|++ |..||.+.
T Consensus 159 ~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~~~~~p~~~~ 236 (288)
T cd05050 159 RNCLVGENM-VVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGMQPYYGM 236 (288)
T ss_pred hheEecCCC-ceEECccccceecccCccccccCCCccChhhcCHHHHhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999888 799999999875432211 1223346679999998655 48999999999999999997 88999876
Q ss_pred CcHHHHHHHHHHhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 344 SGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 344 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
+..+....+.... .. ..+..++.++.+||.+||+.||.+|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~-------------------~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 237 AHEEVIYYVRDGN-------------------VL---------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred CHHHHHHHHhcCC-------------------CC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 6555444332200 00 012346889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=299.92 Aligned_cols=241 Identities=23% Similarity=0.330 Sum_probs=182.9
Q ss_pred ceecccCceEEEEEEEcCCCC--EEEEEEeeccc-----chHHHHHHHHHHc-CCCCcccccceeeecCCCCceEEEEEe
Q 012233 143 RVVGTGSFGVVFQAKCLETGD--SVAIKKVLQDK-----RYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDELYLNLVL 214 (468)
Q Consensus 143 ~~lG~G~fg~Vy~~~~~~~g~--~vaiK~~~~~~-----~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~lv~ 214 (468)
++||+|+||.||+|.+..++. .+++|.+.... ....+|+.+++++ .||||+++++++ ....+.++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~-----~~~~~~~lv~ 75 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC-----EHRGYLYLAI 75 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEE-----ecCCCceEEE
Confidence 368999999999999988776 46888775321 2345699999999 799999999988 3344588999
Q ss_pred ecccch-HHHHHhhhh------------hcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEE
Q 012233 215 EYISET-VYRVSKHYT------------RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKI 281 (468)
Q Consensus 215 e~~~~~-ll~~~~~~~------------~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL 281 (468)
||+.++ +.+.+.... .....+++..+..++.|++.||+|||+ +|++||||||+|||++.++ .+||
T Consensus 76 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~-~~i~H~dikp~nili~~~~-~~kl 153 (270)
T cd05047 76 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARNILVGENY-VAKI 153 (270)
T ss_pred EeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccccceEEEcCCC-eEEE
Confidence 999865 444433211 112347888999999999999999998 8999999999999999888 7999
Q ss_pred eeecCccccCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCC
Q 012233 282 CDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPT 360 (468)
Q Consensus 282 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~ 360 (468)
+|||++..............+..|+|||++... .++.++|+|||||++|||++ |..||.+.+..+....+...
T Consensus 154 ~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~----- 227 (270)
T cd05047 154 ADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG----- 227 (270)
T ss_pred CCCCCccccchhhhccCCCCccccCChHHHccC-CCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCC-----
Confidence 999998533221112223345679999998654 48999999999999999996 99999876654443332110
Q ss_pred HHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 361 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
... ..+..++.++.+|+.+||..||.+|||+.+++.
T Consensus 228 -------------~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 228 -------------YRL----------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred -------------CCC----------CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 000 012346789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=294.51 Aligned_cols=239 Identities=26% Similarity=0.338 Sum_probs=188.0
Q ss_pred ceecccCceEEEEEEEcC-CCC--EEEEEEeecccc-----hHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEEEe
Q 012233 143 RVVGTGSFGVVFQAKCLE-TGD--SVAIKKVLQDKR-----YKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (468)
Q Consensus 143 ~~lG~G~fg~Vy~~~~~~-~g~--~vaiK~~~~~~~-----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv~ 214 (468)
+.||+|+||.||+|.+.. .+. .||||.+..... .+.+|+.++++++||||+++++.+. + ...++||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~-~~~~~v~ 74 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVL-----T-HPLMMVT 74 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEc-----C-CeEEEEE
Confidence 468999999999999865 333 589998865543 3457999999999999999999874 3 4688999
Q ss_pred ecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCCC
Q 012233 215 EYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293 (468)
Q Consensus 215 e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~~ 293 (468)
||+.++ +...+.... ...+++..++.++.|++.||.|||+ +|++|+||||+|||++.++ .+||+|||++......
T Consensus 75 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~di~p~nil~~~~~-~~kl~dfg~~~~~~~~ 150 (257)
T cd05040 75 ELAPLGSLLDRLRKDA--LGHFLISTLCDYAVQIANGMRYLES-KRFIHRDLAARNILLASDD-KVKIGDFGLMRALPQN 150 (257)
T ss_pred EecCCCcHHHHHHhcc--cccCcHHHHHHHHHHHHHHHHHHHh-CCccccccCcccEEEecCC-EEEecccccccccccc
Confidence 999755 444333221 1468899999999999999999998 8999999999999999887 7999999999776432
Q ss_pred CC----CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 012233 294 EP----NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368 (468)
Q Consensus 294 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 368 (468)
.. .....++..|+|||.+.+. .++.++|||||||++|+|++ |..||...+..+....+....
T Consensus 151 ~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~------------ 217 (257)
T cd05040 151 EDHYVMEEHLKVPFAWCAPESLRTR-TFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEG------------ 217 (257)
T ss_pred ccceecccCCCCCceecCHHHhccc-CcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC------------
Confidence 21 1123467789999998654 48999999999999999998 999998777666555443210
Q ss_pred CCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
.... .+..++..+.++|.+||+.+|.+||++.++++
T Consensus 218 ---~~~~------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 218 ---ERLE------------RPEACPQDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred ---CcCC------------CCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 0000 12346789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=298.73 Aligned_cols=248 Identities=19% Similarity=0.265 Sum_probs=191.3
Q ss_pred cceEEeceecccCceEEEEEEEcC----CCCEEEEEEeeccc-----chHHHHHHHHHHcCCCCcccccceeeecCCCCc
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLE----TGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~----~g~~vaiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 207 (468)
++|.+.+.||+|+||.||+|.+.. ++..|++|.+.... ....+|+.+++.++|+||+++++++... .
T Consensus 6 ~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~----~ 81 (280)
T cd05043 6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIED----G 81 (280)
T ss_pred hheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC----C
Confidence 469999999999999999999865 35789999875432 2345799999999999999999977433 2
Q ss_pred eEEEEEeecccchHHH-HHhhhhhc----CCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEe
Q 012233 208 LYLNLVLEYISETVYR-VSKHYTRM----NQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKIC 282 (468)
Q Consensus 208 ~~~~lv~e~~~~~ll~-~~~~~~~~----~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~ 282 (468)
...+++++|++++.+. .+...... ...+++..+..++.||+.||.|||+ .|++|+||||+|||++.++ .+||+
T Consensus 82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~i~H~di~p~nil~~~~~-~~kl~ 159 (280)
T cd05043 82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK-RGVIHKDIAARNCVIDEEL-QVKIT 159 (280)
T ss_pred CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccCHhhEEEcCCC-cEEEC
Confidence 3477999999865443 33222111 1568899999999999999999998 8999999999999999887 79999
Q ss_pred eecCccccCCCCCC---ccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCC
Q 012233 283 DFGSAKMLVPGEPN---ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGT 358 (468)
Q Consensus 283 DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~ 358 (468)
|||+++.+...... ....++..|+|||++.+.. ++.++|||||||++||+++ |+.||...+..+....+...
T Consensus 160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~--- 235 (280)
T cd05043 160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKE-YSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDG--- 235 (280)
T ss_pred CCCCcccccCCceEEeCCCCCcchhccCHHHHhcCC-CCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcC---
Confidence 99999765433211 1234567899999986554 8999999999999999998 99999876554433222110
Q ss_pred CCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 359 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
..++ ....+++++.+++.+||..||++|||+.+++.
T Consensus 236 ---------------~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 236 ---------------YRLA----------QPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred ---------------CCCC----------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0000 12346889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=326.93 Aligned_cols=245 Identities=24% Similarity=0.324 Sum_probs=198.6
Q ss_pred ceEEeceecccCceEEEEEEEcC-----CCCEEEEEEeeccc-----chHHHHHHHHHHcCCCCcccccceeeecCCCCc
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLE-----TGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~-----~g~~vaiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 207 (468)
+-+..+.||+|+||+||+|+... ....||||.+++.. .++++|+++|..|+|||||+|+|++.. .
T Consensus 487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~-----~ 561 (774)
T KOG1026|consen 487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCRE-----G 561 (774)
T ss_pred heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc-----C
Confidence 56677889999999999998743 34679999986543 457899999999999999999999943 3
Q ss_pred eEEEEEeeccc-chHHHHHhhhhhc----------CCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCC
Q 012233 208 LYLNLVLEYIS-ETVYRVSKHYTRM----------NQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHT 276 (468)
Q Consensus 208 ~~~~lv~e~~~-~~ll~~~~~~~~~----------~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~ 276 (468)
.-+|||+|||. |+|.++++..... ...++..+...|+.||+.|+.||-+ +.+|||||-..|+||..+.
T Consensus 562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~-~~FVHRDLATRNCLVge~l 640 (774)
T KOG1026|consen 562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS-HHFVHRDLATRNCLVGENL 640 (774)
T ss_pred CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-Ccccccchhhhhceeccce
Confidence 34889999998 5555555433211 2237788899999999999999998 8999999999999999888
Q ss_pred CcEEEeeecCccccCCCCCCc---cccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHH
Q 012233 277 HQLKICDFGSAKMLVPGEPNI---SYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEI 352 (468)
Q Consensus 277 ~~vkL~DFG~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i 352 (468)
.|||+|||+++.+-..+... ...-..+|||||.|... +|+.++|||||||+|||+++ |..||.+.++.+.+..|
T Consensus 641 -~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~-kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i 718 (774)
T KOG1026|consen 641 -VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYG-KFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECI 718 (774)
T ss_pred -EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcC-cccchhhhhhhhhhhhhhhccccCcccccchHHHHHHH
Confidence 89999999998764332211 22336799999999755 49999999999999999996 99999999998888776
Q ss_pred HHHhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 012233 353 IKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEAC 418 (468)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell 418 (468)
.+.- . + ..+..+|.++.+|+..||+.+|.+||++.||-
T Consensus 719 ~~g~----------------l--L----------~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 719 RAGQ----------------L--L----------SCPENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred HcCC----------------c--c----------cCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 5520 0 1 13467999999999999999999999999873
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=298.34 Aligned_cols=243 Identities=21% Similarity=0.296 Sum_probs=185.7
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCE----EEEEEeeccc-----chHHHHHHHHHHcCCCCcccccceeeecCCCCc
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDS----VAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~----vaiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 207 (468)
.+|++.+.||+|+||.||+|.+..+|.. +++|.+.... .....|+.+++.+.||||+++++++. +.
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-----~~ 81 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-----GA 81 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-----CC
Confidence 4699999999999999999999877764 6777664321 12335667788999999999999762 22
Q ss_pred eEEEEEeecccchHH-HHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecC
Q 012233 208 LYLNLVLEYISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (468)
Q Consensus 208 ~~~~lv~e~~~~~ll-~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~ 286 (468)
..++++||+.++.+ +.+. .....+++..+..++.||+.||.|||+ +|++||||||+|||++.++ .+||+|||+
T Consensus 82 -~~~~i~e~~~~gsL~~~l~---~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~iiH~dlkp~nili~~~~-~~kl~Dfg~ 155 (279)
T cd05111 82 -SLQLVTQLSPLGSLLDHVR---QHRDSLDPQRLLNWCVQIAKGMYYLEE-HRMVHRNLAARNILLKSDS-IVQIADFGV 155 (279)
T ss_pred -ccEEEEEeCCCCcHHHHHH---hcccCCCHHHHHHHHHHHHHHHHHHHH-CCEeccccCcceEEEcCCC-cEEEcCCcc
Confidence 35689999986544 3332 223568899999999999999999998 8999999999999999887 799999999
Q ss_pred ccccCCCCC---CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 012233 287 AKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTRE 362 (468)
Q Consensus 287 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~ 362 (468)
++....... .....++..|+|||.+.+.. ++.++|||||||++|||++ |..||.+..... +.+++.....+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~-~~~~~~~~~~~--- 230 (279)
T cd05111 156 ADLLYPDDKKYFYSEHKTPIKWMALESILFGR-YTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE-VPDLLEKGERL--- 230 (279)
T ss_pred ceeccCCCcccccCCCCCcccccCHHHhccCC-cCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-HHHHHHCCCcC---
Confidence 986643322 12334667899999986544 8999999999999999998 999998765433 23332211000
Q ss_pred HHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 363 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
. .+...+.++.+++.+||..||.+|||+.+++.
T Consensus 231 ------------~------------~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 231 ------------A------------QPQICTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred ------------C------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 0 11235678999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=294.60 Aligned_cols=236 Identities=25% Similarity=0.342 Sum_probs=184.2
Q ss_pred ceecccCceEEEEEEEcCCC---CEEEEEEeecccc-----hHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEEEe
Q 012233 143 RVVGTGSFGVVFQAKCLETG---DSVAIKKVLQDKR-----YKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (468)
Q Consensus 143 ~~lG~G~fg~Vy~~~~~~~g---~~vaiK~~~~~~~-----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv~ 214 (468)
+.||+|+||.||+|.+...+ ..||+|.+..... ...+|+.+++.+.|+||+++++++. .. ..++||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~-~~~~v~ 74 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-----GE-PLMLVM 74 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-----CC-ceEEEE
Confidence 46999999999999876554 7899998865443 3457899999999999999998762 22 368999
Q ss_pred ecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCCC
Q 012233 215 EYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293 (468)
Q Consensus 215 e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~~ 293 (468)
||+.++ +.+.+. ....+++..+..++.|++.||.|||. .||+|+||||+|||++.++ .+||+|||+++.....
T Consensus 75 e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lh~-~~i~H~di~p~nili~~~~-~~kl~df~~~~~~~~~ 148 (257)
T cd05060 75 ELAPLGPLLKYLK----KRREIPVSDLKELAHQVAMGMAYLES-KHFVHRDLAARNVLLVNRH-QAKISDFGMSRALGAG 148 (257)
T ss_pred EeCCCCcHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHhh-cCeeccCcccceEEEcCCC-cEEeccccccceeecC
Confidence 999865 444332 23468899999999999999999998 8999999999999999888 7999999999766433
Q ss_pred CCCc----cccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 012233 294 EPNI----SYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368 (468)
Q Consensus 294 ~~~~----~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 368 (468)
.... ...++..|+|||.+.+. .++.++|||||||++|+|++ |..||...+..+....+... .
T Consensus 149 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~-~----------- 215 (257)
T cd05060 149 SDYYRATTAGRWPLKWYAPECINYG-KFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESG-E----------- 215 (257)
T ss_pred CcccccccCccccccccCHHHhcCC-CCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC-C-----------
Confidence 3211 12234679999998654 48999999999999999997 99999877655443333221 0
Q ss_pred CCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
. ...+..++..++++|.+||..||.+||++.++++
T Consensus 216 ------~----------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 216 ------R----------LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred ------c----------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 0 0022347889999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=296.57 Aligned_cols=245 Identities=22% Similarity=0.291 Sum_probs=181.7
Q ss_pred eecccCceEEEEEEEcC--CCCEEEEEEeeccc-----chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEEEeec
Q 012233 144 VVGTGSFGVVFQAKCLE--TGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEY 216 (468)
Q Consensus 144 ~lG~G~fg~Vy~~~~~~--~g~~vaiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv~e~ 216 (468)
.||+|+||.||+|.... ....+|+|.+.... ..+.+|+.+++.++|+||+++++.+ ......|+||||
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~-----~~~~~~~lv~e~ 76 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQC-----IESIPYLLVLEF 76 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEE-----CCCCceEEEEEe
Confidence 58999999999997532 34578888764332 2345789999999999999999988 334458899999
Q ss_pred ccchHHH-HHhhhhh-cCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCCCC
Q 012233 217 ISETVYR-VSKHYTR-MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGE 294 (468)
Q Consensus 217 ~~~~ll~-~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~~~ 294 (468)
++++.+. .+..... .....++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++.......
T Consensus 77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nill~~~~-~~kl~dfg~~~~~~~~~ 154 (269)
T cd05042 77 CPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ-ADFIHSDLALRNCQLTADL-SVKIGDYGLALEQYPED 154 (269)
T ss_pred CCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh-cCEecccccHhheEecCCC-cEEEeccccccccccch
Confidence 9875444 3332221 12334677788999999999999998 8999999999999999888 79999999986543221
Q ss_pred C---CccccccCCccccccccC------CCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 012233 295 P---NISYICSRYYRAPELIFG------ATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEI 364 (468)
Q Consensus 295 ~---~~~~~gt~~y~aPE~~~~------~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 364 (468)
. .....+++.|+|||++.. ...++.++|||||||++|||++ |..||......+.+..++.....
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~------ 228 (269)
T cd05042 155 YYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDI------ 228 (269)
T ss_pred heeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCc------
Confidence 1 122345678999998742 2346889999999999999998 88999877766655554432111
Q ss_pred hhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 365 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
.++ ...+...++..+.+++..|| .||.+|||+++++.
T Consensus 229 ----------~~~-------~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 229 ----------KLP-------KPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred ----------cCC-------CCcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 111 01133457888999999999 59999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=300.68 Aligned_cols=242 Identities=26% Similarity=0.362 Sum_probs=185.0
Q ss_pred EEeceecccCceEEEEEEEc----CCCCEEEEEEeecc-----cchHHHHHHHHHHcCCCCcccccceeeecCCCCceEE
Q 012233 140 MAERVVGTGSFGVVFQAKCL----ETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (468)
Q Consensus 140 ~~~~~lG~G~fg~Vy~~~~~----~~g~~vaiK~~~~~-----~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~ 210 (468)
.+.+.||.|.||.||+|.+. ..+..|+||.+... ...+.+|++++++++||||+++++++.... ..
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~-----~~ 76 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENE-----PL 76 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSS-----SE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccc-----cc
Confidence 45678999999999999997 44677999998542 234557999999999999999999986322 27
Q ss_pred EEEeecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccc
Q 012233 211 NLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (468)
Q Consensus 211 ~lv~e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~ 289 (468)
++||||+.++ +.+.+... ....+++..+..++.||+.||.|||+ ++|+|+||++.||||+.++ .+||+|||++..
T Consensus 77 ~lv~e~~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~-~~iiH~~l~~~nill~~~~-~~Kl~~f~~~~~ 152 (259)
T PF07714_consen 77 FLVMEYCPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHS-NNIIHGNLSPSNILLDSNG-QVKLSDFGLSRP 152 (259)
T ss_dssp EEEEE--TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHH-TTEEEST-SGGGEEEETTT-EEEEESTTTGEE
T ss_pred ccccccccccccccccccc--cccccccccccccccccccccccccc-ccccccccccccccccccc-cccccccccccc
Confidence 8999999865 44443332 24668999999999999999999998 8999999999999999888 899999999977
Q ss_pred cCCCCC---CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 012233 290 LVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIK 365 (468)
Q Consensus 290 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 365 (468)
...... .....+...|+|||.+.+.. ++.++||||||+++|||++ |+.||...+..+....+.+...
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~-------- 223 (259)
T PF07714_consen 153 ISEKSKYKNDSSQQLPLRYLAPEVLKDGE-YTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQR-------- 223 (259)
T ss_dssp TTTSSSEEESTTSESGGGGS-HHHHHHSE-ESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEE--------
T ss_pred ccccccccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccc--------
Confidence 622211 22345677899999986654 8999999999999999999 7899988876665555533100
Q ss_pred hcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 366 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
..++..++..+.++|.+||..||.+|||+.++++
T Consensus 224 --------------------~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 224 --------------------LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp --------------------TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred --------------------ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 0123457899999999999999999999999874
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=292.72 Aligned_cols=242 Identities=27% Similarity=0.378 Sum_probs=191.3
Q ss_pred EEeceecccCceEEEEEEEcCCC----CEEEEEEeeccc-----chHHHHHHHHHHcCCCCcccccceeeecCCCCceEE
Q 012233 140 MAERVVGTGSFGVVFQAKCLETG----DSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (468)
Q Consensus 140 ~~~~~lG~G~fg~Vy~~~~~~~g----~~vaiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~ 210 (468)
.+.+.||.|+||.||+|.+...+ ..||+|.+.... ....+|+.+++.++|+||+++++++. +....
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~ 76 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCT-----EEEPL 76 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEc-----CCCee
Confidence 46678999999999999998766 889999986443 24457999999999999999999883 33468
Q ss_pred EEEeecccchHHH-HHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccc
Q 012233 211 NLVLEYISETVYR-VSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (468)
Q Consensus 211 ~lv~e~~~~~ll~-~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~ 289 (468)
+++|||+.++.+. .+.... ...+++..+..++.|++.||.|||+ .|++|+||||+||+++.++ .++|+|||++..
T Consensus 77 ~~i~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lh~-~~~~h~dl~~~nil~~~~~-~~~l~dfg~~~~ 152 (258)
T smart00219 77 MIVMEYMEGGDLLDYLRKNR--PKELSLSDLLSFALQIARGMEYLES-KNFIHRDLAARNCLVGENL-VVKISDFGLSRD 152 (258)
T ss_pred EEEEeccCCCCHHHHHHhhh--hccCCHHHHHHHHHHHHHHHHHHhc-CCeeecccccceEEEccCC-eEEEcccCCcee
Confidence 8999999875443 322211 1228999999999999999999998 8999999999999999887 799999999976
Q ss_pred cCCCCCCc--cccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 012233 290 LVPGEPNI--SYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKC 366 (468)
Q Consensus 290 ~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 366 (468)
........ ...+++.|+|||.+.+ ..++.++|+|||||++|+|++ |++||...+..+....+.....
T Consensus 153 ~~~~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~--------- 222 (258)
T smart00219 153 LYDDDYYKKKGGKLPIRWMAPESLKD-GKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYR--------- 222 (258)
T ss_pred cccccccccccCCCcccccChHHhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC---------
Confidence 64432211 1336789999999854 458999999999999999998 8999987665555544432100
Q ss_pred cCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 367 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
...+..++.++.+++.+||..||.+|||+.++++
T Consensus 223 -------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 223 -------------------LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred -------------------CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 0022347889999999999999999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=298.66 Aligned_cols=236 Identities=18% Similarity=0.225 Sum_probs=179.9
Q ss_pred eecccCceEEEEEEEcCC------------------------CCEEEEEEeeccc----chHHHHHHHHHHcCCCCcccc
Q 012233 144 VVGTGSFGVVFQAKCLET------------------------GDSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVSL 195 (468)
Q Consensus 144 ~lG~G~fg~Vy~~~~~~~------------------------g~~vaiK~~~~~~----~~~~~E~~il~~l~hpnIv~l 195 (468)
.||+|+||.||+|....+ ...||+|.+.... ..+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 599999999999985322 2358888875432 234468889999999999999
Q ss_pred cceeeecCCCCceEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCC
Q 012233 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPH 275 (468)
Q Consensus 196 ~~~~~~~~~~~~~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~ 275 (468)
++++.. ..+.++||||++++.+..... .....+++..+..++.||+.||+|||+ +||+||||||+|||++..
T Consensus 82 ~~~~~~-----~~~~~lv~ey~~~g~L~~~l~--~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~iiH~dlkp~Nill~~~ 153 (274)
T cd05076 82 HGVCVR-----GSENIMVEEFVEHGPLDVCLR--KEKGRVPVAWKITVAQQLASALSYLED-KNLVHGNVCAKNILLARL 153 (274)
T ss_pred EEEEEe-----CCceEEEEecCCCCcHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHc-CCccCCCCCcccEEEecc
Confidence 998843 335789999999886654332 224568899999999999999999998 899999999999999754
Q ss_pred CC------cEEEeeecCccccCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHH-hCCCCCCCCCcHHH
Q 012233 276 TH------QLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVDQ 348 (468)
Q Consensus 276 ~~------~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell-~G~~pf~~~~~~~~ 348 (468)
+. .+||+|||++...... ....++..|+|||.+.+...++.++|||||||++|||+ +|..||......+.
T Consensus 154 ~~~~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 230 (274)
T cd05076 154 GLAEGTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK 230 (274)
T ss_pred CcccCccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH
Confidence 31 3899999988644222 23457888999999876556899999999999999985 79999987654332
Q ss_pred HHHHHHHhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCC
Q 012233 349 LVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (468)
Q Consensus 349 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~h 420 (468)
.. .... ... ++...++++.++|.+||+.+|.+|||+.+++++
T Consensus 231 ~~-~~~~-----------------~~~------------~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 231 ER-FYEK-----------------KHR------------LPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred HH-HHHh-----------------ccC------------CCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 21 1110 000 112345789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=315.61 Aligned_cols=254 Identities=25% Similarity=0.311 Sum_probs=199.1
Q ss_pred CcccceEEeceecccCceEEEEEEEcCCCC---E-EEEEEeecc-------cchHHHHHHHHHHcCCCCcccccceeeec
Q 012233 134 KQTISYMAERVVGTGSFGVVFQAKCLETGD---S-VAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFST 202 (468)
Q Consensus 134 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~---~-vaiK~~~~~-------~~~~~~E~~il~~l~hpnIv~l~~~~~~~ 202 (468)
....+-.+.+.||+|+||.||+|..+..+. . ||+|..... ...+.+|.++|++++|||||++||+.
T Consensus 154 l~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa--- 230 (474)
T KOG0194|consen 154 LSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVA--- 230 (474)
T ss_pred EeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEE---
Confidence 334455566899999999999999865433 3 899987642 23345799999999999999999988
Q ss_pred CCCCceEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEe
Q 012233 203 TEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKIC 282 (468)
Q Consensus 203 ~~~~~~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~ 282 (468)
.+..-++||||+|.||.|.. +..+....++..+...++.+.+.||+|||. +++|||||-.+|+|++.++ .+||+
T Consensus 231 --~~~~Pl~ivmEl~~gGsL~~--~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~-k~~IHRDIAARNcL~~~~~-~vKIS 304 (474)
T KOG0194|consen 231 --VLEEPLMLVMELCNGGSLDD--YLKKNKKSLPTLEKLRFCYDAARGLEYLHS-KNCIHRDIAARNCLYSKKG-VVKIS 304 (474)
T ss_pred --cCCCccEEEEEecCCCcHHH--HHHhCCCCCCHHHHHHHHHHHHhHHHHHHH-CCCcchhHhHHHheecCCC-eEEeC
Confidence 34445889999999875542 222333469999999999999999999998 9999999999999999877 68999
Q ss_pred eecCccccCCCCCCccc-cccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCC
Q 012233 283 DFGSAKMLVPGEPNISY-ICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPT 360 (468)
Q Consensus 283 DFG~a~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~ 360 (468)
|||+++........... --...|+|||.+... .|+.++|||||||++||+++ |..||.+....+...+|+.....
T Consensus 305 DFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~-~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r-- 381 (474)
T KOG0194|consen 305 DFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTG-IFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYR-- 381 (474)
T ss_pred ccccccCCcceeeccccccCcceecChhhhccC-ccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCcc--
Confidence 99998754322222212 246789999999655 69999999999999999998 89999999988888887542111
Q ss_pred HHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q 012233 361 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426 (468)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 426 (468)
...+...+.++..++.+||..||+.||++.++.+ +++.+
T Consensus 382 -------------------------~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~--~l~~~ 420 (474)
T KOG0194|consen 382 -------------------------MPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK--KLEAL 420 (474)
T ss_pred -------------------------CCCCCCCHHHHHHHHHHhccCChhhccCHHHHHH--HHHHH
Confidence 1133457889999999999999999999998876 44443
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=321.11 Aligned_cols=264 Identities=25% Similarity=0.383 Sum_probs=217.6
Q ss_pred CCcccceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc---cchHHHHHHHHHHc-CCCCcccccceeeecCCCCce
Q 012233 133 PKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDEL 208 (468)
Q Consensus 133 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~---~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~~~ 208 (468)
+...+-|.+.++||.|.+|.||+++.+.+|+..|+|+..-+ ....+.|.+||+.+ .|||++.+|++|+........
T Consensus 15 pdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~D 94 (953)
T KOG0587|consen 15 PDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGD 94 (953)
T ss_pred CCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCC
Confidence 34455699999999999999999999999999999987443 34455688888887 499999999999887766677
Q ss_pred EEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcc
Q 012233 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (468)
Q Consensus 209 ~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~ 288 (468)
.++||||||++|....+-.... +..+.+..+..|++.++.||.+||+ ..++|||||-.|||++.++ .|||+|||.+.
T Consensus 95 qLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~-nkviHRDikG~NiLLT~e~-~VKLvDFGvSa 171 (953)
T KOG0587|consen 95 QLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHN-NKVIHRDIKGQNVLLTENA-EVKLVDFGVSA 171 (953)
T ss_pred eEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhh-cceeeecccCceEEEeccC-cEEEeeeeeee
Confidence 8999999999765544433333 7889999999999999999999998 8999999999999999998 79999999998
Q ss_pred ccCCC-CCCccccccCCccccccccCCC----CCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 012233 289 MLVPG-EPNISYICSRYYRAPELIFGAT----EYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREE 363 (468)
Q Consensus 289 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~----~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~ 363 (468)
.+... ....+.+|||+|||||++.... .|+..+|+||||++..||--|.+|+-+..+...+..|.. .|++..
T Consensus 172 QldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpR---NPPPkL 248 (953)
T KOG0587|consen 172 QLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR---NPPPKL 248 (953)
T ss_pred eeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCC---CCCccc
Confidence 77543 3456889999999999995432 377899999999999999999999988777666655433 222211
Q ss_pred HhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q 012233 364 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDD 425 (468)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~ 425 (468)
. -++.-+.++.+||..||.+|-.+||+..++|.|||+++
T Consensus 249 k-----------------------rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e 287 (953)
T KOG0587|consen 249 K-----------------------RPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITE 287 (953)
T ss_pred c-----------------------chhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence 1 12345778999999999999999999999999999984
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=296.67 Aligned_cols=237 Identities=18% Similarity=0.216 Sum_probs=179.6
Q ss_pred ceecccCceEEEEEEEcC------------CCCEEEEEEeecccc----hHHHHHHHHHHcCCCCcccccceeeecCCCC
Q 012233 143 RVVGTGSFGVVFQAKCLE------------TGDSVAIKKVLQDKR----YKNRELQIMRLLNHPNVVSLKHCFFSTTEKD 206 (468)
Q Consensus 143 ~~lG~G~fg~Vy~~~~~~------------~g~~vaiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 206 (468)
+.||+|+||.||+|.... ....|++|.+..... .+.+|+.+++.++||||+++++++. +
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~-----~ 75 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCV-----R 75 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEe-----c
Confidence 368999999999998532 223588887644322 3456888999999999999999873 3
Q ss_pred ceEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCC------cEE
Q 012233 207 ELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTH------QLK 280 (468)
Q Consensus 207 ~~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~------~vk 280 (468)
....++||||++++.+..... .....+++..++.++.||+.||.|||+ +||+||||||+|||++.++. .++
T Consensus 76 ~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~Nill~~~~~~~~~~~~~~ 152 (262)
T cd05077 76 DVENIMVEEFVEFGPLDLFMH--RKSDVLTTPWKFKVAKQLASALSYLED-KDLVHGNVCTKNILLAREGIDGECGPFIK 152 (262)
T ss_pred CCCCEEEEecccCCCHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHhhh-CCeECCCCCcccEEEecCCccCCCCceeE
Confidence 334789999999877665432 223568999999999999999999998 89999999999999986552 289
Q ss_pred EeeecCccccCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHH-hCCCCCCCCCcHHHHHHHHHHhCCC
Q 012233 281 ICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVDQLVEIIKILGTP 359 (468)
Q Consensus 281 L~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell-~G~~pf~~~~~~~~~~~i~~~~~~~ 359 (468)
++|||++..... .....++..|+|||.+.+...++.++|||||||++|||+ .|..||......+.. .... .
T Consensus 153 l~d~g~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~---~- 224 (262)
T cd05077 153 LSDPGIPITVLS---RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYE---G- 224 (262)
T ss_pred eCCCCCCccccC---cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHh---c-
Confidence 999999865432 224567889999998865556899999999999999998 588888765432211 1111 0
Q ss_pred CHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCC
Q 012233 360 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (468)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~h 420 (468)
... .....++++.+||.+||+.||.+||++.+++++
T Consensus 225 -------------~~~------------~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 225 -------------QCM------------LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred -------------Ccc------------CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 000 111245789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=292.65 Aligned_cols=243 Identities=20% Similarity=0.315 Sum_probs=191.3
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc---chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEEEe
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~---~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv~ 214 (468)
.|.+.+.||.|+||.||+|.+. .+..+|+|.+.... ..+.+|+++++.++||||+++++++ ......++||
T Consensus 5 ~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~~v~ 78 (256)
T cd05112 5 ELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVC-----TERSPICLVF 78 (256)
T ss_pred HeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEE-----ccCCceEEEE
Confidence 5899999999999999999875 47789999886432 3456799999999999999999887 4444688999
Q ss_pred ecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCCCC
Q 012233 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGE 294 (468)
Q Consensus 215 e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~~~ 294 (468)
||+.++.+..... .....+++..++.++.|++.||+|||+ .|++|+||||+||+++.++ .++|+|||.+.......
T Consensus 79 e~~~~~~L~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~h~dl~p~ni~i~~~~-~~~l~d~g~~~~~~~~~ 154 (256)
T cd05112 79 EFMEHGCLSDYLR--AQRGKFSQETLLGMCLDVCEGMAYLES-SNVIHRDLAARNCLVGENQ-VVKVSDFGMTRFVLDDQ 154 (256)
T ss_pred EcCCCCcHHHHHH--hCccCCCHHHHHHHHHHHHHHHHHHHH-CCccccccccceEEEcCCC-eEEECCCcceeecccCc
Confidence 9999775543222 223457888999999999999999998 8999999999999999877 79999999987553322
Q ss_pred C--CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCC
Q 012233 295 P--NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNY 371 (468)
Q Consensus 295 ~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 371 (468)
. .....++..|+|||.+.+. .++.++|||||||++|||++ |..||......+....+....
T Consensus 155 ~~~~~~~~~~~~~~aPe~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~--------------- 218 (256)
T cd05112 155 YTSSTGTKFPVKWSSPEVFSFS-KYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGF--------------- 218 (256)
T ss_pred ccccCCCccchhhcCHhHhccC-CcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCC---------------
Confidence 1 1123346789999998654 48999999999999999998 999998766554444332100
Q ss_pred ccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 372 TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
. ...+...+..+.+|+.+||+.+|.+|||+.++++
T Consensus 219 ---~----------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~ 253 (256)
T cd05112 219 ---R----------LYKPRLASQSVYELMQHCWKERPEDRPSFSLLLH 253 (256)
T ss_pred ---C----------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 0 0012235789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=296.24 Aligned_cols=249 Identities=23% Similarity=0.306 Sum_probs=192.1
Q ss_pred cceEEeceecccCceEEEEEEEcC-----CCCEEEEEEeecccc-----hHHHHHHHHHHcCCCCcccccceeeecCCCC
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLE-----TGDSVAIKKVLQDKR-----YKNRELQIMRLLNHPNVVSLKHCFFSTTEKD 206 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~-----~g~~vaiK~~~~~~~-----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 206 (468)
.+|.+.+.||.|+||.||+|+++. ..+.|++|.+..... ...+|+.++++++|+||+++++++ .+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~ 79 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLC-----RE 79 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEE-----CC
Confidence 369999999999999999999754 346799998754332 356799999999999999999987 44
Q ss_pred ceEEEEEeecccchHHH-HHhhhhhc-----CCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEE
Q 012233 207 ELYLNLVLEYISETVYR-VSKHYTRM-----NQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLK 280 (468)
Q Consensus 207 ~~~~~lv~e~~~~~ll~-~~~~~~~~-----~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vk 280 (468)
..+.|+||||++++.+. .+...... ...+++..+..++.||+.||.|||+ .||+||||||+|||++.++ .++
T Consensus 80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~-~~i~H~dlkp~Nili~~~~-~~~ 157 (275)
T cd05046 80 AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN-ARFVHRDLAARNCLVSSQR-EVK 157 (275)
T ss_pred CCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh-cCcccCcCccceEEEeCCC-cEE
Confidence 45689999999865444 33322111 1158999999999999999999998 8999999999999999888 799
Q ss_pred EeeecCccccCCCC--CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhC
Q 012233 281 ICDFGSAKMLVPGE--PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILG 357 (468)
Q Consensus 281 L~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~ 357 (468)
|+|||++....... ......++..|+|||.+.+.. ++.++|||||||++|+|++ |..||........+..+..
T Consensus 158 l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~--- 233 (275)
T cd05046 158 VSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDD-FSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQA--- 233 (275)
T ss_pred EcccccccccCcccccccCCceeEEeecChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHc---
Confidence 99999986543221 222345677899999986544 7899999999999999998 8899976654443333221
Q ss_pred CCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCC
Q 012233 358 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (468)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~h 420 (468)
....++ .+..++..+.++|.+||+.||.+||++.+++.+
T Consensus 234 --------------~~~~~~----------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 234 --------------GKLELP----------VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred --------------CCcCCC----------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 000110 123478899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=298.48 Aligned_cols=261 Identities=25% Similarity=0.338 Sum_probs=187.7
Q ss_pred ceEEeceecccCceEEEEEEE----cCCCCEEEEEEeeccc----chHHHHHHHHHHcCCCCcccccceeeecCCCCceE
Q 012233 138 SYMAERVVGTGSFGVVFQAKC----LETGDSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~----~~~g~~vaiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 209 (468)
+|++.+.||+|+||.||+|.. ..++..||+|.+.... ..+.+|+++++.++||||+++++++... +...
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~~~~ 81 (284)
T cd05081 5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSA---GRRN 81 (284)
T ss_pred cceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccC---CCCc
Confidence 599999999999999999974 4578899999985432 2446799999999999999999876543 2335
Q ss_pred EEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccc
Q 012233 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (468)
Q Consensus 210 ~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~ 289 (468)
+++||||++++.+..... .....+++..++.++.|++.||+|||+ +||+||||||+|||++.++ .+||+|||++..
T Consensus 82 ~~lv~e~~~~~~L~~~l~--~~~~~l~~~~~~~~~~~l~~aL~~LH~-~~i~H~dlkp~nili~~~~-~~~l~dfg~~~~ 157 (284)
T cd05081 82 LRLVMEYLPYGSLRDYLQ--KHRERLDHRKLLLYASQICKGMEYLGS-KRYVHRDLATRNILVESEN-RVKIGDFGLTKV 157 (284)
T ss_pred eEEEEEecCCCCHHHHHH--hcCcCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCHhhEEECCCC-eEEECCCccccc
Confidence 789999998654432221 223457889999999999999999998 8999999999999999888 799999999987
Q ss_pred cCCCCCC----ccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC-CCCHHHH
Q 012233 290 LVPGEPN----ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILG-TPTREEI 364 (468)
Q Consensus 290 ~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~-~~~~~~~ 364 (468)
....... ....++..|+|||++.+. .++.++|||||||++|||++|..++...... ....+..... ......+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05081 158 LPQDKEYYKVREPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYSDKSCSPPAE-FMRMMGNDKQGQMIVYHL 235 (284)
T ss_pred ccCCCcceeecCCCCCceEeeCHHHhccC-CcChHHHHHHHHHHHHHHhhcCCcCCCcchh-hhhhcccccccccchHHH
Confidence 6433221 112234569999998654 4899999999999999999998776443211 1000000000 0000000
Q ss_pred hhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 365 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
..... ....+ ..+..++.++.+||.+||..+|++|||+.+++.
T Consensus 236 ~~~~~--~~~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 236 IELLK--NNGRL----------PAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred HHHHh--cCCcC----------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 00000 00000 123457889999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=294.29 Aligned_cols=248 Identities=23% Similarity=0.387 Sum_probs=193.9
Q ss_pred eEEeceecccCceEEEEEEEcC-CCCEEEEEEeeccc--------------chHHHHHHHHHH-cCCCCcccccceeeec
Q 012233 139 YMAERVVGTGSFGVVFQAKCLE-TGDSVAIKKVLQDK--------------RYKNRELQIMRL-LNHPNVVSLKHCFFST 202 (468)
Q Consensus 139 y~~~~~lG~G~fg~Vy~~~~~~-~g~~vaiK~~~~~~--------------~~~~~E~~il~~-l~hpnIv~l~~~~~~~ 202 (468)
|.+.+.||+|+||.||+|.+.. +++.+|+|.+.... ....+|+.++.+ ++||||+++++++
T Consensus 2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~--- 78 (269)
T cd08528 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTF--- 78 (269)
T ss_pred chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeE---
Confidence 7888999999999999999977 67899999874221 112357776654 7899999999988
Q ss_pred CCCCceEEEEEeecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEE
Q 012233 203 TEKDELYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKI 281 (468)
Q Consensus 203 ~~~~~~~~~lv~e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL 281 (468)
....+.++||||+.++ +.+.+.........+++..++.++.|++.||.|||+..||+|+||||+|||++.++ .++|
T Consensus 79 --~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~-~~~l 155 (269)
T cd08528 79 --LENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDD-KVTI 155 (269)
T ss_pred --ccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCC-cEEE
Confidence 4445689999999864 44444433344567899999999999999999999536899999999999999888 7999
Q ss_pred eeecCccccCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 012233 282 CDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTR 361 (468)
Q Consensus 282 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~ 361 (468)
+|||.+.............++..|+|||.+.+.. ++.++|+||||+++|+|++|..||...........+......+
T Consensus 156 ~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-- 232 (269)
T cd08528 156 TDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEP-YGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEP-- 232 (269)
T ss_pred ecccceeecccccccccccCcccCcChhhhcCCC-CchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCc--
Confidence 9999997665444444567889999999997644 8999999999999999999999997665544444333211100
Q ss_pred HHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCC
Q 012233 362 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (468)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~h 420 (468)
.....+++.+.++|.+||+.||.+||++.|+..+
T Consensus 233 -------------------------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 233 -------------------------LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred -------------------------CCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 0112467899999999999999999999998653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=291.23 Aligned_cols=238 Identities=23% Similarity=0.333 Sum_probs=184.6
Q ss_pred ceecccCceEEEEEEEcCCCCEEEEEEeeccc-----chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEEEeecc
Q 012233 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYI 217 (468)
Q Consensus 143 ~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv~e~~ 217 (468)
++||+|+||.||+|.. .++..||+|.+.... ..+.+|+.+++.++||||+++++++. .....++||||+
T Consensus 1 ~~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~ 74 (250)
T cd05085 1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT-----QRQPIYIVMELV 74 (250)
T ss_pred CccCCCCCceEEEEEe-cCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEe-----cCCccEEEEECC
Confidence 3689999999999985 468899999875432 23457999999999999999999873 334588999999
Q ss_pred cchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCCCCCC-
Q 012233 218 SETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPN- 296 (468)
Q Consensus 218 ~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~~~~~- 296 (468)
+++.+.... ......+++..+..++.|++.||.|||+ +|++|+||||+||+++.++ .+||+|||++.........
T Consensus 75 ~~~~L~~~~--~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~~~H~dl~p~nili~~~~-~~~l~d~g~~~~~~~~~~~~ 150 (250)
T cd05085 75 PGGDFLSFL--RKKKDELKTKQLVKFALDAAAGMAYLES-KNCIHRDLAARNCLVGENN-VLKISDFGMSRQEDDGIYSS 150 (250)
T ss_pred CCCcHHHHH--HhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccChheEEEcCCC-eEEECCCccceecccccccc
Confidence 876443322 2223457889999999999999999998 8999999999999999887 7999999998754332211
Q ss_pred -ccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccC
Q 012233 297 -ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEF 374 (468)
Q Consensus 297 -~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 374 (468)
....++..|+|||++.+. .++.++|||||||++|+|++ |..||...........+.... .
T Consensus 151 ~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~----------------~- 212 (250)
T cd05085 151 SGLKQIPIKWTAPEALNYG-RYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGY----------------R- 212 (250)
T ss_pred CCCCCCcccccCHHHhccC-CCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC----------------C-
Confidence 122335679999998654 48999999999999999998 999998776554433332200 0
Q ss_pred CCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 375 KFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
..++..++.++.+|+.+||..+|.+||++.+++.
T Consensus 213 -----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 246 (250)
T cd05085 213 -----------MSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQK 246 (250)
T ss_pred -----------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 0122347889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=300.44 Aligned_cols=253 Identities=21% Similarity=0.278 Sum_probs=188.5
Q ss_pred ceEEeceecccCceEEEEEEEcC----------------CCCEEEEEEeeccc-----chHHHHHHHHHHcCCCCccccc
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLE----------------TGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLK 196 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~----------------~g~~vaiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l~ 196 (468)
+|.+.+.||+|+||.||++.+.. ++..||+|.+.... ..+.+|+.+++.++|+||++++
T Consensus 6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~ 85 (296)
T cd05095 6 RLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLL 85 (296)
T ss_pred hceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEE
Confidence 59999999999999999986532 34468999886432 2345799999999999999999
Q ss_pred ceeeecCCCCceEEEEEeecccch-HHHHHhhhhh-------cCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCC
Q 012233 197 HCFFSTTEKDELYLNLVLEYISET-VYRVSKHYTR-------MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQ 268 (468)
Q Consensus 197 ~~~~~~~~~~~~~~~lv~e~~~~~-ll~~~~~~~~-------~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~ 268 (468)
+++. .....++||||+.++ +...+..... ....+++..+..++.||+.||.|||+ +||+|+||||+
T Consensus 86 ~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~-~~i~H~dlkp~ 159 (296)
T cd05095 86 AVCI-----TSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS-LNFVHRDLATR 159 (296)
T ss_pred EEEe-----cCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH-CCeecccCChh
Confidence 9883 334588999999865 4443332211 11346778899999999999999998 89999999999
Q ss_pred CeeecCCCCcEEEeeecCccccCCCCC---CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh--CCCCCCCC
Q 012233 269 NLLVNPHTHQLKICDFGSAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL--GQPLFPGE 343 (468)
Q Consensus 269 NILl~~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~--G~~pf~~~ 343 (468)
|||++.++ .++|+|||+++.+..... .....+++.|++||+..+.. ++.++|+|||||++|||++ |..||...
T Consensus 160 Nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~DiwSlG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05095 160 NCLVGKNY-TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGK-FTTASDVWAFGVTLWEILTLCKEQPYSQL 237 (296)
T ss_pred eEEEcCCC-CEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCC-ccchhhhhHHHHHHHHHHHhCCCCCcccc
Confidence 99999887 799999999976533221 11233467899999886554 8999999999999999998 78999776
Q ss_pred CcHHHHHHHHHHhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 344 SGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 344 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
+..+.+......... ......++ .+..+++.+.+||.+||+.||.+||++.++++
T Consensus 238 ~~~~~~~~~~~~~~~-----------~~~~~~~~----------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 238 SDEQVIENTGEFFRD-----------QGRQVYLP----------KPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred ChHHHHHHHHHHHhh-----------ccccccCC----------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 655544332221100 00000011 12346789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=294.01 Aligned_cols=246 Identities=20% Similarity=0.219 Sum_probs=181.1
Q ss_pred ceecccCceEEEEEEEc--CCCCEEEEEEeeccc-----chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEEEee
Q 012233 143 RVVGTGSFGVVFQAKCL--ETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLE 215 (468)
Q Consensus 143 ~~lG~G~fg~Vy~~~~~--~~g~~vaiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv~e 215 (468)
+.||+|+||.||+|.+. .++..+|+|.+.... ....+|+.+++.++||||+++++++ .+...+++|||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv~e 75 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQC-----TEVTPYLLVME 75 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----cCCCCcEEEEE
Confidence 36899999999999864 345679999875432 2345699999999999999999987 34445889999
Q ss_pred cccchHHH-HHhhhhh-cCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCCC
Q 012233 216 YISETVYR-VSKHYTR-MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293 (468)
Q Consensus 216 ~~~~~ll~-~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~~ 293 (468)
|++++.+. .+..... .....++..+..++.|++.||+|||+ .|++|+||||+||+++.++ .+||+|||++......
T Consensus 76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~H~dlkp~nil~~~~~-~~kL~dfg~~~~~~~~ 153 (269)
T cd05087 76 FCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK-NNFIHSDLALRNCLLTADL-TVKIGDYGLSHNKYKE 153 (269)
T ss_pred CCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH-CCEeccccCcceEEEcCCC-cEEECCccccccccCc
Confidence 99965443 3332221 12345667788899999999999998 8999999999999999887 7999999998654322
Q ss_pred CC---CccccccCCccccccccCCC------CCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 012233 294 EP---NISYICSRYYRAPELIFGAT------EYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREE 363 (468)
Q Consensus 294 ~~---~~~~~gt~~y~aPE~~~~~~------~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~ 363 (468)
.. .....++..|+|||++.+.. .++.++|+|||||++|||++ |..||......+.........
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~------- 226 (269)
T cd05087 154 DYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQ------- 226 (269)
T ss_pred ceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcc-------
Confidence 21 12345678899999985321 35789999999999999996 999998766555433322210
Q ss_pred HhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 364 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
...++. ..+....++.+.+++.+|+ .+|.+|||+.+++.
T Consensus 227 ---------~~~~~~-------~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 227 ---------QLKLPK-------PRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred ---------cCCCCC-------CccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 000000 0112236778999999999 68999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=296.44 Aligned_cols=244 Identities=24% Similarity=0.319 Sum_probs=190.9
Q ss_pred cceEEeceecccCceEEEEEEEcCCCC----EEEEEEeeccc-----chHHHHHHHHHHcCCCCcccccceeeecCCCCc
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGD----SVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~----~vaiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 207 (468)
.+|++.+.||+|+||.||+|.++.+|. .+|+|.+.... ....+|+.+++.++||||+++++++..
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------ 80 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS------ 80 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec------
Confidence 469999999999999999999877665 58999875443 234579999999999999999998753
Q ss_pred eEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCc
Q 012233 208 LYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (468)
Q Consensus 208 ~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a 287 (468)
...++||||+.++.+.... ......+++..+..++.||+.||+|||+ +||+|+||||+|||++.++ .+||+|||++
T Consensus 81 ~~~~~v~e~~~~g~L~~~l--~~~~~~~~~~~~~~~~~qi~~~l~~LH~-~~i~H~di~p~nil~~~~~-~~kL~dfg~~ 156 (279)
T cd05057 81 SQVQLITQLMPLGCLLDYV--RNHKDNIGSQYLLNWCVQIAKGMSYLEE-KRLVHRDLAARNVLVKTPQ-HVKITDFGLA 156 (279)
T ss_pred CceEEEEecCCCCcHHHHH--HhccCCCCHHHHHHHHHHHHHHHHHHHh-CCEEecccCcceEEEcCCC-eEEECCCccc
Confidence 2478999999865443222 2223458899999999999999999998 9999999999999999887 7999999999
Q ss_pred cccCCCCCCcc---ccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 012233 288 KMLVPGEPNIS---YICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREE 363 (468)
Q Consensus 288 ~~~~~~~~~~~---~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~ 363 (468)
+.......... ..++..|+|||.+... .++.++|+|||||++||+++ |..||.+....+....+... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~------ 228 (279)
T cd05057 157 KLLDVDEKEYHAEGGKVPIKWMALESILHR-IYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKG-E------ 228 (279)
T ss_pred ccccCcccceecCCCcccccccCHHHhhcC-CcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC-C------
Confidence 87653332221 2235679999998644 48999999999999999998 99999887655443333220 0
Q ss_pred HhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 364 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
... .+...+.++.+++.+||..||..||++.++++
T Consensus 229 ---------~~~------------~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 229 ---------RLP------------QPPICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred ---------CCC------------CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 000 12346788999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=297.34 Aligned_cols=237 Identities=19% Similarity=0.266 Sum_probs=180.8
Q ss_pred ceecccCceEEEEEEEcCCCCE-------EEEEEeeccc----chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEE
Q 012233 143 RVVGTGSFGVVFQAKCLETGDS-------VAIKKVLQDK----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (468)
Q Consensus 143 ~~lG~G~fg~Vy~~~~~~~g~~-------vaiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 211 (468)
+.||.|+||.||+|.+...+.. ||+|.+.... ....+|+.+++.+.||||+++++++... ...+
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~-----~~~~ 75 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCG-----DESI 75 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeC-----CCcE
Confidence 3699999999999998655443 8888775432 2345688999999999999999988543 3478
Q ss_pred EEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCc-------EEEeee
Q 012233 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQ-------LKICDF 284 (468)
Q Consensus 212 lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~-------vkL~DF 284 (468)
+||||+.++.+..... .....+++..+..++.||+.||+|||+ +||+||||||+|||++.++.. ++++||
T Consensus 76 lv~e~~~~g~L~~~l~--~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~ 152 (258)
T cd05078 76 MVQEYVKFGSLDTYLK--KNKNLINISWKLEVAKQLAWALHFLED-KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDP 152 (258)
T ss_pred EEEecCCCCcHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCccceEEEecccccccCCCceEEeccc
Confidence 9999999875543322 223457888999999999999999998 899999999999999876532 799999
Q ss_pred cCccccCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhC-CCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 012233 285 GSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLG-QPLFPGESGVDQLVEIIKILGTPTREE 363 (468)
Q Consensus 285 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G-~~pf~~~~~~~~~~~i~~~~~~~~~~~ 363 (468)
|.+..... .....++..|+|||++.+...++.++|||||||++|+|++| ..||...+...... ....
T Consensus 153 g~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-~~~~-------- 220 (258)
T cd05078 153 GISITVLP---KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-FYED-------- 220 (258)
T ss_pred ccccccCC---chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-HHHc--------
Confidence 99865432 22456788999999997655588999999999999999998 46665544333221 1110
Q ss_pred HhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCC
Q 012233 364 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (468)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~h 420 (468)
... ++...+.++.+||.+||+.||.+|||+.++++.
T Consensus 221 ---------~~~------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 221 ---------RHQ------------LPAPKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred ---------ccc------------CCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 001 223356789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=290.66 Aligned_cols=265 Identities=24% Similarity=0.358 Sum_probs=205.6
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeecccc-----hHHHHHHH-HHHcCCCCcccccceeeecCCCCceEEE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR-----YKNRELQI-MRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~~-----~~~~E~~i-l~~l~hpnIv~l~~~~~~~~~~~~~~~~ 211 (468)
+.+-+..||.|+||+|++-.++.+|+..|||.+..... .+..|.+. ++.-+.||||++|+..+..++ .+
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGd-----cW 139 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGD-----CW 139 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCc-----ee
Confidence 34455679999999999999999999999999854332 22335443 455579999999999876554 88
Q ss_pred EEeecccchHHHHHh-hhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcccc
Q 012233 212 LVLEYISETVYRVSK-HYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (468)
Q Consensus 212 lv~e~~~~~ll~~~~-~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~ 290 (468)
|.||+|.-++-.+.+ .+...+..+++..+..+....+.||.||.+...|||||+||+||||+..| .|||||||++-.+
T Consensus 140 iCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G-~vKLCDFGIcGqL 218 (361)
T KOG1006|consen 140 ICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHG-DVKLCDFGICGQL 218 (361)
T ss_pred eeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCC-CEeeecccchHhH
Confidence 999999865443322 23344677899999999999999999998778999999999999999999 7999999999877
Q ss_pred CCCCCCccccccCCccccccccCCCC-CCcchhHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHHHhCCCCHHHHhhcC
Q 012233 291 VPGEPNISYICSRYYRAPELIFGATE-YTTAIDMWSIGCVLAELLLGQPLFPGESG-VDQLVEIIKILGTPTREEIKCMN 368 (468)
Q Consensus 291 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~~DvwSlG~il~ell~G~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~ 368 (468)
...-......|...|||||.+..... |+.++||||||++|||+.||..||+.-+. .+++.+++. |.|+..
T Consensus 219 v~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~--gdpp~l------ 290 (361)
T KOG1006|consen 219 VDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVI--GDPPIL------ 290 (361)
T ss_pred HHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHc--CCCCee------
Confidence 66666667788999999999965544 99999999999999999999999987543 334443332 222110
Q ss_pred CCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCCCC
Q 012233 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNT 431 (468)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~ 431 (468)
.++. -.-+++..+..||..||.+|-+.||...+++.+||++.-.....
T Consensus 291 ------~~~~---------~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~~~~ 338 (361)
T KOG1006|consen 291 ------LFDK---------ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAVEGP 338 (361)
T ss_pred ------cCcc---------cccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhhhcCC
Confidence 0000 00237888999999999999999999999999999987544433
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=293.65 Aligned_cols=244 Identities=27% Similarity=0.360 Sum_probs=189.8
Q ss_pred cceEEeceecccCceEEEEEEEcCC---CCEEEEEEeeccc-----chHHHHHHHHHHcCCCCcccccceeeecCCCCce
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLET---GDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~---g~~vaiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 208 (468)
.+|.+.+.||+|+||.||+|.+... ...||||...... ..+.+|+.+++.++||||+++++++. +.
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~- 79 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVIT-----EN- 79 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEc-----CC-
Confidence 3589999999999999999987544 3468999875432 23457999999999999999998773 22
Q ss_pred EEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcc
Q 012233 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (468)
Q Consensus 209 ~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~ 288 (468)
..++||||+.++.+.... ......+++..+..++.|++.||.|||+ .|++|+||||+|||++.++ .++|+|||++.
T Consensus 80 ~~~lv~e~~~~~~L~~~l--~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~~H~dl~p~nili~~~~-~~~l~d~g~~~ 155 (270)
T cd05056 80 PVWIVMELAPLGELRSYL--QVNKYSLDLASLILYSYQLSTALAYLES-KRFVHRDIAARNVLVSSPD-CVKLGDFGLSR 155 (270)
T ss_pred CcEEEEEcCCCCcHHHHH--HhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccccChheEEEecCC-CeEEccCceee
Confidence 357999999865443222 1223458899999999999999999998 8999999999999999887 79999999987
Q ss_pred ccCCCCCC--ccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 012233 289 MLVPGEPN--ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIK 365 (468)
Q Consensus 289 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 365 (468)
........ ....++..|+|||.+... .++.++|||||||++|||++ |..||...+..+....+....
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~--------- 225 (270)
T cd05056 156 YLEDESYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGE--------- 225 (270)
T ss_pred ecccccceecCCCCccccccChhhhccC-CCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC---------
Confidence 65433211 122335679999998654 48999999999999999986 999998877665554433210
Q ss_pred hcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 366 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
.. ..+..++..+.++|.+||..+|.+|||+.+++.
T Consensus 226 ---------~~----------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~ 260 (270)
T cd05056 226 ---------RL----------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKA 260 (270)
T ss_pred ---------cC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00 023457889999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=319.71 Aligned_cols=206 Identities=29% Similarity=0.402 Sum_probs=173.0
Q ss_pred eEEeceecccCceEEEEEEEcCCCCEEEEEEeecc-----cchHHHHHHHHHHcCCCCcccccceeeecC-CCCceEEEE
Q 012233 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTT-EKDELYLNL 212 (468)
Q Consensus 139 y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~-----~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-~~~~~~~~l 212 (468)
|...+.||+|+||.||+++++.+|+.||||.+.+. ....-+|+++|++|+|+|||++.++=.... .--...-.+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 77788999999999999999999999999988553 233347999999999999999977542211 000122459
Q ss_pred EeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCC--C-CcEEEeeecCccc
Q 012233 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPH--T-HQLKICDFGSAKM 289 (468)
Q Consensus 213 v~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~--~-~~vkL~DFG~a~~ 289 (468)
|||||.||.+.-.........++++.++..+..+++.||.|||+ +|||||||||+||++-.. + +--||+|||+|+.
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrE-n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Are 173 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRE-NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARE 173 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHH-cCceeccCCCCcEEEeecCCCceEEeeeccccccc
Confidence 99999988777666666777889999999999999999999998 999999999999987432 2 2479999999999
Q ss_pred cCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCc
Q 012233 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESG 345 (468)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~ 345 (468)
+.++....+.+||+.|.+||++.....|+..+|.|||||++|++.||..||.....
T Consensus 174 l~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~ 229 (732)
T KOG4250|consen 174 LDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGG 229 (732)
T ss_pred CCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCC
Confidence 99888889999999999999997556799999999999999999999999976443
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=290.54 Aligned_cols=244 Identities=23% Similarity=0.360 Sum_probs=190.4
Q ss_pred ccceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc---chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEE
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~---~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~l 212 (468)
..+|.+.+.||+|+||.||++.+. .+..+|+|.+.... ....+|+.+++.++|+||+++++++.. ...++
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~~~~ 77 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK------EPIYI 77 (260)
T ss_pred ccceeEEeEecCccceEEEEEEec-CCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC------CCeEE
Confidence 346999999999999999999854 55679999886543 234579999999999999999887732 34789
Q ss_pred Eeecccc-hHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccC
Q 012233 213 VLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (468)
Q Consensus 213 v~e~~~~-~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~ 291 (468)
+|||+++ .+.+.+... ....+++..+..++.||+.||.|||+ .|++|+||||+||+++.++ .+||+|||.+....
T Consensus 78 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~-~~i~H~dl~p~ni~i~~~~-~~~l~d~~~~~~~~ 153 (260)
T cd05073 78 ITEFMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQ-RNYIHRDLRAANILVSASL-VCKIADFGLARVIE 153 (260)
T ss_pred EEEeCCCCcHHHHHHhC--CccccCHHHHHHHHHHHHHHHHHHHh-CCccccccCcceEEEcCCC-cEEECCCcceeecc
Confidence 9999986 454443321 23457888899999999999999998 8999999999999999887 79999999987654
Q ss_pred CCCC--CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 012233 292 PGEP--NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368 (468)
Q Consensus 292 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 368 (468)
.... .....++..|+|||++.+. .++.++|+|||||++|+|++ |..||.+.+..+....+...
T Consensus 154 ~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~------------- 219 (260)
T cd05073 154 DNEYTAREGAKFPIKWTAPEAINFG-SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG------------- 219 (260)
T ss_pred CCCcccccCCcccccccCHhHhccC-CcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC-------------
Confidence 3221 1123446779999998654 48999999999999999998 99999877655544433221
Q ss_pred CCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
+..+ ....++.++.+++.+||+.||.+||++.+++.
T Consensus 220 -----~~~~----------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 220 -----YRMP----------RPENCPEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred -----CCCC----------CcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 0000 12347889999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=290.09 Aligned_cols=238 Identities=24% Similarity=0.331 Sum_probs=185.1
Q ss_pred ceecccCceEEEEEEEcCCCCEEEEEEeeccc-----chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEEEeecc
Q 012233 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYI 217 (468)
Q Consensus 143 ~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv~e~~ 217 (468)
+.||.|+||.||+|.+.. ++.||+|.+.... ..+.+|+.+++.++|+||+++++++ .+..+.++||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~~v~e~~ 74 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC-----VQKQPIYIVMELV 74 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEE-----ecCCCeEEEEEcC
Confidence 469999999999999877 9999999875432 2345799999999999999999988 3444588999999
Q ss_pred cchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCCCCCC-
Q 012233 218 SETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPN- 296 (468)
Q Consensus 218 ~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~~~~~- 296 (468)
.++.+.... ......+++..+..++.|++.||.|||+ +|++||||||+|||++.++ .++|+|||.+.........
T Consensus 75 ~~~~l~~~l--~~~~~~~~~~~~~~~~~~~~~~l~~lH~-~~i~h~di~p~nili~~~~-~~~l~d~g~~~~~~~~~~~~ 150 (251)
T cd05041 75 PGGSLLTFL--RKKKNRLTVKKLLQMSLDAAAGMEYLES-KNCIHRDLAARNCLVGENN-VLKISDFGMSREEEGGIYTV 150 (251)
T ss_pred CCCcHHHHH--HhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCEehhhcCcceEEEcCCC-cEEEeeccccccccCCccee
Confidence 866443221 1223457888899999999999999998 8999999999999999887 7999999998755322111
Q ss_pred --ccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCcc
Q 012233 297 --ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTE 373 (468)
Q Consensus 297 --~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 373 (468)
....++..|+|||.+.+. .++.++|+|||||++|+|++ |..||...........+...
T Consensus 151 ~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~------------------ 211 (251)
T cd05041 151 SDGLKQIPIKWTAPEALNYG-RYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESG------------------ 211 (251)
T ss_pred ccccCcceeccCChHhhccC-CCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcC------------------
Confidence 112335679999998655 48999999999999999998 89999876654433332210
Q ss_pred CCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 374 FKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
... ..+..++.++.++|.+||..+|.+|||+.++++
T Consensus 212 ~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 212 YRM----------PAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred CCC----------CCCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 000 022347889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=330.06 Aligned_cols=246 Identities=21% Similarity=0.342 Sum_probs=197.3
Q ss_pred ceEEeceecccCceEEEEEEEcCCCC-----EEEEEEeecc-----cchHHHHHHHHHHcCCCCcccccceeeecCCCCc
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGD-----SVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~-----~vaiK~~~~~-----~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 207 (468)
.-.+.+.||+|+||.||.|....... .||+|.+.+. ...+.+|..+|+.++|||||+++++++...
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~---- 768 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG---- 768 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC----
Confidence 46788899999999999999865433 3999988654 344567999999999999999999996633
Q ss_pred eEEEEEeecccch-HHHHHhhhhh---cCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEee
Q 012233 208 LYLNLVLEYISET-VYRVSKHYTR---MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICD 283 (468)
Q Consensus 208 ~~~~lv~e~~~~~-ll~~~~~~~~---~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~D 283 (468)
..+|++|||.+| |+..++.... ....+....+..++.||++|+.||++ +++|||||...|+||+... .|||+|
T Consensus 769 -~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~-~~fvHRDLAaRNCLL~~~r-~VKIaD 845 (1025)
T KOG1095|consen 769 -PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES-KHFVHRDLAARNCLLDERR-VVKIAD 845 (1025)
T ss_pred -CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh-CCCcCcchhhhheeecccC-cEEEcc
Confidence 367999999865 5554443211 14567889999999999999999998 8999999999999999887 899999
Q ss_pred ecCccccCCCCC-Cccc--cccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCC
Q 012233 284 FGSAKMLVPGEP-NISY--ICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTP 359 (468)
Q Consensus 284 FG~a~~~~~~~~-~~~~--~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~ 359 (468)
||+|+.+..... .... .-...|||||.+... .++.++|||||||+|||+++ |..||.+.++.+.+....+....+
T Consensus 846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~-iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~ 924 (1025)
T KOG1095|consen 846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDG-IFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLD 924 (1025)
T ss_pred cchhHhhhhchheeccCccccceecCCHHHHhhc-ccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccC
Confidence 999985433221 1111 224689999999764 59999999999999999997 999999999888777665532111
Q ss_pred CHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 360 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
.+..+++.+.++|..||+.+|++||++..+++
T Consensus 925 ----------------------------~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 925 ----------------------------PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred ----------------------------CCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 23558999999999999999999999998876
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=291.41 Aligned_cols=240 Identities=24% Similarity=0.346 Sum_probs=179.3
Q ss_pred ceecccCceEEEEEEEcC---CCCEEEEEEeeccc-----chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEEEe
Q 012233 143 RVVGTGSFGVVFQAKCLE---TGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (468)
Q Consensus 143 ~~lG~G~fg~Vy~~~~~~---~g~~vaiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv~ 214 (468)
+.||+|+||.||+|.+.. .+..||||.+.... ....+|+.+++.++||||+++++++... ....++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----~~~~~lv~ 76 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPS----EGSPLVVL 76 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecC----CCCcEEEE
Confidence 468999999999998753 34579999874321 2344688999999999999999866432 22467999
Q ss_pred ecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCCCC
Q 012233 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGE 294 (468)
Q Consensus 215 e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~~~ 294 (468)
||+.++.+..... .......+..+..++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||+++......
T Consensus 77 e~~~~~~L~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlk~~nili~~~~-~~kl~dfg~~~~~~~~~ 152 (262)
T cd05058 77 PYMKHGDLRNFIR--SETHNPTVKDLIGFGLQVAKGMEYLAS-KKFVHRDLAARNCMLDESF-TVKVADFGLARDIYDKE 152 (262)
T ss_pred ecCCCCCHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccCcceEEEcCCC-cEEECCccccccccCCc
Confidence 9998654432221 223345677788899999999999998 8999999999999999887 79999999987553221
Q ss_pred -----CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 012233 295 -----PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368 (468)
Q Consensus 295 -----~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 368 (468)
......++..|+|||.+.+. .++.++|||||||++|||++ |.+||...+..+....+...
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~------------- 218 (262)
T cd05058 153 YYSVHNHTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQG------------- 218 (262)
T ss_pred ceeecccccCcCCccccChhHhccC-ccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC-------------
Confidence 11233456789999998654 48999999999999999999 56777766544433322210
Q ss_pred CCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
.... .+..+++.+.+++.+||..+|++||++.+++.
T Consensus 219 ---~~~~------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~ 254 (262)
T cd05058 219 ---RRLL------------QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVS 254 (262)
T ss_pred ---CCCC------------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0000 12336788999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=296.95 Aligned_cols=259 Identities=24% Similarity=0.356 Sum_probs=187.7
Q ss_pred ceEEeceecccCceEEEEEEE----cCCCCEEEEEEeeccc-----chHHHHHHHHHHcCCCCcccccceeeecCCCCce
Q 012233 138 SYMAERVVGTGSFGVVFQAKC----LETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~----~~~g~~vaiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 208 (468)
.|++.+.||+|+||.||+|.+ ..++..||+|.+.... ....+|+.+++.++||||+++++++... +..
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~ 81 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED---GGN 81 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecC---CCC
Confidence 378999999999999999985 4578899999885332 2355799999999999999999877432 234
Q ss_pred EEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcc
Q 012233 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (468)
Q Consensus 209 ~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~ 288 (468)
..++||||++++.+..... +....+++..+..++.||+.||+|||+ +||+||||||+|||++.++ .++|+|||++.
T Consensus 82 ~~~lv~e~~~g~~L~~~l~--~~~~~~~~~~~~~i~~~i~~aL~~lH~-~gi~H~dlkp~Nil~~~~~-~~~l~dfg~~~ 157 (284)
T cd05079 82 GIKLIMEFLPSGSLKEYLP--RNKNKINLKQQLKYAVQICKGMDYLGS-RQYVHRDLAARNVLVESEH-QVKIGDFGLTK 157 (284)
T ss_pred ceEEEEEccCCCCHHHHHH--hccCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecccchheEEEcCCC-CEEECCCcccc
Confidence 5789999998765543221 223457899999999999999999998 9999999999999999887 79999999997
Q ss_pred ccCCCCC----CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh-CCCCHH-
Q 012233 289 MLVPGEP----NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKIL-GTPTRE- 362 (468)
Q Consensus 289 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~-~~~~~~- 362 (468)
.+..... .....++..|+|||++.+. .++.++|||||||++|+|+++..|+..... ......... +.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~ellt~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 234 (284)
T cd05079 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQS-KFYIASDVWSFGVTLYELLTYCDSESSPMT--LFLKMIGPTHGQMTVTR 234 (284)
T ss_pred ccccCccceeecCCCCCCccccCHHHhccC-CCCccccchhhhhhhhhhhcCCCCCccccc--hhhhhcccccccccHHH
Confidence 6643321 1234567789999998655 489999999999999999998876533211 000000000 000000
Q ss_pred HHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 363 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
...... .. .....+..++..+.+||.+||+.||.+||++.+++.
T Consensus 235 ~~~~~~---~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 278 (284)
T cd05079 235 LVRVLE---EG----------KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIE 278 (284)
T ss_pred HHHHHH---cC----------ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 000000 00 000123457899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=290.41 Aligned_cols=240 Identities=23% Similarity=0.353 Sum_probs=188.7
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc--chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEEEe
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK--RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~--~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv~ 214 (468)
.+|.+.+.||+|+||.||++.. +++.||+|.+.... ....+|+.+++.++||||+++++++.. . ..++||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~-~~~~v~ 77 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILH-----N-GLYIVM 77 (254)
T ss_pred HHceeeeeeccCCCCceEeccc--CCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEEcC-----C-CcEEEE
Confidence 4699999999999999999975 78899999885432 244679999999999999999988732 1 257999
Q ss_pred ecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCCC
Q 012233 215 EYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293 (468)
Q Consensus 215 e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~~ 293 (468)
||+.++ +...+... ....+++..+..++.|++.||.|||+ .|++||||||+|||++.++ .+||+|||++......
T Consensus 78 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~al~~lH~-~~~~H~dl~p~nili~~~~-~~kl~Dfg~~~~~~~~ 153 (254)
T cd05083 78 ELMSKGNLVNFLRTR--GRALVSVIQLLQFSLDVAEGMEYLES-KKLVHRDLAARNILVSEDG-VAKVSDFGLARVGSMG 153 (254)
T ss_pred ECCCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccccCcceEEEcCCC-cEEECCCccceecccc
Confidence 999864 44443321 23457889999999999999999998 8999999999999999887 7999999998754322
Q ss_pred CCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCc
Q 012233 294 EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYT 372 (468)
Q Consensus 294 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 372 (468)
......+..|+|||.+.+. .++.++|+|||||++|+|++ |+.||...+..+....+.+.
T Consensus 154 --~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~----------------- 213 (254)
T cd05083 154 --VDNSKLPVKWTAPEALKHK-KFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKG----------------- 213 (254)
T ss_pred --CCCCCCCceecCHHHhccC-CcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCC-----------------
Confidence 1223446789999998654 48999999999999999997 99999877654433332210
Q ss_pred cCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 373 EFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
+.. .....+++.+.+||.+||+.+|..||++.+++.
T Consensus 214 -~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 214 -YRM----------EPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred -CCC----------CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 000 012347889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=298.46 Aligned_cols=243 Identities=23% Similarity=0.333 Sum_probs=187.6
Q ss_pred cceEEeceecccCceEEEEEEEcCCCC----EEEEEEeecccc-----hHHHHHHHHHHcCCCCcccccceeeecCCCCc
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGD----SVAIKKVLQDKR-----YKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~----~vaiK~~~~~~~-----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 207 (468)
.+|+..+.||+|+||.||+|.+..+|. .||+|.+..... ...+|+.+++.++||||+++++++...
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~----- 81 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP----- 81 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-----
Confidence 358899999999999999999887776 468887754322 345789999999999999999987421
Q ss_pred eEEEEEeecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecC
Q 012233 208 LYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (468)
Q Consensus 208 ~~~~lv~e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~ 286 (468)
..++++||++++ +.+.+. .....+++..+..++.|++.||.|||+ +||+|+||||+|||++.++ .+||+|||+
T Consensus 82 -~~~~v~e~~~~g~l~~~~~---~~~~~~~~~~~~~~~~qi~~~L~~LH~-~~ivH~dikp~Nill~~~~-~~kL~Dfg~ 155 (303)
T cd05110 82 -TIQLVTQLMPHGCLLDYVH---EHKDNIGSQLLLNWCVQIAKGMMYLEE-RRLVHRDLAARNVLVKSPN-HVKITDFGL 155 (303)
T ss_pred -CceeeehhcCCCCHHHHHH---hcccCCCHHHHHHHHHHHHHHHHHHhh-cCeeccccccceeeecCCC-ceEEccccc
Confidence 246899999865 444322 223457888999999999999999998 8999999999999999877 799999999
Q ss_pred ccccCCCCCC---ccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 012233 287 AKMLVPGEPN---ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTRE 362 (468)
Q Consensus 287 a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~ 362 (468)
++........ ....++..|+|||.+.+.. ++.++|||||||++|||++ |..||.+....+ +..++.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~-~~~~~~~~~~---- 229 (303)
T cd05110 156 ARLLEGDEKEYNADGGKMPIKWMALECIHYRK-FTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE-IPDLLEKGER---- 229 (303)
T ss_pred cccccCcccccccCCCccccccCCHHHhccCC-CChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHCCCC----
Confidence 9866433221 2234567899999986544 8999999999999999997 999997765333 3333221100
Q ss_pred HHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 363 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
++ .+...+..+.+++.+||..||.+||++.+++.
T Consensus 230 -------------~~----------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~ 263 (303)
T cd05110 230 -------------LP----------QPPICTIDVYMVMVKCWMIDADSRPKFKELAA 263 (303)
T ss_pred -------------CC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00 12336778999999999999999999999877
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=292.64 Aligned_cols=242 Identities=22% Similarity=0.322 Sum_probs=184.8
Q ss_pred ceecccCceEEEEEEEcCCC------CEEEEEEeecc-----cchHHHHHHHHHHcCCCCcccccceeeecCCCCceEEE
Q 012233 143 RVVGTGSFGVVFQAKCLETG------DSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (468)
Q Consensus 143 ~~lG~G~fg~Vy~~~~~~~g------~~vaiK~~~~~-----~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 211 (468)
+.||+|+||.||+|.+.... ..+|+|.+... .....+|+.+++.++||||+++++++. +....+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 75 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCL-----LNEPQY 75 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeec-----CCCCeE
Confidence 36999999999999986543 67999987543 223457999999999999999999883 344588
Q ss_pred EEeecccchH-HHHHhhhhh---cCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCC----CcEEEee
Q 012233 212 LVLEYISETV-YRVSKHYTR---MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHT----HQLKICD 283 (468)
Q Consensus 212 lv~e~~~~~l-l~~~~~~~~---~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~----~~vkL~D 283 (468)
+||||++++. ...+..... ....+++..+..++.||+.||.|||+ .+++|+||||+|||++.++ ..++|+|
T Consensus 76 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dl~p~nil~~~~~~~~~~~~~l~d 154 (269)
T cd05044 76 IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ-MHFIHRDLAARNCLVSEKGYDADRVVKIGD 154 (269)
T ss_pred EEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh-CCcccCCCChheEEEecCCCCCCcceEECC
Confidence 9999998654 443332211 22447888899999999999999998 8999999999999998754 2599999
Q ss_pred ecCccccCCCCC---CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCC
Q 012233 284 FGSAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTP 359 (468)
Q Consensus 284 FG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~ 359 (468)
||++........ .....++..|+|||.+.+.. ++.++|||||||++|+|++ |..||...+..+....+... .
T Consensus 155 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~-~-- 230 (269)
T cd05044 155 FGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGK-FTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAG-G-- 230 (269)
T ss_pred cccccccccccccccCcccCCCccccCHHHHccCC-cccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcC-C--
Confidence 999876533221 12234568899999996554 8999999999999999998 99999877655544333210 0
Q ss_pred CHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 360 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
.. ..+..++..+.+||.+||..+|.+||++.++++
T Consensus 231 -------------~~------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 231 -------------RL------------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred -------------cc------------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 00 022347889999999999999999999999864
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=291.76 Aligned_cols=250 Identities=21% Similarity=0.318 Sum_probs=189.2
Q ss_pred eEEeceecccCceEEEEEEEcC---CCCEEEEEEeeccc------chHHHHHHHHHHcCCCCcccccceeeecCCCCc-e
Q 012233 139 YMAERVVGTGSFGVVFQAKCLE---TGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE-L 208 (468)
Q Consensus 139 y~~~~~lG~G~fg~Vy~~~~~~---~g~~vaiK~~~~~~------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~-~ 208 (468)
|.+.+.||+|+||.||+|.+.. ++..||||++.... ....+|+.+++.++||||+++++++......+. .
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 5678899999999999998643 57889999885432 124578999999999999999998755433222 2
Q ss_pred EEEEEeecccchHHHHHhhhh---hcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeec
Q 012233 209 YLNLVLEYISETVYRVSKHYT---RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG 285 (468)
Q Consensus 209 ~~~lv~e~~~~~ll~~~~~~~---~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG 285 (468)
..+++++|+.++.+....... .....+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~-~~i~H~dikp~nili~~~~-~~kl~dfg 158 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS-KNFIHRDLAARNCMLNENM-TVCVADFG 158 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeecccchhhEEEcCCC-CEEECccc
Confidence 356889999866543222111 112347888899999999999999998 8999999999999999887 79999999
Q ss_pred CccccCCCC---CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCH
Q 012233 286 SAKMLVPGE---PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTR 361 (468)
Q Consensus 286 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~ 361 (468)
+++...... ......+++.|++||.+.+.. ++.++|||||||++|+|++ |++||.+.+..+....+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~------ 231 (273)
T cd05074 159 LSKKIYSGDYYRQGCASKLPVKWLALESLADNV-YTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKG------ 231 (273)
T ss_pred ccccccCCcceecCCCccCchhhcCHhHHhcCc-cchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcC------
Confidence 987653322 112334567899999986544 8899999999999999998 89999876654443333221
Q ss_pred HHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 362 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
.... .....+..+.+++.+||+.+|.+||++.+++.
T Consensus 232 ----------~~~~------------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~ 267 (273)
T cd05074 232 ----------NRLK------------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRD 267 (273)
T ss_pred ----------CcCC------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0000 11346789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=287.98 Aligned_cols=245 Identities=19% Similarity=0.243 Sum_probs=180.1
Q ss_pred eecccCceEEEEEEEcCC--CCEEEEEEeeccc-----chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEEEeec
Q 012233 144 VVGTGSFGVVFQAKCLET--GDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEY 216 (468)
Q Consensus 144 ~lG~G~fg~Vy~~~~~~~--g~~vaiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv~e~ 216 (468)
.||+|+||.||+|..... ...+++|.+.... ....+|+.+++.++||||+++++.+ .+....|+||||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~-----~~~~~~~lv~e~ 76 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQC-----VEAIPYLLVFEY 76 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEe-----cCCCccEEEEec
Confidence 599999999999975433 2346677654332 2445788899999999999999988 444568999999
Q ss_pred ccchHH-HHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCCCC-
Q 012233 217 ISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGE- 294 (468)
Q Consensus 217 ~~~~ll-~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~~~- 294 (468)
+.++.+ ..+..........++..++.++.||+.||.|||+ .+|+||||||+|||++.++ .++|+|||++.......
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~-~~i~H~dikp~nil~~~~~-~~~l~Dfg~~~~~~~~~~ 154 (268)
T cd05086 77 CELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK-HNFLHSDLALRNCFLTSDL-TVKVGDYGIGPSRYKEDY 154 (268)
T ss_pred CCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH-CCeeccCCccceEEEcCCc-cEEecccccccccCcchh
Confidence 996544 3333222223456777788999999999999998 8999999999999999888 79999999985432111
Q ss_pred --CCccccccCCccccccccCC------CCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 012233 295 --PNISYICSRYYRAPELIFGA------TEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIK 365 (468)
Q Consensus 295 --~~~~~~gt~~y~aPE~~~~~------~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 365 (468)
......++..|+|||++... ..++.++|||||||++|||++ |..||...+..+.+..+.......
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~------ 228 (268)
T cd05086 155 IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVK------ 228 (268)
T ss_pred hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccc------
Confidence 12345678899999987421 235789999999999999996 678898776666555544321100
Q ss_pred hcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 366 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
.+...+...+++.+.+++..|| .+|.+||++.+++.
T Consensus 229 -----------------~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 229 -----------------LFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred -----------------cCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 0011122346788999999999 68999999999864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=287.51 Aligned_cols=235 Identities=21% Similarity=0.218 Sum_probs=180.2
Q ss_pred ceecccCceEEEEEEEcCCC----------CEEEEEEeeccc---chHHHHHHHHHHcCCCCcccccceeeecCCCCceE
Q 012233 143 RVVGTGSFGVVFQAKCLETG----------DSVAIKKVLQDK---RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (468)
Q Consensus 143 ~~lG~G~fg~Vy~~~~~~~g----------~~vaiK~~~~~~---~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 209 (468)
+.||+|+||.||+|.+..++ ..+++|.+.... ..+.+|+.+++.++||||+++++++.. ..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~ 74 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR------DE 74 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec------CC
Confidence 46899999999999997766 357888765433 345678999999999999999998744 23
Q ss_pred EEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCC------cEEEee
Q 012233 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTH------QLKICD 283 (468)
Q Consensus 210 ~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~------~vkL~D 283 (468)
.++||||+.++.+...... ....+++..+..++.||+.||.|||+ +||+||||||+|||++.++. .+||+|
T Consensus 75 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~D 151 (259)
T cd05037 75 NIMVEEYVKFGPLDVFLHR--EKNNVSLHWKLDVAKQLASALHYLED-KKLVHGNVCGKNILVARYGLNEGYVPFIKLSD 151 (259)
T ss_pred cEEEEEcCCCCcHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHhh-CCeecccCccceEEEecCccccCCceeEEeCC
Confidence 6799999998766533221 12368889999999999999999998 89999999999999987652 499999
Q ss_pred ecCccccCCCCCCccccccCCccccccccCC-CCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCH
Q 012233 284 FGSAKMLVPGEPNISYICSRYYRAPELIFGA-TEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTR 361 (468)
Q Consensus 284 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~ 361 (468)
||++..... .....++..|+|||++.+. ..++.++|||||||++|+|++ |..||...+..+....... .
T Consensus 152 fg~a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~----~-- 222 (259)
T cd05037 152 PGIPITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQD----Q-- 222 (259)
T ss_pred CCccccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhc----C--
Confidence 999976543 2234567789999998765 358999999999999999999 5888866543222111110 0
Q ss_pred HHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 362 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
.. .+......+.++|.+||..+|.+|||+.+++.
T Consensus 223 ----------~~--------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 223 ----------HR--------------LPMPDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred ----------CC--------------CCCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 00 00112378999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=302.36 Aligned_cols=241 Identities=29% Similarity=0.441 Sum_probs=193.5
Q ss_pred eEEeceecccCceEEEEEEEcCC--CC--EEEEEEeecc-----cchHHHHHHHHHHcCCCCcccccceeeecCCCCceE
Q 012233 139 YMAERVVGTGSFGVVFQAKCLET--GD--SVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (468)
Q Consensus 139 y~~~~~lG~G~fg~Vy~~~~~~~--g~--~vaiK~~~~~-----~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 209 (468)
..+.++||.|.||.||.|..... |+ -||||..+.+ ...+..|..+|+.++||||++|+|++.. . -
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-----~-P 464 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-----Q-P 464 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-----c-c
Confidence 44567899999999999987432 33 4889988654 2334569999999999999999999832 2 2
Q ss_pred EEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccc
Q 012233 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (468)
Q Consensus 210 ~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~ 289 (468)
.+||||.++-|-+.... ......++...+..|++||+.||.|||+ ..+|||||-..||||.+.. .|||+|||+++.
T Consensus 465 ~WivmEL~~~GELr~yL--q~nk~sL~l~tL~ly~~Qi~talaYLeS-krfVHRDIAaRNiLVsSp~-CVKLaDFGLSR~ 540 (974)
T KOG4257|consen 465 MWIVMELAPLGELREYL--QQNKDSLPLRTLTLYCYQICTALAYLES-KRFVHRDIAARNILVSSPQ-CVKLADFGLSRY 540 (974)
T ss_pred eeEEEecccchhHHHHH--HhccccchHHHHHHHHHHHHHHHHHHHh-hchhhhhhhhhheeecCcc-eeeecccchhhh
Confidence 78999999966554322 2335668889999999999999999998 8999999999999999887 799999999998
Q ss_pred cCCCCCCccccc--cCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 012233 290 LVPGEPNISYIC--SRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKC 366 (468)
Q Consensus 290 ~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 366 (468)
+..........| ..-|||||.+. -..++.++|||-|||.+||++. |..||.+-.+.+.+..|.+..+.|
T Consensus 541 ~ed~~yYkaS~~kLPIKWmaPESIN-fRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP------- 612 (974)
T KOG4257|consen 541 LEDDAYYKASRGKLPIKWMAPESIN-FRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLP------- 612 (974)
T ss_pred ccccchhhccccccceeecCccccc-hhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCC-------
Confidence 866554333333 56799999984 4459999999999999999985 999999988877766655432222
Q ss_pred cCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 012233 367 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEAC 418 (468)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell 418 (468)
.++.+|+.+..|+.+||.+||.+||++.++.
T Consensus 613 ---------------------~P~nCPp~LYslmskcWayeP~kRPrftei~ 643 (974)
T KOG4257|consen 613 ---------------------CPPNCPPALYSLMSKCWAYEPSKRPRFTEIK 643 (974)
T ss_pred ---------------------CCCCCChHHHHHHHHHhccCcccCCcHHHHH
Confidence 4567999999999999999999999877643
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=287.23 Aligned_cols=260 Identities=25% Similarity=0.354 Sum_probs=188.3
Q ss_pred ceEEeceecccCceEEEEEEEcC----CCCEEEEEEeecccc-----hHHHHHHHHHHcCCCCcccccceeeecCCCCce
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLE----TGDSVAIKKVLQDKR-----YKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~----~g~~vaiK~~~~~~~-----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 208 (468)
.|.+.+.||+|+||.||+|.... ++..||+|.+..... .+.+|+.+++.+.|+||+++++++.. .+..
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~---~~~~ 81 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEK---PGGR 81 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeec---CCCC
Confidence 47888999999999999998643 478999998865433 45679999999999999999987733 2244
Q ss_pred EEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcc
Q 012233 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (468)
Q Consensus 209 ~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~ 288 (468)
+.++||||+.++.+..... .....+++..+..++.||+.||+|||+ .||+|+||||+|||++.++ .++|+|||.+.
T Consensus 82 ~~~lv~e~~~~~~l~~~l~--~~~~~~~~~~~~~~~~~l~~aL~~lH~-~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~ 157 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQ--RHRDQINLKRLLLFSSQICKGMDYLGS-QRYIHRDLAARNILVESED-LVKISDFGLAK 157 (284)
T ss_pred ceEEEEecCCCCCHHHHHH--hCccccCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHhEEEcCCC-CEEEccccccc
Confidence 6889999998654432222 223358889999999999999999998 8999999999999999887 79999999998
Q ss_pred ccCCCCCC----ccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH-HhCCCCHHH
Q 012233 289 MLVPGEPN----ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIK-ILGTPTREE 363 (468)
Q Consensus 289 ~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~-~~~~~~~~~ 363 (468)
........ ....++..|+|||.+.+. .++.++|+|||||++|||++|..||......... +.. ..+......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~--~~~~~~~~~~~~~ 234 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTS-KFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR--MIGIAQGQMIVTR 234 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccC-CCCcccchHHHhhhhheeeccCCCcccccchhcc--ccccccccccHHH
Confidence 76532221 122345679999998655 4899999999999999999999998654321100 000 000000000
Q ss_pred HhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 364 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
+...... ...++ .+..++.++.+|+.+||+.+|.+|||+.+++.
T Consensus 235 ~~~~~~~--~~~~~----------~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 235 LLELLKE--GERLP----------RPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred HHHHHHc--CCcCC----------CCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0000000 00000 12346788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=302.27 Aligned_cols=274 Identities=21% Similarity=0.276 Sum_probs=182.9
Q ss_pred CcccceEEeceecccCceEEEEEEEc----------------CCCCEEEEEEeecccc------------------hHHH
Q 012233 134 KQTISYMAERVVGTGSFGVVFQAKCL----------------ETGDSVAIKKVLQDKR------------------YKNR 179 (468)
Q Consensus 134 ~~~~~y~~~~~lG~G~fg~Vy~~~~~----------------~~g~~vaiK~~~~~~~------------------~~~~ 179 (468)
...++|.+.++||+|+||.||+|.+. ..+..||||.+..... ....
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 34668999999999999999999752 2456799998753321 1123
Q ss_pred HHHHHHHcCCCCc-----ccccceeeecCC---CCceEEEEEeecccchHHHHHhhhhh---------------------
Q 012233 180 ELQIMRLLNHPNV-----VSLKHCFFSTTE---KDELYLNLVLEYISETVYRVSKHYTR--------------------- 230 (468)
Q Consensus 180 E~~il~~l~hpnI-----v~l~~~~~~~~~---~~~~~~~lv~e~~~~~ll~~~~~~~~--------------------- 230 (468)
|+.++.+++|.++ ++++++|..... ......+|||||++++.+....+...
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 6667777776654 667776643211 11234789999999765543322110
Q ss_pred cCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCCCCCCcc--ccccCCcccc
Q 012233 231 MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS--YICSRYYRAP 308 (468)
Q Consensus 231 ~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~~~~~~~--~~gt~~y~aP 308 (468)
....+++..++.++.|++.+|.|||+ .+|+||||||+|||++.++ .+||+|||++........... ..+++.|+||
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~-~~ivHrDLKp~NILl~~~~-~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHR-IGIVHRDIKPENLLVTVDG-QVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCchHhEEECCCC-cEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 11234567788999999999999998 8999999999999999887 799999999976543322222 2347899999
Q ss_pred ccccCCCC-------------------C--CcchhHHHHHHHHHHHHhCCC-CCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 012233 309 ELIFGATE-------------------Y--TTAIDMWSIGCVLAELLLGQP-LFPGESGVDQLVEIIKILGTPTREEIKC 366 (468)
Q Consensus 309 E~~~~~~~-------------------~--~~~~DvwSlG~il~ell~G~~-pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 366 (468)
|++..... | ..+.||||+||++|+|++|.. ||.+........+. .... ...|+.
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~---~~~~-~~~~r~ 455 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQ---YDND-LNRWRM 455 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhh---ccch-HHHHHh
Confidence 99853210 1 234799999999999999875 77543221111100 0000 000110
Q ss_pred cCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCC---CCCCCHHHHhCCCCCCC
Q 012233 367 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSP---SLRCTALEACAHPFFDD 425 (468)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP---~~R~s~~ell~hp~f~~ 425 (468)
... ..+.|+ .....++.++|||.+||..+| .+|+|+.|+|+||||..
T Consensus 456 ~~~--~~~~~~----------~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 456 YKG--QKYDFS----------LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred hcc--cCCCcc----------cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 000 011111 234578999999999999866 68999999999999953
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=300.45 Aligned_cols=250 Identities=23% Similarity=0.315 Sum_probs=202.9
Q ss_pred ceEEeceecccCceEEEEEEEcCCCC---EEEEEEeeccc-----chHHHHHHHHHHcCCCCcccccceeeecCCCCceE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGD---SVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~---~vaiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 209 (468)
+..+.++||+|.||.|++|.|...+. .||||++..+. ..+.+|+.+|.+|+|||+++||++.... -
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~q------p 184 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQ------P 184 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccc------h
Confidence 35677899999999999999975432 48999986553 3466899999999999999999988431 2
Q ss_pred EEEEeecccc-hHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcc
Q 012233 210 LNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (468)
Q Consensus 210 ~~lv~e~~~~-~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~ 288 (468)
+.||||++.+ +|++.+.. .....|....+..|+.||+.||.||.. +++|||||-..|+||-... .|||+|||+.+
T Consensus 185 ~mMV~ELaplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLes-krlvHRDLAARNlllaspr-tVKI~DFGLmR 260 (1039)
T KOG0199|consen 185 AMMVFELAPLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLES-KRLVHRDLAARNLLLASPR-TVKICDFGLMR 260 (1039)
T ss_pred hhHHhhhcccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhh-hhhhhhhhhhhhheecccc-eeeeeccccee
Confidence 5699999995 56665544 345678888899999999999999997 9999999999999998765 89999999999
Q ss_pred ccCCCCCCccccc----cCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 012233 289 MLVPGEPNISYIC----SRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREE 363 (468)
Q Consensus 289 ~~~~~~~~~~~~g----t~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~ 363 (468)
.+..++..+...+ ...|+|||.+... .++.++|||+|||+||||++ |.-||.+....+.+.+|-+....+
T Consensus 261 aLg~ned~Yvm~p~rkvPfAWCaPEsLrh~-kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLp---- 335 (1039)
T KOG0199|consen 261 ALGENEDMYVMAPQRKVPFAWCAPESLRHR-KFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLP---- 335 (1039)
T ss_pred ccCCCCcceEecCCCcCcccccCHhHhccc-cccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCC----
Confidence 8877766554333 4679999999654 59999999999999999997 899999999888777765321111
Q ss_pred HhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q 012233 364 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426 (468)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 426 (468)
-++.+++++.++++.||..+|.+|||+..|...-++...
T Consensus 336 ------------------------RPk~csedIY~imk~cWah~paDRptFsair~~~~l~ea 374 (1039)
T KOG0199|consen 336 ------------------------RPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAEA 374 (1039)
T ss_pred ------------------------CCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHHhc
Confidence 235689999999999999999999999988655444443
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=293.50 Aligned_cols=242 Identities=23% Similarity=0.353 Sum_probs=197.5
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeecccch---HHHHHHHHHHcCCCCcccccceeeecCCCCceEEEEEe
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRY---KNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~~~---~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv~ 214 (468)
+....+.||-|.||.||.|.|+.-.-.||||.++.+... +..|..+|+.+.|||+|+|+++| ..+.-+|||+
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVC-----T~EpPFYIiT 342 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC-----THEPPFYIIT 342 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhh-----ccCCCeEEEE
Confidence 345667899999999999999999999999999877544 45799999999999999999999 5555689999
Q ss_pred eccc-chHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCCC
Q 012233 215 EYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293 (468)
Q Consensus 215 e~~~-~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~~ 293 (468)
|||. |.||+.++... ...++...+..++.||..|+.||.. +++|||||-..|+||..+. .||++|||+++.+..+
T Consensus 343 EfM~yGNLLdYLRecn--r~ev~avvLlyMAtQIsSaMeYLEk-knFIHRDLAARNCLVgEnh-iVKvADFGLsRlMtgD 418 (1157)
T KOG4278|consen 343 EFMCYGNLLDYLRECN--RSEVPAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLVGENH-IVKVADFGLSRLMTGD 418 (1157)
T ss_pred ecccCccHHHHHHHhc--hhhcchhHHHHHHHHHHHHHHHHHH-hhhhhhhhhhhhccccccc-eEEeeccchhhhhcCC
Confidence 9998 66777665433 2446777788899999999999997 9999999999999999886 8999999999987544
Q ss_pred CCC--ccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCC
Q 012233 294 EPN--ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPN 370 (468)
Q Consensus 294 ~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 370 (468)
... .......-|.|||.+.-.. ++.++|||+|||+|||+.| |-.||++.+..+.+..+.+.+..
T Consensus 419 TYTAHAGAKFPIKWTAPEsLAyNt-FSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM------------ 485 (1157)
T KOG4278|consen 419 TYTAHAGAKFPIKWTAPESLAYNT-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRM------------ 485 (1157)
T ss_pred ceecccCccCcccccCcccccccc-cccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccc------------
Confidence 322 2223367799999986444 8999999999999999986 99999998766655544332111
Q ss_pred CccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHH
Q 012233 371 YTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEA 417 (468)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~el 417 (468)
.-++.+++.+.+|++.||+++|..||++.|+
T Consensus 486 ----------------~~PeGCPpkVYeLMraCW~WsPsDRPsFaei 516 (1157)
T KOG4278|consen 486 ----------------DGPEGCPPKVYELMRACWNWSPSDRPSFAEI 516 (1157)
T ss_pred ----------------cCCCCCCHHHHHHHHHHhcCCcccCccHHHH
Confidence 1235689999999999999999999998876
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=288.76 Aligned_cols=251 Identities=22% Similarity=0.264 Sum_probs=195.2
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc-----cchHHHHHHHHHHcCCCCcccccceeeecCCCCceEEE
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~-----~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 211 (468)
....+++.||+|-||.|.+|.- ..+..||+|.++.+ ...+.+|+++|.+|+|||||+|+++|.... -+|
T Consensus 538 s~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~De-----Pic 611 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDD-----PLC 611 (807)
T ss_pred hheehhhhhcCcccceeEEEEe-cCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCC-----chH
Confidence 3578889999999999999985 34699999998543 355678999999999999999999985433 388
Q ss_pred EEeecccchHHH-HHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcccc
Q 012233 212 LVLEYISETVYR-VSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (468)
Q Consensus 212 lv~e~~~~~ll~-~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~ 290 (468)
+|+||+..|.+. .+....... ........++.||+.|++||.+ .++|||||.+.|||++.+. ++||+|||+++.+
T Consensus 612 mI~EYmEnGDLnqFl~aheapt--~~t~~~vsi~tqiasgmaYLes-~nfVHrd~a~rNcLv~~e~-~iKiadfgmsR~l 687 (807)
T KOG1094|consen 612 MITEYMENGDLNQFLSAHELPT--AETAPGVSICTQIASGMAYLES-LNFVHRDLATRNCLVDGEF-TIKIADFGMSRNL 687 (807)
T ss_pred HHHHHHhcCcHHHHHHhccCcc--cccchhHHHHHHHHHHHHHHHh-hchhhccccccceeecCcc-cEEecCccccccc
Confidence 999999965443 322221111 2334456699999999999998 8999999999999999998 7999999999876
Q ss_pred CCCCCC---ccccccCCccccccccCCCCCCcchhHHHHHHHHHHHH--hCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 012233 291 VPGEPN---ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELL--LGQPLFPGESGVDQLVEIIKILGTPTREEIK 365 (468)
Q Consensus 291 ~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell--~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 365 (468)
..+... ...+-..+|||+|.+.-.+ ++.++|+|+||+++||++ +...||...++++.+.+....+..+.....
T Consensus 688 ysg~yy~vqgr~vlpiRwmawEsillgk-FttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~- 765 (807)
T KOG1094|consen 688 YSGDYYRVQGRAVLPIRWMAWESILLGK-FTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVV- 765 (807)
T ss_pred ccCCceeeecceeeeeeehhHHHHHhcc-ccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCccee-
Confidence 544322 2344578999999997554 999999999999999986 478999888877777666554433322111
Q ss_pred hcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 366 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
...+.-++..+.+||.+||..|-.+||+.+++-.
T Consensus 766 --------------------l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 766 --------------------LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred --------------------ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 1133457889999999999999999999999843
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=306.91 Aligned_cols=251 Identities=30% Similarity=0.445 Sum_probs=192.7
Q ss_pred ceEEeceecccCceE-EEEEEEcCCCCEEEEEEeecccc-hHHHHHHHHHHcC-CCCcccccceeeecCCCCceEEEEEe
Q 012233 138 SYMAERVVGTGSFGV-VFQAKCLETGDSVAIKKVLQDKR-YKNRELQIMRLLN-HPNVVSLKHCFFSTTEKDELYLNLVL 214 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~-Vy~~~~~~~g~~vaiK~~~~~~~-~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~~~~~~lv~ 214 (468)
-|.-.+++|.|+-|+ ||+|.. .|+.||||.+..... ...+|+..|+.-+ |||||++++.- .+..++||..
T Consensus 510 ~~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E-----~d~qF~YIal 582 (903)
T KOG1027|consen 510 FFSPKEILGYGSNGTVVFRGVY--EGREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSE-----QDRQFLYIAL 582 (903)
T ss_pred eeccHHHcccCCCCcEEEEEee--CCceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeec-----cCCceEEEEe
Confidence 366678899999886 799998 789999998866544 6678999999885 99999975543 7788999999
Q ss_pred ecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecC---CC-CcEEEeeecCcccc
Q 012233 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNP---HT-HQLKICDFGSAKML 290 (468)
Q Consensus 215 e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~---~~-~~vkL~DFG~a~~~ 290 (468)
|.|..+|-+++...........-...+.+..|++.||++||+ .+||||||||.||||+. ++ ..++|+|||+++++
T Consensus 583 ELC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs-l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 583 ELCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS-LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred hHhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHh-cccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 999999888776521111111114456788899999999998 89999999999999976 23 36899999999998
Q ss_pred CCCCC----CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhC-CCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 012233 291 VPGEP----NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLG-QPLFPGESGVDQLVEIIKILGTPTREEIK 365 (468)
Q Consensus 291 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 365 (468)
..+.. ..+..||-.|+|||++.... -+.++|||||||++|..++| .+||... .+.-.+|+..
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~-~~~avDiFslGCvfyYvltgG~HpFGd~--~~R~~NIl~~---------- 728 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLREDR-KTQAVDIFSLGCVFYYVLTGGSHPFGDS--LERQANILTG---------- 728 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhccc-cCcccchhhcCceEEEEecCCccCCCch--HHhhhhhhcC----------
Confidence 76543 34567899999999997654 67799999999999999885 9999643 2333344331
Q ss_pred hcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q 012233 366 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDD 425 (468)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~ 425 (468)
+++-.. +.+.-..++.|||.+||.+||..||+|.++|+||||=+
T Consensus 729 ----~~~L~~------------L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~ 772 (903)
T KOG1027|consen 729 ----NYTLVH------------LEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWD 772 (903)
T ss_pred ----ccceee------------eccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCC
Confidence 111111 11111228999999999999999999999999999854
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=269.85 Aligned_cols=238 Identities=39% Similarity=0.663 Sum_probs=191.0
Q ss_pred CceEEEEEEEcCCCCEEEEEEeecc-----cchHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEEEeecccc-hHH
Q 012233 149 SFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISE-TVY 222 (468)
Q Consensus 149 ~fg~Vy~~~~~~~g~~vaiK~~~~~-----~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv~e~~~~-~ll 222 (468)
+||.||+|.+..+|+.+|+|++... .....+|+.+++.++|+||+++++++.. ....+++|||+++ .+.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~l~~e~~~~~~L~ 75 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFED-----EDKLYLVMEYCDGGDLF 75 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheee-----CCEEEEEEeCCCCCCHH
Confidence 5899999999888999999998543 2455689999999999999999998843 3458899999998 444
Q ss_pred HHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCCCCCCcccccc
Q 012233 223 RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICS 302 (468)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~~~~~~~~~gt 302 (468)
..+.. ...++...++.++.+++.+|.|||+ .||+|+||+|.||+++.++ .++|+|||.+.............++
T Consensus 76 ~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~~i~~~ni~~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~ 149 (244)
T smart00220 76 DLLKK----RGRLSEDEARFYARQILSALEYLHS-NGIIHRDLKPENILLDEDG-HVKLADFGLARQLDPGGLLTTFVGT 149 (244)
T ss_pred HHHHh----ccCCCHHHHHHHHHHHHHHHHHHHH-cCeecCCcCHHHeEECCCC-cEEEccccceeeeccccccccccCC
Confidence 43322 2238889999999999999999998 8999999999999999887 7999999999877555445567788
Q ss_pred CCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccCCCCcccCC
Q 012233 303 RYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAH 382 (468)
Q Consensus 303 ~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (468)
..|++||.+.+. .++.++|+||||+++|+|++|..||......+...+........ ..
T Consensus 150 ~~~~~pE~~~~~-~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~----------------~~----- 207 (244)
T smart00220 150 PEYMAPEVLLGK-GYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPP----------------FP----- 207 (244)
T ss_pred cCCCCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCC----------------Cc-----
Confidence 999999998644 47889999999999999999999998744444433332210000 00
Q ss_pred CcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 012233 383 PWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (468)
Q Consensus 383 ~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f 423 (468)
.....++.++.+++.+||..||.+||++.++++||||
T Consensus 208 ----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 208 ----PPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred ----cccccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence 0111167899999999999999999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=281.04 Aligned_cols=281 Identities=30% Similarity=0.508 Sum_probs=211.7
Q ss_pred ccceEEeceecccCceEEEEEEEcC---CCCEEEEEEeecc--cchHHHHHHHHHHcC-CCCcccccceeeecCCCCceE
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLE---TGDSVAIKKVLQD--KRYKNRELQIMRLLN-HPNVVSLKHCFFSTTEKDELY 209 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~---~g~~vaiK~~~~~--~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~~~~ 209 (468)
...|..+++||.|.|+.||++.+.. ....||+|.+... .....+|+++|..+. +.||+++.+++ .....
T Consensus 35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~-----rnnd~ 109 (418)
T KOG1167|consen 35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCF-----RNNDQ 109 (418)
T ss_pred hhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhh-----ccCCe
Confidence 3469999999999999999999877 7889999988543 344568999999985 89999999998 55666
Q ss_pred EEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccc
Q 012233 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (468)
Q Consensus 210 ~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~ 289 (468)
+++||||++..-...+ ...++...++.|++.++.||.++|. +|||||||||.|+|.+.....-.|+|||+|..
T Consensus 110 v~ivlp~~~H~~f~~l------~~~l~~~~i~~Yl~~ll~Al~~~h~-~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~ 182 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDL------YRSLSLAEIRWYLRNLLKALAHLHK-NGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQR 182 (418)
T ss_pred eEEEecccCccCHHHH------HhcCCHHHHHHHHHHHHHHhhhhhc-cCccccCCCccccccccccCCceEEechhHHH
Confidence 8999999996533322 2346678899999999999999997 99999999999999998877789999999852
Q ss_pred c-----------------CC--CC--------------------------CCccccccCCccccccccCCCCCCcchhHH
Q 012233 290 L-----------------VP--GE--------------------------PNISYICSRYYRAPELIFGATEYTTAIDMW 324 (468)
Q Consensus 290 ~-----------------~~--~~--------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~Dvw 324 (468)
. .+ +. ......||+.|+|||++...+..++++|||
T Consensus 183 ~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiw 262 (418)
T KOG1167|consen 183 YDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIW 262 (418)
T ss_pred HHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcccee
Confidence 1 00 00 001356899999999999888889999999
Q ss_pred HHHHHHHHHHhCCCCCCC-CCcHHHHHHHHHHhCCCCHHHHhh------------------cCCCCccCCCCc-ccC---
Q 012233 325 SIGCVLAELLLGQPLFPG-ESGVDQLVEIIKILGTPTREEIKC------------------MNPNYTEFKFPQ-IKA--- 381 (468)
Q Consensus 325 SlG~il~ell~G~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~------------------~~~~~~~~~~~~-~~~--- 381 (468)
|.|||+.-+++++.||-. .+..+.+.+|...+|.......-. ....|....... .+.
T Consensus 263 s~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~ 342 (418)
T KOG1167|consen 263 SAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQP 342 (418)
T ss_pred eccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccc
Confidence 999999999999999864 455566777776665433222111 111111110000 000
Q ss_pred CCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCC
Q 012233 382 HPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRD 428 (468)
Q Consensus 382 ~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~ 428 (468)
..+........+..+.+|+.+||..||.+|+||+++|.||||.+...
T Consensus 343 n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~~ 389 (418)
T KOG1167|consen 343 NTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEADR 389 (418)
T ss_pred ceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchhh
Confidence 12333334445668999999999999999999999999999996543
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=302.37 Aligned_cols=244 Identities=24% Similarity=0.352 Sum_probs=205.6
Q ss_pred ceEEeceecccCceEEEEEEEcCCCC---EEEEEEeec-----ccchHHHHHHHHHHcCCCCcccccceeeecCCCCceE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGD---SVAIKKVLQ-----DKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~---~vaiK~~~~-----~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 209 (468)
.-.|+++||.|.||.|+.|+.+..|+ .||||.++. .+..+..|..||-+++||||++|.++. ....-
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVV-----Tks~P 704 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVV-----TKSKP 704 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEE-----ecCce
Confidence 45788999999999999999887764 599999854 345566799999999999999999988 44445
Q ss_pred EEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccc
Q 012233 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (468)
Q Consensus 210 ~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~ 289 (468)
+.||+|||.++.|+.+... ....|...++..|++.|+.|++||-+ .|+|||||-..||||+.+- .+|++|||+++.
T Consensus 705 vMIiTEyMENGsLDsFLR~--~DGqftviQLVgMLrGIAsGMkYLsd-m~YVHRDLAARNILVNsnL-vCKVsDFGLSRv 780 (996)
T KOG0196|consen 705 VMIITEYMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIASGMKYLSD-MNYVHRDLAARNILVNSNL-VCKVSDFGLSRV 780 (996)
T ss_pred eEEEhhhhhCCcHHHHHhh--cCCceEeehHHHHHHHHHHHhHHHhh-cCchhhhhhhhheeeccce-EEEeccccceee
Confidence 8899999998877654332 34669999999999999999999998 8999999999999999987 899999999998
Q ss_pred cCCCC-CCcccc-c--cCCccccccccCCCCCCcchhHHHHHHHHHHHH-hCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 012233 290 LVPGE-PNISYI-C--SRYYRAPELIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVDQLVEIIKILGTPTREEI 364 (468)
Q Consensus 290 ~~~~~-~~~~~~-g--t~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell-~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 364 (468)
+.++. ...+.. | ..+|.|||.+.-. +++.++||||+|++|||.+ .|..||-..++.+.+..|.+.++.|++
T Consensus 781 ledd~~~~ytt~GGKIPiRWTAPEAIa~R-KFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpP--- 856 (996)
T KOG0196|consen 781 LEDDPEAAYTTLGGKIPIRWTAPEAIAYR-KFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPP--- 856 (996)
T ss_pred cccCCCccccccCCccceeecChhHhhhc-ccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCC---
Confidence 75544 222222 2 5789999999644 5999999999999999977 599999999999999998887666542
Q ss_pred hhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 365 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
-++|..+..|+..||++|-.+||.+.|++.
T Consensus 857 -------------------------mDCP~aL~qLMldCWqkdR~~RP~F~qiV~ 886 (996)
T KOG0196|consen 857 -------------------------MDCPAALYQLMLDCWQKDRNRRPKFAQIVS 886 (996)
T ss_pred -------------------------CCCcHHHHHHHHHHHHHHhhcCCCHHHHHH
Confidence 358999999999999999999999998775
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=319.62 Aligned_cols=257 Identities=21% Similarity=0.294 Sum_probs=185.3
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeecccchHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEEEeecc
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYI 217 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv~e~~ 217 (468)
.|...++||+|+||.||+|.+..+|..||+|.+........+|++++++++|||||++++++.. ....|+||||+
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~l~~l~HpnIv~~~~~~~~-----~~~~~lv~Ey~ 765 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCRS-----EKGAYLIHEYI 765 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccccHHHHHHHhhCCCCCcceEEEEEEc-----CCCCEEEEeCC
Confidence 3566778999999999999998899999999987665555678999999999999999999843 33478999999
Q ss_pred cchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhH---hcCCccccCCCCCCeeecCCCCcEEEeeecCccccCCCC
Q 012233 218 SETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH---HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGE 294 (468)
Q Consensus 218 ~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH---~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~~~ 294 (468)
+++.+..... .+++..+..++.||+.||+||| + .+|+||||||+||+++.++ ..++. ||.......
T Consensus 766 ~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~-~~iiH~dlkp~Nil~~~~~-~~~~~-~~~~~~~~~-- 834 (968)
T PLN00113 766 EGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCS-PAVVVGNLSPEKIIIDGKD-EPHLR-LSLPGLLCT-- 834 (968)
T ss_pred CCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCC-CCeecCCCCHHhEEECCCC-ceEEE-ecccccccc--
Confidence 9765543321 3788889999999999999999 5 6999999999999999876 56664 666543221
Q ss_pred CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCCCCHHHHhhcCCCCcc
Q 012233 295 PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGV-DQLVEIIKILGTPTREEIKCMNPNYTE 373 (468)
Q Consensus 295 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~ 373 (468)
.....+|+.|+|||++.+. .++.++|||||||++|||++|+.||...... ..+.++.+....... ...
T Consensus 835 -~~~~~~t~~y~aPE~~~~~-~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---------~~~ 903 (968)
T PLN00113 835 -DTKCFISSAYVAPETRETK-DITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCH---------LDM 903 (968)
T ss_pred -CCCccccccccCcccccCC-CCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccc---------hhh
Confidence 2234678999999998654 4899999999999999999999999543211 112222111100000 000
Q ss_pred CCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q 012233 374 FKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426 (468)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 426 (468)
+.-+.+.... ........++.+++.+||+.||.+|||+.|+++. ++.+
T Consensus 904 ~~~~~~~~~~---~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~--L~~~ 951 (968)
T PLN00113 904 WIDPSIRGDV---SVNQNEIVEVMNLALHCTATDPTARPCANDVLKT--LESA 951 (968)
T ss_pred eeCccccCCC---CccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH--HHHh
Confidence 0001000000 0011122367899999999999999999999873 5544
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=250.05 Aligned_cols=213 Identities=24% Similarity=0.433 Sum_probs=175.7
Q ss_pred ccceEEeceecccCceEEEEEEEcCCCCEEEEEEeecccch-----HHHHHHHH-HHcCCCCcccccceeeecCCCCceE
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRY-----KNRELQIM-RLLNHPNVVSLKHCFFSTTEKDELY 209 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~~~-----~~~E~~il-~~l~hpnIv~l~~~~~~~~~~~~~~ 209 (468)
.+....+..||+|++|.|-+-++..+|...|+|.+...... ..+|+.+. +...+|.+|.+|+.++...+
T Consensus 45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd----- 119 (282)
T KOG0984|consen 45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD----- 119 (282)
T ss_pred hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcccc-----
Confidence 34455667899999999999999999999999988544322 22455543 33469999999998855544
Q ss_pred EEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccc
Q 012233 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (468)
Q Consensus 210 ~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~ 289 (468)
++|.||.+.-++-.+..+....+..+++..+-+++..++.||.|||+...|||||+||+|||++.+| +||+||||++-.
T Consensus 120 vwIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~G-qVKiCDFGIsG~ 198 (282)
T KOG0984|consen 120 VWICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDG-QVKICDFGISGY 198 (282)
T ss_pred EEEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCC-cEEEccccccee
Confidence 8999999998877777777778899999999999999999999999877999999999999999999 799999999988
Q ss_pred cCCCCCCccccccCCccccccccC---CCCCCcchhHHHHHHHHHHHHhCCCCCCC-CCcHHHHHHHHH
Q 012233 290 LVPGEPNISYICSRYYRAPELIFG---ATEYTTAIDMWSIGCVLAELLLGQPLFPG-ESGVDQLVEIIK 354 (468)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DvwSlG~il~ell~G~~pf~~-~~~~~~~~~i~~ 354 (468)
+.+.-......|...|||||.+.. ...|+.++||||||+.++||.+++.||.. .++.+++.++++
T Consensus 199 L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe 267 (282)
T KOG0984|consen 199 LVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE 267 (282)
T ss_pred ehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence 766655555778889999999843 23589999999999999999999999976 455566666554
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=266.33 Aligned_cols=264 Identities=23% Similarity=0.311 Sum_probs=187.1
Q ss_pred ccCCCCCCCCcc-----cceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc-cchHHHHHHHHH--HcCCCCccccc
Q 012233 125 TVGGRNGQPKQT-----ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-KRYKNRELQIMR--LLNHPNVVSLK 196 (468)
Q Consensus 125 ~~~~~~~~~~~~-----~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~-~~~~~~E~~il~--~l~hpnIv~l~ 196 (468)
+.|+..|.|... .+-++.+.||+|.||.||+|.| .|+.||||++... +....+|.+|.+ .|+|+||+.++
T Consensus 194 tSGSGSGlplLVQRTiarqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFI 271 (513)
T KOG2052|consen 194 TSGSGSGLPLLVQRTIARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFI 271 (513)
T ss_pred cCCCCCCchhHhHHhhhheeEEEEEecCccccceeeccc--cCCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhh
Confidence 444445554322 2578999999999999999999 7999999999654 445567777765 56999999988
Q ss_pred ceeeecCCCCceEEEEEeecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHh-------cCCccccCCCCC
Q 012233 197 HCFFSTTEKDELYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH-------VVGVCHRDIKPQ 268 (468)
Q Consensus 197 ~~~~~~~~~~~~~~~lv~e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~-------~~givHrDlkp~ 268 (468)
+.=.... ..-..++||++|.+.| |++.+. ...++.....+++..++.||++||. ...|.|||||..
T Consensus 272 aaD~~~~-gs~TQLwLvTdYHe~GSL~DyL~-----r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSK 345 (513)
T KOG2052|consen 272 AADNKDN-GSWTQLWLVTDYHEHGSLYDYLN-----RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSK 345 (513)
T ss_pred hccccCC-CceEEEEEeeecccCCcHHHHHh-----hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccc
Confidence 7542222 3344699999999954 554433 2568888999999999999999993 135999999999
Q ss_pred CeeecCCCCcEEEeeecCccccCCCC-----CCccccccCCccccccccCCCC-----CCcchhHHHHHHHHHHHHh---
Q 012233 269 NLLVNPHTHQLKICDFGSAKMLVPGE-----PNISYICSRYYRAPELIFGATE-----YTTAIDMWSIGCVLAELLL--- 335 (468)
Q Consensus 269 NILl~~~~~~vkL~DFG~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~-----~~~~~DvwSlG~il~ell~--- 335 (468)
||||..++ ++.|+|+|+|-...... ..+..+||.+|||||++..... .-..+||||||.|+||+..
T Consensus 346 NILVKkn~-~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~ 424 (513)
T KOG2052|consen 346 NILVKKNG-TCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCE 424 (513)
T ss_pred cEEEccCC-cEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhh
Confidence 99999998 89999999997664432 3456899999999999954432 1236899999999999985
Q ss_pred --C-----CCCCCCCCcH----HHHHHHHHHhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhc
Q 012233 336 --G-----QPLFPGESGV----DQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLL 404 (468)
Q Consensus 336 --G-----~~pf~~~~~~----~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L 404 (468)
| ++||.+.-+. +.+.+++ ..-++.......|... .+-..+..|++.||
T Consensus 425 ~ggi~eey~~Pyyd~Vp~DPs~eeMrkVV------------------Cv~~~RP~ipnrW~s~---~~l~~m~klMkeCW 483 (513)
T KOG2052|consen 425 SGGIVEEYQLPYYDVVPSDPSFEEMRKVV------------------CVQKLRPNIPNRWKSD---PALRVMAKLMKECW 483 (513)
T ss_pred cCCEehhhcCCcccCCCCCCCHHHHhcce------------------eecccCCCCCcccccC---HHHHHHHHHHHHhh
Confidence 2 4777653222 2222211 1111111112222110 11235678899999
Q ss_pred ccCCCCCCCHHHHh
Q 012233 405 QYSPSLRCTALEAC 418 (468)
Q Consensus 405 ~~dP~~R~s~~ell 418 (468)
..||.-|.||-.+.
T Consensus 484 ~~Np~aRltALriK 497 (513)
T KOG2052|consen 484 YANPAARLTALRIK 497 (513)
T ss_pred cCCchhhhHHHHHH
Confidence 99999999987654
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=267.08 Aligned_cols=268 Identities=25% Similarity=0.306 Sum_probs=186.4
Q ss_pred eEEeceecccCceEEEEEEEcCCCCEEEEEEeecc-cchHHHHHHHHHH--cCCCCcccccceeeecCCCCceEEEEEee
Q 012233 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-KRYKNRELQIMRL--LNHPNVVSLKHCFFSTTEKDELYLNLVLE 215 (468)
Q Consensus 139 y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~-~~~~~~E~~il~~--l~hpnIv~l~~~~~~~~~~~~~~~~lv~e 215 (468)
..+.++||+|.||.||+|.. +++.||||++... +..+..|.+|.+. ++|+||+++++.--..+ .+...++||++
T Consensus 212 l~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t-~~~~eywLVt~ 288 (534)
T KOG3653|consen 212 LQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGT-ADRMEYWLVTE 288 (534)
T ss_pred hhhHHHhhcCccceeehhhc--cCceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCC-ccccceeEEee
Confidence 56678899999999999987 6799999999654 4455667777664 57999999987643333 23445789999
Q ss_pred cccchH-HHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhc--------CCccccCCCCCCeeecCCCCcEEEeeecC
Q 012233 216 YISETV-YRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV--------VGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (468)
Q Consensus 216 ~~~~~l-l~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~--------~givHrDlkp~NILl~~~~~~vkL~DFG~ 286 (468)
|.+.|. .++++ ...+++....+++..+++||+|||+. .+|+|||||..||||.+|. ++.|+|||+
T Consensus 289 fh~kGsL~dyL~-----~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~Dl-TccIaDFGL 362 (534)
T KOG3653|consen 289 FHPKGSLCDYLK-----ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDL-TCCIADFGL 362 (534)
T ss_pred eccCCcHHHHHH-----hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCC-cEEeeccce
Confidence 998554 44433 35589999999999999999999951 3699999999999999998 899999999
Q ss_pred ccccCCCCC---CccccccCCccccccccCCCCCC-----cchhHHHHHHHHHHHHhCCCCCC-CCCcHHHHHHHHHHhC
Q 012233 287 AKMLVPGEP---NISYICSRYYRAPELIFGATEYT-----TAIDMWSIGCVLAELLLGQPLFP-GESGVDQLVEIIKILG 357 (468)
Q Consensus 287 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~-----~~~DvwSlG~il~ell~G~~pf~-~~~~~~~~~~i~~~~~ 357 (468)
|..+.++.. ....+||.+|||||++.+...+. .+.||||+|.|||||++...-+. +..+.-++.=-.+...
T Consensus 363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~ 442 (534)
T KOG3653|consen 363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGN 442 (534)
T ss_pred eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcC
Confidence 988865543 33578999999999997766555 36899999999999998654332 1111111100111222
Q ss_pred CCCHHHHhhcC-CCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHH------HhCCCC
Q 012233 358 TPTREEIKCMN-PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALE------ACAHPF 422 (468)
Q Consensus 358 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~e------ll~hp~ 422 (468)
.|+.+.+.... ..-..-.+|. .|.. -..-.-+++.|..||+.||+.|+|+.= .+.|.|
T Consensus 443 hPt~e~mq~~VV~kK~RP~~p~----~W~~---h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~ 507 (534)
T KOG3653|consen 443 HPTLEEMQELVVRKKQRPKIPD----AWRK---HAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW 507 (534)
T ss_pred CCCHHHHHHHHHhhccCCCChh----hhhc---CccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence 33333322211 0000001110 1111 123456899999999999999999863 445665
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=272.90 Aligned_cols=201 Identities=26% Similarity=0.421 Sum_probs=174.3
Q ss_pred CCCcccceEEeceecccCceEEEEEEEcCCCCEEEEEEeecccchH------------HHHHHHHHHcC---CCCccccc
Q 012233 132 QPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYK------------NRELQIMRLLN---HPNVVSLK 196 (468)
Q Consensus 132 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~~~~------------~~E~~il~~l~---hpnIv~l~ 196 (468)
.+++.-+|...+.||.|+||.|++|.++.+...|+||.|.+.+... -.|+.||..|+ |+||+|++
T Consensus 556 ~~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlL 635 (772)
T KOG1152|consen 556 EYKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLL 635 (772)
T ss_pred eecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhh
Confidence 3455567999999999999999999999999999999887654332 25999999998 99999999
Q ss_pred ceeeecCCCCceEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCC
Q 012233 197 HCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHT 276 (468)
Q Consensus 197 ~~~~~~~~~~~~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~ 276 (468)
++| ++..|+||+||--+.+ .++.. +...+..+++.++..++.|++.|+++||+ .||||||||-+|+.|+.+|
T Consensus 636 dfF-----Eddd~yyl~te~hg~g-IDLFd-~IE~kp~m~E~eAk~IFkQV~agi~hlh~-~~ivhrdikdenvivd~~g 707 (772)
T KOG1152|consen 636 DFF-----EDDDYYYLETEVHGEG-IDLFD-FIEFKPRMDEPEAKLIFKQVVAGIKHLHD-QGIVHRDIKDENVIVDSNG 707 (772)
T ss_pred hee-----ecCCeeEEEecCCCCC-cchhh-hhhccCccchHHHHHHHHHHHhccccccc-cCceecccccccEEEecCC
Confidence 999 8888899999988765 33332 33446779999999999999999999998 8999999999999999999
Q ss_pred CcEEEeeecCccccCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 012233 277 HQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPG 342 (468)
Q Consensus 277 ~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~ 342 (468)
.+||+|||.|.... ..+.-.++||..|.|||++.|.+..+..-|||++|++||.++....||.+
T Consensus 708 -~~klidfgsaa~~k-sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 708 -FVKLIDFGSAAYTK-SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred -eEEEeeccchhhhc-CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 79999999997654 44566899999999999998888788999999999999999999999864
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-33 Score=279.10 Aligned_cols=255 Identities=25% Similarity=0.371 Sum_probs=207.3
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc----cchHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEE
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~----~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~l 212 (468)
++|.+...+|.|.||.||+++++.+++..|+|+++.. -.....|+-+++.++|||||.+++.|.... .++|
T Consensus 15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~d-----klwi 89 (829)
T KOG0576|consen 15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRD-----KLWI 89 (829)
T ss_pred cchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhc-----CcEE
Confidence 4699999999999999999999999999999998643 334567999999999999999999985433 3899
Q ss_pred EeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCC
Q 012233 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (468)
Q Consensus 213 v~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~ 292 (468)
.||||+|+.++.+.+ ....+++.++..+++..+.||+|||+ .|=+|||||-.|||++..+ .+||.|||.+..+..
T Consensus 90 cMEycgggslQdiy~---~TgplselqiayvcRetl~gl~ylhs-~gk~hRdiKGanilltd~g-DvklaDfgvsaqita 164 (829)
T KOG0576|consen 90 CMEYCGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLKYLHS-QGKIHRDIKGANILLTDEG-DVKLADFGVSAQITA 164 (829)
T ss_pred EEEecCCCcccceee---ecccchhHHHHHHHhhhhccchhhhc-CCcccccccccceeecccC-ceeecccCchhhhhh
Confidence 999999887765544 35778999999999999999999998 8999999999999999888 799999999866532
Q ss_pred -CCCCccccccCCcccccccc--CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 012233 293 -GEPNISYICSRYYRAPELIF--GATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (468)
Q Consensus 293 -~~~~~~~~gt~~y~aPE~~~--~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 369 (468)
-.....++||++|||||+.. ....|...+|+|++|+...|+---++|.....++..+..+-+-.-.|+
T Consensus 165 ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp--------- 235 (829)
T KOG0576|consen 165 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPP--------- 235 (829)
T ss_pred hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCC---------
Confidence 23456799999999999863 234599999999999999999888888766655555554443222221
Q ss_pred CCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q 012233 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDD 425 (468)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~ 425 (468)
.++. ...-++.+.+|++.+|.++|.+||+++.+|.|||...
T Consensus 236 --------~lkD-------k~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~ 276 (829)
T KOG0576|consen 236 --------TLKD-------KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ 276 (829)
T ss_pred --------cccC-------CccchHHHHHHHHHHhcCCCccCCChhhheeceeecc
Confidence 1111 1224667899999999999999999999999999865
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=279.24 Aligned_cols=247 Identities=26% Similarity=0.393 Sum_probs=188.5
Q ss_pred ceEEeceecccCceEEEEEEEcC-------CCCEEEEEEeecc-----cchHHHHHHHHHHcC-CCCcccccceeeecCC
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLE-------TGDSVAIKKVLQD-----KRYKNRELQIMRLLN-HPNVVSLKHCFFSTTE 204 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~-------~g~~vaiK~~~~~-----~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~ 204 (468)
+..+.+.||+|.||.|++|.... ....||||.++.. ...+..|+++|+.+. |+||+.+++++..
T Consensus 297 ~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~--- 373 (609)
T KOG0200|consen 297 NLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ--- 373 (609)
T ss_pred hccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc---
Confidence 34566799999999999997531 1456999987543 344567999999996 9999999999843
Q ss_pred CCceEEEEEeecccc-hHHHHHhhhh---h-------cC--CCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCee
Q 012233 205 KDELYLNLVLEYISE-TVYRVSKHYT---R-------MN--QHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLL 271 (468)
Q Consensus 205 ~~~~~~~lv~e~~~~-~ll~~~~~~~---~-------~~--~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NIL 271 (468)
...+++|+||+.. .++..+++.. . .. ..++...+..++.||+.|++||++ .++|||||-..|||
T Consensus 374 --~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~-~~~vHRDLAaRNVL 450 (609)
T KOG0200|consen 374 --DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS-VPCVHRDLAARNVL 450 (609)
T ss_pred --CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh-CCccchhhhhhhEE
Confidence 4458899999984 5555554433 0 01 138888999999999999999998 89999999999999
Q ss_pred ecCCCCcEEEeeecCccccCCCCCCc--ccc--ccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcH
Q 012233 272 VNPHTHQLKICDFGSAKMLVPGEPNI--SYI--CSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGV 346 (468)
Q Consensus 272 l~~~~~~vkL~DFG~a~~~~~~~~~~--~~~--gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~ 346 (468)
|..+. .+||+|||+|+......... ... -...|||||.+.. ..|+.++||||||++|||+++ |..||++....
T Consensus 451 i~~~~-~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~ 528 (609)
T KOG0200|consen 451 ITKNK-VIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-RVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT 528 (609)
T ss_pred ecCCC-EEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc-CcccccchhhHHHHHHHHHhhCCCCCCCCCCcH
Confidence 99886 89999999998654433221 122 2345999999976 559999999999999999997 89999985533
Q ss_pred HHHHHHHHHhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 347 DQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 347 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
..+.+.++.... . ..+..+++++.++++.||+.+|.+||+..++..
T Consensus 529 ~~l~~~l~~G~r---------------~------------~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 529 EELLEFLKEGNR---------------M------------EQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred HHHHHHHhcCCC---------------C------------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 333333221111 0 133568999999999999999999999998876
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=268.82 Aligned_cols=241 Identities=25% Similarity=0.369 Sum_probs=190.1
Q ss_pred eEEeceecccCceEEEEEEEcCCCCE----EEEEEeecc-----cchHHHHHHHHHHcCCCCcccccceeeecCCCCceE
Q 012233 139 YMAERVVGTGSFGVVFQAKCLETGDS----VAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (468)
Q Consensus 139 y~~~~~lG~G~fg~Vy~~~~~~~g~~----vaiK~~~~~-----~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 209 (468)
.+..++||+|+||+||+|.|...|+. ||||++... ...+.+|+-+|..|+|||+++|++++....
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~------ 771 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST------ 771 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch------
Confidence 45567899999999999999766664 788877443 234457999999999999999999985433
Q ss_pred EEEEeecccchH-HHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcc
Q 012233 210 LNLVLEYISETV-YRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (468)
Q Consensus 210 ~~lv~e~~~~~l-l~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~ 288 (468)
+.||++|++.|. ++.++. ....+.......|.+||++||.|||. +++|||||-..||||..-. .+||.|||+++
T Consensus 772 ~qlvtq~mP~G~LlDyvr~---hr~~igsq~lLnw~~QIAkgM~YLe~-qrlVHrdLaaRNVLVksP~-hvkitdfgla~ 846 (1177)
T KOG1025|consen 772 LQLVTQLMPLGCLLDYVRE---HRDNIGSQDLLNWCYQIAKGMKYLEE-QRLVHRDLAARNVLVKSPN-HVKITDFGLAK 846 (1177)
T ss_pred HHHHHHhcccchHHHHHHH---hhccccHHHHHHHHHHHHHHHHHHHh-cchhhhhhhhhheeecCCC-eEEEEecchhh
Confidence 568999999664 443332 34667788899999999999999998 8999999999999998777 59999999999
Q ss_pred ccCCCCCCccccc---cCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 012233 289 MLVPGEPNISYIC---SRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEI 364 (468)
Q Consensus 289 ~~~~~~~~~~~~g---t~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 364 (468)
.+.++.......+ .+-|||-|.+.. ..|+.++|||||||++||++| |..|+.+....+.- +.++. +
T Consensus 847 ll~~d~~ey~~~~gK~pikwmale~i~~-~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~-dlle~---g----- 916 (1177)
T KOG1025|consen 847 LLAPDEKEYSAPGGKVPIKWMALESIRI-RKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIP-DLLEK---G----- 916 (1177)
T ss_pred ccCcccccccccccccCcHHHHHHHhhc-cCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhh-HHHhc---c-----
Confidence 8877766554443 567999999964 459999999999999999997 99999887654432 22221 0
Q ss_pred hhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 365 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
.... .++..+-++.-++.+||..|+..||+++++..
T Consensus 917 -------eRLs------------qPpiCtiDVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 917 -------ERLS------------QPPICTIDVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred -------ccCC------------CCCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence 1111 23558889999999999999999999987653
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-29 Score=226.85 Aligned_cols=207 Identities=36% Similarity=0.588 Sum_probs=172.8
Q ss_pred ecccCceEEEEEEEcCCCCEEEEEEeeccc-----chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEEEeecccc
Q 012233 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISE 219 (468)
Q Consensus 145 lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv~e~~~~ 219 (468)
||+|.+|.||++....+++.+++|++.... ....+|+.+++.+.|++|+++++++. .....+++|||+.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~~~~~e~~~~ 75 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFE-----DENHLYLVMEYCEG 75 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeee-----cCCeEEEEEecCCC
Confidence 689999999999998789999999987654 34678999999999999999999883 33468899999995
Q ss_pred h-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecC-CCCcEEEeeecCccccCCCC-CC
Q 012233 220 T-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNP-HTHQLKICDFGSAKMLVPGE-PN 296 (468)
Q Consensus 220 ~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~-~~~~vkL~DFG~a~~~~~~~-~~ 296 (468)
. +...+.. ....+++..++.++.+++.+|.+||+ .|++|+||+|.||+++. ++ .++|+|||.+....... ..
T Consensus 76 ~~l~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~-~~~~H~dl~~~ni~~~~~~~-~~~l~d~~~~~~~~~~~~~~ 150 (215)
T cd00180 76 GSLKDLLKE---NEGKLSEDEILRILLQILEGLEYLHS-NGIIHRDLKPENILLDSDNG-KVKLADFGLSKLLTSDKSLL 150 (215)
T ss_pred CcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHhhEEEeCCCC-cEEEecCCceEEccCCcchh
Confidence 4 4433222 11468889999999999999999998 89999999999999998 56 79999999997654332 13
Q ss_pred ccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccCCC
Q 012233 297 ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKF 376 (468)
Q Consensus 297 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 376 (468)
....+...|++||.+.....++.+.|+|++|+++++|
T Consensus 151 ~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------- 187 (215)
T cd00180 151 KTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------- 187 (215)
T ss_pred hcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------------
Confidence 3456788999999986543588999999999999999
Q ss_pred CcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCC
Q 012233 377 PQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHP 421 (468)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp 421 (468)
..+.+++.+||+.||.+||++.+++.|+
T Consensus 188 -----------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 -----------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred -----------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 1267999999999999999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-31 Score=236.10 Aligned_cols=247 Identities=21% Similarity=0.308 Sum_probs=181.1
Q ss_pred ccceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc---cchHHHHHHHHHHc-CCCCcccccceeeecCCCCceEEE
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDELYLN 211 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~---~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~ 211 (468)
.+.|.|.+.||+|.||.+.+|.++.+...+++|.+... ...+.+|..---.| .|.||+.-|+.-+...+ +++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d----~Yv 98 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSD----AYV 98 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCc----eEE
Confidence 34699999999999999999999999999999988654 34455666543334 48999998887665443 677
Q ss_pred EEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeee-cCCCCcEEEeeecCcccc
Q 012233 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLV-NPHTHQLKICDFGSAKML 290 (468)
Q Consensus 212 lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl-~~~~~~vkL~DFG~a~~~ 290 (468)
+++||++.+.|.. . -...++-+...+.++.|+++||.|||+ +++||||||.+|||| +.+...|||||||.++..
T Consensus 99 F~qE~aP~gdL~s--n--v~~~GigE~~~K~v~~ql~SAi~fMHs-knlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~ 173 (378)
T KOG1345|consen 99 FVQEFAPRGDLRS--N--VEAAGIGEANTKKVFAQLLSAIEFMHS-KNLVHRDLKAENILIFDADFYRVKLCDFGLTRKV 173 (378)
T ss_pred EeeccCccchhhh--h--cCcccccHHHHHHHHHHHHHHHHHhhc-cchhhcccccceEEEecCCccEEEeeeccccccc
Confidence 9999999664431 1 123668888899999999999999998 999999999999998 556668999999998754
Q ss_pred CCCCCCccccccCCccccccccCC----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhCCCCHHHHh
Q 012233 291 VPGEPNISYICSRYYRAPELIFGA----TEYTTAIDMWSIGCVLAELLLGQPLFPGESGVD-QLVEIIKILGTPTREEIK 365 (468)
Q Consensus 291 ~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~ 365 (468)
.... ...-.+..|.+||++... ....+.+|+|.||+|+|.+++|.+||+.....+ .+.+..+-.+.-..
T Consensus 174 g~tV--~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~---- 247 (378)
T KOG1345|consen 174 GTTV--KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNP---- 247 (378)
T ss_pred Ccee--hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCc----
Confidence 2211 112335679999987432 225678999999999999999999998543332 23333332211100
Q ss_pred hcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHH
Q 012233 366 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTAL 415 (468)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ 415 (468)
..| .....+++.+..+.++-|..+|.+|.-..
T Consensus 248 ---------~~P---------~~F~~fs~~a~r~Fkk~lt~~~~drcki~ 279 (378)
T KOG1345|consen 248 ---------ALP---------KKFNPFSEKALRLFKKSLTPRFKDRCKIW 279 (378)
T ss_pred ---------cCc---------hhhcccCHHHHHHHHHhcCCcccccchhH
Confidence 111 12234788999999999999999995433
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-30 Score=283.66 Aligned_cols=208 Identities=19% Similarity=0.201 Sum_probs=147.1
Q ss_pred HHcCC-CCcccccceeeecCC--CCceEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCcc
Q 012233 185 RLLNH-PNVVSLKHCFFSTTE--KDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVC 261 (468)
Q Consensus 185 ~~l~h-pnIv~l~~~~~~~~~--~~~~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~giv 261 (468)
+.++| +||+++++.|..... .....++++|||++++|...+.. ....+++..++.+++||+.||.|||+ +||+
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~-~gIv 102 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDN---PDRSVDAFECFHVFRQIVEIVNAAHS-QGIV 102 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhc---ccccccHHHHHHHHHHHHHHHHHHHh-CCee
Confidence 34555 588888887622221 11234678899998887776542 24568999999999999999999997 9999
Q ss_pred ccCCCCCCeeecCCC------------------CcEEEeeecCccccCCCC-----------------CCccccccCCcc
Q 012233 262 HRDIKPQNLLVNPHT------------------HQLKICDFGSAKMLVPGE-----------------PNISYICSRYYR 306 (468)
Q Consensus 262 HrDlkp~NILl~~~~------------------~~vkL~DFG~a~~~~~~~-----------------~~~~~~gt~~y~ 306 (468)
||||||+||||+..+ ..+||+|||+++...... ......||+.||
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence 999999999995432 146777777765321100 011246789999
Q ss_pred ccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccCCCCcccCCCccc
Q 012233 307 APELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHK 386 (468)
Q Consensus 307 aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (468)
|||++.+.. |+.++|||||||+||||++|.+||.... ..+..+.... .|+.
T Consensus 183 APE~~~~~~-~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~-~~~~------------------------- 233 (793)
T PLN00181 183 SPEEDNGSS-SNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRV-LPPQ------------------------- 233 (793)
T ss_pred ChhhhccCC-CCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhh-cChh-------------------------
Confidence 999997654 8999999999999999999998875321 1111111110 0000
Q ss_pred ccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q 012233 387 IFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (468)
Q Consensus 387 ~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~ 427 (468)
+ ....+.+.+++.+||++||.+||++.|+|+||||...+
T Consensus 234 -~-~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~~ 272 (793)
T PLN00181 234 -I-LLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINEPR 272 (793)
T ss_pred -h-hhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhhhh
Confidence 0 01134567899999999999999999999999998753
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-29 Score=235.26 Aligned_cols=248 Identities=19% Similarity=0.224 Sum_probs=187.9
Q ss_pred cceEEeceecccCceEEEEEEEcCCCC-----EEEEEEeecccch-----HHHHHHHHHHcCCCCcccccceeeecCCCC
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGD-----SVAIKKVLQDKRY-----KNRELQIMRLLNHPNVVSLKHCFFSTTEKD 206 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~-----~vaiK~~~~~~~~-----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 206 (468)
.++++..++-+|.||.||.|.|.+... .|.+|.++..... +..|-.++..+.|||++.+.++.....+
T Consensus 284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~-- 361 (563)
T KOG1024|consen 284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYA-- 361 (563)
T ss_pred hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccC--
Confidence 357788889999999999998865433 3445555444332 2357777788889999999988754332
Q ss_pred ceEEEEEeecccchHHHHHhh-----hhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEE
Q 012233 207 ELYLNLVLEYISETVYRVSKH-----YTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKI 281 (468)
Q Consensus 207 ~~~~~lv~e~~~~~ll~~~~~-----~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL 281 (468)
.-++++.+.+-+.+..+.. .....+.+...++..++.|++.|++|||+ +||||.||-..|++|+..- ++||
T Consensus 362 --~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~-~~ViHkDiAaRNCvIdd~L-qVkl 437 (563)
T KOG1024|consen 362 --TPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN-HGVIHKDIAARNCVIDDQL-QVKL 437 (563)
T ss_pred --cceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh-cCcccchhhhhcceehhhe-eEEe
Confidence 3557788888554443333 22234556777788899999999999998 9999999999999999775 8999
Q ss_pred eeecCccccCCCCCCcc---ccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhC
Q 012233 282 CDFGSAKMLVPGEPNIS---YICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILG 357 (468)
Q Consensus 282 ~DFG~a~~~~~~~~~~~---~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~ 357 (468)
+|-.+++.+.+...+.- .-....||+||.+... .|+.++|+|||||+||||+| |+.||...++.+...-+....+
T Consensus 438 tDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~-~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyR 516 (563)
T KOG1024|consen 438 TDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNS-HYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYR 516 (563)
T ss_pred ccchhccccCcccccccCCCCCCcccccCHHHHhhh-hhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccce
Confidence 99999988766554321 1225679999999755 49999999999999999997 9999988877766555444211
Q ss_pred CCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 358 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
. ..+-++|+++..++..||..+|++||+.+|+..
T Consensus 517 l----------------------------aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 517 L----------------------------AQPFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred e----------------------------cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 0 122368999999999999999999999999753
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-28 Score=226.38 Aligned_cols=203 Identities=33% Similarity=0.573 Sum_probs=165.5
Q ss_pred eEEeceecccCceEEEEEEEcCCCCEEEEEEeecc-----cchHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEEE
Q 012233 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV 213 (468)
Q Consensus 139 y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~-----~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv 213 (468)
|.+.+.||.|++|.||++....+++.+|+|.+... .....+|+..++.++|+|++++++++.. ....+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~-----~~~~~~v 75 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFED-----PEPLYLV 75 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeec-----CCceEEE
Confidence 56778999999999999999888999999998653 3455679999999999999999998733 3458899
Q ss_pred eecccch-HHHHHhhhhhcCCC-CCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccC
Q 012233 214 LEYISET-VYRVSKHYTRMNQH-VPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (468)
Q Consensus 214 ~e~~~~~-ll~~~~~~~~~~~~-~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~ 291 (468)
+||+.++ +...+.. ... +++..+..++.|++.+|.|||+ .|++|+||+|.||+++.++ .++|+|||.+....
T Consensus 76 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~di~~~ni~v~~~~-~~~l~d~g~~~~~~ 149 (225)
T smart00221 76 MEYCEGGDLFDYLRK----KGGKLSEEEARFYLRQILEALEYLHS-LGIVHRDLKPENILLGMDG-LVKLADFGLARFIH 149 (225)
T ss_pred EeccCCCCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCC-CEEEeeCceeeEec
Confidence 9999984 4443332 222 7888999999999999999998 8999999999999999887 79999999998765
Q ss_pred CCC--CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCC-CCcHHHHHHH
Q 012233 292 PGE--PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPG-ESGVDQLVEI 352 (468)
Q Consensus 292 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~-~~~~~~~~~i 352 (468)
... ......++..|++||.+.+...++.++|+|+||+++|+|++|+.||.. .+....+.+.
T Consensus 150 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~ 213 (225)
T smart00221 150 RDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDV 213 (225)
T ss_pred CcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHH
Confidence 443 334567788999999984334477899999999999999999999977 5555444443
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-27 Score=213.29 Aligned_cols=156 Identities=24% Similarity=0.243 Sum_probs=119.4
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCCCCCCccccccCCccccccc
Q 012233 232 NQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELI 311 (468)
Q Consensus 232 ~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~ 311 (468)
...+++..++.++.||+.||.|||+ .+ ||+|||++.++ .+|+ ||++...... ...||+.|+|||++
T Consensus 11 ~~~l~~~~~~~i~~qi~~~L~~lH~-~~------kp~Nil~~~~~-~~~~--fG~~~~~~~~----~~~g~~~y~aPE~~ 76 (176)
T smart00750 11 GRPLNEEEIWAVCLQCLRALRELHR-QA------KSGNILLTWDG-LLKL--DGSVAFKTPE----QSRVDPYFMAPEVI 76 (176)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHh-cC------CcccEeEcCcc-ceee--ccceEeeccc----cCCCcccccChHHh
Confidence 4569999999999999999999998 67 99999999887 6888 9998765332 23689999999999
Q ss_pred cCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHHhCCCCHHHHhhcCCCCccCCCCcccCCCccccccc
Q 012233 312 FGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQ-LVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHK 390 (468)
Q Consensus 312 ~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (468)
.+.. ++.++|||||||++|||++|+.||........ +..+........ +. ......
T Consensus 77 ~~~~-~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----------------~~------~~~~~~ 133 (176)
T smart00750 77 QGQS-YTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADD----------------PR------DRSNLE 133 (176)
T ss_pred cCCC-CcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCC----------------cc------ccccHH
Confidence 7654 89999999999999999999999976544332 222222111000 00 000011
Q ss_pred CCCH--HHHHHHHHhcccCCCCCCCHHHHhCCCCCC
Q 012233 391 RMPP--EALDLVSRLLQYSPSLRCTALEACAHPFFD 424 (468)
Q Consensus 391 ~~~~--~l~~li~~~L~~dP~~R~s~~ell~hp~f~ 424 (468)
.++. +++++|.+||..||.+||++.+++.|+|+.
T Consensus 134 ~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 134 SVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 2333 699999999999999999999999999975
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-28 Score=254.68 Aligned_cols=259 Identities=25% Similarity=0.350 Sum_probs=192.2
Q ss_pred e-EEeceecccCceEEEEEEEcCCCCEEEEEEee----cccch------HHHHHHHHHHcCCCCcccccceeeecCCCCc
Q 012233 139 Y-MAERVVGTGSFGVVFQAKCLETGDSVAIKKVL----QDKRY------KNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (468)
Q Consensus 139 y-~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~----~~~~~------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 207 (468)
| ....++|.|++|.|+.+......+.++.|.+. ..... ...|+.+-..+.|+|++..+..++....
T Consensus 319 y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~--- 395 (601)
T KOG0590|consen 319 YGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDG--- 395 (601)
T ss_pred cCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhccc---
Confidence 5 56678999999999888887777777776543 11111 1235566677889999887776643322
Q ss_pred eEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCc
Q 012233 208 LYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (468)
Q Consensus 208 ~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a 287 (468)
.+-+||||+++++.++.. ...+....+..++.|++.||.|||. .||.|||||++|++++.++ .+||+|||.+
T Consensus 396 --~~~~mE~~~~Dlf~~~~~----~~~~~~~e~~c~fKqL~~Gv~y~h~-~GiahrdlK~enll~~~~g-~lki~Dfg~~ 467 (601)
T KOG0590|consen 396 --ILQSMEYCPYDLFSLVMS----NGKLTPLEADCFFKQLLRGVKYLHS-MGLAHRDLKLENLLVTENG-ILKIIDFGAA 467 (601)
T ss_pred --chhhhhcccHHHHHHHhc----ccccchhhhhHHHHHHHHHHHHHHh-cCceeccCccccEEEecCC-ceEEeecCcc
Confidence 233499999966665543 2457778899999999999999998 8999999999999999998 8999999998
Q ss_pred cccCCC-----CCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 012233 288 KMLVPG-----EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTRE 362 (468)
Q Consensus 288 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~ 362 (468)
....-. ......+|+..|+|||++.+........||||.|++++.|++|+.||......+....-..
T Consensus 468 ~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~-------- 539 (601)
T KOG0590|consen 468 SVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNN-------- 539 (601)
T ss_pred eeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhc--------
Confidence 765322 2345678999999999998777555689999999999999999999976554433210000
Q ss_pred HHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCC
Q 012233 363 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRD 428 (468)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~ 428 (468)
....+.. ... ...+...++.+.+.+|.+||++||.+|+|+++|++.+||+.+..
T Consensus 540 -------~~~~~~~---~~~--~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~ 593 (601)
T KOG0590|consen 540 -------YSDQRNI---FEG--PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIEC 593 (601)
T ss_pred -------ccccccc---ccC--hHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcce
Confidence 0000000 000 11133557889999999999999999999999999999998754
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.8e-25 Score=218.81 Aligned_cols=250 Identities=20% Similarity=0.204 Sum_probs=189.2
Q ss_pred ceEEeceecccCceEEEEEEEcCCC-CEEEEEEeeccc----chHHHHHHHHHHcCC----CCcccccceeeecCCCCce
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETG-DSVAIKKVLQDK----RYKNRELQIMRLLNH----PNVVSLKHCFFSTTEKDEL 208 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g-~~vaiK~~~~~~----~~~~~E~~il~~l~h----pnIv~l~~~~~~~~~~~~~ 208 (468)
+|.+.+.||+|+||.||.|.+..++ ..+|+|...... ..+..|..++..+.. .++..+++.+. ....
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~----~~~~ 94 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR----STED 94 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc----CCCc
Confidence 6999999999999999999987764 678898775432 146679999999973 57777776652 2455
Q ss_pred EEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCC----CcEEEeee
Q 012233 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHT----HQLKICDF 284 (468)
Q Consensus 209 ~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~----~~vkL~DF 284 (468)
+-||||+.++.++.++..... .+.++...+..++.|++.+|.+||+ .|++||||||+|+++.... ..+.|.||
T Consensus 95 ~~~iVM~l~G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~-~G~iHRDiKp~N~~~g~~~~~~~~~~~llDf 171 (322)
T KOG1164|consen 95 FNFIVMSLLGPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHS-KGFIHRDIKPENFVVGQSSRSEVRTLYLLDF 171 (322)
T ss_pred eeEEEEeccCccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHh-cCcccCCcCHHHeeecCCCCcccceEEEEec
Confidence 688999999999888665443 6789999999999999999999998 8999999999999997553 47999999
Q ss_pred cCcc--ccCCCC--------C-CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH
Q 012233 285 GSAK--MLVPGE--------P-NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEII 353 (468)
Q Consensus 285 G~a~--~~~~~~--------~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~ 353 (468)
|+++ ...... . ...+.||..|+++.+..+.. .+.+.|+||++.++.+|+.|..||.+........+..
T Consensus 172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e-~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~ 250 (322)
T KOG1164|consen 172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIE-QGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFE 250 (322)
T ss_pred CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCc-cCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHH
Confidence 9998 321111 1 23456999999999987655 8999999999999999999999998766444433333
Q ss_pred HHhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 354 KILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
+...... ... +....+.++.++...+-..+...+|....+..
T Consensus 251 ~~~~~~~---------------~~~---------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~ 292 (322)
T KOG1164|consen 251 KDPRKLL---------------TDR---------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAE 292 (322)
T ss_pred HHhhhhc---------------ccc---------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHH
Confidence 2110000 000 11224567777777777788888998776654
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-25 Score=198.34 Aligned_cols=209 Identities=23% Similarity=0.318 Sum_probs=167.5
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc--chHHHHHHHHHHcCC-CCcccccceeeecCCCCceEEEEE
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK--RYKNRELQIMRLLNH-PNVVSLKHCFFSTTEKDELYLNLV 213 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~--~~~~~E~~il~~l~h-pnIv~l~~~~~~~~~~~~~~~~lv 213 (468)
.+|++++.||+|+||.+|+|....+|+.||||.-.... ..+..|..+.+.|++ ..|..+..++ ....+-.+|
T Consensus 15 gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~-----~e~~ynvlV 89 (341)
T KOG1163|consen 15 GKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYG-----TEKDYNVLV 89 (341)
T ss_pred cceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhc-----cccccceee
Confidence 35999999999999999999999999999999765443 345579999999985 4555555544 445567799
Q ss_pred eecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCC--CCcEEEeeecCccccC
Q 012233 214 LEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPH--THQLKICDFGSAKMLV 291 (468)
Q Consensus 214 ~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~--~~~vkL~DFG~a~~~~ 291 (468)
||.++.++-+++. -+.+.|+...+..++-|++.-++|+|. +++|||||||+|+|..-+ .+.+.|+|||+|+.+.
T Consensus 90 MdLLGPsLEdLfn---fC~R~ftmkTvLMLaDQml~RiEyvH~-r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 90 MDLLGPSLEDLFN---FCSRRFTMKTVLMLADQMLSRIEYVHL-RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred eeccCccHHHHHH---HHhhhhhHHhHHHHHHHHHHHHHHHHh-hccccccCCccceeeccccccceEEEEeccchhhhc
Confidence 9999998877654 346779999999999999999999997 999999999999998543 3479999999998774
Q ss_pred CCC--------CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcH---HHHHHHHHH
Q 012233 292 PGE--------PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGV---DQLVEIIKI 355 (468)
Q Consensus 292 ~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~---~~~~~i~~~ 355 (468)
+.. ......||.+|.+-....+.. .+.+.|+-|+|.+|..+..|..||++.... +.+.+|.+.
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~e-qSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~Ek 239 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIE-QSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEK 239 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhh-hhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHh
Confidence 332 234578999999988776554 788999999999999999999999986543 334455443
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.8e-26 Score=238.50 Aligned_cols=245 Identities=27% Similarity=0.473 Sum_probs=180.1
Q ss_pred cccceEEeceecccCceEEEEEEEcCCCCEEEEEEeecccchHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEEEe
Q 012233 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (468)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv~ 214 (468)
...+|..++.|-.|+||.||+++++.+.+.+|+| +.++....++ |+.....|.+ |
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~lilRn---ilt~a~npfv--------------------v- 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLILRN---ILTFAGNPFV--------------------V- 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhc-ccccchhhhc---cccccCCcce--------------------e-
Confidence 3446999999999999999999999999999994 4443333222 2222222222 2
Q ss_pred ecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCCCC
Q 012233 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGE 294 (468)
Q Consensus 215 e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~~~ 294 (468)
|+...+++. -+.++. +++.+++|||+ .||+|||+||+|.||+.-| .+|++|||+++......
T Consensus 136 ----gDc~tllk~----~g~lPv--------dmvla~Eylh~-ygivhrdlkpdnllIT~mG-hiKlTDfgLsk~GLms~ 197 (1205)
T KOG0606|consen 136 ----GDCATLLKN----IGPLPV--------DMVLAVEYLHS-YGIVHRDLKPDNLLITSMG-HIKLTDFGLSKKGLMSL 197 (1205)
T ss_pred ----chhhhhccc----CCCCcc--------hhhHHhHhhcc-CCeecCCCCCCcceeeecc-cccccchhhhhhhhhhc
Confidence 322222221 223332 33788999998 8999999999999999988 59999999986542111
Q ss_pred ----------------CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Q 012233 295 ----------------PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGT 358 (468)
Q Consensus 295 ----------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~ 358 (468)
.....+|||.|.|||++.... |+..+|+|++|+|+||.+.|..||.++++++.+...+..
T Consensus 198 atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqg-ygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd--- 273 (1205)
T KOG0606|consen 198 ATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQG-YGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISD--- 273 (1205)
T ss_pred cchhhhcchHHHHHHhhhccccCCccccChhhhhhhc-cCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhh---
Confidence 112468999999999997654 999999999999999999999999999999988887762
Q ss_pred CCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCC---CHHHHhCCCCCCCCCCCCCCCCC
Q 012233 359 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC---TALEACAHPFFDDLRDPNTCLPN 435 (468)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~---s~~ell~hp~f~~~~~~~~~~~~ 435 (468)
++.+|. . ...++++++++|.++|+.+|..|. .+.++.+|+||+.+.....---+
T Consensus 274 --------------~i~wpE--------~-dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~~llRqk 330 (1205)
T KOG0606|consen 274 --------------DIEWPE--------E-DEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWKSLLRQK 330 (1205)
T ss_pred --------------hccccc--------c-CcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccchhhhhh
Confidence 223322 1 245789999999999999999996 57789999999998776443333
Q ss_pred CCCCCcccccCHHH
Q 012233 436 GRPLPTLFNFTAQE 449 (468)
Q Consensus 436 ~~~~~~~~~~~~~~ 449 (468)
..-+|.+.++++-.
T Consensus 331 aefvpql~~eddts 344 (1205)
T KOG0606|consen 331 AEFVPQLESEDDTS 344 (1205)
T ss_pred ccccccccccccch
Confidence 44466666666433
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-24 Score=200.82 Aligned_cols=214 Identities=22% Similarity=0.310 Sum_probs=174.2
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEee--cccchHHHHHHHHHHcC-CCCcccccceeeecCCCCceEEEEEe
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVL--QDKRYKNRELQIMRLLN-HPNVVSLKHCFFSTTEKDELYLNLVL 214 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~--~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~~~~~~lv~ 214 (468)
.|++++.||+|+||.++.|.+.-+++.||||.-. .+...+..|....+.|. .+.|..+|-+. ....+-.|||
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFG-----qeG~~NiLVi 103 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFG-----QEGKYNILVI 103 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeec-----cccchhhhhh
Confidence 5999999999999999999999999999999653 33455677999998886 67888775443 4445566999
Q ss_pred ecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecC----CCCcEEEeeecCcccc
Q 012233 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNP----HTHQLKICDFGSAKML 290 (468)
Q Consensus 215 e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~----~~~~vkL~DFG~a~~~ 290 (468)
|+++.+|-+++ ..+.+.|+...+..++.|++.-++|+|+ +.+|+|||||+|+||.. +.+.|.|+|||+|+.+
T Consensus 104 dLLGPSLEDLF---D~CgR~FSvKTV~miA~Qmi~rie~vH~-k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 104 DLLGPSLEDLF---DLCGRRFSVKTVAMIAKQMITRIEYVHE-KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred hhhCcCHHHHH---HHhcCcccHHhHHHHHHHHHHHHHHHHh-cceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 99999887754 4467889999999999999999999998 99999999999999953 3346999999999877
Q ss_pred CCC--------CCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC---CcHHHHHHHHHHhCCC
Q 012233 291 VPG--------EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGE---SGVDQLVEIIKILGTP 359 (468)
Q Consensus 291 ~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~---~~~~~~~~i~~~~~~~ 359 (468)
.+. ....+..||.+||+-....|.. .+.+.|+-|||-+++..|.|..||.+. +..+.+.+|-......
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrE-QSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T 258 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRST 258 (449)
T ss_pred cCccccccCccccccccccceeeeEeeccccch-hhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccC
Confidence 433 2345678999999999888765 799999999999999999999999884 4555566665544433
Q ss_pred CH
Q 012233 360 TR 361 (468)
Q Consensus 360 ~~ 361 (468)
+.
T Consensus 259 ~i 260 (449)
T KOG1165|consen 259 PI 260 (449)
T ss_pred CH
Confidence 33
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-25 Score=219.97 Aligned_cols=157 Identities=19% Similarity=0.282 Sum_probs=121.0
Q ss_pred ccceEEeceecccCceEEEEEEEcC-CCCEEEEEEeecc---------cchHHHHHHHHHHcCCCCcccccceeeecCCC
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLE-TGDSVAIKKVLQD---------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEK 205 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~-~g~~vaiK~~~~~---------~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 205 (468)
...|.+.+.||+|+||+||+|.+.. +++.||||++... ...+.+|+++|+.++|+||+..+..+ .
T Consensus 17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---~-- 91 (365)
T PRK09188 17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---G-- 91 (365)
T ss_pred cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---C--
Confidence 4469999999999999999999876 6778899986422 22357899999999999998533211 1
Q ss_pred CceEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCC-CCCCeeecCCCCcEEEeee
Q 012233 206 DELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDI-KPQNLLVNPHTHQLKICDF 284 (468)
Q Consensus 206 ~~~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDl-kp~NILl~~~~~~vkL~DF 284 (468)
..||||||+.|+.+.... . .. ...++.|++.+|.|||+ +||+|||| ||+|||++.++ .+||+||
T Consensus 92 ---~~~LVmE~~~G~~L~~~~---~----~~---~~~~~~~i~~aL~~lH~-~gIiHrDL~KP~NILv~~~~-~ikLiDF 156 (365)
T PRK09188 92 ---KDGLVRGWTEGVPLHLAR---P----HG---DPAWFRSAHRALRDLHR-AGITHNDLAKPQNWLMGPDG-EAAVIDF 156 (365)
T ss_pred ---CcEEEEEccCCCCHHHhC---c----cc---hHHHHHHHHHHHHHHHH-CCCeeCCCCCcceEEEcCCC-CEEEEEC
Confidence 268999999987664221 0 11 14578899999999998 89999999 99999998777 7999999
Q ss_pred cCccccCCCCC---------CccccccCCcccccccc
Q 012233 285 GSAKMLVPGEP---------NISYICSRYYRAPELIF 312 (468)
Q Consensus 285 G~a~~~~~~~~---------~~~~~gt~~y~aPE~~~ 312 (468)
|+|+.+..... .....+++.|+|||.+.
T Consensus 157 GlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~ 193 (365)
T PRK09188 157 QLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT 193 (365)
T ss_pred ccceecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence 99986643221 12456788899999884
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.7e-24 Score=205.62 Aligned_cols=264 Identities=33% Similarity=0.468 Sum_probs=197.9
Q ss_pred eEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-------chHHHHHHHHHHcCCC-CcccccceeeecCCCCceEE
Q 012233 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHP-NVVSLKHCFFSTTEKDELYL 210 (468)
Q Consensus 139 y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-------~~~~~E~~il~~l~hp-nIv~l~~~~~~~~~~~~~~~ 210 (468)
|.+...||.|+||.||.+.+. ..+++|.+.... ....+|+.++..+.|+ +|+++++++ ......
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~ 73 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFF-----QDEGSL 73 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEE-----ecCCEE
Confidence 778899999999999999985 788999885432 2345788999999988 799999988 233337
Q ss_pred EEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcccc
Q 012233 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (468)
Q Consensus 211 ~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~ 290 (468)
+++++++.++.+............+.......++.|++.++.|+|. .|++|||+||+||+++..+..++++|||.+...
T Consensus 74 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~-~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~ 152 (384)
T COG0515 74 YLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS-KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLL 152 (384)
T ss_pred EEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHeeecCCCCeEEEeccCcceec
Confidence 8999999987665221111000268889999999999999999998 899999999999999987635999999999755
Q ss_pred CCCC-------CCccccccCCccccccccCC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCc---HHHHHHHHHHhCC
Q 012233 291 VPGE-------PNISYICSRYYRAPELIFGA--TEYTTAIDMWSIGCVLAELLLGQPLFPGESG---VDQLVEIIKILGT 358 (468)
Q Consensus 291 ~~~~-------~~~~~~gt~~y~aPE~~~~~--~~~~~~~DvwSlG~il~ell~G~~pf~~~~~---~~~~~~i~~~~~~ 358 (468)
.... ......|+..|++||.+.+. ..+....|+||+|++++++++|..||..... .......+.....
T Consensus 153 ~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 232 (384)
T COG0515 153 PDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPT 232 (384)
T ss_pred CCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCC
Confidence 4333 23567899999999999763 4588999999999999999999999887764 4444444443222
Q ss_pred CCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCCC
Q 012233 359 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPN 430 (468)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~ 430 (468)
+ ....+.. ..........+.+++.+|+..+|..|.+..+...++|........
T Consensus 233 ~-------------~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~~~~ 285 (384)
T COG0515 233 P-------------SLASPLS------PSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKE 285 (384)
T ss_pred c-------------ccccccC------ccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCccccc
Confidence 2 0000000 000011235789999999999999999999999987776644433
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-25 Score=225.11 Aligned_cols=237 Identities=30% Similarity=0.446 Sum_probs=187.9
Q ss_pred eecccCceEEEEEEE---cCCCCEEEEEEeecc------cchHHHHHHHHHHcC-CCCcccccceeeecCCCCceEEEEE
Q 012233 144 VVGTGSFGVVFQAKC---LETGDSVAIKKVLQD------KRYKNRELQIMRLLN-HPNVVSLKHCFFSTTEKDELYLNLV 213 (468)
Q Consensus 144 ~lG~G~fg~Vy~~~~---~~~g~~vaiK~~~~~------~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~~~~~~lv 213 (468)
++|+|.||.|+++.- ...|..+|+|+..+. ......|..++..++ ||.+|++.-+|.+ +..++++
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt-----~~kl~l~ 75 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQT-----DGKLYLI 75 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeecc-----ccchhHh
Confidence 379999999988753 345777888876432 112335888888887 9999999888843 3448899
Q ss_pred eecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCCC
Q 012233 214 LEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293 (468)
Q Consensus 214 ~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~~ 293 (468)
++|..++.+- .+ ......+.+...+.+...++-+++++|+ .||+|||+|++||+++.+|+ +++.|||+++.....
T Consensus 76 ld~~rgg~lf--t~-l~~~~~f~~~~~~~~~aelaLald~lh~-l~iiyrd~k~enilld~~Gh-i~~tdfglske~v~~ 150 (612)
T KOG0603|consen 76 LDFLRGGDLF--TR-LSKEVMFDELDVAFYLAELALALDHLHK-LGIAYRDYKLENVLLLLEGH-IKLTDFGLSKEAVKE 150 (612)
T ss_pred hhhcccchhh--hc-cccCCchHHHHHHHHHHHHHHHHhhcch-hHHHHhcccccceeecccCc-cccCCchhhhHhHhh
Confidence 9999876332 22 2234567788889999999999999998 89999999999999999994 999999999877554
Q ss_pred CCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCcc
Q 012233 294 EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTE 373 (468)
Q Consensus 294 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 373 (468)
... |||..|||||++. ....++|+||||+++|||++|..||.. +....|... .
T Consensus 151 ~~~---cgt~eymApEI~~---gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~-----------------~ 203 (612)
T KOG0603|consen 151 KIA---CGTYEYRAPEIIN---GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKA-----------------E 203 (612)
T ss_pred hhc---ccchhhhhhHhhh---ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhh-----------------c
Confidence 433 9999999999996 368899999999999999999999987 555555441 1
Q ss_pred CCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCC-----HHHHhCCCCCCCCCCC
Q 012233 374 FKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCT-----ALEACAHPFFDDLRDP 429 (468)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s-----~~ell~hp~f~~~~~~ 429 (468)
.. ++..++.++.+++..++..+|..|.- +.++++|+||+.+...
T Consensus 204 ~~------------~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~ 252 (612)
T KOG0603|consen 204 LE------------MPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWN 252 (612)
T ss_pred cC------------CchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHh
Confidence 11 33457889999999999999999984 5799999999987553
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-23 Score=198.59 Aligned_cols=195 Identities=25% Similarity=0.357 Sum_probs=144.3
Q ss_pred CCCCcccccceeeecCC----------------------CCceEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHH
Q 012233 188 NHPNVVSLKHCFFSTTE----------------------KDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTY 245 (468)
Q Consensus 188 ~hpnIv~l~~~~~~~~~----------------------~~~~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~ 245 (468)
.|||||++..+|.+... .....+|+||.....++..++. .+..+....+.++.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~-----~~~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLW-----TRHRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHh-----cCCCchHHHHHHHH
Confidence 49999999988744321 1134588999999888776554 35567778888999
Q ss_pred HHHHHHHHhHhcCCccccCCCCCCeeecCCCC---cEEEeeecCccccCC-------CCCCccccccCCccccccccCCC
Q 012233 246 QICRALNYLHHVVGVCHRDIKPQNLLVNPHTH---QLKICDFGSAKMLVP-------GEPNISYICSRYYRAPELIFGAT 315 (468)
Q Consensus 246 qi~~aL~yLH~~~givHrDlkp~NILl~~~~~---~vkL~DFG~a~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~ 315 (468)
|+++|+.|||+ +||.|||||.+||||.-+.+ .+.|+|||++-.-.. ........|...-||||+....+
T Consensus 349 QlLEav~hL~~-hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P 427 (598)
T KOG4158|consen 349 QLLEAVTHLHK-HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP 427 (598)
T ss_pred HHHHHHHHHHH-ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence 99999999998 99999999999999843322 588999999743211 11223456788899999986543
Q ss_pred C-----CCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccCCCCcccCCCccccccc
Q 012233 316 E-----YTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHK 390 (468)
Q Consensus 316 ~-----~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (468)
. .-.++|.|+.|.+.||++....||.+....-. -..+|.+-++|. ++.
T Consensus 428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L------------------~~r~Yqe~qLPa---------lp~ 480 (598)
T KOG4158|consen 428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLL------------------DTRTYQESQLPA---------LPS 480 (598)
T ss_pred CCceeeccchhhhhhhhhhHHHHhccCCcccccchhee------------------chhhhhhhhCCC---------Ccc
Confidence 3 23478999999999999999999987321100 011234444443 567
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHH
Q 012233 391 RMPPEALDLVSRLLQYSPSLRCTAL 415 (468)
Q Consensus 391 ~~~~~l~~li~~~L~~dP~~R~s~~ 415 (468)
.+++.+++|+..+|+.||++|+++.
T Consensus 481 ~vpp~~rqlV~~lL~r~pskRvsp~ 505 (598)
T KOG4158|consen 481 RVPPVARQLVFDLLKRDPSKRVSPN 505 (598)
T ss_pred cCChHHHHHHHHHhcCCccccCCcc
Confidence 7999999999999999999999854
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.5e-23 Score=194.51 Aligned_cols=237 Identities=24% Similarity=0.316 Sum_probs=144.5
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeecccchHH-------HHHHHHHHcC----------CCCcccccceee
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-------RELQIMRLLN----------HPNVVSLKHCFF 200 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~~~~~-------~E~~il~~l~----------hpnIv~l~~~~~ 200 (468)
.+..++.||.|+|+.||.+.+..+|+.+|+|++........ +|.-....+. |-.++..++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 36788899999999999999999999999998854332221 2221111111 111222222211
Q ss_pred --------ecCCCCce----EEEEEeecccchHHHHHhhhhhcCCC---CCHHHHHHHHHHHHHHHHHhHhcCCccccCC
Q 012233 201 --------STTEKDEL----YLNLVLEYISETVYRVSKHYTRMNQH---VPILYVQLYTYQICRALNYLHHVVGVCHRDI 265 (468)
Q Consensus 201 --------~~~~~~~~----~~~lv~e~~~~~ll~~~~~~~~~~~~---~~~~~~~~~~~qi~~aL~yLH~~~givHrDl 265 (468)
........ ..+++|+-+.+++..++......... ........+..|+++.+++||. .|++|+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~-~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS-YGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH-TTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh-cceEeccc
Confidence 11111111 24678888888887765543332222 2222234456899999999998 99999999
Q ss_pred CCCCeeecCCCCcEEEeeecCccccCCCCCCccccccCCccccccccCC-------CCCCcchhHHHHHHHHHHHHhCCC
Q 012233 266 KPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGA-------TEYTTAIDMWSIGCVLAELLLGQP 338 (468)
Q Consensus 266 kp~NILl~~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~~DvwSlG~il~ell~G~~ 338 (468)
||+|+|++.+| .++|+||+....... .......+..|.+||..... ..++.+.|.|+||+++|.|.+|..
T Consensus 172 ~~~nfll~~~G-~v~Lg~F~~~~r~g~--~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l 248 (288)
T PF14531_consen 172 KPENFLLDQDG-GVFLGDFSSLVRAGT--RYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL 248 (288)
T ss_dssp SGGGEEE-TTS--EEE--GGGEEETTE--EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred ceeeEEEcCCC-CEEEcChHHHeecCc--eeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence 99999999998 799999998765422 11113456789999977332 237889999999999999999999
Q ss_pred CCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCC
Q 012233 339 LFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLR 411 (468)
Q Consensus 339 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 411 (468)
||........ .+. .|.. .. ++|+.+++||..+|++||.+|
T Consensus 249 Pf~~~~~~~~-----------------------~~~--------~f~~-C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 249 PFGLSSPEAD-----------------------PEW--------DFSR-CR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp STCCCGGGST-----------------------SGG--------GGTT-SS----HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCcccc-----------------------ccc--------cchh-cC-CcCHHHHHHHHHHccCCcccC
Confidence 9975432110 000 1111 22 689999999999999999987
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.1e-23 Score=216.85 Aligned_cols=241 Identities=27% Similarity=0.411 Sum_probs=169.9
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeecccc-----h---HHHHHHHHHHcCCCCcccccceeeecCCCCceE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR-----Y---KNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~~-----~---~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 209 (468)
.|...+.||++.|=+|.+|++. .| .|+||++.+... . .-+|++ ...+++||++.+..+. .....
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~-eG-~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~-----~t~kA 95 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDR-EG-LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVL-----VTDKA 95 (1431)
T ss_pred ceeeecccCchhhhhhhhccCC-Cc-eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHH-----HhhHH
Confidence 4888899999999999999873 34 488999855431 1 123444 6677899999987765 44445
Q ss_pred EEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccc
Q 012233 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (468)
Q Consensus 210 ~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~ 289 (468)
.|||-+|+...|++.+.. ..-+...+.+.|+.||+.||.-+|+ .||+|||||.|||||++-.+ +.|+||..-+.
T Consensus 96 AylvRqyvkhnLyDRlST----RPFL~~iEKkWiaFQLL~al~qcH~-~gVcHGDIKsENILiTSWNW-~~LtDFAsFKP 169 (1431)
T KOG1240|consen 96 AYLVRQYVKHNLYDRLST----RPFLVLIEKKWIAFQLLKALSQCHK-LGVCHGDIKSENILITSWNW-LYLTDFASFKP 169 (1431)
T ss_pred HHHHHHHHhhhhhhhhcc----chHHHHHHHHHHHHHHHHHHHHHHH-cCccccccccceEEEeeech-hhhhcccccCC
Confidence 789999999988875542 2334566778899999999999998 89999999999999998774 89999987643
Q ss_pred c--CCCCC-Ccc-----ccccCCccccccccCCC----------CCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHH
Q 012233 290 L--VPGEP-NIS-----YICSRYYRAPELIFGAT----------EYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLV 350 (468)
Q Consensus 290 ~--~~~~~-~~~-----~~gt~~y~aPE~~~~~~----------~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~ 350 (468)
. +.+.+ ..+ ...-.+|.|||.+.... ..+++-||||+||+++||++ |++||.- .++.
T Consensus 170 tYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L----SQL~ 245 (1431)
T KOG1240|consen 170 TYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL----SQLL 245 (1431)
T ss_pred ccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH----HHHH
Confidence 3 22211 111 11235799999985421 15678999999999999987 7999842 1111
Q ss_pred HHHHHhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCC
Q 012233 351 EIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (468)
Q Consensus 351 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~h 420 (468)
.....- ....+. .+.+--+..++.||..|++.||++|.+|++.|+-
T Consensus 246 aYr~~~-~~~~e~-----------------------~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 246 AYRSGN-ADDPEQ-----------------------LLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred hHhccC-ccCHHH-----------------------HHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 111100 000000 0111123468999999999999999999999874
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.8e-22 Score=181.78 Aligned_cols=135 Identities=18% Similarity=0.248 Sum_probs=103.4
Q ss_pred eceecccCceEEEEEEEcCCCCEEEEEEeecccc------------------------------hHHHHHHHHHHcCCCC
Q 012233 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR------------------------------YKNRELQIMRLLNHPN 191 (468)
Q Consensus 142 ~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~~------------------------------~~~~E~~il~~l~hpn 191 (468)
...||+|+||.||+|.+. +|+.||||++..... ...+|+.++..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 357999999999999986 899999999854311 1124899999998887
Q ss_pred cccccceeeecCCCCceEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHh-HhcCCccccCCCCCCe
Q 012233 192 VVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL-HHVVGVCHRDIKPQNL 270 (468)
Q Consensus 192 Iv~l~~~~~~~~~~~~~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yL-H~~~givHrDlkp~NI 270 (468)
+....... . .. .+|||||++++.+.... .....++...+..++.|++.+|.|| |+ .||+||||||+||
T Consensus 81 v~~p~~~~-~----~~--~~iVmE~i~g~~l~~~~---~~~~~~~~~~~~~i~~qi~~~L~~l~H~-~giiHrDlkP~NI 149 (190)
T cd05147 81 IPCPEPIL-L----KS--HVLVMEFIGDDGWAAPR---LKDAPLSESKARELYLQVIQIMRILYQD-CRLVHADLSEYNL 149 (190)
T ss_pred CCCCcEEE-e----cC--CEEEEEEeCCCCCcchh---hhcCCCCHHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHE
Confidence 74433221 1 11 26999999986443211 1135688889999999999999999 66 8999999999999
Q ss_pred eecCCCCcEEEeeecCcccc
Q 012233 271 LVNPHTHQLKICDFGSAKML 290 (468)
Q Consensus 271 Ll~~~~~~vkL~DFG~a~~~ 290 (468)
|++. + .++|+|||+|...
T Consensus 150 li~~-~-~v~LiDFG~a~~~ 167 (190)
T cd05147 150 LYHD-G-KLYIIDVSQSVEH 167 (190)
T ss_pred EEEC-C-cEEEEEccccccC
Confidence 9984 4 6999999999643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=9.9e-22 Score=180.64 Aligned_cols=170 Identities=14% Similarity=0.149 Sum_probs=125.1
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc----cch---------HHHHHHHHHHcCCCCcccccceeeecC
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRY---------KNRELQIMRLLNHPNVVSLKHCFFSTT 203 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~----~~~---------~~~E~~il~~l~hpnIv~l~~~~~~~~ 203 (468)
.+|++.++||.|+||.||++.. ++..+|||++... ... .++|+..+.++.|++|..+.+++....
T Consensus 31 ~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~ 108 (232)
T PRK10359 31 YNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE 108 (232)
T ss_pred CceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence 3699999999999999999765 5778999988532 111 467888999999999999988865432
Q ss_pred CC---CceEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEE
Q 012233 204 EK---DELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLK 280 (468)
Q Consensus 204 ~~---~~~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vk 280 (468)
.. .....+|||||++|..+.... .++. ....+++.+|..||+ .|++|||+||+||++++++ ++
T Consensus 109 ~~~~~~~~~~~lvmEyi~G~tL~~~~-------~~~~----~~~~~i~~~l~~lH~-~gi~H~Dikp~Nili~~~g--i~ 174 (232)
T PRK10359 109 RKTLRYAHTYIMLIEYIEGVELNDMP-------EISE----DVKAKIKASIESLHQ-HGMVSGDPHKGNFIVSKNG--LR 174 (232)
T ss_pred cccccccCCeEEEEEEECCccHHHhh-------hccH----HHHHHHHHHHHHHHH-cCCccCCCChHHEEEeCCC--EE
Confidence 11 122477999999986553221 1222 245699999999998 8999999999999999876 99
Q ss_pred EeeecCccccCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHH
Q 012233 281 ICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELL 334 (468)
Q Consensus 281 L~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell 334 (468)
|+|||..+........ . ..+.. ..|+.++|+|+||+.+..+.
T Consensus 175 liDfg~~~~~~e~~a~-d----------~~vle-r~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 175 IIDLSGKRCTAQRKAK-D----------RIDLE-RHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEECCCcccccchhhH-H----------HHHHH-hHhcccccccceeEeehHHH
Confidence 9999988654221111 0 02222 23678999999999987654
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.9e-21 Score=173.08 Aligned_cols=181 Identities=18% Similarity=0.139 Sum_probs=133.5
Q ss_pred EEeceecccCceEEEEEEEcCCCCEEEEEEeecccc--------hHHHHHHHHHHcC-CCCcccccceeeecCCCCceEE
Q 012233 140 MAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR--------YKNRELQIMRLLN-HPNVVSLKHCFFSTTEKDELYL 210 (468)
Q Consensus 140 ~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~~--------~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~~~~~ 210 (468)
.+...|++|+||+||++.. .+..++.+.+..... .+.+|+++|++|. |++|++++++. ..
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~---------~~ 73 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD---------GR 73 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc---------CE
Confidence 3556899999999998775 678888776644332 3568999999996 47888887742 15
Q ss_pred EEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCC-CCCCeeecCCCCcEEEeeecCccc
Q 012233 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDI-KPQNLLVNPHTHQLKICDFGSAKM 289 (468)
Q Consensus 211 ~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDl-kp~NILl~~~~~~vkL~DFG~a~~ 289 (468)
+++|||+.|..+.... +.. ...++.|++.+|.+||. +||+|||| ||+|||++.++ .++|+|||++..
T Consensus 74 ~lvmeyI~G~~L~~~~---------~~~-~~~~~~qi~~~L~~lH~-~GIvHrDL~kp~NILv~~~g-~i~LIDFG~A~~ 141 (218)
T PRK12274 74 HLDRSYLAGAAMYQRP---------PRG-DLAYFRAARRLLQQLHR-CGVAHNDLAKEANWLVQEDG-SPAVIDFQLAVR 141 (218)
T ss_pred EEEEeeecCccHHhhh---------hhh-hHHHHHHHHHHHHHHHH-CcCccCCCCCcceEEEcCCC-CEEEEECCCcee
Confidence 7999999987654211 001 13467899999999998 89999999 79999999887 799999999986
Q ss_pred cCCCCCC--------------ccccccCCccccccccCCCCCC-cchhHHHHHHHHHHHHhCCCCCCCC
Q 012233 290 LVPGEPN--------------ISYICSRYYRAPELIFGATEYT-TAIDMWSIGCVLAELLLGQPLFPGE 343 (468)
Q Consensus 290 ~~~~~~~--------------~~~~gt~~y~aPE~~~~~~~~~-~~~DvwSlG~il~ell~G~~pf~~~ 343 (468)
....... .-..+++.|+.|+...-....+ ...++++.|+-+|.++|+..++-++
T Consensus 142 ~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 142 GNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred cCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 5433211 0112478888888753322233 4678889999999999999887544
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=5e-21 Score=173.97 Aligned_cols=137 Identities=18% Similarity=0.235 Sum_probs=104.8
Q ss_pred eceecccCceEEEEEEEcCCCCEEEEEEeecccc------------------------------hHHHHHHHHHHcCCCC
Q 012233 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR------------------------------YKNRELQIMRLLNHPN 191 (468)
Q Consensus 142 ~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~~------------------------------~~~~E~~il~~l~hpn 191 (468)
...||+|+||.||+|.+. +|+.||||++..... ...+|...+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 467999999999999986 899999998864310 1246888999999998
Q ss_pred cccccceeeecCCCCceEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCee
Q 012233 192 VVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLL 271 (468)
Q Consensus 192 Iv~l~~~~~~~~~~~~~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NIL 271 (468)
|.....+... . .||||||++|+.+.... . ....++...+..++.|++.+|.+||...||+||||||+|||
T Consensus 81 i~~p~~~~~~-----~--~~lVmE~~~g~~~~~~~--l-~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIl 150 (190)
T cd05145 81 VPVPEPILLK-----K--NVLVMEFIGDDGSPAPR--L-KDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNIL 150 (190)
T ss_pred CCCceEEEec-----C--CEEEEEEecCCCchhhh--h-hhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEE
Confidence 7554433311 1 36999999986322110 1 12456778889999999999999995379999999999999
Q ss_pred ecCCCCcEEEeeecCccccC
Q 012233 272 VNPHTHQLKICDFGSAKMLV 291 (468)
Q Consensus 272 l~~~~~~vkL~DFG~a~~~~ 291 (468)
++ ++ .++|+|||++....
T Consensus 151 l~-~~-~~~liDFG~a~~~~ 168 (190)
T cd05145 151 YH-DG-KPYIIDVSQAVELD 168 (190)
T ss_pred EE-CC-CEEEEEcccceecC
Confidence 99 55 79999999997653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.1e-21 Score=173.36 Aligned_cols=239 Identities=17% Similarity=0.204 Sum_probs=177.4
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeec------ccchHHHHHHHHHHcCCCCcccccceeeecCCCCceEEE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ------DKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~------~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 211 (468)
+..+.-+|.+...|..|+|+| .|..++.|++.- ..+.+.+|.-.|+.+.||||+.+++.+ .....+.
T Consensus 191 ~lnl~tkl~e~hsgelwrgrw--qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgac-----nsppnlv 263 (448)
T KOG0195|consen 191 SLNLITKLAESHSGELWRGRW--QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGAC-----NSPPNLV 263 (448)
T ss_pred hhhhhhhhccCCCcccccccc--cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhc-----cCCCCce
Confidence 345566788999999999999 555666676532 235567788899999999999999999 5556688
Q ss_pred EEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCcccc-CCCCCCeeecCCCCcEEE--eeecCcc
Q 012233 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHR-DIKPQNLLVNPHTHQLKI--CDFGSAK 288 (468)
Q Consensus 212 lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHr-Dlkp~NILl~~~~~~vkL--~DFG~a~ 288 (468)
+|..|++-+.+.-+.+. ...--++-.++.+++.++++|++|||+.-.++-| -|....++||.+. +.+| +|--++-
T Consensus 264 ~isq~mp~gslynvlhe-~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedl-tarismad~kfsf 341 (448)
T KOG0195|consen 264 IISQYMPFGSLYNVLHE-QTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDL-TARISMADTKFSF 341 (448)
T ss_pred EeeeeccchHHHHHHhc-CccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchh-hhheecccceeee
Confidence 99999995544433332 1223356677899999999999999985556654 6888899999876 5554 3332221
Q ss_pred ccCCCCCCccccccCCccccccccCCCC--CCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 012233 289 MLVPGEPNISYICSRYYRAPELIFGATE--YTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKC 366 (468)
Q Consensus 289 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 366 (468)
...+....|.||+||.+...+. .-.++|+|||++++|||.|...||...++.+--.+|.-.
T Consensus 342 ------qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkiale----------- 404 (448)
T KOG0195|consen 342 ------QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALE----------- 404 (448)
T ss_pred ------eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhc-----------
Confidence 1224456899999999976554 235899999999999999999999988877765554321
Q ss_pred cCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 012233 367 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEAC 418 (468)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell 418 (468)
.+...+++.++.....|+.-|+..||.+||.++.+.
T Consensus 405 ----------------glrv~ippgis~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 405 ----------------GLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred ----------------cccccCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 111225677899999999999999999999987754
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.81 E-value=3e-20 Score=183.36 Aligned_cols=181 Identities=28% Similarity=0.448 Sum_probs=136.4
Q ss_pred ceEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecC
Q 012233 207 ELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (468)
Q Consensus 207 ~~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~ 286 (468)
..++||.|++|....+.......+.....+......++.|+..|++| +|.+|+|+||.||+...+. ++||.|||+
T Consensus 328 ~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y----k~~ihrdlkp~nif~~~d~-q~kIgDFgl 402 (516)
T KOG1033|consen 328 KVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY----KGLIHRDLKPSNIFFSDDD-QLKIGDFGL 402 (516)
T ss_pred ccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh----ccchhhhccccccccccch-hhhhhhhhh
Confidence 34689999999977666555445556667778889999999999999 5999999999999998777 899999999
Q ss_pred ccccCCCC-------CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCC
Q 012233 287 AKMLVPGE-------PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGT 358 (468)
Q Consensus 287 a~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~ 358 (468)
........ ......||..||+||.+.+.. |+.++||||||+||+||++ =...|. .....
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~-y~~kvdIyaLGlil~EL~~~f~T~~e------r~~t~------ 469 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQ-YSEKVDIYALGLILAELLIQFSTQFE------RIATL------ 469 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhh-hhhhcchhhHHHHHHHHHHHhccHHH------HHHhh------
Confidence 98776555 566788999999999998765 9999999999999999997 222221 11110
Q ss_pred CCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCC
Q 012233 359 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFD 424 (468)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~ 424 (468)
..+....|.+.+..+. +.-.+|+..||...|.+||++.+.-.|+|.+
T Consensus 470 ------------------~d~r~g~ip~~~~~d~-p~e~~ll~~lls~~p~~RP~~~~~~~~~~~~ 516 (516)
T KOG1033|consen 470 ------------------TDIRDGIIPPEFLQDY-PEEYTLLQQLLSPSPEERPSAIEVALHEFLQ 516 (516)
T ss_pred ------------------hhhhcCCCChHHhhcC-cHHHHHHHHhcCCCcccCchHHHHhhhhhcC
Confidence 0111111111122222 3456899999999999999988888888863
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=5.2e-19 Score=162.04 Aligned_cols=133 Identities=18% Similarity=0.238 Sum_probs=97.5
Q ss_pred eceecccCceEEEEEEEcCCCCEEEEEEeecc----cchHHHHHHHHHHc-----CCCCcccccceeeecCCCCceE-EE
Q 012233 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLL-----NHPNVVSLKHCFFSTTEKDELY-LN 211 (468)
Q Consensus 142 ~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~----~~~~~~E~~il~~l-----~hpnIv~l~~~~~~~~~~~~~~-~~ 211 (468)
.+.||+|+||.||. +..++.. +||++... .....+|+.+++.+ .||||+++++++.+.. +..+ +.
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~--g~g~v~~ 81 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDC--GTGYVYD 81 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCC--CCeEEEE
Confidence 46799999999996 6667666 68987643 34567899999999 5799999999885543 2234 34
Q ss_pred EEeeccc--c-hHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHH-HHhHhcCCccccCCCCCCeeecCCC---CcEEEeee
Q 012233 212 LVLEYIS--E-TVYRVSKHYTRMNQHVPILYVQLYTYQICRAL-NYLHHVVGVCHRDIKPQNLLVNPHT---HQLKICDF 284 (468)
Q Consensus 212 lv~e~~~--~-~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL-~yLH~~~givHrDlkp~NILl~~~~---~~vkL~DF 284 (468)
+||||++ + ++.+.+.. ..+++. ..++.|++.++ +|||+ ++|+||||||+|||++..+ ..++|+||
T Consensus 82 ~I~e~~G~~~~tL~~~l~~-----~~~~e~--~~~~~~~L~~l~~yLh~-~~IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQ-----CRYEED--VAQLRQLLKKLKRYLLD-NRIVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EEecCCCCcchhHHHHHHc-----ccccHh--HHHHHHHHHHHHHHHHH-CCEeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 7899954 4 44444422 235544 35677888777 99998 9999999999999997432 26999995
Q ss_pred cCc
Q 012233 285 GSA 287 (468)
Q Consensus 285 G~a 287 (468)
+-+
T Consensus 154 ~G~ 156 (210)
T PRK10345 154 IGE 156 (210)
T ss_pred CCC
Confidence 443
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.80 E-value=3e-19 Score=191.30 Aligned_cols=189 Identities=24% Similarity=0.387 Sum_probs=144.9
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeecccc-hHHHHHHHHHHcC---CCCcccccceeeecCCCCceEEEE
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR-YKNRELQIMRLLN---HPNVVSLKHCFFSTTEKDELYLNL 212 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~~-~~~~E~~il~~l~---hpnIv~l~~~~~~~~~~~~~~~~l 212 (468)
..|.|.+.||+|+||.||+|.... |+.||||+-....- .+.--.+++.+|+ -+-|+.+..++...+. .+|
T Consensus 698 ~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~-----S~l 771 (974)
T KOG1166|consen 698 EKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQNA-----SVL 771 (974)
T ss_pred eeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHccCCc-----cee
Confidence 469999999999999999999866 99999996533211 1111223444444 3455555555543332 568
Q ss_pred Eeeccc-chHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecC------CCCcEEEeeec
Q 012233 213 VLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNP------HTHQLKICDFG 285 (468)
Q Consensus 213 v~e~~~-~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~------~~~~vkL~DFG 285 (468)
|+||.+ |++++++. ..+.+++..+..++.|+++-++.||. .+|||+||||+|+||.. +...++|+|||
T Consensus 772 v~ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH~-~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG 846 (974)
T KOG1166|consen 772 VSEYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLHA-MGIIHGDIKPDNFLLRREICADSDSKGLYLIDFG 846 (974)
T ss_pred eeeccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHHh-cceecccCCcceeEeecccCCCCcccceEEEecc
Confidence 999999 56666655 46778888899999999999999997 89999999999999832 22259999999
Q ss_pred Ccccc---CCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCC
Q 012233 286 SAKML---VPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQ 337 (468)
Q Consensus 286 ~a~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~ 337 (468)
.+-.+ .++......++|-.+-.+|+..|.+ +++.+|.|.|+.+++-||.|+
T Consensus 847 ~siDm~lfp~~~~F~~~~~td~f~C~EM~~grp-WtYq~DyfGlAa~~h~mLFG~ 900 (974)
T KOG1166|consen 847 RSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRP-WTYQIDYFGLAATVHVMLFGK 900 (974)
T ss_pred cceeeeEcCCCcEEeeeeccccchhHHHhcCCC-CchhhhhHHHHHHHHHHHHHH
Confidence 98544 3343455677888999999998776 999999999999999999996
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.8e-19 Score=166.76 Aligned_cols=139 Identities=17% Similarity=0.144 Sum_probs=105.0
Q ss_pred ceEEeceecccCceEEEEEE-EcCCCCEEEEEEeeccc----------------------------chHHHHHHHHHHcC
Q 012233 138 SYMAERVVGTGSFGVVFQAK-CLETGDSVAIKKVLQDK----------------------------RYKNRELQIMRLLN 188 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~-~~~~g~~vaiK~~~~~~----------------------------~~~~~E~~il~~l~ 188 (468)
.|.+.+.||+|+||.||+|. +..+|+.||||++.... ....+|+.+++++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 48899999999999999998 66789999999885431 11346999999997
Q ss_pred CCCcccccceeeecCCCCceEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCC-ccccCCCC
Q 012233 189 HPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG-VCHRDIKP 267 (468)
Q Consensus 189 hpnIv~l~~~~~~~~~~~~~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~g-ivHrDlkp 267 (468)
+. ++.+...+.. . ..++||||+++..+.... .....+....+..++.||+.+|.+||. .| |+||||||
T Consensus 109 ~~-~i~~p~~~~~-~-----~~~lV~E~~~g~~L~~~~---~~~~~~~~~~~~~i~~qi~~~l~~LH~-~g~iiH~Dikp 177 (237)
T smart00090 109 EA-GVPVPKPIAW-R-----RNVLVMEFIGGDGLPAPR---LKDVEPEEEEEFELYDDILEEMRKLYK-EGELVHGDLSE 177 (237)
T ss_pred hc-CCCCCeeeEe-c-----CceEEEEEecCCcccccc---cccCCcchHHHHHHHHHHHHHHHHHHh-cCCEEeCCCCh
Confidence 53 3333333321 1 136999999986543211 112334555677899999999999998 89 99999999
Q ss_pred CCeeecCCCCcEEEeeecCccc
Q 012233 268 QNLLVNPHTHQLKICDFGSAKM 289 (468)
Q Consensus 268 ~NILl~~~~~~vkL~DFG~a~~ 289 (468)
+||+++ ++ .++|+|||.+..
T Consensus 178 ~NIli~-~~-~i~LiDFg~a~~ 197 (237)
T smart00090 178 YNILVH-DG-KVVIIDVSQSVE 197 (237)
T ss_pred hhEEEE-CC-CEEEEEChhhhc
Confidence 999999 55 799999999864
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.74 E-value=3.2e-19 Score=187.26 Aligned_cols=257 Identities=26% Similarity=0.328 Sum_probs=192.5
Q ss_pred ceEEeceecccCceEEEEEEEcC-CCCEEEEEEeecc---cchH---HHHHHHHHHcC-CCCcccccceeeecCCCCceE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLE-TGDSVAIKKVLQD---KRYK---NRELQIMRLLN-HPNVVSLKHCFFSTTEKDELY 209 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~-~g~~vaiK~~~~~---~~~~---~~E~~il~~l~-hpnIv~l~~~~~~~~~~~~~~ 209 (468)
.|.+.+.||+|+|+.|-.+.... ....+|.|.+... .... ..|..+-+.+. |.|++++++.. .+..+
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~-----~~~~~ 95 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPS-----SSPRS 95 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCcc-----CCCcc
Confidence 48888899999999998887633 3445666655332 2222 24777878887 99999999987 56666
Q ss_pred EEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhH-hcCCccccCCCCCCeeecCCCCcEEEeeecCcc
Q 012233 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH-HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (468)
Q Consensus 210 ~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH-~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~ 288 (468)
.+++++|..|+.+-.... .......+...+..++.|+..++.|+| . .++.|+|+||+|.+++..+..+++.|||+|.
T Consensus 96 ~~~~~~~s~g~~~f~~i~-~~~~~~~~~~~~~~~~~ql~s~l~~~H~~-~~~~h~~ikP~n~~l~~s~~~l~~~df~~At 173 (601)
T KOG0590|consen 96 YLLSLSYSDGGSLFSKIS-HPDSTGTSSSSASRYLPQLNSGLSYLHPE-NGVTHRDIKPSNSLLDESGSALKIADFGLAT 173 (601)
T ss_pred cccccCcccccccccccc-cCCccCCCCcchhhhhhhhccCccccCcc-cccccCCCCCccchhccCCCcccCCCchhhc
Confidence 889999977653321110 111225667778899999999999999 7 8999999999999999776469999999998
Q ss_pred ccCC-CC---CCccccc-cCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 012233 289 MLVP-GE---PNISYIC-SRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREE 363 (468)
Q Consensus 289 ~~~~-~~---~~~~~~g-t~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~ 363 (468)
.+.. .. .....+| ++.|+|||...+.....+..|+||+|+++.-+++|..|+......+..
T Consensus 174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-------------- 239 (601)
T KOG0590|consen 174 AYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-------------- 239 (601)
T ss_pred cccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc--------------
Confidence 7755 22 2335678 999999999987555788999999999999999999999765432210
Q ss_pred HhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q 012233 364 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDD 425 (468)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~ 425 (468)
|. .+...+ .......+..++..+.+++.++|..+|..|.+..++..+||+..
T Consensus 240 -------~~--~~~~~~-~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 240 -------YS--SWKSNK-GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred -------ce--eecccc-cccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 00 000000 11122345678999999999999999999999999999999998
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.6e-17 Score=151.97 Aligned_cols=131 Identities=18% Similarity=0.166 Sum_probs=100.8
Q ss_pred eEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc--------------------------chHHHHHHHHHHcCCCC-
Q 012233 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK--------------------------RYKNRELQIMRLLNHPN- 191 (468)
Q Consensus 139 y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~--------------------------~~~~~E~~il~~l~hpn- 191 (468)
|.+.+.||+|+||.||++... +|+.||||++.... ....+|..++..+.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 888899999999999999874 79999999864321 11346888888888774
Q ss_pred -cccccceeeecCCCCceEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCe
Q 012233 192 -VVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNL 270 (468)
Q Consensus 192 -Iv~l~~~~~~~~~~~~~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NI 270 (468)
+..+++. ...++||||+.|..+..... ......++.+++.++.++|+ .||+|+||||+||
T Consensus 96 ~v~~~~~~---------~~~~lv~e~~~g~~L~~~~~---------~~~~~~~~~~i~~~l~~lh~-~gi~H~Dl~p~Ni 156 (198)
T cd05144 96 PVPKPIDW---------NRHAVVMEYIDGVELYRVRV---------LEDPEEVLDEILEEIVKAYK-HGIIHGDLSEFNI 156 (198)
T ss_pred CCCceeec---------CCceEEEEEeCCcchhhccc---------cccHHHHHHHHHHHHHHHHH-CCCCcCCCCcccE
Confidence 3333221 12479999999875542211 02356788899999999998 8999999999999
Q ss_pred eecCCCCcEEEeeecCcccc
Q 012233 271 LVNPHTHQLKICDFGSAKML 290 (468)
Q Consensus 271 Ll~~~~~~vkL~DFG~a~~~ 290 (468)
+++.++ .++|+|||.+...
T Consensus 157 ll~~~~-~~~liDfg~~~~~ 175 (198)
T cd05144 157 LVDDDE-KIYIIDWPQMVST 175 (198)
T ss_pred EEcCCC-cEEEEECCccccC
Confidence 999877 8999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=4e-17 Score=150.84 Aligned_cols=130 Identities=21% Similarity=0.315 Sum_probs=100.6
Q ss_pred ceecccCceEEEEEEEcCCCCEEEEEEeeccc------------chHHHHHHHHHHcCCCCcccccceeeecCCCCceEE
Q 012233 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (468)
Q Consensus 143 ~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~------------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~ 210 (468)
+.||+|++|.||+|.+ .|..+++|+..... ....+|+.++..+.|++|.....++... ...
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-----~~~ 74 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDP-----ENF 74 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeC-----CCC
Confidence 5799999999999987 77889999754211 1234689999999999987766655332 236
Q ss_pred EEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccc
Q 012233 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (468)
Q Consensus 211 ~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~ 289 (468)
++||||++|..+...... . .. ....++.+++.+|.+||+ .|++|+|++|.|||++ ++ .++|+|||.+..
T Consensus 75 ~lv~e~~~G~~L~~~~~~---~---~~-~~~~i~~~i~~~l~~lH~-~~i~H~Dl~p~Nil~~-~~-~~~liDf~~a~~ 143 (211)
T PRK14879 75 IIVMEYIEGEPLKDLINS---N---GM-EELELSREIGRLVGKLHS-AGIIHGDLTTSNMILS-GG-KIYLIDFGLAEF 143 (211)
T ss_pred EEEEEEeCCcCHHHHHHh---c---cH-HHHHHHHHHHHHHHHHHh-CCcccCCCCcccEEEE-CC-CEEEEECCcccC
Confidence 799999987655432221 1 11 677889999999999998 8999999999999999 55 799999999864
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=2.3e-17 Score=165.98 Aligned_cols=206 Identities=24% Similarity=0.324 Sum_probs=146.2
Q ss_pred HHHcCCCCcccccceeeecCCCCceEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCcccc
Q 012233 184 MRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHR 263 (468)
Q Consensus 184 l~~l~hpnIv~l~~~~~~~~~~~~~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHr 263 (468)
|+.+.|.|+.++++.++.. ..+++|.+||+.+.+..+... ....++......++++|+.||.|||+.....|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~-----~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg 73 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDG-----PEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSPIGYHG 73 (484)
T ss_pred CcccchhhhhhheeeEecC-----CceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCcceeee
Confidence 4678999999999999655 348899999996544433322 345677777888999999999999984444999
Q ss_pred CCCCCCeeecCCCCcEEEeeecCccccCCC---CCCccccccCCccccccccCCCC------CCcchhHHHHHHHHHHHH
Q 012233 264 DIKPQNLLVNPHTHQLKICDFGSAKMLVPG---EPNISYICSRYYRAPELIFGATE------YTTAIDMWSIGCVLAELL 334 (468)
Q Consensus 264 Dlkp~NILl~~~~~~vkL~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~------~~~~~DvwSlG~il~ell 334 (468)
.|+..|+++|... .+||+|||+....... .......-..-|.|||.+.+... .+.+.|+||||++++|++
T Consensus 74 ~l~s~nClvd~~w-~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~ 152 (484)
T KOG1023|consen 74 ALKSSNCLVDSRW-VLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEIL 152 (484)
T ss_pred eeccccceeeeeE-EEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHH
Confidence 9999999999887 8999999998765321 11111122456999999976421 366799999999999999
Q ss_pred hCCCCCCCCCcH----HHHHHHHHHhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCC
Q 012233 335 LGQPLFPGESGV----DQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSL 410 (468)
Q Consensus 335 ~G~~pf~~~~~~----~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 410 (468)
+...||...... +.+..+.+....+.+. . .... ..+++++..++..||..+|..
T Consensus 153 ~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP---------------~------i~~~-~e~~~~l~~l~~~cw~e~P~~ 210 (484)
T KOG1023|consen 153 FRSGPFDLRNLVEDPDEIILRVKKGGSNPFRP---------------S------IELL-NELPPELLLLVARCWEEIPEK 210 (484)
T ss_pred hccCccccccccCChHHHHHHHHhcCCCCcCc---------------c------hhhh-hhcchHHHHHHHHhcccChhh
Confidence 999999863322 2222222201111111 0 0001 135668999999999999999
Q ss_pred CCCHHHHhC
Q 012233 411 RCTALEACA 419 (468)
Q Consensus 411 R~s~~ell~ 419 (468)
||+++++-.
T Consensus 211 rPs~~~i~~ 219 (484)
T KOG1023|consen 211 RPSIEQIRS 219 (484)
T ss_pred CccHHHHHh
Confidence 999998854
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.70 E-value=9.7e-17 Score=146.85 Aligned_cols=126 Identities=19% Similarity=0.302 Sum_probs=94.8
Q ss_pred eecccCceEEEEEEEcCCCCEEEEEEeeccc------------chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEE
Q 012233 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (468)
Q Consensus 144 ~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~------------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 211 (468)
.||+|+||.||+|.+ +|..|++|...... ....+|+++++.+.|+++.....++... ...+
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-----~~~~ 73 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDP-----DNKT 73 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEC-----CCCE
Confidence 489999999999985 67889999854321 2234699999999988765544443222 1257
Q ss_pred EEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccc
Q 012233 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (468)
Q Consensus 212 lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~ 289 (468)
+||||++|..+...... .. ..++.|++.+|.+||+ .|++|+|++|.||+++ ++ .++++|||++..
T Consensus 74 lv~e~~~g~~l~~~~~~---~~-------~~~~~~i~~~l~~lH~-~gi~H~Dl~~~Nil~~-~~-~~~liDfg~a~~ 138 (199)
T TIGR03724 74 IVMEYIEGKPLKDVIEE---GN-------DELLREIGRLVGKLHK-AGIVHGDLTTSNIIVR-DD-KLYLIDFGLGKY 138 (199)
T ss_pred EEEEEECCccHHHHHhh---cH-------HHHHHHHHHHHHHHHH-CCeecCCCCcceEEEE-CC-cEEEEECCCCcC
Confidence 99999988655432211 10 0678899999999998 8999999999999999 55 799999999865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.3e-16 Score=167.75 Aligned_cols=131 Identities=18% Similarity=0.280 Sum_probs=98.8
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc------------cchHHHHHHHHHHcCCCCcccccceeeecCCC
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEK 205 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~------------~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 205 (468)
.|...+.||+|+||.||++.+. +..+++|+.... .....+|+++++.++|++|+..+.++...
T Consensus 334 ~~~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~--- 408 (535)
T PRK09605 334 RKIPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP--- 408 (535)
T ss_pred ccCccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC---
Confidence 4567889999999999999874 344444432111 12245799999999999998876555332
Q ss_pred CceEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeec
Q 012233 206 DELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG 285 (468)
Q Consensus 206 ~~~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG 285 (468)
...++||||++++.+..... ....++.|++.+|.|||+ .||+||||||+|||++ ++ .++|+|||
T Consensus 409 --~~~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~-~giiHrDlkp~NILl~-~~-~~~liDFG 472 (535)
T PRK09605 409 --EEKTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHK-AGIVHGDLTTSNFIVR-DD-RLYLIDFG 472 (535)
T ss_pred --CCCEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHh-CCCccCCCChHHEEEE-CC-cEEEEeCc
Confidence 23579999999865543221 246788999999999998 8999999999999995 44 69999999
Q ss_pred Cccc
Q 012233 286 SAKM 289 (468)
Q Consensus 286 ~a~~ 289 (468)
+++.
T Consensus 473 la~~ 476 (535)
T PRK09605 473 LGKY 476 (535)
T ss_pred cccc
Confidence 9865
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.66 E-value=5.3e-16 Score=140.45 Aligned_cols=131 Identities=22% Similarity=0.195 Sum_probs=90.9
Q ss_pred eceecccCceEEEEEEEcCCCCEEEEEEeecccchH----------------------------HHHHHHHHHcCCCC--
Q 012233 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYK----------------------------NRELQIMRLLNHPN-- 191 (468)
Q Consensus 142 ~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~~~~----------------------------~~E~~il~~l~hpn-- 191 (468)
.+.||+|+||+||+|.+. +|+.||||++....... ..|...+..+.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 467999999999999976 79999999875432110 23444455554332
Q ss_pred cccccceeeecCCCCceEEEEEeecccchHHH--HHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCC
Q 012233 192 VVSLKHCFFSTTEKDELYLNLVLEYISETVYR--VSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQN 269 (468)
Q Consensus 192 Iv~l~~~~~~~~~~~~~~~~lv~e~~~~~ll~--~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~N 269 (468)
+.+++.+. ..++||||++++... .+.... .. ..++.++.+++.++.+||...||+|+||||+|
T Consensus 81 ~~~~~~~~---------~~~lv~e~~~g~~~~~~~l~~~~-----~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~N 145 (187)
T cd05119 81 VPKPIDLN---------RHVLVMEFIGGDGIPAPRLKDVR-----LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYN 145 (187)
T ss_pred CCceEecC---------CCEEEEEEeCCCCccChhhhhhh-----hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhh
Confidence 23332211 247999999983211 011110 01 45788999999999999953799999999999
Q ss_pred eeecCCCCcEEEeeecCcccc
Q 012233 270 LLVNPHTHQLKICDFGSAKML 290 (468)
Q Consensus 270 ILl~~~~~~vkL~DFG~a~~~ 290 (468)
|+++ ++ .++|+|||.+...
T Consensus 146 ili~-~~-~~~liDfg~a~~~ 164 (187)
T cd05119 146 ILVD-DG-KVYIIDVPQAVEI 164 (187)
T ss_pred EEEE-CC-cEEEEECcccccc
Confidence 9999 55 7999999999654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.61 E-value=1.9e-15 Score=130.89 Aligned_cols=131 Identities=21% Similarity=0.284 Sum_probs=103.2
Q ss_pred EeceecccCceEEEEEEEcCCCCEEEEEEeecccc--hHHHHHHHHHHcCC--CCcccccceeeecCCCCceEEEEEeec
Q 012233 141 AERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR--YKNRELQIMRLLNH--PNVVSLKHCFFSTTEKDELYLNLVLEY 216 (468)
Q Consensus 141 ~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~~--~~~~E~~il~~l~h--pnIv~l~~~~~~~~~~~~~~~~lv~e~ 216 (468)
+.+.||.|.++.||++.. .+..+++|....... ...+|+.+++.++| .++.+++.++ ......+++|||
T Consensus 2 ~~~~i~~g~~~~v~~~~~--~~~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~-----~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGT--KDEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASG-----ESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEe--cCCeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEc-----CCCCccEEEEEe
Confidence 346799999999999997 347899998866543 56789999999987 4888877665 222457899999
Q ss_pred ccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhc--CCccccCCCCCCeeecCCCCcEEEeeecCccc
Q 012233 217 ISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV--VGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (468)
Q Consensus 217 ~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~--~givHrDlkp~NILl~~~~~~vkL~DFG~a~~ 289 (468)
+.+..+... +......++.+++.+|++||.. .+++|+|++|+|||++..+ .++++|||.+..
T Consensus 75 ~~g~~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~-~~~l~Df~~~~~ 138 (155)
T cd05120 75 IEGETLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGK-ILGIIDWEYAGY 138 (155)
T ss_pred cCCeecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCc-EEEEEecccccC
Confidence 987644311 4455667889999999999963 2799999999999999866 799999999864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.60 E-value=4.7e-15 Score=149.49 Aligned_cols=247 Identities=26% Similarity=0.298 Sum_probs=187.1
Q ss_pred ceEEeceecc--cCceEEEEEEE--cCCCCEEEEEEee------cccchHHHHHHHHHHcC-CCCcccccceeeecCCCC
Q 012233 138 SYMAERVVGT--GSFGVVFQAKC--LETGDSVAIKKVL------QDKRYKNRELQIMRLLN-HPNVVSLKHCFFSTTEKD 206 (468)
Q Consensus 138 ~y~~~~~lG~--G~fg~Vy~~~~--~~~g~~vaiK~~~------~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~ 206 (468)
.+.+...+|. |.+|.||.+.+ ..++..+|+|.-+ .......+|+.-.+.+. |+|.++.+..+ .+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~-----e~ 189 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAW-----EG 189 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccc-----cc
Confidence 3667788999 99999999999 8899999999631 12233345666656664 89999977777 55
Q ss_pred ceEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHH----HHHHhHhcCCccccCCCCCCeeecCCCCcEEEe
Q 012233 207 ELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICR----ALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKIC 282 (468)
Q Consensus 207 ~~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~----aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~ 282 (468)
...+|+-+|+|+..+..... .....++...++.+..+... ||..+|. .+++|-|+||+||++..+...++++
T Consensus 190 ~~~lfiqtE~~~~sl~~~~~---~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs-~~~~~~~~kp~~i~~~~~~~s~~~~ 265 (524)
T KOG0601|consen 190 SGILFIQTELCGESLQSYCH---TPCNFLPDNLLWNSLRDWLSRDVTALSHLHS-NNIVHDDLKPANIFTTSDWTSCKLT 265 (524)
T ss_pred CCcceeeeccccchhHHhhh---cccccCCchhhhhHHhhhhhcccccccccCC-CcccccccchhheecccccceeecC
Confidence 55689999999976665332 22344788889999999999 9999997 8999999999999999884479999
Q ss_pred eecCccccCCCCCCc------cccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC--CcHHHHHHHHH
Q 012233 283 DFGSAKMLVPGEPNI------SYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGE--SGVDQLVEIIK 354 (468)
Q Consensus 283 DFG~a~~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~--~~~~~~~~i~~ 354 (468)
|||+...+....... ...|...|++||+..+ -++...|+|++|.++.+..+|..++... +.+.++..
T Consensus 266 df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~--l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~--- 340 (524)
T KOG0601|consen 266 DFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG--LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ--- 340 (524)
T ss_pred CcceeEEccCCccccceeeeecCCCCceEeChhhhcc--ccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc---
Confidence 999998876554221 2256778999999854 3899999999999999999988776543 22221111
Q ss_pred HhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q 012233 355 ILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDD 425 (468)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~ 425 (468)
.| ....|-...+.++...+..|++.+|..|+++..+++|+++..
T Consensus 341 ---------------~~------------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s 384 (524)
T KOG0601|consen 341 ---------------GY------------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS 384 (524)
T ss_pred ---------------cc------------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence 11 011122345667777999999999999999999999999885
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.60 E-value=1.4e-14 Score=136.20 Aligned_cols=133 Identities=16% Similarity=0.253 Sum_probs=94.8
Q ss_pred ceec-ccCceEEEEEEEcCCCCEEEEEEeecc-----------------cchHHHHHHHHHHcCCCCc--ccccceeeec
Q 012233 143 RVVG-TGSFGVVFQAKCLETGDSVAIKKVLQD-----------------KRYKNRELQIMRLLNHPNV--VSLKHCFFST 202 (468)
Q Consensus 143 ~~lG-~G~fg~Vy~~~~~~~g~~vaiK~~~~~-----------------~~~~~~E~~il~~l~hpnI--v~l~~~~~~~ 202 (468)
.+|| .|+.|+||.+.. .+..++||.+... .....+|+.++..|.|++| ++.+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4577 788888988876 4788999977321 1123569999999998885 5555543221
Q ss_pred CCCCceEEEEEeecccc--hHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEE
Q 012233 203 TEKDELYLNLVLEYISE--TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLK 280 (468)
Q Consensus 203 ~~~~~~~~~lv~e~~~~--~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vk 280 (468)
. ......++|||+++| .+...+. ...++.. .+.||+.+|.+||+ .||+||||||+|||++.++ .++
T Consensus 115 ~-~~~~~~~lV~e~l~G~~~L~~~l~-----~~~l~~~----~~~~i~~~l~~lH~-~GI~HrDlkp~NILv~~~~-~v~ 182 (239)
T PRK01723 115 H-GLFYRADILIERIEGARDLVALLQ-----EAPLSEE----QWQAIGQLIARFHD-AGVYHADLNAHNILLDPDG-KFW 182 (239)
T ss_pred c-CcceeeeEEEEecCCCCCHHHHHh-----cCCCCHH----HHHHHHHHHHHHHH-CCCCCCCCCchhEEEcCCC-CEE
Confidence 1 111123599999996 3333322 1234433 35689999999998 8999999999999999877 799
Q ss_pred EeeecCccc
Q 012233 281 ICDFGSAKM 289 (468)
Q Consensus 281 L~DFG~a~~ 289 (468)
|+|||.+..
T Consensus 183 LIDfg~~~~ 191 (239)
T PRK01723 183 LIDFDRGEL 191 (239)
T ss_pred EEECCCccc
Confidence 999999864
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.56 E-value=2.2e-15 Score=159.12 Aligned_cols=271 Identities=25% Similarity=0.289 Sum_probs=193.1
Q ss_pred ccceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-------chHHHHHHHHHHcCCCCcccccceeeecCCCCce
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 208 (468)
.+.+.+.+-+-+|.++.++.+.-..+|...++|...... .....+-.++-...+|-++...-.| ....
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~-----~~rs 877 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSF-----PCRS 877 (1205)
T ss_pred CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCC-----CCCC
Confidence 346778888999999999999887788666666543322 1122233333334456666543332 2222
Q ss_pred EEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcc
Q 012233 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (468)
Q Consensus 209 ~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~ 288 (468)
..+|+++|++++-+....+. ....+..-++.++..+..+++|||. ..++|+|++|.|+|+..++ ..++.|||...
T Consensus 878 P~~L~~~~~~~~~~~Skl~~---~~~~saepaRs~i~~~vqs~e~L~s-~~r~h~~~~p~~~l~~~~g-h~~l~~~~t~~ 952 (1205)
T KOG0606|consen 878 PLPLVGHYLNGGDLPSKLHN---SGCLSAEPARSPILERVQSLESLHS-SLRKHRDLKPDSLLIAYDG-HRPLTDFGTLS 952 (1205)
T ss_pred CcchhhHHhccCCchhhhhc---CCCcccccccchhHHHHhhhhcccc-chhhcccccccchhhcccC-CcccCcccccc
Confidence 37789999976433222221 2234555577788889999999997 6799999999999999888 48999998432
Q ss_pred ccCCC--------------------------------CCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhC
Q 012233 289 MLVPG--------------------------------EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLG 336 (468)
Q Consensus 289 ~~~~~--------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G 336 (468)
...-. .......+|+.|.+||.+.+.. ....+|+|++|++++|.++|
T Consensus 953 ~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~-hgs~ad~~~~g~~l~e~l~g 1031 (1205)
T KOG0606|consen 953 KVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRR-HGSAADWWSSGVCLFEVLTG 1031 (1205)
T ss_pred ccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccccc-CCCcchhhhhhhhhhhhhcC
Confidence 22100 0112356799999999998765 78899999999999999999
Q ss_pred CCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHH-
Q 012233 337 QPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTAL- 415 (468)
Q Consensus 337 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~- 415 (468)
.+||....+.+...+|... ...+|. -+...+.++++++.++|..+|.+|..+.
T Consensus 1032 ~pp~na~tpq~~f~ni~~~-----------------~~~~p~---------g~~~~s~~aq~~~~~ll~~~~~qr~~a~~ 1085 (1205)
T KOG0606|consen 1032 IPPFNAETPQQIFENILNR-----------------DIPWPE---------GPEEGSYEAQDLINRLLTEEPTQRLGAKG 1085 (1205)
T ss_pred CCCCCCcchhhhhhccccC-----------------CCCCCC---------CccccChhhhhhhhhhhccCchhccCccc
Confidence 9999998887777665541 111221 2345788999999999999999999888
Q ss_pred --HHhCCCCCCCCCCCCCCCCCCCCCCccc
Q 012233 416 --EACAHPFFDDLRDPNTCLPNGRPLPTLF 443 (468)
Q Consensus 416 --ell~hp~f~~~~~~~~~~~~~~~~~~~~ 443 (468)
++..||||+++.-.+..+-+...+|..-
T Consensus 1086 ~~e~k~~~~~~~~~~~~l~~q~~~~~p~~~ 1115 (1205)
T KOG0606|consen 1086 AAEVKGHPFFQDVDWENLALQKAEFVPQPE 1115 (1205)
T ss_pred ccccccCCccCCCCccccccccCccCCCCC
Confidence 8999999999988777776666666554
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.48 E-value=6.2e-14 Score=130.99 Aligned_cols=242 Identities=18% Similarity=0.202 Sum_probs=158.9
Q ss_pred EEEEEEEcCCCCEEEEEEee----cc----cchHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEEEeeccc-chHH
Q 012233 152 VVFQAKCLETGDSVAIKKVL----QD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYIS-ETVY 222 (468)
Q Consensus 152 ~Vy~~~~~~~g~~vaiK~~~----~~----~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv~e~~~-~~ll 222 (468)
.||++.+...|..|.-..+. ++ ....+.-..-|-.+.|-|||+++.++......+...+.+++||+. +.+.
T Consensus 81 ~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~ 160 (458)
T KOG1266|consen 81 DVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLK 160 (458)
T ss_pred HHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHH
Confidence 46777776666665433221 11 111111223355567999999999887666656677889999998 4555
Q ss_pred HHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhc-CCccccCCCCCCeeecCCCCcEEEeeecCccccCCC------CC
Q 012233 223 RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV-VGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG------EP 295 (468)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~-~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~~------~~ 295 (468)
..++...+....+.....++|+.||+.||.|||.. ..|+|+.+...-|++..++ -+|++- +.-....+. ..
T Consensus 161 ~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ng-LIkig~-~ap~s~h~s~~~~~~~E 238 (458)
T KOG1266|consen 161 QFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNG-LIKIGS-VAPDSTHPSVNSTREAE 238 (458)
T ss_pred HHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCc-eEEecc-cCccccchhhhhhhHhh
Confidence 66666666677788888999999999999999962 3699999999999999777 455532 211111110 01
Q ss_pred CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCC-CCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccC
Q 012233 296 NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPL-FPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEF 374 (468)
Q Consensus 296 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 374 (468)
.....+-+.|.+||.=. ....+-++|||+||+...+|..|..- -.+.+....-..|...+
T Consensus 239 k~~~~~~~g~~a~~sg~-~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i------------------ 299 (458)
T KOG1266|consen 239 KSVNTSLPGFSAPESGT-TTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVI------------------ 299 (458)
T ss_pred hhccccCCccccCCcCc-ccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhhe------------------
Confidence 11234567899999643 23367789999999999999988643 22222222111111110
Q ss_pred CCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCC
Q 012233 375 KFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRD 428 (468)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~ 428 (468)
+ ..-.+.-+++|.+||+-.|..||++.+++.||.+-++.-
T Consensus 300 -~-------------~len~lqr~~i~kcl~~eP~~rp~ar~llfHpllfeVhs 339 (458)
T KOG1266|consen 300 -I-------------GLENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFEVHS 339 (458)
T ss_pred -e-------------eccCccccCcCcccccCCCCCCcchhhhhcCceeeecch
Confidence 0 000112347899999999999999999999999877654
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.39 E-value=5.2e-13 Score=137.94 Aligned_cols=142 Identities=17% Similarity=0.195 Sum_probs=87.7
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeecccc------------------------------------------
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR------------------------------------------ 175 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~~------------------------------------------ 175 (468)
.|.. +.||+|++|+||+|+.+.+|+.||||++.....
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ 199 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD 199 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence 3555 689999999999999987899999998853310
Q ss_pred --hHHHHHHHHHHcC----CCCcccccceeeecCCCCceEEEEEeecccchHHHHHhhhhhcCC---CCCHHHHHHHHHH
Q 012233 176 --YKNRELQIMRLLN----HPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQ---HVPILYVQLYTYQ 246 (468)
Q Consensus 176 --~~~~E~~il~~l~----hpnIv~l~~~~~~~~~~~~~~~~lv~e~~~~~ll~~~~~~~~~~~---~~~~~~~~~~~~q 246 (468)
.+.+|...+.++. +.+.+.+-.+|..-. ...+|||||+.|.-+..+......+. .+....+..++.|
T Consensus 200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~s----t~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q 275 (537)
T PRK04750 200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYC----SETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ 275 (537)
T ss_pred hhCHHHHHHHHHHHHHHccCCCCeecceeecccC----CCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH
Confidence 0012332222221 333333333332111 12459999999875543322111111 1333334444555
Q ss_pred HHHHHHHhHhcCCccccCCCCCCeeecCCC---CcEEEeeecCccccCC
Q 012233 247 ICRALNYLHHVVGVCHRDIKPQNLLVNPHT---HQLKICDFGSAKMLVP 292 (468)
Q Consensus 247 i~~aL~yLH~~~givHrDlkp~NILl~~~~---~~vkL~DFG~a~~~~~ 292 (468)
++ . .|++|+|+||.||+|+.++ .+++++|||++..+..
T Consensus 276 if-------~-~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 276 VF-------R-DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HH-------h-CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 54 4 6999999999999998765 2699999999977644
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.38 E-value=2.6e-12 Score=131.12 Aligned_cols=138 Identities=21% Similarity=0.256 Sum_probs=89.7
Q ss_pred eceecccCceEEEEEEEcCCCCEEEEEEeeccc-c-------------------------------------------hH
Q 012233 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-R-------------------------------------------YK 177 (468)
Q Consensus 142 ~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-~-------------------------------------------~~ 177 (468)
.+.||.|++|+||+|+. .+|+.||||+..... . .+
T Consensus 122 ~~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf 200 (437)
T TIGR01982 122 EKPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL 200 (437)
T ss_pred CcceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence 35799999999999986 479999999874321 0 01
Q ss_pred HHHHHHHHHc----CCCCcccccceeeecCCCCceEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHH-HHH
Q 012233 178 NRELQIMRLL----NHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICR-ALN 252 (468)
Q Consensus 178 ~~E~~il~~l----~hpnIv~l~~~~~~~~~~~~~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~-aL~ 252 (468)
.+|...+.++ +|.+-+.+-..|..... ..+|||||+.|..+........ .... ...++.+++. .+.
T Consensus 201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~----~~vLvmE~i~G~~L~~~~~~~~--~~~~---~~~ia~~~~~~~l~ 271 (437)
T TIGR01982 201 RREAANASELGENFKNDPGVYVPEVYWDRTS----ERVLTMEWIDGIPLSDIAALDE--AGLD---RKALAENLARSFLN 271 (437)
T ss_pred HHHHHHHHHHHHhcCCCCCEEeCCEehhhcC----CceEEEEeECCcccccHHHHHh--cCCC---HHHHHHHHHHHHHH
Confidence 1244444444 23333343344422111 1469999999865543322111 1122 2345555555 467
Q ss_pred HhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccC
Q 012233 253 YLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (468)
Q Consensus 253 yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~ 291 (468)
.+|. .|++|+|+||.||+++.++ .++|+|||++..+.
T Consensus 272 ql~~-~g~~H~D~hPgNilv~~~g-~i~liDfG~~~~l~ 308 (437)
T TIGR01982 272 QVLR-DGFFHADLHPGNIFVLKDG-KIIALDFGIVGRLS 308 (437)
T ss_pred HHHh-CCceeCCCCcccEEECCCC-cEEEEeCCCeeECC
Confidence 8897 8999999999999999887 79999999997664
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.38 E-value=9.3e-12 Score=127.06 Aligned_cols=180 Identities=22% Similarity=0.256 Sum_probs=125.3
Q ss_pred eEEeceecccCceEEEEEEEcCCCCEEEEEEeecccc----hHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEEEe
Q 012233 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR----YKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (468)
Q Consensus 139 y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv~ 214 (468)
|.+ ...+-++.+..-.|..+.++..|.+........ ..++-++-|+.++||||+++++++ .....+|||+
T Consensus 15 Y~l-e~~~~~~~a~~~~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~-----e~~~~~ylvT 88 (690)
T KOG1243|consen 15 YDL-EETAFSSEALWPDGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTT-----EEEGTLYLVT 88 (690)
T ss_pred ccc-ccccCCCcccccccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhh-----cccCceEEEe
Confidence 555 334444444322466677888998887754433 245678889999999999999998 4444699999
Q ss_pred ecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCCCC
Q 012233 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGE 294 (468)
Q Consensus 215 e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~~~ 294 (468)
|-+..--.. ++. +....+..-+.||+.||.|||+..+++|++|.-..|+|+..| ..||++|.++.......
T Consensus 89 ErV~Pl~~~-lk~-------l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~G-eWkLggle~v~~~~~~~ 159 (690)
T KOG1243|consen 89 ERVRPLETV-LKE-------LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESG-EWKLGGLELVSKASGFN 159 (690)
T ss_pred eccccHHHH-HHH-------hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCC-cEEEeeeEEEeccccCC
Confidence 998742111 111 113456667889999999998658999999999999999999 79999999886543222
Q ss_pred C-CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhC
Q 012233 295 P-NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLG 336 (468)
Q Consensus 295 ~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G 336 (468)
. .....---.|..|+.+.. -.-..|.|-|||++++++.|
T Consensus 160 ~~~~~~~~~~s~~~P~~~~~---s~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 160 APAKSLYLIESFDDPEEIDP---SEWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cccccchhhhcccChhhcCc---cccchhhhhHHHHHHHHhCc
Confidence 1 111111223566665422 12457999999999999999
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.38 E-value=2.2e-12 Score=114.60 Aligned_cols=123 Identities=16% Similarity=0.212 Sum_probs=90.6
Q ss_pred ceecccCceEEEEEEEcCCCCEEEEEEeeccc---chHHHHHHHHHHcCCCCccc-ccceeeecCCCCceEEEEEeeccc
Q 012233 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLLNHPNVVS-LKHCFFSTTEKDELYLNLVLEYIS 218 (468)
Q Consensus 143 ~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~---~~~~~E~~il~~l~hpnIv~-l~~~~~~~~~~~~~~~~lv~e~~~ 218 (468)
+.|+.|.++.||++.. .+..|++|...... ....+|+.+++.+.+.+++. ++.+. ... .++||||++
T Consensus 4 ~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~-----~~~--~~lv~e~i~ 74 (170)
T cd05151 4 SPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFD-----PET--GVLITEFIE 74 (170)
T ss_pred eecCCcccCceEEEEE--CCeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEe-----CCC--CeEEEEecC
Confidence 5688999999999987 47899999875543 34578999999987655543 33322 111 358999999
Q ss_pred chHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCc-----cccCCCCCCeeecCCCCcEEEeeecCcc
Q 012233 219 ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGV-----CHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (468)
Q Consensus 219 ~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~gi-----vHrDlkp~NILl~~~~~~vkL~DFG~a~ 288 (468)
|..+... . .....++.+++.+|..||. .++ +|+|++|.||+++ ++ .++++|||.+.
T Consensus 75 G~~l~~~--------~---~~~~~~~~~l~~~l~~LH~-~~~~~~~~~HgD~~~~Nil~~-~~-~~~liDf~~a~ 135 (170)
T cd05151 75 GSELLTE--------D---FSDPENLEKIAKLLKKLHS-SPLPDLVPCHNDLLPGNFLLD-DG-RLWLIDWEYAG 135 (170)
T ss_pred CCccccc--------c---ccCHHHHHHHHHHHHHHhC-CCCCCceeecCCCCcCcEEEE-CC-eEEEEeccccc
Confidence 8644311 0 0123456799999999997 675 9999999999999 44 69999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.34 E-value=5.7e-13 Score=134.52 Aligned_cols=249 Identities=20% Similarity=0.177 Sum_probs=175.3
Q ss_pred ccceEEeceecccCceEEEEEEEc-CCCCEEEEEEeecccc------hHHHHHHHHHHc-CCCCcccccceeeecCCCCc
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCL-ETGDSVAIKKVLQDKR------YKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDE 207 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~g~~vaiK~~~~~~~------~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~~ 207 (468)
..+|..+..||.|.|+.|+.+... .++..|++|-..+... .-..|+.+...+ .|.+++..+..+.. .
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~-----~ 338 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQ-----L 338 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccc-----c
Confidence 456888999999999999998755 6788899986644322 222466665555 48888887766632 2
Q ss_pred eEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCc
Q 012233 208 LYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (468)
Q Consensus 208 ~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a 287 (468)
...||-.|||.++...+.. .....+.+...+++..|++.++.++|+ ..++|+|+||+||++..++...++.|||++
T Consensus 339 r~~~ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s-~~~~~~d~~psni~i~~~~~~~~~~~~~~~ 414 (524)
T KOG0601|consen 339 RQGYIPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHS-KLFVHLDVKPSNILISNDGFFSKLGDFGCW 414 (524)
T ss_pred ccccCchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccc-hhhhcccccccceeeccchhhhhccccccc
Confidence 2356889999876655433 334556777788999999999999997 899999999999999876447899999998
Q ss_pred cccCCCCCCccccccCCcc-ccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 012233 288 KMLVPGEPNISYICSRYYR-APELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKC 366 (468)
Q Consensus 288 ~~~~~~~~~~~~~gt~~y~-aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 366 (468)
+.+. -........-++. ..|++.....+..+.|++|||.-+++.++|.+.-........ |..
T Consensus 415 t~~~--~~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~~---i~~------------ 477 (524)
T KOG0601|consen 415 TRLA--FSSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSLT---IRS------------ 477 (524)
T ss_pred cccc--eecccccccccccccchhhccccccccccccccccccccccccCcccCccccccee---eec------------
Confidence 6421 1112233334444 366666666689999999999999999998744322211110 000
Q ss_pred cCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q 012233 367 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (468)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~ 427 (468)
-..+. ......++..+.+.++..++..|+.+.++..|+=|....
T Consensus 478 -------~~~p~----------~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~~~ 521 (524)
T KOG0601|consen 478 -------GDTPN----------LPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYRDS 521 (524)
T ss_pred -------ccccC----------CCchHHhhhhhhhhhcCCccccchhhhhhcccchhhhhc
Confidence 00010 112336788899999999999999999999988776543
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.30 E-value=1.5e-11 Score=110.88 Aligned_cols=133 Identities=18% Similarity=0.192 Sum_probs=91.8
Q ss_pred ceecccCceEEEEEEEcC------CCCEEEEEEeec--------------ccc------------hH----HHHHHHHHH
Q 012233 143 RVVGTGSFGVVFQAKCLE------TGDSVAIKKVLQ--------------DKR------------YK----NRELQIMRL 186 (468)
Q Consensus 143 ~~lG~G~fg~Vy~~~~~~------~g~~vaiK~~~~--------------~~~------------~~----~~E~~il~~ 186 (468)
-.||.|--+.||.|.... .+..+|||+.+. +.+ .. ++|...|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 368999999999998643 357899997621 100 11 268888888
Q ss_pred cCC--CCcccccceeeecCCCCceEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHh-HhcCCcccc
Q 012233 187 LNH--PNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL-HHVVGVCHR 263 (468)
Q Consensus 187 l~h--pnIv~l~~~~~~~~~~~~~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yL-H~~~givHr 263 (468)
+.. -++.+++++. . -+|||||++++.+.... . ....++...+..+..|++.+|..| |+ .||||+
T Consensus 83 l~~~Gv~vP~pi~~~-----~----~~lvME~Ig~~~~~~~~--L-kd~~~~~~~~~~i~~~i~~~l~~l~H~-~glVHG 149 (197)
T cd05146 83 MQKAGIPCPEVVVLK-----K----HVLVMSFIGDDQVPAPK--L-KDAKLNDEEMKNAYYQVLSMMKQLYKE-CNLVHA 149 (197)
T ss_pred HHHcCCCCCeEEEec-----C----CEEEEEEcCCCCccchh--h-hccccCHHHHHHHHHHHHHHHHHHHHh-CCeecC
Confidence 863 3455554431 1 45899999874221000 0 012244455667788999999999 87 899999
Q ss_pred CCCCCCeeecCCCCcEEEeeecCcccc
Q 012233 264 DIKPQNLLVNPHTHQLKICDFGSAKML 290 (468)
Q Consensus 264 Dlkp~NILl~~~~~~vkL~DFG~a~~~ 290 (468)
||++.|||++. + .+.|+|||.+...
T Consensus 150 DLs~~NIL~~~-~-~v~iIDF~qav~~ 174 (197)
T cd05146 150 DLSEYNMLWHD-G-KVWFIDVSQSVEP 174 (197)
T ss_pred CCCHHHEEEEC-C-cEEEEECCCceeC
Confidence 99999999984 4 6999999988644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.26 E-value=2.1e-10 Score=113.78 Aligned_cols=214 Identities=19% Similarity=0.243 Sum_probs=154.5
Q ss_pred ceEEEEEEEcCCCCEEEEEEeecccch----HHHHHHHHHHcCCCCcccccceeeecCCCCceEEEEEeecccc--hHHH
Q 012233 150 FGVVFQAKCLETGDSVAIKKVLQDKRY----KNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISE--TVYR 223 (468)
Q Consensus 150 fg~Vy~~~~~~~g~~vaiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv~e~~~~--~ll~ 223 (468)
-.+.|+|....+|..|.+|.+..++.. ...-+++++++.|+|||++..+|.+.. .+..-+++|++|.++ +|++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~t-F~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYT-FGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhc-cCcceEEEEEecCCCCchHHH
Confidence 356799999999999999998433322 224688999999999999999987444 556668899999984 5555
Q ss_pred HHhhh-----------hhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCC
Q 012233 224 VSKHY-----------TRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (468)
Q Consensus 224 ~~~~~-----------~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~ 292 (468)
+.-.. ...+...++..+|.|+.||..||.++|+ .|...+-|.|.+||++.+. +++|...|....+..
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs-sGLAck~L~~~kIlv~G~~-RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS-SGLACKTLDLKKILVTGKM-RIRISGCGIMDVLQE 445 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh-cCceeecccHhHeEeeCcc-eEEEecccceeeecC
Confidence 43211 1223557889999999999999999998 8999999999999999887 799998888765543
Q ss_pred CCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCC-CCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCC
Q 012233 293 GEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPL-FPGESGVDQLVEIIKILGTPTREEIKCMNPNY 371 (468)
Q Consensus 293 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 371 (468)
+. . |.+. --.+-|.=.||.+++.|.||..- +..........+.
T Consensus 446 d~-----------~--~~le----~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~------------------- 489 (655)
T KOG3741|consen 446 DP-----------T--EPLE----SQQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTR------------------- 489 (655)
T ss_pred CC-----------C--cchh----HHhhhhHHHHHHHHHHHhhcccccccccchHHHHHHH-------------------
Confidence 33 0 1121 22356999999999999999532 1111111111111
Q ss_pred ccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 372 TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
+...++.+++++|.-+...++++ -++.+++.
T Consensus 490 ----------------I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp 520 (655)
T KOG3741|consen 490 ----------------ITTTYSTDLRNVVEYLESLNFRE-KSIQDLLP 520 (655)
T ss_pred ----------------hhhhhhHHHHHHHHHHHhcCccc-ccHHHHHH
Confidence 22347888999999999888886 56666654
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.3e-11 Score=126.47 Aligned_cols=159 Identities=21% Similarity=0.330 Sum_probs=116.9
Q ss_pred HHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCCCCC--------Ccc--ccccCCccccccccCCC
Q 012233 246 QICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEP--------NIS--YICSRYYRAPELIFGAT 315 (468)
Q Consensus 246 qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~~~~--------~~~--~~gt~~y~aPE~~~~~~ 315 (468)
+++.||.|+|+..++||+.|.|++|.++..+ ..||+.|+++....+... ... ..-...|.|||.+.+ .
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~-~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~-~ 184 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANG-DWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG-T 184 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCc-ceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc-c
Confidence 3448999999878999999999999999888 799999999865433111 111 122567999999976 4
Q ss_pred CCCcchhHHHHHHHHHHHH-hCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCH
Q 012233 316 EYTTAIDMWSIGCVLAELL-LGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPP 394 (468)
Q Consensus 316 ~~~~~~DvwSlG~il~ell-~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (468)
..+.++|+||+||++|.+. .|+..+........+..-....+. . ...+...++.
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~-------------~------------~~~~s~~~p~ 239 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNA-------------G------------AFGYSNNLPS 239 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhccccc-------------c------------cccccccCcH
Confidence 4899999999999999998 677666554433322221111000 0 0113357899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCCCC
Q 012233 395 EALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNT 431 (468)
Q Consensus 395 ~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~ 431 (468)
++++=+.++|..++..||++.+++..|||.+..-...
T Consensus 240 el~~~l~k~l~~~~~~rp~~~~l~~~~ff~D~~~~aL 276 (700)
T KOG2137|consen 240 ELRESLKKLLNGDSAVRPTLDLLLSIPFFSDPGLKAL 276 (700)
T ss_pred HHHHHHHHHhcCCcccCcchhhhhcccccCCchhhhh
Confidence 9999999999999999999999999999998655443
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.14 E-value=1.7e-09 Score=105.03 Aligned_cols=255 Identities=16% Similarity=0.207 Sum_probs=155.7
Q ss_pred EeceecccCceEEEEEEEcCCCCEEEEEEeecccchH-HHHHHHHHHc-CCCCcccccce----eeecCCCCceEEEEEe
Q 012233 141 AERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYK-NRELQIMRLL-NHPNVVSLKHC----FFSTTEKDELYLNLVL 214 (468)
Q Consensus 141 ~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~~~~-~~E~~il~~l-~hpnIv~l~~~----~~~~~~~~~~~~~lv~ 214 (468)
..+.||+|+-+.+|-.-. -+..|| |++....-.. .+.+..|... .||-+-.-+.+ .+.. .....+.+.|
T Consensus 15 ~gr~LgqGgea~ly~l~e--~~d~VA-KIYh~Pppa~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~--~~~~~iGflm 89 (637)
T COG4248 15 PGRPLGQGGEADLYTLGE--VRDQVA-KIYHAPPPAAQAQKVAELAATPDAPLLNYRVAWPQATLHGG--RRGKVIGFLM 89 (637)
T ss_pred CCccccCCccceeeecch--hhchhh-eeecCCCchHHHHHHHHhccCCCCcchhhhhcccHHHhhCC--CccceeEEec
Confidence 346799999999987643 334444 7775543222 1223333322 35543320111 1111 2222366788
Q ss_pred ecccch--HHHHHhh--hhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcccc
Q 012233 215 EYISET--VYRVSKH--YTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (468)
Q Consensus 215 e~~~~~--ll~~~~~--~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~ 290 (468)
..+++. ...+..- ....-..+.+..+.+.++.|+.+.+-||. .|.+-+|+.++|+||..++ .|.|.|=..-...
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~-~Gh~vGDVn~~~~lVsd~~-~V~LVdsDsfqi~ 167 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE-HGHVVGDVNQNSFLVSDDS-KVVLVDSDSFQIN 167 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh-cCCcccccCccceeeecCc-eEEEEcccceeec
Confidence 888753 2222211 12223446788899999999999999998 8999999999999999887 7899876655444
Q ss_pred CCCCCCccccccCCcccccccc----CCCCCCcchhHHHHHHHHHHHHhC-CCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 012233 291 VPGEPNISYICSRYYRAPELIF----GATEYTTAIDMWSIGCVLAELLLG-QPLFPGESGVDQLVEIIKILGTPTREEIK 365 (468)
Q Consensus 291 ~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DvwSlG~il~ell~G-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 365 (468)
..+......+|.+.|.+||.-. ....-+...|.|.||+++|++|.| ++||.+... ....|..-+..
T Consensus 168 ~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~---------~~~ap~p~E~~ 238 (637)
T COG4248 168 ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPL---------ISDAPNPLETD 238 (637)
T ss_pred cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccc---------cCCCCCcchhh
Confidence 4555566678899999999753 112356789999999999999986 999987321 01111111100
Q ss_pred hcCCCC------ccCCCCcccCCCcccccccCCCHHHHHHHHHhccc--CCCCCCCHHH
Q 012233 366 CMNPNY------TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQY--SPSLRCTALE 416 (468)
Q Consensus 366 ~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~--dP~~R~s~~e 416 (468)
...-.| ..-..|.....+| .-+++++..|..+|+.. ++.-|||++.
T Consensus 239 Ia~g~f~ya~~~~~g~~p~P~~~P~-----~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a 292 (637)
T COG4248 239 IAHGRFAYASDQRRGLKPPPRSIPL-----SMLPPDVQALFQQAFTESGVATPRPTAKA 292 (637)
T ss_pred hhcceeeechhccCCCCCCCCCCCh-----hhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence 000000 1111111222222 34789999999999976 5678999763
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.14 E-value=4.9e-10 Score=97.50 Aligned_cols=139 Identities=17% Similarity=0.245 Sum_probs=94.1
Q ss_pred EeceecccCceEEEEEEEcCCCCEEEEEEeec-c-----------cchHHHHHHHHHHcCCCCcccccceeeecCCCCce
Q 012233 141 AERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ-D-----------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (468)
Q Consensus 141 ~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~-~-----------~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 208 (468)
...+|-+|+-+.|+++.+ .|+.+.||.-.. . .....+|..+|.++.--.|.-..-+|....
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~----- 83 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTY----- 83 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecC-----
Confidence 345788999999999988 889988885321 1 122346888888886433322222222211
Q ss_pred EEEEEeecccc--hHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcE--EEeee
Q 012233 209 YLNLVLEYISE--TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQL--KICDF 284 (468)
Q Consensus 209 ~~~lv~e~~~~--~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~v--kL~DF 284 (468)
.-+|+|||+.| .+.+.+.... ...........++.+|-..+.-||. .+|||+||..+||+|.+++.++ .|+||
T Consensus 84 ~~~i~ME~~~g~~~vk~~i~~~~--~~~~~d~~~~~~~~~iG~~igklH~-ndiiHGDLTTSNill~~~~~~~~~~lIdf 160 (229)
T KOG3087|consen 84 GGQIYMEFIDGASTVKDFILSTM--EDESEDEGLAELARRIGELIGKLHD-NDIIHGDLTTSNILLRSDGNQITPILIDF 160 (229)
T ss_pred CCeEEEEeccchhHHHHHHHHHc--cCcccchhHHHHHHHHHHHHHHhhh-CCeecccccccceEEecCCCcCceEEEee
Confidence 14589999998 4444333222 1222222236788889999999998 8999999999999998777654 89999
Q ss_pred cCccc
Q 012233 285 GSAKM 289 (468)
Q Consensus 285 G~a~~ 289 (468)
|++..
T Consensus 161 gls~~ 165 (229)
T KOG3087|consen 161 GLSSV 165 (229)
T ss_pred cchhc
Confidence 99854
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.09 E-value=1.3e-09 Score=95.37 Aligned_cols=127 Identities=17% Similarity=0.285 Sum_probs=85.5
Q ss_pred ceecccCceEEEEEEEcCCCCEEEEEEee-cc-----------cchHHHHHHHHHHcCCCCcccccceeeecCCCCceEE
Q 012233 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVL-QD-----------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (468)
Q Consensus 143 ~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~-~~-----------~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~ 210 (468)
..+++|+-+.+|.+.+ -|..+.+|.-. +. .....+|..++.++.--.|...+-+++... ..
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~-----~~ 74 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPD-----NG 74 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCC-----CC
Confidence 3578999999999977 45557777432 11 111236999988886443332222222221 24
Q ss_pred EEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccc
Q 012233 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (468)
Q Consensus 211 ~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~ 289 (468)
.|+|||++|.++....... . ..++..+=.-+.-||. .||||+||.++||++..++ +.++|||++..
T Consensus 75 ~I~me~I~G~~lkd~l~~~------~----~~~~r~vG~~vg~lH~-~givHGDLTtsNiIl~~~~--i~~IDfGLg~~ 140 (204)
T COG3642 75 LIVMEYIEGELLKDALEEA------R----PDLLREVGRLVGKLHK-AGIVHGDLTTSNIILSGGR--IYFIDFGLGEF 140 (204)
T ss_pred EEEEEEeCChhHHHHHHhc------c----hHHHHHHHHHHHHHHh-cCeecCCCccceEEEeCCc--EEEEECCcccc
Confidence 5899999998776322211 1 3345566677788998 8999999999999999664 99999999864
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.01 E-value=2.3e-09 Score=99.34 Aligned_cols=140 Identities=16% Similarity=0.190 Sum_probs=94.5
Q ss_pred ceecccCceEEEEEEEcCCCCEEEEEEeecc-----cchHHHHHHHHHHcCCCC--cccccceeeecCCCCceEEEEEee
Q 012233 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPN--VVSLKHCFFSTTEKDELYLNLVLE 215 (468)
Q Consensus 143 ~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~-----~~~~~~E~~il~~l~hpn--Iv~l~~~~~~~~~~~~~~~~lv~e 215 (468)
+.|+.|.++.||++... +|+.+++|..... .....+|+.+++.+.+.+ +.+++.+..... .....++|||
T Consensus 4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~--~~~~~~~v~e 80 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPS--VLGTPFYVME 80 (223)
T ss_pred eecCCCccceEEEEEec-CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCC--ccCCceEEEE
Confidence 46899999999999863 3688999987543 345678999999997643 455555432111 0123579999
Q ss_pred cccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHh---------------------------------------
Q 012233 216 YISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH--------------------------------------- 256 (468)
Q Consensus 216 ~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~--------------------------------------- 256 (468)
|++|..+..... ...++......++.+++.+|.+||+
T Consensus 81 ~i~G~~l~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (223)
T cd05154 81 RVDGRVLRDRLL----RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPA 156 (223)
T ss_pred EeCCEecCCCCC----CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHH
Confidence 999864431110 0234555555666666666666663
Q ss_pred ----------------cCCccccCCCCCCeeecCC-CCcEEEeeecCccc
Q 012233 257 ----------------VVGVCHRDIKPQNLLVNPH-THQLKICDFGSAKM 289 (468)
Q Consensus 257 ----------------~~givHrDlkp~NILl~~~-~~~vkL~DFG~a~~ 289 (468)
...++|+|++|.|||++.+ ...+.|+||+.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 157 MERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 1347999999999999983 22588999998853
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.94 E-value=3.8e-09 Score=94.94 Aligned_cols=121 Identities=23% Similarity=0.288 Sum_probs=75.7
Q ss_pred EEEEEEEcCCCCEEEEEEeeccc------------------------------chHHHHHHHHHHcCCC--Cccccccee
Q 012233 152 VVFQAKCLETGDSVAIKKVLQDK------------------------------RYKNRELQIMRLLNHP--NVVSLKHCF 199 (468)
Q Consensus 152 ~Vy~~~~~~~g~~vaiK~~~~~~------------------------------~~~~~E~~il~~l~hp--nIv~l~~~~ 199 (468)
.||.|.. .+|..+|+|+..... ....+|.+.|.++..- ++.+++.+.
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 4899986 467899999763210 1123699999999865 455554432
Q ss_pred eecCCCCceEEEEEeeccc--chHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHH-hHhcCCccccCCCCCCeeecCCC
Q 012233 200 FSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY-LHHVVGVCHRDIKPQNLLVNPHT 276 (468)
Q Consensus 200 ~~~~~~~~~~~~lv~e~~~--~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~y-LH~~~givHrDlkp~NILl~~~~ 276 (468)
. -+|||||++ |..+..+.... +.......++.+++..+.. +|. .||+|+||.+.|||++.+
T Consensus 80 -----~----~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~-~givHGDLs~~NIlv~~~- 143 (188)
T PF01163_consen 80 -----R----NVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHK-AGIVHGDLSEYNILVDDG- 143 (188)
T ss_dssp -----T----TEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHC-TTEEESS-STTSEEEETT-
T ss_pred -----C----CEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHh-cCceecCCChhhEEeecc-
Confidence 2 248999999 64333222211 1122355667788885555 577 899999999999999966
Q ss_pred CcEEEeeecCcccc
Q 012233 277 HQLKICDFGSAKML 290 (468)
Q Consensus 277 ~~vkL~DFG~a~~~ 290 (468)
.+.|+|||.+...
T Consensus 144 -~~~iIDf~qav~~ 156 (188)
T PF01163_consen 144 -KVYIIDFGQAVDS 156 (188)
T ss_dssp -CEEE--GTTEEET
T ss_pred -eEEEEecCcceec
Confidence 5999999998644
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.92 E-value=3.2e-08 Score=94.27 Aligned_cols=133 Identities=14% Similarity=0.121 Sum_probs=87.1
Q ss_pred eEEEEEEEcCCCCEEEEEEeeccc---------------chHHHHHHHHHHcCCCCcccc--cceeeecCCCCceEEEEE
Q 012233 151 GVVFQAKCLETGDSVAIKKVLQDK---------------RYKNRELQIMRLLNHPNVVSL--KHCFFSTTEKDELYLNLV 213 (468)
Q Consensus 151 g~Vy~~~~~~~g~~vaiK~~~~~~---------------~~~~~E~~il~~l~hpnIv~l--~~~~~~~~~~~~~~~~lv 213 (468)
..|++... .|+.|.||...... ....+|...+..|..-+|... +.++..........-+||
T Consensus 36 rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LV 113 (268)
T PRK15123 36 RRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFII 113 (268)
T ss_pred ceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEE
Confidence 34555544 56778888552211 135678888888854443333 333322111112346799
Q ss_pred eecccch--HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCC------CCcEEEeeec
Q 012233 214 LEYISET--VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPH------THQLKICDFG 285 (468)
Q Consensus 214 ~e~~~~~--ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~------~~~vkL~DFG 285 (468)
||++++. +.+++.... ....+......++.+++..+.-||. .||+|+||++.|||++.+ ...+.|+||+
T Consensus 114 te~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~-~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~ 190 (268)
T PRK15123 114 TEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHA-AGINHRDCYICHFLLHLPFPGREEDLKLSVIDLH 190 (268)
T ss_pred EeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHH-CcCccCCCChhhEEEeccccCCCCCceEEEEECC
Confidence 9999974 444432221 2344566677899999999999998 899999999999999852 2379999999
Q ss_pred Ccc
Q 012233 286 SAK 288 (468)
Q Consensus 286 ~a~ 288 (468)
.+.
T Consensus 191 r~~ 193 (268)
T PRK15123 191 RAQ 193 (268)
T ss_pred ccc
Confidence 875
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.82 E-value=1.5e-08 Score=93.96 Aligned_cols=131 Identities=19% Similarity=0.167 Sum_probs=90.4
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc--------------------------cchHHHHHHHHHHcCCC-
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD--------------------------KRYKNRELQIMRLLNHP- 190 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~--------------------------~~~~~~E~~il~~l~hp- 190 (468)
-+.++..||-|--+.||.|.+. .|..+|||.-... ....++|.++|.+|...
T Consensus 92 ve~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G 170 (304)
T COG0478 92 VEAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEG 170 (304)
T ss_pred HHhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcC
Confidence 3667789999999999999964 7899999953110 12235799999999755
Q ss_pred -CcccccceeeecCCCCceEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCC
Q 012233 191 -NVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQN 269 (468)
Q Consensus 191 -nIv~l~~~~~~~~~~~~~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~N 269 (468)
.|.+.+++- .-++||||+.|-.+..... .......++..|+.-+.-+-. .||||+|+.+-|
T Consensus 171 ~~VP~P~~~n---------RHaVvMe~ieG~eL~~~r~--------~~en~~~il~~il~~~~~~~~-~GiVHGDlSefN 232 (304)
T COG0478 171 VKVPKPIAWN---------RHAVVMEYIEGVELYRLRL--------DVENPDEILDKILEEVRKAYR-RGIVHGDLSEFN 232 (304)
T ss_pred CCCCCccccc---------cceeeeehcccceeecccC--------cccCHHHHHHHHHHHHHHHHH-cCccccCCchhe
Confidence 566554432 2458999999864432211 122233344444444444435 799999999999
Q ss_pred eeecCCCCcEEEeeecCcc
Q 012233 270 LLVNPHTHQLKICDFGSAK 288 (468)
Q Consensus 270 ILl~~~~~~vkL~DFG~a~ 288 (468)
|||+.++ .+.++||--+.
T Consensus 233 IlV~~dg-~~~vIDwPQ~v 250 (304)
T COG0478 233 ILVTEDG-DIVVIDWPQAV 250 (304)
T ss_pred EEEecCC-CEEEEeCcccc
Confidence 9999998 69999997654
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.74 E-value=2.1e-09 Score=109.27 Aligned_cols=253 Identities=19% Similarity=0.165 Sum_probs=168.4
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeecccchHHHHHHHHHHcCCCC-cccccceeeecCCCCceEEEEEeec
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPN-VVSLKHCFFSTTEKDELYLNLVLEY 216 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~~~~~~E~~il~~l~hpn-Iv~l~~~~~~~~~~~~~~~~lv~e~ 216 (468)
.|...+-+++|+++++++.+...+...+ .+.+... ....-++++|.+++||| .+..++-+ ..+.+..+++++
T Consensus 243 ws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-l~~rl~~eLLdK~n~P~~~v~~~~d~-----~~E~~~~i~~~i 315 (829)
T KOG0576|consen 243 WSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-LSRRLAIELLDKVNNPNPVVRYLEDY-----DGEDYLWIPMRI 315 (829)
T ss_pred chHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-hhhHHHHHHHHHccCCCCcccccccC-----Ccccccchhhhh
Confidence 4677788999999999999876655444 6665544 33445899999999999 44443333 666788999999
Q ss_pred ccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCCCCCC
Q 012233 217 ISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPN 296 (468)
Q Consensus 217 ~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~~~~~ 296 (468)
++++--.. .........+..-....+.+.-+++|++||+ .-=+|+| ||+..+. ..++.||+....+......
T Consensus 316 ~s~~rs~~-~~~~~se~~~~~~~~~~~~r~et~~l~~l~~-~~~~~~d----~~l~s~~--~~~~~~~~v~~~L~~~~~~ 387 (829)
T KOG0576|consen 316 CSTGRSSA-LEMTVSEIALEQYQFAYPLRKETRPLAELHS-SYKVHRD----NILGSEE--EVKLLDFAVPPQLTRTMKP 387 (829)
T ss_pred hcCCcccc-ccCChhhHhhhhhhhhhhhhhhccccccccc-ccccCcc----ccccccc--ccccccccCCcccCccccc
Confidence 98761000 0000001111112233344555778999997 4458888 8888864 5899999998877666566
Q ss_pred ccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccCCC
Q 012233 297 ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKF 376 (468)
Q Consensus 297 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 376 (468)
....+++.++|||+..... +....|+|++|+--.+|--|-+|-.... .....+ . .....
T Consensus 388 ~t~~~~~~~~~pev~~~~~-~~~~p~~~~~~~~~~~~ap~~pPr~~P~--~~~~~~---------------g---~~p~s 446 (829)
T KOG0576|consen 388 RTAIGTPEPLAPEVIQENT-IDGCPDSGSLAVSAIQMAPGLPPRSSPP--AVLPMI---------------G---NGPNS 446 (829)
T ss_pred ccCCCCCCCCCchhhcccc-cccCCCccCCCcchhhcCCCCCCCCCCc--cccCCC---------------C---CCCCc
Confidence 7889999999999987655 8889999999987777777877754411 000000 0 00000
Q ss_pred CcccC-CCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCCCCCC
Q 012233 377 PQIKA-HPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNTCL 433 (468)
Q Consensus 377 ~~~~~-~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~~~ 433 (468)
+.+.. ..|...++. ++...|+..-|..|+....++-|.+|...+....|.
T Consensus 447 ~~L~~~~aw~~~~~~-------~~~~~~~~g~P~~pkv~mgacfsKvfngCpl~i~~a 497 (829)
T KOG0576|consen 447 PMLTDKSAWSPVFHR-------DFPAPCLNGLPPTPKVHMGACFSKVFNGCPLRIHCA 497 (829)
T ss_pred cccchhhhcCccccc-------CCcccccCCCCCCCcchhhHHHHHHhccCcccceec
Confidence 11101 222222211 677899999999999999999999999987766653
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.58 E-value=6.9e-07 Score=82.10 Aligned_cols=107 Identities=16% Similarity=0.253 Sum_probs=74.1
Q ss_pred HHHHHHHHHHcCCCC--cccccceeeecCCCCceEEEEEeecccch--HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHH
Q 012233 177 KNRELQIMRLLNHPN--VVSLKHCFFSTTEKDELYLNLVLEYISET--VYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252 (468)
Q Consensus 177 ~~~E~~il~~l~hpn--Iv~l~~~~~~~~~~~~~~~~lv~e~~~~~--ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~ 252 (468)
..+|...+..|..-. +.+.+.+....... ....+||+|++++. +...+... ...+......++.+++..+.
T Consensus 58 a~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~-~~~s~lite~l~~~~~L~~~~~~~----~~~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 58 AKREWRNLQRLREAGIPTPEPVAYGERRKGG-GYRSYLITEALPGAQDLRDLLQQW----EQLDPSQRRELLRALARLIA 132 (206)
T ss_pred HHHHHHHHHHHHHcCCCCCcEEEEEEEcCCC-ceeEEEEEEeCCCcccHHHHHHhh----cccchhhHHHHHHHHHHHHH
Confidence 456888777775333 33344444332222 24467999999873 33333221 11455667788999999999
Q ss_pred HhHhcCCccccCCCCCCeeecCCC--CcEEEeeecCccc
Q 012233 253 YLHHVVGVCHRDIKPQNLLVNPHT--HQLKICDFGSAKM 289 (468)
Q Consensus 253 yLH~~~givHrDlkp~NILl~~~~--~~vkL~DFG~a~~ 289 (468)
-||. .||+|+|+++.|||++.+. ..+.|+||+.++.
T Consensus 133 ~lH~-~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 133 KLHD-AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHH-CcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 9998 8999999999999998764 2589999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.55 E-value=2.4e-06 Score=77.47 Aligned_cols=139 Identities=13% Similarity=0.077 Sum_probs=94.1
Q ss_pred ecccCceEEEEEEEcCCCCEEEEEEee----------cccchHHHHHHHHHHcCCCC--cccccceeeecCCCCceEEEE
Q 012233 145 VGTGSFGVVFQAKCLETGDSVAIKKVL----------QDKRYKNRELQIMRLLNHPN--VVSLKHCFFSTTEKDELYLNL 212 (468)
Q Consensus 145 lG~G~fg~Vy~~~~~~~g~~vaiK~~~----------~~~~~~~~E~~il~~l~hpn--Iv~l~~~~~~~~~~~~~~~~l 212 (468)
-|+||.+-|+.... .|..+-+|.-. .....+.+|...++.|..-+ +.++. ++-.........-+|
T Consensus 26 ~~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L 102 (216)
T PRK09902 26 YRRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL 102 (216)
T ss_pred cCCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence 35688888888765 45567788542 12345568999988886433 44444 222122233445779
Q ss_pred Eeecccc--hHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCC-cEEEeeecCccc
Q 012233 213 VLEYISE--TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTH-QLKICDFGSAKM 289 (468)
Q Consensus 213 v~e~~~~--~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~-~vkL~DFG~a~~ 289 (468)
|+|-+++ ++.+.+... .-...+......++.+|+..|.-||. .|+.|+|+-+.|||++.++. .++++||.-++.
T Consensus 103 VTe~L~g~~~L~~~l~~~--~~~~~~~~~k~~il~~va~~ia~LH~-~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 103 VTEDMAGFISIADWYAQH--AVSPYSDEVRQAMLKAVALAFKKMHS-VNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEEeCCCCccHHHHHhcC--CcCCcchHHHHHHHHHHHHHHHHHHH-CCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 9998884 443333221 12234566667899999999999998 89999999999999986552 499999987754
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.53 E-value=2e-07 Score=96.19 Aligned_cols=138 Identities=22% Similarity=0.246 Sum_probs=83.0
Q ss_pred ceecccCceEEEEEEEcCCCCEEEEEEeeccc--------------------------------------------chHH
Q 012233 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK--------------------------------------------RYKN 178 (468)
Q Consensus 143 ~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~--------------------------------------------~~~~ 178 (468)
..|+.++-|+||.|..+ +|+.||||+..-.. ....
T Consensus 131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 46899999999999975 59999999763211 0012
Q ss_pred HHHHHHHHcC----CCCcccccceeeecCCCCceEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHH-HHH
Q 012233 179 RELQIMRLLN----HPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRA-LNY 253 (468)
Q Consensus 179 ~E~~il~~l~----hpnIv~l~~~~~~~~~~~~~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~a-L~y 253 (468)
+|...+.+++ ...-+++-.+|...+.. -.|+|||+.|.-......... ..++...+. ..++.+ +.-
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~----~VLtmE~i~Gi~i~d~~~l~~--~g~d~k~ia---~~~~~~f~~q 280 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTR----RVLTMEWIDGIKISDIAALKS--AGIDRKELA---ELLVRAFLRQ 280 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCC----cEEEEEeeCCEecccHHHHHh--cCCCHHHHH---HHHHHHHHHH
Confidence 3554444442 22223333444322211 459999999854433322222 334422222 222221 111
Q ss_pred hHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCC
Q 012233 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (468)
Q Consensus 254 LH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~ 292 (468)
+=. .|++|.|.+|.||+++.++ .+.+.|||+...+.+
T Consensus 281 ~~~-dgffHaDpHpGNi~v~~~g-~i~~lDfGi~g~l~~ 317 (517)
T COG0661 281 LLR-DGFFHADPHPGNILVRSDG-RIVLLDFGIVGRLDP 317 (517)
T ss_pred HHh-cCccccCCCccceEEecCC-cEEEEcCcceecCCH
Confidence 222 5999999999999999998 799999999876543
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.49 E-value=2.6e-06 Score=77.56 Aligned_cols=135 Identities=18% Similarity=0.236 Sum_probs=83.5
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeecccchH-------------HHHHHHHHHcCCCCcccccceeeecC-
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYK-------------NRELQIMRLLNHPNVVSLKHCFFSTT- 203 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~~~~-------------~~E~~il~~l~hpnIv~l~~~~~~~~- 203 (468)
+|.+.+++-......|.+-.- +|+.+.+|......... .+++..+..+....+..+-+.++...
T Consensus 32 ~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ek 109 (229)
T PF06176_consen 32 NYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEK 109 (229)
T ss_pred CceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeee
Confidence 588888888877777766654 78899999764432211 23444344443222222222111111
Q ss_pred --CCCceEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEE
Q 012233 204 --EKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKI 281 (468)
Q Consensus 204 --~~~~~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL 281 (468)
..-....+|||||++|.-+.... .++. .+...|..++.-||. .|+.|+|..|.|++++.++ +++
T Consensus 110 k~~~~~~~~~ll~EYIeG~~l~d~~-------~i~e----~~~~ki~~~ikqlH~-~G~~HGD~hpgNFlv~~~~--i~i 175 (229)
T PF06176_consen 110 KIFRYTSSYVLLMEYIEGVELNDIE-------DIDE----DLAEKIVEAIKQLHK-HGFYHGDPHPGNFLVSNNG--IRI 175 (229)
T ss_pred eeccceeEEEEEEEEecCeecccch-------hcCH----HHHHHHHHHHHHHHH-cCCccCCCCcCcEEEECCc--EEE
Confidence 11122356899999986432111 1221 234567788999998 8999999999999999654 999
Q ss_pred eeecCcc
Q 012233 282 CDFGSAK 288 (468)
Q Consensus 282 ~DFG~a~ 288 (468)
+||+..+
T Consensus 176 ID~~~k~ 182 (229)
T PF06176_consen 176 IDTQGKR 182 (229)
T ss_pred EECcccc
Confidence 9998764
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.47 E-value=5.8e-07 Score=97.66 Aligned_cols=206 Identities=20% Similarity=0.282 Sum_probs=133.4
Q ss_pred HHHHHHHHHHcCCCCcccccceeeecCCCCceEEEEEeecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhH
Q 012233 177 KNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255 (468)
Q Consensus 177 ~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv~e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH 255 (468)
.+-|...+.++.|+|++.++.+-+.....+ ..+.+..++|+.. +...+. ....++...++.+..+++.||.|+|
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g-~~~~v~~~~~s~~~~~~~~q----~v~~i~~~~~r~~~~~~~~GL~~~h 303 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRG-IVLDVLQEICSKVELRSLLQ----SVGSIPLETLRILHQKLLEGLAYLH 303 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcch-HHHHHHHhhcCccchHHHHh----hccccCHHHHHHHHHHHhhhHHHHH
Confidence 345777788899999999877654433222 1222345666643 222222 2456788889999999999999999
Q ss_pred hcCCccccCCCCC---CeeecCCCCcEEEe--eecCccccCCCCCCccccccCCccccccccCCC-CCCcchhHHHHHHH
Q 012233 256 HVVGVCHRDIKPQ---NLLVNPHTHQLKIC--DFGSAKMLVPGEPNISYICSRYYRAPELIFGAT-EYTTAIDMWSIGCV 329 (468)
Q Consensus 256 ~~~givHrDlkp~---NILl~~~~~~vkL~--DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DvwSlG~i 329 (468)
. ....|.-|... +..++..+ .+.++ ||+.+.................+.++|...... ......|+|.+|.+
T Consensus 304 ~-~~l~~v~L~~s~~~~~~~~~e~-~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll 381 (1351)
T KOG1035|consen 304 S-LSLEHVVLSASSSKESTVDGEG-VVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLL 381 (1351)
T ss_pred H-hccceeEEecccccccccCccc-eeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHH
Confidence 7 54444333333 22233333 45555 999888776666666667778888999874332 12334799999999
Q ss_pred HHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCC
Q 012233 330 LAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPS 409 (468)
Q Consensus 330 l~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 409 (468)
+..+..|..+-.... ..... ..........+++.+|+.-+++
T Consensus 382 ~~~~~~~~~i~~~~~------~~~~~--------------------------------l~~~~~~~~~d~~~~~~~~~~~ 423 (1351)
T KOG1035|consen 382 LLQLSQGEDISEKSA------VPVSL--------------------------------LDVLSTSELLDALPKCLDEDSE 423 (1351)
T ss_pred HhhhhhcCccccccc------chhhh--------------------------------hccccchhhhhhhhhhcchhhh
Confidence 999998764321110 00000 0011112678999999999999
Q ss_pred CCCCHHHHhCCCCCCCCC
Q 012233 410 LRCTALEACAHPFFDDLR 427 (468)
Q Consensus 410 ~R~s~~ell~hp~f~~~~ 427 (468)
+|+++.+++.|||.+.-.
T Consensus 424 ~Rl~~~~ll~~~f~~~~~ 441 (1351)
T KOG1035|consen 424 ERLSALELLTHPFLRFPT 441 (1351)
T ss_pred hccchhhhhhchhccccc
Confidence 999999999999987633
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.41 E-value=3.4e-06 Score=77.70 Aligned_cols=131 Identities=19% Similarity=0.210 Sum_probs=88.5
Q ss_pred eecccCceEEEEEEEcCCCCEEEEEEeecccch----------------------------HHHHHHHHHHcC--CCCcc
Q 012233 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRY----------------------------KNRELQIMRLLN--HPNVV 193 (468)
Q Consensus 144 ~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~~~----------------------------~~~E~~il~~l~--hpnIv 193 (468)
.|.+|--+.||+|.. .++..+|+|++...... .++|+.-|+++. +=.+.
T Consensus 55 ~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP 133 (268)
T COG1718 55 CISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP 133 (268)
T ss_pred eecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence 677788889999984 56899999987432111 124777777774 33444
Q ss_pred cccceeeecCCCCceEEEEEeecccchHHHHHhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeee
Q 012233 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRM-NQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLV 272 (468)
Q Consensus 194 ~l~~~~~~~~~~~~~~~~lv~e~~~~~ll~~~~~~~~~-~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl 272 (468)
+-+.++ . -.|||||++..-. ..... .-......+..+..+++..+.-|-...|+||+||+.-|||+
T Consensus 134 ~Pi~~~-----~----nVLvMEfIg~~g~----pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~ 200 (268)
T COG1718 134 EPIAFR-----N----NVLVMEFIGDDGL----PAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILV 200 (268)
T ss_pred Cceeec-----C----CeEEEEeccCCCC----CCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEE
Confidence 444443 2 3589999986411 11111 11222235777788888888887644799999999999999
Q ss_pred cCCCCcEEEeeecCcccc
Q 012233 273 NPHTHQLKICDFGSAKML 290 (468)
Q Consensus 273 ~~~~~~vkL~DFG~a~~~ 290 (468)
. ++ .+.|+|||-|...
T Consensus 201 ~-~~-~p~iID~~QaV~~ 216 (268)
T COG1718 201 H-DG-EPYIIDVSQAVTI 216 (268)
T ss_pred E-CC-eEEEEECcccccc
Confidence 9 54 6999999998643
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.26 E-value=7.1e-06 Score=76.35 Aligned_cols=77 Identities=18% Similarity=0.158 Sum_probs=51.0
Q ss_pred eceecccCceEEEEEEEcCCCCEEEEEEeecc--cchHHHHHHHHHHcCCCC--cccccceeeecCCCCceEEEEEeecc
Q 012233 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD--KRYKNRELQIMRLLNHPN--VVSLKHCFFSTTEKDELYLNLVLEYI 217 (468)
Q Consensus 142 ~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~--~~~~~~E~~il~~l~hpn--Iv~l~~~~~~~~~~~~~~~~lv~e~~ 217 (468)
++.|+.|..+.||+..... ..+++|..... .....+|..+++.+.... +.+++..... .......+++|+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~--~~~~~~~~~~~~~i 77 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFDTS--DEFNGFPYLLMEYI 77 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEE--TEETSEEEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeeccc--ccccccceEEEEEe
Confidence 3578999999999999743 58999987655 344567889988886443 3455442211 12233478999999
Q ss_pred cchHH
Q 012233 218 SETVY 222 (468)
Q Consensus 218 ~~~ll 222 (468)
.|..+
T Consensus 78 ~g~~~ 82 (239)
T PF01636_consen 78 PGRPL 82 (239)
T ss_dssp SSEEH
T ss_pred ccccc
Confidence 87533
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.22 E-value=7.6e-06 Score=71.40 Aligned_cols=127 Identities=20% Similarity=0.266 Sum_probs=85.8
Q ss_pred EEeceecccCceEEEEEEEcCCCCEEEEEEeecc--cchHHHHHHHHHHcCCCCccc-ccceeeecCCCCceEEEEEeec
Q 012233 140 MAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD--KRYKNRELQIMRLLNHPNVVS-LKHCFFSTTEKDELYLNLVLEY 216 (468)
Q Consensus 140 ~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~--~~~~~~E~~il~~l~hpnIv~-l~~~~~~~~~~~~~~~~lv~e~ 216 (468)
+..+.||+|.+|.||+|.+ .|..+|+|+-..+ ...+..|+++|..+.-.++.. +|.+- + .++.|||
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~yg-----~----~~i~me~ 93 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEW--RGGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFYG-----E----DFIRMEY 93 (201)
T ss_pred hhhhhhhcccccEEEEeec--cCceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEec-----h----hhhhhhh
Confidence 4557899999999999998 6779999976544 445678999999998666544 22211 1 3467999
Q ss_pred ccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCC-CCCeeecCCCCcEEEeeecCccc
Q 012233 217 ISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIK-PQNLLVNPHTHQLKICDFGSAKM 289 (468)
Q Consensus 217 ~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlk-p~NILl~~~~~~vkL~DFG~a~~ 289 (468)
+.|--+.....- . -++-...++.+---|-. .||-|..|. |..++|..++ .+.|+||..|+.
T Consensus 94 i~G~~L~~~~~~------~----~rk~l~~vlE~a~~LD~-~GI~H~El~~~~k~vlv~~~-~~~iIDFd~At~ 155 (201)
T COG2112 94 IDGRPLGKLEIG------G----DRKHLLRVLEKAYKLDR-LGIEHGELSRPWKNVLVNDR-DVYIIDFDSATF 155 (201)
T ss_pred hcCcchhhhhhc------c----cHHHHHHHHHHHHHHHH-hccchhhhcCCceeEEecCC-cEEEEEccchhh
Confidence 998433321110 0 12234456666445555 799999996 6555555455 699999999874
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.19 E-value=1.1e-05 Score=83.06 Aligned_cols=140 Identities=16% Similarity=0.208 Sum_probs=82.9
Q ss_pred eceecccCceEEEEEEEcCCCCEEEEEEeecccc-----------------------------------------hHHHH
Q 012233 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR-----------------------------------------YKNRE 180 (468)
Q Consensus 142 ~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~~-----------------------------------------~~~~E 180 (468)
.+.||..+.|+||+|+.+. |+.||||+-+...+ .+.+|
T Consensus 166 ~~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~E 244 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKE 244 (538)
T ss_pred cchhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHH
Confidence 3579999999999999754 99999997532210 01123
Q ss_pred HHH----HHHcCCCC---cccccceeeecCCCCceEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHH
Q 012233 181 LQI----MRLLNHPN---VVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253 (468)
Q Consensus 181 ~~i----l~~l~hpn---Iv~l~~~~~~~~~~~~~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~y 253 (468)
.+- .+.+.|-+ -|++-.+|...+. .-.|+||||.|.-+..+.... ...++...+...+.++..-+-
T Consensus 245 A~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st----~RVLtME~~~G~~i~Dl~~i~--~~gi~~~~i~~~l~~~~~~qI- 317 (538)
T KOG1235|consen 245 AKNAERFRENFKDFSLLTYVLVPKVYWDLST----KRVLTMEYVDGIKINDLDAID--KRGISPHDILNKLVEAYLEQI- 317 (538)
T ss_pred HHhHHHHHHHHHhcccccceeCCeehhhcCc----ceEEEEEecCCccCCCHHHHH--HcCCCHHHHHHHHHHHHHHHH-
Confidence 322 22334555 2223333432222 246999999985443333322 233554443332222221111
Q ss_pred hHhcCCccccCCCCCCeeecC---CCCcEEEeeecCccccC
Q 012233 254 LHHVVGVCHRDIKPQNLLVNP---HTHQLKICDFGSAKMLV 291 (468)
Q Consensus 254 LH~~~givHrDlkp~NILl~~---~~~~vkL~DFG~a~~~~ 291 (468)
++ .|++|+|=.|.||++++ .+..+.+-|||+...+.
T Consensus 318 f~--~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 318 FK--TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred Hh--cCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 12 58999999999999984 24479999999987653
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.14 E-value=2.3e-05 Score=73.09 Aligned_cols=135 Identities=16% Similarity=0.131 Sum_probs=75.9
Q ss_pred ceecccCceEEEEEEEcCCCCEEEEEEeecc--cchHHHHHHHHHHcCCCCc--ccccceeeecCCCCceEEEEEeeccc
Q 012233 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQD--KRYKNRELQIMRLLNHPNV--VSLKHCFFSTTEKDELYLNLVLEYIS 218 (468)
Q Consensus 143 ~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~--~~~~~~E~~il~~l~hpnI--v~l~~~~~~~~~~~~~~~~lv~e~~~ 218 (468)
..||.|..+.||+. .|..+++|..... .....+|.++++.+..-.+ .+++++. .+.....+|||++.
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~-----~~~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGFDKETIKREFDASRKVFSLGIPTPHPFDLV-----EDGGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCCCHHHHHHHHHHHHHHHHcCCCCCceEEEE-----ecCCeeeeeeeecC
Confidence 46899999999984 2556778876542 2345789999998864333 4444433 22223568999999
Q ss_pred chH-----HH--------H---Hhh-hhhcC----CCCCHHH-HHHHHHHH----------HH-HHHHhH---hcCCccc
Q 012233 219 ETV-----YR--------V---SKH-YTRMN----QHVPILY-VQLYTYQI----------CR-ALNYLH---HVVGVCH 262 (468)
Q Consensus 219 ~~l-----l~--------~---~~~-~~~~~----~~~~~~~-~~~~~~qi----------~~-aL~yLH---~~~givH 262 (468)
|.. +. + +.. ..+.+ ...+... ...+..++ .. ...+|. ....++|
T Consensus 78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H 157 (226)
T TIGR02172 78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH 157 (226)
T ss_pred CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence 841 10 0 000 00001 0111111 01111111 11 122222 1135789
Q ss_pred cCCCCCCeeecCCCCcEEEeeecCcc
Q 012233 263 RDIKPQNLLVNPHTHQLKICDFGSAK 288 (468)
Q Consensus 263 rDlkp~NILl~~~~~~vkL~DFG~a~ 288 (468)
+|+.|.||+++.++ +.|+||+.+.
T Consensus 158 gD~~~~Nii~~~~~--~~iIDwe~a~ 181 (226)
T TIGR02172 158 GDFQIGNLITSGKG--TYWIDLGDFG 181 (226)
T ss_pred cCCCCCcEEEcCCC--cEEEechhcC
Confidence 99999999999765 8899999875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.02 E-value=3.2e-05 Score=69.69 Aligned_cols=126 Identities=24% Similarity=0.308 Sum_probs=88.0
Q ss_pred cceEEeceecccCc-eEEEEEEEcCCCCEEEEEEeec--------------c-c----------chHHHHHHHHHHc---
Q 012233 137 ISYMAERVVGTGSF-GVVFQAKCLETGDSVAIKKVLQ--------------D-K----------RYKNRELQIMRLL--- 187 (468)
Q Consensus 137 ~~y~~~~~lG~G~f-g~Vy~~~~~~~g~~vaiK~~~~--------------~-~----------~~~~~E~~il~~l--- 187 (468)
.+++..+.||.|.- |.||+++. .|..||||.+.. . . ..+..|.+...+|
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 35889999999999 99999987 788999998311 0 0 0123465554444
Q ss_pred CCCCc--ccccceeeecCC-------------CCceEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHH
Q 012233 188 NHPNV--VSLKHCFFSTTE-------------KDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252 (468)
Q Consensus 188 ~hpnI--v~l~~~~~~~~~-------------~~~~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~ 252 (468)
.+.++ |++++++....+ .......||.||+.... .+. ..-+.+|++-|.
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~----~~~~~~~~~dl~ 178 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQ----IRDIPQMLRDLK 178 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccc----hhHHHHHHHHHH
Confidence 56666 999998865521 11122458888887542 111 123568888899
Q ss_pred HhHhcCCccccCCCCCCeeecCCCCcEEEeeecCc
Q 012233 253 YLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (468)
Q Consensus 253 yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a 287 (468)
.||. .||+-+|+++.|.. + -||+|||.+
T Consensus 179 ~~~k-~gI~~~Dv~~~ny~---~---G~lvDfs~~ 206 (207)
T PF13095_consen 179 ILHK-LGIVPRDVKPRNYR---G---GKLVDFSSS 206 (207)
T ss_pred HHHH-CCeeeccCcccccc---C---CEEEecccC
Confidence 9998 89999999999976 3 379999864
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.92 E-value=0.00013 Score=81.00 Aligned_cols=77 Identities=18% Similarity=0.207 Sum_probs=49.8
Q ss_pred eceecccCceEEEEEEEcCCC--CEEEEEEeec-----ccchHHHHHHHHHHcC-CCCc--ccccceeeecCCCCceEEE
Q 012233 142 ERVVGTGSFGVVFQAKCLETG--DSVAIKKVLQ-----DKRYKNRELQIMRLLN-HPNV--VSLKHCFFSTTEKDELYLN 211 (468)
Q Consensus 142 ~~~lG~G~fg~Vy~~~~~~~g--~~vaiK~~~~-----~~~~~~~E~~il~~l~-hpnI--v~l~~~~~~~~~~~~~~~~ 211 (468)
.+.|+.|.+..+|+......+ ..+++|+... ......+|+.+|+.+. |.+| .+++.++... ......|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~--~v~G~~f 120 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDA--SVIGTAF 120 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCC--CcCCCce
Confidence 356789999999998764332 3677776532 2245678999999996 6664 4544443211 1112357
Q ss_pred EEeecccch
Q 012233 212 LVLEYISET 220 (468)
Q Consensus 212 lv~e~~~~~ 220 (468)
+||||+.|.
T Consensus 121 lVME~v~G~ 129 (822)
T PLN02876 121 YIMEYLEGR 129 (822)
T ss_pred EEEEecCCc
Confidence 999999875
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.91 E-value=9.4e-05 Score=69.76 Aligned_cols=68 Identities=15% Similarity=0.030 Sum_probs=41.8
Q ss_pred CceEEEEEEEcCCCCEEEEEEeecc-cchHHHHHHHHHHcC-CCCcccccceeeecCCCCceEEEEEeecccchHHH
Q 012233 149 SFGVVFQAKCLETGDSVAIKKVLQD-KRYKNRELQIMRLLN-HPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYR 223 (468)
Q Consensus 149 ~fg~Vy~~~~~~~g~~vaiK~~~~~-~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~~~~~~lv~e~~~~~ll~ 223 (468)
.-..||+... .+..+.+|..... .....+|+++++.+. +--+.+++++.. ....-++|||+++|..+.
T Consensus 11 ~~~~v~~~~~--~~~~~~vk~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~-----~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 11 SGATVYRLDG--KNPGLYLKIAPSGPTYELEREAERLRWLAGKLPVPEVIDYGS-----DDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred CcCeEEEEcC--CCCcEEEEecCCCcccchHHHHHHHHHHHhcCCCCeEEEEEe-----cCCccEEEEEeeCCccHh
Confidence 3378899865 3467788876432 234567999998885 323444544431 112356899999885443
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.00037 Score=65.33 Aligned_cols=30 Identities=33% Similarity=0.421 Sum_probs=24.8
Q ss_pred CCccccCCCCCCeeecCCCCcEEEeeecCcc
Q 012233 258 VGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (468)
Q Consensus 258 ~givHrDlkp~NILl~~~~~~vkL~DFG~a~ 288 (468)
.+++|+|+.+.|||++.+. ..-|+||+.+.
T Consensus 164 ~~l~HGD~~~~Nvlv~~~~-i~giIDw~~a~ 193 (235)
T cd05155 164 PVWFHGDLAPGNLLVQDGR-LSAVIDFGCLG 193 (235)
T ss_pred ceEEeCCCCCCcEEEECCC-EEEEEeCcccC
Confidence 3589999999999998654 45699999874
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.00054 Score=66.69 Aligned_cols=137 Identities=20% Similarity=0.250 Sum_probs=91.4
Q ss_pred EEeceecccCceEEEEEEEcCCCCEEEEEEeecc-------cc-----------------------hHHHHHHHHHHcCC
Q 012233 140 MAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KR-----------------------YKNRELQIMRLLNH 189 (468)
Q Consensus 140 ~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~-------~~-----------------------~~~~E~~il~~l~h 189 (468)
.+.-+|..|--+.||.|. ..+|..+|||+++.. .+ -.+.|+.-|++|..
T Consensus 147 ~inGCiSTGKEANVYHat-~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~ 225 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHAT-EEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN 225 (520)
T ss_pred ecccccccCccceeEeee-cCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence 344567888888999998 467889999977321 11 11357777888865
Q ss_pred CCcccccceeeecCCCCceEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCC
Q 012233 190 PNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQN 269 (468)
Q Consensus 190 pnIv~l~~~~~~~~~~~~~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~N 269 (468)
..|...--++ ... -+|||+|++..-.- .-......++...+..+-.|++.-+.-|-+.++.||.||.--|
T Consensus 226 aGIP~PePIl-Lk~------hVLVM~FlGrdgw~---aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN 295 (520)
T KOG2270|consen 226 AGIPCPEPIL-LKN------HVLVMEFLGRDGWA---APKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFN 295 (520)
T ss_pred cCCCCCCcee-eec------ceEeeeeccCCCCc---CcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhh
Confidence 4433221111 111 24899999853111 1111234466667777778888888887555899999999999
Q ss_pred eeecCCCCcEEEeeecCccc
Q 012233 270 LLVNPHTHQLKICDFGSAKM 289 (468)
Q Consensus 270 ILl~~~~~~vkL~DFG~a~~ 289 (468)
+|+.. | .+.|+|.+-+..
T Consensus 296 ~Lyhd-G-~lyiIDVSQSVE 313 (520)
T KOG2270|consen 296 LLYHD-G-KLYIIDVSQSVE 313 (520)
T ss_pred heEEC-C-EEEEEEcccccc
Confidence 99984 4 599999988743
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.54 E-value=0.00037 Score=66.21 Aligned_cols=132 Identities=20% Similarity=0.238 Sum_probs=74.4
Q ss_pred ecccCceEEEEEEEcCCCCEEEEEEeeccc----chHHHHHHHHHHcCCCCcc-cccceeeecCCCCceEEEEEeecccc
Q 012233 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDK----RYKNRELQIMRLLNHPNVV-SLKHCFFSTTEKDELYLNLVLEYISE 219 (468)
Q Consensus 145 lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~----~~~~~E~~il~~l~hpnIv-~l~~~~~~~~~~~~~~~~lv~e~~~~ 219 (468)
+..|-.+.+|+... ++..+++|...... ....+|..+++.+....++ +++... . -++||||++|
T Consensus 4 ~~~G~tn~~y~~~~--~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~-----~----~~~v~e~i~G 72 (256)
T TIGR02721 4 LSGGLTNRSWRIEH--PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN-----E----HWLLVEWLEG 72 (256)
T ss_pred CCCcCcCCeEEEEe--CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe-----C----CEEEEEeccC
Confidence 45677788898863 56788888754332 2356799999999754343 232221 1 2489999987
Q ss_pred hHHHH------------Hh-----hhhh-cCCCCCHH-HHHHHHHHH---------HHHHHHhHh-------cCCccccC
Q 012233 220 TVYRV------------SK-----HYTR-MNQHVPIL-YVQLYTYQI---------CRALNYLHH-------VVGVCHRD 264 (468)
Q Consensus 220 ~ll~~------------~~-----~~~~-~~~~~~~~-~~~~~~~qi---------~~aL~yLH~-------~~givHrD 264 (468)
..+.. .. |... ....+... .+..+..++ ...+..+-. ...++|+|
T Consensus 73 ~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~D 152 (256)
T TIGR02721 73 EVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMD 152 (256)
T ss_pred cccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCC
Confidence 43321 00 0000 01112211 122222222 111222211 12589999
Q ss_pred CCCCCeeecCCCCcEEEeeecCccc
Q 012233 265 IKPQNLLVNPHTHQLKICDFGSAKM 289 (468)
Q Consensus 265 lkp~NILl~~~~~~vkL~DFG~a~~ 289 (468)
+.|.||+++.++ +.|+||+.+..
T Consensus 153 l~~~Nil~~~~~--~~lIDwE~a~~ 175 (256)
T TIGR02721 153 VHAYNLVVTPQG--LKLIDWEYASD 175 (256)
T ss_pred CCcCcEEEeCCC--CEEEeccccCc
Confidence 999999999765 78999998854
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.00095 Score=60.60 Aligned_cols=127 Identities=20% Similarity=0.308 Sum_probs=79.7
Q ss_pred ceecccCceEEEEEEEcCCCCEEEEEEeeccc--------------------chHHHHHHHHHHcC------CCCccccc
Q 012233 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK--------------------RYKNRELQIMRLLN------HPNVVSLK 196 (468)
Q Consensus 143 ~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~--------------------~~~~~E~~il~~l~------hpnIv~l~ 196 (468)
..||+|+.-.||.-- ......||+..... ....+|+.-...+. +.+|.+++
T Consensus 7 ~~i~~G~~R~cy~HP---~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCYQHP---DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEEECC---CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 469999999999753 34456678875544 34456777666666 78899999
Q ss_pred ceeeecCCCCceEEEEEeeccc---chHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeec
Q 012233 197 HCFFSTTEKDELYLNLVLEYIS---ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVN 273 (468)
Q Consensus 197 ~~~~~~~~~~~~~~~lv~e~~~---~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~ 273 (468)
|+..+..+ ..+|+|.+. |..-..+..+.. ...++. .. ...+-.-..||-. .+|+.+||+|.||++.
T Consensus 84 G~veT~~G-----~Glv~e~I~d~dG~~s~TL~~~l~-~~~~~~-~~---~~~L~~f~~~l~~-~~Iv~~dl~~~NIv~~ 152 (199)
T PF10707_consen 84 GFVETNLG-----LGLVVELIRDADGNISPTLEDYLK-EGGLTE-EL---RQALDEFKRYLLD-HHIVIRDLNPHNIVVQ 152 (199)
T ss_pred EEEecCCc-----eEEEEEEEECCCCCcCccHHHHHH-cCCccH-HH---HHHHHHHHHHHHH-cCCeecCCCcccEEEE
Confidence 98744433 567777764 221111112221 233444 22 3334445567776 7999999999999995
Q ss_pred CCC--C-cEEEee
Q 012233 274 PHT--H-QLKICD 283 (468)
Q Consensus 274 ~~~--~-~vkL~D 283 (468)
... . .+.|+|
T Consensus 153 ~~~~~~~~lvlID 165 (199)
T PF10707_consen 153 RRDSGEFRLVLID 165 (199)
T ss_pred ecCCCceEEEEEe
Confidence 432 2 466666
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.001 Score=66.94 Aligned_cols=70 Identities=24% Similarity=0.329 Sum_probs=46.2
Q ss_pred ceecccCceEEEEEEEcCCCCEEEEEEee-------c----ccchHHHHHHHHHHcC---CCCcccccceeeecCCCCce
Q 012233 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVL-------Q----DKRYKNRELQIMRLLN---HPNVVSLKHCFFSTTEKDEL 208 (468)
Q Consensus 143 ~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~-------~----~~~~~~~E~~il~~l~---hpnIv~l~~~~~~~~~~~~~ 208 (468)
+.||.|.+..||++.....++.|+||+-. . .......|.+.|+.+. -.++.+++.+- . .
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D-----~--~ 104 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD-----E--E 104 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC-----C--C
Confidence 56899999999999985433589999742 1 1122345788887763 24566665542 1 2
Q ss_pred EEEEEeecccc
Q 012233 209 YLNLVLEYISE 219 (468)
Q Consensus 209 ~~~lv~e~~~~ 219 (468)
..++||||+++
T Consensus 105 ~~~lVME~L~~ 115 (401)
T PRK09550 105 LAVTVMEDLSD 115 (401)
T ss_pred CCEEEEecCCC
Confidence 25689999875
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.00024 Score=64.06 Aligned_cols=102 Identities=22% Similarity=0.202 Sum_probs=75.1
Q ss_pred HHHHHHHHHcCC-CCcccccceeeecCCCCceEEEEEeecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhH
Q 012233 178 NRELQIMRLLNH-PNVVSLKHCFFSTTEKDELYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255 (468)
Q Consensus 178 ~~E~~il~~l~h-pnIv~l~~~~~~~~~~~~~~~~lv~e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH 255 (468)
..|.-+|+.+++ +++.+++|.+ . -++|.||.+.+ ++... .....-...++..+.+++.+++..+.+|+
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C-----G----~~~v~E~~~~~~~~~~~-~~l~~~~~~~w~~R~~iA~~lL~~l~~l~ 76 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC-----G----RFYVVEYVGAGSLYGIY-RPLSQFLQSPWEQRAKIALQLLELLEELD 76 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC-----C----CEEEEEeecCccccccc-cccccccccCHHHHHHHHHHHHHHHHHHh
Confidence 358889999986 6999999987 2 34789999853 22110 00001133688889999999999999998
Q ss_pred hc--CCccccCCCCCCeeecCCCCcEEEeeecCcccc
Q 012233 256 HV--VGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (468)
Q Consensus 256 ~~--~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~ 290 (468)
+. ..+.-.|++++|+-++.++ .+|++|...+...
T Consensus 77 ~~~~~~~~lcDv~~~nfgv~~~~-~lk~iDld~v~~~ 112 (188)
T PF12260_consen 77 HGPLGFFYLCDVSPDNFGVNDDG-RLKLIDLDDVFVE 112 (188)
T ss_pred cCCCCcEEEeecchHHeEEeCCC-cEEEEechhcchh
Confidence 41 1366689999999999887 7999999987443
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.0019 Score=60.42 Aligned_cols=69 Identities=22% Similarity=0.330 Sum_probs=44.3
Q ss_pred ceecccCceEEEEEEEcC-CCCEEEEEEeeccc---chHHHHHHHHHHcCCCCc-ccccceeeecCCCCceEEEEEeecc
Q 012233 143 RVVGTGSFGVVFQAKCLE-TGDSVAIKKVLQDK---RYKNRELQIMRLLNHPNV-VSLKHCFFSTTEKDELYLNLVLEYI 217 (468)
Q Consensus 143 ~~lG~G~fg~Vy~~~~~~-~g~~vaiK~~~~~~---~~~~~E~~il~~l~hpnI-v~l~~~~~~~~~~~~~~~~lv~e~~ 217 (468)
+.|..|-...||++.... .++.|++|+..... ...++|+.+++.+....+ .+++..+ .+ .+||||+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~-----~~----~~l~e~i 74 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATF-----QN----GLIYEFI 74 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEe-----CC----cEEEEee
Confidence 457788888999987532 35788899764322 233579999999864444 3333222 11 3799998
Q ss_pred cch
Q 012233 218 SET 220 (468)
Q Consensus 218 ~~~ 220 (468)
+|.
T Consensus 75 ~G~ 77 (235)
T cd05157 75 PGR 77 (235)
T ss_pred CCC
Confidence 864
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.0025 Score=61.97 Aligned_cols=75 Identities=7% Similarity=0.002 Sum_probs=50.1
Q ss_pred eceecccCceEEEEEEEcCCCCEEEEEEeec--ccchHHHHHHHHHHcCC---CCcccccceeeecCCCCceEEEEEeec
Q 012233 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ--DKRYKNRELQIMRLLNH---PNVVSLKHCFFSTTEKDELYLNLVLEY 216 (468)
Q Consensus 142 ~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~--~~~~~~~E~~il~~l~h---pnIv~l~~~~~~~~~~~~~~~~lv~e~ 216 (468)
.+.||.|..+.||.... .+..+.+|..+. ....+..|...|+.|.. -.+.++++++.... ....-+||||+
T Consensus 19 ~~~i~~G~~~~vy~~~~--~~~~~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~--~~g~~~LVmE~ 94 (297)
T PRK10593 19 VECISEQPYAALWALYD--SQGNPMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQ--SPGPDVLLLER 94 (297)
T ss_pred eeecCCccceeEEEEEc--CCCCEEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCC--cCCCeEEEEec
Confidence 35699999999999864 333566777544 23477889999998864 24666665542211 11236799999
Q ss_pred ccch
Q 012233 217 ISET 220 (468)
Q Consensus 217 ~~~~ 220 (468)
+.|.
T Consensus 95 i~G~ 98 (297)
T PRK10593 95 LRGV 98 (297)
T ss_pred cCCE
Confidence 8864
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.35 E-value=0.00019 Score=68.64 Aligned_cols=128 Identities=16% Similarity=0.201 Sum_probs=85.9
Q ss_pred eEEeceecccCceEEEEEEEcCCCCEEEEEEee----------cc----------------cchHHHHHHHHHHcC-CCC
Q 012233 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVL----------QD----------------KRYKNRELQIMRLLN-HPN 191 (468)
Q Consensus 139 y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~----------~~----------------~~~~~~E~~il~~l~-hpn 191 (468)
|.+++.||-|--+.||.+-+ ..|...++|.-. .. +....+|+..|+.|. |..
T Consensus 94 ~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 66778899999999999986 458888888421 11 111236888888885 322
Q ss_pred -cccccceeeecCCCCceEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCe
Q 012233 192 -VVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNL 270 (468)
Q Consensus 192 -Iv~l~~~~~~~~~~~~~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NI 270 (468)
|.+.+++. .-|+|||++.|--+..+.+. .. ...+...+..-+.-|-+ +|+||+|..--||
T Consensus 173 pVPkpiD~~---------RH~Vvmelv~g~Pl~~v~~v------~d---~~~ly~~lm~~Iv~la~-~GlIHgDFNEFNi 233 (465)
T KOG2268|consen 173 PVPKPIDHN---------RHCVVMELVDGYPLRQVRHV------ED---PPTLYDDLMGLIVRLAN-HGLIHGDFNEFNI 233 (465)
T ss_pred CCCCccccc---------ceeeHHHhhcccceeeeeec------CC---hHHHHHHHHHHHHHHHH-cCceecccchhee
Confidence 33343332 35689999987544322211 11 22334455555667777 8999999999999
Q ss_pred eecCCCCcEEEeeecCc
Q 012233 271 LVNPHTHQLKICDFGSA 287 (468)
Q Consensus 271 Ll~~~~~~vkL~DFG~a 287 (468)
+|+.++ .++++||--.
T Consensus 234 mv~dd~-~i~vIDFPQm 249 (465)
T KOG2268|consen 234 MVKDDD-KIVVIDFPQM 249 (465)
T ss_pred EEecCC-CEEEeechHh
Confidence 999777 6999999764
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.33 E-value=0.00014 Score=81.50 Aligned_cols=213 Identities=15% Similarity=0.010 Sum_probs=129.7
Q ss_pred HHHHHHHcCCCCcccccceeeecCCCCceEEEEEeecccchH-HHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcC
Q 012233 180 ELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETV-YRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV 258 (468)
Q Consensus 180 E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv~e~~~~~l-l~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ 258 (468)
|...++...|+++...+.-... ......+++++|+.+|. ...+..-..........-+.....+.+.+..-+|...
T Consensus 1279 e~de~~~~~h~~~~~~p~rI~p---s~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1279 ERDELREAKHYLTEVDPLRIPP---SESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhceeeecccccCCC---CCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 4455666789988776543322 22233567899998653 3433332222222222223333334366666666422
Q ss_pred C----ccccCCCCCCeeecCCCCcEEEeeecCccccCCC-CCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHH
Q 012233 259 G----VCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG-EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAEL 333 (468)
Q Consensus 259 g----ivHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~el 333 (468)
+ .+|++||+-|.+|..+. .+|++++|+.+...+. .......+++.|+.|++.. .-.++.++|+|..|+.+|++
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtny-~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N-~ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNY-NVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKN-EIKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred cCCccchhhhhhhhccceecCC-cccccccccccccCchHhhhhhhhCCHHHHHHHHHH-HHhhhhHHHHHHHHHHHHHH
Confidence 2 67999999999998776 7999999999833322 2334567788999999774 44588889999999999999
Q ss_pred HhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCC
Q 012233 334 LLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCT 413 (468)
Q Consensus 334 l~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s 413 (468)
..|..+|. .....+.+ +.-.+-..+.++ ...|.++......+|-+.-..||.
T Consensus 1434 s~~n~~fi-----~flq~~Lk-----------giidn~tf~sIe------------~l~pgdaNve~~~~Ll~K~~~rp~ 1485 (2724)
T KOG1826|consen 1434 SDGNAYFI-----FFLQPALK-----------GIIDNHTFFSIE------------KLKPGDANVEALHRLLWKYMERPG 1485 (2724)
T ss_pred hcccHHHH-----HHHHHHHc-----------Cccccccccccc------------ccCCCcccHHHHHHHHHHhhhcch
Confidence 99987772 22222222 111111222222 223444555555555555678888
Q ss_pred HHHHhCCCCCCC
Q 012233 414 ALEACAHPFFDD 425 (468)
Q Consensus 414 ~~ell~hp~f~~ 425 (468)
-...+.-+.|..
T Consensus 1486 q~isls~d~~a~ 1497 (2724)
T KOG1826|consen 1486 QYISLSRDHFAV 1497 (2724)
T ss_pred hhhhcccccccc
Confidence 888888777654
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.33 E-value=0.00078 Score=65.45 Aligned_cols=144 Identities=11% Similarity=0.023 Sum_probs=77.2
Q ss_pred eceecccCceEEEEEEEcCCCCEEEEEEeec-ccchHHHHHHHHHHcCCCC--cccccceeeec-CCCCceEEEEEeecc
Q 012233 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ-DKRYKNRELQIMRLLNHPN--VVSLKHCFFST-TEKDELYLNLVLEYI 217 (468)
Q Consensus 142 ~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~-~~~~~~~E~~il~~l~hpn--Iv~l~~~~~~~-~~~~~~~~~lv~e~~ 217 (468)
.+.|..|....+|+... .+..+++|+... .......|+.++..|.+.. +.+++...... ........++|++|+
T Consensus 19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i 96 (296)
T cd05153 19 FEGISAGIENTNYFVTT--DSGRYVLTLFEKVSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFL 96 (296)
T ss_pred eecccCccccceEEEEe--CCCcEEEEEcCCCChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeC
Confidence 34577787789998864 445788898763 2334557888888885432 34443321000 001112357899999
Q ss_pred cchHHH---------HHh-----h-hh-hcCC------CCCHHHH--H--------HHHHHHHHHHHHhHh------cCC
Q 012233 218 SETVYR---------VSK-----H-YT-RMNQ------HVPILYV--Q--------LYTYQICRALNYLHH------VVG 259 (468)
Q Consensus 218 ~~~ll~---------~~~-----~-~~-~~~~------~~~~~~~--~--------~~~~qi~~aL~yLH~------~~g 259 (468)
+|..+. +.. | .. .... ...+... . .....+..++.++.. ..+
T Consensus 97 ~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~ 176 (296)
T cd05153 97 AGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRG 176 (296)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCc
Confidence 863221 000 0 00 0000 0000000 0 001112233344431 147
Q ss_pred ccccCCCCCCeeecCCCCcEEEeeecCcc
Q 012233 260 VCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (468)
Q Consensus 260 ivHrDlkp~NILl~~~~~~vkL~DFG~a~ 288 (468)
++|+|+.|.|||++.++ .+.|+||+.+.
T Consensus 177 l~HgD~~~~Nil~~~~~-~~~iIDfe~a~ 204 (296)
T cd05153 177 VIHADLFRDNVLFDGDE-LSGVIDFYFAC 204 (296)
T ss_pred CCccCcCcccEEEeCCc-eEEEeehhhhc
Confidence 99999999999999765 46899999874
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.22 E-value=0.0039 Score=60.94 Aligned_cols=144 Identities=14% Similarity=0.063 Sum_probs=76.8
Q ss_pred eceecccCceEEEEEEEcCCCCEEEEEEeecc--cchHHHHHHHHHHcCCCC--cccccceeeec-CCCCceEEEEEeec
Q 012233 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD--KRYKNRELQIMRLLNHPN--VVSLKHCFFST-TEKDELYLNLVLEY 216 (468)
Q Consensus 142 ~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~--~~~~~~E~~il~~l~hpn--Iv~l~~~~~~~-~~~~~~~~~lv~e~ 216 (468)
.+.++.|....+|+... ++..+++|+.... ......|.+++..|.... +.+++...... ........+++++|
T Consensus 27 i~~~~~G~~n~~y~v~t--~~~~~vLK~~~~~~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~ 104 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTT--DVGRYILTLYEKRVKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEF 104 (307)
T ss_pred ccccCCccccceEEEEe--CCCcEEEEEecCCCCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEe
Confidence 45677777789998864 3446778976543 234456778887775322 33433321000 00112346789999
Q ss_pred ccchHH---------HH---HhhhhhcCCCC--------CHHHH-----H----------HHHHHHHHHHHHhHh-----
Q 012233 217 ISETVY---------RV---SKHYTRMNQHV--------PILYV-----Q----------LYTYQICRALNYLHH----- 256 (468)
Q Consensus 217 ~~~~ll---------~~---~~~~~~~~~~~--------~~~~~-----~----------~~~~qi~~aL~yLH~----- 256 (468)
++|... .. +...-.....+ ..... . .....+...++++..
T Consensus 105 i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~ 184 (307)
T TIGR00938 105 LQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRD 184 (307)
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhc
Confidence 876211 00 00000000000 00000 0 001122334544531
Q ss_pred -cCCccccCCCCCCeeecCCCCcEEEeeecCcc
Q 012233 257 -VVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (468)
Q Consensus 257 -~~givHrDlkp~NILl~~~~~~vkL~DFG~a~ 288 (468)
..+++|+|+.+.||+++.++ .+.|+||+.+.
T Consensus 185 ~~~~l~HgD~~~~Nvl~~~~~-~~~vIDfd~~~ 216 (307)
T TIGR00938 185 LPRGVIHADLFPDNVLFDGDS-VKGVIDFYFAC 216 (307)
T ss_pred CCCccCCCCCCcCcEEEECCc-eEEEeeccccc
Confidence 26899999999999999776 56899999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.14 E-value=0.0078 Score=59.12 Aligned_cols=30 Identities=30% Similarity=0.283 Sum_probs=25.5
Q ss_pred CCccccCCCCCCeeecCCCCcEEEeeecCcc
Q 012233 258 VGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (468)
Q Consensus 258 ~givHrDlkp~NILl~~~~~~vkL~DFG~a~ 288 (468)
.|+||+|+.|.|||++.+. ..-|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~-~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDR-LSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCc-eEEEEeccccc
Confidence 4899999999999998554 45799999875
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.10 E-value=0.00041 Score=70.12 Aligned_cols=204 Identities=19% Similarity=0.174 Sum_probs=125.3
Q ss_pred HHHHHHHcCCCCcccccceeeecCCCCceEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCC
Q 012233 180 ELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG 259 (468)
Q Consensus 180 E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~g 259 (468)
-..+++.+.|+|....+++--.. .....+|||+++-++.+...... ... .+++ | +|
T Consensus 32 r~~~lktl~~~~l~~yl~~~r~~----~~r~IVV~e~~~~Sled~~~~~~--l~~----------~s~~-~-------~~ 87 (725)
T KOG1093|consen 32 RFQYLKSLQHDNLCQYLDFSRGK----HERVIVVMEHYTMSLEDILKTGN--LKD----------ESLL-A-------HG 87 (725)
T ss_pred hhHHHHhhcCccceeeEeeecCc----cceEEEEehhhccchHHHHHhcc--cch----------hhhc-c-------cc
Confidence 46788999999999887754221 12377999999988777544311 110 0111 1 23
Q ss_pred ccccCCCCCCeeecCCCCcEEEeeecCccccCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCC
Q 012233 260 VCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPL 339 (468)
Q Consensus 260 ivHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~p 339 (468)
+.|- | .++++| -+... | |-. .++++||||+|.++.++..|...
T Consensus 88 ~~~~-----~--------~~~~td-~~~t~---------------~--~~~------~~pKsdVwsl~~i~~el~L~~~l 130 (725)
T KOG1093|consen 88 VLHL-----N--------IIYITD-HFLTK---------------Y--PSP------IGPKSDVWSLGFIILELYLGISL 130 (725)
T ss_pred ccee-----h--------hhhccc-ccccc---------------C--CCC------CCcchhhhhHHHHHHHHHHhhHH
Confidence 3221 1 233444 11100 0 111 12499999999999999999988
Q ss_pred CCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 340 FPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 340 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
+......++...+.+..-.+.......+. ..+...++....++..+|+-..|..||...++..
T Consensus 131 ~~~~~~s~~l~~i~k~~~~d~~~~~~a~e-----------------~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k 193 (725)
T KOG1093|consen 131 EAELTESEYLEILLKYYTDDQELLSTAME-----------------HLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSK 193 (725)
T ss_pred HHHHHHHHHHHHHHHhccCchhHHHHHHH-----------------HHHHHhhhHhHHHHhccCCccccccccchhHHhc
Confidence 87776666666665544333322211100 0122346777889999999999999999999999
Q ss_pred CCCCCCCCCCCCCCCCCCCCCcccccCHHHH--hcCCHHHHHhcc
Q 012233 420 HPFFDDLRDPNTCLPNGRPLPTLFNFTAQEL--AGASNELRQRLI 462 (468)
Q Consensus 420 hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 462 (468)
|+-|.++-.--+. ...+++.++.+|++... .+.+--+|.+.+
T Consensus 194 ~~i~~ev~~~~t~-e~~~~L~~e~~~~~~~~r~~~~s~~lw~~~g 237 (725)
T KOG1093|consen 194 RCSFTEVYKDLTV-EMRAALRKEVANNDLFERLVENSYYLWKLAG 237 (725)
T ss_pred CccHHHHHhhhhH-HHHHhhcccccccHHHHHHHHHHHHHHHHhC
Confidence 9999987333333 66677777777774332 344444555543
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.96 E-value=0.0087 Score=59.10 Aligned_cols=69 Identities=23% Similarity=0.221 Sum_probs=43.1
Q ss_pred eecccCceEEEEEEEcCCCCEEEEEEeecc-----------cchHHHHHHHHHHcC--CC-CcccccceeeecCCCCceE
Q 012233 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----------KRYKNRELQIMRLLN--HP-NVVSLKHCFFSTTEKDELY 209 (468)
Q Consensus 144 ~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~-----------~~~~~~E~~il~~l~--hp-nIv~l~~~~~~~~~~~~~~ 209 (468)
.||.|....||++.....++.|+||+-..- .....-|...|+... -| .+.++|.+ +...
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~-------D~e~ 74 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF-------DTEM 74 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE-------cccc
Confidence 579999999999997543368999964211 112234777777664 24 34445432 2223
Q ss_pred EEEEeecccc
Q 012233 210 LNLVLEYISE 219 (468)
Q Consensus 210 ~~lv~e~~~~ 219 (468)
..+|||+++.
T Consensus 75 ~~~vMEdL~~ 84 (370)
T TIGR01767 75 AVTVMEDLSH 84 (370)
T ss_pred ceehHhhCcc
Confidence 4589999964
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.78 E-value=0.0096 Score=59.19 Aligned_cols=137 Identities=19% Similarity=0.258 Sum_probs=74.2
Q ss_pred eecccCceEEEEEEEcC----CCCEEEEEEeeccc---chHHHHHHHHHHcCCCCcc-cccceeeecCCCCceEEEEEee
Q 012233 144 VVGTGSFGVVFQAKCLE----TGDSVAIKKVLQDK---RYKNRELQIMRLLNHPNVV-SLKHCFFSTTEKDELYLNLVLE 215 (468)
Q Consensus 144 ~lG~G~fg~Vy~~~~~~----~g~~vaiK~~~~~~---~~~~~E~~il~~l~hpnIv-~l~~~~~~~~~~~~~~~~lv~e 215 (468)
.|-.|-.-.+|++.... .++.|++|+..... ....+|..+++.+..-++. ++++++ .+. .|.+
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~-----~~g----~v~e 113 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRF-----PNG----RVEE 113 (344)
T ss_pred EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEE-----CCc----eEEE
Confidence 45457778889887532 24678899775432 1235799999988644443 344443 211 4678
Q ss_pred cccchHHHH------------Hh-----hhhhc-CCC-CC-HHHHHHHHHHH-----------------HHHHHHh----
Q 012233 216 YISETVYRV------------SK-----HYTRM-NQH-VP-ILYVQLYTYQI-----------------CRALNYL---- 254 (468)
Q Consensus 216 ~~~~~ll~~------------~~-----~~~~~-~~~-~~-~~~~~~~~~qi-----------------~~aL~yL---- 254 (468)
|+.+..+.. .. |.... ... .. ...+..+..++ ...+..|
T Consensus 114 fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~ 193 (344)
T PLN02236 114 FIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKEL 193 (344)
T ss_pred eeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHh
Confidence 876532210 00 00000 001 11 22222332211 1111111
Q ss_pred Hh---cCCccccCCCCCCeeecCCCCcEEEeeecCccc
Q 012233 255 HH---VVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (468)
Q Consensus 255 H~---~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~ 289 (468)
.. ...++|+|+++.|||++.....+.|+||..+..
T Consensus 194 ~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 194 SGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred cccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 11 136899999999999986433799999998853
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.76 E-value=0.013 Score=57.10 Aligned_cols=69 Identities=19% Similarity=0.243 Sum_probs=42.2
Q ss_pred ceecccCceEEEEEEEcC------CCCEEEEEEeeccc---chHHHHHHHHHHcCCCCcc-cccceeeecCCCCceEEEE
Q 012233 143 RVVGTGSFGVVFQAKCLE------TGDSVAIKKVLQDK---RYKNRELQIMRLLNHPNVV-SLKHCFFSTTEKDELYLNL 212 (468)
Q Consensus 143 ~~lG~G~fg~Vy~~~~~~------~g~~vaiK~~~~~~---~~~~~E~~il~~l~hpnIv-~l~~~~~~~~~~~~~~~~l 212 (468)
+.|..|-...||+..... .++.+++|+..... ....+|..+++.+....+. +++.++ .+ .+
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~-----~~----~~ 74 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIF-----PN----GR 74 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEe-----CC----Cc
Confidence 345566667888876432 25789999875432 3456799999988644433 333332 11 25
Q ss_pred Eeecccch
Q 012233 213 VLEYISET 220 (468)
Q Consensus 213 v~e~~~~~ 220 (468)
|+||+.|.
T Consensus 75 v~e~i~G~ 82 (302)
T cd05156 75 IEEFIPSR 82 (302)
T ss_pred hhheeCCC
Confidence 78887763
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.73 E-value=0.01 Score=59.32 Aligned_cols=71 Identities=21% Similarity=0.237 Sum_probs=45.4
Q ss_pred eceecccCceEEEEEEEcCCCCEEEEEEeecc----------cchHHHHHHHHHHcC--CC-CcccccceeeecCCCCce
Q 012233 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----------KRYKNRELQIMRLLN--HP-NVVSLKHCFFSTTEKDEL 208 (468)
Q Consensus 142 ~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~----------~~~~~~E~~il~~l~--hp-nIv~l~~~~~~~~~~~~~ 208 (468)
.+.||.|.-..||++.+...++.|+||+-..- .....-|.+.|+.+. -| ++.++|.+ +..
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~-------D~e 106 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF-------DSV 106 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE-------CcH
Confidence 45789999999999998444678999964211 112234788888764 34 45555432 222
Q ss_pred EEEEEeecccc
Q 012233 209 YLNLVLEYISE 219 (468)
Q Consensus 209 ~~~lv~e~~~~ 219 (468)
...+|||+++.
T Consensus 107 ~~~~vMEdL~~ 117 (409)
T PRK12396 107 MNCCVMEDLSD 117 (409)
T ss_pred HhhHHHHhCcc
Confidence 34589999964
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.72 E-value=0.015 Score=56.61 Aligned_cols=32 Identities=25% Similarity=0.429 Sum_probs=27.9
Q ss_pred CccccCCCCCCeeecCCCCcEEEeeecCccccC
Q 012233 259 GVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (468)
Q Consensus 259 givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~ 291 (468)
.++|+|+.+.||++++.+ -+-+.||+++..-.
T Consensus 199 ~lvHGD~~~gNlii~~~~-~~gVlDwe~~~lGD 230 (321)
T COG3173 199 VLVHGDYRPGNLIIDPGR-PTGVLDWELATLGD 230 (321)
T ss_pred eeeeCCcccCCEEEeCCC-eeEEEeccccccCC
Confidence 489999999999999888 48999999986543
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.68 E-value=0.027 Score=54.99 Aligned_cols=29 Identities=28% Similarity=0.602 Sum_probs=25.3
Q ss_pred CCccccCCCCCCeeecCCCCcEEEeeecCcc
Q 012233 258 VGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (468)
Q Consensus 258 ~givHrDlkp~NILl~~~~~~vkL~DFG~a~ 288 (468)
.+++|+|+.+.||+++. + .+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~-~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-N-EVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-C-cEEEEECcccc
Confidence 58999999999999987 4 58999999764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.53 E-value=0.013 Score=56.23 Aligned_cols=31 Identities=23% Similarity=0.485 Sum_probs=25.3
Q ss_pred CccccCCCCCCeeecCCCCcEEEeeecCccc
Q 012233 259 GVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (468)
Q Consensus 259 givHrDlkp~NILl~~~~~~vkL~DFG~a~~ 289 (468)
.++|+|++|.|||++.++.-.-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999997542356999998853
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.44 E-value=0.02 Score=56.61 Aligned_cols=30 Identities=27% Similarity=0.434 Sum_probs=25.5
Q ss_pred ccccCCCCCCeeecCCCCcEEEeeecCccc
Q 012233 260 VCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (468)
Q Consensus 260 ivHrDlkp~NILl~~~~~~vkL~DFG~a~~ 289 (468)
++|+|+.+.|||++.++..++++||+.|..
T Consensus 184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred EEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 789999999999975543799999998853
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.20 E-value=0.052 Score=53.10 Aligned_cols=31 Identities=13% Similarity=0.186 Sum_probs=27.1
Q ss_pred CCccccCCCCCCeeecCCCCcEEEeeecCccc
Q 012233 258 VGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (468)
Q Consensus 258 ~givHrDlkp~NILl~~~~~~vkL~DFG~a~~ 289 (468)
.++||+|+.+.|||++.++ .+.++||..+..
T Consensus 196 ~~lcHgD~~~~Nvl~~~~~-~~~iIDfd~~~~ 226 (309)
T TIGR02904 196 TVLVHGKLSLSHFLYDETR-GGYFINFEKASF 226 (309)
T ss_pred eeeeCCCCcHHhEEEcCCC-CEEEEEhhhccc
Confidence 3799999999999998877 689999998753
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.09 E-value=0.092 Score=52.95 Aligned_cols=69 Identities=20% Similarity=0.266 Sum_probs=44.8
Q ss_pred eceecccCceEEEEEEEcCCCCEEEEEEeec-----------ccchHHHHHHHHHHcC---CCCcccccceeeecCCCCc
Q 012233 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ-----------DKRYKNRELQIMRLLN---HPNVVSLKHCFFSTTEKDE 207 (468)
Q Consensus 142 ~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~-----------~~~~~~~E~~il~~l~---hpnIv~l~~~~~~~~~~~~ 207 (468)
.+.||.|....||+..+ .+..++||+-.. .......|...|+.+. ..++.+++.+. .+
T Consensus 37 ~~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~d-----ed- 108 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFD-----RT- 108 (418)
T ss_pred EEEcCCCceeeEEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEEC-----CC-
Confidence 45789999999999886 355688996531 1122234666676654 24666676654 22
Q ss_pred eEEEEEeecccc
Q 012233 208 LYLNLVLEYISE 219 (468)
Q Consensus 208 ~~~~lv~e~~~~ 219 (468)
..+++|||+++
T Consensus 109 -~~vlvME~L~~ 119 (418)
T PLN02756 109 -MALIGMRYLEP 119 (418)
T ss_pred -CCEEEEeecCC
Confidence 24578999976
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.94 E-value=0.027 Score=55.10 Aligned_cols=106 Identities=15% Similarity=0.270 Sum_probs=70.6
Q ss_pred CCceEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeee
Q 012233 205 KDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDF 284 (468)
Q Consensus 205 ~~~~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DF 284 (468)
....|.|++|++-++.+... ....+.++..++.+.+..++-|.....+-|||+...||||+ +| +|-|+||
T Consensus 296 de~~y~yl~~kdhgt~is~i--------k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~G-nvtLIDf 365 (488)
T COG5072 296 DETLYLYLHFKDHGTPISII--------KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EG-NVTLIDF 365 (488)
T ss_pred CCceEEEEEEecCCceeeee--------ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cC-ceEEEEe
Confidence 34568999999987654421 22345667788888888888887646789999999999999 77 7999999
Q ss_pred cCccccCCCCCCccccccCCccccccccCCCCCCcchhHHHH
Q 012233 285 GSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSI 326 (468)
Q Consensus 285 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSl 326 (468)
-+++.-.+.. .+.-...--|-.+.|.. +..-+||-+
T Consensus 366 klsRl~~~q~----~isy~rldhp~lF~G~d--d~QFeIYrl 401 (488)
T COG5072 366 KLSRLSYSQG----IISYNRLDHPDLFNGVD--DYQFEIYRL 401 (488)
T ss_pred eeeecccCCc----eeeccccCchhhhcCcc--ceeeeHHHH
Confidence 9998432221 11112223344444332 555667664
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.22 E-value=0.18 Score=50.88 Aligned_cols=30 Identities=30% Similarity=0.376 Sum_probs=25.0
Q ss_pred CCccccCCCCCCeeecCCCCcEEEeeecCccc
Q 012233 258 VGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (468)
Q Consensus 258 ~givHrDlkp~NILl~~~~~~vkL~DFG~a~~ 289 (468)
...+|.|+-+.|||.+.+ .+.++||..|..
T Consensus 227 ~VfCHNDL~~gNIL~~~~--~l~lID~EYA~~ 256 (383)
T PTZ00384 227 VLFCHNDLFFTNILDFNQ--GIYFIDFDFAGF 256 (383)
T ss_pred eeeeeccCCcccEEecCC--CEEEEEeccccC
Confidence 467999999999998754 499999998753
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.06 E-value=0.21 Score=49.16 Aligned_cols=137 Identities=18% Similarity=0.211 Sum_probs=72.9
Q ss_pred CceEEEEEEEcCCCCEEEEEEeecc--cchHHHHHHHHHHcCCCC------cccccceeeecCCCCceEEEEEeecccch
Q 012233 149 SFGVVFQAKCLETGDSVAIKKVLQD--KRYKNRELQIMRLLNHPN------VVSLKHCFFSTTEKDELYLNLVLEYISET 220 (468)
Q Consensus 149 ~fg~Vy~~~~~~~g~~vaiK~~~~~--~~~~~~E~~il~~l~hpn------Iv~l~~~~~~~~~~~~~~~~lv~e~~~~~ 220 (468)
.-..||+... .+..+++|+.... ......|...|+.|.-.. +..+-+-........ .+.+-|++|++|.
T Consensus 37 ~eN~~f~~~~--~~g~~iLki~~~~~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~-~r~a~lf~~l~G~ 113 (331)
T COG2334 37 EENSNFRVQT--EDGRYILKIYRPGWTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGG-PRPAALFEYLPGR 113 (331)
T ss_pred ccCceEEEEe--cCCCeEEEEecCCCCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCC-ceeEEEEEecCCc
Confidence 4456888875 3344588988664 334456777777774222 222222221111111 3567889999875
Q ss_pred HHHH------H--------------hhhh--hcC--CCCCHH----H---------HHHHHHHHHHHHHHhHh-------
Q 012233 221 VYRV------S--------------KHYT--RMN--QHVPIL----Y---------VQLYTYQICRALNYLHH------- 256 (468)
Q Consensus 221 ll~~------~--------------~~~~--~~~--~~~~~~----~---------~~~~~~qi~~aL~yLH~------- 256 (468)
.+.. + +.+. +.. ....+. . -.....++...+..+..
T Consensus 114 ~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp 193 (331)
T COG2334 114 PLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLP 193 (331)
T ss_pred CcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCC
Confidence 4441 0 0000 000 001111 0 00122344444544442
Q ss_pred cCC--ccccCCCCCCeeecCCCCcEEEeeecCcc
Q 012233 257 VVG--VCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (468)
Q Consensus 257 ~~g--ivHrDlkp~NILl~~~~~~vkL~DFG~a~ 288 (468)
..+ +||+|+.|.|||++.+...+.++|||-+.
T Consensus 194 ~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 194 ALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred cccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 124 99999999999999776227899999874
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=94.45 E-value=0.25 Score=47.75 Aligned_cols=72 Identities=15% Similarity=0.129 Sum_probs=43.5
Q ss_pred eceecccCceEEEEEEEcCCCCEEEEEEeecc-cchHHHHHHHHHHcC---CCCcccccceeeecCCCCceEEEEEeecc
Q 012233 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-KRYKNRELQIMRLLN---HPNVVSLKHCFFSTTEKDELYLNLVLEYI 217 (468)
Q Consensus 142 ~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~-~~~~~~E~~il~~l~---hpnIv~l~~~~~~~~~~~~~~~~lv~e~~ 217 (468)
.+.|+.|....+|+.. .+++.+.||+-... ...+..|.+-|+.|. --.+.+++.+...... -||||||+
T Consensus 22 ~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~-----~fLlle~l 94 (288)
T PF03881_consen 22 IEPVSGGDINEAYRLD--TDGGSYFVKVNSESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDD-----AFLLLEFL 94 (288)
T ss_dssp EEEE--SSSSEEEEEE--TTS-EEEEEEEEGGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSC-----CEEEEE--
T ss_pred eEecCCCChhheEEEE--CCCccEEEEecChhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCC-----ceEEEEee
Confidence 3568889999999987 57888999977643 456778999898884 3345566665533221 37999998
Q ss_pred cch
Q 012233 218 SET 220 (468)
Q Consensus 218 ~~~ 220 (468)
..+
T Consensus 95 ~~~ 97 (288)
T PF03881_consen 95 EMG 97 (288)
T ss_dssp ---
T ss_pred cCC
Confidence 744
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG2269 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=93.01 E-value=0.093 Score=50.67 Aligned_cols=93 Identities=20% Similarity=0.208 Sum_probs=64.3
Q ss_pred HHHHHHHHcC-----CCCcccccceeeecCCCCceEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHH
Q 012233 179 RELQIMRLLN-----HPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253 (468)
Q Consensus 179 ~E~~il~~l~-----hpnIv~l~~~~~~~~~~~~~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~y 253 (468)
+|+.-|.+++ +|-+|.|... .|||-|++..-+. .-...+-.++-.+.+..-.|+..++.-
T Consensus 334 kEmhNL~RMq~~GlpcP~vV~lkkh------------vLVMsFiGd~~~a---APkLK~v~l~d~E~~~aY~q~~~~M~~ 398 (531)
T KOG2269|consen 334 KEMHNLSRMQKHGLPCPQVVKLKKH------------VLVMSFIGDQGLA---APKLKNVELTDDERRNAYDQVQSIMCR 398 (531)
T ss_pred HHHHHHHHHHhcCCCCCceeeeecc------------eEEEEeecCCCCC---CccccccccChHHHHHHHHHHHHHHHH
Confidence 4555555553 5777766432 3899999854221 111123446667777777899988888
Q ss_pred hHhcCCccccCCCCCCeeecCCCCcEEEeeecCcc
Q 012233 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (468)
Q Consensus 254 LH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~ 288 (468)
|-..+-.||.||.--|+|...+ .|-++|..-+.
T Consensus 399 lY~Ec~LVHADlSEyN~Lw~~g--Kvw~IDVsQsv 431 (531)
T KOG2269|consen 399 LYKECLLVHADLSEYNLLWTPG--KVWVIDVSQSV 431 (531)
T ss_pred HHHhhheeecchhhhhheecCC--ceEEEechhcc
Confidence 7433789999999999999976 59999987663
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.93 E-value=1.3 Score=45.55 Aligned_cols=71 Identities=13% Similarity=0.147 Sum_probs=43.7
Q ss_pred EeceecccCceEEEEEEEcCC--------CCEEEEEEeeccc---chHHHHHHHHHHcCCCCcc-cccceeeecCCCCce
Q 012233 141 AERVVGTGSFGVVFQAKCLET--------GDSVAIKKVLQDK---RYKNRELQIMRLLNHPNVV-SLKHCFFSTTEKDEL 208 (468)
Q Consensus 141 ~~~~lG~G~fg~Vy~~~~~~~--------g~~vaiK~~~~~~---~~~~~E~~il~~l~hpnIv-~l~~~~~~~~~~~~~ 208 (468)
-.+.|..|-.-.+|++..... ++.|.+++.-... .....|..+++.+..-+|- ++++.+ .
T Consensus 109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lIdR~~E~~v~~~ls~~gi~P~l~~~f-----~--- 180 (442)
T PTZ00296 109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELYNPISEFEVYKTMSKYRIAPQLLNTF-----S--- 180 (442)
T ss_pred EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccceeCHHHHHHHHHHHHHCCCCCceEEEe-----C---
Confidence 445566777778888875421 5678888774432 2345688888888754444 344443 2
Q ss_pred EEEEEeecccch
Q 012233 209 YLNLVLEYISET 220 (468)
Q Consensus 209 ~~~lv~e~~~~~ 220 (468)
-+.|.+|+.|.
T Consensus 181 -gg~I~efi~g~ 191 (442)
T PTZ00296 181 -GGRIEEWLYGD 191 (442)
T ss_pred -CCEEEEeeCCc
Confidence 12478888764
|
|
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.12 E-value=0.18 Score=48.93 Aligned_cols=38 Identities=24% Similarity=0.326 Sum_probs=26.5
Q ss_pred HHHHHHHHHHHHHHHHh---HhcCCccccCCCCCCeeecCC
Q 012233 238 LYVQLYTYQICRALNYL---HHVVGVCHRDIKPQNLLVNPH 275 (468)
Q Consensus 238 ~~~~~~~~qi~~aL~yL---H~~~givHrDlkp~NILl~~~ 275 (468)
..++.++.||+.-.-.. -...+++|-||||+||||-+.
T Consensus 279 ~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds 319 (444)
T PHA03111 279 EYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDS 319 (444)
T ss_pred HHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecC
Confidence 44777888987644233 212479999999999998433
|
|
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.09 E-value=0.12 Score=46.35 Aligned_cols=29 Identities=24% Similarity=0.335 Sum_probs=25.0
Q ss_pred CccccCCCCCCeeecCCCCcEEEeeecCccc
Q 012233 259 GVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (468)
Q Consensus 259 givHrDlkp~NILl~~~~~~vkL~DFG~a~~ 289 (468)
-.+|+|+.|.||+++.++ ++|+||+.+..
T Consensus 78 ~p~H~D~~~~N~~~~~~~--~~lIDwe~a~~ 106 (188)
T PRK10271 78 APLHMDVHAGNLVHSASG--LRLIDWEYAGD 106 (188)
T ss_pred eeecCCCCCccEEEECCC--EEEEeCCcccC
Confidence 468999999999998665 89999999854
|
|
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=92.04 E-value=0.16 Score=49.39 Aligned_cols=52 Identities=25% Similarity=0.339 Sum_probs=34.0
Q ss_pred HHHHHHHHHHHHHHH---HhHhcCCccccCCCCCCeeecCCCC-----------------cEEEeeecCccc
Q 012233 238 LYVQLYTYQICRALN---YLHHVVGVCHRDIKPQNLLVNPHTH-----------------QLKICDFGSAKM 289 (468)
Q Consensus 238 ~~~~~~~~qi~~aL~---yLH~~~givHrDlkp~NILl~~~~~-----------------~vkL~DFG~a~~ 289 (468)
..++.++.||+.-.- -|-....++|-||||+||||-+... .++|.||.+|..
T Consensus 275 ~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv 346 (434)
T PF05445_consen 275 EYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNRNYVFKEPIRCCLNDFDFSQV 346 (434)
T ss_pred HHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCeEEEecccceeeecccCHHHh
Confidence 446778888864321 1222357999999999999843221 356778888754
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=91.96 E-value=0.34 Score=48.39 Aligned_cols=61 Identities=28% Similarity=0.249 Sum_probs=36.6
Q ss_pred EEEEeecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCC
Q 012233 210 LNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPH 275 (468)
Q Consensus 210 ~~lv~e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~ 275 (468)
..|+-+|..|- +...+. ....++...+.++.-.+.||--+--..+++|.|+.|.||++..+
T Consensus 320 ~vl~E~~~~Gl~v~~~v~-----~~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~ 381 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVK-----WKSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFN 381 (565)
T ss_pred ceeeeeccccccHHhhhh-----cccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEec
Confidence 33555666553 222222 23345555666666566665544434689999999999998533
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 468 | ||||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-142 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-141 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-141 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-141 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-141 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-141 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-140 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-140 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-140 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-140 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-140 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-140 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-139 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-139 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-138 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-138 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-138 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-137 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-137 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-137 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-135 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-130 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 8e-94 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 5e-88 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-46 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-45 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-45 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-44 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-44 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-44 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 5e-44 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 5e-44 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 8e-44 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-43 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-43 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-43 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-43 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-43 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-43 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-43 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-43 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-43 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-43 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-43 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-43 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-43 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-43 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-43 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-43 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-43 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 4e-43 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 4e-43 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 5e-43 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-43 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 5e-43 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-43 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-43 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-43 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 8e-43 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 9e-43 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-42 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-42 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-42 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-42 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-42 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-42 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-42 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-42 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-42 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-42 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-42 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-42 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-42 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-42 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-42 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-42 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-42 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-42 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-42 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-42 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-42 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-42 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-42 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-42 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-42 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-42 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-42 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-42 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-42 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 6e-42 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 6e-42 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 6e-42 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 8e-42 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-41 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-41 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-41 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 9e-41 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 9e-41 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-40 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 6e-40 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-39 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-39 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-39 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-39 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-39 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-39 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 4e-39 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-39 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-39 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 5e-39 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 5e-39 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 6e-39 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-39 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 6e-39 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 6e-39 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 6e-39 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 7e-39 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 7e-39 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 7e-39 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 8e-39 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 8e-39 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 9e-39 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 9e-39 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 9e-39 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 9e-39 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 9e-39 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 9e-39 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 9e-39 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 9e-39 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-38 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-38 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-38 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-38 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-38 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-38 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-38 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-38 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-38 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-38 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-38 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-38 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-38 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-38 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-38 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-38 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-38 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-38 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-38 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-38 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-38 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-38 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-38 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-38 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-38 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-38 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-38 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-38 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-38 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 5e-38 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 9e-38 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-37 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-37 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-37 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-37 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-37 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 8e-37 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 9e-37 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 7e-36 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-35 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-35 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-34 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-34 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-34 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 6e-34 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-33 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-33 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-33 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-33 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-33 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-33 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-33 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-33 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-33 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-33 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-33 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 6e-33 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 6e-33 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 8e-33 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 8e-33 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 9e-33 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 9e-33 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 9e-33 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 1e-32 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-32 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-32 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-32 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-32 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-32 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-32 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-32 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 1e-32 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 1e-32 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-32 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-32 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 2e-32 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-32 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-32 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 2e-32 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-32 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 2e-32 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-32 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 2e-32 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 3e-32 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 6e-32 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 7e-32 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 9e-32 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 1e-31 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 1e-31 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 1e-31 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 1e-31 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 1e-31 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-31 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 1e-31 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 1e-31 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 1e-31 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 1e-31 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-31 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 1e-31 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 2e-31 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-31 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 4e-31 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-30 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-30 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 3e-30 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 3e-30 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 1e-29 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-29 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-28 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 3e-28 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 4e-28 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 1e-27 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 1e-27 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-27 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-27 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-27 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 8e-27 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-24 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-24 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-24 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-24 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-24 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-24 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 3e-24 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-24 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 3e-24 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 4e-24 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 5e-24 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 6e-24 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 6e-24 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 6e-24 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 6e-24 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-24 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 7e-24 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-24 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 8e-24 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 9e-24 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 9e-24 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-24 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-23 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-23 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-23 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-23 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-23 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-23 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-23 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-23 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-23 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-23 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 8e-22 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 1e-21 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 2e-21 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-21 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-21 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-21 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-21 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 4e-21 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-21 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 5e-21 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 6e-21 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 6e-21 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 6e-21 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 7e-21 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 9e-21 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-20 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-20 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-20 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-20 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-20 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-20 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-20 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-20 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-20 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-20 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-20 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-20 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-20 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-20 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-20 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-20 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-20 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-20 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-20 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-20 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-20 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-20 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-20 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-20 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-20 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 4e-20 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 4e-20 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 5e-20 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-20 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 5e-20 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 6e-20 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 6e-20 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 7e-20 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-20 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 7e-20 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 8e-20 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 8e-20 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 9e-20 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-19 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-19 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-19 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-19 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-19 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-19 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-19 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-19 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-19 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-19 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-19 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-19 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-19 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-19 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 5e-19 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 8e-19 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-18 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-18 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-18 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-18 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-18 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-18 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-18 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-18 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-18 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-18 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-18 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-18 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 4e-18 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-18 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-18 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 4e-18 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 5e-18 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 5e-18 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 8e-18 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 8e-18 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 9e-18 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 9e-18 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-18 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-18 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 9e-18 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-18 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-17 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-17 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-17 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-17 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-17 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-17 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-17 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-17 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-17 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-17 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-17 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-17 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-17 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-17 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-17 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-17 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-17 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-17 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-17 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-17 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-17 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-17 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-17 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-17 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-17 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-17 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-17 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-17 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-17 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-17 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-17 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-17 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 4e-17 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 4e-17 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-17 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 4e-17 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-17 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 4e-17 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 4e-17 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 4e-17 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 4e-17 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 4e-17 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 4e-17 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-17 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 4e-17 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 4e-17 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 5e-17 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 5e-17 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 5e-17 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 5e-17 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 5e-17 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 5e-17 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 5e-17 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-17 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 5e-17 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-17 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-17 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-17 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 6e-17 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 6e-17 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 7e-17 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 7e-17 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 7e-17 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 7e-17 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 7e-17 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 8e-17 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 8e-17 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 9e-17 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 9e-17 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 9e-17 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-16 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-16 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-16 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-16 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-16 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-16 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-16 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-16 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-16 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-16 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-16 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-16 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-16 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-16 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-16 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 2e-16 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-16 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-16 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-16 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 3e-16 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-16 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 3e-16 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-16 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-16 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-16 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-16 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 4e-16 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-16 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-16 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 5e-16 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 5e-16 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 5e-16 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 5e-16 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 5e-16 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 5e-16 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 6e-16 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 6e-16 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-16 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 6e-16 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 7e-16 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 7e-16 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 7e-16 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 8e-16 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 8e-16 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 9e-16 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 9e-16 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 9e-16 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-15 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-15 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-15 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-15 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-15 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-15 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-15 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-15 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-15 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-15 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-15 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-15 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-15 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-15 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-15 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-15 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-15 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-15 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-15 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-15 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 3e-15 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-15 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-15 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 4e-15 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 4e-15 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 5e-15 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 5e-15 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 5e-15 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 5e-15 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 6e-15 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 6e-15 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 7e-15 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 8e-15 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 8e-15 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 9e-15 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-15 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 9e-15 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-14 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-14 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-14 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-14 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-14 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-14 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-14 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-14 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-14 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-14 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-14 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-14 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-14 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 4e-14 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 4e-14 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 4e-14 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-14 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-14 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 4e-14 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 5e-14 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 5e-14 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 5e-14 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 5e-14 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 5e-14 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 5e-14 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 5e-14 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 5e-14 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 5e-14 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 6e-14 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 6e-14 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-14 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 6e-14 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 6e-14 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 7e-14 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 7e-14 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-14 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 8e-14 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 8e-14 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 9e-14 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 9e-14 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 9e-14 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-13 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-13 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-13 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-13 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-13 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-13 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-13 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-13 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-13 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-13 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-13 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-13 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-13 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 4e-13 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-13 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 4e-13 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-13 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-13 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 5e-13 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 5e-13 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 5e-13 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 5e-13 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 5e-13 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 6e-13 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 7e-13 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 8e-13 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 9e-13 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 9e-13 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-12 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-12 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 1e-12 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-12 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-12 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-12 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-12 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-12 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-12 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-12 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-12 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-12 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-12 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-12 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-12 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-12 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-12 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-12 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-12 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-12 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-12 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-12 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 3e-12 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-12 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 4e-12 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 4e-12 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-12 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-12 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 4e-12 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-12 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 4e-12 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 5e-12 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 5e-12 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 5e-12 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 6e-12 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 6e-12 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 6e-12 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 8e-12 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 8e-12 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 9e-12 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 1e-11 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-11 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-11 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-11 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-11 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-11 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-11 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-11 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-11 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-11 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-11 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-11 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 3e-11 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 4e-11 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-11 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 4e-11 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 5e-11 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 6e-11 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 7e-11 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-11 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 9e-11 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 9e-11 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-10 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 1e-10 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-10 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-10 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-10 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-10 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-10 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-10 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-10 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-10 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-10 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 2e-10 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-10 | ||
| 2x7g_A | 389 | Structure Of Human Serine-Arginine-Rich Protein-Spe | 2e-10 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 4e-10 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 4e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-10 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-10 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-10 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 5e-10 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 5e-10 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 5e-10 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 6e-10 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 6e-10 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 7e-10 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 7e-10 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 8e-10 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 9e-10 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-09 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-09 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-09 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-09 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-09 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-09 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 2e-09 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-09 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-09 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-09 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-09 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-09 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-09 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-09 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-09 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 4e-09 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-09 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 5e-09 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 5e-09 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 6e-09 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-09 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 6e-09 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-09 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 8e-09 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 8e-09 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-08 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-08 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-08 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-08 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-08 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-08 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-08 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-08 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-08 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-08 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-08 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-08 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-08 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-08 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-08 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-08 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-08 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-08 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-08 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-08 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-08 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-08 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-08 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-08 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-08 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-08 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-08 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-08 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-08 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-08 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-08 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-08 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-08 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-08 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-08 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-08 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-08 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-08 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-08 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-08 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-08 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-08 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-08 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-08 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-08 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-08 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-08 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-08 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-08 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-08 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-08 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-08 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-08 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-08 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-08 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-08 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-08 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-08 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-08 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-08 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-08 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-08 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-08 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-08 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-08 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-08 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-08 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-08 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-08 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-08 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-08 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-08 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-08 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-08 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-08 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-08 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-08 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-08 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 4e-08 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-08 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-08 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-08 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-08 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 4e-08 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 4e-08 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 4e-08 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-08 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 4e-08 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 5e-08 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 5e-08 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 5e-08 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 5e-08 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 5e-08 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-08 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 5e-08 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 5e-08 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 5e-08 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 5e-08 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 6e-08 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 6e-08 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 6e-08 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 7e-08 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 7e-08 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-08 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 7e-08 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 8e-08 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-08 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 9e-08 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-07 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-07 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-07 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-07 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-07 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-07 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-07 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-07 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-07 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-07 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-07 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-07 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-07 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-07 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-07 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-07 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-07 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-07 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-07 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-07 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-07 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-07 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-07 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-07 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 4e-07 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 4e-07 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-07 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-07 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-07 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-07 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-07 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 6e-07 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 6e-07 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-07 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 7e-07 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 7e-07 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 7e-07 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 7e-07 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 8e-07 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 8e-07 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 9e-07 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 9e-07 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-06 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-06 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-06 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-06 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-06 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-06 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-06 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-06 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-06 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-06 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-06 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-06 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-06 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-06 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-06 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-06 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-06 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-06 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-06 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-06 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-06 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-06 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-06 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-06 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-06 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-06 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-06 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-06 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-06 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-06 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 3e-06 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 3e-06 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-06 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 4e-06 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 5e-06 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-06 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 6e-06 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 6e-06 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 7e-06 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 8e-06 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-05 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 1e-05 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-05 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-05 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-05 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-05 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-05 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 6e-05 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 9e-05 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-04 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 6e-04 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 7e-04 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 8e-04 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 8e-04 |
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 637 bits (1645), Expect = 0.0
Identities = 241/403 (59%), Positives = 301/403 (74%), Gaps = 21/403 (5%)
Query: 67 TSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDKDLEPSIVNGNGTEAGQVIATTV 126
+ T + E Q P M++ +K+ G++ V+AT
Sbjct: 2 SGRPRTTSFAESCKPVQQPSAFGSMKVSRDKD----------------GSKVTTVVATP- 44
Query: 127 GGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRL 186
G+ Q +SY +V+G GSFGVV+QAK ++G+ VAIKKVLQDKR+KNRELQIMR
Sbjct: 45 -GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRK 103
Query: 187 LNHPNVVSLKHCFFSTTEK-DELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTY 245
L+H N+V L++ F+S+ EK DE+YLNLVL+Y+ ETVYRV++HY+R Q +P++YV+LY Y
Sbjct: 104 LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 163
Query: 246 QICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYY 305
Q+ R+L Y+H G+CHRDIKPQNLL++P T LK+CDFGSAK LV GEPN+SYICSRYY
Sbjct: 164 QLFRSLAYIHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYY 222
Query: 306 RAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIK 365
RAPELIFGAT+YT++ID+WS GCVLAELLLGQP+FPG+SGVDQLVEIIK+LGTPTRE+I+
Sbjct: 223 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 282
Query: 366 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDD 425
MNPNYTEFKFPQIKAHPW K+F R PPEA+ L SRLL+Y+P+ R T LEACAH FFD+
Sbjct: 283 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 342
Query: 426 LRDPNTCLPNGRPLPTLFNFTAQELAGASNELRQRLIPEHARK 468
LRDPN LPNGR P LFNFT QEL+ ++ L LIP HAR
Sbjct: 343 LRDPNVKLPNGRDTPALFNFTTQELS-SNPPLATILIPPHARI 384
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 625 bits (1615), Expect = 0.0
Identities = 218/372 (58%), Positives = 283/372 (76%), Gaps = 5/372 (1%)
Query: 98 NVNHDDKDLEPSIVNGNGTEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAK 157
+ + L +N + G+ G+ ++ I+Y +V+G GSFGVVFQAK
Sbjct: 2 SFTMSNAPLNGVKLNPLDDPNKVIKVLASDGKTGEQRE-IAYTNCKVIGNGSFGVVFQAK 60
Query: 158 CLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEK-DELYLNLVLEY 216
+E+ + VAIKKVLQDKR+KNRELQIMR++ HPNVV LK F+S +K DE++LNLVLEY
Sbjct: 61 LVESDE-VAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEY 119
Query: 217 ISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHT 276
+ ETVYR S+HY ++ Q +P+L ++LY YQ+ R+L Y+H + G+CHRDIKPQNLL++P +
Sbjct: 120 VPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI-GICHRDIKPQNLLLDPPS 178
Query: 277 HQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLG 336
LK+ DFGSAK+L+ GEPN+SYICSRYYRAPELIFGAT YTT ID+WS GCV+AEL+ G
Sbjct: 179 GVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQG 238
Query: 337 QPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEA 396
QPLFPGESG+DQLVEIIK+LGTP+RE+IK MNPNY E KFPQI+ HP+ K+F R PP+A
Sbjct: 239 QPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDA 298
Query: 397 LDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNTCLPNGRPLPTLFNFTAQELAGASNE 456
+DL+SRLL+Y+PS R TA+EA HPFFD+LR +PNGR LP LFN+T +EL+ +
Sbjct: 299 IDLISRLLEYTPSARLTAIEALCHPFFDELRTGEARMPNGRELPPLFNWTKEELS-VRPD 357
Query: 457 LRQRLIPEHARK 468
L RL+P+HA
Sbjct: 358 LISRLVPQHAEA 369
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 609 bits (1572), Expect = 0.0
Identities = 161/362 (44%), Positives = 231/362 (63%), Gaps = 12/362 (3%)
Query: 113 GNGTEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ 172
G G+ A R+ K+ + ER+ G G+FG V K TG SVAIKKV+Q
Sbjct: 1 GPGSMMSLNAAAAADERS--RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQ 58
Query: 173 DKRYKNRELQIMRLL---NHPNVVSLKHCFFSTTEK--DELYLNLVLEYISETVYRVSKH 227
D R++NRELQIM+ L +HPN+V L+ F++ E+ ++YLN+V+EY+ +T++R ++
Sbjct: 59 DPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRN 118
Query: 228 YTRMNQHVPILYVQLYTYQICRALNYLHHV-VGVCHRDIKPQNLLVNPHTHQLKICDFGS 286
Y R P + ++++ +Q+ R++ LH V VCHRDIKP N+LVN LK+CDFGS
Sbjct: 119 YYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGS 178
Query: 287 AKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGV 346
AK L P EPN++YICSRYYRAPELIFG YTTA+D+WS+GC+ AE++LG+P+F G++
Sbjct: 179 AKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA 238
Query: 347 DQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHK---RMPPEALDLVSRL 403
QL EI+++LG P+RE ++ +NP++T+ K PW +F + EA DL+S L
Sbjct: 239 GQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSAL 298
Query: 404 LQYSPSLRCTALEACAHPFFDDLRDPNTCLPNGRPLP-TLFNFTAQELAGASNELRQRLI 462
LQY P R EA HP+FD+L DP T LPN + LP LF F E+ S + +L+
Sbjct: 299 LQYLPEERMKPYEALCHPYFDELHDPATKLPNNKDLPEDLFRFLPNEIEVMSEAQKAKLV 358
Query: 463 PE 464
+
Sbjct: 359 RK 360
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 585 bits (1511), Expect = 0.0
Identities = 166/380 (43%), Positives = 243/380 (63%), Gaps = 43/380 (11%)
Query: 131 GQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHP 190
G + Y + +GTGSFG+V + +E+G A+KKVLQD RYKNREL IM++L+H
Sbjct: 1 GLETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHV 60
Query: 191 NVVSLKHCFFSTTEK---------------------------------DELYLNLVLEYI 217
N++ L F++T ++ YLN+++EY+
Sbjct: 61 NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 218 SETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTH 277
+T+++V K + R + +P+ + +Y YQ+ RA+ ++H + G+CHRDIKPQNLLVN +
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL-GICHRDIKPQNLLVNSKDN 179
Query: 278 QLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQ 337
LK+CDFGSAK L+P EP+++YICSR+YRAPEL+ GATEYT +ID+WSIGCV EL+LG+
Sbjct: 180 TLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239
Query: 338 PLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAL 397
PLF GE+ +DQLV II+I+GTPT+E++ MNP+YTE +FP +KA W KI + P A+
Sbjct: 240 PLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAI 299
Query: 398 DLVSRLLQYSPSLRCTALEACAHPFFDDLRDP-------NTCLPNG--RPLPTLFNFTAQ 448
DL+ ++L+Y P LR EA AHPFFD LR+ N+ P+G + +P LFNF+
Sbjct: 300 DLLEQILRYEPDLRINPYEAMAHPFFDHLRNSYESEVKNNSNFPHGVNQNIPQLFNFSPY 359
Query: 449 ELAGASNELRQRLIPEHARK 468
EL+ + R++P++
Sbjct: 360 ELSIIPGNVLNRILPKNFSP 379
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 307 bits (790), Expect = e-102
Identities = 106/296 (35%), Positives = 161/296 (54%), Gaps = 21/296 (7%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLKHC 198
+G GS+GVVF+ + +TG VAIKK L+ + RE+++++ L HPN+V+L
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV 258
F K L+L V EY TV R + VP V+ T+Q +A+N+ H
Sbjct: 71 F---RRKRRLHL--VFEYCDHTVLHELD---RYQRGVPEHLVKSITWQTLQAVNFCHKH- 121
Query: 259 GVCHRDIKPQNLLVNPHTHQLKICDFGSAKML-VPGEPNISYICSRYYRAPELIFGATEY 317
HRD+KP+N+L+ H+ +K+CDFG A++L P + + +R+YR+PEL+ G T+Y
Sbjct: 122 NCIHRDVKPENILITKHS-VIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQY 180
Query: 318 TTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM--NPNYTEFK 375
+D+W+IGCV AELL G PL+PG+S VDQL I K LG + N ++ K
Sbjct: 181 GPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVK 240
Query: 376 FPQIK-AHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPN 430
P + P F + AL L+ L P+ R T + HP+F+++R+
Sbjct: 241 IPDPEDMEPLELKF-PNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIE 295
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 300 bits (770), Expect = 2e-99
Identities = 98/295 (33%), Positives = 154/295 (52%), Gaps = 21/295 (7%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLKHC 198
VG GS+G+V + + +TG VAIKK L+ K RE+++++ L H N+V+L
Sbjct: 33 VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV 258
+K YL V E++ T+ + + VQ Y +QI + + H
Sbjct: 93 C---KKKKRWYL--VFEFVDHTILDDLE---LFPNGLDYQVVQKYLFQIINGIGFCHSH- 143
Query: 259 GVCHRDIKPQNLLVNPHTHQLKICDFGSAKML-VPGEPNISYICSRYYRAPELIFGATEY 317
+ HRDIKP+N+LV+ + +K+CDFG A+ L PGE + +R+YRAPEL+ G +Y
Sbjct: 144 NIIHRDIKPENILVS-QSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKY 202
Query: 318 TTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTRE--EIKCMNPNYTEFK 375
A+D+W+IGC++ E+ +G+PLFPG+S +DQL I+ LG E+ NP + +
Sbjct: 203 GKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVR 262
Query: 376 FPQIKAH-PWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDP 429
P+IK P + + ++ +DL + L P R E H FF
Sbjct: 263 LPEIKEREPLERRY-PKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGFA 316
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 298 bits (766), Expect = 8e-99
Identities = 95/315 (30%), Positives = 154/315 (48%), Gaps = 34/315 (10%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV-LQD----KR-YKNRELQIMRLLNHPNV 192
YM + +G G G+VF A + VAIKK+ L D K RE++I+R L+H N+
Sbjct: 13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHAL--REIKIIRRLDHDNI 70
Query: 193 VSLKHCF-----------FSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQ 241
V + S TE + +Y+ V EY+ + V + + +H +
Sbjct: 71 VKVFEILGPSGSQLTDDVGSLTELNSVYI--VQEYMETDLANVLEQGPLLEEHA-----R 123
Query: 242 LYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS--- 298
L+ YQ+ R L Y+H V HRD+KP NL +N LKI DFG A+++ P +
Sbjct: 124 LFMYQLLRGLKYIHSA-NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLS 182
Query: 299 -YICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILG 357
+ +++YR+P L+ YT AIDMW+ GC+ AE+L G+ LF G ++Q+ I++ +
Sbjct: 183 EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIP 242
Query: 358 TPTREEIKCMNPNYTEF--KFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTAL 415
E+ + + + P ++ + EA+D + ++L +SP R TA
Sbjct: 243 VVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPG-ISREAVDFLEQILTFSPMDRLTAE 301
Query: 416 EACAHPFFDDLRDPN 430
EA +HP+ P
Sbjct: 302 EALSHPYMSIYSFPM 316
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 296 bits (761), Expect = 4e-98
Identities = 89/303 (29%), Positives = 153/303 (50%), Gaps = 23/303 (7%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV--LQDKRYKNRELQIMR-LLNHPNVVSL 195
Y R +G G + VF+A + + V +K + ++ K+ K RE++I+ L PN+++L
Sbjct: 38 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIK-REIKILENLRGGPNIITL 96
Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
+ V E+++ T ++ ++ Q + ++ Y Y+I +AL+Y H
Sbjct: 97 ADIVKDPVSRTPAL---VFEHVNNTDFK------QLYQTLTDYDIRFYMYEILKALDYCH 147
Query: 256 HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGAT 315
+ G+ HRD+KP N++++ +L++ D+G A+ PG+ + SRY++ PEL+
Sbjct: 148 SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 206
Query: 316 EYTTAIDMWSIGCVLAELLLG-QPLFPGESGVDQLVEIIKILGTPTREEI--KCMNPNYT 372
Y ++DMWS+GC+LA ++ +P F G DQLV I K+LGT + K
Sbjct: 207 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 266
Query: 373 EFK--FPQIKAHPWHKIFHKR----MPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426
F + W + H + PEALD + +LL+Y R TA EA HP+F +
Sbjct: 267 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 326
Query: 427 RDP 429
Sbjct: 327 VKD 329
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 296 bits (759), Expect = 2e-97
Identities = 109/353 (30%), Positives = 182/353 (51%), Gaps = 42/353 (11%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV-----LQD-KR-YKNRELQIMRLLNHPN 191
+ + ++G G++GVV A TG+ VAIKK+ R RE++I++ H N
Sbjct: 13 FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL--REIKILKHFKHEN 70
Query: 192 VVSLKHCFFSTTEKD--ELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICR 249
++++ + + ++ E+Y+ + E + ++RV + H+ Q + YQ R
Sbjct: 71 IITIFNIQRPDSFENFNEVYI--IQELMQTDLHRVISTQMLSDDHI-----QYFIYQTLR 123
Query: 250 ALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS----------- 298
A+ LH V HRD+KP NLL+N LK+CDFG A+++ + S
Sbjct: 124 AVKVLHGS-NVIHRDLKPSNLLIN-SNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVE 181
Query: 299 YICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGT 358
++ +R+YRAPE++ + +Y+ A+D+WS GC+LAEL L +P+FPG QL+ I I+GT
Sbjct: 182 FVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT 241
Query: 359 PTREEI--KCMNPNYTEF--KFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTA 414
P + +P E+ P A P K+F + + P+ +DL+ R+L + P+ R TA
Sbjct: 242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPR-VNPKGIDLLQRMLVFDPAKRITA 300
Query: 415 LEACAHPFFDDLRDPN---TCLPNGRPLPTLFNFTAQELAGASNELRQRLIPE 464
EA HP+ DPN P P+ F F + A + +L++ + E
Sbjct: 301 KEALEHPYLQTYHDPNDEPEGEP---IPPSFFEFDHYKEALTTKDLKKLIWNE 350
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 292 bits (751), Expect = 3e-96
Identities = 108/338 (31%), Positives = 167/338 (49%), Gaps = 33/338 (9%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---------RELQIMRLLNHPNVVSL 195
+G G F V++A+ T VAIKK+ R + RE+++++ L+HPN++ L
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
F K + L V +++ + + K + + +++ Y + L YLH
Sbjct: 78 LDAF---GHKSNISL--VFDFMETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLH 129
Query: 256 HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISY---ICSRYYRAPELIF 312
+ HRD+KP NLL++ LK+ DFG AK G PN +Y + +R+YRAPEL+F
Sbjct: 130 QH-WILHRDLKPNNLLLD-ENGVLKLADFGLAKSF--GSPNRAYTHQVVTRWYRAPELLF 185
Query: 313 GATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEI---KCMNP 369
GA Y +DMW++GC+LAELLL P PG+S +DQL I + LGTPT EE C P
Sbjct: 186 GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPT-EEQWPDMCSLP 244
Query: 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDP 429
+Y F P H IF + LDL+ L ++P R TA +A +F + P
Sbjct: 245 DYVT--FKSFPGIPLHHIF-SAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR--P 299
Query: 430 NTCLPNGRPLPTLFNFTAQELAGASNELRQRLIPEHAR 467
P P T +E + + ++++ +
Sbjct: 300 GPTPGCQLPRPNCPVETLKEQSNPALAIKRKRTEALEQ 337
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 293 bits (751), Expect = 5e-96
Identities = 99/349 (28%), Positives = 162/349 (46%), Gaps = 39/349 (11%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---------------RELQI 183
Y +R + +GS+G V G VAIK+V RE+++
Sbjct: 24 YTVQRFISSGSYGAVCAGVD-SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82
Query: 184 MRLLNHPNVVSLKHCF--FSTTEKDELYLNLVLEYISETVYRV--SKHYTRMNQHVPILY 239
+ +HPN++ L+ F F +LYL V E + + +V + QH+
Sbjct: 83 LNHFHHPNILGLRDIFVHFEEPAMHKLYL--VTELMRTDLAQVIHDQRIVISPQHI---- 136
Query: 240 VQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISY 299
Q + Y I L+ LH GV HRD+ P N+L+ + + ICDF A+ Y
Sbjct: 137 -QYFMYHILLGLHVLHEA-GVVHRDLHPGNILLA-DNNDITICDFNLAREDTADANKTHY 193
Query: 300 ICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTP 359
+ R+YRAPEL+ +T +DMWS GCV+AE+ + LF G + +QL +I++++GTP
Sbjct: 194 VTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTP 253
Query: 360 TREEIKCM-NP---NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTAL 415
E++ +P +Y + A W + P ALDL++++L+++P R +
Sbjct: 254 KIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPT-ADPVALDLIAKMLEFNPQRRISTE 312
Query: 416 EACAHPFFDDLRDPNTCLPNGRPLPTLFNFTAQELAGASNELRQRLIPE 464
+A HP+F+ L DP L G F+F ++ + E
Sbjct: 313 QALRHPYFESLFDPL-DLTEGLSER--FHFDESVT--DVYDMHKIFTAE 356
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 288 bits (739), Expect = 9e-95
Identities = 100/337 (29%), Positives = 170/337 (50%), Gaps = 33/337 (9%)
Query: 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---------RELQIMRLLN 188
+Y+ +G G++ V++ K T + VA+K++ R ++ RE+ +++ L
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEI----RLEHEEGAPCTAIREVSLLKDLK 58
Query: 189 HPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQIC 248
H N+V+L + L L V EY+ + ++ + + V+L+ +Q+
Sbjct: 59 HANIVTLHDII---HTEKSLTL--VFEYLD---KDLKQYLDDCGNIINMHNVKLFLFQLL 110
Query: 249 RALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISY---ICSRYY 305
R L Y H V HRD+KPQNLL+N +LK+ DFG A+ P +Y + + +Y
Sbjct: 111 RGLAYCHRQ-KVLHRDLKPQNLLIN-ERGELKLADFGLARAK--SIPTKTYDNEVVTLWY 166
Query: 306 RAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTRE--- 362
R P+++ G+T+Y+T IDMW +GC+ E+ G+PLFPG + +QL I +ILGTPT E
Sbjct: 167 RPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWP 226
Query: 363 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPF 422
I + + +P+ +A R+ + DL+++LLQ+ R +A +A HPF
Sbjct: 227 GILSN-EEFKTYNYPKYRAEALLSHA-PRLDSDGADLLTKLLQFEGRNRISAEDAMKHPF 284
Query: 423 FDDLRDPNTCLPNGRPLPTLFNFTAQELAGASNELRQ 459
F L + LP+ + L Q+ A +
Sbjct: 285 FLSLGERIHKLPDTTSIFALKEIQLQKEASLRSAHHH 321
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 289 bits (742), Expect = 1e-94
Identities = 102/308 (33%), Positives = 169/308 (54%), Gaps = 28/308 (9%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV--LQD----KR-YKNRELQIMRLLNHPN 191
Y +G G++G+V A VAIKK+ + +R RE++I+ H N
Sbjct: 29 YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL--REIKILLRFRHEN 86
Query: 192 VVSLKHCFFSTTEKD--ELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICR 249
++ + + T + ++Y+ V + + +Y++ K N H+ + YQI R
Sbjct: 87 IIGINDIIRAPTIEQMKDVYI--VQDLMETDLYKLLKTQHLSNDHI-----CYFLYQILR 139
Query: 250 ALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS----YICSRYY 305
L Y+H V HRD+KP NLL+N T LKICDFG A++ P + Y+ +R+Y
Sbjct: 140 GLKYIHSA-NVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 197
Query: 306 RAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIK 365
RAPE++ + YT +ID+WS+GC+LAE+L +P+FPG+ +DQL I+ ILG+P++E++
Sbjct: 198 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 257
Query: 366 CM-NPNYTEF--KFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPF 422
C+ N + P PW+++F +ALDL+ ++L ++P R +A AHP+
Sbjct: 258 CIINLKARNYLLSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 316
Query: 423 FDDLRDPN 430
+ DP+
Sbjct: 317 LEQYYDPS 324
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 285 bits (731), Expect = 5e-93
Identities = 101/338 (29%), Positives = 168/338 (49%), Gaps = 29/338 (8%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV------LQDKRYKNRELQIMRLLNHPNV 192
Y + VG+G++G V A TG VAIKK+ + REL++++ + H NV
Sbjct: 27 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 86
Query: 193 VSLKHCFF---STTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICR 249
+ L F + + + YL V+ ++ + ++ KH + Q YQ+ +
Sbjct: 87 IGLLDVFTPDETLDDFTDFYL--VMPFMGTDLGKLMKHEKLGEDRI-----QFLVYQMLK 139
Query: 250 ALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPE 309
L Y+H G+ HRD+KP NL VN LKI DFG A+ Y+ +R+YRAPE
Sbjct: 140 GLRYIHAA-GIIHRDLKPGNLAVNEDCE-LKILDFGLARQADSEMTG--YVVTRWYRAPE 195
Query: 310 LIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM-N 368
+I YT +D+WS+GC++AE++ G+ LF G +DQL EI+K+ GTP E ++ + +
Sbjct: 196 VILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 255
Query: 369 PNYTEF--KFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426
+ P+++ + I P A++L+ ++L R TA EA AHP+F+ L
Sbjct: 256 DEAKNYMKGLPELEKKDFASIL-TNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 314
Query: 427 RDPNTCLPNGRPLPTLFNFTAQELAGASNELRQRLIPE 464
D P ++ + ++ +E ++ E
Sbjct: 315 HDTED-----EPQVQKYDDSFDDVDRTLDEWKRVTYKE 347
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 283 bits (727), Expect = 6e-93
Identities = 91/298 (30%), Positives = 156/298 (52%), Gaps = 30/298 (10%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLKHC 198
+G G++G V++A T ++VAIK++ + + RE+ +++ L H N++ LK
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSV 101
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV 258
L+L + EY + K Y N V + ++ + YQ+ +N+ H
Sbjct: 102 I---HHNHRLHL--IFEYAENDL----KKYMDKNPDVSMRVIKSFLYQLINGVNFCHSR- 151
Query: 259 GVCHRDIKPQNLLVNPHTH----QLKICDFGSAKMLVPGEPNISY---ICSRYYRAPELI 311
HRD+KPQNLL++ LKI DFG A+ G P + I + +YR PE++
Sbjct: 152 RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF--GIPIRQFTHEIITLWYRPPEIL 209
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTRE---EIKCMN 368
G+ Y+T++D+WSI C+ AE+L+ PLFPG+S +DQL +I ++LG P + +
Sbjct: 210 LGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTAL- 268
Query: 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426
P++ + FP+ + ++ + E LDL++ +L+ P R +A A HP+F
Sbjct: 269 PDWKQS-FPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN 325
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 283 bits (727), Expect = 1e-92
Identities = 105/343 (30%), Positives = 170/343 (49%), Gaps = 39/343 (11%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV---LQD----KR-YKNRELQIMRLLNHP 190
Y++ VG+G++G V A +G+ VAIKK+ Q KR Y REL +++ + H
Sbjct: 26 YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAY--RELLLLKHMQHE 83
Query: 191 NVVSLKHCFFSTTEKD---ELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQI 247
NV+ L F + + YL V+ ++ + ++ + + Q YQ+
Sbjct: 84 NVIGLLDVFTPASSLRNFYDFYL--VMPFMQTDLQKIMGL-KFSEEKI-----QYLVYQM 135
Query: 248 CRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRA 307
+ L Y+H GV HRD+KP NL VN LKI DFG A+ Y+ +R+YRA
Sbjct: 136 LKGLKYIHSA-GVVHRDLKPGNLAVNEDCE-LKILDFGLARHADAEMTG--YVVTRWYRA 191
Query: 308 PELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367
PE+I Y +D+WS+GC++AE+L G+ LF G+ +DQL +I+K+ G P E ++ +
Sbjct: 192 PEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKL 251
Query: 368 -NPNYTEF--KFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFD 424
+ + PQ + ++F R P+A DL+ ++L+ R TA +A HPFF+
Sbjct: 252 NDKAAKSYIQSLPQTPRKDFTQLF-PRASPQAADLLEKMLELDVDKRLTAAQALTHPFFE 310
Query: 425 DLRDPN---TCLPNGRPLPTLFNFTAQELAGASNELRQRLIPE 464
RDP F+ + + +E +Q + E
Sbjct: 311 PFRDPEEETEA-------QQPFDDSLEHEKLTVDEWKQHIYKE 346
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 281 bits (721), Expect = 3e-92
Identities = 101/294 (34%), Positives = 164/294 (55%), Gaps = 27/294 (9%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLKHC 198
VG G++GVV++AK G VA+K++ D + RE+ +++ L+HPN+VSL
Sbjct: 29 VGEGTYGVVYKAKD-SQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV 258
+ L L V E++ + K + +++Y YQ+ R + + H
Sbjct: 88 I---HSERCLTL--VFEFME---KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH- 138
Query: 259 GVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISY---ICSRYYRAPELIFGAT 315
+ HRD+KPQNLL+N LK+ DFG A+ G P SY + + +YRAP+++ G+
Sbjct: 139 RILHRDLKPQNLLIN-SDGALKLADFGLARAF--GIPVRSYTHEVVTLWYRAPDVLMGSK 195
Query: 316 EYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTRE---EIKCMNPNYT 372
+Y+T++D+WSIGC+ AE++ G+PLFPG + DQL +I ILGTP +++ + P +
Sbjct: 196 KYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQEL-PLWK 254
Query: 373 EFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426
+ F + PW I E +DL+S +L + P+ R +A +A HP+F DL
Sbjct: 255 QRTFQVFEKKPWSSII-PGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 279 bits (715), Expect = 1e-91
Identities = 97/294 (32%), Positives = 159/294 (54%), Gaps = 28/294 (9%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLKHC 198
+G G++GVV++A+ G++ A+KK+ +K + RE+ I++ L H N+V L
Sbjct: 10 IGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV 258
K L L V E++ + + ++ + + + + Q+ + Y H
Sbjct: 69 I---HTKKRLVL--VFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDR- 119
Query: 259 GVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISY---ICSRYYRAPELIFGAT 315
V HRD+KPQNLL+N +LKI DFG A+ G P Y I + +YRAP+++ G+
Sbjct: 120 RVLHRDLKPQNLLIN-REGELKIADFGLARAF--GIPVRKYTHEIVTLWYRAPDVLMGSK 176
Query: 316 EYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTRE---EIKCMNPNYT 372
+Y+T ID+WS+GC+ AE++ G PLFPG S DQL+ I +ILGTP + + + P Y
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL-PKY- 234
Query: 373 EFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426
+ F + PW K + +DL+S++L+ P+ R TA +A H +F +
Sbjct: 235 DPNFTVYEPLPWESFL-KGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 281 bits (720), Expect = 3e-91
Identities = 104/340 (30%), Positives = 167/340 (49%), Gaps = 33/340 (9%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KR-YKNRELQIMRLLNHP 190
Y VG+G++G V A +TG VA+KK+ + KR Y REL++++ + H
Sbjct: 31 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHE 88
Query: 191 NVVSLKHCFFSTTEKD---ELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQI 247
NV+ L F + ++YL V + + + K + HV Q YQI
Sbjct: 89 NVIGLLDVFTPARSLEEFNDVYL--VTHLMGADLNNIVKCQKLTDDHV-----QFLIYQI 141
Query: 248 CRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRA 307
R L Y+H + HRD+KP NL VN +LKI DFG A+ Y+ +R+YRA
Sbjct: 142 LRGLKYIHSA-DIIHRDLKPSNLAVN-EDCELKILDFGLARHTADEMTG--YVATRWYRA 197
Query: 308 PELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367
PE++ Y +D+WS+GC++AELL G+ LFPG +DQL I++++GTP E +K +
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 257
Query: 368 -NPNYTEF--KFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFD 424
+ + + Q+ + +F P A+DL+ ++L R TA +A AH +F
Sbjct: 258 SSESARNYIQSLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 316
Query: 425 DLRDPNTCLPNGRPLPTLFNFTAQELAGASNELRQRLIPE 464
DP+ P+ ++ + + +E + E
Sbjct: 317 QYHDPDD-----EPVADPYDQSLESRDLLIDEWKSLTYDE 351
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 275 bits (705), Expect = 8e-90
Identities = 90/317 (28%), Positives = 156/317 (49%), Gaps = 37/317 (11%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---------RELQIMRLLNHPNVVSL 195
+G G++ V++ TG VA+K+V + + RE+ +M+ L H N+V L
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEV----KLDSEEGTPSTAIREISLMKELKHENIVRL 68
Query: 196 KHCFFSTTEKDELYLNLVLEYISE--TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
+++L L V E++ Y S+ + + + V+ + +Q+ + L +
Sbjct: 69 YDVI---HTENKLTL--VFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAF 123
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISY---ICSRYYRAPEL 310
H + HRD+KPQNLL+N QLK+ DFG A+ G P ++ + + +YRAP++
Sbjct: 124 CHEN-KILHRDLKPQNLLIN-KRGQLKLGDFGLARAF--GIPVNTFSSEVVTLWYRAPDV 179
Query: 311 IFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTRE---EIKCM 367
+ G+ Y+T+ID+WS GC+LAE++ G+PLFPG + +QL I I+GTP + +
Sbjct: 180 LMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKL 239
Query: 368 NPNYTEFKFPQIKAHPWHKIFHK----RMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
P Y Q ++ + +D + LLQ +P +R +A +A HP+F
Sbjct: 240 -PKY-NPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWF 297
Query: 424 DDLRDPNTCLPNGRPLP 440
+ + R
Sbjct: 298 AEYYHH-ASMGGSRSHH 313
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 274 bits (702), Expect = 1e-89
Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 28/298 (9%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLKHC 198
+G G++G VF+AK ET + VA+K+V D + RE+ +++ L H N+V L
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV 258
+L L V E+ + K++ N + V+ + +Q+ + L + H
Sbjct: 70 L---HSDKKLTL--VFEFCD---QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR- 120
Query: 259 GVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISY---ICSRYYRAPELIFGAT 315
V HRD+KPQNLL+N +LK+ +FG A+ G P Y + + +YR P+++FGA
Sbjct: 121 NVLHRDLKPQNLLIN-RNGELKLANFGLARAF--GIPVRCYSAEVVTLWYRPPDVLFGAK 177
Query: 316 EYTTAIDMWSIGCVLAELL-LGQPLFPGESGVDQLVEIIKILGTPTRE---EIKCMNPNY 371
Y+T+IDMWS GC+ AEL G+PLFPG DQL I ++LGTPT E + + P+Y
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL-PDY 236
Query: 372 TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDP 429
+ + ++ DL+ LL+ +P R +A EA HP+F D P
Sbjct: 237 KPYPMYPAT-TSLVNVV-PKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP 292
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 275 bits (705), Expect = 4e-89
Identities = 101/350 (28%), Positives = 168/350 (48%), Gaps = 40/350 (11%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV---LQD----KR-YKNRELQIMRLLNHP 190
Y + +G+G+ G+V A +VAIKK+ Q+ KR Y REL +M+ +NH
Sbjct: 27 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY--RELVLMKCVNHK 84
Query: 191 NVVSLKHCF---FSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQI 247
N++ L + F S E ++Y+ V+E + + +V + ++ + YQ+
Sbjct: 85 NIIGLLNVFTPQKSLEEFQDVYI--VMELMDANLCQVIQM-ELDHERM-----SYLLYQM 136
Query: 248 CRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRA 307
+ +LH G+ HRD+KP N++V LKI DFG A+ Y+ +RYYRA
Sbjct: 137 LCGIKHLHSA-GIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 194
Query: 308 PELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367
PE+I G Y +D+WS+GC++ E++ G LFPG +DQ ++I+ LGTP E +K +
Sbjct: 195 PEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 253
Query: 368 NPNYTEF--KFPQIKAHPWHKIFHKRMP-----------PEALDLVSRLLQYSPSLRCTA 414
P + P+ + + K+F + +A DL+S++L S R +
Sbjct: 254 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV 313
Query: 415 LEACAHPFFDDLRDPNTCLPNGRPLPTLFNFTAQELAGASNELRQRLIPE 464
EA HP+ + DP+ P +E E ++ + E
Sbjct: 314 DEALQHPYINVWYDPSE-AEAPPPKIPDKQLDEREH--TIEEWKELIYKE 360
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 271 bits (696), Expect = 7e-88
Identities = 84/312 (26%), Positives = 142/312 (45%), Gaps = 26/312 (8%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLK-- 196
+G G+FG VF+A+ +TG VA+KKVL + + RE++I++LL H NVV+L
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84
Query: 197 -HCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
S + + + LV ++ + ++ + + + ++ + L Y+H
Sbjct: 85 CRTKASPYNRCKGSIYLVFDFCE---HDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH 141
Query: 256 HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM--LVPGEPNISY---ICSRYYRAPEL 310
+ HRD+K N+L+ LK+ DFG A+ L Y + + +YR PEL
Sbjct: 142 RN-KILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPEL 199
Query: 311 IFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTRE---EIKCM 367
+ G +Y ID+W GC++AE+ P+ G + QL I ++ G+ T E +
Sbjct: 200 LLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNY 259
Query: 368 NPNYTEFKFPQIKAHPWHKIF-HKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426
Y + + + + P ALDL+ +LL P+ R + +A H FF
Sbjct: 260 -ELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS- 317
Query: 427 RDPNTCLPNGRP 438
DP G
Sbjct: 318 -DPMPSDLKGML 328
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 268 bits (688), Expect = 2e-87
Identities = 84/306 (27%), Positives = 143/306 (46%), Gaps = 36/306 (11%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---------RELQIMRLLN---HPNV 192
+G G++G V++A+ +G VA+K V RE+ ++R L HPNV
Sbjct: 17 IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHY--TRMNQHVPILYVQLYTYQICRA 250
V L ++ E+ + LV E++ + + + Y +P ++ Q R
Sbjct: 77 VRLMDVCATSRTDREIKVTLVFEHVDQDL----RTYLDKAPPPGLPAETIKDLMRQFLRG 132
Query: 251 LNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISY---ICSRYYRA 307
L++LH + HRD+KP+N+LV +K+ DFG A++ ++ + + +YRA
Sbjct: 133 LDFLHAN-CIVHRDLKPENILVT-SGGTVKLADFGLARIY--SYQ-MALTPVVVTLWYRA 187
Query: 308 PELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367
PE++ +T Y T +DMWS+GC+ AE+ +PLF G S DQL +I ++G P ++
Sbjct: 188 PEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW--- 243
Query: 368 NPNYTE---FKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFD 424
P FP P + M L+ +L ++P R +A A H +
Sbjct: 244 -PRDVSLPRGAFPPRGPRPVQSVV-PEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLH 301
Query: 425 DLRDPN 430
+ N
Sbjct: 302 KD-EGN 306
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 273 bits (700), Expect = 3e-87
Identities = 100/350 (28%), Positives = 169/350 (48%), Gaps = 40/350 (11%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KR-YKNRELQIMRLLNHP 190
Y + +G+G+ G+V A +VAIKK+ + KR Y REL +M+ +NH
Sbjct: 64 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY--RELVLMKCVNHK 121
Query: 191 NVVSLKHCF---FSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQI 247
N++SL + F + E ++YL V+E + + +V + ++ + YQ+
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYL--VMELMDANLCQVIQM-ELDHERM-----SYLLYQM 173
Query: 248 CRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRA 307
+ +LH G+ HRD+KP N++V LKI DFG A+ Y+ +RYYRA
Sbjct: 174 LCGIKHLHSA-GIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 231
Query: 308 PELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367
PE+I G Y +D+WS+GC++ E++ + LFPG +DQ ++I+ LGTP E +K +
Sbjct: 232 PEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 290
Query: 368 NPNYTEF--KFPQIKAHPWHKIF-----------HKRMPPEALDLVSRLLQYSPSLRCTA 414
P + P+ + K+F +K +A DL+S++L P+ R +
Sbjct: 291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 350
Query: 415 LEACAHPFFDDLRDPNTCLPNGRPLPTLFNFTAQELAGASNELRQRLIPE 464
+A HP+ + DP + P +E E ++ + E
Sbjct: 351 DDALQHPYINVWYDPAE-VEAPPPQIYDKQLDEREH--TIEEWKELIYKE 397
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 272 bits (697), Expect = 3e-87
Identities = 97/356 (27%), Positives = 157/356 (44%), Gaps = 75/356 (21%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV------LQD-KR-YKNRELQIMRLLNHP 190
Y+ + ++G GS+G V+ A T +VAIKKV L D KR RE+ I+ L
Sbjct: 28 YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRIL--REITILNRLKSD 85
Query: 191 NVVSLKHCFFSTTEKD--ELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQIC 248
++ L ELY+ VLE + ++ + + +++ Y +
Sbjct: 86 YIIRLYDLIIPDDLLKFDELYI--VLEIADSDLKKL----FKTPIFLTEEHIKTILYNLL 139
Query: 249 RALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS---------- 298
N++H G+ HRD+KP N L+N +K+CDFG A+ + +
Sbjct: 140 LGENFIHES-GIIHRDLKPANCLLNQDCS-VKVCDFGLARTINSEKDTNIVNDLEENEEP 197
Query: 299 -------------YICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQ-------- 337
++ +R+YRAPELI YT +ID+WS GC+ AELL
Sbjct: 198 GPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPT 257
Query: 338 ---PLFPGESG-----------------VDQLVEIIKILGTPTREEIKCM-NPNYTEF-- 374
PLFPG S DQL I I+GTPT +++K + P ++
Sbjct: 258 NRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIK 317
Query: 375 KFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPN 430
FP K + + + + ++L+ +L+++P+ R T +A HP+ D+R
Sbjct: 318 LFPHRKPINLKQKYPS-ISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKK 372
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 272 bits (696), Expect = 1e-86
Identities = 110/364 (30%), Positives = 162/364 (44%), Gaps = 83/364 (22%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KR-YKNRELQIMRLLNHP 190
Y ++GTGS+G V +A VAIKK+L+ KR RE+ I+ LNH
Sbjct: 55 YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRIL--REIAILNRLNHD 112
Query: 191 NVVSLKHCFFSTTEK--DELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQIC 248
+VV + + DELY +VLE ++ R ++ L+++ Y +
Sbjct: 113 HVVKVLDIVIPKDVEKFDELY--VVLEIADSDFKKL----FRTPVYLTELHIKTLLYNLL 166
Query: 249 RALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS---------- 298
+ Y+H G+ HRD+KP N LVN +K+CDFG A+ + E S
Sbjct: 167 VGVKYVHS-AGILHRDLKPANCLVNQDCS-VKVCDFGLARTVDYPENGNSQLPISPREDD 224
Query: 299 ------------------YICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL----- 335
++ +R+YRAPELI YT AID+WSIGC+ AELL
Sbjct: 225 MNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKEN 284
Query: 336 ------GQPLFPGES--------------------GVDQLVEIIKILGTPTREEIKCM-N 368
PLFPG S DQL I ILGTP+ E+I+ +
Sbjct: 285 VAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEK 344
Query: 369 PNYTEF--KFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426
+ + FP+ + + F +A+ L+ R+L ++P+ R T E AHPFF ++
Sbjct: 345 EDAKRYIRIFPKREGTDLAERF-PASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEV 403
Query: 427 RDPN 430
R
Sbjct: 404 RIAE 407
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 268 bits (688), Expect = 2e-86
Identities = 100/341 (29%), Positives = 172/341 (50%), Gaps = 61/341 (17%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVL---QD----KR-YKNRELQIMRLLN-H 189
Y + +G G++G+V+++ TG+ VA+KK+ Q+ +R + RE+ I+ L+ H
Sbjct: 11 YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTF--REIMILTELSGH 68
Query: 190 PNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICR 249
N+V+L + + ++D +YL V +Y+ ++ V + H Q YQ+ +
Sbjct: 69 ENIVNLLNVLRADNDRD-VYL--VFDYMETDLHAVIRANILEPVHK-----QYVVYQLIK 120
Query: 250 ALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS----------- 298
+ YLH G+ HRD+KP N+L+N H +K+ DFG ++ V +
Sbjct: 121 VIKYLHSG-GLLHRDMKPSNILLNAECH-VKVADFGLSRSFVNIRRVTNNIPLSINENTE 178
Query: 299 -----------YICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVD 347
Y+ +R+YRAPE++ G+T+YT IDMWS+GC+L E+L G+P+FPG S ++
Sbjct: 179 NFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN 238
Query: 348 QLVEIIKILGTPTREEIKCM-NPNYTEF--KFPQIKAHPWHKIFHKRMP----------- 393
QL II ++ P+ E+++ + +P +
Sbjct: 239 QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPK 298
Query: 394 ----PEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPN 430
EALDL+ +LLQ++P+ R +A +A HPF +PN
Sbjct: 299 ADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPN 339
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 265 bits (681), Expect = 6e-86
Identities = 96/316 (30%), Positives = 154/316 (48%), Gaps = 37/316 (11%)
Query: 145 VGTGSFGVVFQAK-CLETGDSVAIKKVLQDKRYKN-------RELQIMRLLN---HPNVV 193
+G G++G VF+A+ G VA+K+V + RE+ ++R L HPNVV
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTG-EEGMPLSTIREVAVLRHLETFEHPNVV 77
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHY--TRMNQHVPILYVQLYTYQICRAL 251
L + E L LV E++ + + Y VP ++ +Q+ R L
Sbjct: 78 RLFDVCTVSRTDRETKLTLVFEHVDQDL----TTYLDKVPEPGVPTETIKDMMFQLLRGL 133
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISY---ICSRYYRAP 308
++LH V HRD+KPQN+LV + Q+K+ DFG A++ ++ + + +YRAP
Sbjct: 134 DFLHSH-RVVHRDLKPQNILVT-SSGQIKLADFGLARIY--SFQ-MALTSVVVTLWYRAP 188
Query: 309 ELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368
E++ ++ Y T +D+WS+GC+ AE+ +PLF G S VDQL +I+ ++G P E+
Sbjct: 189 EVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW---- 243
Query: 369 PNYTE---FKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDD 425
P F A P K + DL+ + L ++P+ R +A A +HP+F D
Sbjct: 244 PRDVALPRQAFHSKSAQPIEKFV-TDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 302
Query: 426 LRDPNTCLPNGRPLPT 441
L LP
Sbjct: 303 L--ERCKENLDSHLPP 316
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 257 bits (659), Expect = 8e-82
Identities = 89/335 (26%), Positives = 150/335 (44%), Gaps = 44/335 (13%)
Query: 145 VGTGSFGVVFQAKCLE--TGDSVAIKKVLQDKRYKN--RELQIMRLLNHPNVVSLKHCFF 200
VG G++G V++AK + A+K++ + RE+ ++R L HPNV+SL+ F
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 88
Query: 201 STTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY-----VQLYTYQICRALNYLH 255
S ++ + L+ +Y ++ + K + + + V+ YQI ++YLH
Sbjct: 89 SHADRK---VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145
Query: 256 HVVGVCHRDIKPQNLLVN---PHTHQLKICDFGSAKMLVPGEPNISY------ICSRYYR 306
V HRD+KP N+LV P ++KI D G A++ P + + +YR
Sbjct: 146 AN-WVLHRDLKPANILVMGEGPERGRVKIADMGFARLF--NSPLKPLADLDPVVVTFWYR 202
Query: 307 APELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGES---------GVDQLVEIIKILG 357
APEL+ GA YT AID+W+IGC+ AELL +P+F DQL I ++G
Sbjct: 203 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMG 262
Query: 358 TPTRE---------EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSP 408
P + E + ++ + + + + +A L+ +LL P
Sbjct: 263 FPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDP 322
Query: 409 SLRCTALEACAHPFFDDLRDPNTCLPNGRPLPTLF 443
R T+ +A P+F + DP +
Sbjct: 323 IKRITSEQAMQDPYFLE--DPLPTSDVFAGCQIPY 355
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 220 bits (562), Expect = 3e-67
Identities = 94/328 (28%), Positives = 150/328 (45%), Gaps = 57/328 (17%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNH------ 189
Y +V+G GSFG V +A + VA+K V +KR+ E++I+ L
Sbjct: 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNT 158
Query: 190 PNVVSLKHCFFSTTEKDELYLN---LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQ 246
NV+ + F + N + E +S +Y + K Q + V+ + +
Sbjct: 159 MNVIHMLENF--------TFRNHICMTFELLSMNLYELIKK--NKFQGFSLPLVRKFAHS 208
Query: 247 ICRALNYLHHVVGVCHRDIKPQN-LLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYY 305
I + L+ LH + H D+KP+N LL +K+ DFGS+ + +YI SR+Y
Sbjct: 209 ILQCLDALHKN-RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE--HQRVYTYIQSRFY 265
Query: 306 RAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIK 365
RAPE+I GA Y IDMWS+GC+LAELL G PL PGE DQL +I++LG P+++ +
Sbjct: 266 RAPEVILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLD 324
Query: 366 -----------CMNPNYTEFKF---------------PQIKAHPWHKIFHKRMPPEA--- 396
P Y +++ P + + +
Sbjct: 325 ASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPL 384
Query: 397 -LDLVSRLLQYSPSLRCTALEACAHPFF 423
LD + + L++ P++R T +A HP+
Sbjct: 385 FLDFLKQCLEWDPAVRMTPGQALRHPWL 412
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 216 bits (551), Expect = 4e-66
Identities = 105/379 (27%), Positives = 162/379 (42%), Gaps = 81/379 (21%)
Query: 94 RDEKNVNHDDKDLEPSIVNGNGTEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVV 153
R N +DD + + + NG R Y + ++G GSFG V
Sbjct: 30 RKVYNDGYDDDNYDYIVKNG----------EKWMDR---------YEIDSLIGKGSFGQV 70
Query: 154 FQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNHP------NVVSLKHCFFSTTE 204
+A + VAIK + K + N E++++ L+N +V LK F
Sbjct: 71 VKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM---- 126
Query: 205 KDELYLN---LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV-VGV 260
+ N LV E +S +Y + ++ + V + + + Q+C AL +L + +
Sbjct: 127 ----FRNHLCLVFEMLSYNLYDLLRNTN--FRGVSLNLTRKFAQQMCTALLFLATPELSI 180
Query: 261 CHRDIKPQN-LLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTT 319
H D+KP+N LL NP +KI DFGS+ L G+ YI SR+YR+PE++ G Y
Sbjct: 181 IHCDLKPENILLCNPKRSAIKIVDFGSSCQL--GQRIYQYIQSRFYRSPEVLLGM-PYDL 237
Query: 320 AIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIK-----------CMN 368
AIDMWS+GC+L E+ G+PLF G + VDQ+ +I+++LG P + +
Sbjct: 238 AIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPD 297
Query: 369 PNYTEFKFPQIKAH---PWHKIFH-----KRMPPEA----------------LDLVSRLL 404
+ K K P + H + P DL+ R+L
Sbjct: 298 GTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRML 357
Query: 405 QYSPSLRCTALEACAHPFF 423
Y P R A H FF
Sbjct: 358 DYDPKTRIQPYYALQHSFF 376
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 215 bits (549), Expect = 7e-66
Identities = 86/358 (24%), Positives = 151/358 (42%), Gaps = 48/358 (13%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLN-----HP 190
Y+ R +G G F V+ AK + VA+K V DK Y E+++++ +N
Sbjct: 21 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 80
Query: 191 NVVSLKHC-----FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTY 245
+ + H F+ + +++ +V E + E + + K Y ++ +P++YV+ +
Sbjct: 81 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYE--HRGIPLIYVKQISK 138
Query: 246 QICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQ-----LKICDFGSAKMLVPGEPNISYI 300
Q+ L+Y+H G+ H DIKP+N+L+ +KI D G+A E + I
Sbjct: 139 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY--DEHYTNSI 196
Query: 301 CSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESG------VDQLVEIIK 354
+R YR+PE++ GA + D+WS C++ EL+ G LF + G D + +II+
Sbjct: 197 QTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 255
Query: 355 ILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPP--------------EALDLV 400
+LG ++ F + K+ + E D +
Sbjct: 256 LLGELPSYLLR-NGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFL 314
Query: 401 SRLLQYSPSLRCTALEACAHPFFDDLRDPNTCLPNGRPLPTLFNFTAQELAGASNELR 458
S +LQ P R A HP+ D R L + ++ G E+R
Sbjct: 315 SPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYG----SGSDIPGWFEEVR 368
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 209 bits (535), Expect = 6e-64
Identities = 86/383 (22%), Positives = 147/383 (38%), Gaps = 85/383 (22%)
Query: 94 RDEKNVNHDDKDLEPSIVNGNGTEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVV 153
R+ DD+ + S G + ++ R +G G+FG V
Sbjct: 11 RENLYFQGDDEIVHFSWKKG----------MLLNNA---------FLVIRKMGDGTFGRV 51
Query: 154 FQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNH-----PNVVSLKHCFFSTTEK 205
+ ++ A+K V K+Y E I++ + + N+V F
Sbjct: 52 LLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKF------ 105
Query: 206 DELYLN---LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCH 262
+Y + L+ E + ++Y + I ++LY +I +ALNYL + + H
Sbjct: 106 --MYYDHMCLIFEPLGPSLYEIITRNNY--NGFHIEDIKLYCIEILKALNYLRKM-SLTH 160
Query: 263 RDIKPQN-LLVNPHTH-----------------------QLKICDFGSAKMLVPGEPNIS 298
D+KP+N LL +P+ +K+ DFG A + + S
Sbjct: 161 TDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFK--SDYHGS 218
Query: 299 YICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGT 358
I +R YRAPE+I + + DMWS GCVLAEL G LF ++ L + I+
Sbjct: 219 IINTRQYRAPEVILNL-GWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQP 277
Query: 359 PTREEI---------KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEA--------LDLVS 401
+ + K +N + + +P+ + K+ P D +
Sbjct: 278 IPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLY 337
Query: 402 RLLQYSPSLRCTALEACAHPFFD 424
+LQ P+LR + E H F +
Sbjct: 338 SILQIDPTLRPSPAELLKHKFLE 360
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 3e-63
Identities = 85/337 (25%), Positives = 138/337 (40%), Gaps = 60/337 (17%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGD-SVAIKKVLQDKRYKN---RELQIMRLLNHP---- 190
Y +G G+FG V + + G VA+K V RY E+Q++ LN
Sbjct: 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNS 75
Query: 191 --NVVSLKHCFFSTTEKDELYLN---LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTY 245
V + F + +V E + + Y K + +++ Y
Sbjct: 76 TFRCVQMLEWFE--------HHGHICIVFELLGLSTYDFIKENGF--LPFRLDHIRKMAY 125
Query: 246 QICRALNYLHHVVGVCHRDIKPQNLLVN------------------PHTHQLKICDFGSA 287
QIC+++N+LH + H D+KP+N+L +K+ DFGSA
Sbjct: 126 QICKSVNFLHSN-KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA 184
Query: 288 KMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVD 347
E + + + +R+YRAPE+I ++ D+WSIGC+L E LG +FP +
Sbjct: 185 TYD--DEHHSTLVSTRHYRAPEVILA-LGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE 241
Query: 348 QLVEIIKILGTPTREEIK---------CMNPNYTEFKFPQIKAHPWHKIFHKRMPPE--- 395
L + +ILG + I+ ++ E K + M +
Sbjct: 242 HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVE 301
Query: 396 ---ALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDP 429
DL+ ++L+Y P+ R T EA HPFFD L+
Sbjct: 302 HERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKKS 338
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 6e-63
Identities = 82/346 (23%), Positives = 131/346 (37%), Gaps = 60/346 (17%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDS-VAIKKVLQDKRYKN---RELQIMRLLNHP---- 190
Y +G G+FG V + G S VA+K + +Y+ E+ +++ +
Sbjct: 21 YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKEN 80
Query: 191 --NVVSLKHCFFSTTEKDELYLN---LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTY 245
V + F + + E + + + K Q P+ +V+ Y
Sbjct: 81 KFLCVLMSDWF--------NFHGHMCIAFELLGKNTFEFLKENN--FQPYPLPHVRHMAY 130
Query: 246 QICRALNYLHHVVGVCHRDIKPQNLLVN------------------PHTHQLKICDFGSA 287
Q+C AL +LH + H D+KP+N+L +++ DFGSA
Sbjct: 131 QLCHALRFLHEN-QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA 189
Query: 288 KMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVD 347
E + + + +R+YR PE+I + D+WSIGC+L E G LF +
Sbjct: 190 TFD--HEHHTTIVATRHYRPPEVILE-LGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE 246
Query: 348 QLVEIIKILGTPTREEIKCM---------NPNYTEFKFPQIKAHPWHKIFHKRMPPEAL- 397
LV + KILG I + E K M ++L
Sbjct: 247 HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLE 306
Query: 398 -----DLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNTCLPNGRP 438
DL+ R+L++ P+ R T EA HPFF L R
Sbjct: 307 HVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFHTSRN 352
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 1e-57
Identities = 65/314 (20%), Positives = 120/314 (38%), Gaps = 60/314 (19%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV----LQDKRYKN--RELQIMRLLNHPN- 191
Y + +G+G VFQ E AIK V ++ + E+ + L +
Sbjct: 30 YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 88
Query: 192 -VVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRA 250
++ L + Y+ +V+E + + K ++ + Y + A
Sbjct: 89 KIIRLYDYE-----ITDQYIYMVMECGNIDLNSWLKKKKSIDPWE----RKSYWKNMLEA 139
Query: 251 LNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI---SYICSRYYRA 307
++ +H G+ H D+KP N L+ LK+ DFG A + P ++ S + + Y
Sbjct: 140 VHTIHQH-GIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 196
Query: 308 PELIFGA----------TEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILG 357
PE I ++ + D+WS+GC+L + G+ F +Q+ ++ I
Sbjct: 197 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII--NQISKLHAI-- 252
Query: 358 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEA 417
++PN+ E +FP I + D++ L+ P R + E
Sbjct: 253 ---------IDPNH-EIEFPDI------------PEKDLQDVLKCCLKRDPKQRISIPEL 290
Query: 418 CAHPFFDDLRDPNT 431
AHP+ P
Sbjct: 291 LAHPYVQIQTHPVN 304
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 2e-57
Identities = 73/338 (21%), Positives = 117/338 (34%), Gaps = 65/338 (19%)
Query: 101 HDDKDLEPSIVNGNGTEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLE 160
L+P V+ G + + + + S+ +G GS+G VF+ + E
Sbjct: 21 QSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKE 80
Query: 161 TGDSVAIKKVL------QDKRYKNRELQIM-RLLNHPNVVSLKHCFFSTTEKDELYLNLV 213
G A+K+ + +D+ K E+ ++ HP V L+ + E LY L
Sbjct: 81 DGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWE---EGGILY--LQ 135
Query: 214 LEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVN 273
E ++ +H +P V Y AL +LH G+ H D+KP N+ +
Sbjct: 136 TELCGPSLQ---QHCEAWGASLPEAQVWGYLRDTLLALAHLHS-QGLVHLDVKPANIFLG 191
Query: 274 PHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAEL 333
P K+ DFG L Y APEL+ Y TA D++S+G + E+
Sbjct: 192 PRGR-CKLGDFGLLVELGTAGAGEVQEGDPRYMAPELL--QGSYGTAADVFSLGLTILEV 248
Query: 334 LLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMP 393
L G W ++ +P
Sbjct: 249 ACNMELPHG--------------------------------------GEGWQQLRQGYLP 270
Query: 394 P--------EALDLVSRLLQYSPSLRCTALEACAHPFF 423
P E ++ +L+ P LR TA A P
Sbjct: 271 PEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVL 308
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 191 bits (486), Expect = 3e-57
Identities = 60/304 (19%), Positives = 112/304 (36%), Gaps = 27/304 (8%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKRYKNRELQIMRLLNHPNVV 193
++ ++G G+ VF+ + +TGD AIK L+ + RE ++++ LNH N+V
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 194 SLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
L TT L ++E+ + + +P + + +
Sbjct: 71 KLFAIEEETT-TRHKVL--IMEFCPCGSLYTVLEEP--SNAYGLPESEFLIVLRDVVGGM 125
Query: 252 NYLHHVVGVCHRDIKPQNLLVNP---HTHQLKICDFGSAKMLVPGEPNISYICSRYYRAP 308
N+L G+ HR+IKP N++ K+ DFG+A+ L E +S + Y P
Sbjct: 126 NHLREN-GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHP 184
Query: 309 ELIFGAT-------EYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIK--ILGTP 359
++ A +Y +D+WSIG G F G + E++ I G P
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244
Query: 360 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419
+ + P + + +++ +L+ + A
Sbjct: 245 SGAISGVQKAENGPIDWS--GDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302
Query: 420 HPFF 423
Sbjct: 303 ETSD 306
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 7e-57
Identities = 69/301 (22%), Positives = 122/301 (40%), Gaps = 51/301 (16%)
Query: 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-RYKNRELQIMR-LLNHPNVVS 194
IS+ + V+G G+ G + + + VA+K++L + + +RE+Q++R HPNV+
Sbjct: 24 ISFCPKDVLGHGAEGTIV-YRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIR 82
Query: 195 LKHCFFSTTEKDELYLNLVLEYISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
TEKD + + +E + T+ V + PI +Q Q L +
Sbjct: 83 YFC-----TEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQ----QTTSGLAH 133
Query: 254 LHHVVGVCHRDIKPQNLLVNPH----THQLKICDFGSAKMLVPGEPNISY---IC-SRYY 305
LH + + HRD+KP N+L++ + I DFG K L G + S + + +
Sbjct: 134 LHSL-NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGW 192
Query: 306 RAPELIFGATE--YTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTRE 362
APE++ + T +D++S GCV ++ G F G +
Sbjct: 193 IAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPF----------------GKSLQR 236
Query: 363 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPF 422
+ + P A +L+ +++ P R +A HPF
Sbjct: 237 QANILLGAC-SLDCLH----PEKHE-----DVIARELIEKMIAMDPQKRPSAKHVLKHPF 286
Query: 423 F 423
F
Sbjct: 287 F 287
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 1e-56
Identities = 70/351 (19%), Positives = 129/351 (36%), Gaps = 69/351 (19%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPN- 191
Y + +G+G VFQ E AIK V ++ E+ + L +
Sbjct: 11 YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69
Query: 192 -VVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRA 250
++ L + Y+ +V+E + + K ++ + Y + A
Sbjct: 70 KIIRLYDYE-----ITDQYIYMVMECGNIDLNSWLKKKKSIDPWE----RKSYWKNMLEA 120
Query: 251 LNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI---SYICSRYYRA 307
++ +H G+ H D+KP N L+ LK+ DFG A + P ++ S + + Y
Sbjct: 121 VHTIHQH-GIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 177
Query: 308 PELIFG----------ATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILG 357
PE I ++ + D+WS+GC+L + G+ F +Q+ ++ I
Sbjct: 178 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII--NQISKLHAI-- 233
Query: 358 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEA 417
++PN+ E +FP I + D++ L+ P R + E
Sbjct: 234 ---------IDPNH-EIEFPDI------------PEKDLQDVLKCCLKRDPKQRISIPEL 271
Query: 418 CAHPFFDDLRDPNTCLPNGRPLPTLFNFTAQELAGASNELRQRLIPEHARK 468
AHP+ P+ + T +E+ +L P K
Sbjct: 272 LAHPYVQ---------IQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSILK 313
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 2e-56
Identities = 54/347 (15%), Positives = 95/347 (27%), Gaps = 59/347 (17%)
Query: 124 TTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYK------ 177
TTV Q ++ + G VVF + +E + A+K
Sbjct: 51 TTVDSLLSQGERK--LKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELER 108
Query: 178 -NRELQIMRLLNHPNVVSLKHCF-------------------FSTTEKDELYLNLVLEYI 217
+ L + + S + D N +L
Sbjct: 109 LHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMP 168
Query: 218 S-----ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLV 272
+ E ++ IL + + T Q+ R L G+ H P NL +
Sbjct: 169 AASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQS-KGLVHGHFTPDNLFI 227
Query: 273 NPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFG-ATEYTTAIDMWSIGCVLA 331
P L + D + G + Y E + +T A++ W +G +
Sbjct: 228 MPDGR-LMLGDVSALW--KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIY 284
Query: 332 ELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKR 391
+ F + + L P +
Sbjct: 285 RVWCLFLPFGLVTPGIKGSWKRPSLRVPGTD--------------------SLAFGSCTP 324
Query: 392 MPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRD-PNTCLPNGR 437
+P L+ R L + R LEA P F L++ ++ L G+
Sbjct: 325 LPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQNEISSSLSTGQ 371
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 190 bits (483), Expect = 5e-56
Identities = 69/351 (19%), Positives = 125/351 (35%), Gaps = 69/351 (19%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPN- 191
Y + +G+G VFQ E AIK V ++ E+ + L +
Sbjct: 58 YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 116
Query: 192 -VVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRA 250
++ L + Y+ +V+E + + K ++ + Y + A
Sbjct: 117 KIIRLYDYE-----ITDQYIYMVMECGNIDLNSWLKKKKSIDPWE----RKSYWKNMLEA 167
Query: 251 LNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI---SYICSRYYRA 307
++ +H G+ H D+KP N L+ LK+ DFG A + P ++ S + + Y
Sbjct: 168 VHTIHQH-GIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMP 224
Query: 308 PELIFGA----------TEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILG 357
PE I ++ + D+WS+GC+L + G+ F + I
Sbjct: 225 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI---- 280
Query: 358 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEA 417
++PN+ E +FP I + D++ L+ P R + E
Sbjct: 281 ---------IDPNH-EIEFPDI------------PEKDLQDVLKCCLKRDPKQRISIPEL 318
Query: 418 CAHPFFDDLRDPNTCLPNGRPLPTLFNFTAQELAGASNELRQRLIPEHARK 468
AHP+ P+ + T +E+ +L P K
Sbjct: 319 LAHPYVQ---------IQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSILK 360
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 9e-56
Identities = 74/314 (23%), Positives = 132/314 (42%), Gaps = 60/314 (19%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-RYKNRELQIMR-LLNHPNVVSLK 196
++E+++G GS G V + G VA+K++L D E++++ +HPNV+
Sbjct: 17 VVSEKILGYGSSGTVV-FQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYY 75
Query: 197 HCFFSTTEKDELYLNLVLEYISETVY-RVSKH--YTRMNQHVPILYVQLYTYQICRALNY 253
+E + +L + LE + + V + QI + +
Sbjct: 76 C-----SETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTH------------QLKICDFGSAKMLVPGE----PNI 297
LH + + HRD+KPQN+LV+ + ++ I DFG K L G+ N+
Sbjct: 131 LHSL-KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189
Query: 298 SYIC-SRYYRAPELIFGATE------YTTAIDMWSIGCVLAELL-LGQPLFPGESGVDQL 349
+ + +RAPEL+ + T +ID++S+GCV +L G+ F + +
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY--SRE 247
Query: 350 VEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPS 409
II+ F ++K + EA DL+S+++ + P
Sbjct: 248 SNIIRG-----------------IFSLDEMKCLHDRSL-----IAEATDLISQMIDHDPL 285
Query: 410 LRCTALEACAHPFF 423
R TA++ HP F
Sbjct: 286 KRPTAMKVLRHPLF 299
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 4e-55
Identities = 67/331 (20%), Positives = 113/331 (34%), Gaps = 58/331 (17%)
Query: 118 AGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVL----QD 173
G ++ + ++ Y+ + +G G F V + L G A+K++L QD
Sbjct: 20 QGHMV--IIDNKH--------YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQD 69
Query: 174 KRYKNRELQIMRLLNHPNVVSLKHCFF-STTEKDELYLNLVLEYISE-TVYRVSKHYTRM 231
+ RE + RL NHPN++ L K E + L+L + T++ +
Sbjct: 70 REEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW--LLLPFFKRGTLWNEIERLKDK 127
Query: 232 NQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291
+ + ICR L +H G HRD+KP N+L+ Q + D GS
Sbjct: 128 GNFLTEDQILWLLLGICRGLEAIHA-KGYAHRDLKPTNILLG-DEGQPVLMDLGSMNQAC 185
Query: 292 PG----------EPNISYICSRYYRAPELIFGA--TEYTTAIDMWSIGCVLAELLLGQPL 339
+ + C+ YRAPEL D+WS+GCVL ++ G+
Sbjct: 186 IHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP 245
Query: 340 FPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDL 399
+ V + + + PQ R L
Sbjct: 246 YDMVFQKGDSVALA-VQN---------------QLSIPQ----------SPRHSSALWQL 279
Query: 400 VSRLLQYSPSLRCTALEACAHPFFDDLRDPN 430
++ ++ P R + P
Sbjct: 280 LNSMMTVDPHQRPHIPLLLSQLEALQPPAPG 310
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 4e-55
Identities = 77/326 (23%), Positives = 131/326 (40%), Gaps = 56/326 (17%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVL------QDKRYKNRELQIMRLLNHPNV 192
Y ++G GSFG V + K T A+K + +D RE+++++ L+HPN+
Sbjct: 24 YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSK--HYTRMNQHVPILYVQLYTYQIC 248
+ L +D +V E + E + K ++ Q+
Sbjct: 84 MKLFEIL-----EDSSSFYIVGELYTGGELFDEIIKRKRFSEH-------DAARIIKQVF 131
Query: 249 RALNYLHHVVGVCHRDIKPQN-LLVNPHTH-QLKICDFGSAKMLVPGEPNISYICSRYYR 306
+ Y+H + HRD+KP+N LL + +KI DFG + I + YY
Sbjct: 132 SGITYMHKH-NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYI 190
Query: 307 APELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKC 366
APE++ G Y D+WS G +L LL G P F G++ + +I+ + ++
Sbjct: 191 APEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKN--EY--DIL--------KRVET 236
Query: 367 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426
+ W I +A DL+ ++L + PSLR TA + HP+
Sbjct: 237 GKYAFDL--------PQWRTI-----SDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283
Query: 427 RDPNTCLPNGRPLPTLF----NFTAQ 448
+ + L + F A+
Sbjct: 284 SSETPTISDLPSLESAMTNIRQFQAE 309
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 6e-55
Identities = 70/297 (23%), Positives = 117/297 (39%), Gaps = 45/297 (15%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV------LQDKRYKNRELQIMRLLNHPNV 192
Y +GTGS+G + + G + K++ +K+ E+ ++R L HPN+
Sbjct: 8 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 67
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
V ++ L +V+EY + V T+ Q++ +V Q+ AL
Sbjct: 68 VRYYDRII---DRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 252 NYLH----HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC-SRYYR 306
H V HRD+KP N+ ++ +K+ DFG A++L + YY
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLD-GKQNVKLGDFGLARILNHDTSFAKTFVGTPYYM 183
Query: 307 APELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKC 366
+PE + Y D+WS+GC+L EL P F S +L I+
Sbjct: 184 SPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFS-QKELAGKIR------------ 229
Query: 367 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
E KF +I R E ++++R+L R + E +P
Sbjct: 230 ------EGKFRRI---------PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 1e-54
Identities = 74/326 (22%), Positives = 129/326 (39%), Gaps = 56/326 (17%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVL------QDKRYKNRELQIMRLLNHPNV 192
Y + +G+G++G V + T AIK + E+ +++LL+HPN+
Sbjct: 39 YQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNI 98
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRV--SKHYTRMNQHVPILYVQLYTYQIC 248
+ L F +D+ LV+E E + + + + Q+
Sbjct: 99 MKLYDFF-----EDKRNYYLVMECYKGGELFDEIIHRMKFNEV-------DAAVIIKQVL 146
Query: 249 RALNYLHHVVGVCHRDIKPQN-LLVNPHTH-QLKICDFGSAKMLVPGEPNISYICSRYYR 306
+ YLH + HRD+KP+N LL + +KI DFG + + + + + YY
Sbjct: 147 SGVTYLHKH-NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYI 205
Query: 307 APELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKC 366
APE++ +Y D+WSIG +L LL G P F G++ DQ EI+ +++
Sbjct: 206 APEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQT--DQ--EIL--------RKVEK 251
Query: 367 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426
+ W + A DL+ ++LQ+ R +A +A HP+ ++
Sbjct: 252 GKYTFDS--------PEWKNV-----SEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM 298
Query: 427 RDPNTCLPNGRPLPTLF----NFTAQ 448
L F
Sbjct: 299 CSKKESGIELPSLANAIENMRKFQNS 324
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 2e-54
Identities = 80/298 (26%), Positives = 133/298 (44%), Gaps = 53/298 (17%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV----LQDKRYKN---RELQIMRLLNHPN 191
Y +RV+G GSFG V K TG A+K + ++ K K RE+Q+++ L+HPN
Sbjct: 28 YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 87
Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRV--SKHYTRMNQHVPILYVQLYTYQI 247
++ L F +D+ Y LV E + E + K ++ + Q+
Sbjct: 88 IMKLYEFF-----EDKGYFYLVGEVYTGGELFDEIISRKRFSEV-------DAARIIRQV 135
Query: 248 CRALNYLHHVVGVCHRDIKPQN-LLVNPHTH-QLKICDFGSAKMLVPGEPNISYICSRYY 305
+ Y+H + HRD+KP+N LL + ++I DFG + + I + YY
Sbjct: 136 LSGITYMHKN-KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYY 194
Query: 306 RAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIK 365
APE++ G Y D+WS G +L LL G P F G + + +I+ ++++
Sbjct: 195 IAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGAN--EY--DIL--------KKVE 240
Query: 366 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
+ W K+ A DL+ ++L Y PS+R +A +A H +
Sbjct: 241 KGKYTFEL--------PQWKKV-----SESAKDLIRKMLTYVPSMRISARDALDHEWI 285
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 4e-54
Identities = 83/306 (27%), Positives = 129/306 (42%), Gaps = 54/306 (17%)
Query: 131 GQPKQTIS--YMAERVVGTGSFGVVFQAKCLETGDSVAIK----KVLQDKRYKNRELQIM 184
G K I+ Y E +G GS+G V A T A K ++D +E++IM
Sbjct: 1 GSTKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIM 60
Query: 185 RLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRV--SKHYTRMNQHVPILYV 240
+ L+HPN++ L F +D + LV+E + E RV + +
Sbjct: 61 KSLDHPNIIRLYETF-----EDNTDIYLVMELCTGGELFERVVHKRVFRES-------DA 108
Query: 241 QLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTH--QLKICDFGSAKMLVPGEPNIS 298
+ A+ Y H + V HRD+KP+N L + LK+ DFG A PG+ +
Sbjct: 109 ARIMKDVLSAVAYCHK-LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM-MR 166
Query: 299 YIC-SRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILG 357
+ YY +P+++ G Y D WS G ++ LL G P F + + +++I +
Sbjct: 167 TKVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIRE--- 221
Query: 358 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEA 417
F FP W + P+A L+ RLL SP R T+L+A
Sbjct: 222 --------------GTFTFP---EKDWLNV-----SPQAESLIRRLLTKSPKQRITSLQA 259
Query: 418 CAHPFF 423
H +F
Sbjct: 260 LEHEWF 265
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 1e-53
Identities = 80/290 (27%), Positives = 128/290 (44%), Gaps = 44/290 (15%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVA---IKKVLQDKRYKNRELQIMRLLNHPNVVSL 195
YM +G G FG+V + + + +K D+ +E+ I+ + H N++ L
Sbjct: 7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHL 66
Query: 196 KHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
F + L ++ E+IS + R++ +N+ + YV Q+C AL +
Sbjct: 67 HESF-----ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVH----QVCEALQF 117
Query: 254 LHHVVGVCHRDIKPQNLL-VNPHTHQLKICDFGSAKMLVPGEPNISYIC-SRYYRAPELI 311
LH + H DI+P+N++ + +KI +FG A+ L PG+ + + Y APE +
Sbjct: 118 LHS-HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN-FRLLFTAPEYYAPE-V 174
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNY 371
+TA DMWS+G ++ LL G F E+ +Q +II E I +
Sbjct: 175 HQHDVVSTATDMWSLGTLVYVLLSGINPFLAET--NQ--QII--------ENIMNAEYTF 222
Query: 372 TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHP 421
E F +I EA+D V RLL R TA EA HP
Sbjct: 223 DEEAFKEIS-------------IEAMDFVDRLLVKERKSRMTASEALQHP 259
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 1e-53
Identities = 82/329 (24%), Positives = 133/329 (40%), Gaps = 65/329 (19%)
Query: 120 QVIATTVGGRNGQPKQTIS--YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYK 177
Q IA G + + I Y R +G+G++G V K AIK + + + K
Sbjct: 17 QGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDK 76
Query: 178 N-----------------RELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYIS-- 218
E+ +++ L+HPN++ L F +D+ Y LV E+
Sbjct: 77 GRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF-----EDKKYFYLVTEFYEGG 131
Query: 219 ETVYRVSK--HYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQN-LLVNPH 275
E ++ + QI + YLH + HRDIKP+N LL N +
Sbjct: 132 ELFEQIINRHKFDEC-------DAANIMKQILSGICYLHKH-NIVHRDIKPENILLENKN 183
Query: 276 TH-QLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELL 334
+ +KI DFG + + + YY APE++ +Y D+WS G ++ LL
Sbjct: 184 SLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILL 241
Query: 335 LGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPP 394
G P F G++ DQ +II ++++ + + W I
Sbjct: 242 CGYPPFGGQN--DQ--DII--------KKVEKGKYYFDF--------NDWKNI-----SD 276
Query: 395 EALDLVSRLLQYSPSLRCTALEACAHPFF 423
EA +L+ +L Y + RCTA EA +
Sbjct: 277 EAKELIKLMLTYDYNKRCTAEEALNSRWI 305
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 2e-53
Identities = 85/307 (27%), Positives = 131/307 (42%), Gaps = 44/307 (14%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIK----KVLQDKRYKNRELQIMRLLNHPNVVS 194
Y +G+G+FGVV + TG K DK E+ IM L+HP +++
Sbjct: 53 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLIN 112
Query: 195 LKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
L F +D+ + L+LE++S E R++ +M++ I Y++ Q C L
Sbjct: 113 LHDAF-----EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMR----QACEGLK 163
Query: 253 YLHHVVGVCHRDIKPQNLL-VNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELI 311
++H + H DIKP+N++ +KI DFG A L P E + + APE I
Sbjct: 164 HMHE-HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPE-I 221
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNY 371
DMW+IG + LL G F GE D E + + +K + +
Sbjct: 222 VDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED--DL--ETL--------QNVKRCDWEF 269
Query: 372 TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF-DDLRDPN 430
E F + PEA D + LLQ P R T +A HP+ D +
Sbjct: 270 DEDAFSSVS-------------PEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLT 316
Query: 431 TCLPNGR 437
+ +P+ R
Sbjct: 317 SRIPSSR 323
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 2e-53
Identities = 81/338 (23%), Positives = 131/338 (38%), Gaps = 84/338 (24%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVL---------QDKRYKNRELQIMRLLNH 189
Y + +G GS+GVV A +T AIK + +D E+++M+ L+H
Sbjct: 28 YHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHH 87
Query: 190 PNVVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQL----- 242
PN+ L + +DE Y+ LV+E + +++ + V+
Sbjct: 88 PNIARLYEVY-----EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPC 142
Query: 243 ------------------------------YTYQICRALNYLHHVVGVCHRDIKPQN-LL 271
QI AL+YLH+ G+CHRDIKP+N L
Sbjct: 143 PECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ-GICHRDIKPENFLF 201
Query: 272 VNPHTHQLKICDFGSAKMLVPGEPNISYIC-----SRYYRAPELIFGATE-YTTAIDMWS 325
+ ++K+ DFG +K Y + Y+ APE++ E Y D WS
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261
Query: 326 IGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWH 385
G +L LL+G FPG + D + +++ + F ++
Sbjct: 262 AGVLLHLLLMGAVPFPGVNDADTISQVLN-----------------KKLCFE---NPNYN 301
Query: 386 KIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
+ P A DL+S LL + R A+ A HP+
Sbjct: 302 VL-----SPLARDLLSNLLNRNVDERFDAMRALQHPWI 334
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 5e-53
Identities = 68/313 (21%), Positives = 112/313 (35%), Gaps = 61/313 (19%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNHPNVVSL 195
+ V+G G+FG V +A+ AIKK+ + + E+ ++ LNH VV
Sbjct: 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRY 67
Query: 196 KHCF--------FSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTY 245
+ T K + L + +EY + N +
Sbjct: 68 YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSE----NLNQQRDEYWRLFR 123
Query: 246 QICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSR-- 303
QI AL+Y+H G+ HRD+KP N+ ++ + +KI DFG AK + +
Sbjct: 124 QILEALSYIHSQ-GIIHRDLKPMNIFID-ESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 304 -------------YYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLV 350
Y A E++ G Y IDM+S+G + E++ P G V
Sbjct: 182 GSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGME----RV 235
Query: 351 EIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSL 410
I+K L + +FP P F ++ L+ + P+
Sbjct: 236 NILKKLRSV-------------SIEFP-----PD---FDDNKMKVEKKIIRLLIDHDPNK 274
Query: 411 RCTALEACAHPFF 423
R A +
Sbjct: 275 RPGARTLLNSGWL 287
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 7e-53
Identities = 72/317 (22%), Positives = 129/317 (40%), Gaps = 58/317 (18%)
Query: 124 TTVGGRNGQPKQTIS--YMAERVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKRY 176
+ G N + TI ++ +R +G+G+FG V + +G IK +
Sbjct: 7 HSSGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQ 66
Query: 177 KNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYIS--------ETVYRVSKHY 228
E+++++ L+HPN++ + F +D + +V+E + K
Sbjct: 67 IEAEIEVLKSLDHPNIIKIFEVF-----EDYHNMYIVMETCEGGELLERIVSAQARGKAL 121
Query: 229 TRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTH--QLKICDFGS 286
+ YV Q+ AL Y H V H+D+KP+N+L + +KI DFG
Sbjct: 122 SEG-------YVAELMKQMMNALAYFHSQ-HVVHKDLKPENILFQDTSPHSPIKIIDFGL 173
Query: 287 AKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGV 346
A++ E + + + Y APE+ + T D+WS G V+ LL G F G S +
Sbjct: 174 AELFKSDEHSTNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTGTS-L 230
Query: 347 DQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQY 406
+++ + Y E + + P+A+DL+ ++L
Sbjct: 231 EEVQQKAT----------------YKEPNYAV---ECRP------LTPQAVDLLKQMLTK 265
Query: 407 SPSLRCTALEACAHPFF 423
P R +A + H +F
Sbjct: 266 DPERRPSAAQVLHHEWF 282
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 8e-53
Identities = 75/312 (24%), Positives = 136/312 (43%), Gaps = 68/312 (21%)
Query: 131 GQPKQTIS-YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-------RELQ 182
+ I + ++G GSF V++A+ + TG VAIK + + YK E++
Sbjct: 4 TCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVK 63
Query: 183 IMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYV 240
I L HP+++ L + F + +Y LVLE E + +++
Sbjct: 64 IHCQLKHPSILELYNYFED---SNYVY--LVLEMCHNGEMNRYLKNRVKPFSENE----A 114
Query: 241 QLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG-SAKMLVPGE----- 294
+ + +QI + YLH G+ HRD+ NLL+ + +KI DFG + ++ +P E
Sbjct: 115 RHFMHQIITGMLYLHS-HGILHRDLTLSNLLLTRN-MNIKIADFGLATQLKMPHEKHYTL 172
Query: 295 ---PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVE 351
PN Y +PE+ + + D+WS+GC+ LL+G+P F ++ + L +
Sbjct: 173 CGTPN--------YISPEIATR-SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNK 223
Query: 352 IIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLR 411
++ +++ P + + EA DL+ +LL+ +P+ R
Sbjct: 224 VVLA-----------------DYEMP-----SF-------LSIEAKDLIHQLLRRNPADR 254
Query: 412 CTALEACAHPFF 423
+ HPF
Sbjct: 255 LSLSSVLDHPFM 266
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 9e-53
Identities = 59/295 (20%), Positives = 110/295 (37%), Gaps = 27/295 (9%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKRYKNRELQIMRLLNHPNVV 193
++ ++G G+ VF+ + +TGD AIK L+ + RE ++++ LNH N+V
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 194 SLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
L TT L ++E+ + + +P + + +
Sbjct: 71 KLFAIEEETT-TRHKVL--IMEFCPCGSLYTVLEEPSNA--YGLPESEFLIVLRDVVGGM 125
Query: 252 NYLHHVVGVCHRDIKPQNLLV---NPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAP 308
N+L G+ HR+IKP N++ K+ DFG+A+ L E +S + Y P
Sbjct: 126 NHLREN-GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHP 184
Query: 309 ELIFGAT-------EYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIK--ILGTP 359
++ A +Y +D+WSIG G F G + E++ I G P
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244
Query: 360 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTA 414
+ + P + + +++ +L+
Sbjct: 245 SGAISGVQKAENGPIDWSGDM--PVSCSLSRGLQVLLTPVLANILEADQEKCWGF 297
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 1e-52
Identities = 84/306 (27%), Positives = 138/306 (45%), Gaps = 56/306 (18%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------------RELQIMRL 186
Y+ + +G+G+ G V A +T VAI+ + + K E++I++
Sbjct: 137 YIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKK 196
Query: 187 LNHPNVVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYT 244
LNHP ++ +K+ F + ++ Y+ VLE + E +V + + + +LY
Sbjct: 197 LNHPCIIKIKNFF----DAEDYYI--VLELMEGGELFDKVVGN-----KRLKEATCKLYF 245
Query: 245 YQICRALNYLHHVVGVCHRDIKPQNLLVNPHTH--QLKICDFGSAKMLVPGEPNISYIC- 301
YQ+ A+ YLH G+ HRD+KP+N+L++ +KI DFG +K+L + +C
Sbjct: 246 YQMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRTLCG 303
Query: 302 SRYYRAPELIFGATE--YTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTP 359
+ Y APE++ Y A+D WS+G +L L G P F L + I G
Sbjct: 304 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT-SG-- 360
Query: 360 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419
++ F W ++ +ALDLV +LL P R T EA
Sbjct: 361 -------------KYNFI---PEVWAEV-----SEKALDLVKKLLVVDPKARFTTEEALR 399
Query: 420 HPFFDD 425
HP+ D
Sbjct: 400 HPWLQD 405
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 1e-52
Identities = 89/347 (25%), Positives = 144/347 (41%), Gaps = 64/347 (18%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIK----KVLQDKRYKN--------RELQIMRL 186
Y+ + +G+G+ G V A +T VAIK + + E++I++
Sbjct: 12 YIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKK 71
Query: 187 LNHPNVVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRV--SKHYTRMNQHVPILYVQL 242
LNHP ++ +K+ F + ++ Y+ VLE + E +V +K +L
Sbjct: 72 LNHPCIIKIKNFF----DAEDYYI--VLELMEGGELFDKVVGNKRLKEA-------TCKL 118
Query: 243 YTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTH--QLKICDFGSAKMLVPGEPNISYI 300
Y YQ+ A+ YLH G+ HRD+KP+N+L++ +KI DFG +K+L + +
Sbjct: 119 YFYQMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRTL 176
Query: 301 C-SRYYRAPELIFGATE--YTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILG 357
C + Y APE++ Y A+D WS+G +L L G P F L + I G
Sbjct: 177 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT-SG 235
Query: 358 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEA 417
++ F W ++ +ALDLV +LL P R T EA
Sbjct: 236 ---------------KYNFI---PEVWAEV-----SEKALDLVKKLLVVDPKARFTTEEA 272
Query: 418 CAHPFFDDLRDPNTCLPNGRPLPTLFNFTAQELAGASNELRQRLIPE 464
HP+ D + L + N + + R P
Sbjct: 273 LRHPWLQD----EDMKRKFQDLLSEENESTALPQVLAQPSTSRKRPR 315
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 2e-52
Identities = 81/307 (26%), Positives = 136/307 (44%), Gaps = 54/307 (17%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN----RELQIMRLLNHPNVVS 194
++ V+G+G+F VF K TG A+K + + +++ E+ +++ + H N+V+
Sbjct: 11 FIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVT 70
Query: 195 LKHCFFSTTEKDELYLNLVLEYIS--ETVYR-VSK-HYT-RMNQHVPILYVQLYTYQICR 249
L+ + YL V++ +S E R + + YT + V Q+
Sbjct: 71 LEDIY---ESTTHYYL--VMQLVSGGELFDRILERGVYTEKDASLV--------IQQVLS 117
Query: 250 ALNYLHHVVGVCHRDIKPQNLLV-NPHTH-QLKICDFGSAKMLVPGEPNISYIC-SRYYR 306
A+ YLH G+ HRD+KP+NLL P + ++ I DFG +KM G +S C + Y
Sbjct: 118 AVKYLHEN-GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI--MSTACGTPGYV 174
Query: 307 APELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKC 366
APE + Y+ A+D WSIG + LL G P F E+ +I +
Sbjct: 175 APE-VLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKE------------ 221
Query: 367 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426
++F + W I A D + LL+ P+ R T +A +HP+ D
Sbjct: 222 -----GYYEFE---SPFWDDI-----SESAKDFICHLLEKDPNERYTCEKALSHPWIDGN 268
Query: 427 RDPNTCL 433
+ +
Sbjct: 269 TALHRDI 275
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 3e-52
Identities = 76/290 (26%), Positives = 130/290 (44%), Gaps = 43/290 (14%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV----LQDKRYKNRELQIMRLLNHPNVVS 194
Y +GTG+FGVV + TG++ A K V DK +E+Q M +L HP +V+
Sbjct: 159 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 218
Query: 195 LKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
L F +D+ + ++ E++S E +V+ + +M++ + Y++ Q+C+ L
Sbjct: 219 LHDAF-----EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMR----QVCKGLC 269
Query: 253 YLHHVVGVCHRDIKPQNLL-VNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELI 311
++H H D+KP+N++ +++LK+ DFG L P + + + APE+
Sbjct: 270 HMHE-NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVA 328
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNY 371
G DMWS+G + LL G F GE+ + T +K + N
Sbjct: 329 EG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE------------TLRNVKSCDWNM 375
Query: 372 TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHP 421
+ F I + D + +LL P+ R T +A HP
Sbjct: 376 DDSAFSGIS-------------EDGKDFIRKLLLADPNTRMTIHQALEHP 412
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 4e-52
Identities = 74/297 (24%), Positives = 121/297 (40%), Gaps = 52/297 (17%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNV 192
Y ++G GSFG V + K T A+K + + RE+++++ L+HPN+
Sbjct: 24 YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSK--HYTRMNQHVPILYVQLYTYQIC 248
+ L +D +V E + E + K ++ Q+
Sbjct: 84 MKLFEIL-----EDSSSFYIVGELYTGGELFDEIIKRKRFSEH-------DAARIIKQVF 131
Query: 249 RALNYLHHVVGVCHRDIKPQNLLV--NPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR 306
+ Y+H + HRD+KP+N+L+ +KI DFG + I + YY
Sbjct: 132 SGITYMHKH-NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYI 190
Query: 307 APELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKC 366
APE++ G Y D+WS G +L LL G P F G++ D L +
Sbjct: 191 APEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVET------------ 236
Query: 367 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
++ F W I +A DL+ ++L + PSLR TA + HP+
Sbjct: 237 -----GKYAFD---LPQWRTI-----SDDAKDLIRKMLTFHPSLRITATQCLEHPWI 280
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 5e-52
Identities = 81/296 (27%), Positives = 128/296 (43%), Gaps = 64/296 (21%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKRYK--NRELQIMRLLNHPNVVSL 195
R +G G FG V+ A+ ++ +A+K ++ + RE++I L HPN++ L
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 196 KHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
F D + L+LEY TVYR + ++ ++ Y ++ AL+Y
Sbjct: 75 YGYF-----HDATRVYLILEYAPLGTVYRELQKLSKFDEQR----TATYITELANALSYC 125
Query: 255 HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP-------GEPNISYICSRYYRA 307
H V HRDIKP+NLL+ LKI DFG + G + Y
Sbjct: 126 HS-KRVIHRDIKPENLLLGSAGE-LKIADFGWSVHAPSSRRTDLCGTLD--------YLP 175
Query: 308 PELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367
PE+I G + +D+WS+G + E L+G+P F + + I ++
Sbjct: 176 PEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV------------ 222
Query: 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
EF FP + + A DL+SRLL+++PS R E HP+
Sbjct: 223 -----EFTFP-----DF-------VTEGARDLISRLLKHNPSQRPMLREVLEHPWI 261
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 6e-52
Identities = 81/308 (26%), Positives = 122/308 (39%), Gaps = 66/308 (21%)
Query: 133 PKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIK----KVLQDKRYKN---RELQIMR 185
P+ Y+ R +G G F F+ +T + A K +L + E+ I R
Sbjct: 11 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHR 70
Query: 186 LLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYT 244
L H +VV F D ++ +VLE ++ + K + + + Y
Sbjct: 71 SLAHQHVVGFHGFFED---NDFVF--VVLELCRRRSLLELHKRRKALTEPE----ARYYL 121
Query: 245 YQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG-SAKMLVPGE--------P 295
QI YLH V HRD+K NL +N ++KI DFG + K+ GE P
Sbjct: 122 RQIVLGCQYLHR-NRVIHRDLKLGNLFLNED-LEVKIGDFGLATKVEYDGERKKVLCGTP 179
Query: 296 NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKI 355
N Y APE++ ++ +D+WSIGC++ LL+G+P F L E
Sbjct: 180 N--------YIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSC----LKE---- 222
Query: 356 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTAL 415
T IK E+ P + P A L+ ++LQ P+ R T
Sbjct: 223 ----TYLRIKK-----NEYSIP-----KH-------INPVAASLIQKMLQTDPTARPTIN 261
Query: 416 EACAHPFF 423
E FF
Sbjct: 262 ELLNDEFF 269
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 8e-52
Identities = 85/336 (25%), Positives = 128/336 (38%), Gaps = 66/336 (19%)
Query: 133 PKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIK----KVLQDKRYKN---RELQIMR 185
P+ Y+ R +G G F F+ +T + A K +L + E+ I R
Sbjct: 37 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHR 96
Query: 186 LLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYT 244
L H +VV F D ++ +VLE ++ + K + + + Y
Sbjct: 97 SLAHQHVVGFHGFFED---NDFVF--VVLELCRRRSLLELHKRRKALTEPE----ARYYL 147
Query: 245 YQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG-SAKMLVPGE--------P 295
QI YLH V HRD+K NL +N ++KI DFG + K+ GE P
Sbjct: 148 RQIVLGCQYLHR-NRVIHRDLKLGNLFLNED-LEVKIGDFGLATKVEYDGERKKVLCGTP 205
Query: 296 NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKI 355
N Y APE++ ++ +D+WSIGC++ LL+G+P F L E
Sbjct: 206 N--------YIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSC----LKE---- 248
Query: 356 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTAL 415
T IK E+ P + P A L+ ++LQ P+ R T
Sbjct: 249 ----TYLRIKK-----NEYSIP-----KH-------INPVAASLIQKMLQTDPTARPTIN 287
Query: 416 EACAHPFFDDLRDPNTCLPNGRPLPTLFNFTAQELA 451
E FF P +P F+ L
Sbjct: 288 ELLNDEFFTSGYIPARLPITCLTIPPRFSIAPSSLD 323
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 8e-52
Identities = 57/295 (19%), Positives = 102/295 (34%), Gaps = 46/295 (15%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHC 198
+ ++G+G FG VF+AK G + IK+V + RE++ + L+H N+V C
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGC 72
Query: 199 FFSTTEKDELYLNLVLEYISETVYRV----------SKHYTRMNQHVPILYVQLYTYQIC 248
+ E ++ ++ R + + + QI
Sbjct: 73 WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQIT 132
Query: 249 RALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAP 308
+ ++Y+H + +RD+KP N+ + T Q+KI DFG L + Y +P
Sbjct: 133 KGVDYIHS-KKLINRDLKPSNIFLV-DTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSP 190
Query: 309 ELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368
E I +Y +D++++G +LAELL ++
Sbjct: 191 EQISS-QDYGKEVDLYALGLILAELL--HVCDTAFETSKFFTDLRDG------------- 234
Query: 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
I + L+ +LL P R E
Sbjct: 235 ------IISDI------------FDKKEKTLLQKLLSKKPEDRPNTSEILRTLTV 271
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 3e-51
Identities = 87/342 (25%), Positives = 139/342 (40%), Gaps = 52/342 (15%)
Query: 96 EKNVNHDDKDLEPSIVNGNGTEAGQVIATTVGGRNGQPKQTIS--YMAERVVGTGSFGVV 153
++ ++ + G +G + +S + E +G G+ +V
Sbjct: 10 GVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIV 69
Query: 154 FQAKCLETGDSVAIKKVLQDKRYKN--RELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211
++ K T A+K + + K E+ ++ L+HPN++ LK F + ++
Sbjct: 70 YRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIF-----ETPTEIS 124
Query: 212 LVLEYIS--ETVYR-VSK-HYT-RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIK 266
LVLE ++ E R V K +Y+ R QI A+ YLH G+ HRD+K
Sbjct: 125 LVLELVTGGELFDRIVEKGYYSERDAADA--------VKQILEAVAYLHEN-GIVHRDLK 175
Query: 267 PQNLL-VNPHTH-QLKICDFGSAKMLVPGEPNISYIC-SRYYRAPELIFGATEYTTAIDM 323
P+NLL P LKI DFG +K++ + +C + Y APE I Y +DM
Sbjct: 176 PENLLYATPAPDAPLKIADFGLSKIVEHQVL-MKTVCGTPGYCAPE-ILRGCAYGPEVDM 233
Query: 324 WSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHP 383
WS+G + LL G F E G + I C E+ F +
Sbjct: 234 WSVGIITYILLCGFEPFYDERGDQFMFRRIL----------NC------EYYFI---SPW 274
Query: 384 WHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDD 425
W ++ A DLV +L+ P R T +A HP+
Sbjct: 275 WDEV-----SLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTG 311
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 4e-51
Identities = 79/307 (25%), Positives = 127/307 (41%), Gaps = 50/307 (16%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIM-RLLNHPNVVSLKH 197
Y + +G GS+ V + T A+K + + KR E++I+ R HPN+++LK
Sbjct: 24 YEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKD 83
Query: 198 CFFSTTEKDELYLNLVLEYIS--ETVYRV--SKHYT-RMNQHVPILYVQLYTYQICRALN 252
+ D Y+ +V E + E + ++ K ++ R V + I + +
Sbjct: 84 VY-----DDGKYVYVVTELMKGGELLDKILRQKFFSEREASAV--------LFTITKTVE 130
Query: 253 YLHHVVGVCHRDIKPQNLLV---NPHTHQLKICDFGSAKMLVPGEPNISYIC-SRYYRAP 308
YLH GV HRD+KP N+L + + ++ICDFG AK L + C + + AP
Sbjct: 131 YLHA-QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAP 189
Query: 309 ELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKIL-GTPTREEIKCM 367
E + Y A D+WS+G +L +L G F + +I G
Sbjct: 190 E-VLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSG---------- 238
Query: 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF-DDL 426
+F W+ + A DLVS++L P R TA HP+
Sbjct: 239 -----KFSLS---GGYWNSV-----SDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWD 285
Query: 427 RDPNTCL 433
+ P L
Sbjct: 286 QLPQYQL 292
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 5e-51
Identities = 75/328 (22%), Positives = 130/328 (39%), Gaps = 47/328 (14%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIM-RLLNHPNVVSLKHCFF 200
++V+G G G V + TG A+K +L D +E+ + P++V + +
Sbjct: 34 KQVLGLGVNGKVLECFHRRTGQKCALK-LLYDSPKARQEVDHHWQASGGPHIVCILD-VY 91
Query: 201 STTEKDELYLNLVLEYIS------ETVYRVSKHYT-RMNQHVPILYVQLYTYQICRALNY 253
+ L +++E + R + +T R + I A+ +
Sbjct: 92 ENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEI--------MRDIGTAIQF 143
Query: 254 LHHVVGVCHRDIKPQNLL-VNPHTH-QLKICDFGSAKMLVPGEPNISYIC-SRYYRAPEL 310
LH + HRD+KP+NLL + LK+ DFG AK + C + YY APE
Sbjct: 144 LHS-HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQTPCYTPYYVAPE- 199
Query: 311 IFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPN 370
+ G +Y + DMWS+G ++ LL G P F +G + + +
Sbjct: 200 VLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRL------------ 247
Query: 371 YTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF-DDLRDP 429
++ FP W ++ +A L+ LL+ P+ R T + HP+ + P
Sbjct: 248 -GQYGFP---NPEWSEV-----SEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVP 298
Query: 430 NTCLPNGRPLPTLFNFTAQELAGASNEL 457
T L R L + + ++ L
Sbjct: 299 QTPLHTARVLQEDKDHWDEVKEEMTSAL 326
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 5e-51
Identities = 72/310 (23%), Positives = 119/310 (38%), Gaps = 58/310 (18%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIK----------KVLQDKRYKNRELQIMRLLN 188
Y +G+G F +V + + TG A K + + RE+ I+R +
Sbjct: 7 YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 66
Query: 189 HPNVVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRV--SKHYTRMNQHVPILYVQLYT 244
HPN+++L F +++ + L+LE +S E + + T +
Sbjct: 67 HPNIITLHDIF-----ENKTDVVLILELVSGGELFDFLAEKESLTEDE-------ATQFL 114
Query: 245 YQICRALNYLHHVVGVCHRDIKPQNLLV---NPHTHQLKICDFGSAKMLVPGEPNISYIC 301
QI ++YLH + H D+KP+N+++ N ++K+ DFG A + G I
Sbjct: 115 KQILDGVHYLHSK-RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE-FKNIF 172
Query: 302 -SRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPT 360
+ + APE I DMWSIG + LL G F GE+ + L I +
Sbjct: 173 GTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAV----- 226
Query: 361 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420
+ F + A D + RLL P R T ++ H
Sbjct: 227 ------------NYDFD---EEYFSNT-----SELAKDFIRRLLVKDPKRRMTIAQSLEH 266
Query: 421 PFFDDLRDPN 430
+ +R N
Sbjct: 267 SWIKAIRRRN 276
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 5e-51
Identities = 75/312 (24%), Positives = 139/312 (44%), Gaps = 44/312 (14%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYK-NRELQIMRLL-NHPNVVSLK 196
+ ++ +G GSF + + ++ + A+K + + +E+ ++L HPN+V L
Sbjct: 13 DLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLH 72
Query: 197 HCFFSTTEKDELYLNLVLEYIS--ETVYRV--SKHYT-RMNQHVPILYVQLYTYQICRAL 251
F D+L+ LV+E ++ E R+ KH++ ++ ++ A+
Sbjct: 73 EVF-----HDQLHTFLVMELLNGGELFERIKKKKHFSETEASYI--------MRKLVSAV 119
Query: 252 NYLHHVVGVCHRDIKPQNLL-VNPHTH-QLKICDFGSAKMLVPGEPNISYIC-SRYYRAP 308
+++H V GV HRD+KP+NLL + + + ++KI DFG A++ P + C + +Y AP
Sbjct: 120 SHMHDV-GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAP 178
Query: 309 ELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368
E + Y + D+WS+G +L +L GQ F ++I+ ++IK
Sbjct: 179 E-LLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIM-----KKIKKG- 231
Query: 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF-DDLR 427
+F F W + EA DL+ LL P+ R + + D +
Sbjct: 232 ----DFSFE---GEAWKNV-----SQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQ 279
Query: 428 DPNTCLPNGRPL 439
+ L L
Sbjct: 280 LSSNPLMTPDIL 291
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 1e-50
Identities = 80/324 (24%), Positives = 129/324 (39%), Gaps = 54/324 (16%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNV 192
Y +G G+F VV + + G A + K RE +I RLL HPN+
Sbjct: 13 YQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNI 72
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSK--HYT-RMNQHVPILYVQLYTYQI 247
V L +E + L+ + ++ E + +Y+ H QI
Sbjct: 73 VRLHDSI-----SEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHC--------IQQI 119
Query: 248 CRALNYLHHVVGVCHRDIKPQNLL-VNPHTH-QLKICDFGSAKMLVPGEPNISYIC-SRY 304
A+ + H + GV HR++KP+NLL + +K+ DFG A + + +
Sbjct: 120 LEAVLHCHQM-GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPG 178
Query: 305 YRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEI 364
Y +PE + Y +D+W+ G +L LL+G P F E +I
Sbjct: 179 YLSPE-VLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKA---------- 227
Query: 365 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFD 424
+ FP + W + PEA DL++++L +PS R TA EA HP+
Sbjct: 228 -------GAYDFP---SPEWDTV-----TPEAKDLINKMLTINPSKRITAAEALKHPWIS 272
Query: 425 DLRDPNTCLPNGRPLPTLFNFTAQ 448
+C+ + L F A+
Sbjct: 273 HRSTVASCMHRQETVDCLKKFNAR 296
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 1e-50
Identities = 79/322 (24%), Positives = 128/322 (39%), Gaps = 45/322 (13%)
Query: 112 NGNGTEAGQVIATTVGGRNGQPKQTIS-YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV 170
G R T++ + E+ +G G F V++A CL G VA+KKV
Sbjct: 6 QGMQGPPVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKV 65
Query: 171 -------LQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISE-TVY 222
+ + +E+ +++ LNHPNV+ F E +EL +VLE +
Sbjct: 66 QIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI---EDNELN--IVLELADAGDLS 120
Query: 223 RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKIC 282
R+ KH+ + + +P V Y Q+C AL ++H V HRDIKP N+ + T +K+
Sbjct: 121 RMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS-RRVMHRDIKPANVFITA-TGVVKLG 178
Query: 283 DFGSAKMLVPGEPNI-SYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFP 341
D G + S + + YY +PE I Y D+WS+GC+L E+ Q F
Sbjct: 179 DLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFY 237
Query: 342 GESG-VDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLV 400
G+ + L + I+ + +P + + E LV
Sbjct: 238 GDKMNLYSLCKKIE------------------QCDYPPLPS--------DHYSEELRQLV 271
Query: 401 SRLLQYSPSLRCTALEACAHPF 422
+ + P R
Sbjct: 272 NMCINPDPEKRPDVTYVYDVAK 293
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 1e-50
Identities = 73/325 (22%), Positives = 119/325 (36%), Gaps = 59/325 (18%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIK----------KVLQDKRYKNRELQIMRLLN 188
Y +G+G F +V + + TG A K + + RE+ I+R +
Sbjct: 14 YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 189 HPNVVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRV--SKHYTRMNQHVPILYVQLYT 244
H NV++L + ++ + L+LE +S E + + + +
Sbjct: 74 HHNVITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEE-------ATSFI 121
Query: 245 YQICRALNYLHHVVGVCHRDIKPQNLLV---NPHTHQLKICDFGSAKMLVPGEPNISYIC 301
QI +NYLH + H D+KP+N+++ N +K+ DFG A + G I
Sbjct: 122 KQILDGVNYLHTK-KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIF 179
Query: 302 -SRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPT 360
+ + APE I DMWSIG + LL G F G++ + L I +
Sbjct: 180 GTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV----- 233
Query: 361 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420
+ F + A D + +LL R T EA H
Sbjct: 234 ------------SYDFD---EEFFSHT-----SELAKDFIRKLLVKETRKRLTIQEALRH 273
Query: 421 PFFDDLRDPNTCLPNGRPLPTLFNF 445
P+ D + + L NF
Sbjct: 274 PWITP-VDNQQAMVRRESVVNLENF 297
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 1e-50
Identities = 77/316 (24%), Positives = 132/316 (41%), Gaps = 67/316 (21%)
Query: 125 TVGGRNGQPKQTIS-YMAERVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKRYK- 177
T + K TI + R +G G FG V+ A+ + +A+K ++ ++
Sbjct: 1 TALAEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ 60
Query: 178 -NRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHV 235
RE++I L HPN++ + + F + +Y L+LE+ +Y+ + + R ++
Sbjct: 61 LRREIEIQSHLRHPNILRMYNYFHD---RKRIY--LMLEFAPRGELYKELQKHGRFDEQR 115
Query: 236 PILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGE- 294
+++ ++ AL+Y H V HRDIKP+NLL+ LKI DFG + P
Sbjct: 116 SATFME----ELADALHYCHE-RKVIHRDIKPENLLMGYKGE-LKIADFGWSVH-APSLR 168
Query: 295 -------PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVD 347
+ Y PE+I G + +D+W G + E L+G P F S +
Sbjct: 169 RRTMCGTLD--------YLPPEMIEG-KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE 219
Query: 348 QLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYS 407
I+ + + KFP P+ + + DL+S+LL+Y
Sbjct: 220 THRRIVNV-----------------DLKFP-----PF-------LSDGSKDLISKLLRYH 250
Query: 408 PSLRCTALEACAHPFF 423
P R HP+
Sbjct: 251 PPQRLPLKGVMEHPWV 266
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 1e-50
Identities = 80/323 (24%), Positives = 131/323 (40%), Gaps = 45/323 (13%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIM-RLLNHPNVVSLKH 197
+ +V+G G G V Q T + A+K +LQD RE+++ R P++V +
Sbjct: 64 KVTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRI-V 121
Query: 198 CFFSTTEKDELYLNLVLEYIS------ETVYRVSKHYT-RMNQHVPILYVQLYTYQICRA 250
+ L +V+E + R + +T R + I A
Sbjct: 122 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI--------MKSIGEA 173
Query: 251 LNYLHHVVGVCHRDIKPQNLL-VNPHTH-QLKICDFGSAKMLVPGEPNISYICSRYYRAP 308
+ YLH + + HRD+KP+NLL + + LK+ DFG AK + + YY AP
Sbjct: 174 IQYLHSI-NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 232
Query: 309 ELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368
E + G +Y + DMWS+G ++ LL G P F G+ + I+
Sbjct: 233 E-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK--------TRIR--- 280
Query: 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF-DDLR 427
+++FP W ++ E L+ LL+ P+ R T E HP+ +
Sbjct: 281 --MGQYEFP---NPEWSEV-----SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 330
Query: 428 DPNTCLPNGRPLPTLFNFTAQEL 450
P T L R L +++
Sbjct: 331 VPQTPLHTSRVL-KEDKERWEDV 352
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 2e-50
Identities = 81/328 (24%), Positives = 121/328 (36%), Gaps = 56/328 (17%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---------RELQIMRLLNH 189
Y V+G G F VV + ETG A+K V K + RE I +L H
Sbjct: 26 YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 190 PNVVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILY----VQLY 243
P++V L + + L +V E++ + + + K +Y Y
Sbjct: 86 PHIVELLETY-----SSDGMLYMVFEFMDGADLCFEIVKR-----ADAGFVYSEAVASHY 135
Query: 244 TYQICRALNYLHHVVGVCHRDIKPQN-LLVNPH-THQLKICDFGSAKMLVPGEPNISYIC 301
QI AL Y H + HRD+KP LL + + +K+ FG A L
Sbjct: 136 MRQILEALRYCHDN-NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV 194
Query: 302 -SRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPT 360
+ ++ APE + Y +D+W G +L LL G F G ++L E I
Sbjct: 195 GTPHFMAPE-VVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK--ERLFEGIIK----- 246
Query: 361 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420
++K W I A DLV R+L P+ R T EA H
Sbjct: 247 -----------GKYKMN---PRQWSHI-----SESAKDLVRRMLMLDPAERITVYEALNH 287
Query: 421 PFFDDLRDPNTCLPNGRPLPTLFNFTAQ 448
P+ + + + L F A+
Sbjct: 288 PWLKERDRYAYKIHLPETVEQLRKFNAR 315
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 2e-50
Identities = 76/323 (23%), Positives = 126/323 (39%), Gaps = 53/323 (16%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNV 192
Y + +G G+F VV + TG A K + K RE +I R L HPN+
Sbjct: 31 YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI 90
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSK--HYT-RMNQHVPILYVQLYTYQI 247
V L ++E + LV + ++ E + Y+ H QI
Sbjct: 91 VRLHDSI-----QEESFHYLVFDLVTGGELFEDIVAREFYSEADASHC--------IQQI 137
Query: 248 CRALNYLHHVVGVCHRDIKPQNLLV--NPHTHQLKICDFGSAKMLVPGEPNISYICSRYY 305
++ Y H G+ HR++KP+NLL+ +K+ DFG A + E + + Y
Sbjct: 138 LESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGY 196
Query: 306 RAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIK 365
+PE + Y+ +D+W+ G +L LL+G P F E +I
Sbjct: 197 LSPE-VLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA----------- 244
Query: 366 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDD 425
+ +P + W + PEA L+ +L +P R TA +A P+ +
Sbjct: 245 ------GAYDYP---SPEWDTV-----TPEAKSLIDSMLTVNPKKRITADQALKVPWICN 290
Query: 426 LRDPNTCLPNGRPLPTLFNFTAQ 448
+ + + L F A+
Sbjct: 291 RERVASAIHRQDTVDCLKKFNAR 313
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 3e-50
Identities = 80/307 (26%), Positives = 133/307 (43%), Gaps = 43/307 (14%)
Query: 126 VGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIK----KVLQDKRYKNREL 181
V + G + ++G G FG V + + TG +A K + ++DK E+
Sbjct: 78 VTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEI 137
Query: 182 QIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILY 239
+M L+H N++ L F + + + LV+EY+ E R+ + + IL+
Sbjct: 138 SVMNQLDHANLIQLYDAF-----ESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILF 192
Query: 240 VQLYTYQICRALNYLHHVVGVCHRDIKPQNLL-VNPHTHQLKICDFGSAKMLVPGEPNIS 298
++ QIC + ++H + + H D+KP+N+L VN Q+KI DFG A+ P E
Sbjct: 193 MK----QICEGIRHMHQ-MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV 247
Query: 299 YICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGT 358
+ + APE + + DMWS+G + LL G F G++ D E +
Sbjct: 248 NFGTPEFLAPE-VVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDN--DA--ETL----- 297
Query: 359 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEAC 418
I + + +F I EA + +S+LL S R +A EA
Sbjct: 298 ---NNILACRWDLEDEEFQDIS-------------EEAKEFISKLLIKEKSWRISASEAL 341
Query: 419 AHPFFDD 425
HP+ D
Sbjct: 342 KHPWLSD 348
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 4e-50
Identities = 69/301 (22%), Positives = 117/301 (38%), Gaps = 58/301 (19%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIK----------KVLQDKRYKNRELQIMRLLN 188
Y +G+G F VV + + TG A K + + RE+ I++ +
Sbjct: 13 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 189 HPNVVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRV--SKHYTRMNQHVPILYVQLYT 244
HPNV++L + +++ + L+LE ++ E + + T +
Sbjct: 73 HPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEE-------ATEFL 120
Query: 245 YQICRALNYLHHVVGVCHRDIKPQNLLV---NPHTHQLKICDFGSAKMLVPGEPNISYIC 301
QI + YLH + + H D+KP+N+++ N ++KI DFG A + G I
Sbjct: 121 KQILNGVYYLHSL-QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIF 178
Query: 302 -SRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPT 360
+ + APE I DMWSIG + LL G F G++ + L + +
Sbjct: 179 GTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV----- 232
Query: 361 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420
++F + A D + RLL P R T ++ H
Sbjct: 233 ------------NYEFE---DEYFSNT-----SALAKDFIRRLLVKDPKKRMTIQDSLQH 272
Query: 421 P 421
P
Sbjct: 273 P 273
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 5e-50
Identities = 57/321 (17%), Positives = 124/321 (38%), Gaps = 52/321 (16%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKRYKN----------------REL 181
R + G F + + + A+K + + + + EL
Sbjct: 37 RTLNQGKFNKIILCE--KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNEL 94
Query: 182 QIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYIS-----ETVYRVSKHYTRMNQHVP 236
QI+ + + ++ + DE+Y+ + EY+ + +P
Sbjct: 95 QIITDIKNEYCLTC-EGIITN--YDEVYI--IYEYMENDSILKFDEYFFVLDKNYTCFIP 149
Query: 237 ILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPN 296
I ++ + + +Y+H+ +CHRD+KP N+L++ + +K+ DFG ++ +V +
Sbjct: 150 IQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGR-VKLSDFGESEYMVDKK-- 206
Query: 297 ISYIC-SRYYRAPELIFGATEY-TTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIK 354
I + + PE + Y +D+WS+G L + F + + +L I+
Sbjct: 207 IKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIR 266
Query: 355 ILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTA 414
+ I+ P F + + + E +D + L+ +P+ R T+
Sbjct: 267 ------TKNIEY--PLDRN-HFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITS 317
Query: 415 LEACAHPFF-----DDLRDPN 430
+A H + +DLR+ +
Sbjct: 318 EDALKHEWLADTNIEDLREFS 338
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 7e-50
Identities = 69/305 (22%), Positives = 120/305 (39%), Gaps = 47/305 (15%)
Query: 128 GRNGQPKQTIS-YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV------LQDKRYKNRE 180
G Q++ Y+ + +G GSFG K E G IK++ +++ RE
Sbjct: 14 GTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRRE 73
Query: 181 LQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILY 239
+ ++ + HPN+V + F E LY +V++Y +++ +
Sbjct: 74 VAVLANMKHPNIVQYRESFE---ENGSLY--IVMDYCEGGDLFKRINA--QKGVLFQEDQ 126
Query: 240 VQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISY 299
+ + QIC AL ++H + HRDIK QN+ + +++ DFG A++L
Sbjct: 127 ILDWFVQICLALKHVHD-RKILHRDIKSQNIFLTKD-GTVQLGDFGIARVLNSTVELARA 184
Query: 300 IC-SRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGT 358
+ YY +PE+ Y D+W++GCVL EL + F S + LV I
Sbjct: 185 CIGTPYYLSPEICEN-KPYNNKSDIWALGCVLYELCTLKHAFEAGS-MKNLVLKII---- 238
Query: 359 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEAC 418
++ +Y + LVS+L + +P R +
Sbjct: 239 --SGSFPPVSLHY---------------------SYDLRSLVSQLFKRNPRDRPSVNSIL 275
Query: 419 AHPFF 423
F
Sbjct: 276 EKGFI 280
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 9e-50
Identities = 75/306 (24%), Positives = 125/306 (40%), Gaps = 54/306 (17%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKV-LQDKRYKN---RELQIMRLLNHPNVVSLKHC 198
V+G G++G+V+ + L +AIK++ +D RY E+ + + L H N+V
Sbjct: 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQ---- 83
Query: 199 FFSTTEKDELYLNLVLEYIS----ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
+ + + ++ + +E + + R + + + + YT QI L YL
Sbjct: 84 -YLGSFSENGFIKIFMEQVPGGSLSALLR--SKWGPLKDNEQT--IGFYTKQILEGLKYL 138
Query: 255 HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI-SYICSRYYRAPELIFG 313
H + HRDIK N+L+N ++ LKI DFG++K L P ++ + Y APE+I
Sbjct: 139 HDN-QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDK 197
Query: 314 ATE-YTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYT 372
Y A D+WS+GC + E+ G+P F +L E +
Sbjct: 198 GPRGYGKAADIWSLGCTIIEMATGKPPFY------ELGEPQAAM---------------- 235
Query: 373 EFKFPQIKAHPWHKIFHKRMP----PEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRD 428
FK K HP +P EA + + + P R A + F
Sbjct: 236 -FKVGMFKVHP-------EIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSK 287
Query: 429 PNTCLP 434
P
Sbjct: 288 KKKTQP 293
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 1e-49
Identities = 74/299 (24%), Positives = 119/299 (39%), Gaps = 55/299 (18%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNV 192
Y + +G G+F VV + TG A K + K RE +I R L HPN+
Sbjct: 8 YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI 67
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYIS--ETVYR-VSK-HYT-RMNQHVPILYVQLYTYQI 247
V L ++E + LV + ++ E V++ Y+ H QI
Sbjct: 68 VRLHDSI-----QEESFHYLVFDLVTGGELFEDIVAREFYSEADASHC--------IQQI 114
Query: 248 CRALNYLHHVVGVCHRDIKPQNLLV--NPHTHQLKICDFGSAKMLVPGEPNISYIC-SRY 304
++ Y H G+ HR++KP+NLL+ +K+ DFG A + E +
Sbjct: 115 LESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA-WHGFAGTPG 172
Query: 305 YRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEI 364
Y +PE + Y+ +D+W+ G +L LL+G P F E +I
Sbjct: 173 YLSPE-VLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA---------- 221
Query: 365 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
+ +P + W + PEA L+ +L +P R TA +A P+
Sbjct: 222 -------GAYDYP---SPEWDTV-----TPEAKSLIDSMLTVNPKKRITADQALKVPWI 265
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 1e-49
Identities = 73/325 (22%), Positives = 121/325 (37%), Gaps = 59/325 (18%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIK----------KVLQDKRYKNRELQIMRLLN 188
Y +G+G F +V + + TG A K + + RE+ I+R +
Sbjct: 14 YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL 73
Query: 189 HPNVVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRV--SKHYTRMNQHVPILYVQLYT 244
HPN+++L + ++ + L+LE +S E + + + +
Sbjct: 74 HPNIITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEE-------ATSFI 121
Query: 245 YQICRALNYLHHVVGVCHRDIKPQNLLV---NPHTHQLKICDFGSAKMLVPGEPNISYIC 301
QI +NYLH + H D+KP+N+++ N +K+ DFG A + G I
Sbjct: 122 KQILDGVNYLHTK-KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIF 179
Query: 302 -SRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPT 360
+ + APE I DMWSIG + LL G F G++ + L I +
Sbjct: 180 GTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV----- 233
Query: 361 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420
+ F + + A D + +LL R T EA H
Sbjct: 234 ------------SYDFD---EEFFSQT-----SELAKDFIRKLLVKETRKRLTIQEALRH 273
Query: 421 PFFDDLRDPNTCLPNGRPLPTLFNF 445
P+ D + + L NF
Sbjct: 274 PWITP-VDTQQAMVRRESVVNLENF 297
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 2e-49
Identities = 82/317 (25%), Positives = 128/317 (40%), Gaps = 25/317 (7%)
Query: 127 GGRNGQPKQTI--SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----R 179
GGR+ + + +GTG FG V + +TG+ VAIK+ Q+ KN
Sbjct: 2 GGRSPSLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCL 61
Query: 180 ELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN-LVLEYIS--ETVYRVSKH--YTRMNQH 234
E+QIM+ LNHPNVVS + + L L +EY + +++ + +
Sbjct: 62 EIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEG 121
Query: 235 VPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQ--LKICDFGSAKMLVP 292
+ I AL YLH + HRD+KP+N+++ P + KI D G AK L
Sbjct: 122 PIRTLLS----DISSALRYLHE-NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ 176
Query: 293 GEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEI 352
GE ++ + Y APEL+ +YT +D WS G + E + G F Q
Sbjct: 177 GELCTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGK 235
Query: 353 IKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC 412
++ + E I + KF + P H + + +L + R
Sbjct: 236 VR---EKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAG--KLERWLQCMLMWHQRQRG 290
Query: 413 TALEACAHPFFDDLRDP 429
T + F L
Sbjct: 291 TDPQNPNVGCFQALDSI 307
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 2e-49
Identities = 67/318 (21%), Positives = 117/318 (36%), Gaps = 60/318 (18%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVL-----QDKRYKNRELQIMRLLNHPNVV 193
+ + +G G FGVVF+AK + AIK++ + RE++ + L HP +V
Sbjct: 7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66
Query: 194 SLKHCFF-------STTEKDELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTY 245
+ + ++YL + ++ E + +
Sbjct: 67 RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGR-CTIEERERSVCLHIFL 125
Query: 246 QICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSR-- 303
QI A+ +LH G+ HRD+KP N+ +K+ DFG + E + +
Sbjct: 126 QIAEAVEFLHS-KGLMHRDLKPSNIFFT-MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183
Query: 304 -----------YYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEI 352
Y +PE I G Y+ +D++S+G +L ELL P F + + +
Sbjct: 184 YARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELL--YP-FSTQMERVRTLTD 239
Query: 353 IKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC 412
++ KFP + + P +V +L SP R
Sbjct: 240 VR------------------NLKFPPL---------FTQKYPCEYVMVQDMLSPSPMERP 272
Query: 413 TALEACAHPFFDDLRDPN 430
A+ + F+DL P
Sbjct: 273 EAINIIENAVFEDLDFPG 290
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 168 bits (429), Expect = 1e-48
Identities = 71/328 (21%), Positives = 121/328 (36%), Gaps = 61/328 (18%)
Query: 140 MAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN--------RELQIMRLLNH-P 190
+ + +G G F VV Q TG A K + KR + E+ ++ L P
Sbjct: 32 LTSKELGRGKFAVVRQCISKSTGQEYAAKFL--KKRRRGQDCRAEILHEIAVLELAKSCP 89
Query: 191 NVVSLKHCFFSTTEKDELYLNLVLEYIS------ETVYRVSKHYTRMNQHVPILYVQLYT 244
V++L + ++ + L+LEY + + +++ + + V
Sbjct: 90 RVINLHEVY-----ENTSEIILILEYAAGGEIFSLCLPELAEMVSEND-------VIRLI 137
Query: 245 YQICRALNYLHHVVGVCHRDIKPQN-LLVNPH-THQLKICDFGSAKMLVPGEPNISYIC- 301
QI + YLH + H D+KPQN LL + + +KI DFG ++ + + I
Sbjct: 138 KQILEGVYYLHQN-NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE-LREIMG 195
Query: 302 SRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTR 361
+ Y APE I TTA DMW+IG + LL F GE + + I ++
Sbjct: 196 TPEYLAPE-ILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQV------ 248
Query: 362 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHP 421
+ + + A D + LL +P R TA +H
Sbjct: 249 -----------NVDYS---EETFSSV-----SQLATDFIQSLLVKNPEKRPTAEICLSHS 289
Query: 422 FFDDLRDPNTCLPNGRPLPTLF-NFTAQ 448
+ N P + + + +
Sbjct: 290 WLQQWDFENLFHPEETSSSSQTQDHSVR 317
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 3e-48
Identities = 76/312 (24%), Positives = 127/312 (40%), Gaps = 66/312 (21%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIK------------KVLQDKRYK-NRELQIMR 185
Y + ++G G VV + T A+K + +Q+ R +E+ I+R
Sbjct: 19 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 78
Query: 186 LLN-HPNVVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRV--SKHYT-RMNQHVPILY 239
++ HPN++ LK + + + LV + + E + + + + +
Sbjct: 79 KVSGHPNIIQLKDTY-----ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKI---- 129
Query: 240 VQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISY 299
+ + LH + + HRD+KP+N+L++ + +K+ DFG + L PGE +
Sbjct: 130 ----MRALLEVICALHKL-NIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDPGEK-LRE 182
Query: 300 IC-SRYYRAPELIFGATE-----YTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEII 353
+C + Y APE+I + Y +DMWS G ++ LL G P F + L I+
Sbjct: 183 VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM 242
Query: 354 KILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCT 413
++F + W DLVSR L P R T
Sbjct: 243 S-----------------GNYQFG---SPEWDDY-----SDTVKDLVSRFLVVQPQKRYT 277
Query: 414 ALEACAHPFFDD 425
A EA AHPFF
Sbjct: 278 AEEALAHPFFQQ 289
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 5e-48
Identities = 60/290 (20%), Positives = 116/290 (40%), Gaps = 42/290 (14%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLKH 197
+G GSF V++ ET VA ++ K K+ E ++++ L HPN+V
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 198 CFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH- 255
+ ST + + + LV E ++ T+ K + M V ++ + QI + L +LH
Sbjct: 93 SWESTVKGKK-CIVLVTELMTSGTLKTYLKRFKVMKIKV----LRSWCRQILKGLQFLHT 147
Query: 256 HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGAT 315
+ HRD+K N+ + T +KI D G A + + I + + APE+
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK-RASFAKAVIGTPEFMAPEMY--EE 204
Query: 316 EYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFK 375
+Y ++D+++ G + E+ + + Q+ ++
Sbjct: 205 KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI------------------------YR 240
Query: 376 FPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDD 425
P F K PE +++ ++ + R + + H FF +
Sbjct: 241 RVTSGVKP--ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 1e-47
Identities = 65/347 (18%), Positives = 124/347 (35%), Gaps = 52/347 (14%)
Query: 85 PKEMNEMRIRDEKNVNHDDKDLEPSIVNGNGTEAGQVIATTVGGRNGQPKQTIS-YMAER 143
+ + + + L P + G ++ + + + ++ + +
Sbjct: 9 QAHSLASLAKTWSSGSAKLQRLGPETED----NEGVLLTEKLKPVDYEYREEVHWMTHQP 64
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKV-LQDKRYKNRELQIMRLLNHPNVVSLKHCFFST 202
VG GSFG V + K +TG A+KKV L+ ++ EL L+ P +V L
Sbjct: 65 RVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV--FRVEELVACAGLSSPRIVPLYGA---- 118
Query: 203 TEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVC 261
++ ++N+ +E + ++ ++ K + + Y Q L YLH +
Sbjct: 119 -VREGPWVNIFMELLEGGSLGQLIKQMGCLPEDR----ALYYLGQALEGLEYLHTR-RIL 172
Query: 262 HRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSR------YYRAPELIFGAT 315
H D+K N+L++ + +CDFG A L P S + + APE++ G
Sbjct: 173 HGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG-K 231
Query: 316 EYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFK 375
+D+WS C++ +L G + ++I P
Sbjct: 232 PCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIAS-EPPPI--------------- 275
Query: 376 FPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPF 422
+I P + L+ P R +A+E
Sbjct: 276 -REIPPS---------CAPLTAQAIQEGLRKEPVHRASAMELRRKVG 312
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 6e-47
Identities = 80/388 (20%), Positives = 154/388 (39%), Gaps = 71/388 (18%)
Query: 66 STSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDKDLEPSIVNGNGTEAGQVIATT 125
A ++ + +RD+ + + + + + + +
Sbjct: 17 KERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQS 76
Query: 126 VGGRNGQPKQTIS------YMAERVVGTGSFGVVFQAKCLETGDSVAIK----------- 168
+G + P + Y + V+G G VV + TG A+K
Sbjct: 77 MGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSP 136
Query: 169 KVLQDKRYK-NRELQIMRLL-NHPNVVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRV 224
+ L++ R RE I+R + HP++++L + + ++ LV + + E +
Sbjct: 137 EQLEEVREATRRETHILRQVAGHPHIITLIDSY-----ESSSFMFLVFDLMRKGELFDYL 191
Query: 225 --SKHYT-RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKI 281
+ + + + + A+++LH + HRD+KP+N+L++ + Q+++
Sbjct: 192 TEKVALSEKETRSI--------MRSLLEAVSFLHAN-NIVHRDLKPENILLDDNM-QIRL 241
Query: 282 CDFGSAKMLVPGEPNISYIC-SRYYRAPELIFGATE-----YTTAIDMWSIGCVLAELLL 335
DFG + L PGE + +C + Y APE++ + + Y +D+W+ G +L LL
Sbjct: 242 SDFGFSCHLEPGEK-LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLA 300
Query: 336 GQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPE 395
G P F + L I++ +++F + W
Sbjct: 301 GSPPFWHRRQILMLRMIME-----------------GQYQFS---SPEWDDR-----SST 335
Query: 396 ALDLVSRLLQYSPSLRCTALEACAHPFF 423
DL+SRLLQ P R TA +A HPFF
Sbjct: 336 VKDLISRLLQVDPEARLTAEQALQHPFF 363
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 9e-47
Identities = 53/317 (16%), Positives = 97/317 (30%), Gaps = 80/317 (25%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV---LQDKRYKNRELQ----IMRLLNHPN 191
+ +G+G FG VF+ G AIK+ L + L+ L H +
Sbjct: 13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72
Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRA 250
VV + E D + + EY + ++ R+ + ++ Q+ R
Sbjct: 73 VVRYFSAWA---EDDHMLI--QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127
Query: 251 LNYLHHVVGVCHRDIKPQNLLVNPH------------------THQLKICDFGSAKMLVP 292
L Y+H + + H DIKP N+ ++ KI D G +
Sbjct: 128 LRYIHSM-SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI-- 184
Query: 293 GEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEI 352
P + A E++ + D++++ + +PL
Sbjct: 185 SSPQ-VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRN---------- 233
Query: 353 IKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPP-------EALDLVSRLLQ 405
WH+I R+P E +L+ ++
Sbjct: 234 ----------------------------GDQWHEIRQGRLPRIPQVLSQEFTELLKVMIH 265
Query: 406 YSPSLRCTALEACAHPF 422
P R +A+ H
Sbjct: 266 PDPERRPSAMALVKHSV 282
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 1e-46
Identities = 83/325 (25%), Positives = 129/325 (39%), Gaps = 55/325 (16%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIK----KVLQDKRYKNRELQIM-RLLNHPNVVSLK 196
E V+G G+ V L T A+K + + RE++++ + H NV+ L
Sbjct: 18 EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77
Query: 197 HCFFSTTEKDELYLNLVLEYIS--ETVYRVSK--HYT-RMNQHVPILYVQLYTYQICRAL 251
F ++E LV E + + + K H+ V + AL
Sbjct: 78 EFF-----EEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVV--------VQDVASAL 124
Query: 252 NYLHHVVGVCHRDIKPQNLL-VNP-HTHQLKICDFGSAKMLVPGE-------PNISYIC- 301
++LH+ G+ HRD+KP+N+L +P +KICDF + P + C
Sbjct: 125 DFLHNK-GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCG 183
Query: 302 SRYYRAPELI----FGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILG 357
S Y APE++ A+ Y D+WS+G +L LL G P F G G D + +
Sbjct: 184 SAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACP 243
Query: 358 TPTR---EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTA 414
E I+ +++FP W I A DL+S+LL R +A
Sbjct: 244 ACQNMLFESIQEG-----KYEFP---DKDWAHI-----SCAAKDLISKLLVRDAKQRLSA 290
Query: 415 LEACAHPFFDDLRDPNTCLPNGRPL 439
+ HP+ P LP L
Sbjct: 291 AQVLQHPWVQG-CAPENTLPTPMVL 314
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 2e-46
Identities = 54/350 (15%), Positives = 105/350 (30%), Gaps = 86/350 (24%)
Query: 123 ATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---- 178
V G+ +T + V+G +A ETG+S + +R +
Sbjct: 61 PFRVESELGERPRT--LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIK 118
Query: 179 ---RELQIMRLL-------------------------NHPNVVSLKHCFFSTTEKDELYL 210
E+ +RLL ++ ++ +L
Sbjct: 119 QMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFL 178
Query: 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNL 270
++ +T V ++ ++ + T Q+ R L LHH G+ H ++P ++
Sbjct: 179 YPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH-YGLVHTYLRPVDI 237
Query: 271 LVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELI----------FGATEYTTA 320
+++ + + F V + SR + PEL T T +
Sbjct: 238 VLDQRGG-VFLTGFEHL---VRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFS 293
Query: 321 IDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIK 380
D W++G V+ + ++ +
Sbjct: 294 FDAWALGLVIYWIWCADLPITKDAALG--------------------------------- 320
Query: 381 AHPWHKIFH--KRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRD 428
IF K +P L+ L+Y R L+A P ++ LR
Sbjct: 321 --GSEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRT 368
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 161 bits (408), Expect = 1e-45
Identities = 76/356 (21%), Positives = 127/356 (35%), Gaps = 72/356 (20%)
Query: 112 NGNGTEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVL 171
GQ + +G RV+ G F V++A+ + +G A+K++L
Sbjct: 13 RDQSDFVGQTV--ELGELR--------LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLL 62
Query: 172 ----QDKRYKNRELQIMR-LLNHPNVVSLKHCFFSTTE----KDELYLNLVLEYISETVY 222
+ R +E+ M+ L HPN+V E +L L+ E +
Sbjct: 63 SNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFL-LLTELCKGQLV 121
Query: 223 RVSKHYTRMNQHVPILYVQLYTYQICRALNYLH-HVVGVCHRDIKPQNLLVNPHTHQLKI 281
K + V YQ CRA+ ++H + HRD+K +NLL++ +K+
Sbjct: 122 EFLKK-MESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQ-GTIKL 179
Query: 282 CDFGSAKMLVPG-------------EPNISYICSRYYRAPELI--FGATEYTTAIDMWSI 326
CDFGSA + E I+ + YR PE+I + D+W++
Sbjct: 180 CDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWAL 239
Query: 327 GCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHK 386
GC+L L Q F + ++I+ N Y+ P
Sbjct: 240 GCILYLLCFRQHPFEDGA-------KLRIV-----------NGKYS---IPP-------- 270
Query: 387 IFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNTCLPNGRPLPTL 442
H L+ +LQ +P R + E ++ P P+ L
Sbjct: 271 --HDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ--EIAAARNVNPK-SPITEL 321
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 1e-44
Identities = 76/318 (23%), Positives = 125/318 (39%), Gaps = 56/318 (17%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKRYKN---RELQIMRLLNHP 190
Y+ ++G GS+G V + ET A+K K+ + + +E+Q++R L H
Sbjct: 7 YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHK 66
Query: 191 NVVSLKHCFFSTTEKDELYLNLVLEYIS----ETVYRVSKHYTRMNQHVPILYVQLYTYQ 246
NV+ L ++ ++ +Y +V+EY E + V + R Y Q
Sbjct: 67 NVIQLVDVLYNEEKQK-MY--MVMEYCVCGMQEMLDSVPEK--RFPVCQAHGYFC----Q 117
Query: 247 ICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPN--ISYIC-SR 303
+ L YLH G+ H+DIKP NLL+ LKI G A+ L P + S
Sbjct: 118 LIDGLEYLHS-QGIVHKDIKPGNLLLTTG-GTLKISALGVAEALHPFAADDTCRTSQGSP 175
Query: 304 YYRAPELIFGATEYT-TAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTRE 362
++ PE+ G ++ +D+WS G L + G F G++ + +L E I
Sbjct: 176 AFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN-IYKLFE--NIGK----- 227
Query: 363 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPF 422
+ P P DL+ +L+Y P+ R + + H +
Sbjct: 228 ---------GSYAIP-----GD-------CGPPLSDLLKGMLEYEPAKRFSIRQIRQHSW 266
Query: 423 FDDLRDPNTCLPNGRPLP 440
F P P P
Sbjct: 267 FRKKHPPAEAPVPIPPSP 284
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 3e-44
Identities = 74/323 (22%), Positives = 122/323 (37%), Gaps = 66/323 (20%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIM-RLLNHPNVVSLKH 197
+ +V+G G G V Q T + A+ K+LQD RE+++ R P++V +
Sbjct: 20 KVTSQVLGLGINGKVLQIFNKRTQEKFAL-KMLQDCPKARREVELHWRASQCPHIVRIVD 78
Query: 198 CFFSTTEKDELYLNLVLEYIS------ETVYRVSKHYT-RMNQHVPILYVQLYTYQICRA 250
+ L +V+E + R + +T R + I A
Sbjct: 79 -VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI--------MKSIGEA 129
Query: 251 LNYLHHVVGVCHRDIKPQNLL-VNPHTH-QLKICDFGSAKMLVPGEPNISYICSRYYRAP 308
+ YLH + + HRD+KP+NLL + + LK+ DFG A
Sbjct: 130 IQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFG--------------------FAK 168
Query: 309 ELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368
E +Y + DMWS+G ++ LL G P F G+ + I+
Sbjct: 169 ETT--GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK--------TRIR--- 215
Query: 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF-DDLR 427
+++FP W ++ E L+ LL+ P+ R T E HP+ +
Sbjct: 216 --MGQYEFP---NPEWSEV-----SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 265
Query: 428 DPNTCLPNGRPLPTLFNFTAQEL 450
P T L R L +++
Sbjct: 266 VPQTPLHTSRVLK-EDKERWEDV 287
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 3e-44
Identities = 72/320 (22%), Positives = 122/320 (38%), Gaps = 73/320 (22%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKRYKN--------------- 178
Y + +G GS+GVV A A+K K+++ +
Sbjct: 15 YTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCI 74
Query: 179 ----------RELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSK 226
+E+ I++ L+HPNVV L +D LY +V E ++ + +
Sbjct: 75 QPRGPIEQVYQEIAILKKLDHPNVVKL-VEVLDDPNEDHLY--MVFELVNQGPVMEVPTL 131
Query: 227 HYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286
+++ Y Q + + + YLH+ + HRDIKP NLLV +KI DFG
Sbjct: 132 --KPLSEDQARFYFQ----DLIKGIEYLHY-QKIIHRDIKPSNLLVG-EDGHIKIADFGV 183
Query: 287 AKMLVPGEPNISYIC-SRYYRAPELIFGAT-EYT-TAIDMWSIGCVLAELLLGQPLFPGE 343
+ + +S + + APE + ++ A+D+W++G L + GQ F E
Sbjct: 184 SNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE 243
Query: 344 SGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRL 403
+ L IK +FP + + DL++R+
Sbjct: 244 R-IMCLHSKIK----------------SQALEFPD----------QPDIAEDLKDLITRM 276
Query: 404 LQYSPSLRCTALEACAHPFF 423
L +P R E HP+
Sbjct: 277 LDKNPESRIVVPEIKLHPWV 296
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 5e-44
Identities = 83/306 (27%), Positives = 132/306 (43%), Gaps = 68/306 (22%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDK--RYKNRELQIMRLLNHPNVVSL 195
+++G GSF V A+ L T AIK ++++ Y RE +M L+HP V L
Sbjct: 36 KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 95
Query: 196 KHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
F +D+ L L Y E + + K ++ + YT +I AL Y
Sbjct: 96 YFTF-----QDDEKLYFGLSYAKNGELLKYIRK-IGSFDETC----TRFYTAEIVSALEY 145
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRY-------YR 306
LH G+ HRD+KP+N+L+N H ++I DFG+AK+L S Y
Sbjct: 146 LHG-KGIIHRDLKPENILLNEDMH-IQITDFGTAKVL----SPESKQARANSFVGTAQYV 199
Query: 307 APELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKC 366
+PEL+ + D+W++GC++ +L+ G P F + + + KI+
Sbjct: 200 SPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGN-EYLIFQ--KII---------- 245
Query: 367 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCT------ALEACAH 420
E+ FP ++ P+A DLV +LL + R AH
Sbjct: 246 ----KLEYDFP------------EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAH 289
Query: 421 PFFDDL 426
PFF+ +
Sbjct: 290 PFFESV 295
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 7e-44
Identities = 77/311 (24%), Positives = 125/311 (40%), Gaps = 47/311 (15%)
Query: 123 ATTVGGRNGQPKQTI-SYMAERVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKRY 176
T G + Y + +G+G+FGV + T + VA+K + +
Sbjct: 5 PVTTGPLDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ 64
Query: 177 KNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQH 234
RE+ R L HPN+V K + L +++EY S E R+ R ++
Sbjct: 65 --REIINHRSLRHPNIVRFKEVILT---PTHLA--IIMEYASGGELYERICNA-GRFSED 116
Query: 235 VPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTH-QLKICDFGSAKMLVPG 293
+ Q Q+ ++Y H + +CHRD+K +N L++ +LKICDFG +K V
Sbjct: 117 EARFFFQ----QLLSGVSYCHS-MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171
Query: 294 EPNISYICSRYYRAPELIFGATEYT-TAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEI 352
S + + Y APE++ EY D+WS G L +L+G F
Sbjct: 172 SQPKSTVGTPAYIAPEVLLR-QEYDGKIADVWSCGVTLYVMLVGAYPFEDPE-------- 222
Query: 353 IKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC 412
T + I + ++ P R+ PE L+SR+ P+ R
Sbjct: 223 EPRDYRKTIQRILSV-----KYSIPD----------DIRISPECCHLISRIFVADPATRI 267
Query: 413 TALEACAHPFF 423
+ E H +F
Sbjct: 268 SIPEIKTHSWF 278
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 8e-44
Identities = 77/296 (26%), Positives = 123/296 (41%), Gaps = 50/296 (16%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----RELQIMRLLNHPNVV 193
+ + +G G++G V A T ++VA+K V + +E+ I ++LNH NVV
Sbjct: 9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68
Query: 194 SLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
E + Y L LEY S E R+ M + + Q+ +
Sbjct: 69 KFYGHR---REGNIQY--LFLEYCSGGELFDRIEPD-IGMPEPDAQRFFH----QLMAGV 118
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPN--ISYIC-SRYYRAP 308
YLH +G+ HRDIKP+NLL++ LKI DFG A + ++ +C + Y AP
Sbjct: 119 VYLHG-IGITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 309 ELIFGATEYT-TAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367
EL+ E+ +D+WS G VL +L G+ P + D E ++
Sbjct: 177 ELLKR-REFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQEYSDWK----EKKTYLN 229
Query: 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
PW K + L L+ ++L +PS R T + ++
Sbjct: 230 ---------------PWKK-----IDSAPLALLHKILVENPSARITIPDIKKDRWY 265
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 5e-43
Identities = 83/342 (24%), Positives = 132/342 (38%), Gaps = 55/342 (16%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----RELQIMRLLNHPNVV 193
+ + +G G++G V A T ++VA+K V + +E+ I ++LNH NVV
Sbjct: 9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68
Query: 194 SLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
E + Y L LEY S E R+ M + + Q+ +
Sbjct: 69 KFYGHR---REGNIQY--LFLEYCSGGELFDRIEPD-IGMPEPDAQRFFH----QLMAGV 118
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPN--ISYIC-SRYYRAP 308
YLH +G+ HRDIKP+NLL++ LKI DFG A + ++ +C + Y AP
Sbjct: 119 VYLHG-IGITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 309 ELIFGATEYT-TAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367
EL+ E+ +D+WS G VL +L G+ P + D E ++
Sbjct: 177 ELLKR-REFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQEYSDWK----EKKTYLN 229
Query: 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF---- 423
PW K + L L+ ++L +PS R T + ++
Sbjct: 230 ---------------PWKK-----IDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 269
Query: 424 -DDLRDPNTCLPNGRPLPTLFNFTAQELAGASNELRQRLIPE 464
+ P P+ F+ Q S P
Sbjct: 270 KKGAKRPRVTSGGVSESPSGFSKHIQSNLDFSPVNSASRTPG 311
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 6e-43
Identities = 61/389 (15%), Positives = 117/389 (30%), Gaps = 90/389 (23%)
Query: 117 EAGQVIATTVGGRNGQPKQTISYMAER--------VVGTGSFGVVFQAKCLETGDSVAIK 168
A + +T GQP + S + ER V+G +A ETG+S +
Sbjct: 50 SAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVH 109
Query: 169 KVLQDKRYKN-------RELQIMRLL-------------------------NHPNVVSLK 196
+R + E+ +RLL ++ ++
Sbjct: 110 VPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVR 169
Query: 197 HCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH 256
+L ++ +T V ++ ++ + T Q+ R L LHH
Sbjct: 170 LDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH 229
Query: 257 VVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRY----YRAPELIF 312
G+ H ++P +++++ + + F G +S I + A ++
Sbjct: 230 -YGLVHTYLRPVDIVLDQRGG-VFLTGFEHLV--RDGASAVSPIGRGFAPPETTAERMLP 285
Query: 313 GA----TEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368
T T A D W++G + + ++ +
Sbjct: 286 FGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGS------------------- 326
Query: 369 PNYTEFKFPQIKAHPWHKIFH--KRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426
IF K +P L+ L+Y R L+A P ++ L
Sbjct: 327 ----------------EWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 370
Query: 427 RD-PNTCLPNGRPLPTLFNFTAQELAGAS 454
R + LP + +G S
Sbjct: 371 RTELSAALPLYQTDGEPTREGGAPPSGTS 399
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 3e-42
Identities = 74/296 (25%), Positives = 128/296 (43%), Gaps = 50/296 (16%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDK--RYKNRELQIMRLLNHPNVVSL 195
R +G GSFG V + +T A+K K ++ R +ELQIM+ L HP +V+L
Sbjct: 21 RAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNL 80
Query: 196 KHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
+ F +DE + +V++ + + Y + ++ + V+L+ ++ AL+Y
Sbjct: 81 WYSF-----QDEEDMFMVVDLLLGGDLRYHLQQN-VHFKEET----VKLFICELVMALDY 130
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIF- 312
L + + HRD+KP N+L++ H H + I DF A ML + ++ Y APE+
Sbjct: 131 LQNQ-RIIHRDMKPDNILLDEHGH-VHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSS 188
Query: 313 -GATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNY 371
Y+ A+D WS+G ELL G+ + S +
Sbjct: 189 RKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFE--------------T 234
Query: 372 TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEA-CAHPFFDDL 426
T +P E + L+ +LL+ +P R + L P+ +D+
Sbjct: 235 TVVTYPS------------AWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDI 278
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 2e-41
Identities = 72/362 (19%), Positives = 130/362 (35%), Gaps = 71/362 (19%)
Query: 100 NHDDKDLEPSIVNGNGTEAGQVIATTVGGRNGQPKQTIS--YMAERVVGTGSFGVVFQAK 157
+H +V A G+ K+ + Y ++G+G FG V+
Sbjct: 4 SHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGI 63
Query: 158 CLETGDSVAIK-----KVLQDKRYKN-----RELQIMRLLNH--PNVVSLKHCFFSTTEK 205
+ VAIK ++ N E+ +++ ++ V+ L +F
Sbjct: 64 RVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD-WFER--P 120
Query: 206 DELYLNLVLEYISETV----YRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVC 261
D L +LE + + + + + + Q+ A+ + H+ GV
Sbjct: 121 DSFVL--ILERPEPVQDLFDFITER--GALQEELARSFFW----QVLEAVRHCHNC-GVL 171
Query: 262 HRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC-SRYYRAPELIFGATEYT-T 319
HRDIK +N+L++ + +LK+ DFGS +L + +R Y PE I Y
Sbjct: 172 HRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVYSPPEWIRY-HRYHGR 228
Query: 320 AIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQI 379
+ +WS+G +L +++ G F + +I+ + F
Sbjct: 229 SAAVWSLGILLYDMVCGDIPFEHDE---------EIIR--------------GQVFFR-- 263
Query: 380 KAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPN-TCLPNGRP 438
+R+ E L+ L PS R T E HP+ D+ P T +
Sbjct: 264 ----------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHS 313
Query: 439 LP 440
L
Sbjct: 314 LS 315
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 2e-41
Identities = 68/312 (21%), Positives = 123/312 (39%), Gaps = 39/312 (12%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKV---LQDKRYKN--RELQIMRLLNHPNVVSLKHC 198
+G G+ GVVF+ +G +A K + ++ RELQ++ N P +V
Sbjct: 40 ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 99
Query: 199 FFSTTEKDELYLNLVLEYIS----ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
F+S E +++ +E++ + V + + +P + + + + L YL
Sbjct: 100 FYSDGE-----ISICMEHMDGGSLDQVLKKAGR-------IPEQILGKVSIAVIKGLTYL 147
Query: 255 HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGA 314
+ HRD+KP N+LVN ++K+CDFG + L+ N S++ +R Y +PE + G
Sbjct: 148 REKHKIMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQGT 205
Query: 315 TEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEF 374
Y+ D+WS+G L E+ +G+ P + + + E
Sbjct: 206 H-YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 264
Query: 375 KFPQIKAHPWHKIF---------------HKRMPPEALDLVSRLLQYSPSLRCTALEACA 419
+ + P IF E D V++ L +P+ R +
Sbjct: 265 NKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324
Query: 420 HPFFDDLRDPNT 431
H F
Sbjct: 325 HAFIKRSDAEEV 336
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 3e-41
Identities = 85/318 (26%), Positives = 137/318 (43%), Gaps = 57/318 (17%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN--------RELQIMRLLNHP 190
Y + +G G+F V A+ + TG VAIK + DK N RE++IM++LNHP
Sbjct: 17 YRLLKTIGKGNFAKVKLARHILTGREVAIKII--DKTQLNPTSLQKLFREVRIMKILNHP 74
Query: 191 NVVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQIC 248
N+V L TEK L L++EY S E + H RM + + QI
Sbjct: 75 NIVKLFEVI--ETEKT---LYLIMEYASGGEVFDYLVAH-GRMKEKEARSKFR----QIV 124
Query: 249 RALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC-SRYYRA 307
A+ Y H + HRD+K +NLL++ +KI DFG + G + C + Y A
Sbjct: 125 SAVQYCHQ-KRIVHRDLKAENLLLD-ADMNIKIADFGFSNEFTVGGK-LDAFCGAPPYAA 181
Query: 308 PELIFGATEYT-TAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKC 366
PEL G +Y +D+WS+G +L L+ G F G++ + +L E +
Sbjct: 182 PELFQG-KKYDGPEVDVWSLGVILYTLVSGSLPFDGQN-LKELRERVL------------ 227
Query: 367 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426
+++ P + M + +L+ R L +P R T + + +
Sbjct: 228 ----RGKYRIP-----FY-------MSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAG 271
Query: 427 RDPNTCLPNGRPLPTLFN 444
+ + P P + +
Sbjct: 272 HEEDELKPFVEPELDISD 289
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 3e-41
Identities = 84/307 (27%), Positives = 130/307 (42%), Gaps = 52/307 (16%)
Query: 127 GGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-------R 179
G ++ + Y+ +G G+FG V + TG VA+K + + K R
Sbjct: 1 GSKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKR 60
Query: 180 ELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPI 237
E+Q ++L HP+++ L + + + +V+EY+S E + KH R+ +
Sbjct: 61 EIQNLKLFRHPHIIKLYQVIST---PTDFF--MVMEYVSGGELFDYICKH-GRVEEMEAR 114
Query: 238 LYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI 297
Q QI A++Y H V HRD+KP+N+L++ H KI DFG + M+ GE +
Sbjct: 115 RLFQ----QILSAVDYCHR-HMVVHRDLKPENVLLDAH-MNAKIADFGLSNMMSDGEF-L 167
Query: 298 SYIC-SRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKIL 356
C S Y APE+I G +D+WS G +L LL G F E V L + KI
Sbjct: 168 RTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH-VPTLFK--KIR 224
Query: 357 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALE 416
G F P + + L+ +LQ P R T +
Sbjct: 225 G--------------GVFYIP-----EY-------LNRSVATLLMHMLQVDPLKRATIKD 258
Query: 417 ACAHPFF 423
H +F
Sbjct: 259 IREHEWF 265
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 8e-41
Identities = 73/309 (23%), Positives = 129/309 (41%), Gaps = 59/309 (19%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDK--RYKNRELQIMRLLNHPNVVSL 195
+V+G G+FG V K A+K ++L+ E ++ + + +L
Sbjct: 80 KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTL 139
Query: 196 KHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
+ F +D+ L LV++Y + + +SK R+ + + + Y ++ A++
Sbjct: 140 HYAF-----QDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEM----ARFYLAEMVIAIDS 190
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISY-ICSRY-YRAPELI 311
+H + HRDIKP N+L++ + H +++ DFGS L+ S Y +PE++
Sbjct: 191 VHQ-LHYVHRDIKPDNILMDMNGH-IRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEIL 248
Query: 312 ----FGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367
G Y D WS+G + E+L G+ F ES + + KI+ R
Sbjct: 249 QAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES-LVETYG--KIMNHKER------ 299
Query: 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCT---ALEACAHPFF- 423
F+FP + A DL+ RL+ S R + HPFF
Sbjct: 300 ------FQFPT---------QVTDVSENAKDLIRRLIC-SREHRLGQNGIEDFKKHPFFS 343
Query: 424 ----DDLRD 428
D++R+
Sbjct: 344 GIDWDNIRN 352
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 2e-40
Identities = 79/317 (24%), Positives = 123/317 (38%), Gaps = 73/317 (23%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKK-----VLQDKR--YKNRELQIMRLLNHPNVVSL 195
+V+G G+F V K +TG A+K +L+ E ++ + + L
Sbjct: 67 KVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQL 126
Query: 196 KHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
F +DE YL LV+EY + + +SK R+ + + Y +I A++
Sbjct: 127 HFAF-----QDENYLYLVMEYYVGGDLLTLLSKFGERIPAEM----ARFYLAEIVMAIDS 177
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS--------YICSRYY 305
+H + G HRDIKP N+L++ H +++ DFGS L S Y+
Sbjct: 178 VHRL-GYVHRDIKPDNILLDRCGH-IRLADFGSCLKLRADGTVRSLVAVGTPDYL----- 230
Query: 306 RAPELI------FGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTP 359
+PE++ G Y D W++G E+ GQ F +S + KI+
Sbjct: 231 -SPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS-TAETYG--KIVHYK 286
Query: 360 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLR---CTALE 416
P + +P EA D + RLL P R A +
Sbjct: 287 EH------------LSLPL---------VDEGVPEEARDFIQRLLC-PPETRLGRGGAGD 324
Query: 417 ACAHPFF-----DDLRD 428
HPFF D LRD
Sbjct: 325 FRTHPFFFGLDWDGLRD 341
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 2e-40
Identities = 69/358 (19%), Positives = 125/358 (34%), Gaps = 103/358 (28%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----RELQIMRLLNHPNVV 193
+ + +G G FGVVF+AK + AIK++ R RE++ + L HP +V
Sbjct: 8 FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 67
Query: 194 SLKHCFF------------------------STTEKDELYLNLVLEYISETVYRVSKHYT 229
+ + ++ ++ + + + +
Sbjct: 68 RYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQL 127
Query: 230 RMNQHVPILYVQL----------------------------YTYQICRALNYLHHVVGVC 261
+ + LY+Q+ QI A+ +LH G+
Sbjct: 128 QPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK-GLM 186
Query: 262 HRDIKPQNLLVNPHTHQLKICDFGSAKML-------------VPGEPNISYICSRYYRAP 308
HRD+KP N+ +K+ DFG + + + ++ Y +P
Sbjct: 187 HRDLKPSNIFFTMD-DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSP 245
Query: 309 ELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368
E I G Y+ +D++S+G +L ELL + V II + R
Sbjct: 246 EQIHG-NNYSHKVDIFSLGLILFELL--YSFSTQ----MERVRIITDV----RNL----- 289
Query: 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426
KFP +F ++ P E +V +L SP+ R A + + F++L
Sbjct: 290 ------KFP--------LLFTQKYPQEH-MMVQDMLSPSPTERPEATDIIENAIFENL 332
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 2e-40
Identities = 71/305 (23%), Positives = 111/305 (36%), Gaps = 70/305 (22%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKRYKN-----RELQIMRLLN 188
Y ++G G FG VF L VAIK +VL + E+ ++ +
Sbjct: 33 YRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVG 92
Query: 189 ----HPNVVSLKHCFFSTTEKDELYLNLVLEYISETV----YRVSKHYTRMNQHVPILYV 240
HP V+ L +F T ++ L VLE Y K + + +
Sbjct: 93 AGGGHPGVIRL-LDWFET--QEGFML--VLERPLPAQDLFDYITEK--GPLGEGPSRCFF 145
Query: 241 QLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYI 300
Q+ A+ + H GV HRDIK +N+L++ K+ DFGS +L +
Sbjct: 146 G----QVVAAIQHCHSR-GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE--PYTDF 198
Query: 301 C-SRYYRAPELIFGATEYT-TAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGT 358
+R Y PE I +Y +WS+G +L +++ G F + +IL
Sbjct: 199 DGTRVYSPPEWISR-HQYHALPATVWSLGILLYDMVCGDIPFERDQ---------EILE- 247
Query: 359 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEAC 418
E FP + P+ L+ R L PS R + E
Sbjct: 248 -------------AELHFP------------AHVSPDCCALIRRCLAPKPSSRPSLEEIL 282
Query: 419 AHPFF 423
P+
Sbjct: 283 LDPWM 287
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 2e-40
Identities = 74/304 (24%), Positives = 123/304 (40%), Gaps = 59/304 (19%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR--------ELQIMRLLNHPNVVS 194
RV+G G FG VF + TG A K L KR K R E +I+ ++ +VS
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACK-KLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVS 249
Query: 195 LKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPIL---YVQLYTYQICR 249
L + F + K +L L V+ ++ + Y H +++ P YT QI
Sbjct: 250 LAYAFET---KTDLCL--VMTIMNGGDIRY----HIYNVDEDNPGFQEPRAIFYTAQIVS 300
Query: 250 ALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC-SRYYRAP 308
L +LH + +RD+KP+N+L++ + ++I D G A L G+ + + AP
Sbjct: 301 GLEHLHQR-NIIYRDLKPENVLLDDDGN-VRISDLGLAVELKAGQTKTKGYAGTPGFMAP 358
Query: 309 ELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEII-KILGTPTREEIKCM 367
EL+ G EY ++D +++G L E++ + F + E+ ++L
Sbjct: 359 ELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVT------ 411
Query: 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLR-----CTALEACAHPF 422
+ + P + D LLQ P R + HP
Sbjct: 412 --------------------YPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPL 451
Query: 423 FDDL 426
F D+
Sbjct: 452 FRDI 455
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 3e-40
Identities = 87/368 (23%), Positives = 155/368 (42%), Gaps = 59/368 (16%)
Query: 77 ERSGFDQLPKEMNEM--RIRDEKNVNHDDKDLEPSIVNGNGTEAGQVIATTVGGRNGQPK 134
ER+ + P+E E I+ + E +G+ ++ V + +
Sbjct: 85 ERTFHVETPEEREEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHR 144
Query: 135 QTIS-YMAERVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKRYKN--RELQIMRL 186
T++ + +++G G+FG V K TG A+K ++ + E ++++
Sbjct: 145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 204
Query: 187 LNHPNVVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYT 244
HP + +LK+ F + D L V+EY + E + +S+ + + Y
Sbjct: 205 SRHPFLTALKYSFQT---HDRLCF--VMEYANGGELFFHLSRE-----RVFSEDRARFYG 254
Query: 245 YQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC-SR 303
+I AL+YLH V +RD+K +NL+++ H +KI DFG K + + C +
Sbjct: 255 AEIVSALDYLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKTFCGTP 313
Query: 304 YYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREE 363
Y APE++ +Y A+D W +G V+ E++ G+ F + ++L E+I
Sbjct: 314 EYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-HEKLFELIL--------- 362
Query: 364 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLR-----CTALEAC 418
E +FP + + PEA L+S LL+ P R A E
Sbjct: 363 -------MEEIRFP------------RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIM 403
Query: 419 AHPFFDDL 426
H FF +
Sbjct: 404 QHRFFAGI 411
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 9e-40
Identities = 83/405 (20%), Positives = 152/405 (37%), Gaps = 65/405 (16%)
Query: 41 EANLVERSASSLEQHMASTSLEPVASTSEAATVARTERSGFDQLPKEMNEMRIRDEKNVN 100
E + S + ++ L S++A Q+P ++ + I +
Sbjct: 98 EEERLVCSREIFDTYIMKELLACSHPFSKSAIEHVQGHLVKKQVPPDLFQPYIEEICQ-- 155
Query: 101 HDDKDLEPSIVNGNGTEAGQVIATTVGGRNGQPKQTIS-YMAERVVGTGSFGVVFQAKCL 159
+L + T++ + R++G G FG V+ +
Sbjct: 156 ----NLRGDVFQKFIESDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKA 211
Query: 160 ETGDSVAIKKVLQDKRYKNRE-----------LQIMRLLNHPNVVSLKHCFFSTTEKDEL 208
+TG A+K L KR K ++ L ++ + P +V + + F + D+L
Sbjct: 212 DTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT---PDKL 267
Query: 209 YLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIK 266
+L+ ++ + Y +S+H ++ Y +I L ++H+ V +RD+K
Sbjct: 268 SF--ILDLMNGGDLHYHLSQH-----GVFSEADMRFYAAEIILGLEHMHNR-FVVYRDLK 319
Query: 267 PQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSI 326
P N+L++ H H ++I D G A +P+ + + + Y APE++ Y ++ D +S+
Sbjct: 320 PANILLDEHGH-VRISDLGLACDFSKKKPH-ASVGTHGYMAPEVLQKGVAYDSSADWFSL 377
Query: 327 GCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHK 386
GC+L +LL G F D+ L + P
Sbjct: 378 GCMLFKLLRGHSPFRQHKTKDKHEIDRMTL--------------TMAVELPD-------- 415
Query: 387 IFHKRMPPEALDLVSRLLQYSPSLR--CT---ALEACAHPFFDDL 426
PE L+ LLQ + R C A E PFF L
Sbjct: 416 ----SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 456
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 1e-39
Identities = 89/300 (29%), Positives = 131/300 (43%), Gaps = 54/300 (18%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR--------ELQIMRLLNHPNVVS 194
RV+G G FG V + TG A K L+ KR K R E QI+ +N VVS
Sbjct: 190 RVLGKGGFGEVCACQVRATGKMYACK-KLEKKRIKKRKGEAMALNEKQILEKVNSRFVVS 248
Query: 195 LKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHV-PILYVQLYTYQICRAL 251
L + + + KD L L VL ++ + + H M Q P Y +IC L
Sbjct: 249 LAYAYET---KDALCL--VLTLMNGGDLKF----HIYHMGQAGFPEARAVFYAAEICCGL 299
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELI 311
LH + +RD+KP+N+L++ H H ++I D G A + G+ + + Y APE++
Sbjct: 300 EDLHRE-RIVYRDLKPENILLDDHGH-IRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVV 357
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNY 371
YT + D W++GC+L E++ GQ F REE+
Sbjct: 358 KN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRK------------KKIKREEV------- 397
Query: 372 TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLR--CT---ALEACAHPFFDDL 426
+K P + + +R P+A L S+LL P+ R C A E HP F L
Sbjct: 398 ----ERLVKEVP--EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKL 451
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 1e-39
Identities = 36/315 (11%), Positives = 92/315 (29%), Gaps = 64/315 (20%)
Query: 138 SYMAERVVGTGSFGVVFQAKCLETGDS-----VAIK----KVLQDKRYKNRELQIMRLLN 188
++G G+F V++A + D+ +K + + ++ ++
Sbjct: 66 LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSM 125
Query: 189 HPNVVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQ 246
+ ++ L V E S + ++ + + +P V + +
Sbjct: 126 QHMFMKFYSAHLF---QNGSVL--VGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMR 180
Query: 247 ICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQ----------LKICDFGSA---KMLVPG 293
+ + +H + H DIKP N ++ + L + D G + K+ G
Sbjct: 181 MLYMIEQVHDC-EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKG 239
Query: 294 EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEII 353
+ + ++ E++ + ID + + + +L G + G
Sbjct: 240 TIFTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCMLFGTYMKVKNEG-------- 290
Query: 354 KILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCT 413
+ + + W++ FH +L
Sbjct: 291 ------GECKPEGLFRRL-------PHLDMWNEFFHV------------MLNIPDCHHLP 325
Query: 414 ALEACAHPFFDDLRD 428
+L+ +
Sbjct: 326 SLDLLRQKLKKVFQQ 340
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 1e-39
Identities = 77/295 (26%), Positives = 126/295 (42%), Gaps = 53/295 (17%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKRYKN--RELQIMRLLNHPN 191
Y+ +G GSFG V A +T VA+K + + + RE+ ++LL HP+
Sbjct: 11 YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPH 70
Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYISETV--YRVSKHYTRMNQHVPILYVQLYTYQICR 249
++ L + ++ +V+EY + Y V K RM + + Q QI
Sbjct: 71 IIKLYDVITT---PTDIV--MVIEYAGGELFDYIVEKK--RMTEDEGRRFFQ----QIIC 119
Query: 250 ALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC-SRYYRAP 308
A+ Y H + HRD+KP+NLL++ + +KI DFG + ++ G + C S Y AP
Sbjct: 120 AIEYCHR-HKIVHRDLKPENLLLDDN-LNVKIADFGLSNIMTDGNF-LKTSCGSPNYAAP 176
Query: 309 ELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368
E+I G +D+WS G VL +L+G+ F E + L + +
Sbjct: 177 EVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEF-IPNLFKKVN-------------- 221
Query: 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
+ P + + P A L+ R++ P R T E P+F
Sbjct: 222 --SCVYVMP-----DF-------LSPGAQSLIRRMIVADPMQRITIQEIRRDPWF 262
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 4e-39
Identities = 69/303 (22%), Positives = 117/303 (38%), Gaps = 68/303 (22%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKRYKN-------RELQIMRL 186
Y +G+G+FG V+ A E V +K KVL+D ++ E+ I+
Sbjct: 26 YSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSR 85
Query: 187 LNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETV----YRVSKHYTRMNQHVPILYVQL 242
+ H N++ + F + LV+E + + R+++ + +
Sbjct: 86 VEHANIIKVLD-IFEN--QGFFQ--LVMEKHGSGLDLFAFIDRH--PRLDEPLASYIFR- 137
Query: 243 YTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC- 301
Q+ A+ YL + HRDIK +N+++ +K+ DFGSA L G+ C
Sbjct: 138 ---QLVSAVGYLRL-KDIIHRDIKDENIVIAED-FTIKLIDFGSAAYLERGKL-FYTFCG 191
Query: 302 SRYYRAPELIFGATEYT-TAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPT 360
+ Y APE++ G Y ++MWS+G L L+ + F +L E ++
Sbjct: 192 TIEYCAPEVLMG-NPYRGPELEMWSLGVTLYTLVFEENPF------CELEETVE------ 238
Query: 361 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420
P + E + LVS LLQ P R T +
Sbjct: 239 -----------AAIHPP-----YL-------VSKELMSLVSGLLQPVPERRTTLEKLVTD 275
Query: 421 PFF 423
P+
Sbjct: 276 PWV 278
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 5e-39
Identities = 71/298 (23%), Positives = 125/298 (41%), Gaps = 43/298 (14%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKV---LQDKRYKN--RELQI-MRLLNHPNVVSLKH 197
+G G++GVV + + + +G +A+K++ + + K +L I MR ++ P V+
Sbjct: 14 ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 73
Query: 198 CFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV 257
F + + + +E + ++ + K Q +P + I +AL +LH
Sbjct: 74 ALFREGD-----VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK 128
Query: 258 VGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFG---A 314
+ V HRD+KP N+L+N Q+K+CDFG + LV + Y APE I
Sbjct: 129 LSVIHRDVKPSNVLIN-ALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQ 187
Query: 315 TEYTTAIDMWSIGCVLAELLLGQPLFPGESGV-DQLVEIIKILGTPTREEIKCMNPNYTE 373
Y+ D+WS+G + EL + + + QL ++++
Sbjct: 188 KGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVE--EPS-------------- 231
Query: 374 FKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNT 431
PQ+ A + E +D S+ L+ + R T E HPFF T
Sbjct: 232 ---PQLPADKF--------SAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHESKGT 278
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 2e-38
Identities = 76/308 (24%), Positives = 123/308 (39%), Gaps = 70/308 (22%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDK--RYKNRELQIMRLLNHPNVVSL 195
+V+G G+FG V + T A+K ++++ + E IM N P VV L
Sbjct: 75 KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 134
Query: 196 KHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
+ F +D+ YL +V+EY+ + V +S + + + + YT ++ AL+
Sbjct: 135 FYAF-----QDDRYLYMVMEYMPGGDLVNLMSNY--DVPEKW----ARFYTAEVVLALDA 183
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS--------YICSRYY 305
+H +G HRD+KP N+L++ H LK+ DFG+ + YI
Sbjct: 184 IHS-MGFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMNKEGMVRCDTAVGTPDYI----- 236
Query: 306 RAPELIF---GATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEII-KILGTPTR 361
+PE++ G Y D WS+G L E+L+G F +S LV KI+
Sbjct: 237 -SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS----LVGTYSKIMNHKNS 291
Query: 362 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCT---ALEAC 418
FP + EA +L+ L +R E
Sbjct: 292 ------------LTFP----------DDNDISKEAKNLICAFLT-DREVRLGRNGVEEIK 328
Query: 419 AHPFFDDL 426
H FF +
Sbjct: 329 RHLFFKND 336
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 7e-38
Identities = 78/304 (25%), Positives = 127/304 (41%), Gaps = 70/304 (23%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDK--RYKNRELQIMRLLNHPNVVSL 195
+ +GTGSFG V K E+G+ A+K KV++ K + E +I++ +N P +V L
Sbjct: 47 KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 196 KHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
+ F KD L +V+EY++ E + R + + Y QI Y
Sbjct: 107 EFSF-----KDNSNLYMVMEYVAGGEMFS-----HLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP------GEPNISYICSRYYRA 307
LH + + +RD+KP+NLL++ + +++ DFG AK + G P A
Sbjct: 157 LHS-LDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVKGRTWTLCGTPE--------ALA 206
Query: 308 PELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367
PE+I Y A+D W++G ++ E+ G P F + Q+ E KI+
Sbjct: 207 PEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQ-PIQIYE--KIVSGK-------- 254
Query: 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTAL-----EACAHPF 422
+FP + DL+ LLQ + R L + H +
Sbjct: 255 ------VRFP------------SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 296
Query: 423 FDDL 426
F
Sbjct: 297 FATT 300
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 7e-38
Identities = 76/299 (25%), Positives = 130/299 (43%), Gaps = 57/299 (19%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKRYKN--RELQIMRLLNHPNVVSL 195
+++G G+FG V + TG A+K ++ + E ++++ HP + +L
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 196 KHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
K+ F T ++ L V+EY + E + +S+ + + Y +I AL Y
Sbjct: 71 KYAF-QTHDR--LCF--VMEYANGGELFFHLSRE-----RVFTEERARFYGAEIVSALEY 120
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRY-YRAPELIF 312
LH V +RDIK +NL+++ H +KI DFG K + + C Y APE++
Sbjct: 121 LHSR-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE 178
Query: 313 GATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYT 372
+Y A+D W +G V+ E++ G+ F + ++L E+I
Sbjct: 179 D-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-HERLFELIL----------------ME 220
Query: 373 EFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLR-----CTALEACAHPFFDDL 426
E +FP + + PEA L++ LL+ P R A E H FF +
Sbjct: 221 EIRFP------------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 8e-38
Identities = 79/304 (25%), Positives = 129/304 (42%), Gaps = 70/304 (23%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDK--RYKNRELQIMRLLNHPNVVSL 195
R +GTGSFG V + G A+K V++ K + N E ++ ++ HP ++ +
Sbjct: 12 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 71
Query: 196 KHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
F +D + ++++YI E + K N + Y ++C AL Y
Sbjct: 72 WGTF-----QDAQQIFMIMDYIEGGELFSLLRKSQRFPNPV-----AKFYAAEVCLALEY 121
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP------GEPNISYICSRYYRA 307
LH + +RD+KP+N+L++ + H +KI DFG AK + G P+ Y A
Sbjct: 122 LHS-KDIIYRDLKPENILLDKNGH-IKITDFGFAKYVPDVTYTLCGTPD--------YIA 171
Query: 308 PELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367
PE++ Y +ID WS G ++ E+L G F + + E KIL
Sbjct: 172 PEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSN-TMKTYE--KIL----------- 216
Query: 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTAL-----EACAHPF 422
E +FP + DL+SRL+ S R L + HP+
Sbjct: 217 ---NAELRFP------------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPW 261
Query: 423 FDDL 426
F ++
Sbjct: 262 FKEV 265
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 143 bits (361), Expect = 9e-38
Identities = 85/313 (27%), Positives = 133/313 (42%), Gaps = 55/313 (17%)
Query: 123 ATTVGGRNGQPKQTI-SYMAERVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKRY 176
+ + I Y+ +G G+FG V K TG VA+K K+
Sbjct: 1 GPMAEKQKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVV 60
Query: 177 KN--RELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMN 232
RE+Q ++L HP+++ L + ST +++ +V+EY+S E + K+ R++
Sbjct: 61 GKIRREIQNLKLFRHPHIIKL-YQVIST--PSDIF--MVMEYVSGGELFDYICKN-GRLD 114
Query: 233 QHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292
+ Q QI ++Y H V HRD+KP+N+L++ H KI DFG + M+
Sbjct: 115 EKESRRLFQ----QILSGVDYCHR-HMVVHRDLKPENVLLDAH-MNAKIADFGLSNMMSD 168
Query: 293 GEPNISYIC-SRYYRAPELIFGATEYT-TAIDMWSIGCVLAELLLGQPLFPGESGVDQLV 350
GE + C S Y APE+I G Y +D+WS G +L LL G F + V L
Sbjct: 169 GEF-LRTSCGSPNYAAPEVISG-RLYAGPEVDIWSSGVILYALLCGTLPFDDDH-VPTLF 225
Query: 351 EIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSL 410
+ KI F P + + P + L+ +LQ P
Sbjct: 226 K--KICD--------------GIFYTP-----QY-------LNPSVISLLKHMLQVDPMK 257
Query: 411 RCTALEACAHPFF 423
R T + H +F
Sbjct: 258 RATIKDIREHEWF 270
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-36
Identities = 80/301 (26%), Positives = 133/301 (44%), Gaps = 59/301 (19%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSV---AIK-----KVLQDKRYKNR-ELQIMRLLNHPNVV 193
+V+G GSFG VF K + D+ A+K + R + + E I+ +NHP +V
Sbjct: 30 KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIV 89
Query: 194 SLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
L + F T K LYL +L+++ + R+SK V+ Y ++ AL
Sbjct: 90 KLHYAF-QTEGK--LYL--ILDFLRGGDLFTRLSKE-----VMFTEEDVKFYLAELALAL 139
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC-SRYYRAPEL 310
++LH + G+ +RD+KP+N+L++ H +K+ DFG +K + E C + Y APE+
Sbjct: 140 DHLHSL-GIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEV 197
Query: 311 IFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPN 370
+ +T + D WS G ++ E+L G F G+ + + IL
Sbjct: 198 VNR-RGHTQSADWWSFGVLMFEMLTGTLPFQGKD-RKETMT--MIL-------------- 239
Query: 371 YTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLR-----CTALEACAHPFFDD 425
+ PQ + PEA L+ L + +P+ R E H FF
Sbjct: 240 KAKLGMPQ------------FLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFST 287
Query: 426 L 426
+
Sbjct: 288 I 288
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-36
Identities = 66/299 (22%), Positives = 113/299 (37%), Gaps = 46/299 (15%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKV---LQDKRYKN--RELQI-MRLLNHPNVVSLKH 197
+G+G+ G V++ + +TG +A+K++ + K +L + ++ + P +V
Sbjct: 32 EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFG 91
Query: 198 CFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV 257
F + T+ + + +E + K RM +P + T I +AL YL
Sbjct: 92 TFITNTD-----VFIAMELMGTCA---EKLKKRMQGPIPERILGKMTVAIVKALYYLKEK 143
Query: 258 VGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELI----FG 313
GV HRD+KP N+L++ Q+K+CDFG + LV + Y APE I
Sbjct: 144 HGVIHRDVKPSNILLD-ERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPT 202
Query: 314 ATEYTTAIDMWSIGCVLAELLLGQPLFPGESGV-DQLVEIIKILGTPTREEIKCMNPNYT 372
+Y D+WS+G L EL GQ + + L ++++ P
Sbjct: 203 KPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ--EEP------------- 247
Query: 373 EFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNT 431
P + H + V L R + H F
Sbjct: 248 ----PLLPG-------HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEV 295
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-36
Identities = 78/364 (21%), Positives = 135/364 (37%), Gaps = 84/364 (23%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYK---NRELQIMRLL-----NHP 190
Y R +G G F V+ + ++ VA+K V + Y E+++++ + N P
Sbjct: 39 YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDP 98
Query: 191 N---VVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQI 247
N VV L F + ++ +V E + + + Q +P+ V+ Q+
Sbjct: 99 NREMVVQLLDDFKISGVNGT-HICMVFEVLGHHLLKWIIKSN--YQGLPLPCVKKIIQQV 155
Query: 248 CRALNYLHHVVGVCHRDIKPQNLLV----------------------------------- 272
+ L+YLH + H DIKP+N+L+
Sbjct: 156 LQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPA 215
Query: 273 -------------NPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTT 319
N ++KI D G+A + I +R YR+ E++ G+ Y T
Sbjct: 216 TAGNFLVNPLEPKNAEKLKVKIADLGNAC--WVHKHFTEDIQTRQYRSLEVLIGS-GYNT 272
Query: 320 AIDMWSIGCVLAELLLGQPLFPGESG------VDQLVEIIKILGTPTREEI-------KC 366
D+WS C+ EL G LF SG D + II++LG R+ I +
Sbjct: 273 PADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEF 332
Query: 367 MNPNYTEFKFPQIKAHPWHKIFHKRMP------PEALDLVSRLLQYSPSLRCTALEACAH 420
++K ++ ++ D + +L+ P R TA E H
Sbjct: 333 FTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392
Query: 421 PFFD 424
P+ +
Sbjct: 393 PWLN 396
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-36
Identities = 65/300 (21%), Positives = 116/300 (38%), Gaps = 43/300 (14%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKV---LQDKRYKN--RELQI-MRLLNHPNVVSLKH 197
+G G++G V + +G +A+K++ + +K K +L + MR + P +V
Sbjct: 29 EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88
Query: 198 CFFSTTEKDELYLNLVLEYI---SETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
F + + +E + + Y+ Y+ ++ +P + T +ALN+L
Sbjct: 89 ALFREGD-----CWICMELMSTSFDKFYK--YVYSVLDDVIPEEILGKITLATVKALNHL 141
Query: 255 HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGA 314
+ + HRDIKP N+L++ + +K+CDFG + LV R Y APE I +
Sbjct: 142 KENLKIIHRDIKPSNILLD-RSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPS 200
Query: 315 TE---YTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNY 371
Y D+WS+G L EL G+ +P + V + +
Sbjct: 201 ASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQV---------------VKG 245
Query: 372 TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNT 431
+ + + F + V+ L S R E HPF +
Sbjct: 246 DPPQLSNSEEREFSPSFI--------NFVNLCLTKDESKRPKYKELLKHPFILMYEERAV 297
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 1e-35
Identities = 82/303 (27%), Positives = 136/303 (44%), Gaps = 61/303 (20%)
Query: 143 RVVGTGSFGVVFQAKCL---ETGDSVAIK-----KVLQDKRYKNR---ELQIMRLLNHPN 191
RV+G G +G VFQ + + TG A+K ++++ + E I+ + HP
Sbjct: 23 RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICR 249
+V L + F T K LYL +LEY+S E ++ + + Y +I
Sbjct: 83 IVDLIYAF-QTGGK--LYL--ILEYLSGGELFMQLERE-GIFMEDT----ACFYLAEISM 132
Query: 250 ALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRY-YRAP 308
AL +LH G+ +RD+KP+N+++N H +K+ DFG K + C Y AP
Sbjct: 133 ALGHLHQK-GIIYRDLKPENIMLNHQGH-VKLTDFGLCKESIHDGTVTHTFCGTIEYMAP 190
Query: 309 ELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368
E++ + + A+D WS+G ++ ++L G P F GE+ + ++ KIL
Sbjct: 191 EILMR-SGHNRAVDWWSLGALMYDMLTGAPPFTGEN-RKKTID--KIL------------ 234
Query: 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLR-----CTALEACAHPFF 423
+ P + EA DL+ +LL+ + + R A E AHPFF
Sbjct: 235 --KCKLNLP------------PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFF 280
Query: 424 DDL 426
+
Sbjct: 281 RHI 283
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-35
Identities = 64/215 (29%), Positives = 99/215 (46%), Gaps = 18/215 (8%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN--RELQIMRLLNHPNVVSLKHCF 199
E VVG G+FGVV +AK VAIK++ + K EL+ + +NHPN+V L
Sbjct: 13 EEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGA- 69
Query: 200 FSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH-- 256
+ LV+EY ++Y V H + + + Q + + YLH
Sbjct: 70 --CLNP----VCLVMEYAEGGSLYNVL-HGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122
Query: 257 VVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATE 316
+ HRD+KP NLL+ LKICDFG+A + + S + APE+ G +
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI--QTHMTNNKGSAAWMAPEVFEG-SN 179
Query: 317 YTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVE 351
Y+ D++S G +L E++ + F G +
Sbjct: 180 YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM 214
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 5e-35
Identities = 85/307 (27%), Positives = 140/307 (45%), Gaps = 61/307 (19%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSV---AIK-----KVLQDKRYKNR---ELQIMRLLNH-P 190
+V+GTG++G VF + + D+ A+K ++Q + E Q++ + P
Sbjct: 60 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 119
Query: 191 NVVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQIC 248
+V+L + F T K L+L +L+YI+ E +S+ + VQ+Y +I
Sbjct: 120 FLVTLHYAF-QTETK--LHL--ILDYINGGELFTHLSQR-----ERFTEHEVQIYVGEIV 169
Query: 249 RALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISY-IC-SRYYR 306
AL +LH + G+ +RDIK +N+L++ + H + + DFG +K V E +Y C + Y
Sbjct: 170 LALEHLHKL-GIIYRDIKLENILLDSNGH-VVLTDFGLSKEFVADETERAYDFCGTIEYM 227
Query: 307 APELIFGATE-YTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEII-KILGTPTREEI 364
AP+++ G + A+D WS+G ++ ELL G F + + EI +IL
Sbjct: 228 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL-------- 279
Query: 365 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLR-----CTALEACA 419
+E +PQ M A DL+ RLL P R A E
Sbjct: 280 ------KSEPPYPQ------------EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 321
Query: 420 HPFFDDL 426
H FF +
Sbjct: 322 HLFFQKI 328
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 6e-35
Identities = 82/336 (24%), Positives = 134/336 (39%), Gaps = 58/336 (17%)
Query: 107 EPSIVNGNGTEAGQVIATTVGGRNGQPKQTIS-YMAERVVGTGSFGVVFQAKCLETGDSV 165
EP ++N N G + P S + +V+G GSFG V A+
Sbjct: 7 EPELMNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFY 66
Query: 166 AIK-----KVLQDK--RYKNRELQIM-RLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYI 217
A+K +L+ K ++ E ++ + + HP +V L F T +K LY VL+YI
Sbjct: 67 AVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF-QTADK--LYF--VLDYI 121
Query: 218 S--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPH 275
+ E Y + + + + Y +I AL YLH + + +RD+KP+N+L++
Sbjct: 122 NGGELFYHLQRE-RCFLEPR----ARFYAAEIASALGYLHSL-NIVYRDLKPENILLDSQ 175
Query: 276 THQLKICDFGSAKMLVPGEPNISYICSRY-YRAPELIFGATEYTTAIDMWSIGCVLAELL 334
H + + DFG K + S C Y APE++ Y +D W +G VL E+L
Sbjct: 176 GH-IVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEML 233
Query: 335 LGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPP 394
G P F + ++ + IL + +
Sbjct: 234 YGLPPFYSRN-TAEMYD--NIL--------------NKPLQLK------------PNITN 264
Query: 395 EALDLVSRLLQYSPSLR--CT--ALEACAHPFFDDL 426
A L+ LLQ + R +E +H FF +
Sbjct: 265 SARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLI 300
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 6e-35
Identities = 77/296 (26%), Positives = 127/296 (42%), Gaps = 54/296 (18%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKRYKN--RELQIMRL-LNHPNVVS 194
+++G GSFG VF A+ +T AIK VL D + E +++ L HP +
Sbjct: 23 KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 82
Query: 195 LKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
+ F T E L+ V+EY++ + +Y + + Y +I L
Sbjct: 83 MFCTF-QTKEN--LFF--VMEYLNGGDLMYHIQSC-----HKFDLSRATFYAAEIILGLQ 132
Query: 253 YLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRY-YRAPELI 311
+LH G+ +RD+K N+L++ H +KI DFG K + G+ + C Y APE++
Sbjct: 133 FLHSK-GIVYRDLKLDNILLDKDGH-IKIADFGMCKENMLGDAKTNTFCGTPDYIAPEIL 190
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNY 371
G +Y ++D WS G +L E+L+GQ F G+ ++L I+
Sbjct: 191 LG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQD-EEELFHSIR----------------M 232
Query: 372 TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEA-CAHPFFDDL 426
+P + + EA DL+ +L P R HP F ++
Sbjct: 233 DNPFYP------------RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI 276
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 7e-35
Identities = 75/300 (25%), Positives = 121/300 (40%), Gaps = 58/300 (19%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKRYKN--RELQIMRL-LNHPNVVS 194
V+G GSFG V ++ T + A+K V+QD + E +++ L P +
Sbjct: 26 MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQ 85
Query: 195 LKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
L CF T ++ LY V+EY++ + +Y + + H Y +I L
Sbjct: 86 LHSCF-QTMDR--LYF--VMEYVNGGDLMYHIQQVGRFKEPHA-----VFYAAEIAIGLF 135
Query: 253 YLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRY-YRAPELI 311
+L G+ +RD+K N++++ H +KI DFG K + C Y APE+I
Sbjct: 136 FLQSK-GIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKTFCGTPDYIAPEII 193
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNY 371
Y ++D W+ G +L E+L GQ F GE D+L + I+
Sbjct: 194 AY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGED-EDELFQ--SIM--------------E 235
Query: 372 TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLR-----CTALEACAHPFFDDL 426
+P K M EA+ + L+ P R + H FF +
Sbjct: 236 HNVAYP------------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 283
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 1e-34
Identities = 79/301 (26%), Positives = 129/301 (42%), Gaps = 59/301 (19%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKRYKN--RELQIMRL-LNHPNVVS 194
RV+G GSFG V A+ ETGD A+K +LQD + E +I+ L NHP +
Sbjct: 29 RVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 88
Query: 195 LKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
L CF T ++ L+ V+E+++ + ++ + K + Y +I AL
Sbjct: 89 LFCCF-QTPDR--LFF--VMEFVNGGDLMFHIQKSRRFDEARA-----RFYAAEIISALM 138
Query: 253 YLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRY-YRAPELI 311
+LH G+ +RD+K N+L++ H K+ DFG K + + C Y APE++
Sbjct: 139 FLHDK-GIIYRDLKLDNVLLDHEGH-CKLADFGMCKEGICNGVTTATFCGTPDYIAPEIL 196
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNY 371
Y A+D W++G +L E+L G F E+ D L E I
Sbjct: 197 QE-MLYGPAVDWWAMGVLLYEMLCGHAPFEAEN-EDDLFEAIL----------------N 238
Query: 372 TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLR------CTALEACAHPFFDD 425
E +P + +A ++ + +P++R HPFF +
Sbjct: 239 DEVVYP------------TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKE 286
Query: 426 L 426
+
Sbjct: 287 I 287
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-34
Identities = 81/303 (26%), Positives = 125/303 (41%), Gaps = 46/303 (15%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----RELQIMRLLNHPNVV 193
Y + V+G+G+ VV A C + VAIK++ +K + +E+Q M +HPN+V
Sbjct: 17 YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV 76
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICR--- 249
S F KDEL+ LV++ +S +V + KH +H + + I R
Sbjct: 77 SYYTSFV---VKDELW--LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 131
Query: 250 -ALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG-SAKMLVPGEPNISYICSR---- 303
L YLH G HRD+K N+L+ ++I DFG SA + G+ + R
Sbjct: 132 EGLEYLHK-NGQIHRDVKAGNILLG-EDGSVQIADFGVSAFLATGGDITRNK--VRKTFV 187
Query: 304 ---YYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPT 360
+ APE++ Y D+WS G EL G + + L+ ++
Sbjct: 188 GTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQ------ 241
Query: 361 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420
N P ++ K K+ ++S LQ P R TA E H
Sbjct: 242 -------ND------PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288
Query: 421 PFF 423
FF
Sbjct: 289 KFF 291
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 3e-34
Identities = 71/301 (23%), Positives = 127/301 (42%), Gaps = 50/301 (16%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKR--YKNRELQIMRL-LNHPNVVS 194
RV+G GS+ V + +T A+K V D+ + E + NHP +V
Sbjct: 15 RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 74
Query: 195 LKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
L CF T + L+ V+EY++ + ++ + + +H + Y+ +I ALN
Sbjct: 75 LHSCF-QTESR--LFF--VIEYVNGGDLMFHMQRQRKLPEEHA-----RFYSAEISLALN 124
Query: 253 YLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC-SRYYRAPELI 311
YLH G+ +RD+K N+L++ H +K+ D+G K + S C + Y APE++
Sbjct: 125 YLHER-GIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEIL 182
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNY 371
G +Y ++D W++G ++ E++ G+ F D + T + +
Sbjct: 183 RG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ-------NTEDYL------- 227
Query: 372 TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLR--CTALEAC----AHPFFDD 425
F I + + +A ++ L P R C HPFF +
Sbjct: 228 ----FQVILEKQIR--IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 281
Query: 426 L 426
+
Sbjct: 282 V 282
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 70/301 (23%), Positives = 127/301 (42%), Gaps = 50/301 (16%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKR--YKNRELQIMRL-LNHPNVVS 194
RV+G GS+ V + +T A++ V D+ + E + NHP +V
Sbjct: 58 RVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 117
Query: 195 LKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
L CF T + L+ V+EY++ + ++ + + +H + Y+ +I ALN
Sbjct: 118 LHSCF-QTESR--LFF--VIEYVNGGDLMFHMQRQRKLPEEHA-----RFYSAEISLALN 167
Query: 253 YLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC-SRYYRAPELI 311
YLH G+ +RD+K N+L++ H +K+ D+G K + S C + Y APE++
Sbjct: 168 YLHER-GIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEIL 225
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNY 371
G +Y ++D W++G ++ E++ G+ F D + T + +
Sbjct: 226 RG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ-------NTEDYL------- 270
Query: 372 TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLR--CTALEAC----AHPFFDD 425
F I + + +A ++ L P R C HPFF +
Sbjct: 271 ----FQVILEKQIR--IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 324
Query: 426 L 426
+
Sbjct: 325 V 325
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 128 bits (322), Expect = 5e-33
Identities = 54/311 (17%), Positives = 111/311 (35%), Gaps = 42/311 (13%)
Query: 146 GTGSFGVVFQAKCLETGDSVAIKKV----LQDKRYKN--RELQIMRLLNHPNVVSLKHCF 199
G V A+ TG+ V ++++ ++ EL + +L NHPN+V + F
Sbjct: 36 GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF 95
Query: 200 FSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV 258
+ +EL+ +V +++ + + + + L + + +AL+Y+HH +
Sbjct: 96 IA---DNELW--VVTSFMAYGSAKDLICTH--FMDGMNELAIAYILQGVLKALDYIHH-M 147
Query: 259 GVCHRDIKPQNLLVNPHTHQLKICDFGSAKML--------VPGEPNISYICSRYYRAPEL 310
G HR +K ++L++ ++ + S + V + + + +PE+
Sbjct: 148 GYVHRSVKASHILIS-VDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEV 206
Query: 311 IF-GATEYTTAIDMWSIGCVLAELLLGQP----------LF-------PGESGVDQLVEI 352
+ Y D++S+G EL G L P +
Sbjct: 207 LQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAE 266
Query: 353 IKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC 412
+ ++ + T +H+ P V + LQ +P R
Sbjct: 267 ELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARP 326
Query: 413 TALEACAHPFF 423
+A H FF
Sbjct: 327 SASTLLNHSFF 337
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 6e-33
Identities = 51/226 (22%), Positives = 87/226 (38%), Gaps = 34/226 (15%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----------RELQIMRLLNHP 190
E+ +G G FG+V + + ++ VAIK ++ RE+ IM LNHP
Sbjct: 24 EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 191 NVVSLKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYT--YQI 247
N+V L +V+E++ +Y ++ PI + I
Sbjct: 84 NIVKLYGL---MHNP----PRMVMEFVPCGDLYHRLL-----DKAHPIKWSVKLRLMLDI 131
Query: 248 CRALNYLH-HVVGVCHRDIKPQNLLVNPHTHQ----LKICDFGSAKMLVPGEPNISYICS 302
+ Y+ + HRD++ N+ + K+ DFG ++ V + +
Sbjct: 132 ALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSV--HSVSGLLGN 189
Query: 303 RYYRAPELIFGATE-YTTAIDMWSIGCVLAELLLGQPLFPGESGVD 347
+ APE I E YT D +S +L +L G+ F S
Sbjct: 190 FQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK 235
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 3e-32
Identities = 75/300 (25%), Positives = 121/300 (40%), Gaps = 58/300 (19%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDK--RYKNRELQIMRLLN-HPNVVS 194
V+G GSFG V ++ T + A+K V+QD E +++ L P +
Sbjct: 347 MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQ 406
Query: 195 LKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
L CF T ++ LY V+EY++ + +Y + + R + Y +I L
Sbjct: 407 LHSCF-QTMDR--LYF--VMEYVNGGDLMYHIQQV-GRFKEPH----AVFYAAEIAIGLF 456
Query: 253 YLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC-SRYYRAPELI 311
+L G+ +RD+K N++++ H +KI DFG K + C + Y APE+I
Sbjct: 457 FLQSK-GIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKTFCGTPDYIAPEII 514
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNY 371
Y ++D W+ G +L E+L GQ F GE D+L + I
Sbjct: 515 AY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGED-EDELFQSIM----------------E 556
Query: 372 TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLR-----CTALEACAHPFFDDL 426
+P K M EA+ + L+ P R + H FF +
Sbjct: 557 HNVAYP------------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 604
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 4e-32
Identities = 78/315 (24%), Positives = 134/315 (42%), Gaps = 55/315 (17%)
Query: 130 NGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVL----QDKRYKNRELQIMR 185
G PK+ Y +G G+ G V+ A + TG VAI+++ K E+ +MR
Sbjct: 15 VGDPKKK--YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMR 72
Query: 186 LLNHPNVVSLKHCFFSTTEKDELYLNLVLEY-----ISETVYRVSKHYTRMNQHVPILYV 240
+PN+V+ + DEL+ +V+EY +++ V T M++ I V
Sbjct: 73 ENKNPNIVNYLDSYLV---GDELW--VVMEYLAGGSLTDVV-----TETCMDEGQ-IAAV 121
Query: 241 QLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPN-ISY 299
+ +AL +LH V HRDIK N+L+ +K+ DFG + P + +
Sbjct: 122 ---CRECLQALEFLHS-NQVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTM 176
Query: 300 ICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTP 359
+ + Y+ APE++ Y +D+WS+G + E++ G+P + E+ + L +I GTP
Sbjct: 177 VGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTP 234
Query: 360 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419
+ IF D ++R L+ R +A E
Sbjct: 235 ELQN-----------------PEKLSAIFR--------DFLNRCLEMDVEKRGSAKELLQ 269
Query: 420 HPFFDDLRDPNTCLP 434
H F + ++ P
Sbjct: 270 HQFLKIAKPLSSLTP 284
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 9e-32
Identities = 76/305 (24%), Positives = 130/305 (42%), Gaps = 49/305 (16%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-------RELQIMRLLNHPN 191
+ R +G GSFG V+ A+ + + VAIKK+ + N +E++ ++ L HPN
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
+ + C+ + + LV+EY + + + + + Q V I V T+ + L
Sbjct: 116 TIQYRGCYL---REHTAW--LVMEYCLGSASDLLEVHKKPLQEVEIAAV---THGALQGL 167
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELI 311
YLH + HRD+K N+L++ +K+ DFGSA ++ P S++ + Y+ APE+I
Sbjct: 168 AYLHS-HNMIHRDVKAGNILLS-EPGLVKLGDFGSASIMAPAN---SFVGTPYWMAPEVI 222
Query: 312 FGATE--YTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369
E Y +D+WS+G EL +P + + L I +
Sbjct: 223 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ------------NES 270
Query: 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDP 429
P +++ W + F + V LQ P R T+ H F R P
Sbjct: 271 -------PALQSGHWSEYFR--------NFVDSCLQKIPQDRPTSEVLLKHRFVLRERPP 315
Query: 430 NTCLP 434
+
Sbjct: 316 TVIMD 320
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-31
Identities = 67/302 (22%), Positives = 119/302 (39%), Gaps = 48/302 (15%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----RELQIMRLLNHPNVV 193
+ +G GSFG VF+ T VAIK + ++ +E+ ++ + P V
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
+ T+ L +++EY+ + + + +++ I + +I + L+
Sbjct: 84 KYYGSYLKDTK-----LWIIMEYLGGGSALDLLEP-GPLDETQ-IATI---LREILKGLD 133
Query: 253 YLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG-SAKMLVPGEPNISYICSRYYRAPELI 311
YLH HRDIK N+L++ ++K+ DFG + ++ +++ + ++ APE+I
Sbjct: 134 YLHS-EKKIHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI 191
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNY 371
+ Y + D+WS+G EL G+P + L I K PT E
Sbjct: 192 KQS-AYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPK-NNPPTLEG-------- 241
Query: 372 TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNT 431
+ K + V L PS R TA E H F +
Sbjct: 242 -----------NYSKPLK--------EFVEACLNKEPSFRPTAKELLKHKFILRNAKKTS 282
Query: 432 CL 433
L
Sbjct: 283 YL 284
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-31
Identities = 64/220 (29%), Positives = 104/220 (47%), Gaps = 34/220 (15%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN--------RELQIMRLLNHPNVV 193
E ++G G FG V++A + GD VA+K D +E ++ +L HPN++
Sbjct: 12 EEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69
Query: 194 SLK-HCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
+L+ C ++ L LV+E+ + RV + +P + + QI R +
Sbjct: 70 ALRGVC----LKEPNLC--LVMEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGM 118
Query: 252 NYLHH--VVGVCHRDIKPQNLLVN-------PHTHQLKICDFGSAKMLVPGEPNISYICS 302
NYLH +V + HRD+K N+L+ LKI DFG A+ +S +
Sbjct: 119 NYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT-KMSAAGA 177
Query: 303 RYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPG 342
+ APE+I + ++ D+WS G +L ELL G+ F G
Sbjct: 178 YAWMAPEVIRASM-FSKGSDVWSYGVLLWELLTGEVPFRG 216
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 3e-31
Identities = 79/316 (25%), Positives = 135/316 (42%), Gaps = 55/316 (17%)
Query: 129 RNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVL----QDKRYKNRELQIM 184
G P+ + +G GS G+V A+ +G VA+K + Q + E+ IM
Sbjct: 39 DQGDPRLL--LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIM 96
Query: 185 RLLNHPNVVSLKHCFFSTTEKDELYLNLVLEY-----ISETVYRVSKHYTRMNQHVPILY 239
R H NVV + + +EL+ +++E+ +++ V R+N+ I
Sbjct: 97 RDYQHFNVVEMYKSYLV---GEELW--VLMEFLQGGALTDIV-----SQVRLNEEQ-IAT 145
Query: 240 VQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPN-IS 298
V + +AL YLH GV HRDIK ++L+ ++K+ DFG + P S
Sbjct: 146 V---CEAVLQALAYLHA-QGVIHRDIKSDSILLT-LDGRVKLSDFGFCAQISKDVPKRKS 200
Query: 299 YICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGT 358
+ + Y+ APE+I + Y T +D+WS+G ++ E++ G+P + +S V + ++
Sbjct: 201 LVGTPYWMAPEVISR-SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK-RLRDSPP 258
Query: 359 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEAC 418
P + +H + D + R+L P R TA E
Sbjct: 259 PKLKN-----------------SHKVSPVLR--------DFLERMLVRDPQERATAQELL 293
Query: 419 AHPFFDDLRDPNTCLP 434
HPF P +P
Sbjct: 294 DHPFLLQTGLPECLVP 309
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-31
Identities = 75/300 (25%), Positives = 122/300 (40%), Gaps = 47/300 (15%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN--RELQIMRLLNHPNVVSLK 196
+ +G GS+G V++A ETG VAIK+V + + +E+ IM+ + P+VV
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYY 90
Query: 197 HCFFSTTEKDELYLNLVLEYIS----ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
+F T+ L +V+EY + R+ ++ I + + L
Sbjct: 91 GSYFKNTD-----LWIVMEYCGAGSVSDIIRLRNKTLTEDE---IATI---LQSTLKGLE 139
Query: 253 YLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG-SAKMLVPGEPNISYICSRYYRAPELI 311
YLH + HRDIK N+L+N K+ DFG + ++ + I + ++ APE+I
Sbjct: 140 YLHF-MRKIHRDIKAGNILLN-TEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI 197
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNY 371
Y D+WS+G E+ G+P + + + I PT
Sbjct: 198 QEI-GYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPT-NPPPT----------- 244
Query: 372 TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNT 431
F+ P W F D V + L SP R TA + HPF + +
Sbjct: 245 --FRKP----ELWSDNFT--------DFVKQCLVKSPEQRATATQLLQHPFVRSAKGVSI 290
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 6e-31
Identities = 72/306 (23%), Positives = 122/306 (39%), Gaps = 52/306 (16%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVL----QDKRYKNRELQIMRLLNHPNVVS 194
+ +G G+FG V++AK ETG A K + ++ E++I+ +HP +V
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 195 LKHCFFSTTEKDELYLNLVLEYIS----ETVYRVSKHYTRMNQHVPILYVQLYTYQICRA 250
L ++ + L +++E+ + + Q I V Q+ A
Sbjct: 81 LLGAYYHDGK-----LWIMIEFCPGGAVDAIMLELDRGLTEPQ---IQVV---CRQMLEA 129
Query: 251 LNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG-SAKMLVPGEPNISYICSRYYRAPE 309
LN+LH + HRD+K N+L+ +++ DFG SAK L + S+I + Y+ APE
Sbjct: 130 LNFLHS-KRIIHRDLKAGNVLMT-LEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPE 187
Query: 310 LIFGAT----EYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIK 365
++ T Y D+WS+G L E+ +P + + L++I K PT
Sbjct: 188 VVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK-SDPPTLLT-- 244
Query: 366 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDD 425
W F D + L +P R +A + HPF
Sbjct: 245 ---------------PSKWSVEFR--------DFLKIALDKNPETRPSAAQLLEHPFVSS 281
Query: 426 LRDPNT 431
+
Sbjct: 282 ITSNKA 287
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 8e-31
Identities = 72/310 (23%), Positives = 127/310 (40%), Gaps = 48/310 (15%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV---LQDKRYKNRELQIMR-LLNHPNVVS 194
+ +VG G++G V++ + ++TG AIK + ++ +E+ +++ +H N+ +
Sbjct: 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 85
Query: 195 LKHCFF-STTEKDELYLNLVLEYIS----ETVYRVSKHYTRMNQHVPILYVQLYTYQICR 249
F + L LV+E+ + + +K T + I Y+ +I R
Sbjct: 86 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEW--IAYI---CREILR 140
Query: 250 ALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG-SAKMLVPGEPNISYICSRYYRAP 308
L++LH V HRDIK QN+L+ ++K+ DFG SA++ ++I + Y+ AP
Sbjct: 141 GLSHLHQ-HKVIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAP 198
Query: 309 ELI----FGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEI 364
E+I Y D+WS+G E+ G P + L I +
Sbjct: 199 EVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR---------- 248
Query: 365 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFD 424
NP P++K+ W K F + L + S R + HPF
Sbjct: 249 ---NP------APRLKSKKWSKKFQ--------SFIESCLVKNHSQRPATEQLMKHPFIR 291
Query: 425 DLRDPNTCLP 434
D +
Sbjct: 292 DQPNERQVRI 301
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-30
Identities = 57/211 (27%), Positives = 100/211 (47%), Gaps = 21/211 (9%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSL 195
+ +G GSFG V +A+ G VA+K +++ + RE+ IM+ L HPN+V
Sbjct: 42 KEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLF 99
Query: 196 K-HCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
T+ L +V EY+S ++YR+ H + + + Y + + +NY
Sbjct: 100 MGAV----TQPPNLS--IVTEYLSRGSLYRLL-HKSGAREQLDERRRLSMAYDVAKGMNY 152
Query: 254 LH-HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI-SYICSRYYRAPELI 311
LH + HR++K NLLV+ + +K+CDFG +++ + S + + APE++
Sbjct: 153 LHNRNPPIVHRNLKSPNLLVDKK-YTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVL 211
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQPLFPG 342
D++S G +L EL Q +
Sbjct: 212 RD-EPSNEKSDVYSFGVILWELATLQQPWGN 241
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-29
Identities = 29/213 (13%), Positives = 72/213 (33%), Gaps = 26/213 (12%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSL 195
+ G +++ + G+ + +K + R N E +R+ +HPNV+ +
Sbjct: 15 LTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPV 72
Query: 196 KHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYT--YQICRALN 252
+ L+ ++ ++Y + + + Q + R +
Sbjct: 73 LGA---CQSPPAPHPTLITHWMPYGSLY----NVLHEGTNFVVDQSQAVKFALDMARGMA 125
Query: 253 YLH-HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELI 311
+LH + + ++++++ +I + + + APE +
Sbjct: 126 FLHTLEPLIPRHALNSRSVMIDED-MTARISMADVKFSFQSP----GRMYAPAWVAPEAL 180
Query: 312 FG--ATEYTTAIDMWSIGCVLAELLLGQPLFPG 342
+ DMWS +L EL+ + F
Sbjct: 181 QKKPEDTNRRSADMWSFAVLLWELVTREVPFAD 213
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-29
Identities = 47/215 (21%), Positives = 84/215 (39%), Gaps = 32/215 (14%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVL-QDKRYKNRELQI--MRLLNHPNVVS-LKH 197
+ +G G +G V+ K G+ VA+K ++ RE +I L+ H N++ +
Sbjct: 42 VKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAA 99
Query: 198 CFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH- 255
T +LYL + +Y ++Y K T + + Y L +LH
Sbjct: 100 DIKGTGSWTQLYL--ITDYHENGSLYDYLKSTT-----LDAKSMLKLAYSSVSGLCHLHT 152
Query: 256 ------HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICS-----RY 304
+ HRD+K +N+LV + I D G A + + + +
Sbjct: 153 EIFSTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLAVKFISDTNEVDIPPNTRVGTKR 211
Query: 305 YRAPELIFGAT-----EYTTAIDMWSIGCVLAELL 334
Y PE++ + + DM+S G +L E+
Sbjct: 212 YMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVA 246
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 4e-29
Identities = 47/215 (21%), Positives = 86/215 (40%), Gaps = 32/215 (14%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVL-QDKRYKNRELQI--MRLLNHPNVVS-LKH 197
VG G +G V++ G++VA+K +D++ RE ++ +L H N++ +
Sbjct: 13 LECVGKGRYGEVWRGSWQ--GENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIAS 70
Query: 198 CFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH- 255
S +L+L + Y ++Y + T + + I L +LH
Sbjct: 71 DMTSRHSSTQLWL--ITHYHEMGSLYDYLQLTT-----LDTVSCLRIVLSIASGLAHLHI 123
Query: 256 ------HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICS-----RY 304
+ HRD+K +N+LV + I D G A M + + +
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQ-CCIADLGLAVMHSQSTNQLDVGNNPRVGTKR 182
Query: 305 YRAPELI-----FGATEYTTAIDMWSIGCVLAELL 334
Y APE++ + +D+W+ G VL E+
Sbjct: 183 YMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA 217
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 7e-29
Identities = 55/221 (24%), Positives = 96/221 (43%), Gaps = 31/221 (14%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ--DKRYKN--RELQIMRLLNHPNVVSLKH 197
V+G G FG + ETG+ + +K++++ ++ + +E+++MR L HPNV+
Sbjct: 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKF-- 72
Query: 198 CFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH 256
+ L + EYI T+ + K M+ P + I + YLH
Sbjct: 73 -IGVLYKDKRLN--FITEYIKGGTLRGIIK---SMDSQYPWSQRVSFAKDIASGMAYLHS 126
Query: 257 VVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSR------------- 303
+ + HRD+ N LV + + DFG A+++V + + S
Sbjct: 127 -MNIIHRDLNSHNCLVR-ENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVG 184
Query: 304 --YYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPG 342
Y+ APE+I G Y +D++S G VL E++ P
Sbjct: 185 NPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPD 224
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-28
Identities = 54/224 (24%), Positives = 99/224 (44%), Gaps = 26/224 (11%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSL 195
+ +G+GSFG V++ K GD VA+K + E+ ++R H N++
Sbjct: 29 GQRIGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL- 84
Query: 196 KHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
F + +L +V ++ ++Y H + + Q R ++YL
Sbjct: 85 ---FMGYSTAPQLA--IVTQWCEGSSLYH---HLHASETKFEMKKLIDIARQTARGMDYL 136
Query: 255 HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISY---ICSRYYRAPELI 311
H + HRD+K N+ ++ + +KI DFG A + + S + APE+I
Sbjct: 137 HA-KSIIHRDLKSNNIFLHED-NTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 194
Query: 312 FGATE--YTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEII 353
Y+ D+++ G VL EL+ GQ + + DQ++E++
Sbjct: 195 RMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV 238
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-28
Identities = 71/239 (29%), Positives = 109/239 (45%), Gaps = 39/239 (16%)
Query: 122 IATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------- 173
I + R Y +G G V+ A+ VAIK +
Sbjct: 5 IGKIINER---------YKIVDKLGGGGMSTVYLAEDTILNIKVAIK-AIFIPPREKEET 54
Query: 174 -KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYIS-ETVYRVSKHYTRM 231
KR++ RE+ L+H N+VS+ E+D+ Y LV+EYI T+ Y
Sbjct: 55 LKRFE-REVHNSSQLSHQNIVSM----IDVDEEDDCYY-LVMEYIEGPTL----SEYIES 104
Query: 232 NQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291
+ + + +T QI + + H + + HRDIKPQN+L++ LKI DFG AK L
Sbjct: 105 HGPLSVDTAINFTNQILDGIKHAHDM-RIVHRDIKPQNILIDS-NKTLKIFDFGIAKAL- 161
Query: 292 PGEPNISY----ICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGV 346
E +++ + + Y +PE G D++SIG VL E+L+G+P F GE+ V
Sbjct: 162 -SETSLTQTNHVLGTVQYFSPEQAKGEAT-DECTDIYSIGIVLYEMLVGEPPFNGETAV 218
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 8e-28
Identities = 55/236 (23%), Positives = 99/236 (41%), Gaps = 46/236 (19%)
Query: 124 TTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLE-TGDSVAIKKVLQD-------KR 175
V G+ Y + + G G ++ A G V +K L
Sbjct: 76 DIVAGQ---------YEVKGCIAHGGLGWIYLALDRNVNGRPVVLK-GLVHSGDAEAQAM 125
Query: 176 YKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN-LVLEYIS-ETVYRVSKHYTRMNQ 233
E Q + + HP++V + F T++ + +V+EY+ +++ R Q
Sbjct: 126 AM-AERQFLAEVVHPSIVQI-FNFVEHTDRHGDPVGYIVMEYVGGQSLKR------SKGQ 177
Query: 234 HVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML--- 290
+P+ Y +I AL+YLH + G+ + D+KP+N+++ QLK+ D G+ +
Sbjct: 178 KLPVAEAIAYLLEILPALSYLHSI-GLVYNDLKPENIMLTEE--QLKLIDLGAVSRINSF 234
Query: 291 --VPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGES 344
+ G P ++APE++ T A D++++G LA L L P G
Sbjct: 235 GYLYGTP--------GFQAPEIVRTGP--TVATDIYTVGRTLAALTLDLPTRNGRY 280
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 1e-27
Identities = 48/215 (22%), Positives = 86/215 (40%), Gaps = 32/215 (14%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVL-QDKRYKNRELQI--MRLLNHPNVVS-LKH 197
+ +G G FG V++ K G+ VA+K +++R RE +I +L H N++ +
Sbjct: 47 QESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAA 104
Query: 198 CFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH- 255
+L+L V +Y +++ YT V + + L +LH
Sbjct: 105 DNKDNGTWTQLWL--VSDYHEHGSLFDYLNRYT-----VTVEGMIKLALSTASGLAHLHM 157
Query: 256 ------HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICS-----RY 304
+ HRD+K +N+LV + I D G A I + +
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGT-CCIADLGLAVRHDSATDTIDIAPNHRVGTKR 216
Query: 305 YRAPELIFGAT-----EYTTAIDMWSIGCVLAELL 334
Y APE++ + E D++++G V E+
Sbjct: 217 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 251
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-27
Identities = 44/223 (19%), Positives = 86/223 (38%), Gaps = 37/223 (16%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSL 195
++G G FG V+ + G+ VAI+ + ++ ++ RE+ R H NVV
Sbjct: 38 GELIGKGRFGQVYHGRWH--GE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLF 94
Query: 196 K-HCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
C L ++ T+Y V + + + + +I + + Y
Sbjct: 95 MGAC----MSPPHLA--IITSLCKGRTLYSVVR---DAKIVLDVNKTRQIAQEIVKGMGY 145
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSR------YYRA 307
LH G+ H+D+K +N+ + + I DFG + + R + A
Sbjct: 146 LHA-KGILHKDLKSKNVFYDNGK--VVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLA 202
Query: 308 PELIFGATE--------YTTAIDMWSIGCVLAELLLGQPLFPG 342
PE+I + ++ D++++G + EL + F
Sbjct: 203 PEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT 245
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-26
Identities = 55/219 (25%), Positives = 90/219 (41%), Gaps = 28/219 (12%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVL-----QDKRYK---NRELQIMRLLNHP 190
Y R+VG G G V++A+ VA+K ++ D ++ RE + L P
Sbjct: 36 YRLRRLVGRGGMGDVYEAEDTVRERIVALK-LMSETLSSDPVFRTRMQREARTAGRLQEP 94
Query: 191 NVVSLKHCFFSTTEKDELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICR 249
+VV + E D + + I+ + R + QI
Sbjct: 95 HVVPI----HDFGEIDGQLY-VDMRLINGVDL----AAMLRRQGPLAPPRAVAIVRQIGS 145
Query: 250 ALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI----SYICSRYY 305
AL+ H G HRD+KP+N+LV+ + DFG A + + + + + YY
Sbjct: 146 ALDAAHAA-GATHRDVKPENILVSA-DDFAYLVDFGIASAT--TDEKLTQLGNTVGTLYY 201
Query: 306 RAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGES 344
APE + T D++++ CVL E L G P + G+
Sbjct: 202 MAPERFSES-HATYRADIYALTCVLYECLTGSPPYQGDQ 239
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 64/241 (26%), Positives = 108/241 (44%), Gaps = 37/241 (15%)
Query: 122 IATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVL-----QDKRY 176
+ + R Y ++G G V A+ L VA+K VL +D +
Sbjct: 6 TPSHLSDR---------YELGEILGFGGMSEVHLARDLRDHRDVAVK-VLRADLARDPSF 55
Query: 177 KNR---ELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN---LVLEYIS-ETVYRVSKHYT 229
R E Q LNHP +V++ + T E + +V+EY+ T+ +
Sbjct: 56 YLRFRREAQNAAALNHPAIVAV----YDTGEAETPAGPLPYIVMEYVDGVTL----RDIV 107
Query: 230 RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289
+ C+ALN+ H G+ HRD+KP N++++ T+ +K+ DFG A+
Sbjct: 108 HTEGPMTPKRAIEVIADACQALNFSHQN-GIIHRDVKPANIMISA-TNAVKVMDFGIARA 165
Query: 290 LVPGEPNISY----ICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESG 345
+ +++ I + Y +PE G + D++S+GCVL E+L G+P F G+S
Sbjct: 166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSV-DARSDVYSLGCVLYEVLTGEPPFTGDSP 224
Query: 346 V 346
V
Sbjct: 225 V 225
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 57/254 (22%), Positives = 103/254 (40%), Gaps = 37/254 (14%)
Query: 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVL-QDKRYKNRELQI--MRLLNHPNV 192
++ V G FG V++A+ + VA+K QDK+ E ++ + + H N+
Sbjct: 23 SMPLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENI 80
Query: 193 VS-LKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRA 250
+ + T+ +L+L + + + ++ + + N + + R
Sbjct: 81 LQFIGAEKRGTSVDVDLWL--ITAFHEKGSLS----DFLKANVVSWNELCHIA-ETMARG 133
Query: 251 LNYLHHVV---------GVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC 301
L YLH + + HRDIK +N+L+ + I DFG A G+ S
Sbjct: 134 LAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNN-LTACIADFGLALKFEAGK---SAGD 189
Query: 302 SRY------YRAPELIFGA----TEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVE 351
+ Y APE++ GA + IDM+++G VL EL G L
Sbjct: 190 THGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPF 249
Query: 352 IIKILGTPTREEIK 365
+I P+ E+++
Sbjct: 250 EEEIGQHPSLEDMQ 263
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-25
Identities = 52/231 (22%), Positives = 87/231 (37%), Gaps = 36/231 (15%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKV-LQDKRYKNRELQIMRL--LNHPNVVSLKHC 198
++G G +G V++ VA+K +++ E I R+ + H N+
Sbjct: 18 LELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVG 75
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVS-KHYTRMNQHVPILYVQLYTYQICRALNYLH-- 255
T + LV+EY S Y ++ + +L + + R L YLH
Sbjct: 76 DERVTADGRMEYLLVMEYYP----NGSLXKYLSLHTSDWVSSCRL-AHSVTRGLAYLHTE 130
Query: 256 ------HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRY----- 304
+ + HRD+ +N+LV I DFG + L
Sbjct: 131 LPRGDHYKPAISHRDLNSRNVLVKNDGT-CVISDFGLSMRLTGNRLVRPGEEDNAAISEV 189
Query: 305 ----YRAPELIFGA------TEYTTAIDMWSIGCVLAELLLG-QPLFPGES 344
Y APE++ GA +DM+++G + E+ + LFPGES
Sbjct: 190 GTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 2e-22
Identities = 56/237 (23%), Positives = 100/237 (42%), Gaps = 50/237 (21%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS----VAIKKVLQDKRYKN-----RELQIMRLLNHPNV 192
+V+G+G+FG V++ + G+ VAIK++ + K E +M +++P+V
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQ-HVPILYVQLYTYQICRAL 251
L + L+ + + + Y R ++ ++ Y+ + QI + +
Sbjct: 80 CRL----LGICLTSTVQ--LITQLMP---FGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 130
Query: 252 NYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR--- 306
NYL +V HRD+ +N+LV +KI DFG AK+L E Y
Sbjct: 131 NYLEDRRLV---HRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEK--------EYHAEG 178
Query: 307 --------APE-LIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVD--QLVE 351
A E ++ YT D+WS G + EL+ G + G + ++E
Sbjct: 179 GKVPIKWMALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 5e-21
Identities = 60/218 (27%), Positives = 104/218 (47%), Gaps = 46/218 (21%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS----VAIKKVLQDKRYKN-----RELQIMRLLNHPNV 192
+ +G G+FG V + D+ VA+KK LQ ++ RE++I++ L H N+
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKK-LQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL--YTYQICRA 250
V K L L++EY+ Y + Y + ++ I +++L YT QIC+
Sbjct: 74 VKYKGV---CYSAGRRNLKLIMEYLP---YGSLRDYLQKHKE-RIDHIKLLQYTSQICKG 126
Query: 251 LNYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR-- 306
+ YL + HRD+ +N+LV + +++KI DFG K+L + +++
Sbjct: 127 MEYLGTKRYI---HRDLATRNILVE-NENRVKIGDFGLTKVLPQDKE--------FFKVK 174
Query: 307 ----------APELIFGATEYTTAIDMWSIGCVLAELL 334
APE + ++++ A D+WS G VL EL
Sbjct: 175 EPGESPIFWYAPESLT-ESKFSVASDVWSFGVVLYELF 211
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 5e-21
Identities = 56/238 (23%), Positives = 100/238 (42%), Gaps = 49/238 (20%)
Query: 140 MAERVVGTGSFGVVFQAKCLETGDS--VAIKKV---LQDKRYKN---RELQIMRLLNHPN 191
+ ++ +G+G+FG V + VA+K + D K+ E +M+ L++P
Sbjct: 20 LEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPY 79
Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
+V + E + LV+E Y + N+HV + +Q+ +
Sbjct: 80 IVRM----IGICEAESWM--LVMEMAE---LGPLNKYLQQNRHVKDKNIIELVHQVSMGM 130
Query: 252 NYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR--- 306
YL + V HRD+ +N+L+ H KI DFG +K L E YY+
Sbjct: 131 KYLEESNFV---HRDLAARNVLLVTQ-HYAKISDFGLSKALRADEN--------YYKAQT 178
Query: 307 ---------APE-LIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVD--QLVE 351
APE + + ++++ D+WS G ++ E GQ + G G + ++E
Sbjct: 179 HGKWPVKWYAPECINYY--KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 234
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 1e-20
Identities = 63/235 (26%), Positives = 99/235 (42%), Gaps = 44/235 (18%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS----VAIKKVLQDKRYKN-----RELQIMRLLNHPNV 192
R +G G FG V T D VA+K + D ++ +E+ I+R L H ++
Sbjct: 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
+ K C + L LV+EY+ + Y + + + + L+ QIC +
Sbjct: 96 IKYKGC---CEDAGAASLQLVMEYVP---LGSLRDYLPRHS-IGLAQLLLFAQQICEGMA 148
Query: 253 YLH--HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR---- 306
YLH H + HRD+ +N+L++ + +KI DFG AK + G YYR
Sbjct: 149 YLHAQHYI---HRDLAARNVLLD-NDRLVKIGDFGLAKAVPEGH--------EYYRVRED 196
Query: 307 --------APELIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVDQLVEI 352
APE + + A D+WS G L ELL + +L+ I
Sbjct: 197 GDSPVFWYAPECLKEYK-FYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGI 250
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 1e-20
Identities = 63/218 (28%), Positives = 95/218 (43%), Gaps = 45/218 (20%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS----VAIKKVLQDKRYKN-----RELQIMRLLNHPNV 192
R +G G FG V + GD+ VA+K + + + +E++I+R L H N+
Sbjct: 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL--YTYQICRA 250
V K TE + L++E++ K Y N++ I Q Y QIC+
Sbjct: 86 VKYKGI---CTEDGGNGIKLIMEFLP---SGSLKEYLPKNKN-KINLKQQLKYAVQICKG 138
Query: 251 LNYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR-- 306
++YL V HRD+ +N+LV HQ+KI DFG K + + YY
Sbjct: 139 MDYLGSRQYV---HRDLAARNVLVE-SEHQVKIGDFGLTKAIETDK--------EYYTVK 186
Query: 307 ----------APELIFGATEYTTAIDMWSIGCVLAELL 334
APE + + + A D+WS G L ELL
Sbjct: 187 DDRDSPVFWYAPECLMQSK-FYIASDVWSFGVTLHELL 223
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 1e-20
Identities = 57/220 (25%), Positives = 90/220 (40%), Gaps = 37/220 (16%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN--RELQIMRLLNHPNVVSLKHCF 199
+ +G G FG V G+ VA+K + D + E +M L H N+V L
Sbjct: 26 LQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGV- 82
Query: 200 FSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL--YTYQICRALNYL--H 255
EK LY +V EY++ Y R + L ++ +C A+ YL +
Sbjct: 83 -IVEEKGGLY--IVTEYMA---KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 136
Query: 256 HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR------APE 309
+ V HRD+ +N+LV+ + K+ DFG K + APE
Sbjct: 137 NFV---HRDLAARNVLVSED-NVAKVSDFGLTKEA--------SSTQDTGKLPVKWTAPE 184
Query: 310 -LIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVD 347
L +++T D+WS G +L E+ G+ +P D
Sbjct: 185 ALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD 222
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 2e-20
Identities = 44/235 (18%), Positives = 84/235 (35%), Gaps = 50/235 (21%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS-------VAIKKVLQDKRYKN----RELQIMRLLNHP 190
+G G+F +F+ E GD V +K + + R + +M L+H
Sbjct: 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 191 NVVSLKH-CFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL-YTYQIC 248
++V C DE LV E++ + Y + N++ + +L Q+
Sbjct: 73 HLVLNYGVC----VCGDENI--LVQEFVK---FGSLDTYLKKNKNCINILWKLEVAKQLA 123
Query: 249 RALNYL--HHVVGVCHRDIKPQNLLVNPHTHQL-------KICDFGSAKMLVPGEPNISY 299
A+++L + ++ H ++ +N+L+ + K+ D G + ++P +
Sbjct: 124 AAMHFLEENTLI---HGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD----- 175
Query: 300 ICSRYYR------APELIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVD 347
+ PE I A D WS G L E+ G
Sbjct: 176 ----ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR 226
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 2e-20
Identities = 56/215 (26%), Positives = 89/215 (41%), Gaps = 37/215 (17%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN--RELQIMRLLNHPNVVSLKHCF 199
+ +G G FG V G+ VA+K + D + E +M L H N+V L
Sbjct: 198 LQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGV- 254
Query: 200 FSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL--YTYQICRALNYL--H 255
EK LY +V EY++ Y R + L ++ +C A+ YL +
Sbjct: 255 -IVEEKGGLY--IVTEYMA---KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 308
Query: 256 HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR------APE 309
+ V HRD+ +N+LV+ + K+ DFG K + APE
Sbjct: 309 NFV---HRDLAARNVLVSED-NVAKVSDFGLTKEA--------SSTQDTGKLPVKWTAPE 356
Query: 310 -LIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPG 342
L +++T D+WS G +L E+ G+ +P
Sbjct: 357 ALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPR 389
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 2e-20
Identities = 48/238 (20%), Positives = 90/238 (37%), Gaps = 50/238 (21%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS---VAIKKVLQDKRYKN------RELQIMRLLNHPNV 192
R++G G FG V +A+ + S VA+K + D + RE M+ +HP+V
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87
Query: 193 VSLKH-CFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHV----PILYVQL--YTY 245
L S + ++L ++ + + ++ + L +
Sbjct: 88 AKLVGVSLRSRAKGRLPIPMVILPFMK---HGDLHAFLLASRIGENPFNLPLQTLVRFMV 144
Query: 246 QICRALNYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSR 303
I + YL + + HRD+ +N ++ + + DFG ++ + G+
Sbjct: 145 DIACGMEYLSSRNFI---HRDLAARNCMLAED-MTVCVADFGLSRKIYSGD--------- 191
Query: 304 YYR------------APE-LIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVD 347
YYR A E L YT D+W+ G + E++ GQ + G +
Sbjct: 192 YYRQGCASKLPVKWLALESLADN--LYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE 247
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 3e-20
Identities = 59/217 (27%), Positives = 102/217 (47%), Gaps = 44/217 (20%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS----VAIK--KVLQDKRYKN--RELQIMRLLNHPNVV 193
+ +G G+FG V + D+ VA+K + ++ ++ RE++I++ L H N+V
Sbjct: 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 105
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL--YTYQICRAL 251
K L L++EY+ R Y + ++ I +++L YT QIC+ +
Sbjct: 106 KYKGV---CYSAGRRNLKLIMEYLPYGSLR---DYLQKHKE-RIDHIKLLQYTSQICKGM 158
Query: 252 NYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR--- 306
YL + HRD+ +N+LV +++KI DFG K+L + YY+
Sbjct: 159 EYLGTKRYI---HRDLATRNILVENE-NRVKIGDFGLTKVLPQDK--------EYYKVKE 206
Query: 307 ---------APELIFGATEYTTAIDMWSIGCVLAELL 334
APE + ++++ A D+WS G VL EL
Sbjct: 207 PGESPIFWYAPESLT-ESKFSVASDVWSFGVVLYELF 242
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 4e-20
Identities = 57/236 (24%), Positives = 98/236 (41%), Gaps = 48/236 (20%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS----VAIKKVLQDKRYKN-----RELQIMRLLNHPNV 192
+V+G+G+FG V++ + G+ VAIK++ + K E +M +++P+V
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQ-HVPILYVQLYTYQICRAL 251
L + L+ + + Y R ++ ++ Y+ + QI + +
Sbjct: 80 CRL----LGICLTSTVQ--LITQLMPFGCLL---DYVREHKDNIGSQYLLNWCVQIAKGM 130
Query: 252 NYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR--- 306
NYL +V HRD+ +N+LV +KI DFG AK+L E Y
Sbjct: 131 NYLEDRRLV---HRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEK--------EYHAEG 178
Query: 307 --------APELIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVD--QLVE 351
A E I YT D+WS G + EL+ G + G + ++E
Sbjct: 179 GKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 5e-20
Identities = 59/218 (27%), Positives = 93/218 (42%), Gaps = 46/218 (21%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS----VAIKKVLQDKRYKN-----RELQIMRLLNHPNV 192
+G G+FG V + GD+ VA+K LQ RE+QI++ L+ +
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVK-QLQHSGPDQQRDFQREIQILKALHSDFI 86
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQ-HVPILYVQLYTYQICRAL 251
V + + + L LV+EY+ + + + ++ + + LY+ QIC+ +
Sbjct: 87 VKYRGVSYGPGRQS-LR--LVMEYLP---SGCLRDFLQRHRARLDASRLLLYSSQICKGM 140
Query: 252 NYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR--- 306
YL V HRD+ +N+LV +KI DFG AK+L + YY
Sbjct: 141 EYLGSRRCV---HRDLAARNILVE-SEAHVKIADFGLAKLLPLDK--------DYYVVRE 188
Query: 307 ---------APE-LIFGATEYTTAIDMWSIGCVLAELL 334
APE L ++ D+WS G VL EL
Sbjct: 189 PGQSPIFWYAPESLSDN--IFSRQSDVWSFGVVLYELF 224
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 9e-20
Identities = 51/226 (22%), Positives = 91/226 (40%), Gaps = 45/226 (19%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNHPNVVSLKH- 197
+ +G+G FG+V L VAIK + + + E ++M L+HP +V L
Sbjct: 13 VQEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 71
Query: 198 CFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLY-TYQICRALNYL-- 254
C E+ + LV E++ + Y R + + L +C + YL
Sbjct: 72 C----LEQAPIC--LVTEFME---HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE 122
Query: 255 HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR-------- 306
V+ HRD+ +N LV + +K+ DFG + ++ + Y
Sbjct: 123 ACVI---HRDLAARNCLVGEN-QVIKVSDFGMTRFVLDDQ---------YTSSTGTKFPV 169
Query: 307 ---APE-LIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVD 347
+PE F Y++ D+WS G ++ E+ G+ + S +
Sbjct: 170 KWASPEVFSFS--RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE 213
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 9e-20
Identities = 49/236 (20%), Positives = 88/236 (37%), Gaps = 47/236 (19%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS---VAIKKVLQDKRYKN------RELQIMRLLNHPNV 192
+++G G FG V + + + VA+K + D + E M+ +HPNV
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISE----TVYRVSKHYTRMNQHVPILYVQL-YTYQI 247
+ L + + ++L ++ T S+ T L L + I
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLET--GPKHIPLQTLLKFMVDI 156
Query: 248 CRALNYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYY 305
+ YL + + HRD+ +N ++ + + DFG +K + G+ YY
Sbjct: 157 ALGMEYLSNRNFL---HRDLAARNCMLRDD-MTVCVADFGLSKKIYSGD---------YY 203
Query: 306 R------------APE-LIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVD 347
R A E L YT+ D+W+ G + E+ G +PG +
Sbjct: 204 RQGRIAKMPVKWIAIESLADRV--YTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE 257
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 1e-19
Identities = 52/222 (23%), Positives = 94/222 (42%), Gaps = 45/222 (20%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNHPNVVSLKHC 198
+ +G G +G V++ + +VA+K + +D +E +M+ + HPN+V L
Sbjct: 18 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL--YTYQICRALNYL-- 254
T + Y ++ E+++ Y Y R + V L QI A+ YL
Sbjct: 78 ---CTREPPFY--IITEFMT---YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 129
Query: 255 HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR-------- 306
+ + HRD+ +N LV + H +K+ DFG ++ + Y
Sbjct: 130 KNFI---HRDLAARNCLVGEN-HLVKVADFGLSR----------LMTGDTYTAHAGAKFP 175
Query: 307 ----APE-LIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPG 342
APE L + +++ D+W+ G +L E+ G +PG
Sbjct: 176 IKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPG 215
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 1e-19
Identities = 55/233 (23%), Positives = 98/233 (42%), Gaps = 49/233 (21%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNHPNVVSLKH- 197
+ +G+G FGVV K D VA+K + + ++ +E Q M L+HP +V
Sbjct: 13 LKELGSGQFGVVKLGKWKGQYD-VAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGV 71
Query: 198 CFFSTTEKDELYLNLVLEYISETVYRVS-KHYTRMNQHVPILYVQLY-TYQICRALNYL- 254
C +++ +Y +V EYIS +Y R + L Y +C + +L
Sbjct: 72 C----SKEYPIY--IVTEYIS----NGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE 121
Query: 255 -HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR------- 306
H + HRD+ +N LV+ +K+ DFG + ++ + Y
Sbjct: 122 SHQFI---HRDLAARNCLVDRD-LCVKVSDFGMTRYVLDDQ---------YVSSVGTKFP 168
Query: 307 ----APE-LIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESG--VDQLVE 351
APE + +Y++ D+W+ G ++ E+ LG+ + + V V
Sbjct: 169 VKWSAPEVFHYF--KYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS 219
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 1e-19
Identities = 52/231 (22%), Positives = 95/231 (41%), Gaps = 38/231 (16%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS----VAIKKVLQDKRYKN-----RELQIMRLLNHPNV 192
+V+G+G FG V + + G+S V IK + ++ + + L+H ++
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQ-HVPILYVQLYTYQICRAL 251
V L L LV +Y+ + R ++ + + + QI + +
Sbjct: 78 VRL----LGLCPGSSLQ--LVTQYLPLGSLL---DHVRQHRGALGPQLLLNWGVQIAKGM 128
Query: 252 NYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR--- 306
YL H +V HR++ +N+L+ Q+++ DFG A +L P+ + +
Sbjct: 129 YYLEEHGMV---HRNLAARNVLLKSP-SQVQVADFGVADLL---PPDDKQLLYSEAKTPI 181
Query: 307 ---APELIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVD--QLVE 351
A E I YT D+WS G + EL+ G + G + L+E
Sbjct: 182 KWMALESIHFGK-YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE 231
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 1e-19
Identities = 57/233 (24%), Positives = 95/233 (40%), Gaps = 49/233 (21%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS---VAIK--KVLQDKRYKN---RELQIMRLLNHPNVV 193
V+G G FG V+ L+ A+K + D + E IM+ +HPNV+
Sbjct: 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL-YTYQICRALN 252
SL + +VL Y+ + +++ R H P + + + Q+ + +
Sbjct: 90 SLLGI--CLRSEGSPL--VVLPYMK---HGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 142
Query: 253 YL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR---- 306
YL V HRD+ +N +++ +K+ DFG A+ + E YY
Sbjct: 143 YLASKKFV---HRDLAARNCMLDEK-FTVKVADFGLARDMYDKE---------YYSVHNK 189
Query: 307 ----------APE-LIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVD 347
A E L ++TT D+WS G +L EL+ G P +P + D
Sbjct: 190 TGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 240
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 1e-19
Identities = 52/226 (23%), Positives = 97/226 (42%), Gaps = 33/226 (14%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNHPNVVSLKHC 198
+ +G G +G V++ + +VA+K + +D +E +M+ + HPN+V L
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 284
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL--YTYQICRALNYL-- 254
T + Y ++ E+++ Y Y R + V L QI A+ YL
Sbjct: 285 ---CTREPPFY--IITEFMT---YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 336
Query: 255 HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR------AP 308
+ + HR++ +N LV H +K+ DFG ++++ Y + AP
Sbjct: 337 KNFI---HRNLAARNCLVG-ENHLVKVADFGLSRLMTGDT----YTAHAGAKFPIKWTAP 388
Query: 309 ELIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVD--QLVE 351
E + ++ D+W+ G +L E+ G +PG +L+E
Sbjct: 389 ESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 433
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 2e-19
Identities = 59/238 (24%), Positives = 96/238 (40%), Gaps = 49/238 (20%)
Query: 140 MAERVVGTGSFGVVFQAKCLETGDS--VAIKKVLQDKRYKNR-----ELQIMRLLNHPNV 192
+A+ +G G+FG V Q VAIK + Q + E QIM L++P +
Sbjct: 13 IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI 72
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQ-HVPILYVQLYTYQICRAL 251
V L + + L LV+E + + +P+ V +Q+ +
Sbjct: 73 VRL----IGVCQAEALM--LVMEMAG---GGPLHKFLVGKREEIPVSNVAELLHQVSMGM 123
Query: 252 NYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR--- 306
YL + V HRD+ +N+L+ + H KI DFG +K L + YY
Sbjct: 124 KYLEEKNFV---HRDLAARNVLLV-NRHYAKISDFGLSKALGADDS--------YYTARS 171
Query: 307 ---------APE-LIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVD--QLVE 351
APE + F ++++ D+WS G + E L GQ + G + +E
Sbjct: 172 AGKWPLKWYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE 227
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 2e-19
Identities = 59/254 (23%), Positives = 97/254 (38%), Gaps = 60/254 (23%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS-----VAIKKV-----LQDKRYKNRELQIM-RLLNHP 190
+ +G G+FG V +A S VA+K + L ++ EL+++ L NH
Sbjct: 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87
Query: 191 NVVSLKHCFFSTTEKDELYLNLVLEYIS-------------ETVYRVSKHYTRMNQHVPI 237
N+V+L T ++ EY + + + + +
Sbjct: 88 NIVNLLGA---CTIGGPTL--VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 238 LYVQLYT--YQICRALNYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293
L + YQ+ + + +L + + HRD+ +N+L+ KICDFG A+ +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKNCI---HRDLAARNILLTHG-RITKICDFGLARDIKND 198
Query: 294 EPNISYICSRYYR------------APELIFGATEYTTAIDMWSIGCVLAELL-LGQPLF 340
Y APE IF YT D+WS G L EL LG +
Sbjct: 199 S---------NYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPY 248
Query: 341 PGESGVDQLVEIIK 354
PG + ++IK
Sbjct: 249 PGMPVDSKFYKMIK 262
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 2e-19
Identities = 52/232 (22%), Positives = 96/232 (41%), Gaps = 47/232 (20%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNHPNVVSLKHC 198
+G G FG V+ VA+K + Q + E +M+ L H +V L
Sbjct: 18 VERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL--- 73
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL--YTYQICRALNYL-- 254
++ ++ +Y ++ EY+ + + + + +L QI + ++
Sbjct: 74 -YAVVTQEPIY--IITEYMENGSLV---DFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 255 HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR-------- 306
+ + HRD++ N+LV+ KI DFG A+++ E Y
Sbjct: 128 RNYI---HRDLRAANILVSDT-LSCKIADFGLARLIEDNE---------YTAREGAKFPI 174
Query: 307 ---APE-LIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESG--VDQLVE 351
APE + +G +T D+WS G +L E++ G+ +PG + V Q +E
Sbjct: 175 KWTAPEAINYG--TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE 224
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 3e-19
Identities = 59/227 (25%), Positives = 96/227 (42%), Gaps = 37/227 (16%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNHPNVVSLKHC 198
E +G G FG V+ T VAIK + +E Q+M+ L H +V L
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--- 244
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVS-KHYTRMNQHVPILYVQL--YTYQICRALNYL- 254
++ ++ +Y +V EY+S+ S + + + QL QI + Y+
Sbjct: 245 -YAVVSEEPIY--IVTEYMSKG----SLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 297
Query: 255 -HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR------A 307
+ V HRD++ N+LV + K+ DFG A+++ E Y + + A
Sbjct: 298 RMNYV---HRDLRAANILVGEN-LVCKVADFGLARLIEDNE----YTARQGAKFPIKWTA 349
Query: 308 PELIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVD--QLVE 351
PE +T D+WS G +L EL G+ +PG + VE
Sbjct: 350 PEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 395
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 89.6 bits (222), Expect = 3e-19
Identities = 57/232 (24%), Positives = 94/232 (40%), Gaps = 47/232 (20%)
Query: 140 MAERVVGTGSFGVVFQAKCLETGDS--VAIKKVLQDKRYKNR-----ELQIMRLLNHPNV 192
+A+ +G G+FG V Q VAIK + Q + E QIM L++P +
Sbjct: 339 IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI 398
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQ-HVPILYVQLYTYQICRAL 251
V L + + L LV+E + + +P+ V +Q+ +
Sbjct: 399 VRL----IGVCQAEALM--LVMEMAG---GGPLHKFLVGKREEIPVSNVAELLHQVSMGM 449
Query: 252 NYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR--- 306
YL + V HR++ +N+L+ + H KI DFG +K L + YY
Sbjct: 450 KYLEEKNFV---HRNLAARNVLLV-NRHYAKISDFGLSKALGADDS--------YYTARS 497
Query: 307 ---------APE-LIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVD 347
APE + F ++++ D+WS G + E L GQ + G +
Sbjct: 498 AGKWPLKWYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE 547
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 4e-19
Identities = 55/237 (23%), Positives = 94/237 (39%), Gaps = 49/237 (20%)
Query: 142 ERVVGTGSFGVVFQAKCLETGD---SVAIKKVLQDKRYKNR-----ELQIMRLLNHPNVV 193
E+++G+G G V + G VAIK + + R E IM +HPN++
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 194 SLKH-CFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL-YTYQICRAL 251
L+ T +V EY+ + R + + + + +
Sbjct: 114 RLEGVV----TRGRLAM--IVTEYME---NGSLDTFLRTHDGQFTIMQLVGMLRGVGAGM 164
Query: 252 NYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR--- 306
YL V HRD+ +N+LV+ + K+ DFG +++L E + Y
Sbjct: 165 RYLSDLGYV---HRDLAARNVLVDSN-LVCKVSDFGLSRVL---EDDPDA----AYTTTG 213
Query: 307 --------APE-LIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVD--QLVE 351
APE + F +++A D+WS G V+ E+L G+ + + D VE
Sbjct: 214 GKIPIRWTAPEAIAFR--TFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE 268
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 4e-19
Identities = 61/243 (25%), Positives = 103/243 (42%), Gaps = 51/243 (20%)
Query: 133 PKQTISYMAERVVGTGSFGVVFQAKCLETGDS---VAIK--KVLQDKRYKN---RELQIM 184
P + + ++RV+G G FGVV+ + ++ + AIK + + + RE +M
Sbjct: 17 PHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLM 76
Query: 185 RLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVS-KHYTRMNQHVPILYVQL- 242
R LNHPNV++L + + ++L Y+ + R Q P + +
Sbjct: 77 RGLNHPNVLALIGI--MLPPEGLPH--VLLPYMC----HGDLLQFIRSPQRNPTVKDLIS 128
Query: 243 YTYQICRALNYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYI 300
+ Q+ R + YL V HRD+ +N +++ + +K+ DFG A+ ++ E
Sbjct: 129 FGLQVARGMEYLAEQKFV---HRDLAARNCMLD-ESFTVKVADFGLARDILDRE------ 178
Query: 301 CSRYYR--------------APE-LIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGES 344
YY A E L +TT D+WS G +L ELL G P +
Sbjct: 179 ---YYSVQQHRHARLPVKWTALESLQTYR--FTTKSDVWSFGVLLWELLTRGAPPYRHID 233
Query: 345 GVD 347
D
Sbjct: 234 PFD 236
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 5e-19
Identities = 56/231 (24%), Positives = 87/231 (37%), Gaps = 51/231 (22%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR-----ELQIMRLLNHPNVVSLK 196
+G G+FG VF + VA+K + + E +I++ +HPN+V L
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL- 177
Query: 197 H--CFFSTTEKDELYLNLVLEYISETVYRVS-KHYTRMNQHVPILYVQL-YTYQICRALN 252
C T+K +Y +V+E + + R + L +
Sbjct: 178 IGVC----TQKQPIY--IVMELVQGG----DFLTFLRTEGARLRVKTLLQMVGDAAAGME 227
Query: 253 YLH--HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR---- 306
YL + HRD+ +N LV + LKI DFG ++ G Y
Sbjct: 228 YLESKCCI---HRDLAARNCLVTEK-NVLKISDFGMSREEADGV---------YAASGGL 274
Query: 307 --------APE-LIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVD 347
APE L +G Y++ D+WS G +L E LG +P S
Sbjct: 275 RQVPVKWTAPEALNYG--RYSSESDVWSFGILLWETFSLGASPYPNLSNQQ 323
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 7e-19
Identities = 53/232 (22%), Positives = 100/232 (43%), Gaps = 47/232 (20%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNHPNVVSLKHC 198
E+ +G G FG V+ A + VA+K + E +M+ L H +V L
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKL--- 248
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL--YTYQICRALNYL-- 254
+ K+ +Y ++ E+++ + + ++ +L ++ QI + ++
Sbjct: 249 -HAVVTKEPIY--IITEFMA---KGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ 302
Query: 255 HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR-------- 306
+ + HRD++ N+LV+ KI DFG A+++ E Y
Sbjct: 303 RNYI---HRDLRAANILVSAS-LVCKIADFGLARVIEDNE---------YTAREGAKFPI 349
Query: 307 ---APE-LIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVD--QLVE 351
APE + FG +T D+WS G +L E++ G+ +PG S + + +E
Sbjct: 350 KWTAPEAINFG--SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE 399
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 8e-19
Identities = 53/226 (23%), Positives = 99/226 (43%), Gaps = 45/226 (19%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNHPNVVSLKH- 197
+ +GTG FGVV K D VAIK + + ++ E ++M L+H +V L
Sbjct: 29 LKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 87
Query: 198 CFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLY-TYQICRALNYL-- 254
C T++ ++ ++ EY++ +Y R +H L +C A+ YL
Sbjct: 88 C----TKQRPIF--IITEYMA---NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES 138
Query: 255 HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR-------- 306
+ HRD+ +N LVN +K+ DFG ++ ++ E Y
Sbjct: 139 KQFL---HRDLAARNCLVNDQ-GVVKVSDFGLSRYVLDDE---------YTSSVGSKFPV 185
Query: 307 ---APE-LIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVD 347
PE L++ ++++ D+W+ G ++ E+ LG+ + + +
Sbjct: 186 RWSPPEVLMYS--KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE 229
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 9e-19
Identities = 59/230 (25%), Positives = 101/230 (43%), Gaps = 48/230 (20%)
Query: 142 ERVVGTGSFGVVFQAKCLETGD---SVAIKKVLQDKRYKNR-----ELQIMRLLNHPNVV 193
R++G G FG V++ +VA+K +D N+ E IM+ L+HP++V
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL-YTYQICRALN 252
L E++ + +++E Y HY N++ + + Y+ QIC+A+
Sbjct: 77 KL----IGIIEEEPTW--IIMELYP---YGELGHYLERNKNSLKVLTLVLYSLQICKAMA 127
Query: 253 YL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR---- 306
YL + V HRDI +N+LV +K+ DFG ++ + + YY+
Sbjct: 128 YLESINCV---HRDIAVRNILVASP-ECVKLGDFGLSRYIEDED---------YYKASVT 174
Query: 307 -------APE-LIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVD 347
+PE + F +TTA D+W + E+L G+ F D
Sbjct: 175 RLPIKWMSPESINFRR--FTTASDVWMFAVCMWEILSFGKQPFFWLENKD 222
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 9e-19
Identities = 54/230 (23%), Positives = 95/230 (41%), Gaps = 43/230 (18%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS---VAIK--KVLQDKRYKN---RELQIMRLLNHPNVV 193
V+G G FG V+ L+ A+K + D + E IM+ +HPNV+
Sbjct: 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL-YTYQICRALN 252
SL + +VL Y+ + +++ R H P + + + Q+ + +
Sbjct: 154 SLLGI--CLRSEGSPL--VVLPYMK---HGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 206
Query: 253 YL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR---- 306
+L V HRD+ +N +++ +K+ DFG A+ + E + +
Sbjct: 207 FLASKKFV---HRDLAARNCMLDEK-FTVKVADFGLARDMYDKEFD------SVHNKTGA 256
Query: 307 -------APE-LIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVD 347
A E L ++TT D+WS G +L EL+ G P +P + D
Sbjct: 257 KLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 304
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 87.6 bits (217), Expect = 1e-18
Identities = 59/227 (25%), Positives = 96/227 (42%), Gaps = 37/227 (16%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNHPNVVSLKHC 198
E +G G FG V+ T VAIK + +E Q+M+ L H +V L
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--- 327
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVS-KHYTRMNQHVPILYVQL--YTYQICRALNYL- 254
++ ++ +Y +V EY+S+ S + + + QL QI + Y+
Sbjct: 328 -YAVVSEEPIY--IVTEYMSKG----SLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 380
Query: 255 -HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR------A 307
+ V HRD++ N+LV + K+ DFG A+++ E Y + + A
Sbjct: 381 RMNYV---HRDLRAANILVGEN-LVCKVADFGLARLIEDNE----YTARQGAKFPIKWTA 432
Query: 308 PELIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVD--QLVE 351
PE +T D+WS G +L EL G+ +PG + VE
Sbjct: 433 PEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 478
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 1e-18
Identities = 55/245 (22%), Positives = 97/245 (39%), Gaps = 54/245 (22%)
Query: 143 RVVGTGSFGVVFQAKCLETGDS-----VAIKKV-----LQDKRYKNRELQIMRLLNHPNV 192
R +G GSFG+V++ VAIK V ++++ E +M+ N +V
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISE----TVYRVSKHYTRMNQHVPILYVQ---LYTY 245
V L ++ +++E ++ + R + N + +
Sbjct: 91 VRLLGV---VSQGQPTL--VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 145
Query: 246 QICRALNYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSR 303
+I + YL + V HRD+ +N +V +KI DFG + + +
Sbjct: 146 EIADGMAYLNANKFV---HRDLAARNCMVAED-FTVKIGDFGMTRDIYETD--------- 192
Query: 304 YYR------------APE-LIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVDQL 349
YYR +PE L G +TT D+WS G VL E+ L + + G S +Q+
Sbjct: 193 YYRKGGKGLLPVRWMSPESLKDG--VFTTYSDVWSFGVVLWEIATLAEQPYQGLS-NEQV 249
Query: 350 VEIIK 354
+ +
Sbjct: 250 LRFVM 254
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 1e-18
Identities = 57/231 (24%), Positives = 94/231 (40%), Gaps = 47/231 (20%)
Query: 142 ERVVGTGSFGVVFQAKCLETGD---SVAIKKVLQDKRYKNR-----ELQIMRLLNHPNVV 193
++VVG G FG V + SVAIK + K R E IM +HPN++
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 194 SLKH-CFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL-YTYQICRAL 251
L+ T+ + +V EY+ + R + + + I +
Sbjct: 110 RLEGVV----TKSKPVM--IVTEYME---NGSLDSFLRKHDAQFTVIQLVGMLRGIASGM 160
Query: 252 NYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR--- 306
YL V HRD+ +N+L+N + K+ DFG ++L E + Y
Sbjct: 161 KYLSDMGYV---HRDLAARNILINSN-LVCKVSDFGLGRVL---EDDPEA----AYTTRG 209
Query: 307 --------APE-LIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVD 347
+PE + + ++T+A D+WS G VL E++ G+ + S D
Sbjct: 210 GKIPIRWTSPEAIAYR--KFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD 258
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 2e-18
Identities = 61/261 (23%), Positives = 103/261 (39%), Gaps = 63/261 (24%)
Query: 133 PKQTISYMAERVVGTGSFGVVFQAKCLETGDS-----VAIKKV----LQDKRYKNRELQI 183
++ I R +G G+FG VF A+C + VA+K + L ++ RE ++
Sbjct: 13 KRRDIVLK--RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAEL 70
Query: 184 MRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYIS-----------ETVYRVSKHYTRMN 232
+ L H ++V + D L +V EY+ +
Sbjct: 71 LTNLQHEHIVKFYGV---CGDGDPLI--MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQ 125
Query: 233 QHVPILYVQLY--TYQICRALNYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288
+ Q+ QI + YL H V HRD+ +N LV + +KI DFG ++
Sbjct: 126 AKGELGLSQMLHIASQIASGMVYLASQHFV---HRDLATRNCLVGAN-LLVKIGDFGMSR 181
Query: 289 MLVPGEPNISYICSRYYR------------APE-LIFGATEYTTAIDMWSIGCVLAELL- 334
+ + YYR PE +++ ++TT D+WS G +L E+
Sbjct: 182 DVYSTD---------YYRVGGHTMLPIRWMPPESIMYR--KFTTESDVWSFGVILWEIFT 230
Query: 335 LG-QPLFPGESGVDQLVEIIK 354
G QP + S +++E I
Sbjct: 231 YGKQP-WFQLS-NTEVIECIT 249
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 3e-18
Identities = 33/245 (13%), Positives = 54/245 (22%), Gaps = 57/245 (23%)
Query: 123 ATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVL----QDKRYKN 178
A GR Y G +QA VA+ V
Sbjct: 26 ARIANGR---------YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQ 76
Query: 179 R---ELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYI-SETVYRVSKHYTRMNQH 234
+ ++ P V + L +V E+I ++ V +
Sbjct: 77 ETLSRTLRLSRIDKPGVARV----LDVVHTRAGGL-VVAEWIRGGSLQEV------ADTS 125
Query: 235 VPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGE 294
+ + A + H GV P + V+ G + P
Sbjct: 126 PSPVGAIRAMQSLAAAADAAHRA-GVALSIDHPSRVRVSID---------GDVVLAYPA- 174
Query: 295 PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIK 354
D+ IG L LL+ + P L +
Sbjct: 175 ----------TMPDA--------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAER 216
Query: 355 ILGTP 359
Sbjct: 217 DTAGQ 221
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 4e-18
Identities = 58/236 (24%), Positives = 98/236 (41%), Gaps = 50/236 (21%)
Query: 142 ERVVGTGSFGVVFQAKCLETGD---SVAIKKVLQDKRYKNR-----ELQIMRLLNHPNVV 193
R +G G FG V Q + + +VAIK R E MR +HP++V
Sbjct: 20 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 79
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL-YTYQICRALN 252
L ++ ++ +++E + + + ++ ++ L + Y YQ+ AL
Sbjct: 80 KL----IGVITENPVW--IIMELCT---LGELRSFLQVRKYSLDLASLILYAYQLSTALA 130
Query: 253 YL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR---- 306
YL V HRDI +N+LV+ + +K+ DFG ++ + YY+
Sbjct: 131 YLESKRFV---HRDIAARNVLVSSN-DCVKLGDFGLSRYMEDST---------YYKASKG 177
Query: 307 -------APE-LIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVD--QLVE 351
APE + F +T+A D+W G + E+L G F G D +E
Sbjct: 178 KLPIKWMAPESINFRR--FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE 231
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 84.2 bits (207), Expect = 4e-18
Identities = 44/330 (13%), Positives = 91/330 (27%), Gaps = 74/330 (22%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKV-LQDKRYKN-----------RELQIMRLL----- 187
+G G FG VFQ VAIK + ++ N E+ I + L
Sbjct: 28 IGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSG 85
Query: 188 ----NHPNVVSLKHCFFSTTEKDELYLNLVLEYISE--------TVYRVSKHYTRM---- 231
+ L L L Y S ++ + + +
Sbjct: 86 EVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEF 145
Query: 232 ---------NQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKIC 282
+ + + +Q+ +L + HRD+ N+L+ + +
Sbjct: 146 GGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHY 205
Query: 283 DFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPG 342
+P L +YT + V ++ + + LF G
Sbjct: 206 TLNGKSSTIPS--------------CGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTG 251
Query: 343 ESGVDQLVEIIKILGTPTREEIKCMNP-------NYTEFKFPQIKAHPWHKIF--HKRMP 393
+ D +I +++ +P +Y K + K++
Sbjct: 252 DG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIK 309
Query: 394 PEALDLVSRLLQYSPSLRCTALEACAHPFF 423
+ + +L +S +A +
Sbjct: 310 RKIQEFHRTMLNFS-----SATDLLCQHSL 334
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 4e-18
Identities = 58/251 (23%), Positives = 100/251 (39%), Gaps = 57/251 (22%)
Query: 143 RVVGTGSFGVVFQAKCL-----ETGDSVAIKKV-----LQDKRYKNRELQIM-RLLNHPN 191
+ +G G+FG V +A T +VA+K + + R EL+I+ + +H N
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYI-----------SETVYRVSKHYTRMNQHVPILYV 240
VV+L T L +++E+ + K +
Sbjct: 93 VVNLLGA--CTKPGGPLM--VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 148
Query: 241 QL--YTYQICRALNYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPN 296
L Y++Q+ + + +L + HRD+ +N+L++ + +KICDFG A+ +
Sbjct: 149 HLICYSFQVAKGMEFLASRKCI---HRDLAARNILLSEK-NVVKICDFGLARDI------ 198
Query: 297 ISYICSRYYR------------APELIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGE 343
Y APE IF YT D+WS G +L E+ LG +PG
Sbjct: 199 ---YKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGV 254
Query: 344 SGVDQLVEIIK 354
++ +K
Sbjct: 255 KIDEEFCRRLK 265
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 5e-18
Identities = 61/251 (24%), Positives = 98/251 (39%), Gaps = 60/251 (23%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS-----VAIKKV----LQDKRYKNRELQIMRLLNHPNV 192
+ +G G+FG VF A+C VA+K + ++ RE +++ +L H ++
Sbjct: 46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI 105
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYI----------SETVYRVSKHYTRMNQHVPILYVQL 242
V TE L +V EY+ S P+ QL
Sbjct: 106 VRFFGV---CTEGRPLL--MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160
Query: 243 --YTYQICRALNYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS 298
Q+ + YL H V HRD+ +N LV +KI DFG ++ + +
Sbjct: 161 LAVASQVAAGMVYLAGLHFV---HRDLATRNCLVGQG-LVVKIGDFGMSRDIYSTD---- 212
Query: 299 YICSRYYR------------APE-LIFGATEYTTAIDMWSIGCVLAELL-LG-QPLFPGE 343
YYR PE +++ ++TT D+WS G VL E+ G QP +
Sbjct: 213 -----YYRVGGRTMLPIRWMPPESILYR--KFTTESDVWSFGVVLWEIFTYGKQP-WYQL 264
Query: 344 SGVDQLVEIIK 354
S + ++ I
Sbjct: 265 S-NTEAIDCIT 274
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 5e-18
Identities = 53/237 (22%), Positives = 96/237 (40%), Gaps = 48/237 (20%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS----VAIKKVLQDKRYKNR-----ELQIMRLLNHPNV 192
++V+G G FG V++ + VAIK + K R E IM +H N+
Sbjct: 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 193 VSLKH-CFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL-YTYQICRA 250
+ L+ ++ + ++ EY+ + R + + I
Sbjct: 109 IRLEGVI----SKYKPMM--IITEYME---NGALDKFLREKDGEFSVLQLVGMLRGIAAG 159
Query: 251 LNYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR-- 306
+ YL + V HRD+ +N+LVN + K+ DFG +++L E + Y
Sbjct: 160 MKYLANMNYV---HRDLAARNILVNSN-LVCKVSDFGLSRVL---EDDPEAT---YTTSG 209
Query: 307 --------APE-LIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESG--VDQLVE 351
APE + + +T+A D+WS G V+ E++ G+ + S V + +
Sbjct: 210 GKIPIRWTAPEAISYRK--FTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN 264
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 6e-18
Identities = 54/239 (22%), Positives = 87/239 (36%), Gaps = 52/239 (21%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS---VAIKKVLQDKRYKN-------RELQIMRLLNHPN 191
+G GSFGVV + + VA+K + D + RE+ M L+H N
Sbjct: 23 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82
Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQ-HVPILYVQLYTYQICRA 250
++ L + + + V E R +Q H + + Y Q+
Sbjct: 83 LIRL----YGVVLTPPMKM--VTELAP---LGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 133
Query: 251 LNYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR-- 306
+ YL + HRD+ +NLL+ +KI DFG + L + +Y
Sbjct: 134 MGYLESKRFI---HRDLAARNLLLATR-DLVKIGDFGLMRALPQNDD--------HYVMQ 181
Query: 307 ----------APE-LIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVD--QLVE 351
APE L ++ A D W G L E+ GQ + G +G ++
Sbjct: 182 EHRKVPFAWCAPESLKTRT--FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID 238
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 8e-18
Identities = 57/260 (21%), Positives = 99/260 (38%), Gaps = 68/260 (26%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS-----VAIKKV-----LQDKRYKNRELQIMRLLNHPN 191
+ +G G FG V +A VA+K + + R E +++ +NHP+
Sbjct: 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87
Query: 192 VVSLKHCFFSTTEKDELYLNLVLEY-------------------ISETVYRVSKHYTRMN 232
V+ L ++ L L++EY + +
Sbjct: 88 VIKLYGA---CSQDGPLL--LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 233 QHVPILYVQL--YTYQICRALNYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288
+ L + +QI + + YL +V HRD+ +N+LV ++KI DFG ++
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAEMKLV---HRDLAARNILVAEG-RKMKISDFGLSR 198
Query: 289 MLVPGEPNISYICSRYYR------------APELIFGATEYTTAIDMWSIGCVLAELL-L 335
+ Y A E +F YTT D+WS G +L E++ L
Sbjct: 199 DV---------YEEDSYVKRSQGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTL 248
Query: 336 G-QPLFPGESGVDQLVEIIK 354
G P +PG ++L ++K
Sbjct: 249 GGNP-YPGIP-PERLFNLLK 266
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 84.5 bits (209), Expect = 1e-17
Identities = 58/236 (24%), Positives = 97/236 (41%), Gaps = 50/236 (21%)
Query: 142 ERVVGTGSFGVVFQAKCLETGD---SVAIKKVLQDKRYKNR-----ELQIMRLLNHPNVV 193
R +G G FG V Q + + +VAIK R E MR +HP++V
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL-YTYQICRALN 252
L ++ ++ +++E + + + ++ + L + Y YQ+ AL
Sbjct: 455 KL----IGVITENPVW--IIMELCT---LGELRSFLQVRKFSLDLASLILYAYQLSTALA 505
Query: 253 YL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR---- 306
YL V HRDI +N+LV+ + +K+ DFG ++ + YY+
Sbjct: 506 YLESKRFV---HRDIAARNVLVSSN-DCVKLGDFGLSRYMEDST---------YYKASKG 552
Query: 307 -------APE-LIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESG--VDQLVE 351
APE + F +T+A D+W G + E+L G F G V +E
Sbjct: 553 KLPIKWMAPESINFR--RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE 606
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 2e-17
Identities = 62/260 (23%), Positives = 101/260 (38%), Gaps = 67/260 (25%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS-----VAIKKV-----LQDKRYKNRELQIM-RLLNHP 190
+V+G+G+FG V A + VA+K + ++ EL++M +L +H
Sbjct: 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109
Query: 191 NVVSLKHCFFSTTEKDELYLNLVLEY------------------ISETVYRVSKHYTRMN 232
N+V+L T +Y L+ EY E Y K
Sbjct: 110 NIVNLLGA---CTLSGPIY--LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164
Query: 233 QHVPILYVQL--YTYQICRALNYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288
+ + L + YQ+ + + +L V HRD+ +N+LV +KICDFG A+
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFLEFKSCV---HRDLAARNVLVTHG-KVVKICDFGLAR 220
Query: 289 MLVPGEPNISYICSRYYR------------APELIFGATEYTTAIDMWSIGCVLAEL--L 334
+ + Y APE +F YT D+WS G +L E+ L
Sbjct: 221 DI---------MSDSNYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSL 270
Query: 335 LGQPLFPGESGVDQLVEIIK 354
P +PG ++I+
Sbjct: 271 GVNP-YPGIPVDANFYKLIQ 289
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 2e-17
Identities = 58/250 (23%), Positives = 98/250 (39%), Gaps = 56/250 (22%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS-----VAIKKV-----LQDKRYKNRELQIM-RLLNHP 190
+ +G G+FG V +A G VA+K + +K EL+IM L H
Sbjct: 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110
Query: 191 NVVSLKHCFFSTTEKDELYL--------NLVLEYISETVYRVSKHYTRMNQHVPILYVQL 242
N+V+L T + + +L L ++ + + L
Sbjct: 111 NIVNLLGA---CTHGGPVLVITEYCCYGDL-LNFLRRKSRVLETDPAFAIANSTASTRDL 166
Query: 243 --YTYQICRALNYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS 298
++ Q+ + + +L + + HRD+ +N+L+ H KI DFG A+ +
Sbjct: 167 LHFSSQVAQGMAFLASKNCI---HRDVAARNVLLTNG-HVAKIGDFGLARDI-------- 214
Query: 299 YICSRYYR------------APELIFGATEYTTAIDMWSIGCVLAELL-LG-QPLFPGES 344
+ Y APE IF YT D+WS G +L E+ LG P +PG
Sbjct: 215 -MNDSNYIVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNP-YPGIL 271
Query: 345 GVDQLVEIIK 354
+ +++K
Sbjct: 272 VNSKFYKLVK 281
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 2e-17
Identities = 54/245 (22%), Positives = 96/245 (39%), Gaps = 52/245 (21%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS-----VAIKKV-----LQDKRYKNRELQIMRLLNHPN 191
R +G G+FG V++ + + VA+K + QD+ E I+ NH N
Sbjct: 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94
Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYISE----TVYRVSKHYTRMNQHVPILYVQLYTYQI 247
+V + + + +++E ++ + R ++ + +L + I
Sbjct: 95 IVRCIGV---SLQSLPRF--ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149
Query: 248 CRALNYL--HHVVGVCHRDIKPQNLLVNPHTHQL--KICDFGSAKMLVPGEPNISYICSR 303
YL +H + HRDI +N L+ KI DFG A+ +
Sbjct: 150 ACGCQYLEENHFI---HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS--------- 197
Query: 304 YYR------------APE-LIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVDQL 349
YYR PE + G +T+ D WS G +L E+ LG +P +S ++
Sbjct: 198 YYRKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-NQEV 254
Query: 350 VEIIK 354
+E +
Sbjct: 255 LEFVT 259
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 4e-17
Identities = 55/245 (22%), Positives = 96/245 (39%), Gaps = 52/245 (21%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS-----VAIKKV-----LQDKRYKNRELQIMRLLNHPN 191
R +G G+FG V++ + + VA+K + QD+ E I+ NH N
Sbjct: 76 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 135
Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYISE----TVYRVSKHYTRMNQHVPILYVQLYTYQI 247
+V + + + ++LE ++ + R ++ + +L + I
Sbjct: 136 IVRCIGV---SLQSLPRF--ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190
Query: 248 CRALNYL--HHVVGVCHRDIKPQNLLVNPHTHQL--KICDFGSAKMLVPGEPNISYICSR 303
YL +H + HRDI +N L+ KI DFG A+ +
Sbjct: 191 ACGCQYLEENHFI---HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG--------- 238
Query: 304 YYR------------APE-LIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVDQL 349
YYR PE + G +T+ D WS G +L E+ LG +P +S ++
Sbjct: 239 YYRKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-NQEV 295
Query: 350 VEIIK 354
+E +
Sbjct: 296 LEFVT 300
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 5e-17
Identities = 59/253 (23%), Positives = 91/253 (35%), Gaps = 62/253 (24%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS-----VAIKKV-----LQDKRYKNRELQIMRLLNHPN 191
+G FG V++ VAIK + + E + L HPN
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73
Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYIS-----------ETVYRVSKHYTRMNQHVPILYV 240
VV L T+ L ++ Y S V +
Sbjct: 74 VVCLLGV---VTKDQPLS--MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128
Query: 241 QL--YTYQICRALNYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPN 296
QI + YL HHVV H+D+ +N+LV +KI D G + + +
Sbjct: 129 DFVHLVAQIAAGMEYLSSHHVV---HKDLATRNVLVYDK-LNVKISDLGLFREVYAAD-- 182
Query: 297 ISYICSRYYR------------APE-LIFGATEYTTAIDMWSIGCVLAELL-LG-QPLFP 341
YY+ APE +++G +++ D+WS G VL E+ G QP +
Sbjct: 183 -------YYKLLGNSLLPIRWMAPEAIMYG--KFSIDSDIWSYGVVLWEVFSYGLQP-YC 232
Query: 342 GESGVDQLVEIIK 354
G S +VE+I+
Sbjct: 233 GYS-NQDVVEMIR 244
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 1e-16
Identities = 58/270 (21%), Positives = 100/270 (37%), Gaps = 72/270 (26%)
Query: 133 PKQTISYMAERVVGTGSFGVVFQAKCLETGDS-----VAIKKV-----LQDKRYKNRELQ 182
P+ I Y+ R +G G+FG VFQA+ VA+K + + RE
Sbjct: 45 PRNNIEYV--RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 102
Query: 183 IMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEY-------------------ISETVYR 223
+M ++PN+V L + L+ EY
Sbjct: 103 LMAEFDNPNIVKLLGV---CAVGKPMC--LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 157
Query: 224 VSKHYTRMNQHVPILYVQL--YTYQICRALNYL--HHVVGVCHRDIKPQNLLVNPHTHQL 279
++ P+ + Q+ + YL V HRD+ +N LV + +
Sbjct: 158 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFV---HRDLATRNCLVGEN-MVV 213
Query: 280 KICDFGSAKMLVPGEPNISYICSRYYR------------APE-LIFGATEYTTAIDMWSI 326
KI DFG ++ + + YY+ PE + + YTT D+W+
Sbjct: 214 KIADFGLSRNIYSAD---------YYKADGNDAIPIRWMPPESIFYN--RYTTESDVWAY 262
Query: 327 GCVLAELL-LG-QPLFPGESGVDQLVEIIK 354
G VL E+ G QP + G + ++++ ++
Sbjct: 263 GVVLWEIFSYGLQP-YYGMA-HEEVIYYVR 290
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 1e-16
Identities = 59/254 (23%), Positives = 104/254 (40%), Gaps = 61/254 (24%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS-------VAIKKV-----LQDKRYKNRELQIM-RLLN 188
+ +G G FG V A+ + VA+K + +D E+++M +
Sbjct: 86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145
Query: 189 HPNVVSLKHCFFSTTEKDELYLNLVLEYI-----------SETVYRVSKHYTRMNQHVPI 237
H N+++L T+ LY +++EY + +
Sbjct: 146 HKNIINLLGA---CTQDGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 238 LYVQL--YTYQICRALNYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293
+ L TYQ+ R + YL + HRD+ +N+LV + + +KI DFG A+ +
Sbjct: 201 TFKDLVSCTYQLARGMEYLASQKCI---HRDLAARNVLVTEN-NVMKIADFGLARDINNI 256
Query: 294 EPNISYICSRYYR------------APELIFGATEYTTAIDMWSIGCVLAELL-LGQPLF 340
+ YY+ APE +F YT D+WS G ++ E+ LG +
Sbjct: 257 D---------YYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPY 306
Query: 341 PGESGVDQLVEIIK 354
PG V++L +++K
Sbjct: 307 PGIP-VEELFKLLK 319
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 2e-16
Identities = 60/254 (23%), Positives = 103/254 (40%), Gaps = 61/254 (24%)
Query: 142 ERVVGTGSFGVVFQAKCL-------ETGDSVAIKKV-----LQDKRYKNRELQIM-RLLN 188
+ +G G+FG V A+ + VA+K + +D E+++M +
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 189 HPNVVSLKHCFFSTTEKDELYLNLVLEYI-----------SETVYRVSKHYTRMNQHVPI 237
H N+++L T+ LY +++EY + N +
Sbjct: 134 HKNIINLLGA---CTQDGPLY--VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188
Query: 238 LYVQL--YTYQICRALNYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293
L YQ+ R + YL + HRD+ +N+LV + +KI DFG A+ +
Sbjct: 189 SSKDLVSCAYQVARGMEYLASKKCI---HRDLAARNVLVTED-NVMKIADFGLARDIHHI 244
Query: 294 EPNISYICSRYYR------------APELIFGATEYTTAIDMWSIGCVLAELL-LGQPLF 340
+ YY+ APE +F YT D+WS G +L E+ LG +
Sbjct: 245 D---------YYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPY 294
Query: 341 PGESGVDQLVEIIK 354
PG V++L +++K
Sbjct: 295 PGVP-VEELFKLLK 307
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 4e-16
Identities = 59/254 (23%), Positives = 105/254 (41%), Gaps = 61/254 (24%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS-------VAIKKV-----LQDKRYKNRELQIM-RLLN 188
+ +G G+FG V A+ + VA+K + +D E+++M +
Sbjct: 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 189 HPNVVSLKHCFFSTTEKDELYLNLVLEYI-----------SETVYRVSKHYTRMNQHVPI 237
H N+++L T+ LY +++EY + +
Sbjct: 100 HKNIINLLGA---CTQDGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 238 LYVQL--YTYQICRALNYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293
+ L TYQ+ R + YL + HRD+ +N+LV + + +KI DFG A+ +
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCI---HRDLAARNVLVTEN-NVMKIADFGLARDINNI 210
Query: 294 EPNISYICSRYYR------------APELIFGATEYTTAIDMWSIGCVLAELL-LGQPLF 340
+ YY+ APE +F YT D+WS G ++ E+ LG +
Sbjct: 211 D---------YYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPY 260
Query: 341 PGESGVDQLVEIIK 354
PG V++L +++K
Sbjct: 261 PGIP-VEELFKLLK 273
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 5e-16
Identities = 45/223 (20%), Positives = 83/223 (37%), Gaps = 43/223 (19%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN--RELQIMRLL-NHPNVVSL 195
Y R +G GSFGV+F+ L VAIK + E + +LL + ++
Sbjct: 12 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNV 71
Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
+ ++ L+ LV++ + + + + + V + Q+ + +H
Sbjct: 72 YYFG-----QEGLHNVLVIDLLGPS---LEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH 123
Query: 256 HVVGVCHRDIKPQNLLV----NPHTHQLKICDFGSAKMLVPGEPNISYICSRY-----YR 306
+ +RDIKP N L+ + + + + + DFG K Y YR
Sbjct: 124 E-KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF---------YRDPVTKQHIPYR 173
Query: 307 APELIFGATEYTTAI------------DMWSIGCVLAELLLGQ 337
+ + G Y +I D+ ++G V L G
Sbjct: 174 EKKNLSGTARY-MSINTHLGREQSRRDDLEALGHVFMYFLRGS 215
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 7e-16
Identities = 58/238 (24%), Positives = 97/238 (40%), Gaps = 60/238 (25%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS--VAIKKV-----LQDKRYKNRELQIM-RLLNHPNVV 193
+ V+G G+FG V +A+ + G AIK++ D R EL+++ +L +HPN++
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 194 SLKHCFFSTTEKDELYLNLVLEYI-----------SETVYRVSKHYTRMNQHVPILYVQL 242
+L + LY L +EY S + + + QL
Sbjct: 90 NLLGA---CEHRGYLY--LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 243 --YTYQICRALNYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS 298
+ + R ++YL + HRD+ +N+LV + + KI DFG ++
Sbjct: 145 LHFAADVARGMDYLSQKQFI---HRDLAARNILVGEN-YVAKIADFGLSRG--------- 191
Query: 299 YICSRYYR------------APE-LIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPG 342
Y A E L + YTT D+WS G +L E++ LG + G
Sbjct: 192 ---QEVYVKKTMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCG 244
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 1e-15
Identities = 49/216 (22%), Positives = 89/216 (41%), Gaps = 31/216 (14%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN--RELQIMRLLNH-PNVVSL 195
Y R +G+GSFG ++ + G+ VAIK ++ E +I +++ + ++
Sbjct: 11 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTI 70
Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
+ C + Y +V+E + + + + ++ + V L Q+ + Y+H
Sbjct: 71 RWCG-----AEGDYNVMVMELLGPS---LEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 122
Query: 256 HVVGVCHRDIKPQNLLV--NPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFG 313
HRD+KP N L+ + + I DFG AK + +I YR + + G
Sbjct: 123 S-KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH-QHIP---YRENKNLTG 177
Query: 314 ATEYTTAI------------DMWSIGCVLAELLLGQ 337
Y +I D+ S+G VL LG
Sbjct: 178 TARY-ASINTHLGIEQSRRDDLESLGYVLMYFNLGS 212
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 2e-15
Identities = 44/223 (19%), Positives = 83/223 (37%), Gaps = 43/223 (19%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIK--KVLQDKRYKNRELQIMRLL-NHPNVVSL 195
+ + +G G+FG + K L T + VAIK + + E + + L + + +
Sbjct: 11 FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQV 70
Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
+ Y +VLE + + + + ++ + V + Q+ + Y+H
Sbjct: 71 YYFG-----PCGKYNAMVLELLGPS---LEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH 122
Query: 256 HVVGVCHRDIKPQNLLV----NPHTHQLKICDFGSAKMLVPGEPNISYICSRY-----YR 306
+ +RD+KP+N L+ N + I DF AK YI YR
Sbjct: 123 S-KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE---------YIDPETKKHIPYR 172
Query: 307 APELIFGATEYTTAI------------DMWSIGCVLAELLLGQ 337
+ + G Y +I D+ ++G + L G
Sbjct: 173 EHKSLTGTARY-MSINTHLGKEQSRRDDLEALGHMFMYFLRGS 214
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 2e-15
Identities = 41/250 (16%), Positives = 85/250 (34%), Gaps = 49/250 (19%)
Query: 118 AGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYK 177
G+V+ G + ++ + +G+G FG+++ A + A V + +
Sbjct: 27 EGKVLDDMEGNQ---------WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQEN 77
Query: 178 N---RELQIMRLLNHPNVVSLK--------------HCFFSTTEKDELYLNLVLEYISET 220
EL+ + + + + + T K Y +V+E +
Sbjct: 78 GPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGID 137
Query: 221 VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNP-HTHQL 279
+ + + N V ++ L Y+H H DIK NLL+ + Q+
Sbjct: 138 L----QKISGQNGTFKKSTVLQLGIRMLDVLEYIHE-NEYVHGDIKAANLLLGYKNPDQV 192
Query: 280 KICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAI------------DMWSIG 327
+ D+G + P + Y + G E+ T++ D+ +G
Sbjct: 193 YLADYGLSYRYCPNGNHKQYQ----ENPRKGHNGTIEF-TSLDAHKGVALSRRSDVEILG 247
Query: 328 CVLAELLLGQ 337
+ L G+
Sbjct: 248 YCMLRWLCGK 257
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 74.5 bits (184), Expect = 6e-15
Identities = 54/228 (23%), Positives = 93/228 (40%), Gaps = 63/228 (27%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR----ELQIMRLLNHPNVVSL-K 196
+ ++G G FG V++ L G VA+K+ + E++ + HP++VSL
Sbjct: 44 KFLIGHGVFGKVYKGV-LRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIG 102
Query: 197 HCFFSTTEKDELYLNLVLEYIS-----ETVYRVSKHY------TRMNQHVPILYVQLYTY 245
C E++E+ L + +Y+ +Y R+
Sbjct: 103 FC----DERNEMIL--IYKYMENGNLKRHLYGSDLPTMSMSWEQRL-------------- 142
Query: 246 QIC----RALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC 301
+IC R L+YLH + HRD+K N+L++ + KI DFG +K + +++
Sbjct: 143 EICIGAARGLHYLHTR-AIIHRDVKSINILLDENFVP-KITDFGISKKGTELDQ--THLS 198
Query: 302 SRY-----YRAPELIFGATEY------TTAIDMWSIGCVLAELLLGQP 338
+ Y P EY T D++S G VL E+L +
Sbjct: 199 TVVKGTLGYIDP-------EYFIKGRLTEKSDVYSFGVVLFEVLCARS 239
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 73.5 bits (180), Expect = 4e-14
Identities = 48/221 (21%), Positives = 90/221 (40%), Gaps = 41/221 (18%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN--RELQIMRLLN-HPNVVSL 195
+ R +G+GSFG ++ ++T + VAIK ++ E +I R+L + ++
Sbjct: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNV 68
Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
+ + Y LV++ + + + + ++ + + V + Q+ + ++H
Sbjct: 69 RWFG-----VEGDYNVLVMDLLGPS---LEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
Query: 256 HVVGVCHRDIKPQNLLV--NPHTHQLKICDFGSAKMLVPGEPNISYICSRY-----YRAP 308
HRDIKP N L+ +Q+ I DFG AK Y + YR
Sbjct: 121 S-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK---------YRDTSTHQHIPYREN 170
Query: 309 ELIFGATEYTTAI------------DMWSIGCVLAELLLGQ 337
+ + G Y ++ D+ S+G VL L G
Sbjct: 171 KNLTGTARY-ASVNTHLGIEQSRRDDLESLGYVLMYFLRGS 210
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 1e-13
Identities = 51/226 (22%), Positives = 95/226 (42%), Gaps = 58/226 (25%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR-----ELQIMRLLNHPNVVSLK 196
+ ++G G FG V++ + L G VA+K++ +++ E++++ + H N++ L+
Sbjct: 35 KNILGRGGFGKVYKGR-LADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR 93
Query: 197 -HCFFSTTEKDELYLNLVLEYIS-----ETVYRVSKHY------TRMNQHVPILYVQLYT 244
C E L V Y++ + + R
Sbjct: 94 GFC----MTPTERLL--VYPYMANGSVASCLRERPESQPPLDWPKRQR------------ 135
Query: 245 YQIC----RALNYLHHVVGVC--HRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS 298
I R L YLH HRD+K N+L++ + + DFG AK++ + +
Sbjct: 136 --IALGSARGLAYLHDHCDPKIIHRDVKAANILLD-EEFEAVVGDFGLAKLM---DYKDT 189
Query: 299 YICSRY-----YRAPE-LIFG-ATEYTTAIDMWSIGCVLAELLLGQ 337
++ + + APE L G ++E T D++ G +L EL+ GQ
Sbjct: 190 HVTTAVRGTIGHIAPEYLSTGKSSEKT---DVFGYGVMLLELITGQ 232
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 1e-13
Identities = 42/252 (16%), Positives = 79/252 (31%), Gaps = 50/252 (19%)
Query: 118 AGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQA-----KCLETGDSVAIKKVLQ 172
G++I + +G G FG ++ A + + + +K
Sbjct: 25 VGEIITDMAAAA---------WKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPS 75
Query: 173 DKRYKNRELQIMRLLNHPNVVSLK--------------HCFFSTTEKDELYLNLVLEYIS 218
D EL+ + P + + + Y ++++
Sbjct: 76 DNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFG 135
Query: 219 ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNP-HTH 277
+ K Y + V + +I L Y+H H DIK NLL+N +
Sbjct: 136 SDL---QKIYEANAKRFSRKTVLQLSLRILDILEYIHEH-EYVHGDIKASNLLLNYKNPD 191
Query: 278 QLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAI------------DMWS 325
Q+ + D+G A P + +Y G E+ T+I D+
Sbjct: 192 QVYLVDYGLAYRYCPEGVHKAYA----ADPKRCHDGTIEF-TSIDAHNGVAPSRRGDLEI 246
Query: 326 IGCVLAELLLGQ 337
+G + + L G
Sbjct: 247 LGYCMIQWLTGH 258
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 5e-13
Identities = 36/253 (14%), Positives = 83/253 (32%), Gaps = 52/253 (20%)
Query: 118 AGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDS--------VAIK- 168
G V+ G + + + + G++++A T ++K
Sbjct: 32 TGTVLTDKSGRQ---------WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKL 82
Query: 169 -----------KVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYI 217
Q + K ++ + L ++++ C +D+ LVL +
Sbjct: 83 DAKDGRLFNEQNFFQ-RAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRF-LVLPSL 140
Query: 218 SETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNP-HT 276
++ + + V ++ AL +LH H ++ +N+ V+P
Sbjct: 141 GRSLQSALDVSPK--HVLSERSVLQVACRLLDALEFLHEN-EYVHGNVTAENIFVDPEDQ 197
Query: 277 HQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAI------------DMW 324
Q+ + +G A P +++Y G E+ ++ D+
Sbjct: 198 SQVTLAGYGFAFRYCPSGKHVAY---VEGSRSPHE-GDLEF-ISMDLHKGCGPSRRSDLQ 252
Query: 325 SIGCVLAELLLGQ 337
S+G + + L G
Sbjct: 253 SLGYCMLKWLYGF 265
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 5e-12
Identities = 57/229 (24%), Positives = 89/229 (38%), Gaps = 68/229 (29%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR--------ELQIMRLLNHPNVVSL 195
+G G FGVV++ + +VA+KK+ E+++M H N+V L
Sbjct: 38 KMGEGGFGVVYKG-YVN-NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL 95
Query: 196 K-HCFFSTTEKDELYLNLVLEYIS-----ETVYRVSKH-----YTRMNQHVPILYVQLYT 244
++ D+L L V Y+ + + + + R
Sbjct: 96 LGFS----SDGDDLCL--VYVYMPNGSLLDRLSCLDGTPPLSWHMRCK------------ 137
Query: 245 YQIC----RALNYLH--HVVGVCHRDIKPQNLLV----NPHTHQLKICDFGSAKMLVPGE 294
I +N+LH H + HRDIK N+L+ KI DFG A+
Sbjct: 138 --IAQGAANGINFLHENHHI---HRDIKSANILLDEAFTA-----KISDFGLAR-ASEKF 186
Query: 295 PNISYICSR----Y-YRAPELIFGATEYTTAIDMWSIGCVLAELLLGQP 338
+ + SR Y APE + G E T D++S G VL E++ G P
Sbjct: 187 AQ-TVMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLP 232
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 56.1 bits (135), Expect = 8e-09
Identities = 34/125 (27%), Positives = 56/125 (44%), Gaps = 25/125 (20%)
Query: 243 YTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICS 302
Y++Q+ + + +L HRD+ +N+L++ + +KICDFG A+ +
Sbjct: 198 YSFQVAKGMEFLASR-KCIHRDLAARNILLS-EKNVVKICDFGLARDIYKDP-------- 247
Query: 303 RYYR------------APELIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVDQL 349
Y APE IF YT D+WS G +L E+ LG +PG ++
Sbjct: 248 -DYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 305
Query: 350 VEIIK 354
+K
Sbjct: 306 CRRLK 310
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 41.1 bits (96), Expect = 6e-04
Identities = 22/86 (25%), Positives = 39/86 (45%), Gaps = 15/86 (17%)
Query: 142 ERVVGTGSFGVVFQAKCL-----ETGDSVAIKKV-----LQDKRYKNRELQIMRLL-NHP 190
+ +G G+FG V +A T +VA+K + + R EL+I+ + +H
Sbjct: 27 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 86
Query: 191 NVVSLKHCFFSTTEKDELYLNLVLEY 216
NVV+L T L +++E+
Sbjct: 87 NVVNLLGA--CTKPGGPLM--VIVEF 108
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 50.2 bits (119), Expect = 1e-06
Identities = 53/366 (14%), Positives = 103/366 (28%), Gaps = 107/366 (29%)
Query: 158 CLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYI 217
L + ++K +++ N + + + S+ + ++D LY N +
Sbjct: 70 TLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIE-QRDRLY-NDNQVFA 127
Query: 218 SETVYRVSKHYTRMNQHV----PILYVQLY----------TYQICRALNYLHHV------ 257
V R+ + Y ++ Q + P V + +C + +
Sbjct: 128 KYNVSRL-QPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFW 186
Query: 258 --VGVCHRD---IKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIF 312
+ C+ ++ L+ +Q+ ++ S NI +
Sbjct: 187 LNLKNCNSPETVLEMLQKLL----YQID-PNWTS---RSDHSSNIKLRIHSIQAELRRLL 238
Query: 313 GATEYTTAI----DMWS--------IGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPT 360
+ Y + ++ + + C KIL T T
Sbjct: 239 KSKPYENCLLVLLNVQNAKAWNAFNLSC-------------------------KILLT-T 272
Query: 361 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRM---PPEALDLVSRLLQYSPS-LRCTALE 416
R T+F H + H M P E L+ + L P L E
Sbjct: 273 R------FKQVTDFLSAATTTHI--SLDHHSMTLTPDEVKSLLLKYLDCRPQDLP---RE 321
Query: 417 ACA-HPFF-----DDLRD-PNTC----LPNGRPLPTLFNFTAQELAGASNELRQR----- 460
+P + +RD T N L T+ + L E R+
Sbjct: 322 VLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVL--EPAEYRKMFDRLS 379
Query: 461 LIPEHA 466
+ P A
Sbjct: 380 VFPPSA 385
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 468 | |||
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.9 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.83 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.72 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.27 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.13 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.06 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.91 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.53 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.42 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.24 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.18 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.13 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.05 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.05 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.03 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.36 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.27 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.25 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.24 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.18 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.06 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.05 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 96.96 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.85 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.83 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.78 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.73 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.44 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.47 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.91 |
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-62 Score=464.82 Aligned_cols=250 Identities=29% Similarity=0.431 Sum_probs=202.4
Q ss_pred ccceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-------chHHHHHHHHHHcCCCCcccccceeeecCCCCce
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 208 (468)
.++|++.+.||+|+||+||+|.++.+|+.||||++.+.. ..+.+|+.+|+.++|||||+++++| .+..
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~~ 86 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVI-----KSKD 86 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSS
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEE-----EECC
Confidence 357999999999999999999999999999999985432 2356899999999999999999998 4455
Q ss_pred EEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcc
Q 012233 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (468)
Q Consensus 209 ~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~ 288 (468)
.+|||||||+|++++.+.. ...+++..++.++.||+.||+|||+ +||+||||||+||||+.++ .+||+|||+|+
T Consensus 87 ~~~ivmEy~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~-~~IiHRDiKP~NILl~~~~-~vkl~DFGla~ 160 (275)
T 3hyh_A 87 EIIMVIEYAGNELFDYIVQ----RDKMSEQEARRFFQQIISAVEYCHR-HKIVHRDLKPENLLLDEHL-NVKIADFGLSN 160 (275)
T ss_dssp EEEEEEECCCEEHHHHHHH----SCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCTTTEEECTTC-CEEECCSSCC-
T ss_pred EEEEEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCChHHeEECCCC-CEEEeecCCCe
Confidence 6999999999988876653 4679999999999999999999998 9999999999999999888 79999999998
Q ss_pred ccCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 012233 289 MLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368 (468)
Q Consensus 289 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 368 (468)
.........+.+||+.|||||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+...
T Consensus 161 ~~~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~------------- 227 (275)
T 3hyh_A 161 IMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNG------------- 227 (275)
T ss_dssp --------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT-------------
T ss_pred ecCCCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC-------------
Confidence 7766666667899999999999987765578999999999999999999999988776666665541
Q ss_pred CCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q 012233 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDD 425 (468)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~ 425 (468)
... ++..+|+++++||.+||++||.+|||+.|+++||||+.
T Consensus 228 ----~~~------------~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 228 ----VYT------------LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp ----CCC------------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred ----CCC------------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence 111 33458999999999999999999999999999999963
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-60 Score=485.96 Aligned_cols=332 Identities=69% Similarity=1.200 Sum_probs=303.9
Q ss_pred CcccceEEeceecccCceEEEEEEEcCCCCEEEEEEeecccchHHHHHHHHHHcCCCCcccccceeeecCC-CCceEEEE
Q 012233 134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTE-KDELYLNL 212 (468)
Q Consensus 134 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~-~~~~~~~l 212 (468)
....+|.+.+.||+|+||.||+|.+..+|+.||||++........+|+++|+.++|||||+++++|+.... .+..++++
T Consensus 51 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l 130 (420)
T 1j1b_A 51 PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 130 (420)
T ss_dssp CEEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred cccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEe
Confidence 34557999999999999999999999999999999998877777789999999999999999999866543 45667889
Q ss_pred EeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCC
Q 012233 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (468)
Q Consensus 213 v~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~ 292 (468)
||||++++++..+..+......+++..++.++.||+.||.|||+ +||+||||||+||||+.++..+||+|||+++....
T Consensus 131 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~ 209 (420)
T 1j1b_A 131 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 209 (420)
T ss_dssp EEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT-TTEECSCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred ehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCChhhEEEeCCCCeEEeccchhhhhccc
Confidence 99999999888887777777889999999999999999999998 89999999999999997765789999999988766
Q ss_pred CCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCc
Q 012233 293 GEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYT 372 (468)
Q Consensus 293 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 372 (468)
.......+||+.|+|||++.+...++.++|||||||++|||++|++||.+.+..+++.++++.++.|..+.+..+++.+.
T Consensus 210 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~ 289 (420)
T 1j1b_A 210 GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYT 289 (420)
T ss_dssp TCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCC
T ss_pred CCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhh
Confidence 66666788999999999997766699999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCCCCCCCCCCCCCcccccCHHHHhc
Q 012233 373 EFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNTCLPNGRPLPTLFNFTAQELAG 452 (468)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (468)
.+.++.+...+|...+...+++++.+||.+||++||.+|||+.|+|+||||++++.+...+++...+|.+++|+.+++..
T Consensus 290 ~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 369 (420)
T 1j1b_A 290 EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSS 369 (420)
T ss_dssp CCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTTCCCTTSCCCCCCCCCCHHHHTT
T ss_pred hhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccccccccCCCCCCCCccCCCCHHHhcc
Confidence 99999999999999999999999999999999999999999999999999999999998889999999999999988875
Q ss_pred CCHHHHHhccccccc
Q 012233 453 ASNELRQRLIPEHAR 467 (468)
Q Consensus 453 ~~~~~~~~~~~~~~~ 467 (468)
.+++...++|+|.+
T Consensus 370 -~~~~~~~~~~~~~~ 383 (420)
T 1j1b_A 370 -NPPLATILIPPHAR 383 (420)
T ss_dssp -CGGGHHHHSCTTTT
T ss_pred -ChhHHHhhCCHhhh
Confidence 66788888899876
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-61 Score=468.77 Aligned_cols=252 Identities=33% Similarity=0.558 Sum_probs=217.5
Q ss_pred ccceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc-------cchHHHHHHHHHHcCCCCcccccceeeecCCCCce
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~-------~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 208 (468)
.++|++++.||+|+||+||+|+++.+|+.||||++.+. .....+|+++|+.|+|||||+++++| .+..
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~~ 105 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF-----QDDE 105 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSS
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeCC
Confidence 34699999999999999999999999999999998643 23456899999999999999999999 5556
Q ss_pred EEEEEeecccc-hHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCc
Q 012233 209 YLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (468)
Q Consensus 209 ~~~lv~e~~~~-~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a 287 (468)
++|||||||.| +|.+.+.. .+.+++..++.|+.||+.||.|||+ +|||||||||+||||+.++ .+||+|||+|
T Consensus 106 ~~yivmEy~~gG~L~~~i~~----~~~l~e~~~~~~~~qi~~al~ylH~-~~IiHRDlKPeNILl~~~g-~vKl~DFGla 179 (311)
T 4aw0_A 106 KLYFGLSYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNEDM-HIQITDFGTA 179 (311)
T ss_dssp EEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTS-CEEECCCTTC
T ss_pred EEEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCCHHHeEEcCCC-CEEEEEcCCc
Confidence 79999999986 45554432 4579999999999999999999998 9999999999999999888 7999999999
Q ss_pred cccCCCC---CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 012233 288 KMLVPGE---PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEI 364 (468)
Q Consensus 288 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 364 (468)
+.+.... ...+.+||+.|||||++.+.. |+.++|||||||++|||++|++||.+.+..+.+.+|.+.
T Consensus 180 ~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~-y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~--------- 249 (311)
T 4aw0_A 180 KVLSPESKQARANSFVGTAQYVSPELLTEKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKL--------- 249 (311)
T ss_dssp EECCTTTTCCCBCCCCSCGGGCCHHHHHHSC-BCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT---------
T ss_pred eecCCCCCcccccCcccCcccCCHHHHcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC---------
Confidence 8775432 345679999999999997654 899999999999999999999999998888877777651
Q ss_pred hhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHH------HhCCCCCCCCCC
Q 012233 365 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALE------ACAHPFFDDLRD 428 (468)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~e------ll~hp~f~~~~~ 428 (468)
.+. ++..+++++++||.+||++||.+|+|++| +++||||+++.-
T Consensus 250 --------~~~------------~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw 299 (311)
T 4aw0_A 250 --------EYD------------FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTW 299 (311)
T ss_dssp --------CCC------------CCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCC
T ss_pred --------CCC------------CCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCH
Confidence 222 33568999999999999999999999988 589999998753
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-61 Score=482.40 Aligned_cols=331 Identities=50% Similarity=0.974 Sum_probs=289.8
Q ss_pred ccceEEeceecccCceEEEEEEEcCCCCEEEEEEeecccchHHHHHHHHHHcCCCCcccccceeeecCC-----------
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTE----------- 204 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~----------- 204 (468)
..+|.+.+.||+|+||.||+|.+..+|+.||||++..+.....+|+.+|+.++||||++++++|.....
T Consensus 6 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~ 85 (383)
T 3eb0_A 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDD 85 (383)
T ss_dssp CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHTTCCCTTBCCEEEEEEEC-------------
T ss_pred cceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHHcCCCCccchhheeeecCcccccccccccc
Confidence 346999999999999999999999999999999998877777789999999999999999999876543
Q ss_pred ----------------------CCceEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccc
Q 012233 205 ----------------------KDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCH 262 (468)
Q Consensus 205 ----------------------~~~~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givH 262 (468)
.+..++++||||+++++...+..+......+++..++.++.||+.||.|||+ +||+|
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~gi~H 164 (383)
T 3eb0_A 86 HNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS-LGICH 164 (383)
T ss_dssp ------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT-TTEEC
T ss_pred cccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CcCcc
Confidence 3455789999999999888887777777889999999999999999999998 89999
Q ss_pred cCCCCCCeeecCCCCcEEEeeecCccccCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 012233 263 RDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPG 342 (468)
Q Consensus 263 rDlkp~NILl~~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~ 342 (468)
|||||+|||++.....+||+|||+++............||+.|+|||++.+...++.++|||||||++|+|++|++||.+
T Consensus 165 ~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 244 (383)
T 3eb0_A 165 RDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSG 244 (383)
T ss_dssp SCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCC
Confidence 99999999998543389999999999877777777788999999999998766799999999999999999999999999
Q ss_pred CCcHHHHHHHHHHhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCC
Q 012233 343 ESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPF 422 (468)
Q Consensus 343 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~ 422 (468)
.+..+++..+++.++.|..+.+..+++.+....++.+....|...++..+++++.+||.+||++||.+|||+.|+|+|||
T Consensus 245 ~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 324 (383)
T 3eb0_A 245 ETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPF 324 (383)
T ss_dssp SSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGG
T ss_pred CChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCC-------CCCCCCCC--CCCCcccccCHHHHhcCCHHHHHhccccccc
Q 012233 423 FDDLRD-------PNTCLPNG--RPLPTLFNFTAQELAGASNELRQRLIPEHAR 467 (468)
Q Consensus 423 f~~~~~-------~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 467 (468)
|++++. +...++++ +++|.+++|+++++.-+..+++.+++|.|.+
T Consensus 325 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 378 (383)
T 3eb0_A 325 FDHLRNSYESEVKNNSNFPHGVNQNIPQLFNFSPYELSIIPGNVLNRILPKNFS 378 (383)
T ss_dssp GHHHHHC------------------CCCCSCCCHHHHHHSCHHHHHHHSCC---
T ss_pred HHHHHhhccccccccccCCCcccCCCCCCCCCCHHHHhcCCHHHHhhcCchhhc
Confidence 998765 56666776 8899999999999999999999999999864
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-61 Score=473.05 Aligned_cols=254 Identities=27% Similarity=0.408 Sum_probs=215.5
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc----cchHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEEE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV 213 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~----~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv 213 (468)
.|.+.+.||+|+||+||+|+++.+|+.||||++... ...+.+|+.+|+.++|||||+++++|.. ...+|||
T Consensus 75 ~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~-----~~~~~iv 149 (346)
T 4fih_A 75 YLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV-----GDELWVV 149 (346)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEEEE
T ss_pred hcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----CCEEEEE
Confidence 599999999999999999999999999999998532 3446789999999999999999999944 4469999
Q ss_pred eecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCCC
Q 012233 214 LEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293 (468)
Q Consensus 214 ~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~~ 293 (468)
||||.|+.|..+.. ...+++..++.|+.||+.||+|||+ +|||||||||+||||+.++ .+||+|||+|+.+...
T Consensus 150 mEy~~gg~L~~~l~----~~~l~e~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~NILl~~~g-~vKl~DFGla~~~~~~ 223 (346)
T 4fih_A 150 MEFLEGGALTDIVT----HTRMNEEQIAAVCLAVLQALSVLHA-QGVIHRDIKSDSILLTHDG-RVKLSDFGFCAQVSKE 223 (346)
T ss_dssp ECCCTTEEHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTC-CEEECCCTTCEECCSS
T ss_pred EeCCCCCcHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCHHHEEECCCC-CEEEecCcCceecCCC
Confidence 99999765443322 2469999999999999999999998 9999999999999999988 7999999999877544
Q ss_pred -CCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCc
Q 012233 294 -EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYT 372 (468)
Q Consensus 294 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 372 (468)
....+.+||+.|||||++.+. .|+.++|||||||++|||++|++||.+.+..+.+..|......
T Consensus 224 ~~~~~~~~GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~-------------- 288 (346)
T 4fih_A 224 VPRRKSLVGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP-------------- 288 (346)
T ss_dssp SCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCC--------------
T ss_pred CCcccccccCcCcCCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC--------------
Confidence 345578999999999999655 4999999999999999999999999998887777766542100
Q ss_pred cCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCC
Q 012233 373 EFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDP 429 (468)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~ 429 (468)
.+ ..+..+++++++||.+||++||.+|||+.|+|+||||++...+
T Consensus 289 --~~----------~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~~p 333 (346)
T 4fih_A 289 --RL----------KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPP 333 (346)
T ss_dssp --CC----------SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCCG
T ss_pred --CC----------CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCCCC
Confidence 00 0224589999999999999999999999999999999875543
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-60 Score=478.06 Aligned_cols=288 Identities=35% Similarity=0.630 Sum_probs=237.1
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc------chHHHHHHHHHHcCCCCcccccceeeecCC-CCceEE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTE-KDELYL 210 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~-~~~~~~ 210 (468)
+|++++.||+|+||+||+|+++.+|+.||||++.+.. ....+|+.+|+.|+|||||++++++..... .+...+
T Consensus 55 ~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~ 134 (398)
T 4b99_A 55 EYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSV 134 (398)
T ss_dssp SEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCE
T ss_pred CeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEE
Confidence 5999999999999999999999999999999996432 233479999999999999999998754321 234568
Q ss_pred EEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcccc
Q 012233 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (468)
Q Consensus 211 ~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~ 290 (468)
|||||||+|+++..+.. .+.+++..++.|+.||+.||.|||+ +|||||||||+|||++.++ .+||+|||+|+.+
T Consensus 135 ~ivmE~~~g~L~~~i~~----~~~l~~~~~~~~~~qil~al~ylH~-~~iiHRDlKP~NIl~~~~~-~~Ki~DFGla~~~ 208 (398)
T 4b99_A 135 YVVLDLMESDLHQIIHS----SQPLTLEHVRYFLYQLLRGLKYMHS-AQVIHRDLKPSNLLVNENC-ELKIGDFGMARGL 208 (398)
T ss_dssp EEEEECCSEEHHHHHTS----SSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTC-CEEECCCTTCBCC
T ss_pred EEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CcCcCCCcCccccccCCCC-CEEEeecceeeec
Confidence 99999999988776543 5679999999999999999999998 9999999999999999888 7999999999866
Q ss_pred CCC-----CCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 012233 291 VPG-----EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIK 365 (468)
Q Consensus 291 ~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 365 (468)
... ....+.+||+.|||||++.+...|+.++||||+||++|||++|++||.+.+..+++..|+...+.|+...+.
T Consensus 209 ~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~ 288 (398)
T 4b99_A 209 CTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQ 288 (398)
T ss_dssp -------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC
T ss_pred ccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence 332 234567999999999999887778999999999999999999999999999999999999999998876543
Q ss_pred hcCCCCc---cCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCCCCC
Q 012233 366 CMNPNYT---EFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNTC 432 (468)
Q Consensus 366 ~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~~ 432 (468)
....... ...++.....+|... .+.++++++|||.+||.+||.+|||+.|+|+||||++..++..-
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~p~~~ 357 (398)
T 4b99_A 289 AVGAERVRAYIQSLPPRQPVPWETV-YPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDPDDE 357 (398)
T ss_dssp -----CHHHHHHSSCCCCCCCHHHH-STTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCCGGGS
T ss_pred hhhhhhhhhhhhcCCCcCCCCHHHh-CCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCCCccc
Confidence 3221110 012233333344433 35689999999999999999999999999999999998876543
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-59 Score=474.72 Aligned_cols=329 Identities=65% Similarity=1.157 Sum_probs=301.2
Q ss_pred cccceEEeceecccCceEEEEEEEcCCCCEEEEEEeecccchHHHHHHHHHHcCCCCcccccceeeecCC-CCceEEEEE
Q 012233 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTE-KDELYLNLV 213 (468)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~-~~~~~~~lv 213 (468)
...+|.+.+.||+|+||.||+|++..++. ||+|++........+|+.+|+.++||||++++++|..... .+..++++|
T Consensus 38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv 116 (394)
T 4e7w_A 38 REIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLV 116 (394)
T ss_dssp EEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEE
T ss_pred ccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcchHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEE
Confidence 34569999999999999999999877665 8999888777777789999999999999999999877654 566778999
Q ss_pred eecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeec-CCCCcEEEeeecCccccCC
Q 012233 214 LEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVN-PHTHQLKICDFGSAKMLVP 292 (468)
Q Consensus 214 ~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~-~~~~~vkL~DFG~a~~~~~ 292 (468)
|||++++++..+..+......+++..++.++.||+.||.|||+ +||+||||||+||||+ .++ .+||+|||+++....
T Consensus 117 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~Nill~~~~~-~~kL~DFG~a~~~~~ 194 (394)
T 4e7w_A 117 LEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS-IGICHRDIKPQNLLLDPPSG-VLKLIDFGSAKILIA 194 (394)
T ss_dssp EECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEETTTT-EEEECCCTTCEECCT
T ss_pred eeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH-CCccCCCCCHHHEEEcCCCC-cEEEeeCCCcccccC
Confidence 9999999988877777777889999999999999999999998 8999999999999999 555 899999999988776
Q ss_pred CCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCc
Q 012233 293 GEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYT 372 (468)
Q Consensus 293 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 372 (468)
........||+.|+|||++.+...++.++|||||||++|||++|++||.+.+..+++..+++.++.|..+.+..+++.+.
T Consensus 195 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~ 274 (394)
T 4e7w_A 195 GEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYM 274 (394)
T ss_dssp TCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGS
T ss_pred CCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhh
Confidence 66777789999999999998776799999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCCCCCCCCCCCCCcccccCHHHHhc
Q 012233 373 EFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNTCLPNGRPLPTLFNFTAQELAG 452 (468)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (468)
...++.+...+|...++..+++++.+||.+||++||.+|||+.|++.||||++++.+...+++.+.+|++++|+.+++.-
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (394)
T 4e7w_A 275 EHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGEARMPNGRELPPLFNWTKEELSV 354 (394)
T ss_dssp SSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSSCCCCTTSSCCCCSCCCCHHHHHT
T ss_pred hhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhccccccCCCCCCCCCcCCCCHHHhhc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999888765
Q ss_pred CCHHHHHhccccccc
Q 012233 453 ASNELRQRLIPEHAR 467 (468)
Q Consensus 453 ~~~~~~~~~~~~~~~ 467 (468)
. .++..+++|.|.+
T Consensus 355 ~-~~~~~~~~~~~~~ 368 (394)
T 4e7w_A 355 R-PDLISRLVPQHAE 368 (394)
T ss_dssp C-GGGHHHHSCGGGC
T ss_pred C-HHHHHhhccHhhh
Confidence 4 4889999998864
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-61 Score=471.46 Aligned_cols=252 Identities=26% Similarity=0.425 Sum_probs=208.6
Q ss_pred ccceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc------chHHHHHHHHHHcCCCCcccccceeeecCCCCceE
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 209 (468)
.++|++++.||+|+||+||+|+++.+|+.||||++.... ..+.+|+.+|+.|+|||||+++++|. +...
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~-----~~~~ 97 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFE-----ENGS 97 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEE-----ECCE
Confidence 457999999999999999999999999999999986532 33568999999999999999999984 4446
Q ss_pred EEEEeecccc-hHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcc
Q 012233 210 LNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (468)
Q Consensus 210 ~~lv~e~~~~-~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~ 288 (468)
+|||||||.| +|.+.+.. .....+++..++.|+.||+.||.|||+ +|||||||||+||||+.++ .+||+|||+|+
T Consensus 98 ~yiVmEy~~gg~L~~~i~~--~~~~~~~e~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~NILl~~~g-~vKl~DFGla~ 173 (350)
T 4b9d_A 98 LYIVMDYCEGGDLFKRINA--QKGVLFQEDQILDWFVQICLALKHVHD-RKILHRDIKSQNIFLTKDG-TVQLGDFGIAR 173 (350)
T ss_dssp EEEEEECCTTCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHHH-TTCEETTCCGGGEEECTTC-CEEECSTTEES
T ss_pred EEEEEeCCCCCcHHHHHHH--cCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCCHHHEEECCCC-CEEEcccccce
Confidence 9999999986 55554432 224557899999999999999999998 9999999999999999988 79999999998
Q ss_pred ccCCCC-CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 012233 289 MLVPGE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367 (468)
Q Consensus 289 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 367 (468)
.+.... ...+.+||+.|||||++.+.. |+.++|||||||++|||++|++||.+.+..+.+.+|....
T Consensus 174 ~~~~~~~~~~~~~GT~~YmAPE~l~~~~-y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~----------- 241 (350)
T 4b9d_A 174 VLNSTVELARACIGTPYYLSPEICENKP-YNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGS----------- 241 (350)
T ss_dssp CCCHHHHHHHHHHSCCTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC-----------
T ss_pred eecCCcccccccCCCccccCHHHHCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC-----------
Confidence 764322 224568999999999997654 9999999999999999999999999998888887776621
Q ss_pred CCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q 012233 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDD 425 (468)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~ 425 (468)
++. ++..+|+++++||.+||++||.+|||+.|+|+||||++
T Consensus 242 --------~~~---------~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 282 (350)
T 4b9d_A 242 --------FPP---------VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK 282 (350)
T ss_dssp --------CCC---------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred --------CCC---------CCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhc
Confidence 110 23458999999999999999999999999999999975
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-60 Score=475.11 Aligned_cols=255 Identities=27% Similarity=0.414 Sum_probs=216.4
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc----cchHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEE
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~----~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~l 212 (468)
..|.+.+.||+|+||.||+|+++.+|+.||||++... ...+.+|+.+|+.|+|||||+++++|.. ...+||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~-----~~~~~i 225 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV-----GDELWV 225 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEE-----CCEEEE
Confidence 3599999999999999999999999999999998532 3456789999999999999999999944 346999
Q ss_pred EeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCC
Q 012233 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (468)
Q Consensus 213 v~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~ 292 (468)
|||||.|+.|..+.. ...+++..++.|+.||+.||+|||+ +|||||||||+||||+.++ .+||+|||+|+.+..
T Consensus 226 VmEy~~gG~L~~~i~----~~~l~e~~~~~~~~qil~aL~ylH~-~~IiHRDiKp~NILl~~~g-~vKl~DFGla~~~~~ 299 (423)
T 4fie_A 226 VMEFLEGGALTDIVT----HTRMNEEQIAAVCLAVLQALSVLHA-QGVIHRDIKSDSILLTHDG-RVKLSDFGFCAQVSK 299 (423)
T ss_dssp EEECCTTEEHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSTTTEEECTTC-CEEECCCTTCEECCS
T ss_pred EEeCCCCCcHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHH-CCeecccCCHHHEEEcCCC-CEEEecCccceECCC
Confidence 999999765543332 2469999999999999999999998 9999999999999999988 799999999987754
Q ss_pred C-CCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCC
Q 012233 293 G-EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNY 371 (468)
Q Consensus 293 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 371 (468)
. ....+.+||+.|||||++.+. .|+.++|||||||++|||++|++||.+.+..+.+..|..... +
T Consensus 300 ~~~~~~~~~GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~------------ 365 (423)
T 4fie_A 300 EVPRRKSLVGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-P------------ 365 (423)
T ss_dssp SCCCBCCCEECTTTCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-C------------
T ss_pred CCccccccccCcCcCCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-C------------
Confidence 3 345578999999999999765 499999999999999999999999999888777776654210 0
Q ss_pred ccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCC
Q 012233 372 TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDP 429 (468)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~ 429 (468)
.+ ..+..+++++++||.+||++||.+|||+.|+|+||||++...+
T Consensus 366 ---~~----------~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~~p 410 (423)
T 4fie_A 366 ---RL----------KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPP 410 (423)
T ss_dssp ---CC----------SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCCG
T ss_pred ---CC----------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCCCC
Confidence 00 1234589999999999999999999999999999999875443
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-59 Score=453.14 Aligned_cols=251 Identities=23% Similarity=0.341 Sum_probs=207.7
Q ss_pred eEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc------chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEE
Q 012233 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (468)
Q Consensus 139 y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~l 212 (468)
|++.+.||+|+||+||+|.+..++..||+|++.... ..+.+|+.+|+.|+|||||+++++|.... .+..++||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~-~~~~~~~l 106 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIVL 106 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEE-TTEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeecc-CCCcEEEE
Confidence 478889999999999999999999999999986432 23568999999999999999999885543 34567899
Q ss_pred EeecccchHH-HHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCC--ccccCCCCCCeeecC-CCCcEEEeeecCcc
Q 012233 213 VLEYISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG--VCHRDIKPQNLLVNP-HTHQLKICDFGSAK 288 (468)
Q Consensus 213 v~e~~~~~ll-~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~g--ivHrDlkp~NILl~~-~~~~vkL~DFG~a~ 288 (468)
|||||.++.| +.+.. ...+++..++.|+.||+.||+|||+ +| ||||||||+||||+. ++ .+||+|||+|+
T Consensus 107 vmEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~ylH~-~~~~IiHRDlKp~NILl~~~~g-~vKl~DFGla~ 180 (290)
T 3fpq_A 107 VTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTG-SVKIGDLGLAT 180 (290)
T ss_dssp EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-SSSCCCCCCCCGGGEEESSTTS-CEEECCTTGGG
T ss_pred EEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCCEEecccChhheeEECCCC-CEEEEeCcCCE
Confidence 9999996544 43332 4678999999999999999999997 78 999999999999985 55 79999999997
Q ss_pred ccCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 012233 289 MLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368 (468)
Q Consensus 289 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 368 (468)
... .....+.+||+.|||||++.+ .|+.++|||||||++|||++|++||.+.+....+...+.....|
T Consensus 181 ~~~-~~~~~~~~GTp~YmAPE~~~~--~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~--------- 248 (290)
T 3fpq_A 181 LKR-ASFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP--------- 248 (290)
T ss_dssp GCC-TTSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC---------
T ss_pred eCC-CCccCCcccCccccCHHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCC---------
Confidence 543 344557899999999999864 49999999999999999999999998877666655443311110
Q ss_pred CCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q 012233 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDD 425 (468)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~ 425 (468)
..++..+++++++||.+||+.||.+|||+.|+|+||||++
T Consensus 249 -----------------~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 249 -----------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp -----------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred -----------------CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 1134557899999999999999999999999999999985
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-60 Score=461.26 Aligned_cols=256 Identities=24% Similarity=0.348 Sum_probs=213.3
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeecccchHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEEEeec
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEY 216 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv~e~ 216 (468)
..|.+.+.||+|+||+||+|+++.+|+.||||++..+.. ..+|+.+|+.|+|||||+++++|. +..++||||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-~~~E~~il~~l~HpnIV~l~~~~~-----~~~~~~ivmEy 131 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-RVEELVACAGLSSPRIVPLYGAVR-----EGPWVNIFMEL 131 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CTHHHHTTTTCCCTTBCCEEEEEE-----ETTEEEEEECC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-HHHHHHHHHhCCCCCCCcEEEEEE-----ECCEEEEEEec
Confidence 359999999999999999999999999999999976543 347999999999999999999984 44468999999
Q ss_pred ccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCCCCC
Q 012233 217 ISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEP 295 (468)
Q Consensus 217 ~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~~~~ 295 (468)
|.|+ |.+++.. ...+++..++.|+.||+.||.|||+ +|||||||||+||||+.++..+||+|||+|+.+.....
T Consensus 132 ~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~ 206 (336)
T 4g3f_A 132 LEGGSLGQLIKQ----MGCLPEDRALYYLGQALEGLEYLHT-RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206 (336)
T ss_dssp CTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred cCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence 9865 5554432 3569999999999999999999998 99999999999999998874699999999987654321
Q ss_pred ------CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 012233 296 ------NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (468)
Q Consensus 296 ------~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 369 (468)
....+||+.|||||++.+.. |+.++|||||||++|||++|++||.+.+..+.+.+|... .+
T Consensus 207 ~~~~~~~~~~~GT~~YmAPE~~~~~~-y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~--~~---------- 273 (336)
T 4g3f_A 207 GKSLLTGDYIPGTETHMAPEVVMGKP-CDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASE--PP---------- 273 (336)
T ss_dssp -------CCCCCCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHS--CC----------
T ss_pred ccceecCCccccCccccCHHHHCCCC-CCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcC--CC----------
Confidence 22358999999999998754 999999999999999999999999987776666666541 00
Q ss_pred CCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHH-------------hCCCCCCCCCCCC
Q 012233 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEA-------------CAHPFFDDLRDPN 430 (468)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~el-------------l~hp~f~~~~~~~ 430 (468)
. ...+++.+++++++||.+||++||.+|||+.|+ |.|||+.+..+|.
T Consensus 274 -----~---------~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~Pr 333 (336)
T 4g3f_A 274 -----P---------IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEPR 333 (336)
T ss_dssp -----G---------GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCCCC
T ss_pred -----C---------chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCCCC
Confidence 0 012456789999999999999999999999997 6899999887654
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-59 Score=454.05 Aligned_cols=250 Identities=28% Similarity=0.457 Sum_probs=207.2
Q ss_pred cceEEeceecccCceEEEEEEEc---CCCCEEEEEEeecc------cchHHHHHHHHHHcCCCCcccccceeeecCCCCc
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCL---ETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~---~~g~~vaiK~~~~~------~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 207 (468)
.+|++.+.||+|+||+||+|++. .+++.||||++.+. .....+|+.+|+.++|||||+++++|. +.
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-----~~ 98 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQ-----TE 98 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEE-----ET
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEE-----EC
Confidence 47999999999999999999984 46889999998543 234567999999999999999999984 44
Q ss_pred eEEEEEeecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecC
Q 012233 208 LYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (468)
Q Consensus 208 ~~~~lv~e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~ 286 (468)
..+|||||||.|+ |.+.+.. ...+++..++.++.||+.||.|||+ +|||||||||+|||++.++ .+||+|||+
T Consensus 99 ~~~~ivmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~NILl~~~g-~vKl~DFGl 172 (304)
T 3ubd_A 99 GKLYLILDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHS-LGIIYRDLKPENILLDEEG-HIKLTDFGL 172 (304)
T ss_dssp TEEEEEECCCTTCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCCGGGEEECTTS-CEEEESSEE
T ss_pred CEEEEEEEcCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCcCCCCCHHHeEEcCCC-CEEeccccc
Confidence 4699999999865 4444432 4579999999999999999999998 9999999999999999998 799999999
Q ss_pred ccccCCC-CCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 012233 287 AKMLVPG-EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIK 365 (468)
Q Consensus 287 a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 365 (468)
|+..... ....+.+||+.|||||++.+.. |+.++|||||||++|||++|++||.+.+..+.+.+|.+.
T Consensus 173 a~~~~~~~~~~~~~~GT~~YmAPE~~~~~~-y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~---------- 241 (304)
T 3ubd_A 173 SKESIDHEKKAYSFCGTVEYMAPEVVNRRG-HTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKA---------- 241 (304)
T ss_dssp EEC-----CCCCSCCCCGGGCCHHHHHTSC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC----------
T ss_pred ceeccCCCccccccccCcccCCHHHhccCC-CCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcC----------
Confidence 9865433 3455789999999999997654 999999999999999999999999998888877777651
Q ss_pred hcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCC-----HHHHhCCCCCCCCC
Q 012233 366 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCT-----ALEACAHPFFDDLR 427 (468)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s-----~~ell~hp~f~~~~ 427 (468)
... ++..+|+++++||.+||++||.+||| ++|+++||||+++.
T Consensus 242 -------~~~------------~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~id 289 (304)
T 3ubd_A 242 -------KLG------------MPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTID 289 (304)
T ss_dssp -------CCC------------CCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCC
T ss_pred -------CCC------------CCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCC
Confidence 111 33458999999999999999999998 47999999999874
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-57 Score=452.16 Aligned_cols=279 Identities=28% Similarity=0.454 Sum_probs=214.3
Q ss_pred ccceEEeceecccCceEEEEEEEc---CCCCEEEEEEeecccc--hHHHHHHHHHHc-CCCCcccccceeeecCCCCceE
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCL---ETGDSVAIKKVLQDKR--YKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDELY 209 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~---~~g~~vaiK~~~~~~~--~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~~~~ 209 (468)
.+.|++.+.||+|+||+||+|+++ .+++.||||++..... ...+|+++|+.+ .|||||+++++|. +..+
T Consensus 20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~-----~~~~ 94 (361)
T 4f9c_A 20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFR-----KNDH 94 (361)
T ss_dssp GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEE-----ETTE
T ss_pred cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEE-----ECCE
Confidence 456999999999999999999875 4678999999865433 345799999998 6999999999984 4456
Q ss_pred EEEEeecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcc
Q 012233 210 LNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (468)
Q Consensus 210 ~~lv~e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~ 288 (468)
+|||||||+++ +.+.+ +.+++..++.++.||+.||+|||+ +|||||||||+||||+.+...+||+|||+|+
T Consensus 95 ~~lvmE~~~g~~L~~~~-------~~l~~~~~~~~~~qll~al~ylH~-~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~ 166 (361)
T 4f9c_A 95 VVIAMPYLEHESFLDIL-------NSLSFQEVREYMLNLFKALKRIHQ-FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQ 166 (361)
T ss_dssp EEEEEECCCCCCHHHHH-------TTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEEeCCCcccHHHHH-------cCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence 99999999865 44433 348999999999999999999998 9999999999999998874489999999997
Q ss_pred ccCCCC-----------------------------CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCC
Q 012233 289 MLVPGE-----------------------------PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPL 339 (468)
Q Consensus 289 ~~~~~~-----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~p 339 (468)
...... ...+.+||+.|+|||++.+...|+.++||||+||++|||++|++|
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~P 246 (361)
T 4f9c_A 167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP 246 (361)
T ss_dssp ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCC
Confidence 653321 123458999999999998877799999999999999999999999
Q ss_pred CCC-CCcHHHHHHHHHHhCCCCHHHHhhcCCC--C-------------------ccCCCCc----ccCCCcccccccCCC
Q 012233 340 FPG-ESGVDQLVEIIKILGTPTREEIKCMNPN--Y-------------------TEFKFPQ----IKAHPWHKIFHKRMP 393 (468)
Q Consensus 340 f~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~--~-------------------~~~~~~~----~~~~~~~~~~~~~~~ 393 (468)
|.. .+..+++..|+..+|.+........... . ....+|. ..........+..++
T Consensus 247 f~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is 326 (361)
T 4f9c_A 247 FYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVP 326 (361)
T ss_dssp SSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCC
T ss_pred CCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCC
Confidence 954 5667888889888876543322211000 0 0000110 001111122346789
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q 012233 394 PEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (468)
Q Consensus 394 ~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~ 427 (468)
++++|||.+||++||.+|+|++|+|+||||+++.
T Consensus 327 ~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i~ 360 (361)
T 4f9c_A 327 DEAYDLLDKLLDLNPASRITAEEALLHPFFKDMS 360 (361)
T ss_dssp HHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC-
T ss_pred HHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence 9999999999999999999999999999999874
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-57 Score=440.25 Aligned_cols=263 Identities=25% Similarity=0.420 Sum_probs=192.0
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-----chHHHHHHHHHHcCCCCcccccceeeecCC-------
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTE------- 204 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~------- 204 (468)
.+|++.+.||+|+||+||+|+++.+|+.||||++.... ..+.+|+.+|+.|+|||||+++++|.....
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 46999999999999999999999999999999985432 234579999999999999999999865442
Q ss_pred CCceEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeee
Q 012233 205 KDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDF 284 (468)
Q Consensus 205 ~~~~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DF 284 (468)
....++|||||||.++.+.................++.++.||+.||+|||+ +|||||||||+||||+.++ .+||+||
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~-~~IiHRDlKp~NILl~~~~-~vKl~DF 162 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHS-KGLMHRDLKPSNIFFTMDD-VVKVGDF 162 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTC-CEEECCC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHH-CcCccccCcHHHeEECCCC-cEEEccC
Confidence 2345689999999875444322222222334566788999999999999998 8999999999999999888 7999999
Q ss_pred cCccccCCCCC-------------CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Q 012233 285 GSAKMLVPGEP-------------NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVE 351 (468)
Q Consensus 285 G~a~~~~~~~~-------------~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~ 351 (468)
|+|+.+..... ..+.+||+.|||||++.+. .|+.++|||||||++|||++ ||.+. .+....
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyell~---Pf~~~--~~~~~~ 236 (299)
T 4g31_A 163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGN-SYSHKVDIFSLGLILFELLY---PFSTQ--MERVRT 236 (299)
T ss_dssp CCC--------------------------CCCTTSCHHHHTTC-CCCTHHHHHHHHHHHHHHHS---CCSSH--HHHHHH
T ss_pred ccceecCCCccccccccccccccccCCcccCccccCHHHHcCC-CCCCHHHHHHHHHHHHHHcc---CCCCc--cHHHHH
Confidence 99987644321 2346899999999999765 49999999999999999996 77543 222222
Q ss_pred HHHHhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCCCC
Q 012233 352 IIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNT 431 (468)
Q Consensus 352 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~ 431 (468)
+...... .+|. .....++.+.+||.+||+.||.+|||+.|+|+||||+++..+..
T Consensus 237 ~~~~~~~----------------~~p~---------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~p~~ 291 (299)
T 4g31_A 237 LTDVRNL----------------KFPP---------LFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGK 291 (299)
T ss_dssp HHHHHTT----------------CCCH---------HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC-----
T ss_pred HHHHhcC----------------CCCC---------CCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCCCCc
Confidence 2222111 1111 11234677899999999999999999999999999999865544
Q ss_pred C
Q 012233 432 C 432 (468)
Q Consensus 432 ~ 432 (468)
.
T Consensus 292 ~ 292 (299)
T 4g31_A 292 T 292 (299)
T ss_dssp -
T ss_pred h
Confidence 3
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-55 Score=461.37 Aligned_cols=254 Identities=24% Similarity=0.388 Sum_probs=209.1
Q ss_pred CCcccceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-------chHHHH---HHHHHHcCCCCcccccceeeec
Q 012233 133 PKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRE---LQIMRLLNHPNVVSLKHCFFST 202 (468)
Q Consensus 133 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-------~~~~~E---~~il~~l~hpnIv~l~~~~~~~ 202 (468)
+...++|.+.++||+|+||+||+|+++.+|+.||||++.+.. ....+| +.+++.++|||||+++++|
T Consensus 185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f--- 261 (689)
T 3v5w_A 185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF--- 261 (689)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE---
T ss_pred CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEE---
Confidence 455678999999999999999999999999999999986432 122233 5566677899999999999
Q ss_pred CCCCceEEEEEeecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEE
Q 012233 203 TEKDELYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKI 281 (468)
Q Consensus 203 ~~~~~~~~~lv~e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL 281 (468)
.+..++|||||||.|| |...+.. ...+++..++.|+.||+.||.|||+ +|||||||||+||||+.++ .+||
T Consensus 262 --~~~~~lylVmEy~~GGdL~~~l~~----~~~l~E~~a~~y~~qIl~aL~yLH~-~gIiHRDLKPeNILld~~G-~vKL 333 (689)
T 3v5w_A 262 --HTPDKLSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHN-RFVVYRDLKPANILLDEHG-HVRI 333 (689)
T ss_dssp --ECSSEEEEEECCCCSCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCSGGGEEECTTS-CEEE
T ss_pred --EECCEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCchHHeEEeCCC-CEEe
Confidence 5566799999999965 4444332 4679999999999999999999998 9999999999999999998 6999
Q ss_pred eeecCccccCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHH--H-HHHHHHhCC
Q 012233 282 CDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQ--L-VEIIKILGT 358 (468)
Q Consensus 282 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~--~-~~i~~~~~~ 358 (468)
+|||+|+.+... ...+.+||+.|||||++.+...|+.++|||||||++|||++|++||.+.+..+. + ..+..
T Consensus 334 ~DFGlA~~~~~~-~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~---- 408 (689)
T 3v5w_A 334 SDLGLACDFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT---- 408 (689)
T ss_dssp CCCTTCEECSSC-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHH----
T ss_pred cccceeeecCCC-CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcC----
Confidence 999999876543 345789999999999997555699999999999999999999999986543222 2 22222
Q ss_pred CCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCC-----HHHHhCCCCCCCCC
Q 012233 359 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCT-----ALEACAHPFFDDLR 427 (468)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s-----~~ell~hp~f~~~~ 427 (468)
.... ++..+|+++++||.+||++||.+|++ ++|+++||||+++.
T Consensus 409 -------------~~~~------------~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~id 457 (689)
T 3v5w_A 409 -------------MAVE------------LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD 457 (689)
T ss_dssp -------------CCCC------------CCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCC
T ss_pred -------------CCCC------------CCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCC
Confidence 1111 34568999999999999999999998 79999999999874
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-55 Score=458.47 Aligned_cols=260 Identities=26% Similarity=0.432 Sum_probs=221.4
Q ss_pred ccceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc----chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEE
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 211 (468)
.++|.+.+.||+|+||.||+|.++.+|+.||||++.... ....+|+.+|+.|+|||||+++++| .+...+|
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~-----~~~~~~~ 230 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF-----EDDNEMV 230 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEE-----ECSSEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEE-----EECCEEE
Confidence 457999999999999999999999999999999986542 3456799999999999999999999 5556799
Q ss_pred EEeecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCC-CCcEEEeeecCccc
Q 012233 212 LVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPH-THQLKICDFGSAKM 289 (468)
Q Consensus 212 lv~e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~-~~~vkL~DFG~a~~ 289 (468)
||||||.|+ |++.+. .....+++..++.|+.||+.||.|||+ +||+||||||+|||++.+ ...+||+|||+|+.
T Consensus 231 iv~E~~~gg~L~~~i~---~~~~~l~e~~~~~~~~qi~~al~ylH~-~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~ 306 (573)
T 3uto_A 231 MIYEFMSGGELFEKVA---DEHNKMSEDEAVEYMRQVCKGLCHMHE-NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH 306 (573)
T ss_dssp EEEECCCCCBHHHHHT---CTTSCEEHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSSSCCCEEECCCSSCEE
T ss_pred EEEeecCCCcHHHHHH---HhCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCChhhccccCCCCCCEEEeeccceeE
Confidence 999999865 444332 234568999999999999999999998 899999999999999864 22799999999998
Q ss_pred cCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 012233 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (468)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 369 (468)
+.........+||+.|||||++.+.. |+.++|||||||++|||++|++||.+.+..+.+..|....
T Consensus 307 ~~~~~~~~~~~GT~~y~APEv~~~~~-y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~------------- 372 (573)
T 3uto_A 307 LDPKQSVKVTTGTAEFAAPEVAEGKP-VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCD------------- 372 (573)
T ss_dssp CCTTSEEEEECSSGGGCCHHHHTTCC-BCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTC-------------
T ss_pred ccCCCceeeeEECccccCHHHhCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCC-------------
Confidence 87766667789999999999997754 8999999999999999999999999998888877776521
Q ss_pred CCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCCC
Q 012233 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPN 430 (468)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~ 430 (468)
+.++ ...+..+++++++||.+||++||.+|||+.|+|+||||+....+.
T Consensus 373 ----~~~~--------~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~~ 421 (573)
T 3uto_A 373 ----WNMD--------DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPG 421 (573)
T ss_dssp ----CCCC--------SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCTT
T ss_pred ----CCCC--------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCCC
Confidence 1111 113356899999999999999999999999999999999865544
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-53 Score=424.88 Aligned_cols=324 Identities=46% Similarity=0.869 Sum_probs=274.0
Q ss_pred ccceEEeceecccCceEEEEEEEcCCCCEEEEEEeecccc---hHHHHHHHHHHcCCCCcccccceeeecCC--CCceEE
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR---YKNRELQIMRLLNHPNVVSLKHCFFSTTE--KDELYL 210 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~~---~~~~E~~il~~l~hpnIv~l~~~~~~~~~--~~~~~~ 210 (468)
.++|.+.+.||+|+||.||+|.+..+|+.||||++..... ...+|+..++.++||||++++++|..... ....++
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~ 101 (360)
T 3e3p_A 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYL 101 (360)
T ss_dssp HTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeE
Confidence 4469999999999999999999999999999998865533 33456777788899999999999876543 445678
Q ss_pred EEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhH--hcCCccccCCCCCCeeecC-CCCcEEEeeecCc
Q 012233 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH--HVVGVCHRDIKPQNLLVNP-HTHQLKICDFGSA 287 (468)
Q Consensus 211 ~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH--~~~givHrDlkp~NILl~~-~~~~vkL~DFG~a 287 (468)
++||||++++++..+.........+++..++.++.||+.||.||| + +||+||||||+||||+. ++ .+||+|||++
T Consensus 102 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~-~~ivH~Dlkp~NIll~~~~~-~~kl~Dfg~a 179 (360)
T 3e3p_A 102 NVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADG-TLKLCDFGSA 179 (360)
T ss_dssp EEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTT-TCCBCSCCCGGGEEEETTTT-EEEECCCTTC
T ss_pred EEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCC-CCeecCcCCHHHEEEeCCCC-cEEEeeCCCc
Confidence 899999999988877766666778999999999999999999999 8 89999999999999997 55 8999999999
Q ss_pred cccCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 012233 288 KMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367 (468)
Q Consensus 288 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 367 (468)
.............||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.+.++.+....+...
T Consensus 180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (360)
T 3e3p_A 180 KKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKL 259 (360)
T ss_dssp BCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred eecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhc
Confidence 88776666667789999999999977666899999999999999999999999999999999999999999999999888
Q ss_pred CCCCccCCCCcccCCCccccccc---CCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCCCCCCCCCCCCC-ccc
Q 012233 368 NPNYTEFKFPQIKAHPWHKIFHK---RMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNTCLPNGRPLP-TLF 443 (468)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~~~~~~~~~~-~~~ 443 (468)
.+......+......+|...+.. ..++++.+||.+||+.||.+|||+.|+|+||||+++.++...+++...+| .++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~ 339 (360)
T 3e3p_A 260 NPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPATKLPNNKDLPEDLF 339 (360)
T ss_dssp CTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTTCCCTTSCCCCGGGG
T ss_pred ccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCccccCCCCCCCCcHHH
Confidence 88877777776666666655543 36789999999999999999999999999999999999999999999988 678
Q ss_pred ccCHHHHhcCCHHHHHhc
Q 012233 444 NFTAQELAGASNELRQRL 461 (468)
Q Consensus 444 ~~~~~~~~~~~~~~~~~~ 461 (468)
.|.+.+...+.++...++
T Consensus 340 ~~~~~~~~~~~~~~~~~~ 357 (360)
T 3e3p_A 340 RFLPNEIEVMSEAQKAKL 357 (360)
T ss_dssp CCCHHHHHHSCHHHHHHH
T ss_pred HcCchHHHHHHHHHhhhh
Confidence 999999999999888764
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-54 Score=416.64 Aligned_cols=250 Identities=22% Similarity=0.283 Sum_probs=195.7
Q ss_pred CcccceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc------cchHHHHHHHHHHcCCCCcccccceeeecCCCCc
Q 012233 134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (468)
Q Consensus 134 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~------~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 207 (468)
....++.+.+.||+|+||+||+|++. ..||||+++.. ...+.+|+.+|++++|||||++++++. +.
T Consensus 33 i~~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-----~~ 104 (307)
T 3omv_A 33 IEASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-----KD 104 (307)
T ss_dssp CCTTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----SS
T ss_pred EcHHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----CC
Confidence 34456889999999999999999863 36999988532 234568999999999999999999762 11
Q ss_pred eEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCc
Q 012233 208 LYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (468)
Q Consensus 208 ~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a 287 (468)
.+|||||||+++.|..... .....+++..+..|+.||+.||+|||+ +|||||||||+||||+.++ .+||+|||+|
T Consensus 105 -~~~iVmEy~~gGsL~~~l~--~~~~~l~~~~~~~i~~qia~gL~yLH~-~~IiHRDlKp~NILl~~~~-~~Ki~DFGla 179 (307)
T 3omv_A 105 -NLAIVTQWCEGSSLYKHLH--VQETKFQMFQLIDIARQTAQGMDYLHA-KNIIHRDMKSNNIFLHEGL-TVKIGDFGLA 179 (307)
T ss_dssp -SCEEEEECCSSCBHHHHHH--TSCCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCSCCCSSSEEEETTE-EEEECCCSSC
T ss_pred -eEEEEEEcCCCCCHHHHHh--hcCCCCCHHHHHHHHHHHHHHHHHHHH-CCccCCccCHHHEEECCCC-cEEEeeccCc
Confidence 2689999999654432221 234569999999999999999999998 8999999999999999888 8999999999
Q ss_pred cccCCCC---CCccccccCCccccccccCC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 012233 288 KMLVPGE---PNISYICSRYYRAPELIFGA--TEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTRE 362 (468)
Q Consensus 288 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~--~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~ 362 (468)
+...... .....+||+.|||||++.+. ..|+.++|||||||+||||+||+.||.+.+....+..++.....
T Consensus 180 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~---- 255 (307)
T 3omv_A 180 TVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYA---- 255 (307)
T ss_dssp BC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCC----
T ss_pred eecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCC----
Confidence 8654322 23456899999999999643 34899999999999999999999999988877777666542111
Q ss_pred HHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 363 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
.|.+ ..++..+++++.+||.+||+.||.+|||+.|++.
T Consensus 256 -------------~p~~------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~ 293 (307)
T 3omv_A 256 -------------SPDL------SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILS 293 (307)
T ss_dssp -------------CCCS------TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHH
T ss_pred -------------CCCc------ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 1111 1134568999999999999999999999997643
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-54 Score=420.76 Aligned_cols=248 Identities=23% Similarity=0.324 Sum_probs=195.9
Q ss_pred ccceEEeceecccCceEEEEEEEc-----CCCCEEEEEEeeccc----chHHHHHHHHHHcCCCCcccccceeeecCCCC
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCL-----ETGDSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD 206 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~-----~~g~~vaiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 206 (468)
..+|.+.+.||+|+||+||+|++. .++..||||++.... ..+.+|+++|++|+|||||++++++ .+
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~-----~~ 114 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVC-----TE 114 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----CS
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EE
Confidence 346999999999999999999875 368899999986432 3456899999999999999999998 34
Q ss_pred ceEEEEEeecccchHH-HHHhhhh-----------hcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecC
Q 012233 207 ELYLNLVLEYISETVY-RVSKHYT-----------RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNP 274 (468)
Q Consensus 207 ~~~~~lv~e~~~~~ll-~~~~~~~-----------~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~ 274 (468)
...+|||||||+++.| +++.... .....+++..+..|+.||+.||.|||+ ++||||||||+||||+.
T Consensus 115 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~-~~iiHRDLKp~NILl~~ 193 (329)
T 4aoj_A 115 GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG-LHFVHRDLATRNCLVGQ 193 (329)
T ss_dssp SSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEET
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc-CCeecccccHhhEEECC
Confidence 4458999999996544 4433221 123468999999999999999999998 89999999999999998
Q ss_pred CCCcEEEeeecCccccCCCC---CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHH
Q 012233 275 HTHQLKICDFGSAKMLVPGE---PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLV 350 (468)
Q Consensus 275 ~~~~vkL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~ 350 (468)
++ .+||+|||+|+...... .....+||+.|||||++.+.. |+.++|||||||+||||+| |+.||.+.+..+.+.
T Consensus 194 ~~-~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~-~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~ 271 (329)
T 4aoj_A 194 GL-VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK-FTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAID 271 (329)
T ss_dssp TT-EEEECCCC----------------CCCCGGGCCHHHHTTCC-CCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHH
T ss_pred CC-cEEEcccccceeccCCCcceecCcccccccccChhhhcCCC-CCccccccchHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 88 89999999998764332 223467899999999997654 9999999999999999998 999999988777766
Q ss_pred HHHHHhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 351 EIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 351 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
.+.+... . .++..+++++.+||.+||+.||.+|||+.|++.
T Consensus 272 ~i~~g~~----------------~------------~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 312 (329)
T 4aoj_A 272 CITQGRE----------------L------------ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHA 312 (329)
T ss_dssp HHHHTCC----------------C------------CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHH
T ss_pred HHHcCCC----------------C------------CCcccccHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 6654210 0 133568999999999999999999999999976
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-54 Score=418.27 Aligned_cols=255 Identities=23% Similarity=0.325 Sum_probs=205.0
Q ss_pred cccceEEeceecccCceEEEEEEEc-----CCCCEEEEEEeeccc----chHHHHHHHHHHcCCCCcccccceeeecCCC
Q 012233 135 QTISYMAERVVGTGSFGVVFQAKCL-----ETGDSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEK 205 (468)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~-----~~g~~vaiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 205 (468)
...+|.+.+.||+|+||+||+|++. .++..||||++.... ..+.+|+++|++|+|||||++++++.
T Consensus 11 ~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~----- 85 (299)
T 4asz_A 11 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCV----- 85 (299)
T ss_dssp CGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----
T ss_pred CHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEe-----
Confidence 3457999999999999999999875 357889999986532 34568999999999999999999984
Q ss_pred CceEEEEEeecccch-HHHHHhhhh---------hcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCC
Q 012233 206 DELYLNLVLEYISET-VYRVSKHYT---------RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPH 275 (468)
Q Consensus 206 ~~~~~~lv~e~~~~~-ll~~~~~~~---------~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~ 275 (468)
+...+|||||||++| |.+.+.... .....+++..+..++.||+.||.|||+ ++||||||||+||||+.+
T Consensus 86 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~-~~iiHRDlKp~NILl~~~ 164 (299)
T 4asz_A 86 EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS-QHFVHRDLATRNCLVGEN 164 (299)
T ss_dssp SSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECGG
T ss_pred eCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCccCHhhEEECCC
Confidence 344589999999865 444443321 224568999999999999999999998 899999999999999988
Q ss_pred CCcEEEeeecCccccCCCCC---CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHH
Q 012233 276 THQLKICDFGSAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVE 351 (468)
Q Consensus 276 ~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~ 351 (468)
+ .+||+|||+|+....... .....||+.|||||++.+.. |+.++|||||||++|||+| |+.||.+.+..+.+..
T Consensus 165 ~-~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~-~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~ 242 (299)
T 4asz_A 165 L-LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIEC 242 (299)
T ss_dssp G-CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH
T ss_pred C-cEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 8 799999999986644332 22356899999999997654 9999999999999999998 9999999887777666
Q ss_pred HHHHhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q 012233 352 IIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (468)
Q Consensus 352 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~ 427 (468)
+.+.... .++..+|+++.+||.+||+.||.+|||+.++ |+|++++.
T Consensus 243 i~~~~~~----------------------------~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~~~ 288 (299)
T 4asz_A 243 ITQGRVL----------------------------QRPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQNLA 288 (299)
T ss_dssp HHHTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHHHH
T ss_pred HHcCCCC----------------------------CCCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHHHH
Confidence 6542100 1335689999999999999999999999999 45776543
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-53 Score=414.52 Aligned_cols=249 Identities=22% Similarity=0.263 Sum_probs=201.3
Q ss_pred ccceEEeceecccCceEEEEEEEc-----CCCCEEEEEEeecc-----cchHHHHHHHHHHcCCCCcccccceeeecCCC
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCL-----ETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEK 205 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~-----~~g~~vaiK~~~~~-----~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 205 (468)
...+++.+.||+|+||+||+|.+. .+++.||||++... ...+.+|+.+|++++|||||++++++.
T Consensus 25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~----- 99 (308)
T 4gt4_A 25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVT----- 99 (308)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEEC-----
T ss_pred HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEE-----
Confidence 346889999999999999999863 46788999998543 234678999999999999999999984
Q ss_pred CceEEEEEeecccch-HHHHHhhhh------------hcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeee
Q 012233 206 DELYLNLVLEYISET-VYRVSKHYT------------RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLV 272 (468)
Q Consensus 206 ~~~~~~lv~e~~~~~-ll~~~~~~~------------~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl 272 (468)
+...+|||||||++| |.+.+.... .....+++..+..++.||+.||.|||+ ++||||||||+||||
T Consensus 100 ~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~-~~iiHRDLK~~NILl 178 (308)
T 4gt4_A 100 KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS-HHVVHKDLATRNVLV 178 (308)
T ss_dssp SSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEE
T ss_pred ECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh-CCCCCCCccccceEE
Confidence 334478999999865 444443221 113468999999999999999999998 899999999999999
Q ss_pred cCCCCcEEEeeecCccccCCCC---CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHH
Q 012233 273 NPHTHQLKICDFGSAKMLVPGE---PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQ 348 (468)
Q Consensus 273 ~~~~~~vkL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~ 348 (468)
+.++ .+||+|||+|+...... .....+||+.|||||++.+.. |+.++|||||||+||||+| |..||.+.+..+.
T Consensus 179 ~~~~-~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~-~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~ 256 (308)
T 4gt4_A 179 YDKL-NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGK-FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV 256 (308)
T ss_dssp CGGG-CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHH
T ss_pred CCCC-CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCC-CCccchhhhHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 9888 79999999998664322 233568899999999997654 9999999999999999998 8999999887766
Q ss_pred HHHHHHHhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCC
Q 012233 349 LVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (468)
Q Consensus 349 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~h 420 (468)
+..+...... ..+..+++++.+||.+||+.||.+|||+.||+.+
T Consensus 257 ~~~i~~~~~~----------------------------~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 257 VEMIRNRQVL----------------------------PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HHHHHTTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcCCCC----------------------------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 6555431100 0235689999999999999999999999999863
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-52 Score=415.90 Aligned_cols=252 Identities=24% Similarity=0.343 Sum_probs=203.2
Q ss_pred cccceEEeceecccCceEEEEEEEcCCC-----CEEEEEEeeccc-----chHHHHHHHHHHcCC-CCcccccceeeecC
Q 012233 135 QTISYMAERVVGTGSFGVVFQAKCLETG-----DSVAIKKVLQDK-----RYKNRELQIMRLLNH-PNVVSLKHCFFSTT 203 (468)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~g-----~~vaiK~~~~~~-----~~~~~E~~il~~l~h-pnIv~l~~~~~~~~ 203 (468)
..++|++++.||+|+||+||+|.+...+ +.||||.+.... ..+.+|+.+|+.+.| ||||+++++|...
T Consensus 62 ~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~- 140 (353)
T 4ase_A 62 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP- 140 (353)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT-
T ss_pred cHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec-
Confidence 3457999999999999999999986543 579999986532 335679999999976 8999999987432
Q ss_pred CCCceEEEEEeecccch-HHHHHhhhhh------------cCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCe
Q 012233 204 EKDELYLNLVLEYISET-VYRVSKHYTR------------MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNL 270 (468)
Q Consensus 204 ~~~~~~~~lv~e~~~~~-ll~~~~~~~~------------~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NI 270 (468)
...+|||||||++| |.+++..... ....+++..+..|+.||+.||+|||+ ++||||||||+||
T Consensus 141 ---~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~-~~iiHRDLK~~NI 216 (353)
T 4ase_A 141 ---GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNI 216 (353)
T ss_dssp ---TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGE
T ss_pred ---CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh-CCeecCccCccce
Confidence 23478999999965 4444433221 13458899999999999999999998 9999999999999
Q ss_pred eecCCCCcEEEeeecCccccCCCCC---CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcH
Q 012233 271 LVNPHTHQLKICDFGSAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGV 346 (468)
Q Consensus 271 Ll~~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~ 346 (468)
||+.++ .+||+|||+|+.+..... ....+||+.|||||++.+.. |+.++|||||||+||||+| |+.||.+.+..
T Consensus 217 Ll~~~~-~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~-y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~ 294 (353)
T 4ase_A 217 LLSEKN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKID 294 (353)
T ss_dssp EECGGG-CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred eeCCCC-CEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCC-CCCcccEeehHHHHHHHHhCCCCCCCCCCHH
Confidence 999888 799999999987654432 23467899999999997654 9999999999999999998 99999987766
Q ss_pred HHHHHHHHHhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCC
Q 012233 347 DQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (468)
Q Consensus 347 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~h 420 (468)
+.+..++.....+ .++..+++++.+||.+||+.||.+|||+.|+++|
T Consensus 295 ~~~~~~i~~g~~~---------------------------~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 295 EEFCRRLKEGTRM---------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HHHHHHHHHTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCCC---------------------------CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 6665555432111 1334589999999999999999999999999986
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-51 Score=398.34 Aligned_cols=282 Identities=34% Similarity=0.546 Sum_probs=228.9
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc------chHHHHHHHHHHcCCCCcccccceeeecCCCCceEE
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~ 210 (468)
.+|++.+.||+|+||+||+|.+..+|+.||||++.... ....+|+.+++.++||||+++++++.. ...+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~ 76 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS-----DKKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEe-----CCEE
Confidence 36999999999999999999999999999999986432 334579999999999999999999843 3458
Q ss_pred EEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcccc
Q 012233 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (468)
Q Consensus 211 ~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~ 290 (468)
++||||++++++..+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++...
T Consensus 77 ~lv~e~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~-~~ivH~dikp~Nil~~~~~-~~kl~Dfg~~~~~ 151 (292)
T 3o0g_A 77 TLVFEFCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHS-RNVLHRDLKPQNLLINRNG-ELKLANFGLARAF 151 (292)
T ss_dssp EEEEECCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTS-CEEECCCTTCEEC
T ss_pred EEEEecCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCC-CEEEeecccceec
Confidence 99999999988876543 34679999999999999999999998 8999999999999999888 7999999999876
Q ss_pred CCC-CCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCC-CCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 012233 291 VPG-EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPL-FPGESGVDQLVEIIKILGTPTREEIKCMN 368 (468)
Q Consensus 291 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 368 (468)
... .......||+.|+|||++.+...++.++|||||||++|+|++|..| |.+.+..+.+..+.+..+.+....+..+.
T Consensus 152 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 231 (292)
T 3o0g_A 152 GIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp CSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred CCccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhc
Confidence 432 3344568899999999997766689999999999999999987766 66677778888899988888766554332
Q ss_pred CCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCC
Q 012233 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRD 428 (468)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~ 428 (468)
.......++..........+.+.+++++++||.+||+.||.+|||++|+|+||||+++..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~p 291 (292)
T 3o0g_A 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP 291 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC--
T ss_pred ccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCCC
Confidence 211111222222222223344678999999999999999999999999999999998653
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-51 Score=424.00 Aligned_cols=288 Identities=35% Similarity=0.558 Sum_probs=219.3
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc------chHHHHHHHHHHcCCCCcccccceeeecCCCCceEE
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~ 210 (468)
.+|.+.+.||+|+||+||+|.+..+|+.||||++.... ....+|+.+|+.++|||||++++++..........+
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 46999999999999999999999999999999985431 234579999999999999999999866544445568
Q ss_pred EEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcccc
Q 012233 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (468)
Q Consensus 211 ~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~ 290 (468)
|+||||+++++...+.. ...+++..++.++.||+.||.|||+ .|||||||||+||||+.++ .+||+|||+++..
T Consensus 133 ~lv~e~~~~~L~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~-~~iiHrDlKp~NILl~~~~-~~kl~DFGla~~~ 206 (458)
T 3rp9_A 133 YVVLEIADSDFKKLFRT----PVYLTELHIKTLLYNLLVGVKYVHS-AGILHRDLKPANCLVNQDC-SVKVCDFGLARTV 206 (458)
T ss_dssp EEEECCCSEEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTC-CEEECCCTTCBCT
T ss_pred EEEEeccccchhhhccc----CCCCCHHHHHHHHHHHHHHHHHHHh-CCcCCCCCChhhEEECCCC-CEeecccccchhc
Confidence 99999999988776543 4669999999999999999999998 8999999999999999888 7999999999865
Q ss_pred CCCC----------------------------CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-------
Q 012233 291 VPGE----------------------------PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL------- 335 (468)
Q Consensus 291 ~~~~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~------- 335 (468)
.... .....+||+.|+|||++.....|+.++|||||||++|||++
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~ 286 (458)
T 3rp9_A 207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVA 286 (458)
T ss_dssp TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCS
T ss_pred cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccc
Confidence 3221 22456789999999987666669999999999999999998
Q ss_pred ----CCCCCCCCC--------------------cHHHHHHHHHHhCCCCHHHHhhcCCCCc---cCCCCcccCCCccccc
Q 012233 336 ----GQPLFPGES--------------------GVDQLVEIIKILGTPTREEIKCMNPNYT---EFKFPQIKAHPWHKIF 388 (468)
Q Consensus 336 ----G~~pf~~~~--------------------~~~~~~~i~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~ 388 (468)
|+++|.+.+ ..+++..|+..++.|..+.+........ ...++......+.. .
T Consensus 287 ~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 365 (458)
T 3rp9_A 287 YHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAE-R 365 (458)
T ss_dssp SGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGG-G
T ss_pred ccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHH-H
Confidence 778887754 3578888999999999877654321110 00111111222222 3
Q ss_pred ccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCCCC
Q 012233 389 HKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNT 431 (468)
Q Consensus 389 ~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~ 431 (468)
.+.+++++.+||.+||.+||.+|||++|+|+||||+++..+..
T Consensus 366 ~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~~ 408 (458)
T 3rp9_A 366 FPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAEV 408 (458)
T ss_dssp STTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGGG
T ss_pred CCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCcc
Confidence 3567999999999999999999999999999999999876543
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-52 Score=427.11 Aligned_cols=285 Identities=32% Similarity=0.557 Sum_probs=225.7
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc------cchHHHHHHHHHHcCCCCcccccceeeecCC-CCceE
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTE-KDELY 209 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~------~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~-~~~~~ 209 (468)
.+|++.+.||+|+||.||+|.+..+|+.||||++... .....+|+.+|+.++||||++++++|..... .+...
T Consensus 62 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~ 141 (464)
T 3ttj_A 62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 141 (464)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCe
Confidence 4699999999999999999999999999999998653 2234579999999999999999999854432 23346
Q ss_pred EEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccc
Q 012233 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (468)
Q Consensus 210 ~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~ 289 (468)
+||||||+.++++..+. ..+++..++.++.||+.||+|||+ +||+||||||+||||+.++ .+||+|||+++.
T Consensus 142 ~~lv~E~~~~~l~~~~~------~~l~~~~~~~~~~qil~aL~~lH~-~~iiHrDlkp~NIll~~~~-~~kl~DFG~a~~ 213 (464)
T 3ttj_A 142 VYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDC-TLKILDFGLART 213 (464)
T ss_dssp EEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTS-CEEECCCCCC--
T ss_pred EEEEEeCCCCCHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChHhEEEeCCC-CEEEEEEEeeee
Confidence 89999999999776543 348899999999999999999998 8999999999999999888 799999999987
Q ss_pred cCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 012233 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (468)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 369 (468)
..........+||+.|+|||++.+. .|+.++|||||||++|||++|++||.+.+..+++..|++.++.|..+.+....+
T Consensus 214 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~ 292 (464)
T 3ttj_A 214 AGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 292 (464)
T ss_dssp ---CCCC----CCCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCH
T ss_pred cCCCcccCCCcccccccCHHHHcCC-CCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcch
Confidence 7665556678999999999999775 499999999999999999999999999999999999999999998876654321
Q ss_pred CCccC--CCCcccCCCccccccc-----------CCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCCC
Q 012233 370 NYTEF--KFPQIKAHPWHKIFHK-----------RMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPN 430 (468)
Q Consensus 370 ~~~~~--~~~~~~~~~~~~~~~~-----------~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~ 430 (468)
....+ ..+......+...++. ..++++++||.+||++||.+|||++|+|+||||+.+.++.
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~~~~ 366 (464)
T 3ttj_A 293 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPA 366 (464)
T ss_dssp HHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCHH
T ss_pred hhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhccCcc
Confidence 11100 0011111111111211 1257899999999999999999999999999999776544
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-51 Score=399.63 Aligned_cols=280 Identities=35% Similarity=0.654 Sum_probs=228.1
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc------chHHHHHHHHHHcCCCCcccccceeeecCCCCceEE
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~ 210 (468)
.+|++.+.||+|+||.||+|.+. +|+.||+|++.... ....+|+.+++.++||||+++++++ .+..++
T Consensus 21 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~ 94 (311)
T 3niz_A 21 EKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI-----HSERCL 94 (311)
T ss_dssp CEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEE-----CCSSCE
T ss_pred hhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEE-----ccCCEE
Confidence 46999999999999999999985 58999999985432 2345799999999999999999998 445568
Q ss_pred EEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcccc
Q 012233 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (468)
Q Consensus 211 ~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~ 290 (468)
++||||+.++++..+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++..
T Consensus 95 ~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~a~~~ 169 (311)
T 3niz_A 95 TLVFEFMEKDLKKVLDE---NKTGLQDSQIKIYLYQLLRGVAHCHQ-HRILHRDLKPQNLLINSDG-ALKLADFGLARAF 169 (311)
T ss_dssp EEEEECCSEEHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTC-CEEECCCTTCEET
T ss_pred EEEEcCCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCchHhEEECCCC-CEEEccCcCceec
Confidence 99999999988776543 24568999999999999999999998 8999999999999999888 7999999999876
Q ss_pred CCC-CCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 012233 291 VPG-EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (468)
Q Consensus 291 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 369 (468)
... .......||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+...++.+....+.....
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 249 (311)
T 3niz_A 170 GIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQE 249 (311)
T ss_dssp TSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTT
T ss_pred CCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhc
Confidence 432 2334567899999999997766689999999999999999999999999999999999999998887655443221
Q ss_pred --CCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCC
Q 012233 370 --NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRD 428 (468)
Q Consensus 370 --~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~ 428 (468)
.+....+......+|.. +.+.+++++.+||.+||++||.+|||+.|+|+||||+++..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 309 (311)
T 3niz_A 250 LPLWKQRTFQVFEKKPWSS-IIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLDP 309 (311)
T ss_dssp SHHHHSCCCCCCCCCCHHH-HSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSCT
T ss_pred cchhhhcccccccCCcHHH-hCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCCc
Confidence 11111222222233322 34568999999999999999999999999999999998753
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-51 Score=413.87 Aligned_cols=286 Identities=33% Similarity=0.640 Sum_probs=222.5
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc------cchHHHHHHHHHHcC-CCCcccccceeeecCCCCceE
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLN-HPNVVSLKHCFFSTTEKDELY 209 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~------~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~~~~ 209 (468)
.+|.+.+.||+|+||.||+|.+..+|+.||||++... .....+|+.+++.+. ||||+++++++... +...
T Consensus 9 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~---~~~~ 85 (388)
T 3oz6_A 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRAD---NDRD 85 (388)
T ss_dssp TTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECT---TSSC
T ss_pred CceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecC---CCCE
Confidence 4699999999999999999999999999999988543 123347999999997 99999999988542 2335
Q ss_pred EEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccc
Q 012233 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (468)
Q Consensus 210 ~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~ 289 (468)
+|+|||||.+++...+.. ..+++..++.++.||+.||+|||+ .||+||||||+||||+.++ .+||+|||+++.
T Consensus 86 ~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~ 158 (388)
T 3oz6_A 86 VYLVFDYMETDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHS-GGLLHRDMKPSNILLNAEC-HVKVADFGLSRS 158 (388)
T ss_dssp EEEEEECCSEEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTC-CEEECCCTTCEE
T ss_pred EEEEecccCcCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHh-CCEEeCCCCHHHeEEcCCC-CEEecCCccccc
Confidence 889999999987776543 468899999999999999999998 8999999999999999888 799999999976
Q ss_pred cCCC----------------------CCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHH
Q 012233 290 LVPG----------------------EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVD 347 (468)
Q Consensus 290 ~~~~----------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~ 347 (468)
.... ......+||+.|+|||++.+...++.++|||||||++|||++|++||.+.+..+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~ 238 (388)
T 3oz6_A 159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN 238 (388)
T ss_dssp SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 5321 122346899999999999876679999999999999999999999999999999
Q ss_pred HHHHHHHHhCCCCHHHHhhcCCCCccCCCCc------ccCCCcccc------------cccCCCHHHHHHHHHhcccCCC
Q 012233 348 QLVEIIKILGTPTREEIKCMNPNYTEFKFPQ------IKAHPWHKI------------FHKRMPPEALDLVSRLLQYSPS 409 (468)
Q Consensus 348 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~------------~~~~~~~~l~~li~~~L~~dP~ 409 (468)
++..++..++.|..+.+......+....+.. .....+... ....+++++.+||.+||+.||.
T Consensus 239 ~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~ 318 (388)
T 3oz6_A 239 QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPN 318 (388)
T ss_dssp HHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGG
T ss_pred HHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcc
Confidence 9999999999998877654332221100000 000001111 1236899999999999999999
Q ss_pred CCCCHHHHhCCCCCCCCCCCCCC
Q 012233 410 LRCTALEACAHPFFDDLRDPNTC 432 (468)
Q Consensus 410 ~R~s~~ell~hp~f~~~~~~~~~ 432 (468)
+|||+.|+|+||||+.+..++.-
T Consensus 319 ~R~t~~e~l~Hp~~~~~~~~~~~ 341 (388)
T 3oz6_A 319 KRISANDALKHPFVSIFHNPNEE 341 (388)
T ss_dssp GSCCHHHHTTSTTTTTTCCGGGC
T ss_pred cCCCHHHHhCCHHHHHhcCCccC
Confidence 99999999999999998776543
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-50 Score=398.31 Aligned_cols=257 Identities=27% Similarity=0.424 Sum_probs=217.8
Q ss_pred cccceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc------chHHHHHHHHHHcCCCCcccccceeeecCCCCce
Q 012233 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (468)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 208 (468)
...+|.+.+.||+|+||.||+|.+..+|+.||||++.... ....+|+.+|+.++||||+++++++ ....
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~-----~~~~ 87 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVI-----ETEK 87 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSS
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EECC
Confidence 4557999999999999999999999999999999986542 2245799999999999999999998 4445
Q ss_pred EEEEEeecccc-hHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCc
Q 012233 209 YLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (468)
Q Consensus 209 ~~~lv~e~~~~-~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a 287 (468)
.+|+||||+.+ .+.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~-~~ivHrDlkp~NIll~~~~-~~kl~DFG~a 161 (328)
T 3fe3_A 88 TLYLIMEYASGGEVFDYLVA----HGRMKEKEARSKFRQIVSAVQYCHQ-KRIVHRDLKAENLLLDADM-NIKIADFGFS 161 (328)
T ss_dssp EEEEEECCCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTS-CEEECSTTCC
T ss_pred EEEEEEECCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEeccCCCHHHEEEcCCC-CEEEeeccCc
Confidence 68999999975 45444432 3568999999999999999999998 8999999999999999888 7999999999
Q ss_pred cccCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 012233 288 KMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367 (468)
Q Consensus 288 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 367 (468)
............+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+..+....+...
T Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~------------ 229 (328)
T 3fe3_A 162 NEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG------------ 229 (328)
T ss_dssp GGGSSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------------
T ss_pred eecCCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC------------
Confidence 87766666667889999999999987764568999999999999999999999988877666665541
Q ss_pred CCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCCCC
Q 012233 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNT 431 (468)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~ 431 (468)
.+. ++..+++++.+||.+||+.||.+|||+.|+++||||+....+..
T Consensus 230 -----~~~------------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~~~~ 276 (328)
T 3fe3_A 230 -----KYR------------IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDE 276 (328)
T ss_dssp -----CCC------------CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTCTTCC
T ss_pred -----CCC------------CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCCcccc
Confidence 111 22347899999999999999999999999999999998655443
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-50 Score=393.57 Aligned_cols=283 Identities=29% Similarity=0.515 Sum_probs=231.0
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc---------chHHHHHHHHHHcC---CCCcccccceeeecCC
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---------RYKNRELQIMRLLN---HPNVVSLKHCFFSTTE 204 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~---------~~~~~E~~il~~l~---hpnIv~l~~~~~~~~~ 204 (468)
.+|++.+.||+|+||+||+|.+..+|+.||||++.... ....+|+.+++.+. ||||+++++++.....
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~ 88 (308)
T 3g33_A 9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRT 88 (308)
T ss_dssp -CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCS
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCC
Confidence 46999999999999999999999999999999985322 24457888877765 9999999999977665
Q ss_pred CCceEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeee
Q 012233 205 KDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDF 284 (468)
Q Consensus 205 ~~~~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DF 284 (468)
....++++||||+.+++...+.... ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+||
T Consensus 89 ~~~~~~~lv~e~~~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~Nil~~~~~-~~kl~Df 164 (308)
T 3g33_A 89 DREIKVTLVFEHVDQDLRTYLDKAP--PPGLPAETIKDLMRQFLRGLDFLHA-NCIVHRDLKPENILVTSGG-TVKLADF 164 (308)
T ss_dssp SSEEEEEEEEECCCCBHHHHHHTCC--TTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCTTTEEECTTS-CEEECSC
T ss_pred CCceeEEEEehhhhcCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEcCCC-CEEEeeC
Confidence 5566789999999998877655422 2348999999999999999999998 8999999999999999888 7999999
Q ss_pred cCccccCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 012233 285 GSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEI 364 (468)
Q Consensus 285 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 364 (468)
|+++............||+.|+|||++.+.. ++.++|||||||++|+|++|++||.+.+..+.+.+++..++.+....+
T Consensus 165 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 243 (308)
T 3g33_A 165 GLARIYSYQMALTPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW 243 (308)
T ss_dssp SCTTTSTTCCCSGGGGCCCSSCCHHHHHTSC-CCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred ccccccCCCcccCCccccccccCchHHcCCC-CCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhc
Confidence 9998776666666788999999999997655 899999999999999999999999999999999999999888876544
Q ss_pred hhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q 012233 365 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426 (468)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 426 (468)
.... ......++.....++ ..+.+.+++++.+||.+||++||.+|||+.|+|+||||++.
T Consensus 244 ~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 244 PRDV-SLPRGAFPPRGPRPV-QSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303 (308)
T ss_dssp CSSC-SSCGGGSCCCCCCCH-HHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred cchh-hccccccCCCCCCcH-HHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence 3211 111122222222222 22446789999999999999999999999999999999874
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-51 Score=403.74 Aligned_cols=300 Identities=32% Similarity=0.588 Sum_probs=239.4
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeecccc-----hHHHHHHHHHHcCCCCcccccceeeecCCCCceEEE
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR-----YKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~~-----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 211 (468)
++|.+.+.||+|+||.||+|.+..+++.||||++..... ...+|+.+++.++||||+++++++. +...++
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~ 76 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIH-----TEKSLT 76 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEE-----CSSCEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEe-----eCCEEE
Confidence 469999999999999999999999999999998854322 2236999999999999999999984 344588
Q ss_pred EEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccC
Q 012233 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (468)
Q Consensus 212 lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~ 291 (468)
+||||+++++...+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++....
T Consensus 77 lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~a~~~~ 151 (324)
T 3mtl_A 77 LVFEYLDKDLKQYLDD---CGNIINMHNVKLFLFQLLRGLAYCHR-QKVLHRDLKPQNLLINERG-ELKLADFGLARAKS 151 (324)
T ss_dssp EEEECCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTEEESSCCGGGEEECTTC-CEEECSSSEEECC-
T ss_pred EEecccccCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCccCCCcCHHHEEECCCC-CEEEccCccccccc
Confidence 9999999988876543 24568999999999999999999998 8999999999999999888 79999999997654
Q ss_pred CC-CCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC-
Q 012233 292 PG-EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP- 369 (468)
Q Consensus 292 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~- 369 (468)
.. .......||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+...++.|....+.....
T Consensus 152 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (324)
T 3mtl_A 152 IPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN 231 (324)
T ss_dssp -----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGC
T ss_pred CCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcc
Confidence 22 2333567899999999997766689999999999999999999999999999999999999999887665443211
Q ss_pred -CCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCCCCCCCCCCCCCcccccCH
Q 012233 370 -NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNTCLPNGRPLPTLFNFTA 447 (468)
Q Consensus 370 -~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~~~ 447 (468)
.+..+.++......+ ....+.+++++.+||.+||+.||.+|||+.|+|+||||.++.......+...+...+..+..
T Consensus 232 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~ 309 (324)
T 3mtl_A 232 EEFKTYNYPKYRAEAL-LSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIHKLPDTTSIFALKEIQL 309 (324)
T ss_dssp HHHHHTCCCCCCCCCH-HHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCSTTSSSCTTSCGGGSTTCCC
T ss_pred hhhcccccccccchhh-hhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccccccCCCCCcHhHHHHHHh
Confidence 111222222222221 12345689999999999999999999999999999999999988888888777777766653
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-50 Score=411.85 Aligned_cols=288 Identities=32% Similarity=0.532 Sum_probs=228.3
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc------chHHHHHHHHHHcCCCCcccccceeeecCCCCceEE
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~ 210 (468)
.+|.+.+.||+|+||.||+|.+..+|+.||||++.... ....+|+.+|+.++||||+++++++..........+
T Consensus 26 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 105 (432)
T 3n9x_A 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDEL 105 (432)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeE
Confidence 36999999999999999999999999999999986431 234579999999999999999999865433333568
Q ss_pred EEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcccc
Q 012233 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (468)
Q Consensus 211 ~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~ 290 (468)
|+||||+++++...+.. ...+++..++.++.||+.||.|||+ .||+||||||+||||+.++ .+||+|||+++..
T Consensus 106 ~lv~e~~~~~L~~~~~~----~~~l~~~~~~~i~~qil~aL~~LH~-~givHrDlkp~NILl~~~~-~~kL~DFGla~~~ 179 (432)
T 3n9x_A 106 YIVLEIADSDLKKLFKT----PIFLTEEHIKTILYNLLLGENFIHE-SGIIHRDLKPANCLLNQDC-SVKVCDFGLARTI 179 (432)
T ss_dssp EEEEECCSEEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTC-CEEECCCTTCEEC
T ss_pred EEEEecCCcCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCCCCCCCHHHeEECCCC-CEEEccCCCcccc
Confidence 99999999988776543 4668999999999999999999998 8999999999999999888 7999999999876
Q ss_pred CCCC-----------------------CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-----------C
Q 012233 291 VPGE-----------------------PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-----------G 336 (468)
Q Consensus 291 ~~~~-----------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-----------G 336 (468)
.... .....+||+.|+|||++.....++.++|||||||++|||++ |
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~ 259 (432)
T 3n9x_A 180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNR 259 (432)
T ss_dssp -------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGC
T ss_pred cccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccc
Confidence 4332 12567899999999997666679999999999999999998 4
Q ss_pred CCCCCCCC-----------------cHHHHHHHHHHhCCCCHHHHhhcCCCCcc---CCCCcccCCCcccccccCCCHHH
Q 012233 337 QPLFPGES-----------------GVDQLVEIIKILGTPTREEIKCMNPNYTE---FKFPQIKAHPWHKIFHKRMPPEA 396 (468)
Q Consensus 337 ~~pf~~~~-----------------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l 396 (468)
.++|.+.+ ..+++..|+..++.|..+.+......... ..++......+.. ..+.+++++
T Consensus 260 ~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~ 338 (432)
T 3n9x_A 260 FPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQ-KYPSISDDG 338 (432)
T ss_dssp CCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHH-HSTTSCHHH
T ss_pred cccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHH-HCCCCCHHH
Confidence 55555543 36788999999999998776543311100 0111111111222 235689999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCCCC
Q 012233 397 LDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNT 431 (468)
Q Consensus 397 ~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~ 431 (468)
.+||.+||++||.+|||+.|+|+||||+++..+..
T Consensus 339 ~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~ 373 (432)
T 3n9x_A 339 INLLESMLKFNPNKRITIDQALDHPYLKDVRKKKL 373 (432)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCTTT
T ss_pred HHHHHHHhcCCcccCCCHHHHhcChhhhhccCccc
Confidence 99999999999999999999999999999977654
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-50 Score=400.34 Aligned_cols=256 Identities=26% Similarity=0.403 Sum_probs=216.6
Q ss_pred ccceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc----------chHHHHHHHHHHcCCCCcccccceeeecCCC
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK----------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEK 205 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~----------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 205 (468)
.+.|.+.+.||+|+||.||+|.++.+|+.||+|++.+.. ..+.+|+.+|+.++||||++++++| .
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-----~ 85 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVY-----E 85 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEE-----E
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEE-----E
Confidence 346999999999999999999999999999999986532 3456899999999999999999998 4
Q ss_pred CceEEEEEeecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCC---cEEE
Q 012233 206 DELYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTH---QLKI 281 (468)
Q Consensus 206 ~~~~~~lv~e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~---~vkL 281 (468)
+...+|+||||+.++ +.+.+. ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++. .+||
T Consensus 86 ~~~~~~lv~e~~~gg~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDlkp~NIll~~~~~~~~~vkl 160 (361)
T 2yab_A 86 NRTDVVLILELVSGGELFDFLA----QKESLSEEEATSFIKQILDGVNYLHT-KKIAHFDLKPENIMLLDKNIPIPHIKL 160 (361)
T ss_dssp CSSEEEEEEECCCSCBHHHHHT----TCSCCBHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESCTTSSSCCEEE
T ss_pred eCCEEEEEEEcCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEeCCCCCccCEEE
Confidence 445689999999754 444332 24578999999999999999999998 89999999999999987653 5999
Q ss_pred eeecCccccCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 012233 282 CDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTR 361 (468)
Q Consensus 282 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~ 361 (468)
+|||++............+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+.+..+.....
T Consensus 161 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~---- 235 (361)
T 2yab_A 161 IDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSY---- 235 (361)
T ss_dssp CCCSSCEECCTTCCCCCCCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCC----
T ss_pred EecCCceEcCCCCccccCCCCccEECchHHcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC----
Confidence 999999887666666678899999999999654 489999999999999999999999999887777766654211
Q ss_pred HHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q 012233 362 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (468)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~ 427 (468)
.+ ...++..+++++++||.+||..||.+|||+.|+|+||||+.+.
T Consensus 236 -------------~~--------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~ 280 (361)
T 2yab_A 236 -------------DF--------DEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD 280 (361)
T ss_dssp -------------CC--------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSS
T ss_pred -------------CC--------CchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCc
Confidence 11 1123456899999999999999999999999999999998653
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-50 Score=401.26 Aligned_cols=253 Identities=28% Similarity=0.475 Sum_probs=208.2
Q ss_pred CcccceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-------chHHHHHHHHHHc-CCCCcccccceeeecCCC
Q 012233 134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLL-NHPNVVSLKHCFFSTTEK 205 (468)
Q Consensus 134 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-------~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~ 205 (468)
....+|.+.+.||+|+||+||+|+++.+|+.||||++.+.. ....+|..+++.+ +||||++++++| .
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~-----~ 94 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCF-----Q 94 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEE-----E
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEE-----E
Confidence 34457999999999999999999999999999999986532 2345789999988 699999999998 4
Q ss_pred CceEEEEEeecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeee
Q 012233 206 DELYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDF 284 (468)
Q Consensus 206 ~~~~~~lv~e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DF 284 (468)
+...+|+||||+.++ +...+.. ...+++..++.++.||+.||.|||+ +||+||||||+||||+.++ .+||+||
T Consensus 95 ~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NILl~~~g-~ikL~DF 168 (353)
T 3txo_A 95 TPDRLFFVMEFVNGGDLMFHIQK----SRRFDEARARFYAAEIISALMFLHD-KGIIYRDLKLDNVLLDHEG-HCKLADF 168 (353)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTS-CEEECCC
T ss_pred eCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCHHHEEECCCC-CEEEccc
Confidence 455699999999875 4433322 3569999999999999999999998 8999999999999999888 7999999
Q ss_pred cCccccC-CCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 012233 285 GSAKMLV-PGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREE 363 (468)
Q Consensus 285 G~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~ 363 (468)
|+++... ........+||+.|+|||++.+.. ++.++|||||||++|||++|++||.+.+..+.+..|...
T Consensus 169 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~-------- 239 (353)
T 3txo_A 169 GMCKEGICNGVTTATFCGTPDYIAPEILQEML-YGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND-------- 239 (353)
T ss_dssp TTCBCSCC---------CCGGGCCHHHHHHHH-CTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--------
T ss_pred cceeecccCCccccccCCCcCeEChhhcCCCC-cCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcC--------
Confidence 9998643 233445678999999999997554 899999999999999999999999998888877777651
Q ss_pred HhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCH------HHHhCCCCCCCCC
Q 012233 364 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTA------LEACAHPFFDDLR 427 (468)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~------~ell~hp~f~~~~ 427 (468)
... ++..+++++.+||.+||++||.+||++ .++++||||+++.
T Consensus 240 ---------~~~------------~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~ 288 (353)
T 3txo_A 240 ---------EVV------------YPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEID 288 (353)
T ss_dssp ---------CCC------------CCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCC
T ss_pred ---------CCC------------CCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCC
Confidence 122 234588999999999999999999998 8999999999874
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-50 Score=388.39 Aligned_cols=277 Identities=34% Similarity=0.641 Sum_probs=221.5
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc------chHHHHHHHHHHcCCCCcccccceeeecCCCCceEE
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~ 210 (468)
.+|.+.+.||+|+||.||+|.+ .+|+.||+|++.... ....+|+.+++.++||||+++++++. +...+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~ 75 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIH-----TKKRL 75 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEE-----CSSCE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEc-----cCCeE
Confidence 3699999999999999999998 679999999985432 33458999999999999999999984 33458
Q ss_pred EEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcccc
Q 012233 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (468)
Q Consensus 211 ~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~ 290 (468)
++||||+.+++...+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++...
T Consensus 76 ~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~ 150 (288)
T 1ob3_A 76 VLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHD-RRVLHRDLKPQNLLINREG-ELKIADFGLARAF 150 (288)
T ss_dssp EEEEECCSEEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTS-CEEECCTTHHHHH
T ss_pred EEEEEecCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcCCC-CEEEeECcccccc
Confidence 99999999987776543 23568999999999999999999998 8999999999999999888 7999999999766
Q ss_pred CCC-CCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC-
Q 012233 291 VPG-EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN- 368 (468)
Q Consensus 291 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~- 368 (468)
... .......||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.+.++.+....+....
T Consensus 151 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T 1ob3_A 151 GIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE 230 (288)
T ss_dssp CC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred CccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhc
Confidence 432 233456789999999999776668999999999999999999999999999889999999888877654432211
Q ss_pred -CCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q 012233 369 -PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426 (468)
Q Consensus 369 -~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 426 (468)
+.+. ..++.....+|. .+...+++++.+||.+||+.||.+|||+.|+|+||||++.
T Consensus 231 ~~~~~-~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 287 (288)
T 1ob3_A 231 LPKYD-PNFTVYEPLPWE-SFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287 (288)
T ss_dssp STTCC-TTCCCCCCCCGG-GTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred ccccc-cccccccCccHH-HHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 1110 111112222232 2346689999999999999999999999999999999863
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=398.16 Aligned_cols=285 Identities=34% Similarity=0.612 Sum_probs=225.2
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc------chHHHHHHHHHHcCCCCcccccceeeecCC-CCceEE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTE-KDELYL 210 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~-~~~~~~ 210 (468)
+|.+.+.||+|+||.||+|.+..+|+.||||++.... ....+|+.+|+.++||||+++++++..... .+...+
T Consensus 26 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~ 105 (367)
T 1cm8_A 26 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDF 105 (367)
T ss_dssp SEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCC
T ss_pred eEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceE
Confidence 5999999999999999999999999999999985421 234579999999999999999999854322 122346
Q ss_pred EEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcccc
Q 012233 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (468)
Q Consensus 211 ~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~ 290 (468)
|+||||+++++..++.. ..+++..++.++.||+.||.|||+ +||+||||||+||||+.++ .+||+|||+++..
T Consensus 106 ~lv~e~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~ 178 (367)
T 1cm8_A 106 YLVMPFMGTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHA-AGIIHRDLKPGNLAVNEDC-ELKILDFGLARQA 178 (367)
T ss_dssp EEEEECCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTC-CEEECCCTTCEEC
T ss_pred EEEEecCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCccccCcCHHHEEEcCCC-CEEEEeeeccccc
Confidence 89999997777665543 468999999999999999999998 8999999999999999888 7999999999875
Q ss_pred CCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCC
Q 012233 291 VPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPN 370 (468)
Q Consensus 291 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 370 (468)
.. .....++|+.|+|||++.+...++.++|||||||++|||++|++||.+.+..+++..+++..+.|+.+.+..+...
T Consensus 179 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~ 256 (367)
T 1cm8_A 179 DS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD 256 (367)
T ss_dssp CS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCH
T ss_pred cc--ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhH
Confidence 33 3446788999999999987566999999999999999999999999999999999999999999988766543211
Q ss_pred Ccc---CCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCCCCC
Q 012233 371 YTE---FKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNTC 432 (468)
Q Consensus 371 ~~~---~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~~ 432 (468)
... ..++......+.. +...+++++.+||.+||+.||.+|||+.|+|+||||+++.++...
T Consensus 257 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~~~~ 320 (367)
T 1cm8_A 257 EAKNYMKGLPELEKKDFAS-ILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDE 320 (367)
T ss_dssp HHHHHHHHSCCCCCCCGGG-TCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-----
T ss_pred HHHHHHHhCCCCCCCCHHH-HCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCCccC
Confidence 100 0112222222322 335689999999999999999999999999999999998876543
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-50 Score=393.23 Aligned_cols=286 Identities=31% Similarity=0.560 Sum_probs=217.5
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-----chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEE
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 211 (468)
.+|.+.+.||+|+||.||+|.+..+|+.||+|++.... ....+|+.+++.++||||+++++++ .+...+|
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~~ 79 (317)
T 2pmi_A 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVI-----HTENKLT 79 (317)
T ss_dssp --------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEE-----CCTTEEE
T ss_pred cceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEE-----EECCeEE
Confidence 36999999999999999999999999999999985432 3456899999999999999999998 4455689
Q ss_pred EEeecccchHHHHHhhhhh--cCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccc
Q 012233 212 LVLEYISETVYRVSKHYTR--MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (468)
Q Consensus 212 lv~e~~~~~ll~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~ 289 (468)
+||||+.+++...+..... ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++.
T Consensus 80 lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~-~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~~~~ 157 (317)
T 2pmi_A 80 LVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE-NKILHRDLKPQNLLINKRG-QLKLGDFGLARA 157 (317)
T ss_dssp EEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTC-CEEECCCSSCEE
T ss_pred EEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCChHHeEEcCCC-CEEECcCcccee
Confidence 9999999988876654332 22458999999999999999999998 8999999999999999888 799999999987
Q ss_pred cCCC-CCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 012233 290 LVPG-EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368 (468)
Q Consensus 290 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 368 (468)
.... .......||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..++...+.+....+....
T Consensus 158 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (317)
T 2pmi_A 158 FGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT 237 (317)
T ss_dssp TTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred cCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence 6432 233456889999999999776568999999999999999999999999999999999999988887655443221
Q ss_pred --CCCccCCCCcccCCCc----ccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCCC
Q 012233 369 --PNYTEFKFPQIKAHPW----HKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPN 430 (468)
Q Consensus 369 --~~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~ 430 (468)
+.+.. .++......+ .......+++++.+||.+||+.||.+|||+.|+|+||||++...++
T Consensus 238 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~ 304 (317)
T 2pmi_A 238 KLPKYNP-NIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHHA 304 (317)
T ss_dssp GCTTCCT-TCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC--
T ss_pred hhhhccc-ccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccchh
Confidence 11110 0111111111 1223346889999999999999999999999999999999865543
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=397.93 Aligned_cols=312 Identities=34% Similarity=0.634 Sum_probs=245.2
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-----chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~l 212 (468)
+|.+.+.||+|+||.||+|.+..++..||||++.... ....+|+.+++.++||||+++++++..........+|+
T Consensus 28 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~i 107 (364)
T 3qyz_A 28 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYI 107 (364)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred cEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEE
Confidence 5999999999999999999999999999999986432 23457999999999999999999986655444456889
Q ss_pred EeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCC
Q 012233 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (468)
Q Consensus 213 v~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~ 292 (468)
||||+.+++...+.. ..+++..++.++.||+.||.|||+ +||+||||||+||||+.++ .+||+|||++.....
T Consensus 108 v~e~~~~~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~a~~~~~ 180 (364)
T 3qyz_A 108 VQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLNTTC-DLKICDFGLARVADP 180 (364)
T ss_dssp EEECCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTC-CEEECCCTTCEECCG
T ss_pred EEcccCcCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCChHhEEECCCC-CEEEEeCcceEecCC
Confidence 999999988776543 468999999999999999999998 8999999999999999888 799999999986643
Q ss_pred CCC----CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 012233 293 GEP----NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368 (468)
Q Consensus 293 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 368 (468)
... ....+||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..++..++.|..+.+.+..
T Consensus 181 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 260 (364)
T 3qyz_A 181 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 260 (364)
T ss_dssp GGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCC
T ss_pred CCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence 322 2345899999999998776668999999999999999999999999999999999999999999887765432
Q ss_pred CCC---ccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCCCCCCCCCCCCCccccc
Q 012233 369 PNY---TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNTCLPNGRPLPTLFNF 445 (468)
Q Consensus 369 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~ 445 (468)
... ....++.....+|.. +.+.+++++.+||.+||++||.+|||+.|+|+||||++...+........+ +.+
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~----~~~ 335 (364)
T 3qyz_A 261 NLKARNYLLSLPHKNKVPWNR-LFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAP----FKF 335 (364)
T ss_dssp CHHHHHHHHTSCCCCCCCHHH-HCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCCGGGSCCCSSC----CCC
T ss_pred hhhHHHHHHhcCCccCCCHHH-hCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccCcccccCCCCc----CCc
Confidence 110 001112222223322 335689999999999999999999999999999999998655433222221 233
Q ss_pred CHHHHhcCCHHHHHhcc
Q 012233 446 TAQELAGASNELRQRLI 462 (468)
Q Consensus 446 ~~~~~~~~~~~~~~~~~ 462 (468)
+ .++...+.|.++.++
T Consensus 336 ~-~~~~~~~~~~~~~~~ 351 (364)
T 3qyz_A 336 D-MELDDLPKEKLKELI 351 (364)
T ss_dssp C------CCHHHHHHHH
T ss_pred c-cccccCCHHHHHHHH
Confidence 3 345556666666554
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=388.21 Aligned_cols=284 Identities=36% Similarity=0.628 Sum_probs=225.1
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc------chHHHHHHHHHHcCCCCcccccceeeecCCCCceEE
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~ 210 (468)
.+|.+.+.||+|+||.||+|.+..+|+.||||++.... ....+|+.+++.++||||+++++++.. ....
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~ 77 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRR-----KRRL 77 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeec-----CCeE
Confidence 46999999999999999999999999999999885442 234579999999999999999999843 3458
Q ss_pred EEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcccc
Q 012233 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (468)
Q Consensus 211 ~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~ 290 (468)
++||||++++++..+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++...
T Consensus 78 ~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~i~~~l~~~l~~lH~-~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~ 152 (311)
T 4agu_A 78 HLVFEYCDHTVLHELDR---YQRGVPEHLVKSITWQTLQAVNFCHK-HNCIHRDVKPENILITKHS-VIKLCDFGFARLL 152 (311)
T ss_dssp EEEEECCSEEHHHHHHH---TSSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTS-CEEECCCTTCEEC
T ss_pred EEEEEeCCCchHHHHHh---hhcCCCHHHHHHHHHHHHHHHHHHHH-CCCcCCCCChhhEEEcCCC-CEEEeeCCCchhc
Confidence 89999999987764432 34668999999999999999999998 8999999999999999888 7999999999876
Q ss_pred CCC-CCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh--c
Q 012233 291 VPG-EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKC--M 367 (468)
Q Consensus 291 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~--~ 367 (468)
... .......||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+...++......... .
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (311)
T 4agu_A 153 TGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFST 232 (311)
T ss_dssp C------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHT
T ss_pred cCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccc
Confidence 432 2334568899999999998766689999999999999999999999999999999988888887766544332 2
Q ss_pred CCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCCC
Q 012233 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPN 430 (468)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~ 430 (468)
...+.....+............+.+++++.+||.+||+.||.+|||+.|+++||||++++...
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~ 295 (311)
T 4agu_A 233 NQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIE 295 (311)
T ss_dssp CGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC---
T ss_pred ccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCHH
Confidence 222233333332222222223356899999999999999999999999999999999987643
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=395.28 Aligned_cols=285 Identities=33% Similarity=0.587 Sum_probs=229.6
Q ss_pred ccceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc---------cchHHHHHHHHHHcCCCCcccccceeeecCCCC
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD 206 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~---------~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 206 (468)
..+|.+.+.||+|+||.||+|.+..+|+.||||++... .....+|+.+++.++||||++++++| .+
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~ 83 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAF-----GH 83 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEE-----CC
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEE-----ee
Confidence 34699999999999999999999999999999988532 12345799999999999999999998 34
Q ss_pred ceEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecC
Q 012233 207 ELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (468)
Q Consensus 207 ~~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~ 286 (468)
...+++||||+.+++...+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus 84 ~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg~ 158 (346)
T 1ua2_A 84 KSNISLVFDFMETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQ-HWILHRDLKPNNLLLDENG-VLKLADFGL 158 (346)
T ss_dssp TTCCEEEEECCSEEHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTC-CEEECCCGG
T ss_pred CCceEEEEEcCCCCHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHH-CCEECCCCCHHHEEEcCCC-CEEEEeccc
Confidence 445889999999987765543 23468888999999999999999998 8999999999999999888 799999999
Q ss_pred ccccCCC-CCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 012233 287 AKMLVPG-EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIK 365 (468)
Q Consensus 287 a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 365 (468)
++..... ......+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..++...+.+....+.
T Consensus 159 a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 238 (346)
T 1ua2_A 159 AKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWP 238 (346)
T ss_dssp GSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSS
T ss_pred ceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhh
Confidence 9876432 234456889999999999766668999999999999999999999999999999999999998888766554
Q ss_pred hcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCCCC
Q 012233 366 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNT 431 (468)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~ 431 (468)
..........+......++.. +...+++++++||.+||+.||.+|||+.|+|+||||++...+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~~~ 303 (346)
T 1ua2_A 239 DMCSLPDYVTFKSFPGIPLHH-IFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTP 303 (346)
T ss_dssp STTSSTTCCCCCCCCCCCHHH-HCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCC
T ss_pred hhccCcccccccccCCCChHH-hhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCCCC
Confidence 332222222222222222222 33568999999999999999999999999999999998765544
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=392.32 Aligned_cols=251 Identities=27% Similarity=0.429 Sum_probs=212.5
Q ss_pred ccceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc-------cchHHHHHHHHHHcCCCCcccccceeeecCCCCce
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~-------~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 208 (468)
..+|.+.+.||+|+||+||+|+++.+|+.||||++.+. .....+|+.+|+.++||||++++++| .+..
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~-----~~~~ 78 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHD 78 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE-----ECSS
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEE-----EeCC
Confidence 45799999999999999999999999999999998643 22345799999999999999999998 4445
Q ss_pred EEEEEeecccchHH-HHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCc
Q 012233 209 YLNLVLEYISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (468)
Q Consensus 209 ~~~lv~e~~~~~ll-~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a 287 (468)
.+|+||||+.++.+ ..+. ....+++..++.++.||+.||.|||+ +||+||||||+||||+.++ .+||+|||++
T Consensus 79 ~~~lv~E~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~g-~vkL~DFG~a 152 (337)
T 1o6l_A 79 RLCFVMEYANGGELFFHLS----RERVFTEERARFYGAEIVSALEYLHS-RDVVYRDIKLENLMLDKDG-HIKITDFGLC 152 (337)
T ss_dssp EEEEEEECCTTCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTS-CEEECCCTTC
T ss_pred EEEEEEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCcCCHHHEEECCCC-CEEEeeccch
Confidence 68999999987544 3332 23568999999999999999999998 8999999999999999888 7999999999
Q ss_pred cccC-CCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 012233 288 KMLV-PGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKC 366 (468)
Q Consensus 288 ~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 366 (468)
+... ........+||+.|+|||++.+. .++.++|||||||++|||++|..||.+.+..+....+..
T Consensus 153 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~------------ 219 (337)
T 1o6l_A 153 KEGISDGATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM------------ 219 (337)
T ss_dssp BCSCCTTCCBCCCEECGGGCCGGGGSSS-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH------------
T ss_pred hhcccCCCcccccccChhhCChhhhcCC-CCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHc------------
Confidence 8643 33345567899999999999765 489999999999999999999999998877666666554
Q ss_pred cCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCC-----CHHHHhCCCCCCCCC
Q 012233 367 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC-----TALEACAHPFFDDLR 427 (468)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~-----s~~ell~hp~f~~~~ 427 (468)
.... ++..+++++++||.+||+.||.+|| ++.|+++||||+.+.
T Consensus 220 -----~~~~------------~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~ 268 (337)
T 1o6l_A 220 -----EEIR------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 268 (337)
T ss_dssp -----CCCC------------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred -----CCCC------------CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCC
Confidence 1111 3345899999999999999999999 999999999999864
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-50 Score=394.62 Aligned_cols=282 Identities=31% Similarity=0.600 Sum_probs=225.5
Q ss_pred cccceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc------chHHHHHHHHHHcCCCCcccccceeeecCCCCce
Q 012233 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (468)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 208 (468)
..++|.+.+.||+|+||.||+|.+..+|+.||||++.... ....+|+.+++.++||||+++++++. +..
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~ 106 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIH-----HNH 106 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEE-----ETT
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEe-----cCC
Confidence 4457999999999999999999999999999999985432 22347999999999999999999984 344
Q ss_pred EEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCC----CcEEEeee
Q 012233 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHT----HQLKICDF 284 (468)
Q Consensus 209 ~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~----~~vkL~DF 284 (468)
.+|+||||+.+++...+.. ...+++..++.++.||+.||.|||+ +||+||||||+||||+.++ ..+||+||
T Consensus 107 ~~~lv~e~~~~~L~~~~~~----~~~~~~~~~~~i~~ql~~~l~~LH~-~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Df 181 (329)
T 3gbz_A 107 RLHLIFEYAENDLKKYMDK----NPDVSMRVIKSFLYQLINGVNFCHS-RRCLHRDLKPQNLLLSVSDASETPVLKIGDF 181 (329)
T ss_dssp EEEEEEECCSEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEEC-----CCEEEECCT
T ss_pred EEEEEEecCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCEECCCCCHHHEEEecCCCCccceEEECcC
Confidence 5899999999988776543 4568999999999999999999998 8999999999999995332 25999999
Q ss_pred cCccccCCC-CCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 012233 285 GSAKMLVPG-EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREE 363 (468)
Q Consensus 285 G~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~ 363 (468)
|++...... ......+||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..++..++.|....
T Consensus 182 g~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 261 (329)
T 3gbz_A 182 GLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTT 261 (329)
T ss_dssp THHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred CCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhh
Confidence 999876432 2334567899999999997766689999999999999999999999999999999999999888877654
Q ss_pred HhhcC--CCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q 012233 364 IKCMN--PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (468)
Q Consensus 364 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~ 427 (468)
+.... +.+ ...++......+...+...+++++.+||.+||+.||.+|||+.|+|+||||++..
T Consensus 262 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 326 (329)
T 3gbz_A 262 WPGVTALPDW-KQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHND 326 (329)
T ss_dssp STTGGGSTTC-CTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSC
T ss_pred hhhhhhhhhh-hhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCC
Confidence 43211 111 1223333444444555666899999999999999999999999999999999864
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-49 Score=397.84 Aligned_cols=254 Identities=26% Similarity=0.485 Sum_probs=208.3
Q ss_pred CcccceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-------chHHHHHHHHHHc-CCCCcccccceeeecCCC
Q 012233 134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLL-NHPNVVSLKHCFFSTTEK 205 (468)
Q Consensus 134 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-------~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~ 205 (468)
....+|.+.++||+|+||+||+|+++.+++.||||++.+.. ....+|..+++.+ +||||++++++| .
T Consensus 49 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~-----~ 123 (396)
T 4dc2_A 49 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-----Q 123 (396)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEE-----E
T ss_pred CChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEE-----E
Confidence 44567999999999999999999999999999999986532 2345788998877 899999999998 4
Q ss_pred CceEEEEEeecccchHH-HHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeee
Q 012233 206 DELYLNLVLEYISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDF 284 (468)
Q Consensus 206 ~~~~~~lv~e~~~~~ll-~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DF 284 (468)
+...+||||||+.++.+ ..+.. ...+++..++.++.||+.||.|||+ +||+||||||+||||+.++ .+||+||
T Consensus 124 ~~~~~~lV~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDLKp~NILl~~~g-~ikL~DF 197 (396)
T 4dc2_A 124 TESRLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHE-RGIIYRDLKLDNVLLDSEG-HIKLTDY 197 (396)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTS-CEEECCC
T ss_pred ECCEEEEEEEcCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEEeccCCHHHEEECCCC-CEEEeec
Confidence 45569999999987544 33322 3569999999999999999999998 8999999999999999998 7999999
Q ss_pred cCcccc-CCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCc--------HHHHHHHHHH
Q 012233 285 GSAKML-VPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESG--------VDQLVEIIKI 355 (468)
Q Consensus 285 G~a~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~--------~~~~~~i~~~ 355 (468)
|+++.. .........+||+.|+|||++.+.. ++.++|||||||++|||++|++||..... .+.+.+.+..
T Consensus 198 Gla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~-~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~ 276 (396)
T 4dc2_A 198 GMCKEGLRPGDTTSTFCGTPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE 276 (396)
T ss_dssp TTCBCCCCTTCCBCCCCBCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHH
T ss_pred ceeeecccCCCccccccCCcccCCchhhcCCC-CChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhc
Confidence 999863 3444556789999999999997654 89999999999999999999999975321 2222222211
Q ss_pred hCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCH------HHHhCCCCCCCCC
Q 012233 356 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTA------LEACAHPFFDDLR 427 (468)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~------~ell~hp~f~~~~ 427 (468)
.... ++..+++++++||.+||+.||.+|+++ .|+++||||+++.
T Consensus 277 ----------------~~~~------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~ 326 (396)
T 4dc2_A 277 ----------------KQIR------------IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD 326 (396)
T ss_dssp ----------------CCCC------------CCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCC
T ss_pred ----------------cccC------------CCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCC
Confidence 1111 345689999999999999999999985 7999999999874
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-49 Score=386.61 Aligned_cols=249 Identities=27% Similarity=0.504 Sum_probs=213.2
Q ss_pred ccceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc-------cchHHHHHHHHHHcCCCCcccccceeeecCCCCce
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~-------~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 208 (468)
..+|.+.+.||+|+||.||+|++..+|+.||+|++.+. .....+|+.+++.++||||++++++| .+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~~ 79 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF-----QDAQ 79 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEE-----ECSS
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEE-----EeCC
Confidence 45799999999999999999999999999999998643 23345799999999999999999998 4455
Q ss_pred EEEEEeecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCc
Q 012233 209 YLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (468)
Q Consensus 209 ~~~lv~e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a 287 (468)
.+|+||||+.++ +...+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++
T Consensus 80 ~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~g-~~kL~Dfg~a 153 (318)
T 1fot_A 80 QIFMIMDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHS-KDIIYRDLKPENILLDKNG-HIKITDFGFA 153 (318)
T ss_dssp EEEEEECCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECTTS-CEEECCCSSC
T ss_pred EEEEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCChheEEEcCCC-CEEEeecCcc
Confidence 689999999864 4444332 4568999999999999999999998 8999999999999999888 7999999999
Q ss_pred cccCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 012233 288 KMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367 (468)
Q Consensus 288 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 367 (468)
+.... .....+||+.|+|||++.+. .++.++|||||||++|||++|..||.+.+..+.+.++...
T Consensus 154 ~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~------------ 218 (318)
T 1fot_A 154 KYVPD--VTYTLCGTPDYIAPEVVSTK-PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA------------ 218 (318)
T ss_dssp EECSS--CBCCCCSCTTTCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC------------
T ss_pred eecCC--ccccccCCccccCHhHhcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC------------
Confidence 86533 34467899999999999765 4899999999999999999999999988877777776651
Q ss_pred CCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCC-----CHHHHhCCCCCCCCC
Q 012233 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC-----TALEACAHPFFDDLR 427 (468)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~-----s~~ell~hp~f~~~~ 427 (468)
... ++..+++++++||.+||..||.+|+ +++++++||||+++.
T Consensus 219 -----~~~------------~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~ 266 (318)
T 1fot_A 219 -----ELR------------FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVV 266 (318)
T ss_dssp -----CCC------------CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCC
T ss_pred -----CCC------------CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCC
Confidence 111 2345889999999999999999999 999999999999864
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-49 Score=396.40 Aligned_cols=285 Identities=34% Similarity=0.578 Sum_probs=217.0
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc------chHHHHHHHHHHcCCCCcccccceeeecCC-CCceE
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTE-KDELY 209 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~-~~~~~ 209 (468)
.+|.+.+.||+|+||.||+|.+..+|+.||||++.... ....+|+.+|+.++||||+++++++..... .....
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 108 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 108 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence 36999999999999999999999999999999985431 234579999999999999999998854321 11234
Q ss_pred EEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccc
Q 012233 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (468)
Q Consensus 210 ~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~ 289 (468)
+|+||||+++++..++. ...+++..++.++.||+.||.|||+ .||+||||||+||||+.++ .+||+|||+++.
T Consensus 109 ~~lv~e~~~~~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~-~givH~Dlkp~NIll~~~~-~~kL~DFG~a~~ 181 (367)
T 2fst_X 109 VYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDC-ELKILDFGLARH 181 (367)
T ss_dssp CEEEEECCCEECC----------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTC-CEEECC------
T ss_pred EEEEecccCCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHhhEEECCCC-CEEEeecccccc
Confidence 78999999877655443 2568999999999999999999998 8999999999999999888 799999999976
Q ss_pred cCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 012233 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (468)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 369 (468)
... .....+||+.|+|||++.+...++.++|||||||++|||++|++||.+.+..+++..+++.++.|..+.+.....
T Consensus 182 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~ 259 (367)
T 2fst_X 182 TAD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 259 (367)
T ss_dssp -----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCC
T ss_pred ccc--cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 532 344578999999999997756699999999999999999999999999999999999999999998876654332
Q ss_pred CCcc---CCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCCCC
Q 012233 370 NYTE---FKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNT 431 (468)
Q Consensus 370 ~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~ 431 (468)
.... ..++..+...+.. ....+++++.+||.+||+.||.+|||+.|+|+||||+++..+..
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~ 323 (367)
T 2fst_X 260 ESARNYIQSLTQMPKMNFAN-VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDD 323 (367)
T ss_dssp HHHHHHHHTSCCCCCCCHHH-HTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCGGG
T ss_pred HHHHHHHhccCCCCCCCHHH-HCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCCCC
Confidence 1100 0112222222322 23468999999999999999999999999999999999877654
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-49 Score=391.60 Aligned_cols=251 Identities=27% Similarity=0.430 Sum_probs=211.7
Q ss_pred cccceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc-------cchHHHHHHHHHHcCCCCcccccceeeecCCCCc
Q 012233 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (468)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~-------~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 207 (468)
..++|.+.+.||+|+||.||+|.+..+|+.||||++... .....+|+.+++.++||||+++++++. ..
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~-----~~ 81 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVIT-----TP 81 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEE-----CS
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----eC
Confidence 445799999999999999999999999999999998543 234568999999999999999999984 34
Q ss_pred eEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCc
Q 012233 208 LYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (468)
Q Consensus 208 ~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a 287 (468)
..+++||||++|++++.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++
T Consensus 82 ~~~~lv~E~~~g~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~-~givH~Dlkp~NIll~~~~-~~kl~DFG~s 155 (336)
T 3h4j_B 82 TDIVMVIEYAGGELFDYIVE----KKRMTEDEGRRFFQQIICAIEYCHR-HKIVHRDLKPENLLLDDNL-NVKIADFGLS 155 (336)
T ss_dssp SEEEEEECCCCEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-HTCCCCCCSTTTEEECTTC-CEEECCSSCT
T ss_pred CEEEEEEECCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCchhhEEEcCCC-CEEEEEeccc
Confidence 45899999999888876544 3568999999999999999999998 8999999999999999888 7999999999
Q ss_pred cccCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 012233 288 KMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367 (468)
Q Consensus 288 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 367 (468)
............+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+....+...
T Consensus 156 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~----------------- 218 (336)
T 3h4j_B 156 NIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK----------------- 218 (336)
T ss_dssp BTTTTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC-----------------
T ss_pred eeccCCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH-----------------
Confidence 887666666778999999999999876645789999999999999999999997643211000
Q ss_pred CCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q 012233 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDD 425 (468)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~ 425 (468)
. +.. ....++..+++++.+||.+||+.||.+|||+.|+++||||+.
T Consensus 219 -----~-----i~~--~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 264 (336)
T 3h4j_B 219 -----K-----VNS--CVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNV 264 (336)
T ss_dssp -----C-----CCS--SCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHT
T ss_pred -----H-----HHc--CCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhcc
Confidence 0 000 011234568999999999999999999999999999999985
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-50 Score=399.81 Aligned_cols=286 Identities=32% Similarity=0.560 Sum_probs=217.0
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc------chHHHHHHHHHHcCCCCcccccceeeecCC-CCceE
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTE-KDELY 209 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~-~~~~~ 209 (468)
.+|.+.+.||+|+||.||+|.+..+|+.||||++.... ....+|+.+++.++||||+++++++..... .....
T Consensus 25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 104 (371)
T 2xrw_A 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 104 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence 46999999999999999999999999999999986532 234579999999999999999998854321 22336
Q ss_pred EEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccc
Q 012233 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (468)
Q Consensus 210 ~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~ 289 (468)
+|+||||+.+++...+. ..+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++.
T Consensus 105 ~~lv~e~~~~~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~a~~ 176 (371)
T 2xrw_A 105 VYIVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDC-TLKILDFGLART 176 (371)
T ss_dssp EEEEEECCSEEHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTS-CEEECCCCC---
T ss_pred eEEEEEcCCCCHHHHHh------hccCHHHHHHHHHHHHHHHHHHHH-CCeecccCCHHHEEEcCCC-CEEEEEeecccc
Confidence 88999999998877553 348899999999999999999998 8999999999999999888 799999999987
Q ss_pred cCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 012233 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (468)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 369 (468)
..........+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+++.++.+..+.+..+.+
T Consensus 177 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 255 (371)
T 2xrw_A 177 AGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP 255 (371)
T ss_dssp -------------CTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCH
T ss_pred cccccccCCceecCCccCHHHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 6554445567899999999999765 489999999999999999999999999999999999999888887766544321
Q ss_pred CCccC--CCCcccCCCccccc-----------ccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCCCC
Q 012233 370 NYTEF--KFPQIKAHPWHKIF-----------HKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNT 431 (468)
Q Consensus 370 ~~~~~--~~~~~~~~~~~~~~-----------~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~ 431 (468)
....+ ..+......+...+ ....++++++||.+||+.||.+|||+.|+|+||||+...++..
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~~ 330 (371)
T 2xrw_A 256 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSE 330 (371)
T ss_dssp HHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTCCHHH
T ss_pred HHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhcCccc
Confidence 11000 00000001111111 1123678999999999999999999999999999998766543
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-49 Score=394.40 Aligned_cols=256 Identities=29% Similarity=0.446 Sum_probs=212.3
Q ss_pred CcccceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-------chHHHHHHHHHHcCCCCcccccceeeecCCCC
Q 012233 134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD 206 (468)
Q Consensus 134 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 206 (468)
....+|.+.+.||+|+||.||+|.+..+++.||+|++.+.. ....+|+.+|+.++|||||+++++| .+
T Consensus 12 v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----~~ 86 (384)
T 4fr4_A 12 VNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSF-----QD 86 (384)
T ss_dssp CCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----EC
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----Ee
Confidence 34567999999999999999999999999999999985432 3445799999999999999999998 44
Q ss_pred ceEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecC
Q 012233 207 ELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (468)
Q Consensus 207 ~~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~ 286 (468)
...+|+||||+.++.+.... .....+++..++.++.||+.||.|||+ +||+||||||+||||+.++ .+||+|||+
T Consensus 87 ~~~~~lv~e~~~gg~L~~~l---~~~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NIll~~~g-~vkL~DFG~ 161 (384)
T 4fr4_A 87 EEDMFMVVDLLLGGDLRYHL---QQNVHFKEETVKLFICELVMALDYLQN-QRIIHRDMKPDNILLDEHG-HVHITDFNI 161 (384)
T ss_dssp SSEEEEEECCCTTEEHHHHH---HTTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTS-CEEECCCTT
T ss_pred CCEEEEEEecCCCCcHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCcHHHeEECCCC-CEEEeccce
Confidence 45689999999876444222 224679999999999999999999998 8999999999999999888 799999999
Q ss_pred ccccCCCCCCccccccCCccccccccCC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCc--HHHHHHHHHHhCCCCHH
Q 012233 287 AKMLVPGEPNISYICSRYYRAPELIFGA--TEYTTAIDMWSIGCVLAELLLGQPLFPGESG--VDQLVEIIKILGTPTRE 362 (468)
Q Consensus 287 a~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DvwSlG~il~ell~G~~pf~~~~~--~~~~~~i~~~~~~~~~~ 362 (468)
++...........+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||..... ...+...+..
T Consensus 162 a~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~------- 234 (384)
T 4fr4_A 162 AAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET------- 234 (384)
T ss_dssp CEECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHH-------
T ss_pred eeeccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhh-------
Confidence 9887766666788999999999999642 3488999999999999999999999986432 2222222221
Q ss_pred HHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCC-HHHHhCCCCCCCCC
Q 012233 363 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCT-ALEACAHPFFDDLR 427 (468)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s-~~ell~hp~f~~~~ 427 (468)
.... ++..+++++.+||.+||+.||.+||+ ++++++||||+++.
T Consensus 235 ---------~~~~------------~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~ 279 (384)
T 4fr4_A 235 ---------TVVT------------YPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDIN 279 (384)
T ss_dssp ---------CCCC------------CCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCC
T ss_pred ---------cccC------------CCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCC
Confidence 0111 33458899999999999999999998 89999999999864
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-50 Score=391.99 Aligned_cols=254 Identities=29% Similarity=0.428 Sum_probs=214.5
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc---chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEEE
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV 213 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~---~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv 213 (468)
.+|.+.+.||+|+||.||+|.+..+++.||+|.+.... ....+|+.+++.++||||+++++++.. ...+++|
T Consensus 5 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-----~~~~~lv 79 (321)
T 1tki_A 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFES-----MEELVMI 79 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEE-----TTEEEEE
T ss_pred hceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEec-----CCEEEEE
Confidence 46999999999999999999999999999999986442 334689999999999999999999843 3458999
Q ss_pred eecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecC--CCCcEEEeeecCcccc
Q 012233 214 LEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNP--HTHQLKICDFGSAKML 290 (468)
Q Consensus 214 ~e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~--~~~~vkL~DFG~a~~~ 290 (468)
||||.++ +.+.+. .....+++..++.++.||+.||.|||+ +||+||||||+|||++. ++ .+||+|||++...
T Consensus 80 ~e~~~g~~L~~~l~---~~~~~~~~~~~~~i~~qi~~al~~lH~-~givH~Dlkp~NIl~~~~~~~-~~kl~Dfg~a~~~ 154 (321)
T 1tki_A 80 FEFISGLDIFERIN---TSAFELNEREIVSYVHQVCEALQFLHS-HNIGHFDIRPENIIYQTRRSS-TIKIIEFGQARQL 154 (321)
T ss_dssp ECCCCCCBHHHHHT---SSSCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSSSCC-CEEECCCTTCEEC
T ss_pred EEeCCCCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCCcCCCCHHHEEEccCCCC-CEEEEECCCCeEC
Confidence 9999874 444332 223468999999999999999999998 89999999999999986 45 7999999999887
Q ss_pred CCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCC
Q 012233 291 VPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPN 370 (468)
Q Consensus 291 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 370 (468)
..........||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+.+..+.........
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~--------- 224 (321)
T 1tki_A 155 KPGDNFRLLFTAPEYYAPEVHQHDV-VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDE--------- 224 (321)
T ss_dssp CTTCEEEEEESCGGGSCHHHHTTCE-ECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCH---------
T ss_pred CCCCccccccCChhhcCcHHhcCCC-CCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCCh---------
Confidence 6665556678999999999997654 899999999999999999999999998887777776653222111
Q ss_pred CccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q 012233 371 YTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426 (468)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 426 (468)
..+..+++++++||.+||..||.+|||+.|+|+||||++.
T Consensus 225 ----------------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 225 ----------------EAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp ----------------HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred ----------------hhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence 1234589999999999999999999999999999999874
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-49 Score=399.27 Aligned_cols=255 Identities=29% Similarity=0.463 Sum_probs=214.0
Q ss_pred ccceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc-------cchHHHHHHHHHHcCCCCcccccceeeecCCCCce
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~-------~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 208 (468)
..+|.+.+.||+|+||+||+|+++.+++.||+|++.+. .....+|+.+++.++|||||+++++| .+..
T Consensus 68 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----~~~~ 142 (410)
T 3v8s_A 68 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF-----QDDR 142 (410)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEE-----ECSS
T ss_pred ccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EECC
Confidence 44699999999999999999999999999999998542 23456899999999999999999998 4555
Q ss_pred EEEEEeecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCc
Q 012233 209 YLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (468)
Q Consensus 209 ~~~lv~e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a 287 (468)
++|||||||.++ +..++. ...+++..++.++.||+.||.|||+ +||+||||||+||||+.++ .+||+|||++
T Consensus 143 ~~~lV~E~~~gg~L~~~l~-----~~~~~e~~~~~~~~qi~~aL~~LH~-~givHrDLKp~NILl~~~g-~ikL~DFG~a 215 (410)
T 3v8s_A 143 YLYMVMEYMPGGDLVNLMS-----NYDVPEKWARFYTAEVVLALDAIHS-MGFIHRDVKPDNMLLDKSG-HLKLADFGTC 215 (410)
T ss_dssp EEEEEECCCTTEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTS-CEEECCCTTC
T ss_pred EEEEEEeCCCCCcHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCCHHHeeECCCC-CEEEecccee
Confidence 799999999765 444332 2458999999999999999999998 8999999999999999988 7999999999
Q ss_pred cccCCCC--CCccccccCCccccccccCCCC---CCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 012233 288 KMLVPGE--PNISYICSRYYRAPELIFGATE---YTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTRE 362 (468)
Q Consensus 288 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~---~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~ 362 (468)
+...... .....+||+.|+|||++.+... ++.++|||||||++|||++|++||.+.+..+.+.+|.....
T Consensus 216 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~----- 290 (410)
T 3v8s_A 216 MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKN----- 290 (410)
T ss_dssp EECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH-----
T ss_pred EeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccc-----
Confidence 8765433 2346789999999999975432 77899999999999999999999999888888877765210
Q ss_pred HHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCC--CCCHHHHhCCCCCCCCC
Q 012233 363 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSL--RCTALEACAHPFFDDLR 427 (468)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~--R~s~~ell~hp~f~~~~ 427 (468)
.+.+|. +..+++++++||.+||..+|.+ |++++|+++||||+++.
T Consensus 291 ----------~~~~p~----------~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~ 337 (410)
T 3v8s_A 291 ----------SLTFPD----------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ 337 (410)
T ss_dssp ----------HCCCCT----------TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSS
T ss_pred ----------cccCCC----------cccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCC
Confidence 111221 1358999999999999999988 99999999999999864
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=389.00 Aligned_cols=301 Identities=34% Similarity=0.616 Sum_probs=234.9
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-----chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEE
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 211 (468)
.+|.+.+.||+|+||.||+|.+..+|+.||||++.... ....+|+.+++.++||||+++++++...........|
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 90 (353)
T 2b9h_A 11 SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVY 90 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEE
T ss_pred cceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEE
Confidence 46999999999999999999999999999999985432 2334799999999999999999987544333345689
Q ss_pred EEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccC
Q 012233 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (468)
Q Consensus 212 lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~ 291 (468)
+||||+.+++...+.. ..+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++....
T Consensus 91 lv~e~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~-~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg~a~~~~ 163 (353)
T 2b9h_A 91 IIQELMQTDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHG-SNVIHRDLKPSNLLINSNC-DLKVCDFGLARIID 163 (353)
T ss_dssp EEECCCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECTTC-CEEECCCTTCEECC
T ss_pred EEEeccCccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEEcCCC-cEEEEecccccccc
Confidence 9999999987775543 468999999999999999999998 8999999999999999888 79999999998664
Q ss_pred CCCC-----------CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Q 012233 292 PGEP-----------NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPT 360 (468)
Q Consensus 292 ~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~ 360 (468)
.... ....+||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+....+.+.
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 243 (353)
T 2b9h_A 164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPH 243 (353)
T ss_dssp ----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred cccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCc
Confidence 3221 22357899999999987656689999999999999999999999999998888888888887765
Q ss_pred HHHHhhcCCCC--cc--CCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCCCCCCCCC
Q 012233 361 REEIKCMNPNY--TE--FKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNTCLPNG 436 (468)
Q Consensus 361 ~~~~~~~~~~~--~~--~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~~~~~~ 436 (468)
........... .+ ..++......+ ....+.+++++.+||.+||+.||.+|||+.|+++||||+.+..+.... ..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~~-~~ 321 (353)
T 2b9h_A 244 SDNDLRCIESPRAREYIKSLPMYPAAPL-EKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPNDEP-EG 321 (353)
T ss_dssp STTTTTTCCCHHHHHHHHTSCCCCCCCH-HHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSSC-CC
T ss_pred hhccccccccchhhHHhhcccCCCCcch-hhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCccccc-cc
Confidence 32111000000 00 00111111111 123457899999999999999999999999999999999998877663 44
Q ss_pred CCCC-cccccC
Q 012233 437 RPLP-TLFNFT 446 (468)
Q Consensus 437 ~~~~-~~~~~~ 446 (468)
.++| ..++|.
T Consensus 322 ~~~~~~~~~~~ 332 (353)
T 2b9h_A 322 EPIPPSFFEFD 332 (353)
T ss_dssp CCCCGGGGGGG
T ss_pred CCCCcceeeec
Confidence 4444 556666
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-49 Score=385.65 Aligned_cols=255 Identities=25% Similarity=0.393 Sum_probs=214.1
Q ss_pred ccceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc----------cchHHHHHHHHHHcCCCCcccccceeeecCCC
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEK 205 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~----------~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 205 (468)
.+.|.+.+.||+|+||.||+|.+..+|+.||+|++... ...+.+|+.+|+.++||||++++++| .
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~ 84 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY-----E 84 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----E
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEE-----E
Confidence 34699999999999999999999999999999998543 23456899999999999999999998 4
Q ss_pred CceEEEEEeecccc-hHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCC---cEEE
Q 012233 206 DELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTH---QLKI 281 (468)
Q Consensus 206 ~~~~~~lv~e~~~~-~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~---~vkL 281 (468)
+...+++||||+.+ ++.+.+. ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++. .+||
T Consensus 85 ~~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~NIll~~~~~~~~~~kl 159 (326)
T 2y0a_A 85 NKTDVILILELVAGGELFDFLA----EKESLTEEEATEFLKQILNGVYYLHS-LQIAHFDLKPENIMLLDRNVPKPRIKI 159 (326)
T ss_dssp CSSEEEEEEECCCSCBHHHHHT----TSSCCBHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESCSSSSSCCEEE
T ss_pred eCCEEEEEEEcCCCCCHHHHHH----hcCCcCHHHHHHHHHHHHHHHHHHHH-CCeEcCCCCHHHEEEecCCCCCCCEEE
Confidence 44568999999976 4444332 24668999999999999999999998 89999999999999987652 5999
Q ss_pred eeecCccccCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 012233 282 CDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTR 361 (468)
Q Consensus 282 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~ 361 (468)
+|||+++............||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+........
T Consensus 160 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~- 237 (326)
T 2y0a_A 160 IDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE- 237 (326)
T ss_dssp CCCTTCEECCTTSCCCCCCSCTTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCC-
T ss_pred EECCCCeECCCCCccccccCCcCcCCceeecCC-CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcC-
Confidence 999999887655555667899999999999654 489999999999999999999999998887776666554211111
Q ss_pred HHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q 012233 362 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426 (468)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 426 (468)
..++..+++.+++||.+||+.||.+|||+.|+|+||||+..
T Consensus 238 ------------------------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 278 (326)
T 2y0a_A 238 ------------------------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 278 (326)
T ss_dssp ------------------------HHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred ------------------------ccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence 11335688999999999999999999999999999999864
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-49 Score=401.44 Aligned_cols=262 Identities=24% Similarity=0.404 Sum_probs=216.5
Q ss_pred ccceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc-------cchHHHHHHHHHHcCCCCcccccceeeecCCCCce
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~-------~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 208 (468)
..+|.+.++||+|+||+||+|+++.+++.||+|++.+. .....+|..+++.++||||++++++| .+..
T Consensus 73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~-----~~~~ 147 (437)
T 4aw2_A 73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF-----QDDN 147 (437)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE-----ECSS
T ss_pred hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-----eeCC
Confidence 34699999999999999999999999999999998642 23366899999999999999999998 4455
Q ss_pred EEEEEeecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCc
Q 012233 209 YLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (468)
Q Consensus 209 ~~~lv~e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a 287 (468)
.+|||||||.++ +...+.. ....+++..++.++.||+.||.|||+ +|||||||||+||||+.++ .+||+|||++
T Consensus 148 ~~~lV~Ey~~gg~L~~~l~~---~~~~l~e~~~~~~~~qi~~aL~~LH~-~giiHrDLKp~NILl~~~g-~vkL~DFGla 222 (437)
T 4aw2_A 148 NLYLVMDYYVGGDLLTLLSK---FEDRLPEEMARFYLAEMVIAIDSVHQ-LHYVHRDIKPDNILMDMNG-HIRLADFGSC 222 (437)
T ss_dssp EEEEEECCCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTS-CEEECCCTTC
T ss_pred EEEEEEecCCCCcHHHHHHH---ccCCCCHHHHHHHHHHHHHHHHHHHh-CCeEecccCHHHeeEcCCC-CEEEcchhhh
Confidence 699999999764 4444332 24679999999999999999999998 8999999999999999888 7999999999
Q ss_pred cccCCCCC--CccccccCCcccccccc----CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 012233 288 KMLVPGEP--NISYICSRYYRAPELIF----GATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTR 361 (468)
Q Consensus 288 ~~~~~~~~--~~~~~gt~~y~aPE~~~----~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~ 361 (468)
+....... ....+||+.|+|||++. +...++.++|||||||++|||++|++||.+.+..+.+.+|+....
T Consensus 223 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~---- 298 (437)
T 4aw2_A 223 LKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE---- 298 (437)
T ss_dssp EECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH----
T ss_pred hhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccc----
Confidence 77654432 23468999999999986 234589999999999999999999999999888888877764210
Q ss_pred HHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCC--CCCHHHHhCCCCCCCCCCCCC
Q 012233 362 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSL--RCTALEACAHPFFDDLRDPNT 431 (468)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~--R~s~~ell~hp~f~~~~~~~~ 431 (468)
.+.+|. ....+++++++||++||..+|.+ |++++|+++||||+++.-...
T Consensus 299 -----------~~~~p~---------~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~l 350 (437)
T 4aw2_A 299 -----------RFQFPT---------QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDNI 350 (437)
T ss_dssp -----------HCCCCS---------SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTTG
T ss_pred -----------cccCCc---------ccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHHH
Confidence 112221 12348999999999999998888 999999999999998754433
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-49 Score=390.84 Aligned_cols=300 Identities=31% Similarity=0.588 Sum_probs=232.0
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc---------------chHHHHHHHHHHcCCCCcccccceeee
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---------------RYKNRELQIMRLLNHPNVVSLKHCFFS 201 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~---------------~~~~~E~~il~~l~hpnIv~l~~~~~~ 201 (468)
.+|.+.+.||+|+||.||+|.+.. |..||||++.... ....+|+.+++.++||||+++++++..
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 100 (362)
T 3pg1_A 22 SPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVH 100 (362)
T ss_dssp CSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEE
T ss_pred cceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEe
Confidence 359999999999999999999754 9999999884321 345689999999999999999999977
Q ss_pred cCCCCceEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEE
Q 012233 202 TTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKI 281 (468)
Q Consensus 202 ~~~~~~~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL 281 (468)
........+|+||||+.++++..+.. ....+++..++.++.||+.||.|||+ +||+||||||+||||+.++ .+||
T Consensus 101 ~~~~~~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~NIl~~~~~-~~kl 175 (362)
T 3pg1_A 101 FEEPAMHKLYLVTELMRTDLAQVIHD---QRIVISPQHIQYFMYHILLGLHVLHE-AGVVHRDLHPGNILLADNN-DITI 175 (362)
T ss_dssp CCTTTCCEEEEEEECCSEEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTC-CEEE
T ss_pred ccCCCcceEEEEEccCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH-CcCEecCCChHHEEEcCCC-CEEE
Confidence 66666678899999999988876553 24568999999999999999999998 8999999999999999888 7999
Q ss_pred eeecCccccCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 012233 282 CDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTR 361 (468)
Q Consensus 282 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~ 361 (468)
+|||++.............||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..++...+.+..
T Consensus 176 ~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 255 (362)
T 3pg1_A 176 CDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKI 255 (362)
T ss_dssp CCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCH
T ss_pred EecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCh
Confidence 99999986655555566789999999999977566999999999999999999999999999999999999999998887
Q ss_pred HHHhhcCCC----CccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCCCCCCCCCC
Q 012233 362 EEIKCMNPN----YTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNTCLPNGR 437 (468)
Q Consensus 362 ~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~~~~~~~ 437 (468)
......... +............|. .+.+.+++.+.+||.+||+.||.+|||+.|+|+||||+.+..+.... .
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~---~ 331 (362)
T 3pg1_A 256 EDVVMFSSPSARDYLRNSLSNVPARAWT-AVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDPLDLT---E 331 (362)
T ss_dssp HHHHHTSCHHHHHHTTTCCCCCCCCCHH-HHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCGGGGT---T
T ss_pred HHhhhccchhhhHHHHhhcccCChhhHH-hhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCccccc---c
Confidence 654322110 001111111222222 23456799999999999999999999999999999999986654432 2
Q ss_pred CCCcccccC
Q 012233 438 PLPTLFNFT 446 (468)
Q Consensus 438 ~~~~~~~~~ 446 (468)
.++.-+.|.
T Consensus 332 ~~~~~~~~~ 340 (362)
T 3pg1_A 332 GLSERFHFD 340 (362)
T ss_dssp TCCCCCCCC
T ss_pred ccccccChh
Confidence 334445555
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-49 Score=391.71 Aligned_cols=252 Identities=27% Similarity=0.470 Sum_probs=211.6
Q ss_pred cccceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-------chHHHHHHHHHHc-CCCCcccccceeeecCCCC
Q 012233 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKD 206 (468)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-------~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~ 206 (468)
...+|.+.+.||+|+||.||+|+++.+|+.||||++.+.. ....+|..+++.+ +||||++++++| .+
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~-----~~ 89 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF-----QT 89 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE-----EC
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEE-----Ee
Confidence 3457999999999999999999999999999999986532 2345688888877 899999999998 44
Q ss_pred ceEEEEEeecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeec
Q 012233 207 ELYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG 285 (468)
Q Consensus 207 ~~~~~lv~e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG 285 (468)
...+|+||||+.++ +...+.. ...+++..++.++.||+.||.|||+ +||+||||||+||||+.++ .+||+|||
T Consensus 90 ~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~g-~vkL~DFG 163 (345)
T 1xjd_A 90 KENLFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHS-KGIVYRDLKLDNILLDKDG-HIKIADFG 163 (345)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTS-CEEECCCT
T ss_pred CCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCChhhEEECCCC-CEEEeECh
Confidence 55689999999864 4443332 3568999999999999999999998 8999999999999999988 79999999
Q ss_pred CccccCC-CCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 012233 286 SAKMLVP-GEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEI 364 (468)
Q Consensus 286 ~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 364 (468)
+++.... .......+||+.|+|||++.+.. ++.++|||||||++|||++|..||.+.+..+.+..+...
T Consensus 164 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~--------- 233 (345)
T 1xjd_A 164 MCKENMLGDAKTNTFCGTPDYIAPEILLGQK-YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--------- 233 (345)
T ss_dssp TCBCCCCTTCCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC---------
T ss_pred hhhhcccCCCcccCCCCCcccCChhhhcCCC-CCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhC---------
Confidence 9986432 33445678999999999997654 899999999999999999999999988877766665441
Q ss_pred hhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHH-HHhCCCCCCCCC
Q 012233 365 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTAL-EACAHPFFDDLR 427 (468)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~-ell~hp~f~~~~ 427 (468)
... ++..+++++++||.+||+.||.+||++. ++++||||+++.
T Consensus 234 --------~~~------------~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~ 277 (345)
T 1xjd_A 234 --------NPF------------YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN 277 (345)
T ss_dssp --------CCC------------CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred --------CCC------------CCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCC
Confidence 111 2345899999999999999999999998 999999999874
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-50 Score=392.21 Aligned_cols=252 Identities=19% Similarity=0.218 Sum_probs=184.1
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeecccc-h--HHHHHHHHHHcCCCCcccccceeeecCCCCceEEEEEe
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR-Y--KNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~~-~--~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv~ 214 (468)
+|.+.+.||+|+||+||+|++ +|+.||||++..... . .+.|+.++..++|||||++++++.... .....+||||
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~-~~~~~~~lV~ 80 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWLVS 80 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecC-CCceEEEEEe
Confidence 599999999999999999998 689999999865432 2 234555667889999999999986543 2234688999
Q ss_pred ecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcC--------CccccCCCCCCeeecCCCCcEEEeeecC
Q 012233 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV--------GVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (468)
Q Consensus 215 e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~--------givHrDlkp~NILl~~~~~~vkL~DFG~ 286 (468)
|||+++.|....+ ...+++..+..++.|++.||+|||+ + +||||||||+||||+.++ .+||+|||+
T Consensus 81 Ey~~~gsL~~~l~----~~~l~~~~~~~i~~~ia~gl~ylH~-~~~~~~~~~~IiHRDlKp~NILl~~~~-~~Ki~DFGl 154 (303)
T 3hmm_A 81 DYHEHGSLFDYLN----RYTVTVEGMIKLALSTASGLAHLHM-EIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIADLGL 154 (303)
T ss_dssp ECCTTCBHHHHHH----HCCBCHHHHHHHHHHHHHHHHHHHC-CBCSTTCBCCEECSCCCGGGEEECTTS-CEEECCCTT
T ss_pred cCCCCCcHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHH-hhhhccCCCCEeeccCCcccEEECCCC-CEEEEeCCC
Confidence 9999654443322 2468999999999999999999996 5 999999999999999988 799999999
Q ss_pred ccccCCCCC-----CccccccCCccccccccCCC-----CCCcchhHHHHHHHHHHHHhCCCCCCCCCc-----------
Q 012233 287 AKMLVPGEP-----NISYICSRYYRAPELIFGAT-----EYTTAIDMWSIGCVLAELLLGQPLFPGESG----------- 345 (468)
Q Consensus 287 a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~-----~~~~~~DvwSlG~il~ell~G~~pf~~~~~----------- 345 (468)
|+....... ....+||+.|||||++.+.. .++.++|||||||+||||+||.+||.....
T Consensus 155 a~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~ 234 (303)
T 3hmm_A 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp CEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred CccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccc
Confidence 987644332 22458999999999996542 367799999999999999999877643221
Q ss_pred ---HHHHHHHHHHhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 346 ---VDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 346 ---~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
.+.+.+.+... . ....+|. .......++.+.+||.+||+.||.+|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~-------------~-~rp~~p~-------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~ 290 (303)
T 3hmm_A 235 DPSVEEMRKVVCEQ-------------K-LRPNIPN-------RWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp SCCHHHHHHHHTTS-------------C-CCCCCCG-------GGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred cchHHHHHHHHhcc-------------c-CCCCCCc-------cccchHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 11111111100 0 0000110 0001123457899999999999999999999875
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=399.53 Aligned_cols=279 Identities=33% Similarity=0.572 Sum_probs=227.4
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeecccc---hHHHHHHHHHHc------CCCCcccccceeeecCCCCc
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR---YKNRELQIMRLL------NHPNVVSLKHCFFSTTEKDE 207 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~~---~~~~E~~il~~l------~hpnIv~l~~~~~~~~~~~~ 207 (468)
.+|.+.+.||+|+||.||+|.+..+++.||||++..... ...+|+.+++.+ .|+||+++++++.. .
T Consensus 97 ~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~-----~ 171 (429)
T 3kvw_A 97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF-----R 171 (429)
T ss_dssp TTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE-----T
T ss_pred CcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc-----C
Confidence 469999999999999999999999999999999976542 345688888887 57799999998843 3
Q ss_pred eEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCC-cEEEeeecC
Q 012233 208 LYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTH-QLKICDFGS 286 (468)
Q Consensus 208 ~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~-~vkL~DFG~ 286 (468)
..+|+||||+++++++.+.... ...+++..++.++.||+.||.|||+ +||+||||||+||||+.++. .+||+|||+
T Consensus 172 ~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlKp~NILl~~~~~~~vkL~DFG~ 248 (429)
T 3kvw_A 172 NHICMTFELLSMNLYELIKKNK--FQGFSLPLVRKFAHSILQCLDALHK-NRIIHCDLKPENILLKQQGRSGIKVIDFGS 248 (429)
T ss_dssp TEEEEEECCCCCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHH-HTEECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred CeEEEEEeccCCCHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEEccCCCcceEEeeccc
Confidence 4589999999998888765432 3458999999999999999999998 89999999999999998772 299999999
Q ss_pred ccccCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 012233 287 AKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKC 366 (468)
Q Consensus 287 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 366 (468)
+.... ......+||+.|+|||++.+.. ++.++|||||||++|||++|.+||.+.+..+.+..++..++.|+...+..
T Consensus 249 a~~~~--~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~ 325 (429)
T 3kvw_A 249 SCYEH--QRVYTYIQSRFYRAPEVILGAR-YGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDA 325 (429)
T ss_dssp CEETT--CCCCSSCSCGGGCCHHHHHTBC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred ceecC--CcccccCCCCCccChHHHhCCC-CCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHh
Confidence 97643 3344678999999999998765 89999999999999999999999999999999999999999998876543
Q ss_pred cCCCC---ccCCCC---------------------------cccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHH
Q 012233 367 MNPNY---TEFKFP---------------------------QIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALE 416 (468)
Q Consensus 367 ~~~~~---~~~~~~---------------------------~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~e 416 (468)
..... ....++ ......|...+....++++.+||.+||++||.+|||+.|
T Consensus 326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e 405 (429)
T 3kvw_A 326 SKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQ 405 (429)
T ss_dssp BTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred hhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHH
Confidence 22100 000000 011223444455567899999999999999999999999
Q ss_pred HhCCCCCCCC
Q 012233 417 ACAHPFFDDL 426 (468)
Q Consensus 417 ll~hp~f~~~ 426 (468)
+|+||||++.
T Consensus 406 ~L~Hpw~~~~ 415 (429)
T 3kvw_A 406 ALRHPWLRRR 415 (429)
T ss_dssp HHTSTTTC--
T ss_pred HhCChhhccC
Confidence 9999999874
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-49 Score=382.69 Aligned_cols=252 Identities=25% Similarity=0.382 Sum_probs=210.4
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc----cchHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEE
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~----~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~l 212 (468)
.+|.+.+.||+|+||.||+|.+..+|+.||||++... .....+|+.+++.++||||++++++|... ..+|+
T Consensus 20 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~~l 94 (297)
T 3fxz_A 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG-----DELWV 94 (297)
T ss_dssp GTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TEEEE
T ss_pred hceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEEC-----CEEEE
Confidence 4699999999999999999999999999999998533 23456799999999999999999998543 35889
Q ss_pred EeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCC
Q 012233 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (468)
Q Consensus 213 v~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~ 292 (468)
||||+.++.+..... ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++.....
T Consensus 95 v~e~~~~~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~Dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~ 168 (297)
T 3fxz_A 95 VMEYLAGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITP 168 (297)
T ss_dssp EEECCTTCBHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTC-CEEECCCTTCEECCS
T ss_pred EEECCCCCCHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCHHHEEECCCC-CEEEeeCCCceecCC
Confidence 999997654443222 2358999999999999999999998 8999999999999999888 799999999987654
Q ss_pred CC-CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCC
Q 012233 293 GE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNY 371 (468)
Q Consensus 293 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 371 (468)
.. ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+....+.......
T Consensus 169 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~------------ 235 (297)
T 3fxz_A 169 EQSKRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPE------------ 235 (297)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHCSC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCC------------
T ss_pred cccccCCccCCcCccChhhhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC------------
Confidence 33 344568999999999997654 8999999999999999999999999888777666655421110
Q ss_pred ccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q 012233 372 TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426 (468)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 426 (468)
. ..+..+++.+.+||.+||+.||.+|||+.|+++||||+..
T Consensus 236 --~------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 276 (297)
T 3fxz_A 236 --L------------QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIA 276 (297)
T ss_dssp --C------------SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred --C------------CCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhccc
Confidence 0 0234578999999999999999999999999999999864
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-49 Score=392.74 Aligned_cols=255 Identities=27% Similarity=0.428 Sum_probs=213.0
Q ss_pred ccceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc------chHHHHHHHHHHcCCCCcccccceeeecCCCCceE
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 209 (468)
..+|.+.+.||+|+||.||+|.+..+|+.||+|++.... ..+.+|+.+++.++||||+++++++ .+...
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~~ 102 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEESF 102 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSSE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeCCE
Confidence 346999999999999999999999999999999986532 2345799999999999999999998 44556
Q ss_pred EEEEeecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCC--CcEEEeeecC
Q 012233 210 LNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHT--HQLKICDFGS 286 (468)
Q Consensus 210 ~~lv~e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~--~~vkL~DFG~ 286 (468)
.|+||||+.++ +.+.+. ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ ..+||+|||+
T Consensus 103 ~~lv~e~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~ 177 (362)
T 2bdw_A 103 HYLVFDLVTGGELFEDIV----AREFYSEADASHCIQQILESIAYCHS-NGIVHRNLKPENLLLASKAKGAAVKLADFGL 177 (362)
T ss_dssp EEEEECCCCSCBHHHHHT----TCSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEEecCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCchHHEEEecCCCCCCEEEeecCc
Confidence 89999999874 444332 24568999999999999999999998 8999999999999998653 2599999999
Q ss_pred ccccCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 012233 287 AKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKC 366 (468)
Q Consensus 287 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 366 (468)
+............+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+.+..+....
T Consensus 178 a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~---------- 246 (362)
T 2bdw_A 178 AIEVNDSEAWHGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA---------- 246 (362)
T ss_dssp CBCCTTCCSCCCSCSCTTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC----------
T ss_pred ceEecCCcccccCCCCccccCHHHHccC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC----------
Confidence 9877655555567899999999999765 48999999999999999999999999887776666665421
Q ss_pred cCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q 012233 367 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426 (468)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 426 (468)
+.++. ..+..+++++++||.+||+.||.+|||+.++|+||||...
T Consensus 247 -------~~~~~--------~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 291 (362)
T 2bdw_A 247 -------YDYPS--------PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR 291 (362)
T ss_dssp -------CCCCT--------TGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred -------CCCCc--------ccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCCC
Confidence 11111 1224579999999999999999999999999999999753
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-49 Score=398.08 Aligned_cols=289 Identities=30% Similarity=0.511 Sum_probs=212.0
Q ss_pred ceEE-eceecccCceEEEEEEEc--CCCCEEEEEEeeccc--chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEE
Q 012233 138 SYMA-ERVVGTGSFGVVFQAKCL--ETGDSVAIKKVLQDK--RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (468)
Q Consensus 138 ~y~~-~~~lG~G~fg~Vy~~~~~--~~g~~vaiK~~~~~~--~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~l 212 (468)
.|.+ +++||+|+||.||+|.++ .+++.||||++.... ....+|+.+|+.++||||++++++|... ....+||
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~---~~~~~~l 97 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSH---ADRKVWL 97 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEET---TTTEEEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEecC---CCCeEEE
Confidence 4776 568999999999999976 568899999986543 3456899999999999999999998653 2346889
Q ss_pred EeecccchHHHHHhhhhhc-----CCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeee----cCCCCcEEEee
Q 012233 213 VLEYISETVYRVSKHYTRM-----NQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLV----NPHTHQLKICD 283 (468)
Q Consensus 213 v~e~~~~~ll~~~~~~~~~-----~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl----~~~~~~vkL~D 283 (468)
||||+.++++..+...... ...+++..++.++.||+.||.|||+ +||+||||||+|||| +.++ .+||+|
T Consensus 98 v~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~ivH~Dlkp~NIll~~~~~~~~-~~kl~D 175 (405)
T 3rgf_A 98 LFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA-NWVLHRDLKPANILVMGEGPERG-RVKIAD 175 (405)
T ss_dssp EEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECCSSTTTT-CEEECC
T ss_pred EEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh-CCEeCCCcCHHHeEEecCCCCCC-cEEEEE
Confidence 9999999988876543321 2348999999999999999999998 899999999999999 5555 799999
Q ss_pred ecCccccCCC----CCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCc---------HHHHH
Q 012233 284 FGSAKMLVPG----EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESG---------VDQLV 350 (468)
Q Consensus 284 FG~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~---------~~~~~ 350 (468)
||+++..... ......+||+.|+|||++.+...++.++|||||||++|+|++|++||.+... .+++.
T Consensus 176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~ 255 (405)
T 3rgf_A 176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD 255 (405)
T ss_dssp TTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHH
T ss_pred CCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHH
Confidence 9999866432 2234568899999999998766699999999999999999999999976554 47888
Q ss_pred HHHHHhCCCCHHHHhhcCCCC---------ccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCC
Q 012233 351 EIIKILGTPTREEIKCMNPNY---------TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHP 421 (468)
Q Consensus 351 ~i~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp 421 (468)
.++..++.|....+....... ....+.......+........++++.+||.+||++||.+|||+.|+|+||
T Consensus 256 ~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp 335 (405)
T 3rgf_A 256 RIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDP 335 (405)
T ss_dssp HHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred HHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 999999988765443321100 00000000000011112233478899999999999999999999999999
Q ss_pred CCCCCCCCCC
Q 012233 422 FFDDLRDPNT 431 (468)
Q Consensus 422 ~f~~~~~~~~ 431 (468)
||.+...+..
T Consensus 336 ~f~~~~~~~~ 345 (405)
T 3rgf_A 336 YFLEDPLPTS 345 (405)
T ss_dssp GGTSSSCCCS
T ss_pred hhccCCCCcc
Confidence 9998766544
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-49 Score=397.05 Aligned_cols=261 Identities=26% Similarity=0.443 Sum_probs=214.1
Q ss_pred ccceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc-------cchHHHHHHHHHHcCCCCcccccceeeecCCCCce
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~-------~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 208 (468)
..+|.+.+.||+|+||.||+|+++.+|+.||||++.+. .....+|..++..++||||++++++| .+..
T Consensus 60 ~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~-----~~~~ 134 (412)
T 2vd5_A 60 RDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF-----QDEN 134 (412)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE-----ECSS
T ss_pred hhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE-----eeCC
Confidence 44699999999999999999999999999999998642 23456899999999999999999988 4555
Q ss_pred EEEEEeecccc-hHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCc
Q 012233 209 YLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (468)
Q Consensus 209 ~~~lv~e~~~~-~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a 287 (468)
++||||||+.+ ++...+.. ....+++..++.++.||+.||.|||+ +||+||||||+||||+.++ .+||+|||++
T Consensus 135 ~~~lVmE~~~gg~L~~~l~~---~~~~l~~~~~~~~~~qi~~aL~~LH~-~giiHrDLKp~NILld~~g-~vkL~DFGla 209 (412)
T 2vd5_A 135 YLYLVMEYYVGGDLLTLLSK---FGERIPAEMARFYLAEIVMAIDSVHR-LGYVHRDIKPDNILLDRCG-HIRLADFGSC 209 (412)
T ss_dssp EEEEEECCCCSCBHHHHHHH---HSSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTS-CEEECCCTTC
T ss_pred EEEEEEcCCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecccCHHHeeecCCC-CEEEeechhh
Confidence 79999999975 44444432 23579999999999999999999998 8999999999999999988 6999999999
Q ss_pred cccCCCCC--CccccccCCccccccccC------CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Q 012233 288 KMLVPGEP--NISYICSRYYRAPELIFG------ATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTP 359 (468)
Q Consensus 288 ~~~~~~~~--~~~~~gt~~y~aPE~~~~------~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~ 359 (468)
+....... ....+||+.|+|||++.+ ...++.++|||||||++|||++|++||.+.+..+.+.+|.....
T Consensus 210 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~-- 287 (412)
T 2vd5_A 210 LKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKE-- 287 (412)
T ss_dssp EECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH--
T ss_pred eeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhccc--
Confidence 87654432 234689999999999962 23489999999999999999999999999888887777764210
Q ss_pred CHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCC---CCHHHHhCCCCCCCCCCCCC
Q 012233 360 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLR---CTALEACAHPFFDDLRDPNT 431 (468)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R---~s~~ell~hp~f~~~~~~~~ 431 (468)
...+|. ++..+++++++||++||. +|.+| ++++|+++||||+++.-...
T Consensus 288 -------------~~~~p~---------~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~l 339 (412)
T 2vd5_A 288 -------------HLSLPL---------VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGL 339 (412)
T ss_dssp -------------HCCCC-------------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTTS
T ss_pred -------------CcCCCc---------cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHHH
Confidence 011111 224589999999999999 99998 59999999999998754433
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=391.33 Aligned_cols=293 Identities=33% Similarity=0.610 Sum_probs=231.5
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc------chHHHHHHHHHHcCCCCcccccceeeecCCC-CceE
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEK-DELY 209 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~-~~~~ 209 (468)
.+|.+.+.||+|+||.||+|.+..+|+.||||++.... ....+|+.+++.++||||+++++++...... ....
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 121 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 121 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence 36999999999999999999999999999999986532 2345799999999999999999998544321 1122
Q ss_pred EEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccc
Q 012233 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (468)
Q Consensus 210 ~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~ 289 (468)
+|+||||+.+++...+ ...+++..++.++.||+.||.|||+ +||+||||||+||||+.++ .+||+|||+++.
T Consensus 122 ~~lv~e~~~~~l~~~~------~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIll~~~~-~~kL~Dfg~a~~ 193 (371)
T 4exu_A 122 FYLVMPFMQTDLQKIM------GMEFSEEKIQYLVYQMLKGLKYIHS-AGVVHRDLKPGNLAVNEDC-ELKILDFGLARH 193 (371)
T ss_dssp CEEEEECCCEEHHHHT------TSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTC-CEEECSTTCC--
T ss_pred EEEEEccccccHHHHh------hcCCCHHHHHHHHHHHHHHHHHHHH-CCCcCCCcCHHHeEECCCC-CEEEEecCcccc
Confidence 4899999998876643 3458999999999999999999998 8999999999999999888 799999999976
Q ss_pred cCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 012233 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (468)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 369 (468)
.. .......||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..++...+.+..+.+..+..
T Consensus 194 ~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 271 (371)
T 4exu_A 194 AD--AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND 271 (371)
T ss_dssp --------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSC
T ss_pred cc--cCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhh
Confidence 53 2344568899999999997756699999999999999999999999999999999999999999888766544321
Q ss_pred CCccC---CCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCCCCCCCCCCCCC
Q 012233 370 NYTEF---KFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNTCLPNGRPLP 440 (468)
Q Consensus 370 ~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~~~~~~~~~~ 440 (468)
..... ..+......+ ..+...+++++.+||.+||+.||.+|||+.|+|+||||+.+..+.......++..
T Consensus 272 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~~~~~ 344 (371)
T 4exu_A 272 KAAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQPFD 344 (371)
T ss_dssp HHHHHHHHHSCCCCCCCH-HHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGCCCCSSCCC
T ss_pred hhhhhhhhccCCCcchhH-HHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCCcccccccccCcC
Confidence 11100 0111111111 1234568999999999999999999999999999999999887665544444443
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=389.18 Aligned_cols=258 Identities=28% Similarity=0.369 Sum_probs=209.7
Q ss_pred ccceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc---------cchHHHHHHHHHHcCCCCcccccceeeecCCCC
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD 206 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~---------~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 206 (468)
...|.+.+.||+|+||.||+|.++.+|+.||||++... ...+.+|+.+++.++||||+++++++..
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~----- 97 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSS----- 97 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEe-----
Confidence 34699999999999999999999999999999998532 3345689999999999999999999843
Q ss_pred ceEEEEEeecccc-hHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCC--cEEEee
Q 012233 207 ELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTH--QLKICD 283 (468)
Q Consensus 207 ~~~~~lv~e~~~~-~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~--~vkL~D 283 (468)
...+|+|||||.+ ++...+.........+++..++.++.||+.||.|||+ +||+||||||+|||++.++. .+||+|
T Consensus 98 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivHrDlkp~NIl~~~~~~~~~vkl~D 176 (351)
T 3c0i_A 98 DGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD-NNIIHRDVKPHCVLLASKENSAPVKLGG 176 (351)
T ss_dssp TTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECSSSTTCCEEECC
T ss_pred CCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCChHHeEEecCCCCCcEEEec
Confidence 3468999999985 4545554444445568999999999999999999998 89999999999999986542 499999
Q ss_pred ecCccccCCCCC-CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 012233 284 FGSAKMLVPGEP-NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTRE 362 (468)
Q Consensus 284 FG~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~ 362 (468)
||++........ ....+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.. .+.+..+........
T Consensus 177 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~-- 252 (351)
T 3c0i_A 177 FGVAIQLGESGLVAGGRVGTPHFMAPEVVKREP-YGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMN-- 252 (351)
T ss_dssp CTTCEECCTTSCBCCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCC--
T ss_pred CcceeEecCCCeeecCCcCCcCccCHHHHcCCC-CCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCC--
Confidence 999987654332 34568999999999997654 8999999999999999999999998743 333344433111111
Q ss_pred HHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q 012233 363 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426 (468)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 426 (468)
...+..+++++++||.+||+.||.+|||+.++|+||||++.
T Consensus 253 -----------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 293 (351)
T 3c0i_A 253 -----------------------PRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER 293 (351)
T ss_dssp -----------------------HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred -----------------------ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence 11224589999999999999999999999999999999864
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=386.14 Aligned_cols=250 Identities=27% Similarity=0.454 Sum_probs=213.0
Q ss_pred cccceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-------chHHHHHHHHHHcCCCCcccccceeeecCCCCc
Q 012233 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (468)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 207 (468)
...+|.+.+.||+|+||.||+|++..+|+.||||++.+.. ....+|+.+|+.++||||+++++++ .+.
T Consensus 39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~ 113 (350)
T 1rdq_E 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-----KDN 113 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECS
T ss_pred CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EcC
Confidence 3457999999999999999999999999999999985432 2345799999999999999999988 445
Q ss_pred eEEEEEeecccc-hHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecC
Q 012233 208 LYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (468)
Q Consensus 208 ~~~~lv~e~~~~-~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~ 286 (468)
..+|+||||+.+ ++...+.. ...+++..++.++.||+.||.|||+ +||+||||||+||||+.++ .+||+|||+
T Consensus 114 ~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~g-~~kL~DFg~ 187 (350)
T 1rdq_E 114 SNLYMVMEYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHS-LDLIYRDLKPENLLIDQQG-YIQVTDFGF 187 (350)
T ss_dssp SEEEEEEECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTS-CEEECCCTT
T ss_pred CEEEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCccceEEECCCC-CEEEccccc
Confidence 568999999975 44444432 3568999999999999999999998 8999999999999999888 799999999
Q ss_pred ccccCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 012233 287 AKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKC 366 (468)
Q Consensus 287 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 366 (468)
++.... .....+||+.|+|||++.+. .++.++|||||||++|||++|.+||.+.+..+.+..+...
T Consensus 188 a~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~----------- 253 (350)
T 1rdq_E 188 AKRVKG--RTWTLCGTPEALAPEIILSK-GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----------- 253 (350)
T ss_dssp CEECSS--CBCCCEECGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----------
T ss_pred ceeccC--CcccccCCccccCHHHhcCC-CCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcC-----------
Confidence 987643 34467899999999999765 4899999999999999999999999988877777666551
Q ss_pred cCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCC-----HHHHhCCCCCCCCC
Q 012233 367 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCT-----ALEACAHPFFDDLR 427 (468)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s-----~~ell~hp~f~~~~ 427 (468)
... ++..+++++.+||.+||+.||.+||+ +.++++||||+.+.
T Consensus 254 ------~~~------------~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~ 301 (350)
T 1rdq_E 254 ------KVR------------FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTD 301 (350)
T ss_dssp ------CCC------------CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCC
T ss_pred ------CCC------------CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCC
Confidence 111 33458999999999999999999998 99999999999753
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=386.28 Aligned_cols=254 Identities=26% Similarity=0.498 Sum_probs=207.1
Q ss_pred CcccceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-------chHHHHHHHHHHc-CCCCcccccceeeecCCC
Q 012233 134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLL-NHPNVVSLKHCFFSTTEK 205 (468)
Q Consensus 134 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-------~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~ 205 (468)
....+|.+.+.||+|+||.||+|+++.+|+.||||++.+.. ....+|..+++.+ +||||++++++| .
T Consensus 6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~-----~ 80 (345)
T 3a8x_A 6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-----Q 80 (345)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE-----E
T ss_pred CchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEE-----E
Confidence 44567999999999999999999999999999999986542 2245789999888 899999999998 4
Q ss_pred CceEEEEEeecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeee
Q 012233 206 DELYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDF 284 (468)
Q Consensus 206 ~~~~~~lv~e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DF 284 (468)
+...+|+||||+.++ +...+.. ...+++..++.++.||+.||.|||+ +||+||||||+||||+.++ .+||+||
T Consensus 81 ~~~~~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~g-~~kL~DF 154 (345)
T 3a8x_A 81 TESRLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHE-RGIIYRDLKLDNVLLDSEG-HIKLTDY 154 (345)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTS-CEEECCG
T ss_pred eCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCHHHEEECCCC-CEEEEec
Confidence 455689999999865 4443322 3568999999999999999999998 8999999999999999888 7999999
Q ss_pred cCccccC-CCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC--------cHHHHHHHHHH
Q 012233 285 GSAKMLV-PGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGES--------GVDQLVEIIKI 355 (468)
Q Consensus 285 G~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~--------~~~~~~~i~~~ 355 (468)
|+++... ........+||+.|+|||++.+. .++.++|||||||++|||++|+.||.... ..+.+.+.+..
T Consensus 155 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~ 233 (345)
T 3a8x_A 155 GMCKEGLRPGDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE 233 (345)
T ss_dssp GGCBCSCCTTCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHH
T ss_pred cccccccCCCCcccccCCCccccCccccCCC-CCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHc
Confidence 9998643 33345567899999999999765 48999999999999999999999997532 11222221111
Q ss_pred hCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCH------HHHhCCCCCCCCC
Q 012233 356 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTA------LEACAHPFFDDLR 427 (468)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~------~ell~hp~f~~~~ 427 (468)
.... ++..+++++++||.+||+.||.+||++ .++++||||+++.
T Consensus 234 ----------------~~~~------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~ 283 (345)
T 3a8x_A 234 ----------------KQIR------------IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD 283 (345)
T ss_dssp ----------------CCCC------------CCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCC
T ss_pred ----------------CCCC------------CCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCC
Confidence 1111 334689999999999999999999995 8999999999865
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=385.57 Aligned_cols=281 Identities=33% Similarity=0.590 Sum_probs=230.7
Q ss_pred cccceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc------chHHHHHHHHHHcCCCCcccccceeeecCCCCce
Q 012233 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (468)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 208 (468)
...+|.+.+.||+|+||.||+|.+..+|+.||||++.... ....+|+.+++.++||||+++++++. +..
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~ 97 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCK-----KKK 97 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETT
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEee-----cCC
Confidence 4457999999999999999999999999999999885432 22357999999999999999999984 344
Q ss_pred EEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcc
Q 012233 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (468)
Q Consensus 209 ~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~ 288 (468)
..|+||||+.++++..+.. ....+++..++.++.||+.||.|||+ .||+||||||+||||+.++ .+||+|||++.
T Consensus 98 ~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~ 172 (331)
T 4aaa_A 98 RWYLVFEFVDHTILDDLEL---FPNGLDYQVVQKYLFQIINGIGFCHS-HNIIHRDIKPENILVSQSG-VVKLCDFGFAR 172 (331)
T ss_dssp EEEEEEECCSEEHHHHHHH---STTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTS-CEEECCCTTC-
T ss_pred EEEEEEecCCcchHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHH-CCEEccCcChheEEEcCCC-cEEEEeCCCce
Confidence 5899999999988775432 34569999999999999999999998 8999999999999999888 79999999997
Q ss_pred ccCCC-CCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh--
Q 012233 289 MLVPG-EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIK-- 365 (468)
Q Consensus 289 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~-- 365 (468)
..... .......||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+....+........
T Consensus 173 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (331)
T 4aaa_A 173 TLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELF 252 (331)
T ss_dssp -----------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHH
T ss_pred eecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHh
Confidence 65432 233456789999999999776568999999999999999999999999999999999999888877665433
Q ss_pred hcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q 012233 366 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDD 425 (468)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~ 425 (468)
...+.+....++.+..........+.+++++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 312 (331)
T 4aaa_A 253 NKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM 312 (331)
T ss_dssp HHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred hhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence 234445555555555544444455678999999999999999999999999999999975
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=388.69 Aligned_cols=252 Identities=26% Similarity=0.423 Sum_probs=211.6
Q ss_pred cccceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-------chHHHHHHHHHHc-CCCCcccccceeeecCCCC
Q 012233 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKD 206 (468)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-------~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~ 206 (468)
...+|.+.+.||+|+||.||+|+++.+|+.||||++.+.. ....+|..++..+ .||||++++++| .+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~-----~~ 92 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QT 92 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEE-----EC
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEE-----Ec
Confidence 4457999999999999999999999999999999986532 2345688888887 799999999998 44
Q ss_pred ceEEEEEeecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeec
Q 012233 207 ELYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG 285 (468)
Q Consensus 207 ~~~~~lv~e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG 285 (468)
...+|+||||+.|+ +...+.. ...+++..++.++.||+.||.|||+ +||+||||||+||||+.++ .+||+|||
T Consensus 93 ~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NIll~~~g-~vkL~DFG 166 (353)
T 2i0e_A 93 MDRLYFVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQS-KGIIYRDLKLDNVMLDSEG-HIKIADFG 166 (353)
T ss_dssp SSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTS-CEEECCCT
T ss_pred CCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEEeccCCHHHEEEcCCC-cEEEEeCC
Confidence 55699999999864 4443332 3568999999999999999999998 8999999999999999988 79999999
Q ss_pred CccccC-CCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 012233 286 SAKMLV-PGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEI 364 (468)
Q Consensus 286 ~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 364 (468)
+++... ........+||+.|+|||++.+.. ++.++|||||||++|||++|++||.+.+..+.+..|...
T Consensus 167 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~--------- 236 (353)
T 2i0e_A 167 MCKENIWDGVTTKTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH--------- 236 (353)
T ss_dssp TCBCCCCTTCCBCCCCSCGGGCCHHHHTTCC-BSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC---------
T ss_pred cccccccCCcccccccCCccccChhhhcCCC-cCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhC---------
Confidence 998643 233455678999999999997654 899999999999999999999999988877777776651
Q ss_pred hhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCC-----HHHHhCCCCCCCCC
Q 012233 365 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCT-----ALEACAHPFFDDLR 427 (468)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s-----~~ell~hp~f~~~~ 427 (468)
... ++..+++++++||.+||+.||.+||+ +.++++||||+.+.
T Consensus 237 --------~~~------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~ 284 (353)
T 2i0e_A 237 --------NVA------------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID 284 (353)
T ss_dssp --------CCC------------CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCC
T ss_pred --------CCC------------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCC
Confidence 111 33468999999999999999999994 69999999999764
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-48 Score=385.06 Aligned_cols=289 Identities=28% Similarity=0.458 Sum_probs=225.6
Q ss_pred ccceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc------chHHHHHHHHHHcCCCCcccccceeeecCC---CC
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTE---KD 206 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~---~~ 206 (468)
..+|.+.+.||+|+||.||+|.+..+|+.||||++.... ....+|+.+++.++||||+++++++..... ..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 457999999999999999999999999999999884432 234579999999999999999998855321 11
Q ss_pred ceEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecC
Q 012233 207 ELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (468)
Q Consensus 207 ~~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~ 286 (468)
...+|+||||+.++++..+... ...+++..++.++.||+.||.|||+ +||+||||||+||||+.++ .+||+|||+
T Consensus 96 ~~~~~lv~e~~~~~l~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~ 170 (351)
T 3mi9_A 96 KGSIYLVFDFCEHDLAGLLSNV---LVKFTLSEIKRVMQMLLNGLYYIHR-NKILHRDMKAANVLITRDG-VLKLADFGL 170 (351)
T ss_dssp -CEEEEEEECCSEEHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTS-CEEECCCTT
T ss_pred CceEEEEEeccCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeCCCCCHHHEEEcCCC-CEEEccchh
Confidence 3468899999999887765432 3568999999999999999999998 8999999999999999888 799999999
Q ss_pred ccccCCC-----CCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 012233 287 AKMLVPG-----EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTR 361 (468)
Q Consensus 287 a~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~ 361 (468)
++..... .......||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+.++.
T Consensus 171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 250 (351)
T 3mi9_A 171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 250 (351)
T ss_dssp CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 9766422 22345678999999999977666899999999999999999999999999999999999888887765
Q ss_pred HHHhhcCC--CCccCCCCcccCCCcccc-cccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCC
Q 012233 362 EEIKCMNP--NYTEFKFPQIKAHPWHKI-FHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDP 429 (468)
Q Consensus 362 ~~~~~~~~--~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~ 429 (468)
..+..... .+................ .....++++.+||.+||+.||.+|||+.|+|+||||+....+
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 321 (351)
T 3mi9_A 251 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMP 321 (351)
T ss_dssp TTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCC
T ss_pred hhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCc
Confidence 44332111 011111110000000000 001137789999999999999999999999999999875443
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-49 Score=380.63 Aligned_cols=255 Identities=27% Similarity=0.394 Sum_probs=206.1
Q ss_pred CcccceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc------------------------------chHHHHHHH
Q 012233 134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------------------------------RYKNRELQI 183 (468)
Q Consensus 134 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~------------------------------~~~~~E~~i 183 (468)
....+|.+.+.||+|+||.||+|.+..+|+.||||++.... ....+|+.+
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 89 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI 89 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence 34557999999999999999999999999999999985432 335679999
Q ss_pred HHHcCCCCcccccceeeecCCCCceEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCcccc
Q 012233 184 MRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHR 263 (468)
Q Consensus 184 l~~l~hpnIv~l~~~~~~~~~~~~~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHr 263 (468)
++.++||||+++++++... ....+|+||||+.++.+..+ .....+++..++.++.||+.||.|||+ +||+||
T Consensus 90 l~~l~h~~iv~~~~~~~~~---~~~~~~lv~e~~~~~~l~~~----~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~ 161 (298)
T 2zv2_A 90 LKKLDHPNVVKLVEVLDDP---NEDHLYMVFELVNQGPVMEV----PTLKPLSEDQARFYFQDLIKGIEYLHY-QKIIHR 161 (298)
T ss_dssp HHTCCCTTBCCEEEEEECS---SSSEEEEEEECCTTCBSCCS----SCSSCCCHHHHHHHHHHHHHHHHHHHH-TTEECC
T ss_pred HHhCCCCCCCeEEEEEEcC---CCCEEEEEEecCCCCcHHHH----hhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeecc
Confidence 9999999999999988542 23468899999987644321 224568999999999999999999998 899999
Q ss_pred CCCCCCeeecCCCCcEEEeeecCccccCCCC-CCccccccCCccccccccCCCC--CCcchhHHHHHHHHHHHHhCCCCC
Q 012233 264 DIKPQNLLVNPHTHQLKICDFGSAKMLVPGE-PNISYICSRYYRAPELIFGATE--YTTAIDMWSIGCVLAELLLGQPLF 340 (468)
Q Consensus 264 Dlkp~NILl~~~~~~vkL~DFG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~--~~~~~DvwSlG~il~ell~G~~pf 340 (468)
||||+|||++.++ .+||+|||++....... ......||+.|+|||++.+... ++.++|||||||++|+|++|+.||
T Consensus 162 Dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf 240 (298)
T 2zv2_A 162 DIKPSNLLVGEDG-HIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF 240 (298)
T ss_dssp CCCGGGEEECTTS-CEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSS
T ss_pred CCCHHHEEECCCC-CEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCC
Confidence 9999999999888 79999999998764432 2335679999999999965442 478899999999999999999999
Q ss_pred CCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCC
Q 012233 341 PGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (468)
Q Consensus 341 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~h 420 (468)
.+.........+... ...++ ....+++++.+||.+||+.||.+|||+.|+++|
T Consensus 241 ~~~~~~~~~~~~~~~-----------------~~~~~----------~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 241 MDERIMCLHSKIKSQ-----------------ALEFP----------DQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp CCSSHHHHHHHHHHC-----------------CCCCC----------SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred CCccHHHHHHHHhcc-----------------cCCCC----------CccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 887665544444331 11111 123588999999999999999999999999999
Q ss_pred CCCC
Q 012233 421 PFFD 424 (468)
Q Consensus 421 p~f~ 424 (468)
|||+
T Consensus 294 p~~~ 297 (298)
T 2zv2_A 294 PWVT 297 (298)
T ss_dssp HHHH
T ss_pred cccc
Confidence 9995
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-49 Score=389.58 Aligned_cols=256 Identities=28% Similarity=0.448 Sum_probs=208.9
Q ss_pred ccceEEeceecccCceEEEEEEEcCCCCEEEEEEeecccchHHHHHHHHHHc-CCCCcccccceeeecCCCCceEEEEEe
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDELYLNLVL 214 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~lv~ 214 (468)
.++|.+.+.||+|+||.||+|.++.+|+.||||++.+......+|++++.++ +||||++++++| .+..++|+||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~-----~~~~~~~lv~ 95 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVY-----DDGKYVYVVT 95 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCCCHHHHHHHHHHTTSTTBCCEEEEE-----ECSSEEEEEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCChHHHHHHHHHhcCCCCcCeEEEEE-----EcCCEEEEEE
Confidence 4569999999999999999999999999999999988777777899999888 799999999998 4555799999
Q ss_pred ecccc-hHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCC---cEEEeeecCcccc
Q 012233 215 EYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTH---QLKICDFGSAKML 290 (468)
Q Consensus 215 e~~~~-~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~---~vkL~DFG~a~~~ 290 (468)
|||.+ ++.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||+..+.. .+||+|||+++..
T Consensus 96 E~~~gg~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~-~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 96 ELMKGGELLDKILR----QKFFSEREASAVLFTITKTVEYLHA-QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp CCCCSCBHHHHHHT----CTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred eCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 99986 45544332 4568999999999999999999998 89999999999999854321 4999999999876
Q ss_pred CCC-CCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC---CcHHHHHHHHHHhCCCCHHHHhh
Q 012233 291 VPG-EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGE---SGVDQLVEIIKILGTPTREEIKC 366 (468)
Q Consensus 291 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~---~~~~~~~~i~~~~~~~~~~~~~~ 366 (468)
... ......+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+. +..+.+..+..
T Consensus 171 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~------------ 237 (342)
T 2qr7_A 171 RAENGLLMTPCYTANFVAPEVLERQG-YDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGS------------ 237 (342)
T ss_dssp BCTTCCBCCSSCCSSCCCHHHHHHHH-HHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHH------------
T ss_pred cCCCCceeccCCCccccCHHHhcCCC-CCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHcc------------
Confidence 433 3345678899999999996543 889999999999999999999999863 22233333322
Q ss_pred cCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q 012233 367 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (468)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~ 427 (468)
..+.++ ..++..+++++++||.+||..||.+|||+.++++||||.+..
T Consensus 238 -----~~~~~~--------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~ 285 (342)
T 2qr7_A 238 -----GKFSLS--------GGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWD 285 (342)
T ss_dssp -----CCCCCC--------STTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTGG
T ss_pred -----CCcccC--------ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCcc
Confidence 111111 113456899999999999999999999999999999997753
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-48 Score=396.41 Aligned_cols=255 Identities=29% Similarity=0.428 Sum_probs=210.4
Q ss_pred ccceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc------chHHHHHHHHHHcCCCCcccccceeeecCCCCceE
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 209 (468)
..+|.+.+.||+|+||.||+|.+..+|+.||+|++.... ....+|+.+++.++||||+++++++ .+...
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-----~~~~~ 84 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSI-----SEEGH 84 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEE-----ECSSE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEE-----EECCE
Confidence 357999999999999999999999999999999986543 2346899999999999999999998 45556
Q ss_pred EEEEeecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCC--CCcEEEeeecC
Q 012233 210 LNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPH--THQLKICDFGS 286 (468)
Q Consensus 210 ~~lv~e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~--~~~vkL~DFG~ 286 (468)
.|+|||||.++ +.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.+ ...+||+|||+
T Consensus 85 ~~lv~E~~~gg~L~~~i~~----~~~~~e~~~~~i~~qil~aL~~lH~-~givHrDlKp~NIll~~~~~~~~vkL~DFG~ 159 (444)
T 3soa_A 85 HYLIFDLVTGGELFEDIVA----REYYSEADASHCIQQILEAVLHCHQ-MGVVHRNLKPENLLLASKLKGAAVKLADFGL 159 (444)
T ss_dssp EEEEECCCBCCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSSTTEEESBSSTTCCEEECCCSS
T ss_pred EEEEEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEEeccCCCCcEEEccCce
Confidence 89999999864 4444332 4569999999999999999999998 899999999999999842 23799999999
Q ss_pred ccccCCCC-CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 012233 287 AKMLVPGE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIK 365 (468)
Q Consensus 287 a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 365 (468)
+....... .....+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+.+..+....
T Consensus 160 a~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~--------- 229 (444)
T 3soa_A 160 AIEVEGEQQAWFGFAGTPGYLSPEVLRKD-PYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGA--------- 229 (444)
T ss_dssp CBCCCTTCCBCCCSCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC---------
T ss_pred eEEecCCCceeecccCCcccCCHHHhcCC-CCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCC---------
Confidence 97765433 23457899999999999655 48999999999999999999999999888777777665521
Q ss_pred hcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q 012233 366 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426 (468)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 426 (468)
+.++. ..+..+++++++||.+||+.||.+|||+.|+|+||||+..
T Consensus 230 --------~~~~~--------~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~ 274 (444)
T 3soa_A 230 --------YDFPS--------PEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHR 274 (444)
T ss_dssp --------CCCCT--------TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred --------CCCCc--------cccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence 11111 1224589999999999999999999999999999999753
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=374.36 Aligned_cols=289 Identities=33% Similarity=0.544 Sum_probs=232.5
Q ss_pred CcccceEEeceecccCceEEEEEEEc-CCCCEEEEEEeecc------cchHHHHHHHHHHc---CCCCcccccceeeecC
Q 012233 134 KQTISYMAERVVGTGSFGVVFQAKCL-ETGDSVAIKKVLQD------KRYKNRELQIMRLL---NHPNVVSLKHCFFSTT 203 (468)
Q Consensus 134 ~~~~~y~~~~~lG~G~fg~Vy~~~~~-~~g~~vaiK~~~~~------~~~~~~E~~il~~l---~hpnIv~l~~~~~~~~ 203 (468)
....+|.+.+.||+|+||.||+|.+. .+|+.||+|++... .....+|+.+++.+ .||||+++++++....
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 34457999999999999999999995 67889999988532 22455788888777 8999999999986444
Q ss_pred CCCceEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEee
Q 012233 204 EKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICD 283 (468)
Q Consensus 204 ~~~~~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~D 283 (468)
......+++||||+.+++...+.... ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|
T Consensus 88 ~~~~~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~-~gi~H~dlkp~Nili~~~~-~~kl~D 163 (326)
T 1blx_A 88 TDRETKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHS-HRVVHRDLKPQNILVTSSG-QIKLAD 163 (326)
T ss_dssp CSSEEEEEEEEECCSCBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTC-CEEECS
T ss_pred cCCCceEEEEEecCCCCHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCHHHeEEcCCC-CEEEec
Confidence 34566789999999998877655422 3458999999999999999999998 8999999999999999888 799999
Q ss_pred ecCccccCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 012233 284 FGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREE 363 (468)
Q Consensus 284 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~ 363 (468)
||++.............||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..++..++.+....
T Consensus 164 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 242 (326)
T 1blx_A 164 FGLARIYSFQMALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 242 (326)
T ss_dssp CCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred CcccccccCCCCccccccccceeCHHHHhcCC-CCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCccc
Confidence 99998665444445678899999999997654 89999999999999999999999999999999999999888877655
Q ss_pred HhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCC
Q 012233 364 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDP 429 (468)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~ 429 (468)
+....... ...+...... ....+...+++.+++||.+||+.||.+|||+.++++||||+++...
T Consensus 243 ~~~~~~~~-~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~ 306 (326)
T 1blx_A 243 WPRDVALP-RQAFHSKSAQ-PIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERC 306 (326)
T ss_dssp SCTTCSSC-GGGSCCCCCC-CGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred Cccccccc-hhhhcccCcc-hhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccchh
Confidence 43211110 0111111111 1233556789999999999999999999999999999999987654
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-48 Score=380.72 Aligned_cols=257 Identities=28% Similarity=0.334 Sum_probs=207.8
Q ss_pred ccceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc-----cchHHHHHHHHHHcCCCCcccccceeeecCCCCceEE
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~-----~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~ 210 (468)
..+|.+.+.||+|+||.||+|.+..+++.||||++... .....+|+.+++.++||||+++++++ .+....
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-----~~~~~~ 80 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR-----REGNIQ 80 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEE-----ECSSEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEE-----ecCCeE
Confidence 35699999999999999999999999999999998543 24456899999999999999999988 444568
Q ss_pred EEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcccc
Q 012233 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (468)
Q Consensus 211 ~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~ 290 (468)
|+||||+.++.+. .+......+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++..
T Consensus 81 ~lv~e~~~~~~L~---~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~-~givH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~ 155 (323)
T 3tki_A 81 YLFLEYCSGGELF---DRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERD-NLKISDFGLATVF 155 (323)
T ss_dssp EEEEECCTTEEGG---GGSBTTTBCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTC-CEEECCCTTCEEC
T ss_pred EEEEEcCCCCcHH---HHHhhcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccccchHHEEEeCCC-CEEEEEeecccee
Confidence 9999999875432 222334569999999999999999999998 8999999999999999888 7999999999765
Q ss_pred CCC---CCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 012233 291 VPG---EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367 (468)
Q Consensus 291 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 367 (468)
... ......+||+.|+|||++.+...++.++|||||||++|+|++|+.||..................
T Consensus 156 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~--------- 226 (323)
T 3tki_A 156 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT--------- 226 (323)
T ss_dssp EETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCT---------
T ss_pred ccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccc---------
Confidence 322 22345689999999999987665588999999999999999999999876544332222211000
Q ss_pred CCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCC
Q 012233 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRD 428 (468)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~ 428 (468)
..+ .+..+++++.+||.+||+.||.+|||+.|+++||||+....
T Consensus 227 -------~~~----------~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~ 270 (323)
T 3tki_A 227 -------YLN----------PWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLK 270 (323)
T ss_dssp -------TST----------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred -------cCC----------ccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhccccc
Confidence 000 12347899999999999999999999999999999987544
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-48 Score=389.16 Aligned_cols=257 Identities=29% Similarity=0.452 Sum_probs=213.8
Q ss_pred ccceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc----cchHHHHHHHHHHcCCCCcccccceeeecCCCCceEEE
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~----~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 211 (468)
.+.|.+.+.||+|+||.||+|.+..+|+.||+|++... .....+|+.+|+.++||||++++++| .+...++
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~~~~ 124 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF-----EDKYEMV 124 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEE-----ECSSEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEE-----EeCCEEE
Confidence 35699999999999999999999999999999998653 23456899999999999999999998 4445689
Q ss_pred EEeecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCC-CCcEEEeeecCccc
Q 012233 212 LVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPH-THQLKICDFGSAKM 289 (468)
Q Consensus 212 lv~e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~-~~~vkL~DFG~a~~ 289 (468)
+||||+.++ +.+.+. .....+++..++.++.||+.||.|||+ +||+||||||+|||++.+ ...+||+|||+++.
T Consensus 125 lv~E~~~gg~L~~~l~---~~~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~ 200 (387)
T 1kob_A 125 LILEFLSGGELFDRIA---AEDYKMSEAEVINYMRQACEGLKHMHE-HSIVHLDIKPENIMCETKKASSVKIIDFGLATK 200 (387)
T ss_dssp EEEECCCCCBHHHHTT---CTTCCBCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred EEEEcCCCCcHHHHHH---hhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccchHHeEEecCCCCceEEEeccccee
Confidence 999999865 433322 223468999999999999999999998 899999999999999743 23699999999988
Q ss_pred cCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 012233 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (468)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 369 (468)
..........+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+...
T Consensus 201 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~-------------- 265 (387)
T 1kob_A 201 LNPDEIVKVTTATAEFAAPEIVDRE-PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC-------------- 265 (387)
T ss_dssp CCTTSCEEEECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHC--------------
T ss_pred cCCCcceeeeccCCCccCchhccCC-CCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhC--------------
Confidence 7665555567899999999999765 4899999999999999999999999988877766665541
Q ss_pred CCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q 012233 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (468)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~ 427 (468)
.+.++ ...+..+++++++||.+||+.||.+|||+.|+|+||||+...
T Consensus 266 ---~~~~~--------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 312 (387)
T 1kob_A 266 ---DWEFD--------EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 312 (387)
T ss_dssp ---CCCCC--------SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred ---CCCCC--------ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence 11111 112345899999999999999999999999999999998743
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-49 Score=391.95 Aligned_cols=258 Identities=27% Similarity=0.417 Sum_probs=195.5
Q ss_pred ccceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc---chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEE
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~---~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~l 212 (468)
..+|.+.+.||+|+||.||+|++..+++.||||++.... ....+|+.+++.++||||+++++++. +...+|+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~~~~l 93 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVIL-----TPTHLAI 93 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSSEEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEe-----eCCEEEE
Confidence 346999999999999999999999999999999986543 34568999999999999999999984 4446899
Q ss_pred Eeecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCC-cEEEeeecCcccc
Q 012233 213 VLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTH-QLKICDFGSAKML 290 (468)
Q Consensus 213 v~e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~-~vkL~DFG~a~~~ 290 (468)
||||+.++ +...+.. ...+++..++.++.||+.||.|||+ +||+||||||+||||+.++. .+||+|||+++..
T Consensus 94 v~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~-~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~ 168 (361)
T 3uc3_A 94 IMEYASGGELYERICN----AGRFSEDEARFFFQQLLSGVSYCHS-MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS 168 (361)
T ss_dssp EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCSCCCCGGGEEECSSSSCCEEECCCCCC---
T ss_pred EEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEcCCCCceEEEeecCccccc
Confidence 99999764 4444332 3568999999999999999999998 89999999999999986652 4999999999765
Q ss_pred CCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCC
Q 012233 291 VPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPN 370 (468)
Q Consensus 291 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 370 (468)
.........+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+......+..++.....
T Consensus 169 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~------------ 236 (361)
T 3uc3_A 169 VLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILS------------ 236 (361)
T ss_dssp ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHT------------
T ss_pred cccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhc------------
Confidence 44445556789999999999987663445599999999999999999999876544333333322111
Q ss_pred CccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q 012233 371 YTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426 (468)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 426 (468)
....++ ....+++++++||.+||+.||.+|||+.|+++||||...
T Consensus 237 -~~~~~~----------~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 237 -VKYSIP----------DDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp -TCCCCC----------TTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred -CCCCCC----------CcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence 011111 112478999999999999999999999999999999653
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-48 Score=382.02 Aligned_cols=282 Identities=30% Similarity=0.542 Sum_probs=219.6
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc-cchHHHHHHHHHHcC-CCCcccccceeeecCCCCceEEEEEe
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-KRYKNRELQIMRLLN-HPNVVSLKHCFFSTTEKDELYLNLVL 214 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~-~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~~~~~~lv~ 214 (468)
++|++.+.||+|+||.||+|.+..+++.||||++... .....+|+.+++.++ ||||+++++++... ...+.++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~---~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDP---VSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECT---TTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeeccC---CCCceEEEE
Confidence 4699999999999999999999999999999998643 345678999999997 99999999988542 234588999
Q ss_pred ecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCCCC
Q 012233 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGE 294 (468)
Q Consensus 215 e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~~~ 294 (468)
||+.++.+.... ..+++..++.++.||+.||.|||+ +||+||||||+||||+.++..+||+|||+++......
T Consensus 113 e~~~~~~l~~~~------~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~ 185 (330)
T 3nsz_A 113 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHS-MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 185 (330)
T ss_dssp ECCCCCCHHHHG------GGCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred eccCchhHHHHH------HhCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC
Confidence 999976554322 238889999999999999999998 8999999999999999776579999999998776666
Q ss_pred CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCC-CCcHHHHHHHHHHhCCCCHHHHhh-cCCCCc
Q 012233 295 PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPG-ESGVDQLVEIIKILGTPTREEIKC-MNPNYT 372 (468)
Q Consensus 295 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~-~~~~~~ 372 (468)
......|++.|+|||++.+...++.++|||||||++|+|++|..||.. ....+.+..+...++.+....... ......
T Consensus 186 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 265 (330)
T 3nsz_A 186 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 265 (330)
T ss_dssp CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCC
T ss_pred ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccc
Confidence 666778999999999997756699999999999999999999999954 455566666666655433221111 000000
Q ss_pred c---CCCCcccCCCcccc----cccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCC
Q 012233 373 E---FKFPQIKAHPWHKI----FHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRD 428 (468)
Q Consensus 373 ~---~~~~~~~~~~~~~~----~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~ 428 (468)
. ..........|... ....+++++.+||.+||+.||.+|||+.|+|+||||+++.+
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~ 328 (330)
T 3nsz_A 266 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK 328 (330)
T ss_dssp THHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC-
T ss_pred cchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhcc
Confidence 0 00000011112111 22347999999999999999999999999999999998764
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-48 Score=371.84 Aligned_cols=269 Identities=26% Similarity=0.400 Sum_probs=220.5
Q ss_pred ccceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc------chHHHHHHHHHHcCCCCcccccceeeecCCCCceE
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 209 (468)
.++|.+.+.||+|+||.||+|.+..+|+.||+|++.... ....+|+.+++.++||||+++++++ .+...
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~ 79 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEESF 79 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSSE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEE-----EcCCE
Confidence 346999999999999999999999999999999986543 2345799999999999999999998 44456
Q ss_pred EEEEeecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCC--cEEEeeecC
Q 012233 210 LNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTH--QLKICDFGS 286 (468)
Q Consensus 210 ~~lv~e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~--~vkL~DFG~ 286 (468)
.++||||+.++ +...+.. ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++. .+||+|||+
T Consensus 80 ~~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~ 154 (284)
T 3kk8_A 80 HYLVFDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHS-NGIVHRNLKPENLLLASKAKGAAVKLADFGL 154 (284)
T ss_dssp EEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcCcCCCCHHHEEEecCCCCCcEEEeecee
Confidence 88999999865 4443332 3568999999999999999999998 89999999999999976542 499999999
Q ss_pred ccccCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 012233 287 AKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKC 366 (468)
Q Consensus 287 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 366 (468)
+.............||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+....+.....
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~--------- 224 (284)
T 3kk8_A 155 AIEVNDSEAWHGFAGTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY--------- 224 (284)
T ss_dssp CEECCSSCBCCCSCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC---------
T ss_pred eEEcccCccccCCCCCcCCcCchhhcCCC-CCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccc---------
Confidence 98776555555678999999999997654 89999999999999999999999998877766666554211
Q ss_pred cCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCCCCCCCCCCCCC
Q 012233 367 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNTCLPNGRPLP 440 (468)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~~~~~~~~~~ 440 (468)
.++. ..+..+++++.+||.+||+.||.+|||+.|+++||||++...........+.+.
T Consensus 225 --------~~~~--------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~~~~~~~~~~~ 282 (284)
T 3kk8_A 225 --------DYPS--------PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTVD 282 (284)
T ss_dssp --------CCCT--------TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCCGGGSCCCCCCCC
T ss_pred --------cCCc--------hhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCChhHHhHhhcCCCcc
Confidence 1111 012457899999999999999999999999999999998777666655544443
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-48 Score=383.56 Aligned_cols=276 Identities=27% Similarity=0.457 Sum_probs=219.9
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc---chHHHHHHHHHHcC-----CCCcccccceeeecCCCCce
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLLN-----HPNVVSLKHCFFSTTEKDEL 208 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~---~~~~~E~~il~~l~-----hpnIv~l~~~~~~~~~~~~~ 208 (468)
.+|.+.+.||+|+||.||+|.+..+++.||||++.... .....|+.+++.+. ||||+++++++... .
T Consensus 35 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~-----~ 109 (360)
T 3llt_A 35 NAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYY-----D 109 (360)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEET-----T
T ss_pred CEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeEC-----C
Confidence 36999999999999999999999999999999986533 33456999999997 99999999998543 3
Q ss_pred EEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecC--------------
Q 012233 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNP-------------- 274 (468)
Q Consensus 209 ~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~-------------- 274 (468)
.+|+||||+++++.+.+.... ...+++..++.++.||+.||.|||+ +||+||||||+||||+.
T Consensus 110 ~~~lv~e~~~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~ 186 (360)
T 3llt_A 110 HMCLIFEPLGPSLYEIITRNN--YNGFHIEDIKLYCIEILKALNYLRK-MSLTHTDLKPENILLDDPYFEKSLITVRRVT 186 (360)
T ss_dssp EEEEEECCCCCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESCTTCCEEEEEEECTT
T ss_pred eeEEEEcCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCcccEEEccccccccccchhccc
Confidence 589999999888877665422 3458999999999999999999998 89999999999999975
Q ss_pred -----------CCCcEEEeeecCccccCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 012233 275 -----------HTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGE 343 (468)
Q Consensus 275 -----------~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~ 343 (468)
++ .+||+|||++..... ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.
T Consensus 187 ~~~~~~~~~~~~~-~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~ 262 (360)
T 3llt_A 187 DGKKIQIYRTKST-GIKLIDFGCATFKSD--YHGSIINTRQYRAPEVILNLG-WDVSSDMWSFGCVLAELYTGSLLFRTH 262 (360)
T ss_dssp TCCEEEEEEESCC-CEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccccCCC-CEEEEeccCceecCC--CCcCccCcccccCcHHHcCCC-CCCccchHHHHHHHHHHHHCCCCCCCC
Confidence 44 799999999986433 334678999999999997654 999999999999999999999999999
Q ss_pred CcHHHHHHHHHHhCCCCHHHHhhcCCCCc---------cCCCCcccCC--------CcccccccCCCHHHHHHHHHhccc
Q 012233 344 SGVDQLVEIIKILGTPTREEIKCMNPNYT---------EFKFPQIKAH--------PWHKIFHKRMPPEALDLVSRLLQY 406 (468)
Q Consensus 344 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~--------~~~~~~~~~~~~~l~~li~~~L~~ 406 (468)
+..+.+..+....+.++...+........ ...+|..... .....+....++.+.+||.+||+.
T Consensus 263 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 342 (360)
T 3llt_A 263 EHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQI 342 (360)
T ss_dssp SHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCS
T ss_pred cHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcC
Confidence 98888888888887777665443221110 0011100000 000112223457889999999999
Q ss_pred CCCCCCCHHHHhCCCCCC
Q 012233 407 SPSLRCTALEACAHPFFD 424 (468)
Q Consensus 407 dP~~R~s~~ell~hp~f~ 424 (468)
||.+|||+.|+|+||||+
T Consensus 343 dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 343 DPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp SGGGSCCHHHHTTSGGGC
T ss_pred ChhhCCCHHHHhcCcccC
Confidence 999999999999999996
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-48 Score=391.16 Aligned_cols=301 Identities=21% Similarity=0.335 Sum_probs=213.0
Q ss_pred ccceEEeceeccc--CceEEEEEEEcCCCCEEEEEEeeccc------chHHHHHHHHHHcCCCCcccccceeeecCCCCc
Q 012233 136 TISYMAERVVGTG--SFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (468)
Q Consensus 136 ~~~y~~~~~lG~G--~fg~Vy~~~~~~~g~~vaiK~~~~~~------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 207 (468)
..+|++.+.||+| +||.||+|.+..+|+.||||++.... ....+|+.+++.++|||||+++++|.. .
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~ 98 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIA-----D 98 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----T
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEE-----C
Confidence 3469999999999 99999999999999999999986542 334579999999999999999999843 3
Q ss_pred eEEEEEeecccchHH-HHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecC
Q 012233 208 LYLNLVLEYISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (468)
Q Consensus 208 ~~~~lv~e~~~~~ll-~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~ 286 (468)
..+|+|||||.++.+ +++.. .....+++..++.++.||+.||.|||+ +||+||||||+||||+.++ .+||+|||.
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivHrDlkp~NIll~~~~-~~kl~dfg~ 174 (389)
T 3gni_B 99 NELWVVTSFMAYGSAKDLICT--HFMDGMNELAIAYILQGVLKALDYIHH-MGYVHRSVKASHILISVDG-KVYLSGLRS 174 (389)
T ss_dssp TEEEEEEECCTTCBHHHHHHH--TCTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTC-CEEECCGGG
T ss_pred CEEEEEEEccCCCCHHHHHhh--hcccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCC-CEEEccccc
Confidence 458999999986544 43332 123568999999999999999999998 8999999999999999888 799999998
Q ss_pred ccccCCC--------CCCccccccCCccccccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Q 012233 287 AKMLVPG--------EPNISYICSRYYRAPELIFGA-TEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILG 357 (468)
Q Consensus 287 a~~~~~~--------~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~ 357 (468)
+...... ......+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..+.....
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 254 (389)
T 3gni_B 175 NLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTV 254 (389)
T ss_dssp CEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----
T ss_pred ceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCC
Confidence 7644211 112235789999999999763 4589999999999999999999999998776666555433211
Q ss_pred CCCHH-------HHhh------cCCCCcc-----CCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 358 TPTRE-------EIKC------MNPNYTE-----FKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 358 ~~~~~-------~~~~------~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
..... .... ....... ...+. ........++..+++++.+||.+||+.||.+|||+.|+|+
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~ 333 (389)
T 3gni_B 255 PCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPS-NGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN 333 (389)
T ss_dssp ----------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CccccccccccccccccccccccccccccccccCccccc-cCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 00000 0000 0000000 00000 0001112245668999999999999999999999999999
Q ss_pred CCCCCCCCCCCCC--CCCCCCCCcccccC
Q 012233 420 HPFFDDLRDPNTC--LPNGRPLPTLFNFT 446 (468)
Q Consensus 420 hp~f~~~~~~~~~--~~~~~~~~~~~~~~ 446 (468)
||||+++...... .+..++.+++.+|.
T Consensus 334 hp~f~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (389)
T 3gni_B 334 HSFFKQIKRRASEALPELLRPVTPITNFE 362 (389)
T ss_dssp SGGGGGC---CCSSHHHHTTTCCCCC---
T ss_pred CHHHHHHhhcchhhhhhhhcCCCcccccc
Confidence 9999998764332 23344556666665
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=370.47 Aligned_cols=256 Identities=27% Similarity=0.442 Sum_probs=206.1
Q ss_pred cccceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-----chHHHHHHHHHHcCCCCcccccceeeecCCCCceE
Q 012233 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (468)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 209 (468)
..+.|.+.+.||+|+||.||+|.+..++..||+|++.... ....+|+.+++.++||||+++++++ .+...
T Consensus 20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~ 94 (285)
T 3is5_A 20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF-----EDYHN 94 (285)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSSE
T ss_pred hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHhe-----ecCCe
Confidence 3457999999999999999999999999999999986543 3456899999999999999999998 44456
Q ss_pred EEEEeecccc-hHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecC---CCCcEEEeeec
Q 012233 210 LNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNP---HTHQLKICDFG 285 (468)
Q Consensus 210 ~~lv~e~~~~-~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~---~~~~vkL~DFG 285 (468)
.++||||+.+ .+.+.+.........+++..++.++.||+.||.|||+ +||+||||||+|||++. ++ .+||+|||
T Consensus 95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~dikp~NIl~~~~~~~~-~~kl~Dfg 172 (285)
T 3is5_A 95 MYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS-QHVVHKDLKPENILFQDTSPHS-PIKIIDFG 172 (285)
T ss_dssp EEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEESSSSTTC-CEEECCCC
T ss_pred EEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh-CCEEECCCCHHHEEEecCCCCC-CEEEEeee
Confidence 8999999986 5666665554556779999999999999999999998 89999999999999943 34 69999999
Q ss_pred CccccCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 012233 286 SAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIK 365 (468)
Q Consensus 286 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 365 (468)
++.............||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+..+....+... .
T Consensus 173 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~--~------- 241 (285)
T 3is5_A 173 LAELFKSDEHSTNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYK--E------- 241 (285)
T ss_dssp CCCC----------CTTGGGCCHHHHTT--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--C-------
T ss_pred cceecCCcccCcCcccccCcCChHHhcc--CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccC--C-------
Confidence 9987665555567789999999999853 4899999999999999999999999987766554443321 0
Q ss_pred hcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q 012233 366 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDD 425 (468)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~ 425 (468)
+. ++ .....+++++.+||.+||+.||.+|||+.|+|+||||++
T Consensus 242 ---~~-----~~---------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 242 ---PN-----YA---------VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp ---CC-----CC---------C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred ---cc-----cc---------cccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 00 00 011337899999999999999999999999999999986
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-48 Score=379.87 Aligned_cols=253 Identities=29% Similarity=0.479 Sum_probs=204.5
Q ss_pred CcccceEEeceecccCceEEEEEEEc---CCCCEEEEEEeeccc--------chHHHHHHHHHHcCCCCcccccceeeec
Q 012233 134 KQTISYMAERVVGTGSFGVVFQAKCL---ETGDSVAIKKVLQDK--------RYKNRELQIMRLLNHPNVVSLKHCFFST 202 (468)
Q Consensus 134 ~~~~~y~~~~~lG~G~fg~Vy~~~~~---~~g~~vaiK~~~~~~--------~~~~~E~~il~~l~hpnIv~l~~~~~~~ 202 (468)
....+|.+.+.||+|+||.||+|++. .+|+.||+|++.+.. ....+|+.+|+.++||||+++++++.
T Consensus 14 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-- 91 (327)
T 3a62_A 14 IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQ-- 91 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEE--
T ss_pred CCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEE--
Confidence 34457999999999999999999985 689999999986432 23457999999999999999999884
Q ss_pred CCCCceEEEEEeecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEE
Q 012233 203 TEKDELYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKI 281 (468)
Q Consensus 203 ~~~~~~~~~lv~e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL 281 (468)
....+|+||||+.++ +...+.. ...+++..++.++.||+.||.|||+ +||+||||||+||||+.++ .+||
T Consensus 92 ---~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~Dlkp~Nill~~~~-~~kl 162 (327)
T 3a62_A 92 ---TGGKLYLILEYLSGGELFMQLER----EGIFMEDTACFYLAEISMALGHLHQ-KGIIYRDLKPENIMLNHQG-HVKL 162 (327)
T ss_dssp ---CSSCEEEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCTTTEEECTTS-CEEE
T ss_pred ---cCCEEEEEEeCCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHh-CCEEcccCCHHHeEECCCC-cEEE
Confidence 344589999999864 4443332 3568899999999999999999998 8999999999999999888 7999
Q ss_pred eeecCccccCCC-CCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Q 012233 282 CDFGSAKMLVPG-EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPT 360 (468)
Q Consensus 282 ~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~ 360 (468)
+|||+++..... ......+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..+...
T Consensus 163 ~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~----- 236 (327)
T 3a62_A 163 TDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSG-HNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKC----- 236 (327)
T ss_dssp CCCSCC----------CTTSSCCTTSCHHHHTTSC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT-----
T ss_pred EeCCcccccccCCccccccCCCcCccCHhhCcCCC-CCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC-----
Confidence 999998754322 2344568999999999997654 899999999999999999999999988877777666552
Q ss_pred HHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCC-----CHHHHhCCCCCCCCC
Q 012233 361 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC-----TALEACAHPFFDDLR 427 (468)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~-----s~~ell~hp~f~~~~ 427 (468)
... ++..+++++.+||.+||+.||.+|| ++.++++||||+.+.
T Consensus 237 ------------~~~------------~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~ 284 (327)
T 3a62_A 237 ------------KLN------------LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHIN 284 (327)
T ss_dssp ------------CCC------------CCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCC
T ss_pred ------------CCC------------CCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCC
Confidence 111 2345789999999999999999999 889999999999864
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-48 Score=387.32 Aligned_cols=252 Identities=26% Similarity=0.439 Sum_probs=207.0
Q ss_pred cccceEEeceecccCceEEEEEEEcCCCCEEEEEEeecccc-------hHHHHHHH-HHHcCCCCcccccceeeecCCCC
Q 012233 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR-------YKNRELQI-MRLLNHPNVVSLKHCFFSTTEKD 206 (468)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~~-------~~~~E~~i-l~~l~hpnIv~l~~~~~~~~~~~ 206 (468)
...+|.+.+.||+|+||.||+|+++.+++.||||++.+... ...+|..+ ++.++||||++++++| .+
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~-----~~ 110 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF-----QT 110 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEE-----EC
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEE-----Ee
Confidence 34579999999999999999999999999999999865432 12235554 5678899999999988 44
Q ss_pred ceEEEEEeecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeec
Q 012233 207 ELYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG 285 (468)
Q Consensus 207 ~~~~~lv~e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG 285 (468)
...+|+||||+.++ +...+.. ...+++..++.++.||+.||.|||+ +||+||||||+||||+.++ .+||+|||
T Consensus 111 ~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NIll~~~g-~ikL~DFG 184 (373)
T 2r5t_A 111 ADKLYFVLDYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHS-LNIVYRDLKPENILLDSQG-HIVLTDFG 184 (373)
T ss_dssp SSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTS-CEEECCCC
T ss_pred CCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCHHHEEECCCC-CEEEeeCc
Confidence 55699999999875 4443322 3568999999999999999999998 8999999999999999988 79999999
Q ss_pred Ccccc-CCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 012233 286 SAKML-VPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEI 364 (468)
Q Consensus 286 ~a~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 364 (468)
+++.. .........+||+.|+|||++.+. .++.++|||||||++|||++|..||.+.+..+.+..|...
T Consensus 185 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~--------- 254 (373)
T 2r5t_A 185 LCKENIEHNSTTSTFCGTPEYLAPEVLHKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK--------- 254 (373)
T ss_dssp BCGGGBCCCCCCCSBSCCCCCCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHS---------
T ss_pred cccccccCCCccccccCCccccCHHHhCCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc---------
Confidence 99864 233345577899999999999765 4899999999999999999999999988877777776651
Q ss_pred hhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCH----HHHhCCCCCCCCC
Q 012233 365 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTA----LEACAHPFFDDLR 427 (468)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~----~ell~hp~f~~~~ 427 (468)
... ++..+++++++||.+||+.||.+|+++ .+++.||||+.+.
T Consensus 255 --------~~~------------~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~ 301 (373)
T 2r5t_A 255 --------PLQ------------LKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLIN 301 (373)
T ss_dssp --------CCC------------CCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCC
T ss_pred --------ccC------------CCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCC
Confidence 111 334689999999999999999999986 6999999999864
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-48 Score=396.20 Aligned_cols=255 Identities=27% Similarity=0.410 Sum_probs=206.3
Q ss_pred CcccceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-------chHHHHHHHHHHcCCCCcccccceeeecCCCC
Q 012233 134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD 206 (468)
Q Consensus 134 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 206 (468)
....+|.+.+.||+|+||.||+|.+..+|+.||||++.... ....+|+.+++.++||||++++++|..
T Consensus 145 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~----- 219 (446)
T 4ejn_A 145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT----- 219 (446)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEE-----
T ss_pred CChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEee-----
Confidence 34567999999999999999999999999999999986431 233468889999999999999999843
Q ss_pred ceEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecC
Q 012233 207 ELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (468)
Q Consensus 207 ~~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~ 286 (468)
...+||||||+.++.+..... ....+++..++.++.||+.||.|||+.+||+||||||+||||+.++ .+||+|||+
T Consensus 220 ~~~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~-~~kl~DFG~ 295 (446)
T 4ejn_A 220 HDRLCFVMEYANGGELFFHLS---RERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG-HIKITDFGL 295 (446)
T ss_dssp TTEEEEEECCCSSCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSS-CEEECCCCC
T ss_pred CCEEEEEEeeCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCC-CEEEccCCC
Confidence 345899999998754432221 2356899999999999999999999437999999999999999888 799999999
Q ss_pred ccccCC-CCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 012233 287 AKMLVP-GEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIK 365 (468)
Q Consensus 287 a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 365 (468)
++.... .......+||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+.+..+....+..
T Consensus 296 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~----------- 363 (446)
T 4ejn_A 296 CKEGIKDGATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM----------- 363 (446)
T ss_dssp CCTTCC-----CCSSSCGGGCCHHHHHTSC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-----------
T ss_pred ceeccCCCcccccccCCccccCHhhcCCCC-CCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHh-----------
Confidence 976432 33445678999999999997654 89999999999999999999999998887766666554
Q ss_pred hcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCC-----CHHHHhCCCCCCCCC
Q 012233 366 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC-----TALEACAHPFFDDLR 427 (468)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~-----s~~ell~hp~f~~~~ 427 (468)
.... ++..+++++.+||.+||++||.+|| ++.|+++||||+++.
T Consensus 364 ------~~~~------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~ 412 (446)
T 4ejn_A 364 ------EEIR------------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIV 412 (446)
T ss_dssp ------CCCC------------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred ------CCCC------------CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCC
Confidence 1111 3345899999999999999999999 999999999999874
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-48 Score=398.52 Aligned_cols=252 Identities=29% Similarity=0.431 Sum_probs=214.6
Q ss_pred cccceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-------chHHHHHHHHHHcCCCCcccccceeeecCCCCc
Q 012233 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (468)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 207 (468)
..++|.+.+.||+|+||.||+|.+..+|+.||||++.... ....+|+.+++.++||||+++++++. ..
T Consensus 14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~-----~~ 88 (476)
T 2y94_A 14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIS-----TP 88 (476)
T ss_dssp EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CS
T ss_pred eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----EC
Confidence 4457999999999999999999999999999999985432 24568999999999999999999983 34
Q ss_pred eEEEEEeecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecC
Q 012233 208 LYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (468)
Q Consensus 208 ~~~~lv~e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~ 286 (468)
..+|+||||+.++ +.+.+ .....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus 89 ~~~~lv~E~~~gg~L~~~l----~~~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDLkp~NIll~~~~-~vkL~DFG~ 162 (476)
T 2y94_A 89 SDIFMVMEYVSGGELFDYI----CKNGRLDEKESRRLFQQILSGVDYCHR-HMVVHRDLKPENVLLDAHM-NAKIADFGL 162 (476)
T ss_dssp SEEEEEEECCSSEEHHHHT----TSSSSCCHHHHHHHHHHHHHHHHHHHT-TTEECSCCSGGGEEECTTC-CEEECCCSS
T ss_pred CEEEEEEeCCCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCCcccccHHHEEEecCC-CeEEEeccc
Confidence 4689999999764 44433 235679999999999999999999998 8999999999999999888 799999999
Q ss_pred ccccCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 012233 287 AKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKC 366 (468)
Q Consensus 287 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 366 (468)
+............+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+....+.++....
T Consensus 163 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~---------- 232 (476)
T 2y94_A 163 SNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGI---------- 232 (476)
T ss_dssp CEECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTC----------
T ss_pred hhhccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC----------
Confidence 9887666666678999999999999876645789999999999999999999999887776666654411
Q ss_pred cCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q 012233 367 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426 (468)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 426 (468)
+. .+..+++++.+||.+||+.||.+|||+.++++||||+.-
T Consensus 233 -------~~------------~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 233 -------FY------------TPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp -------CC------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred -------cC------------CCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 11 223478999999999999999999999999999999863
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=375.87 Aligned_cols=256 Identities=25% Similarity=0.378 Sum_probs=214.4
Q ss_pred ccceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc----------chHHHHHHHHHHcCCCCcccccceeeecCCC
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK----------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEK 205 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~----------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 205 (468)
.+.|.+.+.||+|+||.||+|.+..+|+.||+|++.... ..+.+|+.+++.++||||+++++++ .
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~ 85 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVY-----E 85 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----E
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEE-----e
Confidence 346999999999999999999999999999999985432 3356899999999999999999998 4
Q ss_pred CceEEEEEeecccc-hHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCC---cEEE
Q 012233 206 DELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTH---QLKI 281 (468)
Q Consensus 206 ~~~~~~lv~e~~~~-~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~---~vkL 281 (468)
+...+++||||+.+ ++.+.+. ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++. .+||
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~lH~-~~ivH~dikp~NIl~~~~~~~~~~~kl 160 (321)
T 2a2a_A 86 NRTDVVLILELVSGGELFDFLA----QKESLSEEEATSFIKQILDGVNYLHT-KKIAHFDLKPENIMLLDKNIPIPHIKL 160 (321)
T ss_dssp CSSEEEEEECCCCSCBHHHHHH----TCSCEEHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESCTTSSSCCEEE
T ss_pred cCCEEEEEEEcCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCChHHEEEecCCCCcCCEEE
Confidence 44568999999976 4444433 24568999999999999999999998 89999999999999987763 5999
Q ss_pred eeecCccccCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 012233 282 CDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTR 361 (468)
Q Consensus 282 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~ 361 (468)
+|||++.............||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+.......
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~-- 237 (321)
T 2a2a_A 161 IDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDF-- 237 (321)
T ss_dssp CCCTTCEECCTTCCCCCCCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCC--
T ss_pred ccCccceecCccccccccCCCCCccCcccccCC-CCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhccccc--
Confidence 999999877665555667899999999999655 48999999999999999999999999887776666654421111
Q ss_pred HHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q 012233 362 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (468)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~ 427 (468)
...++..+++.+.+||.+||+.||.+|||+.|+++||||+.+.
T Consensus 238 -----------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~ 280 (321)
T 2a2a_A 238 -----------------------DEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD 280 (321)
T ss_dssp -----------------------CHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSS
T ss_pred -----------------------ChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCC
Confidence 1123356889999999999999999999999999999998764
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-47 Score=377.83 Aligned_cols=285 Identities=34% Similarity=0.619 Sum_probs=224.9
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc------chHHHHHHHHHHcCCCCcccccceeeecCCC-CceE
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEK-DELY 209 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~-~~~~ 209 (468)
.+|.+.+.||+|+||.||+|.+..+|+.||||++.... ....+|+.+++.++||||+++++++...... ....
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 35999999999999999999999999999999985432 2345799999999999999999988543321 1123
Q ss_pred EEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccc
Q 012233 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (468)
Q Consensus 210 ~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~ 289 (468)
+|+||||+.+++...+ ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++..
T Consensus 104 ~~lv~e~~~~~l~~~~------~~~~~~~~~~~i~~qi~~al~~LH~-~~ivH~dlkp~NIl~~~~~-~~kl~Dfg~~~~ 175 (353)
T 3coi_A 104 FYLVMPFMQTDLQKIM------GLKFSEEKIQYLVYQMLKGLKYIHS-AGVVHRDLKPGNLAVNEDC-ELKILDFGLARH 175 (353)
T ss_dssp CEEEEECCSEEGGGTT------TSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCCGGGEEECTTC-CEEECSTTCTTC
T ss_pred EEEEeccccCCHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEeECCCC-cEEEeecccccC
Confidence 5899999998654422 3458999999999999999999998 8999999999999999888 799999999976
Q ss_pred cCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 012233 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (468)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 369 (468)
... ......||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+....+.+....+..+..
T Consensus 176 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 253 (353)
T 3coi_A 176 ADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND 253 (353)
T ss_dssp ----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSC
T ss_pred CCC--CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhh
Confidence 432 234568899999999997756689999999999999999999999999999999999999988887765544321
Q ss_pred CCcc---CCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCCCCC
Q 012233 370 NYTE---FKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNTC 432 (468)
Q Consensus 370 ~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~~ 432 (468)
.... ..++......+ ..+...+++++.+||.+||+.||.+|||+.++|+||||+.+..+...
T Consensus 254 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~~~~ 318 (353)
T 3coi_A 254 KAAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEE 318 (353)
T ss_dssp HHHHHHHHTSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGC
T ss_pred HHHHHHHHhCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccCcccc
Confidence 1100 00111111111 11335689999999999999999999999999999999998776544
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=380.17 Aligned_cols=257 Identities=29% Similarity=0.422 Sum_probs=195.1
Q ss_pred ccceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc--cchHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEEE
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD--KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV 213 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~--~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv 213 (468)
.+.|.+.+.||+|+||.||+|.+..+++.||||++... .....+|+.+++.++||||+++++++. +...+++|
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~~~~lv 126 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFE-----TPTEISLV 126 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCCTTBCCEEEEEE-----CSSEEEEE
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeEe-----cCCeEEEE
Confidence 34699999999999999999999999999999998654 334567999999999999999999983 44468999
Q ss_pred eecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecC---CCCcEEEeeecCccc
Q 012233 214 LEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNP---HTHQLKICDFGSAKM 289 (468)
Q Consensus 214 ~e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~---~~~~vkL~DFG~a~~ 289 (468)
|||+.++ +.+.+. ....+++..++.++.||+.||.|||+ .||+||||||+|||++. ++ .+||+|||+++.
T Consensus 127 ~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dikp~NIll~~~~~~~-~~kl~Dfg~a~~ 200 (349)
T 2w4o_A 127 LELVTGGELFDRIV----EKGYYSERDAADAVKQILEAVAYLHE-NGIVHRDLKPENLLYATPAPDA-PLKIADFGLSKI 200 (349)
T ss_dssp ECCCCSCBHHHHHT----TCSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEESSSSTTC-CEEECCCC----
T ss_pred EEeCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCcccEEEecCCCCC-CEEEccCccccc
Confidence 9999864 444332 24568999999999999999999998 89999999999999975 55 799999999987
Q ss_pred cCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 012233 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (468)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 369 (468)
..........+||+.|+|||++.+.. ++.++|||||||++|+|++|..||......+.+...+...
T Consensus 201 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~------------- 266 (349)
T 2w4o_A 201 VEHQVLMKTVCGTPGYCAPEILRGCA-YGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNC------------- 266 (349)
T ss_dssp ------------CGGGSCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTT-------------
T ss_pred cCcccccccccCCCCccCHHHhcCCC-CCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhC-------------
Confidence 65544455678999999999997654 8999999999999999999999998877665433322210
Q ss_pred CCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCC
Q 012233 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRD 428 (468)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~ 428 (468)
...++ ..++..++.++.+||.+||+.||.+|||+.|+|+||||.....
T Consensus 267 ---~~~~~--------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 314 (349)
T 2w4o_A 267 ---EYYFI--------SPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAA 314 (349)
T ss_dssp ---CCCCC--------TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTTC
T ss_pred ---CCccC--------CchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCcc
Confidence 00000 1123468999999999999999999999999999999987543
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-48 Score=404.36 Aligned_cols=256 Identities=29% Similarity=0.447 Sum_probs=211.7
Q ss_pred CcccceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc-------cchHHHHHHHHHHcCCCCcccccceeeecCCCC
Q 012233 134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD 206 (468)
Q Consensus 134 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~-------~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 206 (468)
....+|.+.+.||+|+||.||+|.+..+|+.||||++.+. .....+|+.+|+.++|||||+++++| .+
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~-----~~ 255 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY-----ET 255 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE-----EC
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEE-----ee
Confidence 4455799999999999999999999999999999998543 22345799999999999999999988 44
Q ss_pred ceEEEEEeecccchHH-HHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeec
Q 012233 207 ELYLNLVLEYISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG 285 (468)
Q Consensus 207 ~~~~~lv~e~~~~~ll-~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG 285 (468)
...+|+||||+.|+.+ ..+.. .....+++..++.++.||+.||.|||+ +||+||||||+||||+.++ .+||+|||
T Consensus 256 ~~~l~lVmEy~~gg~L~~~l~~--~~~~~l~e~~~~~i~~qIl~aL~yLH~-~gIvHrDLKPeNILld~~g-~vKL~DFG 331 (576)
T 2acx_A 256 KDALCLVLTLMNGGDLKFHIYH--MGQAGFPEARAVFYAAEICCGLEDLHR-ERIVYRDLKPENILLDDHG-HIRISDLG 331 (576)
T ss_dssp SSEEEEEECCCCSCBHHHHHHS--SSSCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTS-CEEECCCT
T ss_pred CCEEEEEEEcCCCCcHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeccCCchheEEEeCCC-CeEEEecc
Confidence 4569999999986544 33322 123458999999999999999999998 8999999999999999888 79999999
Q ss_pred CccccCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCc---HHHHHHHHHHhCCCCHH
Q 012233 286 SAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESG---VDQLVEIIKILGTPTRE 362 (468)
Q Consensus 286 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~---~~~~~~i~~~~~~~~~~ 362 (468)
+++...........+||+.|+|||++.+.. ++.++|||||||++|||++|++||.+... ...+...+...
T Consensus 332 la~~~~~~~~~~~~~GT~~Y~APEvl~~~~-~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~------ 404 (576)
T 2acx_A 332 LAVHVPEGQTIKGRVGTVGYMAPEVVKNER-YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV------ 404 (576)
T ss_dssp TCEECCTTCCEECCCSCGGGCCHHHHTTCE-ESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC------
T ss_pred cceecccCccccccCCCccccCHHHHcCCC-CCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc------
Confidence 998876665556679999999999997654 89999999999999999999999987542 23333322210
Q ss_pred HHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCC-----CHHHHhCCCCCCCCC
Q 012233 363 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC-----TALEACAHPFFDDLR 427 (468)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~-----s~~ell~hp~f~~~~ 427 (468)
.. .++..+++++++||.+||+.||.+|| ++.|+++||||+++.
T Consensus 405 ----------~~------------~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~ 452 (576)
T 2acx_A 405 ----------PE------------EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLN 452 (576)
T ss_dssp ----------CC------------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCC
T ss_pred ----------cc------------cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCC
Confidence 01 13356899999999999999999999 899999999999864
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-47 Score=366.16 Aligned_cols=252 Identities=30% Similarity=0.462 Sum_probs=212.7
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc----cchHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEE
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~----~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~l 212 (468)
.+|.+.+.||+|+||.||+|.+..++..||+|++... .....+|+.+++.++||||+++++++ .+....++
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~l 83 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF-----EDNTDIYL 83 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSSEEEE
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEE-----ecCCeEEE
Confidence 4699999999999999999999999999999998543 34456899999999999999999998 44456899
Q ss_pred Eeecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeee---cCCCCcEEEeeecCcc
Q 012233 213 VLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLV---NPHTHQLKICDFGSAK 288 (468)
Q Consensus 213 v~e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl---~~~~~~vkL~DFG~a~ 288 (468)
||||+.++ +.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||+ +.++ .+||+|||++.
T Consensus 84 v~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~~-~~~l~Dfg~~~ 157 (277)
T 3f3z_A 84 VMELCTGGELFERVVH----KRVFRESDAARIMKDVLSAVAYCHK-LNVAHRDLKPENFLFLTDSPDS-PLKLIDFGLAA 157 (277)
T ss_dssp EEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESSSSTTC-CEEECCCTTCE
T ss_pred EEeccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccCCCCCHHHEEEecCCCCC-cEEEEecccce
Confidence 99999864 4443332 3568999999999999999999998 899999999999999 6565 79999999998
Q ss_pred ccCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 012233 289 MLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368 (468)
Q Consensus 289 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 368 (468)
............||+.|+|||++.+. ++.++|||||||++|+|++|+.||...+..+....+.......+..
T Consensus 158 ~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~------ 229 (277)
T 3f3z_A 158 RFKPGKMMRTKVGTPYYVSPQVLEGL--YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEK------ 229 (277)
T ss_dssp ECCTTSCBCCCCSCTTTCCHHHHTTC--BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHH------
T ss_pred eccCccchhccCCCCCccChHHhccc--CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCch------
Confidence 87666666677899999999998643 8999999999999999999999999888777776665532221111
Q ss_pred CCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q 012233 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426 (468)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 426 (468)
.+..+++++.+||.+||+.||.+|||+.++|+||||++.
T Consensus 230 -------------------~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~ 268 (277)
T 3f3z_A 230 -------------------DWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQ 268 (277)
T ss_dssp -------------------HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred -------------------hhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcc
Confidence 123578999999999999999999999999999999763
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=375.41 Aligned_cols=258 Identities=24% Similarity=0.397 Sum_probs=199.3
Q ss_pred ccceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-----chHHHHHHHHHHcCCCCcccccceeeecCC------
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTE------ 204 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~------ 204 (468)
..+|.+.+.||+|+||.||+|.+..+|+.||||++.... ....+|+.+|+.++||||++++++|.....
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 346999999999999999999999999999999986322 345689999999999999999998865432
Q ss_pred ----------------------------------------------CCceEEEEEeecccchHHHHHhhhhhcCCCCCHH
Q 012233 205 ----------------------------------------------KDELYLNLVLEYISETVYRVSKHYTRMNQHVPIL 238 (468)
Q Consensus 205 ----------------------------------------------~~~~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~ 238 (468)
....++++|||||.++.+..............+.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 1233589999999875444333332233445666
Q ss_pred HHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCCCC-------------CCccccccCCc
Q 012233 239 YVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGE-------------PNISYICSRYY 305 (468)
Q Consensus 239 ~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~~~-------------~~~~~~gt~~y 305 (468)
.++.++.||+.||.|||+ +||+||||||+||||+.++ .+||+|||+++...... ......||+.|
T Consensus 165 ~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~-~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 242 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHS-KGLMHRDLKPSNIFFTMDD-VVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242 (332)
T ss_dssp HHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTC-CEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred HHHHHHHHHHHHHHHHHh-CCeeecCCCcccEEEeCCC-CEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence 789999999999999998 8999999999999999888 79999999998765432 22346799999
Q ss_pred cccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccCCCCcccCCCcc
Q 012233 306 RAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWH 385 (468)
Q Consensus 306 ~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (468)
+|||++.+.. ++.++|||||||++|+|++|..|+. +....+....... ++.
T Consensus 243 ~aPE~~~~~~-~~~~~Di~slG~il~el~~~~~~~~-----~~~~~~~~~~~~~----------------~~~------- 293 (332)
T 3qd2_B 243 MSPEQIHGNN-YSHKVDIFSLGLILFELLYSFSTQM-----ERVRIITDVRNLK----------------FPL------- 293 (332)
T ss_dssp SCHHHHHCCC-CCTHHHHHHHHHHHHHHHSCCCCHH-----HHHHHHHHHHTTC----------------CCH-------
T ss_pred cChHHhcCCC-CcchhhHHHHHHHHHHHHHcCCChh-----HHHHHHHHhhccC----------------CCc-------
Confidence 9999997654 8999999999999999999876652 1111111111111 110
Q ss_pred cccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q 012233 386 KIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426 (468)
Q Consensus 386 ~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 426 (468)
.....++++.+||.+||+.||.+|||+.|+++||||+++
T Consensus 294 --~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~~ 332 (332)
T 3qd2_B 294 --LFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFENL 332 (332)
T ss_dssp --HHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCCC
T ss_pred --ccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhcC
Confidence 112356788999999999999999999999999999875
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=374.09 Aligned_cols=247 Identities=27% Similarity=0.355 Sum_probs=197.4
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeecccc------hHHHHHHHHHH-cCCCCcccccceeeecCCCCceE
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR------YKNRELQIMRL-LNHPNVVSLKHCFFSTTEKDELY 209 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~~------~~~~E~~il~~-l~hpnIv~l~~~~~~~~~~~~~~ 209 (468)
.+|.+.+.||+|+||+||+|.+..+|+.||||++..... ....|+..+.. ++||||+++++++. +...
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~-----~~~~ 131 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWE-----EGGI 131 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEE-----eCCE
Confidence 469999999999999999999999999999998754321 11234444444 48999999999984 3445
Q ss_pred EEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccc
Q 012233 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (468)
Q Consensus 210 ~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~ 289 (468)
+|+||||+++++...+... ...+++..++.++.||+.||.|||+ .||+||||||+||||+.++ .+||+|||++..
T Consensus 132 ~~lv~e~~~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIll~~~~-~~kl~DFG~a~~ 206 (311)
T 3p1a_A 132 LYLQTELCGPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHS-QGLVHLDVKPANIFLGPRG-RCKLGDFGLLVE 206 (311)
T ss_dssp EEEEEECCCCBHHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECGGG-CEEECCCTTCEE
T ss_pred EEEEEeccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHEEECCCC-CEEEccceeeee
Confidence 8999999999887765443 4569999999999999999999998 8999999999999999888 799999999987
Q ss_pred cCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 012233 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (468)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 369 (468)
...........||+.|+|||++.+ .++.++|||||||++|||++|..||.+....+ .+.. .
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~~~~~---~~~~---~----------- 267 (311)
T 3p1a_A 207 LGTAGAGEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGGEGWQ---QLRQ---G----------- 267 (311)
T ss_dssp CC------CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHH---HHTT---T-----------
T ss_pred cccCCCCcccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCccHHH---HHhc---c-----------
Confidence 765555556789999999999875 48999999999999999999977765432211 1111 0
Q ss_pred CCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q 012233 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDD 425 (468)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~ 425 (468)
.....++..+++++.+||.+||+.||.+|||+.|+|+||||++
T Consensus 268 -------------~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 268 -------------YLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp -------------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred -------------CCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 0011234568999999999999999999999999999999976
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-48 Score=371.12 Aligned_cols=257 Identities=26% Similarity=0.383 Sum_probs=197.9
Q ss_pred cccceEEeceecccCceEEEEEEEcCCCCEEEEEEeecccc------hHHHHHHHHHHcCCCCcccccceeeecCCCCce
Q 012233 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR------YKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (468)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~~------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 208 (468)
...+|.+.+.||+|+||.||+|.+..+|+.||+|++..... ...++...++.++||||+++++++.. ..
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~-----~~ 79 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFR-----EG 79 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SS
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeec-----cC
Confidence 44579999999999999999999999999999999864422 12234455778899999999999843 33
Q ss_pred EEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcC-CccccCCCCCCeeecCCCCcEEEeeecCc
Q 012233 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV-GVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (468)
Q Consensus 209 ~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~-givHrDlkp~NILl~~~~~~vkL~DFG~a 287 (468)
..++||||+++++...+.........+++..++.++.||+.||.|||+ + ||+||||||+|||++.++ .+||+|||++
T Consensus 80 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~ 157 (290)
T 3fme_A 80 DVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS-KLSVIHRDVKPSNVLINALG-QVKMCDFGIS 157 (290)
T ss_dssp SEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-HSCCCCCCCSGGGCEECTTC-CEEBCCC---
T ss_pred CEEEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh-cCCeecCCCCHHHEEECCCC-CEEEeecCCc
Confidence 488999999998887776666667789999999999999999999997 7 999999999999999888 7999999999
Q ss_pred cccCCCCCCccccccCCccccccc---cCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-cHHHHHHHHHHhCCCCHHH
Q 012233 288 KMLVPGEPNISYICSRYYRAPELI---FGATEYTTAIDMWSIGCVLAELLLGQPLFPGES-GVDQLVEIIKILGTPTREE 363 (468)
Q Consensus 288 ~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~-~~~~~~~i~~~~~~~~~~~ 363 (468)
.............||+.|+|||++ .....++.++|||||||++|+|++|+.||.... ....+..+.... .+
T Consensus 158 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~---- 232 (290)
T 3fme_A 158 GYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEP-SP---- 232 (290)
T ss_dssp ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSC-CC----
T ss_pred ccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccC-CC----
Confidence 877655555566899999999997 234458999999999999999999999998743 333333333310 00
Q ss_pred HhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q 012233 364 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDD 425 (468)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~ 425 (468)
. .....+++++.+||.+||+.||.+|||+.|+++||||+.
T Consensus 233 -----------~-----------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~ 272 (290)
T 3fme_A 233 -----------Q-----------LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272 (290)
T ss_dssp -----------C-----------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred -----------C-----------cccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence 0 012357899999999999999999999999999999975
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-48 Score=387.35 Aligned_cols=253 Identities=28% Similarity=0.425 Sum_probs=205.3
Q ss_pred eEEeceecccCceEEEEEEEcCCCCEEEEEEeecc----cchHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEEEe
Q 012233 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (468)
Q Consensus 139 y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~----~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv~ 214 (468)
|...+.||+|+||.||+|.+..+|+.||+|++... ...+.+|+.+|+.++||||+++++++ .+...++|||
T Consensus 91 ~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-----~~~~~~~lv~ 165 (373)
T 2x4f_A 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAF-----ESKNDIVLVM 165 (373)
T ss_dssp EEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSEEEEEE
T ss_pred eecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEE-----EECCEEEEEE
Confidence 34467899999999999999999999999998653 33456899999999999999999998 3444689999
Q ss_pred ecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeec--CCCCcEEEeeecCccccC
Q 012233 215 EYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVN--PHTHQLKICDFGSAKMLV 291 (468)
Q Consensus 215 e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~--~~~~~vkL~DFG~a~~~~ 291 (468)
||+.++ +.+.+.. ....+++..++.++.||+.||.|||+ .||+||||||+|||++ .++ .+||+|||+++...
T Consensus 166 E~~~~~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~~-~~kl~DFG~a~~~~ 240 (373)
T 2x4f_A 166 EYVDGGELFDRIID---ESYNLTELDTILFMKQICEGIRHMHQ-MYILHLDLKPENILCVNRDAK-QIKIIDFGLARRYK 240 (373)
T ss_dssp ECCTTCEEHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEEETTTT-EEEECCCSSCEECC
T ss_pred eCCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCHHHEEEecCCCC-cEEEEeCCCceecC
Confidence 999864 4443322 23458899999999999999999998 8999999999999994 444 79999999998876
Q ss_pred CCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCC
Q 012233 292 PGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNY 371 (468)
Q Consensus 292 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 371 (468)
........+||+.|+|||++.+. .++.++|||||||++|||++|..||.+.+..+.+.++......
T Consensus 241 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~------------- 306 (373)
T 2x4f_A 241 PREKLKVNFGTPEFLAPEVVNYD-FVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWD------------- 306 (373)
T ss_dssp TTCBCCCCCSSCTTCCHHHHTTC-BCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC-------------
T ss_pred CccccccccCCCcEeChhhccCC-CCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC-------------
Confidence 65555567899999999999654 4899999999999999999999999998888877777663111
Q ss_pred ccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q 012233 372 TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (468)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~ 427 (468)
++ ...+..+++++++||.+||+.||.+|||+.|+|+||||++.+
T Consensus 307 ----~~--------~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~~ 350 (373)
T 2x4f_A 307 ----LE--------DEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHK 350 (373)
T ss_dssp ----SC--------SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCHH
T ss_pred ----CC--------hhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCCc
Confidence 11 112245899999999999999999999999999999998753
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=397.26 Aligned_cols=258 Identities=27% Similarity=0.441 Sum_probs=212.7
Q ss_pred cccceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc------cchHHHHHHHHHHcCCCCcccccceeeecCCCCce
Q 012233 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (468)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~------~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 208 (468)
...+|.+.+.||+|+||+||+|.+..+|+.||||++... .....+|+.+|+.++||||+++++++ .+..
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~~ 94 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL-----EDSS 94 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSS
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEE-----EcCC
Confidence 345799999999999999999999999999999998432 33456899999999999999999998 4455
Q ss_pred EEEEEeecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCC--CcEEEeeec
Q 012233 209 YLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHT--HQLKICDFG 285 (468)
Q Consensus 209 ~~~lv~e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~--~~vkL~DFG 285 (468)
.+|+|||||.++ +.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+||||+..+ ..+||+|||
T Consensus 95 ~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg 169 (486)
T 3mwu_A 95 SFYIVGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHK-HNIVHRDLKPENILLESKEKDCDIKIIDFG 169 (486)
T ss_dssp EEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEESSSSTTCCEEECSCS
T ss_pred EEEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCchHHEEEecCCCCCCEEEEECC
Confidence 689999999864 4444332 3568999999999999999999998 8999999999999996432 269999999
Q ss_pred CccccCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 012233 286 SAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIK 365 (468)
Q Consensus 286 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 365 (468)
+++...........+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..+.+..+.....
T Consensus 170 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~-------- 239 (486)
T 3mwu_A 170 LSTCFQQNTKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKY-------- 239 (486)
T ss_dssp CTTTBCCC----CCTTGGGGCCGGGGGS--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC--------
T ss_pred cCeECCCCCccCCCcCCCCCCCHHHhCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC--------
Confidence 9987766666667789999999999965 389999999999999999999999999887777766655211
Q ss_pred hcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCC
Q 012233 366 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDP 429 (468)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~ 429 (468)
.++ ...+..+++++++||.+||+.||.+|||+.++|+||||+.....
T Consensus 240 ---------~~~--------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~~ 286 (486)
T 3mwu_A 240 ---------AFD--------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSE 286 (486)
T ss_dssp ---------CSC--------SGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCCC
T ss_pred ---------CCC--------CcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCccc
Confidence 111 01224589999999999999999999999999999999876543
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-47 Score=368.44 Aligned_cols=270 Identities=29% Similarity=0.417 Sum_probs=222.1
Q ss_pred ccceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-------chHHHHHHHHHHcCCCCcccccceeeecCCCCce
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 208 (468)
..+|.+.+.||+|+||.||+|.+..+++.||+|++.... ....+|+.+++.++||||+++++++ .+..
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~ 88 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF-----EDND 88 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSS
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeee-----ccCC
Confidence 346999999999999999999999999999999986432 2345799999999999999999998 4445
Q ss_pred EEEEEeecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCc
Q 012233 209 YLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (468)
Q Consensus 209 ~~~lv~e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a 287 (468)
..++||||+.++ +.+.+. ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++
T Consensus 89 ~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~~~-~~kl~dfg~~ 162 (294)
T 2rku_A 89 FVFVVLELCRRRSLLELHK----RRKALTEPEARYYLRQIVLGCQYLHR-NRVIHRDLKLGNLFLNEDL-EVKIGDFGLA 162 (294)
T ss_dssp EEEEEEECCTTCBHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTC-CEEECCCTTC
T ss_pred EEEEEEecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCChHhEEEcCCC-CEEEEeccCc
Confidence 689999999865 444332 23568999999999999999999998 8999999999999999888 7999999999
Q ss_pred cccCCC-CCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 012233 288 KMLVPG-EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKC 366 (468)
Q Consensus 288 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 366 (468)
...... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||......+....+...
T Consensus 163 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~----------- 230 (294)
T 2rku_A 163 TKVEYDGERKKVLCGTPNYIAPEVLSKK-GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN----------- 230 (294)
T ss_dssp EECCSTTCCBCCCCSCCSSCCHHHHTTS-CBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT-----------
T ss_pred eecccCccccccccCCCCcCCcchhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc-----------
Confidence 876432 234456789999999999654 4899999999999999999999999887766555444321
Q ss_pred cCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCCCCCCCCCCCCCcccccC
Q 012233 367 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNTCLPNGRPLPTLFNFT 446 (468)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~~ 446 (468)
... ++..+++.+.+||.+||+.||.+|||+.++++||||.+...+..........|+.+++.
T Consensus 231 ------~~~------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (294)
T 2rku_A 231 ------EYS------------IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPRFSIA 292 (294)
T ss_dssp ------CCC------------CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCSCCCGGGGTSCCCCCSS
T ss_pred ------cCC------------CccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCCcCCCCCccCCCCCCCcccC
Confidence 111 23457899999999999999999999999999999998777766655566667777664
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=388.46 Aligned_cols=256 Identities=31% Similarity=0.457 Sum_probs=199.0
Q ss_pred ccceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc------------chHHHHHHHHHHcCCCCcccccceeeecC
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------------RYKNRELQIMRLLNHPNVVSLKHCFFSTT 203 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~------------~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 203 (468)
..+|.+.+.||+|+||.||+|.+..+++.||||++.... ....+|+.+|+.++||||+++++++.
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~--- 210 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD--- 210 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE---
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe---
Confidence 357999999999999999999999999999999986532 23568999999999999999999872
Q ss_pred CCCceEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCC--CcEEE
Q 012233 204 EKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHT--HQLKI 281 (468)
Q Consensus 204 ~~~~~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~--~~vkL 281 (468)
.. ..|+||||+.++.+. ........+++..++.++.||+.||.|||+ +||+||||||+|||++.++ ..+||
T Consensus 211 --~~-~~~lv~e~~~~g~L~---~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivHrDlkp~NIll~~~~~~~~~kl 283 (419)
T 3i6u_A 211 --AE-DYYIVLELMEGGELF---DKVVGNKRLKEATCKLYFYQMLLAVQYLHE-NGIIHRDLKPENVLLSSQEEDCLIKI 283 (419)
T ss_dssp --SS-EEEEEEECCTTCBGG---GGTSSSCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESSSSSSCCEEE
T ss_pred --cC-ceEEEEEcCCCCcHH---HHHhccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCChHhEEEecCCCcceEEE
Confidence 22 267999999875332 223335679999999999999999999998 8999999999999997543 25999
Q ss_pred eeecCccccCCCCCCccccccCCccccccccC--CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Q 012233 282 CDFGSAKMLVPGEPNISYICSRYYRAPELIFG--ATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTP 359 (468)
Q Consensus 282 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~ 359 (468)
+|||+++...........+||+.|+|||++.+ ...++.++|||||||++|+|++|++||........+...+......
T Consensus 284 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~ 363 (419)
T 3i6u_A 284 TDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN 363 (419)
T ss_dssp CCSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCC
T ss_pred eecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCC
Confidence 99999987765555567789999999999853 3457889999999999999999999998765443333333211100
Q ss_pred CHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q 012233 360 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDD 425 (468)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~ 425 (468)
+....+..+++.+.+||.+||+.||.+|||+.|+|+||||++
T Consensus 364 ------------------------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 405 (419)
T 3i6u_A 364 ------------------------FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405 (419)
T ss_dssp ------------------------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred ------------------------CCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence 111233568999999999999999999999999999999986
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-47 Score=396.40 Aligned_cols=257 Identities=28% Similarity=0.435 Sum_probs=214.0
Q ss_pred ccceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-----------------chHHHHHHHHHHcCCCCcccccce
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----------------RYKNRELQIMRLLNHPNVVSLKHC 198 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-----------------~~~~~E~~il~~l~hpnIv~l~~~ 198 (468)
..+|.+.+.||+|+||+||+|.+..++..||||++.... ....+|+.+|+.++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 346999999999999999999999999999999986432 234579999999999999999999
Q ss_pred eeecCCCCceEEEEEeecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCC
Q 012233 199 FFSTTEKDELYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTH 277 (468)
Q Consensus 199 ~~~~~~~~~~~~~lv~e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~ 277 (468)
| .+..++|||||||.++ +.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++.
T Consensus 115 ~-----~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~~ 184 (504)
T 3q5i_A 115 F-----EDKKYFYLVTEFYEGGELFEQIIN----RHKFDECDAANIMKQILSGICYLHK-HNIVHRDIKPENILLENKNS 184 (504)
T ss_dssp E-----ECSSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESSTTC
T ss_pred E-----EcCCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCcHHHEEEecCCC
Confidence 8 4555789999999864 4444432 3568999999999999999999998 89999999999999987653
Q ss_pred --cEEEeeecCccccCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHH
Q 012233 278 --QLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKI 355 (468)
Q Consensus 278 --~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~ 355 (468)
.+||+|||++............+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..+.+..+...
T Consensus 185 ~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~ 262 (504)
T 3q5i_A 185 LLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKG 262 (504)
T ss_dssp CSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred CccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC
Confidence 599999999988766666667889999999999863 4899999999999999999999999998887777776552
Q ss_pred hCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCC
Q 012233 356 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDP 429 (468)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~ 429 (468)
...... ..+..+++++++||.+||++||.+|||+.|+|+||||+.....
T Consensus 263 ~~~~~~-------------------------~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~ 311 (504)
T 3q5i_A 263 KYYFDF-------------------------NDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANN 311 (504)
T ss_dssp CCCCCH-------------------------HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCCC
T ss_pred CCCCCc-------------------------cccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchhc
Confidence 111111 1234689999999999999999999999999999999876543
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-47 Score=393.70 Aligned_cols=258 Identities=26% Similarity=0.404 Sum_probs=211.5
Q ss_pred CCcccceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-------chHHHHHHHHHHcCCCCcccccceeeecCCC
Q 012233 133 PKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEK 205 (468)
Q Consensus 133 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 205 (468)
+....+|.+.++||+|+||.||+|+++.+|+.||||++.+.. ....+|+.+|+.++||||++++++| .
T Consensus 181 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~-----~ 255 (543)
T 3c4z_A 181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAF-----E 255 (543)
T ss_dssp CCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE-----E
T ss_pred cCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEE-----e
Confidence 344568999999999999999999999999999999985432 2345799999999999999999988 4
Q ss_pred CceEEEEEeecccchHH-HHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeee
Q 012233 206 DELYLNLVLEYISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDF 284 (468)
Q Consensus 206 ~~~~~~lv~e~~~~~ll-~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DF 284 (468)
+...+|+||||+.|+.+ ..+.........+++..++.++.||+.||.|||+ +||+||||||+||||+.++ .+||+||
T Consensus 256 ~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~-~gIvHrDLKP~NILl~~~g-~vkL~DF 333 (543)
T 3c4z_A 256 TKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ-RNIIYRDLKPENVLLDDDG-NVRISDL 333 (543)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTS-CEEECCC
T ss_pred eCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH-cCCcccCCChHHEEEeCCC-CEEEeec
Confidence 44568999999986544 4443333334579999999999999999999998 8999999999999999988 7999999
Q ss_pred cCccccCCCCC-CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCc----HHHHHHHHHHhCCC
Q 012233 285 GSAKMLVPGEP-NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESG----VDQLVEIIKILGTP 359 (468)
Q Consensus 285 G~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~----~~~~~~i~~~~~~~ 359 (468)
|+++....... ....+||+.|+|||++.+. .++.++|||||||++|||++|++||.+... .+....+..
T Consensus 334 Gla~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~----- 407 (543)
T 3c4z_A 334 GLAVELKAGQTKTKGYAGTPGFMAPELLLGE-EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLE----- 407 (543)
T ss_dssp TTCEECCTTCCCBCCCCSCTTTSCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHH-----
T ss_pred ceeeeccCCCcccccccCCccccChhhhcCC-CCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhh-----
Confidence 99987654443 3346899999999999765 489999999999999999999999987542 222233322
Q ss_pred CHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCC-----HHHHhCCCCCCCCC
Q 012233 360 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCT-----ALEACAHPFFDDLR 427 (468)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s-----~~ell~hp~f~~~~ 427 (468)
.... ++..+++++++||.+||+.||.+||+ +.++++||||+++.
T Consensus 408 ------------~~~~------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~ 456 (543)
T 3c4z_A 408 ------------QAVT------------YPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDIS 456 (543)
T ss_dssp ------------CCCC------------CCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCC
T ss_pred ------------cccC------------CCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCC
Confidence 0111 33568999999999999999999995 58999999999864
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-48 Score=399.28 Aligned_cols=257 Identities=31% Similarity=0.508 Sum_probs=215.3
Q ss_pred cccceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc-------cchHHHHHHHHHHcCCCCcccccceeeecCCCCc
Q 012233 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (468)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~-------~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 207 (468)
...+|.+.+.||+|+||.||+|.+..+|+.||||++... .....+|+.+++.++||||++++++| .+.
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~ 98 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFF-----EDK 98 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECS
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EeC
Confidence 345799999999999999999999999999999998533 23456899999999999999999998 445
Q ss_pred eEEEEEeecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeec---CCCCcEEEee
Q 012233 208 LYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVN---PHTHQLKICD 283 (468)
Q Consensus 208 ~~~~lv~e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~---~~~~~vkL~D 283 (468)
.++|+|||||.++ +.+.+. ....+++..++.++.||+.||.|||+ +||+||||||+|||++ .++ .+||+|
T Consensus 99 ~~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~~~~-~~kl~D 172 (484)
T 3nyv_A 99 GYFYLVGEVYTGGELFDEII----SRKRFSEVDAARIIRQVLSGITYMHK-NKIVHRDLKPENLLLESKSKDA-NIRIID 172 (484)
T ss_dssp SEEEEEECCCCSCBHHHHHH----TCSCCBHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESSSSTTC-CEEECC
T ss_pred CEEEEEEecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHHHEEEecCCCCC-cEEEEe
Confidence 5789999999865 444332 24668999999999999999999998 8999999999999994 444 799999
Q ss_pred ecCccccCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 012233 284 FGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREE 363 (468)
Q Consensus 284 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~ 363 (468)
||+++...........+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..+.+..+....
T Consensus 173 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~------- 243 (484)
T 3nyv_A 173 FGLSTHFEASKKMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGK------- 243 (484)
T ss_dssp TTHHHHBCCCCSHHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-------
T ss_pred eeeeEEcccccccccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC-------
Confidence 999988766666667789999999999975 48999999999999999999999999988877777665521
Q ss_pred HhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCC
Q 012233 364 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDP 429 (468)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~ 429 (468)
+.++ ...+..+++++++||.+||++||.+|||+.|+|+||||+....+
T Consensus 244 ----------~~~~--------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~~ 291 (484)
T 3nyv_A 244 ----------YTFE--------LPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKE 291 (484)
T ss_dssp ----------CCCC--------SGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC-
T ss_pred ----------CCCC--------CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcccccc
Confidence 1111 01224589999999999999999999999999999999876543
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=366.54 Aligned_cols=253 Identities=31% Similarity=0.473 Sum_probs=207.9
Q ss_pred CcccceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc-------cchHHHHHHHHHHcCCCCcccccceeeecCCCC
Q 012233 134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD 206 (468)
Q Consensus 134 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~-------~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 206 (468)
....+|.+.+.||+|+||.||+|.+..++..||+|++... .....+|+.+++.++||||+++++++ .+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~ 80 (279)
T 3fdn_A 6 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF-----HD 80 (279)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----EC
T ss_pred eecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheE-----ec
Confidence 3456799999999999999999999999999999998543 23456799999999999999999998 44
Q ss_pred ceEEEEEeecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeec
Q 012233 207 ELYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG 285 (468)
Q Consensus 207 ~~~~~lv~e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG 285 (468)
....++||||+.++ +...+.. ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~----~~~~~~~~~~~~~~qi~~~l~~LH~-~~i~H~dlkp~Nili~~~~-~~~l~Dfg 154 (279)
T 3fdn_A 81 ATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHS-KRVIHRDIKPENLLLGSAG-ELKIADFG 154 (279)
T ss_dssp SSEEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-TTCEECCCCGGGEEECTTS-CEEECSCC
T ss_pred CCEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCEecccCChHhEEEcCCC-CEEEEecc
Confidence 45689999999864 4443332 3568999999999999999999998 8999999999999999888 79999999
Q ss_pred CccccCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 012233 286 SAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIK 365 (468)
Q Consensus 286 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 365 (468)
++..... .......|++.|+|||++.+. .++.++|||||||++|+|++|..||...+..+....+...
T Consensus 155 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---------- 222 (279)
T 3fdn_A 155 WSVHAPS-SRRTDLCGTLDYLPPEMIEGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---------- 222 (279)
T ss_dssp EESCC---------CCCCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT----------
T ss_pred ccccCCc-ccccccCCCCCccCHhHhccC-CCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhC----------
Confidence 9865433 233456889999999999765 4899999999999999999999999987766666555441
Q ss_pred hcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCC
Q 012233 366 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRD 428 (468)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~ 428 (468)
... ++..+++++.+||.+||+.||.+|||+.|+++||||+....
T Consensus 223 -------~~~------------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~~ 266 (279)
T 3fdn_A 223 -------EFT------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSS 266 (279)
T ss_dssp -------CCC------------CCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHCS
T ss_pred -------CCC------------CCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCcc
Confidence 111 23457899999999999999999999999999999997544
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-47 Score=374.05 Aligned_cols=256 Identities=28% Similarity=0.470 Sum_probs=186.4
Q ss_pred cceEEe---ceecccCceEEEEEEEcCCCCEEEEEEeeccc-chHHHHHHHHHHcC-CCCcccccceeeecCCCCceEEE
Q 012233 137 ISYMAE---RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-RYKNRELQIMRLLN-HPNVVSLKHCFFSTTEKDELYLN 211 (468)
Q Consensus 137 ~~y~~~---~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~~~~~~ 211 (468)
.+|.+. +.||+|+||.||+|.+..+|+.||||++.... ....+|+.+++.+. ||||+++++++ .+....|
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~-----~~~~~~~ 82 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVF-----HDQLHTF 82 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECSSEEE
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEE-----EcCCEEE
Confidence 357765 78999999999999999999999999986543 45568999999997 99999999998 4455689
Q ss_pred EEeecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCC--cEEEeeecCcc
Q 012233 212 LVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTH--QLKICDFGSAK 288 (468)
Q Consensus 212 lv~e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~--~vkL~DFG~a~ 288 (468)
+||||+.++ +.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++. .+||+|||+++
T Consensus 83 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~ 157 (325)
T 3kn6_A 83 LVMELLNGGELFERIKK----KKHFSETEASYIMRKLVSAVSHMHD-VGVVHRDLKPENLLFTDENDNLEIKIIDFGFAR 157 (325)
T ss_dssp EEECCCCSCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEEC----CEEEECCCTTCE
T ss_pred EEEEccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCHHHEEEecCCCcccEEEeccccce
Confidence 999999874 4444332 4679999999999999999999998 89999999999999976542 69999999998
Q ss_pred ccCCCC-CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcH-------HHHHHHHHHhCCCC
Q 012233 289 MLVPGE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGV-------DQLVEIIKILGTPT 360 (468)
Q Consensus 289 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~-------~~~~~i~~~~~~~~ 360 (468)
...... .....+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.... +.+..+..
T Consensus 158 ~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~------ 230 (325)
T 3kn6_A 158 LKPPDNQPLKTPCFTLHYAAPELLNQN-GYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKK------ 230 (325)
T ss_dssp ECCC----------------------C-CCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTT------
T ss_pred ecCCCCCcccccCCCcCccCHHHhcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHc------
Confidence 664432 33456789999999999655 4899999999999999999999999875432 12222211
Q ss_pred HHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCC
Q 012233 361 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRD 428 (468)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~ 428 (468)
..+. +....+..+++++++||.+||+.||.+|||+.|+++||||++...
T Consensus 231 -----------~~~~--------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~ 279 (325)
T 3kn6_A 231 -----------GDFS--------FEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQ 279 (325)
T ss_dssp -----------TCCC--------CCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCC
T ss_pred -----------CCCC--------CCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCcc
Confidence 0011 111123468999999999999999999999999999999987543
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-47 Score=383.21 Aligned_cols=259 Identities=27% Similarity=0.410 Sum_probs=197.8
Q ss_pred ccceEEe-ceecccCceEEEEEEEcCCCCEEEEEEeecccchHHHHHHHH-HHcCCCCcccccceeeecCCCCceEEEEE
Q 012233 136 TISYMAE-RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIM-RLLNHPNVVSLKHCFFSTTEKDELYLNLV 213 (468)
Q Consensus 136 ~~~y~~~-~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~~~~~~E~~il-~~l~hpnIv~l~~~~~~~~~~~~~~~~lv 213 (468)
..+|.+. ++||+|+||+||+|.+..+|+.||||++... ....+|+.++ +.++||||++++++|.... .+..++|||
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~-~~~~~~~lv 137 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-PKARREVELHWRASQCPHIVRIVDVYENLY-AGRKCLLIV 137 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-hhHHHHHHHHHHhcCCCCcceEeEEEeecc-cCCcEEEEE
Confidence 3457776 7999999999999999999999999998654 3456788886 5568999999999885422 345678999
Q ss_pred eecccc-hHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecC---CCCcEEEeeecCccc
Q 012233 214 LEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNP---HTHQLKICDFGSAKM 289 (468)
Q Consensus 214 ~e~~~~-~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~---~~~~vkL~DFG~a~~ 289 (468)
||||.+ ++.+.+.. .....+++..++.++.||+.||.|||+ +||+||||||+||||+. ++ .+||+|||+++.
T Consensus 138 ~E~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~Nill~~~~~~~-~~kl~DFG~a~~ 213 (400)
T 1nxk_A 138 MECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNA-ILKLTDFGFAKE 213 (400)
T ss_dssp EECCCSEEHHHHHHC--C---CCBHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSSSTTC-CEEECCCTTCEE
T ss_pred EEeCCCCcHHHHHHH--hCCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCcCcceEEEecCCCCc-cEEEEecccccc
Confidence 999986 55554432 123458999999999999999999998 89999999999999987 45 799999999987
Q ss_pred cCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHH----HHHHHHHHhCCCCHHHHh
Q 012233 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVD----QLVEIIKILGTPTREEIK 365 (468)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~----~~~~i~~~~~~~~~~~~~ 365 (468)
..........+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+..... ....+..
T Consensus 214 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~----------- 281 (400)
T 1nxk_A 214 TTSHNSLTTPCYTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM----------- 281 (400)
T ss_dssp CC-----------CTTCCGGGSCCC-CSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHH-----------
T ss_pred cCCCCccccCCCCCCccCHhhcCCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHc-----------
Confidence 7655555677899999999999654 59999999999999999999999998754322 1122211
Q ss_pred hcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q 012233 366 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426 (468)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 426 (468)
..+.++. ..+..+++++++||.+||+.||.+|||+.|+++||||...
T Consensus 282 ------~~~~~~~--------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 328 (400)
T 1nxk_A 282 ------GQYEFPN--------PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 328 (400)
T ss_dssp ------TCCCCCT--------TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred ------CcccCCC--------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence 1111111 1224589999999999999999999999999999999863
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-47 Score=370.76 Aligned_cols=287 Identities=30% Similarity=0.504 Sum_probs=217.7
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc----chHHHHHHHHHHcCCCCcccccceeeecC---------C
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVSLKHCFFSTT---------E 204 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~---------~ 204 (468)
+|.+.+.||+|+||.||+|.+..+|+.||||++.... ....+|+.+++.++||||+++++++.... .
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~ 91 (320)
T 2i6l_A 12 RYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSL 91 (320)
T ss_dssp TEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----C
T ss_pred ceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccc
Confidence 5999999999999999999999999999999886432 33457999999999999999998873321 1
Q ss_pred CCceEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeee
Q 012233 205 KDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDF 284 (468)
Q Consensus 205 ~~~~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DF 284 (468)
.+...+|+||||+.+++.+.+. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++..+||+||
T Consensus 92 ~~~~~~~lv~e~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~~kl~Df 165 (320)
T 2i6l_A 92 TELNSVYIVQEYMETDLANVLE-----QGPLLEEHARLFMYQLLRGLKYIHS-ANVLHRDLKPANLFINTEDLVLKIGDF 165 (320)
T ss_dssp CSCSEEEEEEECCSEEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSGGGEEEETTTTEEEECCC
T ss_pred cccCceeEEeeccCCCHHHHhh-----cCCccHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEcCCCCeEEEccC
Confidence 2335688999999988776553 3568999999999999999999998 899999999999999855448999999
Q ss_pred cCccccCCC----CCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Q 012233 285 GSAKMLVPG----EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPT 360 (468)
Q Consensus 285 G~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~ 360 (468)
|++...... .......+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+......+.
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 245 (320)
T 2i6l_A 166 GLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVH 245 (320)
T ss_dssp TTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCC
T ss_pred ccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCc
Confidence 999865332 1223456799999999987656689999999999999999999999999998888888888766655
Q ss_pred HHHHhhcCCCCccCCCCc-ccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCCC
Q 012233 361 REEIKCMNPNYTEFKFPQ-IKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPN 430 (468)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~ 430 (468)
.............+.... .........+.+.+++++.+||.+||+.||.+|||+.|+|+||||+....+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p~ 316 (320)
T 2i6l_A 246 EEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFPM 316 (320)
T ss_dssp HHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC--
T ss_pred hhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCcc
Confidence 544332211110000000 0000011223456899999999999999999999999999999999876554
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=378.10 Aligned_cols=263 Identities=30% Similarity=0.475 Sum_probs=208.0
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc---------chHHHHHHHHHHcCCCCcccccceeeecCCCCc
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~---------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 207 (468)
.+|.+.+.||+|+||.||+|.+..++..||+|++.... ....+|+.+++.++||||+++++++ .+.
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~ 100 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVY-----EDE 100 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECS
T ss_pred hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhh-----ccC
Confidence 46999999999999999999999999999999985432 3456799999999999999999998 445
Q ss_pred eEEEEEeecccch-HHHHHhhhhh------------------------------------cCCCCCHHHHHHHHHHHHHH
Q 012233 208 LYLNLVLEYISET-VYRVSKHYTR------------------------------------MNQHVPILYVQLYTYQICRA 250 (468)
Q Consensus 208 ~~~~lv~e~~~~~-ll~~~~~~~~------------------------------------~~~~~~~~~~~~~~~qi~~a 250 (468)
...|+||||+.++ +.+.+..+.. ....+++..++.++.||+.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 5689999999765 4443321110 01223567788999999999
Q ss_pred HHHhHhcCCccccCCCCCCeeecCCCC-cEEEeeecCccccCCCC-----CCccccccCCccccccccCC-CCCCcchhH
Q 012233 251 LNYLHHVVGVCHRDIKPQNLLVNPHTH-QLKICDFGSAKMLVPGE-----PNISYICSRYYRAPELIFGA-TEYTTAIDM 323 (468)
Q Consensus 251 L~yLH~~~givHrDlkp~NILl~~~~~-~vkL~DFG~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~-~~~~~~~Dv 323 (468)
|.|||+ +||+||||||+||||+.++. .+||+|||++..+.... ......||+.|+|||++.+. ..++.++||
T Consensus 181 l~~LH~-~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di 259 (345)
T 3hko_A 181 LHYLHN-QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDA 259 (345)
T ss_dssp HHHHHH-TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHH
T ss_pred HHHHHH-CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHH
Confidence 999998 89999999999999986542 69999999997653211 23456789999999999642 458999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHh
Q 012233 324 WSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRL 403 (468)
Q Consensus 324 wSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 403 (468)
|||||++|+|++|+.||.+.+..+.+..+...... ++. .....+++++.+||.+|
T Consensus 260 wslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~-----------------~~~--------~~~~~~~~~~~~li~~~ 314 (345)
T 3hko_A 260 WSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLC-----------------FEN--------PNYNVLSPLARDLLSNL 314 (345)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC-----------------TTS--------GGGGGSCHHHHHHHHHH
T ss_pred HHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccc-----------------cCC--------cccccCCHHHHHHHHHH
Confidence 99999999999999999998888777776652111 110 01234789999999999
Q ss_pred cccCCCCCCCHHHHhCCCCCCCCCCCC
Q 012233 404 LQYSPSLRCTALEACAHPFFDDLRDPN 430 (468)
Q Consensus 404 L~~dP~~R~s~~ell~hp~f~~~~~~~ 430 (468)
|+.||.+|||+.++|+||||+++.+.-
T Consensus 315 l~~~p~~Rps~~~~l~hp~~~~~~~~~ 341 (345)
T 3hko_A 315 LNRNVDERFDAMRALQHPWISQFSDKI 341 (345)
T ss_dssp SCSCTTTSCCHHHHHHSHHHHTTSSCS
T ss_pred cCCChhHCCCHHHHhcChhhccChHhh
Confidence 999999999999999999999876643
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-47 Score=377.28 Aligned_cols=253 Identities=27% Similarity=0.432 Sum_probs=210.4
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc------------chHHHHHHHHHHc-CCCCcccccceeeecC
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------------RYKNRELQIMRLL-NHPNVVSLKHCFFSTT 203 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~------------~~~~~E~~il~~l-~hpnIv~l~~~~~~~~ 203 (468)
.+|.+.+.||+|+||.||+|.+..+|+.||||++.... ....+|+.+++.+ +||||+++++++.
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~--- 170 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYE--- 170 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE---
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe---
Confidence 46999999999999999999999899999999885432 2345799999999 7999999999883
Q ss_pred CCCceEEEEEeecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEe
Q 012233 204 EKDELYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKIC 282 (468)
Q Consensus 204 ~~~~~~~~lv~e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~ 282 (468)
.....|+||||+.++ +.+.+.. ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++ .+||+
T Consensus 171 --~~~~~~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~-~gi~H~Dlkp~NIl~~~~~-~ikl~ 242 (365)
T 2y7j_A 171 --SSSFMFLVFDLMRKGELFDYLTE----KVALSEKETRSIMRSLLEAVSFLHA-NNIVHRDLKPENILLDDNM-QIRLS 242 (365)
T ss_dssp --BSSEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTC-CEEEC
T ss_pred --eCCEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECCCC-CEEEE
Confidence 344689999999874 4443332 3568999999999999999999998 8999999999999999888 79999
Q ss_pred eecCccccCCCCCCccccccCCccccccccC-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Q 012233 283 DFGSAKMLVPGEPNISYICSRYYRAPELIFG-----ATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILG 357 (468)
Q Consensus 283 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~ 357 (468)
|||++..+.........+||+.|+|||++.+ ...++.++|||||||++|+|++|..||...+....+..+.....
T Consensus 243 DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~ 322 (365)
T 2y7j_A 243 DFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQY 322 (365)
T ss_dssp CCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred ecCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC
Confidence 9999988766666667889999999999853 23478899999999999999999999988776666655544211
Q ss_pred CCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q 012233 358 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDD 425 (468)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~ 425 (468)
.+... .+..+++.+.+||.+||+.||.+|||+.++|+||||+.
T Consensus 323 ~~~~~-------------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 323 QFSSP-------------------------EWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp CCCHH-------------------------HHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred CCCCc-------------------------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence 11111 12457899999999999999999999999999999974
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=378.26 Aligned_cols=280 Identities=34% Similarity=0.582 Sum_probs=217.7
Q ss_pred ccceEEeceecccCceEEEEEEEcCCCCEEEEEEeecccc---hHHHHHHHHHHcC-CC-----CcccccceeeecCCCC
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR---YKNRELQIMRLLN-HP-----NVVSLKHCFFSTTEKD 206 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~~---~~~~E~~il~~l~-hp-----nIv~l~~~~~~~~~~~ 206 (468)
..+|.+.+.||+|+||+||+|.+..+++.||||++..... ...+|+.+++.+. |+ +|+++++++..
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~----- 127 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF----- 127 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE-----
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc-----
Confidence 3579999999999999999999999999999999975543 3346888888886 55 38888888843
Q ss_pred ceEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHh-cCCccccCCCCCCeeecC--CCCcEEEee
Q 012233 207 ELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH-VVGVCHRDIKPQNLLVNP--HTHQLKICD 283 (468)
Q Consensus 207 ~~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~-~~givHrDlkp~NILl~~--~~~~vkL~D 283 (468)
...+||||||+++++.+.+.... ...+++..++.++.||+.||.|||. ..||+||||||+||||+. ++ .+||+|
T Consensus 128 ~~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~-~~kL~D 204 (382)
T 2vx3_A 128 RNHLCLVFEMLSYNLYDLLRNTN--FRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRS-AIKIVD 204 (382)
T ss_dssp TTEEEEEEECCCCBHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSC-CEEECC
T ss_pred CCceEEEEecCCCCHHHHHhhcC--cCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCC-cEEEEe
Confidence 34589999999998887765432 2458999999999999999999993 269999999999999953 44 799999
Q ss_pred ecCccccCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 012233 284 FGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREE 363 (468)
Q Consensus 284 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~ 363 (468)
||+++.... .....+||+.|+|||++.+.. ++.++|||||||++|||++|++||.+.+..+.+..++..++.++...
T Consensus 205 FG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 281 (382)
T 2vx3_A 205 FGSSCQLGQ--RIYQYIQSRFYRSPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHI 281 (382)
T ss_dssp CTTCEETTC--CCCSSCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred ccCceeccc--ccccccCCccccChHHHcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 999987633 344678999999999997654 89999999999999999999999999999999999999999888765
Q ss_pred HhhcCCCCccCCCCcccCCCc--------------------cccccc-----------------CCCHHHHHHHHHhccc
Q 012233 364 IKCMNPNYTEFKFPQIKAHPW--------------------HKIFHK-----------------RMPPEALDLVSRLLQY 406 (468)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~-----------------~~~~~l~~li~~~L~~ 406 (468)
+...... .. .+..+....| ...+.. ..++++++||.+||++
T Consensus 282 ~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~ 359 (382)
T 2vx3_A 282 LDQAPKA-RK-FFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDY 359 (382)
T ss_dssp HTTCTTH-HH-HEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCS
T ss_pred HHhhHHH-HH-HHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCC
Confidence 5432110 00 0000000000 000000 0014789999999999
Q ss_pred CCCCCCCHHHHhCCCCCCCCCC
Q 012233 407 SPSLRCTALEACAHPFFDDLRD 428 (468)
Q Consensus 407 dP~~R~s~~ell~hp~f~~~~~ 428 (468)
||.+|||+.|+|+||||++..+
T Consensus 360 dP~~Rpta~e~L~hp~f~~~~~ 381 (382)
T 2vx3_A 360 DPKTRIQPYYALQHSFFKKTAD 381 (382)
T ss_dssp CTTTSCCHHHHTTSGGGCC---
T ss_pred ChhhCCCHHHHhcCcccccCCC
Confidence 9999999999999999998654
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-47 Score=374.79 Aligned_cols=250 Identities=27% Similarity=0.426 Sum_probs=210.1
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-------chHHHHHHHHHHcCCCCcccccceeeecCCCCceEE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~ 210 (468)
.|.+.+.||+|+||.||+|.+..+|+.||||++.... ..+.+|+.+++.++||||+++++++.. ....
T Consensus 55 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~~~ 129 (348)
T 1u5q_A 55 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----EHTA 129 (348)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEE
T ss_pred heeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-----CCeE
Confidence 5999999999999999999999999999999985432 234579999999999999999999854 3358
Q ss_pred EEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcccc
Q 012233 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (468)
Q Consensus 211 ~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~ 290 (468)
++||||+.|++++.+.. ....+++..++.++.||+.||.|||+ +||+||||||+||||+.++ .+||+|||++...
T Consensus 130 ~lv~e~~~g~l~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~-~~kL~DfG~a~~~ 204 (348)
T 1u5q_A 130 WLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHS-HNMIHRDVKAGNILLSEPG-LVKLGDFGSASIM 204 (348)
T ss_dssp EEEEECCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSGGGEEEETTT-EEEECCCTTCBSS
T ss_pred EEEEecCCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEECCCC-CEEEeeccCceec
Confidence 89999999988776543 24668999999999999999999998 8999999999999999888 8999999999765
Q ss_pred CCCCCCccccccCCccccccccC--CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 012233 291 VPGEPNISYICSRYYRAPELIFG--ATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368 (468)
Q Consensus 291 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 368 (468)
.. .....||+.|+|||++.+ ...++.++|||||||++|||++|+.||.+.+..+.+..+.....
T Consensus 205 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~----------- 270 (348)
T 1u5q_A 205 AP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES----------- 270 (348)
T ss_dssp SS---BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-----------
T ss_pred CC---CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-----------
Confidence 33 335689999999999853 34589999999999999999999999998887776665544110
Q ss_pred CCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q 012233 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (468)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~ 427 (468)
+. .....+++.+.+||.+||+.||.+|||+.++++||||....
T Consensus 271 --------~~--------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~ 313 (348)
T 1u5q_A 271 --------PA--------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER 313 (348)
T ss_dssp --------CC--------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred --------CC--------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhccC
Confidence 00 01234788999999999999999999999999999997643
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=369.70 Aligned_cols=253 Identities=27% Similarity=0.400 Sum_probs=208.8
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc----chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEEE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV 213 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv 213 (468)
.|...+.||+|+||.||+|.+..+|+.||||++.... ....+|+.+++.++||||+++++++... ...++|
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~lv 120 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVG-----EELWVL 120 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TEEEEE
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEEC-----CEEEEE
Confidence 4888889999999999999999999999999985432 3356899999999999999999988543 348899
Q ss_pred eecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCCC
Q 012233 214 LEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293 (468)
Q Consensus 214 ~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~~ 293 (468)
|||+.++.+..+.. ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||++......
T Consensus 121 ~e~~~~~~L~~~l~----~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~~~~~~~~ 194 (321)
T 2c30_A 121 MEFLQGGALTDIVS----QVRLNEEQIATVCEAVLQALAYLHA-QGVIHRDIKSDSILLTLDG-RVKLSDFGFCAQISKD 194 (321)
T ss_dssp ECCCCSCBHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTC-CEEECCCTTCEECCSS
T ss_pred EecCCCCCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECCCC-cEEEeeeeeeeecccC
Confidence 99998765543322 3468999999999999999999998 8999999999999999888 7999999999876443
Q ss_pred C-CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCc
Q 012233 294 E-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYT 372 (468)
Q Consensus 294 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 372 (468)
. ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+..+.+..+.... .+ .
T Consensus 195 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~-~~----------~-- 260 (321)
T 2c30_A 195 VPKRKSLVGTPYWMAPEVISRS-LYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP-PP----------K-- 260 (321)
T ss_dssp SCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSS-CC----------C--
T ss_pred ccccccccCCccccCHhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-CC----------C--
Confidence 2 33456899999999999654 48999999999999999999999998887666555543310 00 0
Q ss_pred cCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCC
Q 012233 373 EFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRD 428 (468)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~ 428 (468)
+ .....+++++.+||.+||+.||.+|||+.++++||||.....
T Consensus 261 ---~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~ 303 (321)
T 2c30_A 261 ---L----------KNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTGL 303 (321)
T ss_dssp ---C----------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGCCC
T ss_pred ---c----------CccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccCCC
Confidence 0 012347899999999999999999999999999999986543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-47 Score=373.38 Aligned_cols=269 Identities=29% Similarity=0.422 Sum_probs=219.9
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-------chHHHHHHHHHHcCCCCcccccceeeecCCCCceE
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 209 (468)
.+|.+.+.||+|+||.||+|.+..+++.||+|++.... ....+|+.+++.++||||+++++++ .+...
T Consensus 41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~ 115 (335)
T 2owb_A 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF-----EDNDF 115 (335)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSSE
T ss_pred CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----ecCCe
Confidence 46999999999999999999999999999999986532 3345799999999999999999998 44456
Q ss_pred EEEEeecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcc
Q 012233 210 LNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (468)
Q Consensus 210 ~~lv~e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~ 288 (468)
+|+||||+.++ +.+++.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++.
T Consensus 116 ~~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIl~~~~~-~~kl~Dfg~~~ 189 (335)
T 2owb_A 116 VFVVLELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHR-NRVIHRDLKLGNLFLNEDL-EVKIGDFGLAT 189 (335)
T ss_dssp EEEEECCCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECTTC-CEEECCCTTCE
T ss_pred EEEEEecCCCCCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCEecCCCchhEEEcCCC-CEEEeeccCce
Confidence 89999999864 4443322 3568999999999999999999998 8999999999999999888 79999999998
Q ss_pred ccCCC-CCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 012233 289 MLVPG-EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367 (468)
Q Consensus 289 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 367 (468)
..... .......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||......+.+..+...
T Consensus 190 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~------------ 256 (335)
T 2owb_A 190 KVEYDGERKKVLCGTPNYIAPEVLSKKG-HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN------------ 256 (335)
T ss_dssp ECCSTTCCBCCCCSCCSSCCHHHHHTSC-BCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT------------
T ss_pred ecccCcccccccCCCccccCHHHhccCC-CCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcC------------
Confidence 76432 2344567899999999997654 899999999999999999999999887766655554431
Q ss_pred CCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCCCCCCCCCCCCCcccccC
Q 012233 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNTCLPNGRPLPTLFNFT 446 (468)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~~ 446 (468)
... ++..+++++.+||.+||+.||.+|||+.|+++||||.....+.........+|+.++.+
T Consensus 257 -----~~~------------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (335)
T 2owb_A 257 -----EYS------------IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPRFSIA 318 (335)
T ss_dssp -----CCC------------CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCSCCCGGGGTSCCCCCSS
T ss_pred -----CCC------------CCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCCccccCCcccccCCCccccC
Confidence 111 23457899999999999999999999999999999998766555544444455554444
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-47 Score=394.21 Aligned_cols=253 Identities=28% Similarity=0.467 Sum_probs=209.9
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc------cchHHHHHHHHHHcCCCCcccccceeeecCCCCceEE
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~------~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~ 210 (468)
..|.+.+.||+|+||.||+|.+..++..||||++... .....+|+.+++.++||||++++++| .+...+
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~~~~ 111 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFF-----EDKRNY 111 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeCCEE
Confidence 4699999999999999999999999999999998643 23456899999999999999999998 445568
Q ss_pred EEEeecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCC--CcEEEeeecCc
Q 012233 211 NLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHT--HQLKICDFGSA 287 (468)
Q Consensus 211 ~lv~e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~--~~vkL~DFG~a 287 (468)
|+|||||.++ +++.+.. ...+++..++.++.||+.||.|||+ +||+||||||+||||+..+ ..+||+|||++
T Consensus 112 ~lv~e~~~~g~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a 186 (494)
T 3lij_A 112 YLVMECYKGGELFDEIIH----RMKFNEVDAAVIIKQVLSGVTYLHK-HNIVHRDLKPENLLLESKEKDALIKIVDFGLS 186 (494)
T ss_dssp EEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCChhhEEEeCCCCCCcEEEEECCCC
Confidence 9999999864 4443332 3568999999999999999999998 8999999999999997643 25999999999
Q ss_pred cccCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 012233 288 KMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367 (468)
Q Consensus 288 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 367 (468)
............+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..+.+..+......
T Consensus 187 ~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~--------- 255 (494)
T 3lij_A 187 AVFENQKKMKERLGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYT--------- 255 (494)
T ss_dssp EECBTTBCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC---------
T ss_pred eECCCCccccccCCCcCeeCHHHHcc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC---------
Confidence 88766666667889999999999853 4899999999999999999999999998887777766552111
Q ss_pred CCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q 012233 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426 (468)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 426 (468)
++ ...+..+++++++||.+||+.||.+|||+.|+|+||||++.
T Consensus 256 --------~~--------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 298 (494)
T 3lij_A 256 --------FD--------SPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM 298 (494)
T ss_dssp --------CC--------SGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred --------CC--------chhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence 11 11234689999999999999999999999999999999875
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-47 Score=406.10 Aligned_cols=253 Identities=26% Similarity=0.416 Sum_probs=213.2
Q ss_pred CcccceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-------chHHHHHHHHHHc-CCCCcccccceeeecCCC
Q 012233 134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLL-NHPNVVSLKHCFFSTTEK 205 (468)
Q Consensus 134 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-------~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~ 205 (468)
....+|.+.++||+|+||.||+|.++.+++.||||++.+.. .....|..++..+ .||||++++++| .
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~-----~ 412 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----Q 412 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEEC-----B
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEE-----E
Confidence 34567999999999999999999999999999999986432 2345688888877 699999999988 5
Q ss_pred CceEEEEEeecccchHH-HHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeee
Q 012233 206 DELYLNLVLEYISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDF 284 (468)
Q Consensus 206 ~~~~~~lv~e~~~~~ll-~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DF 284 (468)
+...+||||||+.++.| ..+.. ...+++..++.|+.||+.||.|||+ +|||||||||+||||+.++ .+||+||
T Consensus 413 ~~~~~~lV~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~gIiHrDLKp~NILl~~~g-~ikL~DF 486 (674)
T 3pfq_A 413 TMDRLYFVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQS-KGIIYRDLKLDNVMLDSEG-HIKIADF 486 (674)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TSEECCCCCSTTEEECSSS-CEEECCC
T ss_pred eCCEEEEEEeCcCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeccCChhhEEEcCCC-cEEEeec
Confidence 55679999999986544 33322 3569999999999999999999998 8999999999999999998 7999999
Q ss_pred cCccccC-CCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 012233 285 GSAKMLV-PGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREE 363 (468)
Q Consensus 285 G~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~ 363 (468)
|+++... ........+||+.|+|||++.+. .|+.++|||||||++|||++|++||.+.+..+.+..|..
T Consensus 487 Gla~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~--------- 556 (674)
T 3pfq_A 487 GMCKENIWDGVTTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME--------- 556 (674)
T ss_dssp TTCEECCCTTCCBCCCCSCSSSCCHHHHTCC-CBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHS---------
T ss_pred ceeeccccCCcccccccCCCcccCHhhhcCC-CCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHh---------
Confidence 9998643 33345567899999999999765 489999999999999999999999999888777777654
Q ss_pred HhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCH-----HHHhCCCCCCCCC
Q 012233 364 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTA-----LEACAHPFFDDLR 427 (468)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~-----~ell~hp~f~~~~ 427 (468)
.... ++..+++++++||.+||+.||.+|+++ .|+++||||+.+.
T Consensus 557 --------~~~~------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~ 605 (674)
T 3pfq_A 557 --------HNVA------------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID 605 (674)
T ss_dssp --------SCCC------------CCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCC
T ss_pred --------CCCC------------CCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCC
Confidence 1112 345689999999999999999999997 9999999999864
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-47 Score=375.83 Aligned_cols=244 Identities=25% Similarity=0.397 Sum_probs=205.6
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc------------chHHHHHHHHHHcCCCCcccccceeeecCC
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------------RYKNRELQIMRLLNHPNVVSLKHCFFSTTE 204 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~------------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 204 (468)
.+|.+.+.||+|+||.||+|.+..+|+.||||++.... ....+|+.+++.++||||++++++|
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~----- 98 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIF----- 98 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEE-----
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----
Confidence 46999999999999999999999999999999986542 2345799999999999999999998
Q ss_pred CCceEEEEEeecccc--hHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEe
Q 012233 205 KDELYLNLVLEYISE--TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKIC 282 (468)
Q Consensus 205 ~~~~~~~lv~e~~~~--~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~ 282 (468)
.+...+++||||+.+ .+...+. ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+
T Consensus 99 ~~~~~~~lv~e~~~~g~~l~~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~-~~kL~ 172 (335)
T 3dls_A 99 ENQGFFQLVMEKHGSGLDLFAFID----RHPRLDEPLASYIFRQLVSAVGYLRL-KDIIHRDIKDENIVIAEDF-TIKLI 172 (335)
T ss_dssp ECSSEEEEEEECCTTSCBHHHHHH----TCCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTS-CEEEC
T ss_pred eeCCEEEEEEEeCCCCccHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEEeccCHHHEEEcCCC-cEEEe
Confidence 445568999999865 4444332 34569999999999999999999998 8999999999999999887 79999
Q ss_pred eecCccccCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 012233 283 DFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTRE 362 (468)
Q Consensus 283 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~ 362 (468)
|||++............+||+.|+|||++.+...++.++|||||||++|+|++|..||...... ..
T Consensus 173 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~-------- 238 (335)
T 3dls_A 173 DFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------VE-------- 238 (335)
T ss_dssp CCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------TT--------
T ss_pred ecccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------Hh--------
Confidence 9999988766666667889999999999987664588999999999999999999999652110 00
Q ss_pred HHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q 012233 363 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426 (468)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 426 (468)
... ..+..+++++.+||.+||+.||.+|||+.++++||||++.
T Consensus 239 ---------~~~------------~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 281 (335)
T 3dls_A 239 ---------AAI------------HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP 281 (335)
T ss_dssp ---------TCC------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred ---------hcc------------CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence 000 1223478999999999999999999999999999999873
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=377.45 Aligned_cols=282 Identities=26% Similarity=0.388 Sum_probs=221.0
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc---chHHHHHHHHHHcC--------CCCcccccceeeecCCC
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLLN--------HPNVVSLKHCFFSTTEK 205 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~---~~~~~E~~il~~l~--------hpnIv~l~~~~~~~~~~ 205 (468)
.+|.+.+.||+|+||+||+|.+..+++.||||++.... ....+|+.+++.++ |+||++++++|.... .
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~-~ 115 (397)
T 1wak_A 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG-V 115 (397)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE-T
T ss_pred CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC-C
Confidence 46999999999999999999999999999999997543 33457999999986 788999999885432 2
Q ss_pred CceEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcC-CccccCCCCCCeeecCCC--------
Q 012233 206 DELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV-GVCHRDIKPQNLLVNPHT-------- 276 (468)
Q Consensus 206 ~~~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~-givHrDlkp~NILl~~~~-------- 276 (468)
+..++||||||++++++..+... ....+++..++.++.||+.||.|||+ + ||+||||||+||||+.++
T Consensus 116 ~~~~~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~-~~givHrDikp~NIll~~~~~~~~~~~~ 192 (397)
T 1wak_A 116 NGTHICMVFEVLGHHLLKWIIKS--NYQGLPLPCVKKIIQQVLQGLDYLHT-KCRIIHTDIKPENILLSVNEQYIRRLAA 192 (397)
T ss_dssp TEEEEEEEECCCCCBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHH-TTCEECCCCSGGGEEECCCHHHHHHHHH
T ss_pred CCceEEEEEeccCccHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHH-hCCEecCCCCHHHeeEeccchhhhhhhh
Confidence 45678999999999988866542 23568999999999999999999998 8 999999999999998664
Q ss_pred ----------------------------------------CcEEEeeecCccccCCCCCCccccccCCccccccccCCCC
Q 012233 277 ----------------------------------------HQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATE 316 (468)
Q Consensus 277 ----------------------------------------~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 316 (468)
..+||+|||++..... .....+||+.|+|||++.+..
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~- 269 (397)
T 1wak_A 193 EATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK--HFTEDIQTRQYRSLEVLIGSG- 269 (397)
T ss_dssp HHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB--CSCSCCSCGGGCCHHHHHTSC-
T ss_pred hhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc--cCccCCCCCcccCChhhcCCC-
Confidence 2699999999987643 344568999999999998765
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCC------cHHHHHHHHHHhCCCCHHHHhhcCCCCccC-------CCCcccCCC
Q 012233 317 YTTAIDMWSIGCVLAELLLGQPLFPGES------GVDQLVEIIKILGTPTREEIKCMNPNYTEF-------KFPQIKAHP 383 (468)
Q Consensus 317 ~~~~~DvwSlG~il~ell~G~~pf~~~~------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~ 383 (468)
++.++|||||||++|+|++|+.||...+ ..+.+..+...++.++...+........-+ .+.......
T Consensus 270 ~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (397)
T 1wak_A 270 YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWG 349 (397)
T ss_dssp CCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCC
T ss_pred CCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcc
Confidence 8999999999999999999999998755 456777888888888776543321110000 000000000
Q ss_pred ccc------ccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q 012233 384 WHK------IFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDD 425 (468)
Q Consensus 384 ~~~------~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~ 425 (468)
... .++...++.+.+||.+||+.||.+|||+.|+|+||||++
T Consensus 350 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 350 LFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp HHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred hhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 000 112334567899999999999999999999999999964
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-47 Score=371.85 Aligned_cols=262 Identities=26% Similarity=0.335 Sum_probs=208.8
Q ss_pred cceEEe-ceecccCceEEEEEEEcCCCCEEEEEEeecc------cchHHHHHHHHHHcC-CCCcccccceeeecCCCCce
Q 012233 137 ISYMAE-RVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLN-HPNVVSLKHCFFSTTEKDEL 208 (468)
Q Consensus 137 ~~y~~~-~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~------~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~~~ 208 (468)
..|.+. +.||+|+||.||+|.+..+|+.||+|++... .....+|+.+++.+. ||||+++++++ .+..
T Consensus 28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~-----~~~~ 102 (327)
T 3lm5_A 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY-----ENTS 102 (327)
T ss_dssp HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECSS
T ss_pred hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE-----EeCC
Confidence 358887 8999999999999999999999999998643 234567999999995 69999999998 4445
Q ss_pred EEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecC---CCCcEEEeeec
Q 012233 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNP---HTHQLKICDFG 285 (468)
Q Consensus 209 ~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~---~~~~vkL~DFG 285 (468)
.+++||||+.++.+..... ......+++..++.++.||+.||.|||+ +||+||||||+||||+. ++ .+||+|||
T Consensus 103 ~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~i~~ql~~~L~~LH~-~givH~Dikp~NIl~~~~~~~~-~~kL~Dfg 179 (327)
T 3lm5_A 103 EIILILEYAAGGEIFSLCL-PELAEMVSENDVIRLIKQILEGVYYLHQ-NNIVHLDLKPQNILLSSIYPLG-DIKIVDFG 179 (327)
T ss_dssp EEEEEEECCTTEEGGGGGS-SCC-CCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEESCBTTBC-CEEECCGG
T ss_pred eEEEEEEecCCCcHHHHHH-HhcccCCCHHHHHHHHHHHHHHHHHHHH-CCeecCcCChHHEEEecCCCCC-cEEEeeCc
Confidence 6899999998754432211 1224668999999999999999999998 89999999999999987 45 79999999
Q ss_pred CccccCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 012233 286 SAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIK 365 (468)
Q Consensus 286 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 365 (468)
++.............||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+........
T Consensus 180 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~----- 253 (327)
T 3lm5_A 180 MSRKIGHACELREIMGTPEYLAPEILNYD-PITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYS----- 253 (327)
T ss_dssp GCEEC---------CCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC-----
T ss_pred cccccCCccccccccCCcCccCCeeecCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccC-----
Confidence 99877655555567899999999999655 489999999999999999999999999887777766655221111
Q ss_pred hcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCCCCC
Q 012233 366 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNTC 432 (468)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~~ 432 (468)
......+++.+.+||.+||+.||.+|||+.++|+||||+++......
T Consensus 254 --------------------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~~~~ 300 (327)
T 3lm5_A 254 --------------------EETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLF 300 (327)
T ss_dssp --------------------TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTTCC-
T ss_pred --------------------chhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccccccccc
Confidence 11224578999999999999999999999999999999987665443
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=368.31 Aligned_cols=258 Identities=27% Similarity=0.418 Sum_probs=196.1
Q ss_pred ccceEEe-ceecccCceEEEEEEEcCCCCEEEEEEeeccc----chHHHHHHHHHHc-CCCCcccccceeeecCCCCceE
Q 012233 136 TISYMAE-RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK----RYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDELY 209 (468)
Q Consensus 136 ~~~y~~~-~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~----~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~~~~ 209 (468)
...|.+. +.||+|+||.||+|.+..+++.||||++.... ....+|+.+++++ +||||+++++++.. ...
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~-----~~~ 85 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEE-----EDR 85 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEee-----CCE
Confidence 3469885 78999999999999999999999999986542 3456799999885 79999999999843 345
Q ss_pred EEEEeecccc-hHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCC--cEEEeeecC
Q 012233 210 LNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTH--QLKICDFGS 286 (468)
Q Consensus 210 ~~lv~e~~~~-~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~--~vkL~DFG~ 286 (468)
+|+||||+.+ .+.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++. .+||+|||+
T Consensus 86 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~ 160 (316)
T 2ac3_A 86 FYLVFEKMRGGSILSHIHK----RRHFNELEASVVVQDVASALDFLHN-KGIAHRDLKPENILCEHPNQVSPVKICDFDL 160 (316)
T ss_dssp EEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEESCSSSSCSEEECCTTC
T ss_pred EEEEEEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCHHHEEEccCCCcCceEEEEccC
Confidence 8999999985 55554432 3568999999999999999999998 89999999999999987662 399999999
Q ss_pred ccccCCCC--------CCccccccCCccccccccCC----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcH--------
Q 012233 287 AKMLVPGE--------PNISYICSRYYRAPELIFGA----TEYTTAIDMWSIGCVLAELLLGQPLFPGESGV-------- 346 (468)
Q Consensus 287 a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~----~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~-------- 346 (468)
+....... .....+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~ 240 (316)
T 2ac3_A 161 GSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGE 240 (316)
T ss_dssp CC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----
T ss_pred ccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccc
Confidence 87653211 12245689999999998641 23789999999999999999999999875431
Q ss_pred ------HH-HHHHHHHhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 347 ------DQ-LVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 347 ------~~-~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
.. ...+... ...++ ...+..+++++++||.+||+.||.+|||+.|+|+
T Consensus 241 ~~~~~~~~~~~~i~~~-----------------~~~~~--------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 241 ACPACQNMLFESIQEG-----------------KYEFP--------DKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp CCHHHHHHHHHHHHHC-----------------CCCCC--------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred cchhHHHHHHHHHhcc-----------------CcccC--------chhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 11 1222110 11111 0112457899999999999999999999999999
Q ss_pred CCCCCCCCC
Q 012233 420 HPFFDDLRD 428 (468)
Q Consensus 420 hp~f~~~~~ 428 (468)
||||++...
T Consensus 296 hp~~~~~~~ 304 (316)
T 2ac3_A 296 HPWVQGCAP 304 (316)
T ss_dssp STTCC----
T ss_pred ChhhcCCCC
Confidence 999997643
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=362.46 Aligned_cols=258 Identities=28% Similarity=0.423 Sum_probs=212.8
Q ss_pred ccceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-------------chHHHHHHHHHHcC-CCCcccccceeee
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------------RYKNRELQIMRLLN-HPNVVSLKHCFFS 201 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-------------~~~~~E~~il~~l~-hpnIv~l~~~~~~ 201 (468)
..+|.+.+.||+|+||.||+|.+..+|+.||||++.... ....+|+.+++.+. ||||+++++++
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~-- 93 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY-- 93 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE--
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee--
Confidence 457999999999999999999999999999999985432 23347999999996 99999999988
Q ss_pred cCCCCceEEEEEeecccc-hHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEE
Q 012233 202 TTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLK 280 (468)
Q Consensus 202 ~~~~~~~~~~lv~e~~~~-~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vk 280 (468)
.+....++||||+.+ .+.+.+.. ...+++..++.++.||+.||.|||+ +||+|+||||+|||++.++ .+|
T Consensus 94 ---~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~~~-~~k 164 (298)
T 1phk_A 94 ---ETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHK-LNIVHRDLKPENILLDDDM-NIK 164 (298)
T ss_dssp ---ECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTC-CEE
T ss_pred ---ccCCeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCcceEEEcCCC-cEE
Confidence 445568999999986 45444432 3568999999999999999999998 8999999999999999888 799
Q ss_pred EeeecCccccCCCCCCccccccCCcccccccc-----CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHH
Q 012233 281 ICDFGSAKMLVPGEPNISYICSRYYRAPELIF-----GATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKI 355 (468)
Q Consensus 281 L~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~ 355 (468)
|+|||++.............|++.|+|||++. ....++.++|||||||++|+|++|..||...+..+....+...
T Consensus 165 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 244 (298)
T 1phk_A 165 LTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG 244 (298)
T ss_dssp ECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred EecccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcC
Confidence 99999998776665666678999999999985 2345789999999999999999999999887766665555442
Q ss_pred hCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCC
Q 012233 356 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDP 429 (468)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~ 429 (468)
. ..++. ..+..+++++.+||.+||+.||.+|||+.++++||||++...+
T Consensus 245 ~-----------------~~~~~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~ 293 (298)
T 1phk_A 245 N-----------------YQFGS--------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVE 293 (298)
T ss_dssp C-----------------CCCCT--------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC--
T ss_pred C-----------------cccCc--------ccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccch
Confidence 1 11110 0123478999999999999999999999999999999986543
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=365.94 Aligned_cols=266 Identities=26% Similarity=0.396 Sum_probs=215.2
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc--------cchHHHHHHHHHHcCCCCcccccceeeecCCCCce
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD--------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~--------~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 208 (468)
.+|.+.+.||+|+||.||+|.+..++..||+|++... .....+|+.+++.++||||+++++++... +..
T Consensus 5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~~ 81 (305)
T 2wtk_C 5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNE---EKQ 81 (305)
T ss_dssp CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC------
T ss_pred cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcC---CCC
Confidence 4699999999999999999999999999999998543 23456899999999999999999987532 233
Q ss_pred EEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcc
Q 012233 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (468)
Q Consensus 209 ~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~ 288 (468)
..|+||||+.+++.+.+.... ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++.
T Consensus 82 ~~~lv~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~-~~i~H~dlkp~NIl~~~~~-~~kl~dfg~~~ 157 (305)
T 2wtk_C 82 KMYMVMEYCVCGMQEMLDSVP--EKRFPVCQAHGYFCQLIDGLEYLHS-QGIVHKDIKPGNLLLTTGG-TLKISALGVAE 157 (305)
T ss_dssp CEEEEEECCSEEHHHHHHHST--TCSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTC-CEEECCCTTCE
T ss_pred eEEEEehhccCCHHHHHHhCc--ccccCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCcccEEEcCCC-cEEeecccccc
Confidence 588999999998776655432 4668999999999999999999998 8999999999999999888 79999999998
Q ss_pred ccCCCC---CCccccccCCccccccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 012233 289 MLVPGE---PNISYICSRYYRAPELIFGAT-EYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEI 364 (468)
Q Consensus 289 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~-~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 364 (468)
...... ......||+.|+|||++.+.. .++.++|||||||++|+|++|+.||.+.+..+....+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~--------- 228 (305)
T 2wtk_C 158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKG--------- 228 (305)
T ss_dssp ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC---------
T ss_pred ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcC---------
Confidence 764322 223457899999999986533 2477999999999999999999999987766655554431
Q ss_pred hhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCCCCCCCCCCC
Q 012233 365 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNTCLPNGRP 438 (468)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~~~~~~~~ 438 (468)
... ++..+++.+.+||.+||+.||.+|||+.++++||||++...+.......++
T Consensus 229 --------~~~------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~~~~~~~~~ 282 (305)
T 2wtk_C 229 --------SYA------------IPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPVPIPP 282 (305)
T ss_dssp --------CCC------------CCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC-CCCCCCCC
T ss_pred --------CCC------------CCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCCCcCCCCCCCC
Confidence 111 234578999999999999999999999999999999987665544333333
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-47 Score=364.44 Aligned_cols=257 Identities=25% Similarity=0.407 Sum_probs=208.3
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc----------cchHHHHHHHHHHcCCCCcccccceeeecCCCC
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD 206 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~----------~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 206 (468)
++|.+.+.||+|+||.||+|.+..+|+.||+|++... ...+.+|+.+++.++||||+++++++. +
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~ 79 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFE-----N 79 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----C
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheec-----C
Confidence 3699999999999999999999999999999998543 234568999999999999999999983 4
Q ss_pred ceEEEEEeecccc-hHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCC---cEEEe
Q 012233 207 ELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTH---QLKIC 282 (468)
Q Consensus 207 ~~~~~lv~e~~~~-~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~---~vkL~ 282 (468)
....++||||+.+ .+.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++. .+||+
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~~~~~~kl~ 154 (283)
T 3bhy_A 80 KTDVVLILELVSGGELFDFLAE----KESLTEDEATQFLKQILDGVHYLHS-KRIAHFDLKPENIMLLDKNVPNPRIKLI 154 (283)
T ss_dssp SSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESCSSSSSCCEEEC
T ss_pred CCeEEEEEeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCChHHEEEecCCCCCCceEEE
Confidence 4468999999975 45444332 3568999999999999999999998 89999999999999987652 59999
Q ss_pred eecCccccCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 012233 283 DFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTRE 362 (468)
Q Consensus 283 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~ 362 (468)
|||++.............|++.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+.......
T Consensus 155 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--- 230 (283)
T 3bhy_A 155 DFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDF--- 230 (283)
T ss_dssp CCTTCEECC--------CCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCC---
T ss_pred ecccceeccCCCcccccCCCcCccCcceecCC-CCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCC---
Confidence 99999877555555567799999999999655 48999999999999999999999999887666655543311110
Q ss_pred HHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCC
Q 012233 363 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDP 429 (468)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~ 429 (468)
...+...+++.+.+||.+||+.||.+|||+.++++||||+.++..
T Consensus 231 ----------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~ 275 (283)
T 3bhy_A 231 ----------------------DEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRR 275 (283)
T ss_dssp ----------------------CHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHC
T ss_pred ----------------------cchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHH
Confidence 111334578999999999999999999999999999999986544
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-46 Score=373.48 Aligned_cols=289 Identities=28% Similarity=0.470 Sum_probs=221.4
Q ss_pred CcccceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc---chHHHHHHHHHHcC-----------CCCccccccee
Q 012233 134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLLN-----------HPNVVSLKHCF 199 (468)
Q Consensus 134 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~---~~~~~E~~il~~l~-----------hpnIv~l~~~~ 199 (468)
....+|.+.+.||+|+||.||+|.+..+++.||||++.... ....+|+.+++.+. ||||+++++++
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~ 95 (373)
T 1q8y_A 16 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 95 (373)
T ss_dssp ETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred ccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence 34457999999999999999999999999999999987543 33457999998886 89999999998
Q ss_pred eecCCCCceEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcC-CccccCCCCCCeeecCCC--
Q 012233 200 FSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV-GVCHRDIKPQNLLVNPHT-- 276 (468)
Q Consensus 200 ~~~~~~~~~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~-givHrDlkp~NILl~~~~-- 276 (468)
.... .+..++++||||+++++...+.... ...+++..++.++.||+.||.|||+ + ||+||||||+||||+.++
T Consensus 96 ~~~~-~~~~~~~lv~e~~~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~-~~~ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 96 NHKG-PNGVHVVMVFEVLGENLLALIKKYE--HRGIPLIYVKQISKQLLLGLDYMHR-RCGIIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEEE-TTEEEEEEEECCCCEEHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHH-TTCEECSCCSGGGEEEEEEETT
T ss_pred hccC-CCCceEEEEEecCCCCHHHHHHHhh--ccCCcHHHHHHHHHHHHHHHHHHHh-cCCEEecCCChHHeEEeccCCC
Confidence 6543 3445789999999888887665432 3458999999999999999999998 8 999999999999995322
Q ss_pred ---CcEEEeeecCccccCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC------cHH
Q 012233 277 ---HQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGES------GVD 347 (468)
Q Consensus 277 ---~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~------~~~ 347 (468)
..+||+|||++..... ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+.+ ..+
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 248 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 248 (373)
T ss_dssp TTEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCC-CCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred cCcceEEEcccccccccCC--CCCCCCCCccccCcHHHhCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHH
Confidence 2699999999986643 334568899999999997655 8999999999999999999999998654 456
Q ss_pred HHHHHHHHhCCCCHHHHhhcCCCC-------ccCCCCcccCCCccc------ccccCCCHHHHHHHHHhcccCCCCCCCH
Q 012233 348 QLVEIIKILGTPTREEIKCMNPNY-------TEFKFPQIKAHPWHK------IFHKRMPPEALDLVSRLLQYSPSLRCTA 414 (468)
Q Consensus 348 ~~~~i~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~~L~~dP~~R~s~ 414 (468)
.+..++..++.++...+....... .-..+......+... .++..+++++.+||.+||+.||.+|||+
T Consensus 249 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~ 328 (373)
T 1q8y_A 249 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 328 (373)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCH
Confidence 778888888887765543211100 000000111111110 1233456789999999999999999999
Q ss_pred HHHhCCCCCCCCCCC
Q 012233 415 LEACAHPFFDDLRDP 429 (468)
Q Consensus 415 ~ell~hp~f~~~~~~ 429 (468)
.|+|+||||++....
T Consensus 329 ~ell~hp~f~~~~~~ 343 (373)
T 1q8y_A 329 GGLVNHPWLKDTLGM 343 (373)
T ss_dssp HHHHTCGGGTTCTTC
T ss_pred HHHhhChhhhcccCc
Confidence 999999999986443
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-47 Score=372.87 Aligned_cols=276 Identities=21% Similarity=0.290 Sum_probs=205.6
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-----chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEE
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 211 (468)
.+|.+.+.||+|+||.||+|.+..+|+.||||++.... ....+|+.+++.++||||+++++++... +..++|
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~~~~ 85 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEET---TTRHKV 85 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECT---TTCCEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecC---CCceEE
Confidence 36999999999999999999999999999999986432 3345899999999999999999987543 233578
Q ss_pred EEeecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeee----cCCCCcEEEeeecC
Q 012233 212 LVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLV----NPHTHQLKICDFGS 286 (468)
Q Consensus 212 lv~e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl----~~~~~~vkL~DFG~ 286 (468)
+||||+.++ +...+.. ......+++..++.++.||+.||.|||+ +||+||||||+|||| +.++ .+||+|||+
T Consensus 86 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~~~~~-~~kL~Dfg~ 162 (319)
T 4euu_A 86 LIMEFCPCGSLYTVLEE-PSNAYGLPESEFLIVLRDVVGGMNHLRE-NGIVHRNIKPGNIMRVIGEDGQS-VYKLTDFGA 162 (319)
T ss_dssp EEEECCTTCBHHHHHHS-GGGTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEECTTSCE-EEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHH-hccccCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHEEEeccCCCCc-eEEEccCCC
Confidence 999999864 4444433 3334448999999999999999999998 899999999999998 6555 699999999
Q ss_pred ccccCCCCCCccccccCCccccccccC-------CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCc----HHHHHHHHHH
Q 012233 287 AKMLVPGEPNISYICSRYYRAPELIFG-------ATEYTTAIDMWSIGCVLAELLLGQPLFPGESG----VDQLVEIIKI 355 (468)
Q Consensus 287 a~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~----~~~~~~i~~~ 355 (468)
++............||+.|+|||++.. ...++.++|||||||++|||++|+.||..... .+.+..+...
T Consensus 163 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (319)
T 4euu_A 163 ARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (319)
T ss_dssp CEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred ceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence 988766666667789999999999852 24589999999999999999999999975433 3334444332
Q ss_pred hCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCC
Q 012233 356 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPF 422 (468)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~ 422 (468)
.............. ..+.+. ...+....+...+++.+.+||.+||+.||.+|||+.|+|+||-
T Consensus 243 ~p~~~~~~~~~~~~--~~~~~~--~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 243 KPSGAISGVQKAEN--GPIDWS--GDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp CCTTCCEEEECSTT--CCEEEE--SSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred CCcccchhhhcccC--CccccC--ccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 11100000000000 000000 0000111123445678999999999999999999999999874
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=361.76 Aligned_cols=253 Identities=28% Similarity=0.458 Sum_probs=211.3
Q ss_pred CcccceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc-------cchHHHHHHHHHHcCCCCcccccceeeecCCCC
Q 012233 134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD 206 (468)
Q Consensus 134 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~-------~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 206 (468)
....+|.+.+.||+|+||.||+|.+..++..||+|++... .....+|+.+++.++||||+++++++ .+
T Consensus 11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~ 85 (284)
T 2vgo_A 11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYF-----HD 85 (284)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----EC
T ss_pred hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEE-----Ec
Confidence 4456799999999999999999999999999999998543 23456899999999999999999998 34
Q ss_pred ceEEEEEeecccc-hHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeec
Q 012233 207 ELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG 285 (468)
Q Consensus 207 ~~~~~lv~e~~~~-~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG 285 (468)
...+++||||+.+ .+.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||
T Consensus 86 ~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~~~-~~kl~Dfg 159 (284)
T 2vgo_A 86 RKRIYLMLEFAPRGELYKELQK----HGRFDEQRSATFMEELADALHYCHE-RKVIHRDIKPENLLMGYKG-ELKIADFG 159 (284)
T ss_dssp SSEEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCSGGGEEECTTC-CEEECCCT
T ss_pred CCEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCHHHEEEcCCC-CEEEeccc
Confidence 4568999999986 55554432 3468999999999999999999998 8999999999999999888 79999999
Q ss_pred CccccCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 012233 286 SAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIK 365 (468)
Q Consensus 286 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 365 (468)
++..... .......|++.|+|||++.+.. ++.++|||||||++|+|++|..||...+..+....+...
T Consensus 160 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~---------- 227 (284)
T 2vgo_A 160 WSVHAPS-LRRRTMCGTLDYLPPEMIEGKT-HDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV---------- 227 (284)
T ss_dssp TCEECSS-SCBCCCCSCGGGCCHHHHTTCC-BCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT----------
T ss_pred ccccCcc-cccccccCCCCcCCHHHhccCC-CCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhcc----------
Confidence 9876533 2334568899999999997654 899999999999999999999999887766655544331
Q ss_pred hcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCC
Q 012233 366 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRD 428 (468)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~ 428 (468)
... ++..+++++++||.+||+.||.+|||+.++++||||+....
T Consensus 228 -------~~~------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~ 271 (284)
T 2vgo_A 228 -------DLK------------FPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSR 271 (284)
T ss_dssp -------CCC------------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHCC
T ss_pred -------ccC------------CCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhcc
Confidence 111 23457899999999999999999999999999999986443
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=360.94 Aligned_cols=252 Identities=29% Similarity=0.465 Sum_probs=184.2
Q ss_pred ccceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-------chHHHHHHHHHHcCCCCcccccceeeecCCCCce
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 208 (468)
..+|.+.+.||+|+||.||+|.+..+|+.||||++.... ....+|+.+++.++||||+++++++ .+..
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~ 84 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYF-----EDSN 84 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEE-----ECSS
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEE-----ccCC
Confidence 456999999999999999999999999999999985432 3456799999999999999999998 4445
Q ss_pred EEEEEeecccchHH-HHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCc
Q 012233 209 YLNLVLEYISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (468)
Q Consensus 209 ~~~lv~e~~~~~ll-~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a 287 (468)
..++||||+.++.+ ..+. .....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++
T Consensus 85 ~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nili~~~~-~~kl~dfg~~ 159 (278)
T 3cok_A 85 YVYLVLEMCHNGEMNRYLK---NRVKPFSENEARHFMHQIITGMLYLHS-HGILHRDLTLSNLLLTRNM-NIKIADFGLA 159 (278)
T ss_dssp EEEEEEECCTTEEHHHHHH---TCSSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSSCCGGGEEECTTC-CEEECCCTTC
T ss_pred eEEEEEecCCCCcHHHHHh---hccCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcCCC-CEEEEeecce
Confidence 68999999986544 3332 223568999999999999999999998 8999999999999999888 7999999999
Q ss_pred cccCCC-CCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 012233 288 KMLVPG-EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKC 366 (468)
Q Consensus 288 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 366 (468)
...... .......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||......+.+..+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------------ 226 (278)
T 3cok_A 160 TQLKMPHEKHYTLCGTPNYISPEIATRSA-HGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVL------------ 226 (278)
T ss_dssp EECC-----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCS------------
T ss_pred eeccCCCCcceeccCCCCcCCcchhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhh------------
Confidence 866432 2334567899999999986554 89999999999999999999999987654332221100
Q ss_pred cCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q 012233 367 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (468)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~ 427 (468)
... .++..++.++.+||.+||+.||.+|||+.++++||||.+..
T Consensus 227 -----~~~------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 270 (278)
T 3cok_A 227 -----ADY------------EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNS 270 (278)
T ss_dssp -----SCC------------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC---
T ss_pred -----ccc------------CCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCCC
Confidence 011 12345789999999999999999999999999999998743
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-46 Score=358.59 Aligned_cols=252 Identities=23% Similarity=0.340 Sum_probs=206.0
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc------chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 211 (468)
.|.+.+.||+|+||.||+|.+..++..||+|.+.... ..+.+|+.+++.++||||+++++++.... .+..+++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~~ 105 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIV 105 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSCEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecccc-CCCceEE
Confidence 4999999999999999999999999999999986432 23457999999999999999999885543 3456789
Q ss_pred EEeecccc-hHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCC--ccccCCCCCCeeec-CCCCcEEEeeecCc
Q 012233 212 LVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG--VCHRDIKPQNLLVN-PHTHQLKICDFGSA 287 (468)
Q Consensus 212 lv~e~~~~-~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~g--ivHrDlkp~NILl~-~~~~~vkL~DFG~a 287 (468)
+||||+.+ ++.+.+.. ...+++..++.++.||+.||.|||+ .| |+||||||+|||++ .++ .+||+|||++
T Consensus 106 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~~~i~H~dikp~Nil~~~~~~-~~kl~Dfg~~ 179 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTG-SVKIGDLGLA 179 (290)
T ss_dssp EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-SSSCCCCSCCCGGGEEESSTTS-CEEECCTTGG
T ss_pred EEEEecCCCCHHHHHHH----ccCCCHHHHHHHHHHHHHHHHHHHc-CCCCEEECCCCHHHEEEECCCC-CEEEeeCCCc
Confidence 99999976 44444332 3568999999999999999999998 88 99999999999998 555 7999999999
Q ss_pred cccCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 012233 288 KMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367 (468)
Q Consensus 288 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 367 (468)
..... .......||+.|+|||++.+ .++.++|||||||++|+|++|+.||............+.....
T Consensus 180 ~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~--------- 247 (290)
T 1t4h_A 180 TLKRA-SFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK--------- 247 (290)
T ss_dssp GGCCT-TSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC---------
T ss_pred ccccc-cccccccCCcCcCCHHHHhc--cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCC---------
Confidence 75433 33445679999999998864 3899999999999999999999999886666555443321100
Q ss_pred CCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q 012233 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDD 425 (468)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~ 425 (468)
...++...++++.+||.+||+.||.+|||+.++++||||++
T Consensus 248 -----------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 248 -----------------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp -----------------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred -----------------ccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence 01134457889999999999999999999999999999986
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-46 Score=357.15 Aligned_cols=257 Identities=27% Similarity=0.324 Sum_probs=205.9
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-----chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEE
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 211 (468)
.+|.+.+.||+|+||.||+|.+..+++.||||++.... ....+|+.+++.++||||+++++++.. ....|
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 81 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE-----GNIQY 81 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEEE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEc-----CCEEE
Confidence 46999999999999999999999999999999985432 345679999999999999999998843 34588
Q ss_pred EEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccC
Q 012233 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (468)
Q Consensus 212 lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~ 291 (468)
+||||+.++.+. .+......+++..++.++.||+.||.|||+ +||+|+||||+|||++.++ .+||+|||++....
T Consensus 82 lv~e~~~~~~L~---~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~Nil~~~~~-~~kl~dfg~~~~~~ 156 (276)
T 2yex_A 82 LFLEYCSGGELF---DRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERD-NLKISDFGLATVFR 156 (276)
T ss_dssp EEEECCTTEEGG---GGSBTTTBCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTC-CEEECCCTTCEECE
T ss_pred EEEEecCCCcHH---HHHhhccCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCChHHEEEccCC-CEEEeeCCCccccC
Confidence 999999875332 222334568999999999999999999998 8999999999999999888 79999999997653
Q ss_pred CC---CCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 012233 292 PG---EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368 (468)
Q Consensus 292 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 368 (468)
.. .......|++.|+|||++.+...++.++|||||||++|+|++|..||................
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~------------ 224 (276)
T 2yex_A 157 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK------------ 224 (276)
T ss_dssp ETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTT------------
T ss_pred CCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhc------------
Confidence 22 123456789999999999766545789999999999999999999998765433222211100
Q ss_pred CCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCC
Q 012233 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDP 429 (468)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~ 429 (468)
....+ .+..+++.+.+||.+||+.||.+|||+.|+++||||++....
T Consensus 225 ----~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~ 271 (276)
T 2yex_A 225 ----KTYLN----------PWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKK 271 (276)
T ss_dssp ----CTTST----------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC-
T ss_pred ----ccccC----------chhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccChhhc
Confidence 00000 123478999999999999999999999999999999986443
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=360.34 Aligned_cols=252 Identities=29% Similarity=0.417 Sum_probs=200.6
Q ss_pred cccceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-------chHHHHHHHHHHcCCCCcccccceeeecCCCCc
Q 012233 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (468)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 207 (468)
...+|.+.+.||+|+||.||+|.+..+|+.||||++.... ....+|+.+++.++||||+++++++. ..
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~ 83 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIS-----TP 83 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CS
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEe-----cC
Confidence 3457999999999999999999999999999999985432 24467999999999999999999883 34
Q ss_pred eEEEEEeecccc-hHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecC
Q 012233 208 LYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (468)
Q Consensus 208 ~~~~lv~e~~~~-~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~ 286 (468)
...|+||||+.+ ++.+.+.. ...+++..++.++.||+.||.|||+ +||+|+||||+|||++.++ .+||+|||+
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~~~-~~~l~dfg~ 157 (276)
T 2h6d_A 84 TDFFMVMEYVSGGELFDYICK----HGRVEEMEARRLFQQILSAVDYCHR-HMVVHRDLKPENVLLDAHM-NAKIADFGL 157 (276)
T ss_dssp SEEEEEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-HCSSCCCCCGGGEEECTTS-CEEECCCCG
T ss_pred CeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCChhhEEECCCC-CEEEeeccc
Confidence 468999999976 55554432 3568999999999999999999998 8999999999999999888 799999999
Q ss_pred ccccCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 012233 287 AKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKC 366 (468)
Q Consensus 287 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 366 (468)
+.............|++.|+|||++.+....+.++|||||||++|+|++|..||......+....+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~----------- 226 (276)
T 2h6d_A 158 SNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGG----------- 226 (276)
T ss_dssp GGCCCC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----------
T ss_pred ccccCCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC-----------
Confidence 987765554556788999999999976654478999999999999999999999887665554444331
Q ss_pred cCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q 012233 367 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426 (468)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 426 (468)
... ++..++..+.+||.+||+.||.+|||+.++++||||++.
T Consensus 227 ------~~~------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 227 ------VFY------------IPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD 268 (276)
T ss_dssp ------CCC------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred ------ccc------------CchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence 001 234578999999999999999999999999999999763
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=368.29 Aligned_cols=255 Identities=32% Similarity=0.481 Sum_probs=204.0
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc------------chHHHHHHHHHHcCCCCcccccceeeecCC
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------------RYKNRELQIMRLLNHPNVVSLKHCFFSTTE 204 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~------------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 204 (468)
.+|.+.+.||+|+||.||+|.+..+++.||||++.... ..+.+|+.+++.++||||+++++++..
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--- 86 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA--- 86 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES---
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC---
Confidence 46999999999999999999999999999999985432 235689999999999999999998732
Q ss_pred CCceEEEEEeecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCC--cEEE
Q 012233 205 KDELYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTH--QLKI 281 (468)
Q Consensus 205 ~~~~~~~lv~e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~--~vkL 281 (468)
.. .|+||||+.++ +.+.+. ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++. .+||
T Consensus 87 --~~-~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~NIl~~~~~~~~~~kl 158 (322)
T 2ycf_A 87 --ED-YYIVLELMEGGELFDKVV----GNKRLKEATCKLYFYQMLLAVQYLHE-NGIIHRDLKPENVLLSSQEEDCLIKI 158 (322)
T ss_dssp --SS-EEEEEECCTTEETHHHHS----TTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESSSSSSCCEEE
T ss_pred --Cc-eEEEEecCCCCcHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHEEEecCCCCCeEEE
Confidence 22 68999999864 444332 24678999999999999999999998 89999999999999986652 4999
Q ss_pred eeecCccccCCCCCCccccccCCcccccccc--CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Q 012233 282 CDFGSAKMLVPGEPNISYICSRYYRAPELIF--GATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTP 359 (468)
Q Consensus 282 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~ 359 (468)
+|||++.............||+.|+|||++. +...++.++|||||||++|+|++|..||........+...+......
T Consensus 159 ~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 238 (322)
T 2ycf_A 159 TDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN 238 (322)
T ss_dssp CCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCC
T ss_pred ccCccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccc
Confidence 9999998765443334567899999999974 34458999999999999999999999998765443333322211110
Q ss_pred CHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q 012233 360 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426 (468)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 426 (468)
+....+..+++++.+||.+||+.||.+|||+.++|+||||++.
T Consensus 239 ------------------------~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~ 281 (322)
T 2ycf_A 239 ------------------------FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 281 (322)
T ss_dssp ------------------------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCH
T ss_pred ------------------------cCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCH
Confidence 0111234589999999999999999999999999999999863
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=358.67 Aligned_cols=252 Identities=19% Similarity=0.256 Sum_probs=201.9
Q ss_pred cccceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc------cchHHHHHHHHHHc-CCCCcccccceeeecCCCCc
Q 012233 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDE 207 (468)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~------~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~~ 207 (468)
...+|.+.+.||+|+||.||+|.+..+++.||||++... .....+|+.++..+ +||||+++++++.. .
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~-----~ 83 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAE-----D 83 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEE-----T
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeec-----C
Confidence 445799999999999999999999999999999998643 22345688888888 89999999998843 3
Q ss_pred eEEEEEeecccc-hHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCC----------
Q 012233 208 LYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHT---------- 276 (468)
Q Consensus 208 ~~~~lv~e~~~~-~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~---------- 276 (468)
..+++||||+.+ ++.+.+.........+++..++.++.||+.||.|||+ +||+||||||+|||++.++
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dikp~NIl~~~~~~~~~~~~~~~ 162 (289)
T 1x8b_A 84 DHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS-MSLVHMDIKPSNIFISRTSIPNAASEEGD 162 (289)
T ss_dssp TEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEC-------------
T ss_pred CeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh-CCEeecCCCHHHEEEcCCCCCcccccccc
Confidence 358899999976 6666665554445779999999999999999999998 8999999999999998432
Q ss_pred --------CcEEEeeecCccccCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHH
Q 012233 277 --------HQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQ 348 (468)
Q Consensus 277 --------~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~ 348 (468)
..+||+|||.+...... ....||+.|+|||++.+...++.++|||||||++|+|++|.+++.....
T Consensus 163 ~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~--- 236 (289)
T 1x8b_A 163 EDDWASNKVMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ--- 236 (289)
T ss_dssp -------CCCEEECCCTTCEETTCS---CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---
T ss_pred cccccCCceEEEEcccccccccCCc---cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---
Confidence 26999999999876432 2356899999999997765577899999999999999999988754432
Q ss_pred HHHHHHHhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q 012233 349 LVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426 (468)
Q Consensus 349 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 426 (468)
...+... .++ .++..+++++.+||.+||+.||.+|||+.++++||||++.
T Consensus 237 ~~~~~~~-------------------~~~---------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 237 WHEIRQG-------------------RLP---------RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA 286 (289)
T ss_dssp HHHHHTT-------------------CCC---------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred HHHHHcC-------------------CCC---------CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence 2222110 011 1345689999999999999999999999999999999874
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-46 Score=365.70 Aligned_cols=280 Identities=29% Similarity=0.507 Sum_probs=218.8
Q ss_pred cceEEeceecccCceEEEEEEE-cCCCCEEEEEEeeccc---chHHHHHHHHHHcCCCC------cccccceeeecCCCC
Q 012233 137 ISYMAERVVGTGSFGVVFQAKC-LETGDSVAIKKVLQDK---RYKNRELQIMRLLNHPN------VVSLKHCFFSTTEKD 206 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~-~~~g~~vaiK~~~~~~---~~~~~E~~il~~l~hpn------Iv~l~~~~~~~~~~~ 206 (468)
.+|.+.+.||+|+||.||+|.+ ..+|+.||||++.... ....+|+.+++.++|++ |+++++++. .
T Consensus 14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~-----~ 88 (339)
T 1z57_A 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFE-----H 88 (339)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEE-----E
T ss_pred CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccc-----c
Confidence 3699999999999999999998 5688999999986543 34457999999987654 899998883 3
Q ss_pred ceEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecC------------
Q 012233 207 ELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNP------------ 274 (468)
Q Consensus 207 ~~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~------------ 274 (468)
..++|+||||+++++.+.+.... ...+++..++.++.||+.||.|||+ +||+||||||+|||++.
T Consensus 89 ~~~~~lv~e~~~~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~ 165 (339)
T 1z57_A 89 HGHICIVFELLGLSTYDFIKENG--FLPFRLDHIRKMAYQICKSVNFLHS-NKLTHTDLKPENILFVQSDYTEAYNPKIK 165 (339)
T ss_dssp TTEEEEEEECCCCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESCCCEEEEEC----
T ss_pred CCcEEEEEcCCCCCHHHHHHhcC--CCCCcHHHHHHHHHHHHHHHHHHHH-CCCcCCCCCHHHEEEeccccccccCCccc
Confidence 34689999999888887665422 2468899999999999999999998 89999999999999986
Q ss_pred -------CCCcEEEeeecCccccCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHH
Q 012233 275 -------HTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVD 347 (468)
Q Consensus 275 -------~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~ 347 (468)
++ .+||+|||++..... ......||+.|+|||++.+.. ++.++|||||||++|||++|..||...+..+
T Consensus 166 ~~~~~~~~~-~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 241 (339)
T 1z57_A 166 RDERTLINP-DIKVVDFGSATYDDE--HHSTLVSTRHYRAPEVILALG-WSQPCDVWSIGCILIEYYLGFTVFPTHDSKE 241 (339)
T ss_dssp CEEEEESCC-CEEECCCSSCEETTS--CCCSSCSCGGGCCHHHHTTSC-CCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred cccccccCC-CceEeeCcccccCcc--ccccccCCccccChHHhhCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence 34 699999999976432 334568999999999997654 8999999999999999999999999998888
Q ss_pred HHHHHHHHhCCCCHHHHhhcCCCC----ccCCCCccc---------CCCccc--ccccCCCHHHHHHHHHhcccCCCCCC
Q 012233 348 QLVEIIKILGTPTREEIKCMNPNY----TEFKFPQIK---------AHPWHK--IFHKRMPPEALDLVSRLLQYSPSLRC 412 (468)
Q Consensus 348 ~~~~i~~~~~~~~~~~~~~~~~~~----~~~~~~~~~---------~~~~~~--~~~~~~~~~l~~li~~~L~~dP~~R~ 412 (468)
.+..+....+..+...+....... ....++... ..++.. ......++++.+||.+||+.||.+||
T Consensus 242 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 321 (339)
T 1z57_A 242 HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRI 321 (339)
T ss_dssp HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccccc
Confidence 888888888877766544322110 000000000 000000 01122457899999999999999999
Q ss_pred CHHHHhCCCCCCCCCC
Q 012233 413 TALEACAHPFFDDLRD 428 (468)
Q Consensus 413 s~~ell~hp~f~~~~~ 428 (468)
|+.|+++||||+.+++
T Consensus 322 t~~ell~hp~f~~~~~ 337 (339)
T 1z57_A 322 TLREALKHPFFDLLKK 337 (339)
T ss_dssp CHHHHTTSGGGGGGGC
T ss_pred CHHHHhcCHHHHHHhc
Confidence 9999999999998764
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-46 Score=362.32 Aligned_cols=252 Identities=28% Similarity=0.452 Sum_probs=208.1
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc----chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEE
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~l 212 (468)
.+|.+.+.||+|+||.||+|.+..+|+.||+|++.... ....+|+.+++.++||||+++++++ .+...+|+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l 83 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY-----ESTTHYYL 83 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEE-----ECSSEEEE
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhc-----ccCCEEEE
Confidence 46999999999999999999999999999999986532 3456899999999999999999988 34446899
Q ss_pred Eeecccc-hHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeee---cCCCCcEEEeeecCcc
Q 012233 213 VLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLV---NPHTHQLKICDFGSAK 288 (468)
Q Consensus 213 v~e~~~~-~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl---~~~~~~vkL~DFG~a~ 288 (468)
||||+.+ .+.+.+.. ...+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++ .+||+|||++.
T Consensus 84 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dikp~NIl~~~~~~~~-~~kl~Dfg~~~ 157 (304)
T 2jam_A 84 VMQLVSGGELFDRILE----RGVYTEKDASLVIQQVLSAVKYLHE-NGIVHRDLKPENLLYLTPEENS-KIMITDFGLSK 157 (304)
T ss_dssp EECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCSCCGGGCEESSSSTTC-CEEBCSCSTTC
T ss_pred EEEcCCCccHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEEecCCCCC-CEEEccCCcce
Confidence 9999986 55454432 3468999999999999999999998 899999999999999 5555 79999999987
Q ss_pred ccCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 012233 289 MLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368 (468)
Q Consensus 289 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 368 (468)
.... .......||+.|+|||++.+. .++.++|||||||++|+|++|..||...+..+....+....
T Consensus 158 ~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~------------ 223 (304)
T 2jam_A 158 MEQN-GIMSTACGTPGYVAPEVLAQK-PYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGY------------ 223 (304)
T ss_dssp CCCC-BTTHHHHSCCCBCCTTTBSSC-SCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCC------------
T ss_pred ecCC-CccccccCCCCccChHHhccC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC------------
Confidence 5432 233456789999999999654 48999999999999999999999999887766666555421
Q ss_pred CCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q 012233 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426 (468)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 426 (468)
..+ ...++..+++++.+||.+||+.||.+|||+.++++||||+..
T Consensus 224 -----~~~--------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 224 -----YEF--------ESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp -----CCC--------CTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred -----CCC--------CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence 111 111335689999999999999999999999999999999864
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-46 Score=373.93 Aligned_cols=252 Identities=24% Similarity=0.366 Sum_probs=198.4
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc------chHHHHHHHHHHcC--CCCcccccceeeecCCCCceE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLN--HPNVVSLKHCFFSTTEKDELY 209 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~------~~~~~E~~il~~l~--hpnIv~l~~~~~~~~~~~~~~ 209 (468)
.|.+.+.||+|+||.||+|.+.. ++.||||++.... ..+.+|+.+|+.++ ||||+++++++. ...+
T Consensus 57 ~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~-----~~~~ 130 (390)
T 2zmd_A 57 IYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI-----TDQY 130 (390)
T ss_dssp EEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CSSE
T ss_pred ceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEe-----cCCE
Confidence 59999999999999999999764 8999999986432 33467999999997 599999999884 3445
Q ss_pred EEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccc
Q 012233 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (468)
Q Consensus 210 ~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~ 289 (468)
+|||||+.++++.+++.. ...+++..++.++.||+.||.|||+ +||+||||||+||||+ ++ .+||+|||+++.
T Consensus 131 ~~lv~E~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~-~~ivHrDlkp~NIll~-~~-~~kl~DFG~a~~ 203 (390)
T 2zmd_A 131 IYMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQ-HGIVHSDLKPANFLIV-DG-MLKLIDFGIANQ 203 (390)
T ss_dssp EEEEEECCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHT-TTCCCCCCCGGGEEES-SS-CEEECCCSSSCC
T ss_pred EEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHEEEE-CC-eEEEEecCcccc
Confidence 899999777777766543 3568889999999999999999998 8999999999999996 44 699999999987
Q ss_pred cCCCC---CCccccccCCccccccccCC----------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHH
Q 012233 290 LVPGE---PNISYICSRYYRAPELIFGA----------TEYTTAIDMWSIGCVLAELLLGQPLFPGESGV-DQLVEIIKI 355 (468)
Q Consensus 290 ~~~~~---~~~~~~gt~~y~aPE~~~~~----------~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~-~~~~~i~~~ 355 (468)
+.... .....+||+.|+|||++.+. ..++.++|||||||++|||++|+.||...... ..+..++.
T Consensus 204 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~- 282 (390)
T 2zmd_A 204 MQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID- 282 (390)
T ss_dssp C---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHC-
T ss_pred ccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhC-
Confidence 64332 23356899999999998652 34889999999999999999999999875433 22332221
Q ss_pred hCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCC
Q 012233 356 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDP 429 (468)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~ 429 (468)
.. .... ++...+.++.+||.+||+.||.+|||+.|+|+||||+....+
T Consensus 283 --~~------------~~~~------------~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~~ 330 (390)
T 2zmd_A 283 --PN------------HEIE------------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 330 (390)
T ss_dssp --TT------------SCCC------------CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC--
T ss_pred --cc------------ccCC------------CCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccCcc
Confidence 00 0111 233457899999999999999999999999999999865443
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-47 Score=379.31 Aligned_cols=263 Identities=16% Similarity=0.142 Sum_probs=188.2
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-------chHHHHHHHHHHc--CCCCcccccceee-------e
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLL--NHPNVVSLKHCFF-------S 201 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-------~~~~~E~~il~~l--~hpnIv~l~~~~~-------~ 201 (468)
.|.+.+.||+|+||.||+|.+..+|+.||||++.... ....+|+.+++.| +||||++++..+. .
T Consensus 63 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~ 142 (371)
T 3q60_A 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAV 142 (371)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEE
T ss_pred eeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheec
Confidence 4999999999999999999999999999999997643 2234675555555 5999888664332 1
Q ss_pred cCC------------CCceEEEEEeecccchHHHHHhhhhhcCCCCCHHHH------HHHHHHHHHHHHHhHhcCCcccc
Q 012233 202 TTE------------KDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYV------QLYTYQICRALNYLHHVVGVCHR 263 (468)
Q Consensus 202 ~~~------------~~~~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~------~~~~~qi~~aL~yLH~~~givHr 263 (468)
... .....+||||||+++++.+++..... .+..... ..++.||+.||+|||+ +||+||
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~---~~~~~~~~~~~vk~~i~~qi~~aL~~LH~-~~ivHr 218 (371)
T 3q60_A 143 QSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDF---VYVFRGDEGILALHILTAQLIRLAANLQS-KGLVHG 218 (371)
T ss_dssp TTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHHHHH-TTEEET
T ss_pred CCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhcc---ccchhhhhhhhhHHHHHHHHHHHHHHHHH-CCCccC
Confidence 110 01145899999999888887765432 2233333 5666999999999998 899999
Q ss_pred CCCCCCeeecCCCCcEEEeeecCccccCCCCCCccccccCCccccccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 012233 264 DIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGA-TEYTTAIDMWSIGCVLAELLLGQPLFPG 342 (468)
Q Consensus 264 Dlkp~NILl~~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwSlG~il~ell~G~~pf~~ 342 (468)
||||+||||+.++ .+||+|||+++.... ......+|+.|+|||++.+. ..++.++|||||||++|||++|+.||.+
T Consensus 219 Dikp~NIll~~~~-~~kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~ 295 (371)
T 3q60_A 219 HFTPDNLFIMPDG-RLMLGDVSALWKVGT--RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGL 295 (371)
T ss_dssp TCSGGGEEECTTS-CEEECCGGGEEETTC--EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTB
T ss_pred cCCHHHEEECCCC-CEEEEecceeeecCC--CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999888 799999999986532 22255677999999999651 3589999999999999999999999987
Q ss_pred CCcHHHHHHHHHHhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCC
Q 012233 343 ESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPF 422 (468)
Q Consensus 343 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~ 422 (468)
..... ...+............+.......+++++.+||.+||+.||.+|||+.++|+|||
T Consensus 296 ~~~~~--------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 355 (371)
T 3q60_A 296 VTPGI--------------------KGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPE 355 (371)
T ss_dssp CCTTC--------------------TTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHH
T ss_pred cCccc--------------------ccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHH
Confidence 54210 0011111111111111111223578999999999999999999999999999999
Q ss_pred CCCCC
Q 012233 423 FDDLR 427 (468)
Q Consensus 423 f~~~~ 427 (468)
|+++.
T Consensus 356 f~~~~ 360 (371)
T 3q60_A 356 FLQLQ 360 (371)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 98754
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=366.43 Aligned_cols=251 Identities=24% Similarity=0.360 Sum_probs=197.9
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc------chHHHHHHHHHHcCC--CCcccccceeeecCCCCceE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNH--PNVVSLKHCFFSTTEKDELY 209 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~------~~~~~E~~il~~l~h--pnIv~l~~~~~~~~~~~~~~ 209 (468)
.|.+.+.||+|+||.||+|.+ .+++.||||++.... ..+.+|+.+|+.++| |||+++++++ .+..+
T Consensus 10 ~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~-----~~~~~ 83 (343)
T 3dbq_A 10 IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE-----ITDQY 83 (343)
T ss_dssp EEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECSSE
T ss_pred EEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeE-----eeCCE
Confidence 599999999999999999987 568999999986432 234579999999987 9999999988 34456
Q ss_pred EEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccc
Q 012233 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (468)
Q Consensus 210 ~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~ 289 (468)
+|||||+.++++.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+||||+ ++ .+||+|||+++.
T Consensus 84 ~~lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~-~~iiHrDikp~NIll~-~~-~~kl~DFG~a~~ 156 (343)
T 3dbq_A 84 IYMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQ-HGIVHSDLKPANFLIV-DG-MLKLIDFGIANQ 156 (343)
T ss_dssp EEEEECCCSEEHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEE-TT-EEEECCCSSSCC
T ss_pred EEEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCcceEEEE-CC-cEEEeecccccc
Confidence 899999888887776543 4678999999999999999999998 8999999999999998 44 699999999987
Q ss_pred cCCCCC---CccccccCCccccccccC----------CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHH
Q 012233 290 LVPGEP---NISYICSRYYRAPELIFG----------ATEYTTAIDMWSIGCVLAELLLGQPLFPGESGV-DQLVEIIKI 355 (468)
Q Consensus 290 ~~~~~~---~~~~~gt~~y~aPE~~~~----------~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~-~~~~~i~~~ 355 (468)
...... ....+||+.|+|||++.+ ...++.++|||||||++|+|++|+.||...... ..+..++.
T Consensus 157 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~- 235 (343)
T 3dbq_A 157 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID- 235 (343)
T ss_dssp C------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHC-
T ss_pred cCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhc-
Confidence 643332 235679999999999853 245889999999999999999999999875433 22222211
Q ss_pred hCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCC
Q 012233 356 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRD 428 (468)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~ 428 (468)
.. ... .++...++++.+||.+||+.||.+|||+.|+|+||||+.-..
T Consensus 236 --~~------------~~~------------~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~ 282 (343)
T 3dbq_A 236 --PN------------HEI------------EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH 282 (343)
T ss_dssp --TT------------SCC------------CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCCC
T ss_pred --CC------------ccc------------CCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccCC
Confidence 00 011 133456789999999999999999999999999999986443
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=366.29 Aligned_cols=280 Identities=27% Similarity=0.468 Sum_probs=218.2
Q ss_pred cceEEeceecccCceEEEEEEEcCCC-CEEEEEEeeccc---chHHHHHHHHHHcCCCC------cccccceeeecCCCC
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETG-DSVAIKKVLQDK---RYKNRELQIMRLLNHPN------VVSLKHCFFSTTEKD 206 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g-~~vaiK~~~~~~---~~~~~E~~il~~l~hpn------Iv~l~~~~~~~~~~~ 206 (468)
.+|.+.+.||+|+||.||+|.+..++ ..||+|++.... ....+|+.+++.++|++ ++.+++++..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~----- 93 (355)
T 2eu9_A 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF----- 93 (355)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE-----
T ss_pred ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee-----
Confidence 46999999999999999999998777 689999986543 34457999999998766 8888887733
Q ss_pred ceEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeee--------------
Q 012233 207 ELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLV-------------- 272 (468)
Q Consensus 207 ~~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl-------------- 272 (468)
...+||||||++++++..+... ....+++..++.++.||+.||.|||+ +||+||||||+||||
T Consensus 94 ~~~~~lv~e~~~~~l~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~lH~-~~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 170 (355)
T 2eu9_A 94 HGHMCIAFELLGKNTFEFLKEN--NFQPYPLPHVRHMAYQLCHALRFLHE-NQLTHTDLKPENILFVNSEFETLYNEHKS 170 (355)
T ss_dssp TTEEEEEEECCCCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred CCeEEEEEeccCCChHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEeccccccccccccc
Confidence 3368999999999988766542 23468999999999999999999998 899999999999999
Q ss_pred -----cCCCCcEEEeeecCccccCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHH
Q 012233 273 -----NPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVD 347 (468)
Q Consensus 273 -----~~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~ 347 (468)
+.++ .+||+|||+++.... ......||+.|+|||++.+.. ++.++|||||||++|||++|..||...+..+
T Consensus 171 ~~~~~~~~~-~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 246 (355)
T 2eu9_A 171 CEEKSVKNT-SIRVADFGSATFDHE--HHTTIVATRHYRPPEVILELG-WAQPCDVWSIGCILFEYYRGFTLFQTHENRE 246 (355)
T ss_dssp CCEEEESCC-CEEECCCTTCEETTS--CCCSSCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred ccccccCCC-cEEEeecCccccccc--cccCCcCCCcccCCeeeecCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 4455 799999999976432 334568999999999997654 8999999999999999999999999998888
Q ss_pred HHHHHHHHhCCCCHHHHhhcCCCCc----cCCCCcc---------cCCCccc--ccccCCCHHHHHHHHHhcccCCCCCC
Q 012233 348 QLVEIIKILGTPTREEIKCMNPNYT----EFKFPQI---------KAHPWHK--IFHKRMPPEALDLVSRLLQYSPSLRC 412 (468)
Q Consensus 348 ~~~~i~~~~~~~~~~~~~~~~~~~~----~~~~~~~---------~~~~~~~--~~~~~~~~~l~~li~~~L~~dP~~R~ 412 (468)
.+..+....+.++...+........ ...++.. ...++.. ......+.++.+||.+||+.||.+||
T Consensus 247 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 326 (355)
T 2eu9_A 247 HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI 326 (355)
T ss_dssp HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCc
Confidence 8888888888877665543221100 0000000 0000000 00112345899999999999999999
Q ss_pred CHHHHhCCCCCCCCCC
Q 012233 413 TALEACAHPFFDDLRD 428 (468)
Q Consensus 413 s~~ell~hp~f~~~~~ 428 (468)
|+.|+|+||||+++..
T Consensus 327 t~~e~l~hp~f~~~~~ 342 (355)
T 2eu9_A 327 TLAEALLHPFFAGLTP 342 (355)
T ss_dssp CHHHHTTSGGGGGCCH
T ss_pred CHHHHhcChhhcCCCh
Confidence 9999999999998754
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=371.13 Aligned_cols=258 Identities=29% Similarity=0.475 Sum_probs=202.8
Q ss_pred CcccceEEeceecccCceEEEEEEEc---CCCCEEEEEEeecc--------cchHHHHHHHHHHc-CCCCcccccceeee
Q 012233 134 KQTISYMAERVVGTGSFGVVFQAKCL---ETGDSVAIKKVLQD--------KRYKNRELQIMRLL-NHPNVVSLKHCFFS 201 (468)
Q Consensus 134 ~~~~~y~~~~~lG~G~fg~Vy~~~~~---~~g~~vaiK~~~~~--------~~~~~~E~~il~~l-~hpnIv~l~~~~~~ 201 (468)
....+|.+.+.||+|+||.||+|++. .+|+.||||++... .....+|+.+++.+ .||||+++++++..
T Consensus 51 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 130 (355)
T 1vzo_A 51 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 130 (355)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred ccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee
Confidence 34457999999999999999999984 58999999988532 23345699999999 69999999998843
Q ss_pred cCCCCceEEEEEeecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEE
Q 012233 202 TTEKDELYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLK 280 (468)
Q Consensus 202 ~~~~~~~~~~lv~e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vk 280 (468)
...++|||||+.++ +...+.. ...+++..++.++.||+.||.|||+ +||+||||||+||||+.++ .+|
T Consensus 131 -----~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~-~~k 199 (355)
T 1vzo_A 131 -----ETKLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHK-LGIIYRDIKLENILLDSNG-HVV 199 (355)
T ss_dssp -----TTEEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTS-CEE
T ss_pred -----CceEEEEeecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCC-cEE
Confidence 34588999999864 4444332 3568999999999999999999998 8999999999999999888 799
Q ss_pred EeeecCccccCCCC--CCccccccCCccccccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Q 012233 281 ICDFGSAKMLVPGE--PNISYICSRYYRAPELIFGA-TEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILG 357 (468)
Q Consensus 281 L~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~ 357 (468)
|+|||+++...... .....+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||...........+.....
T Consensus 200 l~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 279 (355)
T 1vzo_A 200 LTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL 279 (355)
T ss_dssp ESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHH
T ss_pred EeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHh
Confidence 99999997653322 23346799999999999753 3478999999999999999999999976432222222221100
Q ss_pred CCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCC-----CHHHHhCCCCCCCCC
Q 012233 358 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC-----TALEACAHPFFDDLR 427 (468)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~-----s~~ell~hp~f~~~~ 427 (468)
. .. ..++..++..+.+||.+||+.||.+|| ++.++++||||+.+.
T Consensus 280 ~-------------~~------------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~ 329 (355)
T 1vzo_A 280 K-------------SE------------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN 329 (355)
T ss_dssp H-------------CC------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred c-------------cC------------CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCC
Confidence 0 00 013356889999999999999999999 999999999999864
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-48 Score=387.28 Aligned_cols=253 Identities=17% Similarity=0.242 Sum_probs=193.0
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc-------cchHHHHHH---HHHHcCCCCcccccceee------
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQ---IMRLLNHPNVVSLKHCFF------ 200 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~-------~~~~~~E~~---il~~l~hpnIv~l~~~~~------ 200 (468)
.+|.+.+.||+|+||.||+|.+..+|+.||||++... ...+.+|+. +++.++|||||++++.+.
T Consensus 73 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~ 152 (377)
T 3byv_A 73 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 152 (377)
T ss_dssp EEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEE
T ss_pred ceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhh
Confidence 4699999999999999999999889999999998532 134457884 455557999999984442
Q ss_pred -ecC---------CCCce---EEEEEeecccchHHHHHhhhhhcCC---CCCHHHHHHHHHHHHHHHHHhHhcCCccccC
Q 012233 201 -STT---------EKDEL---YLNLVLEYISETVYRVSKHYTRMNQ---HVPILYVQLYTYQICRALNYLHHVVGVCHRD 264 (468)
Q Consensus 201 -~~~---------~~~~~---~~~lv~e~~~~~ll~~~~~~~~~~~---~~~~~~~~~~~~qi~~aL~yLH~~~givHrD 264 (468)
... +.+.. ..||||||++|++.+.+........ .+++..++.++.||+.||.|||+ +||+|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrD 231 (377)
T 3byv_A 153 KDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH-YGLVHTY 231 (377)
T ss_dssp ECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH-TTEECSC
T ss_pred hccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh-CCeecCC
Confidence 111 11111 3789999999888877665432221 23357788899999999999998 8999999
Q ss_pred CCCCCeeecCCCCcEEEeeecCccccCCCCCCccccccCCccccccccCC----------CCCCcchhHHHHHHHHHHHH
Q 012233 265 IKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGA----------TEYTTAIDMWSIGCVLAELL 334 (468)
Q Consensus 265 lkp~NILl~~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~----------~~~~~~~DvwSlG~il~ell 334 (468)
|||+||||+.++ .+||+|||+++... ......+| +.|+|||++.+. ..++.++|||||||++|||+
T Consensus 232 ikp~NIll~~~~-~~kL~DFG~a~~~~--~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~ell 307 (377)
T 3byv_A 232 LRPVDIVLDQRG-GVFLTGFEHLVRDG--ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIW 307 (377)
T ss_dssp CCGGGEEECTTC-CEEECCGGGCEETT--CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHH
T ss_pred CCHHHEEEcCCC-CEEEEechhheecC--CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHH
Confidence 999999999888 79999999998642 23345677 999999999765 24899999999999999999
Q ss_pred hCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCH
Q 012233 335 LGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTA 414 (468)
Q Consensus 335 ~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~ 414 (468)
+|+.||.+.+..+....+. .....+++++.+||.+||+.||.+|||+
T Consensus 308 tg~~Pf~~~~~~~~~~~~~---------------------------------~~~~~~~~~~~~li~~~L~~dp~~Rpt~ 354 (377)
T 3byv_A 308 CADLPITKDAALGGSEWIF---------------------------------RSCKNIPQPVRALLEGFLRYPKEDRLLP 354 (377)
T ss_dssp HSSCCC------CCSGGGG---------------------------------SSCCCCCHHHHHHHHHHTCSSGGGCCCH
T ss_pred HCCCCCcccccccchhhhh---------------------------------hhccCCCHHHHHHHHHHcCCCchhCCCH
Confidence 9999997644221111000 0124589999999999999999999999
Q ss_pred HHHhCCCCCCCCC
Q 012233 415 LEACAHPFFDDLR 427 (468)
Q Consensus 415 ~ell~hp~f~~~~ 427 (468)
.|+++||||+++.
T Consensus 355 ~e~l~hp~f~~~~ 367 (377)
T 3byv_A 355 LQAMETPEYEQLR 367 (377)
T ss_dssp HHHHTSHHHHHHH
T ss_pred HHHhhChHHHHHH
Confidence 9999999998754
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=367.25 Aligned_cols=260 Identities=25% Similarity=0.368 Sum_probs=205.5
Q ss_pred ccceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-------chHHHHHHHHHHcCCCCcccccceeeecCCCCce
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 208 (468)
.++|.+.+.||+|+||.||+|.+..+++.||||++.... ..+.+|+.+++.++||||+++++++.... ....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~~ 89 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAGP 89 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEE-TTEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccC-CCCc
Confidence 346999999999999999999999999999999986532 23457899999999999999999885544 2334
Q ss_pred EEEEEeecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCc
Q 012233 209 YLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (468)
Q Consensus 209 ~~~lv~e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a 287 (468)
+.|+||||+.++ +.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~a 163 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQ-NGIIHRDVKPANIMISATN-AVKVMDFGIA 163 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEETTS-CEEECCCSCC
T ss_pred ccEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCCcCCCCHHHEEEcCCC-CEEEeeccCc
Confidence 568999999764 4443332 3568999999999999999999998 8999999999999999888 7999999999
Q ss_pred cccCCCC----CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 012233 288 KMLVPGE----PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREE 363 (468)
Q Consensus 288 ~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~ 363 (468)
....... ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+....+......+.
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~--- 239 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPP--- 239 (311)
T ss_dssp ------------------CCTTCCHHHHHTCC-CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCH---
T ss_pred ccccccccccccccccCcCcccCCHHHhcCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCc---
Confidence 7654332 223457899999999997654 89999999999999999999999998887776666554211111
Q ss_pred HhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCC
Q 012233 364 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRD 428 (468)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~ 428 (468)
......+++++.+||.+||+.||.+||++.+++.|+|++....
T Consensus 240 ----------------------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~ 282 (311)
T 3ork_A 240 ----------------------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNG 282 (311)
T ss_dssp ----------------------HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTT
T ss_pred ----------------------ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcC
Confidence 1123458999999999999999999999999999999986443
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=357.92 Aligned_cols=257 Identities=25% Similarity=0.387 Sum_probs=205.0
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc----cchHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEE
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~----~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~l 212 (468)
..|.+.+.||+|+||.||+|.+..+|+.||+|++... .....+|+.+++.++||||+++++++.. ...+++
T Consensus 19 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~l 93 (302)
T 2j7t_A 19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYH-----DGKLWI 93 (302)
T ss_dssp GTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----C-CEEE
T ss_pred cceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeee-----CCeEEE
Confidence 3699999999999999999999999999999988543 2345579999999999999999999843 345889
Q ss_pred EeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCC
Q 012233 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (468)
Q Consensus 213 v~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~ 292 (468)
||||+.++.+..... .....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++.....
T Consensus 94 v~e~~~~~~l~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~ 169 (302)
T 2j7t_A 94 MIEFCPGGAVDAIML--ELDRGLTEPQIQVVCRQMLEALNFLHS-KRIIHRDLKAGNVLMTLEG-DIRLADFGVSAKNLK 169 (302)
T ss_dssp EEECCTTEEHHHHHH--HHTSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEECTTS-CEEECCCHHHHHHHH
T ss_pred EEEeCCCCcHHHHHH--hhccCCCHHHHHHHHHHHHHHHHHHhc-CCcccCCCCHHHEEECCCC-CEEEEECCCCccccc
Confidence 999998765543322 224668999999999999999999998 8999999999999999888 799999998753311
Q ss_pred -CCCCccccccCCcccccccc----CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 012233 293 -GEPNISYICSRYYRAPELIF----GATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367 (468)
Q Consensus 293 -~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 367 (468)
........||+.|+|||++. ....++.++|||||||++|+|++|..||...+..+.+..+..... +
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~-------- 240 (302)
T 2j7t_A 170 TLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDP-P-------- 240 (302)
T ss_dssp HHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-C--------
T ss_pred cccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCC-c--------
Confidence 11223467899999999984 334588999999999999999999999998877666655544100 0
Q ss_pred CCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCC
Q 012233 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRD 428 (468)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~ 428 (468)
. ...+..++.++.+||.+||+.||.+|||+.++++||||+.+..
T Consensus 241 -----~------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 284 (302)
T 2j7t_A 241 -----T------------LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITS 284 (302)
T ss_dssp -----C------------CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCCC
T ss_pred -----c------------cCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhcc
Confidence 0 0122447889999999999999999999999999999998653
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=352.89 Aligned_cols=258 Identities=25% Similarity=0.381 Sum_probs=210.6
Q ss_pred CcccceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc------chHHHHHHHHHHcCCCCcccccceeeecCCCCc
Q 012233 134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (468)
Q Consensus 134 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 207 (468)
....+|++.+.||+|+||.||+|.+..+|+.||+|++.... ..+.+|+.+++.++||||+++++++... ..
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~ 79 (279)
T 2w5a_A 3 SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR---TN 79 (279)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEG---GG
T ss_pred CchhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecC---CC
Confidence 34567999999999999999999999999999999986432 2345799999999999999999987543 23
Q ss_pred eEEEEEeecccc-hHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCC-----ccccCCCCCCeeecCCCCcEEE
Q 012233 208 LYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG-----VCHRDIKPQNLLVNPHTHQLKI 281 (468)
Q Consensus 208 ~~~~lv~e~~~~-~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~g-----ivHrDlkp~NILl~~~~~~vkL 281 (468)
..+|+||||+.+ ++.+.+.........+++..++.++.||+.||.|||+ .| |+||||||+|||++.++ .+||
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~~~ivH~dl~p~NIl~~~~~-~~kl 157 (279)
T 2w5a_A 80 TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR-RSDGGHTVLHRDLKPANVFLDGKQ-NVKL 157 (279)
T ss_dssp TEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-HC------CCCCCSGGGEEECSSS-CEEE
T ss_pred ceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhc-ccCCCCeeEEeccchhhEEEcCCC-CEEE
Confidence 358899999986 6666665544445669999999999999999999998 78 99999999999999888 7999
Q ss_pred eeecCccccCCCCC-CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Q 012233 282 CDFGSAKMLVPGEP-NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPT 360 (468)
Q Consensus 282 ~DFG~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~ 360 (468)
+|||++........ .....|++.|+|||++.+.. ++.++|||||||++|+|++|..||...+..+....+....
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~---- 232 (279)
T 2w5a_A 158 GDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMS-YNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK---- 232 (279)
T ss_dssp CCCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC--CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC----
T ss_pred ecCchheeeccccccccccCCCccccChHHhccCC-CCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcc----
Confidence 99999976543221 23457899999999997654 8999999999999999999999999877655555444310
Q ss_pred HHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q 012233 361 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDD 425 (468)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~ 425 (468)
++ .++..+++++.+||.+||+.||.+|||+.|+++|+|+.+
T Consensus 233 ---------------~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~ 273 (279)
T 2w5a_A 233 ---------------FR---------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273 (279)
T ss_dssp ---------------CC---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCG
T ss_pred ---------------cc---------cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhh
Confidence 00 123457899999999999999999999999999999976
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=355.64 Aligned_cols=254 Identities=28% Similarity=0.464 Sum_probs=209.1
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc------cchHHHHHHHHHHcCCCCcccccceeeecCCCCceEE
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~------~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~ 210 (468)
.+|.+.+.||+|+||.||+|.+..+++.||||++... ...+.+|+.+++.++||||+++++++ .+...+
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 96 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL-----EDSSSF 96 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSSEE
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEE-----eCCCeE
Confidence 4699999999999999999999999999999998543 23456899999999999999999988 344468
Q ss_pred EEEeecccc-hHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCC--CcEEEeeecCc
Q 012233 211 NLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHT--HQLKICDFGSA 287 (468)
Q Consensus 211 ~lv~e~~~~-~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~--~~vkL~DFG~a 287 (468)
++||||+.+ .+.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ ..+||+|||++
T Consensus 97 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~ 171 (287)
T 2wei_A 97 YIVGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHK-HNIVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (287)
T ss_dssp EEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred EEEEEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCChhhEEEecCCCcccEEEeccCcc
Confidence 999999975 44444332 3468999999999999999999998 8999999999999997643 26999999999
Q ss_pred cccCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 012233 288 KMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367 (468)
Q Consensus 288 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 367 (468)
.............|++.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+....+....
T Consensus 172 ~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~----------- 238 (287)
T 2wei_A 172 TCFQQNTKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGK----------- 238 (287)
T ss_dssp GTBCCCSSCSCHHHHHTTCCHHHHTT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-----------
T ss_pred eeecCCCccccccCcccccChHHhcC--CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-----------
Confidence 87765555556678999999999865 38999999999999999999999999887666555544411
Q ss_pred CCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q 012233 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (468)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~ 427 (468)
..++ ...+..+++++.+||.+||+.||.+|||+.++++||||++..
T Consensus 239 ------~~~~--------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 284 (287)
T 2wei_A 239 ------YAFD--------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS 284 (287)
T ss_dssp ------CCCC--------SGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHC
T ss_pred ------CCCC--------chhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhccc
Confidence 0000 001245789999999999999999999999999999998654
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-46 Score=360.97 Aligned_cols=269 Identities=26% Similarity=0.390 Sum_probs=190.8
Q ss_pred cccceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc-----cchHHHHHHHHHHcCCCCcccccceeeecCCCCceE
Q 012233 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (468)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~-----~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 209 (468)
...+|.+.+.||+|+||.||+|.+..+++.||||++... .....+|+.+++.++||||+++++++... ..
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~ 87 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVK-----DE 87 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESS-----SC
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeec-----CC
Confidence 345699999999999999999999889999999987532 23345789999999999999999988433 34
Q ss_pred EEEEeecccc-hHHHHHhhhhh----cCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeee
Q 012233 210 LNLVLEYISE-TVYRVSKHYTR----MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDF 284 (468)
Q Consensus 210 ~~lv~e~~~~-~ll~~~~~~~~----~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DF 284 (468)
.++||||+.+ .+.+.+..... ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+||
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~~~-~~kl~df 165 (303)
T 2vwi_A 88 LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK-NGQIHRDVKAGNILLGEDG-SVQIADF 165 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEECTTC-CEEECCC
T ss_pred cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCCCCChhhEEEcCCC-CEEEEec
Confidence 8899999975 45554443221 24558999999999999999999998 8999999999999999888 7999999
Q ss_pred cCccccCCCC------CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Q 012233 285 GSAKMLVPGE------PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGT 358 (468)
Q Consensus 285 G~a~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~ 358 (468)
|++....... ......||+.|+|||++.+...++.++|||||||++|+|++|..||......+.........
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-- 243 (303)
T 2vwi_A 166 GVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQND-- 243 (303)
T ss_dssp HHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSS--
T ss_pred cchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccC--
Confidence 9987654322 12345789999999998654458999999999999999999999998877665544333210
Q ss_pred CCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCC
Q 012233 359 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDP 429 (468)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~ 429 (468)
+. ..............+++++.+||.+||+.||.+|||+.++++||||++....
T Consensus 244 ~~-----------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~ 297 (303)
T 2vwi_A 244 PP-----------------SLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNK 297 (303)
T ss_dssp CC-----------------CTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC------
T ss_pred CC-----------------ccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCCC
Confidence 00 0000001112335688999999999999999999999999999999986543
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=361.17 Aligned_cols=254 Identities=23% Similarity=0.368 Sum_probs=194.8
Q ss_pred CcccceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc------chHHHHHHHHHHcCCCCcccccceeeecCCCCc
Q 012233 134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (468)
Q Consensus 134 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 207 (468)
....+|.+.+.||+|+||.||+|.+ +|..||||++.... ..+.+|+.+++.++||||+++++++ .+.
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~ 106 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV-----TQP 106 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----CST
T ss_pred CChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EEC
Confidence 3445799999999999999999987 68899999985442 2345799999999999999999988 334
Q ss_pred eEEEEEeecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCC--ccccCCCCCCeeecCCCCcEEEeee
Q 012233 208 LYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG--VCHRDIKPQNLLVNPHTHQLKICDF 284 (468)
Q Consensus 208 ~~~~lv~e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~g--ivHrDlkp~NILl~~~~~~vkL~DF 284 (468)
..+++||||+.++ +.+.+.. ......+++..++.++.||+.||.|||+ +| |+||||||+|||++.++ .+||+||
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~~~ivH~Dikp~NIll~~~~-~~kL~Df 183 (309)
T 3p86_A 107 PNLSIVTEYLSRGSLYRLLHK-SGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKY-TVKVCDF 183 (309)
T ss_dssp TCCEEEEECCTTCBHHHHHHS-TTHHHHSCHHHHHHHHHHHHHHHHHHHT-SSSCCCCTTCCGGGEEECTTC-CEEECCC
T ss_pred CceEEEEecCCCCcHHHHHhh-cCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCEECCCCChhhEEEeCCC-cEEECCC
Confidence 4578999999874 4444332 1112348899999999999999999998 89 99999999999999888 7999999
Q ss_pred cCccccCCCC-CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 012233 285 GSAKMLVPGE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREE 363 (468)
Q Consensus 285 G~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~ 363 (468)
|+++...... ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+....+.....
T Consensus 184 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~------ 256 (309)
T 3p86_A 184 GLSRLKASTFLSSKSAAGTPEWMAPEVLRDEP-SNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCK------ 256 (309)
T ss_dssp C-----------------CCTTSCHHHHTTCC-CCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCC------
T ss_pred CCCccccccccccccCCCCccccChhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC------
Confidence 9997553322 234568899999999997654 89999999999999999999999998876665554432110
Q ss_pred HhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC--CCCCCC
Q 012233 364 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA--HPFFDD 425 (468)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~--hp~f~~ 425 (468)
. ..++..+++++.+||.+||+.||.+|||+.++++ ++|++.
T Consensus 257 ---------~------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 257 ---------R------------LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp ---------C------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred ---------C------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 0 1134568999999999999999999999999988 555544
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-45 Score=357.04 Aligned_cols=261 Identities=25% Similarity=0.380 Sum_probs=203.9
Q ss_pred ccceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc---cchHHHHHHHHHHc-CCCCcccccceeeecCCC-CceEE
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLL-NHPNVVSLKHCFFSTTEK-DELYL 210 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~---~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~-~~~~~ 210 (468)
..+|.+.+.||+|+||.||+|.+..+|+.||||++... .....+|+.+++.+ +||||+++++++...... ....+
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~ 102 (326)
T 2x7f_A 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQL 102 (326)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceE
Confidence 34699999999999999999999999999999998543 34556899999999 799999999998654321 13468
Q ss_pred EEEeecccc-hHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccc
Q 012233 211 NLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (468)
Q Consensus 211 ~lv~e~~~~-~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~ 289 (468)
|+||||+.+ .+.+++... ....+++..++.++.||+.||.|||+ +||+|+||||+|||++.++ .+||+|||++..
T Consensus 103 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~NIl~~~~~-~~kl~Dfg~~~~ 178 (326)
T 2x7f_A 103 WLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQ-HKVIHRDIKGQNVLLTENA-EVKLVDFGVSAQ 178 (326)
T ss_dssp EEEEECCTTEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEECTTC-CEEECCCTTTC-
T ss_pred EEEEEcCCCCcHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCcHHHEEEcCCC-CEEEeeCcCcee
Confidence 899999987 555544432 13568899999999999999999998 8999999999999999888 799999999876
Q ss_pred cCCCC-CCccccccCCccccccccC----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 012233 290 LVPGE-PNISYICSRYYRAPELIFG----ATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEI 364 (468)
Q Consensus 290 ~~~~~-~~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 364 (468)
..... ......||+.|+|||++.. ...++.++|||||||++|+|++|..||........+..+....
T Consensus 179 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-------- 250 (326)
T 2x7f_A 179 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP-------- 250 (326)
T ss_dssp ------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC--------
T ss_pred cCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc--------
Confidence 54322 2345678999999999862 2348899999999999999999999998877666555443310
Q ss_pred hhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q 012233 365 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (468)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~ 427 (468)
.+ ......+++.+.+||.+||..||.+|||+.++++||||++..
T Consensus 251 -----------~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 294 (326)
T 2x7f_A 251 -----------AP--------RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQP 294 (326)
T ss_dssp -----------CC--------CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCT
T ss_pred -----------cc--------cCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCc
Confidence 00 012245789999999999999999999999999999998753
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-45 Score=355.03 Aligned_cols=254 Identities=29% Similarity=0.432 Sum_probs=204.7
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc--chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEEEe
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK--RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~--~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv~ 214 (468)
..|.+.+.||+|+||.||+|.+..+|+.||||++.... ....+|+.+++.++||||+++++++.. ...+|+||
T Consensus 29 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~ 103 (314)
T 3com_A 29 EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFK-----NTDLWIVM 103 (314)
T ss_dssp -CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEEEEEE
T ss_pred hhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe-----CCEEEEEe
Confidence 35999999999999999999999999999999986543 445689999999999999999998854 33588999
Q ss_pred ecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCCC
Q 012233 215 EYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293 (468)
Q Consensus 215 e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~~ 293 (468)
||+.++ +.+.+. .....+++..++.++.||+.||.|||+ .||+|+||||+|||++.++ .+||+|||++......
T Consensus 104 e~~~~~~L~~~~~---~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dl~p~Nil~~~~~-~~kl~dfg~~~~~~~~ 178 (314)
T 3com_A 104 EYCGAGSVSDIIR---LRNKTLTEDEIATILQSTLKGLEYLHF-MRKIHRDIKAGNILLNTEG-HAKLADFGVAGQLTDT 178 (314)
T ss_dssp ECCTTEEHHHHHH---HHTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTC-CEEECCCTTCEECBTT
T ss_pred ecCCCCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcCCCcCHHHEEECCCC-CEEEeecccchhhhhh
Confidence 999875 444332 124678999999999999999999998 8999999999999999888 7999999999766433
Q ss_pred C-CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCc
Q 012233 294 E-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYT 372 (468)
Q Consensus 294 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 372 (468)
. ......|++.|+|||++.+. .++.++|||||||++|+|++|..||...........+.... + +
T Consensus 179 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~---------~--- 243 (314)
T 3com_A 179 MAKRNTVIGTPFWMAPEVIQEI-GYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNP--P---------P--- 243 (314)
T ss_dssp BSCBCCCCSCGGGCCHHHHSSS-CBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC--C---------C---
T ss_pred ccccCccCCCCCccChhhcCCC-CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCC--C---------c---
Confidence 2 23456789999999999765 48999999999999999999999998877655544433210 0 0
Q ss_pred cCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q 012233 373 EFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (468)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~ 427 (468)
.+. .+..+++++.+||.+||..||.+|||+.++++||||+...
T Consensus 244 ~~~------------~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~ 286 (314)
T 3com_A 244 TFR------------KPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAK 286 (314)
T ss_dssp CCS------------SGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred ccC------------CcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCC
Confidence 000 1234788999999999999999999999999999998754
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-45 Score=353.30 Aligned_cols=249 Identities=26% Similarity=0.380 Sum_probs=207.2
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-----chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~l 212 (468)
.|.+.+.||+|+||.||+|.+..+++.||||++.... ....+|+.+++.++||||+++++++.. ...+|+
T Consensus 23 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~l 97 (303)
T 3a7i_A 23 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-----DTKLWI 97 (303)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEEE
T ss_pred HHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec-----CCeEEE
Confidence 5999999999999999999999999999999985432 345689999999999999999998843 335889
Q ss_pred EeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCC
Q 012233 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (468)
Q Consensus 213 v~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~ 292 (468)
||||+.++.+..... ...+++..++.++.||+.||.|||+ .||+|+||||+|||++.++ .+||+|||++.....
T Consensus 98 v~e~~~~~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~~~-~~kl~Dfg~~~~~~~ 171 (303)
T 3a7i_A 98 IMEYLGGGSALDLLE----PGPLDETQIATILREILKGLDYLHS-EKKIHRDIKAANVLLSEHG-EVKLADFGVAGQLTD 171 (303)
T ss_dssp EEECCTTEEHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTS-CEEECCCTTCEECBT
T ss_pred EEEeCCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCChheEEECCCC-CEEEeecccceecCc
Confidence 999998754433221 3568999999999999999999998 8999999999999999888 799999999977644
Q ss_pred CC-CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCC
Q 012233 293 GE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNY 371 (468)
Q Consensus 293 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 371 (468)
.. ......||+.|+|||++.+. .++.++|||||||++|+|++|..||...........+... .+
T Consensus 172 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~------------ 236 (303)
T 3a7i_A 172 TQIKRNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKN--NP------------ 236 (303)
T ss_dssp TBCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS--CC------------
T ss_pred cccccCccCCCcCccCHHHHhcC-CCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcC--CC------------
Confidence 33 23456789999999999765 4899999999999999999999999887766554443321 00
Q ss_pred ccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q 012233 372 TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426 (468)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 426 (468)
..+...++..+.+||.+||+.||.+|||+.++++||||..-
T Consensus 237 --------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 277 (303)
T 3a7i_A 237 --------------PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN 277 (303)
T ss_dssp --------------CCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred --------------CCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence 01234578999999999999999999999999999999763
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=353.06 Aligned_cols=259 Identities=25% Similarity=0.390 Sum_probs=198.7
Q ss_pred eEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc----chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEEEe
Q 012233 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (468)
Q Consensus 139 y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv~ 214 (468)
|....+||+|+||.||+|.+..++..||||.+.... ..+.+|+.+++.++||||+++++++.. ....++||
T Consensus 24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~ 98 (295)
T 2clq_A 24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSE-----NGFIKIFM 98 (295)
T ss_dssp TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEEEEEE
T ss_pred CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEe-----CCcEEEEE
Confidence 333448999999999999999999999999986542 335679999999999999999998843 33588999
Q ss_pred ecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecC-CCCcEEEeeecCccccCCC
Q 012233 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNP-HTHQLKICDFGSAKMLVPG 293 (468)
Q Consensus 215 e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~-~~~~vkL~DFG~a~~~~~~ 293 (468)
||+.++.+............+++..++.++.||+.||.|||+ +||+|+||||+|||++. ++ .+||+|||++......
T Consensus 99 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~-~~kl~Dfg~~~~~~~~ 176 (295)
T 2clq_A 99 EQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD-NQIVHRDIKGDNVLINTYSG-VLKISDFGTSKRLAGI 176 (295)
T ss_dssp ECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTTC-CEEECCTTTCEESCC-
T ss_pred EeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHh-CCEEccCCChhhEEEECCCC-CEEEeecccccccCCC
Confidence 999765444333222223456788899999999999999998 89999999999999987 55 7999999999876432
Q ss_pred C-CCccccccCCccccccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCC
Q 012233 294 E-PNISYICSRYYRAPELIFGA-TEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNY 371 (468)
Q Consensus 294 ~-~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 371 (468)
. ......|++.|+|||++.+. ..++.++|||||||++|+|++|+.||..................
T Consensus 177 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~------------- 243 (295)
T 2clq_A 177 NPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKV------------- 243 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCC-------------
T ss_pred CCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccc-------------
Confidence 2 23456789999999998643 23789999999999999999999999765443322211111100
Q ss_pred ccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCCC
Q 012233 372 TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPN 430 (468)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~ 430 (468)
...++..+++++.+||.+||+.||.+|||+.++++||||+......
T Consensus 244 -------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~ 289 (295)
T 2clq_A 244 -------------HPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKKK 289 (295)
T ss_dssp -------------CCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC-----
T ss_pred -------------cccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhccccC
Confidence 0113456899999999999999999999999999999998765443
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-46 Score=369.45 Aligned_cols=281 Identities=23% Similarity=0.374 Sum_probs=204.6
Q ss_pred ccceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-----chHHHHHHHHHHcCCCCcccccceeeecCCCCceEE
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~ 210 (468)
..+|.+.+.||+|+||.||+|.+..+|..||+|++.... ....+|+.+++.++||||+++++++.. ...+
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~ 106 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DGEI 106 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE-----TTEE
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEE-----CCEE
Confidence 446999999999999999999999999999999986542 334579999999999999999998854 3358
Q ss_pred EEEeecccc-hHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccc
Q 012233 211 NLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (468)
Q Consensus 211 ~lv~e~~~~-~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~ 289 (468)
|+||||+.+ ++.+.+.. ...+++..++.++.||+.||.|||+.+||+||||||+||||+.++ .+||+|||++..
T Consensus 107 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~ 181 (360)
T 3eqc_A 107 SICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQ 181 (360)
T ss_dssp EEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTC-CEEECCCCCCHH
T ss_pred EEEEECCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCC-CEEEEECCCCcc
Confidence 899999986 44444432 346899999999999999999999723999999999999999888 799999999865
Q ss_pred cCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC-CCCHHHHh--h
Q 012233 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILG-TPTREEIK--C 366 (468)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~--~ 366 (468)
.... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+..+....+..... .+...... .
T Consensus 182 ~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (360)
T 3eqc_A 182 LIDS-MANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 259 (360)
T ss_dssp HHHH-C----CCCCTTCCHHHHTTC-CCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----------------
T ss_pred cccc-cccCCCCCCCeECHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCccc
Confidence 4222 23456889999999999765 489999999999999999999999988765544322211110 00000000 0
Q ss_pred cCCCCccCCCCcc------------cCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCC
Q 012233 367 MNPNYTEFKFPQI------------KAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRD 428 (468)
Q Consensus 367 ~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~ 428 (468)
....+..+..... ............++.++.+||.+||+.||.+|||+.|+|+||||+....
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 333 (360)
T 3eqc_A 260 PGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDA 333 (360)
T ss_dssp --------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHHH
T ss_pred CCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcchH
Confidence 0000000000000 0000001112347889999999999999999999999999999987543
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-45 Score=362.15 Aligned_cols=272 Identities=19% Similarity=0.328 Sum_probs=206.0
Q ss_pred ccceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc---------------------chHHHHHHHHHHcCCCCccc
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---------------------RYKNRELQIMRLLNHPNVVS 194 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~---------------------~~~~~E~~il~~l~hpnIv~ 194 (468)
..+|.+.+.||+|+||.||+|.+ +|+.||||++.... ..+.+|+.+++.++||||++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 45799999999999999999998 89999999985431 55678999999999999999
Q ss_pred ccceeeecCCCCceEEEEEeecccchHHHHH-hhh--hhc--CCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCC
Q 012233 195 LKHCFFSTTEKDELYLNLVLEYISETVYRVS-KHY--TRM--NQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQN 269 (468)
Q Consensus 195 l~~~~~~~~~~~~~~~~lv~e~~~~~ll~~~-~~~--~~~--~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~N 269 (468)
+++++. +...+|+||||+.++.+... ... ... ...+++..++.++.||+.||.|||+.+||+||||||+|
T Consensus 108 ~~~~~~-----~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~N 182 (348)
T 2pml_X 108 CEGIIT-----NYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSN 182 (348)
T ss_dssp CSEEEE-----SSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGG
T ss_pred EEEEEe-----eCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHh
Confidence 999983 34468999999987533311 000 111 46789999999999999999999952799999999999
Q ss_pred eeecCCCCcEEEeeecCccccCCCCCCccccccCCccccccccCCCCCCc-chhHHHHHHHHHHHHhCCCCCCCCCc-HH
Q 012233 270 LLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTT-AIDMWSIGCVLAELLLGQPLFPGESG-VD 347 (468)
Q Consensus 270 ILl~~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~DvwSlG~il~ell~G~~pf~~~~~-~~ 347 (468)
||++.++ .+||+|||++...... ......|++.|+|||++.+...++. ++|||||||++|+|++|..||..... .+
T Consensus 183 il~~~~~-~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 260 (348)
T 2pml_X 183 ILMDKNG-RVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE 260 (348)
T ss_dssp EEECTTS-CEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH
T ss_pred EEEcCCC-cEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH
Confidence 9999888 7999999999875433 3345678999999999976644666 99999999999999999999998776 34
Q ss_pred HHHHHHHHhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q 012233 348 QLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426 (468)
Q Consensus 348 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 426 (468)
....+... ..... .....+..+. .. .........+++++.+||.+||+.||.+|||+.|+++||||+++
T Consensus 261 ~~~~i~~~-~~~~~-------~~~~~~~~~~-~~-~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~ 329 (348)
T 2pml_X 261 LFNNIRTK-NIEYP-------LDRNHFLYPL-TN-KKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADT 329 (348)
T ss_dssp HHHHHTSC-CCCCC-------CSSSSSTTTT-CC---------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTC
T ss_pred HHHHHhcc-CcCCc-------cchhhhhccc-cc-cccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCC
Confidence 33333221 00000 0000000000 00 00011235689999999999999999999999999999999875
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=363.61 Aligned_cols=265 Identities=24% Similarity=0.381 Sum_probs=184.5
Q ss_pred cccceEEe-ceecccCceEEEEEEEcCCCCEEEEEEeecccchHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEEE
Q 012233 135 QTISYMAE-RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV 213 (468)
Q Consensus 135 ~~~~y~~~-~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv 213 (468)
..++|.+. ++||+|+||.||+|.+..+|+.||||++........+....++.+.||||+++++++.... .+..++++|
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~~~lv 104 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVYENMH-HGKRCLLII 104 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHHHHHHHHHHHhcCCCChHHHHHHHhhcc-CCCceEEEE
Confidence 34579985 5799999999999999999999999999876665555566678889999999999885433 345678999
Q ss_pred eecccc-hHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCC--CcEEEeeecCcccc
Q 012233 214 LEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHT--HQLKICDFGSAKML 290 (468)
Q Consensus 214 ~e~~~~-~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~--~~vkL~DFG~a~~~ 290 (468)
|||+.+ ++.+.+.. .....+++..++.++.||+.||.|||+ +||+||||||+||||+.++ ..+||+|||++...
T Consensus 105 ~e~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~ql~~~l~~LH~-~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~ 181 (336)
T 3fhr_A 105 MECMEGGELFSRIQE--RGDQAFTEREAAEIMRDIGTAIQFLHS-HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET 181 (336)
T ss_dssp EECCTTEEHHHHHHT--C-CCCCBHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred EeccCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEEecCCCceEEEeccccceec
Confidence 999987 55554432 223468999999999999999999998 8999999999999997643 25999999999765
Q ss_pred CCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCC
Q 012233 291 VPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPN 370 (468)
Q Consensus 291 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 370 (468)
... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||...........+......
T Consensus 182 ~~~-~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~------------ 247 (336)
T 3fhr_A 182 TQN-ALQTPCYTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRL------------ 247 (336)
T ss_dssp -----------------------C-HHHHHHHHHHHHHHHHHHHHSSCCC------------------------------
T ss_pred ccc-ccccCCCCcCccChhhhCCC-CCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhc------------
Confidence 432 33456789999999998654 4889999999999999999999999776543322211111000
Q ss_pred CccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q 012233 371 YTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426 (468)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 426 (468)
....++ ...+..+++++.+||.+||+.||.+|||+.|+++||||++.
T Consensus 248 -~~~~~~--------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 248 -GQYGFP--------NPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp ----CCC--------TTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred -cccccC--------chhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 001111 01224589999999999999999999999999999999863
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=354.35 Aligned_cols=257 Identities=26% Similarity=0.375 Sum_probs=202.0
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-------chHHHHHHHHHHcCCCCcccccceeeecCCCCceE
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 209 (468)
.+|++.+.||+|+||.||+|.+..++..||+|++.... ..+.+|+.+++.++||||+++++++ .+...
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~-----~~~~~ 85 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVD-----EEDDC 85 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEE-----ECSSE
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEee-----eeCCe
Confidence 36999999999999999999999999999999884321 2345799999999999999999988 44556
Q ss_pred EEEEeecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcc
Q 012233 210 LNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (468)
Q Consensus 210 ~~lv~e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~ 288 (468)
+|+||||+.++ +.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++.
T Consensus 86 ~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~Dlkp~Nil~~~~~-~~kl~Dfg~~~ 159 (294)
T 4eqm_A 86 YYLVMEYIEGPTLSEYIES----HGPLSVDTAINFTNQILDGIKHAHD-MRIVHRDIKPQNILIDSNK-TLKIFDFGIAK 159 (294)
T ss_dssp EEEEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTS-CEEECCCSSST
T ss_pred EEEEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCC-CEEEEeCCCcc
Confidence 89999999874 4443332 3568999999999999999999998 8999999999999999888 79999999997
Q ss_pred ccCCCC--CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 012233 289 MLVPGE--PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKC 366 (468)
Q Consensus 289 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 366 (468)
...... ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+...+.+... .+
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~-~~------- 230 (294)
T 4eqm_A 160 ALSETSLTQTNHVLGTVQYFSPEQAKGEA-TDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDS-VP------- 230 (294)
T ss_dssp TC-------------CCSSCCHHHHHTCC-CCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSC-CC-------
T ss_pred ccccccccccCccccCccccCHhHhcCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcc-CC-------
Confidence 664332 223467899999999997654 8999999999999999999999999887766554443310 00
Q ss_pred cCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCC
Q 012233 367 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDP 429 (468)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~ 429 (468)
.....+...+++.+.++|.+||+.||.+||+..+.+.+.|..-+...
T Consensus 231 ----------------~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~ 277 (294)
T 4eqm_A 231 ----------------NVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHEN 277 (294)
T ss_dssp ----------------CHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred ----------------CcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence 01112345689999999999999999999976666666666544443
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=348.41 Aligned_cols=258 Identities=25% Similarity=0.365 Sum_probs=197.2
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc---chHHHHHHHHHHcCCCCcccccceeeecCC--------C
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLLNHPNVVSLKHCFFSTTE--------K 205 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~---~~~~~E~~il~~l~hpnIv~l~~~~~~~~~--------~ 205 (468)
.+|.+.+.||+|+||.||+|.+..+|+.||||++.... ....+|+.+++.++||||+++++++..... .
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 85 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVK 85 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccc
Confidence 46999999999999999999999999999999986543 234579999999999999999998755321 2
Q ss_pred CceEEEEEeecccc-hHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeee
Q 012233 206 DELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDF 284 (468)
Q Consensus 206 ~~~~~~lv~e~~~~-~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DF 284 (468)
....+|+||||+.+ ++.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+||
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dlkp~Nil~~~~~-~~kl~df 160 (303)
T 1zy4_A 86 KKSTLFIQMEYCENGTLYDLIHS---ENLNQQRDEYWRLFRQILEALSYIHS-QGIIHRDLKPMNIFIDESR-NVKIGDF 160 (303)
T ss_dssp CEEEEEEEEECCCSCBHHHHHHH---SCGGGCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTS-CEEECCC
T ss_pred cCCceEEEEecCCCCCHHHhhhc---cccccchHHHHHHHHHHHHHHHHHHh-CCeecccCCHHhEEEcCCC-CEEEeeC
Confidence 35678999999986 55554432 23457888899999999999999998 8999999999999999888 7999999
Q ss_pred cCccccCCC---------------CCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHH
Q 012233 285 GSAKMLVPG---------------EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQL 349 (468)
Q Consensus 285 G~a~~~~~~---------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~ 349 (468)
|++...... .......||+.|+|||++.+...++.++|||||||++|+|++ ||.........
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~ 237 (303)
T 1zy4_A 161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNI 237 (303)
T ss_dssp CCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHH
T ss_pred cchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHH
Confidence 999765321 122346789999999999766568999999999999999998 55433222222
Q ss_pred HHHHHHhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q 012233 350 VEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426 (468)
Q Consensus 350 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 426 (468)
...+... ...++ ..+....++.+.+||.+||+.||.+|||+.++++||||+..
T Consensus 238 ~~~~~~~----------------~~~~~--------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (303)
T 1zy4_A 238 LKKLRSV----------------SIEFP--------PDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK 290 (303)
T ss_dssp HHHHHST----------------TCCCC--------TTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred HHhcccc----------------ccccC--------ccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence 2211100 01111 11345678889999999999999999999999999999753
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=352.97 Aligned_cols=256 Identities=25% Similarity=0.374 Sum_probs=188.7
Q ss_pred cccceEEeceecccCceEEEEEEEcCCCCEEEEEEeecccc------hHHHHHHHHHHcCCCCcccccceeeecCCCCce
Q 012233 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR------YKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (468)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~~------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 208 (468)
...+|.+.+.||+|+||.||+|.+..+|+.||||++..... ...++..+++.++||||+++++++. +..
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~-----~~~ 97 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFI-----TNT 97 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CSS
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEe-----cCC
Confidence 45679999999999999999999999999999999865422 2234455788889999999999984 344
Q ss_pred EEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcC-CccccCCCCCCeeecCCCCcEEEeeecCc
Q 012233 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV-GVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (468)
Q Consensus 209 ~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~-givHrDlkp~NILl~~~~~~vkL~DFG~a 287 (468)
.+|+||||+++.+..+.. .....+++..++.++.||+.||.|||+ . ||+||||||+|||++.++ .+||+|||++
T Consensus 98 ~~~lv~e~~~~~~~~l~~---~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~~i~H~dlkp~Nil~~~~~-~~kl~dfg~~ 172 (318)
T 2dyl_A 98 DVFIAMELMGTCAEKLKK---RMQGPIPERILGKMTVAIVKALYYLKE-KHGVIHRDVKPSNILLDERG-QIKLCDFGIS 172 (318)
T ss_dssp EEEEEECCCSEEHHHHHH---HHTSCCCHHHHHHHHHHHHHHHHHHHH-HHCCCCCCCCGGGEEECTTS-CEEECCCTTC
T ss_pred cEEEEEeccCCcHHHHHH---HhccCCCHHHHHHHHHHHHHHHHHHHh-hCCEEeCCCCHHHEEECCCC-CEEEEECCCc
Confidence 689999999655444332 224678999999999999999999997 5 999999999999999888 7999999999
Q ss_pred cccCCCCCCccccccCCccccccccC----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHHHhCCCCHH
Q 012233 288 KMLVPGEPNISYICSRYYRAPELIFG----ATEYTTAIDMWSIGCVLAELLLGQPLFPGESG-VDQLVEIIKILGTPTRE 362 (468)
Q Consensus 288 ~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~-~~~~~~i~~~~~~~~~~ 362 (468)
.............||+.|+|||++.+ ...++.++|||||||++|+|++|+.||..... .+.+..+.... .+
T Consensus 173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~--- 248 (318)
T 2dyl_A 173 GRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEE-PP--- 248 (318)
T ss_dssp --------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSC-CC---
T ss_pred hhccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccC-CC---
Confidence 87655555556789999999999852 34488999999999999999999999987543 33344443310 00
Q ss_pred HHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q 012233 363 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426 (468)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 426 (468)
.++ ....+++++.+||.+||+.||.+|||+.++++||||+..
T Consensus 249 ------------~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (318)
T 2dyl_A 249 ------------LLP----------GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRY 290 (318)
T ss_dssp ------------CCC----------SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHH
T ss_pred ------------CCC----------ccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhc
Confidence 000 113478999999999999999999999999999999864
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-44 Score=351.04 Aligned_cols=246 Identities=18% Similarity=0.215 Sum_probs=197.8
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc--cchHHHHHHHHHHc-CCCCcccccceeeecCCCCceEEEEEe
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD--KRYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDELYLNLVL 214 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~--~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~lv~ 214 (468)
+|.+.+.||+|+||.||+|.+..+|+.||||++... ...+.+|+.+++.+ +||||+++++++.. ..+.++||
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-----~~~~~lv~ 84 (330)
T 2izr_A 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPC-----GKYNAMVL 84 (330)
T ss_dssp TEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEE-----TTEEEEEE
T ss_pred CeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEec-----CCccEEEE
Confidence 599999999999999999999999999999998543 34567899999999 99999999998843 34688999
Q ss_pred ecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCc-----EEEeeecCccc
Q 012233 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQ-----LKICDFGSAKM 289 (468)
Q Consensus 215 e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~-----vkL~DFG~a~~ 289 (468)
||+++++.+++... ...+++..++.++.||+.||.|||+ +||+||||||+||||+.++ . +||+|||+++.
T Consensus 85 e~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~-~~iiHrDlkp~Nill~~~~-~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 85 ELLGPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHS-KNLIYRDVKPENFLIGRPG-NKTQQVIHIIDFALAKE 159 (330)
T ss_dssp ECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECCGG-GTCTTSEEECCCTTCEE
T ss_pred EeCCCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHeeeccCC-CCCCceEEEEEccccee
Confidence 99977777655432 4679999999999999999999998 8999999999999998776 4 99999999987
Q ss_pred cCCCCC--------CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcH---HHHHHHHHHhCC
Q 012233 290 LVPGEP--------NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGV---DQLVEIIKILGT 358 (468)
Q Consensus 290 ~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~---~~~~~i~~~~~~ 358 (468)
...... .....||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+.+.. +.+..+......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~ 238 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKE-QSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRA 238 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHH
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCC-CCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhcc
Confidence 643322 24678999999999997654 899999999999999999999999875433 333333322111
Q ss_pred CCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 359 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
.+... +...++ ++.+||.+||+.||.+||++.++++
T Consensus 239 ~~~~~------------------------~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 239 TPIEV------------------------LCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp SCHHH------------------------HTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred CCHHH------------------------HhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 11110 112244 8999999999999999999988765
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=354.43 Aligned_cols=262 Identities=26% Similarity=0.355 Sum_probs=185.4
Q ss_pred cccceEEeceecccCceEEEEEEEcCCCCEEEEEEeecccc-----hHHHHHH-HHHHcCCCCcccccceeeecCCCCce
Q 012233 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR-----YKNRELQ-IMRLLNHPNVVSLKHCFFSTTEKDEL 208 (468)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~~-----~~~~E~~-il~~l~hpnIv~l~~~~~~~~~~~~~ 208 (468)
...+|.+.+.||+|+||.||+|.+..+|+.||||++..... ...+|+. +++.++||||+++++++. ...
T Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~-----~~~ 94 (327)
T 3aln_A 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALF-----REG 94 (327)
T ss_dssp CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEE-----CSS
T ss_pred CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEE-----eCC
Confidence 34579999999999999999999999999999999865421 1223444 677789999999999984 334
Q ss_pred EEEEEeecccchHHHHHhhhhh-cCCCCCHHHHHHHHHHHHHHHHHhHhcC-CccccCCCCCCeeecCCCCcEEEeeecC
Q 012233 209 YLNLVLEYISETVYRVSKHYTR-MNQHVPILYVQLYTYQICRALNYLHHVV-GVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (468)
Q Consensus 209 ~~~lv~e~~~~~ll~~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~yLH~~~-givHrDlkp~NILl~~~~~~vkL~DFG~ 286 (468)
..++||||+.+++...+..... ....+++..++.++.|++.||.|||+ . ||+||||||+|||++.++ .+||+|||+
T Consensus 95 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~ivH~dlkp~NIll~~~~-~~kl~Dfg~ 172 (327)
T 3aln_A 95 DCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE-NLKIIHRDIKPSNILLDRSG-NIKLCDFGI 172 (327)
T ss_dssp EEEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH-HHSCCCSCCCGGGEEEETTT-EEEECCCSS
T ss_pred ceEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc-cCCEeECCCCHHHEEEcCCC-CEEEccCCC
Confidence 6889999999987776654322 35678999999999999999999998 7 999999999999999888 899999999
Q ss_pred ccccCCCCCCccccccCCcccccccc---CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhCCCCHH
Q 012233 287 AKMLVPGEPNISYICSRYYRAPELIF---GATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVD-QLVEIIKILGTPTRE 362 (468)
Q Consensus 287 a~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~-~~~~i~~~~~~~~~~ 362 (468)
+.............||+.|+|||++. ....++.++|||||||++|+|++|..||....... .+..+
T Consensus 173 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~---------- 242 (327)
T 3aln_A 173 SGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQV---------- 242 (327)
T ss_dssp SCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCC----------
T ss_pred ceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHH----------
Confidence 98765544444568999999999983 23348999999999999999999999997643211 11000
Q ss_pred HHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q 012233 363 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (468)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~ 427 (468)
.....+. +.......+++++.+||.+||+.||.+|||+.++++||||....
T Consensus 243 ---------~~~~~~~-----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 293 (327)
T 3aln_A 243 ---------VKGDPPQ-----LSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYE 293 (327)
T ss_dssp ---------CCSCCCC-----CCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred ---------hcCCCCC-----CCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhH
Confidence 0000000 11112345899999999999999999999999999999997643
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-45 Score=356.30 Aligned_cols=247 Identities=26% Similarity=0.416 Sum_probs=202.8
Q ss_pred ccceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc----------chHHHHHHHHHHcC--CCCcccccceeeecC
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK----------RYKNRELQIMRLLN--HPNVVSLKHCFFSTT 203 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~----------~~~~~E~~il~~l~--hpnIv~l~~~~~~~~ 203 (468)
..+|.+.+.||+|+||.||+|.+..+|+.||||++.... ....+|+.+++.+. |+||+++++++.
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~--- 118 (320)
T 3a99_A 42 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE--- 118 (320)
T ss_dssp TTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE---
T ss_pred cCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe---
Confidence 346999999999999999999999999999999985432 23457999999996 599999999983
Q ss_pred CCCceEEEEEeeccc--chHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEE
Q 012233 204 EKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKI 281 (468)
Q Consensus 204 ~~~~~~~~lv~e~~~--~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL 281 (468)
.....++|||++. +.+.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+||||+.+...+||
T Consensus 119 --~~~~~~lv~e~~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~~~~kL 191 (320)
T 3a99_A 119 --RPDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKL 191 (320)
T ss_dssp --CSSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTTTEEEE
T ss_pred --cCCcEEEEEEcCCCCccHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeCCCCHHHEEEeCCCCCEEE
Confidence 4445889999997 456655443 3568999999999999999999998 899999999999999943338999
Q ss_pred eeecCccccCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 012233 282 CDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTR 361 (468)
Q Consensus 282 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~ 361 (468)
+|||++..... .......||+.|+|||++.+...++.++|||||||++|||++|+.||.... .+..
T Consensus 192 ~Dfg~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~------- 257 (320)
T 3a99_A 192 IDFGSGALLKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIR------- 257 (320)
T ss_dssp CCCTTCEECCS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHH-------
T ss_pred eeCcccccccc-ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhc-------
Confidence 99999987643 233456799999999999766545789999999999999999999996531 1111
Q ss_pred HHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCC
Q 012233 362 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRD 428 (468)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~ 428 (468)
... .+...+++++.+||.+||+.||.+|||+.++++||||+++..
T Consensus 258 ----------~~~------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~ 302 (320)
T 3a99_A 258 ----------GQV------------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLL 302 (320)
T ss_dssp ----------CCC------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCC
T ss_pred ----------ccc------------cccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCccC
Confidence 000 123468999999999999999999999999999999998654
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=354.41 Aligned_cols=261 Identities=19% Similarity=0.262 Sum_probs=186.9
Q ss_pred ccceEEeceecccCceEEEEEEEcCCCC---EEEEEEeecc------cchHHHHHHHHHHcCCCCcccccceeeecCCCC
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLETGD---SVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD 206 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~---~vaiK~~~~~------~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 206 (468)
..+|.+.+.||+|+||.||+|.+..++. .||||++... ...+.+|+.+++.++||||+++++++......+
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG 101 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence 3469999999999999999999877665 8999988543 234557999999999999999999985543221
Q ss_pred c-eEEEEEeecccch-HHHHHhhhh--hcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEe
Q 012233 207 E-LYLNLVLEYISET-VYRVSKHYT--RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKIC 282 (468)
Q Consensus 207 ~-~~~~lv~e~~~~~-ll~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~ 282 (468)
. ...++||||+.++ +...+.... .....+++..++.++.||+.||.|||+ +||+||||||+||||+.++ .+||+
T Consensus 102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~ivH~Dikp~NIli~~~~-~~kl~ 179 (323)
T 3qup_A 102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS-RNFIHRDLAARNCMLAEDM-TVCVA 179 (323)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECTTS-CEEEC
T ss_pred CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc-CCcccCCCCcceEEEcCCC-CEEEe
Confidence 1 1248999999874 444443222 112258999999999999999999998 8999999999999999887 79999
Q ss_pred eecCccccCCCCC---CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCC
Q 012233 283 DFGSAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGT 358 (468)
Q Consensus 283 DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~ 358 (468)
|||+++....... .....+++.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+....+.....
T Consensus 180 Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~- 257 (323)
T 3qup_A 180 DFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNL-YTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNR- 257 (323)
T ss_dssp CCCC-----------------CCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC-
T ss_pred eccccccccccccccccccccCcccccCchhhcCCC-CCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCC-
Confidence 9999976643322 22345678899999997654 8999999999999999999 9999998877666655543110
Q ss_pred CCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCC-------HHHHhCCCCCCCCC
Q 012233 359 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCT-------ALEACAHPFFDDLR 427 (468)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s-------~~ell~hp~f~~~~ 427 (468)
...+..+++++.+||.+||+.||.+||| +++++.|||+....
T Consensus 258 ---------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~ 306 (323)
T 3qup_A 258 ---------------------------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTS 306 (323)
T ss_dssp ---------------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-------
T ss_pred ---------------------------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCC
Confidence 0123458899999999999999999999 77889999998743
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=358.22 Aligned_cols=249 Identities=22% Similarity=0.334 Sum_probs=199.1
Q ss_pred cccceEEeceecccCceEEEEEEEc-------CCCCEEEEEEeeccc-----chHHHHHHHHHHc-CCCCcccccceeee
Q 012233 135 QTISYMAERVVGTGSFGVVFQAKCL-------ETGDSVAIKKVLQDK-----RYKNRELQIMRLL-NHPNVVSLKHCFFS 201 (468)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~-------~~g~~vaiK~~~~~~-----~~~~~E~~il~~l-~hpnIv~l~~~~~~ 201 (468)
...+|.+.+.||+|+||.||+|.+. .++..||||++.... ..+.+|+.+|+.+ +||||+++++++
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~-- 156 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC-- 156 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEE--
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE--
Confidence 3457999999999999999999975 345679999986542 2345799999999 899999999988
Q ss_pred cCCCCceEEEEEeecccc-hHHHHHhhhhh------------cCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCC
Q 012233 202 TTEKDELYLNLVLEYISE-TVYRVSKHYTR------------MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQ 268 (468)
Q Consensus 202 ~~~~~~~~~~lv~e~~~~-~ll~~~~~~~~------------~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~ 268 (468)
.+...+|+||||+.+ ++.+.+..... ....+++..++.++.||+.||.|||+ +||+||||||+
T Consensus 157 ---~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~ 232 (370)
T 2psq_A 157 ---TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS-QKCIHRDLAAR 232 (370)
T ss_dssp ---CSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGG
T ss_pred ---ccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh-CCeeccccchh
Confidence 334458899999986 45554443211 12458899999999999999999998 89999999999
Q ss_pred CeeecCCCCcEEEeeecCccccCCCC---CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 012233 269 NLLVNPHTHQLKICDFGSAKMLVPGE---PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGES 344 (468)
Q Consensus 269 NILl~~~~~~vkL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~ 344 (468)
||||+.++ .+||+|||+++...... ......+|+.|+|||++.+.. ++.++|||||||++|||++ |..||.+..
T Consensus 233 NIll~~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DvwslG~il~ellt~g~~p~~~~~ 310 (370)
T 2psq_A 233 NVLVTENN-VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIP 310 (370)
T ss_dssp GEEECTTC-CEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred hEEECCCC-CEEEccccCCcccCcccceecccCCCcccceECHhHhcCCC-CCcHHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 99999888 79999999998664332 223456688999999997654 9999999999999999999 999998877
Q ss_pred cHHHHHHHHHHhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 345 GVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 345 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
..+....+.... ....+..+++++.+||.+||+.||.+|||+.|+++
T Consensus 311 ~~~~~~~~~~~~----------------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 357 (370)
T 2psq_A 311 VEELFKLLKEGH----------------------------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 357 (370)
T ss_dssp GGGHHHHHHTTC----------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHhcCC----------------------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 655444332210 00123457899999999999999999999999986
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=350.83 Aligned_cols=253 Identities=25% Similarity=0.437 Sum_probs=199.2
Q ss_pred ccceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc----cchHHHHHHHHHHcCCCCcccccceeeecCCCCceEEE
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~----~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 211 (468)
..+|.+.+.||+|+||+||+|.+..+++.||+|++... ...+.+|+.+++.++||||+++++++.. ....+
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~~~ 83 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYK-----DKRLN 83 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEec-----CCeeE
Confidence 35799999999999999999999999999999988543 2345579999999999999999999853 34588
Q ss_pred EEeecccchHH-HHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcccc
Q 012233 212 LVLEYISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (468)
Q Consensus 212 lv~e~~~~~ll-~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~ 290 (468)
+||||+.++.+ +.+. .....+++..+..++.||+.||.|||+ +||+||||||+||||+.++ .+||+|||++...
T Consensus 84 lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~ 158 (310)
T 3s95_A 84 FITEYIKGGTLRGIIK---SMDSQYPWSQRVSFAKDIASGMAYLHS-MNIIHRDLNSHNCLVRENK-NVVVADFGLARLM 158 (310)
T ss_dssp EEEECCTTCBHHHHHH---HCCTTSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSTTSEEECTTS-CEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHH---hccCCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCCcCeEEECCCC-CEEEeecccceec
Confidence 99999987544 4332 224668999999999999999999998 8999999999999999888 7999999999766
Q ss_pred CCCCCC---------------ccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHH
Q 012233 291 VPGEPN---------------ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKI 355 (468)
Q Consensus 291 ~~~~~~---------------~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~ 355 (468)
...... ...+||+.|+|||++.+. .++.++|||||||++|+|++|..||.........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~------ 231 (310)
T 3s95_A 159 VDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGR-SYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMD------ 231 (310)
T ss_dssp C--------------------CCCCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTT------
T ss_pred ccccccccccccccccccccccccCCCcceeCHHHhcCC-CCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHH------
Confidence 433221 156799999999999764 4899999999999999999999998753221100
Q ss_pred hCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q 012233 356 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (468)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~ 427 (468)
+...........++..+++.+.+||.+||+.||.+|||+.++++ |++.++
T Consensus 232 --------------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~--~L~~l~ 281 (310)
T 3s95_A 232 --------------------FGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLETLR 281 (310)
T ss_dssp --------------------SSBCHHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH--HHHHHH
T ss_pred --------------------HhhhhhccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH--HHHHHH
Confidence 00000000011134568889999999999999999999999987 666543
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=362.04 Aligned_cols=254 Identities=20% Similarity=0.217 Sum_probs=201.7
Q ss_pred ccceEEeceecccCceEEEEEEE-----cCCCCEEEEEEeecc-----cchHHHHHHHHHHcCCCCcccccceeeecCCC
Q 012233 136 TISYMAERVVGTGSFGVVFQAKC-----LETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEK 205 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~-----~~~g~~vaiK~~~~~-----~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 205 (468)
..+|.+.+.||+|+||.||+|.+ ..++..||||++... .....+|+.+++.++||||+++++++.
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~----- 144 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL----- 144 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEe-----
Confidence 35799999999999999999994 456788999998543 223457999999999999999999983
Q ss_pred CceEEEEEeecccc-hHHHHHhhhhh---cCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCC--CcE
Q 012233 206 DELYLNLVLEYISE-TVYRVSKHYTR---MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHT--HQL 279 (468)
Q Consensus 206 ~~~~~~lv~e~~~~-~ll~~~~~~~~---~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~--~~v 279 (468)
+....|+||||+.+ ++.+.+..... ....+++..++.++.||+.||.|||+ +||+||||||+||||+.++ ..+
T Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~~~~~~ 223 (367)
T 3l9p_A 145 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE-NHFIHRDIAARNCLLTCPGPGRVA 223 (367)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESCSSTTCCE
T ss_pred cCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChhhEEEecCCCCceE
Confidence 33447899999975 55555543321 22458999999999999999999998 8999999999999998544 259
Q ss_pred EEeeecCccccCC---CCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHH
Q 012233 280 KICDFGSAKMLVP---GEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKI 355 (468)
Q Consensus 280 kL~DFG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~ 355 (468)
||+|||+++.... ........||+.|+|||++.+.. ++.++|||||||++|||++ |..||.+.+..+.+..+...
T Consensus 224 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~ 302 (367)
T 3l9p_A 224 KIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 302 (367)
T ss_dssp EECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT
T ss_pred EECCCccccccccccccccCCCcCCcccEECHHHhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 9999999975421 22334567799999999997654 8999999999999999998 99999988776665554431
Q ss_pred hCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCC
Q 012233 356 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFD 424 (468)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~ 424 (468)
... ..+..+++.+.+||.+||+.||.+|||+.++++|.|+-
T Consensus 303 ~~~----------------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 303 GRM----------------------------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp CCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCC----------------------------CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 100 02345789999999999999999999999999987653
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=352.97 Aligned_cols=246 Identities=22% Similarity=0.309 Sum_probs=198.0
Q ss_pred cccceEEeceecccCceEEEEEEEcCCCCE---EEEEEeecc-----cchHHHHHHHHHHcCCCCcccccceeeecCCCC
Q 012233 135 QTISYMAERVVGTGSFGVVFQAKCLETGDS---VAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD 206 (468)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~---vaiK~~~~~-----~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 206 (468)
...+|.+.+.||+|+||.||+|.+..+++. ||||++... ...+.+|+.+++.++||||+++++++ .+
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~ 121 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVV-----TR 121 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----CG
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----Ee
Confidence 345799999999999999999999866654 999998653 23345799999999999999999998 44
Q ss_pred ceEEEEEeecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeec
Q 012233 207 ELYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG 285 (468)
Q Consensus 207 ~~~~~lv~e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG 285 (468)
....|+||||+.++ +.+.+. .....+++..++.++.||+.||.|||+ +||+||||||+||||+.++ .+||+|||
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~-~~kl~Dfg 196 (325)
T 3kul_A 122 GRLAMIVTEYMENGSLDTFLR---THDGQFTIMQLVGMLRGVGAGMRYLSD-LGYVHRDLAARNVLVDSNL-VCKVSDFG 196 (325)
T ss_dssp GGCCEEEEECCTTCBHHHHHH---TTTTCSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTC-CEEECCCS
T ss_pred CCccEEEeeCCCCCcHHHHHH---hcccCCCHHHHHHHHHHHHHHHHHHHH-CCeeCCCCCcceEEECCCC-CEEECCCC
Confidence 44588999999864 444332 224568999999999999999999998 8999999999999999888 79999999
Q ss_pred CccccCCCCC----CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCC
Q 012233 286 SAKMLVPGEP----NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPT 360 (468)
Q Consensus 286 ~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~ 360 (468)
+++....... .....+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+....+....+......
T Consensus 197 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~-- 273 (325)
T 3kul_A 197 LSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRT-FSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRL-- 273 (325)
T ss_dssp SCEECC----CCEECC---CCGGGSCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCC--
T ss_pred cccccccCccceeeccCCCCcccccCHhHhcCCC-CCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCC--
Confidence 9987644322 12234577899999997554 8999999999999999999 99999988777666655432111
Q ss_pred HHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 361 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
..+..+++++.+||.+||+.||.+|||+.++++
T Consensus 274 --------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 274 --------------------------PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp --------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------------------CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 023458899999999999999999999999886
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-44 Score=341.57 Aligned_cols=247 Identities=19% Similarity=0.310 Sum_probs=200.8
Q ss_pred cccceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc---chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEE
Q 012233 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (468)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~---~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 211 (468)
...+|.+.+.||+|+||.||+|.+. +++.||+|++.... ....+|+.+++.++||||+++++++ .+....+
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 81 (269)
T 4hcu_A 8 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC-----LEQAPIC 81 (269)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEE-----CSSSSEE
T ss_pred ChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEE-----ecCCceE
Confidence 3457999999999999999999986 57789999986543 3456899999999999999999988 3444588
Q ss_pred EEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccC
Q 012233 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (468)
Q Consensus 212 lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~ 291 (468)
+||||+.++.+..... .....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++....
T Consensus 82 lv~e~~~~~~L~~~l~--~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dikp~Nil~~~~~-~~kl~Dfg~~~~~~ 157 (269)
T 4hcu_A 82 LVFEFMEHGCLSDYLR--TQRGLFAAETLLGMCLDVCEGMAYLEE-ACVIHRDLAARNCLVGENQ-VIKVSDFGMTRFVL 157 (269)
T ss_dssp EEEECCTTCBHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECGGG-CEEECCTTGGGGBC
T ss_pred EEEEeCCCCcHHHHHH--hcCcccCHHHHHHHHHHHHHHHHHHHh-CCeecCCcchheEEEcCCC-CEEecccccccccc
Confidence 9999998754432221 224568999999999999999999998 8999999999999999887 79999999998654
Q ss_pred CCC--CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 012233 292 PGE--PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368 (468)
Q Consensus 292 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 368 (468)
... ......+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||......+....+.....
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~----------- 225 (269)
T 4hcu_A 158 DDQYTSSTGTKFPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR----------- 225 (269)
T ss_dssp CHHHHSTTSTTCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC-----------
T ss_pred ccccccccCcccccccCCHHHhcCCC-CCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCcc-----------
Confidence 322 233456678899999996554 8999999999999999999 9999998877666555543100
Q ss_pred CCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCC
Q 012233 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (468)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~h 420 (468)
...+..+++++.+||.+||+.||.+|||+.++++|
T Consensus 226 -----------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 226 -----------------LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp -----------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------------CCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 01234478999999999999999999999999874
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=341.41 Aligned_cols=249 Identities=18% Similarity=0.218 Sum_probs=201.4
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc--cchHHHHHHHHHHc-CCCCcccccceeeecCCCCceEEEEE
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD--KRYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDELYLNLV 213 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~--~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~lv 213 (468)
.+|.+.+.||+|+||.||+|.+..+|+.||||++... .....+|+.+++.+ +|+||+++++++ .+....++|
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~~~~lv 84 (298)
T 1csn_A 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFG-----QEGLHNVLV 84 (298)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEE-----EETTEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeec-----CCCceeEEE
Confidence 3599999999999999999999999999999988543 34567899999999 799999999887 334458899
Q ss_pred eecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCC----cEEEeeecCccc
Q 012233 214 LEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTH----QLKICDFGSAKM 289 (468)
Q Consensus 214 ~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~----~vkL~DFG~a~~ 289 (468)
|||+++++.+.+... ...+++..++.++.||+.||.|||+ +||+||||||+||||+.++. .+||+|||++..
T Consensus 85 ~e~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 85 IDLLGPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHE-KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp EECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred EEecCCCHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 999977777665432 4568999999999999999999998 89999999999999986652 399999999987
Q ss_pred cCCCC--------CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC---cHHHHHHHHHHhCC
Q 012233 290 LVPGE--------PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGES---GVDQLVEIIKILGT 358 (468)
Q Consensus 290 ~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~---~~~~~~~i~~~~~~ 358 (468)
..... ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.. ..+.+..+......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (298)
T 1csn_A 161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 239 (298)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred cccccccccccccCccCCCCCcccCCchhhcCCC-CChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccC
Confidence 64332 234567899999999997654 8999999999999999999999998743 33333433332211
Q ss_pred CCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 359 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
+... .+...+++++.+||.+||+.||.+||++.++++
T Consensus 240 ~~~~------------------------~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 240 TPLR------------------------ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 276 (298)
T ss_dssp SCHH------------------------HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred ccHH------------------------HHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 1111 123458899999999999999999999999876
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=345.05 Aligned_cols=254 Identities=24% Similarity=0.352 Sum_probs=195.7
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc------chHHHHHHHHHHcC--CCCcccccceeeecCCCCce
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLN--HPNVVSLKHCFFSTTEKDEL 208 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~------~~~~~E~~il~~l~--hpnIv~l~~~~~~~~~~~~~ 208 (468)
.+|.+.+.||+|+||.||+|.+. +++.||||++.... ....+|+.+++.++ ||||+++++++. ...
T Consensus 28 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~-----~~~ 101 (313)
T 3cek_A 28 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI-----TDQ 101 (313)
T ss_dssp EEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEE-----CSS
T ss_pred ceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEee-----cCC
Confidence 36999999999999999999975 58999999985432 33457999999997 599999999883 444
Q ss_pred EEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcc
Q 012233 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (468)
Q Consensus 209 ~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~ 288 (468)
++|+|||+.++++.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++. + .+||+|||++.
T Consensus 102 ~~~lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIl~~~-~-~~kL~Dfg~~~ 174 (313)
T 3cek_A 102 YIYMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQ-HGIVHSDLKPANFLIVD-G-MLKLIDFGIAN 174 (313)
T ss_dssp EEEEEECCCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEET-T-EEEECCCSSSC
T ss_pred EEEEEEecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCcccEEEEC-C-eEEEeeccccc
Confidence 6899999877887776543 4568999999999999999999998 89999999999999974 4 79999999998
Q ss_pred ccCCCCC---CccccccCCccccccccCC----------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHH
Q 012233 289 MLVPGEP---NISYICSRYYRAPELIFGA----------TEYTTAIDMWSIGCVLAELLLGQPLFPGESGVD-QLVEIIK 354 (468)
Q Consensus 289 ~~~~~~~---~~~~~gt~~y~aPE~~~~~----------~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~-~~~~i~~ 354 (468)
....... .....||+.|+|||++.+. ..++.++|||||||++|+|++|..||....... .+..+..
T Consensus 175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 254 (313)
T 3cek_A 175 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID 254 (313)
T ss_dssp C--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHC
T ss_pred cccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHh
Confidence 6643322 2345789999999998641 348889999999999999999999998754332 2222211
Q ss_pred HhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCCC
Q 012233 355 ILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPN 430 (468)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~ 430 (468)
. . ... .++...++++.+||.+||+.||.+|||+.|+++||||+....+.
T Consensus 255 ---~-----------~-~~~------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~~ 303 (313)
T 3cek_A 255 ---P-----------N-HEI------------EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPV 303 (313)
T ss_dssp ---T-----------T-SCC------------CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC----
T ss_pred ---c-----------c-ccc------------CCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCCCch
Confidence 0 0 001 12344688999999999999999999999999999998754443
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-45 Score=367.51 Aligned_cols=273 Identities=22% Similarity=0.305 Sum_probs=200.7
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-----chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEE
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 211 (468)
.+|.+.+.||+|+||.||+|.+..+|+.||||++.... ....+|+.+++.++||||+++++++.... ....|
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~---~~~~~ 85 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETT---TRHKV 85 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT---TCCEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCC---CCeeE
Confidence 35999999999999999999999999999999986432 33458999999999999999999875432 33578
Q ss_pred EEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeee----cCCCCcEEEeeecCc
Q 012233 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLV----NPHTHQLKICDFGSA 287 (468)
Q Consensus 212 lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl----~~~~~~vkL~DFG~a 287 (468)
+||||+.++.+............+++..++.++.||+.||.|||+ +||+||||||+|||| +.++ .+||+|||++
T Consensus 86 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~~~~-~~kL~DFG~a 163 (396)
T 4eut_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE-NGIVHRNIKPGNIMRVIGEDGQS-VYKLTDFGAA 163 (396)
T ss_dssp EEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEEECTTSCE-EEEECCGGGC
T ss_pred EEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHH-CCEEECCcCHHHEEEeecCCCce-eEEEecCCCc
Confidence 999999865443333323333448999999999999999999998 899999999999998 5555 6999999999
Q ss_pred cccCCCCCCccccccCCccccccccCC-------CCCCcchhHHHHHHHHHHHHhCCCCCCCCC----cHHHHHHHHHHh
Q 012233 288 KMLVPGEPNISYICSRYYRAPELIFGA-------TEYTTAIDMWSIGCVLAELLLGQPLFPGES----GVDQLVEIIKIL 356 (468)
Q Consensus 288 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~~DvwSlG~il~ell~G~~pf~~~~----~~~~~~~i~~~~ 356 (468)
+............||+.|+|||++.+. ..++.++|||||||++|||++|+.||.... ..+.+..+..
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~-- 241 (396)
T 4eut_A 164 RELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT-- 241 (396)
T ss_dssp EECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH--
T ss_pred eEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc--
Confidence 887666555667899999999998541 347889999999999999999999997533 3334444433
Q ss_pred CCCCHHHHhhcC-CCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 357 GTPTREEIKCMN-PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 357 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
+.|. ..+.... .....+.+. ...+....+...+++.+.+||.+||+.||.+||++.++++
T Consensus 242 ~~p~-~~~~~~~~~~~~~~~~~--~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~ 302 (396)
T 4eut_A 242 GKPS-GAISGVQKAENGPIDWS--GDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302 (396)
T ss_dssp SCCT-TCCEEEECSTTCCEEEE--SSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred CCCc-ccchhheeccCCCcccC--ccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence 1221 1110000 000000000 0000011122345678899999999999999999998754
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-44 Score=354.96 Aligned_cols=252 Identities=24% Similarity=0.335 Sum_probs=199.9
Q ss_pred cccceEEeceecccCceEEEEEE-----EcCCCCEEEEEEeeccc-----chHHHHHHHHHHc-CCCCcccccceeeecC
Q 012233 135 QTISYMAERVVGTGSFGVVFQAK-----CLETGDSVAIKKVLQDK-----RYKNRELQIMRLL-NHPNVVSLKHCFFSTT 203 (468)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~-----~~~~g~~vaiK~~~~~~-----~~~~~E~~il~~l-~hpnIv~l~~~~~~~~ 203 (468)
..++|.+.+.||+|+||.||+|. ...+++.||||++.... ..+.+|+.+++.+ +||||+++++++...
T Consensus 20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~- 98 (359)
T 3vhe_A 20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP- 98 (359)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST-
T ss_pred cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecC-
Confidence 34579999999999999999999 45567899999986532 2356799999999 789999999988432
Q ss_pred CCCceEEEEEeecccc-hHHHHHhhhhhc---------------------------------------------------
Q 012233 204 EKDELYLNLVLEYISE-TVYRVSKHYTRM--------------------------------------------------- 231 (468)
Q Consensus 204 ~~~~~~~~lv~e~~~~-~ll~~~~~~~~~--------------------------------------------------- 231 (468)
...+++||||+.+ ++.+.+......
T Consensus 99 ---~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (359)
T 3vhe_A 99 ---GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSD 175 (359)
T ss_dssp ---TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------
T ss_pred ---CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccch
Confidence 2247899999986 444444332110
Q ss_pred -----------CCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCCCCC---Cc
Q 012233 232 -----------NQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEP---NI 297 (468)
Q Consensus 232 -----------~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~~~~---~~ 297 (468)
...+++..++.++.||+.||.|||+ +||+||||||+||||+.++ .+||+|||+++....... ..
T Consensus 176 ~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~-~~ivH~Dikp~NIll~~~~-~~kl~Dfg~a~~~~~~~~~~~~~ 253 (359)
T 3vhe_A 176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNILLSEKN-VVKICDFGLARDIYKDPDYVRKG 253 (359)
T ss_dssp --------CTTTTCBCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECGGG-CEEECCCGGGSCTTSCTTCEEC-
T ss_pred hhhcccccchhccccCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChhhEEEcCCC-cEEEEeccceeeecccccchhcc
Confidence 1228899999999999999999998 8999999999999999887 799999999986543322 23
Q ss_pred cccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccCCC
Q 012233 298 SYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKF 376 (468)
Q Consensus 298 ~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 376 (468)
...||+.|+|||++.+. .++.++|||||||++|||++ |..||.+....+.+...+.....+
T Consensus 254 ~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~----------------- 315 (359)
T 3vhe_A 254 DARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM----------------- 315 (359)
T ss_dssp -CEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCC-----------------
T ss_pred ccCCCceeEChhhhcCC-CCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCC-----------------
Confidence 45678999999999754 48999999999999999998 999999877666655544421111
Q ss_pred CcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCC
Q 012233 377 PQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (468)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~h 420 (468)
..+..+++++.+||.+||+.||.+|||+.|+++|
T Consensus 316 ----------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 316 ----------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp ----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 1234578999999999999999999999999875
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=344.65 Aligned_cols=250 Identities=23% Similarity=0.338 Sum_probs=206.0
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeecccchHHHHHHHHHHcCCCCcccccceeeecCC-----------C
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTE-----------K 205 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~-----------~ 205 (468)
.+|.+.+.||+|+||.||+|.+..+|+.||+|++........+|+.+++.++||||+++++++..... .
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~ 90 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRS 90 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CC
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccccccc
Confidence 46999999999999999999999899999999998777778899999999999999999998743211 1
Q ss_pred CceEEEEEeecccc-hHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeee
Q 012233 206 DELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDF 284 (468)
Q Consensus 206 ~~~~~~lv~e~~~~-~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DF 284 (468)
....+++||||+.+ ++.+.+... ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+||
T Consensus 91 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~-~~kl~Df 166 (284)
T 2a19_B 91 KTKCLFIQMEFCDKGTLEQWIEKR--RGEKLDKVLALELFEQITKGVDYIHS-KKLINRDLKPSNIFLVDTK-QVKIGDF 166 (284)
T ss_dssp EEEEEEEEECCCCSCBHHHHHHHG--GGSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEETT-EEEECCC
T ss_pred CcceEEEEEeccCCCCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCCHHHEEEcCCC-CEEECcc
Confidence 24568899999997 555544332 23568999999999999999999998 8999999999999999887 7999999
Q ss_pred cCccccCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 012233 285 GSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEI 364 (468)
Q Consensus 285 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 364 (468)
|++.............||+.|+|||++.+.. ++.++|||||||++|+|++|..||... ........ .
T Consensus 167 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~~~~~~~~---~~~~~~~~---~------ 233 (284)
T 2a19_B 167 GLVTSLKNDGKRTRSKGTLRYMSPEQISSQD-YGKEVDLYALGLILAELLHVCDTAFET---SKFFTDLR---D------ 233 (284)
T ss_dssp TTCEESSCCSCCCCCCSCCTTSCHHHHHCSC-CCTHHHHHHHHHHHHHHHSCCSSHHHH---HHHHHHHH---T------
T ss_pred hhheeccccccccccCCcccccChhhhccCC-CcchhhhHHHHHHHHHHHhcCCcchhH---HHHHHHhh---c------
Confidence 9998876665566678999999999997654 899999999999999999999887421 11111111 0
Q ss_pred hhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCC
Q 012233 365 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFD 424 (468)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~ 424 (468)
..++..+++++.+||.+||+.||.+|||+.|+++|.|.-
T Consensus 234 ---------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~ 272 (284)
T 2a19_B 234 ---------------------GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVW 272 (284)
T ss_dssp ---------------------TCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---------------------ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 002234788999999999999999999999999987653
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=338.50 Aligned_cols=243 Identities=27% Similarity=0.418 Sum_probs=189.1
Q ss_pred ccceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc--------cchHHHHHHHHHHcCCCCcccccceeeecCCCCc
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD--------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~--------~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 207 (468)
..+|.+.+.||+|+||.||+|.+ +|..||||++... .....+|+.+++.++||||+++++++ .+.
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~ 78 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVC-----LKE 78 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEE-----CCC
T ss_pred hhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE-----ecC
Confidence 34699999999999999999998 5899999987543 13456799999999999999999998 444
Q ss_pred eEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCC---ccccCCCCCCeeecC--------CC
Q 012233 208 LYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG---VCHRDIKPQNLLVNP--------HT 276 (468)
Q Consensus 208 ~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~g---ivHrDlkp~NILl~~--------~~ 276 (468)
...++||||+.++.+..+.. ...+++..++.++.||+.||.|||+ +| |+||||||+|||++. ++
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~-~~~~~i~H~dikp~Nil~~~~~~~~~~~~~ 153 (271)
T 3dtc_A 79 PNLCLVMEFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHD-EAIVPIIHRDLKSSNILILQKVENGDLSNK 153 (271)
T ss_dssp --CEEEEECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHH-SSSSCCCCSCCSGGGEEESSCCSSSCCSSC
T ss_pred CceEEEEEcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeecCCchHHEEEecccccccccCc
Confidence 56889999998765543322 4578999999999999999999998 88 999999999999986 34
Q ss_pred CcEEEeeecCccccCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh
Q 012233 277 HQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKIL 356 (468)
Q Consensus 277 ~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~ 356 (468)
.+||+|||++....... .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 154 -~~kl~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~- 229 (271)
T 3dtc_A 154 -ILKITDFGLAREWHRTT-KMSAAGAYAWMAPEVIRASM-FSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMN- 229 (271)
T ss_dssp -CEEECCCCC--------------CCGGGSCHHHHHHCC-CSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTS-
T ss_pred -ceEEccCCccccccccc-ccCCCCccceeCHHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcC-
Confidence 69999999997654332 33567899999999997554 899999999999999999999999987766555443321
Q ss_pred CCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCC
Q 012233 357 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (468)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~h 420 (468)
... ..++..+++.+.+||.+||+.||.+|||+.|+++|
T Consensus 230 ----------------~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 230 ----------------KLA----------LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp ----------------CCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------CCC----------CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 000 11335688999999999999999999999999864
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-44 Score=364.63 Aligned_cols=253 Identities=25% Similarity=0.365 Sum_probs=189.5
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc-cchHHHHHHHHHHc-CCCCcccccceeeecCCCCceEEEEEee
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-KRYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDELYLNLVLE 215 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~-~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~lv~e 215 (468)
+|.+.++||+|+||+||. ....+|+.||||++... .....+|+.+|+.+ +|||||++++++ .+..++|||||
T Consensus 25 ~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~-----~~~~~~~lv~E 98 (432)
T 3p23_A 25 SFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTE-----KDRQFQYIAIE 98 (432)
T ss_dssp EEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEE-----EETTEEEEEEE
T ss_pred EEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEE-----ecCCEEEEEEE
Confidence 599999999999999764 33468999999998543 34457899999999 799999999887 44456899999
Q ss_pred cccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCC----CcEEEeeecCccccC
Q 012233 216 YISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHT----HQLKICDFGSAKMLV 291 (468)
Q Consensus 216 ~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~----~~vkL~DFG~a~~~~ 291 (468)
||++++.+.+... ...+....++.++.||+.||.|||+ +||+||||||+||||+.++ ..+||+|||+++...
T Consensus 99 ~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~ 174 (432)
T 3p23_A 99 LCAATLQEYVEQK---DFAHLGLEPITLLQQTTSGLAHLHS-LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA 174 (432)
T ss_dssp CCSEEHHHHHHSS---SCCCCSSCHHHHHHHHHHHHHHHHH-TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred CCCCCHHHHHHhc---CCCccchhHHHHHHHHHHHHHHHHH-CcCEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence 9999888766532 2234444567899999999999998 8999999999999995322 258899999998765
Q ss_pred CCC----CCccccccCCccccccccC--CCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 012233 292 PGE----PNISYICSRYYRAPELIFG--ATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEI 364 (468)
Q Consensus 292 ~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 364 (468)
... .....+||+.|+|||++.+ ...++.++|||||||++|||++ |..||........ ..+.. ..
T Consensus 175 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~-~~~~~---~~----- 245 (432)
T 3p23_A 175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA-NILLG---AC----- 245 (432)
T ss_dssp -----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH-HHHTT---CC-----
T ss_pred CCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH-HHHhc---cC-----
Confidence 432 2345679999999999964 2347889999999999999999 9999965443221 11111 00
Q ss_pred hhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q 012233 365 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426 (468)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 426 (468)
..+... .....+..+.+||.+||+.||.+|||+.++++||||..+
T Consensus 246 ----------~~~~~~-------~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~ 290 (432)
T 3p23_A 246 ----------SLDCLH-------PEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSL 290 (432)
T ss_dssp ----------CCTTSC-------TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCH
T ss_pred ----------CccccC-------ccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccCh
Confidence 000000 011235668999999999999999999999999999864
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=350.81 Aligned_cols=255 Identities=17% Similarity=0.183 Sum_probs=195.4
Q ss_pred ceEEeceecccCceEEEEEEEcCC-----CCEEEEEEeecccchHHHHHH---------------HHHHcCCCCcccccc
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLET-----GDSVAIKKVLQDKRYKNRELQ---------------IMRLLNHPNVVSLKH 197 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~-----g~~vaiK~~~~~~~~~~~E~~---------------il~~l~hpnIv~l~~ 197 (468)
+|.+.+.||+|+||.||+|.+..+ ++.||||++........+|+. .++.++||||+++++
T Consensus 36 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~ 115 (364)
T 3op5_A 36 AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWG 115 (364)
T ss_dssp EEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEE
T ss_pred eEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEe
Confidence 599999999999999999998764 588999998766544444444 444557999999999
Q ss_pred eeeecCCCCceEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeec--CC
Q 012233 198 CFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVN--PH 275 (468)
Q Consensus 198 ~~~~~~~~~~~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~--~~ 275 (468)
++.... .+..+.||||||+++++..++.. ....+++..++.++.||+.||.|||+ +||+||||||+||||+ .+
T Consensus 116 ~~~~~~-~~~~~~~lv~e~~g~~L~~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~-~~iiHrDlkp~Nill~~~~~ 190 (364)
T 3op5_A 116 SGLHDK-NGKSYRFMIMDRFGSDLQKIYEA---NAKRFSRKTVLQLSLRILDILEYIHE-HEYVHGDIKASNLLLNYKNP 190 (364)
T ss_dssp EEEEEE-TTEEEEEEEEECEEEEHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEESSCT
T ss_pred eeeecc-CCcceEEEEEeCCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeEEecCCHHHEEEecCCC
Confidence 886543 34567899999996666665543 24679999999999999999999998 8999999999999998 66
Q ss_pred CCcEEEeeecCccccCCCCC--------CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHH
Q 012233 276 THQLKICDFGSAKMLVPGEP--------NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVD 347 (468)
Q Consensus 276 ~~~vkL~DFG~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~ 347 (468)
+ .+||+|||+++.+..... .....||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+.....
T Consensus 191 ~-~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~ 268 (364)
T 3op5_A 191 D-QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVA-PSRRGDLEILGYCMIQWLTGHLPWEDNLKDP 268 (364)
T ss_dssp T-CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred C-eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCC-CCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence 6 799999999976543221 13456999999999997654 8999999999999999999999998644333
Q ss_pred HHHHHHHH-hCCCCHHHH-hhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 348 QLVEIIKI-LGTPTREEI-KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 348 ~~~~i~~~-~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
........ ......... .|+ ....+++++.+||.+||+.||.+||++.++++
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 269 KYVRDSKIRYRENIASLMDKCF--------------------PAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHHHHHHHCHHHHHHHHS--------------------CTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHHHHhhhhHHHHHHHhc--------------------ccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 33322221 111111111 010 01457899999999999999999999998775
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=353.98 Aligned_cols=268 Identities=22% Similarity=0.241 Sum_probs=195.5
Q ss_pred ccceEEeceecccCceEEEEEEEcCCCCEEEEEEeecccc---hHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEE
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR---YKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~~---~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~l 212 (468)
..+|++.+.||+|+||.||+|.+ .++.||||++..... ...+|+.+++.++||||+++++++..... ....+++
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~-~~~~~~l 99 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTS-VDVDLWL 99 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS-SSEEEEE
T ss_pred hhhchhhheecccCceEEEEEEE--CCCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCC-CCceEEE
Confidence 34699999999999999999998 489999999865432 23458888999999999999999865442 2445789
Q ss_pred Eeecccc-hHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcC----------CccccCCCCCCeeecCCCCcEEE
Q 012233 213 VLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV----------GVCHRDIKPQNLLVNPHTHQLKI 281 (468)
Q Consensus 213 v~e~~~~-~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~----------givHrDlkp~NILl~~~~~~vkL 281 (468)
||||+.+ ++.+.+.. ..+++..++.++.||+.||.|||+ . ||+||||||+|||++.++ .+||
T Consensus 100 v~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~-~~~~l~~~~~~~ivH~Dlkp~Nill~~~~-~~kL 172 (322)
T 3soc_A 100 ITAFHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHE-DIPGLKDGHKPAISHRDIKSKNVLLKNNL-TACI 172 (322)
T ss_dssp EEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTC-CEEEETTEEECEEECSCCSGGGEEECTTC-CEEE
T ss_pred EEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHh-hccccccccCCCEEeCCCChHhEEECCCC-eEEE
Confidence 9999987 45444432 458999999999999999999997 8 999999999999999888 7999
Q ss_pred eeecCccccCCCCC---CccccccCCccccccccCC----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH
Q 012233 282 CDFGSAKMLVPGEP---NISYICSRYYRAPELIFGA----TEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIK 354 (468)
Q Consensus 282 ~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~----~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~ 354 (468)
+|||+++....... .....||+.|+|||++.+. ..++.++|||||||++|||++|+.||.+............
T Consensus 173 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~ 252 (322)
T 3soc_A 173 ADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE 252 (322)
T ss_dssp CCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHH
T ss_pred ccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhh
Confidence 99999977644332 3346789999999999763 2356688999999999999999999987543221111111
Q ss_pred HhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 355 ILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
....+....+..... .....+.+.. ..-....++++.+||.+||+.||.+|||+.++++
T Consensus 253 ~~~~~~~~~~~~~~~--~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 253 IGQHPSLEDMQEVVV--HKKKRPVLRD----YWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp HCSSCCHHHHHHHHT--TSCCCCCCCG----GGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hccCCchhhhhhhhh--cccCCCCccc----cccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 122222222211000 0000000000 0001123456999999999999999999999975
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=338.66 Aligned_cols=245 Identities=22% Similarity=0.333 Sum_probs=195.5
Q ss_pred ccceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-----------chHHHHHHHHHHcCCCCcccccceeeecCC
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----------RYKNRELQIMRLLNHPNVVSLKHCFFSTTE 204 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-----------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 204 (468)
..+|.+.+.||+|+||.||+|.+..+++.||+|++.... ..+.+|+.+++.++||||+++++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~----- 92 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLM----- 92 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEE-----
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheee-----
Confidence 346999999999999999999999999999999884321 3456799999999999999999987
Q ss_pred CCceEEEEEeecccc-hHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCC--ccccCCCCCCeeecCCCC----
Q 012233 205 KDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG--VCHRDIKPQNLLVNPHTH---- 277 (468)
Q Consensus 205 ~~~~~~~lv~e~~~~-~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~g--ivHrDlkp~NILl~~~~~---- 277 (468)
.+.. ++||||+.+ ++.+.+. .....+++..++.++.||+.||.|||+ +| |+||||||+|||++.++.
T Consensus 93 ~~~~--~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~~ivH~dikp~Nil~~~~~~~~~~ 166 (287)
T 4f0f_A 93 HNPP--RMVMEFVPCGDLYHRLL---DKAHPIKWSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPV 166 (287)
T ss_dssp TTTT--EEEEECCTTCBHHHHHH---CTTSCCCHHHHHHHHHHHHHHHHHHHT-SSSCCBCSCCSGGGEEESCCCTTCSC
T ss_pred cCCC--eEEEEecCCCCHHHHHh---cccCCccHHHHHHHHHHHHHHHHHHHh-CCCCeecCCCCcceEEEeccCCCCce
Confidence 3333 589999985 4444332 234568999999999999999999998 89 999999999999987662
Q ss_pred cEEEeeecCccccCCCCCCccccccCCccccccccC-CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHH-HHHHHH
Q 012233 278 QLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFG-ATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQL-VEIIKI 355 (468)
Q Consensus 278 ~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~-~~i~~~ 355 (468)
.+||+|||+++... .......||+.|+|||++.+ ...++.++|||||||++|+|++|+.||......... ......
T Consensus 167 ~~kl~Dfg~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 244 (287)
T 4f0f_A 167 CAKVADFGLSQQSV--HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIRE 244 (287)
T ss_dssp CEEECCCTTCBCCS--SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHH
T ss_pred eEEeCCCCcccccc--ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhc
Confidence 29999999997543 33445789999999999843 234788999999999999999999999876544331 221111
Q ss_pred hCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 356 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
.+ +...++..+++++.+||.+||+.||.+|||+.++++
T Consensus 245 ~~--------------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 245 EG--------------------------LRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp SC--------------------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cC--------------------------CCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 10 011134568999999999999999999999999975
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=337.65 Aligned_cols=246 Identities=20% Similarity=0.285 Sum_probs=200.3
Q ss_pred cccceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc---chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEE
Q 012233 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (468)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~---~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 211 (468)
...+|.+.+.||+|+||.||+|.+. ++..||+|++.... ....+|+.+++.++||||+++++++ .+....+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 79 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVC-----SKEYPIY 79 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSSSEE
T ss_pred chhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEE-----ccCCceE
Confidence 3457999999999999999999875 56789999986543 3456899999999999999999988 4444588
Q ss_pred EEeecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcccc
Q 012233 212 LVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (468)
Q Consensus 212 lv~e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~ 290 (468)
+||||++++ +.+.+... ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||++...
T Consensus 80 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~Nil~~~~~-~~~l~Dfg~~~~~ 154 (268)
T 3sxs_A 80 IVTEYISNGCLLNYLRSH---GKGLEPSQLLEMCYDVCEGMAFLES-HQFIHRDLAARNCLVDRDL-CVKVSDFGMTRYV 154 (268)
T ss_dssp EEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHH-TTEEESSCSGGGEEECTTC-CEEECCTTCEEEC
T ss_pred EEEEccCCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCcCcceEEECCCC-CEEEccCccceec
Confidence 999999765 55544332 3458999999999999999999998 8999999999999999888 7999999999866
Q ss_pred CCCCC--CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 012233 291 VPGEP--NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367 (468)
Q Consensus 291 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 367 (468)
..... .....+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||......+....+.....
T Consensus 155 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~---------- 223 (268)
T 3sxs_A 155 LDDQYVSSVGTKFPVKWSAPEVFHYFK-YSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHR---------- 223 (268)
T ss_dssp CTTCEEECCSCCCCGGGCCHHHHHHSE-EETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC----------
T ss_pred chhhhhcccCCCcCcccCCHHHHhccC-CchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCC----------
Confidence 44321 22345577899999997544 8999999999999999999 9999988877766655433110
Q ss_pred CCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCC
Q 012233 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (468)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~h 420 (468)
...+..+++.+.+||.+||+.||.+|||+.++++|
T Consensus 224 ------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 224 ------------------LYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp ------------------CCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ------------------CCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00223478899999999999999999999999874
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=349.36 Aligned_cols=246 Identities=26% Similarity=0.425 Sum_probs=195.8
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc----------chHHHHHHHHHHc----CCCCcccccceeeec
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK----------RYKNRELQIMRLL----NHPNVVSLKHCFFST 202 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~----------~~~~~E~~il~~l----~hpnIv~l~~~~~~~ 202 (468)
.+|.+.+.||+|+||.||+|.+..+++.||||++.... ....+|+.+++.+ +||||+++++++
T Consensus 31 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~--- 107 (312)
T 2iwi_A 31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF--- 107 (312)
T ss_dssp --CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC---
T ss_pred hceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE---
Confidence 35999999999999999999999999999999985432 2234699999999 899999999988
Q ss_pred CCCCceEEEEEeec-cc-chHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeec-CCCCcE
Q 012233 203 TEKDELYLNLVLEY-IS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVN-PHTHQL 279 (468)
Q Consensus 203 ~~~~~~~~~lv~e~-~~-~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~-~~~~~v 279 (468)
......++|||| +. +++.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++ .+
T Consensus 108 --~~~~~~~~v~e~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~-~~ 179 (312)
T 2iwi_A 108 --ETQEGFMLVLERPLPAQDLFDYITE----KGPLGEGPSRCFFGQVVAAIQHCHS-RGVVHRDIKDENILIDLRRG-CA 179 (312)
T ss_dssp -------CEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-HTEECCCCSGGGEEEETTTT-EE
T ss_pred --ecCCeEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCChhhEEEeCCCC-eE
Confidence 334457899998 55 455554433 3568999999999999999999998 8999999999999999 555 89
Q ss_pred EEeeecCccccCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Q 012233 280 KICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTP 359 (468)
Q Consensus 280 kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~ 359 (468)
||+|||++...... ......|++.|+|||++.+....+.++|||||||++|+|++|+.||.... .+..
T Consensus 180 kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~----- 247 (312)
T 2iwi_A 180 KLIDFGSGALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILE----- 247 (312)
T ss_dssp EECCCSSCEECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHH-----
T ss_pred EEEEcchhhhcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhh-----
Confidence 99999999876433 34466789999999998765544568999999999999999999996531 1111
Q ss_pred CHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCC
Q 012233 360 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDP 429 (468)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~ 429 (468)
.... ++..+++++.+||.+||+.||.+|||+.|+++||||+...+.
T Consensus 248 ------------~~~~------------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~~ 293 (312)
T 2iwi_A 248 ------------AELH------------FPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAED 293 (312)
T ss_dssp ------------TCCC------------CCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC----
T ss_pred ------------hccC------------CcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchhc
Confidence 0111 334588999999999999999999999999999999986553
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-44 Score=358.22 Aligned_cols=248 Identities=21% Similarity=0.286 Sum_probs=199.2
Q ss_pred CCcccceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-----chHHHHHHHHHHcCCCCcccccceeeecCCCCc
Q 012233 133 PKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (468)
Q Consensus 133 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 207 (468)
.....+|.+.+.||+|+||.||+|.+..+++.||||++.... ..+.+|+.+|+.++||||+++++++ .+.
T Consensus 110 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~ 184 (377)
T 3cbl_A 110 VLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC-----TQK 184 (377)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEE-----CSS
T ss_pred EEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-----ecC
Confidence 344568999999999999999999999899999999986542 2345799999999999999999998 333
Q ss_pred eEEEEEeecccc-hHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecC
Q 012233 208 LYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (468)
Q Consensus 208 ~~~~lv~e~~~~-~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~ 286 (468)
..+|+||||+.+ ++.+.+.. ....+++..+..++.||+.||.|||+ +||+||||||+||||+.++ .+||+|||+
T Consensus 185 ~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivHrDlkp~Nil~~~~~-~~kl~DfG~ 259 (377)
T 3cbl_A 185 QPIYIVMELVQGGDFLTFLRT---EGARLRVKTLLQMVGDAAAGMEYLES-KCCIHRDLAARNCLVTEKN-VLKISDFGM 259 (377)
T ss_dssp SSCEEEEECCTTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTC-CEEECCGGG
T ss_pred CCcEEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCcCCcccCHHHEEEcCCC-cEEECcCCC
Confidence 457899999985 45554432 23458899999999999999999998 8999999999999999888 799999999
Q ss_pred ccccCCCCCC---ccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 012233 287 AKMLVPGEPN---ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTRE 362 (468)
Q Consensus 287 a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~ 362 (468)
++........ ....+++.|+|||++.+.. ++.++|||||||++|||++ |..||.+.+..+....+....
T Consensus 260 s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~------ 332 (377)
T 3cbl_A 260 SREEADGVYAASGGLRQVPVKWTAPEALNYGR-YSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGG------ 332 (377)
T ss_dssp CEECTTSEEECCSSCCEEEGGGSCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTC------
T ss_pred ceecCCCceeecCCCCCCCcCcCCHhHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC------
Confidence 9765332211 1223577899999997544 8999999999999999998 999999877655444332210
Q ss_pred HHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 363 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
.. .++..+++++.+||.+||+.||.+|||+.++++
T Consensus 333 ------------~~----------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 333 ------------RL----------PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp ------------CC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------CC----------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 00 023457899999999999999999999999875
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=339.81 Aligned_cols=247 Identities=19% Similarity=0.287 Sum_probs=198.3
Q ss_pred CcccceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc---cchHHHHHHHHHHcCCCCcccccceeeecCCCCceEE
Q 012233 134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (468)
Q Consensus 134 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~---~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~ 210 (468)
....+|.+.+.||+|+||.||+|.+. ++..||+|++... .....+|+.+++.++||||+++++++ .+...+
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~ 94 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC-----TKQRPI 94 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEE-----CSSSSE
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEE-----ecCCCe
Confidence 34457999999999999999999875 6778999998654 34456899999999999999999988 444458
Q ss_pred EEEeecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccc
Q 012233 211 NLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (468)
Q Consensus 211 ~lv~e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~ 289 (468)
++||||+.++ +.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++..
T Consensus 95 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~Nili~~~~-~~kl~Dfg~~~~ 169 (283)
T 3gen_A 95 FIITEYMANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLES-KQFLHRDLAARNCLVNDQG-VVKVSDFGLSRY 169 (283)
T ss_dssp EEEECCCTTCBHHHHHHC---GGGCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCSGGGEEECTTS-CEEECSTTGGGG
T ss_pred EEEEeccCCCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHH-CCccCCCCccceEEEcCCC-CEEEcccccccc
Confidence 8999999765 4444332 23568999999999999999999998 8999999999999999888 799999999976
Q ss_pred cCCCC--CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 012233 290 LVPGE--PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKC 366 (468)
Q Consensus 290 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 366 (468)
..... ......+|+.|+|||++.+.. ++.++|||||||++|+|++ |+.||...+..+....+......
T Consensus 170 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~-------- 240 (283)
T 3gen_A 170 VLDDEYTSSVGSKFPVRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL-------- 240 (283)
T ss_dssp BCCHHHHSTTSTTSCGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC--------
T ss_pred ccccccccccCCccCcccCCHHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCC--------
Confidence 54322 223445678899999997554 8999999999999999998 99999988776666555432110
Q ss_pred cCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCC
Q 012233 367 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (468)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~h 420 (468)
..+..+++.+.+||.+||+.||.+|||+.++++|
T Consensus 241 --------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 241 --------------------YRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp --------------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred --------------------CCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 1224478899999999999999999999999874
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=360.88 Aligned_cols=257 Identities=28% Similarity=0.414 Sum_probs=189.7
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-chHHHHHHHHHHc-CCCCcccccceeeecCCCCceEEEEEee
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-RYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDELYLNLVLE 215 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~lv~e 215 (468)
.|.+.++||+|+||+||.+. ..+|+.||||++..+. ....+|+.+++.+ +|||||++++++ .+..++|||||
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~-----~~~~~~~lv~E 89 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSE-----TTDRFLYIALE 89 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEE-----ECSSEEEEEEC
T ss_pred eeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEE-----ecCCeEEEEEe
Confidence 47888999999999998754 4679999999986543 3446799999876 899999999887 44556899999
Q ss_pred cccchHHHHHhhhhhcCCC---CCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCC------------CcEE
Q 012233 216 YISETVYRVSKHYTRMNQH---VPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHT------------HQLK 280 (468)
Q Consensus 216 ~~~~~ll~~~~~~~~~~~~---~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~------------~~vk 280 (468)
||++++.+.+......... ..+..++.++.||+.||.|||+ +||+||||||+||||+.++ ..+|
T Consensus 90 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k 168 (434)
T 2rio_A 90 LCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS-LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168 (434)
T ss_dssp CCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred cCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH-CCccccCCChHhEEEecCcccccccccCCCceEEE
Confidence 9998887766543222111 1223456799999999999998 8999999999999997532 2699
Q ss_pred EeeecCccccCCCCC-----CccccccCCccccccccC------CCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHH
Q 012233 281 ICDFGSAKMLVPGEP-----NISYICSRYYRAPELIFG------ATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQ 348 (468)
Q Consensus 281 L~DFG~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~------~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~ 348 (468)
|+|||+++....... ....+||+.|+|||++.+ ...++.++|||||||++|||++ |..||......+
T Consensus 169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~- 247 (434)
T 2rio_A 169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE- 247 (434)
T ss_dssp ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH-
T ss_pred EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH-
Confidence 999999987654332 224579999999999965 2458999999999999999999 999997654433
Q ss_pred HHHHHHHhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q 012233 349 LVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDD 425 (468)
Q Consensus 349 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~ 425 (468)
..+... ...++.... .....+++++.+||.+||+.||.+|||+.++++||||..
T Consensus 248 -~~i~~~-----------------~~~~~~~~~-----~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 248 -SNIIRG-----------------IFSLDEMKC-----LHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp -HHHHHT-----------------CCCCCCCTT-----CCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred -HHHhcC-----------------CCCcccccc-----cccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 222221 111111100 011235688999999999999999999999999999975
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-43 Score=351.59 Aligned_cols=251 Identities=22% Similarity=0.316 Sum_probs=200.5
Q ss_pred CcccceEEeceecccCceEEEEEEEcCC-------CCEEEEEEeeccc-----chHHHHHHHHHHc-CCCCcccccceee
Q 012233 134 KQTISYMAERVVGTGSFGVVFQAKCLET-------GDSVAIKKVLQDK-----RYKNRELQIMRLL-NHPNVVSLKHCFF 200 (468)
Q Consensus 134 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~-------g~~vaiK~~~~~~-----~~~~~E~~il~~l-~hpnIv~l~~~~~ 200 (468)
....+|.+.+.||+|+||.||+|.+..+ +..||||++.... ....+|+.+++.+ +||||+++++++.
T Consensus 66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 145 (382)
T 3tt0_A 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 145 (382)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence 3445799999999999999999997543 3579999986542 2345799999999 8999999999883
Q ss_pred ecCCCCceEEEEEeecccc-hHHHHHhhhhh------------cCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCC
Q 012233 201 STTEKDELYLNLVLEYISE-TVYRVSKHYTR------------MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKP 267 (468)
Q Consensus 201 ~~~~~~~~~~~lv~e~~~~-~ll~~~~~~~~------------~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp 267 (468)
....+++||||+.+ ++.+.+..... ....+++..++.++.||+.||.|||+ .||+||||||
T Consensus 146 -----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp 219 (382)
T 3tt0_A 146 -----QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS-KKCIHRDLAA 219 (382)
T ss_dssp -----SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCG
T ss_pred -----cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCc
Confidence 34447899999986 55554443221 12458999999999999999999998 8999999999
Q ss_pred CCeeecCCCCcEEEeeecCccccCCCC---CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 012233 268 QNLLVNPHTHQLKICDFGSAKMLVPGE---PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGE 343 (468)
Q Consensus 268 ~NILl~~~~~~vkL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~ 343 (468)
+||||+.++ .+||+|||+++...... ......+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.
T Consensus 220 ~NIll~~~~-~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwslG~il~ellt~g~~p~~~~ 297 (382)
T 3tt0_A 220 RNVLVTEDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGV 297 (382)
T ss_dssp GGEEECTTC-CEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ceEEEcCCC-cEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCC-CCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999888 79999999998664332 233456788999999997654 8999999999999999999 99999887
Q ss_pred CcHHHHHHHHHHhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCC
Q 012233 344 SGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (468)
Q Consensus 344 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~h 420 (468)
...+....+.... . ...+..+++++.+||.+||+.||.+|||+.+++++
T Consensus 298 ~~~~~~~~~~~~~----------------~------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 298 PVEELFKLLKEGH----------------R------------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp CHHHHHHHHHTTC----------------C------------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHcCC----------------C------------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 7655544433210 0 01234588999999999999999999999999873
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=350.12 Aligned_cols=248 Identities=23% Similarity=0.291 Sum_probs=198.9
Q ss_pred ccceEEeceecccCceEEEEEEEc-----CCCCEEEEEEeeccc-----chHHHHHHHHHHcCCCCcccccceeeecCCC
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCL-----ETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEK 205 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~-----~~g~~vaiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 205 (468)
..+|.+.+.||+|+||.||+|.+. .+++.||||++.... ..+.+|+.+++.++||||+++++++.
T Consensus 46 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~----- 120 (343)
T 1luf_A 46 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA----- 120 (343)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-----
T ss_pred HHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc-----
Confidence 456999999999999999999986 355889999986542 33567999999999999999999983
Q ss_pred CceEEEEEeecccc-hHHHHHhhhhh--------------------cCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccC
Q 012233 206 DELYLNLVLEYISE-TVYRVSKHYTR--------------------MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRD 264 (468)
Q Consensus 206 ~~~~~~lv~e~~~~-~ll~~~~~~~~--------------------~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrD 264 (468)
+...+|+||||+.+ ++.+.+..... ....+++..++.++.||+.||.|||+ +||+|||
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~ivH~D 199 (343)
T 1luf_A 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE-RKFVHRD 199 (343)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSC
T ss_pred cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCC
Confidence 34458899999986 55554443211 12568999999999999999999998 8999999
Q ss_pred CCCCCeeecCCCCcEEEeeecCccccCCCC---CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCC
Q 012233 265 IKPQNLLVNPHTHQLKICDFGSAKMLVPGE---PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLF 340 (468)
Q Consensus 265 lkp~NILl~~~~~~vkL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf 340 (468)
|||+|||++.++ .+||+|||++....... ......+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||
T Consensus 200 lkp~NIl~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~ 277 (343)
T 1luf_A 200 LATRNCLVGENM-VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGLQPY 277 (343)
T ss_dssp CSGGGEEECGGG-CEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred CCcceEEECCCC-eEEEeecCCCcccccCccccccCCCcccceecChhhhccCC-cCcccccHHHHHHHHHHHhcCCCcC
Confidence 999999999887 79999999997653322 223456789999999987554 8999999999999999999 99999
Q ss_pred CCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 341 PGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 341 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
.+.+..+....+.... . ..++..+++++.+||.+||+.||.+|||+.++++
T Consensus 278 ~~~~~~~~~~~~~~~~-------------------~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~ 328 (343)
T 1luf_A 278 YGMAHEEVIYYVRDGN-------------------I---------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 328 (343)
T ss_dssp TTSCHHHHHHHHHTTC-------------------C---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCChHHHHHHHhCCC-------------------c---------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 9877666555443310 0 0123458899999999999999999999999986
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=345.97 Aligned_cols=250 Identities=26% Similarity=0.411 Sum_probs=184.2
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc----chHHHHHHHHHHcC-CCCcccccceeeecCC---CCceE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK----RYKNRELQIMRLLN-HPNVVSLKHCFFSTTE---KDELY 209 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~----~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~---~~~~~ 209 (468)
+|++.+.||+|+||.||+|.+..+|+.||||++.... ....+|+.+++.+. ||||+++++++..... .....
T Consensus 29 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~ 108 (337)
T 3ll6_A 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAE 108 (337)
T ss_dssp EEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEE
T ss_pred eEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCce
Confidence 6999999999999999999999999999999885432 23457999999996 9999999998854332 44566
Q ss_pred EEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCC--ccccCCCCCCeeecCCCCcEEEeeecCc
Q 012233 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG--VCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (468)
Q Consensus 210 ~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~g--ivHrDlkp~NILl~~~~~~vkL~DFG~a 287 (468)
+++||||+.+++.+.+.... ....+++..++.++.||+.||.|||+ +| |+||||||+||||+.++ .+||+|||++
T Consensus 109 ~~lv~e~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~~ 185 (337)
T 3ll6_A 109 FLLLTELCKGQLVEFLKKME-SRGPLSCDTVLKIFYQTCRAVQHMHR-QKPPIIHRDLKVENLLLSNQG-TIKLCDFGSA 185 (337)
T ss_dssp EEEEEECCSEEHHHHHHHHH-TTCSCCHHHHHHHHHHHHHHHHHHHT-SSSCCBCCCCCGGGCEECTTS-CEEBCCCTTC
T ss_pred EEEEEEecCCCHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCEEEccCCcccEEECCCC-CEEEecCccc
Confidence 88999999998888765433 34569999999999999999999998 89 99999999999999888 7999999999
Q ss_pred cccCCCCC-------------CccccccCCcccccccc--CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH
Q 012233 288 KMLVPGEP-------------NISYICSRYYRAPELIF--GATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEI 352 (468)
Q Consensus 288 ~~~~~~~~-------------~~~~~gt~~y~aPE~~~--~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i 352 (468)
........ .....||+.|+|||++. ....++.++|||||||++|+|++|+.||...........
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~- 264 (337)
T 3ll6_A 186 TTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNG- 264 (337)
T ss_dssp BCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------------
T ss_pred eeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcC-
Confidence 87643221 11456899999999983 233478899999999999999999999976443221110
Q ss_pred HHHhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCC
Q 012233 353 IKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHP 421 (468)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp 421 (468)
....+ .....+..+.+||.+||+.||.+|||+.|+++|-
T Consensus 265 --------------------~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l 303 (337)
T 3ll6_A 265 --------------------KYSIP----------PHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQL 303 (337)
T ss_dssp ---------------------CCCC----------TTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred --------------------cccCC----------cccccchHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 00000 1234677899999999999999999999999863
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=344.20 Aligned_cols=253 Identities=23% Similarity=0.334 Sum_probs=192.8
Q ss_pred ccceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-chHHHHHHHHHH--cCCCCcccccceeeecCCCCceEEEE
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-RYKNRELQIMRL--LNHPNVVSLKHCFFSTTEKDELYLNL 212 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-~~~~~E~~il~~--l~hpnIv~l~~~~~~~~~~~~~~~~l 212 (468)
..+|.+.+.||+|+||.||+|.+ +|+.||||++.... ....+|.+++.. ++||||+++++++.... .....+++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~-~~~~~~~l 83 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSR-HSSTQLWL 83 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE-TTEEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeecccc-CCCceeEE
Confidence 44699999999999999999998 78999999986543 333457777777 78999999999875543 34556889
Q ss_pred Eeecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhH--------hcCCccccCCCCCCeeecCCCCcEEEee
Q 012233 213 VLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH--------HVVGVCHRDIKPQNLLVNPHTHQLKICD 283 (468)
Q Consensus 213 v~e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH--------~~~givHrDlkp~NILl~~~~~~vkL~D 283 (468)
||||+.++ +.+.+. ...+++..++.++.||+.||.||| + +||+||||||+||||+.++ .+||+|
T Consensus 84 v~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~-~~ivH~Dlkp~Nill~~~~-~~kl~D 156 (301)
T 3q4u_A 84 ITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGK-PAIAHRDLKSKNILVKKNG-QCCIAD 156 (301)
T ss_dssp EECCCTTCBHHHHHT-----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCB-CEEECSCCCGGGEEECTTS-CEEECC
T ss_pred ehhhccCCCHHHHHh-----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCC-CCeecCCCChHhEEEcCCC-CEEEee
Confidence 99999864 444432 356899999999999999999999 8 8999999999999999888 799999
Q ss_pred ecCccccCCCCC-----CccccccCCccccccccCCC-----CCCcchhHHHHHHHHHHHHhC----------CCCCCCC
Q 012233 284 FGSAKMLVPGEP-----NISYICSRYYRAPELIFGAT-----EYTTAIDMWSIGCVLAELLLG----------QPLFPGE 343 (468)
Q Consensus 284 FG~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~-----~~~~~~DvwSlG~il~ell~G----------~~pf~~~ 343 (468)
||+++....... .....||+.|+|||++.+.. .++.++|||||||++|||++| ..||...
T Consensus 157 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~ 236 (301)
T 3q4u_A 157 LGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV 236 (301)
T ss_dssp CTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccccc
Confidence 999976543322 22347999999999997653 244789999999999999999 8888653
Q ss_pred Cc----HHHHHHHHHHhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 344 SG----VDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 344 ~~----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
.. ...+..+..... ..+.++ ...+...+++++.+||.+||+.||.+|||+.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~-----------------~~~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 237 VPNDPSFEDMRKVVCVDQ-----------------QRPNIP----NRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp SCSSCCHHHHHHHHTTSC-----------------CCCCCC----GGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred CCCCcchhhhhHHHhccC-----------------CCCCCC----hhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 32 222222211000 000000 01122335678999999999999999999999975
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=342.99 Aligned_cols=249 Identities=22% Similarity=0.339 Sum_probs=198.6
Q ss_pred ccceEEeceecccCceEEEEEEEc-----CCCCEEEEEEeeccc-----chHHHHHHHHHHcCCCCcccccceeeecCCC
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCL-----ETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEK 205 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~-----~~g~~vaiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 205 (468)
..+|.+.+.||+|+||.||+|.+. .++..||+|++.... ....+|+.+++.++||||+++++++ .
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~ 96 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGAC-----S 96 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----C
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEE-----e
Confidence 457999999999999999999983 456889999986532 3345799999999999999999988 3
Q ss_pred CceEEEEEeecccc-hHHHHHhhhhh--------------------cCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccC
Q 012233 206 DELYLNLVLEYISE-TVYRVSKHYTR--------------------MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRD 264 (468)
Q Consensus 206 ~~~~~~lv~e~~~~-~ll~~~~~~~~--------------------~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrD 264 (468)
+...+++||||+.+ ++.+.+..... ....+++..++.++.||+.||.|||+ +||+|||
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~d 175 (314)
T 2ivs_A 97 QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE-MKLVHRD 175 (314)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH-TTEECCC
T ss_pred cCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH-CCCcccc
Confidence 34458899999985 55554443221 12348899999999999999999998 8999999
Q ss_pred CCCCCeeecCCCCcEEEeeecCccccCCCCC---CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCC
Q 012233 265 IKPQNLLVNPHTHQLKICDFGSAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLF 340 (468)
Q Consensus 265 lkp~NILl~~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf 340 (468)
|||+|||++.++ .+||+|||++........ .....+++.|+|||++.+.. ++.++|||||||++|+|++ |..||
T Consensus 176 ikp~NIli~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~ 253 (314)
T 2ivs_A 176 LAARNILVAEGR-KMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPY 253 (314)
T ss_dssp CSGGGEEEETTT-EEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred cchheEEEcCCC-CEEEccccccccccccccceeccCCCCcccccChhhhcCCC-cCchhhHHHHHHHHHHHHhCCCCCC
Confidence 999999999887 799999999986643322 23445688899999997654 8999999999999999999 99999
Q ss_pred CCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCC
Q 012233 341 PGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (468)
Q Consensus 341 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~h 420 (468)
.+....+....+.... . ...+..+++++.+||.+||+.||.+|||+.+++++
T Consensus 254 ~~~~~~~~~~~~~~~~----------------~------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 254 PGIPPERLFNLLKTGH----------------R------------MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp TTCCGGGHHHHHHTTC----------------C------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCHHHHHHHhhcCC----------------c------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 8877655444332210 0 01234589999999999999999999999999863
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=334.73 Aligned_cols=249 Identities=20% Similarity=0.239 Sum_probs=199.3
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc--cchHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEEEe
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD--KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~--~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv~ 214 (468)
.+|.+.+.||+|+||.||+|.+..+|+.||||++... .....+|+.+++.++|++++..+..+... ..+.++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~----~~~~~lv~ 84 (296)
T 3uzp_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAE----GDYNVMVM 84 (296)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEEE----TTEEEEEE
T ss_pred cEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccCC----CCceEEEE
Confidence 4699999999999999999999999999999988543 34567899999999999988877666432 23578999
Q ss_pred ecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeec---CCCCcEEEeeecCccccC
Q 012233 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVN---PHTHQLKICDFGSAKMLV 291 (468)
Q Consensus 215 e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~---~~~~~vkL~DFG~a~~~~ 291 (468)
||+++++.+++.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++ .++ .+||+|||++....
T Consensus 85 e~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~NIl~~~~~~~~-~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 85 ELLGPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHS-KNFIHRDVKPDNFLMGLGKKGN-LVYIIDFGLAKKYR 159 (296)
T ss_dssp ECCCCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECCGGGTT-CEEECCCTTCEECB
T ss_pred EecCCCHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHeEEecCCCCC-eEEEeeCCCccccc
Confidence 9997777765542 24569999999999999999999998 8999999999999994 555 79999999998764
Q ss_pred CCCC--------CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCc---HHHHHHHHHHhCCCC
Q 012233 292 PGEP--------NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESG---VDQLVEIIKILGTPT 360 (468)
Q Consensus 292 ~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~---~~~~~~i~~~~~~~~ 360 (468)
.... .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+... .+.+..+.......+
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred ccccccccccccccccccccccCChhhhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence 4322 24567899999999997654 89999999999999999999999987432 233333333211111
Q ss_pred HHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 361 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
. ..+...+++++.+||.+||+.||.+|||+.++++
T Consensus 239 ~------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 239 I------------------------EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp H------------------------HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred h------------------------HHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 1 1123458899999999999999999999999876
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=348.20 Aligned_cols=251 Identities=22% Similarity=0.307 Sum_probs=199.1
Q ss_pred ccceEEeceecccCceEEEEEEEc-----CCCCEEEEEEeecc-----cchHHHHHHHHHHc-CCCCcccccceeeecCC
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCL-----ETGDSVAIKKVLQD-----KRYKNRELQIMRLL-NHPNVVSLKHCFFSTTE 204 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~-----~~g~~vaiK~~~~~-----~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~ 204 (468)
..+|.+.+.||+|+||.||+|.+. .++..||||++... ...+.+|+.+++.+ +||||+++++++.
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~---- 119 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT---- 119 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC----
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe----
Confidence 457999999999999999999973 45678999998543 23456899999999 8999999999884
Q ss_pred CCceEEEEEeecccc-hHHHHHhhhhhc-------------------CCCCCHHHHHHHHHHHHHHHHHhHhcCCccccC
Q 012233 205 KDELYLNLVLEYISE-TVYRVSKHYTRM-------------------NQHVPILYVQLYTYQICRALNYLHHVVGVCHRD 264 (468)
Q Consensus 205 ~~~~~~~lv~e~~~~-~ll~~~~~~~~~-------------------~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrD 264 (468)
....+++||||+.+ ++.+.+...... ...+++..++.++.||+.||.|||+ +||+|||
T Consensus 120 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~D 197 (344)
T 1rjb_A 120 -LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF-KSCVHRD 197 (344)
T ss_dssp -SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH-TTEEETT
T ss_pred -eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh-CCcccCC
Confidence 33458899999976 555554432110 1347889999999999999999998 8999999
Q ss_pred CCCCCeeecCCCCcEEEeeecCccccCCCCC---CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCC
Q 012233 265 IKPQNLLVNPHTHQLKICDFGSAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLF 340 (468)
Q Consensus 265 lkp~NILl~~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf 340 (468)
|||+||||+.++ .+||+|||++........ .....||+.|+|||++.+.. ++.++|||||||++|+|++ |..||
T Consensus 198 ikp~NIll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~ 275 (344)
T 1rjb_A 198 LAARNVLVTHGK-VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGVNPY 275 (344)
T ss_dssp CSGGGEEEETTT-EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred CChhhEEEcCCC-cEEeCCCccCcccccCccceeccCccCccCccCHHHhccCC-CChhHhHHHHHHHHHHHHcCCCCCc
Confidence 999999999888 899999999976543322 22345688999999987654 8999999999999999998 99999
Q ss_pred CCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCC
Q 012233 341 PGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (468)
Q Consensus 341 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~h 420 (468)
.+......+..++..... ...+..+++++.+||.+||+.||.+|||+.++++|
T Consensus 276 ~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 328 (344)
T 1rjb_A 276 PGIPVDANFYKLIQNGFK---------------------------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 328 (344)
T ss_dssp TTCCCSHHHHHHHHTTCC---------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccCCcHHHHHHHHhcCCC---------------------------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 987766665555442100 01234578999999999999999999999999874
Q ss_pred C
Q 012233 421 P 421 (468)
Q Consensus 421 p 421 (468)
-
T Consensus 329 l 329 (344)
T 1rjb_A 329 L 329 (344)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=339.17 Aligned_cols=249 Identities=20% Similarity=0.242 Sum_probs=197.9
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc--cchHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEEEe
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD--KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~--~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv~ 214 (468)
.+|.+.+.||+|+||.||+|.+..+++.||||++... .....+|+.+++.++|++++..+..+... ..+.++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~----~~~~~lv~ 84 (296)
T 4hgt_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAE----GDYNVMVM 84 (296)
T ss_dssp --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEEE----TTEEEEEE
T ss_pred CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecCC----CCceEEEE
Confidence 4699999999999999999999999999999986433 34567899999999999988887766443 23578999
Q ss_pred ecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeee---cCCCCcEEEeeecCccccC
Q 012233 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLV---NPHTHQLKICDFGSAKMLV 291 (468)
Q Consensus 215 e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl---~~~~~~vkL~DFG~a~~~~ 291 (468)
||+++++.+++.. ....+++..++.++.||+.||.|||+ +||+||||||+|||| +.++ .+||+|||+++...
T Consensus 85 e~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dlkp~NIl~~~~~~~~-~~kL~Dfg~a~~~~ 159 (296)
T 4hgt_A 85 ELLGPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHS-KNFIHRDVKPDNFLMGLGKKGN-LVYIIDFGLAKKYR 159 (296)
T ss_dssp ECCCCBHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECCGGGTT-CEEECCCTTCEECB
T ss_pred EccCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeeeeccCCCC-eEEEecCccceecc
Confidence 9997777765542 24569999999999999999999998 899999999999999 6666 79999999998764
Q ss_pred CCCC--------CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcH---HHHHHHHHHhCCCC
Q 012233 292 PGEP--------NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGV---DQLVEIIKILGTPT 360 (468)
Q Consensus 292 ~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~---~~~~~i~~~~~~~~ 360 (468)
.... .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+.. ..+..+.......+
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 4hgt_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred CcccCccCCCCcccccCCCccccchHHhcCCC-CCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch
Confidence 4322 23567899999999997654 899999999999999999999999875432 22333222111111
Q ss_pred HHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 361 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
. ..+...+++++.+||.+||+.||.+|||+.++++
T Consensus 239 ~------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 239 I------------------------EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp H------------------------HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred h------------------------hhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 0 1122457899999999999999999999999876
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=340.79 Aligned_cols=249 Identities=24% Similarity=0.327 Sum_probs=200.2
Q ss_pred ccceEEeceecccCceEEEEEEE-----cCCCCEEEEEEeeccc-----chHHHHHHHHHHc-CCCCcccccceeeecCC
Q 012233 136 TISYMAERVVGTGSFGVVFQAKC-----LETGDSVAIKKVLQDK-----RYKNRELQIMRLL-NHPNVVSLKHCFFSTTE 204 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~-----~~~g~~vaiK~~~~~~-----~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~ 204 (468)
..+|.+.+.||+|+||.||+|.+ ..+++.||+|++.... ....+|+.+++.+ +||||+++++++.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~---- 97 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT---- 97 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC----
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe----
Confidence 35799999999999999999985 4567899999986442 3455799999999 8999999999883
Q ss_pred CCceEEEEEeecccc-hHHHHHhhhhh--------------cCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCC
Q 012233 205 KDELYLNLVLEYISE-TVYRVSKHYTR--------------MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQN 269 (468)
Q Consensus 205 ~~~~~~~lv~e~~~~-~ll~~~~~~~~--------------~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~N 269 (468)
+....++||||+.+ ++.+.+..... ....+++..++.++.||+.||.|||+ +||+||||||+|
T Consensus 98 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~N 175 (313)
T 1t46_A 98 -IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS-KNCIHRDLAARN 175 (313)
T ss_dssp -SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGG
T ss_pred -cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCccce
Confidence 33457899999986 55554443211 12358999999999999999999998 899999999999
Q ss_pred eeecCCCCcEEEeeecCccccCCCCC---CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCc
Q 012233 270 LLVNPHTHQLKICDFGSAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESG 345 (468)
Q Consensus 270 ILl~~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~ 345 (468)
||++.++ .+||+|||++........ .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+...
T Consensus 176 il~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 253 (313)
T 1t46_A 176 ILLTHGR-ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (313)
T ss_dssp EEEETTT-EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred EEEcCCC-CEEEccccccccccccccceeccCCCCcceeeChHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence 9999887 799999999987644332 2234567899999998755 48999999999999999998 9999988776
Q ss_pred HHHHHHHHHHhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 346 VDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 346 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
...+..++.....+ ..+..+++++.+||.+||+.||.+|||+.++++
T Consensus 254 ~~~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 300 (313)
T 1t46_A 254 DSKFYKMIKEGFRM---------------------------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (313)
T ss_dssp SHHHHHHHHHTCCC---------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhHHHHHhccCCCC---------------------------CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 66655554421110 122457899999999999999999999999986
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=346.80 Aligned_cols=245 Identities=21% Similarity=0.295 Sum_probs=192.7
Q ss_pred ccceEEeceecccCceEEEEEEEcCCCCE----EEEEEeecc-----cchHHHHHHHHHHcCCCCcccccceeeecCCCC
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLETGDS----VAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD 206 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~----vaiK~~~~~-----~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 206 (468)
..+|++.+.||+|+||.||+|.+..+++. ||+|.+... .....+|+.+++.++||||+++++++. +
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~ 86 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-----G 86 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-----B
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-----C
Confidence 34699999999999999999999888876 666766332 233457999999999999999999872 2
Q ss_pred ceEEEEEeecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeec
Q 012233 207 ELYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG 285 (468)
Q Consensus 207 ~~~~~lv~e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG 285 (468)
...++||||+.++ +.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||
T Consensus 87 -~~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dikp~Nil~~~~~-~~kl~Dfg 160 (325)
T 3kex_A 87 -SSLQLVTQYLPLGSLLDHVRQ---HRGALGPQLLLNWGVQIAKGMYYLEE-HGMVHRNLAARNVLLKSPS-QVQVADFG 160 (325)
T ss_dssp -SSEEEEEECCTTCBSHHHHHS---SGGGSCTTHHHHHHHHHHHHHHHHHH-TTCCCSCCSSTTEEESSSS-CEEECSCS
T ss_pred -CccEEEEEeCCCCCHHHHHHH---ccccCCHHHHHHHHHHHHHHHHHHHh-CCCCCCccchheEEECCCC-eEEECCCC
Confidence 2377999999854 4443322 23468888999999999999999998 8999999999999999888 79999999
Q ss_pred CccccCCCCC---CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCH
Q 012233 286 SAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTR 361 (468)
Q Consensus 286 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~ 361 (468)
+++....... .....+++.|+|||++.+.. ++.++|||||||++|+|++ |..||.+....+....+....
T Consensus 161 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~----- 234 (325)
T 3kex_A 161 VADLLPPDDKQLLYSEAKTPIKWMALESIHFGK-YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGE----- 234 (325)
T ss_dssp GGGGSCCCTTCCC-----CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTC-----
T ss_pred cccccCcccccccccCCCCcccccChHHhccCC-CChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCC-----
Confidence 9987644332 23456788999999997554 8999999999999999999 999998876555444332210
Q ss_pred HHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCC
Q 012233 362 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (468)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~h 420 (468)
.. ..+..++.++.+||.+||+.||.+|||+.++++|
T Consensus 235 -----------~~------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 235 -----------RL------------AQPQICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp -----------BC------------CCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred -----------CC------------CCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00 1223467789999999999999999999999875
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=346.39 Aligned_cols=251 Identities=22% Similarity=0.289 Sum_probs=199.8
Q ss_pred CcccceEEeceecccCceEEEEEEEcCCCCEE--EEEEeecc-----cchHHHHHHHHHHc-CCCCcccccceeeecCCC
Q 012233 134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSV--AIKKVLQD-----KRYKNRELQIMRLL-NHPNVVSLKHCFFSTTEK 205 (468)
Q Consensus 134 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~v--aiK~~~~~-----~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~ 205 (468)
....+|.+.+.||+|+||.||+|.+..+|..+ |+|.+... ...+.+|+.+++.+ +||||+++++++.
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~----- 96 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE----- 96 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEE-----
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeee-----
Confidence 44467999999999999999999998888865 99988542 33456799999999 8999999999984
Q ss_pred CceEEEEEeecccc-hHHHHHhhhh------------hcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeee
Q 012233 206 DELYLNLVLEYISE-TVYRVSKHYT------------RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLV 272 (468)
Q Consensus 206 ~~~~~~lv~e~~~~-~ll~~~~~~~------------~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl 272 (468)
+...+|+||||+.+ ++.+.+.... .....+++..++.++.||+.||.|||+ +||+||||||+|||+
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIl~ 175 (327)
T 1fvr_A 97 HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARNILV 175 (327)
T ss_dssp ETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEE
T ss_pred eCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCccceEEE
Confidence 33468999999976 5555544321 223578999999999999999999998 899999999999999
Q ss_pred cCCCCcEEEeeecCccccCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHH
Q 012233 273 NPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVE 351 (468)
Q Consensus 273 ~~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~ 351 (468)
+.++ .+||+|||+++............+++.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....
T Consensus 176 ~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~ 253 (327)
T 1fvr_A 176 GENY-VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK 253 (327)
T ss_dssp CGGG-CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH
T ss_pred cCCC-eEEEcccCcCccccccccccCCCCCccccChhhhccc-cCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHH
Confidence 9887 7999999999754433334455678899999999654 48999999999999999998 9999988776554443
Q ss_pred HHHHhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCC
Q 012233 352 IIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (468)
Q Consensus 352 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~h 420 (468)
+.... . ...+..+++++.+||.+||+.||.+|||+.++++|
T Consensus 254 ~~~~~------------------~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 254 LPQGY------------------R----------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp GGGTC------------------C----------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hhcCC------------------C----------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 32210 0 01234578999999999999999999999999873
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=345.73 Aligned_cols=245 Identities=22% Similarity=0.327 Sum_probs=189.9
Q ss_pred ccceEEeceecccCceEEEEEEEcCCCCEE----EEEEeecc-----cchHHHHHHHHHHcCCCCcccccceeeecCCCC
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLETGDSV----AIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD 206 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~v----aiK~~~~~-----~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 206 (468)
..+|.+.+.||+|+||.||+|.+..+|+.+ |+|.+... ...+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---- 89 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS---- 89 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS----
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC----
Confidence 346999999999999999999998887765 77766322 23456799999999999999999988532
Q ss_pred ceEEEEEeecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeec
Q 012233 207 ELYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG 285 (468)
Q Consensus 207 ~~~~~lv~e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG 285 (468)
. .++|+||+.++ +.+.+. .....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||
T Consensus 90 -~-~~~v~e~~~~g~L~~~l~---~~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivH~Dikp~NIll~~~~-~~kl~Dfg 162 (327)
T 3poz_A 90 -T-VQLITQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQ-HVKITDFG 162 (327)
T ss_dssp -S-EEEEEECCTTCBHHHHHH---HSTTSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEEETT-EEEECCTT
T ss_pred -C-eEEEEEecCCCcHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHhh-CCeeCCCCChheEEECCCC-CEEEccCc
Confidence 2 56788888854 444333 234668999999999999999999998 8999999999999999888 79999999
Q ss_pred CccccCCCCCC---ccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCH
Q 012233 286 SAKMLVPGEPN---ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTR 361 (468)
Q Consensus 286 ~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~ 361 (468)
+++........ ....+|+.|+|||++.+.. ++.++|||||||++|||++ |+.||.+....+....+.... .
T Consensus 163 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~-~--- 237 (327)
T 3poz_A 163 LAKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE-R--- 237 (327)
T ss_dssp HHHHHTTTCC-------CCCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-C---
T ss_pred ceeEccCCcccccccCCCccccccChHHhccCC-CCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCC-C---
Confidence 99876443322 2345688999999997654 8999999999999999999 999998876555433332210 0
Q ss_pred HHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCC
Q 012233 362 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (468)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~h 420 (468)
. ..+..++.++.+||.+||+.||.+|||+.+++.+
T Consensus 238 --------------~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 238 --------------L----------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp --------------C----------CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred --------------C----------CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 0 0234578899999999999999999999999864
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=342.08 Aligned_cols=257 Identities=24% Similarity=0.381 Sum_probs=191.2
Q ss_pred ccceEEeceecccCceEEEEEE----EcCCCCEEEEEEeeccc----chHHHHHHHHHHcCCCCcccccceeeecCCCCc
Q 012233 136 TISYMAERVVGTGSFGVVFQAK----CLETGDSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~----~~~~g~~vaiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 207 (468)
..+|++.+.||+|+||.||+|+ +..+++.||||++.... ..+.+|+.+++.++||||+++++++.... .
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~ 85 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG---R 85 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHH---H
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC---C
Confidence 3579999999999999999998 56689999999986543 33467999999999999999999875432 2
Q ss_pred eEEEEEeecccc-hHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecC
Q 012233 208 LYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (468)
Q Consensus 208 ~~~~lv~e~~~~-~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~ 286 (468)
..+++||||+.+ ++.+.+... ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus 86 ~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dikp~Nil~~~~~-~~kl~Dfg~ 160 (295)
T 3ugc_A 86 RNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGT-KRYIHRDLATRNILVENEN-RVKIGDFGL 160 (295)
T ss_dssp TSCEEEEECCTTCBHHHHHHHC---GGGCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEETT-EEEECCCCS
T ss_pred CceEEEEEeCCCCCHHHHHHhc---ccccCHHHHHHHHHHHHHHHHHHhc-CCcccCCCCHhhEEEcCCC-eEEEccCcc
Confidence 247899999976 555444322 3458999999999999999999998 8999999999999999887 799999999
Q ss_pred ccccCCCCC----CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 012233 287 AKMLVPGEP----NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTRE 362 (468)
Q Consensus 287 a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~ 362 (468)
+........ .....++..|+|||++.+.. ++.++|||||||++|+|++|..||..... .... ..+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~~~~~~~~--~~~~---~~~~~~~~ 234 (295)
T 3ugc_A 161 TKVLPQDKEFFKVKEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFTYIEKSKSPPA--EFMR---MIGNDKQG 234 (295)
T ss_dssp CC-------------CTTCGGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHHTTCTTCSHHH--HHHH---HHCTTCCT
T ss_pred cccccCCcceeeeccCCCCccceeCcHHhcCCC-CChHHHHHHHHHHHHHHHhcccccCCChH--HHHh---hhcCcccc
Confidence 987643321 22345678899999997654 89999999999999999999999864321 1111 11111000
Q ss_pred H------HhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 363 E------IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 363 ~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
. ..... ... ....+..+++++.+||.+||+.||.+|||+.|+++
T Consensus 235 ~~~~~~~~~~~~---~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 235 QMIVFHLIELLK---NNG----------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HHHHHHHHHHHH---TTC----------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred chhHHHHHHHHh---ccC----------cCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0 00000 000 01123568999999999999999999999999875
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=346.28 Aligned_cols=262 Identities=22% Similarity=0.275 Sum_probs=206.4
Q ss_pred CcccceEEeceecccCceEEEEEEEc-----CCCCEEEEEEeecccc-----hHHHHHHHHHHcCCCCcccccceeeecC
Q 012233 134 KQTISYMAERVVGTGSFGVVFQAKCL-----ETGDSVAIKKVLQDKR-----YKNRELQIMRLLNHPNVVSLKHCFFSTT 203 (468)
Q Consensus 134 ~~~~~y~~~~~lG~G~fg~Vy~~~~~-----~~g~~vaiK~~~~~~~-----~~~~E~~il~~l~hpnIv~l~~~~~~~~ 203 (468)
....+|.+.+.||+|+||.||+|.+. .++..||||.+..... .+.+|+.+++.++||||+++++++
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~---- 97 (322)
T 1p4o_A 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV---- 97 (322)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE----
T ss_pred chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE----
Confidence 34457999999999999999999876 3578899999865422 345799999999999999999988
Q ss_pred CCCceEEEEEeecccc-hHHHHHhhhhh------cCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCC
Q 012233 204 EKDELYLNLVLEYISE-TVYRVSKHYTR------MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHT 276 (468)
Q Consensus 204 ~~~~~~~~lv~e~~~~-~ll~~~~~~~~------~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~ 276 (468)
.+....++||||+.+ ++.+.+..... ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++
T Consensus 98 -~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~NIli~~~~ 175 (322)
T 1p4o_A 98 -SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA-NKFVHRDLAARNCMVAEDF 175 (322)
T ss_dssp -CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCSCCSGGGEEECTTC
T ss_pred -ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH-CCCccCCCccceEEEcCCC
Confidence 334457899999986 55555443221 12456889999999999999999998 8999999999999999888
Q ss_pred CcEEEeeecCccccCCCCC---CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHH
Q 012233 277 HQLKICDFGSAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEI 352 (468)
Q Consensus 277 ~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i 352 (468)
.+||+|||++........ .....+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+....+
T Consensus 176 -~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 253 (322)
T 1p4o_A 176 -TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 253 (322)
T ss_dssp -CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHH
T ss_pred -eEEECcCccccccccccccccccCCCCCCCccChhhhccCC-CCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHH
Confidence 799999999976533221 22345688999999987544 8999999999999999999 89999887766555544
Q ss_pred HHHhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCC------CCCCCC
Q 012233 353 IKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH------PFFDDL 426 (468)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~h------p~f~~~ 426 (468)
.... .+ ..+..+++.+.+||.+||+.||.+|||+.++++| +||+++
T Consensus 254 ~~~~-------------------~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~~~~ 305 (322)
T 1p4o_A 254 MEGG-------------------LL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREV 305 (322)
T ss_dssp HTTC-------------------CC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHH
T ss_pred HcCC-------------------cC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCCccc
Confidence 3310 00 0234588999999999999999999999999885 777765
Q ss_pred CCCCC
Q 012233 427 RDPNT 431 (468)
Q Consensus 427 ~~~~~ 431 (468)
.....
T Consensus 306 ~~~~~ 310 (322)
T 1p4o_A 306 SFYYS 310 (322)
T ss_dssp CSTTS
T ss_pred ccccc
Confidence 54443
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=337.04 Aligned_cols=246 Identities=26% Similarity=0.340 Sum_probs=187.3
Q ss_pred CcccceEEeceecccCceEEEEEEEcCC---CCEEEEEEeeccc-----chHHHHHHHHHHcCCCCcccccceeeecCCC
Q 012233 134 KQTISYMAERVVGTGSFGVVFQAKCLET---GDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEK 205 (468)
Q Consensus 134 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~---g~~vaiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 205 (468)
....+|.+.+.||+|+||.||+|.+..+ +..||+|.+.... ..+.+|+.+++.++||||+++++++.
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~----- 86 (281)
T 1mp8_A 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT----- 86 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-----
T ss_pred EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-----
Confidence 3445799999999999999999998654 4569999875432 23457999999999999999999872
Q ss_pred CceEEEEEeecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeee
Q 012233 206 DELYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDF 284 (468)
Q Consensus 206 ~~~~~~lv~e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DF 284 (468)
+. ..|+||||+.++ +.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+||
T Consensus 87 ~~-~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~-~~kl~Df 160 (281)
T 1mp8_A 87 EN-PVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLES-KRFVHRDIAARNVLVSSND-CVKLGDF 160 (281)
T ss_dssp SS-SCEEEEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEETT-EEEECC-
T ss_pred cC-ccEEEEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecccccHHHEEECCCC-CEEECcc
Confidence 11 367999999864 4443332 23468999999999999999999998 8999999999999999887 7999999
Q ss_pred cCccccCCCCC--CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCH
Q 012233 285 GSAKMLVPGEP--NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTR 361 (468)
Q Consensus 285 G~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~ 361 (468)
|+++....... .....+++.|+|||++.+. .++.++|||||||++|+|++ |..||.+....+.+..+.....
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~---- 235 (281)
T 1mp8_A 161 GLSRYMEDSTYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER---- 235 (281)
T ss_dssp ------------------CCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC----
T ss_pred ccccccCcccccccccCCCcccccChhhcccC-CCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCC----
Confidence 99987643322 2234567889999999654 48999999999999999996 9999998877665555433100
Q ss_pred HHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 362 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
..++..+++++.+||.+||+.||.+|||+.++++
T Consensus 236 ------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 269 (281)
T 1mp8_A 236 ------------------------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 269 (281)
T ss_dssp ------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 0133568999999999999999999999999876
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=343.75 Aligned_cols=262 Identities=15% Similarity=0.147 Sum_probs=193.9
Q ss_pred cceEEeceecccCceEEEEEEEcC---CCCEEEEEEeecccch---------------HHHHHHHHHHcCCCCcccccce
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLE---TGDSVAIKKVLQDKRY---------------KNRELQIMRLLNHPNVVSLKHC 198 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~---~g~~vaiK~~~~~~~~---------------~~~E~~il~~l~hpnIv~l~~~ 198 (468)
.+|.+.+.||+|+||.||+|.+.. ++..||||++...... ..+|+.+++.++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 359999999999999999999987 7889999998654322 2346677788899999999999
Q ss_pred eeecCCCCceEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCC-C
Q 012233 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHT-H 277 (468)
Q Consensus 199 ~~~~~~~~~~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~-~ 277 (468)
+.... .+..++|+||||+++++.+++.. ...+++..++.++.||+.||.|||+ +||+||||||+||||+.++ .
T Consensus 117 ~~~~~-~~~~~~~lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~~ 190 (345)
T 2v62_A 117 GLTEF-KGRSYRFMVMERLGIDLQKISGQ----NGTFKKSTVLQLGIRMLDVLEYIHE-NEYVHGDIKAANLLLGYKNPD 190 (345)
T ss_dssp EEEES-SSCEEEEEEEECEEEEHHHHCBG----GGBCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEESSSTT
T ss_pred ccccc-CCCcEEEEEEeccCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCcCHHHEEEccCCCC
Confidence 86543 33567899999996666654432 2378999999999999999999998 8999999999999998654 2
Q ss_pred cEEEeeecCccccCCCC--------CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC-CcHHH
Q 012233 278 QLKICDFGSAKMLVPGE--------PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGE-SGVDQ 348 (468)
Q Consensus 278 ~vkL~DFG~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~-~~~~~ 348 (468)
.+||+|||+++.+.... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+. .....
T Consensus 191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~ 269 (345)
T 2v62_A 191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGV-ALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA 269 (345)
T ss_dssp SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH
T ss_pred cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCccccccccHH
Confidence 69999999997663321 11456789999999999765 4899999999999999999999999653 22222
Q ss_pred HHHHHHHh-CCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q 012233 349 LVEIIKIL-GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (468)
Q Consensus 349 ~~~i~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~ 427 (468)
........ ...+.....+ . -...+++++.+||.+||+.||.+|||+.++++ .|+++.
T Consensus 270 ~~~~~~~~~~~~~~~~~~~-~-------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~--~L~~~~ 327 (345)
T 2v62_A 270 VQTAKTNLLDELPQSVLKW-A-------------------PSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK--ILNPHG 327 (345)
T ss_dssp HHHHHHHHHHTTTHHHHHH-S-------------------CTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH--HHCTTC
T ss_pred HHHHHHhhcccccHHHHhh-c-------------------cccccHHHHHHHHHHHhhcCcccCCCHHHHHH--HHhccC
Confidence 22222211 1111111110 0 01258899999999999999999999999887 455433
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=339.85 Aligned_cols=254 Identities=19% Similarity=0.252 Sum_probs=191.2
Q ss_pred ccceEEeceecccCceEEEEEEEcC---CCCEEEEEEeeccc------chHHHHHHHHHHcCCCCcccccceeeecCCCC
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLE---TGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD 206 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~---~g~~vaiK~~~~~~------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 206 (468)
..+|.+.+.||+|+||.||+|.+.. ++..||+|.+.... ..+.+|+.+++.++||||+++++++.......
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 112 (313)
T 3brb_A 33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQG 112 (313)
T ss_dssp GGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-----
T ss_pred HHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccC
Confidence 3469999999999999999998865 45589999985432 23457999999999999999999986655444
Q ss_pred ceEEEEEeecccch-HHHHHhhh--hhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEee
Q 012233 207 ELYLNLVLEYISET-VYRVSKHY--TRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICD 283 (468)
Q Consensus 207 ~~~~~lv~e~~~~~-ll~~~~~~--~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~D 283 (468)
....++||||+.++ +...+... ......+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|
T Consensus 113 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dikp~NIli~~~~-~~kl~D 190 (313)
T 3brb_A 113 IPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN-RNFLHRDLAARNCMLRDDM-TVCVAD 190 (313)
T ss_dssp --CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT-TTCCCCCCSGGGEEECTTS-CEEECS
T ss_pred CcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCcceEEEcCCC-cEEEee
Confidence 44578999999864 44433221 1234668999999999999999999998 8999999999999999888 799999
Q ss_pred ecCccccCCCC---CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCC
Q 012233 284 FGSAKMLVPGE---PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTP 359 (468)
Q Consensus 284 FG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~ 359 (468)
||++....... ......+++.|+|||++.+. .++.++|||||||++|+|++ |..||.+....+....+.....
T Consensus 191 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~-- 267 (313)
T 3brb_A 191 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADR-VYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHR-- 267 (313)
T ss_dssp CSCC----------------CCGGGSCHHHHHSS-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC--
T ss_pred cCcceecccccccCcccccCCCccccCchhhcCC-CccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCC--
Confidence 99997654332 12234568899999999765 48999999999999999999 9999988776665554433100
Q ss_pred CHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCC
Q 012233 360 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (468)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~h 420 (468)
..++..+++++.+||.+||..||.+|||+.+++++
T Consensus 268 --------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 268 --------------------------LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp --------------------------CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred --------------------------CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 01234688999999999999999999999999863
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-43 Score=336.30 Aligned_cols=248 Identities=21% Similarity=0.332 Sum_probs=202.3
Q ss_pred CcccceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc---chHHHHHHHHHHcCCCCcccccceeeecCCCCceEE
Q 012233 134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (468)
Q Consensus 134 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~---~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~ 210 (468)
....+|.+.+.||+|+||.||+|.+..++..||+|++.... ....+|+.+++.++||||+++++++ .+...+
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~ 84 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC-----TREPPF 84 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSSSE
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----ccCCCE
Confidence 34557999999999999999999999999999999986554 3345799999999999999999988 444458
Q ss_pred EEEeecccc-hHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccc
Q 012233 211 NLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (468)
Q Consensus 211 ~lv~e~~~~-~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~ 289 (468)
|+||||+.+ .+.+.+... ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++..
T Consensus 85 ~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dikp~Nil~~~~~-~~~l~Dfg~~~~ 160 (288)
T 3kfa_A 85 YIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLVGENH-LVKVADFGLSRL 160 (288)
T ss_dssp EEEEECCTTEEHHHHHHHC--CTTTSCHHHHHHHHHHHHHHHHHHHH-HTCCCSCCSGGGEEECGGG-CEEECCCCGGGT
T ss_pred EEEEEcCCCCcHHHHHHhc--ccCCccHhHHHHHHHHHHHHHHHHHH-CCccCCCCCcceEEEcCCC-CEEEccCcccee
Confidence 899999985 555544322 23558999999999999999999998 8999999999999999887 799999999986
Q ss_pred cCCCCC--CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 012233 290 LVPGEP--NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKC 366 (468)
Q Consensus 290 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 366 (468)
...... .....+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+....+....
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~---------- 229 (288)
T 3kfa_A 161 MTGDTYTAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY---------- 229 (288)
T ss_dssp SCSSSSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC----------
T ss_pred ccCCccccccCCccccCcCChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccC----------
Confidence 643332 22345678899999997554 8999999999999999999 999998876555444332210
Q ss_pred cCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 367 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
. ...+..+++++.+||.+||+.||.+|||+.++++
T Consensus 230 --------~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 230 --------R----------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp --------C----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------C----------CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 0 0123458899999999999999999999999976
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=338.32 Aligned_cols=251 Identities=18% Similarity=0.235 Sum_probs=194.6
Q ss_pred cccceEEeceecccCceEEEEEEEcCCC-------CEEEEEEeeccc----chHHHHHHHHHHcCCCCcccccceeeecC
Q 012233 135 QTISYMAERVVGTGSFGVVFQAKCLETG-------DSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVSLKHCFFSTT 203 (468)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~g-------~~vaiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 203 (468)
...+|.+.+.||+|+||.||+|.+..++ ..||+|++.... ..+.+|+.+++.++||||+++++++.
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--- 82 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCV--- 82 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEEC---
T ss_pred chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEE---
Confidence 3457999999999999999999998777 469999985432 33457999999999999999999984
Q ss_pred CCCceEEEEEeecccc-hHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCc----
Q 012233 204 EKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQ---- 278 (468)
Q Consensus 204 ~~~~~~~~lv~e~~~~-~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~---- 278 (468)
+....++||||+.+ ++.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++..
T Consensus 83 --~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~~~~~~~ 156 (289)
T 4fvq_A 83 --CGDENILVQEFVKFGSLDTYLKK---NKNCINILWKLEVAKQLAAAMHFLEE-NTLIHGNVCAKNILLIREEDRKTGN 156 (289)
T ss_dssp --CTTCCEEEEECCTTCBHHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEEECCBGGGTB
T ss_pred --eCCCCEEEEECCCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHhh-CCeECCCcCcceEEEecCCcccccc
Confidence 33347899999985 55554432 23348999999999999999999998 899999999999999877621
Q ss_pred ---EEEeeecCccccCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCC-CCCCCCCcHHHHHHHHH
Q 012233 279 ---LKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQ-PLFPGESGVDQLVEIIK 354 (468)
Q Consensus 279 ---vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~-~pf~~~~~~~~~~~i~~ 354 (468)
+||+|||++.... ......||+.|+|||++.+...++.++|||||||++|+|++|. +||.... ......+..
T Consensus 157 ~~~~kl~Dfg~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~-~~~~~~~~~ 232 (289)
T 4fvq_A 157 PPFIKLSDPGISITVL---PKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD-SQRKLQFYE 232 (289)
T ss_dssp CCEEEECCCCSCTTTS---CHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSC-HHHHHHHHH
T ss_pred cceeeeccCccccccc---CccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccc-hHHHHHHhh
Confidence 9999999986542 2234568999999999987566999999999999999999955 5554443 333333222
Q ss_pred HhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCC
Q 012233 355 ILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDP 429 (468)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~ 429 (468)
. .. .++...++++.+||.+||+.||.+|||+.++++ .|+++-.+
T Consensus 233 ~-----------------~~------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~--~l~~l~~p 276 (289)
T 4fvq_A 233 D-----------------RH------------QLPAPKAAELANLINNCMDYEPDHRPSFRAIIR--DLNSLFTP 276 (289)
T ss_dssp T-----------------TC------------CCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHH--HHHTCC--
T ss_pred c-----------------cC------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH--HHHHhcCC
Confidence 1 00 122345778999999999999999999999998 34444333
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=378.76 Aligned_cols=284 Identities=26% Similarity=0.332 Sum_probs=205.8
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc-----cchHHHHHHHHHHcCCCCcccccceeeecCC-CCceEE
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTE-KDELYL 210 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~-----~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~-~~~~~~ 210 (468)
++|.+.+.||+|+||.||+|.+..+|+.||||++... ...+.+|+.+++.++||||+++++++..... ......
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 4699999999999999999999999999999988653 2334579999999999999999988633111 124457
Q ss_pred EEEeecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCC--cEEEeeecCc
Q 012233 211 NLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTH--QLKICDFGSA 287 (468)
Q Consensus 211 ~lv~e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~--~vkL~DFG~a 287 (468)
|+||||+.++ +...+.. ......+++..++.++.||+.||.|||+ .||+||||||+|||++.++. .+||+|||++
T Consensus 94 ~LVmEy~~ggsL~~~L~~-~~~~~~lse~~i~~I~~QLl~aL~yLHs-~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a 171 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQ-FENCCGLKEGPIRTLLSDISSALRYLHE-NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA 171 (676)
T ss_dssp CCEEECCSSCBHHHHHHS-SSCTTCCCSSHHHHHHHHHHHHHHHHHH-TTBCCCCCCSTTEEEECCSSSCEEEECSCCCC
T ss_pred EEEEEeCCCCCHHHHHHh-cccCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCCHHHeEeecCCCceeEEEcccccc
Confidence 8999999764 4444332 2223468889999999999999999998 89999999999999987652 3899999999
Q ss_pred cccCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 012233 288 KMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367 (468)
Q Consensus 288 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 367 (468)
.............||+.|+|||++.+. .++.++|||||||++|+|++|..||.+..........+. ..........
T Consensus 172 ~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~---~~~~~~~~~~ 247 (676)
T 3qa8_A 172 KELDQGELCTEFVGTLQYLAPELLEQK-KYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVR---EKSNEHIVVY 247 (676)
T ss_dssp CBTTSCCCCCCCCSCCTTCSSCSSCCS-CCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC---------CCSC
T ss_pred cccccccccccccCCcccCChHHhccC-CCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhh---cccchhhhhh
Confidence 887666666677899999999999755 489999999999999999999999987543322111000 0000000000
Q ss_pred CCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCC
Q 012233 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRD 428 (468)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~ 428 (468)
........++. ..+....+...+++.+.+||.+||..||.+|||+.+++.||||+.+.+
T Consensus 248 ~~l~g~~~~~~--~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~ 306 (676)
T 3qa8_A 248 DDLTGAVKFSS--VLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDS 306 (676)
T ss_dssp CCCSSSCCCCS--SSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHH
T ss_pred hhhcccccccc--ccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHH
Confidence 01111111111 111122244557789999999999999999999999999999988543
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=337.06 Aligned_cols=253 Identities=29% Similarity=0.409 Sum_probs=190.0
Q ss_pred ccceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc--chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEEE
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK--RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV 213 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~--~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv 213 (468)
..+|.+.+.||+|+||.||+|.+ .++.||||++.... ..+.+|+.+++.++||||+++++++. +. .++|
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~--~~lv 77 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACL-----NP--VCLV 77 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCT-----TT--TEEE
T ss_pred HhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEc-----CC--cEEE
Confidence 44699999999999999999998 57899999986543 34568999999999999999998773 22 5799
Q ss_pred eecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhc--CCccccCCCCCCeeecCCCCcEEEeeecCcccc
Q 012233 214 LEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV--VGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (468)
Q Consensus 214 ~e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~--~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~ 290 (468)
|||+.++ +.+.+.. ......++...+..++.||+.||.|||+. +||+||||||+|||++.++..+||+|||++...
T Consensus 78 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~ 156 (307)
T 2eva_A 78 MEYAEGGSLYNVLHG-AEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI 156 (307)
T ss_dssp EECCTTCBHHHHHHC-SSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----
T ss_pred EEcCCCCCHHHHHhc-cCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccc
Confidence 9999864 4444332 22223478888999999999999999962 589999999999999988745899999999755
Q ss_pred CCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHHhCCCCHHHHhhcCC
Q 012233 291 VPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQ-LVEIIKILGTPTREEIKCMNP 369 (468)
Q Consensus 291 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~ 369 (468)
.. ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||........ ...... .+..
T Consensus 157 ~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~-~~~~---------- 222 (307)
T 2eva_A 157 QT--HMTNNKGSAAWMAPEVFEGS-NYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVH-NGTR---------- 222 (307)
T ss_dssp ----------CCTTSSCHHHHTCC-CCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHH-TTCC----------
T ss_pred cc--ccccCCCCCceEChhhhCCC-CCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHh-cCCC----------
Confidence 32 22345789999999999765 489999999999999999999999986543222 111111 0000
Q ss_pred CCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC-----CCCCCCCCC
Q 012233 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA-----HPFFDDLRD 428 (468)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~-----hp~f~~~~~ 428 (468)
..+...+++.+.+||.+||+.||.+|||+.++++ ..+|.....
T Consensus 223 ----------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~ 270 (307)
T 2eva_A 223 ----------------PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADE 270 (307)
T ss_dssp ----------------CCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTS
T ss_pred ----------------CCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCC
Confidence 0123458899999999999999999999999987 456655443
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=345.21 Aligned_cols=268 Identities=21% Similarity=0.271 Sum_probs=200.2
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-----chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEE
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 211 (468)
.+|.+.+.||+|+||.||+|.+ .+|+.||||++.... ..+.+|+.+++.++||||+++++++. .....+
T Consensus 30 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~ 103 (326)
T 3uim_A 30 DNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM-----TPTERL 103 (326)
T ss_dssp TSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEEC-----CSSCCE
T ss_pred hccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEe-----cCCceE
Confidence 4699999999999999999985 468999999985432 24578999999999999999999984 334478
Q ss_pred EEeecccc-hHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcC---CccccCCCCCCeeecCCCCcEEEeeecCc
Q 012233 212 LVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV---GVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (468)
Q Consensus 212 lv~e~~~~-~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---givHrDlkp~NILl~~~~~~vkL~DFG~a 287 (468)
+||||+.+ ++.+.+.........+++..++.++.||+.||.|||+ + ||+||||||+|||++.++ .+||+|||++
T Consensus 104 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg~~ 181 (326)
T 3uim_A 104 LVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHD-HCDPKIIHRDVKAANILLDEEF-EAVVGDFGLA 181 (326)
T ss_dssp EEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHH-SSSSCEECCCCSGGGEEECTTC-CEEECCCSSC
T ss_pred EEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCchhhEEECCCC-CEEeccCccc
Confidence 99999986 5555554444445568999999999999999999998 8 999999999999999887 7999999999
Q ss_pred cccCCCCC--CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC----CcHHHHHHHHHHhCCCCH
Q 012233 288 KMLVPGEP--NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGE----SGVDQLVEIIKILGTPTR 361 (468)
Q Consensus 288 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~----~~~~~~~~i~~~~~~~~~ 361 (468)
........ .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||... ............
T Consensus 182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------ 254 (326)
T 3uim_A 182 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG------ 254 (326)
T ss_dssp EECCSSSSCEECCCCSCGGGCCHHHHHHSE-ECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTT------
T ss_pred cccCcccccccccccCCcCccCHHHhccCC-CCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHH------
Confidence 87643322 23456899999999996554 899999999999999999999999521 100011111110
Q ss_pred HHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q 012233 362 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (468)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~ 427 (468)
.........+........+....++.+.+||.+||+.||.+|||+.++++|-+-..+.
T Consensus 255 --------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~ 312 (326)
T 3uim_A 255 --------LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLA 312 (326)
T ss_dssp --------TTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCS
T ss_pred --------HhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchh
Confidence 0011111111111111122333457899999999999999999999999976544443
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=342.09 Aligned_cols=250 Identities=23% Similarity=0.331 Sum_probs=200.3
Q ss_pred cccceEEeceecccCceEEEEEEEcCCCC-----EEEEEEeeccc-----chHHHHHHHHHHc-CCCCcccccceeeecC
Q 012233 135 QTISYMAERVVGTGSFGVVFQAKCLETGD-----SVAIKKVLQDK-----RYKNRELQIMRLL-NHPNVVSLKHCFFSTT 203 (468)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~-----~vaiK~~~~~~-----~~~~~E~~il~~l-~hpnIv~l~~~~~~~~ 203 (468)
...+|.+.+.||+|+||.||+|.+..++. .||+|.+.... ..+.+|+.+++.+ +||||+++++++.
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~--- 120 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT--- 120 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC---
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe---
Confidence 34579999999999999999999977664 79999986542 3355799999999 8999999999883
Q ss_pred CCCceEEEEEeecccc-hHHHHHhhhhh----------cCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeee
Q 012233 204 EKDELYLNLVLEYISE-TVYRVSKHYTR----------MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLV 272 (468)
Q Consensus 204 ~~~~~~~~lv~e~~~~-~ll~~~~~~~~----------~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl 272 (468)
+...+++||||+.+ ++.+.+..... ....+++..++.++.||+.||.|||+ +||+||||||+|||+
T Consensus 121 --~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 121 --HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS-KNCIHRDVAARNVLL 197 (333)
T ss_dssp --SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGCEE
T ss_pred --cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc-CCcccCCcccceEEE
Confidence 33458899999986 55555443221 13567899999999999999999998 899999999999999
Q ss_pred cCCCCcEEEeeecCccccCCCCC---CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHH
Q 012233 273 NPHTHQLKICDFGSAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQ 348 (468)
Q Consensus 273 ~~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~ 348 (468)
+.++ .+||+|||++........ .....+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+......
T Consensus 198 ~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~ 275 (333)
T 2i1m_A 198 TNGH-VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK 275 (333)
T ss_dssp EGGG-EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH
T ss_pred CCCC-eEEECccccccccccccceeecCCCCCCccccCHHHhccCC-CChHHHHHHHHHHHHHHHcCCCCCCcccchhHH
Confidence 9887 799999999976533322 22345678999999987554 8999999999999999998 9999998776666
Q ss_pred HHHHHHHhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 349 LVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 349 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
+..+......+ ..+..+++++.+||.+||+.||.+|||+.++++
T Consensus 276 ~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 319 (333)
T 2i1m_A 276 FYKLVKDGYQM---------------------------AQPAFAPKNIYSIMQACWALEPTHRPTFQQICS 319 (333)
T ss_dssp HHHHHHHTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhcCCCC---------------------------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 65555421110 022347889999999999999999999999986
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=341.35 Aligned_cols=250 Identities=22% Similarity=0.328 Sum_probs=197.5
Q ss_pred CcccceEEeceecccCceEEEEEEEc-------CCCCEEEEEEeeccc-----chHHHHHHHHHHc-CCCCcccccceee
Q 012233 134 KQTISYMAERVVGTGSFGVVFQAKCL-------ETGDSVAIKKVLQDK-----RYKNRELQIMRLL-NHPNVVSLKHCFF 200 (468)
Q Consensus 134 ~~~~~y~~~~~lG~G~fg~Vy~~~~~-------~~g~~vaiK~~~~~~-----~~~~~E~~il~~l-~hpnIv~l~~~~~ 200 (468)
....+|.+.+.||+|+||.||+|.+. .++..||||++.... ....+|+.+++.+ +||||+++++++
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~- 110 (334)
T 2pvf_A 32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC- 110 (334)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-
T ss_pred CCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE-
Confidence 33457999999999999999999975 467789999986542 2345799999999 899999999988
Q ss_pred ecCCCCceEEEEEeecccc-hHHHHHhhhhh------------cCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCC
Q 012233 201 STTEKDELYLNLVLEYISE-TVYRVSKHYTR------------MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKP 267 (468)
Q Consensus 201 ~~~~~~~~~~~lv~e~~~~-~ll~~~~~~~~------------~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp 267 (468)
.+...+|+||||+.+ ++.+.+..... ....+++..++.++.||+.||.|||+ +||+||||||
T Consensus 111 ----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp 185 (334)
T 2pvf_A 111 ----TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS-QKCIHRDLAA 185 (334)
T ss_dssp ----CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSG
T ss_pred ----ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCcc
Confidence 334458899999986 55554433211 12348899999999999999999998 8999999999
Q ss_pred CCeeecCCCCcEEEeeecCccccCCCC---CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 012233 268 QNLLVNPHTHQLKICDFGSAKMLVPGE---PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGE 343 (468)
Q Consensus 268 ~NILl~~~~~~vkL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~ 343 (468)
+||||+.++ .+||+|||++....... ......+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.
T Consensus 186 ~NIll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~ 263 (334)
T 2pvf_A 186 RNVLVTENN-VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGI 263 (334)
T ss_dssp GGEEECTTC-CEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ceEEEcCCC-CEEEccccccccccccccccccCCCCcccceeChHHhcCCC-cChHHHHHHHHHHHHHHHhCCCCCcCcC
Confidence 999999888 79999999998764432 123345688999999997554 8999999999999999999 99999887
Q ss_pred CcHHHHHHHHHHhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 344 SGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 344 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
...+....+..... ...+..+++++.+||.+||+.||.+|||+.++++
T Consensus 264 ~~~~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 311 (334)
T 2pvf_A 264 PVEELFKLLKEGHR----------------------------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311 (334)
T ss_dssp CHHHHHHHHHHTCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHhcCCC----------------------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 76655544433110 0123457899999999999999999999999986
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=337.64 Aligned_cols=247 Identities=25% Similarity=0.306 Sum_probs=188.6
Q ss_pred cccceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-------chHHHHHHHHHHcCCCCcccccceeeecCCCCc
Q 012233 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (468)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 207 (468)
...+|.+.+.||+|+||.||+|.+..+++.||||++.... ..+.+|+.+++.++||||+++++++.. .
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-----~ 106 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI-----D 106 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----T
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee-----C
Confidence 3457999999999999999999999999999999986432 334579999999999999999998843 3
Q ss_pred eEEEEEeecccc-hHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecC
Q 012233 208 LYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (468)
Q Consensus 208 ~~~~lv~e~~~~-~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~ 286 (468)
..+|+||||+.+ .+.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dlkp~NIl~~~~~-~~kl~Dfg~ 180 (309)
T 2h34_A 107 GQLYVDMRLINGVDLAAMLRR----QGPLAPPRAVAIVRQIGSALDAAHA-AGATHRDVKPENILVSADD-FAYLVDFGI 180 (309)
T ss_dssp TEEEEEEECCCCEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTS-CEEECSCCC
T ss_pred CeEEEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CcCCcCCCChHHEEEcCCC-CEEEecCcc
Confidence 458899999986 44444432 3568999999999999999999998 8999999999999999888 799999999
Q ss_pred ccccCCCC--CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 012233 287 AKMLVPGE--PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEI 364 (468)
Q Consensus 287 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 364 (468)
+....... ......|++.|+|||++.+. .++.++|||||||++|+|++|+.||.+.... .+...+... .
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~~-~------ 251 (309)
T 2h34_A 181 ASATTDEKLTQLGNTVGTLYYMAPERFSES-HATYRADIYALTCVLYECLTGSPPYQGDQLS-VMGAHINQA-I------ 251 (309)
T ss_dssp ----------------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-HHHHHHHSC-C------
T ss_pred CccccccccccccccCCCcCccCHHHHcCC-CCCchHhHHHHHHHHHHHHHCCCCCCCchHH-HHHHHhccC-C------
Confidence 87654332 22356789999999999755 4899999999999999999999999876543 222222210 0
Q ss_pred hhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCC-CHHHHhC
Q 012233 365 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC-TALEACA 419 (468)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~-s~~ell~ 419 (468)
+....++..+++++.+||.+||+.||.+|| +++++++
T Consensus 252 ------------------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 252 ------------------PRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp ------------------CCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred ------------------CCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 001123456899999999999999999999 7887765
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-43 Score=340.85 Aligned_cols=254 Identities=24% Similarity=0.390 Sum_probs=196.7
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc----cchHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEE
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~----~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~l 212 (468)
.+|.+.+.||+|+||.||+|.+..+|+.||||++... .....+|+.+++.++||||+++++++.... ......++
T Consensus 29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~~l 107 (317)
T 2buj_A 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRER-GAKHEAWL 107 (317)
T ss_dssp EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEE-TTEEEEEE
T ss_pred eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEecc-CCCceeEE
Confidence 3699999999999999999999999999999988543 234457999999999999999999886432 24456889
Q ss_pred Eeecccc-hHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccC
Q 012233 213 VLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (468)
Q Consensus 213 v~e~~~~-~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~ 291 (468)
||||+.+ ++...+.........+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++....
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~dlkp~NIl~~~~~-~~kl~dfg~~~~~~ 185 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA-KGYAHRDLKPTNILLGDEG-QPVLMDLGSMNQAC 185 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTS-CEEECCCSSCEESC
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEEcCCC-CEEEEecCcchhcc
Confidence 9999987 5656555544456779999999999999999999998 8999999999999999888 79999999987543
Q ss_pred CCCCC----------ccccccCCccccccccCCC--CCCcchhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCC
Q 012233 292 PGEPN----------ISYICSRYYRAPELIFGAT--EYTTAIDMWSIGCVLAELLLGQPLFPGESGV-DQLVEIIKILGT 358 (468)
Q Consensus 292 ~~~~~----------~~~~gt~~y~aPE~~~~~~--~~~~~~DvwSlG~il~ell~G~~pf~~~~~~-~~~~~i~~~~~~ 358 (468)
..... ....||+.|+|||++.+.. .++.++|||||||++|+|++|+.||...... +.......
T Consensus 186 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~---- 261 (317)
T 2buj_A 186 IHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQ---- 261 (317)
T ss_dssp EEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHH----
T ss_pred cccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhh----
Confidence 21111 1345799999999986543 2688999999999999999999999531100 00111111
Q ss_pred CCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCC
Q 012233 359 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (468)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~h 420 (468)
....++ ....+++++.+||.+||+.||.+|||+.++++|
T Consensus 262 -------------~~~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 262 -------------NQLSIP----------QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp -------------CC--CC----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------ccCCCC----------ccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 001111 123578999999999999999999999999984
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=335.39 Aligned_cols=250 Identities=30% Similarity=0.491 Sum_probs=188.5
Q ss_pred ccceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc-------cchHHHHHHHHHHcCCCCcccccceeeecCCCCce
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~-------~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 208 (468)
..+|.+.+.||+|+||.||+|.+..+|+.||||++... .....+|+.+++.++||||+++++++.. ..
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~ 105 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE-----DN 105 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TT
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc-----CC
Confidence 34699999999999999999999999999999998642 1234579999999999999999999854 33
Q ss_pred EEEEEeecccc-hHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCc
Q 012233 209 YLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (468)
Q Consensus 209 ~~~lv~e~~~~-~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a 287 (468)
..++||||+.+ .+.+++.........+++..++.++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||++
T Consensus 106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dl~p~NIl~~~~~-~~kl~Dfg~~ 183 (310)
T 2wqm_A 106 ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS-RRVMHRDIKPANVFITATG-VVKLGDLGLG 183 (310)
T ss_dssp EEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTS-CEEECCC---
T ss_pred cEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh-CCeeCCCCcHHHEEEcCCC-CEEEEeccce
Confidence 58899999987 5556555555556778999999999999999999998 8999999999999999888 7999999998
Q ss_pred cccCCCC-CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHHHhCCCCHHHHh
Q 012233 288 KMLVPGE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESG-VDQLVEIIKILGTPTREEIK 365 (468)
Q Consensus 288 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~ 365 (468)
....... ......|++.|+|||++.+. .++.++|||||||++|+|++|..||.+... ...+...+...
T Consensus 184 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--------- 253 (310)
T 2wqm_A 184 RFFSSKTTAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC--------- 253 (310)
T ss_dssp ---------------CCSSCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTT---------
T ss_pred eeecCCCccccccCCCeeEeChHHhCCC-CCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcc---------
Confidence 7654322 22345789999999999765 489999999999999999999999976532 22222222211
Q ss_pred hcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 366 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
.++. .....+++++.+||.+||+.||.+|||+.++++
T Consensus 254 ---------~~~~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~ 290 (310)
T 2wqm_A 254 ---------DYPP--------LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYD 290 (310)
T ss_dssp ---------CSCC--------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------cCCC--------CcccccCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 1110 012457899999999999999999999999986
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=352.84 Aligned_cols=246 Identities=23% Similarity=0.319 Sum_probs=197.9
Q ss_pred CCcccceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc--chHHHHHHHHHHcCCCCcccccceeeecCCCCceEE
Q 012233 133 PKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK--RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (468)
Q Consensus 133 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~--~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~ 210 (468)
.....+|.+.+.||+|+||.||+|.+ .|+.||||++.... ..+.+|+.+|+.++||||+++++++.... ..+
T Consensus 189 ~i~~~~~~~~~~lG~G~fg~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~ 262 (450)
T 1k9a_A 189 ALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK----GGL 262 (450)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTT----SCE
T ss_pred ccChHHeEEEeeecCcCCeeEEEEEe--cCCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcCC----Cce
Confidence 44556899999999999999999998 57899999986543 34568999999999999999999875432 247
Q ss_pred EEEeecccc-hHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccc
Q 012233 211 NLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (468)
Q Consensus 211 ~lv~e~~~~-~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~ 289 (468)
||||||+.+ ++.+.+... ....+++..+..++.||+.||.|||+ +||+||||||+||||+.++ .+||+|||+++.
T Consensus 263 ~iv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivHrDlkp~Nill~~~~-~~kl~DfG~a~~ 338 (450)
T 1k9a_A 263 YIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEG-NNFVHRDLAARNVLVSEDN-VAKVSDFGLTKE 338 (450)
T ss_dssp EEEEECCTTCBHHHHHHHH--CTTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECTTS-CEEECCCTTCEE
T ss_pred EEEEEecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCCHhhEEECCCC-CEEEeeCCCccc
Confidence 899999986 555544432 22347899999999999999999998 8999999999999999888 799999999985
Q ss_pred cCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 012233 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368 (468)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 368 (468)
.... .....+++.|+|||++.+.. ++.++|||||||++|||++ |+.||.+.+..+....+....
T Consensus 339 ~~~~--~~~~~~~~~y~aPE~~~~~~-~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~------------ 403 (450)
T 1k9a_A 339 ASST--QDTGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY------------ 403 (450)
T ss_dssp CC--------CCCTTTSCHHHHHSSC-CCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTC------------
T ss_pred cccc--ccCCCCCcceeCHHHhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC------------
Confidence 4322 22346788999999997654 8999999999999999998 999999877665554443210
Q ss_pred CCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
. ...+..+++++.+||.+||+.||.+|||+.+++.
T Consensus 404 ------~----------~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 404 ------K----------MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp ------C----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------C----------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 0 0133568999999999999999999999999875
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=339.06 Aligned_cols=251 Identities=24% Similarity=0.343 Sum_probs=198.7
Q ss_pred ccceEEeceecccCceEEEEEEE-----cCCCCEEEEEEeeccc-----chHHHHHHHHHHc-CCCCcccccceeeecCC
Q 012233 136 TISYMAERVVGTGSFGVVFQAKC-----LETGDSVAIKKVLQDK-----RYKNRELQIMRLL-NHPNVVSLKHCFFSTTE 204 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~-----~~~g~~vaiK~~~~~~-----~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~ 204 (468)
..+|.+.+.||+|+||.||+|.+ ..+++.||||++.... ....+|+.+++.+ +||||+++++++...
T Consensus 26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~-- 103 (316)
T 2xir_A 26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-- 103 (316)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT--
T ss_pred hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC--
Confidence 35799999999999999999985 3567899999986542 2345799999999 699999999987432
Q ss_pred CCceEEEEEeecccc-hHHHHHhhhhhc------------CCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCee
Q 012233 205 KDELYLNLVLEYISE-TVYRVSKHYTRM------------NQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLL 271 (468)
Q Consensus 205 ~~~~~~~lv~e~~~~-~ll~~~~~~~~~------------~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NIL 271 (468)
...+++||||+.+ ++.+.+...... ...+++..++.++.||+.||.|||+ +||+||||||+|||
T Consensus 104 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~H~dikp~Nil 180 (316)
T 2xir_A 104 --GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNIL 180 (316)
T ss_dssp --TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEE
T ss_pred --CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh-CCcccccCccceEE
Confidence 2347899999986 454444332110 1237899999999999999999998 89999999999999
Q ss_pred ecCCCCcEEEeeecCccccCCCCC---CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHH
Q 012233 272 VNPHTHQLKICDFGSAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVD 347 (468)
Q Consensus 272 l~~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~ 347 (468)
++.++ .+||+|||+++....... .....||+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+....+
T Consensus 181 ~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~ 258 (316)
T 2xir_A 181 LSEKN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 258 (316)
T ss_dssp ECGGG-CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred ECCCC-CEEECCCccccccccCccceeccCCCcceeecCchhhcccc-ccchhHHHHHHHHHHHHHhCCCCCCcccchhH
Confidence 99887 799999999986644332 22456788999999997654 8999999999999999998 999998877655
Q ss_pred HHHHHHHHhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCC
Q 012233 348 QLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (468)
Q Consensus 348 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~h 420 (468)
.+...+.....+ ..+..+++++.++|.+||+.||.+|||+.++++|
T Consensus 259 ~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 259 EFCRRLKEGTRM---------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp HHHHHHHHTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhccCccC---------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 554444321110 0234478999999999999999999999999875
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=331.58 Aligned_cols=247 Identities=26% Similarity=0.341 Sum_probs=194.4
Q ss_pred CcccceEEeceecccCceEEEEEEEcCC---CCEEEEEEeecc-----cchHHHHHHHHHHcCCCCcccccceeeecCCC
Q 012233 134 KQTISYMAERVVGTGSFGVVFQAKCLET---GDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEK 205 (468)
Q Consensus 134 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~---g~~vaiK~~~~~-----~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 205 (468)
....+|.+.+.||+|+||.||+|.+... +..||+|.+... ...+.+|+.+++.++||||+++++++.
T Consensus 9 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~----- 83 (281)
T 3cc6_A 9 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIE----- 83 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEEC-----
T ss_pred ecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEc-----
Confidence 3455799999999999999999997543 346999998654 234457999999999999999999873
Q ss_pred CceEEEEEeecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeee
Q 012233 206 DELYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDF 284 (468)
Q Consensus 206 ~~~~~~lv~e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DF 284 (468)
+. ..|+||||+.++ +.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+||
T Consensus 84 ~~-~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~~~-~~kl~Df 157 (281)
T 3cc6_A 84 EE-PTWIIMELYPYGELGHYLER---NKNSLKVLTLVLYSLQICKAMAYLES-INCVHRDIAVRNILVASPE-CVKLGDF 157 (281)
T ss_dssp SS-SCEEEEECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEEEETT-EEEECCC
T ss_pred CC-CCEEEEecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCccceEEECCCC-cEEeCcc
Confidence 22 247999999864 4443332 24568999999999999999999998 8999999999999999887 8999999
Q ss_pred cCccccCCCC--CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCH
Q 012233 285 GSAKMLVPGE--PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTR 361 (468)
Q Consensus 285 G~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~ 361 (468)
|++....... ......+++.|+|||++.+. .++.++|||||||++|+|++ |+.||......+....+......
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~--- 233 (281)
T 3cc6_A 158 GLSRYIEDEDYYKASVTRLPIKWMSPESINFR-RFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRL--- 233 (281)
T ss_dssp CGGGCC---------CCCCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCC---
T ss_pred CCCcccccccccccccCCCCcceeCchhhccC-CCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCC---
Confidence 9998664332 12334568899999999654 48999999999999999998 99999877666555444331100
Q ss_pred HHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCC
Q 012233 362 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (468)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~h 420 (468)
..+..+++.+.+||.+||+.||.+|||+.+++++
T Consensus 234 -------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 234 -------------------------PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp -------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------------------CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 0224578999999999999999999999999863
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=361.48 Aligned_cols=248 Identities=21% Similarity=0.331 Sum_probs=201.8
Q ss_pred CcccceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc---chHHHHHHHHHHcCCCCcccccceeeecCCCCceEE
Q 012233 134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (468)
Q Consensus 134 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~---~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~ 210 (468)
....+|.+.+.||+|+||.||+|.+..++..||||++.... ..+.+|+.+|+.++||||+++++++. +...+
T Consensus 217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-----~~~~~ 291 (495)
T 1opk_A 217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT-----REPPF 291 (495)
T ss_dssp CCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SSSSC
T ss_pred cCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEe-----cCCcE
Confidence 34567999999999999999999999889999999986543 34568999999999999999999983 33457
Q ss_pred EEEeecccc-hHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccc
Q 012233 211 NLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (468)
Q Consensus 211 ~lv~e~~~~-~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~ 289 (468)
||||||+.+ ++.+.+... ....+++..+..++.||+.||.|||+ +||+||||||+||||+.++ .+||+|||+++.
T Consensus 292 ~lv~E~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~ 367 (495)
T 1opk_A 292 YIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEK-KNFIHRNLAARNCLVGENH-LVKVADFGLSRL 367 (495)
T ss_dssp EEEEECCTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECGGG-CEEECCTTCEEC
T ss_pred EEEEEccCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCChhhEEECCCC-cEEEeeccccee
Confidence 899999985 555544332 23558899999999999999999998 8999999999999999887 799999999987
Q ss_pred cCCCC--CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 012233 290 LVPGE--PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKC 366 (468)
Q Consensus 290 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 366 (468)
..... ......+++.|+|||++.+.. ++.++|||||||++|||++ |..||.+.+..+....+....
T Consensus 368 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~---------- 436 (495)
T 1opk_A 368 MTGDTYTAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY---------- 436 (495)
T ss_dssp CTTCCEECCTTCCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC----------
T ss_pred ccCCceeecCCCcCCcceeCHhHHhcCC-CCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC----------
Confidence 64332 122345578899999997544 8999999999999999999 999999877655444332210
Q ss_pred cCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 367 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
. ...+..+++++.+||.+||+.||.+|||+.++++
T Consensus 437 --------~----------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 437 --------R----------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp --------C----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------C----------CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 0 0123458899999999999999999999999986
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=329.62 Aligned_cols=246 Identities=15% Similarity=0.213 Sum_probs=197.5
Q ss_pred CcccceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc------chHHHHHHHHHHcCCCCcccccceeeecCCCCc
Q 012233 134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (468)
Q Consensus 134 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 207 (468)
....+|.+.+.||+|+||.||+|.+ .|..||+|++.... ..+.+|+.+++.++||||+++++++... ..
T Consensus 7 i~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~ 81 (271)
T 3kmu_A 7 IDFKQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSP---PA 81 (271)
T ss_dssp CCGGGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTT---TS
T ss_pred CCHHHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccC---CC
Confidence 3455799999999999999999998 58999999986432 2355799999999999999999988432 12
Q ss_pred eEEEEEeecccc-hHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCC--ccccCCCCCCeeecCCCCcEEEeee
Q 012233 208 LYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG--VCHRDIKPQNLLVNPHTHQLKICDF 284 (468)
Q Consensus 208 ~~~~lv~e~~~~-~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~g--ivHrDlkp~NILl~~~~~~vkL~DF 284 (468)
...++||||+.+ ++.+.+.. .....+++..++.++.||+.||.|||+ +| |+||||||+|||++.++ .++|+||
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~~~i~H~dikp~Nil~~~~~-~~~l~~~ 157 (271)
T 3kmu_A 82 PHPTLITHWMPYGSLYNVLHE--GTNFVVDQSQAVKFALDMARGMAFLHT-LEPLIPRHALNSRSVMIDEDM-TARISMA 157 (271)
T ss_dssp SSCEEEEECCTTCBHHHHHHS--CSSCCCCHHHHHHHHHHHHHHHHHHTT-SSSCCTTCCCSGGGEEECTTS-CEEEEGG
T ss_pred CCeEeeecccCCCcHHHHHhh--cccCCCCHHHHHHHHHHHHHHHHHHhc-CCCceecCCCccceEEEcCCc-ceeEEec
Confidence 457899999986 55554432 112358999999999999999999997 89 99999999999999887 7999999
Q ss_pred cCccccCCCCCCccccccCCccccccccCCCC--CCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 012233 285 GSAKMLVPGEPNISYICSRYYRAPELIFGATE--YTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTRE 362 (468)
Q Consensus 285 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~ 362 (468)
|++... ......||+.|+|||++.+... ++.++|||||||++|+|++|+.||.+.+..+....+......
T Consensus 158 ~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~---- 229 (271)
T 3kmu_A 158 DVKFSF----QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLR---- 229 (271)
T ss_dssp GSCCTT----SCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCC----
T ss_pred cceeee----cccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCC----
Confidence 887543 2234578999999999976432 334899999999999999999999988877766655441111
Q ss_pred HHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 363 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
..++..+++++.+||.+||+.||.+|||+.++++
T Consensus 230 -----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 230 -----------------------PTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp -----------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1134568999999999999999999999999986
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=329.85 Aligned_cols=244 Identities=20% Similarity=0.319 Sum_probs=198.5
Q ss_pred ccceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc---chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEE
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~---~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~l 212 (468)
..+|.+.+.||+|+||.||+|.+. ++..||+|++.... ....+|+.+++.++||||+++++++. +....++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l 80 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL-----EQAPICL 80 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEEC-----SSSSCEE
T ss_pred hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEc-----cCCCeEE
Confidence 357999999999999999999986 67889999986543 34568999999999999999999883 3345889
Q ss_pred Eeecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccC
Q 012233 213 VLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (468)
Q Consensus 213 v~e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~ 291 (468)
||||+.++ +.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++....
T Consensus 81 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~Nili~~~~-~~kl~dfg~~~~~~ 155 (267)
T 3t9t_A 81 VTEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEE-ACVIHRDLAARNCLVGENQ-VIKVSDFGMTRFVL 155 (267)
T ss_dssp EECCCTTCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCCGGGEEECGGG-CEEECCTTGGGGBC
T ss_pred EEeCCCCCcHHHHHhh---CcccCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCchheEEECCCC-CEEEcccccccccc
Confidence 99999864 4444332 23568999999999999999999998 8999999999999999887 79999999997654
Q ss_pred CCC--CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 012233 292 PGE--PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368 (468)
Q Consensus 292 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 368 (468)
... ......+++.|+|||++.+.. ++.++|||||||++|+|++ |+.||...+..+....+.....
T Consensus 156 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~----------- 223 (267)
T 3t9t_A 156 DDQYTSSTGTKFPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR----------- 223 (267)
T ss_dssp CHHHHSTTSTTCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC-----------
T ss_pred cccccccccccccccccChhhhcCCC-ccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCc-----------
Confidence 321 223456678899999996544 8999999999999999999 8999998776665555433100
Q ss_pred CCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
...+..+++.+.+||.+||+.||.+|||+.++++
T Consensus 224 -----------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 257 (267)
T 3t9t_A 224 -----------------LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLR 257 (267)
T ss_dssp -----------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------CCCCccCcHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 0122347889999999999999999999999986
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=341.82 Aligned_cols=244 Identities=22% Similarity=0.331 Sum_probs=188.2
Q ss_pred ccceEEeceecccCceEEEEEEEcCCCCEE----EEEEeec-----ccchHHHHHHHHHHcCCCCcccccceeeecCCCC
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLETGDSV----AIKKVLQ-----DKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD 206 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~v----aiK~~~~-----~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 206 (468)
..+|.+.+.||+|+||.||+|.+..+++.| |+|.+.. ....+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~---- 89 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS---- 89 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS----
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC----
Confidence 346999999999999999999998888766 5555532 223456799999999999999999988432
Q ss_pred ceEEEEEeecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeec
Q 012233 207 ELYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG 285 (468)
Q Consensus 207 ~~~~~lv~e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG 285 (468)
. .++|++|+.++ +.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||
T Consensus 90 -~-~~~v~~~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIl~~~~~-~~kL~DfG 162 (327)
T 3lzb_A 90 -T-VQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQ-HVKITDFG 162 (327)
T ss_dssp -S-EEEEECCCSSCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEEETT-EEEECCTT
T ss_pred -C-ceEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhh-CCCcCCCCCHHHEEEcCCC-CEEEccCc
Confidence 2 56788888764 4444332 24568999999999999999999998 8999999999999999888 79999999
Q ss_pred CccccCCCCC---CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCH
Q 012233 286 SAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTR 361 (468)
Q Consensus 286 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~ 361 (468)
+++....... .....+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+....+....+....
T Consensus 163 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~----- 236 (327)
T 3lzb_A 163 LAKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE----- 236 (327)
T ss_dssp C----------------CCCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-----
T ss_pred ceeEccCccccccccCCCccccccCHHHHcCCC-CChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC-----
Confidence 9987643322 22345678899999997654 8999999999999999999 999998876655444332210
Q ss_pred HHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 362 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
.. ..+..++.++.+||.+||+.||.+|||+.|++.
T Consensus 237 -------------~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 237 -------------RL----------PQPPICTIDVYMIMRKCWMIDADSRPKFRELII 271 (327)
T ss_dssp -------------CC----------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------CC----------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 00 023457889999999999999999999999886
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=347.69 Aligned_cols=264 Identities=21% Similarity=0.211 Sum_probs=195.5
Q ss_pred ccceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc----chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEE
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 211 (468)
..+|.+.+.||+|+||.||+|.+ .+|+.||||++.... ..+.+|+.+++.++||||+++++++. +....+
T Consensus 38 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~ 111 (321)
T 2qkw_B 38 TNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCD-----ERNEMI 111 (321)
T ss_dssp CCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECC-----CTTCCE
T ss_pred HhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEc-----CCCeEE
Confidence 34699999999999999999996 468999999875432 34568999999999999999999883 344578
Q ss_pred EEeecccchHH-HHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcccc
Q 012233 212 LVLEYISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (468)
Q Consensus 212 lv~e~~~~~ll-~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~ 290 (468)
+||||+.++.+ +.+.........+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++..
T Consensus 112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~ 189 (321)
T 2qkw_B 112 LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT-RAIIHRDVKSINILLDENF-VPKITDFGISKKG 189 (321)
T ss_dssp EEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCSTTEEECTTC-CEEECCCTTCEEC
T ss_pred EEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC-CCeecCCCCHHHEEECCCC-CEEEeeccccccc
Confidence 99999986544 3222222223458999999999999999999998 8999999999999999888 7999999999765
Q ss_pred CCCC---CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 012233 291 VPGE---PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367 (468)
Q Consensus 291 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 367 (468)
.... ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+....+....+... .. ...
T Consensus 190 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~-----~~--~~~ 261 (321)
T 2qkw_B 190 TELDQTHLSTVVKGTLGYIDPEYFIKGR-LTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWA-----VE--SHN 261 (321)
T ss_dssp SSSSCCCCBCCCEEETTTCCHHHHHHCB-CCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHT-----HH--HHT
T ss_pred ccccccccccccCCCccccCHHHhcCCC-CCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHh-----hh--ccc
Confidence 3222 223456899999999987554 899999999999999999999999765432211100000 00 000
Q ss_pred CCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCC
Q 012233 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (468)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~h 420 (468)
.. .+...........+...++..+.+||.+||+.||.+|||+.|+++|
T Consensus 262 ~~-----~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 309 (321)
T 2qkw_B 262 NG-----QLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK 309 (321)
T ss_dssp TT-----CCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cc-----cHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 00 0111111111112333456789999999999999999999999875
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-43 Score=349.89 Aligned_cols=246 Identities=24% Similarity=0.342 Sum_probs=186.0
Q ss_pred cccceEEeceecccCceEEEEEEEc---CCCCEEEEEEeecc-----cchHHHHHHHHHHcCCCCcccccceeeecCCCC
Q 012233 135 QTISYMAERVVGTGSFGVVFQAKCL---ETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD 206 (468)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~---~~g~~vaiK~~~~~-----~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 206 (468)
...+|.+.+.||+|+||.||+|++. .++..||||++... ...+.+|+.+++.++||||+++++++ .+
T Consensus 43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~ 117 (373)
T 2qol_A 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVV-----TK 117 (373)
T ss_dssp CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----CS
T ss_pred CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----ee
Confidence 3457999999999999999999876 46778999998643 23455799999999999999999998 33
Q ss_pred ceEEEEEeecccc-hHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeec
Q 012233 207 ELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG 285 (468)
Q Consensus 207 ~~~~~lv~e~~~~-~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG 285 (468)
...+++||||+.+ ++.+.+. .....+++..+..++.||+.||.|||+ +||+||||||+||||+.++ .+||+|||
T Consensus 118 ~~~~~lv~e~~~~~sL~~~l~---~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~-~~kl~Dfg 192 (373)
T 2qol_A 118 SKPVMIVTEYMENGSLDSFLR---KHDAQFTVIQLVGMLRGIASGMKYLSD-MGYVHRDLAARNILINSNL-VCKVSDFG 192 (373)
T ss_dssp SSSCEEEEECCTTCBHHHHHH---TTTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTC-CEEECCC-
T ss_pred CCceEEEEeCCCCCcHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeCCCCCcceEEEcCCC-CEEECcCc
Confidence 4458899999976 4444432 224568999999999999999999998 8999999999999999888 79999999
Q ss_pred CccccCCCCC----CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCC
Q 012233 286 SAKMLVPGEP----NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPT 360 (468)
Q Consensus 286 ~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~ 360 (468)
+++....... .....+++.|+|||++.+. .++.++|||||||++|||++ |+.||...+..+....+.....
T Consensus 193 ~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~--- 268 (373)
T 2qol_A 193 LGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR-KFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYR--- 268 (373)
T ss_dssp ---------------------CTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEE---
T ss_pred cccccccCCccceeccCCCcCCCccChhhhccC-CcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---
Confidence 9987643321 1123447789999999754 48999999999999999997 9999988776665544432110
Q ss_pred HHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 361 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
.+ .+..++..+.+||.+||+.||.+||++.++++
T Consensus 269 ---------------~~----------~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 269 ---------------LP----------PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp ---------------CC----------CCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------CC----------CCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 00 12357889999999999999999999998875
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-43 Score=343.07 Aligned_cols=255 Identities=20% Similarity=0.217 Sum_probs=196.6
Q ss_pred cccceEEeceecccCceEEEEEE-----EcCCCCEEEEEEeecc-----cchHHHHHHHHHHcCCCCcccccceeeecCC
Q 012233 135 QTISYMAERVVGTGSFGVVFQAK-----CLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTE 204 (468)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~-----~~~~g~~vaiK~~~~~-----~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 204 (468)
...+|.+.+.||+|+||.||+|. +..++..||||.+... ...+.+|+.+++.++||||+++++++.
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~---- 103 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL---- 103 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC----
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEc----
Confidence 34579999999999999999999 5567889999998543 223457999999999999999999883
Q ss_pred CCceEEEEEeecccc-hHHHHHhhhhh---cCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCC--Cc
Q 012233 205 KDELYLNLVLEYISE-TVYRVSKHYTR---MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHT--HQ 278 (468)
Q Consensus 205 ~~~~~~~lv~e~~~~-~ll~~~~~~~~---~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~--~~ 278 (468)
+....|+||||+.+ ++.+.+..... ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ ..
T Consensus 104 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~i~H~dlkp~NIli~~~~~~~~ 181 (327)
T 2yfx_A 104 -QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE-NHFIHRDIAARNCLLTCPGPGRV 181 (327)
T ss_dssp -SSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESCSSTTCC
T ss_pred -CCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh-CCeecCcCCHhHEEEecCCCcce
Confidence 33447899999965 55555443221 12458899999999999999999998 8999999999999998433 26
Q ss_pred EEEeeecCccccCCCC---CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHH
Q 012233 279 LKICDFGSAKMLVPGE---PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIK 354 (468)
Q Consensus 279 vkL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~ 354 (468)
+||+|||++....... ......+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||......+....+..
T Consensus 182 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~ 260 (327)
T 2yfx_A 182 AKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS 260 (327)
T ss_dssp EEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT
T ss_pred EEECccccccccccccccccCCCcCCCcceeCHhHhcCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhc
Confidence 9999999987543222 223456789999999986554 8999999999999999998 9999988776555444432
Q ss_pred HhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCC
Q 012233 355 ILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFD 424 (468)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~ 424 (468)
... ...+..+++.+.+||.+||+.||.+|||+.++++|.|+-
T Consensus 261 ~~~----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 261 GGR----------------------------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp TCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCC----------------------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 100 012345789999999999999999999999999998764
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=359.94 Aligned_cols=253 Identities=19% Similarity=0.230 Sum_probs=192.0
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc-------cchHHHHHHHHHHcCC-CCcccccce---------e
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNH-PNVVSLKHC---------F 199 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~-------~~~~~~E~~il~~l~h-pnIv~l~~~---------~ 199 (468)
..|...++||+|+||.||+|.+..+|+.||||++... ...+.+|+.+++.+.| .|+..+..+ .
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 3589999999999999999999999999999988632 2335689999999987 332221111 1
Q ss_pred ------------eecCCCCceEEEEEeecccchHHHHHhhh---hhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccC
Q 012233 200 ------------FSTTEKDELYLNLVLEYISETVYRVSKHY---TRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRD 264 (468)
Q Consensus 200 ------------~~~~~~~~~~~~lv~e~~~~~ll~~~~~~---~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrD 264 (468)
..........++++|+++.+++.+++... ......+++..+..++.||+.||.|||+ +||+|||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~iiHrD 236 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH-YGLVHTY 236 (413)
T ss_dssp ECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH-TTEECSC
T ss_pred ccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCC
Confidence 00000112236789999988887766433 2223446677888899999999999998 8999999
Q ss_pred CCCCCeeecCCCCcEEEeeecCccccCCCCCCccccccCCcccccccc---------CCCCCCcchhHHHHHHHHHHHHh
Q 012233 265 IKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIF---------GATEYTTAIDMWSIGCVLAELLL 335 (468)
Q Consensus 265 lkp~NILl~~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~---------~~~~~~~~~DvwSlG~il~ell~ 335 (468)
|||+||||+.++ .+||+|||+++..... ....+| +.|+|||++. ....++.++|||||||++|||++
T Consensus 237 iKp~NILl~~~~-~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ellt 312 (413)
T 3dzo_A 237 LRPVDIVLDQRG-GVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC 312 (413)
T ss_dssp CCGGGEEECTTC-CEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHH
T ss_pred cccceEEEecCC-eEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHH
Confidence 999999999998 6999999998765332 445677 9999999983 33348889999999999999999
Q ss_pred CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHH
Q 012233 336 GQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTAL 415 (468)
Q Consensus 336 G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ 415 (468)
|+.||...+..+....+ +. ....+++++.+||.+||+.||.+||++.
T Consensus 313 g~~Pf~~~~~~~~~~~~-----------------------~~----------~~~~~~~~~~~li~~~l~~dP~~Rpt~~ 359 (413)
T 3dzo_A 313 ADLPNTDDAALGGSEWI-----------------------FR----------SCKNIPQPVRALLEGFLRYPKEDRLLPL 359 (413)
T ss_dssp SSCCCCTTGGGSCSGGG-----------------------GS----------SCCCCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred CCCCCCCcchhhhHHHH-----------------------Hh----------hcccCCHHHHHHHHHHccCChhhCcCHH
Confidence 99999765432111100 00 1135789999999999999999999999
Q ss_pred HHhCCCCCCCCC
Q 012233 416 EACAHPFFDDLR 427 (468)
Q Consensus 416 ell~hp~f~~~~ 427 (468)
++++||||+.+.
T Consensus 360 ~~l~~~~~~~~~ 371 (413)
T 3dzo_A 360 QAMETPEYEQLR 371 (413)
T ss_dssp HHTTSHHHHHHH
T ss_pred HHHhCHHHHHHH
Confidence 999999998764
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=343.20 Aligned_cols=254 Identities=13% Similarity=0.129 Sum_probs=195.5
Q ss_pred ceEEeceecccCceEEEEEEEcC--------CCCEEEEEEeecccchHHHHHHHHHHcCCCCcccc--------------
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLE--------TGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSL-------------- 195 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~--------~g~~vaiK~~~~~~~~~~~E~~il~~l~hpnIv~l-------------- 195 (468)
+|.+.+.||+|+||.||+|.+.. .++.||||++... ....+|+.+++.++||||+++
T Consensus 43 ~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~ 121 (352)
T 2jii_A 43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPT 121 (352)
T ss_dssp EEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCC
T ss_pred eEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-chHHHHHHHHHHhcccchhhhhhhhccCCccCccc
Confidence 59999999999999999999987 4889999998765 456789999999999999984
Q ss_pred -cceeeecCCCCceEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecC
Q 012233 196 -KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNP 274 (468)
Q Consensus 196 -~~~~~~~~~~~~~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~ 274 (468)
++++.. ...+.|+||||++++|.+++.... ...+++..++.++.||+.||.|||+ +||+||||||+|||++.
T Consensus 122 ~~~~~~~----~~~~~~lv~e~~~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dikp~NIl~~~ 194 (352)
T 2jii_A 122 CMGFGVH----QDKYRFLVLPSLGRSLQSALDVSP--KHVLSERSVLQVACRLLDALEFLHE-NEYVHGNVTAENIFVDP 194 (352)
T ss_dssp CCEEEEE----TTTEEEEEEECCCEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHH-TTCBCSCCCGGGEEEET
T ss_pred hhhcccc----CCcEEEEEecCCCcCHHHHHHhCC--cCCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCCHHHEEEcC
Confidence 333322 234688999999767776655321 3568999999999999999999998 89999999999999997
Q ss_pred CCC-cEEEeeecCccccCCCC--------CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-
Q 012233 275 HTH-QLKICDFGSAKMLVPGE--------PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGES- 344 (468)
Q Consensus 275 ~~~-~vkL~DFG~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~- 344 (468)
++. .+||+|||+++...... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||....
T Consensus 195 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~ 273 (352)
T 2jii_A 195 EDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGC-GPSRRSDLQSLGYCMLKWLYGFLPWTNCLP 273 (352)
T ss_dssp TEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred CCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCcccCCc
Confidence 752 69999999997654322 12345789999999999765 48999999999999999999999998764
Q ss_pred cHHHHHHHHHHhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 345 GVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 345 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
..+.+........... +.+.. ....+..+++++.+||.+||+.||.+|||+.++++
T Consensus 274 ~~~~~~~~~~~~~~~~--------~~~~~-----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 274 NTEDIMKQKQKFVDKP--------GPFVG-----------PCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp CHHHHHHHHHHHHHSC--------CCEEC-----------TTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred CHHHHHHHHHhccCCh--------hhhhh-----------hccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 3444433332211000 00000 00012357899999999999999999999999876
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=337.86 Aligned_cols=246 Identities=22% Similarity=0.315 Sum_probs=190.6
Q ss_pred cccceEEeceecccCceEEEEEEEcCCC----CEEEEEEeeccc-----chHHHHHHHHHHcCCCCcccccceeeecCCC
Q 012233 135 QTISYMAERVVGTGSFGVVFQAKCLETG----DSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEK 205 (468)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~g----~~vaiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 205 (468)
....|.+.+.||+|+||.||+|.+..++ ..||||++.... ..+.+|+.+++.++||||+++++++ .
T Consensus 42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~ 116 (333)
T 1mqb_A 42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVI-----S 116 (333)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----C
T ss_pred ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----e
Confidence 3446999999999999999999986554 359999986432 2345799999999999999999988 3
Q ss_pred CceEEEEEeecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeee
Q 012233 206 DELYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDF 284 (468)
Q Consensus 206 ~~~~~~lv~e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DF 284 (468)
+...++|||||+.++ +...+. .....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+||
T Consensus 117 ~~~~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIl~~~~~-~~kl~Df 191 (333)
T 1mqb_A 117 KYKPMMIITEYMENGALDKFLR---EKDGEFSVLQLVGMLRGIAAGMKYLAN-MNYVHRDLAARNILVNSNL-VCKVSDF 191 (333)
T ss_dssp SSSSEEEEEECCTTEEHHHHHH---HTTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTC-CEEECCC
T ss_pred cCCCcEEEEeCCCCCcHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChheEEECCCC-cEEECCC
Confidence 444588999999875 444332 224568999999999999999999998 8999999999999999887 7999999
Q ss_pred cCccccCCCCC----CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCC
Q 012233 285 GSAKMLVPGEP----NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTP 359 (468)
Q Consensus 285 G~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~ 359 (468)
|++........ .....+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||...+..+....+.....
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~-- 268 (333)
T 1mqb_A 192 GLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRK-FTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR-- 268 (333)
T ss_dssp CC-----------------CCCGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC--
T ss_pred CcchhhccccccccccCCCCccccccCchhcccCC-CCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCc--
Confidence 99987643321 12234578899999997554 8999999999999999998 9999988776655554433110
Q ss_pred CHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 360 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
.+ .+..+++.+.+||.+||+.||.+||++.++++
T Consensus 269 ----------------~~----------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 302 (333)
T 1mqb_A 269 ----------------LP----------TPMDCPSAIYQLMMQCWQQERARRPKFADIVS 302 (333)
T ss_dssp ----------------CC----------CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ----------------CC----------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00 22357899999999999999999999999876
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=353.65 Aligned_cols=250 Identities=20% Similarity=0.239 Sum_probs=197.5
Q ss_pred ccceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc--cchHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEEE
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD--KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV 213 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~--~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv 213 (468)
..+|.+.+.||+|+||.||+|.+..+++.||||++... ...+.+|+++++.|.|++++..+.+|.. ...+.+||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~----~~~~~~lv 81 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGV----EGDYNVLV 81 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEE----ETTEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEe----eCCEEEEE
Confidence 34699999999999999999999999999999987543 3456789999999998666655555433 23357899
Q ss_pred eecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeee---cCCCCcEEEeeecCcccc
Q 012233 214 LEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLV---NPHTHQLKICDFGSAKML 290 (468)
Q Consensus 214 ~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl---~~~~~~vkL~DFG~a~~~ 290 (468)
|||+++.+.+++.. ....+++..++.++.||+.||.|||+ +|||||||||+|||| +.++ .+||+|||+++.+
T Consensus 82 me~~g~sL~~ll~~---~~~~l~~~~~~~i~~qi~~aL~yLH~-~gIvHrDIKP~NILl~~~~~~~-~vkL~DFGla~~~ 156 (483)
T 3sv0_A 82 MDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKKY 156 (483)
T ss_dssp EECCCCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECCGGGTT-CEEECCCTTCEEC
T ss_pred EECCCCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccCcceEEEecCCCCC-eEEEEeCCcceec
Confidence 99997777776543 24579999999999999999999998 899999999999999 4555 7999999999876
Q ss_pred CCCCC--------CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCc---HHHHHHHHHHhCCC
Q 012233 291 VPGEP--------NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESG---VDQLVEIIKILGTP 359 (468)
Q Consensus 291 ~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~---~~~~~~i~~~~~~~ 359 (468)
..... .....||+.|+|||++.+.. ++.++|||||||+||||++|+.||.+... .+.+..+.......
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (483)
T 3sv0_A 157 RDTSTHQHIPYRENKNLTGTARYASVNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVAT 235 (483)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHS
T ss_pred cCCccccccccccccccCCCccccCHHHhcCCC-CChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccc
Confidence 44322 22568999999999997654 89999999999999999999999987543 23333333321111
Q ss_pred CHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 360 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
.. ..+...+++++.+||.+||+.||.+||++.+|++
T Consensus 236 ~~------------------------~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 236 SI------------------------EALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp CH------------------------HHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred cH------------------------HHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 11 1122457899999999999999999999987653
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=353.95 Aligned_cols=247 Identities=23% Similarity=0.347 Sum_probs=199.7
Q ss_pred CCcccceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc---chHHHHHHHHHHcCCCCcccccceeeecCCCCceE
Q 012233 133 PKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (468)
Q Consensus 133 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~---~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 209 (468)
.....+|.+.+.||+|+||.||+|.+. .+..||||++.... ..+.+|+.+|+.++||||+++++++. + ..
T Consensus 184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-----~-~~ 256 (454)
T 1qcf_A 184 EIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-----K-EP 256 (454)
T ss_dssp BCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-----S-SS
T ss_pred eechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-----C-Cc
Confidence 344568999999999999999999985 46789999986543 34568999999999999999999873 1 13
Q ss_pred EEEEeecccc-hHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcc
Q 012233 210 LNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (468)
Q Consensus 210 ~~lv~e~~~~-~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~ 288 (468)
+||||||+.+ ++.+.+.... ...+++..+..++.||+.||.|||+ +||+||||||+||||+.++ .+||+|||+++
T Consensus 257 ~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivHrDlkp~Nill~~~~-~~kl~DFG~a~ 332 (454)
T 1qcf_A 257 IYIITEFMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQ-RNYIHRDLRAANILVSASL-VCKIADFGLAR 332 (454)
T ss_dssp CEEEECCCTTCBHHHHHHSHH--HHTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCSGGGEEECTTC-CEEECSTTGGG
T ss_pred cEEEEeecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCCHHHEEECCCC-cEEEeeCCCce
Confidence 7899999986 5555443221 2357888999999999999999998 8999999999999999887 79999999998
Q ss_pred ccCCCC--CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 012233 289 MLVPGE--PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIK 365 (468)
Q Consensus 289 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 365 (468)
...... ......+++.|+|||++.... ++.++|||||||++|||++ |+.||.+.+..+.+..+......+
T Consensus 333 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~------ 405 (454)
T 1qcf_A 333 VIEDNEYTAREGAKFPIKWTAPEAINFGS-FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMP------ 405 (454)
T ss_dssp GBCCHHHHTTCSSSSCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCC------
T ss_pred EcCCCceeccCCCcccccccCHHHhccCC-CCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC------
Confidence 764321 122345678899999996544 8999999999999999999 999999888777666554421111
Q ss_pred hcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 366 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
.+..+++++.+||.+||+.||.+|||+.+++.
T Consensus 406 ----------------------~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 406 ----------------------RPENCPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp ----------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 22457899999999999999999999999876
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-42 Score=330.00 Aligned_cols=247 Identities=26% Similarity=0.282 Sum_probs=196.7
Q ss_pred ccceEEec-eecccCceEEEEEEEc--CCCCEEEEEEeeccc-----chHHHHHHHHHHcCCCCcccccceeeecCCCCc
Q 012233 136 TISYMAER-VVGTGSFGVVFQAKCL--ETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (468)
Q Consensus 136 ~~~y~~~~-~lG~G~fg~Vy~~~~~--~~g~~vaiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 207 (468)
..+|.+.+ .||+|+||.||+|.+. .++..||||++.... ....+|+.+++.++||||+++++++. . .
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~----~ 82 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-A----E 82 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-S----S
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec-C----C
Confidence 34577766 9999999999999864 467889999986532 23457999999999999999999872 1 1
Q ss_pred eEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCc
Q 012233 208 LYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (468)
Q Consensus 208 ~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a 287 (468)
..++||||+.++.+..... .....+++..++.++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||++
T Consensus 83 -~~~lv~e~~~~~~L~~~l~--~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nili~~~~-~~kl~Dfg~~ 157 (287)
T 1u59_A 83 -ALMLVMEMAGGGPLHKFLV--GKREEIPVSNVAELLHQVSMGMKYLEE-KNFVHRDLAARNVLLVNRH-YAKISDFGLS 157 (287)
T ss_dssp -SEEEEEECCTTEEHHHHHT--TCTTTSCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEEETT-EEEECCCTTC
T ss_pred -CcEEEEEeCCCCCHHHHHH--hCCccCCHHHHHHHHHHHHHHHHHHHH-CCEeeCCCchheEEEcCCC-CEEECcccce
Confidence 2789999998754432221 234568999999999999999999998 8999999999999999887 8999999999
Q ss_pred cccCCCCC----CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 012233 288 KMLVPGEP----NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTRE 362 (468)
Q Consensus 288 ~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~ 362 (468)
........ .....+|+.|+|||++.+.. ++.++|||||||++|+|++ |+.||......+....+....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~------ 230 (287)
T 1u59_A 158 KALGADDSYYTARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK------ 230 (287)
T ss_dssp EECTTCSCEECCCCSSCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTC------
T ss_pred eeeccCcceeeccccccccccccCHHHhccCC-CCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCC------
Confidence 87643322 22345688999999996544 8999999999999999998 999998877666554443210
Q ss_pred HHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCC
Q 012233 363 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHP 421 (468)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp 421 (468)
. ..++..+++++.+||.+||+.||.+||++.++++|.
T Consensus 231 ----------~------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l 267 (287)
T 1u59_A 231 ----------R------------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 267 (287)
T ss_dssp ----------C------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred ----------c------------CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 0 013356899999999999999999999999998753
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=331.29 Aligned_cols=248 Identities=22% Similarity=0.284 Sum_probs=186.4
Q ss_pred ccceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc------chHHHHHHHHHHcCCCCcccccceeeecCCCCceE
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 209 (468)
..+|.+.+.||+|+||.||+|.+ ...||+|++.... ..+.+|+.+++.++||||++++++. .+ ..
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~-~~ 93 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-----TA-PQ 93 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEES---SSEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----CS-SS
T ss_pred ccceeeeeEecCCCCeEEEEEEE---cCceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-----cC-Cc
Confidence 34699999999999999999985 3469999885432 3356799999999999999998854 11 13
Q ss_pred EEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccc
Q 012233 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (468)
Q Consensus 210 ~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~ 289 (468)
.++||||+.++.+.... ......+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++..
T Consensus 94 ~~lv~e~~~~~~L~~~l--~~~~~~~~~~~~~~i~~qi~~~L~~lH~-~~i~H~Dlkp~Nil~~~~~-~~kl~Dfg~~~~ 169 (289)
T 3og7_A 94 LAIVTQWCEGSSLYHHL--HASETKFEMKKLIDIARQTARGMDYLHA-KSIIHRDLKSNNIFLHEDN-TVKIGDFGLATE 169 (289)
T ss_dssp CEEEEECCCEEEHHHHH--TTC---CCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEETTT-EEEECCCC----
T ss_pred cEEEEEecCCCcHHHHH--hhccCCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCccceEEECCCC-CEEEccceeccc
Confidence 67999999865443222 2234668999999999999999999998 8999999999999999888 899999999975
Q ss_pred cCCC---CCCccccccCCccccccccC--CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 012233 290 LVPG---EPNISYICSRYYRAPELIFG--ATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEI 364 (468)
Q Consensus 290 ~~~~---~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 364 (468)
.... .......||+.|+|||++.. ...++.++|||||||++|+|++|+.||.+....+.+..++.....+.
T Consensus 170 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~---- 245 (289)
T 3og7_A 170 KSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSP---- 245 (289)
T ss_dssp --------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCC----
T ss_pred cccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCc----
Confidence 5321 22334678999999999852 33478899999999999999999999998887777766655321111
Q ss_pred hhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 365 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
. ...+...+++++.+||.+||+.||.+|||+.++++
T Consensus 246 -----~--------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 246 -----D--------------LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp -----C--------------TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----c--------------hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 0 01123468899999999999999999999999986
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=339.45 Aligned_cols=262 Identities=24% Similarity=0.289 Sum_probs=196.3
Q ss_pred ccceEEeceecccCceEEEEEE----EcCCCCEEEEEEeeccc----chHHHHHHHHHHcCCCCcccccceeeecCCCCc
Q 012233 136 TISYMAERVVGTGSFGVVFQAK----CLETGDSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~----~~~~g~~vaiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 207 (468)
..+|++.+.||+|+||.||+|. +..+++.||||++.... ..+.+|+.+++.++||||+++++++.. .+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~ 98 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYG---PGR 98 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC---SSS
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEec---CCC
Confidence 4579999999999999999999 46788999999986543 235689999999999999999998754 234
Q ss_pred eEEEEEeecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecC
Q 012233 208 LYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (468)
Q Consensus 208 ~~~~lv~e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~ 286 (468)
..+|+||||+.++ +.+.+... ...+++..++.++.||+.||.|||+ +||+||||||+||||+.++ .+||+|||+
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~ 173 (327)
T 3lxl_A 99 QSLRLVMEYLPSGCLRDFLQRH---RARLDASRLLLYSSQICKGMEYLGS-RRCVHRDLAARNILVESEA-HVKIADFGL 173 (327)
T ss_dssp CEEEEEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEETT-EEEECCGGG
T ss_pred ceEEEEEeecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCChhhEEECCCC-CEEEccccc
Confidence 5688999999754 44444322 2458999999999999999999998 8999999999999999888 799999999
Q ss_pred ccccCCCC----CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 012233 287 AKMLVPGE----PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTRE 362 (468)
Q Consensus 287 a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~ 362 (468)
+....... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||........... ......+...
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~-~~~~~~~~~~ 251 (327)
T 3lxl_A 174 AKLLPLDKDYYVVREPGQSPIFWYAPESLSDNI-FSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMM-GCERDVPALS 251 (327)
T ss_dssp CEECCTTCSEEECSSCCCSCGGGSCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHC-C----CCHHH
T ss_pred ceecccCCccceeeccCCccccccCHHHhccCC-CChHHhHHHHHHHHHHHHhCCCCCccccchhhhhc-ccccccccHH
Confidence 98764333 223456788899999997654 89999999999999999999999965432211000 0000000000
Q ss_pred HHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 363 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
....... .. .....+..+++++.+||.+||+.||.+|||+.++++
T Consensus 252 ~~~~~~~--~~----------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 296 (327)
T 3lxl_A 252 RLLELLE--EG----------QRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGP 296 (327)
T ss_dssp HHHHHHH--TT----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhh--cc----------cCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0000000 00 001123568999999999999999999999999965
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=331.24 Aligned_cols=242 Identities=24% Similarity=0.284 Sum_probs=192.9
Q ss_pred cceEEec-eecccCceEEEEEEE--cCCCCEEEEEEeecc------cchHHHHHHHHHHcCCCCcccccceeeecCCCCc
Q 012233 137 ISYMAER-VVGTGSFGVVFQAKC--LETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (468)
Q Consensus 137 ~~y~~~~-~lG~G~fg~Vy~~~~--~~~g~~vaiK~~~~~------~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 207 (468)
.+|.+.+ .||+|+||.||+|.+ ..+++.||||++... ...+.+|+.+++.++||||+++++++ ...
T Consensus 16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~---- 90 (291)
T 1xbb_A 16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAE---- 90 (291)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESS----
T ss_pred hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCC----
Confidence 4699988 999999999999954 566789999998643 23456799999999999999999987 211
Q ss_pred eEEEEEeecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecC
Q 012233 208 LYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (468)
Q Consensus 208 ~~~~lv~e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~ 286 (468)
..++||||+.++ +.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus 91 -~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dikp~Nil~~~~~-~~kl~Dfg~ 163 (291)
T 1xbb_A 91 -SWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEE-SNFVHRDLAARNVLLVTQH-YAKISDFGL 163 (291)
T ss_dssp -SEEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEETT-EEEECCCTT
T ss_pred -CcEEEEEeCCCCCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHHHh-CCeEcCCCCcceEEEeCCC-cEEEccCCc
Confidence 267999999865 4443332 4568999999999999999999998 8999999999999999887 899999999
Q ss_pred ccccCCCCC----CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCH
Q 012233 287 AKMLVPGEP----NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTR 361 (468)
Q Consensus 287 a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~ 361 (468)
+........ .....+++.|+|||++.+.. ++.++|||||||++|+|++ |+.||.+.+..+....+....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~----- 237 (291)
T 1xbb_A 164 SKALRADENYYKAQTHGKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE----- 237 (291)
T ss_dssp CEECCTTCSEEEC----CCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-----
T ss_pred ceeeccCCCcccccccCCCCceeeChHHhccCC-CChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-----
Confidence 987644332 12234578899999996544 8899999999999999999 999999877655444432210
Q ss_pred HHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 362 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
. ..++..+++++.+||.+||+.||.+||++.++++
T Consensus 238 -----------~------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 238 -----------R------------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp -----------C------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -----------C------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0 0123458999999999999999999999999875
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=330.42 Aligned_cols=244 Identities=26% Similarity=0.383 Sum_probs=186.5
Q ss_pred cccceEEe-ceecccCceEEEEEEEcCCCCEEEEEEeecccchHHHHHHHH-HHcCCCCcccccceeeecCCCCceEEEE
Q 012233 135 QTISYMAE-RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIM-RLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (468)
Q Consensus 135 ~~~~y~~~-~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~~~~~~E~~il-~~l~hpnIv~l~~~~~~~~~~~~~~~~l 212 (468)
...+|.+. +.||+|+||.||+|.+..+++.||||++... ....+|+.++ +.++||||+++++++.... .+..++++
T Consensus 15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~~~l 92 (299)
T 3m2w_A 15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-PKARREVELHWRASQCPHIVRIVDVYENLY-AGRKCLLI 92 (299)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEEE
T ss_pred cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-HHHHHHHHHHHHhccCCCchhHHhhhhhhc-CCCceEEE
Confidence 34568777 8899999999999999999999999998654 3455788887 6678999999999885422 23567899
Q ss_pred Eeecccc-hHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecC---CCCcEEEeeecCcc
Q 012233 213 VLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNP---HTHQLKICDFGSAK 288 (468)
Q Consensus 213 v~e~~~~-~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~---~~~~vkL~DFG~a~ 288 (468)
||||+.+ ++.+.+.. .....+++..++.++.||+.||.|||+ +||+||||||+|||++. ++ .+||+|||++.
T Consensus 93 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~~-~~kl~Dfg~a~ 168 (299)
T 3m2w_A 93 VMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNA-ILKLTDFGFAK 168 (299)
T ss_dssp EECCCCSCBHHHHHHH--CTTCCCBHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESSSSTTC-CEEECCCTTCE
T ss_pred EEeecCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEEecCCCCC-cEEEecccccc
Confidence 9999986 55555443 223468999999999999999999998 89999999999999987 45 79999999986
Q ss_pred ccCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 012233 289 MLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368 (468)
Q Consensus 289 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 368 (468)
... ...++.++|||||||++|+|++|+.||.+.........+.
T Consensus 169 ~~~----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~--------------- 211 (299)
T 3m2w_A 169 ETT----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK--------------- 211 (299)
T ss_dssp ECT----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSC---------------
T ss_pred ccc----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHH---------------
Confidence 432 1237889999999999999999999997654322111000
Q ss_pred CCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q 012233 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (468)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~ 427 (468)
.... .....+....+..+++++.+||.+||+.||.+|||+.|+++||||++..
T Consensus 212 ---~~~~---~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~ 264 (299)
T 3m2w_A 212 ---TRIR---MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 264 (299)
T ss_dssp ---CSSC---TTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred ---HHHh---hccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence 0000 0000111112256899999999999999999999999999999998744
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=337.70 Aligned_cols=255 Identities=23% Similarity=0.288 Sum_probs=193.1
Q ss_pred eEEeceecccCceEEEEEEEcCCCCEEEEEEeecc--------cchHHHHHHHHHHcCCCCcccccceeeecCCCCceEE
Q 012233 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD--------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (468)
Q Consensus 139 y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~--------~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~ 210 (468)
|..++.||+|+||.||+|.+ ++..||+|++... ...+.+|+.+++.++||||+++++++. +....
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~ 105 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSS-----DGDDL 105 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SSSSC
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEe-----cCCce
Confidence 55668999999999999986 6899999988542 234567999999999999999999883 33457
Q ss_pred EEEeecccc-hHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccc
Q 012233 211 NLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (468)
Q Consensus 211 ~lv~e~~~~-~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~ 289 (468)
++||||+.+ .+.+.+.. ......+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++..
T Consensus 106 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dlkp~Nili~~~~-~~kl~Dfg~~~~ 182 (307)
T 2nru_A 106 CLVYVYMPNGSLLDRLSC-LDGTPPLSWHMRCKIAQGAANGINFLHE-NHHIHRDIKSANILLDEAF-TAKISDFGLARA 182 (307)
T ss_dssp EEEEECCTTCBHHHHHHT-GGGCCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECTTC-CEEECCCTTCEE
T ss_pred EEEEEecCCCcHHHHHHh-ccCCCCCCHHHHHHHHHHHHHHHHHHhc-CCeecCCCCHHHEEEcCCC-cEEEeecccccc
Confidence 899999975 44444432 3335668999999999999999999998 8999999999999999887 799999999976
Q ss_pred cCCCCC---CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 012233 290 LVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKC 366 (468)
Q Consensus 290 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 366 (468)
...... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||........+..+..............
T Consensus 183 ~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (307)
T 2nru_A 183 SEKFAQTVMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDY 260 (307)
T ss_dssp CCSCSSCEECSSCCSCGGGCCHHHHTT--EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHH
T ss_pred cccccccccccccCCCcCcCChHHhcC--CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhh
Confidence 543222 234578999999999864 378999999999999999999999987654433333332211110000000
Q ss_pred cCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 367 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
... .+ .......++.+.+||.+||+.||.+|||+.++++
T Consensus 261 ~~~-----~~---------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~ 299 (307)
T 2nru_A 261 IDK-----KM---------NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQ 299 (307)
T ss_dssp SCS-----SC---------SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ccc-----cc---------cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 000 00 0012234578999999999999999999999986
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=352.16 Aligned_cols=253 Identities=24% Similarity=0.322 Sum_probs=198.0
Q ss_pred CcccceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc---chHHHHHHHHHHcCCCCcccccceeeecCCCCceEE
Q 012233 134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (468)
Q Consensus 134 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~---~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~ 210 (468)
....+|.+.+.||+|+||.||+|.+.. +..||||++.... ..+.+|+.+|+.++||||+++++++.. ..+
T Consensus 181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~------~~~ 253 (452)
T 1fmk_A 181 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPI 253 (452)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSC
T ss_pred cChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC------Cce
Confidence 445679999999999999999999864 4679999986533 345689999999999999999998732 236
Q ss_pred EEEeecccc-hHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccc
Q 012233 211 NLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (468)
Q Consensus 211 ~lv~e~~~~-~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~ 289 (468)
||||||+.+ ++.+.+... ....+++..+..++.||+.||.|||+ +||+||||||+||||+.++ .+||+|||+++.
T Consensus 254 ~iv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivHrDlkp~Nill~~~~-~~kl~DfG~a~~ 329 (452)
T 1fmk_A 254 YIVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVER-MNYVHRDLRAANILVGENL-VCKVADFGLARL 329 (452)
T ss_dssp EEEECCCTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECGGG-CEEECCCCTTC-
T ss_pred EEEehhhcCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChhhEEECCCC-CEEECCCcccee
Confidence 899999986 555544321 23458899999999999999999998 8999999999999999887 799999999986
Q ss_pred cCCCC--CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 012233 290 LVPGE--PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKC 366 (468)
Q Consensus 290 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 366 (468)
..... ......+++.|+|||++.+. .++.++|||||||++|||++ |+.||.+....+.+..+......
T Consensus 330 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~-------- 400 (452)
T 1fmk_A 330 IEDNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM-------- 400 (452)
T ss_dssp -------------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC--------
T ss_pred cCCCceecccCCcccccccCHhHHhcC-CCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC--------
Confidence 64322 12234567889999999755 48999999999999999999 99999988776665554331100
Q ss_pred cCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC--CCCCCCC
Q 012233 367 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA--HPFFDDL 426 (468)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~--hp~f~~~ 426 (468)
..+..+++.+.+||.+||+.||.+|||+.+++. ..+|...
T Consensus 401 --------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~ 442 (452)
T 1fmk_A 401 --------------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 442 (452)
T ss_dssp --------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred --------------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence 023458899999999999999999999999987 4565543
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=333.48 Aligned_cols=260 Identities=23% Similarity=0.351 Sum_probs=193.0
Q ss_pred cceEEeceecccCceEEEEEE----EcCCCCEEEEEEeeccc-----chHHHHHHHHHHcCCCCcccccceeeecCCCCc
Q 012233 137 ISYMAERVVGTGSFGVVFQAK----CLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~----~~~~g~~vaiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 207 (468)
..|++.+.||+|+||.||+|. +..+++.||+|++.... ....+|+.+++.++||||+++++++... +.
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~ 97 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED---GG 97 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC------
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecC---CC
Confidence 359999999999999999999 46789999999986432 3456899999999999999999988542 22
Q ss_pred eEEEEEeecccc-hHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecC
Q 012233 208 LYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (468)
Q Consensus 208 ~~~~lv~e~~~~-~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~ 286 (468)
..+++||||+.+ ++.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus 98 ~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dikp~Nil~~~~~-~~kl~Dfg~ 172 (302)
T 4e5w_A 98 NGIKLIMEFLPSGSLKEYLPK---NKNKINLKQQLKYAVQICKGMDYLGS-RQYVHRDLAARNVLVESEH-QVKIGDFGL 172 (302)
T ss_dssp CCEEEEEECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEETT-EEEECCCTT
T ss_pred ceEEEEEEeCCCCcHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHhhc-CCcccCCCchheEEEcCCC-CEEECcccc
Confidence 457899999986 44444322 24568999999999999999999998 8999999999999999888 899999999
Q ss_pred ccccCCCCC----CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 012233 287 AKMLVPGEP----NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTRE 362 (468)
Q Consensus 287 a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~ 362 (468)
+........ .....||..|+|||++.+.. ++.++|||||||++|+|++|..|+.... ... ....+.....
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~--~~~---~~~~~~~~~~ 246 (302)
T 4e5w_A 173 TKAIETDKEYYTVKDDRDSPVFWYAPECLMQSK-FYIASDVWSFGVTLHELLTYCDSDSSPM--ALF---LKMIGPTHGQ 246 (302)
T ss_dssp CEECCTTCCEEECCCCTTCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGSHH--HHH---HHHHCSCCGG
T ss_pred cccccCCCcceeccCCCCCCccccCCeeecCCC-CCcchhHHHHHHHHHHHHHccCCCcchh--hHH---hhccCCcccc
Confidence 987654432 23456788899999997654 8899999999999999999998864321 111 1111110000
Q ss_pred HH-hhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 363 EI-KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 363 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
.. ......... .....++..+++++.+||.+||+.||.+|||+.++++
T Consensus 247 ~~~~~~~~~~~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 247 MTVTRLVNTLKE---------GKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp GHHHHHHHHHHT---------TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred cCHHHHHHHHhc---------cCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 00 000000000 0001134568999999999999999999999999875
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=341.81 Aligned_cols=280 Identities=20% Similarity=0.276 Sum_probs=193.4
Q ss_pred CcccceEEeceecccCceEEEEEEEcCCCCEEEEEEeecccc-hHHHHHHH--HHHcCCCCcccccceeeecCCCCceEE
Q 012233 134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR-YKNRELQI--MRLLNHPNVVSLKHCFFSTTEKDELYL 210 (468)
Q Consensus 134 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~~-~~~~E~~i--l~~l~hpnIv~l~~~~~~~~~~~~~~~ 210 (468)
....+|.+.+.||+|+||.||+|.+ +++.||||++..... ....|.++ +..++||||+++++.+......+...+
T Consensus 10 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 10 LDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred cChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 3455799999999999999999987 789999999865432 22334444 445899999999987765555666678
Q ss_pred EEEeecccc-hHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcC---------CccccCCCCCCeeecCCCCcEE
Q 012233 211 NLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV---------GVCHRDIKPQNLLVNPHTHQLK 280 (468)
Q Consensus 211 ~lv~e~~~~-~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---------givHrDlkp~NILl~~~~~~vk 280 (468)
++||||+++ ++.+++. ....++..++.++.||+.||.|||+ . ||+||||||+||||+.++ .+|
T Consensus 88 ~lv~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~qi~~~L~~LH~-~~~~~~~~~~~ivH~Dikp~Nill~~~~-~~k 160 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLS-----LHTSDWVSSCRLAHSVTRGLAYLHT-ELPRGDHYKPAISHRDLNSRNVLVKNDG-TCV 160 (336)
T ss_dssp EEEECCCTTCBHHHHHH-----HCCBCHHHHHHHHHHHHHHHHHHHC-CBCCGGGCBCCEECSSCSGGGEEECTTS-CEE
T ss_pred EEEEecCCCCcHHHHHh-----hcccchhHHHHHHHHHHHHHHHHHh-hhccccccccceeecccccceEEEcCCC-cEE
Confidence 999999976 5554443 2345888899999999999999997 8 999999999999999888 799
Q ss_pred EeeecCccccCCCC---------CCccccccCCccccccccCC------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCc
Q 012233 281 ICDFGSAKMLVPGE---------PNISYICSRYYRAPELIFGA------TEYTTAIDMWSIGCVLAELLLGQPLFPGESG 345 (468)
Q Consensus 281 L~DFG~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~------~~~~~~~DvwSlG~il~ell~G~~pf~~~~~ 345 (468)
|+|||+++.+.... ......||+.|+|||++.+. ..++.++|||||||++|||++|..||.....
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 240 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence 99999998664321 22345799999999999753 2356789999999999999999766543221
Q ss_pred -HHHHHHHHH-HhCCCCHHHHhhc-CCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHH-----
Q 012233 346 -VDQLVEIIK-ILGTPTREEIKCM-NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEA----- 417 (468)
Q Consensus 346 -~~~~~~i~~-~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~el----- 417 (468)
.+....+.. ....+....+... ........++. .|. ....+++++.+||.+||+.||.+|||+.|+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~--~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~ 314 (336)
T 3g2f_A 241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPE----AWK--ENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMA 314 (336)
T ss_dssp CCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCT----TCC--CCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred hhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCc----ccc--cccchHHHHHHHHHHHhcCChhhCcchHHHHHHHH
Confidence 111111111 1111211111110 00000111110 000 011245689999999999999999999999
Q ss_pred -hCCCCCCCCCC
Q 012233 418 -CAHPFFDDLRD 428 (468)
Q Consensus 418 -l~hp~f~~~~~ 428 (468)
+.++|-++-..
T Consensus 315 ~ll~~~~~~~~~ 326 (336)
T 3g2f_A 315 ELMMIWERNKSV 326 (336)
T ss_dssp HHHHCCCC----
T ss_pred HHHHHHHhcccC
Confidence 45788776433
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=326.08 Aligned_cols=245 Identities=23% Similarity=0.312 Sum_probs=196.3
Q ss_pred cccceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc---chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEE
Q 012233 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (468)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~---~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 211 (468)
...+|.+.+.||+|+||.||+|.+. ++..||+|.+.... ..+.+|+.+++.++||||+++++++. +. ..+
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~-~~~ 83 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-----QE-PIY 83 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SS-SCE
T ss_pred CHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEc-----CC-CcE
Confidence 3457999999999999999999974 56789999986543 34568999999999999999998873 21 267
Q ss_pred EEeecccc-hHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcccc
Q 012233 212 LVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (468)
Q Consensus 212 lv~e~~~~-~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~ 290 (468)
+||||+.+ ++.+.+... ....+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++...
T Consensus 84 ~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~Nil~~~~~-~~kl~Dfg~~~~~ 159 (279)
T 1qpc_A 84 IITEYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEE-RNYIHRDLRAANILVSDTL-SCKIADFGLARLI 159 (279)
T ss_dssp EEEECCTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTS-CEEECCCTTCEEC
T ss_pred EEEecCCCCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHhhEEEcCCC-CEEECCCcccccc
Confidence 99999975 444443321 12358899999999999999999998 8999999999999999887 7999999999876
Q ss_pred CCCC--CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 012233 291 VPGE--PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367 (468)
Q Consensus 291 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 367 (468)
.... ......+++.|+|||++.+.. ++.++|||||||++|+|++ |+.||.+.+..+.+..+....
T Consensus 160 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~----------- 227 (279)
T 1qpc_A 160 EDNEYTAREGAKFPIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY----------- 227 (279)
T ss_dssp SSSCEECCTTCCCCTTTSCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-----------
T ss_pred cCcccccccCCCCccCccChhhhccCC-CCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhccc-----------
Confidence 4332 222345678999999996544 8999999999999999999 999999877666555443210
Q ss_pred CCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
....+..+++++.+||.+||+.||.+|||+.++++
T Consensus 228 -----------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 228 -----------------RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp -----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------CCCCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 00123457899999999999999999999999876
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=328.85 Aligned_cols=246 Identities=22% Similarity=0.329 Sum_probs=191.3
Q ss_pred CCcccceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc--chHHHHHHHHHHcCCCCcccccceeeecCCCCceEE
Q 012233 133 PKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK--RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (468)
Q Consensus 133 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~--~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~ 210 (468)
.....+|.+.+.||+|+||.||+|.+ +|+.||||++.... ..+.+|+.+++.++||||+++++++... ...+
T Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----~~~~ 90 (278)
T 1byg_A 17 ALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KGGL 90 (278)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC------CC
T ss_pred cCChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC----CCce
Confidence 34556799999999999999999988 58999999986543 3456799999999999999999986432 2347
Q ss_pred EEEeecccc-hHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccc
Q 012233 211 NLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (468)
Q Consensus 211 ~lv~e~~~~-~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~ 289 (468)
++||||+.+ ++.+.+.... ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++..
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~~~-~~~l~Dfg~~~~ 166 (278)
T 1byg_A 91 YIVTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEG-NNFVHRDLAARNVLVSEDN-VAKVSDFGLTKE 166 (278)
T ss_dssp EEEECCCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECTTS-CEEECCCCC---
T ss_pred EEEEecCCCCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCcceEEEeCCC-cEEEeecccccc
Confidence 899999986 5555544321 2237888899999999999999998 8999999999999999888 799999999875
Q ss_pred cCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 012233 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368 (468)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 368 (468)
.... .....+++.|+|||++.+. .++.++|||||||++|+|++ |+.||......+....+...
T Consensus 167 ~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~------------- 230 (278)
T 1byg_A 167 ASST--QDTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG------------- 230 (278)
T ss_dssp -----------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT-------------
T ss_pred cccc--ccCCCccccccCHHHhCCC-CCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC-------------
Confidence 5332 2344678899999999654 48999999999999999998 99999887655544433220
Q ss_pred CCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
+...++..+++.+.+||.+||+.||.+|||+.++++
T Consensus 231 ---------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 231 ---------------YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp ---------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------CCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 001133568999999999999999999999999875
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=328.76 Aligned_cols=246 Identities=22% Similarity=0.337 Sum_probs=191.8
Q ss_pred ccceEEeceecccCceEEEEEEEcCCCC---EEEEEEeeccc-----chHHHHHHHHHHcCCCCcccccceeeecCCCCc
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLETGD---SVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~---~vaiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 207 (468)
...|.+.+.||+|+||.||+|.+..++. .||+|.+.... ....+|+.+++.++||||+++++++....
T Consensus 20 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---- 95 (298)
T 3pls_A 20 RVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPE---- 95 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS----
T ss_pred ceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCC----
Confidence 3458899999999999999999766555 79999886432 23457999999999999999999884332
Q ss_pred eEEEEEeecccc-hHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecC
Q 012233 208 LYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (468)
Q Consensus 208 ~~~~lv~e~~~~-~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~ 286 (468)
...++||||+.+ ++.+.+. .....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus 96 ~~~~~v~e~~~~~~L~~~~~---~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dikp~Nili~~~~-~~kl~Dfg~ 170 (298)
T 3pls_A 96 GLPHVLLPYMCHGDLLQFIR---SPQRNPTVKDLISFGLQVARGMEYLAE-QKFVHRDLAARNCMLDESF-TVKVADFGL 170 (298)
T ss_dssp SCCEEEECCCTTCBHHHHHH---CTTCCCBHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECTTC-CEEECCTTS
T ss_pred CCcEEEEecccCCCHHHHHh---ccccCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCcceEEEcCCC-cEEeCcCCC
Confidence 234789999975 4444432 234668899999999999999999998 8999999999999999888 799999999
Q ss_pred ccccCCC-----CCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhC-CCCCCCCCcHHHHHHHHHHhCCCC
Q 012233 287 AKMLVPG-----EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLG-QPLFPGESGVDQLVEIIKILGTPT 360 (468)
Q Consensus 287 a~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G-~~pf~~~~~~~~~~~i~~~~~~~~ 360 (468)
++..... .......+++.|+|||.+.+. .++.++|||||||++|+|++| .+||...+..+....+.... .
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~-~-- 246 (298)
T 3pls_A 171 ARDILDREYYSVQQHRHARLPVKWTALESLQTY-RFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGR-R-- 246 (298)
T ss_dssp SCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTC-CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTC-C--
T ss_pred cccccCCcccccccCcCCCCCccccChhhhccC-CCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCC-C--
Confidence 9755332 123345678999999999655 489999999999999999995 55555555444433332210 0
Q ss_pred HHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 361 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
...+..+++.+.+||.+||+.||.+|||+.++++
T Consensus 247 -------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 247 -------------------------LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp -------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------------------CCCCccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 0023457899999999999999999999999876
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=329.66 Aligned_cols=245 Identities=22% Similarity=0.323 Sum_probs=191.3
Q ss_pred cceEEeceecccCceEEEEEEEcCCC---CEEEEEEeeccc-----chHHHHHHHHHHcCCCCcccccceeeecCCCCce
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETG---DSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g---~~vaiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 208 (468)
..|.+.+.||+|+||.||+|.+..++ ..||+|.+.... ....+|+.+++.++||||+++++++... ..
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----~~ 100 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS----EG 100 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS----SS
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcC----CC
Confidence 46999999999999999999975433 358999885432 2345799999999999999999986432 23
Q ss_pred EEEEEeecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCc
Q 012233 209 YLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (468)
Q Consensus 209 ~~~lv~e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a 287 (468)
..++||||+.++ +.+.+. .....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++
T Consensus 101 ~~~~v~e~~~~~~L~~~l~---~~~~~~~~~~~~~i~~ql~~~l~~lH~-~~i~H~dikp~Nil~~~~~-~~kl~Dfg~a 175 (298)
T 3f66_A 101 SPLVVLPYMKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGMKYLAS-KKFVHRDLAARNCMLDEKF-TVKVADFGLA 175 (298)
T ss_dssp CCEEEEECCTTCBHHHHHH---CTTCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECTTC-CEEECSCGGG
T ss_pred ceEEEEeCCCCCCHHHHHH---hcccCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCchheEEECCCC-CEEECccccc
Confidence 477999999874 444432 234568899999999999999999998 8999999999999999888 7999999999
Q ss_pred cccCCCC-----CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCH
Q 012233 288 KMLVPGE-----PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTR 361 (468)
Q Consensus 288 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~ 361 (468)
....... ......+|+.|+|||++.+.. ++.++|||||||++|+|++ |.+||...+..+....+.....
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~---- 250 (298)
T 3f66_A 176 RDMYDKEYYSVHNKTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR---- 250 (298)
T ss_dssp CCCSCGGGCBC-----CCBCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCC----
T ss_pred ccccccchhccccccCCCCCccccChHHhcCCC-CChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCC----
Confidence 7654322 223456788999999996554 8999999999999999999 6777877665555444433110
Q ss_pred HHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 362 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
...+..+++.+.+||.+||+.||.+|||+.++++
T Consensus 251 ------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 251 ------------------------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp ------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0123457899999999999999999999999876
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=337.63 Aligned_cols=252 Identities=22% Similarity=0.308 Sum_probs=186.4
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeecccc-hHHHHHHHHHHc--CCCCcccccceeeecCCCCceEEEEE
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR-YKNRELQIMRLL--NHPNVVSLKHCFFSTTEKDELYLNLV 213 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~~-~~~~E~~il~~l--~hpnIv~l~~~~~~~~~~~~~~~~lv 213 (468)
.+|++.+.||+|+||.||+|.+ +|+.||||++..... ...+|.+++..+ +||||+++++++..... ....+|+|
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~-~~~~~~lv 113 (337)
T 3mdy_A 37 KQIQMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTG-SWTQLYLI 113 (337)
T ss_dssp HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG-GGCEEEEE
T ss_pred cceEEEeEeecCCCeEEEEEEE--CCceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC-CCCceEEE
Confidence 3699999999999999999998 489999999865433 233456665554 89999999998865432 22468899
Q ss_pred eecccc-hHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcC--------CccccCCCCCCeeecCCCCcEEEeee
Q 012233 214 LEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV--------GVCHRDIKPQNLLVNPHTHQLKICDF 284 (468)
Q Consensus 214 ~e~~~~-~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~--------givHrDlkp~NILl~~~~~~vkL~DF 284 (468)
|||+.+ ++.+.+. ...+++..++.++.|++.||.|||+ . ||+||||||+|||++.++ .+||+||
T Consensus 114 ~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~~~~~~ivH~Dikp~Nill~~~~-~~kl~Df 186 (337)
T 3mdy_A 114 TDYHENGSLYDYLK-----STTLDAKSMLKLAYSSVSGLCHLHT-EIFSTQGKPAIAHRDLKSKNILVKKNG-TCCIADL 186 (337)
T ss_dssp ECCCTTCBHHHHHH-----HCCBCHHHHHHHHHHHHHHHHHHHS-CBCSTTCBCCEECSCCCGGGEEECTTS-CEEECCC
T ss_pred EeccCCCcHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHHH-hhhhhccCCCEEecccchHHEEECCCC-CEEEEeC
Confidence 999986 5555443 2468999999999999999999997 7 999999999999999888 7999999
Q ss_pred cCccccCCCCCC-----ccccccCCccccccccCCCCCCc------chhHHHHHHHHHHHHhC----------CCCCCCC
Q 012233 285 GSAKMLVPGEPN-----ISYICSRYYRAPELIFGATEYTT------AIDMWSIGCVLAELLLG----------QPLFPGE 343 (468)
Q Consensus 285 G~a~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~------~~DvwSlG~il~ell~G----------~~pf~~~ 343 (468)
|++......... ....||+.|+|||++.+.. +.. ++|||||||++|||++| ..||...
T Consensus 187 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~ 265 (337)
T 3mdy_A 187 GLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESL-NRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL 265 (337)
T ss_dssp TTCEECC---------CCSSCSCGGGCCHHHHTTCC-CTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCceeeccccccccCCCCCCccCcceeChhhccccc-CCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhh
Confidence 999766433221 2457999999999997654 444 39999999999999999 6777553
Q ss_pred Cc----HHHHHHHHHHhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 344 SG----VDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 344 ~~----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
.. ............ ....++ .......+++++.+||.+||+.||.+|||+.++++
T Consensus 266 ~~~~~~~~~~~~~~~~~~--------------~~~~~~-------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (337)
T 3mdy_A 266 VPSDPSYEDMREIVCIKK--------------LRPSFP-------NRWSSDECLRQMGKLMTECWAHNPASRLTALRVKK 324 (337)
T ss_dssp SCSSCCHHHHHHHHTTSC--------------CCCCCC-------GGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred cCCCCchhhhHHHHhhhc--------------cCcccc-------ccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHH
Confidence 22 122222111000 000000 00111245678999999999999999999999987
Q ss_pred C
Q 012233 420 H 420 (468)
Q Consensus 420 h 420 (468)
|
T Consensus 325 ~ 325 (337)
T 3mdy_A 325 T 325 (337)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=343.62 Aligned_cols=245 Identities=22% Similarity=0.324 Sum_probs=184.6
Q ss_pred cceEEeceecccCceEEEEEEEcCCC---CEEEEEEeeccc-----chHHHHHHHHHHcCCCCcccccceeeecCCCCce
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETG---DSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g---~~vaiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 208 (468)
..|.+.+.||+|+||.||+|.+..++ ..||+|.+.... ..+.+|+.+++.++||||+++++++... ..
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~----~~ 164 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS----EG 164 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCC----SS
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC----CC
Confidence 45999999999999999999975433 458999885422 3345799999999999999999986432 23
Q ss_pred EEEEEeecccc-hHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCc
Q 012233 209 YLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (468)
Q Consensus 209 ~~~lv~e~~~~-~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a 287 (468)
..++||||+.+ ++.+.+. .....+++..++.++.||+.||.|||+ +||+||||||+||||+.++ .+||+|||++
T Consensus 165 ~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~-~~kL~DFG~a 239 (373)
T 3c1x_A 165 SPLVVLPYMKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGMKFLAS-KKFVHRDLAARNCMLDEKF-TVKVADFGLA 239 (373)
T ss_dssp CCEEEEECCTTCBHHHHHH---CTTCCCBHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTC-CEEECCC---
T ss_pred CeEEEEECCCCCCHHHHHh---hcccCCCHHHHHHHHHHHHHHHHHHHH-CCEecCccchheEEECCCC-CEEEeecccc
Confidence 46799999987 4444432 224557889999999999999999998 8999999999999999888 7999999999
Q ss_pred cccCCCC-----CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCH
Q 012233 288 KMLVPGE-----PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTR 361 (468)
Q Consensus 288 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~ 361 (468)
+...... ......+|+.|+|||++.+. .++.++|||||||++|||++ |.+||...+..+....+....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~----- 313 (373)
T 3c1x_A 240 RDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR----- 313 (373)
T ss_dssp ------------------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTC-----
T ss_pred ccccccccccccccCCCCCcccccChHHhcCC-CCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCC-----
Confidence 7653322 12334567899999999755 48999999999999999999 788898766555444433210
Q ss_pred HHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 362 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
. ...+..+++.+.+||.+||+.||.+|||+.++++
T Consensus 314 -----------~------------~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~ 348 (373)
T 3c1x_A 314 -----------R------------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 348 (373)
T ss_dssp -----------C------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------C------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0 0123457899999999999999999999999886
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=355.39 Aligned_cols=252 Identities=24% Similarity=0.329 Sum_probs=201.5
Q ss_pred cccceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc---chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEE
Q 012233 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (468)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~---~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 211 (468)
...+|.+.+.||+|+||.||+|.+.. +..||||++.... ..+.+|+.+|+.++||||+++++++.. ..+|
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~------~~~~ 337 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIY 337 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSCE
T ss_pred chhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee------ccce
Confidence 34579999999999999999999864 4679999986543 345689999999999999999998732 2378
Q ss_pred EEeecccc-hHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcccc
Q 012233 212 LVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (468)
Q Consensus 212 lv~e~~~~-~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~ 290 (468)
|||||+.+ +|.+.+... ....+++..+..++.||+.||.|||+ +||+||||||+||||+.++ .+||+|||+++..
T Consensus 338 lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~~ 413 (535)
T 2h8h_A 338 IVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVER-MNYVHRDLRAANILVGENL-VCKVADFGLARLI 413 (535)
T ss_dssp EEECCCTTEEHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECGGG-CEEECCTTSTTTC
T ss_pred EeeehhcCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCCHhhEEEcCCC-cEEEcccccceec
Confidence 99999986 555544322 23458899999999999999999998 8999999999999999887 7999999999765
Q ss_pred CCCC--CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 012233 291 VPGE--PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367 (468)
Q Consensus 291 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 367 (468)
.... ......++..|+|||++.+. .++.++|||||||+||||++ |+.||.+....+.+..+.....
T Consensus 414 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~---------- 482 (535)
T 2h8h_A 414 EDNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR---------- 482 (535)
T ss_dssp CCHHHHTTCSTTSCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCC----------
T ss_pred CCCceecccCCcCcccccCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC----------
Confidence 4321 12234567889999999754 48999999999999999999 9999998877666555433110
Q ss_pred CCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC--CCCCCCC
Q 012233 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA--HPFFDDL 426 (468)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~--hp~f~~~ 426 (468)
. ..+..+++++.+||.+||+.||.+|||+.+++. ..+|...
T Consensus 483 --------~----------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~ 525 (535)
T 2h8h_A 483 --------M----------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 525 (535)
T ss_dssp --------C----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred --------C----------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence 0 023458899999999999999999999999987 3555543
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=339.96 Aligned_cols=242 Identities=15% Similarity=0.184 Sum_probs=187.0
Q ss_pred cceEEeceecccCceEEEEE-----EEcCCCCEEEEEEeeccc-chHHHHHHHHHHcC---CCCcccccceeeecCCCCc
Q 012233 137 ISYMAERVVGTGSFGVVFQA-----KCLETGDSVAIKKVLQDK-RYKNRELQIMRLLN---HPNVVSLKHCFFSTTEKDE 207 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~-----~~~~~g~~vaiK~~~~~~-~~~~~E~~il~~l~---hpnIv~l~~~~~~~~~~~~ 207 (468)
.+|.+.+.||+|+||.||+| .+..+++.||||++.... ....+|+.+++.+. |+||+++++++...
T Consensus 65 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~----- 139 (365)
T 3e7e_A 65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ----- 139 (365)
T ss_dssp SEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS-----
T ss_pred EEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeeecC-----
Confidence 46999999999999999999 467789999999986543 34567888888887 89999999988443
Q ss_pred eEEEEEeecccc-hHHHHHhhhhh-cCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecC-----------
Q 012233 208 LYLNLVLEYISE-TVYRVSKHYTR-MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNP----------- 274 (468)
Q Consensus 208 ~~~~lv~e~~~~-~ll~~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~----------- 274 (468)
...|||||||.+ ++.+.+..... ....+++..++.++.||+.||.|||+ +|||||||||+||||+.
T Consensus 140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~-~~ivHrDiKp~NIll~~~~~~~~~~~~~ 218 (365)
T 3e7e_A 140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD-CEIIHGDIKPDNFILGNGFLEQDDEDDL 218 (365)
T ss_dssp SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCSGGGEEECGGGTCC------
T ss_pred CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh-CCeecCCCCHHHEEecccccCccccccc
Confidence 347899999985 55555544332 34669999999999999999999998 89999999999999987
Q ss_pred CCCcEEEeeecCccccC---CCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Q 012233 275 HTHQLKICDFGSAKMLV---PGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVE 351 (468)
Q Consensus 275 ~~~~vkL~DFG~a~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~ 351 (468)
++ .+||+|||+++.+. ........+||+.|+|||++.+.. ++.++|||||||++|||++|+.||.......
T Consensus 219 ~~-~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~---- 292 (365)
T 3e7e_A 219 SA-GLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKP-WNYQIDYFGVAATVYCMLFGTYMKVKNEGGE---- 292 (365)
T ss_dssp CT-TEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCC-BSTHHHHHHHHHHHHHHHHSSCCCEEEETTE----
T ss_pred cC-CEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCC-CCccccHHHHHHHHHHHHhCCCccccCCCCc----
Confidence 56 79999999996542 233345678999999999997765 8999999999999999999999995432100
Q ss_pred HHHHhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 352 IIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 352 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
+..... ... ...++.+.+++.+||+.+|.+|++..+.+.
T Consensus 293 ----------------------~~~~~~-----~~~--~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~ 331 (365)
T 3e7e_A 293 ----------------------CKPEGL-----FRR--LPHLDMWNEFFHVMLNIPDCHHLPSLDLLR 331 (365)
T ss_dssp ----------------------EEECSC-----CTT--CSSHHHHHHHHHHHHCCCCTTCCCCHHHHH
T ss_pred ----------------------eeechh-----ccc--cCcHHHHHHHHHHHcCCCCCCcchHHHHHH
Confidence 000000 000 023567899999999999999976554444
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=327.84 Aligned_cols=244 Identities=25% Similarity=0.334 Sum_probs=187.0
Q ss_pred cceEEeceecccCceEEEEEEEcC-CCC--EEEEEEeecc-------cchHHHHHHHHHHcCCCCcccccceeeecCCCC
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLE-TGD--SVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD 206 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~-~g~--~vaiK~~~~~-------~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 206 (468)
.+|.+.+.||+|+||.||+|.+.. ++. .||||++... ...+.+|+.+++.++||||+++++++..
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----- 92 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT----- 92 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc-----
Confidence 469999999999999999998643 333 5899987542 1234579999999999999999998843
Q ss_pred ceEEEEEeecccc-hHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeec
Q 012233 207 ELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG 285 (468)
Q Consensus 207 ~~~~~lv~e~~~~-~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG 285 (468)
.. .++||||+.+ ++.+.+... ...+++..++.++.||+.||.|||+ +||+|+||||+|||++.++ .+||+|||
T Consensus 93 ~~-~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dikp~Nili~~~~-~~kl~Dfg 166 (291)
T 1u46_A 93 PP-MKMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLES-KRFIHRDLAARNLLLATRD-LVKIGDFG 166 (291)
T ss_dssp SS-CEEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEEEETT-EEEECCCT
T ss_pred CC-ceeeEecccCCCHHHHHHhc---cCCcCHHHHHHHHHHHHHHHHHHHh-CCcccCCCchheEEEcCCC-CEEEcccc
Confidence 22 6799999985 555544322 3558899999999999999999998 8999999999999999887 79999999
Q ss_pred CccccCCCCC----CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCC
Q 012233 286 SAKMLVPGEP----NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPT 360 (468)
Q Consensus 286 ~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~ 360 (468)
++........ .....+|+.|+|||++.+.. ++.++|||||||++|+|++ |+.||.+.+..+.+..+....
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~---- 241 (291)
T 1u46_A 167 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEG---- 241 (291)
T ss_dssp TCEECCC-CCEEEC-----CCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSC----
T ss_pred ccccccccccchhhhccCCCCceeeCchhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccC----
Confidence 9987644332 22345678899999997544 8899999999999999999 999999887666555543310
Q ss_pred HHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 361 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
..++ .+..+++++.++|.+||+.||.+|||+.++++
T Consensus 242 -------------~~~~----------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 242 -------------ERLP----------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 277 (291)
T ss_dssp -------------CCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------CCCC----------CCcCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 0000 22458899999999999999999999999987
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=357.38 Aligned_cols=243 Identities=26% Similarity=0.292 Sum_probs=191.2
Q ss_pred ceEEec-eecccCceEEEEEEEcC--CCCEEEEEEeecc-----cchHHHHHHHHHHcCCCCcccccceeeecCCCCceE
Q 012233 138 SYMAER-VVGTGSFGVVFQAKCLE--TGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (468)
Q Consensus 138 ~y~~~~-~lG~G~fg~Vy~~~~~~--~g~~vaiK~~~~~-----~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 209 (468)
+|.+.+ .||+|+||.||+|.+.. ++..||||++... ...+.+|+.+|+.++|||||++++++.. . .
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-----~-~ 409 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-----E-A 409 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-----S-S
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-----C-C
Confidence 455555 89999999999998753 5567999998653 2345689999999999999999998732 1 2
Q ss_pred EEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccc
Q 012233 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (468)
Q Consensus 210 ~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~ 289 (468)
++|||||+.++.+.... ......+++..++.++.||+.||.|||+ +||+||||||+||||+.++ .+||+|||+++.
T Consensus 410 ~~lv~E~~~~g~L~~~l--~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~iiHrDlkp~NILl~~~~-~vkL~DFGla~~ 485 (613)
T 2ozo_A 410 LMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYLEE-KNFVHRNLAARNVLLVNRH-YAKISDFGLSKA 485 (613)
T ss_dssp EEEEEECCTTCBHHHHH--TTCTTTSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEETT-EEEECCCSTTTT
T ss_pred eEEEEEeCCCCcHHHHH--hhccCCCCHHHHHHHHHHHHHHHHHHHH-CCEEcCcCCHHHEEEcCCC-cEEEeeccCccc
Confidence 78999999876444322 1224568999999999999999999998 8999999999999999887 899999999987
Q ss_pred cCCCCCC----ccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 012233 290 LVPGEPN----ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEI 364 (468)
Q Consensus 290 ~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 364 (468)
....... ....+++.|+|||++.+. .++.++|||||||++|||++ |+.||.+.+..+.+..+.....
T Consensus 486 ~~~~~~~~~~~~~~~~~~~y~APE~~~~~-~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~------- 557 (613)
T 2ozo_A 486 LGADDSYYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR------- 557 (613)
T ss_dssp CC--------------CCTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCC-------
T ss_pred ccCCCceeeeccCCCCccceeCHhhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC-------
Confidence 6433221 123456899999999654 48999999999999999998 9999999887776655443110
Q ss_pred hhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 365 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
. .++..+++++.+||.+||+.||.+||++.+++.
T Consensus 558 ---------~------------~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 558 ---------M------------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp ---------C------------CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred ---------C------------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 0 133468999999999999999999999998754
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=330.80 Aligned_cols=246 Identities=26% Similarity=0.349 Sum_probs=190.5
Q ss_pred eEEeceecccCceEEEEEEE----cCCCCEEEEEEeeccc-----chHHHHHHHHHHcCCCCcccccceeeecCCCCceE
Q 012233 139 YMAERVVGTGSFGVVFQAKC----LETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (468)
Q Consensus 139 y~~~~~lG~G~fg~Vy~~~~----~~~g~~vaiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 209 (468)
|++.+.||+|+||.||++.+ ..+|+.||||++.... ..+.+|+.+++.++||||+++++++... +...
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~~ 109 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDA---GAAS 109 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET---TTTE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecC---CCce
Confidence 59999999999999988864 3478899999986542 2356899999999999999999988553 2346
Q ss_pred EEEEeecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcc
Q 012233 210 LNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (468)
Q Consensus 210 ~~lv~e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~ 288 (468)
+++||||+.++ +.+.+. ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||++.
T Consensus 110 ~~lv~e~~~~~~L~~~l~-----~~~~~~~~~~~i~~~l~~~l~~LH~-~~ivH~Dikp~Nil~~~~~-~~kl~Dfg~a~ 182 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLP-----RHSIGLAQLLLFAQQICEGMAYLHA-QHYIHRDLAARNVLLDNDR-LVKIGDFGLAK 182 (318)
T ss_dssp EEEEECCCTTCBHHHHGG-----GSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTC-CEEECCGGGCE
T ss_pred EEEEEecccCCcHHHHHh-----hCCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCchheEEEcCCC-CEEECCccccc
Confidence 88999999864 444332 2348999999999999999999998 8999999999999999887 79999999998
Q ss_pred ccCCCCC----CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHH-----------HHHHHH
Q 012233 289 MLVPGEP----NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVD-----------QLVEII 353 (468)
Q Consensus 289 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~-----------~~~~i~ 353 (468)
....... .....+|+.|+|||++.+.. ++.++|||||||++|+|++|..||....... ....+.
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (318)
T 3lxp_A 183 AVPEGHEYYRVREDGDSPVFWYAPECLKEYK-FYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLT 261 (318)
T ss_dssp ECCTTCSEEEC---CCCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHH
T ss_pred cccccccccccccCCCCCceeeChHHhcCCC-CCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHH
Confidence 7654432 23456788899999997554 8899999999999999999999996532110 001111
Q ss_pred HHhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 354 KILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
..+.. . .....+..+++++.+||.+||+.||.+|||+.++++
T Consensus 262 ~~~~~--------------~----------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 262 ELLER--------------G----------ERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp HHHHT--------------T----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHhc--------------c----------cCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 10000 0 001133568899999999999999999999999985
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=358.52 Aligned_cols=240 Identities=23% Similarity=0.286 Sum_probs=190.0
Q ss_pred eEE-eceecccCceEEEEEEE--cCCCCEEEEEEeeccc------chHHHHHHHHHHcCCCCcccccceeeecCCCCceE
Q 012233 139 YMA-ERVVGTGSFGVVFQAKC--LETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (468)
Q Consensus 139 y~~-~~~lG~G~fg~Vy~~~~--~~~g~~vaiK~~~~~~------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 209 (468)
+.+ .+.||+|+||.||+|.+ ..+++.||||++.... ..+.+|+.+|+.++|||||++++++. +. .
T Consensus 370 ~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-----~~-~ 443 (635)
T 4fl3_A 370 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-----AE-S 443 (635)
T ss_dssp EEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-----SS-S
T ss_pred ccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-----cC-C
Confidence 444 35899999999999965 4567889999986432 34568999999999999999999872 22 2
Q ss_pred EEEEeecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcc
Q 012233 210 LNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (468)
Q Consensus 210 ~~lv~e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~ 288 (468)
++|||||+.++ +.+.+. ....+++..++.++.||+.||.|||+ +|||||||||+||||+.++ .+||+|||+++
T Consensus 444 ~~lv~E~~~~g~L~~~l~----~~~~l~~~~~~~i~~qi~~~L~yLH~-~~iiHrDLkp~NILl~~~~-~~kL~DFGla~ 517 (635)
T 4fl3_A 444 WMLVMEMAELGPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEE-SNFVHRDLAARNVLLVTQH-YAKISDFGLSK 517 (635)
T ss_dssp EEEEEECCTTEEHHHHHH----HCTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEETT-EEEECCTTHHH
T ss_pred EEEEEEccCCCCHHHHHh----hCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeCCCCChHhEEEeCCC-CEEEEEcCCcc
Confidence 67999999865 444332 34678999999999999999999998 8999999999999999887 89999999998
Q ss_pred ccCCCCC----CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 012233 289 MLVPGEP----NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREE 363 (468)
Q Consensus 289 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~ 363 (468)
.+..... .....+|+.|+|||++.+. .++.++|||||||++|||++ |+.||.+.+..+....+......
T Consensus 518 ~~~~~~~~~~~~~~~~~t~~y~APE~~~~~-~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~----- 591 (635)
T 4fl3_A 518 ALRADENYYKAQTHGKWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM----- 591 (635)
T ss_dssp HTTC-------------CGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC-----
T ss_pred ccccCccccccccCCCCceeeeChhhhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-----
Confidence 7644332 2234567889999999654 48999999999999999998 99999988876655554431100
Q ss_pred HhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 364 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
.++..+++++.+||.+||+.||.+||++.++++
T Consensus 592 -----------------------~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 592 -----------------------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp -----------------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -----------------------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 123458999999999999999999999999875
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=346.75 Aligned_cols=247 Identities=17% Similarity=0.187 Sum_probs=184.0
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc------------chHHHHHHHHHHcC---------CCCcccc
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------------RYKNRELQIMRLLN---------HPNVVSL 195 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~------------~~~~~E~~il~~l~---------hpnIv~l 195 (468)
.+|.+.+.||+|+||+||+|++ +|+.||||++.... ....+|+.+++.++ |||||++
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 20 EKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred ccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 4699999999999999999998 78999999986542 44568999999986 5555554
Q ss_pred c-----------------ceeeecC--------CCCceEEEEEeecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHH
Q 012233 196 K-----------------HCFFSTT--------EKDELYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICR 249 (468)
Q Consensus 196 ~-----------------~~~~~~~--------~~~~~~~~lv~e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~ 249 (468)
. ++|.... ..+...+|||||||.++ ++..+. ...+++..++.++.||+.
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~-----~~~~~~~~~~~i~~qi~~ 172 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR-----TKLSSLATAKSILHQLTA 172 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT-----TTCCCHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH-----hcCCCHHHHHHHHHHHHH
Confidence 4 4442210 01244689999999765 444331 256899999999999999
Q ss_pred HHHHhH-hcCCccccCCCCCCeeecCCC-------------------CcEEEeeecCccccCCCCCCccccccCCccccc
Q 012233 250 ALNYLH-HVVGVCHRDIKPQNLLVNPHT-------------------HQLKICDFGSAKMLVPGEPNISYICSRYYRAPE 309 (468)
Q Consensus 250 aL~yLH-~~~givHrDlkp~NILl~~~~-------------------~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE 309 (468)
||.||| + +||+||||||+||||+.++ ..+||+|||+|+.... ...+||+.|+|||
T Consensus 173 aL~~lH~~-~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~----~~~~gt~~y~aPE 247 (336)
T 2vuw_A 173 SLAVAEAS-LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD----GIVVFCDVSMDED 247 (336)
T ss_dssp HHHHHHHH-HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET----TEEECCCCTTCSG
T ss_pred HHHHHHHh-CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC----CcEEEeecccChh
Confidence 999999 8 8999999999999998764 1699999999987643 2458999999999
Q ss_pred cccCCCCCCcchhHHHHHHH-HHHHHhCCCCCCCCCcHHHH-HHHHHHhCCCCHHHHhhcCCCCccCCCCcccCCCcccc
Q 012233 310 LIFGATEYTTAIDMWSIGCV-LAELLLGQPLFPGESGVDQL-VEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKI 387 (468)
Q Consensus 310 ~~~~~~~~~~~~DvwSlG~i-l~ell~G~~pf~~~~~~~~~-~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (468)
++.+.. +.++||||||++ .++++.|..||.+....... ..+.... .++. .....
T Consensus 248 ~~~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~------------------~~~~----~~~~~ 303 (336)
T 2vuw_A 248 LFTGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQM------------------TFKT----KCNTP 303 (336)
T ss_dssp GGCCCS--SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTC------------------CCSS----CCCSH
T ss_pred hhcCCC--ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhh------------------ccCc----ccchh
Confidence 997654 889999998776 77888999999542211111 1222110 0000 00011
Q ss_pred cccCCCHHHHHHHHHhcccCCCCCCCHHHHh-CCCCCC
Q 012233 388 FHKRMPPEALDLVSRLLQYSPSLRCTALEAC-AHPFFD 424 (468)
Q Consensus 388 ~~~~~~~~l~~li~~~L~~dP~~R~s~~ell-~hp~f~ 424 (468)
.+..+++++++||.+||++| |+.|+| +||||+
T Consensus 304 ~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 304 AMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK 336 (336)
T ss_dssp HHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred hhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence 23457889999999999987 999999 999995
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=329.69 Aligned_cols=255 Identities=18% Similarity=0.229 Sum_probs=193.5
Q ss_pred cccceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc------cchHHHHHHHHHHcCCCCcccccceeeecCCCCce
Q 012233 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (468)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~------~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 208 (468)
...+|.+.+.||+|+||.||+|.+.. .||+|++... ...+.+|+.+++.++||||+++++++.. ..
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~ 102 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS-----PP 102 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEEC-----SS
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEec-----CC
Confidence 34569999999999999999999743 4999988532 2334579999999999999999999843 33
Q ss_pred EEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcc
Q 012233 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (468)
Q Consensus 209 ~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~ 288 (468)
.+++||||+.++.+.... ......+++..++.++.||+.||.|||+ +||+||||||+|||++ ++ .+||+|||++.
T Consensus 103 ~~~iv~e~~~~~~L~~~l--~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~i~H~dlkp~NIl~~-~~-~~~l~Dfg~~~ 177 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVV--RDAKIVLDVNKTRQIAQEIVKGMGYLHA-KGILHKDLKSKNVFYD-NG-KVVITDFGLFS 177 (319)
T ss_dssp CEEEECBCCCSEEHHHHT--TSSCCCCCSHHHHHHHHHHHHHHHHHHH-TTCCCCCCCSTTEEEC----CCEECCCSCCC
T ss_pred ceEEEeecccCCcHHHHH--HhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCChhhEEEe-CC-CEEEeecCCcc
Confidence 488999999865443222 1223468899999999999999999998 8999999999999998 45 79999999986
Q ss_pred ccCC------CCCCccccccCCccccccccC--------CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH
Q 012233 289 MLVP------GEPNISYICSRYYRAPELIFG--------ATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIK 354 (468)
Q Consensus 289 ~~~~------~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~ 354 (468)
.... ........||+.|+|||++.+ ...++.++|||||||++|+|++|+.||...........+..
T Consensus 178 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~ 257 (319)
T 2y4i_B 178 ISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGT 257 (319)
T ss_dssp ----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHT
T ss_pred ccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcc
Confidence 5421 122234568999999999864 23478899999999999999999999988776655544432
Q ss_pred HhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCCCC
Q 012233 355 ILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNT 431 (468)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~ 431 (468)
... +. .....++.++.+||.+||..||.+|||+.++++ .|+.+.....
T Consensus 258 ~~~-------------------~~--------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~--~l~~l~~~~~ 305 (319)
T 2y4i_B 258 GMK-------------------PN--------LSQIGMGKEISDILLFCWAFEQEERPTFTKLMD--MLEKLPKRNR 305 (319)
T ss_dssp TCC-------------------CC--------CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH--HHTTC-----
T ss_pred CCC-------------------CC--------CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH--HHHHHHHhhc
Confidence 100 00 011247788999999999999999999999998 6776655443
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=332.17 Aligned_cols=253 Identities=20% Similarity=0.246 Sum_probs=191.8
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-chHHHHHHHHHH--cCCCCcccccceeeecCCCCceEEEEE
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-RYKNRELQIMRL--LNHPNVVSLKHCFFSTTEKDELYLNLV 213 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-~~~~~E~~il~~--l~hpnIv~l~~~~~~~~~~~~~~~~lv 213 (468)
.+|.+.+.||+|+||.||+|.+ +|+.||||++.... ....+|.++++. ++||||+++++++..... ....+|+|
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~-~~~~~~lv 118 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNG-TWTQLWLV 118 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCS-SCCCEEEE
T ss_pred ccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCC-ccceeEEE
Confidence 3699999999999999999998 68999999986543 344578888888 789999999998854431 22358899
Q ss_pred eecccc-hHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhH--------hcCCccccCCCCCCeeecCCCCcEEEeee
Q 012233 214 LEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH--------HVVGVCHRDIKPQNLLVNPHTHQLKICDF 284 (468)
Q Consensus 214 ~e~~~~-~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH--------~~~givHrDlkp~NILl~~~~~~vkL~DF 284 (468)
|||+.+ ++.+.+. ...+++..++.++.||+.||.||| + .||+||||||+||||+.++ .+||+||
T Consensus 119 ~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~-~~ivH~Dlkp~NIll~~~~-~~kL~Df 191 (342)
T 1b6c_B 119 SDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGK-PAIAHRDLKSKNILVKKNG-TCCIADL 191 (342)
T ss_dssp ECCCTTCBHHHHHH-----HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCB-CEEECSCCSGGGEEECTTS-CEEECCC
T ss_pred EeecCCCcHHHHHh-----ccCccHHHHHHHHHHHHHHHHHHHHHHhhhccc-CCeeeCCCCHHHEEECCCC-CEEEEEC
Confidence 999987 5555443 246899999999999999999999 7 8999999999999999888 7999999
Q ss_pred cCccccCCCC-----CCccccccCCccccccccCCCC-----CCcchhHHHHHHHHHHHHhC----------CCCCCCCC
Q 012233 285 GSAKMLVPGE-----PNISYICSRYYRAPELIFGATE-----YTTAIDMWSIGCVLAELLLG----------QPLFPGES 344 (468)
Q Consensus 285 G~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~-----~~~~~DvwSlG~il~ell~G----------~~pf~~~~ 344 (468)
|++....... ......||+.|+|||++.+... ++.++|||||||++|||++| ..||....
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~ 271 (342)
T 1b6c_B 192 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 271 (342)
T ss_dssp TTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccC
Confidence 9997664433 2245578999999999975432 23689999999999999999 78887643
Q ss_pred c----HHHHHHHHHHhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCC
Q 012233 345 G----VDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (468)
Q Consensus 345 ~----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~h 420 (468)
. .+.+...+.... ....++. ......+++.+.+||.+||+.||.+|||+.++++|
T Consensus 272 ~~~~~~~~~~~~~~~~~--------------~~~~~~~-------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 272 PSDPSVEEMRKVVCEQK--------------LRPNIPN-------RWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp CSSCCHHHHHHHHTTSC--------------CCCCCCG-------GGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred cCcccHHHHHHHHHHHH--------------hCCCCcc-------cccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 2 222222211000 0000000 00112345689999999999999999999999874
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=327.97 Aligned_cols=259 Identities=24% Similarity=0.380 Sum_probs=193.6
Q ss_pred cccceEEeceecccCceEEEEEEE----cCCCCEEEEEEeeccc----chHHHHHHHHHHcCCCCcccccceeeecCCCC
Q 012233 135 QTISYMAERVVGTGSFGVVFQAKC----LETGDSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD 206 (468)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~----~~~g~~vaiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 206 (468)
...+|.+.+.||+|+||.||+|.+ ..+|+.||||++.... ..+.+|+.+++.++||||+++++++....
T Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--- 115 (326)
T 2w1i_A 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG--- 115 (326)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-----
T ss_pred CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecC---
Confidence 345799999999999999999984 5689999999986542 24568999999999999999999874422
Q ss_pred ceEEEEEeecccc-hHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeec
Q 012233 207 ELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG 285 (468)
Q Consensus 207 ~~~~~lv~e~~~~-~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG 285 (468)
...+++||||+.+ ++.+.+.. ....+++..++.++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||
T Consensus 116 ~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dikp~NIli~~~~-~~kL~Dfg 190 (326)
T 2w1i_A 116 RRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEYLGT-KRYIHRDLATRNILVENEN-RVKIGDFG 190 (326)
T ss_dssp --CCEEEECCCTTCBHHHHHHH---STTSSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEEEETT-EEEECCCT
T ss_pred CCceEEEEECCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHh-CCEeccCCCcceEEEcCCC-cEEEecCc
Confidence 2347899999986 55544432 23568999999999999999999998 8999999999999999887 79999999
Q ss_pred CccccCCCCC----CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 012233 286 SAKMLVPGEP----NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTR 361 (468)
Q Consensus 286 ~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~ 361 (468)
++........ .....++..|+|||++.+.. ++.++|||||||++|+|++|..||.... .... +..+....
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~tg~~~~~~~~--~~~~---~~~~~~~~ 264 (326)
T 2w1i_A 191 LTKVLPQDKEYYKVKEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFTYIEKSKSPP--AEFM---RMIGNDKQ 264 (326)
T ss_dssp TCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHHTTCGGGSHH--HHHH---HHHCTTCC
T ss_pred chhhccccccccccccCCCCceeEECchhhcCCC-CCchhhHHHHHHHHHHHHhcCCCCCCCH--HHHH---Hhhccccc
Confidence 9987654332 22345677899999997654 8899999999999999999999986421 1111 11111100
Q ss_pred HH-----HhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 362 EE-----IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 362 ~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
.. +..... ..... ..+..+++++.+||.+||+.||.+|||+.++++
T Consensus 265 ~~~~~~~~~~~~~--~~~~~----------~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 265 GQMIVFHLIELLK--NNGRL----------PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp THHHHHHHHHHHH--TTCCC----------CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hhhhHHHHHHHhh--cCCCC----------CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00 000000 00000 123458899999999999999999999999875
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=351.10 Aligned_cols=246 Identities=26% Similarity=0.341 Sum_probs=195.5
Q ss_pred CcccceEEeceecccCceEEEEEEEcCC---CCEEEEEEeeccc-----chHHHHHHHHHHcCCCCcccccceeeecCCC
Q 012233 134 KQTISYMAERVVGTGSFGVVFQAKCLET---GDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEK 205 (468)
Q Consensus 134 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~---g~~vaiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 205 (468)
....+|.+.+.||+|+||.||+|.+..+ +..||+|.+.... ..+.+|+.+++.++||||+++++++.
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~----- 461 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT----- 461 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----
Confidence 3456799999999999999999998653 4579999875432 33457999999999999999999872
Q ss_pred CceEEEEEeecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeee
Q 012233 206 DELYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDF 284 (468)
Q Consensus 206 ~~~~~~lv~e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DF 284 (468)
+. .+|+||||+.++ +.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+||
T Consensus 462 ~~-~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDikp~NILl~~~~-~vkL~DF 535 (656)
T 2j0j_A 462 EN-PVWIIMELCTLGELRSFLQV---RKFSLDLASLILYAYQLSTALAYLES-KRFVHRDIAARNVLVSSND-CVKLGDF 535 (656)
T ss_dssp SS-SCEEEEECCTTCBHHHHHHH---TTTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEETT-EEEECCC
T ss_pred cC-ceEEEEEcCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccchHhEEEeCCC-CEEEEec
Confidence 11 267999999865 4443322 23468899999999999999999998 8999999999999999888 7999999
Q ss_pred cCccccCCCCC--CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCH
Q 012233 285 GSAKMLVPGEP--NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTR 361 (468)
Q Consensus 285 G~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~ 361 (468)
|+++....... .....+|+.|+|||++.+. .++.++|||||||++|||++ |..||.+....+.+..+......
T Consensus 536 G~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~--- 611 (656)
T 2j0j_A 536 GLSRYMEDSTYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL--- 611 (656)
T ss_dssp CCCCSCCC----------CCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCC---
T ss_pred CCCeecCCCcceeccCCCCCcceeCHHHhcCC-CCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC---
Confidence 99987643322 2234567899999999655 48999999999999999997 99999988877766665442100
Q ss_pred HHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 362 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
.++..+++.+.+||.+||+.||.+|||+.++++
T Consensus 612 -------------------------~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 612 -------------------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp -------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------------------CCCccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 123458899999999999999999999999875
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=354.02 Aligned_cols=241 Identities=24% Similarity=0.344 Sum_probs=195.1
Q ss_pred cceEEeceecccCceEEEEEEEcC-CCCEEEEEEeeccc-----chHHHHHHHHHHcCCCCcccccceeeecCCCCceEE
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLE-TGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~-~g~~vaiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~ 210 (468)
.+|.+.+.||+|+||.||+|.+.. +|+.||||++.... ..+.+|+.+++.++||||+++++++......+....
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 469999999999999999999976 78999999885432 234579999999999999999999877665555567
Q ss_pred EEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcccc
Q 012233 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (468)
Q Consensus 211 ~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~ 290 (468)
||||||+.++.+.... ...+++..++.++.||+.||.|||+ +|||||||||+||||+.+ .+||+|||+++..
T Consensus 160 ~lv~E~~~g~~L~~~~-----~~~l~~~~~~~~~~qi~~aL~~lH~-~giiHrDlkp~NIll~~~--~~kl~DFG~a~~~ 231 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSK-----GQKLPVAEAIAYLLEILPALSYLHS-IGLVYNDLKPENIMLTEE--QLKLIDLGAVSRI 231 (681)
T ss_dssp EEEEECCCCEECC---------CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECSS--CEEECCCTTCEET
T ss_pred EEEEEeCCCCcHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecccChHHeEEeCC--cEEEEecccchhc
Confidence 9999999976553221 2368999999999999999999998 899999999999999975 6999999999876
Q ss_pred CCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCC
Q 012233 291 VPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPN 370 (468)
Q Consensus 291 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 370 (468)
... ....||+.|+|||++.+. ++.++|||||||++|+|++|.+||.+....
T Consensus 232 ~~~---~~~~gt~~y~aPE~~~~~--~~~~sDi~slG~~l~~l~~g~~~~~~~~~~------------------------ 282 (681)
T 2pzi_A 232 NSF---GYLYGTPGFQAPEIVRTG--PTVATDIYTVGRTLAALTLDLPTRNGRYVD------------------------ 282 (681)
T ss_dssp TCC---SCCCCCTTTSCTTHHHHC--SCHHHHHHHHHHHHHHHHSCCCEETTEECS------------------------
T ss_pred ccC---CccCCCccccCHHHHcCC--CCCceehhhhHHHHHHHHhCCCCCcccccc------------------------
Confidence 433 456799999999998653 589999999999999999999988642100
Q ss_pred CccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q 012233 371 YTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDD 425 (468)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~ 425 (468)
..+. .. .....++.+.+||.+||+.||.+||+..+++.|+|+.-
T Consensus 283 ----~~~~--~~-----~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 283 ----GLPE--DD-----PVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp ----SCCT--TC-----HHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred ----cccc--cc-----cccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 0000 00 00124678999999999999999999999999988754
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=305.21 Aligned_cols=226 Identities=14% Similarity=0.050 Sum_probs=174.3
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-------chHHHHHHHHHHcCCCCcccccceeeecCCCCceE
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 209 (468)
++|.+.+.||+|+||.||+|.+..+|+.||||++.... ..+.+|+.+++.++||||+++++++.. ...
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-----~~~ 105 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHT-----RAG 105 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEE-----CCc
Confidence 35999999999999999999999999999999986542 345679999999999999999999843 345
Q ss_pred EEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccc
Q 012233 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (468)
Q Consensus 210 ~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~ 289 (468)
.|+||||+.|+.+..+.. .......+..++.||+.||.|||+ +||+||||||+||||+.++ .+||+++|.
T Consensus 106 ~~lv~e~~~g~~L~~~l~-----~~~~~~~~~~i~~ql~~aL~~lH~-~givH~Dikp~NIll~~~g-~~kl~~~~~--- 175 (286)
T 3uqc_A 106 GLVVAEWIRGGSLQEVAD-----TSPSPVGAIRAMQSLAAAADAAHR-AGVALSIDHPSRVRVSIDG-DVVLAYPAT--- 175 (286)
T ss_dssp EEEEEECCCEEEHHHHHT-----TCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEEETTS-CEEECSCCC---
T ss_pred EEEEEEecCCCCHHHHHh-----cCCChHHHHHHHHHHHHHHHHHHH-CCCccCCCCcccEEEcCCC-CEEEEeccc---
Confidence 899999998654433221 224556788899999999999998 8999999999999999888 799985542
Q ss_pred cCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 012233 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (468)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 369 (468)
++ .++.++|||||||++|+|++|+.||.+.+..+.+...
T Consensus 176 ----------------~~--------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~----------------- 214 (286)
T 3uqc_A 176 ----------------MP--------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA----------------- 214 (286)
T ss_dssp ----------------CT--------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC-----------------
T ss_pred ----------------cC--------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH-----------------
Confidence 22 2789999999999999999999999876532211000
Q ss_pred CCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q 012233 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426 (468)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 426 (468)
...- .........+...+++++.+||.+||+.||.+| |+.|+++ .++.+
T Consensus 215 ----~~~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~--~L~~~ 263 (286)
T 3uqc_A 215 ----ERDT-AGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLN--LMQQA 263 (286)
T ss_dssp ----CBCT-TSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHH--HHHHH
T ss_pred ----HHHh-ccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHH--HHHHH
Confidence 0000 000011122446789999999999999999999 9999987 45443
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-32 Score=288.56 Aligned_cols=181 Identities=14% Similarity=0.036 Sum_probs=123.4
Q ss_pred eecccCceEEEEEEEcCCCCEEEEEEeeccc--------------chHHHHHHHHHHc-CCCCcccccceeeecCCCCce
Q 012233 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQDK--------------RYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDEL 208 (468)
Q Consensus 144 ~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~--------------~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~~~ 208 (468)
.++.|++|.+..++....|+.||+|++.++. ..+.+|+++|+++ .|+||+++++++ ++..
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-----ed~~ 315 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHG-----ENAQ 315 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEE-----ECSS
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEE-----EECC
Confidence 4677788877777777789999999986541 2355799999999 699999999998 6666
Q ss_pred EEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcc
Q 012233 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (468)
Q Consensus 209 ~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~ 288 (468)
.+|||||||+|+.|..... ....++.. .|+.||+.||+|||+ +|||||||||+||||+.++ .+||+|||+|+
T Consensus 316 ~~yLVMEyv~G~~L~d~i~---~~~~l~~~---~I~~QIl~AL~ylH~-~GIIHRDIKPeNILL~~dg-~vKL~DFGlAr 387 (569)
T 4azs_A 316 SGWLVMEKLPGRLLSDMLA---AGEEIDRE---KILGSLLRSLAALEK-QGFWHDDVRPWNVMVDARQ-HARLIDFGSIV 387 (569)
T ss_dssp EEEEEEECCCSEEHHHHHH---TTCCCCHH---HHHHHHHHHHHHHHH-TTCEESCCCGGGEEECTTS-CEEECCCTTEE
T ss_pred EEEEEEecCCCCcHHHHHH---hCCCCCHH---HHHHHHHHHHHHHHH-CCceeccCchHhEEECCCC-CEEEeecccCe
Confidence 7999999999865543322 23456553 578999999999998 9999999999999999988 79999999998
Q ss_pred ccCCC-CCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCC
Q 012233 289 MLVPG-EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPL 339 (468)
Q Consensus 289 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~p 339 (468)
..... ....+.+||+.|||||++.+. +..++|+||+|+++++|.+|..+
T Consensus 388 ~~~~~~~~~~t~vGTp~YmAPE~l~g~--~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 388 TTPQDCSWPTNLVQSFFVFVNELFAEN--KSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp SCC---CCSHHHHHHHHHHHHHHC-------------------CCCCTTHHH
T ss_pred eCCCCCccccCceechhhccHHHhCCC--CCCcccccccccchhhhccccch
Confidence 76443 334567899999999999753 67889999999998887665433
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.7e-27 Score=246.40 Aligned_cols=179 Identities=18% Similarity=0.238 Sum_probs=132.8
Q ss_pred EEeceecccCceEEEEEEEcCCCCEEEEEEeeccc------------chHHHHHHHHHHcCCCCcccccceeeecCCCCc
Q 012233 140 MAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (468)
Q Consensus 140 ~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~------------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 207 (468)
...+.||+|+||.||+|.. .+..+++|+..... ..+.+|+++|++++||||+++..++....
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~---- 412 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLD---- 412 (540)
T ss_dssp ---------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETT----
T ss_pred CCCCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCC----
Confidence 4567899999999999954 68899999763321 12468999999999999996655544322
Q ss_pred eEEEEEeecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecC
Q 012233 208 LYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (468)
Q Consensus 208 ~~~~lv~e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~ 286 (468)
..||||||++++ +.+.+.. +..++.||+.||.|||+ +||+||||||+|||++. .+||+|||+
T Consensus 413 -~~~lVmE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~-~gIiHrDiKp~NILl~~---~~kL~DFGl 475 (540)
T 3en9_A 413 -NKRIMMSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHK-NDVIHNDLTTSNFIFDK---DLYIIDFGL 475 (540)
T ss_dssp -TTEEEEECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHH-TTEECTTCCTTSEEESS---SEEECCCTT
T ss_pred -ccEEEEECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHH-CcCccCCCCHHHEEECC---eEEEEECcc
Confidence 247999999854 4443322 45789999999999998 89999999999999997 699999999
Q ss_pred ccccCCCCC--------CccccccCCccccccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCC
Q 012233 287 AKMLVPGEP--------NISYICSRYYRAPELIFGA-TEYTTAIDMWSIGCVLAELLLGQPLFP 341 (468)
Q Consensus 287 a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwSlG~il~ell~G~~pf~ 341 (468)
++....... ....+||+.|||||++.+. ..|+..+|+|+..+-..+.+.++.+|.
T Consensus 476 a~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 476 GKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp CEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred CEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 987754322 1356899999999999641 237888999999999998888877663
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=3.7e-24 Score=205.54 Aligned_cols=139 Identities=17% Similarity=0.160 Sum_probs=110.4
Q ss_pred eEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc----------------------chHHHHHHHHHHcCCCCccccc
Q 012233 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK----------------------RYKNRELQIMRLLNHPNVVSLK 196 (468)
Q Consensus 139 y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~----------------------~~~~~E~~il~~l~hpnIv~l~ 196 (468)
|.+.+.||+|+||.||+|.+ .+|+.||||++.... ....+|+.+|+.++ | ++++
T Consensus 92 ~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~ 167 (282)
T 1zar_A 92 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVP 167 (282)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSC
T ss_pred EEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcC
Confidence 66779999999999999999 889999999985321 23458999999999 5 7777
Q ss_pred ceeeecCCCCceEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCC
Q 012233 197 HCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHT 276 (468)
Q Consensus 197 ~~~~~~~~~~~~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~ 276 (468)
+++.. ...|+||||++|+.+..+ .......++.||+.||.|||+ +||+||||||+||||+ ++
T Consensus 168 ~~~~~------~~~~lvmE~~~g~~L~~l----------~~~~~~~i~~qi~~~l~~lH~-~giiHrDlkp~NILl~-~~ 229 (282)
T 1zar_A 168 KVYAW------EGNAVLMELIDAKELYRV----------RVENPDEVLDMILEEVAKFYH-RGIVHGDLSQYNVLVS-EE 229 (282)
T ss_dssp CEEEE------ETTEEEEECCCCEEGGGC----------CCSCHHHHHHHHHHHHHHHHH-TTEECSCCSTTSEEEE-TT
T ss_pred eEEec------cceEEEEEecCCCcHHHc----------chhhHHHHHHHHHHHHHHHHH-CCCEeCCCCHHHEEEE-CC
Confidence 76522 235899999987644321 112245789999999999998 8999999999999999 76
Q ss_pred CcEEEeeecCccccCCCCCCccccccCCcccccccc
Q 012233 277 HQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIF 312 (468)
Q Consensus 277 ~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~ 312 (468)
.+||+|||+++. +..|+|||.+.
T Consensus 230 -~vkl~DFG~a~~------------~~~~~a~e~l~ 252 (282)
T 1zar_A 230 -GIWIIDFPQSVE------------VGEEGWREILE 252 (282)
T ss_dssp -EEEECCCTTCEE------------TTSTTHHHHHH
T ss_pred -cEEEEECCCCeE------------CCCCCHHHHHH
Confidence 799999999863 34578999874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=2.2e-20 Score=176.91 Aligned_cols=134 Identities=19% Similarity=0.251 Sum_probs=101.8
Q ss_pred eEEeceecccCceEEEEEEEcCCCCE--EEEEEeeccc----------------------------chHHHHHHHHHHcC
Q 012233 139 YMAERVVGTGSFGVVFQAKCLETGDS--VAIKKVLQDK----------------------------RYKNRELQIMRLLN 188 (468)
Q Consensus 139 y~~~~~lG~G~fg~Vy~~~~~~~g~~--vaiK~~~~~~----------------------------~~~~~E~~il~~l~ 188 (468)
|.+.+.||+|+||.||+|.+..+|+. ||||++.... ....+|+.+|+.+.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 88999999999999999998778999 9999864321 13467999999999
Q ss_pred CCCcccccceeeecCCCCceEEEEEeecccc------hHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhH-hcCCcc
Q 012233 189 HPNVVSLKHCFFSTTEKDELYLNLVLEYISE------TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH-HVVGVC 261 (468)
Q Consensus 189 hpnIv~l~~~~~~~~~~~~~~~~lv~e~~~~------~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH-~~~giv 261 (468)
|++|... ..+.. . ..+|||||+++ .+...... .++..+..++.||+.||.||| + .||+
T Consensus 129 ~~~i~~p-~~~~~-~-----~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~-~giv 193 (258)
T 1zth_A 129 EAGVSVP-QPYTY-M-----KNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQE-AELV 193 (258)
T ss_dssp HTTCCCC-CEEEE-E-----TTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHT-SCEE
T ss_pred hCCCCCC-eEEEc-C-----CCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHH-CCEE
Confidence 8865222 22211 1 25799999953 33332111 123457789999999999999 8 8999
Q ss_pred ccCCCCCCeeecCCCCcEEEeeecCcccc
Q 012233 262 HRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (468)
Q Consensus 262 HrDlkp~NILl~~~~~~vkL~DFG~a~~~ 290 (468)
||||||+|||++. .++|+|||+|...
T Consensus 194 HrDlkp~NILl~~---~~~liDFG~a~~~ 219 (258)
T 1zth_A 194 HADLSEYNIMYID---KVYFIDMGQAVTL 219 (258)
T ss_dssp CSSCSTTSEEESS---SEEECCCTTCEET
T ss_pred eCCCCHHHEEEcC---cEEEEECcccccC
Confidence 9999999999997 5999999999653
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.72 E-value=2.3e-18 Score=170.19 Aligned_cols=141 Identities=13% Similarity=0.102 Sum_probs=92.2
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeecccc------------------hHHHHHHHHHHcCCCCccccccee
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR------------------YKNRELQIMRLLNHPNVVSLKHCF 199 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~~------------------~~~~E~~il~~l~hpnIv~l~~~~ 199 (468)
-|.+...||.|+||.||+|.+ .+|+.||||++..... ....+..++....|+|+++++...
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 399999999999999999997 4699999998742210 001122222233344444443322
Q ss_pred eecCC-CCceEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCC-
Q 012233 200 FSTTE-KDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTH- 277 (468)
Q Consensus 200 ~~~~~-~~~~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~- 277 (468)
..... .+....+|||||++|..+..+ . .......++.||+.+|.|||+ .|||||||||.||||+.++.
T Consensus 175 v~vp~p~~~~~~~LVME~i~G~~L~~l---~------~~~~~~~l~~qll~~l~~lH~-~gIVHrDLKp~NILl~~dgd~ 244 (397)
T 4gyi_A 175 FPVPEPIAQSRHTIVMSLVDALPMRQV---S------SVPDPASLYADLIALILRLAK-HGLIHGDFNEFNILIREEKDA 244 (397)
T ss_dssp CSCCCEEEEETTEEEEECCSCEEGGGC---C------CCSCHHHHHHHHHHHHHHHHH-TTEECSCCSTTSEEEEEEECS
T ss_pred CCCCeeeeccCceEEEEecCCccHhhh---c------ccHHHHHHHHHHHHHHHHHHH-CCCcCCCCCHHHEEEeCCCCc
Confidence 11000 000012589999998644211 1 112346678999999999998 89999999999999987652
Q ss_pred --------cEEEeeecCccc
Q 012233 278 --------QLKICDFGSAKM 289 (468)
Q Consensus 278 --------~vkL~DFG~a~~ 289 (468)
.+.|+||+-+..
T Consensus 245 ~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 245 EDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp SCTTSEEEEEEECCCTTCEE
T ss_pred ccccccccceEEEEeCCccc
Confidence 288999998753
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.27 E-value=1.2e-11 Score=116.54 Aligned_cols=135 Identities=15% Similarity=0.145 Sum_probs=101.7
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeec----ccchHHHHHHHHHHcC-CCCcccccceeeecCCCCceEEEE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ----DKRYKNRELQIMRLLN-HPNVVSLKHCFFSTTEKDELYLNL 212 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~----~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~~~~~~l 212 (468)
.|.+...++.|+++.||++.. .+..+++|.... ......+|+.+++.+. +..+.++++++.. ....|+
T Consensus 15 ~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~-----~~~~~l 87 (263)
T 3tm0_A 15 KYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERH-----DGWSNL 87 (263)
T ss_dssp TSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE-----TTEEEE
T ss_pred cceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEec-----CCceEE
Confidence 588889999999999999975 478999998853 3445778999999995 5667788777632 335789
Q ss_pred EeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhc-----------------------------------
Q 012233 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV----------------------------------- 257 (468)
Q Consensus 213 v~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~----------------------------------- 257 (468)
||||++|..+... .. +......++.+++.+|..||+.
T Consensus 88 v~e~i~G~~l~~~--~~------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T 3tm0_A 88 LMSEADGVLCSEE--YE------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEECCSSEEHHHH--CC------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGS
T ss_pred EEEecCCeehhhc--cC------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccc
Confidence 9999998755422 10 1112346778999999999961
Q ss_pred -----------------------CCccccCCCCCCeeecCCCCcEEEeeecCcc
Q 012233 258 -----------------------VGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (468)
Q Consensus 258 -----------------------~givHrDlkp~NILl~~~~~~vkL~DFG~a~ 288 (468)
..++|+|++|.|||++.+. .+.|+||+.+.
T Consensus 160 ~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~-~~~lIDwe~a~ 212 (263)
T 3tm0_A 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGK-VSGFIDLGRSG 212 (263)
T ss_dssp TTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTE-EEEECCCTTCE
T ss_pred ccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCc-EEEEEEchhcc
Confidence 3489999999999998643 46799999874
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.13 E-value=1.5e-10 Score=108.52 Aligned_cols=132 Identities=17% Similarity=0.095 Sum_probs=91.5
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc-cchHHHHHHHHHHcCCCC--cccccceeeecCCCCceEEEEEe
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-KRYKNRELQIMRLLNHPN--VVSLKHCFFSTTEKDELYLNLVL 214 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~-~~~~~~E~~il~~l~hpn--Iv~l~~~~~~~~~~~~~~~~lv~ 214 (468)
.|.+..+.+.|..+.||++.. .+|..+++|+.... .....+|+.+++.+.+.+ +.+++.++.. ....++||
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~-----~~~~~~v~ 94 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTE-----AGRDWLLL 94 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEEC-----SSCEEEEE
T ss_pred CCceEecccCCCCceEEEEec-CCCCeEEEEeCCcccchhhhHHHHHHHHHHhCCCCCCeEEEeccC-----CCCCEEEE
Confidence 356655555667799999964 56778999987543 244678999999996544 4456665522 22378999
Q ss_pred ecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCC-----------------------------------
Q 012233 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG----------------------------------- 259 (468)
Q Consensus 215 e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~g----------------------------------- 259 (468)
||++|..+. . . ... ...++.+++..|..||. ..
T Consensus 95 e~i~G~~l~-~---~----~~~---~~~~~~~l~~~l~~lh~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (264)
T 1nd4_A 95 GEVPGQDLL-S---S----HLA---PAEKVSIMADAMRRLHT-LDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEH 162 (264)
T ss_dssp ECCSSEETT-T---S----CCC---HHHHHHHHHHHHHHHTT-SCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGG
T ss_pred EecCCcccC-c---C----cCC---HhHHHHHHHHHHHHHhC-CCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhc
Confidence 999986442 1 0 011 22456677777888875 32
Q ss_pred -----------------------ccccCCCCCCeeecCCCCcEEEeeecCcc
Q 012233 260 -----------------------VCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (468)
Q Consensus 260 -----------------------ivHrDlkp~NILl~~~~~~vkL~DFG~a~ 288 (468)
++|+|++|.|||++.++ .+.|+|||.+.
T Consensus 163 ~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~-~~~liD~~~a~ 213 (264)
T 1nd4_A 163 QGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGR-FSGFIDCGRLG 213 (264)
T ss_dssp TTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTE-EEEECCCTTCE
T ss_pred cCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCc-EEEEEcchhcc
Confidence 99999999999998654 46699999874
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.06 E-value=3.3e-10 Score=111.92 Aligned_cols=140 Identities=15% Similarity=0.166 Sum_probs=99.6
Q ss_pred eceecccCceEEEEEEEcCCCCEEEEEEee--c-----ccchHHHHHHHHHHcCC--CCcccccceeeecCCCCceEEEE
Q 012233 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVL--Q-----DKRYKNRELQIMRLLNH--PNVVSLKHCFFSTTEKDELYLNL 212 (468)
Q Consensus 142 ~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~--~-----~~~~~~~E~~il~~l~h--pnIv~l~~~~~~~~~~~~~~~~l 212 (468)
.+.|+.|.++.||++.. .+..+++|+.. . ......+|+.+++.|.. ..+.+++.++.... .....|+
T Consensus 43 ~~~l~~G~sn~~y~v~~--~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~--~~g~~~~ 118 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVT--PGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDES--VIGRAFY 118 (359)
T ss_dssp EEECCC-CCSCEEEEEC--SSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTT--TTSSCEE
T ss_pred EEEcCCcccceEEEEEE--CCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCC--ccCCeEE
Confidence 45689999999999875 45688888765 2 23456789999999984 45677766552221 1123578
Q ss_pred EeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhc-----------------------------------
Q 012233 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV----------------------------------- 257 (468)
Q Consensus 213 v~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~----------------------------------- 257 (468)
||||++|..+.. ..-..++......++.+++..|..||..
T Consensus 119 vme~v~G~~l~~-----~~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (359)
T 3dxp_A 119 IMEFVSGRVLWD-----QSLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETES 193 (359)
T ss_dssp EEECCCCBCCCC-----TTCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSC
T ss_pred EEEecCCeecCC-----CccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcC
Confidence 999999864321 1123466777888899999999999961
Q ss_pred ----------------------CCccccCCCCCCeeecCCCC-cEEEeeecCcccc
Q 012233 258 ----------------------VGVCHRDIKPQNLLVNPHTH-QLKICDFGSAKML 290 (468)
Q Consensus 258 ----------------------~givHrDlkp~NILl~~~~~-~vkL~DFG~a~~~ 290 (468)
.+++|+|+++.|||++.++. .+.|+||+.+...
T Consensus 194 ~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 194 IPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp CHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred ChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 46999999999999987652 3689999998653
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.91 E-value=9.1e-10 Score=106.17 Aligned_cols=185 Identities=15% Similarity=0.184 Sum_probs=111.0
Q ss_pred ceecccCceEEEEEEEcCCCCEEEEEEeecc--cchHHHHHHHHHHcCCCCcccccceeeecCC-CCceEEEEEeecccc
Q 012233 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQD--KRYKNRELQIMRLLNHPNVVSLKHCFFSTTE-KDELYLNLVLEYISE 219 (468)
Q Consensus 143 ~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~--~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~-~~~~~~~lv~e~~~~ 219 (468)
+.++.|....||++. ..+++|+.... .....+|..+|+.+.+..-+.+-..+..... ......|+||++++|
T Consensus 26 ~~~~~G~~n~v~~v~-----~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G 100 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN-----RDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKG 100 (304)
T ss_dssp CEEEECSSEEEEEST-----TSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCC
T ss_pred EecCCCCcceEEEEC-----CEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCC
Confidence 458999999999863 46888976543 2446689999998853222222222222111 111234789999998
Q ss_pred hHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhc------------------------------------------
Q 012233 220 TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV------------------------------------------ 257 (468)
Q Consensus 220 ~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~------------------------------------------ 257 (468)
..+.... ...++......++.|++..|..||..
T Consensus 101 ~~l~~~~-----~~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 175 (304)
T 3sg8_A 101 VPLTPLL-----LNNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDD 175 (304)
T ss_dssp EECCHHH-----HHTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHH
T ss_pred eECCccc-----cccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHH
Confidence 5432111 02345555666667777777776630
Q ss_pred ---------------CCccccCCCCCCeeecCC-CCcEEEeeecCccccCCCCCCccccccCCc---ccccccc----CC
Q 012233 258 ---------------VGVCHRDIKPQNLLVNPH-THQLKICDFGSAKMLVPGEPNISYICSRYY---RAPELIF----GA 314 (468)
Q Consensus 258 ---------------~givHrDlkp~NILl~~~-~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y---~aPE~~~----~~ 314 (468)
..++|+|++|.||+++.+ +..+.|+||+.+....+.. .......+ ..|+... ..
T Consensus 176 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~---Dl~~~~~~~~~~~~~~~~~~l~~Y 252 (304)
T 3sg8_A 176 FYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN---DFISLMEDDEEYGMEFVSKILNHY 252 (304)
T ss_dssp HHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH---HHHTTCCTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH---HHHHHHhhccccCHHHHHHHHHHc
Confidence 247999999999999974 3357899999986542211 11111111 2222210 00
Q ss_pred CC---------CCcchhHHHHHHHHHHHHhCCCCC
Q 012233 315 TE---------YTTAIDMWSIGCVLAELLLGQPLF 340 (468)
Q Consensus 315 ~~---------~~~~~DvwSlG~il~ell~G~~pf 340 (468)
.. .....+.|+++.++|.+.+|..+|
T Consensus 253 ~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 253 KHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp TCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 00 112368999999999999998776
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.42 E-value=1.7e-06 Score=83.21 Aligned_cols=134 Identities=16% Similarity=0.128 Sum_probs=80.1
Q ss_pred ceecccCceEEEEEEEcCCCCEEEEEEeecc--cchHHHHHHHHHHcCCCC---cccccceeeecCCCCceEEEEEeecc
Q 012233 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQD--KRYKNRELQIMRLLNHPN---VVSLKHCFFSTTEKDELYLNLVLEYI 217 (468)
Q Consensus 143 ~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~--~~~~~~E~~il~~l~hpn---Iv~l~~~~~~~~~~~~~~~~lv~e~~ 217 (468)
+.++.|....||+. |..+++|+-... .....+|..+|+.|.+.. +.+++.+.. . .....|+||||+
T Consensus 25 ~~l~~G~~n~v~~v-----g~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~--~--~~g~~~~v~e~i 95 (306)
T 3tdw_A 25 ESLGEGFRNYAILV-----NGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGK--R--SDGNPFVGYRKV 95 (306)
T ss_dssp EEEEECSSEEEEEE-----TTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEE--C--TTSCEEEEEECC
T ss_pred eecCCCcceeEEEE-----CCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecc--c--CCCceEEEEecc
Confidence 35788888899987 567888875332 234568999999997532 333433332 1 122356999999
Q ss_pred cchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHh-----------------------------------------
Q 012233 218 SETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH----------------------------------------- 256 (468)
Q Consensus 218 ~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~----------------------------------------- 256 (468)
+|..+..... ..++......++.|+...|..||+
T Consensus 96 ~G~~l~~~~~-----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~ 170 (306)
T 3tdw_A 96 QGQILGEDGM-----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRD 170 (306)
T ss_dssp CSEECHHHHH-----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHH
T ss_pred CCeECchhhh-----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHH
Confidence 9854322100 111222222233333333333332
Q ss_pred ------------------cCCccccCCCCCCeeecC---CCCcEEEeeecCcccc
Q 012233 257 ------------------VVGVCHRDIKPQNLLVNP---HTHQLKICDFGSAKML 290 (468)
Q Consensus 257 ------------------~~givHrDlkp~NILl~~---~~~~vkL~DFG~a~~~ 290 (468)
...++|+|++|.|||++. ++..+.|+||+.+...
T Consensus 171 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 171 YLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 135699999999999987 3434589999988654
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.18 E-value=9.2e-06 Score=76.26 Aligned_cols=131 Identities=15% Similarity=0.058 Sum_probs=80.6
Q ss_pred ecccCce-EEEEEEEcCCCCEEEEEEeecc-cchHHHHHHHHHHcCC-CCcccccceeeecCCCCceEEEEEeecccchH
Q 012233 145 VGTGSFG-VVFQAKCLETGDSVAIKKVLQD-KRYKNRELQIMRLLNH-PNVVSLKHCFFSTTEKDELYLNLVLEYISETV 221 (468)
Q Consensus 145 lG~G~fg-~Vy~~~~~~~g~~vaiK~~~~~-~~~~~~E~~il~~l~h-pnIv~l~~~~~~~~~~~~~~~~lv~e~~~~~l 221 (468)
+..|..| .||+......+..+.+|+-... .....+|..+|+.|.. --+.+++.++.. ....|+|||+++|..
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~-----~~~~~lvme~l~G~~ 106 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFIRT-----PDDAWLLTTAIPGKT 106 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETHHHHHHHHHHHHHHHHTTTSCCCCEEEEEEE-----TTEEEEEEECCCSEE
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCCCHhHHHHHHHHHHHhccCCCcCeEEEEEEE-----CCeEEEEEEeeCCcc
Confidence 3344444 6898887667788999976543 2345679999998852 224455554422 234689999998754
Q ss_pred HHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHh---------------------------------------------
Q 012233 222 YRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH--------------------------------------------- 256 (468)
Q Consensus 222 l~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~--------------------------------------------- 256 (468)
+....... ......+..++...|.-||.
T Consensus 107 ~~~~~~~~-------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (272)
T 4gkh_A 107 AFQVLEEY-------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV 179 (272)
T ss_dssp HHHHHHHC-------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred ccccccCC-------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence 33211100 01122233444444444442
Q ss_pred ------------cCCccccCCCCCCeeecCCCCcEEEeeecCcc
Q 012233 257 ------------VVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (468)
Q Consensus 257 ------------~~givHrDlkp~NILl~~~~~~vkL~DFG~a~ 288 (468)
...++|+|+.+.|||++.++ .+-|+||+.+.
T Consensus 180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~-~~~viDwe~a~ 222 (272)
T 4gkh_A 180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGK-LIGCIDVGRVG 222 (272)
T ss_dssp HHHHHTTCCCCCCEEEECSCCCTTSEEEETTE-EEEECCCTTCE
T ss_pred HHHHHhcccccCCcEEEcCCCCCCeEEEECCe-EEEEEECcccc
Confidence 01278999999999999765 56799999875
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.13 E-value=1.9e-05 Score=76.55 Aligned_cols=72 Identities=17% Similarity=0.273 Sum_probs=40.4
Q ss_pred eecccCceEEEEEEEcCCCCEEEEEEeecccchHHHHHHHHHHcCC--CCccccccee----eecCCCCceEEEEEeecc
Q 012233 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNH--PNVVSLKHCF----FSTTEKDELYLNLVLEYI 217 (468)
Q Consensus 144 ~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~~~~~~E~~il~~l~h--pnIv~l~~~~----~~~~~~~~~~~~lv~e~~ 217 (468)
.|+.|..+.||++.. .+..+++|+..........|..+++.|.. -.+.+++... +. ......++||+|+
T Consensus 39 ~l~gG~~n~~~~v~~--~~~~~vlk~~~~~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~---~~~~~~~~l~~~i 113 (346)
T 2q83_A 39 VIQGNQMALVWKVHT--DSGAVCLKRIHRPEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYS---KHGSFLFVVYDWI 113 (346)
T ss_dssp ECC----CEEEEEEE--TTEEEEEEEECSCHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCE---EETTEEEEEEECC
T ss_pred eccccccCcEEEEEe--CCCCEEEEecCCCHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEE---EECCEEEEEEEee
Confidence 466677889999875 34468999887654444556777776642 1233333210 00 0122467999999
Q ss_pred cch
Q 012233 218 SET 220 (468)
Q Consensus 218 ~~~ 220 (468)
+|.
T Consensus 114 ~G~ 116 (346)
T 2q83_A 114 EGR 116 (346)
T ss_dssp CCB
T ss_pred cCc
Confidence 873
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.05 E-value=2.6e-05 Score=77.68 Aligned_cols=71 Identities=18% Similarity=0.202 Sum_probs=44.5
Q ss_pred eceecccCceEEEEEEEcCCCCEEEEEEeecc-----------cchHHHHHHHHHHcCC--CCcc-cccceeeecCCCCc
Q 012233 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----------KRYKNRELQIMRLLNH--PNVV-SLKHCFFSTTEKDE 207 (468)
Q Consensus 142 ~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~-----------~~~~~~E~~il~~l~h--pnIv-~l~~~~~~~~~~~~ 207 (468)
.+.||.|.++.||++....++..++||..... ......|.++|+.+.. +.++ +++.+ . .+.
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d---~~~ 109 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--D---TEM 109 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--E---TTT
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--c---CCc
Confidence 35789999999999976556788999975321 1223568999988743 3333 44332 1 111
Q ss_pred eEEEEEeecccc
Q 012233 208 LYLNLVLEYISE 219 (468)
Q Consensus 208 ~~~~lv~e~~~~ 219 (468)
.++||||+++
T Consensus 110 --~~lvmE~l~g 119 (397)
T 2olc_A 110 --AVTVMEDLSH 119 (397)
T ss_dssp --TEEEECCCTT
T ss_pred --cEEEEEeCCC
Confidence 3689999976
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.05 E-value=6.2e-06 Score=80.90 Aligned_cols=78 Identities=10% Similarity=0.099 Sum_probs=49.5
Q ss_pred Eecee-cccCceEEEEEEEc--C----CCCEEEEEEeeccc-------chHHHHHHHHHHcCC---CCcccccceeeecC
Q 012233 141 AERVV-GTGSFGVVFQAKCL--E----TGDSVAIKKVLQDK-------RYKNRELQIMRLLNH---PNVVSLKHCFFSTT 203 (468)
Q Consensus 141 ~~~~l-G~G~fg~Vy~~~~~--~----~g~~vaiK~~~~~~-------~~~~~E~~il~~l~h---pnIv~l~~~~~~~~ 203 (468)
..+.| +.|....+|+.... . ++..+++|...... ....+|+.+++.|.. -.+.+++.+.....
T Consensus 24 ~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~ 103 (357)
T 3ats_A 24 VESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGD 103 (357)
T ss_dssp EEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSST
T ss_pred EEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCC
Confidence 34567 88888999988752 0 15678899765432 456789999988853 24555655442111
Q ss_pred CCCceEEEEEeecccch
Q 012233 204 EKDELYLNLVLEYISET 220 (468)
Q Consensus 204 ~~~~~~~~lv~e~~~~~ 220 (468)
.....|+||||++|.
T Consensus 104 --~~g~~~~v~e~l~G~ 118 (357)
T 3ats_A 104 --VLGTPFFLMDYVEGV 118 (357)
T ss_dssp --TTSSCEEEEECCCCB
T ss_pred --ccCCceEEEEecCCC
Confidence 012346899999863
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.36 E-value=0.0011 Score=62.79 Aligned_cols=74 Identities=14% Similarity=0.098 Sum_probs=49.5
Q ss_pred eEEeceecccCceEEEEEEEcCCCCEEEEEEeecc----cchHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEEEe
Q 012233 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (468)
Q Consensus 139 y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~----~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv~ 214 (468)
..-.+.+|.|..+.||+... .+|+.|.+|+.... ...+..|...|+.|..-.-|.+-.++.... -++||
T Consensus 17 v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~~------~~lv~ 89 (288)
T 3f7w_A 17 VAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWDD------RTLAM 89 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEET------TEEEE
T ss_pred eEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEeccC------ceEEE
Confidence 44567799999999999984 57899999976433 235678999999986332222222222111 25799
Q ss_pred ecccc
Q 012233 215 EYISE 219 (468)
Q Consensus 215 e~~~~ 219 (468)
||+.+
T Consensus 90 e~l~~ 94 (288)
T 3f7w_A 90 EWVDE 94 (288)
T ss_dssp ECCCC
T ss_pred Eeecc
Confidence 99864
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.27 E-value=0.0011 Score=63.06 Aligned_cols=65 Identities=17% Similarity=0.116 Sum_probs=41.2
Q ss_pred eceecccCceEEEEEEEcCCCCEEEEEEeeccc---chHHHHHHHHHHcCCCCcc-cccceeeecCCCCceEEEEEeecc
Q 012233 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLLNHPNVV-SLKHCFFSTTEKDELYLNLVLEYI 217 (468)
Q Consensus 142 ~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~---~~~~~E~~il~~l~hpnIv-~l~~~~~~~~~~~~~~~~lv~e~~ 217 (468)
.+.|+.|....+|++ ..+++|+..... ....+|+.+++.+....+. +++... .+. -++|+||+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~-----~~~--~~~v~e~i 89 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVD-----PAT--GVMVTRYI 89 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEEC-----TTT--CCEEEECC
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEE-----CCC--CEEEEeec
Confidence 467888999999998 558888775421 2346788888887533333 443322 111 24799999
Q ss_pred -cc
Q 012233 218 -SE 219 (468)
Q Consensus 218 -~~ 219 (468)
+|
T Consensus 90 ~~g 92 (301)
T 3dxq_A 90 AGA 92 (301)
T ss_dssp TTC
T ss_pred CCC
Confidence 65
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.25 E-value=0.0021 Score=61.65 Aligned_cols=143 Identities=14% Similarity=0.071 Sum_probs=74.8
Q ss_pred eceecccCceEEEEEEEcCCCCEEEEEEeec--ccchHHHHHHHHHHcCCCC--cccccceeeecCC--CCceEEEEEee
Q 012233 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ--DKRYKNRELQIMRLLNHPN--VVSLKHCFFSTTE--KDELYLNLVLE 215 (468)
Q Consensus 142 ~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~--~~~~~~~E~~il~~l~hpn--Iv~l~~~~~~~~~--~~~~~~~lv~e 215 (468)
.+.|+.|....||+... ++..+++|.... .......|+.+++.|.... +.+++... .+.. ......+++|+
T Consensus 27 ~~~i~~G~~n~~~~v~~--~~g~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~-~g~~~~~~~g~~~~l~~ 103 (322)
T 2ppq_A 27 YKGIAEGVENSNFLLHT--TKDPLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPRK-DGELLGELSGRPAALIS 103 (322)
T ss_dssp EEEECC---EEEEEEEE--SSCCEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCBT-TCCSCEEETTEEEEEEE
T ss_pred eeccCCCcccceEEEEe--CCccEEEEEeCCCCCHHHHHHHHHHHHHHHHCCCCCCcccCCC-CCCEEEEECCEEEEEEE
Confidence 35678888899999875 334688998765 3445667888888775322 23333210 0000 00123578999
Q ss_pred cccchHH--------H--------HHhhhhhcCCC----CCHHHHHHH---------------HHHHHHHHHHhHh----
Q 012233 216 YISETVY--------R--------VSKHYTRMNQH----VPILYVQLY---------------TYQICRALNYLHH---- 256 (468)
Q Consensus 216 ~~~~~ll--------~--------~~~~~~~~~~~----~~~~~~~~~---------------~~qi~~aL~yLH~---- 256 (468)
|++|..+ . +.......... ......... ...+...+.+|..
T Consensus 104 ~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~ 183 (322)
T 2ppq_A 104 FLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPK 183 (322)
T ss_dssp CCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCC
T ss_pred eCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcc
Confidence 9986311 0 10000000000 111100000 0113344555542
Q ss_pred --cCCccccCCCCCCeeecCCCCcEEEeeecCcc
Q 012233 257 --VVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (468)
Q Consensus 257 --~~givHrDlkp~NILl~~~~~~vkL~DFG~a~ 288 (468)
..+++|+|+.+.|||++.++ .+.|+||+.+.
T Consensus 184 ~~~~~liHgDl~~~Nil~~~~~-~~~lIDf~~a~ 216 (322)
T 2ppq_A 184 DLPAGVIHADLFQDNVFFLGDE-LSGLIDFYFAC 216 (322)
T ss_dssp SSCEEEECSCCCGGGEEEETTE-EEEECCCTTCE
T ss_pred cCCcccCCCCCCccCEEEeCCc-eEEEecchhcc
Confidence 14799999999999998664 45799999875
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.24 E-value=0.00059 Score=68.38 Aligned_cols=77 Identities=10% Similarity=-0.060 Sum_probs=47.1
Q ss_pred CCccccCCCCCCeeecCCCCcEEEeeecCccccCCCCCCccccc--cCCccccccccCCCC--CCcchhHHHHHHHHHHH
Q 012233 258 VGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC--SRYYRAPELIFGATE--YTTAIDMWSIGCVLAEL 333 (468)
Q Consensus 258 ~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~--~~~~~DvwSlG~il~el 333 (468)
..++|+|++|.|||++.++ ++|+||+.+....+......... ...|++|+....... .....++..+...+|+.
T Consensus 232 ~~liHGDl~~~Nil~~~~~--~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS--TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp CEEECSCCSGGGEEECSSC--EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC--CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 6899999999999998664 99999999865432211111111 234666665431110 11234455777777777
Q ss_pred HhC
Q 012233 334 LLG 336 (468)
Q Consensus 334 l~G 336 (468)
+.+
T Consensus 310 y~~ 312 (420)
T 2pyw_A 310 FNK 312 (420)
T ss_dssp HHH
T ss_pred HHH
Confidence 764
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.18 E-value=0.0081 Score=53.77 Aligned_cols=98 Identities=15% Similarity=0.106 Sum_probs=60.4
Q ss_pred hHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCCCCCCccc
Q 012233 220 TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISY 299 (468)
Q Consensus 220 ~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~~~~~~~~ 299 (468)
+|.+++..+ +.++++.++|.+++|.+.+|.-+-....-..+=+.|..|+|..+| .|-+.+ +.+ .
T Consensus 34 SL~eIL~~~---~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG-~V~f~~-~~s-----------~ 97 (229)
T 2yle_A 34 SLEEILRLY---NQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDG-AVTLAP-AAD-----------D 97 (229)
T ss_dssp EHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTS-CEEECC-C--------------
T ss_pred cHHHHHHHc---CCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCC-ceeccc-ccc-----------c
Confidence 344444443 688999999999999999987762101112233357889999888 565543 111 0
Q ss_pred cccCCccccccccCCCCCCcchhHHHHHHHHHHHHh
Q 012233 300 ICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL 335 (468)
Q Consensus 300 ~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~ 335 (468)
.....+.|||... ...+.+.=|||||+++|..+-
T Consensus 98 ~~~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 AGEPPPVAGKLGY--SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp ---------CCSS--SSSCHHHHHHHHHHHHHHHHT
T ss_pred ccccCCCChhhcc--ccchHHHHHHHHHHHHHHHhh
Confidence 1233567888763 336788999999999999985
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.06 E-value=0.0054 Score=62.02 Aligned_cols=69 Identities=14% Similarity=0.236 Sum_probs=45.3
Q ss_pred eceecccCceEEEEEEEcCCCCEEEEEEeeccc---chHHHHHHHHHHcCCCCc-ccccceeeecCCCCceEEEEEeecc
Q 012233 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLLNHPNV-VSLKHCFFSTTEKDELYLNLVLEYI 217 (468)
Q Consensus 142 ~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~---~~~~~E~~il~~l~hpnI-v~l~~~~~~~~~~~~~~~~lv~e~~ 217 (468)
.+.|+.|-...+|++.....+..+++|+..... ....+|..+++.|...++ .++++++ .+ .+||||+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~-----~~----G~v~e~I 183 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFF-----TN----GRIEEFM 183 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEE-----TT----EEEEECC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEe-----CC----eEEEEee
Confidence 356888888999999874435788899774322 223689999999976555 4555544 21 2499998
Q ss_pred cc
Q 012233 218 SE 219 (468)
Q Consensus 218 ~~ 219 (468)
+|
T Consensus 184 ~G 185 (458)
T 2qg7_A 184 DG 185 (458)
T ss_dssp CS
T ss_pred CC
Confidence 75
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.05 E-value=0.0041 Score=62.46 Aligned_cols=68 Identities=19% Similarity=0.257 Sum_probs=45.9
Q ss_pred ceecccCceEEEEEEEcC-------CCCEEEEEEeec-cc-chHHHHHHHHHHcCCCCc-ccccceeeecCCCCceEEEE
Q 012233 143 RVVGTGSFGVVFQAKCLE-------TGDSVAIKKVLQ-DK-RYKNRELQIMRLLNHPNV-VSLKHCFFSTTEKDELYLNL 212 (468)
Q Consensus 143 ~~lG~G~fg~Vy~~~~~~-------~g~~vaiK~~~~-~~-~~~~~E~~il~~l~hpnI-v~l~~~~~~~~~~~~~~~~l 212 (468)
+.|+.|....||++.... .+..+++|+... .. ....+|..+++.|...++ .++++.+ .+ .+
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~~~~li~E~~~l~~L~~~g~~P~l~~~~-----~~----g~ 149 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIF-----SG----GR 149 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEE-----TT----EE
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCcHHHHHHHHHHHHHHHhCCCCCcEEEEe-----CC----CE
Confidence 467888889999998642 257899998744 22 344479999888864444 4555543 22 27
Q ss_pred Eeecccc
Q 012233 213 VLEYISE 219 (468)
Q Consensus 213 v~e~~~~ 219 (468)
|+||++|
T Consensus 150 v~e~l~G 156 (429)
T 1nw1_A 150 LEEYIPS 156 (429)
T ss_dssp EECCCCE
T ss_pred EEEEeCC
Confidence 8999875
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=96.96 E-value=0.0024 Score=61.16 Aligned_cols=72 Identities=15% Similarity=0.083 Sum_probs=51.4
Q ss_pred eceecccCceEEEEEEEcCCCCEEEEEEeecc-cchHHHHHHHHHHcCC---CCcccccceeeecCCCCceEEEEEeecc
Q 012233 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-KRYKNRELQIMRLLNH---PNVVSLKHCFFSTTEKDELYLNLVLEYI 217 (468)
Q Consensus 142 ~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~-~~~~~~E~~il~~l~h---pnIv~l~~~~~~~~~~~~~~~~lv~e~~ 217 (468)
.+.|+.|.+..+|+... ++..+++|+.... ...+..|...|+.|.. ..+.+++.+.. .....++||||+
T Consensus 41 ~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~-----~~g~~~lvme~l 113 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND--EVQTVFVKINERSYRSMFRAEADQLALLAKTNSINVPLVYGIGN-----SQGHSFLLLEAL 113 (312)
T ss_dssp EEEECCSSSSEEEEEES--SSCEEEEEEEEGGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEE-----CSSEEEEEEECC
T ss_pred eEEeCCccceeeeEEEE--CCCeEEEEeCCcccHHHHHHHHHHHHHHHhhCCCCcceEEEEee-----cCCceEEEEEec
Confidence 35689999999999874 5778889987543 3446789999988852 45666666542 223478999999
Q ss_pred cch
Q 012233 218 SET 220 (468)
Q Consensus 218 ~~~ 220 (468)
++.
T Consensus 114 ~G~ 116 (312)
T 3jr1_A 114 NKS 116 (312)
T ss_dssp CCC
T ss_pred cCC
Confidence 863
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.85 E-value=0.0036 Score=60.33 Aligned_cols=32 Identities=38% Similarity=0.549 Sum_probs=27.3
Q ss_pred CCccccCCCCCCeeecCC----CCcEEEeeecCcccc
Q 012233 258 VGVCHRDIKPQNLLVNPH----THQLKICDFGSAKML 290 (468)
Q Consensus 258 ~givHrDlkp~NILl~~~----~~~vkL~DFG~a~~~ 290 (468)
..++|+|+.+.|||++.+ + .+.|+||+.+...
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~-~~~lIDf~~a~~G 218 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLA-RVGVIDFQDAKLG 218 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGG-GEEECCCTTCEEE
T ss_pred CeeEeCCcCcccEEeccCcCCCC-CeEEEeCCCcCcC
Confidence 579999999999999864 4 6899999998654
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.83 E-value=0.0021 Score=63.08 Aligned_cols=68 Identities=12% Similarity=0.157 Sum_probs=41.0
Q ss_pred ceecccCceEEEEEEEcC--------CCCEEEEEEeecccc---hHHHHHHHHHHcCCCCc-ccccceeeecCCCCceEE
Q 012233 143 RVVGTGSFGVVFQAKCLE--------TGDSVAIKKVLQDKR---YKNRELQIMRLLNHPNV-VSLKHCFFSTTEKDELYL 210 (468)
Q Consensus 143 ~~lG~G~fg~Vy~~~~~~--------~g~~vaiK~~~~~~~---~~~~E~~il~~l~hpnI-v~l~~~~~~~~~~~~~~~ 210 (468)
+.|+.|....+|++.... .+..+++|+...... ....|..+++.|...++ .++++.+ . -
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~-----~----~ 109 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF-----N----G 109 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE-----T----T
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec-----C----C
Confidence 457788888999988632 126888997654322 24678999888864443 3555433 1 1
Q ss_pred EEEeecccc
Q 012233 211 NLVLEYISE 219 (468)
Q Consensus 211 ~lv~e~~~~ 219 (468)
++||||++|
T Consensus 110 ~~v~e~i~G 118 (369)
T 3c5i_A 110 GRIEEWLYG 118 (369)
T ss_dssp EEEEECCCS
T ss_pred cEEEEEecC
Confidence 478999876
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.78 E-value=0.0058 Score=60.16 Aligned_cols=137 Identities=18% Similarity=0.250 Sum_probs=75.6
Q ss_pred eecccCceEEEEEEEcC-------CCCEEEEEEeec---ccchHHHHHHHHHHcCCCCc-ccccceeeecCCCCceEEEE
Q 012233 144 VVGTGSFGVVFQAKCLE-------TGDSVAIKKVLQ---DKRYKNRELQIMRLLNHPNV-VSLKHCFFSTTEKDELYLNL 212 (468)
Q Consensus 144 ~lG~G~fg~Vy~~~~~~-------~g~~vaiK~~~~---~~~~~~~E~~il~~l~hpnI-v~l~~~~~~~~~~~~~~~~l 212 (468)
.|..|-...+|++.... ++..+.+|+... ......+|..+++.|..-++ .++++++ .+ .+
T Consensus 57 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~-----~~----g~ 127 (379)
T 3feg_A 57 PVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVF-----PE----GR 127 (379)
T ss_dssp EC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEE-----TT----EE
T ss_pred EcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEc-----CC----cc
Confidence 46667777888887532 357888997633 22344579999988853333 4455443 22 27
Q ss_pred EeecccchHHH------------HH---h--hhh--hcCCCCC--HHHHHHHHHHHHH-------------------HHH
Q 012233 213 VLEYISETVYR------------VS---K--HYT--RMNQHVP--ILYVQLYTYQICR-------------------ALN 252 (468)
Q Consensus 213 v~e~~~~~ll~------------~~---~--~~~--~~~~~~~--~~~~~~~~~qi~~-------------------aL~ 252 (468)
||||++|..+. +. . |.. ....... +..+..+..++-. .+.
T Consensus 128 v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 207 (379)
T 3feg_A 128 LEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMG 207 (379)
T ss_dssp EEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHH
T ss_pred EEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHH
Confidence 99999863221 10 0 000 0111122 2445555544422 233
Q ss_pred HhH----h---cCCccccCCCCCCeeecCC---CCcEEEeeecCccc
Q 012233 253 YLH----H---VVGVCHRDIKPQNLLVNPH---THQLKICDFGSAKM 289 (468)
Q Consensus 253 yLH----~---~~givHrDlkp~NILl~~~---~~~vkL~DFG~a~~ 289 (468)
.|. . ...++|+|+.+.|||++.+ ...+.|+||..+..
T Consensus 208 ~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 208 NLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 332 1 1359999999999999876 12699999998853
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.73 E-value=0.0083 Score=57.50 Aligned_cols=72 Identities=13% Similarity=0.017 Sum_probs=43.4
Q ss_pred eecccCceEEEEEEEcCCCCEEEEEEeec---ccchHHHHHHHHHHcCCCC--cccccceeeecCC--CCceEEEEEeec
Q 012233 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQ---DKRYKNRELQIMRLLNHPN--VVSLKHCFFSTTE--KDELYLNLVLEY 216 (468)
Q Consensus 144 ~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~---~~~~~~~E~~il~~l~hpn--Iv~l~~~~~~~~~--~~~~~~~lv~e~ 216 (468)
.|+ |....||++.. .+|+.+++|.... .......|..+++.|.... +.+++.. .+.. ......++||+|
T Consensus 33 ~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~--~g~~~~~~~g~~~~l~~~ 108 (328)
T 1zyl_A 33 PLN-SYENRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAF--NGQTLLNHQGFYFAVFPS 108 (328)
T ss_dssp EEC-CSSSEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCB--TTBSCEEETTEEEEEEEC
T ss_pred eec-CcccceEEEEc-CCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeec--CCcEEEEECCEEEEEEEe
Confidence 355 77788998763 3566799998853 2344567888888775322 3444332 1100 012245789999
Q ss_pred ccc
Q 012233 217 ISE 219 (468)
Q Consensus 217 ~~~ 219 (468)
++|
T Consensus 109 i~G 111 (328)
T 1zyl_A 109 VGG 111 (328)
T ss_dssp CCC
T ss_pred cCC
Confidence 986
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.44 E-value=0.0042 Score=60.25 Aligned_cols=32 Identities=28% Similarity=0.511 Sum_probs=27.4
Q ss_pred CCccccCCCCCCeeecCCCCcEEEeeecCcccc
Q 012233 258 VGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (468)
Q Consensus 258 ~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~ 290 (468)
..++|+|+.+.||+++.++ .+.|+||+.+...
T Consensus 206 ~~~~HgD~~~~N~l~~~~~-~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEE-SIYIIDWDEPMLA 237 (339)
T ss_dssp CEEECSCCCGGGEEECGGG-CEEECCCSSCEEE
T ss_pred ceeEeCCCCcCCEEEeCCC-eEEEEECCCCeeC
Confidence 4699999999999998766 6999999987654
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.47 E-value=0.083 Score=52.65 Aligned_cols=69 Identities=14% Similarity=0.193 Sum_probs=44.6
Q ss_pred ceecccCceEEEEEEEcCC-------CCEEEEEEeeccc---chHHHHHHHHHHcCCCCc-ccccceeeecCCCCceEEE
Q 012233 143 RVVGTGSFGVVFQAKCLET-------GDSVAIKKVLQDK---RYKNRELQIMRLLNHPNV-VSLKHCFFSTTEKDELYLN 211 (468)
Q Consensus 143 ~~lG~G~fg~Vy~~~~~~~-------g~~vaiK~~~~~~---~~~~~E~~il~~l~hpnI-v~l~~~~~~~~~~~~~~~~ 211 (468)
+.|..|-...+|++..... +..+++|+..... ....+|..+++.|..-++ .++++.+ . -+
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~-----~----~~ 146 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF-----P----EG 146 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE-----T----TE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc-----C----CC
Confidence 4566777888999886421 5789999864322 234689999988863333 3444322 2 14
Q ss_pred EEeecccch
Q 012233 212 LVLEYISET 220 (468)
Q Consensus 212 lv~e~~~~~ 220 (468)
+||||++|.
T Consensus 147 ~I~efI~G~ 155 (424)
T 3mes_A 147 RIEEFIDGE 155 (424)
T ss_dssp EEEECCCSE
T ss_pred EEEEEeCCc
Confidence 789999873
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 468 | ||||
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-128 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-74 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-71 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 5e-71 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-69 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-69 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 5e-69 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 7e-68 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-67 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-67 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-66 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 8e-66 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 8e-65 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-62 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-62 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 5e-62 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-61 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 7e-61 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-60 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-60 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-60 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-60 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 9e-60 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-59 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-59 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-57 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-57 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-57 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-53 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-53 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-52 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-52 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 5e-52 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 7e-49 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 5e-48 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 6e-48 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-45 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-44 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 7e-44 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-43 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 5e-43 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-41 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 5e-41 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 6e-40 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-39 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-39 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-39 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-39 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 7e-39 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 7e-39 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-38 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-38 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 8e-38 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 7e-36 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 8e-36 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-35 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-34 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-34 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-33 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-32 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-32 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-30 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 5e-20 |
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 373 bits (959), Expect = e-128
Identities = 233/347 (67%), Positives = 285/347 (82%), Gaps = 4/347 (1%)
Query: 122 IATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNREL 181
+ T G +P Q +SY +V+G GSFGVV+QAK ++G+ VAIKKVLQDKR+KNREL
Sbjct: 6 VVATPGQGPDRP-QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNREL 64
Query: 182 QIMRLLNHPNVVSLKHCFFSTTE-KDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYV 240
QIMR L+H N+V L++ F+S+ E KDE+YLNLVL+Y+ ETVYRV++HY+R Q +P++YV
Sbjct: 65 QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 124
Query: 241 QLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYI 300
+LY YQ+ R+L Y+H G+CHRDIKPQNLL++P T LK+CDFGSAK LV GEPN+SYI
Sbjct: 125 KLYMYQLFRSLAYIHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI 183
Query: 301 CSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPT 360
CSRYYRAPELIFGAT+YT++ID+WS GCVLAELLLGQP+FPG+SGVDQLVEIIK+LGTPT
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 243
Query: 361 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420
RE+I+ MNPNYTEFKFPQIKAHPW K+F R PPEA+ L SRLL+Y+P+ R T LEACAH
Sbjct: 244 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303
Query: 421 PFFDDLRDPNTCLPNGRPLPTLFNFTAQELAGASNELRQRLIPEHAR 467
FFD+LRDPN LPNGR P LFNFT QEL+ ++ L LIP HAR
Sbjct: 304 SFFDELRDPNVKLPNGRDTPALFNFTTQELS-SNPPLATILIPPHAR 349
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 236 bits (602), Expect = 1e-74
Identities = 108/342 (31%), Positives = 176/342 (51%), Gaps = 25/342 (7%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV--LQDKRYKN---RELQIMRLLNHPNVV 193
Y +G G++G+V A VAIKK+ + + Y RE++I+ H N++
Sbjct: 10 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 69
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
+ + T + + LV + +Y++ K QH+ ++ + YQI R L Y
Sbjct: 70 GINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKY 124
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI----SYICSRYYRAPE 309
+H V HRD+KP NLL+N T LKICDFG A++ P + Y+ +R+YRAPE
Sbjct: 125 IHSA-NVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182
Query: 310 LIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM-- 367
++ + YT +ID+WS+GC+LAE+L +P+FPG+ +DQL I+ ILG+P++E++ C+
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242
Query: 368 -NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426
P PW+++F +ALDL+ ++L ++P R +A AHP+ +
Sbjct: 243 LKARNYLLSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301
Query: 427 RDPNTCLPNGRPLPTLFNFTAQELAGASNELRQRLIPEHARK 468
DP+ P+ EL E + LI E +
Sbjct: 302 YDPSD-----EPIAEAPFKFDMELDDLPKEKLKELIFEETAR 338
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 227 bits (580), Expect = 1e-71
Identities = 69/305 (22%), Positives = 122/305 (40%), Gaps = 31/305 (10%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----RELQIMRLLNHPNVV 193
+ +G G+ GVVF+ +G +A K + + + RELQ++ N P +V
Sbjct: 8 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
F E+ + +E++ + +P + + + + L Y
Sbjct: 68 GFYGAF---YSDGEISI--CMEHMDGGSLD---QVLKKAGRIPEQILGKVSIAVIKGLTY 119
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFG 313
L + HRD+KP N+LVN +K+CDFG + L+ N S++ +R Y +PE + G
Sbjct: 120 LREKHKIMHRDVKPSNILVNSRGE-IKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG 177
Query: 314 ATEYTTAIDMWSIGCVLAELLLGQPLFPGESG-VDQLVEIIKILGTPTREEIKCMNPNYT 372
T Y+ D+WS+G L E+ +G+ P +L+ ++ G + P
Sbjct: 178 -THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236
Query: 373 EFKF--------------PQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEAC 418
+ I P K+ E D V++ L +P+ R +
Sbjct: 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLM 296
Query: 419 AHPFF 423
H F
Sbjct: 297 VHAFI 301
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 225 bits (573), Expect = 5e-71
Identities = 97/297 (32%), Positives = 147/297 (49%), Gaps = 21/297 (7%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---------RELQIMRLLNHPNVV 193
+G G F V++A+ T VAIKK+ R + RE+++++ L+HPN++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
L F K + L V +++ + + + +++ Y + L Y
Sbjct: 64 GLLDAF---GHKSNISL--VFDFMETDLEV---IIKDNSLVLTPSHIKAYMLMTLQGLEY 115
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV-PGEPNISYICSRYYRAPELIF 312
LH + HRD+KP NLL++ + LK+ DFG AK P + +R+YRAPEL+F
Sbjct: 116 LHQHW-ILHRDLKPNNLLLDEN-GVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLF 173
Query: 313 GATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYT 372
GA Y +DMW++GC+LAELLL P PG+S +DQL I + LGTPT E+ M
Sbjct: 174 GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 233
Query: 373 EFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDP 429
F P H IF + LDL+ L ++P R TA +A +F + P
Sbjct: 234 YVTFKSFPGIPLHHIF-SAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP 289
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (566), Expect = 3e-69
Identities = 96/335 (28%), Positives = 159/335 (47%), Gaps = 23/335 (6%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV------LQDKRYKNRELQIMRLLNHPNV 192
Y VG+G++G V A +TG VA+KK+ + + REL++++ + H NV
Sbjct: 20 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 79
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
+ L F +E ++ ++ ++ +VQ YQI R L
Sbjct: 80 IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD----HVQFLIYQILRGLK 135
Query: 253 YLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIF 312
Y+H + HRD+KP NL VN KI DFG A+ + Y+ +R+YRAPE++
Sbjct: 136 YIHSA-DIIHRDLKPSNLAVNEDCEL-KILDFGLARH--TDDEMTGYVATRWYRAPEIML 191
Query: 313 GATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYT 372
Y +D+WS+GC++AELL G+ LFPG +DQL I++++GTP E +K ++
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 251
Query: 373 EF---KFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDP 429
Q+ + +F P A+DL+ ++L R TA +A AH +F DP
Sbjct: 252 RNYIQSLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 310
Query: 430 NTCLPNGRPLPTLFNFTAQELAGASNELRQRLIPE 464
+ P+ ++ + + +E + E
Sbjct: 311 DD-----EPVADPYDQSFESRDLLIDEWKSLTYDE 340
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 220 bits (561), Expect = 3e-69
Identities = 101/308 (32%), Positives = 167/308 (54%), Gaps = 23/308 (7%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNV 192
+ +G G++GVV++A+ TG+ VA+KK+ D + RE+ +++ LNHPN+
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
V L E L LV E++ + + + +P+ ++ Y +Q+ + L
Sbjct: 64 VKLLDVI-----HTENKLYLVFEFLHQDLKKFMDA--SALTGIPLPLIKSYLFQLLQGLA 116
Query: 253 YLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML-VPGEPNISYICSRYYRAPELI 311
+ H V HRD+KPQNLL+N +K+ DFG A+ VP + + +YRAPE++
Sbjct: 117 FCHSHR-VLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 174
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN--P 369
G Y+TA+D+WS+GC+ AE++ + LFPG+S +DQL I + LGTP + P
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 234
Query: 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDP 429
+Y + FP+ + K+ + + L+S++L Y P+ R +A A AHPFF D+ P
Sbjct: 235 DY-KPSFPKWARQDFSKVV-PPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292
Query: 430 NTCLPNGR 437
+P+ R
Sbjct: 293 ---VPHLR 297
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 220 bits (562), Expect = 5e-69
Identities = 90/300 (30%), Positives = 153/300 (51%), Gaps = 21/300 (7%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYK-NRELQIMRLLN-HPNVVSLK 196
Y R +G G + VF+A + + V +K + K+ K RE++I+ L PN+++L
Sbjct: 37 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLA 96
Query: 197 HCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH 256
+ LV E+++ T ++ ++ Q + ++ Y Y+I +AL+Y H
Sbjct: 97 DIV---KDPVSRTPALVFEHVNNTDFK------QLYQTLTDYDIRFYMYEILKALDYCHS 147
Query: 257 VVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATE 316
+ G+ HRD+KP N++++ +L++ D+G A+ PG+ + SRY++ PEL+
Sbjct: 148 M-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQM 206
Query: 317 YTTAIDMWSIGCVLAELLLGQ-PLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFK 375
Y ++DMWS+GC+LA ++ + P F G DQLV I K+LGT + + +
Sbjct: 207 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 266
Query: 376 FPQI----KAHPWHKIFHKR----MPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427
F I W + H + PEALD + +LL+Y R TA EA HP+F +
Sbjct: 267 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 326
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (554), Expect = 7e-68
Identities = 81/309 (26%), Positives = 142/309 (45%), Gaps = 22/309 (7%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNV 192
Y +G G+FG VF+A+ +TG VA+KKVL + + RE++I++LL H NV
Sbjct: 12 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 71
Query: 193 VSLKHCFFSTTE---KDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICR 249
V+L + + + + LV ++ + + + + ++ +
Sbjct: 72 VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG---LLSNVLVKFTLSEIKRVMQMLLN 128
Query: 250 ALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI-----SYICSRY 304
L Y+H + HRD+K N+L+ LK+ DFG A+ + + + + + +
Sbjct: 129 GLYYIHRN-KILHRDMKAANVLITRDGV-LKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186
Query: 305 YRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEI 364
YR PEL+ G +Y ID+W GC++AE+ P+ G + QL I ++ G+ T E
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246
Query: 365 KCMNPNYTEFKFPQIKAHP---WHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHP 421
++ K +K ++ P ALDL+ +LL P+ R + +A H
Sbjct: 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 306
Query: 422 FFDDLRDPN 430
FF P+
Sbjct: 307 FFWSDPMPS 315
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (550), Expect = 1e-67
Identities = 97/299 (32%), Positives = 153/299 (51%), Gaps = 18/299 (6%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNV 192
Y +G G++G VF+AK ET + VA+K+V D + RE+ +++ L H N+
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
V L + L LV E+ + + + ++ N + V+ + +Q+ + L
Sbjct: 64 VRLHDVL-----HSDKKLTLVFEFCDQDLKK---YFDSCNGDLDPEIVKSFLFQLLKGLG 115
Query: 253 YLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML-VPGEPNISYICSRYYRAPELI 311
+ H V HRD+KPQNLL+N + K+ +FG A+ +P + + + +YR P+++
Sbjct: 116 FCHSR-NVLHRDLKPQNLLINRNGEL-KLANFGLARAFGIPVRCYSAEVVTLWYRPPDVL 173
Query: 312 FGATEYTTAIDMWSIGCVLAELLLG-QPLFPGESGVDQLVEIIKILGTPTREEIKCMNPN 370
FGA Y+T+IDMWS GC+ AEL +PLFPG DQL I ++LGTPT E+ M
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233
Query: 371 YTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDP 429
+P A ++ DL+ LL+ +P R +A EA HP+F D P
Sbjct: 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP 292
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (555), Expect = 1e-67
Identities = 101/336 (30%), Positives = 169/336 (50%), Gaps = 25/336 (7%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNV 192
Y + VG+G++G V A TG VAIKK+ + + + REL++++ + H NV
Sbjct: 20 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 79
Query: 193 VSLKHCFFS-TTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
+ L F T D LV+ ++ + ++ KH + + +Q YQ+ + L
Sbjct: 80 IGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH-----EKLGEDRIQFLVYQMLKGL 134
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELI 311
Y+H G+ HRD+KP NL VN KI DFG A+ Y+ +R+YRAPE+I
Sbjct: 135 RYIHAA-GIIHRDLKPGNLAVNEDCEL-KILDFGLARQ--ADSEMTGYVVTRWYRAPEVI 190
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNY 371
YT +D+WS+GC++AE++ G+ LF G +DQL EI+K+ GTP E ++ + +
Sbjct: 191 LNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE 250
Query: 372 TEF---KFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRD 428
+ P+++ + I P A++L+ ++L R TA EA AHP+F+ L D
Sbjct: 251 AKNYMKGLPELEKKDFASIL-TNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 309
Query: 429 PNTCLPNGRPLPTLFNFTAQELAGASNELRQRLIPE 464
P ++ + ++ +E ++ E
Sbjct: 310 TED-----EPQVQKYDDSFDDVDRTLDEWKRVTYKE 340
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 214 bits (546), Expect = 3e-66
Identities = 72/309 (23%), Positives = 125/309 (40%), Gaps = 41/309 (13%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVL----QDKRYKNRELQIMRLLNHPNVVS 194
Y +GTG+FGVV + TG++ A K V+ DK +E+Q M +L HP +V+
Sbjct: 28 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 87
Query: 195 LKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
L F +D+ + ++ E++S + + + Y Q+C+ L ++
Sbjct: 88 LHDAF-----EDDNEMVMIYEFMSGGELF--EKVADEHNKMSEDEAVEYMRQVCKGLCHM 140
Query: 255 HHVVGVCHRDIKPQNLLVNPH-THQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFG 313
H H D+KP+N++ +++LK+ DFG L P + + + APE+ G
Sbjct: 141 HEN-NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEG 199
Query: 314 ATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTE 373
DMWS+G + LL G F GE+ + L +
Sbjct: 200 -KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSA---------- 248
Query: 374 FKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDP--NT 431
+ + D + +LL P+ R T +A HP+ P ++
Sbjct: 249 ---------------FSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDS 293
Query: 432 CLPNGRPLP 440
+P+ R
Sbjct: 294 QIPSSRYTK 302
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (539), Expect = 8e-66
Identities = 95/299 (31%), Positives = 152/299 (50%), Gaps = 17/299 (5%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDS-VAIKKVLQDKRYKN------RELQIMRLL---N 188
Y +G G++G VF+A+ L+ G VA+K+V + RE+ ++R L
Sbjct: 9 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 68
Query: 189 HPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQIC 248
HPNVV L + E L LV E++ + + VP ++ +Q+
Sbjct: 69 HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTY--LDKVPEPGVPTETIKDMMFQLL 126
Query: 249 RALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAP 308
R L++LH V HRD+KPQN+LV + Q+K+ DFG A++ S + + +YRAP
Sbjct: 127 RGLDFLHSH-RVVHRDLKPQNILVT-SSGQIKLADFGLARIYSFQMALTSVVVTLWYRAP 184
Query: 309 ELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368
E++ + Y T +D+WS+GC+ AE+ +PLF G S VDQL +I+ ++G P E+ +
Sbjct: 185 EVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP-RD 242
Query: 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427
F A P K + DL+ + L ++P+ R +A A +HP+F DL
Sbjct: 243 VALPRQAFHSKSAQPIEKFVTD-IDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 300
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 208 bits (531), Expect = 8e-65
Identities = 93/295 (31%), Positives = 155/295 (52%), Gaps = 20/295 (6%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNV 192
Y +G G++GVV++A+ G++ A+KK+ +K + RE+ I++ L H N+
Sbjct: 4 YHGLEKIGEGTYGVVYKAQ-NNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
V L + L LV E++ + + + + + + + Q+ +
Sbjct: 63 VKLYDVIH-----TKKRLVLVFEHLDQDLKK---LLDVCEGGLESVTAKSFLLQLLNGIA 114
Query: 253 YLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML-VPGEPNISYICSRYYRAPELI 311
Y H V HRD+KPQNLL+N +LKI DFG A+ +P I + +YRAP+++
Sbjct: 115 YCHDR-RVLHRDLKPQNLLIN-REGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVL 172
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPN- 370
G+ +Y+T ID+WS+GC+ AE++ G PLFPG S DQL+ I +ILGTP + +
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232
Query: 371 YTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDD 425
+ F + PW K + +DL+S++L+ P+ R TA +A H +F +
Sbjct: 233 KYDPNFTVYEPLPWESFL-KGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 1e-62
Identities = 74/294 (25%), Positives = 117/294 (39%), Gaps = 44/294 (14%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----RELQIMRLLNHPNVV 193
+ + +G G++G V A T ++VA+K V + +E+ I ++LNH NVV
Sbjct: 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 66
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
L LEY S + +P Q + +Q+ + Y
Sbjct: 67 KFYGHRREGN-----IQYLFLEYCSGGELF---DRIEPDIGMPEPDAQRFFHQLMAGVVY 118
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI---SYICSRYYRAPEL 310
LH + G+ HRDIKP+NLL++ + LKI DFG A + + Y APEL
Sbjct: 119 LHGI-GITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 176
Query: 311 IFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPN 370
+ + +D+WS G VL +L G+ + S Q K T
Sbjct: 177 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL---------- 226
Query: 371 YTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFD 424
+PW KI L L+ ++L +PS R T + +++
Sbjct: 227 -----------NPWKKI-----DSAPLALLHKILVENPSARITIPDIKKDRWYN 264
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (520), Expect = 2e-62
Identities = 95/346 (27%), Positives = 166/346 (47%), Gaps = 32/346 (9%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNV 192
Y + +G+G+ G+V A +VAIKK+ + + + REL +M+ +NH N+
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 193 VSLKHCFFS-TTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
+SL + F T ++ + LV+E + + +V + + + YQ+ +
Sbjct: 79 ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQV------IQMELDHERMSYLLYQMLCGI 132
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELI 311
+LH + HRD+KP N++V KI DFG A+ Y+ +RYYRAPE+I
Sbjct: 133 KHLHSAG-IIHRDLKPSNIVVKSDCTL-KILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 190
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNY 371
G Y +D+WS+GC++ E++ + LFPG +DQ ++I+ LGTP E +K + P
Sbjct: 191 LG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249
Query: 372 TEF--KFPQIKAHPWHKIF-----------HKRMPPEALDLVSRLLQYSPSLRCTALEAC 418
+ P+ + K+F +K +A DL+S++L P+ R + +A
Sbjct: 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 309
Query: 419 AHPFFDDLRDPNTCLPNGRPLPTLFNFTAQELAGASNELRQRLIPE 464
HP+ + DP P P +++ E E ++ + E
Sbjct: 310 QHPYINVWYDPAEVEA---PPPQIYDKQLDEREHTIEEWKELIYKE 352
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (516), Expect = 5e-62
Identities = 76/304 (25%), Positives = 125/304 (41%), Gaps = 32/304 (10%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIM-RLLNHPNVVSLKHCFF 200
+V+G G G V Q T + A+K +LQD RE+++ R P++V + +
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDVYE 75
Query: 201 STTEKDELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG 259
+ + L +V+E + ++ + R +Q I A+ YLH +
Sbjct: 76 NLYAGRK-CLLIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHS-IN 131
Query: 260 VCHRDIKPQNLLVNPHTHQ--LKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEY 317
+ HRD+KP+NLL LK+ DFG AK + + YY APE++ +Y
Sbjct: 132 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP-EKY 190
Query: 318 TTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFP 377
+ DMWS+G ++ LL G P F G+ + + +++FP
Sbjct: 191 DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG-------------QYEFP 237
Query: 378 QIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF-DDLRDPNTCLPNG 436
+ + E L+ LL+ P+ R T E HP+ + P T L
Sbjct: 238 NPE--------WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTS 289
Query: 437 RPLP 440
R L
Sbjct: 290 RVLK 293
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 201 bits (513), Expect = 2e-61
Identities = 77/305 (25%), Positives = 122/305 (40%), Gaps = 40/305 (13%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV----LQDKRYKNRELQIMRLLNHPNVVS 194
Y +G+G+FGVV + TG K + DK E+ IM L+HP +++
Sbjct: 31 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLIN 90
Query: 195 LKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
L F +D+ + L+LE++S + + + V Y Q C L ++
Sbjct: 91 LHDAF-----EDKYEMVLILEFLSGG--ELFDRIAAEDYKMSEAEVINYMRQACEGLKHM 143
Query: 255 HHVVGVCHRDIKPQNLLV-NPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFG 313
H + H DIKP+N++ +KI DFG A L P E + + APE++
Sbjct: 144 HEH-SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDR 202
Query: 314 ATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTE 373
DMW+IG + LL G F GE ++ L + + +
Sbjct: 203 -EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAF--------- 252
Query: 374 FKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF-DDLRDPNTC 432
+ PEA D + LLQ P R T +A HP+ D + +
Sbjct: 253 ----------------SSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSR 296
Query: 433 LPNGR 437
+P+ R
Sbjct: 297 IPSSR 301
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 7e-61
Identities = 66/294 (22%), Positives = 115/294 (39%), Gaps = 44/294 (14%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV----LQDKRYKNRELQIMRLLNHPNVVS 194
+ +G G+FG V++A+ ET A K + ++ E+ I+ +HPN+V
Sbjct: 14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 73
Query: 195 LKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
L F E L +++E+ + + + + +Q+ Q ALNYL
Sbjct: 74 LLDAF-----YYENNLWILIEFCAGGAVD--AVMLELERPLTESQIQVVCKQTLDALNYL 126
Query: 255 HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV-PGEPNISYICSRYYRAPELIFG 313
H + HRD+K N+L +K+ DFG + + S+I + Y+ APE++
Sbjct: 127 HDN-KIIHRDLKAGNILFTLDGD-IKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMC 184
Query: 314 AT----EYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369
T Y D+WS+G L E+ +P + + L++I
Sbjct: 185 ETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKI----------------- 227
Query: 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
K+ P R D + + L+ + R T + HPF
Sbjct: 228 ---------AKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFV 272
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 1e-60
Identities = 58/289 (20%), Positives = 116/289 (40%), Gaps = 40/289 (13%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSL 195
+ +G GSF V++ ET VA ++ K K+ E ++++ L HPN+V
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
+ + +T K + + LV E ++ + Y + + + I ++ + QI + L +LH
Sbjct: 74 -YDSWESTVKGKKCIVLVTELMTSGTLK---TYLKRFKVMKIKVLRSWCRQILKGLQFLH 129
Query: 256 -HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGA 314
+ HRD+K N+ + T +KI D G A L + I + + APE+
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT-LKRASFAKAVIGTPEFMAPEMYEE- 187
Query: 315 TEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEF 374
+Y ++D+++ G + E+ + + Q+
Sbjct: 188 -KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR---------------------- 224
Query: 375 KFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
+ + F K PE +++ ++ + R + + H FF
Sbjct: 225 ----VTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 269
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 198 bits (504), Expect = 1e-60
Identities = 70/305 (22%), Positives = 123/305 (40%), Gaps = 49/305 (16%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-------RELQIMRLLNHPN 191
+ R +G GSFG V+ A+ + + VAIKK+ + N +E++ ++ L HPN
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
+ + C+ E LV+EY + + + + + + + + T+ + L
Sbjct: 77 TIQYRGCYL-----REHTAWLVMEYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGL 128
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELI 311
YLH + HRD+K N+L++ +K+ DFGSA ++ P S++ + Y+ APE+I
Sbjct: 129 AYLHSH-NMIHRDVKAGNILLS-EPGLVKLGDFGSASIMAPAN---SFVGTPYWMAPEVI 183
Query: 312 FGATE--YTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369
E Y +D+WS+G EL +P + + L I +
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ--------------- 228
Query: 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDP 429
+ + + V LQ P R T+ H F R P
Sbjct: 229 ------------NESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPP 276
Query: 430 NTCLP 434
+
Sbjct: 277 TVIMD 281
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 199 bits (507), Expect = 2e-60
Identities = 90/349 (25%), Positives = 154/349 (44%), Gaps = 49/349 (14%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNHPNVVSL 195
Y+ R +G G F V+ AK + VA+K V DK Y E+++++ +N +
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 74
Query: 196 KH----------CFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTY 245
F+ + +++ +V E + E + + K Y ++ +P++YV+ +
Sbjct: 75 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKY--EHRGIPLIYVKQISK 132
Query: 246 QICRALNYLHHVVGVCHRDIKPQNLLVNPHTH-----QLKICDFGSAKMLVPGEPNISYI 300
Q+ L+Y+H G+ H DIKP+N+L+ Q+KI D G+A E + I
Sbjct: 133 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD--EHYTNSI 190
Query: 301 CSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESG------VDQLVEIIK 354
+R YR+PE++ GA + D+WS C++ EL+ G LF + G D + +II+
Sbjct: 191 QTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 249
Query: 355 ILGTPTREEIKCMNPNYTEF-------KFPQIKAHPWHKI------FHKRMPPEALDLVS 401
+LG ++ T F ++K P + F K E D +S
Sbjct: 250 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLS 309
Query: 402 RLLQYSPSLRCTALEACAHPFFDD------LRDPNT-CLPNGRPLPTLF 443
+LQ P R A HP+ D +R P+ +G +P F
Sbjct: 310 PMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSDIPGWF 358
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (498), Expect = 3e-60
Identities = 82/293 (27%), Positives = 130/293 (44%), Gaps = 50/293 (17%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-------RELQIMRLLNHPN 191
+ R +G G FG V+ A+ ++ +A+K + + + K RE++I L HPN
Sbjct: 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 67
Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRA 250
++ L F D + L+LEY TVYR + ++ ++ Y ++ A
Sbjct: 68 ILRLYGYF-----HDATRVYLILEYAPLGTVYRELQKLSKFDEQR----TATYITELANA 118
Query: 251 LNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPEL 310
L+Y H V HRDIKP+NLL+ LKI DFG + P + + Y PE+
Sbjct: 119 LSYCHSK-RVIHRDIKPENLLLGSAGE-LKIADFGWSVH-APSSRRTTLCGTLDYLPPEM 175
Query: 311 IFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPN 370
I G + +D+WS+G + E L+G+P F + + I ++
Sbjct: 176 IEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--------------- 219
Query: 371 YTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
EF FP + A DL+SRLL+++PS R E HP+
Sbjct: 220 --EFTFP------------DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 258
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (495), Expect = 9e-60
Identities = 68/296 (22%), Positives = 118/296 (39%), Gaps = 45/296 (15%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVL------QDKRYKNRELQIMRLLNHPNV 192
Y +GTGS+G + + G + K++ +K+ E+ ++R L HPN+
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
V T L +V+EY + V T+ Q++ +V Q+ AL
Sbjct: 66 VRYYDRIIDRTNT---TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122
Query: 252 NYLH----HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI-SYICSRYYR 306
H V HRD+KP N+ ++ + +K+ DFG A++L +++ + YY
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQN-VKLGDFGLARILNHDTSFAKAFVGTPYYM 181
Query: 307 APELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKC 366
+PE + Y D+WS+GC+L EL P F S + +I +
Sbjct: 182 SPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG----------- 229
Query: 367 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPF 422
KF +I E ++++R+L R + E +P
Sbjct: 230 --------KFRRIPYR---------YSDELNEIITRMLNLKDYHRPSVEEILENPL 268
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 1e-59
Identities = 72/301 (23%), Positives = 125/301 (41%), Gaps = 43/301 (14%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV----LQDKRYKNRELQIMRLLNHPNVVS 194
Y +G G+ G V+ A + TG VAI+++ K E+ +MR +PN+V+
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 195 LKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
+ DEL++ V+EY + S + + + +AL +L
Sbjct: 82 YLDSY---LVGDELWV--VMEY----LAGGSLTDVVTETCMDEGQIAAVCRECLQALEFL 132
Query: 255 HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC-SRYYRAPELIFG 313
H V HRDIK N+L+ +K+ DFG + P + S + + Y+ APE++
Sbjct: 133 HSN-QVIHRDIKSDNILLGMDGS-VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR 190
Query: 314 ATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTE 373
Y +D+WS+G + E++ G+P + E+ + L I GTP E
Sbjct: 191 -KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-GTP-------------E 235
Query: 374 FKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNTCL 433
+ P +++ D ++R L R +A E H F + ++
Sbjct: 236 LQNP------------EKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLT 283
Query: 434 P 434
P
Sbjct: 284 P 284
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 3e-59
Identities = 74/289 (25%), Positives = 119/289 (41%), Gaps = 38/289 (13%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV---LQDKRYKNRELQIMRLLNHPNVVSL 195
YM +G G FG+V + + + K V D+ +E+ I+ + H N++ L
Sbjct: 7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHL 66
Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
F + L ++ E+IS + + + + Y +Q+C AL +LH
Sbjct: 67 HESF-----ESMEELVMIFEFISGL--DIFERINTSAFELNEREIVSYVHQVCEALQFLH 119
Query: 256 HVVGVCHRDIKPQNLLV-NPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGA 314
+ H DI+P+N++ + +KI +FG A+ L PG+ + Y APE+
Sbjct: 120 SH-NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQH- 177
Query: 315 TEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEF 374
+TA DMWS+G ++ LL G F E+ + I+ T E
Sbjct: 178 DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAF---------- 227
Query: 375 KFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
K + EA+D V RLL R TA EA HP+
Sbjct: 228 ---------------KEISIEAMDFVDRLLVKERKSRMTASEALQHPWL 261
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 1e-57
Identities = 87/313 (27%), Positives = 136/313 (43%), Gaps = 58/313 (18%)
Query: 132 QPKQTI--SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYK-------NRELQ 182
QP++ + +++G GSF V A+ L T AIK + + K RE
Sbjct: 1 QPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERD 60
Query: 183 IMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL 242
+M L+HP V L F + ++LY L Y Y R +
Sbjct: 61 VMSRLDHPFFVKLYFTF---QDDEKLYF--GLSYAKNGELL---KYIRKIGSFDETCTRF 112
Query: 243 YTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI---SY 299
YT +I AL YLH + HRD+KP+N+L+N H ++I DFG+AK+L P S+
Sbjct: 113 YTAEIVSALEYLHGKG-IIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANSF 170
Query: 300 ICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTP 359
+ + Y +PEL+ + D+W++GC++ +L+ G P F + +IIK+
Sbjct: 171 VGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL---- 225
Query: 360 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEAC- 418
E+ FP+ + P+A DLV +LL + R E
Sbjct: 226 -------------EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEG 260
Query: 419 -----AHPFFDDL 426
AHPFF+ +
Sbjct: 261 YGPLKAHPFFESV 273
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 189 bits (481), Expect = 1e-57
Identities = 76/304 (25%), Positives = 122/304 (40%), Gaps = 54/304 (17%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV-------------LQDKRYKNRELQIMR 185
Y + ++G G VV + T A+K + + + +E+ I+R
Sbjct: 5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64
Query: 186 LLN-HPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYT 244
++ HPN++ LK + + + LV + + + Y + +
Sbjct: 65 KVSGHPNIIQLKDTY-----ETNTFFFLVFDLMKKGELF---DYLTEKVTLSEKETRKIM 116
Query: 245 YQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRY 304
+ + LH + + HRD+KP+N+L++ + +K+ DFG + L PGE +
Sbjct: 117 RALLEVICALHKL-NIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDPGEKLREVCGTPS 174
Query: 305 YRAPELIFGATE-----YTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTP 359
Y APE+I + Y +DMWS G ++ LL G P F + L I
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI------- 227
Query: 360 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419
M+ NY +F P+ DLVSR L P R TA EA A
Sbjct: 228 -------MSGNY-QFGSPE----------WDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269
Query: 420 HPFF 423
HPFF
Sbjct: 270 HPFF 273
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 189 bits (482), Expect = 3e-57
Identities = 72/292 (24%), Positives = 115/292 (39%), Gaps = 42/292 (14%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----RELQIMRLLNHPNVV 193
Y V+GTG+F V A+ T VAIK + + E+ ++ + HPN+V
Sbjct: 11 YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIV 70
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
+L + LYL +++ +S +Q+ A+ Y
Sbjct: 71 ALDDIY---ESGGHLYL--IMQLVSGGELF---DRIVEKGFYTERDASRLIFQVLDAVKY 122
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTH--QLKICDFGSAKMLVPGEPNISYICSRYYRAPELI 311
LH + + HRD+KP+NLL ++ I DFG +KM PG + + Y APE++
Sbjct: 123 LHDLG-IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVL 181
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNY 371
Y+ A+D WSIG + LL G P F E+ +I+K
Sbjct: 182 AQ-KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSP--------- 231
Query: 372 TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
+ + A D + L++ P R T +A HP+
Sbjct: 232 ----------------YWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWI 267
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 2e-53
Identities = 66/303 (21%), Positives = 116/303 (38%), Gaps = 56/303 (18%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN----------RELQIMRLLN 188
Y ++G+G FG V+ + VAIK V +D+ E+ +++ ++
Sbjct: 6 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 189 --HPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQ 246
V+ L F L+LE + + + + + +Q
Sbjct: 66 SGFSGVIRLLDWFE-----RPDSFVLILERPEP--VQDLFDFITERGALQEELARSFFWQ 118
Query: 247 ICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR 306
+ A+ + H+ GV HRDIK +N+L++ + +LK+ DFGS L+ + +R Y
Sbjct: 119 VLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFDGTRVYS 176
Query: 307 APELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKC 366
PE I + + +WS+G +L +++ G F + EII+
Sbjct: 177 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIR------------ 218
Query: 367 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426
F +R+ E L+ L PS R T E HP+ D+
Sbjct: 219 -----------------GQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261
Query: 427 RDP 429
P
Sbjct: 262 LLP 264
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 2e-53
Identities = 67/322 (20%), Positives = 125/322 (38%), Gaps = 51/322 (15%)
Query: 134 KQTIS--YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN----------REL 181
++ + Y +G+G F VV + + TG A K + + + + RE+
Sbjct: 5 QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 64
Query: 182 QIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQ 241
I++ + HPNV++L + +++ + L+LE ++ + + +
Sbjct: 65 SILKEIQHPNVITLHEVY-----ENKTDVILILELVAGGELF---DFLAEKESLTEEEAT 116
Query: 242 LYTYQICRALNYLHHVVGVCHRDIKPQNLLV---NPHTHQLKICDFGSAKMLVPGEPNIS 298
+ QI + Y H + + H D+KP+N+++ N ++KI DFG A + G +
Sbjct: 117 EFLKQILNGVYY-LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 175
Query: 299 YICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGT 358
+ + APE++ DMWSIG + LL G F G++ + L + +
Sbjct: 176 IFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE 234
Query: 359 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEAC 418
E + A D + RLL P R T ++
Sbjct: 235 FEDE-------------------------YFSNTSALAKDFIRRLLVKDPKKRMTIQDSL 269
Query: 419 AHPFFDDLRDPNTCLPNGRPLP 440
HP+ +D L + P
Sbjct: 270 QHPWIKP-KDTQQALSSAWSHP 290
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 2e-52
Identities = 71/298 (23%), Positives = 125/298 (41%), Gaps = 50/298 (16%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQ--------IMRLLNHP 190
++ +++G GSFG VF A+ +T AIK + +D + +++ + HP
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 191 NVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRA 250
+ + F + + L V+EY++ ++ + + Y +I
Sbjct: 64 FLTHMFCTF-----QTKENLFFVMEYLNGGDLM---YHIQSCHKFDLSRATFYAAEIILG 115
Query: 251 LNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC-SRYYRAPE 309
L +LH G+ +RD+K N+L++ H KI DFG K + G+ + C + Y APE
Sbjct: 116 LQFLHSK-GIVYRDLKLDNILLDKDGHI-KIADFGMCKENMLGDAKTNTFCGTPDYIAPE 173
Query: 310 LIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369
++ G +Y ++D WS G +L E+L+GQ F G+ + I+ NP
Sbjct: 174 ILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF------------HSIRMDNP 220
Query: 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEAC-AHPFFDDL 426
Y + + EA DL+ +L P R HP F ++
Sbjct: 221 FYPRW-----------------LEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI 261
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 178 bits (451), Expect = 4e-52
Identities = 68/303 (22%), Positives = 122/303 (40%), Gaps = 52/303 (17%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK----------RYKNRELQIMRLLN 188
+ R++G G FG V+ + +TG A+K + + + + L ++ +
Sbjct: 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65
Query: 189 HPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQIC 248
P +V + + F D+L +L+ ++ ++ + ++ Y +I
Sbjct: 66 CPFIVCMSYAF---HTPDKLSF--ILDLMNGGDLH---YHLSQHGVFSEADMRFYAAEII 117
Query: 249 RALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAP 308
L ++H+ V +RD+KP N+L++ H H ++I D G A +P+ S + Y AP
Sbjct: 118 LGLEHMHNR-FVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHASV-GTHGYMAP 174
Query: 309 ELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368
E++ Y ++ D +S+GC+L +LL G F D+ EI ++ T E
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTLTMAVE------ 227
Query: 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCT-----ALEACAHPFF 423
PE L+ LLQ + R A E PFF
Sbjct: 228 -------------------LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 268
Query: 424 DDL 426
L
Sbjct: 269 RSL 271
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 176 bits (446), Expect = 5e-52
Identities = 72/300 (24%), Positives = 127/300 (42%), Gaps = 54/300 (18%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV-------LQDKRYKNRELQIMRLLNHPN 191
+ R +GTGSFG V + G A+K + L+ + N E ++ ++ HP
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65
Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
++ + F +D + ++++YI R +Q P + Y ++C AL
Sbjct: 66 IIRMWGTF-----QDAQQIFMIMDYIEGGELF---SLLRKSQRFPNPVAKFYAAEVCLAL 117
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELI 311
YLH + +RD+KP+N+L++ + H +KI DFG AK + + + + Y APE++
Sbjct: 118 EYLHS-KDIIYRDLKPENILLDKNGH-IKITDFGFAKYV--PDVTYTLCGTPDYIAPEVV 173
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNY 371
Y +ID WS G ++ E+L G F + + +I+
Sbjct: 174 ST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN----------------- 215
Query: 372 TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC-----TALEACAHPFFDDL 426
E +FP + DL+SRL+ S R + HP+F ++
Sbjct: 216 AELRFP------------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 263
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 166 bits (422), Expect = 7e-49
Identities = 64/295 (21%), Positives = 110/295 (37%), Gaps = 43/295 (14%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-------RELQIMRLLNHPN 191
Y ++G G V A+ L VA+K + D RE Q LNHP
Sbjct: 9 YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 68
Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
+V++ + +V+EY+ R + C+AL
Sbjct: 69 IVAV-YDTGEAETPAGPLPYIVMEYVDGVTLR---DIVHTEGPMTPKRAIEVIADACQAL 124
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI----SYICSRYYRA 307
N+ H G+ HRD+KP N++++ + +K+ DFG A+ + ++ + I + Y +
Sbjct: 125 NFSHQN-GIIHRDVKPANIMISAT-NAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 182
Query: 308 PELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367
PE G D++S+GCVL E+L G+P F G+S V + ++ P
Sbjct: 183 PEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSA----- 236
Query: 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPF 422
H+ + + +V + L +P R
Sbjct: 237 --------------------RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADL 271
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 5e-48
Identities = 54/290 (18%), Positives = 106/290 (36%), Gaps = 47/290 (16%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSL 195
+ +G+GSFG V++ K VA+K + E+ ++R H N++
Sbjct: 13 GQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 69
Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
L +V ++ + + H + ++ + Q + ++YLH
Sbjct: 70 MGYS------TAPQLAIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH 121
Query: 256 HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISY---ICSRYYRAPELIF 312
+ HRD+K N+ ++ +KI DFG A + + + S + APE+I
Sbjct: 122 AK-SIIHRDLKSNNIFLHEDLT-VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 179
Query: 313 G--ATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPN 370
Y+ D+++ G VL EL+ GQ + + DQ++ ++
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG---------------- 223
Query: 371 YTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420
+ P + P L++ L+ R + A
Sbjct: 224 -RGYLSPDLSKVR------SNCPKAMKRLMAECLKKKRDERPLFPQILAS 266
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 6e-48
Identities = 66/296 (22%), Positives = 114/296 (38%), Gaps = 51/296 (17%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-------RELQIMRLLNHPNVVSL 195
+++G G+FG V + TG A+K + ++ E ++++ HP + +L
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
K+ F D L + E + +S+ + + Y +I AL Y
Sbjct: 71 KYAF---QTHDRLCFVMEYANGGELFFHLSRERVFTEERA-----RFYGAEIVSALEY-L 121
Query: 256 HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGAT 315
H V +RDIK +NL+++ H +KI DFG K + + C +
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN 180
Query: 316 EYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFK 375
+Y A+D W +G V+ E++ G+ F + I+ E +
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM-----------------EEIR 223
Query: 376 FPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLR-----CTALEACAHPFFDDL 426
FP + + PEA L++ LL+ P R A E H FF +
Sbjct: 224 FP------------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 158 bits (399), Expect = 3e-45
Identities = 54/313 (17%), Positives = 102/313 (32%), Gaps = 54/313 (17%)
Query: 126 VGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN--RELQI 183
VG R Y R +G+GSFG ++ + G+ VAIK ++ E +I
Sbjct: 5 VGNR---------YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKI 55
Query: 184 MRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLY 243
+++ + + + Y +V+E + ++ + ++ + V L
Sbjct: 56 YKMMQGGVGIPTIRWCGA----EGDYNVMVMELLGPSLED---LFNFCSRKFSLKTVLLL 108
Query: 244 TYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKIC--DFGSAKMLVPGEPNI---- 297
Q+ + Y+H HRD+KP N L+ + DFG AK +
Sbjct: 109 ADQMISRIEYIHS-KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPY 167
Query: 298 ----SYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEII 353
+ + Y + G E + D+ S+G VL LG + G + +
Sbjct: 168 RENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYE 226
Query: 354 KILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCT 413
+I I+ + Y P E ++ +
Sbjct: 227 RISEKKMSTPIEVLCKGY---------------------PSEFATYLNFCRSLRFDDKPD 265
Query: 414 A---LEACAHPFF 423
+ + F
Sbjct: 266 YSYLRQLFRNLFH 278
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 1e-44
Identities = 56/281 (19%), Positives = 105/281 (37%), Gaps = 43/281 (15%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN--RELQIMRLLNHPNVVSLKHCFF 200
+ +G G FG V G+ VA+K + D + E +M L H N+V L
Sbjct: 13 QTIGKGEFGDVMLGD--YRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIV 70
Query: 201 STTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGV 260
+++ L +V EY+++ +R + + ++ +C A+ YL
Sbjct: 71 ----EEKGGLYIVTEYMAKGSLV-DYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN-NF 124
Query: 261 CHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTA 320
HRD+ +N+LV+ K+ DFG K + + + APE + +++T
Sbjct: 125 VHRDLAARNVLVSEDNV-AKVSDFGLTKEASSTQD--TGKLPVKWTAPEALRE-KKFSTK 180
Query: 321 IDMWSIGCVLAELL-LGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQI 379
D+WS G +L E+ G+ +P D + + K + P
Sbjct: 181 SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY----------------KMDAPD- 223
Query: 380 KAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420
PP +++ ++R + L+
Sbjct: 224 -----------GCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 153 bits (388), Expect = 7e-44
Identities = 50/280 (17%), Positives = 96/280 (34%), Gaps = 33/280 (11%)
Query: 126 VGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN--RELQI 183
VG Y R +G GSFGV+F+ L VAIK + E +
Sbjct: 3 VGVH---------YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRT 53
Query: 184 MRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLY 243
+LL + + F + L+ LV++ + ++ + + V +
Sbjct: 54 YKLLAGCTGIPNVYYFGQ----EGLHNVLVIDLLGPSLE---DLLDLCGRKFSVKTVAMA 106
Query: 244 TYQICRALNYLHHVVGVCHRDIKPQNLLVN----PHTHQLKICDFGSAKMLVPGEPNI-- 297
Q+ + +H + +RDIKP N L+ + + + + DFG K
Sbjct: 107 AKQMLARVQSIHEK-SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHI 165
Query: 298 ------SYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVE 351
+ + Y + G E + D+ ++G V L G + G +
Sbjct: 166 PYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQK 224
Query: 352 IIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKR 391
+I ++ + + E +F + + + F
Sbjct: 225 YERIGEKKQSTPLRELCAGFPE-EFYKYMHYARNLAFDAT 263
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 1e-43
Identities = 77/308 (25%), Positives = 131/308 (42%), Gaps = 55/308 (17%)
Query: 139 YMAERVVGTGSFGVVFQAKCL---ETGDSVAIKKV--------LQDKRYKNRELQIMRLL 187
+ +V+GTG++G VF + + +TG A+K + + + E Q++ +
Sbjct: 26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 85
Query: 188 NH-PNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQ 246
P +V+L + F + E L+L+L+YI+ + + VQ+Y +
Sbjct: 86 RQSPFLVTLHYAF-----QTETKLHLILDYINGGELF---THLSQRERFTEHEVQIYVGE 137
Query: 247 ICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC---SR 303
I AL +LH + G+ +RDIK +N+L++ + H + + DFG +K V E +Y
Sbjct: 138 IVLALEHLHKL-GIIYRDIKLENILLDSNGH-VVLTDFGLSKEFVADETERAYDFCGTIE 195
Query: 304 YYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREE 363
Y + G + + A+D WS+G ++ ELL G F + + EI + +
Sbjct: 196 YMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS---- 251
Query: 364 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLR-----CTALEAC 418
E +PQ M A DL+ RLL P R A E
Sbjct: 252 ---------EPPYPQ------------EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIK 290
Query: 419 AHPFFDDL 426
H FF +
Sbjct: 291 EHLFFQKI 298
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 153 bits (387), Expect = 5e-43
Identities = 63/295 (21%), Positives = 112/295 (37%), Gaps = 54/295 (18%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-------RELQIMRLLNHPNVVSL 195
+ +GTGSFG V K E+G+ A+K + + K K E +I++ +N P +V L
Sbjct: 47 KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
+ F + + + + + R + + Y QI YLH
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRR--------IGRFSEPHARFYAAQIVLTFEYLH 158
Query: 256 HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGAT 315
+ + +RD+KP+NLL++ + +++ DFG AK + + APE+I
Sbjct: 159 S-LDLIYRDLKPENLLIDQQGY-IQVTDFGFAK--RVKGRTWTLCGTPEALAPEIILS-K 213
Query: 316 EYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFK 375
Y A+D W++G ++ E+ G P F + + +I
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----------------------- 250
Query: 376 FPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSP-----SLRCTALEACAHPFFDD 425
F + DL+ LLQ +L+ + H +F
Sbjct: 251 ------VSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 2e-41
Identities = 59/293 (20%), Positives = 103/293 (35%), Gaps = 47/293 (16%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNHPNVVSL 195
+G G FG V+ VA+K + Q + E +M+ L H +V L
Sbjct: 15 LKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL 73
Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
++ +Y+ + EY+ E V T + I + QI + ++
Sbjct: 74 YAVV----TQEPIYI--ITEYM-ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126
Query: 256 HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC--SRYYRAPELIFG 313
HRD++ N+LV+ KI DFG A+++ E + APE I
Sbjct: 127 ER-NYIHRDLRAANILVSDTLSC-KIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY 184
Query: 314 ATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYT 372
+T D+WS G +L E++ G+ +PG + + + + +
Sbjct: 185 G-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER------------------ 225
Query: 373 EFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA--HPFF 423
+ + P E L+ + P R T + FF
Sbjct: 226 ----------GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 5e-41
Identities = 62/290 (21%), Positives = 105/290 (36%), Gaps = 47/290 (16%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNHPNVVSLKHC 198
E +G G FG V+ VAIK + +E Q+M+ L H +V L
Sbjct: 22 EVKLGQGCFGEVWMGT-WNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 80
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV 258
++ +Y+ V EY+S+ +++ + + QI + Y+ +
Sbjct: 81 V----SEEPIYI--VTEYMSKGSLL-DFLKGETGKYLRLPQLVDMAAQIASGMAYVERM- 132
Query: 259 GVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI--SYICSRYYRAPELIFGATE 316
HRD++ N+LV + K+ DFG A+++ E + APE
Sbjct: 133 NYVHRDLRAANILVGENLV-CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GR 190
Query: 317 YTTAIDMWSIGCVLAELL-LGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFK 375
+T D+WS G +L EL G+ +PG + L ++ + P E
Sbjct: 191 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC----------- 239
Query: 376 FPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA--HPFF 423
P DL+ + + P R T A +F
Sbjct: 240 -----------------PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 6e-40
Identities = 50/283 (17%), Positives = 98/283 (34%), Gaps = 43/283 (15%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNHPNVVSLKHCF 199
+ +G+G FG+V D VAIK + + + E ++M L+HP +V L
Sbjct: 11 QEIGSGQFGLVHLGY-WLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 69
Query: 200 FSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG 259
E+ + LV E++ +S + + +C + YL
Sbjct: 70 ---LEQAPIC--LVFEFMEHG--CLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE-AC 121
Query: 260 VCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC--SRYYRAPELIFGATEY 317
V HRD+ +N LV + +K+ DFG + ++ + S + +PE+ + Y
Sbjct: 122 VIHRDLAARNCLVGENQV-IKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF-SRY 179
Query: 318 TTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFP 377
++ D+WS G ++ E+ + ++VE I
Sbjct: 180 SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS----------------------- 216
Query: 378 QIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420
+ + +++ + P R
Sbjct: 217 ----TGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 1e-39
Identities = 52/284 (18%), Positives = 107/284 (37%), Gaps = 45/284 (15%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNHPNVVSLKHCF 199
+ +GTG FGVV K VAIK + + ++ E ++M L+H +V L
Sbjct: 10 KELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 68
Query: 200 FSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG 259
T++ ++ ++ EY++ + + M + +C A+ YL
Sbjct: 69 ---TKQRPIF--IITEYMANG--CLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES-KQ 120
Query: 260 VCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS--YICSRYYRAPELIFGATEY 317
HRD+ +N LVN +K+ DFG ++ ++ E S + PE++ +++
Sbjct: 121 FLHRDLAARNCLVNDQGV-VKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY-SKF 178
Query: 318 TTAIDMWSIGCVLAELL-LGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKF 376
++ D+W+ G ++ E+ LG+ + + + I + L
Sbjct: 179 SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL----------------RLYR 222
Query: 377 PQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420
P + + ++ R T ++
Sbjct: 223 PHL------------ASEKVYTIMYSCWHEKADERPTFKILLSN 254
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 142 bits (359), Expect = 1e-39
Identities = 62/309 (20%), Positives = 113/309 (36%), Gaps = 54/309 (17%)
Query: 138 SYMAERVVGTGSFGVVFQAKCLETGDS---VAIKKVL-----QDKRYKNRELQIMRLLNH 189
E+V+G G FG V G VAIK + + +R E IM +H
Sbjct: 27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH 86
Query: 190 PNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICR 249
PNV+ L+ T+ + ++ E++ + + ++ + I
Sbjct: 87 PNVIHLEGVV---TKSTPVM--IITEFMENGSLD--SFLRQNDGQFTVIQLVGMLRGIAA 139
Query: 250 ALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSR------ 303
+ YL + HRD+ +N+LVN + K+ DFG ++ L + +Y +
Sbjct: 140 GMKYLAD-MNYVHRDLAARNILVNSNLV-CKVSDFGLSRFLEDDTSDPTYTSALGGKIPI 197
Query: 304 YYRAPELIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVDQLVEIIKILGTPTRE 362
+ APE I ++T+A D+WS G V+ E++ G+ + + D + I + P
Sbjct: 198 RWTAPEAIQY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPM 256
Query: 363 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPF 422
+ P L+ Q + R +
Sbjct: 257 DC----------------------------PSALHQLMLDCWQKDRNHRPKFGQIVNT-L 287
Query: 423 FDDLRDPNT 431
+R+PN+
Sbjct: 288 DKMIRNPNS 296
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 4e-39
Identities = 54/300 (18%), Positives = 109/300 (36%), Gaps = 37/300 (12%)
Query: 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR---YKNRELQIMRLLNHPNVVS 194
+ + + +G G FG V++ K G+ VA+K + ++ E+ +L H N++
Sbjct: 4 TIVLQESIGKGRFGEVWRGK--WRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILG 61
Query: 195 LKHCFFSTTEKDELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
+ L LV +Y +++ YT + + L +
Sbjct: 62 F-IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGLAH 115
Query: 254 LHHVV-------GVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS-----YIC 301
LH + + HRD+K +N+LV I D G A I +
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILVK-KNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 174
Query: 302 SRYYRAPELIFGA-----TEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKIL 356
++ Y APE++ + E D++++G V E+ + G QL +
Sbjct: 175 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG-GIHEDYQLPYYDLVP 233
Query: 357 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALE 416
P+ EE++ + +++ + ++ ++ + + R TAL
Sbjct: 234 SDPSVEEMRKV------VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALR 287
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 4e-39
Identities = 59/299 (19%), Positives = 105/299 (35%), Gaps = 56/299 (18%)
Query: 142 ERVVGTGSFGVVFQAKC--LETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVV 193
++ +G+G+FG V + + +VA+K + + E +M+ L++P +V
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
+ E + L V+E Y + N+HV + +Q+ + Y
Sbjct: 72 RMIGIC----EAESWML--VMEMAELGPLN---KYLQQNRHVKDKNIIELVHQVSMGMKY 122
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS----YICSRYYRAPE 309
L HRD+ +N+L+ H KI DFG +K L E + APE
Sbjct: 123 LEES-NFVHRDLAARNVLLVTQ-HYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 180
Query: 310 LIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368
I ++++ D+WS G ++ E GQ + G G + + K
Sbjct: 181 CINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMG--------- 230
Query: 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA---HPFFD 424
P E DL++ Y R + ++D
Sbjct: 231 -------------------CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 7e-39
Identities = 65/314 (20%), Positives = 112/314 (35%), Gaps = 70/314 (22%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS-----VAIKKVLQDKRYKN-----RELQIM-RLLNHP 190
+V+G+G+FG V A + VA+K + + EL++M +L +H
Sbjct: 42 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 101
Query: 191 NVVSLKHCFFSTTEKDELYLNLVLEYIS------------------ETVYRVSKHYTRMN 232
N+V+L T +Y L+ EY E Y K
Sbjct: 102 NIVNLLGAC---TLSGPIY--LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 233 QHVPILYVQL--YTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290
+ + L + YQ+ + + +L HRD+ +N+LV +KICDFG A+ +
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEF-KSCVHRDLAARNVLVTHGKV-VKICDFGLARDI 214
Query: 291 VPGEPNISYICSR---YYRAPELIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGV 346
+ + +R + APE +F YT D+WS G +L E+ LG +PG
Sbjct: 215 MSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273
Query: 347 DQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQY 406
++I+ N + P E ++ +
Sbjct: 274 ANFYKLIQ---------------NGFKMDQP------------FYATEEIYIIMQSCWAF 306
Query: 407 SPSLRCTALEACAH 420
R + +
Sbjct: 307 DSRKRPSFPNLTSF 320
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 7e-39
Identities = 56/288 (19%), Positives = 96/288 (33%), Gaps = 51/288 (17%)
Query: 143 RVVGTGSFGVVFQAKCLETGDS---VAIKKVLQDKRYKN-------RELQIMRLLNHPNV 192
+G GSFGVV + + VA+K + D + RE+ M L+H N+
Sbjct: 14 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
+ L + + +V E + H + + Y Q+ +
Sbjct: 74 IRLYGVVLTP------PMKMVTELAPLGSLL--DRLRKHQGHFLLGTLSRYAVQVAEGMG 125
Query: 253 YLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI---SYICSRYYRAPE 309
YL HRD+ +NLL+ +KI DFG + L + + + +
Sbjct: 126 YLESK-RFIHRDLAARNLLLA-TRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183
Query: 310 LIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368
++ A D W G L E+ GQ + G +G L +I K R E
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPE----- 238
Query: 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALE 416
P + +++ + + P R T +
Sbjct: 239 ----------------------DCPQDIYNVMVQCWAHKPEDRPTFVA 264
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 1e-38
Identities = 65/303 (21%), Positives = 106/303 (34%), Gaps = 54/303 (17%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS--VAIKKVLQDKRYKN-----RELQIMRLLNHPNVVS 194
+ +G G+FG V Q VAIK + Q + RE QIM L++P +V
Sbjct: 14 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 73
Query: 195 LKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
L + + L L V+E + K + +P+ V +Q+ + YL
Sbjct: 74 LIGVC----QAEALML--VMEMAGGGP--LHKFLVGKREEIPVSNVAELLHQVSMGMKYL 125
Query: 255 HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSR----YYRAPEL 310
HRD+ +N+L+ + KI DFG +K L + + + + APE
Sbjct: 126 EEK-NFVHRDLAARNVLLVNRHY-AKISDFGLSKALGADDSYYTARSAGKWPLKWYAPEC 183
Query: 311 IFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369
I ++++ D+WS G + E L GQ + G + + I + E
Sbjct: 184 INF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPEC----- 237
Query: 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA---HPFFDDL 426
PPE L+S Y R L ++
Sbjct: 238 -----------------------PPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 274
Query: 427 RDP 429
Sbjct: 275 SKV 277
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 1e-38
Identities = 66/304 (21%), Positives = 112/304 (36%), Gaps = 53/304 (17%)
Query: 143 RVVGTGSFGVVFQAKCLETGDS----VAIKKVLQDKRYKN-----RELQIMRLLNHPNVV 193
+V+G+G+FG V++ + G+ VAIK++ + K E +M +++P+V
Sbjct: 15 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
L ++T + L+ + + + + ++ Y+ + QI + +NY
Sbjct: 75 RLLGICLTST------VQLITQLMPF--GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 126
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSR---YYRAPEL 310
L + HRD+ +N+LV H +KI DFG AK+L E + + A E
Sbjct: 127 LED-RRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184
Query: 311 IFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369
I YT D+WS G + EL+ G + G EI IL R
Sbjct: 185 ILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIP----ASEISSILEKGERLPQ----- 234
Query: 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDP 429
+ ++ + R E F RDP
Sbjct: 235 -------------------PPICTIDVYMIMVKCWMIDADSRPKFRELIIE-FSKMARDP 274
Query: 430 NTCL 433
L
Sbjct: 275 QRYL 278
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 137 bits (346), Expect = 8e-38
Identities = 53/280 (18%), Positives = 109/280 (38%), Gaps = 41/280 (14%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNHPNVVSLKHC 198
+ +G G +G V++ + +VA+K + +D +E +M+ + HPN+V L
Sbjct: 22 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 81
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV 258
T + Y+ + + + + V +LY QI A+ YL
Sbjct: 82 C---TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLY---MATQISSAMEYLEKK- 134
Query: 259 GVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSR--YYRAPELIFGATE 316
HRD+ +N LV + H +K+ DFG ++++ + APE + +
Sbjct: 135 NFIHRDLAARNCLVGEN-HLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY-NK 192
Query: 317 YTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKF 376
++ D+W+ G +L E+ + Q+ E+++ +++
Sbjct: 193 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-----------------KDYRM 235
Query: 377 PQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALE 416
+ P + +L+ Q++PS R + E
Sbjct: 236 E----------RPEGCPEKVYELMRACWQWNPSDRPSFAE 265
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (334), Expect = 7e-36
Identities = 53/293 (18%), Positives = 106/293 (36%), Gaps = 51/293 (17%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS---VAIKKVLQDKRYKN-----RELQIMRLLNHPNVV 193
V+G G FG V+ L+ A+K + + E IM+ +HPNV+
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
SL + E +VL Y+ R + + + + Q+ + + +
Sbjct: 92 SLLGICL----RSEGSPLVVLPYMKHGDLR--NFIRNETHNPTVKDLIGFGLQVAKGMKF 145
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRY-----YRAP 308
HRD+ +N +++ +K+ DFG A+ + E + + + + A
Sbjct: 146 -LASKKFVHRDLAARNCMLDEK-FTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 203
Query: 309 ELIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367
E + ++TT D+WS G +L EL+ G P +P + D V +++
Sbjct: 204 ESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ------------- 249
Query: 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420
+ + P +++ + +R + E +
Sbjct: 250 ---------------GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 8e-36
Identities = 66/293 (22%), Positives = 103/293 (35%), Gaps = 50/293 (17%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDS---VAIKKVLQDKRYKN-----RELQIMRLLNHP 190
R +G G FG V Q + + VAIK +E MR +HP
Sbjct: 9 IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 68
Query: 191 NVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRA 250
++V L E + +++E + R + + + LY YQ+ A
Sbjct: 69 HIVKLIGVI------TENPVWIIMELCTLGELR--SFLQVRKYSLDLASLILYAYQLSTA 120
Query: 251 LNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC--SRYYRAP 308
L YL HRDI +N+LV+ + +K+ DFG ++ + + + AP
Sbjct: 121 LAYLESK-RFVHRDIAARNVLVSSNDC-VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 178
Query: 309 ELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367
E I +T+A D+W G + E+L+ G F G D + I P
Sbjct: 179 ESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC--- 234
Query: 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420
PP L+++ Y PS R E A
Sbjct: 235 -------------------------PPTLYSLMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 3e-35
Identities = 64/305 (20%), Positives = 110/305 (36%), Gaps = 65/305 (21%)
Query: 142 ERVVGTGSFGVVFQAKCL-----ETGDSVAIKKVLQDKRYKN-----RELQIM-RLLNHP 190
+ +G G+FG V +A + +VA+K + EL+++ L NH
Sbjct: 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87
Query: 191 NVVSLKHCFFSTTEKDELYLNLVLEYIS----ETVYRVSKHYTRMNQHVPILY------- 239
N+V+L T + + EY R + ++ P +
Sbjct: 88 NIVNLLGAC---TIGGPTLV--ITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 240 ----VQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEP 295
+ ++YQ+ + + +L HRD+ +N+L+ KICDFG A+ +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASK-NCIHRDLAARNILLTHGRIT-KICDFGLARDIKNDSN 200
Query: 296 NISYICSR---YYRAPELIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVDQLVE 351
+ +R + APE IF YT D+WS G L EL LG +PG + +
Sbjct: 201 YVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259
Query: 352 IIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLR 411
+IK + + + P E D++ P R
Sbjct: 260 MIK---------------------------EGFRMLSPEHAPAEMYDIMKTCWDADPLKR 292
Query: 412 CTALE 416
T +
Sbjct: 293 PTFKQ 297
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 1e-34
Identities = 54/292 (18%), Positives = 100/292 (34%), Gaps = 50/292 (17%)
Query: 138 SYMAERVVGTGSFGVVFQAKCLETGDS----VAIKKVLQDKRYKN-----RELQIMRLLN 188
++V+G G FG V++ + VAIK + K E IM +
Sbjct: 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 67
Query: 189 HPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQIC 248
H N++ L+ + ++ EY+ K + +L + I
Sbjct: 68 HHNIIRLEGVIS-----KYKPMMIITEYMENGALD--KFLREKDGEFSVLQLVGMLRGIA 120
Query: 249 RALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC----SRY 304
+ YL + + HRD+ +N+LVN + K+ DFG +++L
Sbjct: 121 AGMKYLAN-MNYVHRDLAARNILVNSNLV-CKVSDFGLSRVLEDDPEATYTTSGGKIPIR 178
Query: 305 YRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEI 364
+ APE I ++T+A D+WS G V+ E++ E ++++ I
Sbjct: 179 WTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN---------- 227
Query: 365 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALE 416
+ P L+ + Q + R +
Sbjct: 228 -----------------DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFAD 262
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (321), Expect = 4e-34
Identities = 60/299 (20%), Positives = 109/299 (36%), Gaps = 54/299 (18%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS--VAIKKV-----LQDKRYKNRELQIM-RLLNHPNVV 193
+ V+G G+FG V +A+ + G AIK++ D R EL+++ +L +HPN++
Sbjct: 15 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 74
Query: 194 SLKHCFFSTTEKDELYL-----------NLVLEYISETVYRVSKHYTRMNQHVPILYVQL 242
+L + LYL + + + + +
Sbjct: 75 NLLGAC---EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 131
Query: 243 YTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICS 302
+ + R ++YL HRD+ +N+LV + + KI DFG ++
Sbjct: 132 FAADVARGMDYLSQK-QFIHRDLAARNILVGEN-YVAKIADFGLSRGQEVYVKKTMGRLP 189
Query: 303 RYYRAPELIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVDQLVEIIKILGTPTR 361
+ A E + + YTT D+WS G +L E++ LG + G + E+ + L R
Sbjct: 190 VRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT----CAELYEKLPQGYR 244
Query: 362 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420
E E DL+ + + P R + +
Sbjct: 245 LEKP------------------------LNCDDEVYDLMRQCWREKPYERPSFAQILVS 279
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 126 bits (316), Expect = 1e-33
Identities = 59/309 (19%), Positives = 104/309 (33%), Gaps = 71/309 (22%)
Query: 143 RVVGTGSFGVVFQAKC-----LETGDSVAIKKVLQDKRYKN-----RELQIMRLLNHPNV 192
R +G G+FG VFQA+ E VA+K + ++ RE +M ++PN+
Sbjct: 19 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 78
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYIS---------------------ETVYRVSKHYTRM 231
V + L + EY++ + ++ +
Sbjct: 79 V---KLLGVCAVGKPMCL--LFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 133
Query: 232 NQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291
+ Q+ + YL HRD+ +N LV + +KI DFG ++ +
Sbjct: 134 PPPLSCAEQLCIARQVAAGMAYLSER-KFVHRDLATRNCLVGENMV-VKIADFGLSRNIY 191
Query: 292 PGEPNI---SYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVD 347
+ + + PE IF YTT D+W+ G VL E+ G + G + +
Sbjct: 192 SADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE 250
Query: 348 QLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYS 407
+ + I A P + P E +L+
Sbjct: 251 VIYYVRD----------------------GNILACP------ENCPLELYNLMRLCWSKL 282
Query: 408 PSLRCTALE 416
P+ R +
Sbjct: 283 PADRPSFCS 291
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 1e-32
Identities = 64/309 (20%), Positives = 112/309 (36%), Gaps = 66/309 (21%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDS-------VAIKKVLQDKRYKN-----RELQIM-R 185
+ + +G G+FG V A+ + VA+K + D K+ E+++M
Sbjct: 15 LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKM 74
Query: 186 LLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISET-------------VYRVSKHYTRMN 232
+ H N+++L T+ LY+ ++EY S+ +
Sbjct: 75 IGKHKNIINLLGAC---TQDGPLYV--IVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 129
Query: 233 QHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292
+ + + YQ+ R + YL HRD+ +N+LV KI DFG A+ +
Sbjct: 130 EQLSSKDLVSCAYQVARGMEYLASK-KCIHRDLAARNVLVTEDNVM-KIADFGLARDIHH 187
Query: 293 GEPN---ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVDQ 348
+ + + APE +F YT D+WS G +L E+ LG +PG V++
Sbjct: 188 IDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-VEE 245
Query: 349 LVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSP 408
L +++K P E ++ P
Sbjct: 246 LFKLLK---------------EGHRMDKP------------SNCTNELYMMMRDCWHAVP 278
Query: 409 SLRCTALEA 417
S R T +
Sbjct: 279 SQRPTFKQL 287
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 1e-32
Identities = 59/306 (19%), Positives = 107/306 (34%), Gaps = 54/306 (17%)
Query: 139 YMAERVVGTGSFGVVFQAKC-----LETGDSVAIKKVLQD------KRYKNRELQIMRLL 187
+ +G G+FG V +A T +VA+K + + + + ++ +
Sbjct: 15 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG 74
Query: 188 NHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVP---------IL 238
+H NVV+L + + T R ++ + P +
Sbjct: 75 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 134
Query: 239 YVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI- 297
++ Y++Q+ + + +L HRD+ +N+L++ +KICDFG A+ + +
Sbjct: 135 HLICYSFQVAKGMEFLAS-RKCIHRDLAARNILLSEKNV-VKICDFGLARDIYKDPDYVR 192
Query: 298 --SYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLG-QPLFPGESGVDQLVEIIK 354
+ APE IF YT D+WS G +L E+ +PG ++ +K
Sbjct: 193 KGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 251
Query: 355 ILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTA 414
T + P PE + PS R T
Sbjct: 252 ---------------EGTRMRAPDY------------TTPEMYQTMLDCWHGEPSQRPTF 284
Query: 415 LEACAH 420
E H
Sbjct: 285 SELVEH 290
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (295), Expect = 2e-30
Identities = 57/312 (18%), Positives = 110/312 (35%), Gaps = 63/312 (20%)
Query: 142 ERVVGTGSFGVVFQAKC-----LETGDSVAIKKV-----LQDKRYKNRELQIMRLLNHPN 191
R +G GSFG+V++ E VAIK V ++++ E +M+ N +
Sbjct: 25 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 84
Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPIL------YVQLYT 244
VV ++ + ++E ++ + + + P+L +
Sbjct: 85 VV---RLLGVVSQGQPTLV--IMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 245 YQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC--- 301
+I + YL+ HRD+ +N +V +KI DFG + + +
Sbjct: 140 GEIADGMAYLNAN-KFVHRDLAARNCMVAEDFT-VKIGDFGMTRDIYETDYYRKGGKGLL 197
Query: 302 SRYYRAPELIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVDQLVEIIKILGTPT 360
+ +PE + +TT D+WS G VL E+ L + + G S L +++
Sbjct: 198 PVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME------ 250
Query: 361 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTA------ 414
P +L+ QY+P +R +
Sbjct: 251 ----------------------GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 288
Query: 415 LEACAHPFFDDL 426
++ P F ++
Sbjct: 289 IKEEMEPGFREV 300
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 85.2 bits (210), Expect = 5e-20
Identities = 29/204 (14%), Positives = 53/204 (25%), Gaps = 32/204 (15%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKV--------------LQDKRYKNRELQIMRLLN 188
+++G G VF E +K + +
Sbjct: 6 KLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64
Query: 189 HPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQIC 248
+ L+ +++E + V + I
Sbjct: 65 FRALQKLQGLAV-PKVYAWEGNAVLMEL----------IDAKELYRVRVENPDEVLDMIL 113
Query: 249 RALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAP 308
+ +H + H D+ N+LV + I DF + + GE I R R
Sbjct: 114 EEVAKFYHRG-IVHGDLSQYNVLV--SEEGIWIIDFPQSVEV--GEEGWREILERDVRNI 168
Query: 309 ELIFGATEYTTAIDMWSIGCVLAE 332
F Y T D+ S + +
Sbjct: 169 ITYFS-RTYRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 468 | |||
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.91 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.22 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.74 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.68 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.78 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.41 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.66 |
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-65 Score=507.19 Aligned_cols=329 Identities=70% Similarity=1.208 Sum_probs=300.7
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeecccchHHHHHHHHHHcCCCCcccccceeeecCC-CCceEEEEEee
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTE-KDELYLNLVLE 215 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~-~~~~~~~lv~e 215 (468)
.+|...++||+|+||+||+|+++.+|+.||||++..+.....+|+.+|++++||||++++++|..... .+..++|||||
T Consensus 20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~E 99 (350)
T d1q5ka_ 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD 99 (350)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEE
T ss_pred CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEe
Confidence 36999999999999999999999999999999998887777899999999999999999999876543 45678999999
Q ss_pred cccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCCCCC
Q 012233 216 YISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEP 295 (468)
Q Consensus 216 ~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~~~~ 295 (468)
||+++++..+.........+++..++.++.||+.||+|||+ +||+||||||+|||++.++..+||+|||+++.......
T Consensus 100 y~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~-~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~ 178 (350)
T d1q5ka_ 100 YVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 178 (350)
T ss_dssp CCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTSC
T ss_pred ccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHh-cCCcccCCCcceEEEecCCCceeEecccchhhccCCcc
Confidence 99999888777777777889999999999999999999998 99999999999999998766799999999998877777
Q ss_pred CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccCC
Q 012233 296 NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFK 375 (468)
Q Consensus 296 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 375 (468)
....+||+.|+|||++.+...|+.++|||||||++|||++|++||...+..+++.++++.++.+..+.+....+.+....
T Consensus 179 ~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~ 258 (350)
T d1q5ka_ 179 NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 258 (350)
T ss_dssp CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCC
T ss_pred cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhcc
Confidence 77889999999999998777799999999999999999999999999999999999999999999999999999999999
Q ss_pred CCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCCCCCCCCCCCCCcccccCHHHHhcCCH
Q 012233 376 FPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNTCLPNGRPLPTLFNFTAQELAGASN 455 (468)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 455 (468)
++.....+|.......+++++.+||.+||++||.+|||+.|+|+||||+++..++..+++.++++.+++|+.+|+... .
T Consensus 259 ~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~-~ 337 (350)
T d1q5ka_ 259 FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSN-P 337 (350)
T ss_dssp CCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTTCCCTTSCCCCCCCCCCHHHHTTC-G
T ss_pred ccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccCCCCCCCCCCCCCccCCCCHhhccCC-c
Confidence 999999999888889999999999999999999999999999999999999999999999999999999999998764 4
Q ss_pred HHHHhccccccc
Q 012233 456 ELRQRLIPEHAR 467 (468)
Q Consensus 456 ~~~~~~~~~~~~ 467 (468)
++...++|+|+|
T Consensus 338 ~~~~~~~p~~~r 349 (350)
T d1q5ka_ 338 PLATILIPPHAR 349 (350)
T ss_dssp GGHHHHSCTTTT
T ss_pred cccccCCCcccc
Confidence 577889999998
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-58 Score=447.30 Aligned_cols=277 Identities=34% Similarity=0.598 Sum_probs=229.7
Q ss_pred eceecccCceEEEEEEEcCCCCEEEEEEeeccc---------chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEE
Q 012233 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (468)
Q Consensus 142 ~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~---------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~l 212 (468)
+++||+|+||+||+|+++.+|+.||||++.... ....+|+.+|+.++|||||+++++| .+..++||
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~-----~~~~~~~i 77 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAF-----GHKSNISL 77 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEE-----CCTTCCEE
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeee-----ccCCceee
Confidence 578999999999999999999999999985332 2355899999999999999999999 44455899
Q ss_pred EeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCC
Q 012233 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (468)
Q Consensus 213 v~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~ 292 (468)
|||||.++++..+. .....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++....
T Consensus 78 vmE~~~~~~~~~~~---~~~~~l~~~~~~~~~~qil~aL~~lH~-~~iiHrDiKp~NIli~~~~-~~KL~DFG~a~~~~~ 152 (299)
T d1ua2a_ 78 VFDFMETDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQ-HWILHRDLKPNNLLLDENG-VLKLADFGLAKSFGS 152 (299)
T ss_dssp EEECCSEEHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTC-CEEECCCGGGSTTTS
T ss_pred hhhhhcchHHhhhh---hcccCCCHHHHHHHHHHHHHHHHHhhc-cceecccCCcceEEecCCC-ccccccCccccccCC
Confidence 99999988776443 335668889999999999999999998 9999999999999999888 799999999987644
Q ss_pred CC-CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCC
Q 012233 293 GE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNY 371 (468)
Q Consensus 293 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 371 (468)
.. .....+||+.|+|||++.+...|+.++|||||||++|||++|.+||.+.+..+++.+|.+.++.|....+.......
T Consensus 153 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~ 232 (299)
T d1ua2a_ 153 PNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP 232 (299)
T ss_dssp CCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSST
T ss_pred CcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccc
Confidence 33 34467899999999999776668999999999999999999999999999999999999999998876654433333
Q ss_pred ccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCC
Q 012233 372 TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDP 429 (468)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~ 429 (468)
....+......++.. ..+.+++++++||.+||++||.+|||+.|+|+||||++.+.+
T Consensus 233 ~~~~~~~~~~~~~~~-~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p 289 (299)
T d1ua2a_ 233 DYVTFKSFPGIPLHH-IFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP 289 (299)
T ss_dssp TCCCCCCCCCCCHHH-HCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCC
T ss_pred hhhhhccCCCCChHH-hcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCC
Confidence 333333333333333 335689999999999999999999999999999999986544
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-58 Score=441.29 Aligned_cols=254 Identities=28% Similarity=0.327 Sum_probs=208.7
Q ss_pred ccceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc-----cchHHHHHHHHHHcCCCCcccccceeeecCCCCceEE
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~-----~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~ 210 (468)
.++|++.+.||+|+||+||+|.++.+|+.||||++... .....+|+.+|+.++|||||++++++. +...+
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~-----~~~~~ 78 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR-----EGNIQ 78 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEE-----ETTEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeec-----cCcee
Confidence 45799999999999999999999999999999998543 234568999999999999999999994 34468
Q ss_pred EEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcccc
Q 012233 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (468)
Q Consensus 211 ~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~ 290 (468)
|||||||.++.+. .+......+++..++.++.||+.||.|||+ +||+||||||+||||+.++ .+||+|||+|+..
T Consensus 79 ~ivmEy~~gg~L~---~~l~~~~~l~e~~~~~i~~qi~~al~ylH~-~~IiHrDiKp~NILl~~~~-~~KL~DFG~a~~~ 153 (271)
T d1nvra_ 79 YLFLEYCSGGELF---DRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERD-NLKISDFGLATVF 153 (271)
T ss_dssp EEEEECCTTEEGG---GGSBTTTBCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECTTC-CEEECCCTTCEEC
T ss_pred EEEEeccCCCcHH---HHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCCccCcccHHHEEECCCC-CEEEccchhheee
Confidence 9999999875332 222335679999999999999999999998 8999999999999999888 7999999999876
Q ss_pred CCCC---CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 012233 291 VPGE---PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367 (468)
Q Consensus 291 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 367 (468)
.... .....+||+.|||||++.+...++.++|||||||++|||++|++||...................
T Consensus 154 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~-------- 225 (271)
T d1nvra_ 154 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY-------- 225 (271)
T ss_dssp EETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTT--------
T ss_pred ccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC--------
Confidence 4322 34467899999999999876656788999999999999999999998766544433333210000
Q ss_pred CCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q 012233 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDD 425 (468)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~ 425 (468)
...+..+++++++||.+||+.||.+|||++|+|+||||++
T Consensus 226 ------------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 226 ------------------LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp ------------------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred ------------------CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence 0012457999999999999999999999999999999975
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-58 Score=443.44 Aligned_cols=253 Identities=32% Similarity=0.552 Sum_probs=212.4
Q ss_pred ccceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc-------cchHHHHHHHHHHcCCCCcccccceeeecCCCCce
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~-------~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 208 (468)
.++|++++.||+|+||+||+|+++.+|+.||||++.+. .....+|+++|++++|||||+++++| .+..
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~~ 81 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF-----QDDE 81 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEE-----ECSS
T ss_pred CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEE-----EECC
Confidence 35799999999999999999999999999999998542 13456899999999999999999998 4555
Q ss_pred EEEEEeecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCc
Q 012233 209 YLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (468)
Q Consensus 209 ~~~lv~e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a 287 (468)
.+|||||||.++ +.+.+. ..+.+++..++.++.||+.||+|||+ +|||||||||+||||+.++ .+||+|||+|
T Consensus 82 ~~~ivmEy~~gg~L~~~~~----~~~~l~e~~~~~~~~qi~~al~ylH~-~~iiHrDiKp~NIll~~~~-~vkl~DFG~a 155 (288)
T d1uu3a_ 82 KLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNEDM-HIQITDFGTA 155 (288)
T ss_dssp EEEEEECCCTTEEHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTS-CEEECCCTTC
T ss_pred EEEEEEEccCCCCHHHhhh----ccCCCCHHHHHHHHHHHHHHHHhhcc-ccEEcCcCCccccccCCCc-eEEecccccc
Confidence 689999999975 444333 24679999999999999999999998 8999999999999999888 7999999999
Q ss_pred cccCCCC---CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 012233 288 KMLVPGE---PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEI 364 (468)
Q Consensus 288 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 364 (468)
+.+.... .....+||+.|+|||++.+.. |+.++|||||||++|||++|++||.+.+..+.+.+|.+.
T Consensus 156 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~-~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~--------- 225 (288)
T d1uu3a_ 156 KVLSPESKQARANSFVGTAQYVSPELLTEKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL--------- 225 (288)
T ss_dssp EECC----------CCCCGGGCCHHHHHTCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTT---------
T ss_pred eecccCCcccccccccCCccccCceeeccCC-CCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcC---------
Confidence 8764332 234568999999999997654 899999999999999999999999998877777666541
Q ss_pred hhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHH------HhCCCCCCCCCCC
Q 012233 365 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALE------ACAHPFFDDLRDP 429 (468)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~e------ll~hp~f~~~~~~ 429 (468)
.+. ++..+++++++||.+||+.||.+|||++| +++||||+++.-.
T Consensus 226 --------~~~------------~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~ 276 (288)
T d1uu3a_ 226 --------EYD------------FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWE 276 (288)
T ss_dssp --------CCC------------CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCT
T ss_pred --------CCC------------CCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHH
Confidence 112 33468999999999999999999999988 5889999998543
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-58 Score=437.24 Aligned_cols=247 Identities=31% Similarity=0.480 Sum_probs=211.5
Q ss_pred ccceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc-------cchHHHHHHHHHHcCCCCcccccceeeecCCCCce
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~-------~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 208 (468)
.++|.+.+.||+|+||+||+|+++.+|+.||+|++.+. .....+|+.+|+.++|||||++++++ .+..
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~ 79 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF-----HDAT 79 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSS
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEE-----EECC
Confidence 45799999999999999999999999999999998532 23346799999999999999999998 4555
Q ss_pred EEEEEeecccchHH-HHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCc
Q 012233 209 YLNLVLEYISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (468)
Q Consensus 209 ~~~lv~e~~~~~ll-~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a 287 (468)
.+|||||||+++.+ ..+.. ...+++..++.++.||+.||+|||+ +||+||||||+||||+.++ .+||+|||+|
T Consensus 80 ~~~ivmEy~~~g~L~~~l~~----~~~l~e~~~~~i~~qi~~al~~lH~-~~ivHrDiKp~Nill~~~~-~~kl~DFG~a 153 (263)
T d2j4za1 80 RVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHS-KRVIHRDIKPENLLLGSAG-ELKIADFGWS 153 (263)
T ss_dssp EEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTS-CEEECCCCSC
T ss_pred EEEEEEeecCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeeeeccccceecCCC-CEeeccccee
Confidence 69999999996544 43332 4569999999999999999999998 8999999999999999888 7999999999
Q ss_pred cccCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 012233 288 KMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367 (468)
Q Consensus 288 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 367 (468)
+..... .....+||+.|+|||++.+.. |+.++|||||||++|||++|+.||.+.+..+.+..+.+.
T Consensus 154 ~~~~~~-~~~~~~Gt~~Y~APE~~~~~~-~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~------------ 219 (263)
T d2j4za1 154 VHAPSS-RRTTLCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV------------ 219 (263)
T ss_dssp SCCCCC-CCEETTEEGGGCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT------------
T ss_pred eecCCC-cccccCCCCcccCHHHHcCCC-CCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcC------------
Confidence 865433 345678999999999997654 899999999999999999999999988777766665431
Q ss_pred CCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCC
Q 012233 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFD 424 (468)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~ 424 (468)
.+. +++.+++++++||.+||+.||.+|||+.|+|+||||+
T Consensus 220 -----~~~------------~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~ 259 (263)
T d2j4za1 220 -----EFT------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 259 (263)
T ss_dssp -----CCC------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHH
T ss_pred -----CCC------------CCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcC
Confidence 111 3345899999999999999999999999999999996
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-58 Score=444.18 Aligned_cols=250 Identities=24% Similarity=0.386 Sum_probs=213.1
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc----chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEEE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV 213 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv 213 (468)
+|.+.+.||+|+||+||+|.++.+|+.||||++.... ....+|+.+|+.++|||||+++++|.. ..++|||
T Consensus 21 ~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~~~iv 95 (293)
T d1yhwa1 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-----GDELWVV 95 (293)
T ss_dssp TBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEEEE
T ss_pred ccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEE-----CCEEEEE
Confidence 5999999999999999999999999999999985432 345689999999999999999999843 4458999
Q ss_pred eecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCCC
Q 012233 214 LEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293 (468)
Q Consensus 214 ~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~~ 293 (468)
||||.++.+..+.. ...+++..++.++.||+.||.|||+ +|||||||||+||||+.++ .+||+|||+|+.+...
T Consensus 96 mEy~~gg~L~~~~~----~~~l~~~~~~~i~~qi~~aL~yLH~-~~iiHrDiKp~NILl~~~~-~vkl~DFG~a~~~~~~ 169 (293)
T d1yhwa1 96 MEYLAGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPE 169 (293)
T ss_dssp EECCTTCBHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTC-CEEECCCTTCEECCST
T ss_pred EEecCCCcHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCcHHHeEECCCC-cEeeccchhheeeccc
Confidence 99999765543322 3569999999999999999999998 8999999999999999888 7999999999877543
Q ss_pred C-CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCc
Q 012233 294 E-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYT 372 (468)
Q Consensus 294 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 372 (468)
. .....+||+.|+|||++.+. .|+.++|||||||++|+|++|++||.+.+..+.+..+......+
T Consensus 170 ~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~------------- 235 (293)
T d1yhwa1 170 QSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPE------------- 235 (293)
T ss_dssp TCCBCCCCSCGGGCCHHHHSSS-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCC-------------
T ss_pred cccccccccCCCccChhhhcCC-CCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCC-------------
Confidence 3 44567899999999999765 48999999999999999999999999988887777766531100
Q ss_pred cCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q 012233 373 EFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDD 425 (468)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~ 425 (468)
+ ..+..+++++++||.+||+.||.+|||+.|+|+||||+.
T Consensus 236 -~------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 236 -L------------QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp -C------------SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred -C------------CCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence 0 123458999999999999999999999999999999974
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-57 Score=438.53 Aligned_cols=283 Identities=33% Similarity=0.618 Sum_probs=231.8
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc------cchHHHHHHHHHHcCCCCcccccceeeecCCCCceEE
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~------~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~ 210 (468)
++|.+.+.||+|+||+||+|++..+|+.||||++... .....+|+++|++++|||||+++++|. +...+
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~-----~~~~~ 76 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH-----TENKL 76 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEE-----ETTEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccc-----cccce
Confidence 5799999999999999999999999999999998543 234567999999999999999999994 44468
Q ss_pred EEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcccc
Q 012233 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (468)
Q Consensus 211 ~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~ 290 (468)
|+||||+.++++..... .....+++..++.++.||+.||.|||+ +|||||||||+|||++.++ .+||+|||+|+..
T Consensus 77 ~iv~e~~~~~~~~~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH~-~~IiHrDiKpeNIl~~~~~-~~kl~DFG~a~~~ 152 (298)
T d1gz8a_ 77 YLVFEFLHQDLKKFMDA--SALTGIPLPLIKSYLFQLLQGLAFCHS-HRVLHRDLKPQNLLINTEG-AIKLADFGLARAF 152 (298)
T ss_dssp EEEEECCSEEHHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTS-CEEECSTTHHHHH
T ss_pred eEEEeecCCchhhhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhc-CCEEccccCchheeecccC-cceeccCCcceec
Confidence 99999999987765433 235669999999999999999999998 9999999999999999888 7999999999876
Q ss_pred CC-CCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 012233 291 VP-GEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (468)
Q Consensus 291 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 369 (468)
.. ........||+.|+|||++.....++.++|||||||++|+|++|+.||.+.+..+.+.++....+.+....+.....
T Consensus 153 ~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 232 (298)
T d1gz8a_ 153 GVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 232 (298)
T ss_dssp CCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred cCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccc
Confidence 43 33455678999999999987777678999999999999999999999999999999999999888876554432111
Q ss_pred CC-ccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCC
Q 012233 370 NY-TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDP 429 (468)
Q Consensus 370 ~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~ 429 (468)
.. ....++......+ ......+++++++||.+||++||.+|||+.|+|+||||+++.+|
T Consensus 233 ~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p 292 (298)
T d1gz8a_ 233 MPDYKPSFPKWARQDF-SKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292 (298)
T ss_dssp STTCCTTSCCCCCCCH-HHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred ccccccccccccccch-hhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence 00 0111111111111 12335688999999999999999999999999999999998665
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-56 Score=434.06 Aligned_cols=285 Identities=33% Similarity=0.565 Sum_probs=234.9
Q ss_pred cceEEeceecccCceEEEEEEEcCC-CCEEEEEEeecc------cchHHHHHHHHHHc---CCCCcccccceeeecCCCC
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLET-GDSVAIKKVLQD------KRYKNRELQIMRLL---NHPNVVSLKHCFFSTTEKD 206 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~-g~~vaiK~~~~~------~~~~~~E~~il~~l---~hpnIv~l~~~~~~~~~~~ 206 (468)
.+|++.+.||+|+||+||+|++..+ ++.||||++... .....+|+.+|+.| +||||++++++|.......
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~ 86 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 86 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence 4799999999999999999999765 567999998532 22345788887776 7999999999987666566
Q ss_pred ceEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecC
Q 012233 207 ELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (468)
Q Consensus 207 ~~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~ 286 (468)
..+++++|||+.++.+..... .....+++..++.++.||+.||+|||+ +|||||||||+|||++.++ .+||+|||+
T Consensus 87 ~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~-~~ivHrDiKp~NILi~~~~-~~kl~dfg~ 162 (305)
T d1blxa_ 87 ETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHS-HRVVHRDLKPQNILVTSSG-QIKLADFGL 162 (305)
T ss_dssp EEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTC-CEEECSCCS
T ss_pred CceEEEEEEeccCCchhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHHh-CCEEecCCCccEEEEcCCC-Ceeecchhh
Confidence 778999999999987765433 335678999999999999999999998 9999999999999999888 799999999
Q ss_pred ccccCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 012233 287 AKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKC 366 (468)
Q Consensus 287 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 366 (468)
++...........+||+.|+|||++.+.. |+.++|||||||++|||++|++||.+.+..+.+.++++.++.+....+..
T Consensus 163 ~~~~~~~~~~~~~~gT~~Y~APE~~~~~~-y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 241 (305)
T d1blxa_ 163 ARIYSFQMALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 241 (305)
T ss_dssp CCCCCGGGGGCCCCCCCTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCT
T ss_pred hhhhcccccCCCcccChhhcCcchhcCCC-CChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccc
Confidence 98766556666789999999999997654 99999999999999999999999999999999999999999887765543
Q ss_pred cCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCC
Q 012233 367 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRD 428 (468)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~ 428 (468)
..... ...+......+ ...+...+++++++||.+||++||.+|||+.|+|+||||+++..
T Consensus 242 ~~~~~-~~~~~~~~~~~-~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~ 301 (305)
T d1blxa_ 242 DVALP-RQAFHSKSAQP-IEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 301 (305)
T ss_dssp TCSSC-GGGSCCCCCCC-GGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred cccch-hhhhccccccc-hhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchh
Confidence 21111 11111111111 23355678999999999999999999999999999999999853
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-57 Score=441.58 Aligned_cols=252 Identities=29% Similarity=0.475 Sum_probs=198.2
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-----chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEE
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 211 (468)
+.|.+.+.||+|+||+||+|+++.+|+.||||++.+.. ....+|+.+|+.++|||||+++++| .+..++|
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-----~~~~~~~ 83 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIY-----ESGGHLY 83 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEE-----ECSSEEE
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCEEE
Confidence 45999999999999999999999999999999986432 2345799999999999999999998 4555799
Q ss_pred EEeecccc-hHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecC---CCCcEEEeeecCc
Q 012233 212 LVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNP---HTHQLKICDFGSA 287 (468)
Q Consensus 212 lv~e~~~~-~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~---~~~~vkL~DFG~a 287 (468)
||||||.| +|.+.+. ....+++..++.++.||+.||.|||+ +||+||||||+|||+.. ++ .+||+|||+|
T Consensus 84 lvmE~~~gg~L~~~l~----~~~~l~e~~~~~~~~qi~~al~ylH~-~~iiHrDiKp~Nil~~~~~~~~-~vkl~DFG~a 157 (307)
T d1a06a_ 84 LIMQLVSGGELFDRIV----EKGFYTERDASRLIFQVLDAVKYLHD-LGIVHRDLKPENLLYYSLDEDS-KIMISDFGLS 157 (307)
T ss_dssp EEECCCCSCBHHHHHH----TCSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESSSSTTC-CEEECCC---
T ss_pred EEEeccCCCcHHHhhh----cccCCCHHHHHHHHHHHHHHHHhhhh-ceeeeEEecccceeecccCCCc-eEEEecccee
Confidence 99999985 4555443 25679999999999999999999998 89999999999999953 45 7999999999
Q ss_pred cccCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 012233 288 KMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367 (468)
Q Consensus 288 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 367 (468)
+...........+||+.|+|||++.+.. |+.++|||||||++|||++|++||.+.+..+....+.+..
T Consensus 158 ~~~~~~~~~~~~~GT~~y~APE~~~~~~-~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~----------- 225 (307)
T d1a06a_ 158 KMEDPGSVLSTACGTPGYVAPEVLAQKP-YSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAE----------- 225 (307)
T ss_dssp ---------------CTTSCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTC-----------
T ss_pred EEccCCCeeeeeeeCccccCcHHHcCCC-CCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccC-----------
Confidence 8776666666788999999999997654 8999999999999999999999999888777766665521
Q ss_pred CCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q 012233 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDD 425 (468)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~ 425 (468)
..++ ..+++.+|+++++||.+||++||.+|||+.|+|+||||+.
T Consensus 226 ------~~~~--------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 269 (307)
T d1a06a_ 226 ------YEFD--------SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG 269 (307)
T ss_dssp ------CCCC--------TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred ------CCCC--------CccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence 1111 1133568999999999999999999999999999999975
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-57 Score=434.23 Aligned_cols=254 Identities=26% Similarity=0.386 Sum_probs=202.8
Q ss_pred ccceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc------chHHHHHHHHHHcCCCCcccccceeeecCCCCceE
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 209 (468)
.++|++.+.||+|+||+||+|+++.+|+.||||++.... ..+.+|+++|++++|||||++++++... ....
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~---~~~~ 79 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR---TNTT 79 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC-------C
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeC---CCCE
Confidence 457999999999999999999999999999999985432 2345799999999999999999988542 2335
Q ss_pred EEEEeecccc-hHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCC-----ccccCCCCCCeeecCCCCcEEEee
Q 012233 210 LNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG-----VCHRDIKPQNLLVNPHTHQLKICD 283 (468)
Q Consensus 210 ~~lv~e~~~~-~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~g-----ivHrDlkp~NILl~~~~~~vkL~D 283 (468)
+|||||||++ ++.+++.........+++..++.++.||+.||.|||+ +| ||||||||+||||+.++ .+||+|
T Consensus 80 ~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~-~~~~~~~IiHrDiKp~NIll~~~~-~vkl~D 157 (269)
T d2java1 80 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR-RSDGGHTVLHRDLKPANVFLDGKQ-NVKLGD 157 (269)
T ss_dssp EEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH-HCC---------CCGGGEEECTTS-CEEECC
T ss_pred EEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH-hcCCCCCEEeCcCchhhcCcCCCC-cEEEee
Confidence 8899999986 5556555555567789999999999999999999997 55 99999999999999888 799999
Q ss_pred ecCccccCCCC-CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 012233 284 FGSAKMLVPGE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTRE 362 (468)
Q Consensus 284 FG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~ 362 (468)
||+|+.+.... .....+||+.|+|||++.+. .|+.++|||||||++|||++|++||.+.+..+...++...
T Consensus 158 FG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~------- 229 (269)
T d2java1 158 FGLARILNHDTSFAKAFVGTPYYMSPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG------- 229 (269)
T ss_dssp HHHHHHC-----------CCCSCCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT-------
T ss_pred ccceeecccCCCccccCCCCcccCCHHHHcCC-CCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcC-------
Confidence 99998765433 33467899999999999665 4999999999999999999999999988877766665541
Q ss_pred HHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 012233 363 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (468)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f 423 (468)
.++ .++..+|+++++||.+||+.||.+|||+.|+|+|||+
T Consensus 230 ------------~~~---------~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 230 ------------KFR---------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp ------------CCC---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred ------------CCC---------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 000 1334689999999999999999999999999999996
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-57 Score=431.04 Aligned_cols=250 Identities=23% Similarity=0.338 Sum_probs=206.5
Q ss_pred eEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc------chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEE
Q 012233 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (468)
Q Consensus 139 y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~l 212 (468)
|++.+.||+|+||+||+|.+..+++.||+|++.... ..+.+|+++|++++|||||+++++|.... .+...+||
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-~~~~~~~i 89 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIVL 89 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSCEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecc-ccCCEEEE
Confidence 578889999999999999999999999999985432 23468999999999999999999986544 34567899
Q ss_pred EeecccchHH-HHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCC--ccccCCCCCCeeecC-CCCcEEEeeecCcc
Q 012233 213 VLEYISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG--VCHRDIKPQNLLVNP-HTHQLKICDFGSAK 288 (468)
Q Consensus 213 v~e~~~~~ll-~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~g--ivHrDlkp~NILl~~-~~~~vkL~DFG~a~ 288 (468)
|||||+++.+ +.+.. ...+++..++.++.||+.||+|||+ +| |+||||||+||||+. ++ .+||+|||+|+
T Consensus 90 vmE~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~gl~yLH~-~~~~IiHrDiKp~NILl~~~~~-~~Kl~DFGla~ 163 (270)
T d1t4ha_ 90 VTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTG-SVKIGDLGLAT 163 (270)
T ss_dssp EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-SSSCCCCSCCCGGGEEESSTTS-CEEECCTTGGG
T ss_pred EEeCCCCCcHHHHHhc----cccccHHHHHHHHHHHHHHHHHHHH-CCCCEEeCCcChhhceeeCCCC-CEEEeecCcce
Confidence 9999987544 33322 4568999999999999999999997 78 999999999999975 55 79999999997
Q ss_pred ccCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 012233 289 MLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368 (468)
Q Consensus 289 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 368 (468)
... .......+||+.|||||++.+ .++.++|||||||++|||++|+.||.+......+.+.+.....|
T Consensus 164 ~~~-~~~~~~~~GT~~Y~aPE~~~~--~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~--------- 231 (270)
T d1t4ha_ 164 LKR-ASFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP--------- 231 (270)
T ss_dssp GCC-TTSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC---------
T ss_pred ecc-CCccCCcccCccccCHHHhCC--CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCC---------
Confidence 643 333456789999999999864 48999999999999999999999998876666554433211000
Q ss_pred CCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCC
Q 012233 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFD 424 (468)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~ 424 (468)
..++..+++++++||.+||++||++|||++|+|+||||+
T Consensus 232 -----------------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 232 -----------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp -----------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred -----------------cccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 113456889999999999999999999999999999996
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3.9e-57 Score=445.77 Aligned_cols=259 Identities=26% Similarity=0.417 Sum_probs=218.5
Q ss_pred ccceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc----chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEE
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 211 (468)
.++|.+.+.||+|+||.||+|+++.+|+.||||++.... ..+.+|+.+|+.++|||||+++++|. +...+|
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~~~~ 99 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE-----DDNEMV 99 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEE-----ETTEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECCEEE
Confidence 347999999999999999999999999999999986542 33457999999999999999999984 444689
Q ss_pred EEeecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCC-CCcEEEeeecCccc
Q 012233 212 LVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPH-THQLKICDFGSAKM 289 (468)
Q Consensus 212 lv~e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~-~~~vkL~DFG~a~~ 289 (468)
||||||.|+ +.+.+. .....+++..++.++.||+.||.|||+ +|||||||||+||||+.+ ...+||+|||+|+.
T Consensus 100 ivmE~~~gg~L~~~l~---~~~~~l~e~~~~~i~~qi~~aL~ylH~-~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~ 175 (350)
T d1koaa2 100 MIYEFMSGGELFEKVA---DEHNKMSEDEAVEYMRQVCKGLCHMHE-NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH 175 (350)
T ss_dssp EEECCCCSCBHHHHHT---CTTSCBCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSTTSCCEEECCCTTCEE
T ss_pred EEEEcCCCCCHHHHHH---hhcCCCCHHHHHHHHHHHHHHHHHHHh-cCCeeeeechhHeeeccCCCCeEEEeecchhee
Confidence 999999865 444332 234569999999999999999999998 999999999999999643 23799999999998
Q ss_pred cCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 012233 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (468)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 369 (468)
+.........+||+.|||||++.+.. |+.++|||||||++|+|++|+.||.+.+..+.+.+|......
T Consensus 176 ~~~~~~~~~~~gT~~Y~aPEv~~~~~-~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~----------- 243 (350)
T d1koaa2 176 LDPKQSVKVTTGTAEFAAPEVAEGKP-VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWN----------- 243 (350)
T ss_dssp CCTTSCEEEECSCTTTCCHHHHHTCC-BCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC-----------
T ss_pred cccccccceecCcccccCHHHHcCCC-CChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-----------
Confidence 87766677789999999999998755 899999999999999999999999998888877777653211
Q ss_pred CCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCC
Q 012233 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDP 429 (468)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~ 429 (468)
++ ......+++++++||.+||+.||.+|||+.|+|+||||+....+
T Consensus 244 ------~~--------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~~ 289 (350)
T d1koaa2 244 ------MD--------DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAP 289 (350)
T ss_dssp ------SC--------CGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTCC
T ss_pred ------CC--------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCCC
Confidence 11 11234589999999999999999999999999999999986543
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=4.1e-57 Score=445.96 Aligned_cols=256 Identities=29% Similarity=0.424 Sum_probs=217.9
Q ss_pred ccceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc----chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEE
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 211 (468)
.+.|++.+.||+|+||+||+|.++.+|+.||||++.... ....+|+.+|+.|+|||||+++++| .+...+|
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~~~~~ 102 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF-----EDKYEMV 102 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEE-----ECSSEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCEEE
Confidence 356999999999999999999999999999999986543 3345799999999999999999998 4555689
Q ss_pred EEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeec--CCCCcEEEeeecCccc
Q 012233 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVN--PHTHQLKICDFGSAKM 289 (468)
Q Consensus 212 lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~--~~~~~vkL~DFG~a~~ 289 (468)
||||||.|+.|.. ........+++..++.++.||+.||.|||+ +|||||||||+||||+ .++ .+||+|||+|+.
T Consensus 103 ivmE~~~gg~L~~--~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~-~~iiHRDiKp~NILl~~~~~~-~vkL~DFGla~~ 178 (352)
T d1koba_ 103 LILEFLSGGELFD--RIAAEDYKMSEAEVINYMRQACEGLKHMHE-HSIVHLDIKPENIMCETKKAS-SVKIIDFGLATK 178 (352)
T ss_dssp EEEECCCCCBHHH--HTTCTTCCBCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSTTCC-CEEECCCTTCEE
T ss_pred EEEEcCCCChHHH--HHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecccccccccccccCCC-eEEEeeccccee
Confidence 9999999764421 222334569999999999999999999998 9999999999999997 344 799999999998
Q ss_pred cCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 012233 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (468)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 369 (468)
+..........||+.|+|||++.+.. |+.++|||||||++|+|++|++||.+.+..+.+..+....
T Consensus 179 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~------------- 244 (352)
T d1koba_ 179 LNPDEIVKVTTATAEFAAPEIVDREP-VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCD------------- 244 (352)
T ss_dssp CCTTSCEEEECSSGGGCCHHHHTTCC-BCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCC-------------
T ss_pred cCCCCceeeccCcccccCHHHHcCCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-------------
Confidence 87777777789999999999997654 9999999999999999999999999988888877776521
Q ss_pred CCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q 012233 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426 (468)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 426 (468)
+.++ ...+..+++++++||.+||++||.+|||+.|+|+||||+..
T Consensus 245 ----~~~~--------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 245 ----WEFD--------EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp ----CCCC--------SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred ----CCCC--------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 1111 11335689999999999999999999999999999999864
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-57 Score=435.70 Aligned_cols=254 Identities=26% Similarity=0.370 Sum_probs=211.3
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc----cchHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEE
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~----~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~l 212 (468)
+.|++.+.||+|+||+||+|+++.+|+.||||++... ...+.+|+++|+.++|||||+++++|.. ...+||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-----~~~~~l 86 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYY-----ENNLWI 86 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-----CCeEEE
Confidence 3599999999999999999999999999999998543 2345689999999999999999999843 445899
Q ss_pred EeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCC
Q 012233 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (468)
Q Consensus 213 v~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~ 292 (468)
|||||.++.+..+.. .....+++..++.++.||+.||.|||+ +||+||||||+||||+.++ .+||+|||+|+....
T Consensus 87 vmEy~~~g~L~~~~~--~~~~~l~e~~~~~i~~qi~~gL~ylH~-~~ivHrDiKp~NIll~~~~-~~Kl~DFG~a~~~~~ 162 (288)
T d2jfla1 87 LIEFCAGGAVDAVML--ELERPLTESQIQVVCKQTLDALNYLHD-NKIIHRDLKAGNILFTLDG-DIKLADFGVSAKNTR 162 (288)
T ss_dssp EEECCTTEEHHHHHH--HHTSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTS-CEEECCCTTCEECHH
T ss_pred EEecCCCCcHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHH-CCEEEeecChhheeECCCC-CEEEEechhhhccCC
Confidence 999999765543322 224669999999999999999999998 8999999999999999888 799999999976532
Q ss_pred C-CCCccccccCCccccccccC----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 012233 293 G-EPNISYICSRYYRAPELIFG----ATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367 (468)
Q Consensus 293 ~-~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 367 (468)
. ......+||+.|+|||++.+ ...|+.++|||||||++|||++|++||.+.+..+.+.++.... +
T Consensus 163 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~--~-------- 232 (288)
T d2jfla1 163 TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSE--P-------- 232 (288)
T ss_dssp HHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSC--C--------
T ss_pred CcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC--C--------
Confidence 2 12335789999999999842 3348899999999999999999999999988888777766521 0
Q ss_pred CCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q 012233 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDD 425 (468)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~ 425 (468)
..+ ..+..+++++++||.+||+.||.+|||+.|+|+||||+.
T Consensus 233 ----~~~------------~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~ 274 (288)
T d2jfla1 233 ----PTL------------AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV 274 (288)
T ss_dssp ----CCC------------SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred ----CCC------------CccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 000 123458999999999999999999999999999999974
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-56 Score=439.86 Aligned_cols=252 Identities=27% Similarity=0.426 Sum_probs=216.3
Q ss_pred ccceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc-------cchHHHHHHHHHHcCCCCcccccceeeecCCCCce
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~-------~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 208 (468)
.++|.+++.||+|+||.||+|+++.+|+.||||++.+. .....+|+.+|+.++|||||+++++| .+..
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----~~~~ 78 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHD 78 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE-----ECSS
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeee-----cccc
Confidence 45799999999999999999999999999999998643 23345799999999999999999999 5566
Q ss_pred EEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcc
Q 012233 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (468)
Q Consensus 209 ~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~ 288 (468)
++|+|||||.|+.+... ......+++..++.++.||+.||+|||+ +|||||||||+|||++.++ .+||+|||+|+
T Consensus 79 ~~~iv~ey~~gg~L~~~---~~~~~~~~e~~~~~~~~qil~al~ylH~-~~iiHRDlKP~NILl~~~g-~vkl~DFG~a~ 153 (337)
T d1o6la_ 79 RLCFVMEYANGGELFFH---LSRERVFTEERARFYGAEIVSALEYLHS-RDVVYRDIKLENLMLDKDG-HIKITDFGLCK 153 (337)
T ss_dssp EEEEEEECCTTCBHHHH---HHHHSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTS-CEEECCCTTCB
T ss_pred ccccceeccCCCchhhh---hhcccCCcHHHHHHHHHHHhhhhhhhhh-cCccccccCHHHeEecCCC-CEEEeeccccc
Confidence 79999999997655322 2234678999999999999999999998 8999999999999999998 79999999998
Q ss_pred ccCC-CCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 012233 289 MLVP-GEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367 (468)
Q Consensus 289 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 367 (468)
.... .......+||+.|+|||++.+.. |+.++|||||||++|||++|++||.+.+..+.+..+..
T Consensus 154 ~~~~~~~~~~~~~GT~~Y~aPE~~~~~~-y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~------------- 219 (337)
T d1o6la_ 154 EGISDGATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM------------- 219 (337)
T ss_dssp CSCCTTCCBCCCEECGGGCCGGGGSSSC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-------------
T ss_pred ccccCCcccccceeCHHHhhhhhccCCC-CChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhc-------------
Confidence 7643 34455689999999999997654 89999999999999999999999999887776666554
Q ss_pred CCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCC-----HHHHhCCCCCCCCC
Q 012233 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCT-----ALEACAHPFFDDLR 427 (468)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s-----~~ell~hp~f~~~~ 427 (468)
.... ++..+|+++++||.+||++||.+|++ +.|+++||||+++.
T Consensus 220 ----~~~~------------~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~ 268 (337)
T d1o6la_ 220 ----EEIR------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 268 (337)
T ss_dssp ----CCCC------------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred ----CCCC------------CCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccCC
Confidence 1122 34568999999999999999999994 99999999999863
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-57 Score=434.59 Aligned_cols=255 Identities=25% Similarity=0.405 Sum_probs=216.4
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc----------cchHHHHHHHHHHcCCCCcccccceeeecCCCC
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD 206 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~----------~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 206 (468)
+.|.+++.||+|+||+||+|+++.+|+.||||++.+. ...+.+|+.+|++++|||||+++++| .+
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~ 84 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY-----EN 84 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----EC
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EE
Confidence 4699999999999999999999999999999998542 13356899999999999999999998 45
Q ss_pred ceEEEEEeecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCC---cEEEe
Q 012233 207 ELYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTH---QLKIC 282 (468)
Q Consensus 207 ~~~~~lv~e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~---~vkL~ 282 (468)
...+|||||||.++ +.+.+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++. .+||+
T Consensus 85 ~~~~~iv~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~qi~~al~yLH~-~~ivHrDiKp~Nill~~~~~~~~~vkl~ 159 (293)
T d1jksa_ 85 KTDVILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHS-LQIAHFDLKPENIMLLDRNVPKPRIKII 159 (293)
T ss_dssp SSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESCSSSSSCCEEEC
T ss_pred CCEEEEEEEcCCCccccchhcc----ccccchhHHHHHHHHHHHHHHhhhh-cceeecccccceEEEecCCCcccceEec
Confidence 56799999999865 4444332 3579999999999999999999998 89999999999999987653 49999
Q ss_pred eecCccccCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 012233 283 DFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTRE 362 (468)
Q Consensus 283 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~ 362 (468)
|||+|+............||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+.+..+......
T Consensus 160 DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~---- 234 (293)
T d1jksa_ 160 DFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE---- 234 (293)
T ss_dssp CCTTCEECTTSCBCSCCCCCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCC----
T ss_pred chhhhhhcCCCccccccCCCCcccCHHHHcCC-CCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC----
Confidence 99999887766666678899999999999765 4899999999999999999999999998888777776552111
Q ss_pred HHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q 012233 363 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (468)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~ 427 (468)
+...+++.+|+++++||++||+.||.+|||++|+|+||||+...
T Consensus 235 ---------------------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 278 (293)
T d1jksa_ 235 ---------------------FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 278 (293)
T ss_dssp ---------------------CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC--
T ss_pred ---------------------CCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 11223456899999999999999999999999999999998753
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.9e-56 Score=435.24 Aligned_cols=249 Identities=28% Similarity=0.486 Sum_probs=215.0
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc-------cchHHHHHHHHHHcCCCCcccccceeeecCCCCceE
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~-------~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 209 (468)
.+|++.+.||+|+||+||+|+++.+|+.||||++.+. .....+|+.+|+.++|||||++++++ .+..+
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~~ 78 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF-----QDAQQ 78 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEE-----ECSSE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeE-----eeCCe
Confidence 4699999999999999999999999999999998543 23456799999999999999999998 45557
Q ss_pred EEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccc
Q 012233 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (468)
Q Consensus 210 ~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~ 289 (468)
+|+|||||.|+.+... ......+++..++.++.||+.||.|||+ +|||||||||+||||+.++ .+||+|||+|+.
T Consensus 79 ~~ivmE~~~gg~l~~~---~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~iiHrDiKp~NILl~~~g-~vkL~DFG~a~~ 153 (316)
T d1fota_ 79 IFMIMDYIEGGELFSL---LRKSQRFPNPVAKFYAAEVCLALEYLHS-KDIIYRDLKPENILLDKNG-HIKITDFGFAKY 153 (316)
T ss_dssp EEEEECCCCSCBHHHH---HHHTSSCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECTTS-CEEECCCSSCEE
T ss_pred eeeEeeecCCcccccc---ccccccccccHHHHHHHHHHHhhhhhcc-CcEEccccCchheeEcCCC-CEEEecCccceE
Confidence 9999999998755432 2335678899999999999999999998 9999999999999999988 799999999987
Q ss_pred cCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 012233 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (468)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 369 (468)
... .....+||+.|+|||++.+.. |+.++|||||||++|||++|+.||.+.+..+.+.++...
T Consensus 154 ~~~--~~~~~~Gt~~Y~APE~l~~~~-y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~-------------- 216 (316)
T d1fota_ 154 VPD--VTYTLCGTPDYIAPEVVSTKP-YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA-------------- 216 (316)
T ss_dssp CSS--CBCCCCSCTTTCCHHHHTTCC-BCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC--------------
T ss_pred ecc--ccccccCcccccCHHHHcCCC-CCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcC--------------
Confidence 643 344678999999999997654 899999999999999999999999998888877777651
Q ss_pred CCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCC-----CHHHHhCCCCCCCCC
Q 012233 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC-----TALEACAHPFFDDLR 427 (468)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~-----s~~ell~hp~f~~~~ 427 (468)
... ++..++++++++|.+||++||.+|+ |++++++||||+++.
T Consensus 217 ---~~~------------~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~ 264 (316)
T d1fota_ 217 ---ELR------------FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVV 264 (316)
T ss_dssp ---CCC------------CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCC
T ss_pred ---CCC------------CCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCC
Confidence 111 3345899999999999999999996 999999999999874
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.6e-57 Score=436.07 Aligned_cols=248 Identities=27% Similarity=0.426 Sum_probs=211.4
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-------chHHHHHHHHHHcCCCCcccccceeeecCCCCceEE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~ 210 (468)
.|.+.+.||+|+||+||+|++..+|+.||||++.... ..+.+|+.+|+.++|||||+++++|.. ...+
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-----~~~~ 90 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----EHTA 90 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEE-----CCEE
Confidence 4999999999999999999999999999999986432 234579999999999999999999843 3458
Q ss_pred EEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcccc
Q 012233 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (468)
Q Consensus 211 ~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~ 290 (468)
|||||||.++++..... ....+++..++.++.||+.||.|||+ +|||||||||+||||+.++ .+||+|||+|+..
T Consensus 91 ~iv~E~~~~g~l~~~~~---~~~~l~e~~~~~i~~qi~~aL~yLH~-~~iiHrDiKp~NILl~~~~-~~Kl~DFG~a~~~ 165 (309)
T d1u5ra_ 91 WLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHS-HNMIHRDVKAGNILLSEPG-LVKLGDFGSASIM 165 (309)
T ss_dssp EEEEECCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSGGGEEEETTT-EEEECCCTTCBSS
T ss_pred EEEEEecCCCchHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeccCCCcceEEECCCC-CEEEeeccccccc
Confidence 99999999887764332 34679999999999999999999998 9999999999999999888 7999999999865
Q ss_pred CCCCCCccccccCCccccccccCC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 012233 291 VPGEPNISYICSRYYRAPELIFGA--TEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368 (468)
Q Consensus 291 ~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 368 (468)
.. ....+||+.|||||++.+. ..|+.++|||||||++|||++|+.||.+.+..+.+..+.....
T Consensus 166 ~~---~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~----------- 231 (309)
T d1u5ra_ 166 AP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES----------- 231 (309)
T ss_dssp SS---BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-----------
T ss_pred CC---CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC-----------
Confidence 33 3457899999999998643 3489999999999999999999999999888777777665210
Q ss_pred CCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q 012233 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDD 425 (468)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~ 425 (468)
+. ..+..+|+++++||.+||+.||.+|||++|+|+||||..
T Consensus 232 --------~~--------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~ 272 (309)
T d1u5ra_ 232 --------PA--------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (309)
T ss_dssp --------CC--------CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred --------CC--------CCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcC
Confidence 00 012457899999999999999999999999999999975
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-57 Score=442.30 Aligned_cols=279 Identities=25% Similarity=0.397 Sum_probs=205.1
Q ss_pred cccceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-----chHHHHHHHHHHcCCCCcccccceeeecCCCCceE
Q 012233 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (468)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 209 (468)
..++|++.+.||+|+||+||+|+++.+|+.||+|++.... ....+|+.+|+.++|||||+++++| .+...
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-----~~~~~ 78 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF-----YSDGE 78 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEE-----ECSSE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCE
Confidence 3467999999999999999999999999999999986432 2346799999999999999999999 44456
Q ss_pred EEEEeecccchHH-HHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcc
Q 012233 210 LNLVLEYISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (468)
Q Consensus 210 ~~lv~e~~~~~ll-~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~ 288 (468)
+|||||||.++.+ .++.. ...+++..++.++.||+.||.|||+.+||+||||||+||||+.++ .+||+|||+|+
T Consensus 79 ~~iVmEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~-~vkl~DFGla~ 153 (322)
T d1s9ja_ 79 ISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSG 153 (322)
T ss_dssp EEEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTC-CEEECCCCCCH
T ss_pred EEEEEEcCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCC-CEEEeeCCCcc
Confidence 8999999997544 43332 356999999999999999999999624999999999999999888 79999999998
Q ss_pred ccCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHHhCCCCHHHHhhc
Q 012233 289 MLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQ-LVEIIKILGTPTREEIKCM 367 (468)
Q Consensus 289 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~ 367 (468)
..... ...+.+||+.|+|||++.+.. |+.++|||||||++|||++|+.||.+.+..+. ...+....+.+........
T Consensus 154 ~~~~~-~~~~~~GT~~Y~APEvl~~~~-y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (322)
T d1s9ja_ 154 QLIDS-MANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 231 (322)
T ss_dssp HHHHH-TC---CCSSCCCCHHHHHCSC-CCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------
T ss_pred ccCCC-ccccccCCccccCchHHcCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccc
Confidence 66432 334679999999999998765 99999999999999999999999987664432 2222222222111100000
Q ss_pred CCC-----CccCCCCc---------ccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q 012233 368 NPN-----YTEFKFPQ---------IKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDD 425 (468)
Q Consensus 368 ~~~-----~~~~~~~~---------~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~ 425 (468)
... +.....+. +............++.++++||.+||++||.+|||++|+|+||||++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~ 303 (322)
T d1s9ja_ 232 TPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 303 (322)
T ss_dssp --------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred cccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence 000 00000000 00000001112346889999999999999999999999999999975
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.4e-55 Score=424.10 Aligned_cols=277 Identities=33% Similarity=0.608 Sum_probs=224.6
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc------cchHHHHHHHHHHcCCCCcccccceeeecCCCCceEE
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~------~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~ 210 (468)
++|.+.+.||+|+||+||+|+++ +|+.||||++... ...+.+|+.+|+.++|||||+++++|. +....
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~~~ 75 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIH-----TKKRL 75 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEE-----CSSCE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecc-----cCCce
Confidence 47999999999999999999985 7899999998543 234568999999999999999999994 44458
Q ss_pred EEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcccc
Q 012233 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (468)
Q Consensus 211 ~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~ 290 (468)
+++|||+.++++..+. .....+++..++.++.||+.||+|||+ .|||||||||+||||+.++ .+||+|||.+...
T Consensus 76 ~i~~e~~~~~~~~~~~---~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~IvHrDiKp~NIll~~~~-~~kl~DfG~a~~~ 150 (286)
T d1ob3a_ 76 VLVFEHLDQDLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYCHD-RRVLHRDLKPQNLLINREG-ELKIADFGLARAF 150 (286)
T ss_dssp EEEEECCSEEHHHHHH---TSTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTS-CEEECCTTHHHHH
T ss_pred eEEEEeehhhhHHHHH---hhcCCcchhhhHHHHHHHHHHHHHhcc-CcEEecCCCCceeeEcCCC-CEEecccccceec
Confidence 8999999998877554 335779999999999999999999998 8999999999999999988 7999999999876
Q ss_pred CCCC-CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 012233 291 VPGE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (468)
Q Consensus 291 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 369 (468)
.... ......+++.|+|||.+.+...++.++|||||||++|||++|++||.+.+..+++.++....+.+....+.....
T Consensus 151 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 230 (286)
T d1ob3a_ 151 GIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE 230 (286)
T ss_dssp CC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred ccCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhh
Confidence 4332 344567899999999998777789999999999999999999999999999999999999888877655433211
Q ss_pred CC-ccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q 012233 370 NY-TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDD 425 (468)
Q Consensus 370 ~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~ 425 (468)
.. ....+......++ ..+...++++++|||.+||++||++|||+.|+|+||||++
T Consensus 231 ~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 231 LPKYDPNFTVYEPLPW-ESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp STTCCTTCCCCCCCCG-GGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred hhhcccccccccCcch-hhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 10 0111111111222 3345678999999999999999999999999999999975
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.1e-55 Score=421.87 Aligned_cols=253 Identities=28% Similarity=0.438 Sum_probs=215.9
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-------------chHHHHHHHHHHcC-CCCcccccceeeec
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------------RYKNRELQIMRLLN-HPNVVSLKHCFFST 202 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-------------~~~~~E~~il~~l~-hpnIv~l~~~~~~~ 202 (468)
++|++.+.||+|+||+||+|+++.+|+.||||++.+.. ....+|+.+|++++ |||||+++++|
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~--- 79 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY--- 79 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE---
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeec---
Confidence 47999999999999999999999999999999986532 12457999999997 99999999999
Q ss_pred CCCCceEEEEEeecccc-hHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEE
Q 012233 203 TEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKI 281 (468)
Q Consensus 203 ~~~~~~~~~lv~e~~~~-~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL 281 (468)
.+...+|||||||.+ ++.+.+.. ...+++..++.++.||+.||+|||+ +||+||||||+||||+.++ .+||
T Consensus 80 --~~~~~~~ivmE~~~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~~lH~-~~ivHrDlkp~Nill~~~~-~~kl 151 (277)
T d1phka_ 80 --ETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHK-LNIVHRDLKPENILLDDDM-NIKL 151 (277)
T ss_dssp --ECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTC-CEEE
T ss_pred --ccCcceEEEEEcCCCchHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-cCCcccccccceEEEcCCC-CeEE
Confidence 555679999999986 55555432 4579999999999999999999998 8999999999999999888 7999
Q ss_pred eeecCccccCCCCCCccccccCCccccccccC-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh
Q 012233 282 CDFGSAKMLVPGEPNISYICSRYYRAPELIFG-----ATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKIL 356 (468)
Q Consensus 282 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~ 356 (468)
+|||+++.+.........+||+.|+|||.+.+ ...++.++||||+||++|+|++|++||.+.+..+....+...-
T Consensus 152 ~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~ 231 (277)
T d1phka_ 152 TDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGN 231 (277)
T ss_dssp CCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred ccchheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCC
Confidence 99999998876666677889999999999853 3347889999999999999999999999988877777766521
Q ss_pred CCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q 012233 357 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDD 425 (468)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~ 425 (468)
..++ ......+|+++++||.+||+.||.+|||++|+|+||||++
T Consensus 232 -----------------~~~~--------~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 232 -----------------YQFG--------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp -----------------CCCC--------TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred -----------------CCCC--------CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 1111 0122458999999999999999999999999999999986
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.3e-55 Score=435.15 Aligned_cols=251 Identities=27% Similarity=0.435 Sum_probs=214.0
Q ss_pred cccceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-------chHHHHHHHHHHcCCCCcccccceeeecCCCCc
Q 012233 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (468)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 207 (468)
..++|++++.||+|+||.||+|+++.+|+.||||++.+.. ....+|+.+|+.++|||||+++++| .+.
T Consensus 39 ~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~ 113 (350)
T d1rdqe_ 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-----KDN 113 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECS
T ss_pred CccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccc-----ccc
Confidence 3467999999999999999999999999999999985431 2345799999999999999999998 455
Q ss_pred eEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCc
Q 012233 208 LYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (468)
Q Consensus 208 ~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a 287 (468)
..+++||||+.++.+.... .....+++..++.++.||+.||.|||+ +|||||||||+||||+.++ .+||+|||+|
T Consensus 114 ~~~~~v~e~~~~g~l~~~l---~~~~~l~e~~~~~i~~qi~~aL~yLH~-~~iiHRDIKP~NILl~~~g-~ikL~DFG~a 188 (350)
T d1rdqe_ 114 SNLYMVMEYVAGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLHS-LDLIYRDLKPENLLIDQQG-YIQVTDFGFA 188 (350)
T ss_dssp SEEEEEEECCTTCBHHHHH---HHHCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTS-CEEECCCTTC
T ss_pred cccccccccccccchhhhH---hhcCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCcCCHHHcccCCCC-CEEeeeceee
Confidence 5689999999876443222 123569999999999999999999998 8999999999999999888 7999999999
Q ss_pred cccCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 012233 288 KMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367 (468)
Q Consensus 288 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 367 (468)
+.+.. .....+||+.|||||++.+.. |+.++|||||||++|||++|++||.+.+....+.+|...
T Consensus 189 ~~~~~--~~~~~~Gt~~Y~APE~~~~~~-~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~------------ 253 (350)
T d1rdqe_ 189 KRVKG--RTWTLCGTPEALAPEIILSKG-YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG------------ 253 (350)
T ss_dssp EECSS--CBCCCEECGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------------
T ss_pred eeccc--ccccccCccccCCHHHHcCCC-CCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcC------------
Confidence 87643 344678999999999997654 899999999999999999999999998877777776551
Q ss_pred CCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCC-----CHHHHhCCCCCCCCC
Q 012233 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC-----TALEACAHPFFDDLR 427 (468)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~-----s~~ell~hp~f~~~~ 427 (468)
... ++..+++++.+||.+||++||.+|+ |++++++||||+++.
T Consensus 254 -----~~~------------~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~ 301 (350)
T d1rdqe_ 254 -----KVR------------FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTD 301 (350)
T ss_dssp -----CCC------------CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCC
T ss_pred -----CCC------------CCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCC
Confidence 111 2346899999999999999999995 999999999999864
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.6e-55 Score=436.80 Aligned_cols=254 Identities=24% Similarity=0.368 Sum_probs=206.2
Q ss_pred ccceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-------chHHH---HHHHHHHcCCCCcccccceeeecCCC
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNR---ELQIMRLLNHPNVVSLKHCFFSTTEK 205 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-------~~~~~---E~~il~~l~hpnIv~l~~~~~~~~~~ 205 (468)
.++|.+.++||+|+||.||+|+++.+|+.||||++.+.. ....+ |+.+++.++|||||+++++| .
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~-----~ 77 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-----H 77 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE-----E
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEE-----E
Confidence 457999999999999999999999999999999985432 12223 45666677899999999998 4
Q ss_pred CceEEEEEeecccchH-HHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeee
Q 012233 206 DELYLNLVLEYISETV-YRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDF 284 (468)
Q Consensus 206 ~~~~~~lv~e~~~~~l-l~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DF 284 (468)
+...+|||||||.++. ...+.. ...+++..++.++.||+.||.|||+ +|||||||||+||||+.++ .+||+||
T Consensus 78 ~~~~~~ivmE~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~ylH~-~~iiHrDlKP~NILl~~~g-~iKl~DF 151 (364)
T d1omwa3 78 TPDKLSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHN-RFVVYRDLKPANILLDEHG-HVRISDL 151 (364)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECSSS-CEEECCC
T ss_pred ECCEEEEEEEecCCCcHHHHHHh----cccccHHHHHHHHHHHHHHHHHHHH-CCccceeeccceeEEcCCC-cEEEeee
Confidence 4556899999999654 443332 4668899999999999999999998 9999999999999999888 7999999
Q ss_pred cCccccCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 012233 285 GSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEI 364 (468)
Q Consensus 285 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 364 (468)
|+|+..... .....+||+.|+|||++.+...|+.++|||||||++|||++|+.||.+.+..+... +......
T Consensus 152 Gla~~~~~~-~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~-~~~~~~~------ 223 (364)
T d1omwa3 152 GLACDFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTLT------ 223 (364)
T ss_dssp TTCEECSSS-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHH-HHHHSSS------
T ss_pred ceeeecCCC-cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhccc------
Confidence 999876543 34567899999999999766668999999999999999999999998765443322 2221100
Q ss_pred hhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCC-----HHHHhCCCCCCCCC
Q 012233 365 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCT-----ALEACAHPFFDDLR 427 (468)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s-----~~ell~hp~f~~~~ 427 (468)
.. ..++..+++++++||.+||++||.+||| ++|+++||||+++.
T Consensus 224 -------~~------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~ 272 (364)
T d1omwa3 224 -------MA------------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD 272 (364)
T ss_dssp -------CC------------CCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCC
T ss_pred -------CC------------CCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCC
Confidence 00 1134568999999999999999999999 79999999999864
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-56 Score=431.63 Aligned_cols=255 Identities=28% Similarity=0.423 Sum_probs=216.5
Q ss_pred ccceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc---chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEE
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~---~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~l 212 (468)
.++|.+++.||+|+||+||+|.++.+|+.||||++.... ....+|+++|+.++|||||+++++|. +..++||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~-----~~~~~~l 78 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFE-----SMEELVM 78 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEE-----ETTEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEE-----ECCEEEE
Confidence 457999999999999999999999999999999996543 23568999999999999999999984 4446999
Q ss_pred Eeecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCC-CcEEEeeecCcccc
Q 012233 213 VLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHT-HQLKICDFGSAKML 290 (468)
Q Consensus 213 v~e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~-~~vkL~DFG~a~~~ 290 (468)
|||||.|+ +.+.+. .....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ ..+||+|||+++..
T Consensus 79 vmE~~~gg~L~~~i~---~~~~~l~e~~~~~i~~qi~~al~yLH~-~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~ 154 (321)
T d1tkia_ 79 IFEFISGLDIFERIN---TSAFELNEREIVSYVHQVCEALQFLHS-HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp EECCCCCCBHHHHHT---SSSCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred EEecCCCCcHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHH-cCCCcccccccceeecCCCceEEEEcccchhhcc
Confidence 99999975 444332 223468999999999999999999998 8999999999999997543 37999999999887
Q ss_pred CCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCC
Q 012233 291 VPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPN 370 (468)
Q Consensus 291 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 370 (468)
..........+|+.|+|||.+.+.. |+.++|||||||++|+|++|.+||.+.+..+.+..|.+....++.
T Consensus 155 ~~~~~~~~~~~t~~y~ape~~~~~~-~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~--------- 224 (321)
T d1tkia_ 155 KPGDNFRLLFTAPEYYAPEVHQHDV-VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDE--------- 224 (321)
T ss_dssp CTTCEEEEEESCGGGSCHHHHTTCE-ECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCH---------
T ss_pred ccCCcccccccccccccchhccCCC-CCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCh---------
Confidence 6666566778999999999997654 899999999999999999999999999888888887763222111
Q ss_pred CccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q 012233 371 YTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDD 425 (468)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~ 425 (468)
..++.+++++++||.+||+.||.+|||+.|+|+||||++
T Consensus 225 ----------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~ 263 (321)
T d1tkia_ 225 ----------------EAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263 (321)
T ss_dssp ----------------HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred ----------------hhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence 133468999999999999999999999999999999975
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-54 Score=425.70 Aligned_cols=284 Identities=34% Similarity=0.607 Sum_probs=226.4
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc------chHHHHHHHHHHcCCCCcccccceeeecCC-CCceE
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTE-KDELY 209 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~-~~~~~ 209 (468)
.+|++++.||+|+||+||+|.++.+|+.||||++.... ....+|+.+|+.++|||||+++++|..... .....
T Consensus 18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~ 97 (346)
T d1cm8a_ 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 97 (346)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccce
Confidence 46999999999999999999999999999999986432 234579999999999999999999855432 23345
Q ss_pred EEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccc
Q 012233 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (468)
Q Consensus 210 ~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~ 289 (468)
+|||||||+..+..+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+|+.
T Consensus 98 ~~lv~e~~~~~l~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~-~~IiHrDiKp~NIL~~~~~-~~kl~Dfg~a~~ 170 (346)
T d1cm8a_ 98 FYLVMPFMGTDLGKLMK-----HEKLGEDRIQFLVYQMLKGLRYIHA-AGIIHRDLKPGNLAVNEDC-ELKILDFGLARQ 170 (346)
T ss_dssp CEEEEECCSEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTC-CEEECCCTTCEE
T ss_pred EEEEEecccccHHHHHH-----hccccHHHHHHHHHHHHHHHHHHHh-CCCcccccCcchhhccccc-ccccccccceec
Confidence 78999999877666543 3569999999999999999999998 8999999999999999988 799999999987
Q ss_pred cCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 012233 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (468)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 369 (468)
.. ......+||+.|+|||++.+...++.++||||+||++|+|++|++||.+.+..+.+..+....+.++...+.....
T Consensus 171 ~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (346)
T d1cm8a_ 171 AD--SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 248 (346)
T ss_dssp CC--SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred cC--CccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcc
Confidence 53 3345678999999999998777689999999999999999999999999999999999999999888766544321
Q ss_pred CCc---cCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCCC
Q 012233 370 NYT---EFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPN 430 (468)
Q Consensus 370 ~~~---~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~ 430 (468)
... ...++......+.. ....+++++++||.+||++||.+|||+.|+|+||||+++.+..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~ 311 (346)
T d1cm8a_ 249 DEAKNYMKGLPELEKKDFAS-ILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTE 311 (346)
T ss_dssp HHHHHHHHHSCCCCCCCGGG-TCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC---
T ss_pred hhhhhhhccCCcccccchHH-hccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCcc
Confidence 110 01112222222222 3456899999999999999999999999999999999987543
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-55 Score=425.95 Aligned_cols=251 Identities=27% Similarity=0.467 Sum_probs=210.0
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-------chHHHHHHHH-HHcCCCCcccccceeeecCCCCce
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIM-RLLNHPNVVSLKHCFFSTTEKDEL 208 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-------~~~~~E~~il-~~l~hpnIv~l~~~~~~~~~~~~~ 208 (468)
++|.+++.||+|+||+||+|+++.+|+.||||++.++. ....+|..++ +.++|||||+++++| .+..
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~-----~~~~ 76 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF-----QTKE 76 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE-----ECSS
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEE-----ccCC
Confidence 46999999999999999999999999999999986432 1233455555 578999999999998 4555
Q ss_pred EEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcc
Q 012233 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (468)
Q Consensus 209 ~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~ 288 (468)
++|||||||.++.+.... .....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++
T Consensus 77 ~~yivmEy~~~g~L~~~i---~~~~~~~e~~~~~~~~qi~~al~ylH~-~~iiHrDikp~NiL~~~~~-~~kl~DFG~a~ 151 (320)
T d1xjda_ 77 NLFFVMEYLNGGDLMYHI---QSCHKFDLSRATFYAAEIILGLQFLHS-KGIVYRDLKLDNILLDKDG-HIKIADFGMCK 151 (320)
T ss_dssp EEEEEEECCTTCBHHHHH---HHHSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTS-CEEECCCTTCB
T ss_pred ceeEEEeecCCCcHHHHh---hccCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCcccceeecCCC-ceeccccchhh
Confidence 699999999975444222 224668999999999999999999998 8999999999999999888 79999999998
Q ss_pred ccCCCC-CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 012233 289 MLVPGE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367 (468)
Q Consensus 289 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 367 (468)
...... .....+||+.|+|||++.+.. |+.++|||||||++|||++|+.||.+.+..+.+.++...
T Consensus 152 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~------------ 218 (320)
T d1xjda_ 152 ENMLGDAKTNTFCGTPDYIAPEILLGQK-YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD------------ 218 (320)
T ss_dssp CCCCTTCCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------------
T ss_pred hcccccccccccCCCCCcCCHHHHcCCC-CCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcC------------
Confidence 664433 344578999999999997655 899999999999999999999999998877776666441
Q ss_pred CCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHH-HHhCCCCCCCCC
Q 012233 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTAL-EACAHPFFDDLR 427 (468)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~-ell~hp~f~~~~ 427 (468)
... +++.+|+++++||.+||++||.+|||+. ++++||||+++.
T Consensus 219 -----~~~------------~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~~ 262 (320)
T d1xjda_ 219 -----NPF------------YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN 262 (320)
T ss_dssp -----CCC------------CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred -----CCC------------CCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccCC
Confidence 111 3356899999999999999999999995 899999999874
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-54 Score=423.54 Aligned_cols=312 Identities=34% Similarity=0.622 Sum_probs=239.9
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeecccc-----hHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR-----YKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~~-----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~l 212 (468)
+|++++.||+|+||+||+|.++.+|+.||||++.+... ...+|+.+|+.++||||+++++++.........++|+
T Consensus 9 rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l 88 (345)
T d1pmea_ 9 RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYL 88 (345)
T ss_dssp TEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred CeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEE
Confidence 59999999999999999999999999999999864322 3357999999999999999999986655444556778
Q ss_pred EeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCC
Q 012233 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (468)
Q Consensus 213 v~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~ 292 (468)
+|++++++|.+++.. ..+++..++.++.||+.||+|||+ +|||||||||+||||+.++ .+||+|||+++....
T Consensus 89 ~~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH~-~~iiHRDIKp~NILl~~~~-~~kl~DfG~a~~~~~ 161 (345)
T d1pmea_ 89 VTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLNTTC-DLKICDFGLARVADP 161 (345)
T ss_dssp EEECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTC-CEEECCCTTCEECCG
T ss_pred EEeecCCchhhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCCcCCCCCcceEEECCCC-CEEEcccCceeeccC
Confidence 888887888776542 469999999999999999999998 8999999999999999888 799999999976643
Q ss_pred CC----CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 012233 293 GE----PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368 (468)
Q Consensus 293 ~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 368 (468)
.. .....+||+.|+|||++.....++.++||||+||++|+|++|+.||.+.+..+....+...+..+.........
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (345)
T d1pmea_ 162 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 241 (345)
T ss_dssp GGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCC
T ss_pred CCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhh
Confidence 32 23456789999999999766668999999999999999999999999999989888888888887765443211
Q ss_pred CCC---ccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCCCCCCCCCCCCCccccc
Q 012233 369 PNY---TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNTCLPNGRPLPTLFNF 445 (468)
Q Consensus 369 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~ 445 (468)
... .....+.....+|.. ....+++++++||.+||++||.+|||++|+|+||||+....+...... +..++|
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~~~~~~~----~~~~~~ 316 (345)
T d1pmea_ 242 NLKARNYLLSLPHKNKVPWNR-LFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIA----EAPFKF 316 (345)
T ss_dssp CHHHHHHHHTSCCCCCCCHHH-HCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCGGGSCCC----SSCC--
T ss_pred hhhhhcccccCCccCCCCHHH-hCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCCccCccc----cCccCC
Confidence 000 111222223333333 335689999999999999999999999999999999987766543211 223445
Q ss_pred CHHHHhcCCHHHHHhcc
Q 012233 446 TAQELAGASNELRQRLI 462 (468)
Q Consensus 446 ~~~~~~~~~~~~~~~~~ 462 (468)
+ .+..+.+.|.++.++
T Consensus 317 ~-~~~~~~~~~~l~~l~ 332 (345)
T d1pmea_ 317 D-MELDDLPKEKLKELI 332 (345)
T ss_dssp -------CCHHHHHHHH
T ss_pred C-hhhhhCCHHHHHHHH
Confidence 4 667777777777665
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.9e-54 Score=422.97 Aligned_cols=282 Identities=30% Similarity=0.544 Sum_probs=226.1
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-chHHHHHHHHHHcC-CCCcccccceeeecCCCCceEEEEEe
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-RYKNRELQIMRLLN-HPNVVSLKHCFFSTTEKDELYLNLVL 214 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~~~~~~lv~ 214 (468)
++|++++.||+|+||+||+|+++.+|+.||||++.... ....+|+.+|+.+. ||||++++++|... ...++++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~---~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDP---VSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECT---TTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEec---CCCceeEEE
Confidence 47999999999999999999999999999999986543 44568999999996 99999999988542 334588999
Q ss_pred ecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCCCC
Q 012233 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGE 294 (468)
Q Consensus 215 e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~~~ 294 (468)
|||.++.+.. ..+.+++..++.++.||+.||.|||+ +||+||||||+||||+.++..+||+|||+|+......
T Consensus 112 e~~~~~~L~~------~~~~l~e~~i~~i~~qil~aL~~LH~-~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~ 184 (328)
T d3bqca1 112 EHVNNTDFKQ------LYQTLTDYDIRFYMYEILKALDYCHS-MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 184 (328)
T ss_dssp ECCCSCBGGG------TTTSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred eecCCCcHHH------HhcCCCHHHHHHHHHHHHHHHHHHhh-cccccccccccceEEcCCCCeeeecccccceeccCCC
Confidence 9999875431 23569999999999999999999998 9999999999999999776579999999999887777
Q ss_pred CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-cHHHHHHHHHHhCCCCHHHHhhcCCCCcc
Q 012233 295 PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGES-GVDQLVEIIKILGTPTREEIKCMNPNYTE 373 (468)
Q Consensus 295 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 373 (468)
.....++|+.|+|||++.+...++.++||||+||++|+|++|+.||.... ..++...+...++.+....+.........
T Consensus 185 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 264 (328)
T d3bqca1 185 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 264 (328)
T ss_dssp CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCC
T ss_pred cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccC
Confidence 77788999999999999877778999999999999999999999997654 55666777777765544433322111111
Q ss_pred CCCCc----ccCCCccc----ccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCC
Q 012233 374 FKFPQ----IKAHPWHK----IFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRD 428 (468)
Q Consensus 374 ~~~~~----~~~~~~~~----~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~ 428 (468)
..+.. .....+.. .....++++++|||++||++||.+|||++|+|+||||+++..
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~ 327 (328)
T d3bqca1 265 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK 327 (328)
T ss_dssp GGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSCC
T ss_pred cccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence 11110 11111111 123457899999999999999999999999999999999865
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-55 Score=416.93 Aligned_cols=244 Identities=27% Similarity=0.434 Sum_probs=203.8
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc----------chHHHHHHHHHHcC--CCCcccccceeeecCCC
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK----------RYKNRELQIMRLLN--HPNVVSLKHCFFSTTEK 205 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~----------~~~~~E~~il~~l~--hpnIv~l~~~~~~~~~~ 205 (468)
+|++.+.||+|+||+||+|.+..+|+.||||++.+.. ....+|+.+|++++ |||||+++++| .
T Consensus 5 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~-----~ 79 (273)
T d1xwsa_ 5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF-----E 79 (273)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE-----E
T ss_pred eEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEE-----e
Confidence 5999999999999999999999999999999986432 22357999999997 89999999998 4
Q ss_pred CceEEEEEeecccc--hHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEee
Q 012233 206 DELYLNLVLEYISE--TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICD 283 (468)
Q Consensus 206 ~~~~~~lv~e~~~~--~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~D 283 (468)
+...+|+||||+.+ .+...+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.+...+||+|
T Consensus 80 ~~~~~~lv~e~~~~~~~l~~~~~~----~~~l~e~~~~~~~~qi~~al~~lH~-~~iiHrDiKp~NIll~~~~~~vkl~D 154 (273)
T d1xwsa_ 80 RPDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLID 154 (273)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEETTTTEEEECC
T ss_pred eCCeEEEEEEeccCcchHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCccccCcccceEEecCCCeEEECc
Confidence 45568999999964 34443332 4679999999999999999999998 99999999999999986644899999
Q ss_pred ecCccccCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 012233 284 FGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREE 363 (468)
Q Consensus 284 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~ 363 (468)
||+|+... .......+||+.|+|||++.+...++.++|||||||++|||++|+.||.+.+ .+.+
T Consensus 155 FG~a~~~~-~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~--------- 218 (273)
T d1xwsa_ 155 FGSGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIR--------- 218 (273)
T ss_dssp CTTCEECC-SSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHH---------
T ss_pred cccceecc-cccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhh---------
Confidence 99997653 3344567899999999999776656788999999999999999999997532 1221
Q ss_pred HhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q 012233 364 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (468)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~ 427 (468)
... .++..+|+++++||.+||++||.+|||++|+|+||||+++.
T Consensus 219 --------~~~------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~ 262 (273)
T d1xwsa_ 219 --------GQV------------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 262 (273)
T ss_dssp --------CCC------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred --------ccc------------CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence 011 13456899999999999999999999999999999999864
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-53 Score=411.72 Aligned_cols=283 Identities=33% Similarity=0.543 Sum_probs=229.9
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc------chHHHHHHHHHHcCCCCcccccceeeecCCCCceEE
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~ 210 (468)
++|++.+.||+|+||+||+|+++.+|+.||||++.... ....+|+.+|+.++||||++++++| .+....
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~-----~~~~~~ 76 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL-----HSDKKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccc-----ccccce
Confidence 46999999999999999999999999999999985432 2345899999999999999999998 445568
Q ss_pred EEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcccc
Q 012233 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (468)
Q Consensus 211 ~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~ 290 (468)
++||+++.++.+..+. ...+.+++..++.++.|++.||+|||+ +||+||||||+|||++.++ .+||+|||.++..
T Consensus 77 ~iv~~~~~~~~l~~~~---~~~~~~~~~~~~~~~~q~~~aL~~lH~-~~IvHrDiKP~NIli~~~~-~~kl~DFG~a~~~ 151 (292)
T d1unla_ 77 TLVFEFCDQDLKKYFD---SCNGDLDPEIVKSFLFQLLKGLGFCHS-RNVLHRDLKPQNLLINRNG-ELKLANFGLARAF 151 (292)
T ss_dssp EEEEECCSEEHHHHHH---HTTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTC-CEEECCCTTCEEC
T ss_pred eEEeeecccccccccc---ccccccchhHHHHHHHHHHHHHHHhhc-CCEeeecccCcccccccCC-ceeeeecchhhcc
Confidence 8999999988776443 345778999999999999999999998 8999999999999999888 7999999999876
Q ss_pred CCCC-CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCC-CCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 012233 291 VPGE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLF-PGESGVDQLVEIIKILGTPTREEIKCMN 368 (468)
Q Consensus 291 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 368 (468)
.... ......+++.|+|||++.+...++.++|||||||++|||++|+.|| .+.+..+++.++....+.+....+....
T Consensus 152 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (292)
T d1unla_ 152 GIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp CSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred cCCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhh
Confidence 5433 3445567899999999977766899999999999999999999885 5556667778888887777665443322
Q ss_pred CCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCC
Q 012233 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDP 429 (468)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~ 429 (468)
........+..............+++++.+||.+||+.||.+||||+|+|+||||+++..|
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~~~ 292 (292)
T d1unla_ 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP 292 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCSCC
T ss_pred hcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCCCC
Confidence 2222222222222233334556789999999999999999999999999999999987654
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-54 Score=424.08 Aligned_cols=263 Identities=26% Similarity=0.391 Sum_probs=208.3
Q ss_pred ccceEEe-ceecccCceEEEEEEEcCCCCEEEEEEeecccchHHHHHHHHHH-cCCCCcccccceeeecCCCCceEEEEE
Q 012233 136 TISYMAE-RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRL-LNHPNVVSLKHCFFSTTEKDELYLNLV 213 (468)
Q Consensus 136 ~~~y~~~-~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~~~~~~E~~il~~-l~hpnIv~l~~~~~~~~~~~~~~~~lv 213 (468)
.++|.+. ++||+|+||+||+|++..+|+.||||++.+. ....+|+.++.+ ++|||||+++++|.... ....++|||
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~-~~~~~~~iv 87 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-PKARREVELHWRASQCPHIVRIVDVYENLY-AGRKCLLIV 87 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-HHHHHHHHHHHHhcCCCCCCeEEEEEeecc-cCCCEEEEE
Confidence 4579876 5799999999999999999999999998654 445679988654 58999999999885432 335678999
Q ss_pred eecccc-hHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCC--CcEEEeeecCcccc
Q 012233 214 LEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHT--HQLKICDFGSAKML 290 (468)
Q Consensus 214 ~e~~~~-~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~--~~vkL~DFG~a~~~ 290 (468)
||||+| +|.+.+.. +....+++..++.++.||+.||+|||+ +||+||||||+|||++.+. ..+||+|||+|+..
T Consensus 88 mEy~~gg~L~~~i~~--~~~~~l~e~~~~~i~~qi~~al~ylH~-~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~ 164 (335)
T d2ozaa1 88 MECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 164 (335)
T ss_dssp EECCCSEEHHHHHHS--CSCCCEEHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred EECCCCCcHHHHHHh--cCCCCcCHHHHHHHHHHHHHHHHHHHH-cCCccccccccccccccccccccccccccceeeec
Confidence 999986 55554432 224569999999999999999999998 8999999999999998532 26999999999988
Q ss_pred CCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCC
Q 012233 291 VPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPN 370 (468)
Q Consensus 291 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 370 (468)
.........+||+.|+|||++.+. .|+.++|||||||++|+|++|++||.+.+.......+.... .
T Consensus 165 ~~~~~~~~~~gt~~y~aPE~~~~~-~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i-------------~ 230 (335)
T d2ozaa1 165 TSHNSLTTPCYTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI-------------R 230 (335)
T ss_dssp CCCCCCCCCSCCCSSCCCCCCCGG-GGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CC-------------C
T ss_pred cCCCccccccCCcccCCcHHHcCC-CCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHH-------------h
Confidence 777777788999999999999654 49999999999999999999999998776555443332211 0
Q ss_pred CccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q 012233 371 YTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDD 425 (468)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~ 425 (468)
...+.+|. ..+..+|+++++||.+||++||.+|||+.|+|+||||++
T Consensus 231 ~~~~~~~~--------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 277 (335)
T d2ozaa1 231 MGQYEFPN--------PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 277 (335)
T ss_dssp SCSSSCCT--------THHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHT
T ss_pred cCCCCCCC--------cccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhC
Confidence 11122221 122358999999999999999999999999999999965
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-53 Score=415.44 Aligned_cols=286 Identities=28% Similarity=0.450 Sum_probs=222.0
Q ss_pred ccceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc------chHHHHHHHHHHcCCCCcccccceeeecCC---CC
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTE---KD 206 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~---~~ 206 (468)
..+|.+.+.||+|+||+||+|++..+|+.||||++.... ....+|+.+|+.++||||+++++.+..... ..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 357999999999999999999999999999999884332 234589999999999999999998855322 22
Q ss_pred ceEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecC
Q 012233 207 ELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (468)
Q Consensus 207 ~~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~ 286 (468)
...+|+|||||.++++.... .....+++..++.++.||+.||.|||+ +||+||||||+||||+.++ .+||+|||+
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH~-~~ivHrDlKp~NILl~~~~-~~kl~dfg~ 163 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHR-NKILHRDMKAANVLITRDG-VLKLADFGL 163 (318)
T ss_dssp --CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTS-CEEECCCTT
T ss_pred CceEEEEEeccCCCccchhh---hcccccccHHHHHHHHHHHHHHHHhcc-CCEEecCcCchheeecCCC-cEEeeecce
Confidence 34588999999988776433 335678999999999999999999998 8999999999999999988 799999999
Q ss_pred ccccCCC-----CCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 012233 287 AKMLVPG-----EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTR 361 (468)
Q Consensus 287 a~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~ 361 (468)
++.+... ......+||+.|+|||++.+...|+.++|||||||++|||++|++||.+.+..+....+.+..+.+..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 243 (318)
T d3blha1 164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243 (318)
T ss_dssp CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 9766432 23345689999999999987767999999999999999999999999999999999999998888775
Q ss_pred HHHhhcCCCCccCCCCcccC--CCcccc-cccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q 012233 362 EEIKCMNPNYTEFKFPQIKA--HPWHKI-FHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426 (468)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~--~~~~~~-~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 426 (468)
..............+..... ...... .....+++++|||.+||++||++|||+.|+|+||||+.-
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~ 311 (318)
T d3blha1 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 311 (318)
T ss_dssp TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccC
Confidence 54333221111111111000 000000 011247789999999999999999999999999999864
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-54 Score=427.67 Aligned_cols=287 Identities=32% Similarity=0.545 Sum_probs=221.4
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc------chHHHHHHHHHHcCCCCcccccceeeecCC-CCceE
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTE-KDELY 209 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~-~~~~~ 209 (468)
.+|++.+.||+|+||+||+|.++.+|+.||||++.... ....+|+.+|+.++|||||+++++|..... ....+
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 36999999999999999999999999999999996432 234589999999999999999999854432 24567
Q ss_pred EEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccc
Q 012233 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (468)
Q Consensus 210 ~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~ 289 (468)
+|+|||||.++++... ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+|++|||+++.
T Consensus 97 ~~iv~Ey~~~~l~~~~------~~~~~~~~i~~~~~qil~gl~~LH~-~giiHrDlKP~Nil~~~~~-~~kl~df~~~~~ 168 (355)
T d2b1pa1 97 VYLVMELMDANLCQVI------QMELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDC-TLKILDFGLART 168 (355)
T ss_dssp EEEEEECCSEEHHHHH------TSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTC-CEEECCCCC---
T ss_pred eEEEEeccchHHHHhh------hcCCCHHHHHHHHHHHHHHHHHhhh-cccccccCCcccccccccc-ceeeechhhhhc
Confidence 9999999999988754 3568999999999999999999998 8999999999999999888 699999999987
Q ss_pred cCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 012233 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (468)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 369 (468)
..........++|+.|+|||++.+. .++.++||||+||++|+|++|++||.+.+....+.+++..++.+..+.+.....
T Consensus 169 ~~~~~~~~~~~~t~~y~aPE~l~~~-~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 247 (355)
T d2b1pa1 169 AGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247 (355)
T ss_dssp ------------CCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCH
T ss_pred cccccccccccccccccChhhhcCC-CCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhh
Confidence 7666666778899999999999775 489999999999999999999999999999999999999999888876654332
Q ss_pred CCc----------cCCCCccc---CCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCCCCC
Q 012233 370 NYT----------EFKFPQIK---AHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNTC 432 (468)
Q Consensus 370 ~~~----------~~~~~~~~---~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~~ 432 (468)
... ....+... ............++++.+||++||.+||++||||+|+|+||||+...++...
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~~~~~~ 323 (355)
T d2b1pa1 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEV 323 (355)
T ss_dssp HHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCHHHH
T ss_pred hHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCCCcccc
Confidence 211 11111000 0011111222356789999999999999999999999999999986654443
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-53 Score=416.81 Aligned_cols=285 Identities=34% Similarity=0.582 Sum_probs=225.4
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc------chHHHHHHHHHHcCCCCcccccceeeecCC-CCceE
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTE-KDELY 209 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~-~~~~~ 209 (468)
++|++.+.||+|+||+||+|+++.+|+.||||++.+.. ....+|+.+|+.++|||||+++++|..... .+...
T Consensus 18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~ 97 (348)
T d2gfsa1 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 97 (348)
T ss_dssp TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCC
T ss_pred CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCce
Confidence 46999999999999999999999999999999986432 234579999999999999999998855433 22334
Q ss_pred EEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccc
Q 012233 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (468)
Q Consensus 210 ~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~ 289 (468)
+++++++++++|.+++. .+.+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+|++|||++..
T Consensus 98 ~~i~~~~~gg~L~~~~~-----~~~l~e~~~~~i~~qil~aL~~LH~-~giiHrDiKp~NILi~~~~-~~kl~dfg~a~~ 170 (348)
T d2gfsa1 98 VYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDC-ELKILDFGLARH 170 (348)
T ss_dssp CEEEEECCSEEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTC-CEEECCC----C
T ss_pred EEEEEeecCCchhhhcc-----cccccHHHHHHHHHHHHHHHHHHHh-CCCcccccCCccccccccc-cccccccchhcc
Confidence 55555555566655442 3569999999999999999999998 8999999999999999988 799999999975
Q ss_pred cCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 012233 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (468)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 369 (468)
. ........||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+.......+....+.+..+.......
T Consensus 171 ~--~~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 248 (348)
T d2gfsa1 171 T--DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 248 (348)
T ss_dssp C--TGGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCC
T ss_pred c--CcccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccc
Confidence 4 33445678999999999987777689999999999999999999999999999999999999888887765543221
Q ss_pred CCcc---CCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCCCC
Q 012233 370 NYTE---FKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNT 431 (468)
Q Consensus 370 ~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~ 431 (468)
.... ..++..+...+.. ....+++++++||.+||++||.+|||+.|+|+||||+++.++..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~~ 312 (348)
T d2gfsa1 249 ESARNYIQSLTQMPKMNFAN-VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDD 312 (348)
T ss_dssp HHHHHHHTTSCCCCCCCHHH-HSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTS
T ss_pred hhhhhhhhhcccCCCcchhh-hcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCcc
Confidence 1100 1111222222222 23568999999999999999999999999999999999876554
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.4e-52 Score=399.50 Aligned_cols=255 Identities=25% Similarity=0.371 Sum_probs=200.7
Q ss_pred cceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc-------chHHHHHHHHHHcCCCCcccccceeeecCCCCceE
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~-------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 209 (468)
++|++.+.||+|+||+||+|.+..+|+.||||++.... ..+.+|+.+|+.++|||||++++++.... ....+
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~-~~~~~ 85 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAGPL 85 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEC-SSSEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeecc-CCCce
Confidence 46999999999999999999999999999999985432 23457999999999999999999886544 34456
Q ss_pred EEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccc
Q 012233 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (468)
Q Consensus 210 ~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~ 289 (468)
+|||||||.|+.+... ......+++..++.++.||+.||+|||+ +||+||||||+||||+.++ .++|+|||.+..
T Consensus 86 ~~lvmE~~~g~~L~~~---~~~~~~l~~~~~~~i~~qi~~al~~lH~-~~iiHrDiKP~NIll~~~~-~~~l~d~~~~~~ 160 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDI---VHTEGPMTPKRAIEVIADACQALNFSHQ-NGIIHRDVKPANIMISATN-AVKVMDFGIARA 160 (277)
T ss_dssp EEEEEECCCEEEHHHH---HHHHCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTS-CEEECCCTTCEE
T ss_pred EEEEEECCCCCEehhh---hcccCCCCHHHHHHHHHHHHHHHHHHHh-CCccCccccCcccccCccc-cceeehhhhhhh
Confidence 8899999997655422 2224579999999999999999999998 8999999999999999888 799999999876
Q ss_pred cCCCC----CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 012233 290 LVPGE----PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIK 365 (468)
Q Consensus 290 ~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 365 (468)
..... .....+||+.|+|||++.+. .++.++|||||||++|||++|++||.+.+..+.+.+++.....+
T Consensus 161 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~------ 233 (277)
T d1o6ya_ 161 IADSGNSVTQTAAVIGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP------ 233 (277)
T ss_dssp CC----------------TTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCC------
T ss_pred hccccccccccccccCcccccCHHHHcCC-CCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCC------
Confidence 53322 33456899999999999765 48999999999999999999999999988887777766521111
Q ss_pred hcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q 012233 366 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (468)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f 423 (468)
....++.+|+++.+||.+||++||.+||+..+.+.|+|+
T Consensus 234 -------------------~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~ 272 (277)
T d1o6ya_ 234 -------------------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 272 (277)
T ss_dssp -------------------GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred -------------------CchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHH
Confidence 011345689999999999999999999944444445554
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2e-52 Score=401.46 Aligned_cols=254 Identities=20% Similarity=0.299 Sum_probs=205.0
Q ss_pred CcccceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc---chHHHHHHHHHHcCCCCcccccceeeecCCCCceEE
Q 012233 134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (468)
Q Consensus 134 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~---~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~ 210 (468)
....+|++.+.||+|+||+||+|.+..+|+.||||++..+. ..+.+|+.+|+.++|||||+++++|. +...+
T Consensus 14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~~~ 88 (287)
T d1opja_ 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT-----REPPF 88 (287)
T ss_dssp CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SSSSC
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEe-----eCCee
Confidence 34457999999999999999999999999999999986543 34568999999999999999999983 33457
Q ss_pred EEEeecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccc
Q 012233 211 NLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (468)
Q Consensus 211 ~lv~e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~ 289 (468)
+||||||.++ +...+.. .....+++..+..++.||+.||+|||+ +||+||||||+||||+.++ .+||+|||+|+.
T Consensus 89 ~iv~E~~~~g~l~~~l~~--~~~~~~~~~~~~~i~~qi~~gL~yLH~-~~iiHrDlKp~NILl~~~~-~~Kl~DFG~a~~ 164 (287)
T d1opja_ 89 YIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLVGENH-LVKVADFGLSRL 164 (287)
T ss_dssp EEEEECCTTCBHHHHHHH--SCTTTSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECGGG-CEEECCCCCTTT
T ss_pred EEEeecccCcchHHHhhh--ccccchHHHHHHHHHHHHHHHHHHHHH-CCcccCccccCeEEECCCC-cEEEccccceee
Confidence 8999999965 4443322 234678999999999999999999998 8999999999999999888 799999999987
Q ss_pred cCCCCC--CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 012233 290 LVPGEP--NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367 (468)
Q Consensus 290 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 367 (468)
...... .....|++.|+|||++.+.. |+.++|||||||++|||++|..||........+.+++....
T Consensus 165 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~---------- 233 (287)
T d1opja_ 165 MTGDTYTAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY---------- 233 (287)
T ss_dssp CCSSSSEEETTEEECGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC----------
T ss_pred cCCCCceeeccccccccccChHHHcCCC-CCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCC----------
Confidence 644332 22345789999999997654 99999999999999999997777665555555555444110
Q ss_pred CCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q 012233 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426 (468)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~hp~f~~~ 426 (468)
. ..++..+++++++||.+||+.||.+|||+.|+++ +|+.+
T Consensus 234 -------~----------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~--~L~~~ 273 (287)
T d1opja_ 234 -------R----------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ--AFETM 273 (287)
T ss_dssp -------C----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHT
T ss_pred -------C----------CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH--HHHHH
Confidence 0 1134568999999999999999999999999976 45443
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-52 Score=396.93 Aligned_cols=249 Identities=21% Similarity=0.275 Sum_probs=196.9
Q ss_pred cccceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc------cchHHHHHHHHHHcCCCCcccccceeeecCCCCce
Q 012233 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (468)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~------~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 208 (468)
...+|.+.+.||+|+||+||+|+. +..||||++... ...+.+|+.+|++++|||||++++++. +.
T Consensus 6 ~~~~~~~~~~lG~G~fg~Vy~~~~---~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-----~~- 76 (276)
T d1uwha_ 6 PDGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-----AP- 76 (276)
T ss_dssp CTTCCCCCSEEEECSSCEEEEEES---SSEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----SS-
T ss_pred ccccEEEEEEEeeCCCcEEEEEEE---CCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-----cc-
Confidence 345699999999999999999985 346999998532 134557999999999999999998752 11
Q ss_pred EEEEEeecccch-HHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCc
Q 012233 209 YLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (468)
Q Consensus 209 ~~~lv~e~~~~~-ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a 287 (468)
.++||||||+++ +.+.+. .....+++..+..++.||+.||+|||+ +|||||||||+||||+.++ .+||+|||+|
T Consensus 77 ~~~lv~Ey~~~g~L~~~l~---~~~~~~~~~~~~~i~~qi~~gl~yLH~-~~ivHrDlKp~NiLl~~~~-~~Kl~DFGla 151 (276)
T d1uwha_ 77 QLAIVTQWCEGSSLYHHLH---IIETKFEMIKLIDIARQTAQGMDYLHA-KSIIHRDLKSNNIFLHEDL-TVKIGDFGLA 151 (276)
T ss_dssp SCEEEEECCCEEEHHHHHH---TSCCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEETTS-SEEECCCCCS
T ss_pred EEEEEEecCCCCCHHHHHh---hccCCCCHHHHHHHHHHHHHHHHHHhc-CCEeccccCHHHEEEcCCC-CEEEccccce
Confidence 368999999965 444332 234569999999999999999999998 8999999999999999888 7999999999
Q ss_pred cccCCCC---CCccccccCCccccccccCC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 012233 288 KMLVPGE---PNISYICSRYYRAPELIFGA--TEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTRE 362 (468)
Q Consensus 288 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~--~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~ 362 (468)
+...... ......||+.|||||++.+. ..|+.++|||||||++|||++|+.||.+.+....+..++.....++
T Consensus 152 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p-- 229 (276)
T d1uwha_ 152 TVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSP-- 229 (276)
T ss_dssp CC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCC--
T ss_pred eeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCC--
Confidence 7664322 23456899999999998643 2478999999999999999999999999887777766655322111
Q ss_pred HHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCC
Q 012233 363 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (468)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~h 420 (468)
....++..+++++.+||.+||+.||.+|||+.|++.|
T Consensus 230 ---------------------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 230 ---------------------DLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp ---------------------CGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------------cchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 0111345689999999999999999999999999875
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.1e-52 Score=400.47 Aligned_cols=247 Identities=23% Similarity=0.299 Sum_probs=189.6
Q ss_pred ccceEEeceecccCceEEEEEEEcCCCC---EEEEEEeecc-----cchHHHHHHHHHHcCCCCcccccceeeecCCCCc
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLETGD---SVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~---~vaiK~~~~~-----~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 207 (468)
...|++.++||+|+||+||+|.++.+|+ .||||.+... ...+.+|+.+|++++|||||++++++. +.
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~-----~~ 99 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVT-----KS 99 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----SS
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEe-----eC
Confidence 3469999999999999999999987765 5889987543 234568999999999999999999983 33
Q ss_pred eEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCc
Q 012233 208 LYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (468)
Q Consensus 208 ~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a 287 (468)
..++||||||.++.+..+.. .....+++..+..++.||+.||.|||+ +||+||||||+||||+.++ .+||+|||++
T Consensus 100 ~~~~iv~Ey~~~g~L~~~~~--~~~~~l~~~~~~~i~~qia~gl~yLH~-~~iiHrDlKp~NILl~~~~-~~Kl~DFGla 175 (299)
T d1jpaa_ 100 TPVMIITEFMENGSLDSFLR--QNDGQFTVIQLVGMLRGIAAGMKYLAD-MNYVHRDLAARNILVNSNL-VCKVSDFGLS 175 (299)
T ss_dssp SSCEEEEECCTTEEHHHHHH--TTTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTC-CEEECCC---
T ss_pred CEEEEEEEecCCCcceeeec--cccCCCCHHHHHHHHHHHHHHHHHHhh-CCCccCccccceEEECCCC-cEEECCcccc
Confidence 34889999999775553322 224568999999999999999999998 9999999999999999888 7999999999
Q ss_pred cccCCCCCC------ccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCC
Q 012233 288 KMLVPGEPN------ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPT 360 (468)
Q Consensus 288 ~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~ 360 (468)
+........ ....||+.|+|||++.+. .++.++|||||||++|||++ |++||.+.+..+.+..+......
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~-- 252 (299)
T d1jpaa_ 176 RFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYR-KFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRL-- 252 (299)
T ss_dssp --------------------CGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC--
T ss_pred eEccCCCCcceeeecccccCCccccCHHHHhcC-CCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC--
Confidence 876443221 234578999999999765 49999999999999999998 89999988877666555431111
Q ss_pred HHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCC
Q 012233 361 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (468)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~h 420 (468)
..+..+++++.+||.+||+.||.+|||+.|++++
T Consensus 253 --------------------------~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 253 --------------------------PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp --------------------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred --------------------------CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 0234589999999999999999999999998763
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-52 Score=405.35 Aligned_cols=251 Identities=22% Similarity=0.316 Sum_probs=201.3
Q ss_pred cccceEEeceecccCceEEEEEEEcCCCC-----EEEEEEeecc-----cchHHHHHHHHHHc-CCCCcccccceeeecC
Q 012233 135 QTISYMAERVVGTGSFGVVFQAKCLETGD-----SVAIKKVLQD-----KRYKNRELQIMRLL-NHPNVVSLKHCFFSTT 203 (468)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~-----~vaiK~~~~~-----~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~ 203 (468)
..++|.+++.||+|+||+||+|++..+++ .||+|.+... ...+.+|+.+|+++ +|||||++++++
T Consensus 35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~---- 110 (325)
T d1rjba_ 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC---- 110 (325)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE----
T ss_pred CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEE----
Confidence 34579999999999999999999876554 6999988443 23455799999988 899999999998
Q ss_pred CCCceEEEEEeecccch-HHHHHhhhh-------------------hcCCCCCHHHHHHHHHHHHHHHHHhHhcCCcccc
Q 012233 204 EKDELYLNLVLEYISET-VYRVSKHYT-------------------RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHR 263 (468)
Q Consensus 204 ~~~~~~~~lv~e~~~~~-ll~~~~~~~-------------------~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHr 263 (468)
.+...+|||||||+++ +.+.+.... .....+++..++.++.||+.||+|||+ +|||||
T Consensus 111 -~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~-~~IiHR 188 (325)
T d1rjba_ 111 -TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF-KSCVHR 188 (325)
T ss_dssp -CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH-TTEEET
T ss_pred -eeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh-CCeeec
Confidence 4444589999999865 444443221 112458889999999999999999998 899999
Q ss_pred CCCCCCeeecCCCCcEEEeeecCccccCCCCCC---ccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCC
Q 012233 264 DIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPN---ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPL 339 (468)
Q Consensus 264 Dlkp~NILl~~~~~~vkL~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~p 339 (468)
||||+|||++.++ .+||+|||+|+........ ....||+.|||||++.+.. ++.++|||||||++|||++ |++|
T Consensus 189 DlKp~Nill~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~DiwS~Gvil~emlt~g~~P 266 (325)
T d1rjba_ 189 DLAARNVLVTHGK-VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGVNP 266 (325)
T ss_dssp TCSGGGEEEETTT-EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred cCchhccccccCC-eEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCC-CCcceeccchhHHHHHHHhCCCCC
Confidence 9999999999888 8999999999876443322 2456799999999997654 9999999999999999997 8999
Q ss_pred CCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 340 FPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 340 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
|.+.+..+.+.+++..... + .++..+++++++||.+||+.||.+|||++||++
T Consensus 267 f~~~~~~~~~~~~~~~~~~-----------------~----------~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~ 319 (325)
T d1rjba_ 267 YPGIPVDANFYKLIQNGFK-----------------M----------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS 319 (325)
T ss_dssp STTCCCSHHHHHHHHTTCC-----------------C----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCHHHHHHHHHhcCCC-----------------C----------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 9988777777776652111 1 133568999999999999999999999999987
Q ss_pred C
Q 012233 420 H 420 (468)
Q Consensus 420 h 420 (468)
|
T Consensus 320 ~ 320 (325)
T d1rjba_ 320 F 320 (325)
T ss_dssp H
T ss_pred H
Confidence 5
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-51 Score=391.17 Aligned_cols=244 Identities=20% Similarity=0.311 Sum_probs=189.4
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc---chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEEEe
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~---~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv~ 214 (468)
+|.+.+.||+|+||+||+|.+. +++.||||++.... ..+.+|+.+++.++|||||++++++.. ...+++||
T Consensus 6 ~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-----~~~~~lv~ 79 (263)
T d1sm2a_ 6 ELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE-----QAPICLVF 79 (263)
T ss_dssp CEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSSCEEEE
T ss_pred HcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceecc-----CCceEEEE
Confidence 5999999999999999999975 56789999986543 445689999999999999999999843 33478999
Q ss_pred ecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCCCC
Q 012233 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGE 294 (468)
Q Consensus 215 e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~~~ 294 (468)
|||.++.+.... ......+++..+..++.||+.||.|||+ ++|+||||||+||||+.++ .+||+|||+++......
T Consensus 80 E~~~~g~L~~~l--~~~~~~~~~~~~~~i~~qia~gl~~lH~-~~iiHrDlKp~Nill~~~~-~~Kl~DFGla~~~~~~~ 155 (263)
T d1sm2a_ 80 EFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEE-ACVIHRDLAARNCLVGENQ-VIKVSDFGMTRFVLDDQ 155 (263)
T ss_dssp ECCTTCBHHHHH--HTTTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCTTCSGGGEEECGGG-CEEECSCC---------
T ss_pred EecCCCcHHHHh--hccccCCCHHHHHHHHHHHHHHHHhhhc-cceeecccchhheeecCCC-CeEecccchheeccCCC
Confidence 999976544322 2234568899999999999999999998 8999999999999999888 79999999998764433
Q ss_pred C--CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCC
Q 012233 295 P--NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNY 371 (468)
Q Consensus 295 ~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 371 (468)
. .....||+.|+|||++.+.. |+.++|||||||++|||++ |.+||...+..+.+..+.....
T Consensus 156 ~~~~~~~~gt~~y~aPE~l~~~~-~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~-------------- 220 (263)
T d1sm2a_ 156 YTSSTGTKFPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR-------------- 220 (263)
T ss_dssp ---------CTTSCCHHHHTTCC-CCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCC--------------
T ss_pred ceeecceecCcccCChHHhcCCC-CCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCC--------------
Confidence 2 23467899999999997654 9999999999999999999 5666766665555555443110
Q ss_pred ccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCC
Q 012233 372 TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (468)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~h 420 (468)
...+..+++++.+||.+||+.||.+|||++|+++|
T Consensus 221 --------------~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 221 --------------LYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp --------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------CCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 01234578999999999999999999999999875
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-51 Score=389.32 Aligned_cols=244 Identities=20% Similarity=0.273 Sum_probs=202.5
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc---cchHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEEEe
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~---~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv~ 214 (468)
+|.+.+.||+|+||+||+|+++ ++..||||++.+. ...+.+|+.++++++|||||++++++. +...+++||
T Consensus 5 ~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~-----~~~~~~iv~ 78 (258)
T d1k2pa_ 5 DLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT-----KQRPIFIIT 78 (258)
T ss_dssp CCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEC-----CSSSEEEEE
T ss_pred HCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEe-----eCCceEEEE
Confidence 5899999999999999999984 7789999998653 345568999999999999999999983 334589999
Q ss_pred ecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCCCC
Q 012233 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGE 294 (468)
Q Consensus 215 e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~~~ 294 (468)
||+.++.+.... ......+++..++.++.||+.||.|||+ +||+||||||+||||+.++ .+||+|||+++......
T Consensus 79 Ey~~~g~l~~~~--~~~~~~~~~~~~~~i~~qi~~gl~~LH~-~~iiH~dlk~~Nill~~~~-~~kl~DfG~a~~~~~~~ 154 (258)
T d1k2pa_ 79 EYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYLES-KQFLHRDLAARNCLVNDQG-VVKVSDFGLSRYVLDDE 154 (258)
T ss_dssp ECCTTEEHHHHH--HSGGGCCCHHHHHHHHHHHHHHHHHHHH-TTBCCSCCSGGGEEECTTC-CEEECCCSSCCBCSSSS
T ss_pred EccCCCcHHHhh--hccccCCcHHHHHHHHHHHHHHHHHHhh-cCcccccccceeEEEcCCC-cEEECcchhheeccCCC
Confidence 999866443322 2234568899999999999999999998 8999999999999999888 79999999998764433
Q ss_pred C--CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCC
Q 012233 295 P--NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNY 371 (468)
Q Consensus 295 ~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 371 (468)
. .....||+.|+|||++.+.. ++.++|||||||++|||+| |+.||.+.+..+....+.+....
T Consensus 155 ~~~~~~~~~t~~y~aPE~~~~~~-~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~------------- 220 (258)
T d1k2pa_ 155 YTSSVGSKFPVRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL------------- 220 (258)
T ss_dssp CCCCCCSCCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCC-------------
T ss_pred ceeecccCCCCCcCCcHHhcCCC-CCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCC-------------
Confidence 2 23467899999999997654 8999999999999999998 89999998877766655442110
Q ss_pred ccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCC
Q 012233 372 TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (468)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~h 420 (468)
..+..+++++.+||.+||+.||.+|||+.++++|
T Consensus 221 ---------------~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 221 ---------------YRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp ---------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ---------------CCcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 1234578999999999999999999999999986
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-51 Score=393.55 Aligned_cols=252 Identities=22% Similarity=0.289 Sum_probs=201.0
Q ss_pred CcccceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc---chHHHHHHHHHHcCCCCcccccceeeecCCCCceEE
Q 012233 134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (468)
Q Consensus 134 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~---~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~ 210 (468)
....+|++.+.||+|+||.||+|.+. ++..||||++.... ..+.+|+.+|++++|||||++++++. +. .+
T Consensus 10 i~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-----~~-~~ 82 (272)
T d1qpca_ 10 VPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-----QE-PI 82 (272)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SS-SC
T ss_pred cCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeec-----cC-Ce
Confidence 34457999999999999999999975 57889999986543 34568999999999999999999762 22 25
Q ss_pred EEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcccc
Q 012233 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (468)
Q Consensus 211 ~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~ 290 (468)
+||||||.++.+...... .....+++..+..++.||+.||.|||+ +||+||||||+||||+.++ .+||+|||+|+..
T Consensus 83 ~iv~Ey~~~g~L~~~~~~-~~~~~l~~~~~~~i~~qi~~gl~~lH~-~~ivHrDiKp~NIll~~~~-~~Kl~DFGla~~~ 159 (272)
T d1qpca_ 83 YIITEYMENGSLVDFLKT-PSGIKLTINKLLDMAAQIAEGMAFIEE-RNYIHRDLRAANILVSDTL-SCKIADFGLARLI 159 (272)
T ss_dssp EEEEECCTTCBHHHHTTS-HHHHTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTS-CEEECCCTTCEEC
T ss_pred EEEEEeCCCCcHHHHHhh-cCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCccchhheeeeccc-ceeeccccceEEc
Confidence 799999997655432222 223458999999999999999999998 8999999999999999888 7999999999877
Q ss_pred CCCC--CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhC-CCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 012233 291 VPGE--PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLG-QPLFPGESGVDQLVEIIKILGTPTREEIKCM 367 (468)
Q Consensus 291 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 367 (468)
.... ......||+.|+|||++.+.. ++.++|||||||++|||+|| .+||...+..+.+..+.... .
T Consensus 160 ~~~~~~~~~~~~gt~~y~APE~~~~~~-~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~-~--------- 228 (272)
T d1qpca_ 160 EDNEYTAREGAKFPIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY-R--------- 228 (272)
T ss_dssp SSSCEECCTTCCCCTTTSCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-C---------
T ss_pred cCCccccccccCCcccccChHHHhCCC-CCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC-C---------
Confidence 5433 233567899999999997554 89999999999999999995 55555555555444443210 0
Q ss_pred CCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC--CCCCC
Q 012233 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA--HPFFD 424 (468)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~--hp~f~ 424 (468)
...+..+++++.+||.+||+.||.+|||++++++ |+||.
T Consensus 229 ------------------~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 229 ------------------MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp ------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------------------CCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 0123468999999999999999999999999988 78874
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-51 Score=393.89 Aligned_cols=249 Identities=26% Similarity=0.299 Sum_probs=200.4
Q ss_pred cceEEece-ecccCceEEEEEEEcC--CCCEEEEEEeeccc-----chHHHHHHHHHHcCCCCcccccceeeecCCCCce
Q 012233 137 ISYMAERV-VGTGSFGVVFQAKCLE--TGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (468)
Q Consensus 137 ~~y~~~~~-lG~G~fg~Vy~~~~~~--~g~~vaiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 208 (468)
++|.+.+. ||+|+||.||+|.++. ++..||||++.... ..+.+|+++|++++|||||++++++.. +
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-----~- 81 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-----E- 81 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-----S-
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-----C-
Confidence 46888885 9999999999998754 44579999985432 334579999999999999999998732 1
Q ss_pred EEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcc
Q 012233 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (468)
Q Consensus 209 ~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~ 288 (468)
.+|||||||+++.+.... ......+++..+..++.||+.||.|||+ +||+||||||+||||+.++ .+||+|||+++
T Consensus 82 ~~~lvmE~~~~g~L~~~l--~~~~~~l~~~~~~~i~~qi~~gL~ylH~-~~iiHrDlKp~Nill~~~~-~~Kl~DFGla~ 157 (285)
T d1u59a_ 82 ALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYLEE-KNFVHRDLAARNVLLVNRH-YAKISDFGLSK 157 (285)
T ss_dssp SEEEEEECCTTEEHHHHH--TTCTTTSCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEEETT-EEEECCCTTCE
T ss_pred eEEEEEEeCCCCcHHHHh--hccccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCcCchhheeeccCC-ceeeccchhhh
Confidence 268999999976554322 2234579999999999999999999998 8999999999999999888 89999999998
Q ss_pred ccCCCCC----CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 012233 289 MLVPGEP----NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREE 363 (468)
Q Consensus 289 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~ 363 (468)
.+..... .....||+.|+|||++.+.. ++.++|||||||++|||++ |+.||.+.+..+.+..+.+.. .
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~-~----- 230 (285)
T d1u59a_ 158 ALGADDSYYTARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK-R----- 230 (285)
T ss_dssp ECTTCSCEECCCCSSCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTC-C-----
T ss_pred cccccccccccccccccCccccChHHHhCCC-CCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-C-----
Confidence 7654332 23456899999999997654 8999999999999999998 999999887766655543310 0
Q ss_pred HhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHH---hCCCCCC
Q 012233 364 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEA---CAHPFFD 424 (468)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~el---l~hp~f~ 424 (468)
..+++.+|+++.+||.+||+.||.+|||+.++ |+|+|+.
T Consensus 231 ----------------------~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 231 ----------------------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp ----------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----------------------CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 01345689999999999999999999999887 5677763
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-50 Score=387.77 Aligned_cols=256 Identities=24% Similarity=0.304 Sum_probs=198.2
Q ss_pred CCcccceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc---chHHHHHHHHHHcCCCCcccccceeeecCCCCceE
Q 012233 133 PKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (468)
Q Consensus 133 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~---~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 209 (468)
.....+|++++.||+|+||+||+|.+..+ ..||||++.... ..+.+|+.+|++++|||||++++++. +. .
T Consensus 13 ~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-----~~-~ 85 (285)
T d1fmka3 13 EIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-----EE-P 85 (285)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SS-S
T ss_pred EcCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEe-----cC-C
Confidence 34456899999999999999999998654 679999986543 44668999999999999999999872 22 2
Q ss_pred EEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccc
Q 012233 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (468)
Q Consensus 210 ~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~ 289 (468)
+++|||||.++.+...... .....+++..+..++.||+.||+|||+ +||+||||||+||||+.++ .+||+|||+++.
T Consensus 86 ~~lv~Ey~~~g~l~~~~~~-~~~~~l~~~~~~~i~~~i~~gl~~LH~-~~ivH~DlKp~NIll~~~~-~~kl~DfGla~~ 162 (285)
T d1fmka3 86 IYIVTEYMSKGSLLDFLKG-ETGKYLRLPQLVDMAAQIASGMAYVER-MNYVHRDLRAANILVGENL-VCKVADFGLARL 162 (285)
T ss_dssp CEEEECCCTTCBHHHHHSH-HHHTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECGGG-CEEECCCCTTC-
T ss_pred eEEEEEecCCCchhhhhhh-cccccchHHHHHHHHHHHHHHHHHHhh-hheecccccceEEEECCCC-cEEEcccchhhh
Confidence 5799999997654433222 224569999999999999999999998 8999999999999999888 799999999986
Q ss_pred cCCCC--CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCC-CCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 012233 290 LVPGE--PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQ-PLFPGESGVDQLVEIIKILGTPTREEIKC 366 (468)
Q Consensus 290 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~-~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 366 (468)
..... ......||+.|+|||++.+. .++.++|||||||++|||++|. +||.+....+.+..+.+...
T Consensus 163 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~--------- 232 (285)
T d1fmka3 163 IEDNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR--------- 232 (285)
T ss_dssp -------------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC---------
T ss_pred ccCCCceeeccccccccccChHHHhCC-CCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC---------
Confidence 64333 23346789999999999754 4899999999999999999965 44555554444444433110
Q ss_pred cCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC--CCCCCCCC
Q 012233 367 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA--HPFFDDLR 427 (468)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~--hp~f~~~~ 427 (468)
. .++..+++++++||.+||+.||++|||+++++. |+||....
T Consensus 233 ---------~----------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~ 276 (285)
T d1fmka3 233 ---------M----------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 276 (285)
T ss_dssp ---------C----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred ---------C----------CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence 0 133568999999999999999999999999988 99997753
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-51 Score=392.18 Aligned_cols=241 Identities=23% Similarity=0.288 Sum_probs=191.4
Q ss_pred ceecccCceEEEEEEEc--CCCCEEEEEEeeccc------chHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEEEe
Q 012233 143 RVVGTGSFGVVFQAKCL--ETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (468)
Q Consensus 143 ~~lG~G~fg~Vy~~~~~--~~g~~vaiK~~~~~~------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv~ 214 (468)
+.||+|+||+||+|.+. .+++.||||++.... ..+.+|+.+|++++|||||++++++. +.. .+|||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~-----~~~-~~lvm 86 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-----AES-WMLVM 86 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----SSS-EEEEE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEec-----cCC-EEEEE
Confidence 57999999999999864 355789999985432 23568999999999999999999873 222 57999
Q ss_pred ecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCccccCCCC
Q 012233 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGE 294 (468)
Q Consensus 215 e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~~~~~ 294 (468)
|||+++.+..+ ......+++..+..++.||+.||+|||+ +|||||||||+||||+.++ .+||+|||+++......
T Consensus 87 E~~~~g~L~~~---l~~~~~l~~~~~~~i~~qi~~gl~ylH~-~~iiHrDlKp~Nill~~~~-~~kl~DFGla~~~~~~~ 161 (277)
T d1xbba_ 87 EMAELGPLNKY---LQQNRHVKDKNIIELVHQVSMGMKYLEE-SNFVHRDLAARNVLLVTQH-YAKISDFGLSKALRADE 161 (277)
T ss_dssp ECCTTEEHHHH---HHHCTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEETT-EEEECCCTTCEECCTTC
T ss_pred EcCCCCcHHHH---HhhccCCCHHHHHHHHHHHHHHHhhHHh-CCcccCCCcchhhcccccC-cccccchhhhhhccccc
Confidence 99997654432 2235679999999999999999999998 8999999999999999888 79999999998765433
Q ss_pred C----CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 012233 295 P----NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (468)
Q Consensus 295 ~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 369 (468)
. .....||+.|+|||++.+.. ++.++|||||||++|||++ |++||.+.+..+....+.+.. .
T Consensus 162 ~~~~~~~~~~gt~~y~APE~l~~~~-~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~-~----------- 228 (277)
T d1xbba_ 162 NYYKAQTHGKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE-R----------- 228 (277)
T ss_dssp SEEEC----CCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-C-----------
T ss_pred cccccccccCCCceecCchhhcCCC-CCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCC-C-----------
Confidence 2 22356899999999997654 8999999999999999997 999999887665554443210 0
Q ss_pred CCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHH---hCCCCC
Q 012233 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEA---CAHPFF 423 (468)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~el---l~hp~f 423 (468)
..++..+|+++.+||.+||+.||.+|||+.++ |+|+|+
T Consensus 229 ----------------~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 229 ----------------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp ----------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ----------------CCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 01335689999999999999999999999998 456654
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-51 Score=399.31 Aligned_cols=257 Identities=29% Similarity=0.466 Sum_probs=206.4
Q ss_pred ccceEEeceecccCceEEEEEEEc---CCCCEEEEEEeecc--------cchHHHHHHHHHHcCC-CCcccccceeeecC
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCL---ETGDSVAIKKVLQD--------KRYKNRELQIMRLLNH-PNVVSLKHCFFSTT 203 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~---~~g~~vaiK~~~~~--------~~~~~~E~~il~~l~h-pnIv~l~~~~~~~~ 203 (468)
.++|.+++.||+|+||+||+|++. .+|+.||||++.+. .....+|+++|++++| |||+++++++
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~---- 98 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF---- 98 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE----
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeee----
Confidence 467999999999999999999973 47899999988432 2234579999999977 8999999988
Q ss_pred CCCceEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEee
Q 012233 204 EKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICD 283 (468)
Q Consensus 204 ~~~~~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~D 283 (468)
.+...+++||||+.++.+.... .....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|
T Consensus 99 -~~~~~~~~v~e~~~~~~L~~~i---~~~~~~~e~~~~~~~~Qi~~al~~lH~-~~ivHrDiKp~Nill~~~~-~vkL~D 172 (322)
T d1vzoa_ 99 -QTETKLHLILDYINGGELFTHL---SQRERFTEHEVQIYVGEIVLALEHLHK-LGIIYRDIKLENILLDSNG-HVVLTD 172 (322)
T ss_dssp -EETTEEEEEECCCCSCBHHHHH---HHHSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTS-CEEESC
T ss_pred -ccCCceeeeeecccccHHHHHH---HhcccccHHHHHHHHHHHHHHHHHhhc-CCEEeccCCccceeecCCC-CEEEee
Confidence 4444689999999965443222 224567889999999999999999998 8999999999999999988 799999
Q ss_pred ecCccccCCCC--CCccccccCCccccccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Q 012233 284 FGSAKMLVPGE--PNISYICSRYYRAPELIFGAT-EYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPT 360 (468)
Q Consensus 284 FG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~ 360 (468)
||+++.+.... ......|++.|+|||.+.+.. .++.++|||||||+||+|++|+.||.+.+..+....+.+.....
T Consensus 173 FG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~- 251 (322)
T d1vzoa_ 173 FGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS- 251 (322)
T ss_dssp SSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC-
T ss_pred ccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccC-
Confidence 99998764332 234578999999999997543 47889999999999999999999998876555555544421100
Q ss_pred HHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCC-----CHHHHhCCCCCCCCC
Q 012233 361 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC-----TALEACAHPFFDDLR 427 (468)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~-----s~~ell~hp~f~~~~ 427 (468)
. ..++..+++++.+||.+||++||.+|| |++|+|+||||+++.
T Consensus 252 ------------~------------~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~ 299 (322)
T d1vzoa_ 252 ------------E------------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN 299 (322)
T ss_dssp ------------C------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred ------------C------------CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCC
Confidence 0 013456899999999999999999999 589999999999865
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-50 Score=384.03 Aligned_cols=246 Identities=21% Similarity=0.245 Sum_probs=187.7
Q ss_pred cceEEeceecccCceEEEEEEEcCCC----CEEEEEEeeccc-----chHHHHHHHHHHcCCCCcccccceeeecCCCCc
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETG----DSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g----~~vaiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 207 (468)
..|.+.++||+|+||.||+|.++.++ ..||||++.... ..+.+|+.+|++++|||||++++++. +.
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~-----~~ 81 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS-----KY 81 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-----SS
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEe-----cC
Confidence 35999999999999999999987655 369999985432 23457999999999999999999984 33
Q ss_pred eEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCc
Q 012233 208 LYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (468)
Q Consensus 208 ~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a 287 (468)
..+++|||||.++.+.... ......+++..+..++.||+.||.|||+ +||+||||||+||||+.++ .+||+|||++
T Consensus 82 ~~~~~v~e~~~~~~l~~~~--~~~~~~~~~~~~~~i~~~i~~gl~~lH~-~~iiHrDlKp~NILl~~~~-~~Kl~DFGla 157 (283)
T d1mqba_ 82 KPMMIITEYMENGALDKFL--REKDGEFSVLQLVGMLRGIAAGMKYLAN-MNYVHRDLAARNILVNSNL-VCKVSDFGLS 157 (283)
T ss_dssp SSEEEEEECCTTEEHHHHH--HHTTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTC-CEEECCCCC-
T ss_pred CceEEEEEecccCcchhhh--hcccccccHHHHHHHHHHHHHhhhhccc-cccccCccccceEEECCCC-eEEEcccchh
Confidence 4488999999977554322 2334679999999999999999999998 8999999999999999988 7999999999
Q ss_pred cccCCCCC----CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 012233 288 KMLVPGEP----NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREE 363 (468)
Q Consensus 288 ~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~ 363 (468)
+....... .....||+.|+|||++.+. .++.++|||||||++|||++|..||........+...+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~----- 231 (283)
T d1mqba_ 158 RVLEDDPEATYTTSGGKIPIRWTAPEAISYR-KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR----- 231 (283)
T ss_dssp ----------------CCCGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC-----
T ss_pred hcccCCCccceEeccCCCCccccCHHHHccC-CCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCC-----
Confidence 87644322 2235679999999999765 4999999999999999999965555444444444333331100
Q ss_pred HhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 364 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
...+..+++++.+||.+||+.||.+|||+.|+++
T Consensus 232 ----------------------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 232 ----------------------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp ----------------------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ----------------------CCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 1133457899999999999999999999999976
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-50 Score=385.73 Aligned_cols=247 Identities=26% Similarity=0.336 Sum_probs=190.2
Q ss_pred cccceEEeceecccCceEEEEEEEcCCC---CEEEEEEeeccc-----chHHHHHHHHHHcCCCCcccccceeeecCCCC
Q 012233 135 QTISYMAERVVGTGSFGVVFQAKCLETG---DSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD 206 (468)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~g---~~vaiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 206 (468)
..++|++++.||+|+||.||+|.+..++ ..||||.+.... ..+.+|+.+|++++|||||++++++. +
T Consensus 5 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-----~ 79 (273)
T d1mp8a_ 5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-----E 79 (273)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-----S
T ss_pred CHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-----c
Confidence 3457999999999999999999986543 468899875322 23457999999999999999999872 1
Q ss_pred ceEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecC
Q 012233 207 ELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (468)
Q Consensus 207 ~~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~ 286 (468)
..+|+|||||.++.+.... ......+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus 80 -~~~~iv~E~~~~g~l~~~~--~~~~~~l~~~~~~~~~~qi~~gl~ylH~-~~iiHrDlKp~NIll~~~~-~~Kl~DfG~ 154 (273)
T d1mp8a_ 80 -NPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLES-KRFVHRDIAARNVLVSSND-CVKLGDFGL 154 (273)
T ss_dssp -SSCEEEEECCTTEEHHHHH--HHTTTTSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEETT-EEEECC---
T ss_pred -CeEEEEEEeccCCcHHhhh--hccCCCCCHHHHHHHHHHHHHHhhhhcc-cCeeccccchhheeecCCC-cEEEccchh
Confidence 2378999999976554322 2334568999999999999999999998 9999999999999999888 899999999
Q ss_pred ccccCCCC--CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 012233 287 AKMLVPGE--PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREE 363 (468)
Q Consensus 287 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~ 363 (468)
|+...... ......||+.|+|||++.+.. ++.++|||||||++|||++ |.+||.+.+..+.+..+.....
T Consensus 155 a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~-~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~------ 227 (273)
T d1mp8a_ 155 SRYMEDSTYYKASKGKLPIKWMAPESINFRR-FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER------ 227 (273)
T ss_dssp ----------------CCGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC------
T ss_pred heeccCCcceeccceecCcccchhhHhccCC-CCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC------
Confidence 98764332 233456799999999997554 8999999999999999998 8999998887776666543110
Q ss_pred HhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCC
Q 012233 364 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (468)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~h 420 (468)
..+++.+|+++++||.+||+.||.+|||+.|++.|
T Consensus 228 ----------------------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 228 ----------------------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp ----------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------------CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 01345689999999999999999999999999864
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-49 Score=387.78 Aligned_cols=244 Identities=22% Similarity=0.330 Sum_probs=192.8
Q ss_pred cceEEeceecccCceEEEEEEEcCCCC----EEEEEEeecc-----cchHHHHHHHHHHcCCCCcccccceeeecCCCCc
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLETGD----SVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~----~vaiK~~~~~-----~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 207 (468)
.+|+++++||+|+||+||+|.+..+|+ .||+|.+... ...+.+|+.+|++++|||||++++++...
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~----- 83 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS----- 83 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-----
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-----
Confidence 359999999999999999999988876 4788877432 23456899999999999999999998432
Q ss_pred eEEEEEeeccc-chHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecC
Q 012233 208 LYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (468)
Q Consensus 208 ~~~~lv~e~~~-~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~ 286 (468)
. .+++|||+. ++++..+. .....+++..+..++.||+.||.|||+ +|||||||||+||||+.++ .+||+|||+
T Consensus 84 ~-~~~v~e~~~~~~l~~~~~---~~~~~~~~~~~~~i~~qi~~gl~yLH~-~~iiHrDlKp~NIll~~~~-~~kl~DFGl 157 (317)
T d1xkka_ 84 T-VQLITQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQ-HVKITDFGL 157 (317)
T ss_dssp S-EEEEEECCTTCBHHHHHH---HTSSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEEETT-EEEECCCSH
T ss_pred C-eeEEEEeccCCccccccc---ccccCCCHHHHHHHHHHHHHHHHHHHH-cCcccCcchhhcceeCCCC-CeEeecccc
Confidence 2 456677776 55555332 335678999999999999999999998 8999999999999999888 799999999
Q ss_pred ccccCCCCCC---ccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 012233 287 AKMLVPGEPN---ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTRE 362 (468)
Q Consensus 287 a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~ 362 (468)
|+........ ....||+.|+|||++.+.. |+.++|||||||++|||+| |.+||.+.+..+....+... ..+
T Consensus 158 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~-~~~--- 232 (317)
T d1xkka_ 158 AKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG-ERL--- 232 (317)
T ss_dssp HHHTTTTCC--------CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHT-CCC---
T ss_pred ceecccccccccccccccCccccChHHHhcCC-CChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC-CCC---
Confidence 9876543322 2346899999999997654 9999999999999999998 89999887766554444331 111
Q ss_pred HHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCC
Q 012233 363 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (468)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~h 420 (468)
..++.+++++.+||.+||+.||.+|||+.|++.|
T Consensus 233 ------------------------~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 233 ------------------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 266 (317)
T ss_dssp ------------------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------------------CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence 1234588999999999999999999999999987
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=377.12 Aligned_cols=247 Identities=22% Similarity=0.311 Sum_probs=194.8
Q ss_pred CCCcccceEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc--chHHHHHHHHHHcCCCCcccccceeeecCCCCceE
Q 012233 132 QPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK--RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (468)
Q Consensus 132 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~--~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 209 (468)
+.....+|++.+.||+|+||.||+|.+ .|..||||++.++. ..+.+|++++++++|||||++++++... ...
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~----~~~ 75 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KGG 75 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC------C
T ss_pred CccCHHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEec----CCc
Confidence 445566899999999999999999998 57899999996553 4456899999999999999999987432 223
Q ss_pred EEEEeecccchHH-HHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcc
Q 012233 210 LNLVLEYISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (468)
Q Consensus 210 ~~lv~e~~~~~ll-~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~ 288 (468)
+||||||++++.+ +.+... ....+++..+..++.||+.||.|||+ .+|+||||||+|||++.++ .+||+|||+++
T Consensus 76 ~~lv~ey~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~al~ylH~-~~ivH~dlkp~Nil~~~~~-~~kl~dfg~s~ 151 (262)
T d1byga_ 76 LYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEG-NNFVHRDLAARNVLVSEDN-VAKVSDFGLTK 151 (262)
T ss_dssp CEEEECCCTTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECTTS-CEEECCCCC--
T ss_pred EEEEEeccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHhhcccccc-CceeccccchHhheecCCC-CEeecccccce
Confidence 6899999986544 443321 23358899999999999999999998 8999999999999999988 79999999998
Q ss_pred ccCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 012233 289 MLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367 (468)
Q Consensus 289 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 367 (468)
.... ......+|+.|+|||++.+. .++.++|||||||++|||++ |++||...+..+.+..+.+..
T Consensus 152 ~~~~--~~~~~~~~~~y~aPE~l~~~-~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~----------- 217 (262)
T d1byga_ 152 EASS--TQDTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY----------- 217 (262)
T ss_dssp ------------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTC-----------
T ss_pred ecCC--CCccccccccCCChHHHhCC-CCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC-----------
Confidence 6533 33456789999999999765 48999999999999999998 799998877666555543210
Q ss_pred CCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
...++..+++++++||.+||+.||.+|||+.++++
T Consensus 218 -----------------~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 252 (262)
T d1byga_ 218 -----------------KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 252 (262)
T ss_dssp -----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------CCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 11134568899999999999999999999999976
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-49 Score=379.51 Aligned_cols=251 Identities=24% Similarity=0.332 Sum_probs=188.9
Q ss_pred ccceEEeceecccCceEEEEEEEcC-----CCCEEEEEEeeccc-----chHHHHHHHHHHc-CCCCcccccceeeecCC
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCLE-----TGDSVAIKKVLQDK-----RYKNRELQIMRLL-NHPNVVSLKHCFFSTTE 204 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~-----~g~~vaiK~~~~~~-----~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~ 204 (468)
.++|++.+.||+|+||.||+|.+.. +++.||||++.... ....+|..++.++ +|+|||.+++++...
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~-- 89 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-- 89 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST--
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC--
Confidence 3579999999999999999999754 34689999986432 2233566666665 689999998877432
Q ss_pred CCceEEEEEeecccch-HHHHHhhhhh------------cCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCee
Q 012233 205 KDELYLNLVLEYISET-VYRVSKHYTR------------MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLL 271 (468)
Q Consensus 205 ~~~~~~~lv~e~~~~~-ll~~~~~~~~------------~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NIL 271 (468)
...+++|||||+++ +...+..... ....+++..+..++.||+.||.|||+ +|||||||||+|||
T Consensus 90 --~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~-~~ivHrDlKp~NIL 166 (299)
T d1ywna1 90 --GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNIL 166 (299)
T ss_dssp --TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEE
T ss_pred --CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh-CCCcCCcCCcccee
Confidence 23478999999865 4444432211 13458899999999999999999998 99999999999999
Q ss_pred ecCCCCcEEEeeecCccccCCCC---CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhC-CCCCCCCCcHH
Q 012233 272 VNPHTHQLKICDFGSAKMLVPGE---PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLG-QPLFPGESGVD 347 (468)
Q Consensus 272 l~~~~~~vkL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G-~~pf~~~~~~~ 347 (468)
|+.++ .+||+|||+|+...... ......||+.|+|||++.+.. ++.++|||||||++|||++| .+||.+....+
T Consensus 167 l~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~ 244 (299)
T d1ywna1 167 LSEKN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 244 (299)
T ss_dssp ECGGG-CEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred ECCCC-cEEEccCcchhhccccccccccCceeeCccccchhHhhcCC-CCcccceeehHHHHHHHHhCCCCCCCCCCHHH
Confidence 99888 79999999998654332 233467899999999997654 89999999999999999986 57898877666
Q ss_pred HHHHHHHHhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCC
Q 012233 348 QLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (468)
Q Consensus 348 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~h 420 (468)
.+..++.....+ .++..+++++++||.+||+.||.+|||+.|+++|
T Consensus 245 ~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 245 EFCRRLKEGTRM---------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHHHHHHTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHhcCCCC---------------------------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 666655432111 1334588999999999999999999999999986
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-49 Score=383.93 Aligned_cols=251 Identities=22% Similarity=0.280 Sum_probs=200.2
Q ss_pred CcccceEEeceecccCceEEEEEEEcCCCCE--EEEEEeec-----ccchHHHHHHHHHHc-CCCCcccccceeeecCCC
Q 012233 134 KQTISYMAERVVGTGSFGVVFQAKCLETGDS--VAIKKVLQ-----DKRYKNRELQIMRLL-NHPNVVSLKHCFFSTTEK 205 (468)
Q Consensus 134 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~--vaiK~~~~-----~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~ 205 (468)
...++|+++++||+|+||+||+|.++.+|.. ||||.+.. ....+.+|+++|+++ +|||||++++++..
T Consensus 7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~---- 82 (309)
T d1fvra_ 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH---- 82 (309)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE----
T ss_pred cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEec----
Confidence 3456799999999999999999999888775 67777643 233467899999998 79999999999854
Q ss_pred CceEEEEEeecccch-HHHHHhhh------------hhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeee
Q 012233 206 DELYLNLVLEYISET-VYRVSKHY------------TRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLV 272 (468)
Q Consensus 206 ~~~~~~lv~e~~~~~-ll~~~~~~------------~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl 272 (468)
...++|||||++++ +.+++... ......+++..+..++.||+.||.|||+ +||+||||||+|||+
T Consensus 83 -~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~-~~iiHrDlkp~NIL~ 160 (309)
T d1fvra_ 83 -RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARNILV 160 (309)
T ss_dssp -TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEE
T ss_pred -CCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc-CCccccccccceEEE
Confidence 33589999999965 44443221 1234678999999999999999999998 899999999999999
Q ss_pred cCCCCcEEEeeecCccccCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCC-CCCCCCCcHHHHHH
Q 012233 273 NPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQ-PLFPGESGVDQLVE 351 (468)
Q Consensus 273 ~~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~-~pf~~~~~~~~~~~ 351 (468)
+.++ .+||+|||+++............||+.|+|||.+.+.. ++.++|||||||++|||++|. +||.+.+..+.+..
T Consensus 161 ~~~~-~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~ 238 (309)
T d1fvra_ 161 GENY-VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK 238 (309)
T ss_dssp CGGG-CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH
T ss_pred cCCC-ceEEccccccccccccccccceecCCcccchHHhccCC-CCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence 9888 79999999998765555555677899999999997654 899999999999999999965 67877766665554
Q ss_pred HHHHhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCC
Q 012233 352 IIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (468)
Q Consensus 352 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~h 420 (468)
+.+.. ...++..+++++++||.+||+.||++|||+.|+++|
T Consensus 239 i~~~~----------------------------~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 239 LPQGY----------------------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp GGGTC----------------------------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhcC----------------------------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 43210 011335689999999999999999999999999986
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-49 Score=374.75 Aligned_cols=244 Identities=24% Similarity=0.306 Sum_probs=189.0
Q ss_pred cceEEeceecccCceEEEEEEEcC-CC--CEEEEEEeecc-------cchHHHHHHHHHHcCCCCcccccceeeecCCCC
Q 012233 137 ISYMAERVVGTGSFGVVFQAKCLE-TG--DSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD 206 (468)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~-~g--~~vaiK~~~~~-------~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 206 (468)
.+|++.+.||+|+||.||+|++.. ++ ..||||++.++ ...+.+|+.+|+.++|||||++++++. +
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~-----~ 82 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL-----T 82 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----S
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe-----e
Confidence 369999999999999999998743 33 36899987532 124468999999999999999999883 2
Q ss_pred ceEEEEEeecccchH-HHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeec
Q 012233 207 ELYLNLVLEYISETV-YRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG 285 (468)
Q Consensus 207 ~~~~~lv~e~~~~~l-l~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG 285 (468)
. .+++|||||.++. .+... .....+++..+..++.||+.||.|||+ +||+||||||+||||+.++ .+||+|||
T Consensus 83 ~-~~~lv~e~~~~~~l~~~~~---~~~~~l~~~~~~~~~~qi~~gl~ylH~-~~iiHrDikp~NIll~~~~-~vkl~DfG 156 (273)
T d1u46a_ 83 P-PMKMVTELAPLGSLLDRLR---KHQGHFLLGTLSRYAVQVAEGMGYLES-KRFIHRDLAARNLLLATRD-LVKIGDFG 156 (273)
T ss_dssp S-SCEEEEECCTTCBHHHHHH---HHGGGSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEEEETT-EEEECCCT
T ss_pred c-chheeeeeecCcchhhhhh---cccCCCCHHHHHHHHHHHHHHHHHhhh-CCEeeeeecHHHhcccccc-ceeeccch
Confidence 2 2579999998653 33322 224569999999999999999999998 9999999999999999888 89999999
Q ss_pred CccccCCCCC----CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCC
Q 012233 286 SAKMLVPGEP----NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPT 360 (468)
Q Consensus 286 ~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~ 360 (468)
+++....... .....|+..|+|||++.+. .++.++|||||||++|||++ |.+||.+.+..+.+.++.+..
T Consensus 157 l~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~---- 231 (273)
T d1u46a_ 157 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR-TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEG---- 231 (273)
T ss_dssp TCEECCC-CCEEEC-----CCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSC----
T ss_pred hhhhcccCCCcceecCccccCcccCCHHHHhCC-CCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCC----
Confidence 9987754432 2234578899999999765 48999999999999999998 899999988887777665411
Q ss_pred HHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 361 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
..+ ..+..+|+++.+||.+||+.||.+|||+.++++
T Consensus 232 -------------~~~----------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 232 -------------ERL----------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp -------------CCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------CCC----------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 111 133568999999999999999999999999864
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-48 Score=377.62 Aligned_cols=248 Identities=23% Similarity=0.279 Sum_probs=197.4
Q ss_pred ccceEEeceecccCceEEEEEEEc-----CCCCEEEEEEeeccc-----chHHHHHHHHHHcCCCCcccccceeeecCCC
Q 012233 136 TISYMAERVVGTGSFGVVFQAKCL-----ETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEK 205 (468)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~-----~~g~~vaiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 205 (468)
.++|++.+.||+|+||+||+|+++ .+++.||||++.... ..+.+|+.+|+.++||||+++++++..
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~---- 87 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV---- 87 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS----
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeecc----
Confidence 457999999999999999999975 356789999986432 345689999999999999999999843
Q ss_pred CceEEEEEeecccch-HHHHHhhh--------------------hhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccC
Q 012233 206 DELYLNLVLEYISET-VYRVSKHY--------------------TRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRD 264 (468)
Q Consensus 206 ~~~~~~lv~e~~~~~-ll~~~~~~--------------------~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrD 264 (468)
...+++||||+.++ +.+.+... ......+++..+..++.||+.||+|||+ +||||||
T Consensus 88 -~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~-~~ivHrD 165 (301)
T d1lufa_ 88 -GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE-RKFVHRD 165 (301)
T ss_dssp -SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSC
T ss_pred -CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc-CCeEeeE
Confidence 33478999999854 44443221 1123458889999999999999999998 8999999
Q ss_pred CCCCCeeecCCCCcEEEeeecCccccCCCC---CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCC-CCC
Q 012233 265 IKPQNLLVNPHTHQLKICDFGSAKMLVPGE---PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQ-PLF 340 (468)
Q Consensus 265 lkp~NILl~~~~~~vkL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~-~pf 340 (468)
|||+||||+.++ .+||+|||+|+...... ......||+.|+|||++.+.. |+.++|||||||++|||++|. +||
T Consensus 166 lKp~NILld~~~-~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~t~ksDVwS~Gvvl~ell~~~~~p~ 243 (301)
T d1lufa_ 166 LATRNCLVGENM-VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGLQPY 243 (301)
T ss_dssp CSGGGEEECGGG-CEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred EcccceEECCCC-cEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCC-CChhhhhccchhhHHHHHccCCCCC
Confidence 999999999888 79999999998664332 223467899999999997654 999999999999999999985 688
Q ss_pred CCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 341 PGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 341 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
.+.+..+.+..+.... .+ .++..+++++.+||.+||+.||.+|||+.||++
T Consensus 244 ~~~~~~e~~~~v~~~~-------------------~~---------~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 244 YGMAHEEVIYYVRDGN-------------------IL---------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp TTSCHHHHHHHHHTTC-------------------CC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCHHHHHHHHHcCC-------------------CC---------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 8877776666544310 01 134568999999999999999999999999965
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-48 Score=374.76 Aligned_cols=249 Identities=23% Similarity=0.327 Sum_probs=192.0
Q ss_pred cccceEEeceecccCceEEEEEEEcCCC-------CEEEEEEeeccc-----chHHHHHHHHHHc-CCCCcccccceeee
Q 012233 135 QTISYMAERVVGTGSFGVVFQAKCLETG-------DSVAIKKVLQDK-----RYKNRELQIMRLL-NHPNVVSLKHCFFS 201 (468)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~g-------~~vaiK~~~~~~-----~~~~~E~~il~~l-~hpnIv~l~~~~~~ 201 (468)
..++|++++.||+|+||.||+|++..++ ..||||++..+. ....+|...+.++ +|||||++++++
T Consensus 11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~-- 88 (299)
T d1fgka_ 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC-- 88 (299)
T ss_dssp CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE--
T ss_pred cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccc--
Confidence 3457999999999999999999976554 479999986543 2334577888777 799999999999
Q ss_pred cCCCCceEEEEEeecccchHHH-HHhhhh------------hcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCC
Q 012233 202 TTEKDELYLNLVLEYISETVYR-VSKHYT------------RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQ 268 (468)
Q Consensus 202 ~~~~~~~~~~lv~e~~~~~ll~-~~~~~~------------~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~ 268 (468)
.+...+++|||||.++.+. .+.... .....+++..+..++.||+.||+|||+ +|||||||||+
T Consensus 89 ---~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~-~~ivHrDiKp~ 164 (299)
T d1fgka_ 89 ---TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS-KKCIHRDLAAR 164 (299)
T ss_dssp ---CSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGG
T ss_pred ---ccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh-CCEEeeeeccc
Confidence 3444588999999865444 333221 123568999999999999999999998 99999999999
Q ss_pred CeeecCCCCcEEEeeecCccccCCCC---CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 012233 269 NLLVNPHTHQLKICDFGSAKMLVPGE---PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGES 344 (468)
Q Consensus 269 NILl~~~~~~vkL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~~ 344 (468)
|||++.++ .+||+|||+++...... ......||+.|+|||++.+. .|+.++|||||||++|||++ |.+||.+.+
T Consensus 165 NiLl~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~-~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~ 242 (299)
T d1fgka_ 165 NVLVTEDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 242 (299)
T ss_dssp GEEECTTC-CEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred ceeecCCC-CeEeccchhhccccccccccccccCCCChhhhhhhHhcCC-CCCchhhhHHhHHHHHHhccCCCCCCCCCC
Confidence 99999998 79999999998664332 23346789999999999765 49999999999999999998 789998776
Q ss_pred cHHHHHHHHHHhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 345 GVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 345 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
..+.+..+.. ...+ .++..+++++++||.+||+.||++|||+.|+++
T Consensus 243 ~~~~~~~i~~-~~~~---------------------------~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 243 VEELFKLLKE-GHRM---------------------------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHHHHHHHHT-TCCC---------------------------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHc-CCCC---------------------------CCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 5544433322 1110 133568999999999999999999999999986
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-48 Score=373.27 Aligned_cols=251 Identities=24% Similarity=0.312 Sum_probs=201.2
Q ss_pred CcccceEEeceecccCceEEEEEEEc-----CCCCEEEEEEeeccc-----chHHHHHHHHHHc-CCCCcccccceeeec
Q 012233 134 KQTISYMAERVVGTGSFGVVFQAKCL-----ETGDSVAIKKVLQDK-----RYKNRELQIMRLL-NHPNVVSLKHCFFST 202 (468)
Q Consensus 134 ~~~~~y~~~~~lG~G~fg~Vy~~~~~-----~~g~~vaiK~~~~~~-----~~~~~E~~il~~l-~hpnIv~l~~~~~~~ 202 (468)
...++|.+.+.||+|+||.||+|.+. .+++.||||++.... ..+.+|+.+++.+ +|||||++++++.
T Consensus 20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~-- 97 (311)
T d1t46a_ 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT-- 97 (311)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC--
T ss_pred CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEe--
Confidence 34568999999999999999999863 466789999986532 2345799999999 6999999999983
Q ss_pred CCCCceEEEEEeecccchHHH-HHhhhh--------------hcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCC
Q 012233 203 TEKDELYLNLVLEYISETVYR-VSKHYT--------------RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKP 267 (468)
Q Consensus 203 ~~~~~~~~~lv~e~~~~~ll~-~~~~~~--------------~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp 267 (468)
+...++||||||+++.+. .+.... .....+++..+..++.||+.||+|||+ +|||||||||
T Consensus 98 ---~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~-~~ivHrDLKp 173 (311)
T d1t46a_ 98 ---IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS-KNCIHRDLAA 173 (311)
T ss_dssp ---SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSG
T ss_pred ---eCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccccc
Confidence 334488999999865444 332211 123458899999999999999999998 8999999999
Q ss_pred CCeeecCCCCcEEEeeecCccccCCCCC---CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 012233 268 QNLLVNPHTHQLKICDFGSAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGE 343 (468)
Q Consensus 268 ~NILl~~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~-G~~pf~~~ 343 (468)
+|||++.++ .+||+|||+++....... ....+||+.|+|||++.+. .++.++|||||||++|||++ |.+||.+.
T Consensus 174 ~NIl~~~~~-~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DIwS~G~~l~ellt~g~p~~~~~ 251 (311)
T d1t46a_ 174 RNILLTHGR-ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSPYPGM 251 (311)
T ss_dssp GGEEEETTT-EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred ccccccccC-cccccccchheeccCCCcceEeeecccChHHcCHHHhcCC-CCCCcccccchHHHHHHHHhCCCCCCCCC
Confidence 999999888 899999999987654332 2345789999999999754 48999999999999999998 77778777
Q ss_pred CcHHHHHHHHHHhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 344 SGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 344 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
+..+.+.+++.....+ ..+..+++++.+||.+||+.||.+|||+.++++
T Consensus 252 ~~~~~~~~~i~~~~~~---------------------------~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 252 PVDSKFYKMIKEGFRM---------------------------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp CSSHHHHHHHHHTCCC---------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHhcCCCC---------------------------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 7777777766532111 123457899999999999999999999999885
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-47 Score=370.71 Aligned_cols=254 Identities=20% Similarity=0.251 Sum_probs=198.3
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc--cchHHHHHHHHHHcCCCCcccccceeeecCCCCceEEEEEee
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD--KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLE 215 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~--~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv~e 215 (468)
+|++.+.||+|+||+||+|++..+|+.||||++... ...+.+|+++++.++|+|++.++..+... ....++|||
T Consensus 8 rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~----~~~~~ivme 83 (299)
T d1ckia_ 8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAE----GDYNVMVME 83 (299)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEE----TTEEEEEEE
T ss_pred EEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEec----CCEEEEEEE
Confidence 599999999999999999999999999999987543 34567899999999988877666555432 235789999
Q ss_pred cccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCC--CCcEEEeeecCccccCCC
Q 012233 216 YISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPH--THQLKICDFGSAKMLVPG 293 (468)
Q Consensus 216 ~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~--~~~vkL~DFG~a~~~~~~ 293 (468)
|+++++..... .....+++..+..++.|++.||+|||+ +|||||||||+|||++.. ...+||+|||+|+.+...
T Consensus 84 ~~~~~l~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 84 LLGPSLEDLFN---FCSRKFSLKTVLLLADQMISRIEYIHS-KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp CCCCBHHHHHH---HTTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred EcCCchhhhhh---hccCCCcHHHHHHHHHHHHHHHHHHHH-CCeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 99998776543 235679999999999999999999998 999999999999998542 236999999999876433
Q ss_pred C--------CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC---CCCHH
Q 012233 294 E--------PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILG---TPTRE 362 (468)
Q Consensus 294 ~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~---~~~~~ 362 (468)
. ......||+.|+|||++.+.. ++.++|||||||++|||++|..||......+....+..... .++.
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~- 237 (299)
T d1ckia_ 160 RTHQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI- 237 (299)
T ss_dssp TTCCBCCCCBCCSCCCCSSSCCHHHHTTBC-CCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCH-
T ss_pred ccccceeccccCCcCCCccccCHHHHhCCC-CCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCCh-
Confidence 2 223568999999999997655 99999999999999999999999988665554433322110 0100
Q ss_pred HHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHH---HHhCCCCCC
Q 012233 363 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTAL---EACAHPFFD 424 (468)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~---ell~hp~f~ 424 (468)
..+...+|+++.+||.+||+.||.+||++. ++|+|+|.+
T Consensus 238 -----------------------~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 238 -----------------------EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp -----------------------HHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred -----------------------hHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence 113356899999999999999999999987 456777654
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-48 Score=373.49 Aligned_cols=257 Identities=22% Similarity=0.256 Sum_probs=203.4
Q ss_pred CCcccceEEeceecccCceEEEEEEEcC-----CCCEEEEEEeeccc-----chHHHHHHHHHHcCCCCcccccceeeec
Q 012233 133 PKQTISYMAERVVGTGSFGVVFQAKCLE-----TGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFST 202 (468)
Q Consensus 133 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~-----~g~~vaiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l~~~~~~~ 202 (468)
....++|.+.+.||+|+||.||+|.+.. ++..||||++.... ..+.+|+.++++++|||||++++++.
T Consensus 16 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~-- 93 (308)
T d1p4oa_ 16 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS-- 93 (308)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC--
T ss_pred eecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEe--
Confidence 3445679999999999999999998752 35789999986532 22458999999999999999999883
Q ss_pred CCCCceEEEEEeecccchHH-HHHhhhh------hcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCC
Q 012233 203 TEKDELYLNLVLEYISETVY-RVSKHYT------RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPH 275 (468)
Q Consensus 203 ~~~~~~~~~lv~e~~~~~ll-~~~~~~~------~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~ 275 (468)
....+++|||||.++.+ .++.... .....+++..+..++.||+.||.|||+ ++|+||||||+||||+.+
T Consensus 94 ---~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~-~~ivHrDlk~~NiLld~~ 169 (308)
T d1p4oa_ 94 ---QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA-NKFVHRDLAARNCMVAED 169 (308)
T ss_dssp ---SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCSCCSGGGEEECTT
T ss_pred ---cCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh-CCeeeceEcCCceeecCC
Confidence 33347899999986544 3332211 122446888899999999999999998 899999999999999988
Q ss_pred CCcEEEeeecCccccCCCCC---CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhC-CCCCCCCCcHHHHHH
Q 012233 276 THQLKICDFGSAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLG-QPLFPGESGVDQLVE 351 (468)
Q Consensus 276 ~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G-~~pf~~~~~~~~~~~ 351 (468)
+ .+||+|||+++....... .....||+.|+|||.+.+.. ++.++|||||||++|||++| .+||.+.+..+.+..
T Consensus 170 ~-~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~-~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~ 247 (308)
T d1p4oa_ 170 F-TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF 247 (308)
T ss_dssp C-CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHH
T ss_pred c-eEEEeecccceeccCCcceeeccceecccccCCHHHHccCC-CCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 8 799999999976643322 23346899999999997654 89999999999999999998 588888777766665
Q ss_pred HHHHhCCCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC------CCCCCC
Q 012233 352 IIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA------HPFFDD 425 (468)
Q Consensus 352 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~------hp~f~~ 425 (468)
+.+... ...+..+++.+.+||.+||+.||.+|||+.++++ +|+|++
T Consensus 248 i~~~~~----------------------------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~ 299 (308)
T d1p4oa_ 248 VMEGGL----------------------------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE 299 (308)
T ss_dssp HHTTCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHH
T ss_pred HHhCCC----------------------------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcC
Confidence 543110 0123458899999999999999999999999987 676654
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.9e-47 Score=379.22 Aligned_cols=285 Identities=28% Similarity=0.460 Sum_probs=211.1
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeecccc---hHHHHHHHHHHcC-----------CCCcccccceeeecC
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR---YKNRELQIMRLLN-----------HPNVVSLKHCFFSTT 203 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~~---~~~~E~~il~~l~-----------hpnIv~l~~~~~~~~ 203 (468)
+|++++.||+|+||+||+|+++.+|+.||||++.++.. ...+|+.+++.+. |+||+++++++....
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~ 93 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG 93 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeecc
Confidence 59999999999999999999999999999999976542 3457889888875 578999998875433
Q ss_pred CCCceEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCC-----c
Q 012233 204 EKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTH-----Q 278 (468)
Q Consensus 204 ~~~~~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~-----~ 278 (468)
....+.+++++++.++..... .......+++..++.++.||+.||.|||+..||+||||||+||||+.++. .
T Consensus 94 -~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~ 170 (362)
T d1q8ya_ 94 -PNGVHVVMVFEVLGENLLALI--KKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQ 170 (362)
T ss_dssp -TTEEEEEEEECCCCEEHHHHH--HHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred -ccceeeeeeeccccccccccc--ccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccce
Confidence 222233333444444433322 33445678999999999999999999996479999999999999976542 4
Q ss_pred EEEeeecCccccCCCCCCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC------cHHHHHHH
Q 012233 279 LKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGES------GVDQLVEI 352 (468)
Q Consensus 279 vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~------~~~~~~~i 352 (468)
++|+|||.+.... ......+||+.|+|||++.+.. ++.++|+||+||++++|++|+.||.... ..+.+..+
T Consensus 171 ~kl~dfg~s~~~~--~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~ 247 (362)
T d1q8ya_ 171 IKIADLGNACWYD--EHYTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 247 (362)
T ss_dssp EEECCCTTCEETT--BCCCSCCSCGGGCCHHHHHTCC-CCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHH
T ss_pred eeEeecccccccc--cccccccccccccChhhccccC-CCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHH
Confidence 9999999997653 3345678999999999998654 8999999999999999999999997543 34567778
Q ss_pred HHHhCCCCHHHHhhcCCC-------CccCCCCcccCCCcc------cccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 353 IKILGTPTREEIKCMNPN-------YTEFKFPQIKAHPWH------KIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~------~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
+..++.++...+...... .....+......++. ..+....+++++|||.+||.+||.+|||++|+|+
T Consensus 248 ~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~ 327 (362)
T d1q8ya_ 248 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN 327 (362)
T ss_dssp HHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred HHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 888888777655432111 011111111112211 1123345678999999999999999999999999
Q ss_pred CCCCCCCCC
Q 012233 420 HPFFDDLRD 428 (468)
Q Consensus 420 hp~f~~~~~ 428 (468)
||||+++..
T Consensus 328 Hp~f~~~~~ 336 (362)
T d1q8ya_ 328 HPWLKDTLG 336 (362)
T ss_dssp CGGGTTCTT
T ss_pred CcccCCCCC
Confidence 999997643
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-47 Score=368.08 Aligned_cols=245 Identities=20% Similarity=0.249 Sum_probs=189.3
Q ss_pred eEEeceecccCceEEEEEEEcCCC---CEEEEEEeecc-----cchHHHHHHHHHHcCCCCcccccceeeecCCCCceEE
Q 012233 139 YMAERVVGTGSFGVVFQAKCLETG---DSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (468)
Q Consensus 139 y~~~~~lG~G~fg~Vy~~~~~~~g---~~vaiK~~~~~-----~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~ 210 (468)
+...++||+|+||+||+|.+..++ ..||||.+... ...+.+|+++|++++|||||++++++.... ..+
T Consensus 29 ~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~----~~~ 104 (311)
T d1r0pa_ 29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE----GSP 104 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETT----TEE
T ss_pred eccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecC----Cce
Confidence 444688999999999999986644 35899988532 133568999999999999999999875432 357
Q ss_pred EEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCCCcEEEeeecCcccc
Q 012233 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (468)
Q Consensus 211 ~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~~~vkL~DFG~a~~~ 290 (468)
++|||||+++.+..+.. .....+++..+..++.|++.||.|||+ .||+||||||+||||+.++ .+||+|||+++..
T Consensus 105 ~lv~E~~~~g~l~~~~~--~~~~~~~~~~~~~i~~qia~gL~~lH~-~~iiHrDLK~~NILl~~~~-~~kL~DFG~~~~~ 180 (311)
T d1r0pa_ 105 LVVLPYMKHGDLRNFIR--NETHNPTVKDLIGFGLQVAKGMKFLAS-KKFVHRDLAARNCMLDEKF-TVKVADFGLARDM 180 (311)
T ss_dssp EEEEECCTTCBHHHHHH--CTTCCCBHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECTTC-CEEECSSGGGCCT
T ss_pred EEEEEEeecCchhhhhc--cccccchHHHHHHHHHHHHHhhhhhcc-cCcccCCccHHhEeECCCC-CEEEecccchhhc
Confidence 89999999776654332 234557788899999999999999998 8999999999999999887 7999999999876
Q ss_pred CCCCC-----CccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHHhCCCCHHHH
Q 012233 291 VPGEP-----NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQ-LVEIIKILGTPTREEI 364 (468)
Q Consensus 291 ~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~-~~~i~~~~~~~~~~~~ 364 (468)
..... .....||+.|+|||++.+.. ++.++|||||||++|||++|..||........ ...+... ..
T Consensus 181 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g-~~------ 252 (311)
T d1r0pa_ 181 YDKEFDSVHNKTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG-RR------ 252 (311)
T ss_dssp TTTTCCCTTCTTCSSCCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTT-CC------
T ss_pred cccccccceecccccccccccChHHHhcCC-CCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC-CC------
Confidence 44322 22356899999999987554 89999999999999999998777765433322 2222221 00
Q ss_pred hhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhCC
Q 012233 365 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (468)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~h 420 (468)
...++.+++++.+||.+||+.||.+||++.|+++|
T Consensus 253 ---------------------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 253 ---------------------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp ---------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------------CCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 01234578999999999999999999999999987
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.1e-46 Score=359.65 Aligned_cols=248 Identities=18% Similarity=0.212 Sum_probs=198.1
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc--cchHHHHHHHHHHcCC-CCcccccceeeecCCCCceEEEEEe
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD--KRYKNRELQIMRLLNH-PNVVSLKHCFFSTTEKDELYLNLVL 214 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~--~~~~~~E~~il~~l~h-pnIv~l~~~~~~~~~~~~~~~~lv~ 214 (468)
+|++++.||+|+||+||+|++..+|+.||||++... .....+|+++++.|+| +||+.+++++. .....++||
T Consensus 6 ~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~-----~~~~~~~vm 80 (293)
T d1csna_ 6 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQ-----EGLHNVLVI 80 (293)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEE-----ETTEEEEEE
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEee-----cCCccEEEE
Confidence 599999999999999999999999999999987543 3456789999999986 89999988873 344588999
Q ss_pred ecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCC----CCcEEEeeecCcccc
Q 012233 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPH----THQLKICDFGSAKML 290 (468)
Q Consensus 215 e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~----~~~vkL~DFG~a~~~ 290 (468)
||+++++...... ....++...+..++.|++.||+|||+ +||+||||||+|||++.. ...+||+|||+|+..
T Consensus 81 e~~~~~l~~~~~~---~~~~~~~~~~~~i~~q~~~~l~~lH~-~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~ 156 (293)
T d1csna_ 81 DLLGPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHE-KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156 (293)
T ss_dssp ECCCCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred EecCCCHHHHHHh---hccchhhHHHHHHHHHHHHHHHHHHH-CCceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence 9999888775543 34568999999999999999999998 999999999999999642 236999999999876
Q ss_pred CCCC--------CCccccccCCccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcH---HHHHHHHHHhCCC
Q 012233 291 VPGE--------PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGV---DQLVEIIKILGTP 359 (468)
Q Consensus 291 ~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlG~il~ell~G~~pf~~~~~~---~~~~~i~~~~~~~ 359 (468)
.... .....+||+.|||||++.+.. ++.++|||||||++|||++|..||.+.... ..+..+......+
T Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~-~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (293)
T d1csna_ 157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235 (293)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred ccCccccceeecccCceEEchhhcCHHHhcCCC-CChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC
Confidence 4321 233568999999999997654 999999999999999999999999865433 2233333221111
Q ss_pred CHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 360 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
+.. .+.+.+|+++.+++..|+..+|.+||+.+.+.+
T Consensus 236 ~~~------------------------~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 236 PLR------------------------ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp CHH------------------------HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred ChH------------------------HhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 111 123458899999999999999999998776644
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-46 Score=362.05 Aligned_cols=267 Identities=19% Similarity=0.185 Sum_probs=185.1
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeecccch-H--HHHHHHHHHcCCCCcccccceeeecCCCCceEEEEEe
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRY-K--NRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~~~-~--~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~lv~ 214 (468)
+|.+.+.||+|+||.||+|++ +|+.||||++..+... . +.|+..++.++|||||++++++.... .....+|+||
T Consensus 4 ~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~-~~~~~~~lv~ 80 (303)
T d1vjya_ 4 TIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWLVS 80 (303)
T ss_dssp GEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCC-CcceEEEEEE
Confidence 599999999999999999997 7899999998554322 2 23444556789999999999986554 3445688999
Q ss_pred ecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHh-------cCCccccCCCCCCeeecCCCCcEEEeeecCc
Q 012233 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH-------VVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (468)
Q Consensus 215 e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~-------~~givHrDlkp~NILl~~~~~~vkL~DFG~a 287 (468)
|||.++.+..... ...+++..+..++.|++.||.|||. .+|||||||||+||||+.++ .+||+|||++
T Consensus 81 Ey~~~g~L~~~l~----~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~-~~Kl~DFGl~ 155 (303)
T d1vjya_ 81 DYHEHGSLFDYLN----RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIADLGLA 155 (303)
T ss_dssp ECCTTCBHHHHHH----HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTS-CEEECCCTTC
T ss_pred ecccCCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCC-CeEEEecCcc
Confidence 9998754443332 2468999999999999999999995 15999999999999999888 7999999999
Q ss_pred cccCCCC-----CCccccccCCccccccccCCC-----CCCcchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Q 012233 288 KMLVPGE-----PNISYICSRYYRAPELIFGAT-----EYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILG 357 (468)
Q Consensus 288 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~-----~~~~~~DvwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~ 357 (468)
+...... ......||+.|+|||++.+.. .++.++|||||||+||||++|..||......+..... ....
T Consensus 156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~-~~~~ 234 (303)
T d1vjya_ 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD-LVPS 234 (303)
T ss_dssp EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT-TSCS
T ss_pred ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhh-cccc
Confidence 8764433 223467999999999986532 2567899999999999999999887432211000000 0000
Q ss_pred CCCHHHHhhcCCCCccCCCCcccCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhC
Q 012233 358 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (468)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~s~~ell~ 419 (468)
.+......... .....-|.+ ............+.+|+.+||+.||.+|||+.|++.
T Consensus 235 ~~~~~~~~~~~--~~~~~~p~~----~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~ 290 (303)
T d1vjya_ 235 DPSVEEMRKVV--CEQKLRPNI----PNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp SCCHHHHHHHH--TTSCCCCCC----CGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred cchHHHHHHHH--hccccCCCC----CcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 00000000000 000000000 001111223356899999999999999999999876
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.91 E-value=3.4e-25 Score=198.23 Aligned_cols=160 Identities=17% Similarity=0.121 Sum_probs=116.2
Q ss_pred eEEeceecccCceEEEEEEEcCCCCEEEEEEeeccc----------------------chHHHHHHHHHHcCCCCccccc
Q 012233 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK----------------------RYKNRELQIMRLLNHPNVVSLK 196 (468)
Q Consensus 139 y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~~----------------------~~~~~E~~il~~l~hpnIv~l~ 196 (468)
|.+++.||+|+||+||+|.+. +|+.||||++.... ....+|...+..+.|.+++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 568899999999999999974 78999999864211 1113578889999999998876
Q ss_pred ceeeecCCCCceEEEEEeecccchHHHHHhhhhhcCCCCCHHHHHHHHHHHHHHHHHhHhcCCccccCCCCCCeeecCCC
Q 012233 197 HCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHT 276 (468)
Q Consensus 197 ~~~~~~~~~~~~~~~lv~e~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~givHrDlkp~NILl~~~~ 276 (468)
++. . .+++|||+++.... .++...+..++.|++.+|.|||+ +||+||||||+|||++.+
T Consensus 81 ~~~-----~----~~lvme~~~~~~~~----------~l~~~~~~~i~~ql~~~l~~lH~-~giiHrDiKP~NILv~~~- 139 (191)
T d1zara2 81 AWE-----G----NAVLMELIDAKELY----------RVRVENPDEVLDMILEEVAKFYH-RGIVHGDLSQYNVLVSEE- 139 (191)
T ss_dssp EEE-----T----TEEEEECCCCEEGG----------GCCCSCHHHHHHHHHHHHHHHHH-TTEECSCCSTTSEEEETT-
T ss_pred Eec-----C----CEEEEEeecccccc----------chhhHHHHHHHHHHHHHHHHHhh-CCEEEccCChhheeeeCC-
Confidence 543 2 25899999975321 13334467889999999999998 899999999999999965
Q ss_pred CcEEEeeecCccccCCCCCCccccccCCccc------cccccCCCCCCcchhHHHHHHHH
Q 012233 277 HQLKICDFGSAKMLVPGEPNISYICSRYYRA------PELIFGATEYTTAIDMWSIGCVL 330 (468)
Q Consensus 277 ~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~~~~DvwSlG~il 330 (468)
.++|+|||.|......... .|.. .+.+ . ..|+.++|+||+.--+
T Consensus 140 -~~~liDFG~a~~~~~~~~~-------~~l~rd~~~~~~~f-~-r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 140 -GIWIIDFPQSVEVGEEGWR-------EILERDVRNIITYF-S-RTYRTEKDINSAIDRI 189 (191)
T ss_dssp -EEEECCCTTCEETTSTTHH-------HHHHHHHHHHHHHH-H-HHHCCCCCHHHHHHHH
T ss_pred -CEEEEECCCcccCCCCCcH-------HHHHHHHHHHHHHH-c-CCCCCcccHHHHHHHH
Confidence 4999999998754322110 1111 1222 1 2478899999975443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.22 E-value=1.3e-06 Score=79.49 Aligned_cols=78 Identities=15% Similarity=0.134 Sum_probs=51.1
Q ss_pred ceEEeceecccCceEEEEEEEcCCCCEEEEEEeecc----cchHHHHHHHHHHcC-CCCcccccceeeecCCCCceEEEE
Q 012233 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLN-HPNVVSLKHCFFSTTEKDELYLNL 212 (468)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~~----~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~~~~~~l 212 (468)
.|++.+..+.++.+.||+.. ..+..+.+|..... .....+|..+++.|. +--+.+++.+. .+....++
T Consensus 15 ~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~-----~~~~~~~l 87 (263)
T d1j7la_ 15 KYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFE-----RHDGWSNL 87 (263)
T ss_dssp TSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEE-----EETTEEEE
T ss_pred ceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEE-----ecCCceEE
Confidence 47777665556667899876 36777888977543 234568999988875 22244555444 22235789
Q ss_pred EeecccchHH
Q 012233 213 VLEYISETVY 222 (468)
Q Consensus 213 v~e~~~~~ll 222 (468)
||++++|..+
T Consensus 88 v~~~l~G~~~ 97 (263)
T d1j7la_ 88 LMSEADGVLC 97 (263)
T ss_dssp EEECCSSEEH
T ss_pred EEEecccccc
Confidence 9999988644
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.74 E-value=4.9e-05 Score=68.19 Aligned_cols=69 Identities=13% Similarity=0.090 Sum_probs=43.7
Q ss_pred cccC-ceEEEEEEEcCCCCEEEEEEeeccc-chHHHHHHHHHHcCCCC--cccccceeeecCCCCceEEEEEeecccch
Q 012233 146 GTGS-FGVVFQAKCLETGDSVAIKKVLQDK-RYKNRELQIMRLLNHPN--VVSLKHCFFSTTEKDELYLNLVLEYISET 220 (468)
Q Consensus 146 G~G~-fg~Vy~~~~~~~g~~vaiK~~~~~~-~~~~~E~~il~~l~hpn--Iv~l~~~~~~~~~~~~~~~~lv~e~~~~~ 220 (468)
..|. -+.||+... ..+..+.+|...... .....|...++.|.... +.+++.+. .+....++||++++|.
T Consensus 19 ~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~-----~~~~~~~~v~~~i~G~ 91 (255)
T d1nd4a_ 19 TIGCSDAAVFRLSA-QGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVV-----TEAGRDWLLLGEVPGQ 91 (255)
T ss_dssp SCTTSSCEEEEEEC-TTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEE-----ECSSCEEEEEECCSSE
T ss_pred CCcccCCeEEEEEe-CCCCEEEEEeCCccCHhHHHHHHHHHHHHHhcCCCCCceeeec-----ccccceEEEEEeeecc
Confidence 3443 367898874 456678889765433 34677999988875433 44455443 2223467999999763
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.68 E-value=6.2e-05 Score=72.49 Aligned_cols=70 Identities=20% Similarity=0.222 Sum_probs=42.4
Q ss_pred ceecccCceEEEEEEEcCCCCEEEEEEeec-----------ccchHHHHHHHHHHcC-C-C-CcccccceeeecCCCCce
Q 012233 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQ-----------DKRYKNRELQIMRLLN-H-P-NVVSLKHCFFSTTEKDEL 208 (468)
Q Consensus 143 ~~lG~G~fg~Vy~~~~~~~g~~vaiK~~~~-----------~~~~~~~E~~il~~l~-h-p-nIv~l~~~~~~~~~~~~~ 208 (468)
+.||.|....||++.+..+++.|++|.-.. .......|.+.|+.+. + | .+.+++.+ . .+.
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d---~~~- 105 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--D---TEM- 105 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--E---TTT-
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--c---CCC-
Confidence 468999999999998777788899996421 1112345888888774 2 2 34444332 1 111
Q ss_pred EEEEEeecccc
Q 012233 209 YLNLVLEYISE 219 (468)
Q Consensus 209 ~~~lv~e~~~~ 219 (468)
.++|||++++
T Consensus 106 -~~lvmE~L~~ 115 (392)
T d2pula1 106 -AVTVMEDLSH 115 (392)
T ss_dssp -TEEEECCCTT
T ss_pred -CEEEEeccCC
Confidence 3589999975
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.78 E-value=0.0021 Score=61.31 Aligned_cols=68 Identities=19% Similarity=0.246 Sum_probs=45.2
Q ss_pred ceecccCceEEEEEEEcC-------CCCEEEEEEeeccc--chHHHHHHHHHHcCCCCc-ccccceeeecCCCCceEEEE
Q 012233 143 RVVGTGSFGVVFQAKCLE-------TGDSVAIKKVLQDK--RYKNRELQIMRLLNHPNV-VSLKHCFFSTTEKDELYLNL 212 (468)
Q Consensus 143 ~~lG~G~fg~Vy~~~~~~-------~g~~vaiK~~~~~~--~~~~~E~~il~~l~hpnI-v~l~~~~~~~~~~~~~~~~l 212 (468)
+.|+.|-.-.+|++.... ....|.+++..... ....+|..+++.+.-.++ .++++++ .+ ++
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~-----~~----g~ 118 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIF-----SG----GR 118 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEE-----TT----EE
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHHHHHHHHhCCCCCeEEEEc-----CC----ce
Confidence 467888888999988643 34567777764322 334579999998864444 4566555 22 47
Q ss_pred Eeecccc
Q 012233 213 VLEYISE 219 (468)
Q Consensus 213 v~e~~~~ 219 (468)
|+||+.|
T Consensus 119 I~efi~g 125 (395)
T d1nw1a_ 119 LEEYIPS 125 (395)
T ss_dssp EECCCCE
T ss_pred EEEEecc
Confidence 8999876
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.41 E-value=0.0038 Score=57.78 Aligned_cols=68 Identities=15% Similarity=0.009 Sum_probs=39.1
Q ss_pred eEEEEEEEcCCCCEEEEEEeecc---cchHHHHHHHHHHcCCCCc--ccccceeeecCCCCceEEEEEeecccc
Q 012233 151 GVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLLNHPNV--VSLKHCFFSTTEKDELYLNLVLEYISE 219 (468)
Q Consensus 151 g~Vy~~~~~~~g~~vaiK~~~~~---~~~~~~E~~il~~l~hpnI--v~l~~~~~~~~~~~~~~~~lv~e~~~~ 219 (468)
-.||++.. .+|..|++|+.... ...+..|...+..|....| +..+..--........+.+.++++++|
T Consensus 36 N~vy~v~~-~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G 108 (325)
T d1zyla1 36 NRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 108 (325)
T ss_dssp SEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred ceeEEEEc-CCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence 57999974 57888999987543 3445678888887753222 111111000000122346788998875
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.66 E-value=0.025 Score=51.49 Aligned_cols=30 Identities=27% Similarity=0.269 Sum_probs=26.1
Q ss_pred CCccccCCCCCCeeecCCCCcEEEeeecCcc
Q 012233 258 VGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (468)
Q Consensus 258 ~givHrDlkp~NILl~~~~~~vkL~DFG~a~ 288 (468)
.|+||+|+.+.||+++.+. ..-|+||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~~~-v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDE-LSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTE-EEEECCCTTCE
T ss_pred cccccCCcchhhhhccccc-ceeEecccccc
Confidence 4799999999999999775 46799999875
|